Citrus Sinensis ID: 003039
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 854 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.934 | 0.858 | 0.507 | 0.0 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.888 | 0.871 | 0.350 | 1e-130 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.879 | 0.861 | 0.349 | 1e-128 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.896 | 0.860 | 0.347 | 1e-125 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.901 | 0.856 | 0.347 | 1e-124 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.874 | 0.852 | 0.350 | 1e-123 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.853 | 0.839 | 0.368 | 1e-123 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.902 | 0.870 | 0.359 | 1e-122 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.868 | 0.846 | 0.344 | 1e-120 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.885 | 0.858 | 0.334 | 1e-120 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 830 bits (2144), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/817 (50%), Positives = 549/817 (67%), Gaps = 19/817 (2%)
Query: 4 RHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAA 63
R FP D++KYCY+L R RY++R TFLYG + YPKF + L T W+T+ I + +
Sbjct: 75 RDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATVTIQEVS 134
Query: 64 TIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARIN 123
+ V ELI A+S +DVC+ A TG PF+STLELR N S+Y T +ED ++L V+AR+N
Sbjct: 135 RVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLKVAARVN 194
Query: 124 FGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVM 183
FGA + +RYPDDP+DRIWESD K+ NYLV VA GT +++T I+ + E PP KVM
Sbjct: 195 FGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREYPPMKVM 254
Query: 184 QTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVN 243
QTAVVGT G ++YRLNL+ FP A YFAEIE+L +E+RKF+LV P PD S A+VN
Sbjct: 255 QTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVVN 314
Query: 244 IQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYL------ERND 297
I ENA G Y +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL +R+D
Sbjct: 315 IAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRSD 374
Query: 298 GSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNI 357
S+ + ++ S+ +DWA EGGDPC+PV WSW+ C+S P +T I LS KNL G I
Sbjct: 375 VSV----LDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEI 430
Query: 358 PSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417
P + + +L ELWLD N LTG +PD S +L+I+HLE+NQL+G LP L +LPNL+EL
Sbjct: 431 PPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQEL 490
Query: 418 YVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL-----LL 472
++NN G +PS+LL V+ Y N L + KH I+G S+ A +
Sbjct: 491 SIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAILLLLVGG 549
Query: 473 ATVVSCLFMHKGKKNNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLE 531
+ V+ C + + D E + L V + A+ +L +E+AT
Sbjct: 550 SLVLLCALRKTKRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFS 609
Query: 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
KK+G G FG VYYG++KDGKE+AVK+ S R+F EV LLSRIHHRNLV +GYC
Sbjct: 610 KKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYC 669
Query: 592 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 651
+E R +LVYE+MHNG+L +HL+G+ ++ ++W+ RL+IA+DAAKG+EYLHTGC P+II
Sbjct: 670 EEADRRILVYEYMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTGCNPSII 728
Query: 652 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 711
HRD+KSSNILLD +MRAKVSDFGLS+ + +HVSS+ +GTVGYLDPEYY SQQLT+KS
Sbjct: 729 HRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKS 788
Query: 712 DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS 771
DVYSFGV+L EL+SG++ +S E FG NIV WA+ I GD+ GIIDP + I+S
Sbjct: 789 DVYSFGVVLFELLSGKKPVSAEDFGPEL-NIVHWARSLIRKGDVCGIIDPCIASNVKIES 847
Query: 772 MWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 808
+W++ E A CV GH RP + EV+ IQDAI IER
Sbjct: 848 VWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIER 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 465 bits (1197), Expect = e-130, Method: Compositional matrix adjust.
Identities = 300/857 (35%), Positives = 470/857 (54%), Gaps = 98/857 (11%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
TLR+FP D + C+ L+V T+YLI+ TFLYGN+D NV P FD+ +GP W T+ +
Sbjct: 78 TLRYFP-DGVRNCFSLNVTRGTKYLIKPTFLYGNYDGRNVIPDFDLYIGPNMWITVNTDN 136
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
++E++ ++ S + VCL T P+I+TLELR P D Y + S
Sbjct: 137 T----IKEILHVSKSNTLQVCLVKTGTSIPYINTLELR---------PLADDIYTNESGS 183
Query: 122 INF-----GADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDE 176
+N+ ++ + + YPDD DRIW+ L ++ + ++T L I++ +D
Sbjct: 184 LNYLFRVYYSNLKGYIEYPDDVHDRIWK-QILPYQDWQI--------LTTNLQINVSNDY 234
Query: 177 LPPQKVMQTAVVGTNGSLT---YRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPG 233
PQ+VM+TAV S T + NL+ + +FAE++ L +E+R+F +VL
Sbjct: 235 DLPQRVMKTAVTPIKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQANETREFNVVL-- 292
Query: 234 QPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLS----------FKFGKTYDSSRGPL 283
N ++ Y P + + + + + KT S+ PL
Sbjct: 293 -------------NGNVTFKSYSPKFLEMQTVYSTAPKQCDGGKCLLQLVKTSRSTLPPL 339
Query: 284 LNAMEINKYLE--RNDGSIDGV-AIVSVISLY--SSADWAQEGGDPCLPVPWSW--LQCN 336
+NAME L+ + + ++D V AI ++ S Y S W GDPC+P + W L CN
Sbjct: 340 INAMEAYTVLDFPQIETNVDEVIAIKNIQSTYGLSKTTWQ---GDPCVPKKFLWDGLNCN 396
Query: 337 SDPQ---PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRI 392
+ P IT ++LSS LTG I + L++L EL L N+L+G +P+F + L +
Sbjct: 397 NSDDSTPPIITSLNLSSSGLTGIIVLTIQNLANLQELDLSNNNLSGGVPEFLADMKSLLV 456
Query: 393 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGR 452
I+L N L+G +P L+ L+ N L+ TV S ++K+ EGGR
Sbjct: 457 INLSGNNLSGVVPQKLIEKKMLKLNIEGNPKLNCTV-ESCVNKD-----------EEGGR 504
Query: 453 GAKHLNIIIGSSVGAAV-LLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAP 511
K + I I +S+G+ V +A ++ C+ +KNN ++ S P S + P
Sbjct: 505 QIKSMTIPIVASIGSVVAFTVALMIFCVV----RKNNPSNDEAPTS--CMLPADSRSSEP 558
Query: 512 AEAAHC--FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREF 569
FT +++ T +K +G GGFG+VYYG + +++AVK+L+ +S QG ++F
Sbjct: 559 TIVTKNKKFTYAEVLTMTNNFQKILGKGGFGIVYYGSVNGTEQVAVKMLSHSSAQGYKQF 618
Query: 570 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 629
EV LL R+HH+NLV +GYC+E + L+YE+M NG L EH+ G +NW RL
Sbjct: 619 KAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEYMANGDLDEHMSGK-RGGSILNWGTRL 677
Query: 630 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSS 688
+IA +AA+G+EYLH GC P ++HRD+K++NILL++H K++DFGLS+ F ++G +HVS+
Sbjct: 678 KIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFDTKLADFGLSRSFPIEGETHVST 737
Query: 689 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 748
+V GT+GYLDPEYY + LT+KSDVYSFGV+LL +I+ Q I + R+I +W
Sbjct: 738 VVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVMITNQPVIDQNR---EKRHIAEWVGG 794
Query: 749 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE- 807
+ GDI+ I DP+LL +Y+ S+WK E A+ C+ P RP++S+V+ ++++ + E
Sbjct: 795 MLTKGDIKSITDPNLLGDYNSGSVWKAVELAMSCMNPSSMTRPTMSQVVFELKECLASES 854
Query: 808 -REAAAARDGNSDDMSR 823
RE + M+R
Sbjct: 855 SREVSMTFGTEVAPMAR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 459 bits (1181), Expect = e-128, Method: Compositional matrix adjust.
Identities = 297/851 (34%), Positives = 452/851 (53%), Gaps = 100/851 (11%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
T+R FP R CY ++ ++RYLIRATF YGN+D PKFDI +GP+ W+++ +
Sbjct: 81 TVRSFPEGERN-CYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFDIHIGPSKWTSVKLDG 139
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
V E+I + + ++ +CL G PFIS+LELR N + YLT L AR
Sbjct: 140 VGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLT---QSGSLIGFAR 196
Query: 122 INFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQK 181
+ F A + +RY +D DR+W + G + +ST L +D + PQ
Sbjct: 197 VFFSA-TPTFIRYDEDIHDRVW----------VRQFGNGLKSISTDLLVDTSNPYDVPQA 245
Query: 182 VMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSK 239
V +TA V +N S L + LD + +FAEI+ L ++ R+F + G
Sbjct: 246 VAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNITYNG------ 299
Query: 240 AIVNIQENAQGKYRVYEPGYTNLSLPF----------VLSFKFGKTYDSSRGPLLNAMEI 289
Q Y P +S F S F KT +S+ PL+N +EI
Sbjct: 300 --------GQNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGLEI 351
Query: 290 NKYLERNDGSIDGVAIVSVISLYSSADWAQE---GGDPCLPVPWSW--LQC---NSDPQP 341
K L+ + D + ++I++ ++ D +++ GDPC P + W L C NSD QP
Sbjct: 352 YKVLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSD-QP 410
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN-Q 399
I ++L+ LTG I +++KL+ L+EL L N L+G IP+ F+ L++I+L N
Sbjct: 411 RIISLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINLSGNLG 470
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNI 459
L +P S+ + + L + +LS TV +K V L G+ K I
Sbjct: 471 LNSTIPDSIQQRLDSKSLIL---ILSKTV-----TKTVTLK----------GKSKKVPMI 512
Query: 460 IIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFT 519
I +SV A V L +++ F+ + K +K + + +R + T
Sbjct: 513 PIVASV-AGVFALLVILAIFFVVRRKNGESNKGTNPSIITKERRI--------------T 557
Query: 520 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 579
++ T E+ +G GGFG VY+G L+D ++AVK+L+ +S QG +EF EV LL R+
Sbjct: 558 YPEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVKMLSHSSAQGYKEFKAEVELLLRV 616
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
HHRNLV +GYC + L+YE+M NG LKE++ G + W R++IA +AA+G+
Sbjct: 617 HHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGK-RGGNVLTWENRMQIAVEAAQGL 675
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 698
EYLH GC P ++HRD+K++NILL++ AK++DFGLS+ F VDG SHVS++V GT GYLD
Sbjct: 676 EYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGTPGYLD 735
Query: 699 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758
PEYY + L++KSDVYSFGV+LLE+++ Q + +I +W + GDI+ I
Sbjct: 736 PEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTR---ERTHINEWVGSMLTKGDIKSI 792
Query: 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNS 818
+DP L+ +YD WKI E AL CV P + RP+++ V+ ++ + + +E A R G
Sbjct: 793 LDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVTELNECVALEN---ARRQG-- 847
Query: 819 DDMSRNSLHSS 829
R +H+S
Sbjct: 848 ----REEMHTS 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 451 bits (1160), Expect = e-125, Method: Compositional matrix adjust.
Identities = 302/868 (34%), Positives = 454/868 (52%), Gaps = 102/868 (11%)
Query: 3 LRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDA 62
+R FP R CY +++ +YLIR TF+YGN+D N +P FD+ +GP WS++ I
Sbjct: 82 VRSFPVGQRN-CYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDLHIGPNKWSSVKILGV 140
Query: 63 ATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARI 122
+ E+I + ++VCL PFIS+LE+R N YLT L + AR+
Sbjct: 141 TNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYLT---QSGSLMLFARV 197
Query: 123 NFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKV 182
F + S + +RY +D DR+W S + + T +ST LPID + PQ V
Sbjct: 198 YFPSSSSSFIRYDEDIHDRVWNSFTDDE----------TVWISTDLPIDTSNSYDMPQSV 247
Query: 183 MQTAVVGTNGSLTYRL--NLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKA 240
M+TA V N S + L LD + +FAE+++L +E+R+F
Sbjct: 248 MKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREF------------- 294
Query: 241 IVNIQENAQGKYRVY-EPGYTNLSLPF----------VLSFKFGKTYDSSRGPLLNAMEI 289
NI N ++ Y P ++S F + +F F T +S+ PLLNA+EI
Sbjct: 295 --NITYNGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEI 352
Query: 290 NKY-----LERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW--LQCN-SDPQP 341
LE N + A++++ Y + GDPC P + W L C+ D +
Sbjct: 353 YTVVDILQLETNKDEVS--AMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEG 410
Query: 342 S-ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
S I ++L+ LTG+I SD++KL+ L L L N L+G IP F+ L++I+L N
Sbjct: 411 SRIISLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGN- 469
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL----SKNVVLNYAGNINLHEGGRGAK 455
PNL N+ + +P SL SK++ L N+ L K
Sbjct: 470 ------------PNL-------NLTA--IPDSLQQRVNSKSLTLILGENLTLTPKKESKK 508
Query: 456 HLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLP--------VQRPVSSL 507
+ I +SV A V L +++ F+ K K + + H+ P V+ S
Sbjct: 509 VPMVAIAASV-AGVFALLVILAIFFVIKRK----NVKAHKSPGPPPLVTPGIVKSETRSS 563
Query: 508 NDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKR 567
N + T ++ T E+ +G GGFG VY+G L DG E+AVK+L+ +S QG +
Sbjct: 564 NPSIITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYK 622
Query: 568 EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 627
EF EV LL R+HHR+LV +GYC + L+YE+M NG L+E++ G + W
Sbjct: 623 EFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGK-RGGNVLTWEN 681
Query: 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHV 686
R++IA +AA+G+EYLH GC P ++HRD+K++NILL++ AK++DFGLS+ F +DG HV
Sbjct: 682 RMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHV 741
Query: 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 746
S++V GT GYLDPEYY + L++KSDVYSFGV+LLE+++ Q I + +I W
Sbjct: 742 STVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTR---ERPHINDWV 798
Query: 747 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806
+ GDI+ I+DP L+ +YD WKI E AL CV P + RP+++ V+ ++ D + +
Sbjct: 799 GFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVAL 858
Query: 807 EREAAAARDGNSDDMSRNSLHSSLNVGS 834
E A R G+ + S S+ SL+ S
Sbjct: 859 EN---ARRQGSEEMYSMGSVDYSLSSTS 883
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1148), Expect = e-124, Method: Compositional matrix adjust.
Identities = 301/867 (34%), Positives = 449/867 (51%), Gaps = 97/867 (11%)
Query: 1 MTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVIS 60
+ LR+FP D + CY L+V T YLI+A F+YGN+D N P FD+ LGP W T+ ++
Sbjct: 84 LKLRYFP-DGFRNCYTLNVTQDTNYLIKAVFVYGNYDGLNNPPSFDLYLGPNLWVTVDMN 142
Query: 61 DAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLT-----PFEDRYY 115
++E+I S + VCL T P I+TLELR + Y T + RYY
Sbjct: 143 GRTNGTIQEIIHKTISKSLQVCLVKTGTSSPMINTLELRPLKNNTYNTQSGSLKYFFRYY 202
Query: 116 LSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSD 175
S S + +RYPDD DR W D TE ++T L I+ +
Sbjct: 203 FSGSGQ---------NIRYPDDVNDRKWYP--------FFDAKEWTE-LTTNLNINSSNG 244
Query: 176 ELPPQKVMQTAV--VGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPG 233
PP+ VM +A + T G+ + L + +FAEI+ L ++R+F++ L
Sbjct: 245 YAPPEVVMASASTPISTFGTWNFSWLLPSSTTQFYVYMHFAEIQTLRSLDTREFKVTL-- 302
Query: 234 QPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLS----------FKFGKTYDSSRGPL 283
N + Y Y P F + + KT S+ PL
Sbjct: 303 -------------NGKLAYERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPL 349
Query: 284 LNAMEINKYL---ERNDGSIDGVAIVSVISLY--SSADWAQEGGDPCLPVPWSW--LQCN 336
+NA+E+ + + D AI S+ S Y S W GDPC+P + W L CN
Sbjct: 350 MNALEVFTVIDFPQMETNPDDVAAIKSIQSTYGLSKISWQ---GDPCVPKQFLWEGLNCN 406
Query: 337 ----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLR 391
S P P +T ++LSS +LTG I + L+ L EL L N+LTG IP+F + L
Sbjct: 407 NLDNSTP-PIVTSLNLSSSHLTGIIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLL 465
Query: 392 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGG 451
+I+L N G +P L+ L+ + N L + + +N AGN
Sbjct: 466 VINLSGNNFNGSIPQILLQKKGLKLILEGNANL-------ICPDGLCVNKAGN------- 511
Query: 452 RGAKHLNIIIG--SSVGAAVLL---LATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSS 506
GAK +N++I +SV V+L LA + + V R + S
Sbjct: 512 GGAKKMNVVIPIVASVAFVVVLGSALAFFFIFKKKKTSNSQDLGPSSYTQVSEV-RTIRS 570
Query: 507 LNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 566
A FT S++ T E+ +G GGFG+VY+G + + +++AVK+L+ +S QG
Sbjct: 571 SESAIMTKNRRFTYSEVVTMTNNFERVLGKGGFGMVYHGTVNNTEQVAVKMLSHSSSQGY 630
Query: 567 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 626
+EF EV LL R+HH+NLV +GYC E L+YE+M NG L+EH+ G +NW
Sbjct: 631 KEFKAEVELLLRVHHKNLVGLVGYCDEGENLALIYEYMANGDLREHMSGK-RGGSILNWE 689
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASH 685
RL+I ++A+G+EYLH GC P ++HRD+K++NILL++H+ AK++DFGLS+ F ++G +H
Sbjct: 690 TRLKIVVESAQGLEYLHNGCKPPMVHRDVKTTNILLNEHLHAKLADFGLSRSFPIEGETH 749
Query: 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 745
VS++V GT GYLDPEYY + L +KSDVYSFG++LLE+I+ Q I+ + +I +W
Sbjct: 750 VSTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQLVINQSR---EKPHIAEW 806
Query: 746 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805
L + GDIQ I+DP L +YD S+W+ E A+ C+ P RP++S+V+ ++ + +
Sbjct: 807 VGLMLTKGDIQNIMDPKLYGDYDSGSVWRAVELAMSCLNPSSARRPTMSQVVIELNECLS 866
Query: 806 IEREAAAARDGNSDDM-SRNSLHSSLN 831
E AR G S +M S +S+ S+N
Sbjct: 867 YEN----ARGGTSQNMNSESSIEVSMN 889
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 444 bits (1141), Expect = e-123, Method: Compositional matrix adjust.
Identities = 291/830 (35%), Positives = 449/830 (54%), Gaps = 83/830 (10%)
Query: 3 LRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDA 62
LR FP R CY + + +YLIR TF+YGN+D N P FD+ +GP W+++ I
Sbjct: 78 LRSFPEGQRN-CYNFSLTAKRKYLIRGTFIYGNYDGLNQLPSFDLYIGPNKWTSVSIPGV 136
Query: 63 ATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARI 122
V E+I + + +CL PFIS+LELR N + Y+T L V AR+
Sbjct: 137 RNGSVSEMIHVLRQDHLQICLVKTGETTPFISSLELRPLNNNTYVTKSGS---LIVVARL 193
Query: 123 NFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKV 182
F + + +RY +D DRIW L N L +ST+L +D + PQ V
Sbjct: 194 YF-SPTPPFLRYDEDVHDRIW-IPFLDNKNSL---------LSTELSVDTSNFYNVPQTV 242
Query: 183 MQTAVVGTNGSLTYRLN--LDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKA 240
+TA V N + ++N LD + +FAEIE+L+ +E+R+F + G
Sbjct: 243 AKTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLEANETREFNITYNG------- 295
Query: 241 IVNIQENAQGKYR--------VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 292
EN +R VY P + SL +F F T +S+ PL+N +EI +
Sbjct: 296 ----GENWFSYFRPPKFRITTVYNPAAVS-SLDGNFNFTFSMTGNSTHPPLINGLEIYQV 350
Query: 293 LE--RNDGSIDGV-AIVSVISLYSSADWAQEGGDPCLPVPWSW--LQC---NSDPQPSIT 344
LE + D D V A++++ ++Y + + GDPC P + W L C N P P I
Sbjct: 351 LELPQLDTYQDEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLNCSYPNFAP-PQII 409
Query: 345 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGP 403
++LS NL+G I SD++KL+ L EL L N L+G IP FS +L +I+L N+
Sbjct: 410 SLNLSGSNLSGTITSDISKLTHLRELDLSNNDLSGDIPFVFSDMKNLTLINLSGNK---- 465
Query: 404 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGS 463
L+ +VP +L + + N + + E G+ + ++ + I +
Sbjct: 466 -------------------NLNRSVPETLQKR--IDNKSLTLIRDETGKNSTNV-VAIAA 503
Query: 464 SVGA--AVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLS 521
SV + AVL++ +V + K + N + + V+ S + + FT S
Sbjct: 504 SVASVFAVLVILAIVFVVIRKKQRTNEASGPRSFTTGTVKSDARSSSSSIITKERKFTYS 563
Query: 522 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 581
++ TK E+ +G GGFG VY+G L D ++AVK+L+ +S QG +EF EV LL R+HH
Sbjct: 564 EVLKMTKNFERVLGKGGFGTVYHGNLDD-TQVAVKMLSHSSAQGYKEFKAEVELLLRVHH 622
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI-NWIKRLEIAEDAAKGIE 640
R+LV +GYC + L+YE+M G L+E++ G H + +W R++IA +AA+G+E
Sbjct: 623 RHLVGLVGYCDDGDNLALIYEYMEKGDLRENMSG--KHSVNVLSWETRMQIAVEAAQGLE 680
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 699
YLH GC P ++HRD+K +NILL++ +AK++DFGLS+ F VDG SHV ++V GT GYLDP
Sbjct: 681 YLHNGCRPPMVHRDVKPTNILLNERSQAKLADFGLSRSFPVDGESHVMTVVAGTPGYLDP 740
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759
EYY + L++KSDVYSFGV+LLE+++ Q ++ + +I +W + +GDI+ I+
Sbjct: 741 EYYRTNWLSEKSDVYSFGVVLLEIVTNQPVMNKNR---ERPHINEWVMFMLTNGDIKSIV 797
Query: 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIERE 809
DP L ++YD +WK+ E AL CV P RP++ V+ ++ + + +E E
Sbjct: 798 DPKLNEDYDTNGVWKVVELALACVNPSSSRRPTMPHVVMELNECLALEIE 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 306/831 (36%), Positives = 441/831 (53%), Gaps = 102/831 (12%)
Query: 3 LRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTI--VIS 60
LR+FP D + CY L V T+YLIR F YGN+D N P+FD+ LGP W+++ +I+
Sbjct: 82 LRYFP-DGIRNCYSLSVKQGTKYLIRTLFYYGNYDGLNTSPRFDLFLGPNIWTSVDVLIA 140
Query: 61 DAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSA 120
D V E++ + S +D+CL T P IS +ELR Y L A
Sbjct: 141 DVGDGVVEEIVHVTRSNILDICLVKTGTSTPMISAIELRPLRYDTYTARTGS---LKSMA 197
Query: 121 RINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDEL-PP 179
F EA +RYP+D +DR+W S + +++T + SD PP
Sbjct: 198 HFYFTNSDEA-IRYPEDVYDRVWMPYSQPEWT----------QINTTRNVSGFSDGYNPP 246
Query: 180 QKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDV 237
Q V+QTA + TNGS LT+ NL+ +A +FAEI+ L +E+R+F+++ G +
Sbjct: 247 QGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFFAEIQQLKVNETREFKILANGVDYI 306
Query: 238 SKAIVNIQENAQGKYRVYEPGYTNLSLPF-------VLSFKFGKTYDSSRGPLLNAMEIN 290
Y ++ LS P V + KT S+ PL+NA+EI
Sbjct: 307 D-------------YTPWKFEARTLSNPAPLKCEGGVCRVQLSKTPKSTLPPLMNAIEIF 353
Query: 291 KYLE--RNDGSIDGV-AIVSVISLY--SSADWAQEGGDPCLPVPWSWL--QCN----SDP 339
++ ++D + D V AI + S Y S W GDPC+P +SW+ CN S P
Sbjct: 354 SVIQFPQSDTNTDEVIAIKKIQSTYQLSRISWQ---GDPCVPKQFSWMGVSCNVIDISTP 410
Query: 340 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDN 398
P I + LS LTG I + L+ L EL L N+LTG +P+F + L +IHL N
Sbjct: 411 -PRIISLDLSLSGLTGVISPSIQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGN 469
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKH-- 456
L G +P +L + RE KN L + N+ G+
Sbjct: 470 NLRGSVPQALQD----RE------------------KNDGLKLFVDPNITRRGKHQPKSW 507
Query: 457 LNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAH 516
L I+ S AV ++ V+ +F+ + +K++ K V RP + +
Sbjct: 508 LVAIVASISCVAVTIIVLVL--IFIFRRRKSSTRK--------VIRPSLEMKN------R 551
Query: 517 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLL 576
F S++++ T E +G GGFGVVY+G L + +++AVKVL+ +S QG +EF EV LL
Sbjct: 552 RFKYSEVKEMTNNFEVVLGKGGFGVVYHGFL-NNEQVAVKVLSQSSTQGYKEFKTEVELL 610
Query: 577 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 636
R+HH NLV +GYC E L+YEFM NG LKEHL G +NW RL+IA ++A
Sbjct: 611 LRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGK-RGGSVLNWSSRLKIAIESA 669
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVG 695
GIEYLH GC P ++HRD+KS+NILL AK++DFGLS+ F V +HVS+ V GT+G
Sbjct: 670 LGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLG 729
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755
YLDPEYY+ LT+KSDVYSFG++LLE I+GQ I + + IV+WAK + +GDI
Sbjct: 730 YLDPEYYLKNWLTEKSDVYSFGIVLLESITGQPVIEQSR---DKSYIVEWAKSMLANGDI 786
Query: 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806
+ I+DP+L +YD S WK E A++C+ P RP+++ V ++ + + I
Sbjct: 787 ESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI 837
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 305/848 (35%), Positives = 454/848 (53%), Gaps = 77/848 (9%)
Query: 3 LRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVIS-- 60
LR+FP R CY L V T+YLIR F YGN+D N P+FD+ LGP W+++ +
Sbjct: 83 LRYFPEGIRN-CYSLSVKQGTKYLIRTLFFYGNYDGLNTSPRFDLFLGPNIWTSVDVQKV 141
Query: 61 DAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSA 120
D + E+I + +D+CL T P IS +ELR Y S+
Sbjct: 142 DGGDGVIEEIIHVTRCNILDICLVKTGTTTPMISAIELRPLRYDTYTARTG-----SLKK 196
Query: 121 RINF-GADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDEL-P 178
++F +S VRYP+D +DR+W S + +++T + SD P
Sbjct: 197 ILHFYFTNSGKEVRYPEDVYDRVWIPHSQPEWT----------QINTTRNVSGFSDGYNP 246
Query: 179 PQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPD 236
PQ V++TA + TN S LT+ + +A YFAEI+ L +E+R+F++++ G
Sbjct: 247 PQDVIKTASIPTNVSEPLTFTWMSESSDDETYAYLYFAEIQQLKANETRQFKILVNG--- 303
Query: 237 VSKAIVNIQENAQGKYRVYEPGYTNLSLPF---VLSFKFGKTYDSSRGPLLNAMEINKYL 293
V + K+ E T +L V + KT S+ P +NA+EI +
Sbjct: 304 -----VYYIDYIPRKFEA-ETLITPAALKCGGGVCRVQLSKTPKSTLPPQMNAIEIFSVI 357
Query: 294 E--RNDGSIDGV-AIVSVISLY--SSADWAQEGGDPCLPVPWSWL--QCN----SDPQPS 342
+ ++D + D V AI ++ S Y S W GDPC+P+ +SW+ CN S P P
Sbjct: 358 QFPQSDTNTDEVIAIKNIQSTYKVSRISWQ---GDPCVPIQFSWMGVSCNVIDISTP-PR 413
Query: 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLT 401
I + LSS LTG I + L+ L EL L N+LTG IP LR + L +N LT
Sbjct: 414 IISLDLSSSGLTGVITPSIQNLTMLRELDLSNNNLTGVIPPSLQNLTMLRELDLSNNNLT 473
Query: 402 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIII 461
G +P L + L ++++ N L G+VP +L + N G + L G K + I
Sbjct: 474 GEVPEFLATIKPLLVIHLRGNNLRGSVPQALQDRE---NNDG-LKLLRGKHQPKSWLVAI 529
Query: 462 GSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLS 521
+S+ + + +V +F+ + +K++ K V RP + + F S
Sbjct: 530 VASISCVAVTIIVLV-LIFIFRRRKSSTRK--------VIRPSLEMKN------RRFKYS 574
Query: 522 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 581
++++ T E +G GGFGVVY+G L + +++AVKVL+ +S QG +EF EV LL R+HH
Sbjct: 575 EVKEMTNNFEVVLGKGGFGVVYHGFL-NNEQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 633
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
NLV +GYC + L+YEFM NG LKEHL G +NW RL+IA ++A GIEY
Sbjct: 634 VNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGK-RGGPVLNWPGRLKIAIESALGIEY 692
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 700
LH GC P ++HRD+KS+NILL AK++DFGLS+ F V +HVS+ V GT+GYLDPE
Sbjct: 693 LHIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPE 752
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760
YY LT+KSDVYSFG++LLE+I+GQ I + + IV+WAK + +GDI+ I+D
Sbjct: 753 YYQKNWLTEKSDVYSFGIVLLEIITGQPVIEQSR---DKSYIVEWAKSMLANGDIESIMD 809
Query: 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDD 820
+L +YD S WK E A++C+ P +RP+++ V ++ + + I R +
Sbjct: 810 RNLHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEIYN--LTKRRSQDQN 867
Query: 821 MSRNSLHS 828
S++S H+
Sbjct: 868 SSKSSGHT 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 434 bits (1115), Expect = e-120, Method: Compositional matrix adjust.
Identities = 293/851 (34%), Positives = 453/851 (53%), Gaps = 109/851 (12%)
Query: 3 LRHFPADSRKYCYKLDVITRT--RYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVIS 60
+R FP + +K CY + +YLIR F+YGN+DN P FD+ LG W ++ +
Sbjct: 83 VRSFP-EGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGVNLWDSVTLE 141
Query: 61 DAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSA 120
++ TI +E+I+ S K+ VCL + G PF+S LELR ++Y T + L +
Sbjct: 142 NSTTIVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELRLLKNNIYETASDS---LMLYR 198
Query: 121 RINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDE--LP 178
R + GA + P RY DD FDR W L N+L+ ++T L ID S LP
Sbjct: 199 RWDLGATGDLPARYKDDIFDRFWMP--LMFPNFLI--------LNTSLMIDPTSSNGFLP 248
Query: 179 PQKVMQTAVVGTNGS----LTYRLNLDGFPGFGWAV-TYFAEIEDLDPDESRKFRLVLPG 233
P VM TAV N S + Y D P + + + +FAE+E L +E+R+F + L
Sbjct: 249 PSVVMSTAVAPMNSSIEQIMVYWEPRD--PNWKFYIYIHFAEVEKLPSNETREFSVFL-- 304
Query: 234 QPDVSKAIVNIQENAQGKYRVYEPGYTN--LSLPFVLSFKFGKTYDSSRGPLLNAMEI-- 289
+K ++ + Y + Y +S PF L F + S+R P++NA+E
Sbjct: 305 ----NKEQIDTTSVFRPSYLYTDTLYVQNPVSGPF-LEFVLRQGVKSTRPPIMNAIETYR 359
Query: 290 -NKYLERNDGSIDGVAIVSVISLYSSA-DWAQEGGDPCLPV--PWSWLQCN--SDPQPSI 343
N++L+ D AI+ + + Y +W GDPC P PW + C+ ++ P I
Sbjct: 360 TNEFLDLPTDQNDVDAIMKIKTKYKVKKNWL---GDPCAPFGYPWQGINCSYTANNPPRI 416
Query: 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 403
++LS LTG I P F L+ + L +N+LTG
Sbjct: 417 ISVNLSFSGLTGQID-----------------------PVFITLTPLQKLDLSNNRLTGT 453
Query: 404 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN----VVLNYAGNINL--HEGGRGAK-- 455
+P L NLP+L EL ++ N L+G +P LL ++ + L GN +L + R K
Sbjct: 454 VPDFLANLPDLTELNLEENKLTGILPEKLLERSKDGSLSLRVGGNPDLCVSDSCRNKKTE 513
Query: 456 ---HLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPA 512
++ + S G LLLA + F + + S+ P
Sbjct: 514 RKEYIIPSVASVTGLFFLLLALISFWQFKKRQQ--------------------SVKTGPL 553
Query: 513 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE 572
+ + S+I + T E+ +G GGFG VYYG L+ G+++A+K+L+ +S QG +EF E
Sbjct: 554 DTKRYYKYSEIVEITNNFERVLGQGGFGKVYYGVLR-GEQVAIKMLSKSSAQGYKEFRAE 612
Query: 573 VTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 632
V LL R+HH+NL+ +GYC E + L+YE++ NGTL ++L G + ++W +RL+I+
Sbjct: 613 VELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLSGK--NSSILSWEERLQIS 670
Query: 633 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVR 691
DAA+G+EYLH GC P I+HRD+K +NIL+++ ++AK++DFGLS+ F ++G S VS+ V
Sbjct: 671 LDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFGLSRSFTLEGDSQVSTEVA 730
Query: 692 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 751
GT+GYLDPE+Y QQ ++KSDVYSFGV+LLE+I+GQ IS + N R+I L +
Sbjct: 731 GTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRSRTEEN-RHISDRVSLMLS 789
Query: 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA 811
GDI+ I+DP L + ++ WKI E AL C R ++S+V+ ++++++ R +
Sbjct: 790 KGDIKSIVDPKLGERFNAGLAWKITEVALACASESTKTRLTMSQVVAELKESLCRARTS- 848
Query: 812 AARDGNSDDMS 822
G+S D+S
Sbjct: 849 ----GDSGDIS 855
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1115), Expect = e-120, Method: Compositional matrix adjust.
Identities = 289/865 (33%), Positives = 455/865 (52%), Gaps = 109/865 (12%)
Query: 3 LRHFPADSRKYCYKLDVITRT--RYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVIS 60
+R FP +R CY + +YLIR F+YGN+DN P FD+ LG W ++ I
Sbjct: 84 VRSFPEGNRN-CYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGFNIWDSVTID 142
Query: 61 DAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSA 120
+A TI +E+I S + VCL + G PF+S LE+R + Y TP++ L +
Sbjct: 143 NATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKSNTYETPYDS---LILFK 199
Query: 121 RINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDE--LP 178
R + G PVRY DD FDRIW L+ Y + + L ID ++E P
Sbjct: 200 RWDLGGLGALPVRYKDDVFDRIWIP--LRFPKYTI--------FNASLTIDSNNNEGFQP 249
Query: 179 PQKVMQTAVVGTNGSLTYRLNLD-GFPGFGWAV-TYFAEIEDLDPDESRKFRLVLPGQPD 236
+ VM TA + S + + P + + V +FAE+ +L +E+R+F+++L
Sbjct: 250 ARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKVLL----- 304
Query: 237 VSKAIVNIQENAQGKYRVYEPGYTNLSLPFV--------LSFKFGKTYDSSRGPLLNAME 288
++ +N+ + P Y FV L F+ +T S+ P++NA+E
Sbjct: 305 -NEKEINMSS--------FSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIE 355
Query: 289 ---INKYLERNDGSIDGVAIVSVISLYS-SADWAQEGGDPCLPV--PWSWLQCN--SDPQ 340
+N++L+ D AI+ + S Y W GDPC PV PW + C+ +
Sbjct: 356 TYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWL---GDPCAPVKYPWKDINCSYVDNES 412
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
P I ++LSS LTG I + + L+ L I+ L +N L
Sbjct: 413 PRIISVNLSSSGLTGEIDAAFSNLTLL-----------------------HILDLSNNSL 449
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN----VVLNYAGNINLHEGG----- 451
TG +P L NL NL EL ++ N LSG +P LL ++ ++L GN +L
Sbjct: 450 TGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRIDGNPDLCVSASCQIS 509
Query: 452 --RGAKHLNII--IGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSL 507
+ K++ II + S VG L+LA + L+ K++HR +
Sbjct: 510 DEKTKKNVYIIPLVASVVGVLGLVLAIALFLLY----------KKRHRRG-----GSGGV 554
Query: 508 NDAPAEAA-HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 566
P + + S++ T E+ +G GGFG VY+G L D ++AVK+L+ +S QG
Sbjct: 555 RAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLND-DQVAVKILSESSAQGY 613
Query: 567 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 626
+EF EV LL R+HH+NL +GYC E + L+YEFM NGTL ++L G ++ ++W
Sbjct: 614 KEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEKSYV--LSWE 671
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASH 685
+RL+I+ DAA+G+EYLH GC P I+ RD+K +NIL+++ ++AK++DFGLS+ A+DG +
Sbjct: 672 ERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQ 731
Query: 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 745
++ V GT+GYLDPEY+++Q+L++KSD+YSFGV+LLE++SGQ I+ + A +I
Sbjct: 732 DTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHITDR 791
Query: 746 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805
L + +GDI+GI+DP L + +D S WKI E A+ C RP++S V+ ++++++
Sbjct: 792 VDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSKNRPTMSHVVAELKESVS 851
Query: 806 IEREAAAARDGNSDDMSRNSLHSSL 830
R + + D + + S +
Sbjct: 852 RARAGGGSGASSVTDPAMTNFDSGM 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 854 | ||||||
| 224068652 | 924 | predicted protein [Populus trichocarpa] | 0.997 | 0.922 | 0.824 | 0.0 | |
| 356570730 | 936 | PREDICTED: probable LRR receptor-like se | 0.996 | 0.909 | 0.808 | 0.0 | |
| 224138590 | 921 | predicted protein [Populus trichocarpa] | 0.996 | 0.923 | 0.819 | 0.0 | |
| 356503698 | 937 | PREDICTED: probable LRR receptor-like se | 0.996 | 0.908 | 0.799 | 0.0 | |
| 255568426 | 900 | Nodulation receptor kinase precursor, pu | 0.968 | 0.918 | 0.808 | 0.0 | |
| 297741494 | 924 | unnamed protein product [Vitis vinifera] | 0.997 | 0.922 | 0.802 | 0.0 | |
| 225439769 | 927 | PREDICTED: probable LRR receptor-like se | 0.997 | 0.919 | 0.800 | 0.0 | |
| 357510569 | 932 | Leucine-rich repeat receptor-like protei | 0.998 | 0.915 | 0.787 | 0.0 | |
| 449440057 | 897 | PREDICTED: probable LRR receptor-like se | 0.969 | 0.923 | 0.780 | 0.0 | |
| 147780497 | 879 | hypothetical protein VITISV_001651 [Viti | 0.970 | 0.943 | 0.756 | 0.0 |
| >gi|224068652|ref|XP_002326166.1| predicted protein [Populus trichocarpa] gi|222833359|gb|EEE71836.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1474 bits (3815), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 705/855 (82%), Positives = 780/855 (91%), Gaps = 3/855 (0%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
T+RHFPADSRKYCY+LDV +RTRYL+RATFLYGNFD+NNVYPKFDIS+GPTHWSTIVISD
Sbjct: 71 TVRHFPADSRKYCYRLDVTSRTRYLLRATFLYGNFDSNNVYPKFDISVGPTHWSTIVISD 130
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
A TIE ELIFLASS + VCLSNATTGQPFISTLELRQFNGSVY T FE+++YLS+SAR
Sbjct: 131 ANTIESTELIFLASSSSMSVCLSNATTGQPFISTLELRQFNGSVYYTEFENQFYLSMSAR 190
Query: 122 INFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQK 181
INFGAD+EAP+RYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PID+ DE PP++
Sbjct: 191 INFGADNEAPIRYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPIDVNIDERPPER 250
Query: 182 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 241
VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDP+ESRKFRLVLPG PD+SKAI
Sbjct: 251 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPEESRKFRLVLPGYPDMSKAI 310
Query: 242 VNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID 301
VNI+ENAQGKYR+YEPGYTNLSLPFVLSF+FGKT DSSRGPL+NAMEI+KYLE+NDG++D
Sbjct: 311 VNIEENAQGKYRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLVNAMEIHKYLEKNDGTLD 370
Query: 302 GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 361
G I VI +S+ DWAQEGGDPCLPVPWSW+QCNSD +P I + LSSKNL+GN+PS L
Sbjct: 371 GYVISRVILSHSTEDWAQEGGDPCLPVPWSWVQCNSDARPRIVKLSLSSKNLSGNVPSGL 430
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
T L+ LVELWLDGNSLTGPIPDF+GC L IIHLE+NQLTG LPSSL+NLPNLRELYVQN
Sbjct: 431 TMLTGLVELWLDGNSLTGPIPDFTGCTGLEIIHLENNQLTGELPSSLLNLPNLRELYVQN 490
Query: 422 NMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFM 481
N+LSGT+PS LS+ V LNY+GNINL EG R +H++IIIGSSVGAAVLL+AT+VSCLFM
Sbjct: 491 NLLSGTIPSG-LSRKVALNYSGNINLREGARRGRHMDIIIGSSVGAAVLLIATIVSCLFM 549
Query: 482 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGV 541
HKGKK + D+EQ R SLP+Q VSSL +AP EAAHCFT +IEDATK EKKIGSGGFGV
Sbjct: 550 HKGKKRHPDQEQLRDSLPMQMVVSSLRNAPGEAAHCFTTFEIEDATKKFEKKIGSGGFGV 609
Query: 542 VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601
VYYGK+KDG+EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE+G+S+LVY
Sbjct: 610 VYYGKMKDGREIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEDGKSMLVY 669
Query: 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661
EFMHNGTLKEHLYG L + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL
Sbjct: 670 EFMHNGTLKEHLYGPLKRGKSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 729
Query: 662 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 721
+DK+MRAKV+DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL
Sbjct: 730 VDKNMRAKVADFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 789
Query: 722 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM 781
EL+SGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL EYDIQSMWKI EKALM
Sbjct: 790 ELMSGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLCGEYDIQSMWKIAEKALM 849
Query: 782 CVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTE 839
CV PHGHMRPSISEVLK+IQDAI+IERE AAR+ SD+MSRNS+HSSLN+GS GG E
Sbjct: 850 CVQPHGHMRPSISEVLKEIQDAILIEREVTAAREDISDEMSRNSVHSSLNLGSLDLGGAE 909
Query: 840 NFLSLDESIVRPSAR 854
N+L+LDESI +P+AR
Sbjct: 910 NYLALDESIAQPTAR 924
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570730|ref|XP_003553538.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1461 bits (3783), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 696/861 (80%), Positives = 772/861 (89%), Gaps = 10/861 (1%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
TLRHFPADSRKYCY L+V++RTRYL+RA+FLYGNFDNNNVYPKFDIS+G THWSTIVISD
Sbjct: 78 TLRHFPADSRKYCYTLEVVSRTRYLLRASFLYGNFDNNNVYPKFDISVGATHWSTIVISD 137
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
A +IE+RELIFLASSP + VCLSNATTGQPFISTLELRQFNGSVY T FE +YLSVSAR
Sbjct: 138 ANSIEMRELIFLASSPTVSVCLSNATTGQPFISTLELRQFNGSVYYTQFEQHFYLSVSAR 197
Query: 122 INFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQK 181
INFGA+S+AP+RYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+ DE+PP K
Sbjct: 198 INFGAESDAPIRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRDEMPPVK 257
Query: 182 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 241
VMQTAVVGTNGSLTYRLNLDGFPG GWA TYFAEIEDLDPDESRKFRLVLPGQPD+SKA+
Sbjct: 258 VMQTAVVGTNGSLTYRLNLDGFPGTGWAFTYFAEIEDLDPDESRKFRLVLPGQPDISKAV 317
Query: 242 VNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID 301
VNI+ENAQGKYR+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+NDGS+D
Sbjct: 318 VNIEENAQGKYRLYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEKNDGSLD 377
Query: 302 GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 361
G I +++S YS+ADW QEGGDPCLPVPWSW++CNSDPQP I I LS+KNLTGNIP D+
Sbjct: 378 GATISNILSHYSAADWLQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTGNIPLDI 437
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
TKL LVELWLDGN LTGP PDF+GC DL+IIHLE+NQLTG LP+SL NLP+LRELYVQN
Sbjct: 438 TKLVGLVELWLDGNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLRELYVQN 497
Query: 422 NMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFM 481
NMLSGT+PS LLSK++VLNY+GNINLH R H+ +IIGSSVGA+VLLLAT++SCL+M
Sbjct: 498 NMLSGTIPSELLSKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATIISCLYM 557
Query: 482 HKGKKNNYDKEQHR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIG 535
HKGK+ + EQ R SLP QR S +D PAEAAHCF+ S+IE+AT EKKIG
Sbjct: 558 HKGKRRYH--EQGRILNSCIDSLPTQRLASWKSDDPAEAAHCFSYSEIENATNNFEKKIG 615
Query: 536 SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 595
SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC++E
Sbjct: 616 SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCRDEE 675
Query: 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 655
S+LVYEFMHNGTLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDL
Sbjct: 676 NSMLVYEFMHNGTLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDL 735
Query: 656 KSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS 715
KSSNILLDKHMRAKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS
Sbjct: 736 KSSNILLDKHMRAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS 795
Query: 716 FGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 775
FGVILLELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDP L ++YD+QSMWKI
Sbjct: 796 FGVILLELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPLLRNDYDLQSMWKI 855
Query: 776 EEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS- 834
EKALMCV PHGHMRPSISE LK+IQDAI IER+A A R+GNSDDMS+NS HSS+N+GS
Sbjct: 856 AEKALMCVQPHGHMRPSISEALKEIQDAISIERQAEALREGNSDDMSKNSFHSSMNMGSM 915
Query: 835 -FGGTENFLSLDESIVRPSAR 854
GG E++LS+DESI +P+AR
Sbjct: 916 DLGGAESYLSIDESIAQPTAR 936
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138590|ref|XP_002322852.1| predicted protein [Populus trichocarpa] gi|222867482|gb|EEF04613.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1458 bits (3775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 701/855 (81%), Positives = 777/855 (90%), Gaps = 4/855 (0%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
T+RHFPAD+RKYCY+LDV +RTRYL+RATFLYG+FDNNNVYPKFDIS+GPTHWSTIVISD
Sbjct: 69 TVRHFPADTRKYCYRLDVTSRTRYLLRATFLYGDFDNNNVYPKFDISVGPTHWSTIVISD 128
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
A TIE ELIFLASS I VCLSNATTGQPFISTLELRQFNGSVY T FE++++LSVSAR
Sbjct: 129 ANTIESIELIFLASSSSISVCLSNATTGQPFISTLELRQFNGSVYFTAFENQFFLSVSAR 188
Query: 122 INFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQK 181
INFGADS PVRYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PI++ DE PP+K
Sbjct: 189 INFGADSVDPVRYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPINVNIDERPPEK 248
Query: 182 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 241
VMQTAVVGTNGSLTYRLNLDGFPGFGWA TYFAEIEDLDP ESRKFRLVLPG PD+SKA+
Sbjct: 249 VMQTAVVGTNGSLTYRLNLDGFPGFGWACTYFAEIEDLDPTESRKFRLVLPGNPDMSKAV 308
Query: 242 VNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID 301
VNI+ENAQGKYR+YEPGYTNLSLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+D
Sbjct: 309 VNIEENAQGKYRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLD 368
Query: 302 GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 361
G I VI LYS+ADWAQEGGDPC+PVPWSW+QCNS+ +P I + LSSKNL+G++PSDL
Sbjct: 369 GDVISGVILLYSTADWAQEGGDPCMPVPWSWVQCNSEARPRIVKLSLSSKNLSGSVPSDL 428
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
TKL+ LVELWLDGNSLTGPIPDF+GC DL IIHLE+NQLTG LPSSL+NLPNLRELYVQN
Sbjct: 429 TKLTGLVELWLDGNSLTGPIPDFTGCTDLEIIHLENNQLTGELPSSLLNLPNLRELYVQN 488
Query: 422 NMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFM 481
NMLSGT+PS L + VVLNY+GNINLHEG R +H+ IIIGSSVGAAVLL+ T+VSC+FM
Sbjct: 489 NMLSGTIPSG-LGRKVVLNYSGNINLHEGARRGRHMGIIIGSSVGAAVLLITTLVSCMFM 547
Query: 482 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGV 541
KGKK + D+EQ R SLPVQR VS+L++AP EAAH FT +IEDATK EKKIGSGGFGV
Sbjct: 548 QKGKKRHPDQEQLRDSLPVQRVVSTLSNAPGEAAHRFTSFEIEDATKKFEKKIGSGGFGV 607
Query: 542 VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601
VYYGK+KDG+EIAVKVLTSNS+QGKREF+NEV+LLSRIHHRNLVQFLG+CQE G+S+LVY
Sbjct: 608 VYYGKMKDGREIAVKVLTSNSFQGKREFSNEVSLLSRIHHRNLVQFLGFCQEVGKSMLVY 667
Query: 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661
EFMHNGTLKEHLYG L + I+WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNIL
Sbjct: 668 EFMHNGTLKEHLYGPLKQGRSISWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNIL 727
Query: 662 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 721
LDK+MRAKV+DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILL
Sbjct: 728 LDKNMRAKVADFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTNKSDVYSFGVILL 787
Query: 722 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM 781
EL+SGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL +E+DIQSMWKI EKAL
Sbjct: 788 ELMSGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLCNEFDIQSMWKIAEKALT 847
Query: 782 CVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTE 839
CV PHGHMRPSISEVLK+IQDAI+IERE AAR G SD+MSRNS+ SS N+GS GGTE
Sbjct: 848 CVQPHGHMRPSISEVLKEIQDAILIEREVTAAR-GFSDEMSRNSVQSSFNLGSLDLGGTE 906
Query: 840 NFLSLDESIVRPSAR 854
N L+LDESI RP+AR
Sbjct: 907 NCLALDESIARPTAR 921
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503698|ref|XP_003520642.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1452 bits (3759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 688/861 (79%), Positives = 772/861 (89%), Gaps = 10/861 (1%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
TLRHFPADSRKYCY L+V++RTRYL+RA+FLYGNFD+NNVYPKFDIS+GPTHWSTIVISD
Sbjct: 79 TLRHFPADSRKYCYTLEVVSRTRYLLRASFLYGNFDDNNVYPKFDISIGPTHWSTIVISD 138
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
A +IE+RELIFLASSP + VCLSNATTGQPFISTLELRQFNGSVY T FE+ +YLSVSAR
Sbjct: 139 ANSIEMRELIFLASSPTVSVCLSNATTGQPFISTLELRQFNGSVYYTQFEEHFYLSVSAR 198
Query: 122 INFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQK 181
INFGA+S+AP+RYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+ DE+PP K
Sbjct: 199 INFGAESDAPIRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRDEMPPVK 258
Query: 182 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 241
VMQTAVVGTNGSLTYRLNLDGFPG GWA TYFAEIEDLDP+ESRKFRLVLPGQPD+SKA+
Sbjct: 259 VMQTAVVGTNGSLTYRLNLDGFPGTGWAFTYFAEIEDLDPNESRKFRLVLPGQPDISKAV 318
Query: 242 VNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID 301
VNI+ENAQGKYR+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+NDGS+D
Sbjct: 319 VNIEENAQGKYRLYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEKNDGSLD 378
Query: 302 GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 361
G I +++S YS+ DWAQEGGDPCLPVPWSW++CNSDPQP I I LS+KNLTGNIP D+
Sbjct: 379 GATISNILSHYSAEDWAQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTGNIPMDI 438
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
TKL LVELWLDGN LTGP PDF+GC DL+IIHLE+NQLTG LP+SL NLP+LRELYVQN
Sbjct: 439 TKLVGLVELWLDGNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLRELYVQN 498
Query: 422 NMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFM 481
NMLSGT+PS LLSK++VLNY+GNINLH R H+ +IIGSSVGA+VLLLAT++SCL+M
Sbjct: 499 NMLSGTIPSELLSKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATIISCLYM 558
Query: 482 HKGKKNNYDKEQHR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIG 535
KGK+ + EQ R SLP QR S +D PAEAAHCF+ +IE+AT E KIG
Sbjct: 559 RKGKRRYH--EQGRILNNRIDSLPTQRLASWKSDDPAEAAHCFSFPEIENATNNFETKIG 616
Query: 536 SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 595
SGGFG+VYYGKLKDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC++E
Sbjct: 617 SGGFGIVYYGKLKDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCRDEE 676
Query: 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 655
S+LVYEFMHNGTLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGC+P +IHRDL
Sbjct: 677 SSMLVYEFMHNGTLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCIPVVIHRDL 736
Query: 656 KSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS 715
KSSNILLDKHMRAKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS
Sbjct: 737 KSSNILLDKHMRAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS 796
Query: 716 FGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 775
FGVILLELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDP L ++YD+QSMWKI
Sbjct: 797 FGVILLELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPLLRNDYDLQSMWKI 856
Query: 776 EEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS- 834
EKALMCV PHGHMRP+ISEV+K+IQDAI IER+A A R+GNSDDMS++S HSS+N+GS
Sbjct: 857 AEKALMCVQPHGHMRPTISEVIKEIQDAISIERQAEALREGNSDDMSKHSFHSSMNMGSM 916
Query: 835 -FGGTENFLSLDESIVRPSAR 854
GG E++LS+DESI +P+AR
Sbjct: 917 DLGGAESYLSIDESIAQPTAR 937
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568426|ref|XP_002525187.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223535484|gb|EEF37153.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1425 bits (3688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 692/856 (80%), Positives = 758/856 (88%), Gaps = 29/856 (3%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
TLRHFPADSRKYCY LDVI+RTRYL+RATFLYGNFDNNNVYPKFDIS+G THWSTIVISD
Sbjct: 71 TLRHFPADSRKYCYTLDVISRTRYLLRATFLYGNFDNNNVYPKFDISVGATHWSTIVISD 130
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
A TIE ELIFLASSP I VCLSNATTGQPFISTLELRQFNGSVY T FE+++YLS+SAR
Sbjct: 131 ANTIESIELIFLASSPTISVCLSNATTGQPFISTLELRQFNGSVYYTSFENQFYLSISAR 190
Query: 122 INFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQK 181
INFGADSEAPVRYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST + ID+ +DE PP+K
Sbjct: 191 INFGADSEAPVRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTNMSIDVSNDERPPEK 250
Query: 182 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 241
VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDL PDESRKFRL+LPG PD+SK I
Sbjct: 251 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLAPDESRKFRLILPGFPDMSKPI 310
Query: 242 VNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID 301
VNIQENAQGKYR+Y+PGY N+SLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+D
Sbjct: 311 VNIQENAQGKYRLYQPGYPNISLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLD 370
Query: 302 GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 361
G I SVISLY+S DWAQEGGDPCLPVPWSWLQCNSD +P I I LSSKNLTGNIPSDL
Sbjct: 371 GEVIASVISLYTSTDWAQEGGDPCLPVPWSWLQCNSDARPRIIKISLSSKNLTGNIPSDL 430
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
KL L E L E+NQLTG LPSSLMNLP+LRELYVQN
Sbjct: 431 PKLKGLAEFHL-----------------------ENNQLTGGLPSSLMNLPHLRELYVQN 467
Query: 422 NMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFM 481
N+LSGTVPS LL KN+ LNY+GN+++HEGGR KH IIIGSSVGAAVLL+AT+ SC F+
Sbjct: 468 NLLSGTVPSGLLDKNLFLNYSGNLHVHEGGRREKHTGIIIGSSVGAAVLLIATIASCFFI 527
Query: 482 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGV 541
+GKK+N+D E HR PVQR VS+LND PAE A+CFT S+IEDAT+ LEKKIGSGGFG+
Sbjct: 528 RRGKKSNHDYEHHRVPPPVQRLVSTLNDNPAEGAYCFTFSEIEDATRKLEKKIGSGGFGI 587
Query: 542 VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601
VYYGKLK+GKEIAVKVLT+NS+QGKREF+NEVTLLSRIHHRNLVQFLG+CQE+GRS+LVY
Sbjct: 588 VYYGKLKNGKEIAVKVLTNNSFQGKREFSNEVTLLSRIHHRNLVQFLGFCQEDGRSMLVY 647
Query: 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661
E+MHNGTLKEHLYG + + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNIL
Sbjct: 648 EYMHNGTLKEHLYG--SRGRSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNIL 705
Query: 662 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 721
LDKHMRAKVSDFGLSK A+DGASHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILL
Sbjct: 706 LDKHMRAKVSDFGLSKLALDGASHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 765
Query: 722 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL-LDEYDIQSMWKIEEKAL 780
EL+SG+EAISNE FG NCRNIVQWAKLHIESGDIQG+ID S DEYDIQSMWKI EKAL
Sbjct: 766 ELMSGKEAISNE-FGTNCRNIVQWAKLHIESGDIQGVIDSSFDDDEYDIQSMWKIAEKAL 824
Query: 781 MCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGT 838
MCV PHGHMRPSISEVLK+IQDAI IERE+ A R+GNSDDMSRNS+HSSLN+GS GGT
Sbjct: 825 MCVQPHGHMRPSISEVLKEIQDAIAIERESVAVREGNSDDMSRNSVHSSLNLGSLELGGT 884
Query: 839 ENFLSLDESIVRPSAR 854
EN+LSLDES+ RP+AR
Sbjct: 885 ENYLSLDESVARPTAR 900
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741494|emb|CBI32626.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1418 bits (3671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 685/854 (80%), Positives = 760/854 (88%), Gaps = 2/854 (0%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
TLRHFPAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG T WSTIVISD
Sbjct: 72 TLRHFPADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLGATPWSTIVISD 131
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
A TIE ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +E+ ++LSVSAR
Sbjct: 132 ANTIESSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEYEEDFFLSVSAR 191
Query: 122 INFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQK 181
+NFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PID+ D PP+K
Sbjct: 192 VNFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPIDVNKDSRPPEK 251
Query: 182 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 241
VMQTAVVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+LP PD+SK
Sbjct: 252 VMQTAVVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLILPNMPDLSKPA 311
Query: 242 VNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID 301
VNIQENAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEINKYLE+ DG +D
Sbjct: 312 VNIQENAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEINKYLEKRDGCLD 371
Query: 302 GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 361
G AI S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS KNLTGNIP+DL
Sbjct: 372 GSAIASIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSGKNLTGNIPTDL 431
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
TKLS LVELWLDGN+L GPIPDF+G +L+ IHLE+NQL+G LPSSL++L +L+ELYVQN
Sbjct: 432 TKLSGLVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVDLQSLKELYVQN 491
Query: 422 NMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFM 481
NMLSG VPS LL++N+ NY+GN NLH+G G +H+ IIIGSSVGA VLL+AT+ SCLFM
Sbjct: 492 NMLSGKVPSGLLNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVLLIATIASCLFM 551
Query: 482 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGV 541
HKGKK Y+++Q H LP QR VSSLNDA EAA+CF+LS+IEDAT+ EKKIGSGGFGV
Sbjct: 552 HKGKKRYYEQDQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKFEKKIGSGGFGV 611
Query: 542 VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601
VYYGK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGYCQEEGRS+LVY
Sbjct: 612 VYYGKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGYCQEEGRSMLVY 671
Query: 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661
EFMHNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+IIHRDLKSSNIL
Sbjct: 672 EFMHNGTLKEHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSIIHRDLKSSNIL 731
Query: 662 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 721
LDK+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILL
Sbjct: 732 LDKYMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 791
Query: 722 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM 781
ELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL DEYDIQSMWKI EKALM
Sbjct: 792 ELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLRDEYDIQSMWKIAEKALM 851
Query: 782 CVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVG-SFGGTEN 840
CV PHG MRP ISEV+K+IQ+AI IER A AAR+GNS D SRNS+HSS+N+G G TEN
Sbjct: 852 CVQPHGSMRPPISEVIKEIQEAISIERGAEAAREGNS-DASRNSIHSSINMGIDVGPTEN 910
Query: 841 FLSLDESIVRPSAR 854
+LS DESI RP+ R
Sbjct: 911 YLSFDESIARPTPR 924
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439769|ref|XP_002275389.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1415 bits (3662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 685/856 (80%), Positives = 760/856 (88%), Gaps = 4/856 (0%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
TLRHFPAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG T WSTIVISD
Sbjct: 73 TLRHFPADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLGATPWSTIVISD 132
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
A TIE ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +E+ ++LSVSAR
Sbjct: 133 ANTIESSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEYEEDFFLSVSAR 192
Query: 122 INFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQK 181
+NFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PID+ D PP+K
Sbjct: 193 VNFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPIDVNKDSRPPEK 252
Query: 182 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 241
VMQTAVVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+LP PD+SK
Sbjct: 253 VMQTAVVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLILPNMPDLSKPA 312
Query: 242 VNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID 301
VNIQENAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEINKYLE+ DG +D
Sbjct: 313 VNIQENAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEINKYLEKRDGCLD 372
Query: 302 GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 361
G AI S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS KNLTGNIP+DL
Sbjct: 373 GSAIASIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSGKNLTGNIPTDL 432
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
TKLS LVELWLDGN+L GPIPDF+G +L+ IHLE+NQL+G LPSSL++L +L+ELYVQN
Sbjct: 433 TKLSGLVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVDLQSLKELYVQN 492
Query: 422 NMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFM 481
NMLSG VPS LL++N+ NY+GN NLH+G G +H+ IIIGSSVGA VLL+AT+ SCLFM
Sbjct: 493 NMLSGKVPSGLLNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVLLIATIASCLFM 552
Query: 482 HKGKKNNYDKEQHR--HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGF 539
HKGKK Y++ H+ H LP QR VSSLNDA EAA+CF+LS+IEDAT+ EKKIGSGGF
Sbjct: 553 HKGKKRYYEQGMHQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKFEKKIGSGGF 612
Query: 540 GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599
GVVYYGK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGYCQEEGRS+L
Sbjct: 613 GVVYYGKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGYCQEEGRSML 672
Query: 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 659
VYEFMHNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+IIHRDLKSSN
Sbjct: 673 VYEFMHNGTLKEHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSIIHRDLKSSN 732
Query: 660 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 719
ILLDK+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVI
Sbjct: 733 ILLDKYMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 792
Query: 720 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKA 779
LLELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL DEYDIQSMWKI EKA
Sbjct: 793 LLELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLRDEYDIQSMWKIAEKA 852
Query: 780 LMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVG-SFGGT 838
LMCV PHG MRP ISEV+K+IQ+AI IER A AAR+GNS D SRNS+HSS+N+G G T
Sbjct: 853 LMCVQPHGSMRPPISEVIKEIQEAISIERGAEAAREGNS-DASRNSIHSSINMGIDVGPT 911
Query: 839 ENFLSLDESIVRPSAR 854
EN+LS DESI RP+ R
Sbjct: 912 ENYLSFDESIARPTPR 927
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510569|ref|XP_003625573.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355500588|gb|AES81791.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1410 bits (3649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 673/855 (78%), Positives = 754/855 (88%), Gaps = 2/855 (0%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
TLRHFPADSRKYCY LDVI+RTRYL+RA+FLYGNFDNNNVYPKFDIS+G THWSTIVISD
Sbjct: 78 TLRHFPADSRKYCYTLDVISRTRYLLRASFLYGNFDNNNVYPKFDISVGATHWSTIVISD 137
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
A IE+RELIFLASS + VCLSNATTGQPFISTLELRQFNGS+Y T FE ++YLSVSAR
Sbjct: 138 ANIIEMRELIFLASSSTVSVCLSNATTGQPFISTLELRQFNGSIYYTQFEQQFYLSVSAR 197
Query: 122 INFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQK 181
INFGA+++AP+RYPDDPFDRIWESDS+KKANYLVDVA GTEKVST +PI + D++PP K
Sbjct: 198 INFGAETDAPIRYPDDPFDRIWESDSVKKANYLVDVAVGTEKVSTNVPILVNRDDVPPVK 257
Query: 182 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 241
VMQTAVVGTNGSLTYRLNLDGFPG WAVTYFAEIEDL P+ESRKFRLVLPGQP++SKAI
Sbjct: 258 VMQTAVVGTNGSLTYRLNLDGFPGNAWAVTYFAEIEDLSPNESRKFRLVLPGQPEISKAI 317
Query: 242 VNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID 301
VNI+ENA GKYR+YEPG+TNLSLPFVLSFKF KT DSS+GPL+NAMEINKYLE+NDGS D
Sbjct: 318 VNIEENAFGKYRLYEPGFTNLSLPFVLSFKFAKTPDSSKGPLVNAMEINKYLEKNDGSPD 377
Query: 302 GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 361
AI V+S YSSA+W QEGGDPCLPVPWSW++C+SDPQP I I LS KNLTGNIPSD+
Sbjct: 378 VEAISGVLSHYSSANWTQEGGDPCLPVPWSWIRCSSDPQPRIISILLSGKNLTGNIPSDI 437
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
TKL LVELWLDGN LTGPIPDF+GC DL+IIHLE+NQ G LP+SL NLP+LRELYVQN
Sbjct: 438 TKLVGLVELWLDGNMLTGPIPDFTGCMDLKIIHLENNQFNGVLPASLANLPSLRELYVQN 497
Query: 422 NMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFM 481
NMLSG VP LLSK+++LNY+GN NLH+ R H+ IIIGS+VGA+VLLLATV+SCL +
Sbjct: 498 NMLSGEVPPHLLSKDLILNYSGNTNLHKQSRIKSHMYIIIGSAVGASVLLLATVISCLVI 557
Query: 482 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGV 541
HKGK+ Y+K+ ++P QRP S +D PAEAAHCF+L++IE AT EK+IGSGGFG+
Sbjct: 558 HKGKRRYYEKDHIVSAVPTQRPDSWKSDDPAEAAHCFSLAEIETATNNFEKRIGSGGFGI 617
Query: 542 VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601
VYYGKLK+GKEIAVKVL +NSYQGKREF+NEVTLLSRIHHRNLVQ +GYC+EE S+LVY
Sbjct: 618 VYYGKLKEGKEIAVKVLRNNSYQGKREFSNEVTLLSRIHHRNLVQLIGYCREEENSILVY 677
Query: 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661
EFMHNGTLKEHLYGTL H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLK+SNIL
Sbjct: 678 EFMHNGTLKEHLYGTLEHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKTSNIL 737
Query: 662 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 721
LD+ MRAKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL
Sbjct: 738 LDRQMRAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 797
Query: 722 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM 781
ELISGQEAISNE FG +CRNIVQWAKLHIESGDIQGIIDP L YD+QSMWKI EKALM
Sbjct: 798 ELISGQEAISNESFGLHCRNIVQWAKLHIESGDIQGIIDPLLGSNYDLQSMWKIAEKALM 857
Query: 782 CVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTE 839
CV PHG MRPSISEVLK+IQDAI IE+EA R+GNSD+ SRNS SS+N+GS G E
Sbjct: 858 CVQPHGDMRPSISEVLKEIQDAISIEKEAETLREGNSDEASRNSFQSSMNIGSMDLGRAE 917
Query: 840 NFLSLDESIVRPSAR 854
+FLS+DESI +P+AR
Sbjct: 918 SFLSIDESIAQPTAR 932
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440057|ref|XP_004137801.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] gi|449524194|ref|XP_004169108.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1389 bits (3596), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 668/856 (78%), Positives = 749/856 (87%), Gaps = 28/856 (3%)
Query: 1 MTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVIS 60
MTLRHFPADSRKYCY L+V +RTRYL+RATFLYGNFDNNNVYPKFDISLG THWSTIVIS
Sbjct: 68 MTLRHFPADSRKYCYSLNVTSRTRYLLRATFLYGNFDNNNVYPKFDISLGATHWSTIVIS 127
Query: 61 DAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSA 120
DA TIEVRELIFLAS+P + VCLSNATTGQPFISTLELRQFNGS Y T FED++YLSVSA
Sbjct: 128 DANTIEVRELIFLASTPTVSVCLSNATTGQPFISTLELRQFNGSAYYTQFEDQFYLSVSA 187
Query: 121 RINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQ 180
RINFGADSEAPVRYPDDPFDR+WESDS++KANYLVDVAAGTEKVSTKLPID+ DE PPQ
Sbjct: 188 RINFGADSEAPVRYPDDPFDRMWESDSVRKANYLVDVAAGTEKVSTKLPIDVDRDERPPQ 247
Query: 181 KVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKA 240
KVMQTAVVG NGSLTYRLNLDGFPGFGWAVTYFAEIEDL P ++RKFRLVLPG P++SKA
Sbjct: 248 KVMQTAVVGRNGSLTYRLNLDGFPGFGWAVTYFAEIEDLGPTDTRKFRLVLPGMPEISKA 307
Query: 241 IVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSI 300
+VNI+ENAQGKYR+YEPG+TN++LPFVLSF+FGKT DSS GPLLNAMEINKYLE++DGS+
Sbjct: 308 VVNIEENAQGKYRLYEPGFTNITLPFVLSFRFGKTQDSSLGPLLNAMEINKYLEKSDGSL 367
Query: 301 DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSD 360
DG + SVIS + S+DW EGGDPC+PVPWSWLQCNSDPQP I I LS +NL+GNIP+D
Sbjct: 368 DGAVVASVISKFPSSDW-DEGGDPCMPVPWSWLQCNSDPQPRIIKISLSKQNLSGNIPTD 426
Query: 361 LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420
+ KLS LVE HLE+NQLTG LPSSL +LPNLRELYVQ
Sbjct: 427 IAKLSGLVEF-----------------------HLENNQLTGELPSSLASLPNLRELYVQ 463
Query: 421 NNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLF 480
NNMLSGTVPS LLSKN+V++Y+GNINLHEGG+ H+ II+GS +GA VLLLATVVSC F
Sbjct: 464 NNMLSGTVPSGLLSKNLVVDYSGNINLHEGGK-KNHVYIIVGSVIGAVVLLLATVVSCYF 522
Query: 481 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFG 540
+HKG++ ++++ SL VQR VSS DA E AHCF++++I ATK E+KIGSGGFG
Sbjct: 523 LHKGRRRYHEQDLPEESLAVQRFVSSKGDASKETAHCFSVNEIVQATKDFERKIGSGGFG 582
Query: 541 VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600
VVYYGKL DGKEIAVKVLTSNS+QG+REF NEVTLLSRIHHRNLVQFLGYCQE+ RS+L+
Sbjct: 583 VVYYGKLNDGKEIAVKVLTSNSFQGRREFANEVTLLSRIHHRNLVQFLGYCQEQDRSMLI 642
Query: 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 660
YEFMHNGTLKEHLYG LT E+ I+WIKRLEIAEDAA+G+EYLHTGC+PAIIHRDLKSSNI
Sbjct: 643 YEFMHNGTLKEHLYGPLTREKTISWIKRLEIAEDAARGVEYLHTGCIPAIIHRDLKSSNI 702
Query: 661 LLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVIL 720
LLD+HM+AKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVIL
Sbjct: 703 LLDRHMKAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVIL 762
Query: 721 LELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKAL 780
LELISGQEAISN FGANCRNIVQWAKLHIESGDIQGIIDPSL +EYDIQSMWKI EKAL
Sbjct: 763 LELISGQEAISNVNFGANCRNIVQWAKLHIESGDIQGIIDPSLRNEYDIQSMWKIAEKAL 822
Query: 781 MCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGSFG--GT 838
MCV +GH+RPSISEVLK+IQD+I+IERE+ A ++GNSDDMSRNS+H SLN+GS G
Sbjct: 823 MCVQANGHLRPSISEVLKEIQDSILIERESTATKEGNSDDMSRNSVH-SLNMGSLDLCGN 881
Query: 839 ENFLSLDESIVRPSAR 854
EN++S DESI RP+AR
Sbjct: 882 ENYVSFDESIARPTAR 897
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147780497|emb|CAN67050.1| hypothetical protein VITISV_001651 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1359 bits (3517), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/884 (75%), Positives = 740/884 (83%), Gaps = 55/884 (6%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISD 61
TLRHFPAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG T WSTIVISD
Sbjct: 20 TLRHFPADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLGATPWSTIVISD 79
Query: 62 AATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSAR 121
A TIE ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +E+ ++LSVSAR
Sbjct: 80 AXTIESSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEYEEDFFLSVSAR 139
Query: 122 INFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQK 181
+NFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PID+ D PP+K
Sbjct: 140 VNFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPIDVNKDSRPPEK 199
Query: 182 VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 241
VMQTAVVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+LP PD+SK
Sbjct: 200 VMQTAVVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLILPNMPDLSKPA 259
Query: 242 VNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID 301
VNIQENAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEINKYLE+ DG +D
Sbjct: 260 VNIQENAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEINKYLEKRDGCLD 319
Query: 302 GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 361
G AI S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS KNLTGNIP+DL
Sbjct: 320 GSAIASIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSGKNLTGNIPTDL 379
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
TKLS LVELWLDGN+L GPIPDF+G +L+ IHLE+NQL+G LPSSL++L +L+EL
Sbjct: 380 TKLSGLVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVDLQSLKEL---- 435
Query: 422 NMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFM 481
Y+GN NLH+G G +H+ IIIGSSVGA VLL+AT+ SCLFM
Sbjct: 436 -------------------YSGNDNLHKGSTGGRHIGIIIGSSVGAVVLLIATIASCLFM 476
Query: 482 HKGKKNNYDKEQH------------------------------RHSLPVQRPVSSLNDAP 511
HKGKK Y++ H H LP QR VSSLNDA
Sbjct: 477 HKGKKRYYEQGMHVSNLEVCLFSSIEMSVSVTGFFYEFVSDQLGHGLPAQRIVSSLNDAA 536
Query: 512 AEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTN 571
EAA+CF+LS+IEDAT+ EKKIGSGGFGVVYYGK+KDGKEIAVKVL +NSYQG REF+N
Sbjct: 537 TEAANCFSLSEIEDATRKFEKKIGSGGFGVVYYGKMKDGKEIAVKVLINNSYQGNREFSN 596
Query: 572 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 631
EVTLLSRIHHRNLVQFLGYCQEEGRS+LVYEFMHNGTLKEHLYG LT E+ I+WIKRLEI
Sbjct: 597 EVTLLSRIHHRNLVQFLGYCQEEGRSMLVYEFMHNGTLKEHLYGPLTXERXISWIKRLEI 656
Query: 632 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 691
AEDAAKGIEYLHTGCVP+IIHRDLKSSNILLDK+M+AKVSDFGLSK AVDG+SHVSS+VR
Sbjct: 657 AEDAAKGIEYLHTGCVPSIIHRDLKSSNILLDKYMKAKVSDFGLSKLAVDGSSHVSSVVR 716
Query: 692 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 751
GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE FG NCRNIVQWAKLHIE
Sbjct: 717 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNESFGVNCRNIVQWAKLHIE 776
Query: 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA 811
SGDIQGIIDPSL DEYDIQSMWKI EKALMCV PHG MRP ISEV+K+IQ+AI IER A
Sbjct: 777 SGDIQGIIDPSLRDEYDIQSMWKIAEKALMCVQPHGSMRPPISEVIKEIQEAISIERGAE 836
Query: 812 AARDGNSDDMSRNSLHSSLNVG-SFGGTENFLSLDESIVRPSAR 854
AAR+GNS D SRNS+HSS+N+G G TEN+LS DESI RP+ R
Sbjct: 837 AAREGNS-DASRNSIHSSINMGIDVGPTENYLSFDESIARPTPR 879
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 854 | ||||||
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.997 | 0.912 | 0.705 | 0.0 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.989 | 0.909 | 0.476 | 3.1e-209 | |
| TAIR|locus:2055165 | 868 | AT2G14510 [Arabidopsis thalian | 0.494 | 0.486 | 0.386 | 9.4e-122 | |
| TAIR|locus:2066158 | 884 | AT2G28990 [Arabidopsis thalian | 0.699 | 0.675 | 0.357 | 2e-119 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.503 | 0.490 | 0.370 | 1.1e-118 | |
| TAIR|locus:2066163 | 872 | AT2G29000 [Arabidopsis thalian | 0.495 | 0.485 | 0.395 | 3.7e-118 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.491 | 0.476 | 0.368 | 5.3e-117 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.733 | 0.708 | 0.355 | 6.8e-117 | |
| TAIR|locus:2059093 | 876 | FRK1 "FLG22-induced receptor-l | 0.501 | 0.488 | 0.384 | 7.7e-116 | |
| TAIR|locus:2066133 | 880 | AT2G28960 [Arabidopsis thalian | 0.496 | 0.481 | 0.382 | 3.3e-115 |
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3202 (1132.2 bits), Expect = 0., P = 0.
Identities = 609/863 (70%), Positives = 708/863 (82%)
Query: 2 TLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDN-NNVYPKFDISLGPTHWSTIVIS 60
TLRHFPADSRKYCY L+V +R RYLIRATFLYGNFDN NNVYPKFDISLG THW+TIVIS
Sbjct: 73 TLRHFPADSRKYCYTLNVTSRNRYLIRATFLYGNFDNSNNVYPKFDISLGATHWATIVIS 132
Query: 61 DAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPF-EDRYYLSVS 119
+ IE EL+FLASSP + VCLSNATTGQPFISTLELRQ +GS+Y + EDR+YLSV+
Sbjct: 133 ETYIIETAELVFLASSPTVSVCLSNATTGQPFISTLELRQLSGSMYGSMLSEDRFYLSVA 192
Query: 120 ARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPP 179
ARINFGA+SEA VRYPDDP+DRIWESD KK NYLVDVAAGT +VST LPI+ R D+ PP
Sbjct: 193 ARINFGAESEASVRYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVDDRPP 252
Query: 180 QKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSK 239
QKVMQTAVVGTNGSLTYR+NLDGFPGFGWA TYFAEIEDL DESRKFRLVLP QP+ SK
Sbjct: 253 QKVMQTAVVGTNGSLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQPEYSK 312
Query: 240 AIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGS 299
++VNI+EN Q YRVY PGY N++LPFVL+F+F KT DSSRGP+LNAMEI+KYL ++DGS
Sbjct: 313 SVVNIKENTQRPYRVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLRKSDGS 372
Query: 300 IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPS 359
+D + +V SLYSS +WAQEGGDPC P PWSW+QCNSDPQP + I LSS NLTGNIPS
Sbjct: 373 VDATVMANVASLYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTGNIPS 432
Query: 360 DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYV 419
DL KL+ LVELWLDGNS TGPIPDFS CP+L IIHLE+N+LTG +ELY+
Sbjct: 433 DLVKLTGLVELWLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLKELYL 492
Query: 420 QNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCL 479
QNN+L+GT+PS L +K+V+ N++GN+NL + G K L +II C+
Sbjct: 493 QNNVLTGTIPSDL-AKDVISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATIISCI 551
Query: 480 FMHKGKKNNY----DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIG 535
M K KKNN E LP+QR S+L++A +AAHCFTL +IE+ATK EK+IG
Sbjct: 552 VMCKSKKNNKLGKTSAELTNRPLPIQRVSSTLSEAHGDAAHCFTLYEIEEATKKFEKRIG 611
Query: 536 SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 595
SGGFG+VYYGK ++GKEIAVKVL +NSYQGKREF NEVTLLSRIHHRNLVQFLGYCQEEG
Sbjct: 612 SGGFGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNLVQFLGYCQEEG 671
Query: 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 655
+++LVYEFMHNGTLKEHLYG + ++RI+WIKRLEIAEDAA+GIEYLHTGCVPAIIHRDL
Sbjct: 672 KNMLVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHTGCVPAIIHRDL 731
Query: 656 KSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS 715
K+SNILLDKHMRAKVSDFGLSKFAVDG SHVSSIVRGTVGYLDPEYYISQQLT+KSDVYS
Sbjct: 732 KTSNILLDKHMRAKVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEYYISQQLTEKSDVYS 791
Query: 716 FGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL-DEYDIQSMWK 774
FGVILLEL+SGQEAISNE FG NCRNIVQWAK+HI++GDI+GIIDP+L D+Y +QSMWK
Sbjct: 792 FGVILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIRGIIDPALAEDDYSLQSMWK 851
Query: 775 IEEKALMCVLPHGHMRPSISEVLKDIQXXXXXXXXXXXXXXGNSDDMSRNSLHSS-LNVG 833
I EKAL+CV PHG+MRPS+SEV KDIQ G SD+ SR+S HSS LN+G
Sbjct: 852 IAEKALLCVKPHGNMRPSMSEVQKDIQDAIRIEKEALAARGGISDEFSRSSAHSSSLNMG 911
Query: 834 --SFGGTENFLSLDESIVRPSAR 854
G+++++S+DES+++P+AR
Sbjct: 912 MLDLAGSQSYVSIDESVLQPTAR 934
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2023 (717.2 bits), Expect = 3.1e-209, P = 3.1e-209
Identities = 410/861 (47%), Positives = 545/861 (63%)
Query: 4 RHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAA 63
R FP D++KYCY+L R RY++R TFLYG + YPKF + L T W+T+ I + +
Sbjct: 75 RDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATVTIQEVS 134
Query: 64 TIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARIN 123
+ V ELI A+S +DVC+ A TG PF+STLELR N S+Y T +ED ++L V+AR+N
Sbjct: 135 RVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLKVAARVN 194
Query: 124 FGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVM 183
FGA + +RYPDDP+DRIWESD K+ NYLV VA GT +++T I+ + E PP KVM
Sbjct: 195 FGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREYPPMKVM 254
Query: 184 QTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVN 243
QTAVVGT G ++YRLNL+ FP A YFAEIE+L +E+RKF+LV P PD S A+VN
Sbjct: 255 QTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVVN 314
Query: 244 IQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLE---RNDGSI 300
I ENA G Y +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL + D S
Sbjct: 315 IAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRS- 373
Query: 301 DGVAIVSVI-SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPS 359
V+++ I S+ +DWA EGGDPC+PV WSW+ C+S P +T I LS KNL G IP
Sbjct: 374 -DVSVLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPP 432
Query: 360 DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYV 419
+ + +L ELWLD N LTG +PD S +L+I+HLE+NQL+G +EL +
Sbjct: 433 GINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSI 492
Query: 420 QNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKH----LNIIIXXXXXXXXXXXXXX 475
+NN G +PS+LL V+ Y N L + KH L I I
Sbjct: 493 ENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAILLLLVGGSL 551
Query: 476 XXCLFMHKGKK-NNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKK 533
+ K K+ + D E + L V + A+ +L +E+AT KK
Sbjct: 552 VLLCALRKTKRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSKK 611
Query: 534 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 593
+G G FG VYYG++KDGKE+AVK+ S R+F EV LLSRIHHRNLV +GYC+E
Sbjct: 612 VGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEE 671
Query: 594 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHR 653
R +LVYE+MHNG+L +HL+G+ ++ ++W+ RL+IA+DAAKG+EYLHTGC P+IIHR
Sbjct: 672 ADRRILVYEYMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTGCNPSIIHR 730
Query: 654 DLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 713
D+KSSNILLD +MRAKVSDFGLS+ + +HVSS+ +GTVGYLDPEYY SQQLT+KSDV
Sbjct: 731 DVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDV 790
Query: 714 YSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMW 773
YSFGV+L EL+SG++ +S E FG NIV WA+ I GD+ GIIDP + I+S+W
Sbjct: 791 YSFGVVLFELLSGKKPVSAEDFGPEL-NIVHWARSLIRKGDVCGIIDPCIASNVKIESVW 849
Query: 774 KIEEKALMCVLPHGHMRPSISEVLKDIQXXXXXXXXXXXXXXGNSDDMSRNSLHSSLNVG 833
++ E A CV GH RP + EV+ IQ +S S+ +
Sbjct: 850 RVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTLLT 909
Query: 834 SFGGTENFLSLDESIVRPSAR 854
SF E+ + + + P+AR
Sbjct: 910 SFLELES-PDISRNSLAPAAR 929
|
|
| TAIR|locus:2055165 AT2G14510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 743 (266.6 bits), Expect = 9.4e-122, Sum P(2) = 9.4e-122
Identities = 172/445 (38%), Positives = 250/445 (56%)
Query: 360 DLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELY 418
D++ ++ L L + LTG I P LR + L +N LTG ++
Sbjct: 406 DISTPPRIISLDLSLSGLTGVISPSIQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIH 465
Query: 419 VQNNMLSGTVPSSLLS--KNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXX 476
++ N L G+VP +L KN L + N+ G+ ++
Sbjct: 466 LRGNNLRGSVPQALQDREKNDGLKLFVDPNITRRGKHQPKSWLVAIVASISCVAVTIIVL 525
Query: 477 XCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGS 536
+F+ + +K++ K V RP + + F S++++ T E +G
Sbjct: 526 VLIFIFRRRKSSTRK--------VIRPSLEMKNRR------FKYSEVKEMTNNFEVVLGK 571
Query: 537 GGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 596
GGFGVVY+G L + +++AVKVL+ +S QG +EF EV LL R+HH NLV +GYC E
Sbjct: 572 GGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGID 630
Query: 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 656
L+YEFM NG LKEHL G +NW RL+IA ++A GIEYLH GC P ++HRD+K
Sbjct: 631 LALIYEFMENGNLKEHLSGKRGGSV-LNWSSRLKIAIESALGIEYLHIGCQPPMVHRDVK 689
Query: 657 SSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS 715
S+NILL AK++DFGLS+ F V +HVS+ V GT+GYLDPEYY+ LT+KSDVYS
Sbjct: 690 STNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYS 749
Query: 716 FGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 775
FG++LLE I+GQ I + + IV+WAK + +GDI+ I+DP+L +YD S WK
Sbjct: 750 FGIVLLESITGQPVIEQSR---DKSYIVEWAKSMLANGDIESIMDPNLHQDYDSSSSWKA 806
Query: 776 EEKALMCVLPHGHMRPSISEVLKDI 800
E A++C+ P RP+++ V ++
Sbjct: 807 LELAMLCINPSSTQRPNMTRVAHEL 831
|
|
| TAIR|locus:2066158 AT2G28990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 2.0e-119, Sum P(2) = 2.0e-119
Identities = 238/665 (35%), Positives = 358/665 (53%)
Query: 164 VSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTY--FAEIEDLDP 221
++T L I+ + P+ ++QTA + N S + D P Y FAEI+ L+
Sbjct: 224 ITTDLNINNSNAYEIPKNILQTAAIPRNASAPLIITWDPLPINAEVYLYMHFAEIQTLEA 283
Query: 222 DESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVY--EP---GYTNLSLPFVLSFKFGKTY 276
+E+R+F ++L G + S + +Y EP G L V KT
Sbjct: 284 NETRQFDVILRGNFNHS----GFSPTKLKVFTLYTEEPMKCGSEGCYLQLV------KTP 333
Query: 277 DSSRGPLLNAMEINKYLERN--DGSIDGV-AIVSVISLY--SSADWAQEGGDPCLPVPWS 331
+S+ PL+NA+E +E + + S+ V AI ++ + Y + W GDPCLP S
Sbjct: 334 NSTLPPLINAIEAYSVIEFSQLETSLSDVDAIKNIKNTYKLNKITWQ---GDPCLPQDLS 390
Query: 332 W--LQC---NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 386
W ++C + P+I + LS L G+IP L + L EL L NSLTGP+P F
Sbjct: 391 WESIRCTYVDGSTSPTIISLDLSKSGLNGSIPQILQNFTQLQELDLSNNSLTGPVPIFLA 450
Query: 387 CPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPSSLLSKN---VVLNYAG 443
+++ + L + L+G NN LSG+VP +LL K +VL G
Sbjct: 451 --NMKTLSLIN--LSG------------------NN-LSGSVPQALLDKEKEGLVLKLEG 487
Query: 444 NINLHEGG--RGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNNYDKEQHRH-SLPV 500
N +L + K ++ LF KK H S+PV
Sbjct: 488 NPDLCKSSFCNTEKKNKFLLPVIASAASLVIVVVVVALFFVFRKKKASPSNLHAPPSMPV 547
Query: 501 QRPV-SSLNDAPAEAAHC-FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL 558
P +S +++ + FT S++++ T +K +G GGFGVVY+G + +++AVK+L
Sbjct: 548 SNPGHNSQSESSFTSKKIRFTYSEVQEMTNNFDKALGEGGFGVVYHGFVNVIEQVAVKLL 607
Query: 559 TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT 618
+ +S QG + F EV LL R+HH NLV +GYC E L+YE+M NG LK+HL G
Sbjct: 608 SQSSSQGYKHFKAEVELLMRVHHINLVSLVGYCDEGEHLALIYEYMPNGDLKQHLSGK-- 665
Query: 619 HEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
H + +W RL+I DAA G+EYLHTGCVP ++HRD+K++NILLD+H++AK++DFGLS+
Sbjct: 666 HGGFVLSWESRLKIVLDAALGLEYLHTGCVPPMVHRDIKTTNILLDQHLQAKLADFGLSR 725
Query: 678 -FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 736
F + +VS++V GT GYLDPEYY + LT+KSD+YSFG++LLE+IS + I +
Sbjct: 726 SFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTEKSDIYSFGIVLLEIISNRPIIQQSR-- 783
Query: 737 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 796
+IV+W I GD++ I+DP+L +YDI S+WK E A+ CV RP++S V
Sbjct: 784 -EKPHIVEWVSFMITKGDLRSIMDPNLHQDYDIGSVWKAIELAMSCVSLSSARRPNMSRV 842
Query: 797 LKDIQ 801
+ +++
Sbjct: 843 VNELK 847
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 1.1e-118, Sum P(2) = 1.1e-118
Identities = 168/454 (37%), Positives = 263/454 (57%)
Query: 359 SDLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXREL 417
SD + L L + LTG I P F+ + + L +N LTG EL
Sbjct: 403 SDNNTSPKSIALNLSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTEL 462
Query: 418 YVQNNMLSGTVPSSLLSKN----VVLNYAGNINLHEGGR----GAKHLNIIIXXXXXXXX 469
++ N L+G++P+ LL K+ + L + GN +L + K + I+
Sbjct: 463 NLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAG 522
Query: 470 XXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATK 528
L H + K R ++ +P+ +N P + A F S++ + T
Sbjct: 523 LLIVLTALALIWH------FKKRSRRGTIS-NKPLG-VNTGPLDTAKRYFIYSEVVNITN 574
Query: 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
E+ +G GGFG VY+G L +G ++AVK+L+ S QG +EF EV LL R+HH NL +
Sbjct: 575 NFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLI 633
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
GYC E+ L+YE+M NG L ++L G + ++W +RL+I+ DAA+G+EYLH GC P
Sbjct: 634 GYCNEDNHMALIYEYMANGNLGDYLSGKSS--LILSWEERLQISLDAAQGLEYLHYGCKP 691
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
I+HRD+K +NILL+++++AK++DFGLS+ F V+G+S VS++V GT+GYLDPEYY ++Q+
Sbjct: 692 PIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQM 751
Query: 708 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767
+KSDVYSFGV+LLE+I+G+ AI + + ++ + +GDI+GI+D L D +
Sbjct: 752 NEKSDVYSFGVVLLEVITGKPAIWHSR--TESVHLSDQVGSMLANGDIKGIVDQRLGDRF 809
Query: 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801
++ S WKI E AL C RP++S+V+ +++
Sbjct: 810 EVGSAWKITELALACASESSEQRPTMSQVVMELK 843
|
|
| TAIR|locus:2066163 AT2G29000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 3.7e-118, Sum P(2) = 3.7e-118
Identities = 174/440 (39%), Positives = 243/440 (55%)
Query: 367 LVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 425
++ L L L G I P L + L N+L+G + + N L
Sbjct: 408 IISLDLSNRGLKGIIEPVLQNLTQLEKLDLSINRLSGEVPEFLANMKSLSNINLSWNNLK 467
Query: 426 GTVPSSLLSKN---VVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMH 482
G +P +L K + LN GN NL G + + L +
Sbjct: 468 GLIPPALEEKRKNGLKLNTQGNQNLCPGDECKRSIPKFPVTTVVSISAILLTVVVLLIVF 527
Query: 483 KGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVV 542
KK K +HR LP+ + S + FT S++E T E+ IG GGFG+V
Sbjct: 528 IYKKKKTSKVRHR--LPITK--SEILTKKRR----FTYSEVEAVTNKFERVIGEGGFGIV 579
Query: 543 YYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602
Y+G L D +++AVK+L+ +S QG ++F EV LL R+HH NLV +GYC EE LVYE
Sbjct: 580 YHGHLNDTEQVAVKLLSHSSTQGYKQFKAEVELLLRVHHTNLVNLVGYCNEEDHLALVYE 639
Query: 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 662
+ NG LK+HL G + +NW RL IA + A+G+EYLH GC P +IHRD+K++NILL
Sbjct: 640 YAANGDLKQHLSGE-SSSAALNWASRLGIATETAQGLEYLHIGCEPPMIHRDVKTTNILL 698
Query: 663 DKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 721
D+H AK++DFGLS+ F V SHVS+ V GT GYLDPEYY + LT+KSDVYS G++LL
Sbjct: 699 DEHFHAKLADFGLSRSFPVGVESHVSTNVAGTPGYLDPEYYRTNWLTEKSDVYSMGIVLL 758
Query: 722 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM 781
E+I+ Q I + +I +W L + GDI+ I+DP L EYD S+WK E A+
Sbjct: 759 EIITNQPVIQQVR---EKPHIAEWVGLMLTKGDIKSIMDPKLNGEYDSSSVWKALELAMS 815
Query: 782 CVLPHGHMRPSISEVLKDIQ 801
CV P RP++S+V+ +++
Sbjct: 816 CVNPSSGGRPTMSQVISELK 835
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 5.3e-117, Sum P(2) = 5.3e-117
Identities = 165/448 (36%), Positives = 254/448 (56%)
Query: 367 LVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 425
++ + L + LTG I FS L I+ L +N LTG EL ++ N LS
Sbjct: 415 IISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLS 474
Query: 426 GTVPSSLLSKN----VVLNYAGNINL------HEGGRGAKHLNIIIXXXXXXXXXXXXXX 475
G +P LL ++ ++L GN +L K II
Sbjct: 475 GAIPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVL 534
Query: 476 XXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATKMLEKKI 534
LF+ Y K++HR + P + + S++ T E+ +
Sbjct: 535 AIALFLL------Y-KKRHRRG-----GSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVL 582
Query: 535 GSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 594
G GGFG VY+G L D ++AVK+L+ +S QG +EF EV LL R+HH+NL +GYC E
Sbjct: 583 GQGGFGKVYHGVLNDD-QVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEG 641
Query: 595 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 654
+ L+YEFM NGTL ++L G ++ ++W +RL+I+ DAA+G+EYLH GC P I+ RD
Sbjct: 642 KKMALIYEFMANGTLGDYLSGEKSYV--LSWEERLQISLDAAQGLEYLHNGCKPPIVQRD 699
Query: 655 LKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 713
+K +NIL+++ ++AK++DFGLS+ A+DG + ++ V GT+GYLDPEY+++Q+L++KSD+
Sbjct: 700 VKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDI 759
Query: 714 YSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMW 773
YSFGV+LLE++SGQ I+ + A +I L + +GDI+GI+DP L + +D S W
Sbjct: 760 YSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAW 819
Query: 774 KIEEKALMCVLPHGHMRPSISEVLKDIQ 801
KI E A+ C RP++S V+ +++
Sbjct: 820 KITEVAMACASSSSKNRPTMSHVVAELK 847
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 869 (311.0 bits), Expect = 6.8e-117, Sum P(2) = 6.8e-117
Identities = 247/695 (35%), Positives = 363/695 (52%)
Query: 163 KVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTY--FAEIEDLD 220
+VST L +++ + Q VM T N S T + + P +Y FAE+E L
Sbjct: 221 QVSTTLGVNVTDNYDLSQDVMATGATPLNDSETLNITWNVEPPTTKVYSYMHFAELETLR 280
Query: 221 PDESRKFRLVLPGQP---DVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYD 277
+++R+F ++L G S + + K E G L L KT
Sbjct: 281 ANDTREFNVMLNGNDLFGPYSPIPLKTETETNLKPEECEDGACILQLV--------KTSK 332
Query: 278 SSRGPLLNAME---INKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW-- 332
S+ PLLNA+E + +L+ D AI +V + Y + + GDPC+P +SW
Sbjct: 333 STLPPLLNAIEAFTVIDFLQVETDEDDAAAIKNVQNAYGLINRSSWQGDPCVPKQYSWDG 392
Query: 333 LQCN-SDPQPSI-TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL 390
L+C+ SD P I + LS+ LTG I + L+ L L L N+LTG +P+F DL
Sbjct: 393 LKCSYSDSTPPIINFLDLSASGLTGIIAPAIQNLTHLEILALSNNNLTGEVPEFLA--DL 450
Query: 391 RIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPSSLLSKN-VVLNYAGNINL-- 447
+ I + D L G NN LSG VP+SLL K ++L+ N ++
Sbjct: 451 KSIMVID--LRG------------------NN-LSGPVPASLLQKKGLMLHLDDNPHILC 489
Query: 448 ------HEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNNYDKE----QHRHS 497
H+G G K +II+ LF+ KK E + +
Sbjct: 490 TTGSCMHKG-EGEKK-SIIVPVVASIVSLAVIIGALILFLVFRKKKASKVEGTLPSYMQA 547
Query: 498 LPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKV 557
+ P SS A FT S + T ++ +G GGFG+VY+G + +++AVK+
Sbjct: 548 SDGRSPRSS-EPAIVTKNKRFTYSQVVIMTNNFQRILGKGGFGIVYHGFVNGVEQVAVKI 606
Query: 558 LTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL 617
L+ +S QG ++F EV LL R+HH+NLV +GYC E L+YE+M NG LKEH+ GT
Sbjct: 607 LSHSSSQGYKQFKAEVELLLRVHHKNLVGLVGYCDEGENMALIYEYMANGDLKEHMSGT- 665
Query: 618 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
+ +NW RL+I D+A+G+EYLH GC P ++HRD+K++NILL++H AK++DFGLS+
Sbjct: 666 RNRFILNWETRLKIVIDSAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFEAKLADFGLSR 725
Query: 678 -FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 736
F + G +HVS++V GT GYLDPEYY + +LT+KSDVYSFG++LLE+I+ + I +
Sbjct: 726 SFPIGGETHVSTVVAGTPGYLDPEYYKTNRLTEKSDVYSFGIVLLEMITNRPVIDQSR-- 783
Query: 737 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 796
I +W + + GDI I+DPSL +YD S+WK E A+ C+ P RP++S+V
Sbjct: 784 -EKPYISEWVGIMLTKGDIISIMDPSLNGDYDSGSVWKAVELAMSCLNPSSTRRPTMSQV 842
Query: 797 LKDIQXXXXXXXXXXXXXXGNSDDM-SRNSLHSSL 830
L + G S DM S++SL SL
Sbjct: 843 LIALNECLVSENSRG----GASRDMDSKSSLEVSL 873
|
|
| TAIR|locus:2059093 FRK1 "FLG22-induced receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 7.7e-116, Sum P(2) = 7.7e-116
Identities = 175/455 (38%), Positives = 259/455 (56%)
Query: 357 IPSDLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXR 415
I SD T +V L + + L G I P FS +R + L N LTG
Sbjct: 406 IQSDNTTNPRVVSLNISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLT 465
Query: 416 ELYVQNNMLSGTVPSSL--LSKN--VVLNYAGNINL----HEGGRGAKHLNIIIXXXXXX 467
EL V+ N L+G VP L SKN + L + N +L K+ N I
Sbjct: 466 ELNVEGNKLTGIVPQRLHERSKNGSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVV 525
Query: 468 XXXXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDAT 527
LF + K+Q R +L +R N A F S++ + T
Sbjct: 526 GIIVVLLTALALF------RRFKKKQQRGTLG-ER-----NGPLKTAKRYFKYSEVVNIT 573
Query: 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 587
E+ IG GGFG VY+G + +G+++AVKVL+ S QG +EF EV LL R+HH NL
Sbjct: 574 NNFERVIGKGGFGKVYHGVI-NGEQVAVKVLSEESAQGYKEFRAEVDLLMRVHHTNLTSL 632
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+GYC E VL+YE+M N L ++L G + ++W +RL+I+ DAA+G+EYLH GC
Sbjct: 633 VGYCNEINHMVLIYEYMANENLGDYLAGKRSFI--LSWEERLKISLDAAQGLEYLHNGCK 690
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
P I+HRD+K +NILL++ ++AK++DFGLS+ F+V+G+ +S++V G++GYLDPEYY ++Q
Sbjct: 691 PPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVEGSGQISTVVAGSIGYLDPEYYSTRQ 750
Query: 707 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766
+ +KSDVYS GV+LLE+I+GQ AI++ K +I + + +GDI+GI+D L +
Sbjct: 751 MNEKSDVYSLGVVLLEVITGQPAIASSK--TEKVHISDHVRSILANGDIRGIVDQRLRER 808
Query: 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801
YD+ S WK+ E AL C RP++S+V+ +++
Sbjct: 809 YDVGSAWKMSEIALACTEHTSAQRPTMSQVVMELK 843
|
|
| TAIR|locus:2066133 AT2G28960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 3.3e-115, Sum P(2) = 3.3e-115
Identities = 170/445 (38%), Positives = 241/445 (54%)
Query: 367 LVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 425
++ L L L G I P F +LR + L +N TG + + N L+
Sbjct: 410 IISLDLSSRGLKGVIAPAFQNLTELRKLDLSNNSFTGGVPEFLASMKSLSIINLNWNDLT 469
Query: 426 GTVPSSLLS--KN-VVLNYAGNINLHEGGRGAKHLN---II-IXXXXXXXXXXXXXXXXC 478
G +P LL KN + L GN L + N I+ +
Sbjct: 470 GPLPKLLLDREKNGLKLTIQGNPKLCNDASCKNNNNQTYIVPVVASVASVLIIIAVLILI 529
Query: 479 LFMHKGKKNNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSG 537
L K + D +H LP RP S FT S++E T E+ +G G
Sbjct: 530 LVFKKRRPTQVDSLPTVQHGLP-NRP-SIFTQTKR-----FTYSEVEALTDNFERVLGEG 582
Query: 538 GFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 597
GFGVVY+G L + IAVK+L+ +S QG +EF EV LL R+HH NLV +GYC EE
Sbjct: 583 GFGVVYHGILNGTQPIAVKLLSQSSVQGYKEFKAEVELLLRVHHVNLVSLVGYCDEESNL 642
Query: 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 657
L+YE+ NG LK+HL G + W RL+I + A+G+EYLHTGC P ++HRD+K+
Sbjct: 643 ALLYEYAPNGDLKQHLSGERGGSP-LKWSSRLKIVVETAQGLEYLHTGCKPPMVHRDVKT 701
Query: 658 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 716
+NILLD+H +AK++DFGLS+ F V G +HVS+ V GT GYLDPEYY + +L +KSDVYSF
Sbjct: 702 TNILLDEHFQAKLADFGLSRSFPVGGETHVSTAVAGTPGYLDPEYYRTNRLNEKSDVYSF 761
Query: 717 GVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 776
G++LLE+I+ + I + +I W + GDI+ ++DP L +Y+ S+WK
Sbjct: 762 GIVLLEIITSRPVIQQTR---EKPHIAAWVGYMLTKGDIENVVDPRLNRDYEPTSVWKAL 818
Query: 777 EKALMCVLPHGHMRPSISEVLKDIQ 801
E A+ CV P RP++S+V +++
Sbjct: 819 EIAMSCVNPSSEKRPTMSQVTNELK 843
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_280116 | hypothetical protein (924 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 854 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 1e-78 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-35 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-32 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-28 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 1e-78
Identities = 109/304 (35%), Positives = 154/304 (50%), Gaps = 29/304 (9%)
Query: 1 MTLRHFPADSRKYCYKLDVIT--RTRYLIRATFLYGNFDNNN---VYPKFDISLGPTHWS 55
TLR FP D ++ CY L V T+YLIRATFLYGN+D N P FD+ LG W+
Sbjct: 49 KTLRSFP-DGKRNCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWT 107
Query: 56 TIVISDAA--TIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDR 113
T+ +S+ + ++ +I + S + VCL N TG PFIS LELR S+Y +
Sbjct: 108 TVNLSNDSGDSVVKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGS- 166
Query: 114 YYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLR 173
L + AR+NFG +RYPDD +DRIWE + G ++ST L +D+
Sbjct: 167 QALKLVARLNFGGSEGT-IRYPDDVYDRIWEPFF---------SSPGWSQISTSLSVDIS 216
Query: 174 SD---ELPPQKVMQTAVVGTNGSLTYRLNLD-GFPGFG-WAVTYFAEIEDLDPDESRKFR 228
S+ +PP V+QTAV TN S D P F + +FAEI+ L E+R+F
Sbjct: 217 SNNAPYIPPSAVLQTAVTPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFD 273
Query: 229 LVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAME 288
+ + G+ V+ + +Y N+S +L+ T S+ PLLNA+E
Sbjct: 274 IYINGKTVYGD--VSPKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALE 331
Query: 289 INKY 292
I K
Sbjct: 332 IFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 583
L KK+G G FG VY GKLK E+AVK L + S Q EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+V+ LG C EE +V E+M G L +L + +++ L A A+G+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703
+ IHRDL + N L+ +++ K+SDFGLS+ D + + + ++ PE
Sbjct: 120 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 704 SQQLTDKSDVYSFGVILLELIS-GQE 728
+ T KSDV+SFGV+L E+ + G++
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQ 202
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 3e-50
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 12/206 (5%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 583
L KK+G G FG VY G LK E+AVK L + S Q EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+V+ LG C EE ++V E+M G L ++L + ++ L A A+G+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703
+ IHRDL + N L+ +++ K+SDFGLS+ D + + + ++ PE
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 704 SQQLTDKSDVYSFGVILLELIS-GQE 728
+ T KSDV+SFGV+L E+ + G+E
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE 203
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 8e-49
Identities = 75/204 (36%), Positives = 117/204 (57%), Gaps = 13/204 (6%)
Query: 534 IGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
+G GGFG VY + K GK++A+K++ +S E E+ +L +++H N+V+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 592 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAI 650
++E LV E+ G+LK+ L +E +++ + L I +G+EYLH G I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSNG----I 113
Query: 651 IHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-LT 708
IHRDLK NILLD + + K++DFGLSK S + +IV GT Y+ PE + + +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYS 172
Query: 709 DKSDVYSFGVILLELISGQEAISN 732
+KSD++S GVIL EL ++ I
Sbjct: 173 EKSDIWSLGVILYELPELKDLIRK 196
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 7e-46
Identities = 66/202 (32%), Positives = 112/202 (55%), Gaps = 15/202 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 587
+ +K+G G FG VY + K GK +A+KV+ + RE E+ +L ++ H N+V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
++E + LV E+ G L + L G L+ ++ +++ +I +EYLH+
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR--QILS----ALEYLHSK 116
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
I+HRDLK NILLD+ K++DFGL++ +D +++ V GT Y+ PE + +
Sbjct: 117 G---IVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 706 QLTDKSDVYSFGVILLELISGQ 727
D++S GVIL EL++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 73/204 (35%), Positives = 114/204 (55%), Gaps = 16/204 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
L +K+GSG FG VY K K GK +AVK+L S + + E+ +L R+ H N+V+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
+ +++ LV E+ G L ++L G L+ ++ ++ +G+EYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQI------LRGLEYLH- 115
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
IIHRDLK NILLD++ K++DFGL+K + +S +++ V GT Y+ PE +
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLG 172
Query: 705 QQL-TDKSDVYSFGVILLELISGQ 727
K DV+S GVIL EL++G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 532 KKIGSGGFGVVYYGKLKDGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 586
KK+G G FG VY GKLK E+AVK L + S + +++F E ++ ++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 641
LG C EE LV E+M G L ++L + ++ L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-----IVRGTVGY 696
L + +HRDL + N L+ + + K+SDFGLS+ D + +R +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ PE T KSDV+SFGV+L E+ +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (406), Expect = 4e-44
Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLT-SNSYQGKREFTNEVTLLSRIHHRN 583
L KK+G G FG VY G LK E +AVK L S + + EF E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+V+ LG C + +V E+M G L + L H +++ L++A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 702
+ +HRDL + N L+ +++ K+SDFGLS+ D + + ++ PE
Sbjct: 120 SKN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 703 ISQQLTDKSDVYSFGVILLELISG 726
+ T KSDV+SFGV+L E+ +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-37
Identities = 139/485 (28%), Positives = 234/485 (48%), Gaps = 54/485 (11%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
+ + LS L+G IP +L+ LV L L N L+G IP FS P L + L NQ
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS--LLSKNVVLNYAGNINLHEGG------ 451
L+G +P +L N+ +L ++ + +N L G++PS+ L+ N AGNI+L G
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS-AVAGNIDLCGGDTTSGLP 617
Query: 452 -----RGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDK--EQHRHSLPVQRPV 504
R I ++GA L+LA V +G+ N K E + +Q
Sbjct: 618 PCKRVRKTPSWWFYITCTLGA-FLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD 676
Query: 505 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNS 562
S + + T++DI + K E I G G Y GK +K+G + VK + NS
Sbjct: 677 S-------KVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728
Query: 563 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 622
++E+ + ++ H N+V+ +G C+ E + L++E++ L E L
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------- 776
Query: 623 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAV 680
++W +R +IA AK + +LH C PA++ +L I++D ++S GL
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGL--LCT 834
Query: 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 740
D +SS Y+ PE ++ +T+KSD+Y FG+IL+EL++G+ ++ +FG +
Sbjct: 835 DTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVH-G 886
Query: 741 NIVQWAKLHIESGDIQGIIDPSLLDEYDI--QSMWKIEEKALMCVLPHGHMRPSISEVLK 798
+IV+WA+ + IDPS+ + + + ++ AL C RP ++VLK
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 799 DIQDA 803
++ A
Sbjct: 947 TLESA 951
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 532 KKIGSGGFGVVYYGKLKD-GKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ +G G FG VY KD G+ +AVK L+ +S + E+ +LS + H N+V++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 589 G-YCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
G EE ++ ++ E++ G+L L +G L I++ +G+ YLH+
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKY--TRQILEGLAYLHS 119
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYI 703
I+HRD+K +NIL+D K++DFG +K D + VRGT ++ PE
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 704 SQQLTDKSDVYSFGVILLELISGQ 727
++ +D++S G ++E+ +G+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 69/200 (34%), Positives = 111/200 (55%), Gaps = 15/200 (7%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
+KIG GGFG VY + + GKE+A+KV+ S + K + NE+ +L + H N+V++ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 591 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
++ +V EF G+LK+ TLT E +I ++ + + KG+EYLH+
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLT-ESQIAYVCK-----ELLKGLEYLHSN-- 117
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
IIHRD+K++NILL K+ DFGLS D + + + GT ++ PE +
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPY 174
Query: 708 TDKSDVYSFGVILLELISGQ 727
K+D++S G+ +EL G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 7/198 (3%)
Query: 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
K++GSG FGVV+ GK + ++A+K++ + + +F E ++ ++ H NLVQ
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLY 65
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
G C ++ +V E+M NG L +L + ++ L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNGF- 121
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
IHRDL + N L+ + KVSDFGL+++ +D S + V + PE + + +
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 709 DKSDVYSFGVILLELISG 726
KSDV+SFGV++ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 68/195 (34%), Positives = 111/195 (56%), Gaps = 9/195 (4%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
K++G+G FGVV YGK + ++A+K++ S + EF E ++ ++ H LVQ G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 592 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 651
++ +V E+M NG L +L H +R + LE+ +D +G+ YL + I
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLES---KQFI 122
Query: 652 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQLTDK 710
HRDL + N L+D KVSDFGLS++ +D + SS+ + V + PE + + + K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 711 SDVYSFGVILLELIS 725
SDV++FGV++ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 532 KKIGSGGFGVVYYGKL-----KDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 585
K++G G FG V + G+++AVK L S Q + +F E+ +L + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 586 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
++ G C++ G L+ E++ +G+L+++L H +IN + L + KG++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG 126
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--DGASHVSSIVRGTVGYLDPEY 701
+ IHRDL + NIL++ K+SDFGL+K +V + + PE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 702 YISQQLTDKSDVYSFGVILLELIS 725
+ + + SDV+SFGV L EL +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 48/284 (16%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-TSNSYQGKREFT-NEVTLLSRIHHRNLVQ 586
+ K+IG G FG VY + DGK +K + SN + +RE NEV +L +++H N+++
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAAKGIE 640
+ +E+G+ +V E+ G L + + EQ ++W +L ++
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALK 117
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
YLH+ I+HRD+K NI L + K+ DFG+SK ++V GT YL PE
Sbjct: 118 YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------SGD 754
++ KSD++S G +L EL + + E I+ K S +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL---KGQYPPIPSQYSSE 230
Query: 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
++ ++ SLL K E+ RPSI+++L+
Sbjct: 231 LRNLVS-SLL--------QKDPEE-----------RPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 65/199 (32%), Positives = 108/199 (54%), Gaps = 13/199 (6%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
L ++IGSG FG+V+ G + +++A+K + + +F E ++ ++ H LVQ G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
C E LV+EFM +G L ++L G + E L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE------TLLGMCLDVCEGMAYLESSN 120
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
V IHRDL + N L+ ++ KVSDFG+++F +D S+ + V + PE + +
Sbjct: 121 V---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 707 LTDKSDVYSFGVILLELIS 725
+ KSDV+SFGV++ E+ S
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 74/202 (36%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 534 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 589
+G G FG V + KD GK A+KVL ++E E +LSRI+H +V+ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59
Query: 590 YC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 645
Y Q E + LV E+ G L HL G + E+R R AE +EYLH+ G
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS-EERA----RFYAAE-IVLALEYLHSLG 113
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
II+RDLK NILLD K++DFGL+K S ++ GT YL PE + +
Sbjct: 114 ----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 706 QLTDKSDVYSFGVILLELISGQ 727
D +S GV+L E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 8e-29
Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRI-HHRNL 584
+ +K+G G FG VY + D K +A+KVL + + F E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
V+ + Q+EG LV E++ G+L++ L + + ++ + L I +EYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 645 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-----SIVRGTVGYLD 698
IIHRD+K NILLD+ K+ DFGL+K D S S S GT GY+
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 699 PEYYISQQL---TDKSDVYSFGVILLELISGQ 727
PE + L + SD++S G+ L EL++G
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 11/192 (5%)
Query: 534 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 593
IG G FG V G + G+++AVK L +S + F E ++++ + H NLVQ LG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 594 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHR 653
+V E+M G+L ++L I ++L A D +G+EYL +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 654 DLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 713
DL + N+L+ + + AKVSDFGL+K AS + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 714 YSFGVILLELIS 725
+SFG++L E+ S
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
LE+K+GSG FG V+ G K+ +A+K+L S+ +++F EV L R+ H++L+
Sbjct: 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
C ++ E M G+L L Q + +++A A+G+ YL
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE---QN 124
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
IHRDL + NIL+ + + KV+DFGL++ + ++SS + + PE +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFST 183
Query: 710 KSDVYSFGVILLELIS 725
KSDV+SFG++L E+ +
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 580
++E ++ K+G G +G VY G K +AVK L ++ + + EF E ++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 60
Query: 581 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
H NLVQ LG C E ++ EFM G L ++L + Q +N + L +A + +E
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAME 118
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
YL IHRDL + N L+ ++ KV+DFGLS+ + + + + PE
Sbjct: 119 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 701 YYISQQLTDKSDVYSFGVILLEL 723
+ + KSDV++FGV+L E+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 68/197 (34%), Positives = 105/197 (53%), Gaps = 8/197 (4%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGY 590
+KIG G FG VY G LK E+AVK S KR+F E +L + H N+V+ +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 591 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 650
C ++ +V E + G+L L + R+ K L+++ DAA G+EYL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114
Query: 651 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLTD 709
IHRDL + N L+ ++ K+SDFG+S+ G VS ++ + + PE + T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 710 KSDVYSFGVILLELISG 726
+SDV+S+G++L E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-28
Identities = 138/528 (26%), Positives = 225/528 (42%), Gaps = 67/528 (12%)
Query: 2 TLRHFP-ADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVI- 59
TLR+FP +D + CY ++ + + Y +R F N + P FD+S+ T S++
Sbjct: 71 TLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSG 130
Query: 60 --SDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYL--TPFEDRYY 115
S + L+FL +C + G P I ++E+ Q + Y +
Sbjct: 131 WSSHDEQVFAEALVFLTDG-SASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWGQGVI 189
Query: 116 LSVSARINFGA-DSEAPVRYPDDPF--DRIWESDSLKKANYLVDVAAGTEKVSTKLPIDL 172
L + R++ GA S+ Y D + DR W + D A TE V K
Sbjct: 190 LRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSG--SDQAISTENVIKKA---S 244
Query: 173 RSDELPPQKVMQTAVVGTNG--SLTYRLNLDGFPGFGWAV-TYFAEIED-LDPDESRKFR 228
+ P+ + Q+A+V T+ L+Y +++D P ++V +FAEI++ + + R F
Sbjct: 245 NAPNFYPESLYQSALVSTDTQPDLSYTMDVD--PNRNYSVWLHFAEIDNSITAEGKRVFD 302
Query: 229 LVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLP---FVLSFKFGKTYDSSRGP--L 283
+++ G D + V+I + + +Y T L L V +G +
Sbjct: 303 VLING--DTAFKDVDIVKMSGERY-------TALVLNKTVAVSGRTLTIVLQPKKGTHAI 353
Query: 284 LNAMEINKYLERNDGSIDGVA-----IVSVISLYSSADWAQEGGDPCLPV--PWSWLQCN 336
+NA+E+ + + ++ + S + L W GDPC+P PWS C
Sbjct: 354 INAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGW---NGDPCVPQQHPWSGADCQ 410
Query: 337 SDPQPS---ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRI 392
D I + L ++ L G IP+D++KL L + L GNS+ G IP L +
Sbjct: 411 FDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV 470
Query: 393 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINL-- 447
+ L N G +P SL L +LR L + N LSG VP++L L N+ N L
Sbjct: 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530
Query: 448 ----HEGGR----GAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKN 487
G GAK IG + G +V L V+ + K ++N
Sbjct: 531 IPGLRACGPHLSVGAK-----IGIAFGVSVAFLFLVICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 529 MLEKKIGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLV 585
L IG G FGVVY G L+ G +A+K L + + E+ LL + H N+V
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+++G + ++ E+ NG+L++ + +G ++ ++ +G+ YLH
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAYLH 116
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703
+IHRD+K++NIL K K++DFG++ ++ S + V GT ++ PE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 704 SQQLTDKSDVYSFGVILLELISGQ 727
+ SD++S G ++EL++G
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
+KIG G G VY GKE+A+K + Q K NE+ ++ H N+V +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 591 CQEEGRSV-LVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
G + +V E+M G+L + + +E +I ++ R E+ + G+EYLH+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-EVLQ----GLEYLHSQ-- 135
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---GASHVSSIVRGTVGYLDPEYYIS 704
+IHRD+KS NILL K K++DFG FA S +S+V GT ++ PE
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 705 QQLTDKSDVYSFGVILLELISGQ 727
+ K D++S G++ +E+ G+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 64/197 (32%), Positives = 107/197 (54%), Gaps = 13/197 (6%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
K++GSG FGVV+ GK + ++A+K + + + +F E ++ ++ H LVQ G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 592 QEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
++ +V EFM NG L +L G L+ + L + +D +G+EYL
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML------LSMCQDVCEGMEYLERN--- 119
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
+ IHRDL + N L+ KVSDFG++++ +D SS + V + PE + + +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 709 DKSDVYSFGVILLELIS 725
KSDV+SFGV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 534 IGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGK---REFTNEVTLLSRIHHRNLVQF 587
+GSG FG VY G L DG AVK L + G+ ++ E+ LLS++ H N+VQ+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
LG +EE + E + G+L + L YG+ + +++ G+EYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LLGLEYLHDR 121
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
+HRD+K +NIL+D + K++DFG++K V+ + S +G+ ++ PE Q
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 706 QLTD-KSDVYSFGVILLELISGQ 727
+D++S G +LE+ +G+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 529 MLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 583
+EK IG G FG V G+L K ++A+K L + S +R +F E +++ + H N
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+++ G + +++ E+M NG+L + L ++ + + + + A G++YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLDPE 700
+HRDL + NIL++ ++ KVSDFGLS+ S + +G + + PE
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSR--RLEDSEATYTTKGGKIPIRWTAPE 178
Query: 701 YYISQQLTDKSDVYSFGVILLELIS 725
++ T SDV+SFG+++ E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 581
+I+ + L +K+G+G FG V+ G + +AVK L + K +F E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRH 60
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAK 637
L+Q C E +V E M G+L E+L G L Q I ++A A
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI------DMAAQVAS 114
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 697
G+ YL IHRDL + N+L+ ++ KV+DFGL++ + + + +
Sbjct: 115 GMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 698 DPEYYISQQLTDKSDVYSFGVILLELIS 725
PE + + + KSDV+SFG++L E+++
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 530 LEKKIGSGGFGVVYYGKL-----KDGKEI-AVKVLT-SNSYQGKREFTNEVTLLSRIHHR 582
L++++G G FG V+ G+ ++ KE+ AVK L + S +++F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEIA 632
N+V+F G C E ++V+E+M +G L + L + + + L+IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 633 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 692
A G+ YL + +HRDL + N L+ + K+ DFG+S+ D + V G
Sbjct: 129 VQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGG 182
Query: 693 T----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ ++ PE + ++ T +SDV+SFGV+L E+ +
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLG 589
K +G G GVVY + K GK A+K + + + +++ E+ L +V+ G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTGC 646
+EG +V E+M G+L + L +++ I IA KG++YLHT
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGLDYLHT-- 117
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
IIHRD+K SN+L++ K++DFG+SK + ++ V GTV Y+ PE +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176
Query: 707 LTDKSDVYSFGVILLELISGQ 727
+ +D++S G+ LLE G+
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
LE+K+G+G FG V+ G ++AVK L + F E ++ ++ H LVQ
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
C EE +V E+M G+L + L + R+ + +++A A+G+ YL +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES---RN 123
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
IHRDL + NIL+ +++ K++DFGL++ D + + + PE + T
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 710 KSDVYSFGVILLELIS 725
KSDV+SFG++L E+++
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 47/219 (21%)
Query: 532 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+++G G FG V Y L+D G+ +AVK L ++ + R+F E+ +L + H N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 587 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
+ G C GR LV E++ G+L+++L H +R++ K L A KG+EYL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
+HRDL + NIL++ R K+ DFGL+K V D EYY
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTK----------------VLPQDKEYYKV 167
Query: 705 QQ-------------LTD-----KSDVYSFGVILLELIS 725
++ LT+ SDV+SFGV+L EL +
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLT-SNSYQGKREFT 570
LS + +++G G FG VY G+L +A+K L + + ++EF
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 571 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE---------- 620
E L+S + H N+V LG C +E + +++E++ +G L E L H
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 621 --QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678
++ L IA A G+EYL + +HRDL + N L+ + + K+SDFGLS+
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR- 172
Query: 679 AVDGASH----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
D S V S V ++ PE + + T +SD++SFGV+L E+ S
Sbjct: 173 --DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 39/227 (17%)
Query: 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREF-TNEVTLLSRI-HHR 582
K IG G F V K K KE A+K+L + K ++ E +L+R+ H
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 640
+++ Q+E V E+ NG L +++ YG+L E+ + AE +E
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTRFY----AAE-ILLALE 116
Query: 641 YLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----------AVDGASHVSSI 689
YLH+ G IIHRDLK NILLDK M K++DFG +K D + S I
Sbjct: 117 YLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 690 VR---------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
+ GT Y+ PE + SD+++ G I+ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 534 IGSGGFG-VVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
+G G FG Y + +D + K LT S + +R+ NE+ +LS + H N++ + +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 591 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
++ ++ E+ + GTL + G L E+ + W + Y+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY-----LFQIVSAVSYIHKA-- 120
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
I+HRD+K+ NI L K K+ DFG+SK S ++V GT Y+ PE +
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 708 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 744
KSD+++ G +L EL++ + IVQ
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 18/200 (9%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
KKIG G FG +Y K K D + +K LT + K EV LL+++ H N+V F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 644
QE GR +V E+ G L + + G L E +I +W ++ + G++++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119
Query: 645 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703
I+HRD+KS NI L K+ M AK+ DFG+++ ++ + ++ GT YL PE
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 704 SQQLTDKSDVYSFGVILLEL 723
++ +K+D++S G +L EL
Sbjct: 176 NRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 66/196 (33%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
L + IG G FG V G+ G+++AVK + + + F E +++++HH+NLV+ LG
Sbjct: 10 LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
G + V E M G L L ++ I+ L+ + D A+G+EYL +
Sbjct: 67 VILHNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
++HRDL + NIL+ + AKVSDFGL++ G + V+ T PE ++ +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSS 176
Query: 710 KSDVYSFGVILLELIS 725
KSDV+S+GV+L E+ S
Sbjct: 177 KSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ LG
Sbjct: 10 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 590 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
EE + +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN--- 121
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
+HRDL + N+L+ + AKVSDFGL+K AS + V + PE ++ +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 709 DKSDVYSFGVILLELIS 725
KSDV+SFG++L E+ S
Sbjct: 178 TKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 532 KKIGSGGFGVVYYGKLKD-GKEIAVKVLT--SNSYQGKRE---FTNEVTLLSRIHHRNLV 585
K +G G FG VY D G+E+AVK + +S + K+E E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 586 QFLGYCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
Q+ G C + ++ ++ E+M G++K+ L YG LT + + +I E G+EYL
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR--QILE----GVEYL 120
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPE 700
H+ I+HRD+K +NIL D K+ DFG SK S + + V GT ++ PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 701 YYISQQLTDKSDVYSFGVILLELIS 725
+ K+DV+S G ++E+++
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 532 KKIGSGGFGVVYYG--KLKDGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 586
K++G G FG V G +K GKE+ AVK L GK+EF E ++++++ H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
+G C+ E +LV E G L ++L + I E+A A G+ YL +
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-- 113
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE--YY 702
+HRDL + N+LL +AK+SDFG+S+ G+ + + G + + PE Y
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 703 ISQQLTDKSDVYSFGVILLELIS 725
+ + KSDV+S+GV L E S
Sbjct: 173 --GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 23/209 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 584
+E+ IG+G FG V G+LK GK +A+K L S + + +R+F +E +++ + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
+ G + +++ EFM NG L L ++ + I+ + + A G++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS---HVSSI-----VRGTVGY 696
+HRDL + NIL++ ++ KVSDFGLS+F D S + SS+ +R T
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA-- 179
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELIS 725
PE ++ T SDV+S+G+++ E++S
Sbjct: 180 --PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 62/210 (29%), Positives = 114/210 (54%), Gaps = 13/210 (6%)
Query: 523 IEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQGKREFTNEVTLLS 577
I+ + +EK IG+G FG V G+LK +EI V + T + + +R+F +E +++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 578 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 637
+ H N++ G + ++V E+M NG+L L H+ + I+ + + A
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIAS 117
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVG 695
G++YL +HRDL + NIL++ ++ KVSDFGLS+ D A++ + + +
Sbjct: 118 GMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ PE ++ T SDV+S+G+++ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 9/218 (4%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+ KIG G FGVV+ K D + A+K L+ + + + E +E +L+++ +++
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
+ ++G+ +V E+ NG L + L + + R I G+ +LH+
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK- 120
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
I+HRD+KS N+ LD + K+ D G++K D + ++IV GT YL PE +
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKP 177
Query: 707 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 744
+KSDV++ GV+L E +G+ GA I++
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
L KK+G+G FG V+ G ++A+K L S F E L+ ++ H LV+
Sbjct: 10 LVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYA 68
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
+E ++ E+M NG+L + L + IN K +++A A+G+ ++
Sbjct: 69 VVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKN 122
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
IHRDL+++NIL+ + + K++DFGL++ D + + + PE T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 710 KSDVYSFGVILLELIS 725
KSDV+SFG++L E+++
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
EE +V E+M G+L + L G + R+ + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVER---MN 122
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 710 KSDVYSFGVILLELIS 725
KSDV+SFG++L EL +
Sbjct: 183 KSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-22
Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 37/278 (13%)
Query: 534 IGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTN---EVTLLSRIHHRNLVQF 587
+G G +G VY G G+ IAVK + TSN ++E+ EV LL + H N+VQ+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
LG C ++ + EF+ G++ L +G L + K++ G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDGVAYLHNN 121
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSS----IVRGTVGYLDPE 700
CV +HRD+K +N++L + K+ DFG + + A G S + GT ++ PE
Sbjct: 122 CV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760
KSD++S G + E+ +G+ +++ A A +I G +G++
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYI--GAHRGLM- 227
Query: 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
P L D + ++ + C+ H RPS ++L+
Sbjct: 228 PRLPDSFSAAAI----DFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 533 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
++G G G V +LK+ I A+K + T + +++ E+ + +V++ G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 591 CQEEGRSVL--VYEFMHNGTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+E S + E+ G+L + +Y RI +IAE KG+ YLH+
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--- 123
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
IIHRD+K SNILL + + K+ DFG+S V + ++ GT Y+ PE +
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYMAPERIQGKPY 180
Query: 708 TDKSDVYSFGVILLELISG 726
+ SDV+S G+ LLE+
Sbjct: 181 SITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 73/252 (28%), Positives = 106/252 (42%), Gaps = 40/252 (15%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 589
I G +G V+ K K +I A+KV+ K + E +LS+ +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 590 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
Q + LV E++ G L G+L + + R+ IAE +EYLH+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIAE-IVLALEYLHSN-- 112
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--------DGASHVSSIVRGTVGYLDP 699
IIHRDLK NIL+D + K++DFGLSK + D IV GT Y+ P
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAP 170
Query: 700 EYYISQQLTDKSDVYSFGVILLELISG----QEAISNEKFGANCRNIVQWAKLHIESGDI 755
E + Q + D +S G IL E + G E F +I +G I
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ------------NILNGKI 218
Query: 756 QGIIDPSLLDEY 767
+ D + DE
Sbjct: 219 EWPEDVEVSDEA 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 40/278 (14%)
Query: 532 KKIGSGGFGVVYYGKLKDG------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 585
+ +G G FG+V+ + K K+I V+ +T + + NE +L + H N++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
++ E+ ++V E+ GTL E++ ++ + + I + + LH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 646 CVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
I+HRDLK+ NILLDKH M K+ DFG+SK + + + V GT Y+ PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEG 175
Query: 705 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID---P 761
+ KSD+++ G +L EL S + A AN +V L I SG I D P
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFE----AANLPALV----LKIMSGTFAPISDRYSP 227
Query: 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
L I SM + RP +S+++
Sbjct: 228 DL--RQLILSMLNL----------DPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 532 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 588
KIG G FG VY L G+ +AVK + K +E +E+ +L + H NLV++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGC 646
G + + E+ GTL+E L +G + E I + +L +G+ YLH+
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL------LEGLAYLHSH- 118
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYI 703
I+HRD+K +NI LD + K+ DFG + + + + V+ G Y+ PE
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 704 SQQLTDK---SDVYSFGVILLELISG 726
+ +D++S G ++LE+ +G
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 68/295 (23%), Positives = 128/295 (43%), Gaps = 58/295 (19%)
Query: 534 IGSGGFGVVYYGKLK----DGKE--IAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 586
+G G FG V+ K K +G E + VK L + + EF E+ + ++ H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-----QRINWIKRLEIAEDAAKGIEY 641
LG C+E ++ E+ G LK+ L T + + ++ +++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDP 699
L +HRDL + N L+ KVS LSK + + ++++ + +L P
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAP 187
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLHIESGDI 755
E + KSDV+SFGV++ E+ + E +S+E+ +++G +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----------LQAGKL 236
Query: 756 QGIIDPSLLDEYDIQSMWKIEEKA------LM--CVLPHGHMRPSISEVLKDIQD 802
+ + E LM C + RPS SE++ + +
Sbjct: 237 E----------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 59/202 (29%), Positives = 113/202 (55%), Gaps = 13/202 (6%)
Query: 531 EKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLV 585
+K IG+G FG V+ G LK G++ +A+K L + +R +F +E +++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
+ G + ++++ E+M NG L ++L H+ + + + + A G++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLR---DHDGEFSSYQLVGMLRGIAAGMKYLSD- 125
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEYYI 703
+HRDL + NIL++ ++ KVSDFGLS+ D ++ +S + + + PE
Sbjct: 126 --MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 704 SQQLTDKSDVYSFGVILLELIS 725
++ T SDV+SFG+++ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 534 IGSGGFGVVYYGKL--KDGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLVQFL 588
IG G FG VY+G L DG++I AVK L + +F E ++ H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 589 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTGC 646
G C EG ++V +M +G L+ + E +K L AKG+EYL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI----RSETHNPTVKDLIGFGLQVAKGMEYLAS-- 116
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYI 703
+HRDL + N +LD+ KV+DFGL++ D + H + + V ++ E
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 704 SQQLTDKSDVYSFGVILLELIS 725
+Q+ T KSDV+SFGV+L EL++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 532 KKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 585
K +GSG FG VY G E +A+KVL S + +E +E +++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 642
+ LG C + L+ + M G L +++ + + +NW AKG+ YL
Sbjct: 73 RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY 701
++HRDL + N+L+ K++DFGL+K VD + + + + ++ E
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 702 YISQQLTDKSDVYSFGVILLELIS 725
+ + T KSDV+S+GV + EL++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 589
++IG G FG V+ G+L+ D +AVK K +F E +L + H N+V+ +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
C ++ +V E + G L T R+ + +++ E+AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKHC-- 115
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLT 708
IHRDL + N L+ + K+SDFG+S+ DG + ++ V + PE + +
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 709 DKSDVYSFGVILLELIS 725
+SDV+SFG++L E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 26/221 (11%)
Query: 534 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE----------FTNEVTLLSRIHHR 582
IG G +G VY + G+ +AVK + + R +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 640
N+VQ+LG+ E + E++ G++ L YG EQ + + E +G+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF-EEQLVRFF-----TEQVLEGLA 122
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDP 699
YLH+ I+HRDLK+ N+L+D K+SDFG+SK + D + ++ ++G+V ++ P
Sbjct: 123 YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 700 EYYISQQ--LTDKSDVYSFGVILLELISGQEAISN-EKFGA 737
E S + K D++S G ++LE+ +G+ S+ E A
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-21
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 529 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 582
+L++++G G FG V+ + +D +AVK L S +++F E LL+ + H
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----GTLTHE----QRINWIKRLEIAE 633
++V+F G C E ++V+E+M +G L + L L E + + L IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 634 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVR 691
A G+ YL + +HRDL + N L+ +++ K+ DFG+S+ ++ D V
Sbjct: 128 QIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTM 183
Query: 692 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ ++ PE + ++ T +SDV+S GV+L E+ +
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
++G+G GVV + GK +AVK L N K+ E+ +L + + +V F
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-ILRELDILHKCNSPYIVGFY 65
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTG 645
G G + E+M G+L + L ++ I +IA KG+ YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE- 118
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
IIHRD+K SNIL++ + K+ DFG+S V+ + GT Y+ PE
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGN 174
Query: 706 QLTDKSDVYSFGVILLELISGQEAISNEKFGAN 738
+ KSD++S G+ L+EL +G+ E +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 34/222 (15%)
Query: 529 MLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 582
+L++++G G FG V+ + KD +AVK L + +++F E LL+ + H
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 67
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIKRLE 630
++V+F G C + ++V+E+M +G L + L + + + L
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 631 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 683
IA A G+ YL + +HRDL + N L+ ++ K+ DFG+S+ + V G
Sbjct: 128 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG- 183
Query: 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
H +R ++ PE + ++ T +SDV+SFGVIL E+ +
Sbjct: 184 -HTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 28/211 (13%)
Query: 534 IGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKRE-------FTNEVTLLSRIHHRN 583
IGSG FG VY G G+ +AVK L S S K E+ LL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 641
+VQ+LG + + E++ G++ L YG N+++++ KG+ Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGLNY 121
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------FAVDGASHVSSIVRGTVG 695
LH IIHRD+K +NIL+D K+SDFG+SK + S+ +G+V
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL-QGSVF 177
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELISG 726
++ PE T K+D++S G +++E+++G
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 532 KKIGSGGFGVVY---YGKLKD--GKEIAVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLV 585
+ +G G FG V Y D G+ +AVK L Q + E+ +L ++H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 586 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
++ G C E+G L+ E++ G+L+++L + ++N + L A+ +G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 701
+ IHRDL + N+LLD K+ DFGL+K +G + V V + E
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 702 YISQQLTDKSDVYSFGVILLELIS 725
+ + SDV+SFGV L EL++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 81/293 (27%), Positives = 126/293 (43%), Gaps = 60/293 (20%)
Query: 529 MLEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 579
+L++++G G FG VY K LK KEI V L N + E LLS++
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKL 59
Query: 580 HHRNLVQFLG-------------YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 626
H +V+F YC+ + E H G TL+ Q W
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-------TLSENQVCEWF 112
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686
+L + G+ Y+H I+HRDLK+ NI L ++ K+ DFG+S+ + G+ +
Sbjct: 113 IQLLL------GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDL 161
Query: 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 746
++ GT Y+ PE Q KSD++S G IL E+ A + F + IV+
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-- 219
Query: 747 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
G PSL + Y + + I + L +RPS +E+L++
Sbjct: 220 ------GPT-----PSLPETYS-RQLNSIMQSMLN---KDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 8e-21
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 35/224 (15%)
Query: 531 EKKIGSGGFGVVYYGK---LKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 583
+ IG G FG V+ + L + +AVK+L S + +F E L++ H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ------------------RINW 625
+V+ LG C L++E+M G L E L Q ++
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 626 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVD-- 681
++L IA+ A G+ YL +HRDL + N L+ ++M K++DFGLS+ ++ D
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
AS +I + ++ PE + T +SDV+++GV+L E+ S
Sbjct: 187 KASENDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 588
KIG G +GVVY + K EI A+K + T E+ LL ++H N+++ L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 640
+ +G LV+EFM LY + QR + E K G+
Sbjct: 65 DVFRHKGDLYLVFEFMD-----TDLYKLIKDRQR-------GLPESLIKSYLYQLLQGLA 112
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 699
+ H+ I+HRDLK N+L++ K++DFGL++ F + +V T Y P
Sbjct: 113 FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAP 167
Query: 700 E-YYISQQLTDKSDVYSFGVILLELISGQ 727
E + + D++S G I EL+S +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-------AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
IG G FG V + +D K++ K + S + NE +L ++H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL---NERRILQELNHPFLVN 64
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
Q+E LV + + G L+ HL + EQ + I E +EYLH+
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-----VKFWICE-IVLALEYLHS 118
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
IIHRD+K NILLD+ ++DF ++ S GT GY+ PE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS--TSGTPGYMAPEVLCR 173
Query: 705 QQLTDKSDVYSFGVILLELISG 726
Q + D +S GV E + G
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLV 585
+ IG G FG V + K DGK + K + Y + K++ +EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 586 QFLGYCQEEGRSVL--VYEFMHNGTL--------KEHLYGTLTHEQRINWIKRLEIAEDA 635
++ + L V E+ G L KE Y + E + +L +A
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY--IEEEFIWRILTQLLLA--- 117
Query: 636 AKGIEYLHTGCVP--AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 693
+ H P ++HRDLK +NI LD + K+ DFGL+K +S + V GT
Sbjct: 118 ---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
Query: 694 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
Y+ PE +KSD++S G ++ EL +
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
L KK+G+G FG V+ G ++AVK L + F E ++ ++ H LVQ
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
EE +V E+M G+L + L + + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER---MN 122
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
IHRDL+S+NIL+ + K++DFGL++ D + + + PE + + T
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 710 KSDVYSFGVILLELIS 725
KSDV+SFG++L EL++
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 529 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 582
+L+ ++G G FG V+ + +D +AVK L S +++F E LL+ + H+
Sbjct: 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ 67
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----------GTLTHEQRINWIKRLEI 631
++V+F G C E ++V+E+M +G L L G ++ + L I
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 632 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSI 689
A A G+ YL + +HRDL + N L+ + + K+ DFG+S+ ++ D V
Sbjct: 128 ASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGR 183
Query: 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ ++ PE + ++ T +SD++SFGV+L E+ +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 530 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHR 582
L + +G G FG VY G + D E+ V V T S S Q + +F E ++S+ +H+
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGI 639
N+V+ +G E ++ E M G LK L +R + L A D AKG
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 640 EYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGT--V 694
+YL IHRD+ + N LL AK++DFG+++ + AS+ R +
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-DIYRASYYRKGGRAMLPI 185
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
++ PE ++ T K+DV+SFGV+L E+ S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 29/209 (13%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQG-----KREFTNEVTLLSRIHHRNL 584
+IG G +G VY + K G+ +A+K + N +G RE + LL ++ H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPNI 60
Query: 585 VQFLGYCQEEGR-SV-LVYEFM-H--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
V+ +G+ S+ +V+E+M H G L T Q ++K+L +G+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQL------LEGL 113
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 698
+YLH+ I+HRD+K SNIL++ K++DFGL+ + ++ ++ V T+ Y
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 699 PEYYI-SQQLTDKSDVYSFGVILLELISG 726
PE + + + + D++S G IL EL G
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 530 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHR 582
L +++G G FG+VY G K +A+K + N+ +R EF NE +++ +
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 630
++V+ LG +++V E M G LK +L G T ++ I
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM----- 124
Query: 631 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 683
A + A G+ YL +HRDL + N ++ + + K+ DFG+++ + G
Sbjct: 125 -AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ VR ++ PE T KSDV+SFGV+L E+ +
Sbjct: 181 GLLP--VR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 534 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQ 592
+G G FG V+ G LKD +AVK + Q K +F +E +L + H N+V+ +G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 593 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAII 651
+ +V E + G L + + + ++ A DAA G+ YL + C I
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 652 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 711
HRDL + N L+ ++ K+SDFG+S+ DG S + + + + PE + + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 712 DVYSFGVILLELIS 725
DV+S+G++L E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 7e-20
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 34/211 (16%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKV---------LTSNSYQGKREFTNEVTLLSRIHH 581
+K+G G +GVVY + K G+ +A+K + S + + E++LL + H
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKH 57
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKG 638
N+V+ L E + LV+E+ LK + G L+ N IK I +G
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS----PNLIKS--IMYQLLRG 110
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYL 697
+ Y H+ I+HRDLK NIL+++ K++DFGL++ F + ++ +V T+ Y
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYR 165
Query: 698 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
PE + + + D++S G I E+I+G+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-20
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 532 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLV 585
+ +G G FG V Y D G+++AVK L S + E+ +L ++H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 586 QFLGYCQEEG-RSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
++ G C E+G + L+ EF+ +G+LKE+L IN ++L+ A KG++YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 701
+ +HRDL + N+L++ + K+ DFGL+K + V + V + PE
Sbjct: 127 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 702 YISQQLTDKSDVYSFGVILLELIS 725
I + SDV+SFGV L EL++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 525 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 584
++ K++ KK+G+G FG V+ G + ++AVK L + + F E L+ + H L
Sbjct: 6 ESIKLV-KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKL 63
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
V+ +E ++ E+M G+L + L ++ K ++ + A+G+ Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
IHRDL+++N+L+ + + K++DFGL++ D + + + PE
Sbjct: 122 ---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 705 QQLTDKSDVYSFGVILLELIS 725
T KSDV+SFG++L E+++
Sbjct: 179 GSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 7/204 (3%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 581
+I + LEKK+G+G FG V+ ++AVK + S F E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
LV+ +E ++ EFM G+L + L +Q + K ++ + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAF 117
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
+ IHRDL+++NIL+ + K++DFGL++ D + + + PE
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 702 YISQQLTDKSDVYSFGVILLELIS 725
T KSDV+SFG++L+E+++
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 532 KKIGSGGFGVVYYGKLKD--GKEI--AVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 586
KK+G G FGVV G+ GK I AVK L S+ +F E ++ + H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTG 645
G ++V E G+L + L I L + A A G+ YL +
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLR---KDALGHFLISTLCDYAVQIANGMRYLES- 115
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV--GYLDPEYYI 703
IHRDL + NILL + K+ DFGL + H V + PE
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 704 SQQLTDKSDVYSFGVILLELIS-GQE 728
++ + SDV+ FGV L E+ + G+E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 44/278 (15%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
KK+G G +G VY K L D + A+K L S S + + + NE+ +L+ ++H N++ +
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 589 GYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+ + +V E+ G L K L EQ I W +++ +G++ LH
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI-WRIFIQLL----RGLQALH 120
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703
I+HRDLKS+NILL + K+ D G+SK +++ GT Y+ PE +
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174
Query: 704 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL----HIESGDIQGII 759
+ + KSD++S G +L E+ + + + R VQ K I S D+Q I
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233
Query: 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 797
++++ V P +RP+ ++L
Sbjct: 234 ------------------RSMLQVKP--KLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLK--DGK--EIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRN 583
L K +G G FG V G+L DG ++AVK L ++Y EF +E + H N
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 584 LVQFLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 635
+++ +G C Q+ + +++ FM +G L L + L+ D
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 636 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTV 694
A G+EYL IHRDL + N +L + M V+DFGLSK G + I + V
Sbjct: 123 ALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 727
++ E + T KSDV++FGV + E+ + GQ
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 529 MLEKKIGSGGFGVVYYGKLKDGKE---------------IAVKVLTSNSYQGKR-EFTNE 572
L++K+G G FG V+ + + E +AVK+L ++ + R +F E
Sbjct: 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67
Query: 573 VTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIK 627
+ ++SR+ + N+++ LG C + ++ E+M NG L + L T TH I +
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 628 R---LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684
L +A A G++YL + +HRDL + N L+ H K++DFG+S+ G
Sbjct: 128 IANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 685 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ + + ++ E + + T SDV++FGV L E+ +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 532 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREF--TNEVTLLSRIHHRNLV 585
K +G G FG V+ + G + A+KVL + + + E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
+ Q EG+ L+ +F+ G L KE ++ T E + +AE A ++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF---TEED-----VKFYLAE-LALALD 112
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
+LH+ II+RDLK NILLD+ K++DFGLSK ++D S GTV Y+ PE
Sbjct: 113 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 168
Query: 701 YYISQQLTDKSDVYSFGVILLELISG 726
+ T +D +SFGV++ E+++G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 74/230 (32%), Positives = 111/230 (48%), Gaps = 46/230 (20%)
Query: 524 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI 579
ED E IG G FG V +K DG ++ A+K+L S R+F E+ +L ++
Sbjct: 2 EDIK--FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 580 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL-----------------KEH-LYGTLTHE 620
HH N++ LG C+ G + E+ G L KEH TLT +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 621 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680
Q L+ A D A G++YL IHRDL + N+L+ +++ +K++DFGLS+
Sbjct: 120 QL------LQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGE- 169
Query: 681 DGASHVSSIVRGTVGYLDPEYYISQQL-----TDKSDVYSFGVILLELIS 725
V+ T+G L + + L T KSDV+SFGV+L E++S
Sbjct: 170 ------EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 526 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTS-NSYQGKREFTNEVTLLSRI 579
A + +E+ +G FG +Y G L + +A+K L N+ Q EF E +L++ +
Sbjct: 6 AVRFMEE-LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL 64
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------EQRINWI 626
HH N+V LG +E +++E+++ G L E L H + ++
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGAS 684
L IA A G+EYL + +H+DL + NIL+ + + K+SD GLS+ ++ D
Sbjct: 125 DFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD-YY 180
Query: 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
V + ++ PE + + + SD++SFGV+L E+ S
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 534 IGSGGFGVVYYGKLKD----GKE---IAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLV 585
+GSG FG VY G D G +AVK L + Q K+EF E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYL 642
+ LG C ++ E M G L +L + + L+I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 643 HTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGASHVSSIVRG----T 693
IHRDL + N L+ D K+ DFGL++ D G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLLP 176
Query: 694 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE---AISN 732
V ++ PE + + T +SDV+SFGV++ E+++ GQ+ A++N
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 588
KKIG G FG K K DGK+ +K + + K E EV +LS + H N+VQ+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 644
+E G +V ++ G L + + G L E +I +W ++ +A ++++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHD 119
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
I+HRD+KS NI L K K+ DFG+++ ++ ++ GT YL PE +
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 705 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP-SL 763
+ +KSD+++ G +L E+ + + A N +N+V L I I+G P S
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFE----AGNMKNLV----LKI----IRGSYPPVSS 223
Query: 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
YD++++ L P RPS++ +L+
Sbjct: 224 HYSYDLRNLV----SQLFKRNPRD--RPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 29/208 (13%)
Query: 534 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 592
+G G +G+VY + L IA+K + + + E+ L S + HRN+VQ+LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 593 EEGRSVLVYEFMHNGTLKEHL---YGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
E G + E + G+L L +G L +EQ I + + +I E G++YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILE----GLKYLHDN--- 127
Query: 649 AIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
I+HRD+K N+L++ + K+SDFG SK + G + + GT+ Y+ PE +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSK-RLAGINPCTETFTGTLQYMAPE------V 180
Query: 708 TDK--------SDVYSFGVILLELISGQ 727
DK +D++S G ++E+ +G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 534 IGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI-HHRNLVQFL 588
IG G FG V ++K DG + A+K + S R+F E+ +L ++ HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------------LEIAEDAA 636
G C+ G L E+ +G L + L + E + L A D A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
+G++YL IHRDL + NIL+ ++ AK++DFGLS+ V+ T+G
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 172
Query: 697 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 725
L + + L T SDV+S+GV+L E++S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 31/225 (13%)
Query: 529 MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSNSYQGK-REFTNEVTLLSRIHH 581
+L K +G G FG V K +AVK+L N+ + R+ +E LL +++H
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------------YGTLTH--EQ 621
++++ G C ++G +L+ E+ G+L+ L L + E+
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 622 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681
+ + A ++G++YL ++HRDL + N+L+ + + K+SDFGLS+ +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 682 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
S+V S R V ++ E T +SDV+SFGV+L E+++
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 534 IGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRI-HHRNLVQFL 588
IG G FG V ++ KDG + + Y K R+F E+ +L ++ HH N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIAEDAA 636
G C+ G L E+ +G L + L + E ++ + L A D A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
+G++YL IHRDL + NIL+ ++ AK++DFGLS+ V+ T+G
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 184
Query: 697 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 725
L + + L T SDV+S+GV+L E++S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 67/253 (26%), Positives = 95/253 (37%), Gaps = 49/253 (19%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 586
K IG G FG V+ + KD ++ A+KVL S KR E +L+ +V+
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
Q+E LV E+M G L L E R IAE ++ +H
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIAELVL-ALDSVHK 119
Query: 645 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS------------------ 684
G IHRD+K NIL+D K++DFGL K
Sbjct: 120 LGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 685 ----------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 734
+S V GT Y+ PE + D +S GVIL E++ G ++
Sbjct: 176 RRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 735 FGANCRNIVQWAK 747
I+ W +
Sbjct: 235 LQETYNKIINWKE 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
L+ K+G G FG V+ G ++A+K L + F E ++ ++ H LV
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
EE +V EFM G+L + L G + + + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQIADGMAYIER---M 121
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
IHRDL+++NIL+ ++ K++DFGL++ D + + + PE + + T
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 709 DKSDVYSFGVILLELIS 725
KSDV+SFG++L EL++
Sbjct: 182 IKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 589
+G GGFG V +++ GK A K L +G+ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS-LA 66
Query: 590 YCQEEGRSV-LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
Y E ++ LV M+ G LK H+Y G E+ + + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG----RAVFYAAEICCGLEDLHQ-- 120
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
I++RDLK NILLD H ++SD GL+ +G + + GTVGY+ PE +++
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNER 177
Query: 707 LTDKSDVYSFGVILLELISGQEAISNEK 734
T D ++ G +L E+I+GQ K
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 534 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 589
+G GGFG V ++K GK A K L + ++ NE +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 590 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGCV 647
Y E + LV M+ G LK H+Y + R A G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
I++RDLK N+LLD H ++SD GL+ G GT GY+ PE +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVY 171
Query: 708 TDKSDVYSFGVILLELISGQ 727
D ++ G L E+I+G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 589
+IGSG G VY + G+ A+KV+ N +R+ E+ +L ++H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
G ++ EFM G+L+ + EQ + ++A GI YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLA-----DVARQILSGIAYLHR---RH 188
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
I+HRD+K SN+L++ K++DFG+S+ +S V GT+ Y+ PE I+ L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINTDLNH 246
Query: 710 ------KSDVYSFGVILLELISGQ 727
D++S GV +LE G+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 27/219 (12%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT----SNSYQGK--REFTNEVTLLSRIHHRNL 584
+++G+G F Y + +K G +AVK +T ++S Q + E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
++ LG E+ L E+M G++ L YG IN+ ++L +G+ YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119
Query: 643 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLS-KFAVD--GASHVSSIVRGTVGYLD 698
H IIHRD+K +N+L+D R +++DFG + + A GA + GT+ ++
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 699 PEYYISQQLTDKSDVYSFGVILLELISGQ-----EAISN 732
PE +Q DV+S G +++E+ + + E SN
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 532 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
KIG G G+V G+++AVK + Q + NEV ++ H N+V+
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 591 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 650
+V EF+ G L + + T +E++I + K + +LH +
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLAVLKALSFLHA---QGV 136
Query: 651 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD- 709
IHRD+KS +ILL R K+SDFG S+V GT ++ PE IS+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPE-VISRLPYGT 194
Query: 710 KSDVYSFGVILLELISGQEAISNE 733
+ D++S G++++E++ G+ NE
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 532 KKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNL 584
+++G G FG+VY G +KD E V + T N RE F NE +++ + ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI------KRLEIAEDAAKG 638
V+ LG + ++++ E M G LK +L + K +++A + A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGY 696
+ YL+ +HRDL + N ++ + K+ DFG+++ + + +G V +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 187
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLHIES 752
+ PE T SDV+SFGV+L E+ + E +SNE+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV----------------- 230
Query: 753 GDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
++ +++ LLD+ D M + E MC + MRPS E++ I++
Sbjct: 231 --LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 64/224 (28%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 529 MLEKKIGSGGFGVVY----YGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRI 579
+L K +G G FG V YG K + +AVK+L N + + + +E+ L+ I
Sbjct: 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI 74
Query: 580 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWI 626
H+N++ LG C +EG ++ E+ G L+E L T E+++++
Sbjct: 75 GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ G +
Sbjct: 135 DLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDI 187
Query: 687 -----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+S R V ++ PE + T +SDV+SFG+++ E+ +
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 32/277 (11%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIA---VKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 585
+EKKIG G F VVY L DG+ +A V++ + +++ E+ LL ++ H N++
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 640
++L E +V E G L + L E+ I W +++ +E
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCS----ALE 120
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
++H+ I+HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760
KSD++S G +L E+ + Q +K N ++ + IE D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCK----KIEKCDYP---- 226
Query: 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 797
P D Y + + + C+ P RP IS VL
Sbjct: 227 PLPADHYSEE----LRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ +K+G G +G VY K+ G+ +A+KV+ +E E+++L + +V++
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYY 64
Query: 589 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
G + +V E+ G+ + + TLT E+ I I KG+EYLH+
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT-EEEIAAILY-----QTLKGLEYLHSN 118
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
IHRD+K+ NILL++ +AK++DFG+S D + ++++ GT ++ PE
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 174
Query: 706 QLTDKSDVYSFGVILLELISG 726
+K+D++S G+ +E+ G
Sbjct: 175 GYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 53/229 (23%)
Query: 520 LSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFT 570
L +D K+ ++IG G FG VY+ + E+ A+K + SY GK+ +
Sbjct: 7 LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDII 63
Query: 571 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF----------MHNGTLKEHLYGTLTHE 620
EV L ++ H N +++ G E + LV E+ +H L+E
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE--------- 114
Query: 621 QRINWIKRLEIA---EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
+EIA A +G+ YLH+ IHRD+K+ NILL + K++DFG +
Sbjct: 115 --------VEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSAS 163
Query: 678 FAVDGASHVSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 723
S V GT ++ PE ++ Q K DV+S G+ +EL
Sbjct: 164 LVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 15/240 (6%)
Query: 533 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
KIG G G+V K GK++AVK + Q + NEV ++ HH N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 592 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 651
+V EF+ G L + + T +E++I + + + YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHN---QGVI 140
Query: 652 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 711
HRD+KS +ILL R K+SDFG S+V GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 712 DVYSFGVILLELISGQEAISNEKFGANCRNI-----VQWAKLHIESGDIQGIIDPSLLDE 766
D++S G++++E+I G+ NE R I + H S ++G +D L+ E
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 12/218 (5%)
Query: 519 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 575
T+ I D K + KIG G G V+ + G+E+A+K + K NE+ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 576 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 635
+ + + N+V FL +V E++ G+L + + T E +I + R +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----EC 124
Query: 636 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695
+ +E+LH +IHRD+KS N+LL K++DFG S S++V GT
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 180
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 733
++ PE + K D++S G++ +E++ G+ NE
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 525 DATKMLEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGK-REFTNEVTLLSRIHHR 582
D +++E IG G VVY E +A+K + Q E EV +S+ +H
Sbjct: 1 DDYELIEV-IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 583 NLVQFLGYCQ-EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA---EDAAK 637
N+V++ Y G + LV ++ G+L + + IA ++ K
Sbjct: 60 NVVKY--YTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLK 113
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR----GT 693
G+EYLH+ IHRD+K+ NILL + K++DFG+S DG + VR GT
Sbjct: 114 GLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFVGT 169
Query: 694 VGYLDPEYYISQQ--LTDKSDVYSFGVILLELISG 726
++ PE + Q K+D++SFG+ +EL +G
Sbjct: 170 PCWMAPE-VMEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 533 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 589
+G G +GVV + K EI A+K S + ++ EV +L ++ H N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHL----YGTLTHE-QRINWIKRLEIAEDAAKGIEYLHT 644
+ +GR LV+E++ TL E L G + W + I Y H+
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW--------QLLQAIAYCHS 118
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI 703
IIHRD+K NIL+ + K+ DFG ++ AS ++ V T Y PE +
Sbjct: 119 H---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLV 174
Query: 704 SQQLTDKS-DVYSFGVILLELISGQ 727
K DV++ G I+ EL+ G+
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 31/212 (14%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
L ++IGSG +G VY + + G+ +A+KV+ E+++L H N+V +
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLY----GTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
G + +V E+ G+L++ +Y G L+ E +I ++ R + KG+ YLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS-ELQIAYVCR-----ETLKGLAYLHE 119
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-----GTVGYLDP 699
IHRD+K +NILL + K++DFG+S A ++I + GT ++ P
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVS------AQLTATIAKRKSFIGTPYWMAP 170
Query: 700 EYYISQQLTD----KSDVYSFGVILLELISGQ 727
E + + K D+++ G+ +EL Q
Sbjct: 171 E-VAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 519 TLSDIEDATKMLEK--KIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTL 575
T+ + D K + KIG G G VY + G+E+A+K + K NE+ +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 576 LSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 634
+ H N+V +L Y + V V E++ G+L + + T E +I + R +
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIAAVCR-----E 123
Query: 635 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
+ +E+LH+ V IHRD+KS NILL K++DFG S S++V GT
Sbjct: 124 CLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 733
++ PE + K D++S G++ +E++ G+ NE
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 532 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 586
++GSG FG V Y K K +AVK+L +N K E E ++ ++ + +V+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
+G C+ E +LV E G L + L + + E+ + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET- 114
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYIS 704
+HRDL + N+LL AK+SDFGLSK ++ + G V + PE
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 705 QQLTDKSDVYSFGVILLELIS-GQE 728
+ + KSDV+SFGV++ E S GQ+
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 30/278 (10%)
Query: 529 MLEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNL 584
+EKKIG G F VY L D K +A+K + + +++ E+ LL +++H N+
Sbjct: 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV 64
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE----QRINWIKRLEIAEDAAKGIE 640
+++L E+ +V E G L + + + +R W +++ +E
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS----AVE 120
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
++H+ ++HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760
KSD++S G +L E+ + Q +K N ++ Q IE D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQ----KIEQCDY----- 225
Query: 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
P L E+ + K+ E MC+ P RP I V +
Sbjct: 226 PPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 14/210 (6%)
Query: 522 DIEDATKMLEK--KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR 578
D D +LE KIG G G+V + K G+++AVK++ Q + NEV ++
Sbjct: 15 DQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 74
Query: 579 IHHRNLVQ-FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 637
H+N+V+ + Y E VL+ EF+ G L + + + R+N + + E +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLM-EFLQGGALTD-----IVSQTRLNEEQIATVCESVLQ 128
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 697
+ YLH+ +IHRD+KS +ILL R K+SDFG S+V GT ++
Sbjct: 129 ALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWM 184
Query: 698 DPEYYISQQLTDKSDVYSFGVILLELISGQ 727
PE + D++S G++++E++ G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN--SYQGKREFTN---EVTLLSRIHHRN 583
L K +G G FG VY D G+E+AVK + + S + +E E+ LL + H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 584 LVQFLGYCQEEGRSVL--VYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 639
+VQ+ G ++ L E M G++K+ L YG LT + +++ +G+
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGV 119
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 695
YLH+ I+HRD+K +NIL D K+ DFG SK + G S V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPY 174
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELIS 725
++ PE + K+D++S G ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 532 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT--SNSYQGKREFTN---EVTLLSRIHHRNLV 585
K +G G FG VY + G+E+A K + S + +E + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 586 QFLGYCQEEGRSVLV--YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 641
Q+ G ++ L E+M G++K+ L YG LT + +++ +G+ Y
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSY 121
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVGYL 697
LH+ I+HRD+K +NIL D K+ DFG SK + G S V GT ++
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWM 176
Query: 698 DPEYYISQQLTDKSDVYSFGVILLELIS 725
PE + K+DV+S G ++E+++
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 537 GGFGVVYYGKLKDGK-----EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLGY 590
G FG ++YG L D K E+ VK + ++ + + E LL + H+N++ L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 591 CQEEGRSVLV-YEFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
C E+G V Y +M+ G LK L G + Q ++ + + +A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDPEYYI 703
+IH+D+ + N ++D+ ++ K++D LS+ F +D + R V ++ E +
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-PVKWMALESLV 192
Query: 704 SQQLTDKSDVYSFGVILLELIS 725
+++ + SDV+SFGV+L EL++
Sbjct: 193 NKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSY--QGKREFT-NEVTLLSRIHHRNLVQF 587
K +G+G FG V + K + A+K+L+ + E NE +L I H LV
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 639
G Q++ LV E++ G L HL R E A+ +
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHL----------RKSGRFP--EPVARFYAAQVVLAL 114
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
EYLH+ I++RDLK N+LLD K++DFG +K + GT YL P
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAP 167
Query: 700 EYYISQQLTDKS-DVYSFGVILLELISG 726
E I + K+ D ++ G+++ E+++G
Sbjct: 168 E-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 532 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 583
K +G+G FG V YG K ++AVK+L ++ +RE +E+ ++S + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+V LG C G +++ E+ G L L E + L + AKG+ +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 644 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT----VGYLD 698
+ C IHRDL + N+LL K+ DFGL++ D + + +V+G V ++
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMA 211
Query: 699 PEYYISQQLTDKSDVYSFGVILLELIS 725
PE + T +SDV+S+G++L E+ S
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 524 EDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKR------EFTNEVTL 575
ED K+ ++IG G FG VY+ + D + V + SY GK+ + EV
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 576 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 635
L RI H N +++ G E + LV E+ G+ + L H++ + ++ I A
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGA 134
Query: 636 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695
+G+ YLH+ +IHRD+K+ NILL + + K++DFG + A S V GT
Sbjct: 135 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPY 186
Query: 696 YLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISN 732
++ PE ++ Q K DV+S G+ +EL + + N
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 533 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
KIG G G+V +K GK +AVK + Q + NEV ++ H N+V+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 592 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 651
+V EF+ G L + + T +E++I + K + LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 652 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 711
HRD+KS +ILL R K+SDFG S+V GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 712 DVYSFGVILLELISGQEAISNE 733
D++S G++++E++ G+ NE
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+KIG G +GVVY + G+ +A+K L + + E++LL ++H N+V+ L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
E + LV+EF+H LK+ + + + IK +G+ + H+ V
Sbjct: 66 DVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSHRV- 121
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 706
+HRDLK N+L++ K++DFGL++ F V ++ +V T+ Y PE + +
Sbjct: 122 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177
Query: 707 LTDKSDVYSFGVILLELIS 725
+ D++S G I E+++
Sbjct: 178 YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 533 KIGSGGFGVVYYGKLKDGK---EIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFL 588
++GSG FG V G K K ++A+KVL + + + R E E ++ ++ + +V+ +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
G C+ E +LV E G L + L G + I +E+ + G++YL
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEG---K 114
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEYYISQQ 706
+HRDL + N+LL AK+SDFGLSK A D S + + + PE ++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 707 LTDKSDVYSFGVILLELIS-GQE 728
+ +SDV+S+G+ + E S GQ+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 589
+G GGFG V +++ GK A K L + ++ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 66
Query: 590 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 645
Y E ++ LV M+ G LK H+Y E+R + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY-----AAEITCGLEDLHR- 120
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
I++RDLK NILLD + ++SD GL+ +G + + GTVGY+ PE ++
Sbjct: 121 --ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNE 176
Query: 706 QLTDKSDVYSFGVILLELISGQEAISNEK 734
+ T D + G ++ E+I G+ K
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTN---EVTLLSRIHHRN 583
L K +G G FG VY D G+E+AVK + +S + +E E+ LL + H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 584 LVQFLGYCQ--EEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 639
+VQ+ G + EE + + E+M G++K+ L YG LT + +++ +G+
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGV 119
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 695
YLH+ I+HRD+K +NIL D K+ DFG SK + G S V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPY 174
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELIS 725
++ PE + K+DV+S ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 532 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
+KIG G G VY + G+E+A++ + K NE+ ++ + N+V +L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 591 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 650
+V E++ G+L + + T E +I + R + + +E+LH+ +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 137
Query: 651 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 710
IHRD+KS NILL K++DFG S S++V GT ++ PE + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 711 SDVYSFGVILLELISGQEAISNE 733
D++S G++ +E+I G+ NE
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 531 EKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN-----EVTLLSRIHHRNL 584
KK+G G + VVY + + G+ +A+K + + ++ N E+ LL + H N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAKGIE 640
+ L + LV+EFM T E + LT +++ +G+E
Sbjct: 65 IGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLE 116
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
YLH I+HRDLK +N+L+ K++DFGL++ ++ V T Y PE
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172
Query: 701 -YYISQQLTDKSDVYSFGVILLELI 724
+ ++ D++S G I EL+
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 530 LEKKIGSGGFGVVY---YGKLKDGK-EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 584
L + IG G FG VY Y ++ K +AVK + + RE F E ++ + H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI---AEDAAKGIEY 641
V+ +G E +V E G L+ +L + + + + + + Y
Sbjct: 70 VKLIGVI-TENPVWIVMELAPLGELRSYL------QVNKYSLDLASLILYSYQLSTALAY 122
Query: 642 LH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
L V HRD+ + N+L+ K+ DFGLS++ D + + +S + + ++ PE
Sbjct: 123 LESKRFV----HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 701 YYISQQLTDKSDVYSFGVILLELIS 725
++ T SDV+ FGV + E++
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 533 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLVQFL 588
++G GG+G V+ K KD EI A+K + + R E +L+ LV+ L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
Q++ L E++ G + L G L+ + R +AE ++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFE-AVDALHE-- 119
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
IHRDLK N L+D K++DFGLSK V ++ +S+V G+ Y+ PE +
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVLRGKG 174
Query: 707 LTDKSDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWAK 747
D +S G +L E + G S NE + N+ W +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW----ENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 532 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
+KIG G G VY + G+E+A+K + K NE+ ++ + N+V +L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 591 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 650
+V E++ G+L + + T E +I + R + + +++LH+ +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSN---QV 136
Query: 651 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 710
IHRD+KS NILL K++DFG S S++V GT ++ PE + K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 711 SDVYSFGVILLELISGQEAISNE 733
D++S G++ +E++ G+ NE
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 589
+G GGFG V +++ GK A K L +G+ NE +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN-LA 66
Query: 590 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 645
Y E ++ LV M+ G LK H+Y E+R L A + G+E LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-----LFYAAEILCGLEDLHR- 120
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
++RDLK NILLD + ++SD GL+ +G S + GTVGY+ PE +Q
Sbjct: 121 --ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQ 176
Query: 706 QLTDKSDVYSFGVILLELISGQEAISNEK 734
+ T D + G ++ E+I GQ K
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 587
L + IG G +G VY + K G+ +A+K++ + E E +L + +H N+ F
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATF 68
Query: 588 LG-YCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGI 639
G + ++ LV E G++ + + G +R+ WI I + +G+
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGL 126
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
YLH V IHRD+K NILL K+ K+ DFG+S +D + GT ++ P
Sbjct: 127 AYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMAP 182
Query: 700 EYYISQQLTD-----KSDVYSFGVILLELISGQ 727
E + D +SDV+S G+ +EL G+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 34/224 (15%)
Query: 529 MLEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSYQGK-REFTNEVTLLSRI 579
+L K +G G FG V K K + ++AVK+L S++ + + +E+ ++ I
Sbjct: 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80
Query: 580 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 626
H+N++ LG C ++G ++ E+ G L+E+L T E+++++
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ H+
Sbjct: 141 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 193
Query: 687 SSIVRGTVG-----YLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ T G ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 530 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 579
L K +G G FG V K K+ +AVK+L ++ + + +E+ ++ I
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 627
H+N++ LG C ++G ++ E+ G L+E+L ++++ +
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687
+ A+G+EYL + IHRDL + N+L+ ++ K++DFGL++ V+ +
Sbjct: 139 LVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYK 194
Query: 688 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
G V ++ PE + T +SDV+SFGV++ E+ +
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 40/225 (17%)
Query: 530 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 581
L K +G G FG V + +AVK+L ++ + + +E+ ++ I H
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRL 629
+N++ LG C +EG +V E+ +G L++ L E+ + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 630 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS---------KFAV 680
A A+G+E+L + IHRDL + N+L+ + K++DFGL+ +
Sbjct: 136 SFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+G R V ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 193 NG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 586
K IG G FG V K K DGK AVKVL + K+E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
Q + V ++++ G L HL E+ + A + A + YLH+
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHS-- 114
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
II+RDLK NILLD ++DFGL K ++ + S+ GT YL PE + +Q
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPE-VLRKQ 171
Query: 707 LTDKS-DVYSFGVILLELISG 726
D++ D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 534 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHH---RNLVQFL 588
IG G +G VY GK + G+ +A+K++ ++ + EV LLS++ N+ ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 589 GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
G +G + ++ E+ G+++ + E+ I+ I R + ++Y+H
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKV-- 120
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
+IHRD+K++NIL+ K+ DFG++ +S S+ V GT ++ PE +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 708 TD-KSDVYSFGVILLELISGQEAISNE 733
D K+D++S G+ + E+ +G S+
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDV 205
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRIHHRNLVQF 587
L + IG G FG VY K + +A+KV+ + + E E+ LS+ + ++
Sbjct: 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
G + + ++ E+ G+ + L G L E I +I R + G+EYLH
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKL-DETYIAFILR-----EVLLGLEYLHEEG 118
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
IHRD+K++NILL + K++DFG+S S ++ V GT ++ PE I Q
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPE-VIKQS 173
Query: 707 LTD-KSDVYSFGVILLELISG 726
D K+D++S G+ +EL G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRN 583
L + +G G FG V +LK +++AVK+L + S EF E + H N
Sbjct: 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62
Query: 584 LVQFLG---YCQEEGR---SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR--LEIAEDA 635
+++ +G + +GR +++ FM +G L L + E+ + + D
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 636 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTV 694
A G+EYL + IHRDL + N +L+++M V+DFGLSK G + + V
Sbjct: 123 ASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 727
+L E T SDV++FGV + E+++ GQ
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEI---AVKVLTSN--SYQGKREFTNEVTLLSRIHHRNL 584
L K +G G FG V G+L I AVK + + +F +E + H N+
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 585 VQFLGYC----QEEG--RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL--EIAEDAA 636
++ +G C + EG V++ FM +G L L + + ++ + D A
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTVG 695
G+EYL + + IHRDL + N +L+++M V+DFGLSK +G + I + V
Sbjct: 123 SGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 727
++ E + T KSDV+SFGV + E+ + GQ
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 35/275 (12%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ +G G +G V + + DGK+ +K L + S + ++ E LLS++ H N+V +
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 589 GYCQ-EEGRSVLVYEFMHNG----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+ E+G +V F G LKE L Q + W ++ +A ++YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLH 119
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703
I+HRDLK+ N+ L + KV D G+++ ++ ++S + GT Y+ PE +
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELFS 175
Query: 704 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763
++ KSDV++ G + E+ + + A + + + I++ KL P +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKL------------PPM 222
Query: 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
+Y + I ++ P RPS+ +L+
Sbjct: 223 PKDYSPELGELI--ATMLSKRP--EKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 533 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFTNEVTLLSRIHHRNLV 585
+IG G FG VY+ E+ AVK + SY GK+ + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
++ G +E + LV E+ G+ + L H++ + ++ I A +G+ YLH+
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
+IHRD+K+ NILL + + K++DFG + + S V GT ++ PE ++
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 706 ---QLTDKSDVYSFGVILLELISGQEAISN 732
Q K DV+S G+ +EL + + N
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 529 MLEKKIGSGGFG--VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+ + +G G FG ++ D K ++ S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYL 642
F + +G +V E+ G L + + G L E I W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 702
H ++HRD+KS NI L ++ + K+ DFG ++ ++ + V GT Y+ PE +
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 703 ISQQLTDKSDVYSFGVILLEL 723
+ +KSD++S G IL EL
Sbjct: 173 ENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 533 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLG 589
+IG G G+V+ K + G+ +A+K + +G + E+ L H +V+ L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGC 646
VLV E+M + L L E+R +K KG+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHAN- 118
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE-YYISQ 705
I+HRDLK +N+L+ K++DFGL++ + + S T Y PE Y ++
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 706 QLTDKSDVYSFGVILLELISGQ 727
+ D+++ G I EL++G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 534 IGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRI---HHRNLVQF 587
IG G +G VY + L G+ +A+K V S +G T E+ LL ++ H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 588 LGYCQ----EEGRSV-LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
L C + + LV+E + T + I + R ++ +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR-QLL----RGVD 121
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
+LH+ I+HRDLK NIL+ + K++DFGL++ + S +V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 701 YYISQQLTDKSDVYSFGVILLEL 723
+ D++S G I EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 589
+G+G G V K + G +A KV+ + +++ E+ ++ +V F G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
E + EFM G+L G + E +IA +G+ YL+ V
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE------ILGKIAVAVVEGLTYLYN--V 122
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
I+HRD+K SNIL++ + K+ DFG+S ++ ++ GT Y+ PE +
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKY 179
Query: 708 TDKSDVYSFGVILLELISGQ 727
T KSDV+S G+ ++EL G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 531 EK--KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQG-KREFTNEVTLLSRIHHRNLV 585
EK +IG G +G+VY + EI KV N G E+TLL + H N+V
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 586 QFLGYCQEEGRSV----LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
+ G+ + LV E+ +L +++ + Q +K L + +G+
Sbjct: 70 ELKEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ----VKCLML--QLLRGL 121
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
+YLH IIHRDLK SN+LL K++DFGL++ A ++ V T+ Y P
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 700 EYYI-SQQLTDKSDVYSFGVILLELISGQ 727
E + T D+++ G IL EL++ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-----NEVTLLSR------I 579
K +G G FG V +LK E A+K L K++ E T++ R
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKAL-------KKDVVLEDDDVECTMVERRVLALAW 53
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
H L Q + V E+++ G L H+ + ++ EI G+
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII----CGL 109
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
++LH II+RDLK N+LLDK K++DFG+ K ++G S+ GT Y+ P
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAP 165
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQEAISNE 733
E Q+ + D +SFGV+L E++ GQ E
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 525 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 581
D TK+ +KIG G +GVVY G+ K G+ +A+K + S + T E++LL + H
Sbjct: 1 DYTKI--EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
N+V +E R L++EF+ + LK++L +L Q ++ +GI +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 700
H+ ++HRDLK N+L+D K++DFGL++ F + + +V T+ Y PE
Sbjct: 117 CHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPE 171
Query: 701 YYI-SQQLTDKSDVYSFGVILLELIS 725
+ S + + D++S G I E+ +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 513 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---- 567
+ A F D E L ++IG G FG VY+ + +++ + +A+K + SY GK+
Sbjct: 3 DVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEK 58
Query: 568 --EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 625
+ EV L ++ H N +Q+ G E + LV E+ G+ + L H++ +
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQE 114
Query: 626 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685
++ + A +G+ YLH+ +IHRD+K+ NILL + K+ DFG +
Sbjct: 115 VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171
Query: 686 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 723
V GT ++ PE ++ Q K DV+S G+ +EL
Sbjct: 172 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 30/237 (12%)
Query: 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 589
+G GGFG V +++ GK A K L + ++ + E +L+++H R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
Q + LV M+ G L+ H+Y + G+E+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
II+RDLK N+LLD ++SD GL+ DG S GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 710 KSDVYSFGVILLELISGQ-------EAISN---------------EKFGANCRNIVQ 744
D ++ GV L E+I+ + E + N +KF ++ +
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 579
D E+ LEK IG G FG V+ G + K +A+K++ + + E E+T+LS+
Sbjct: 1 DPEELFTKLEK-IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
+ ++ G ++ + ++ E++ G+ + L E +I I R + KG+
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGL 114
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
+YLH+ IHRD+K++N+LL +H K++DFG++ D ++ V GT ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQ 727
E K+D++S G+ +EL G+
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTN-EVTLLS 577
D+ D + E IGSG G VY + K G +AVK + T N + KR + +V L S
Sbjct: 13 DLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS 70
Query: 578 RIHHR--NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 635
H +V+ GY + + E M T + L + + + ++ +A
Sbjct: 71 ---HDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--I 123
Query: 636 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695
K + YL +IHRD+K SNILLD K+ DFG+S VD + S G
Sbjct: 124 VKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAA 179
Query: 696 YLDPEYYISQQLTDK----SDVYSFGVILLELISGQ 727
Y+ PE K +DV+S G+ L+EL +GQ
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 585
K +GSG FG V+ G + +G I A+K + S Q +E T+ + + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 586 QFLGYCQEEGRSV-LVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEY 641
+ LG C G S+ LV + G+L +H+ +L ++ +NW ++ AKG+ Y
Sbjct: 73 RLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYY 124
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPE 700
L ++HR+L + NILL +++DFG++ D + S + + ++ E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 701 YYISQQLTDKSDVYSFGVILLELIS 725
+ + T +SDV+S+GV + E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 69/234 (29%), Positives = 99/234 (42%), Gaps = 33/234 (14%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR-----NLV 585
K I G FG VY K + G A+KVL + K + TN V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVA 60
Query: 586 QFLGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
+ Q + LV E+++ G +L + L G L + W K+ IAE G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPED----WAKQY-IAE-VVLGVEDL 113
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 702
H IIHRD+K N+L+D+ K++DFGLS+ + GT YL PE
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETI 165
Query: 703 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756
+ SD +S G ++ E + G F A + V + I S I
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPP-----FHAETPDAV-FDN--ILSRRIN 211
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-15
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR------IHHRNL 584
K +G G FG V+ +LK + A+K L + + E T++ + H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFL 58
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
Q + V E+++ G L H+ + + + A + G+++LH+
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHS 114
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
I++RDLK NILLD K++DFG+ K + G + + GT Y+ PE +
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLG 170
Query: 705 QQLTDKSDVYSFGVILLELISGQ 727
Q+ D +SFGV+L E++ GQ
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 589
+G GGFG V +++ GK A K L +G+ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS-LA 66
Query: 590 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 645
Y E ++ LV M+ G LK H+Y EQR + A + G+E L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----IFYAAELCCGLEDLQR- 120
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
I++RDLK NILLD ++SD GL+ +G + + GTVGY+ PE ++
Sbjct: 121 --ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNE 176
Query: 706 QLTDKSDVYSFGVILLELISGQEAISNEK 734
+ T D + G ++ E+I GQ K
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 9e-15
Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 585
K +GSG FG VY G + +G+ + A+K+L + + EF +E +++ + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
+ LG C LV + M +G L ++++ H+ I L AKG+ YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE- 127
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 704
++HRDL + N+L+ K++DFGL++ D + + + + ++ E
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 705 QQLTDKSDVYSFGVILLELIS 725
++ T +SDV+S+GV + EL++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV----- 585
K +G G FG V +LK G+ AVK L + + E T++ + R L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEK---RVLALAWEN 55
Query: 586 QFLG--YC--QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
FL YC Q + V EF++ G L H+ + R + + A + G+++
Sbjct: 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQF 111
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
LH+ II+RDLK N++LD+ K++DFG+ K V G + S+ GT Y+ PE
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEI 167
Query: 702 YISQQLTDKSDVYSFGVILLELISGQ 727
+ T D +SFGV+L E++ GQ
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLV 585
K +GSG FG VY G + DG+ + A+KVL N S + +E +E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 642
+ LG C LV + M G L +++ + + +NW ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA-VDGASHVSSIVRGTVGYLDPEY 701
++HRDL + N+L+ K++DFGL++ +D + + + + ++ E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 702 YISQQLTDKSDVYSFGVILLELIS 725
+ ++ T +SDV+S+GV + EL++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 59/208 (28%), Positives = 109/208 (52%), Gaps = 22/208 (10%)
Query: 528 KMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLV 585
K LEK +G G + VY G+ + EI A+K + ++ +G E++L+ + H N+V
Sbjct: 3 KQLEK-LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 640
+ E + +LV+E+M + LK+++ G L ++ +L KGI
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL------LKGIA 114
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 699
+ H ++HRDLK N+L++K K++DFGL++ F + + + +V T+ Y P
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAP 169
Query: 700 EYYI-SQQLTDKSDVYSFGVILLELISG 726
+ + S+ + D++S G I+ E+I+G
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 22/271 (8%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNLV 585
+EKKIG G F VY L DG +A+K + + + + E+ LL +++H N++
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
++ E+ +V E G L + ++ I + +E++H+
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS- 124
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
++HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 125 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
Query: 706 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765
KSD++S G +L E+ + Q +K N+ K IE D P L
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK-KIEQCDY-----PPLPS 230
Query: 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEV 796
++ + + ++ MC+ P RP I+ V
Sbjct: 231 DHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 592
+G G FG VY + K+ A K++ S + +F E+ +LS H N+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 593 EEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
E + ++ EF G L L LT E +I ++ R + + +LH+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLT-EPQIRYVCR-----QMLEALNFLHSH---K 123
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
+IHRDLK+ NILL K++DFG+S + + GT ++ PE + D
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKD 182
Query: 710 -----KSDVYSFGVILLEL 723
K+D++S G+ L+EL
Sbjct: 183 NPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 57/231 (24%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 529 MLEKKIGSGGFGVVYYGKLKDGKE-----------------IAVKVLTSNSYQGKR-EFT 570
+ ++K+G G FG V+ ++ + ++ +AVK+L ++ + R +F
Sbjct: 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL 67
Query: 571 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-------- 622
EV +LSR+ N+++ LG C +E ++ E+M NG L + L ++
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 623 -------INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675
I++ L +A A G++YL + +HRDL + N L+ +++ K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 676 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
S+ G + + + ++ E + + T SDV++FGV L E++
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 534 IGSGGFGVVYYG-KLKDGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
+G G G VY L + +AVKV+ + + + +++ +E+ +L + ++ F G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 592 QEEGRSVLVYEFMHNGTLK------EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
E R + EFM G+L EH+ G IA KG+ YL +
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG--------------RIAVAVVKGLTYLWS- 113
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
I+HRD+K SN+L++ + K+ DFG+S V+ ++ GT Y+ PE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGE 168
Query: 706 QLTDKSDVYSFGVILLELISGQ 727
Q SDV+S G+ +EL G+
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 74/225 (32%), Positives = 109/225 (48%), Gaps = 28/225 (12%)
Query: 519 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 577
+L D D +++E IG G +G VY KDG AVK+L S E E +L
Sbjct: 16 SLGDPTDTWEIIET-IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQ 73
Query: 578 RI-HHRNLVQFLG--YCQEE---GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 631
+ +H N+V+F G Y ++ G+ LV E + G++ E + G L QR++ I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 632 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 691
A G+++LH IIHRD+K +NILL K+ DFG+S A S+ +R
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS------AQLTSTRLR 184
Query: 692 -----GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISG 726
GT ++ PE +Q D S DV+S G+ +EL G
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 533 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
++G G FG VY K K+ G A KV+ + S + ++ E+ +L+ +H +V+ LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 592 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 651
+G+ ++ EF G + + L ++ + + I + ++YLH+ II
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLHS---MKII 132
Query: 652 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 709
HRDLK+ N+LL K++DFG+S V S + GT ++ PE + + + D
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191
Query: 710 ---KSDVYSFGVILLEL 723
K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-14
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 26/200 (13%)
Query: 550 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFL--GYCQEEGRSVLVYEFM 604
G E+A+K+L +++ + + + F E L +R++H N+V L G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 605 HNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 662
TL+E L G L + + ++ A A H I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQ---GIVHRDLKPQNIMV 112
Query: 663 ---DKHMRAKVSDFGLSKFAVD-GASHVSSIVR-----GTVGYLDPEYYISQQLTDKSDV 713
AKV DFG+ + V+++ R GT Y PE + +T SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 714 YSFGVILLELISGQEAISNE 733
Y++G+I LE ++GQ +
Sbjct: 173 YAWGLIFLECLTGQRVVQGA 192
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 61/236 (25%)
Query: 532 KKIGSGGFGVVYYGK--------LKDGKE---------IAVKVLTSN-SYQGKREFTNEV 573
+K+G G FG V+ + K E +AVKVL + S + +F EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR----- 628
+LSR+ N+ + LG C + ++ E+M NG L + L H + +
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQ---KHVAETSGLACNSKSL 127
Query: 629 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------ 677
L +A A G+ YL + +HRDL + N L+ K+ K++DFG+S+
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 678 -FAVDGASHV-------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ V G + + S++ G + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLG-------------KFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN----- 571
FT D++D +IG G FG V K G +AVK + S ++E
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDL 53
Query: 572 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-- 629
+V + S +V+F G EG + E M + Y + + + +
Sbjct: 54 DVVMRSS-DCPYIVKFYGALFREGDCWICMELMD--ISLDKFYKYVYEVLKSVIPEEILG 110
Query: 630 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689
+IA K + YL IIHRD+K SNILLD++ K+ DFG+S VD SI
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SI 162
Query: 690 VR----GTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISG 726
+ G Y+ PE +SDV+S G+ L E+ +G
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 65/200 (32%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 586
K IG G FG V K K DG AVKVL + K+E + + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
Q + V ++++ G L HL E+ + A + A I YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS-- 114
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
II+RDLK NILLD ++DFGL K V+ S+ GT YL PE +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEP 172
Query: 707 LTDKSDVYSFGVILLELISG 726
D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 534 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYC 591
+G+G +G VY G+ +K G+ A+KV+ + + E E+ +L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 592 QEEG------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
++ + LV EF G++ + + T + + WI I + +G+ +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
+IHRD+K N+LL ++ K+ DFG+S +D + GT ++ PE
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 706 QLTD-----KSDVYSFGVILLELISG 726
+ D KSD++S G+ +E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLG 589
++IG G FG VY G KE+ A+K++ + + E E+T+LS+ + ++ G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
+ + ++ E++ G+ + L E I I R + KG++YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHS---ER 121
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
IHRD+K++N+LL + K++DFG++ D ++ V GT ++ PE I Q D
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSAYD 179
Query: 710 -KSDVYSFGVILLELISGQEAISN 732
K+D++S G+ +EL G+ S+
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 66/201 (32%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 586
K IG G FG V K K DGK AVKVL ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTG 645
Q + V +F++ G L HL + E R R AE A + YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR----ARFYAAE-IASALGYLHS- 114
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
I++RDLK NILLD ++DFGL K + + ++ GT YL PE Q
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC-GTPEYLAPEVIRKQ 171
Query: 706 QLTDKSDVYSFGVILLELISG 726
+ D + G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 74/293 (25%), Positives = 136/293 (46%), Gaps = 45/293 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 582
L +++G G FG+VY G +D +AVK + S S + + EF NE +++
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 635
++V+ LG + +++V E M +G LK +L +L E N + +++A +
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 636 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 693
A G+ YL+ +HRDL + N ++ K+ DFG+++ + + +G
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 184
Query: 694 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 749
V ++ PE T SD++SFGV+L E+ S E +SNE+
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------------- 230
Query: 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
++ ++D LD+ D ++ + MC + MRP+ E++ ++D
Sbjct: 231 -----LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 6e-14
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 38/218 (17%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT---SNSYQGKREFTNEVTLLSRI-HHRNL 584
+ +K+G G +G+V+ + KE+ A+K + N+ +R F E+ L + H N+
Sbjct: 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNI 69
Query: 585 VQFLG-YCQEEGRSV-LVYEFM----HN----GTLKEHLYGTLTHEQRINWIKRLEIAED 634
V+ L E + + LV+E+M H L++ H++ I +
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED------VHKRYIMY--------Q 115
Query: 635 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 693
K ++Y+H+G +IHRDLK SNILL+ R K++DFGL++ + + + ++
Sbjct: 116 LLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 694 VG---YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 727
V Y PE + S + T D++S G IL E++ G+
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 520 LSDIEDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL 576
LS + D + E + +G+G +G VY G+ +K G+ A+KV+ + + E E+ +L
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINML 66
Query: 577 SRI-HHRNLVQFLGY------CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 629
+ HHRN+ + G + + LV EF G++ + + T + + +WI
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY- 125
Query: 630 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689
I + +G+ +LH +IHRD+K N+LL ++ K+ DFG+S +D +
Sbjct: 126 -ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNT 180
Query: 690 VRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISG 726
GT ++ PE + D +SD++S G+ +E+ G
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 530 LEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSY-QGKREFTNEVTLLSRI- 579
L K +G G FG V K K K +AVK+L ++ + + +E+ ++ I
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---------YGTLT---HEQRINWIK 627
H+N++ LG C ++G ++ E+ G L+E+L Y T E+++ +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ V +
Sbjct: 136 LVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYK 191
Query: 688 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
G V ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEI----AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 585
K +GSG FG VY G + +G+++ A+K L + S + +E +E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
+ LG C L+ + M G L +++ H+ I L AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEE- 127
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYIS 704
++HRDL + N+L+ K++DFGL+K D + + + + ++ E +
Sbjct: 128 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 705 QQLTDKSDVYSFGVILLELIS 725
+ T +SDV+S+GV + EL++
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 587
K +G G FG V + K GK A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
Q + R V E+++ G L HL + E+ + + + ++YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG-- 114
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
I++RDLK N++LDK K++DFGL K + A+ + + GT YL PE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 708 TDKSDVYSFGVILLELISGQEAISNE 733
D + GV++ E++ G+ N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 70/225 (31%), Positives = 95/225 (42%), Gaps = 48/225 (21%)
Query: 520 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREF--------- 569
LSD E + + +G+G FG V K K G+ A+K L KRE
Sbjct: 17 LSDFE-----MGETLGTGSFGRVRIAKHKGTGEYYAIKCLK------KREILKMKQVQHV 65
Query: 570 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 629
E ++L + H +V + Q+E R + EF+ G L HL K
Sbjct: 66 AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR------------KAG 113
Query: 630 EIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681
D AK EYLH+ II+RDLK N+LLD KV+DFG +K D
Sbjct: 114 RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
Query: 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
+ GT YL PE S+ D ++ GV+L E I+G
Sbjct: 171 RTFTLC----GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 531 EKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQF 587
+KIG G +GVVY + + E IA+K + T E++LL + H N+V+
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
E R LV+E++ + LK+H+ + + IK +GI Y H+
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY--LYQILRGIAYCHSH-- 121
Query: 648 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 704
++HRDLK N+L+D+ A K++DFGL++ F + + +V T+ Y PE + S
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGS 178
Query: 705 QQLTDKSDVYSFGVILLELIS 725
+ + D++S G I E+++
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 534 IGSGGFGVVYYGKLKDG-------KEIAVKVLTSNSYQGKRE-------FTNEVTLL-SR 578
+GSG FG VY + K+ KEI V + KRE +EVT++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNP--AFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 579 IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638
+ H N+V++ E R +V + + L EH +QR + I
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
+ YLH I+HRDL +NI+L + + ++DFGL+K S ++S+V GT+ Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTILYSC 181
Query: 699 PEYYISQQLTDKSDVYSFGVILLEL 723
PE ++ +K+DV++FG IL ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 44/120 (36%), Positives = 68/120 (56%), Gaps = 8/120 (6%)
Query: 330 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGC 387
W + CN+ + + I LS KN++G I S + +L + + L N L+GPIPD F+
Sbjct: 60 WQGITCNNSSR--VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 388 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 445
LR ++L +N TG +P ++PNL L + NNMLSG +P+ + S VL+ GN+
Sbjct: 118 SSLRYLNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
|
Length = 968 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 534 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 587
IG GGFG VY + D GK A+K L QG+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 588 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
+ Y + + + M+ G L HL +G + + + A + G+E++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY------AAEIILGLEHMHN 115
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
V ++RDLK +NILLD+H ++SD GL+ H S GT GY+ PE
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 705 QQLTDKS-DVYSFGVILLELISGQ 727
D S D +S G +L +L+ G
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYG--KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLL 576
++++ + +E+ +G+G FG + G KL +E+ V + T S + +R F E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 577 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 636
+ H N+V+ G ++V E+M NG L L HE ++ + + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLA 117
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TV 694
G++YL +H+ L + +L++ + K+S F + D + + + + G V
Sbjct: 118 SGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV 172
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ PE + SDV+SFG+++ E++S
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 534 IGSGGFGVVYYGKLK---DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+G G +GVV K++ G +AVK + T NS + KR + + + V F
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
G EG + E M T + Y I +IA K +EYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL- 123
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY---IS 704
++IHRD+K SN+L++++ + K+ DFG+S + VD S +I G Y+ PE ++
Sbjct: 124 -SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPERINPELN 180
Query: 705 QQLTD-KSDVYSFGVILLELISG 726
Q+ D KSDV+S G+ ++EL +G
Sbjct: 181 QKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 3e-13
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 529 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNL 584
L K IGSG +GVV + G+++A+K ++ + KR E+ LL + H N+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENI 61
Query: 585 VQ----FLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAK- 637
+ E+ V +V E M T H IK + +D +
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELME----------TDLH----KVIKSPQPLTDDHIQY 107
Query: 638 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 690
G++YLH+ +IHRDLK SNIL++ + K+ DFGL++ +
Sbjct: 108 FLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 691 RGTVG--YLDPEYYISQQLTDKS-DVYSFGVILLELISG 726
V Y PE +S K+ D++S G I EL++
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN-----EVTLLS-RI----- 579
K +G G FG V +LK E+ AVKVL K++ E T+ R+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVL-------KKDVILQDDDVECTMTEKRVLALAG 53
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAK 637
H L Q Q + R V E+++ G L H+ G + + A +
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVL 107
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 697
G+++LH II+RDLK N+LLD K++DFG+ K + G S+ GT Y+
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYI 163
Query: 698 DPEYYISQQLTDKSDVYSFGVILLELISGQ 727
PE Q D ++ GV+L E+++GQ
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 534 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 587
IG GGFG VY + D GK A+K L QG+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 588 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
+ Y + + + M+ G L HL +G + ++ + A + G+E++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY------ATEIILGLEHMHN 115
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
V ++RDLK +NILLD+H ++SD GL+ H S GT GY+ PE
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 705 QQLTDKS-DVYSFGVILLELISGQEAISNEK 734
D S D +S G +L +L+ G K
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQF 587
K++G G FG VY + K+ E+ A+K + + E N EV L ++ H N+V+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 588 LGYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
+E V+E+M +K+ + + I ++ +G+ ++H
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQI------LQGLAHIHK 117
Query: 645 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
G HRDLK N+L+ K++DFGL++
Sbjct: 118 HG----FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 530 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKR---EFT-NEVTLLSRIHH 581
L + +G+G +G V+ G GK A+KVL + K E T E +L +
Sbjct: 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR 63
Query: 582 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 637
+ L Y Q + + L+ ++++ G L HLY QR ++ + R+ IAE
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY------QREHFTESEVRVYIAE-IVL 116
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 697
+++LH II+RD+K NILLD ++DFGLSK + + GT+ Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 698 DPEYYISQQL--TDKSDVYSFGVILLELISG 726
PE D +S GV+ EL++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 579
D E+ LE+ IG G FG V+ G + + +A+K++ + + E E+T+LS+
Sbjct: 1 DPEELFTKLER-IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
+ ++ G + + ++ E++ G+ + L E +I + ++ KG+
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGL 114
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
+YLH+ IHRD+K++N+LL + K++DFG++ D ++ V GT ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQ 727
E K+D++S G+ +EL G+
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 533 KIGSGGFGVVYYGKLKD-GKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
KIG G +GVV+ + ++ G+ +A+K V + + K+ E+ +L ++ H NLV +
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 590 YCQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 645
+ + + LV+E+ + L E + G H IK+ I + + + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL-----IKK--IIWQTLQAVNFCHKHN 120
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
C IHRD+K NIL+ K + K+ DFG ++ + V T Y PE +
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGD 175
Query: 706 -QLTDKSDVYSFGVILLELISGQ 727
Q DV++ G + EL++GQ
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 589
IG G FG V + +D + I A+K + + E T+ E T+L++++ +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTGCVP 648
Q + LV F++ G L HL E R + + R AE +E LH V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL----QREGRFDLSRARFYTAE-LLCALENLHKFNV- 114
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
I+RDLK NILLD + DFGL K + ++ GT YL PE + T
Sbjct: 115 --IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYT 171
Query: 709 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 744
D ++ GV+L E+++G +E R I+Q
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEIA---VKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 587
+IG+G FG V G+ G A VK L S + + F EV ++H N++Q
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 646
LG C E +LV EF G LK +L ++ L+ +A + A G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAVDGASHVSSIVRGTVGYLDPE 700
IH DL N L + K+ D+GL+ + + H + +L PE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL-----RWLAPE 172
Query: 701 YYISQQ-------LTDKSDVYSFGVILLEL 723
+ T KS+++S GV + EL
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-12
Identities = 43/106 (40%), Positives = 64/106 (60%), Gaps = 3/106 (2%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 400
S+ + L+S L G IP +L ++ SL ++L N+L+G IP + G L + L N L
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
TGP+PSSL NL NL+ L++ N LSG +P S+ L K + L+ + N
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294
|
Length = 968 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQFLG 589
+G G FG V +LK G+ AVKVL + + +T +LS + + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 590 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
C Q R V EF++ G L H+ + +R + + A + + +LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLHD---K 115
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQL 707
II+RDLK N+LLD K++DFG+ K + +G + +S GT Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLY 173
Query: 708 TDKSDVYSFGVILLELISGQEAISNE 733
D ++ GV+L E++ G E
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 58/231 (25%)
Query: 530 LEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRI 579
+E IG G +G VY K K DGKE A+K + Q RE + LL +
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLREL 59
Query: 580 HHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA 636
H N+V + E +SV L++++ EH L+ + ++ KR+ I
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQA---KRVSIPPSMV 110
Query: 637 K--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSK------- 677
K G+ YLH+ ++HRDLK +NIL+ + K+ D GL++
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 678 --FAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELIS 725
+D V T+ Y PE + ++ T D+++ G I EL++
Sbjct: 168 PLADLDP-------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 517 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK---REFTNEV 573
C DI+ T +L I +Y G + KE+ ++ K NE+
Sbjct: 14 CIESDDIDKYTSVL---IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEI 69
Query: 574 TLLSRIHHRNLVQFLGY----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 629
L RI N+++ G+ + R L+ E+ G L+E L E+ +++ +L
Sbjct: 70 KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKL 125
Query: 630 EIAEDAAKGIEYLHTGC-VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVS 687
++A D KG+ L+ P +++L S + L+ ++ + K+ GL K + +V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 688 SIVRGTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISG 726
+V Y + I + T K D+YS GV+L E+ +G
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 533 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 589
KIG G +G V+ K ++ EI +V + +G E+ LL + H+N+V+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 590 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+ + LV+E+ K + G + E +++ +L KG+ + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFCHS--- 117
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
++HRDLK N+L++K+ K++DFGL++ F + + + +V T+ Y P+ +
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175
Query: 707 LTDKS-DVYSFGVILLELISG 726
L S D++S G I EL +
Sbjct: 176 LYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 581
D+ + LEK +G G + VY GK K +GK +A+KV+ +G FT E +LL + H
Sbjct: 5 DSYEKLEK-LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKH 62
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638
N+V + LV+E++H + +H G ++ + L +G
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RG 115
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
+ Y+H I+HRDLK N+L+ K++DFGL++ A SH S T+ Y
Sbjct: 116 LSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRP 171
Query: 699 PEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEK 734
P+ + S + + D++ G I +E+I G A K
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 37/212 (17%)
Query: 534 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQF 587
IG G +G VY + KD E+ KV N +G F E+ +L +++HRN+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIVNL 71
Query: 588 ----------LGYCQEEGRSVLVYEFM-HN--GTLKEHLYGTLTHEQRINWIKRLEIAED 634
L + +++G LV+E+M H+ G L+ L + + +++K+L
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-HFSEDHIKSFMKQL----- 125
Query: 635 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRG 692
+G+ Y H +HRD+K SNILL+ + K++DFGL++ + + + + ++
Sbjct: 126 -LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-- 179
Query: 693 TVGYLDPEYYISQQLTDKS-DVYSFGVILLEL 723
T+ Y PE + ++ + DV+S G IL EL
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 533 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 589
KIG G +GVVY + G+ +A+K + + T E++LL ++H N+V+ L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 641
E + LV+EF+ LK+++ + + K GI Y
Sbjct: 66 VVHSENKLYLVFEFLDL-DLKKYM----------DSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 700
H+ ++HRDLK N+L+D+ K++DFGL++ F V ++ +V T+ Y PE
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 169
Query: 701 YYI-SQQLTDKSDVYSFGVILLELI 724
+ S+Q + D++S G I E++
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 587
K +G G FG V + K GK A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
Q R V E+ + G L HL + ++ R AE + YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAE-IVSALGYLHSC 114
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 704
+++RDLK N++LDK K++DFGL K + DGA+ GT YL PE
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 169
Query: 705 QQLTDKSDVYSFGVILLELISGQ 727
D + GV++ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 30/208 (14%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLL----------SRI 579
+G G FG V + K E+ A+K L K+ +EV L +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKAL-------KKGDIIARDEVESLMCEKRIFETANSE 59
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
H LV Q E V E+ G L H+ H + + + A G+
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGL 114
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
+YLH I++RDLK N+LLD K++DFGL K + G +S GT +L P
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTPEFLAP 170
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQ 727
E T D + GV++ E++ G+
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRN---LVQ 586
IG G FG VY + KD + I A+KVL+ K+E + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTG 645
Q + LV ++M G L HL E R + + + IAE +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL----QKEGRFSEDRAKFYIAE-LVLALEHLHKY 115
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
I++RDLK NILLD + DFGLSK A + ++ GT YL PE + +
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 706 Q-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 742
+ T D +S GV++ E+ G E RNI
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 533 KIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
+G G +G+V K K+ G+ +A+K + + K+ E+ +L ++ H NLV +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 590 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHE--QRINWIKRLEIAEDAAKGIEYLHTG 645
+ + R LV+EF+ + L E L ++ + +GIE+ H+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF--------QILRGIEFCHSH 119
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 704
IIHRD+K NIL+ + K+ DFG ++ A G + + T Y PE +
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV--ATRWYRAPELLVG 174
Query: 705 QQLTDKS-DVYSFGVILLELISGQ 727
++ D+++ G ++ E+++G+
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 39/180 (21%)
Query: 517 CFTLSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFT--NEV 573
C L D E + K+G G FG VY ++K G+ +A+K + ++ + T E+
Sbjct: 4 CSKLRDYE-----ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREI 58
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSV--------LVYEFM--------HNGTLKEHLYGTL 617
+L ++ H N+V + E +V +M N ++K L
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------L 112
Query: 618 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
T Q ++ +L +GI YLH I+HRD+K++NIL+D K++DFGL++
Sbjct: 113 TESQIKCYMLQL------LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 533 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLVQ 586
+IG G +G VY + G +A+K V + G T EV LL R+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 587 FLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
+ C E + LV+E + + L+ +L IK ++ +G+++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDF 123
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
LH C I+HRDLK NIL+ + K++DFGL++ + +V T+ Y PE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEV 178
Query: 702 YISQQLTDKSDVYSFGVILLEL 723
+ D++S G I E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 533 KIGSGGFGVVYYGKLKDGKEIAV-KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
++G G FG VY + K+ +A KV+ + S + ++ E+ +L+ H N+V+ L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 592 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 651
E ++ EF G + + L E+ + + + + + + YLH II
Sbjct: 72 YYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 652 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 709
HRDLK+ NIL K++DFG+S S + GT ++ PE + + D
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184
Query: 710 ---KSDVYSFGVILLEL 723
K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 532 KKIGSGGFGVVYYGKLKDG---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 587
K+IG+G FG V G++ G ++ VK L + S Q + +F E + H NL+Q
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 646
LG C E +LV EF G LK +L E L+ +A + A G+ +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
IH DL N LL + K+ D+GLS +V+ P +I+ +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-----PLRWIAPE 172
Query: 707 LTDK-------------SDVYSFGVILLEL 723
L D+ S+V+S GV + EL
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 530 LEKKIGSGGFGVVYY----GKLKDGKE-------------IAVKVLTSNSYQGKR-EFTN 571
++K+G G FG V+ G K + +AVK+L ++ + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 572 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------GTLTHEQRIN 624
E+ ++SR+ N+++ L C ++ E+M NG L + L I+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 625 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684
+ + +A A G++YL + +HRDL + N L+ K+ K++DFG+S+ G
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 685 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ + + ++ E + + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 588
+K+G G + VY G + +G+ +A+KV++ + +G FT E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLH 69
Query: 589 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
+ V+E+MH + +H G + R+ + L +G+ Y+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIHG- 121
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 703
I+HRDLK N+L+ K++DFGL++ ++ ++ S +V T+ Y P+ +
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLG 177
Query: 704 SQQLTDKSDVYSFGVILLELISGQEA 729
+ + D++ G I +E++ GQ A
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 62/201 (30%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 586
K IG G FG V + K + K AVKVL + K+E + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTG 645
Q + V ++++ G L HL +R R A + A + YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARFYAAEIASALGYLHS- 114
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
I++RDLK NILLD ++DFGL K ++ S+ GT YL PE Q
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQ 171
Query: 706 QLTDKSDVYSFGVILLELISG 726
D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-12
Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 1/99 (1%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
P + + +S+ NL G I S + SL L L N G +PD G L + L NQ
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQF 487
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS-KNVV 438
+G +P L +L L +L + N LSG +P L S K +V
Sbjct: 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
|
Length = 968 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 60/234 (25%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVK-------VLTSNSYQGKREFTNEV 573
D+ K +E IGSG +GVV + GK++A+K V T KR E+
Sbjct: 2 DVGSRYKPIEN-IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL----AKRTL-REL 55
Query: 574 TLLSRIHHRNLV---QFLGYCQEEGRSV-LVYEFM----H-----NGTLKEH-----LYG 615
+L H N++ L + + V +V + M H + L E LY
Sbjct: 56 KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 616 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG- 674
L +G++Y+H+ V IHRDLK SN+L+++ ++ DFG
Sbjct: 116 LL-------------------RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGM 153
Query: 675 ---LSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI 724
LS + ++ V T Y PE +S + T D++S G I E++
Sbjct: 154 ARGLSSSPTEHKYFMTEYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
L ++IGSG +G VY + + G+ A+KV+ + E+ ++ H N+V +
Sbjct: 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 589 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
G + + EF G+L++ H+ G L+ E +I ++ R + +G+ YLH+
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAYVSR-----ETLQGLYYLHS-- 124
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
+HRD+K +NILL + K++DFG+S + S + GT ++ PE ++
Sbjct: 125 -KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVER 182
Query: 707 ---LTDKSDVYSFGVILLEL 723
D+++ G+ +EL
Sbjct: 183 KGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 532 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 587
K IGSG G+V G +AVK L+ N KR + E+ LL ++H+N++
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 588 LGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
L EE + V LV E M + L + ++ L HE R++++ + GI++
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHE-RMSYLLYQMLC-----GIKH 138
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
LH+ IIHRDLK SNI++ K+ DFGL++ A +V T Y PE
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEV 193
Query: 702 YISQQLTDKSDVYSFGVILLELISG 726
+ + D++S G I+ EL+ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 532 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 585
K IGSG G+V Y G+ +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNII 78
Query: 586 QFLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
L EE + V LV E M + L + + L HE R++++ + GI
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE-RMSYLLYQMLC-----GI 131
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
++LH+ IIHRDLK SNI++ K+ DFGL++ A +V T Y P
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAP 186
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQ 727
E + + D++S G I+ E+I G
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-11
Identities = 36/89 (40%), Positives = 54/89 (60%), Gaps = 1/89 (1%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 400
S+ I+L NL+G IP ++ L+SL L L N+LTGPIP +L+ + L N+L
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVP 429
+GP+P S+ +L L L + +N LSG +P
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 340 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDN 398
++TV+ LS+ NLTG IP L +L +L L NSL G IP C LR + L+DN
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 430
+G LPS LP + L + NN L G + S
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 18/226 (7%)
Query: 519 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 577
+ D D +++E IG G +G V+ K+G + AVK+L + E E +L
Sbjct: 12 SFPDPSDTWEIIET-IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILK 69
Query: 578 RIH-HRNLVQFLG-YCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 631
+ H N+V+F G Y +++ ++ LV E + G++ + + G L +R+ I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 632 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 691
+A G+++LH V IHRD+K +NILL K+ DFG+S + +
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSV 185
Query: 692 GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISGQEAISN 732
GT ++ PE +Q D + DV+S G+ +EL G +++
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKRE-FTNEVT 574
+I +T +++G FG VY G L + + +A+K L + RE F +E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 575 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH------------EQR 622
+ SR+ H N+V LG +E +++ + + L E L H +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 623 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAV 680
+ + I A G+E+L + V +H+DL + N+L+ + K+SD GL + +A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
D + + + + ++ PE + + + SD++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 532 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREFTN----EVTLLSRIHHRN 583
K +G GG+G V+ + G + A+KVL + ++ T E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAK----- 637
+V + Q G+ L+ E++ G L HL +R I ED A
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHL-------------EREGIFMEDTACFYLSE 108
Query: 638 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
+E+LH II+RDLK NILLD K++DFGL K ++ + V+ GT+
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTI 164
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 733
Y+ PE + D +S G ++ ++++G + E
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 532 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 586
K IGSG G+V Y + D + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 587 FLGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
L EE + V LV E M + L + + L HE R++++ + GI+
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 133
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
+LH+ IIHRDLK SNI++ K+ DFGL++ A G S + + T Y PE
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 188
Query: 701 YYISQQLTDKSDVYSFGVILLELI 724
+ + D++S G I+ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSN----------SYQGKREFTNEVTLLSRIHHR 582
+G G FG V + K E+ A+K+L + + KR + L +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV----LALPGKPPF- 62
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---GI 639
L Q Q R V E+++ G L H+ Q++ K AA+ G+
Sbjct: 63 -LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPHAVFYAAEIAIGL 114
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
+LH+ II+RDLK N++LD K++DFG+ K + G + GT Y+ P
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAP 170
Query: 700 EYYISQQLTDKS-DVYSFGVILLELISGQ 727
E I+ Q KS D ++FGV+L E+++GQ
Sbjct: 171 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 532 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQF 587
K +G+G FG V+ + + + A+KV+ + ++ NE +L + H +++
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
++ ++ E++ G L+ L + R + L A + +EYLH+
Sbjct: 67 FWTEHDQRFLYMLMEYVPGG----ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS--- 119
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
I++RDLK NILLDK K++DFG +K D + GT YL PE S+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQSKGH 175
Query: 708 TDKSDVYSFGVILLELISG 726
D ++ G+++ E++ G
Sbjct: 176 NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 530 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
L +++GSG +G VY L G+ AVK++ E+ ++ H N+V +
Sbjct: 13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 589 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
G + + E+ G+L++ H+ G L+ E +I ++ R + +G+ YLH+
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCR-----ETLQGLAYLHS-- 124
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
+HRD+K +NILL + K++DFG+ +K A S I GT ++ PE +
Sbjct: 125 -KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVE 181
Query: 706 Q---LTDKSDVYSFGVILLEL 723
+ D+++ G+ +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 533 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 586
+I G +GVVY + K EI A+K L + ++E T+ E+ +L ++ H N+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLREINILLKLQHPNIVT 68
Query: 587 F----LGYCQEEGRSVLVYEFMHNG--TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
+G + + +V E++ + +L E + + + +L G+
Sbjct: 69 VKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL------LSGVA 120
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
+LH I+HRDLK+SN+LL+ K+ DFGL++ + +V T+ Y PE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176
Query: 701 YYISQQL-TDKSDVYSFGVILLELISG 726
+ + + D++S G I EL++
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 31/227 (13%)
Query: 518 FTLSDIEDATKMLEKK------IGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQG 565
F +I D+T + K+ IGSG G+V Y L+ + +A+K L+ N
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 566 KREFTNEVTLLSRIHHRNLVQFLGY-----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 620
KR + E+ L+ ++H+N++ L EE + V + + + L + + L HE
Sbjct: 68 KRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 621 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680
R++++ + GI++LH+ IIHRDLK SNI++ K+ DFGL++ A
Sbjct: 127 -RMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176
Query: 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
G S + + T Y PE + + D++S G I+ E+I G
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQF 587
IG G +G+V K G ++A+K ++ +Q + T E+ +L R H N++
Sbjct: 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGI 68
Query: 588 LGYCQ----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 637
L + E V +V E M + LY IK ++ D +
Sbjct: 69 LDIIRPPSFESFNDVYIVQELM-----ETDLYKL---------IKTQHLSNDHIQYFLYQ 114
Query: 638 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--G 692
G++Y+H+ V +HRDLK SN+LL+ + K+ DFGL++ A H +
Sbjct: 115 ILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 693 TVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 726
T Y PE ++ + K+ D++S G IL E++S
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 67/260 (25%), Positives = 101/260 (38%), Gaps = 58/260 (22%)
Query: 532 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEV----TLLSRIHHRNLVQ 586
K IG G FG V + KD G A+K L S ++E V +L+ + +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 587 FLGYC--QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
Y Q+E L+ E++ G + L T T E+ R IAE I+ +
Sbjct: 66 L--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIAE-TILAIDSI 117
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK---------------------FAVD 681
H IHRD+K N+LLD K+SDFGL F
Sbjct: 118 HK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 682 GASHVSSIVR----------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ +SS + GT Y+ PE ++ + D +S GVI+ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 726 GQEAISNEKFGANCRNIVQW 745
G ++ R I+ W
Sbjct: 235 GYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 52/217 (23%)
Query: 533 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQFL 588
KIG G F V + K GK A+K + ++ + N E+ L R+ H N+++ +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 589 G--YCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--EQRI-NWIKRLEIAEDAAKGIEYLH 643
+ ++ GR LV+E M + L E + G E+R+ +++ +L K ++++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL------LKSLDHMH 117
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY-- 701
I HRD+K NIL+ K++DFG S RG Y P Y
Sbjct: 118 RN---GIFHRDIKPENILIKDD-ILKLADFG-------------SC-RGI--YSKPPYTE 157
Query: 702 YISQQ--------LTD-----KSDVYSFGVILLELIS 725
YIS + LTD K D+++ G + E++S
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 587
K +G G FG V K K G+ A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
Q R V E+ + G L HL + E+ + + + ++YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE-- 114
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQ 706
+++RDLK N++LDK K++DFGL K + DGA+ + GT YL PE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDND 172
Query: 707 LTDKSDVYSFGVILLELISGQEAISNE 733
D + GV++ E++ G+ N+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 534 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLG 589
+G GGFG V ++K+ GK A K L + G++ E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN-LA 59
Query: 590 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
Y E + LV M+ G LK H+Y + + + + GI +LH+
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV--IHYSAQITCGILHLHS---M 114
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
I++RD+K N+LLD ++SD GL+ DG + GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYS 172
Query: 709 DKSDVYSFGVILLELISGQEAISNEK 734
D ++ G + E+++G+ + K
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 12/206 (5%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 587
K +G G FG V + K G+ A+K+L K E + VT +L H L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
Q R V E+ + G L HL + E+ + + +EYLH+ V
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
++RD+K N++LDK K++DFGL K + + + + GT YL PE
Sbjct: 117 ---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 708 TDKSDVYSFGVILLELISGQEAISNE 733
D + GV++ E++ G+ N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 41/229 (17%)
Query: 530 LEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKRE------------FT--NEVT 574
+G G +G V GK +A+K + FT E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 575 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 634
+++ I H N++ + E LV + M + K E ++ I L+I
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCI-LLQIL-- 129
Query: 635 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS--------- 684
G+ LH +HRDL +NI ++ K++DFGL+ ++ S
Sbjct: 130 --NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 685 -----HVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 727
S +V T+ Y PE + +++ D++S G I EL++G+
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 29/205 (14%)
Query: 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 589
+G GGFG V K+K + A+K + + +E +L +H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 641
+++ ++ E+ G L L R E A+ EY
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR------------DRGLFDEYTARFYIACVVLAFEY 108
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
LH II+RDLK N+LLD + K+ DFG +K G + GT Y+ PE
Sbjct: 109 LHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEI 163
Query: 702 YISQQLTDKSDVYSFGVILLELISG 726
+++ D +S G++L EL++G
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNL 584
++ IG G FGVV+ +DGK +A+K + N +Q KR F E+ +L H N+
Sbjct: 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMP-NVFQNLVSCKRVF-RELKMLCFFKHDNV 61
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------- 637
+ L Q ++ ++ L+ + Q + + D K
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPL--------SSDHVKVFLYQIL 113
Query: 638 -GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVG 695
G++YLH+ I+HRD+K N+L++ + K+ DFGL++ D + H++ V T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 696 YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 727
Y PE + S+ T D++S G I EL+ +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 2e-10
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----KREFTNEVTLLSRIHHRNLVQ 586
KKIG+G FG V+ K K +E + SY+G K + EV ++ + H+N+V+
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFC--WKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76
Query: 587 FLGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
++ + L + EF G L ++ +I ++I + Y H
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 645 ----GCVPAIIHRDLKSSNILLDKHMR-----------------AKVSDFGLSK-FAVDG 682
++HRDLK NI L +R AK+ DFGLSK ++
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 683 ASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQ 727
+H S V GT Y PE + ++ DKSD+++ G I+ EL SG+
Sbjct: 197 MAH--SCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEY 641
+V F G +G + E M G+L + L RI N + ++ IA +G+ Y
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKKAGRIPENILGKISIA--VLRGLTY 114
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
L I+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE
Sbjct: 115 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPER 169
Query: 702 YISQQLTDKSDVYSFGVILLELISGQEAI 730
T +SD++S G+ L+E+ G+ I
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 534 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 590
+G G +GVV + K+ KEI K S + +E T E+ +L + N+V+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 591 CQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+ G+ LV+E++ L+ E G + R ++I +L K I + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQL------IKAIHWCHKN-- 119
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
I+HRD+K N+L+ + K+ DFG ++ +G++ + T Y PE +
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 708 TDKSDVYSFGVILLELISGQEAISNE 733
D++S G IL EL GQ E
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 9/167 (5%)
Query: 565 GKREFT-NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 623
G+R T E +L I+H +++Q G + L+ K LY L ++ I
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNI 179
Query: 624 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683
L I + I+YLH IIHRD+K+ NI ++ + DFG + F VD
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236
Query: 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 730
++ GT+ PE D++S G++L E+ + +++
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 533 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 590
++G+G GVV + K I + L + + + E+ +L + +V F G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 591 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVP 648
+G + E M G+L + L +RI + ++ IA +G+ YL
Sbjct: 72 FYSDGEISICMEHMDGGSLDQ----VLKEAKRIPEEILGKVSIA--VLRGLAYLREK--H 123
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
I+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE +
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYS 180
Query: 709 DKSDVYSFGVILLELISGQEAI 730
+SD++S G+ L+EL G+ I
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 525 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIHH 581
DA + LEK IG G +G VY + GK +A+K +G E++LL +
Sbjct: 1 DAYEKLEK-IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 582 RN-LVQFLGYCQEEGRS-----VLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIA 632
+V+ L E ++ LV+E++ + LK+ + IK
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY- 117
Query: 633 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSK-FAVDGASHVSSIV 690
KG+ + H ++HRDLK N+L+DK K++D GL + F++ S+ IV
Sbjct: 118 -QLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 691 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 727
T+ Y PE + S + D++S G I E+ Q
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSR--IHHRN----LVQ 586
+G G FG V + K E+ A+K+L + + E T++ + + ++ L Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALQDKPPFLTQ 65
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
Q R V E+++ G L H+ G Q + + A + + G+ +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGLFFLHR 119
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 703
II+RDLK N++LD K++DFG+ K VDG + + GT Y+ PE
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIA 174
Query: 704 SQQLTDKSDVYSFGVILLELISGQEAISNE 733
Q D +++GV+L E+++GQ E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 586
K +G G FG V +LK E+ A+KVL + + T + L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
Q + R V E+++ G L + ++ + + A + + +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRH- 115
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
+I+RDLK NILLD K++DFG+ K + ++ GT Y+ PE +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELE 172
Query: 707 LTDKSDVYSFGVILLELISGQ 727
D ++ GV++ E+++GQ
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 530 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKREFTNEVT-----LLSRIH 580
L K +G+G +G V+ GK A+KVL + ++ T E T +L +
Sbjct: 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVR 62
Query: 581 HRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 637
+ L Y Q E + L+ +++ G + HLY QR N+ +ED +
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNF------SEDEVRFY 110
Query: 638 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 691
+E+LH I++RD+K NILLD ++DFGLSK + +
Sbjct: 111 SGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 692 GTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 726
GT+ Y+ PE + K+ D +S G+++ EL++G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 532 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 586
K++GSG +G V + G+++A+K L S +Q KR + E+TLL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAY-RELTLLKHMQHENVIG 78
Query: 587 FLGY--CQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
L G LV +M K + G E ++ ++ G++
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQK--IMGHPLSEDKVQYL-----VYQMLCGLK 131
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
Y+H+ IIHRDLK N+ +++ K+ DFGL++ A A +V T Y PE
Sbjct: 132 YIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPE 184
Query: 701 YYIS-QQLTDKSDVYSFGVILLELISGQ 727
++ D++S G I+ E+++G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 571 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 630
+E+ L+ H +V+ + + + +L+ E+ G L + + +QR+ + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI------KQRLK--EHLP 165
Query: 631 IAEDAAKGIEY--------LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682
E + Y +H+ ++HRDLKS+NI L K+ DFG SK D
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 683 AS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
S V+S GT YL PE + ++ + K+D++S GVIL EL++
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLS-RIHHRN-----LVQ 586
+G G FG V + K E+ A+K+L + + E T++ R+ + L Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALSGKPPFLTQ 65
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR---LEIAEDAAKGIEYLH 643
Q R V E+++ G L + Q++ K + A + A G+ +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQI-------QQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYY 702
+ II+RDLK N++LD K++DFG+ K + DG + + GT Y+ PE
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEII 173
Query: 703 ISQQLTDKSDVYSFGVILLELISGQEAISNE 733
Q D ++FGV+L E+++GQ E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 32/163 (19%)
Query: 533 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 586
KIG G FG V+ + K K+I KVL N +G F E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVN 75
Query: 587 FLGYCQEE--------GRSVLVYEFMHNGTLKEH-LYGTLTHEQ---RINWIKRLEIAED 634
+ C+ + G LV+EF EH L G L+++ ++ IK+ + +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFC------EHDLAGLLSNKNVKFTLSEIKK--VMKM 127
Query: 635 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
G+ Y+H I+HRD+K++NIL+ K K++DFGL++
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 533 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 590
++G+G GVV+ K I + L + + + E+ +L + +V F G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 591 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 650
+G + E M G+L + L ++I + ++ IA KG+ YL I
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 125
Query: 651 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 710
+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 182
Query: 711 SDVYSFGVILLELISGQEAI 730
SD++S G+ L+E+ G+ I
Sbjct: 183 SDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQ 586
+ + +GSG G V K + DG+ AVKV+ K EV L ++V+
Sbjct: 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95
Query: 587 FLGYCQEE------------GRSVLVYEFMHNGTLKEHLYGT-------LTHEQRINWIK 627
C E+ LV ++ + G L++ + HE + +I+
Sbjct: 96 ----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHV 686
L + ++H+ +IHRD+KS+NILL + K+ DFG SK +A + V
Sbjct: 152 VL-------LAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
GT Y+ PE + + + K+D++S GV+L EL++
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 587
K IG G FG V + K +++ L S KR F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 639
Q++ +V E+M G L +N + ++ E AK +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 698
+ +H+ +IHRD+K N+LLDKH K++DFG K G + V GT Y+
Sbjct: 156 DAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYIS 211
Query: 699 PEYYISQ----QLTDKSDVYSFGVILLELISG 726
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 587
K IG G FG V + K K++ A+K+L+ + + F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 639
Q++ +V E+M G L +N + +I E A+ +
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDIPEKWARFYTAEVVLAL 155
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 698
+ +H+ IHRD+K N+LLDK K++DFG K +G + V GT Y+
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYIS 211
Query: 699 PEYYISQ----QLTDKSDVYSFGVILLELISG 726
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPS 406
L L+G IP + L L+ L L NSL+G IP+ +L I+HL N TG +P
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
Query: 407 SLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 444
+L +LP L+ L + +N SG +P +L N VL+ + N
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 400
++ ++HL S N TG IP LT L L L L N +G IP + +L ++ L N L
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
TG +P L + NL +L + +N L G +P SL
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 534 IGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 588
+GSG +G V +A+K L S +Q KR + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTY-RELRLLKHMDHENVIGLL 80
Query: 589 -----GYCQEEGRSV-LVYEFMH---NGTLKEHLYGTLTHEQRINWIKRL--EIAEDAAK 637
E+ + V LV M N +K L+ + I+ L +I +
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDH----IQFLVYQIL----R 129
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG-- 695
G++Y+H+ IIHRDLK SNI +++ K+ DFGL A H + G V
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL-------ARHTDDEMTGYVATR 179
Query: 696 -YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 727
Y PE ++ D++S G I+ EL++G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 534 IGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 585
+G G F ++ G ++ E+ +KVL + F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
G C S++V E++ G+L +L ++ IN +LE+A+ A + +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK---KNKNLINISWKLEVAKQLAWALHFLED- 118
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVGYLDPE-Y 701
+ H ++ + N+LL + K + K + G S I+ + ++ PE
Sbjct: 119 --KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 702 YISQQLTDKSDVYSFGVILLELISG 726
Q L+ +D +SFG L E+ SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 532 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 586
K++GSG +G V + G ++A+K L +Q KR + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAY-RELRLLKHMKHENVIG 78
Query: 587 FLG-YCQEEGRS-----VLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638
L + + LV FM G L +H E RI ++ KG
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFL-----VYQMLKG 130
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV---G 695
++Y+H IIHRDLK N+ +++ K+ DFGL A S + G V
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQTDSEMTGYVVTRW 180
Query: 696 YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 727
Y PE ++ T D++S G I+ E+++G+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 530 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKREFT----NEVTLLSRIHH 581
L K +G+G +G V+ + GK A+KVL + K + T E +L I
Sbjct: 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 582 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 637
+ L Y Q + + L+ ++++ G L HL QR + + ++ E
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHL------SQRERFKEQEVQIYSGE-IVL 116
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 696
+E+LH II+RD+K NILLD + ++DFGLSK F D S GT+ Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEY 172
Query: 697 LDPEYYISQQLT-DKS-DVYSFGVILLELISG 726
+ P+ DK+ D +S GV++ EL++G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 533 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFLGY 590
++G G +G VY + G +A+K + + K + E+ +L + +V F G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 591 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL---HTGCV 647
EG + E+M G+L + LY + I I KG+++L H
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYIS 704
IIHRD+K +N+L++ + + K+ DFG+S + V+S+ + +G Y+ PE S
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 705 QQLTD------KSDVYSFGVILLELISG 726
+SDV+S G+ +LE+ G
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 587
+ +G G FG+V + G+ +A+K + S KR + E+ LL + H N++
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENII-- 72
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE------IAEDAAKGIEY 641
S + + + L GT H R+ + LE +G++Y
Sbjct: 73 -------SLSDIFISPLEDIYFVTELLGTDLH--RLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
+H+ V +HRDLK SNIL++++ K+ DFGL++ ++ V T Y PE
Sbjct: 124 VHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQ---DPQMTGYV-STRYYRAPEI 176
Query: 702 YISQQLTD-KSDVYSFGVILLELISGQ 727
++ Q D + D++S G I E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 533 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 590
K+G G + V+ G+ K +A+K + +G EV+LL + H N+V
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 591 CQEEGRSVLVYEFMHNGTLKEHL--YGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGC 646
E LV+E++ + LK++L G L H +I + L +G+ Y H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL-------RGLSYCHK-- 121
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-S 704
I+HRDLK N+L+++ K++DFGL++ +V ++ + +V T+ Y P+ + S
Sbjct: 122 -RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178
Query: 705 QQLTDKSDVYSFGVILLELISGQ 727
+ + D++ G IL E+ +G+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 54/171 (31%), Positives = 79/171 (46%), Gaps = 29/171 (16%)
Query: 523 IEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 581
IE+ + K I G FG VY G K + K AVKV+ K + N+ +
Sbjct: 3 IEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAE 54
Query: 582 RNLV-----QF---LGYCQEEGRSV-LVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLE 630
R+ + F L Y + +V LV E++ G +K H+YG E + +I +
Sbjct: 55 RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114
Query: 631 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681
+A D YLH IIHRDLK N+L+ K++DFGLSK ++
Sbjct: 115 LALD------YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 21/191 (10%)
Query: 572 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-INWIKRLE 630
E LL ++H ++++ + +V LY LT R + + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLP-----HYSSDLYTYLTKRSRPLPIDQALI 161
Query: 631 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 690
I + +G+ YLH IIHRD+K+ NI ++ + + D G ++F V + + +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 691 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI------SNEKFGANCRN--- 741
GTV PE + K+D++S G++L E+++ I + E++ +C +
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276
Query: 742 -IVQWAKLHIE 751
I+ K+H E
Sbjct: 277 KIISTLKVHPE 287
|
Length = 357 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 68/267 (25%), Positives = 105/267 (39%), Gaps = 78/267 (29%)
Query: 530 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVL----TSNSYQGKREFTNEVTLLSRI 579
L K +G G FG V K + +AVK+L T++ Y + E+ +L I
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEY---KALMTELKILIHI 67
Query: 580 -HHRNLVQFLG--------------YCQEEGRSVLVYEFMH-------NGTLKEHLYGTL 617
HH N+V LG YC+ S + T K +
Sbjct: 68 GHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE 127
Query: 618 THEQRIN------------WI--KRLEIAED-----------------------AAKGIE 640
+QR++ +I K L E+ A+G+E
Sbjct: 128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME 187
Query: 641 YLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLD 698
+L + C IHRDL + NILL ++ K+ DFGL++ +V R + ++
Sbjct: 188 FLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243
Query: 699 PEYYISQQLTDKSDVYSFGVILLELIS 725
PE + T +SDV+SFGV+L E+ S
Sbjct: 244 PESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 1/93 (1%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQ 399
P++ + LS+ L+G IP+D+ SSL L L GN L G IP+ L + L NQ
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
L G +P L + +L+ +Y+ N LSG +P +
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232
|
Length = 968 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 532 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQ 586
K I +G +G VY + K+ ++ A+K + + Q ++ F E +L+ + +V
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVS 65
Query: 587 FLGYCQEEGRSVL--VYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
+C E + L V E++ G TL +++ G L + + R+ AE +EY
Sbjct: 66 M--FCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVD-----MARMYFAE-TVLALEY 116
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--------------AVDGASHVS 687
LH I+HRDLK N+L+ K++DFGLSK D +
Sbjct: 117 LHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
V GT Y+ PE + Q D ++ G+IL E + G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 71/264 (26%)
Query: 530 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 581
L K +G G FG V K +AVK+L + + + +E+ +L I +H
Sbjct: 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNH 70
Query: 582 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHL---------YGTLTHEQRINWIKRLEI 631
N+V LG C + G +++ EF G L L Y + +QR + +E
Sbjct: 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130
Query: 632 A------------------------------------------ED-------AAKGIEYL 642
+ ED A+G+E+L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEY 701
+ IHRDL + NILL ++ K+ DFGL++ +V R + ++ PE
Sbjct: 191 AS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247
Query: 702 YISQQLTDKSDVYSFGVILLELIS 725
+ T +SDV+SFGV+L E+ S
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 37/211 (17%)
Query: 534 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 588
+GSG +G V K G +AVK L S +Q KR + E+ LL + H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 82
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 640
RS E ++ L HL G + N +K ++ +D +G++
Sbjct: 83 DVFTP-ARS---LEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 134
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YL 697
Y+H+ IIHRDLK SN+ +++ K+ DFGL A H + G V Y
Sbjct: 135 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTDDEMTGYVATRWYR 184
Query: 698 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
PE ++ +++ D++S G I+ EL++G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 533 KIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 590
K+G G + VY G+ K +A+K + +G EV+LL + H N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 591 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGCV 647
E LV+E++ + LK++L G + + ++ +L +G+ Y H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL------LRGLNYCHR--- 122
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-SQ 705
++HRDLK N+L+++ K++DFGL++ ++ ++ + +V T+ Y P+ + S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGST 180
Query: 706 QLTDKSDVYSFGVILLELISGQ 727
+ + D++ G I E+ +G+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 54/226 (23%)
Query: 532 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 584
K++G G +G+V + + + +A+K +T S KR E+ LL H+N+
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNI 64
Query: 585 V-----------QFLG-YCQEEGRSVLVYEFMHNGT------LKEHLYGTLTHEQRINWI 626
F Y EE +++ + +G + +Y L
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC-------- 116
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDG 682
G++Y+H+ V +HRDLK N+L++ K+ DFGL++ +
Sbjct: 117 -----------GLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
Query: 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
A ++ V T Y PE +S Q K+ DV+S G IL EL+ +
Sbjct: 163 AGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQFLG 589
IG G + V +LK +I A+KV+ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 590 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 640
C Q R LV E+++ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYAAEICIALN 110
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
+LH II+RDLK N+LLD K++D+G+ K + G +S GT Y+ PE
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPE 166
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQ 727
++ D ++ GV++ E+++G+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 587
K IG G FG V KLK+ ++ A+K+L + E F E +L ++ +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 588 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
Q+E LV ++ G TL L + ++ + IA D+ + Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
+HRD+K NIL+D + +++DFG ++ + SS+ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE--IL 175
Query: 705 QQLTD-------KSDVYSFGVILLELISGQEAISNEKF 735
Q + D + D +S GV + E++ G+ E
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 3e-08
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 366 SLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423
+L L L N LT IPD F G P+L+++ L N LT P + LP+LR L + N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 424 L 424
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEIA---VKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 587
++IG+G FG V ++ +A VK L +N S + + EF + + H N++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
LG C E +LV+E+ G LK +L H + + +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--- 117
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGL--SKFAVD---GASHVSSIVRGTVGYLDPEYY 702
+H DL N L + KV D+G+ S++ D +R L E++
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 703 ---ISQQLTDKSDVYSFGVILLEL 723
I+ + T S+V++ GV L EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 636 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 694
AKG+E+L + IHRDL + NILL ++ K+ DFGL++ +V R +
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
++ PE + T +SDV+SFGV+L E+ S
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-08
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 41/237 (17%)
Query: 532 KKIGSGGFGVVYYG-KLKDGKEIAVKV----LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+ IG GG G VY + +A+K L+ N KR F E + + + H +V
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLIHPGIVP 66
Query: 587 FLGYCQEEGRSVLVY---EFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAA 636
C + VY ++ TLK L ++ + L I
Sbjct: 67 VYSICSD---GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-------------AVDGA 683
IEY+H+ ++HRDLK NILL + D+G + F
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 684 SHVS-----SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 735
+ S IV GT Y+ PE + ++ +D+Y+ GVIL ++++ +K
Sbjct: 181 CYSSMTIPGKIV-GTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 532 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLG 589
+K+G G + V+ G+ K + +A+K + +G EV+LL + H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTG 645
+ LV+E++ + LK+++ G + H +I + L +G+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL-------RGLAYCHR- 122
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 703
++HRDLK N+L+++ K++DFGL++ +V ++ + +V T+ Y P+ +
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 178
Query: 704 SQQLTDKSDVYSFGVILLELISGQ 727
S + + + D++ G I E+ SG+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 533 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 589
K+G G + VY G+ K G+ +A+K + +G FT E +LL + H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+ LV+E++ LK+++ G + RL + + +G+ Y H
Sbjct: 71 IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNV----RLFLFQ-LLRGLAYCHQ--- 121
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 706
++HRDLK N+L+ + K++DFGL++ A S S T+ Y P+ + S +
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 707 LTDKSDVYSFGVILLELISGQ 727
+ D++ G I E+ +G+
Sbjct: 181 YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 532 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTS---NSYQGKREFTNEVTLLSRIHHRNLVQF 587
K IG G +G+V K + +++A+K + + N KR E+ LL + H N++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAI 69
Query: 588 LGYCQEEGRSV-----LVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIE 640
R +VYE M + L + + TL+ + ++ +L +G++
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQL------LRGLK 122
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
Y+H+ ++HRDLK SN+LL+ + K+ DFGL++ + ++ V T Y PE
Sbjct: 123 YIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPE 178
Query: 701 YYIS-QQLTDKSDVYSFGVILLELISGQ 727
++ + T DV+S G I EL+ +
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 588
IG G + V +LK + I A+KV+ + T + +H LV
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 640
Q E R V E+++ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
YLH II+RDLK N+LLD K++D+G+ K + S+ GT Y+ PE
Sbjct: 111 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE 166
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQ 727
+ D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 67/274 (24%), Positives = 98/274 (35%), Gaps = 77/274 (28%)
Query: 532 KKIGSGGFGVV-YYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 587
K IG G FG V K GK A+K L + K + + E +L+ +V
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
Q+ L+ EF+ G L L Y T + + + R +AE
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAE------------ 109
Query: 646 CVPAI--------IHRDLKSSNILLDKHMRAKVSDFGLS------------------KFA 679
CV AI IHRD+K NIL+D+ K+SDFGLS K
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169
Query: 680 VDGASHVSSIV----------------------------RGTVGYLDPEYYISQQLTDKS 711
+ + +S+ GT Y+ PE ++ Q +
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 712 DVYSFGVILLELISGQEAISNEKFGANCRNIVQW 745
D +S G I+ E + G +E R I+ W
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 1/88 (1%)
Query: 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPS 406
LS +L+G IP + +L +L L L N+ TG IP + P L+++ L N+ +G +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 407 SLMNLPNLRELYVQNNMLSGTVPSSLLS 434
+L NL L + N L+G +P L S
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 629 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687
L + AKG+ +L + C IHRDL + NILL K+ DFGL++ D + +
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR---DIRNDSN 269
Query: 688 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+V+G V ++ PE + T +SDV+S+G++L E+ S
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 588
IG G + V +LK + I A+KV+ + T + + +H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 640
Q E R V EF+ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
+LH II+RDLK N+LLD K++D+G+ K + +S GT Y+ PE
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTSTFCGTPNYIAPE 166
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQ 727
+ D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 62/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 587
K IG G FG V + KD I A+K+L K + + E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
Q++ L+ EF+ G + L TL+ E +I +A DA + +
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF---- 122
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 684
IHRD+K N+LLD K+SDFGL S F+ +
Sbjct: 123 -----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 685 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 731
++ GT Y+ PE ++ D +S GVI+ E++ G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 732 NEKFGANCRNIVQW 745
+E R ++ W
Sbjct: 238 SETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 532 KKIGSGGFGVVYYGKLKDGK--EIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQ 586
+ +G+G FG V K+ +A+K + +++ +E +L+ I+H V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
G ++E LV EF+ G + L +R A EYL +
Sbjct: 96 LYGSFKDESYLYLVLEFVIGG----EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-- 149
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
I++RDLK N+LLDK K++DFG +K VD ++ + GT Y+ PE ++
Sbjct: 150 -LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT---LCGTPEYIAPEILLNVG 204
Query: 707 LTDKSDVYSFGVILLELISG 726
+D ++ G+ + E++ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 63/236 (26%), Positives = 90/236 (38%), Gaps = 55/236 (23%)
Query: 532 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNLVQ 586
K +G G G V+ +LK GK A+KVL KR T E +L+ + H L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-EQEILATLDHPFLPT 65
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 638
Q E LV ++ G L+ L + K L E+ A+
Sbjct: 66 LYASFQTETYLCLVMDYCPGG----ELFRLLQRQPG----KCLS--EEVARFYAAEVLLA 115
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------- 691
+EYLH I++RDLK NILL + +SDF LSK + VS +R
Sbjct: 116 LEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 692 ---------------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
GT Y+ PE D ++ G++L E++ G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 61/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 532 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 587
K IG G FG V + KD G A+K+L K + + E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
Q++ L+ EF+ G + L TLT E+ +I +A D+ + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF---- 122
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 684
IHRD+K N+LLD K+SDFGL S F +
Sbjct: 123 -----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 685 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 731
++ GT Y+ PE ++ D +S GVI+ E++ G
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 732 NEKFGANCRNIVQW 745
+E + ++ W
Sbjct: 238 SETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 12/102 (11%)
Query: 629 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687
L A+G+E+L + CV HRDL + N+LL + K+ DFGL++ + +++VS
Sbjct: 240 LSFTYQVARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 688 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+G+ V ++ PE T SDV+S+G++L E+ S
Sbjct: 296 ---KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 42/222 (18%)
Query: 532 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
+ +G G G+V+ D K +AVK + Q + E+ ++ R+ H N+V+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 591 CQEEGRSVLVYEFM-HNGTLKEHLYGTLTHEQRI------------NWIKRLEIAEDAAK 637
VYE + +G+ G+LT + N +++ ++E+ A+
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 638 --------GIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSS 688
G++Y+H+ V +HRDLK +N+ ++ + + K+ DFGL++ SH
Sbjct: 118 LFMYQLLRGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 689 IVRGTVG--YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 727
+ G V Y P +S T D+++ G I E+++G+
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 534 IGSGGFGVV---YYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 587
+GSG +G V Y +L+ +++AVK L S +Q R E+ LL + H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKE----HLYGTLTHEQRINWIKRLEIAEDAA------- 636
L F +++ +L L N +K +++++
Sbjct: 80 LDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 637 -KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695
+G++Y+H+ IIHRDLK SN+ +++ ++ DFGL++ A D ++ V T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYV-ATRW 180
Query: 696 YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
Y PE ++ +++ D++S G I+ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 534 IGSGGFGVVYYGKLKDGKE-IAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
IG+G FGVVY D E +A+K VL Y+ + E+ ++ ++H N++ Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNLNHINIIFLKDYY 128
Query: 592 QEEG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE----DAAKGIEYL 642
E +++ + M H Y + H R N L + + + + Y+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKY--MKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
H+ I HRDLK N+L+D + K+ DFG +K + G VS I + Y PE
Sbjct: 187 HS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC--SRFYRAPEL 241
Query: 702 YI-SQQLTDKSDVYSFGVILLELISGQEAISNE 733
+ + T D++S G I+ E+I G S +
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274
|
Length = 440 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 533 KIGSGGFGVVYYGK-LKDG-KEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLV 585
+IG G +G V+ + LK+G + +A+K V +G T EV +L + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 586 QFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
+ C E + LV+E + + L +L IK ++ +G++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 124
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
+LH+ ++HRDLK NIL+ + K++DFGL++ + S +V T+ Y PE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 179
Query: 701 YYISQQLTDKSDVYSFGVILLEL 723
+ D++S G I E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 587
K IG G FG V K+K+ ++ A+K+L + E F E +L R +
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 588 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
Q+E LV ++ G TL L + ++ + +A D+ + Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYI 703
+HRD+K N+LLDK+ +++DFG + DG S++ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-SNVAVGTPDYISPE--I 174
Query: 704 SQQLTD-------KSDVYSFGVILLELISGQ 727
Q + D + D +S GV + E++ G+
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 587
K IG G FG V + K +++ L S KR F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 639
Q++ +V E+M G L +N + ++ E A+ +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 698
+ +H+ IHRD+K N+LLDK K++DFG K +G + V GT Y+
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 211
Query: 699 PEYYISQ----QLTDKSDVYSFGVILLELISG 726
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 50/181 (27%), Positives = 66/181 (36%), Gaps = 50/181 (27%)
Query: 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKF 678
R IAE IE +H IHRD+K NIL+D+ K++DFGL SK+
Sbjct: 104 RFYIAE-LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 679 AVDGASH----------VSSIVR-----------------------GTVGYLDPEYYISQ 705
G H S I R GT Y+ PE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 706 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-LHIESGDIQGIIDPSLL 764
T D +S GVIL E++ GQ + ++ W LHI S Q +
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS---QAKLSREAS 276
Query: 765 D 765
D
Sbjct: 277 D 277
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 587
K IG G FG V K+K + I A+K+L + E F E +L + +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 588 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
Q+E LV ++ G TL L + +I + +A + + Y
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY--- 123
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
+HRD+K N+LLD + +++DFG + SS+ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE--IL 175
Query: 705 QQLTD-------KSDVYSFGVILLELISGQ 727
Q + D + D +S GV + E++ G+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 43/233 (18%)
Query: 520 LSDIEDATKMLEKKIGSGGFGVVYYGKLK----------------DGKEIAVKVLTSNSY 563
L DI ++K IG GGFG VY + + + I ++ L N+
Sbjct: 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI 65
Query: 564 QGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 620
+++ L IH H + ++ G C R + Y F+ L E L T E
Sbjct: 66 YDI----DKIALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFI----LLEKLVEN-TKE 115
Query: 621 --QRI-NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675
+RI K+L I +D +EY+H I H D+K NI++D + R + D+G+
Sbjct: 116 IFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGI 172
Query: 676 SKFAVDGASHVS------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 722
+ + H+ + RGT+ Y + + +T + D+ S G +L+
Sbjct: 173 ASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 12/102 (11%)
Query: 629 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687
L + A+G+++L + C IHRD+ + N+LL AK+ DFGL++ ++ +++V
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV- 269
Query: 688 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
V+G V ++ PE T +SDV+S+G++L E+ S
Sbjct: 270 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 533 KIGSGGFGVVYYGKLKDG---KEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV-- 585
K+G G +G VY K KDG KE A+K + T S R E+ LL + H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----EIALLRELKHPNVIAL 63
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLT-HEQRINWIKRLEIAEDAAK------ 637
Q + + + L++++ EH L+ + H K +++ K
Sbjct: 64 QKVFLSHSDRKVWLLFDY------AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 638 --GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI-- 689
GI YLH V +HRDLK +NIL+ + R K++D G ++ ++ +
Sbjct: 118 LDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 690 VRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 727
V T Y PE + ++ T D+++ G I EL++ +
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 16/150 (10%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV--QFLG 589
K + G VY KD +K+ S RE EV +L + + L + L
Sbjct: 4 KLLKGGLTNRVYLLGTKDED-YVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLA 60
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
+ +G S L+ E++ TL E ++ E++ + IAE A+ + LH +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDE-----VSEEEKED------IAEQLAELLAKLHQLPLLV 109
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679
+ H DL NIL+D + D+ + +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 26/228 (11%)
Query: 507 LNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 566
++D PA A + + +T+ E G GK K + IA +V +
Sbjct: 153 IDDLPAGAFGKIFICALRASTEEAEA---RRGVNSTNQGKPKCERLIAKRV--KAGSRAA 207
Query: 567 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLT 618
+ NE+ L R++H N+++ + E + ++ Y FM++ L
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 619 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG-LSK 677
+ I +K+L A +EY+H +IHRD+K NI L+ + + DFG
Sbjct: 268 QTRAI--MKQLLCA------VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
F + + V GTV PE + +D++S G+ILL+++S
Sbjct: 317 FEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 7e-06
Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 8/80 (10%)
Query: 650 IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
IIH D+K N+L D+ R + D+GL K S GT+ Y PE I
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPE-KIKGHNY 183
Query: 709 DKS-DVYSFGVILLELISGQ 727
D S D ++ GV+ EL++G+
Sbjct: 184 DVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 585
+++ IG G +GVV G+++A+K + + ++ + T E+ LL + H ++V
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIV 62
Query: 586 Q----FLGYCQEEGRSV-LVYEFMH---------NGTL-KEH----LYGTLTHEQRINWI 626
+ L + E + + +V+E M N L EH LY L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------- 113
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASH 685
+ ++Y+HT V HRDLK NIL + + K+ DFGL++ A D +
Sbjct: 114 ----------RALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 686 V--SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQ 727
+ + V T Y PE S + T D++S G I E+++G+
Sbjct: 161 IFWTDYV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLG 589
+G G FG V + K +I A+KV+ + + F E +LS + + Q
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
Q++ LV E+ G L L Y E + +AE + +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAEL----VLAIHSVHQ 120
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-GTVGYLDPEYYISQQ 706
+HRD+K N+L+D+ K++DFG S + V+S + GT Y+ PE +
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 707 LTDKS------DVYSFGVILLELISGQ 727
K D +S GVI E+I G+
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 533 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG-Y 590
K+G G +G VY K KDGK+ L G E+ LL + H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 591 CQEEGRSV-LVYEFMHNG---TLKEHLYGTLTHEQRINWIKRL--EIAEDAAKGIEYLHT 644
R V L++++ + +K H + +++ + + + + GI YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 645 GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLD 698
V +HRDLK +NIL+ + R K++D G ++ ++ + V T Y
Sbjct: 127 NWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 699 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 727
PE + ++ T D+++ G I EL++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 30/211 (14%)
Query: 535 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGY 590
+V+ K K +AVK + K + E+ ++ H N++ ++
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 591 CQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 645
+ +V M G+ LK H L E I +I + D ++Y+H+ G
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILK-----DVLNALDYIHSKG 121
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG------YLDP 699
IHR +K+S+ILL + +S S + + +L P
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 700 EYYISQQL---TDKSDVYSFGVILLELISGQ 727
E + Q L +KSD+YS G+ EL +G
Sbjct: 178 EV-LQQNLQGYNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 12/95 (12%)
Query: 636 AKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT- 693
A G+E+L + CV HRDL + N+L+ + K+ DFGL++ + ++++S +G+
Sbjct: 249 ANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS---KGST 301
Query: 694 ---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ ++ PE + T SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ + LS N ++P ++ LS+L EL L NS+ + S +L + L +N+L
Sbjct: 186 SNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKL 244
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLS 425
LP S+ NL NL L + NN +S
Sbjct: 245 E-DLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 534 IGSGGFGVVYYGKLKD---------GKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHR 582
+G G F +Y G L+ G+E++V KVL S+ ++ F +L+S++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLSHK 61
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN----WIKRLEIAEDAAKG 638
+LV+ G C + +++V E++ G L L H ++ N W +L++A+ A
Sbjct: 62 HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFL-----HREKNNVSLHW--KLDVAKQLASA 113
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKH-------MRAKVSDFGLSKFAVDGASHVSSIVR 691
+ YL ++H ++ NIL+ ++ K+SD G+ + V I
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-- 168
Query: 692 GTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISGQEA 729
++ PE LT +D +SFG LLE+ S E
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 25/195 (12%)
Query: 570 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 629
+E LL R+ H ++ L G + LV + LY L R+ +
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-----DLYTYLG--ARLRPLGLA 260
Query: 630 EIAEDAAK---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686
++ A + I+Y+H IIHRD+K+ N+L++ + DFG + FA S
Sbjct: 261 QVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFA--RGSWS 315
Query: 687 SSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLE-------LISGQEAISNEKFG 736
+ G G +D PE T D++S G+++ E L S +
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375
Query: 737 ANCRNIVQWAKLHIE 751
A I++ A++H++
Sbjct: 376 AQILRIIRQAQVHVD 390
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 530 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 581
K +G+G FG V GK + +AVK+L ++++ +RE +E+ +LS + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTL 609
+N+V LG C G +++ E+ G L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 28/230 (12%)
Query: 505 SSLNDAPAEAAHCFTLSDIEDATKM---LEKKIGSGGFGVVY----YGKLKDGKEIAVKV 557
S D E + SD +M + + G G V+ +G + K++ VK
Sbjct: 68 SPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKA 126
Query: 558 LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGT 616
+T G + E+ +L I HR ++ + Y + +++ ++ + G
Sbjct: 127 VT-----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP 181
Query: 617 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676
L EQ I +RL A + YLH IIHRD+K+ NI LD+ A + DFG +
Sbjct: 182 LPLEQAITIQRRLLEA------LAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA 232
Query: 677 KFAVDGASHVSSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLEL 723
A + G G L+ PE K+D++S G++L E+
Sbjct: 233 --CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 15/146 (10%)
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 640
N+V Y E LV + G L H+ + + E W + +A DA
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
LH I+ RDL +NILLD +++ F V+ + ++ Y PE
Sbjct: 101 -LHR---EGIVCRDLNPNNILLDDRGHIQLTYFS-RWSEVEDSCDGEAVENM---YCAPE 152
Query: 701 YYISQQLTDKSDVYSFGVILLELISG 726
+ T+ D +S G IL EL++G
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 73/296 (24%), Positives = 103/296 (34%), Gaps = 105/296 (35%)
Query: 530 LEKKIGSGGFGVVYYG-----KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN- 583
L KK+G G FGVVY + K + +K + Y + NE R N
Sbjct: 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK--KATEYGAVEIWMNERV---RRACPNS 190
Query: 584 ----LVQFLGYCQEEGRSV--LVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEI 631
+ FL + LV+ + TL KE Y E + L
Sbjct: 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNV---EPYL-----LGK 242
Query: 632 AEDAAKGIEY------------------LH-TGCVPAIIHRDLKSSNILLDKHMRA-KVS 671
+D KG+E LH TG I+HRD+K NI+ + + K+
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG----IVHRDVKPQNIIFSEGSGSFKII 298
Query: 672 DFGLSKFAVDGASHVSSIVRGTVGY------LDP------EYYISQQ------------- 706
D G A D +R + Y LDP +Y +S Q
Sbjct: 299 DLGA---AAD--------LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 347
Query: 707 --------LTDKSDVYSFGVILLE-----LISGQEAIS-NEKFGANCRNIVQWAKL 748
L D+ D+YS G+I L+ L S I N + N ++V W KL
Sbjct: 348 SPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL 403
|
Length = 566 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 60/248 (24%), Positives = 93/248 (37%), Gaps = 61/248 (24%)
Query: 532 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 587
K +G G FG V K+ A+K L + + + E +L+ + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
Q++ V +++ G + L + + R IAE IE +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVHK--- 119
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS----------- 687
IHRD+K NIL+D K++DFGL SK+ G SH+
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWD 178
Query: 688 ----------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 719
S+V GT Y+ PE + + T D +S GVI
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLV-GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 720 LLELISGQ 727
L E++ GQ
Sbjct: 238 LFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 21/191 (10%)
Query: 549 DGKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606
+G+E+ V KVL + F +L+S++ H +L G C +++V EF+ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 666
G L L + W ++ +A+ A + YL ++H ++ + NILL +
Sbjct: 101 GPLDVCLRKEKGR-VPVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG 154
Query: 667 RA-------KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGV 718
A K+SD G+S A+ V I ++ PE L+ +D +SFG
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALSREERVERI-----PWIAPECVPGGNSLSTAADKWSFGT 209
Query: 719 ILLELISGQEA 729
LLE+ E
Sbjct: 210 TLLEICFDGEV 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 15/114 (13%)
Query: 532 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 583
K +G+G FG V YG K +AVK+L +++ +RE +E+ +LS + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHIN 100
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 635
+V LG C G ++++ E+ G L L +R ++I K + AE A
Sbjct: 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFL-----RRKRDSFICPKHEDHAEAA 149
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 33/112 (29%)
Query: 635 AAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV--- 690
A +G+ YLH G IHR++K+S+IL +S GL ++ G SH+ S+V
Sbjct: 110 ALRGLNYLHQNGY----IHRNIKASHIL--------ISGDGL--VSLSGLSHLYSLVRNG 155
Query: 691 -RGTVGYLDPEYYIS-----------QQLTD---KSDVYSFGVILLELISGQ 727
+ V Y P++ S Q L KSD+YS G+ EL +G+
Sbjct: 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 40/149 (26%), Positives = 55/149 (36%), Gaps = 51/149 (34%)
Query: 651 IHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS-------------- 687
IHRD+K NIL+D+ K++DFGL SK+ G HV
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG-DHVRQDSMDFSNEWGDPA 181
Query: 688 -------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 722
S+V GT Y+ PE + T D +S GVIL E
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLV-GTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 723 LISGQEAISNEKFGANCRNIVQW-AKLHI 750
++ GQ + ++ W LHI
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 854 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.59 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.31 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.06 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.99 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.98 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.98 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.94 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.92 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.89 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.7 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.68 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.68 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.66 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.66 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.65 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.63 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.56 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.52 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.52 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.37 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.37 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.33 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.27 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.26 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.08 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.05 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.03 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.02 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.0 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.99 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.97 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.97 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.93 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-71 Score=651.61 Aligned_cols=436 Identities=25% Similarity=0.406 Sum_probs=349.5
Q ss_pred CceeccCC-CCCcceeeecccCCceeEEEEEeeecCcCCCCCCCeeEEEeCCceeeeEEec--CCCCceEEEEEEEecCC
Q 003039 1 MTLRHFPA-DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVIS--DAATIEVRELIFLASSP 77 (854)
Q Consensus 1 ~tlr~fp~-~~~~~cy~~~~~~~~~y~~r~~~~~g~~d~~~~~p~fd~~~~~~~w~~v~~~--~~~~~~~~e~~~~~~~~ 77 (854)
.|+|+||. .++++||++|++++|||+||+.|+|||||+.+++|.|||++|||+|.+|+.+ ..+...++|+|+.++++
T Consensus 70 ~t~R~F~~~~g~~~cY~~~~~~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~ 149 (623)
T PLN03150 70 KTLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDG 149 (623)
T ss_pred hccccCCcccccccceEeeecCCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCC
Confidence 48999996 3566799999999999999999999999999999999999999999999873 34456789999999999
Q ss_pred CceEEEecCCCCCcceeeeeeeecCCccccCcc--cCceeEEEEEeeccCCCC-CCCccCCCCCC--CCccccCcccccc
Q 003039 78 KIDVCLSNATTGQPFISTLELRQFNGSVYLTPF--EDRYYLSVSARINFGADS-EAPVRYPDDPF--DRIWESDSLKKAN 152 (854)
Q Consensus 78 ~~~vcl~~~~~~~pfis~le~~~l~~~~y~~~~--~~~~~~~~~~r~~~g~~~-~~~iryp~D~~--dR~W~~~~~~~~~ 152 (854)
+++|||++++.|.||||+||||+|++++|.... +.+.+|.++.|.++|+.. ...+|||||+| ||+|.|+...
T Consensus 150 ~l~vcf~~~~~~~pFIs~iEv~~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~--- 226 (623)
T PLN03150 150 SASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTF--- 226 (623)
T ss_pred cEEEEEecCCCCCCceeEEEEEEcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCccc---
Confidence 999999999999999999999999999996442 446779999999999853 34699999999 9999997431
Q ss_pred ccccccCCccccccccccCC--CCCCCChHHHhhhcccccCC--ceEEeecCCCCCCcceEEEEeccccC-CCCCCceEE
Q 003039 153 YLVDVAAGTEKVSTKLPIDL--RSDELPPQKVMQTAVVGTNG--SLTYRLNLDGFPGFGWAVTYFAEIED-LDPDESRKF 227 (854)
Q Consensus 153 ~~~~~~~~~~~~st~~~i~~--~~~~~pP~~v~qtA~t~~~~--~l~~~~~~~~~~~~~y~~~yFae~~~-~~~~~~R~F 227 (854)
+ ...|.++++...|+. ..++.+|++|||||.++.++ .+.|.|+++ ....+++.|||+|++. ....++|+|
T Consensus 227 -~---~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~v~-~~~~Y~VrLhFaEi~~~~~~~~~R~F 301 (623)
T PLN03150 227 -G---SGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTMDVD-PNRNYSVWLHFAEIDNSITAEGKRVF 301 (623)
T ss_pred -C---CCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEeecC-CCCCEEEEEEEEeccCccCCCceEEE
Confidence 1 223556676666653 34777899999999887664 466666644 3345569999999984 557789999
Q ss_pred EEEECCcccccccccccccccCcceEEeccccccccccceeeeecccCCCCCCCcccchhhhceeccCCC--CCccHHHH
Q 003039 228 RLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERND--GSIDGVAI 305 (854)
Q Consensus 228 ~v~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~--~~~~~~~~ 305 (854)
||++||+..++...+. ....+.+..+...+......+...+++.++.. -||+|||+|++++..... ...++.++
T Consensus 302 ~V~ing~~~~~~~di~--~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~--s~pilNaiEI~~~~~~~~~t~~~~~~aL 377 (623)
T PLN03150 302 DVLINGDTAFKDVDIV--KMSGERYTALVLNKTVAVSGRTLTIVLQPKKG--THAIINAIEVFEIITAESKTLLEEVSAL 377 (623)
T ss_pred EEEECCEEeecccChh--hhcCCcccceEEEeEEeecCCeEEEEEeeCCC--CcceeeeeeeeeccccccccCchHHHHH
Confidence 9999998876654432 11112221111111111112445666776553 479999999999988654 55677888
Q ss_pred HHHHhhcCC---CCccCCCCCCCCCC--CCCeeEeCCCC---CCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCC
Q 003039 306 VSVISLYSS---ADWAQEGGDPCLPV--PWSWLQCNSDP---QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSL 377 (854)
Q Consensus 306 ~~l~~l~~~---~~w~~~~~~pc~~~--~~~~~~c~~~~---~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l 377 (854)
..+++.... .+| ++|||.|. +|.|+.|+.+. ...++.|+|++|+|+|.+|..|++|++|+.|+|++|+|
T Consensus 378 ~~~k~~~~~~~~~~W---~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l 454 (623)
T PLN03150 378 QTLKSSLGLPLRFGW---NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSI 454 (623)
T ss_pred HHHHHhcCCcccCCC---CCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcc
Confidence 888877543 267 78999875 69999996432 23599999999999999999999999999999999999
Q ss_pred CCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccccccccccc---ccccccccCccccccCC
Q 003039 378 TGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 451 (854)
Q Consensus 378 ~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l~~---~~~~l~~~~n~~l~~~~ 451 (854)
+|.+|. ++.|++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+.. ++..+++.+|+.+|+.+
T Consensus 455 ~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 455 RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred cCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 998885 899999999999999999999999999999999999999999999998743 44678899999999754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-56 Score=557.34 Aligned_cols=509 Identities=25% Similarity=0.395 Sum_probs=374.4
Q ss_pred ccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCe-eEeCCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW-LQCNSDPQP 341 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~-~~c~~~~~~ 341 (854)
++.+..|+|+.|.++..+|. +..+..|+.|++++|.+....+..+ ....+..+... -|. ..+ +......++
T Consensus 427 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls---~n~---l~~~~~~~~~~l~ 499 (968)
T PLN00113 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLS---RNQ---FSGAVPRKLGSLS 499 (968)
T ss_pred CCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECc---CCc---cCCccChhhhhhh
Confidence 66788999999999877665 7788899999999998754322222 22233333211 111 111 111123567
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
+|+.|+|++|+++|.+|..+.+|++|+.|+|++|+++|.+|. +.++++|+.|+|++|+++|.+|..+..+++|+.|+++
T Consensus 500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls 579 (968)
T PLN00113 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579 (968)
T ss_pred ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEecc
Confidence 899999999999999999999999999999999999999886 8899999999999999999999999999999999999
Q ss_pred cccccccccccc-ccccccccccCccccccCCC-----------CCccceeeecchhhHHHHHHHhhheeeeeecCCCCc
Q 003039 421 NNMLSGTVPSSL-LSKNVVLNYAGNINLHEGGR-----------GAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNN 488 (854)
Q Consensus 421 ~N~l~g~~p~~l-~~~~~~l~~~~n~~l~~~~~-----------~~~~~~iii~~~vg~~vl~l~~~~~~~~~~r~K~~~ 488 (854)
+|+++|.+|..- +..+....+.||+.+|+... ......++++.+++++++++++++++++++++++..
T Consensus 580 ~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (968)
T PLN00113 580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLE 659 (968)
T ss_pred CCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccc
Confidence 999999999764 44556667899999997541 111123344444444433333333222222221111
Q ss_pred CcccccccCCCccCCCCCCCCCccccccccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHH
Q 003039 489 YDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR 567 (854)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~ 567 (854)
.+... . .................+...++... ....+.||+|+||.||+|+.. +++.||||++......
T Consensus 660 -~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--- 729 (968)
T PLN00113 660 -LKRVE-N----EDGTWELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--- 729 (968)
T ss_pred -ccccc-c----ccccccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---
Confidence 11000 0 00000000000111122344444332 223568999999999999874 7899999998643321
Q ss_pred HHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCC
Q 003039 568 EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647 (854)
Q Consensus 568 ~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 647 (854)
..+|++.+++++||||++++|+|.+.+..++||||+++|+|.++++ .++|.++.+|+.|+|+||+|||..+.
T Consensus 730 -~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~ 801 (968)
T PLN00113 730 -PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS 801 (968)
T ss_pred -cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC
Confidence 2356889999999999999999999999999999999999999984 27899999999999999999997767
Q ss_pred CceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCC
Q 003039 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727 (854)
Q Consensus 648 ~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~ 727 (854)
++|+||||||+||+++.++.+++. ||.+...... ....||..|+|||++.+..++.++|||||||++|||+||+
T Consensus 802 ~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~ 875 (968)
T PLN00113 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875 (968)
T ss_pred CCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCC
Confidence 799999999999999999988876 6665432211 1235789999999999999999999999999999999999
Q ss_pred cccccccccccccchHHHHHHhhhcCCcccccCccccCc--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 728 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE--YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 728 ~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.||.... .....+++|++..........++|+.+... .+.++..++.+++.+|++.+|++||+|.||++.|+++..
T Consensus 876 ~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 876 SPADAEF--GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCCccc--CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 9995432 233467888887766666677778777543 345677789999999999999999999999999998754
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-54 Score=472.39 Aligned_cols=279 Identities=35% Similarity=0.526 Sum_probs=221.8
Q ss_pred CceeccCCCCCcceeeeccc--CCceeEEEEEeeecCcCCCC-----CCCeeEEEeCCceeeeEEecCCC-CceEEE-EE
Q 003039 1 MTLRHFPADSRKYCYKLDVI--TRTRYLIRATFLYGNFDNNN-----VYPKFDISLGPTHWSTIVISDAA-TIEVRE-LI 71 (854)
Q Consensus 1 ~tlr~fp~~~~~~cy~~~~~--~~~~y~~r~~~~~g~~d~~~-----~~p~fd~~~~~~~w~~v~~~~~~-~~~~~e-~~ 71 (854)
+|+|+||+|.| +||++|+. +|+|||||+.|+|||||+++ +||.|||++|+|.|++|++++.. ...++| +|
T Consensus 52 ~taR~F~~g~r-~cY~l~~~~~~~~~yliRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii 130 (347)
T PF12819_consen 52 QTARIFPEGSR-NCYTLPVTPPGGGKYLIRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFII 130 (347)
T ss_pred ceEEEcCCCCc-cEEEeeccCCCCceEEEEEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEE
Confidence 58999998877 69999998 57799999999999999873 37899999999999999987621 357899 66
Q ss_pred EEecCCCceEEEecCCCCC-cceeeeeeeecCCccccCc-ccCceeEEEEEeeccCCCCCCCccCCCCCCCCccccCccc
Q 003039 72 FLASSPKIDVCLSNATTGQ-PFISTLELRQFNGSVYLTP-FEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLK 149 (854)
Q Consensus 72 ~~~~~~~~~vcl~~~~~~~-pfis~le~~~l~~~~y~~~-~~~~~~~~~~~r~~~g~~~~~~iryp~D~~dR~W~~~~~~ 149 (854)
+++++++++|||+++++|+ ||||+||||||++++|+.. ...+.+|.++.|.++|+... .||||+|+|||+|+|+..
T Consensus 131 ~v~~~~~l~vclv~~~~g~~pFIsaiEl~~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~-~iryp~D~~dR~W~~~~~- 208 (347)
T PF12819_consen 131 NVTWSDTLSVCLVPTGSGTFPFISAIELRPLPDSLYPDTDANSSQALETVYRLNVGGSSS-FIRYPDDTYDRIWQPYSS- 208 (347)
T ss_pred EEcCCCcEEEEEEeCCCCCCCceeEEEEEECCccceeccccCCCceeEEEEeecCCCccc-ccCCCCCcceeecccccc-
Confidence 6666999999999999999 9999999999999999532 35578899999999998654 399999999999998521
Q ss_pred cccccccccCCccccccccccC---CCCCCCChHHHhhhcccccCCc--eEEeecCCCCCCcceEEEEeccccCCCCCC-
Q 003039 150 KANYLVDVAAGTEKVSTKLPID---LRSDELPPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDE- 223 (854)
Q Consensus 150 ~~~~~~~~~~~~~~~st~~~i~---~~~~~~pP~~v~qtA~t~~~~~--l~~~~~~~~~~~~~y~~~yFae~~~~~~~~- 223 (854)
...|.+++++.+|+ ...++.||.+|||||+++.+.+ +.+.|..++....+|++|||||++.+..++
T Consensus 209 --------~~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~ 280 (347)
T PF12819_consen 209 --------SPGWSNISTTSNININSSNNPYDAPSAVYQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNN 280 (347)
T ss_pred --------CccccccccceeeecccCCccCcChHHHHHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCC
Confidence 34577888877775 2348999999999999988875 889998855556677999999999985444
Q ss_pred ceEEEEEECCcccccccccccccccCcceEEeccccccccccceeeeecccCCCCCCCcccchhhhcee
Q 003039 224 SRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 292 (854)
Q Consensus 224 ~R~F~v~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~l~l~~n~~s~lpP~in~le~l~~ 292 (854)
+|+|||++||+..+++ +.+.........+|..........+...++|.++..|+|||+|||+|++++
T Consensus 281 ~R~F~IyiN~~~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 281 QREFDIYINGQTAYSD--VSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred eEEEEEEECCeEccCc--cCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 7999999999988752 222111111112222112223333456788999999999999999999874
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=469.26 Aligned_cols=288 Identities=49% Similarity=0.859 Sum_probs=254.5
Q ss_pred cccccCHHHHHHHHHHhh--ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeee
Q 003039 514 AAHCFTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591 (854)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~--~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~ 591 (854)
....|++.++..+|.+|. +.||+|+||.||+|.+.+|+.||||++........++|..|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999996 799999999999999999999999988765433156699999999999999999999999
Q ss_pred eecC-eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 003039 592 QEEG-RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 670 (854)
Q Consensus 592 ~~~~-~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 670 (854)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.|.++|+||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999875433 7899999999999999999999999889999999999999999999999
Q ss_pred EeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 671 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 671 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
+|||+|+.......+......||.+|+|||++..+..+.|+|||||||+|+||+||+++.+... +.....+++|++..+
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHH
Confidence 9999997654312222221179999999999999999999999999999999999999887654 444556999999999
Q ss_pred hcCCcccccCcccc-CcCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLL-DEYDI-QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 751 ~~~~~~~~id~~l~-~~~~~-~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.++++.+++|+.+. +.+.. +++.++..+|.+|++.+|++||+|.||++.|+.+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999997 66665 78999999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=398.95 Aligned_cols=253 Identities=36% Similarity=0.588 Sum_probs=211.0
Q ss_pred hhccccccCceEEEEEEECCCcE-EEEEEEccCCccc--HHHHHHHHHHHccCCCCceeeEeeeeeecC-eEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~~~-VAvK~l~~~~~~~--~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~-~~~LV~E~~~ 605 (854)
+.+.||+|+||+||+|.++ |+. ||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus 45 ~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 4566999999999999998 555 9999997653322 568999999999999999999999999987 7999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc-eecCCCCCCCEEEcCCC-cEEEEeeeccccccCCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~~~ 683 (854)
+|+|.++++.. ....+++..++.++.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999754 467899999999999999999999998 7 99999999999999997 99999999998654432
Q ss_pred CceeecccccccccCccccc--cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 684 SHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~--~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
...+...||..|||||++. ...|+.|+||||||++||||+||+.||..... .+-+......+
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~-------- 262 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGG-------- 262 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcC--------
Confidence 2233367999999999999 66999999999999999999999999987652 11111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+...+..+...+..++.+||+.+|+.||++.||+..|+.+..
T Consensus 263 -~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 263 -LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1222233355678899999999999999999999999998765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=391.75 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=221.5
Q ss_pred HHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 522 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 522 ~~~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
++......+.+.||+|.||.||.|.++....||+|.++... ....+|.+|+++|++++|+|||+++|+|..++.++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 45555666889999999999999999977799999998653 34578889999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
|||+.|+|.++|+. ..+..+...+.+.++.|||+||+||+++ .+|||||.++||||+++..|||+|||+|+...+
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999975 3467788999999999999999999999 999999999999999999999999999996655
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
+.........-+..|.|||.+..+.++.|+|||||||+||||+| |+.|+..+...+ +...++.|
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------v~~~le~G------- 420 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------VLELLERG------- 420 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------HHHHHhcc-------
Confidence 55444444455789999999999999999999999999999999 888987765221 12222222
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+-..+..+...+.+|+..||+.+|++|||++.+...|+.+..
T Consensus 421 --yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 421 --YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 2223344566679999999999999999999999999888753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=369.38 Aligned_cols=257 Identities=29% Similarity=0.426 Sum_probs=210.4
Q ss_pred cCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeeecC
Q 003039 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 595 (854)
Q Consensus 518 ~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~ 595 (854)
++..|++. ...||+|..|+|||++++ +++-+|+|++... .....+++.+|++++++++||+||.++|.|...+
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 55666653 467999999999999988 6788999999544 3455788999999999999999999999999998
Q ss_pred -eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeee
Q 003039 596 -RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 674 (854)
Q Consensus 596 -~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 674 (854)
...++||||.+|+|++.+.. .+++++...-+|+.++++||.|||+. .+||||||||+||||+..|+|||||||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 59999999999999999853 36799999999999999999999974 399999999999999999999999999
Q ss_pred ccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 675 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 675 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
.++.+.+. ......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... +....+.+-...... +.
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~-~p 298 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVD-EP 298 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhc-CC
Confidence 99876554 5566789999999999999999999999999999999999999997642 111122221111111 11
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. |.+..+ ....++..++..|++.||.+||+++|+++|
T Consensus 299 p-----P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 P-----PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred C-----CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 222222 233468899999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=357.10 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=212.5
Q ss_pred HHHHhhccccccCceEEEEEEE-CCCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEee-eeeecCe-EEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLG-YCQEEGR-SVLV 600 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~-~~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g-~~~~~~~-~~LV 600 (854)
+.+.+.++||+|.||+||++.. .+|..||.|.++-. ..+...+...|+.+|++++|||||++++ -+.++.. +.+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3466788999999999999964 48999999988733 3344567889999999999999999998 4555544 8999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
||+|..|+|...+.......+.+++..+++++.|++.||.++|.+. +. |+||||||.||+|+.+|.|||+|||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999877777888999999999999999999999932 24 89999999999999999999999999998
Q ss_pred ccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
+.... ......+|||.||+||.+.+..|+.|+||||+||++|||+.-+.||.+.+.-+. ..+++.++...+
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L--------~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL--------CKKIEQGDYPPL 248 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH--------HHHHHcCCCCCC
Confidence 76543 344556799999999999999999999999999999999999999987653222 234455544333
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
-| .-....+.+|+..|+.+||+.||+.-.+++.+..
T Consensus 249 p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 PD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 22 2233468889999999999999996555555544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=372.21 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=205.8
Q ss_pred HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc-------cHHHHHHHHHHHccCCCCceeeEeeeeeecCe
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 596 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~-------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~ 596 (854)
...|.+.+.||+|+||.|-+|..+ +|+.||||++++.... ......+|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 345567899999999999999765 7999999999764221 23345799999999999999999999999999
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEee
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDF 673 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkl~DF 673 (854)
.|+||||++||+|.+++- ....+.+..-..++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999984 344566666678999999999999999 99999999999999866 78999999
Q ss_pred eccccccCCCCceeecccccccccCccccccCcC---CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 674 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL---TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 674 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
|+|+... ....+.+.+||+.|.|||++.+... ..++|+||+|||||-+++|.+||.+...+.. +.+ ++
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l~e----QI 394 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---LKE----QI 394 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---HHH----HH
Confidence 9999765 4567788899999999999986543 3478999999999999999999987653321 111 22
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..|++.. ......+..++..+++.+|+..||++||++.|+++|
T Consensus 395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2333211 112234455678999999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=366.67 Aligned_cols=198 Identities=31% Similarity=0.548 Sum_probs=177.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.+.||+|+||+||+|+++ ++.+||||.+... ..+..+.+..|+.+|+.++|||||.+++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 334567999999999999987 5899999998766 4445667889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC------CcEEEEeeecccc
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH------MRAKVSDFGLSKF 678 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~------~~vkl~DFGla~~ 678 (854)
.+|+|.++|+. .+++++.....++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|+.
T Consensus 92 ~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 92 NGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999963 45789999999999999999999999 99999999999999865 4689999999998
Q ss_pred ccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 734 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~ 734 (854)
+.+ .....+.+|++-|||||++..++|+.|+|+||+|+|+|||++|+.||....
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 764 344567889999999999999999999999999999999999999998655
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=383.00 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=210.3
Q ss_pred HHHHhhccccccCceEEEEEEE-CCCcEEEEEEEccC---CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~-~~~~~VAvK~l~~~---~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+|...+.||+|+|+.||.++. ..|+.||+|++.+. .........+||++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4456678999999999999988 78999999999764 2334567889999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
|+|.+++|.+++. ....+.+.++..++.||+.||.|||+. +|+|||||..|+||++++++||+|||||.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999884 456799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
. .+...+.+|||.|+|||++....++..+||||+|||||-||.|++||+.....+....+.. .+. .-
T Consensus 171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~--------~~Y---~~- 237 (592)
T KOG0575|consen 171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL--------NEY---SM- 237 (592)
T ss_pred c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh--------cCc---cc-
Confidence 3 2344567899999999999999999999999999999999999999987764333322211 110 11
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.....+..+|+..+++.+|.+|||+++|+.+
T Consensus 238 ------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 ------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222356799999999999999999999976
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=388.49 Aligned_cols=264 Identities=25% Similarity=0.445 Sum_probs=224.2
Q ss_pred HHHHHHHHHhhccccccCceEEEEEEEC----CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecC
Q 003039 521 SDIEDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 595 (854)
Q Consensus 521 ~~~~~~~~~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~ 595 (854)
.||......++++||.|.||.||+|+++ ....||||.++... ...+++|..|+.||.++.||||++|.|+.....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 3555556667899999999999999987 24579999998764 345678999999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeec
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 675 (854)
..++|.|||++|+|+.||+.. .+++.+.+...|+++||.||.||.+. ++|||||.++||||+.+..+||+|||+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999754 46699999999999999999999997 999999999999999999999999999
Q ss_pred cccccCCCCceeecccc--cccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhc
Q 003039 676 SKFAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIES 752 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~ 752 (854)
+|.+.++.....+..-| +.+|.|||.+..++++.++||||||+||||.++ |.+||.++...+. -+.
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV--------Ika--- 846 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--------IKA--- 846 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH--------HHH---
Confidence 99776655333333323 468999999999999999999999999999888 9999987763211 111
Q ss_pred CCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 753 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 753 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
++..++-..++++...+.+|++.||+.|-.+||.+.||+..|.+++...
T Consensus 847 ------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 847 ------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 2333444556778889999999999999999999999999999987643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=383.77 Aligned_cols=263 Identities=28% Similarity=0.468 Sum_probs=217.6
Q ss_pred HHHHHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecC
Q 003039 523 IEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 595 (854)
Q Consensus 523 ~~~~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~ 595 (854)
+......+.+.||+|+||+||+|+.. +.+-||||.++..... ...+|++|++++..++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33333346788999999999999864 3456999999877554 6789999999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHhhhccccc------cc----ccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLT------HE----QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 665 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~------~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 665 (854)
..++|+|||..|+|.+||+.... .+ ..++..+.+.||.|||.||+||-+. .+|||||.++|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999964321 22 2388899999999999999999998 99999999999999999
Q ss_pred CcEEEEeeeccccccCCCCceee-cccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchH
Q 003039 666 MRAKVSDFGLSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIV 743 (854)
Q Consensus 666 ~~vkl~DFGla~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~ 743 (854)
..|||+|||++|.....+.+... ...-..+|||||.+..++++.++|||||||||||+++ |+.|+.+.... +.+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~----EVI 715 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ----EVI 715 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH----HHH
Confidence 99999999999865554433322 2334789999999999999999999999999999999 88998765522 222
Q ss_pred HHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 744 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 744 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+ .+..|++ -..+..+..++.+|+..||+.+|++||+++||-..|+....
T Consensus 716 e----~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 E----CIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred H----HHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 3 3334433 23345667789999999999999999999999999998644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=334.00 Aligned_cols=273 Identities=21% Similarity=0.271 Sum_probs=206.3
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
...++|+|+||+|||++.+ +|+.||||++.... ..-++-..+|+++|++++|+|+|.++++|.....++||+|||+.
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 3457999999999999988 59999999986442 33356678999999999999999999999999999999999987
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
.-|.++-+ ....++...+.+++.|+++|+.|+|++ +++||||||+||||+.++.+||||||+|+.... ....
T Consensus 86 TvL~eLe~----~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 86 TVLHELER----YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred HHHHHHHh----ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 55554432 234577788899999999999999999 999999999999999999999999999997653 3344
Q ss_pred eecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccc-------cchHHHHHHhh-hcCCccc
Q 003039 687 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-------RNIVQWAKLHI-ESGDIQG 757 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~-------~~l~~~~~~~~-~~~~~~~ 757 (854)
.+..+.|.+|+|||.+.+ .+|...+||||+||++.||++|.+.|.+...-+.. .+++-.-...+ .++.+..
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 455678999999999987 78999999999999999999999999775511100 00100001111 1111222
Q ss_pred ccCcccc-----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHHHHHHHHH
Q 003039 758 IIDPSLL-----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAIVIEREA 810 (854)
Q Consensus 758 ~id~~l~-----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~~~~~~~~~ 810 (854)
+.=|... ..-.......+++++..|++.||++|++-+|++.| ++..+..+...
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~~~ 297 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIERELKA 297 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHHHHH
Confidence 2111111 11112223468899999999999999999999876 55555444333
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.35 Aligned_cols=245 Identities=28% Similarity=0.411 Sum_probs=200.8
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.++||+|+||.||.++.+ +++.+|+|++++... .+.+....|..+|.+++||.||+++-.|.+.+.++||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 5789999999999999866 588899999987643 235667899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
||.|..+| ..++.+++..+.-++.+|+.||.|||++ +||||||||+|||||.+|+++|+|||+++..... ..
T Consensus 109 GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~ 180 (357)
T KOG0598|consen 109 GGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GD 180 (357)
T ss_pred CccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC-CC
Confidence 99999999 4567889999999999999999999999 9999999999999999999999999999843332 23
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.+.+++||+.|||||++.+..|+.++|.||+|+++|||++|.+||...+... +..... .+++ ....
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~-~~k~------~~~p 246 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKIL-KGKL------PLPP 246 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHh-cCcC------CCCC
Confidence 4455789999999999999999999999999999999999999998765222 222221 1110 0011
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRP----SISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RP----sm~eV~~~ 799 (854)
.+ ...+..+++...++.+|++|- ++.+|-+|
T Consensus 247 ~~---ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 247 GY---LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred cc---CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 11 112466888899999999995 56665544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=353.22 Aligned_cols=264 Identities=28% Similarity=0.497 Sum_probs=210.0
Q ss_pred HHHHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeE
Q 003039 520 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 597 (854)
Q Consensus 520 ~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~ 597 (854)
..||......+.+.||+|.||+||+|+|. ..||||++.... .+..+.|++|+..+++-+|.||+-++|||..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 33455555567899999999999999997 579999998654 3456789999999999999999999999999887
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
.+|+.+|+|.+|..+||.. +.+++..+.+.|+.|||+|+.|||.+ +|||||||..|||+.+++.|||+|||++.
T Consensus 463 AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999854 46788889999999999999999999 99999999999999999999999999985
Q ss_pred cccCC-CCceeecccccccccCcccccc---CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC
Q 003039 678 FAVDG-ASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 678 ~~~~~-~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
.-..- .........|...|||||++.. .+|+..+||||||||+|||++|..||...... +++ ..+..|
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----qIi----fmVGrG 608 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----QII----FMVGRG 608 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----heE----EEeccc
Confidence 32211 1112223347889999999974 46899999999999999999999999843311 111 011122
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+ ..|... ....+.+++.+|+..||..++++||.+.+|+..|++++.
T Consensus 609 ~l--~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 YL--MPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cc--Cccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11 111111 123455678899999999999999999999999998765
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.45 Aligned_cols=260 Identities=24% Similarity=0.320 Sum_probs=202.3
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV~E~ 603 (854)
...++||+|.||.||+|+.. +|+.||+|+++-+. ........+||.||++++||||++|.+...+. +..|||+||
T Consensus 120 eki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY 199 (560)
T KOG0600|consen 120 EKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY 199 (560)
T ss_pred HHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence 34578999999999999754 79999999987554 33456677999999999999999999998776 689999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
|+. +|..++. .....++..++..++.|++.||+|||.+ +|+|||||.+|||||.+|.+||+|||||+++....
T Consensus 200 Mdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 200 MDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred ccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 986 7777774 2356789999999999999999999999 99999999999999999999999999999877666
Q ss_pred CceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh-------hcCCc
Q 003039 684 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-------ESGDI 755 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~-------~~~~~ 755 (854)
....+..+-|.+|+|||++.+ ..|+.++|+||.||||.||+.|++.|.+...- .++...++..- ...++
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv---eQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV---EQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH---HHHHHHHHHhCCCChhccccccC
Confidence 555666778999999999987 57999999999999999999999999875511 11111111100 00011
Q ss_pred c--cccCc------cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 Q--GIIDP------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~--~~id~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ..+-+ .+.+. -..-....++|+..+|..||.+|.|+.++++.
T Consensus 350 P~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1 11111 01000 00112357789999999999999999998864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=354.72 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=203.3
Q ss_pred HHHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeec-C
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-G 595 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~-~ 595 (854)
...+.+.++||+|+||.||+|.+. +++.||||+++... ......+.+|+.++.++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 345667889999999999999742 35679999987543 23346788999999999 899999999988764 4
Q ss_pred eEEEEEEeccCCCHHhhhccccc---------------------------------------------------------
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLT--------------------------------------------------------- 618 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 618 (854)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864211
Q ss_pred -ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce-eecccccccc
Q 003039 619 -HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGY 696 (854)
Q Consensus 619 -~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~Y 696 (854)
....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......... .....++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 013477888899999999999999998 99999999999999999999999999997553332221 2233467889
Q ss_pred cCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHH
Q 003039 697 LDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 775 (854)
Q Consensus 697 ~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l 775 (854)
+|||++.+..++.++|||||||++|||++ |..||......+ .+ ...+..+.... . +......+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~----~~~~~~~~~~~-----~----~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EF----CQRLKDGTRMR-----A----PENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HH----HHHHhcCCCCC-----C----CCCCCHHH
Confidence 99999999999999999999999999997 999997643211 11 11122221111 0 11123458
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 776 EEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 776 ~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+++.+|++.+|++||++.||++.|++++.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=340.40 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=201.2
Q ss_pred HHhhccccccCceEEEEEEECC-CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecC--eEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~--~~~LV~E~~ 604 (854)
+...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|++++|||||+.+|...... .+.+.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 3456889999999999998764 8999999887554333667899999999999999999999855444 689999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeeeccccccC--
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVD-- 681 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~-- 681 (854)
++|+|.+++... +..+++..+..+..||++||+|||++ +|+||||||+||||+. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 99 PGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999643 12699999999999999999999998 9999999999999999 79999999999986553
Q ss_pred CCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
..........||+.|||||++..+ ....++||||+||++.||+||+.||.... ....+......++...
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig~~~~~P---- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIGREDSLP---- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHhccCCCC----
Confidence 222333456799999999999963 33459999999999999999999997631 1122222222222111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
.+ +........+++..|++.+|++|||+.++++|--.
T Consensus 243 -~i----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 -EI----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred -CC----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 11 11223357789999999999999999999998554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.57 Aligned_cols=260 Identities=22% Similarity=0.329 Sum_probs=202.1
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+|.-.++||+|.||.||+|+.. +|+.||||+++..... -.....+|++.|+.++|+||+.++++|...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4555689999999999999764 7999999999755322 245678999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
|+. +|...+++ +...+...++..++.++++||+|||++ .|+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 83 m~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 975 88888864 355678889999999999999999999 99999999999999999999999999999876544
Q ss_pred CceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC--------
Q 003039 684 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD-------- 754 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~-------- 754 (854)
...... +-|.+|+|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+.+ +.+++...+. .+....
T Consensus 156 ~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s---DidQL~~If~-~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS---DIDQLSKIFR-ALGTPTPDQWPEMT 230 (318)
T ss_pred cccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc---hHHHHHHHHH-HcCCCCcccCcccc
Confidence 333322 57999999999986 679999999999999999999998876654 1112221111 111000
Q ss_pred -ccccc------CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 -IQGII------DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 -~~~~i------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.+.+ .+.+..-+ ..+....+++...++..||.+|+++.|.+++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00000 01111111 2233456899999999999999999999876
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=378.88 Aligned_cols=266 Identities=29% Similarity=0.436 Sum_probs=216.9
Q ss_pred HHHHHHHHhhccccccCceEEEEEEECC--Cc----EEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeeec
Q 003039 522 DIEDATKMLEKKIGSGGFGVVYYGKLKD--GK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 594 (854)
Q Consensus 522 ~~~~~~~~~~~~iG~G~fg~Vy~a~~~~--~~----~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~ 594 (854)
++......+.+.||+|+||.||.|...+ |. .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3444555567899999999999998763 33 4899998765 456678999999999999999999999999999
Q ss_pred CeEEEEEEeccCCCHHhhhcccc---cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 003039 595 GRSVLVYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 671 (854)
Q Consensus 595 ~~~~LV~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 671 (854)
+..++++|||++|+|..+|+... .....+...+.+.++.|||+|+.||+++ ++|||||.++|+||+....|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence 99999999999999999997542 1245688889999999999999999999 99999999999999999999999
Q ss_pred eeeccccccCCCCceeecc-cccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHh
Q 003039 672 DFGLSKFAVDGASHVSSIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 672 DFGla~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~ 749 (854)
|||+|+.+.+......... .-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+ +. ...
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~----v~---~~~ 917 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE----VL---LDV 917 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH----HH---HHH
Confidence 9999995544433332222 23578999999999999999999999999999999 889998765211 11 112
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
.+.|++ +.+..+..++.+|+..||+.+|++||++..|++++..+....
T Consensus 918 ~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 918 LEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 233322 233445567889999999999999999999999999887654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=345.71 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=204.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.|++.||.|+|++|++|+.+ .++++|||++.+.- ....+....|-..|.+| .||.|++|+-.|.++..+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 347889999999999999866 68999999986542 22334567788899999 89999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.++|. +.+.+++.....++.+|+.||+|||++ |||||||||+|||||.||++||+|||.|+.+.+.
T Consensus 155 ~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 155 YAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999995 457899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc----------e--eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 683 ASH----------V--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 683 ~~~----------~--~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
... . ...++||..|.+||++.....+..+|+|+|||+||+|+.|.+||.+.+.-..++.+..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~------ 301 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA------ 301 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH------
Confidence 211 1 1447899999999999999999999999999999999999999987662111111111
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+|=.+...++ ..+.+|+.+.+..||.+|++..||.+|
T Consensus 302 --------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 --------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111122233 457899999999999999999999988
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=346.96 Aligned_cols=239 Identities=30% Similarity=0.458 Sum_probs=199.4
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHHh
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 611 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 611 (854)
+-||+|+-|.||+|+++ ++.||||+++.- -+.+++-|++|+||||+.|.|+|.....+|+|||||..|-|.+
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 35899999999999998 799999987522 2357888999999999999999999999999999999999999
Q ss_pred hhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeeccc
Q 003039 612 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 691 (854)
Q Consensus 612 ~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 691 (854)
.|+ .++.+.......+..+||.|+.|||.+ .|||||||.-||||..+..|||+|||.++...+. ...-.++
T Consensus 202 VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 202 VLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred HHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 995 455677777888999999999999998 9999999999999999999999999999865443 2334467
Q ss_pred ccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHH
Q 003039 692 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS 771 (854)
Q Consensus 692 gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 771 (854)
||..|||||++...+.++|+|||||||||||||||..||.+.... .+-| | +=.-.|.-..+..+
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIw-------G----VGsNsL~LpvPstc 336 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIW-------G----VGSNSLHLPVPSTC 336 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEE-------e----ccCCcccccCcccC
Confidence 999999999999999999999999999999999999999654411 1111 0 00111222334456
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 772 MWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 772 ~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
..-+.-|+++||+..|..||++.+|+.||+-.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 66788999999999999999999999999854
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.03 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=206.3
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCccc-HHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~-~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.|.+.+.||.|..++||+|+.. .++.||||++.-..... ...+.+|+..|+.++||||++.+..|..+..+++||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 4667889999999999999765 68999999997654443 478899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
.+|++.+.++.....+ +++..+..|.+++++||.|||++ |.||||||+.||||+.+|.|||+|||.+-.+.+...
T Consensus 107 a~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred cCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999998765443 88999999999999999999999 999999999999999999999999998764443221
Q ss_pred c--ee-ecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 685 H--VS-SIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 685 ~--~~-~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
. .. ....||++|||||++.. ..|+.|+||||||+...||.+|..||..... .+.+..- +. +......
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP---mkvLl~t----Lq-n~pp~~~ 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP---MKVLLLT----LQ-NDPPTLL 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh---HHHHHHH----hc-CCCCCcc
Confidence 1 11 45689999999999543 5799999999999999999999999976541 1111111 11 1111100
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
-..+..+........+.+++..|++.||++|||+.+++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0011111122223478899999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.80 Aligned_cols=266 Identities=20% Similarity=0.250 Sum_probs=204.4
Q ss_pred HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCC-CCceeeEeeeeeecC-eEEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG-RSVLV 600 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~-~~~LV 600 (854)
..+|.+.++||.|.||.||+|+-+ .|+.||||.++..- ..++..=.+|+..|++++ ||||+++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 356778899999999999999865 68999999987553 233334468999999998 999999999998888 99999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
||||+. +|.++++++ .+.+++..+..|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+||...
T Consensus 89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999964 899988654 66789999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCceeecccccccccCccccc-cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC-----
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD----- 754 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~----- 754 (854)
.... .+..+.|.+|+|||++. .+-|+.+.|||++|||++|+.+-++.|.+.+.-+..-.+.+......++.+
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 4333 23445799999999986 577899999999999999999999999875521111111111110000000
Q ss_pred cccccCccc---c----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSL---L----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l---~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+...+.=++ . ...-.....+.++++.+|+++||.+|||+.|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000010000 0 00111245678999999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.03 Aligned_cols=245 Identities=27% Similarity=0.410 Sum_probs=205.9
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
-.+||+|+.|.||.|.-. +++.||||++.......++-+.+|+.+|+..+|+|||.+++.+...+.+++|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 468999999999999644 6889999999877777778889999999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+.+. ...+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... ....
T Consensus 358 TDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~T 428 (550)
T KOG0578|consen 358 TDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRST 428 (550)
T ss_pred hhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccc
Confidence 99884 34588999999999999999999999 999999999999999999999999999876655443 4455
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
..||+.|||||++....|+.|+||||||++++||+-|.+||-.++. .+-.......|.. ++ ....
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~ng~P-~l-------k~~~ 493 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGTP-KL-------KNPE 493 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhcCCC-Cc-------CCcc
Confidence 6799999999999999999999999999999999999999975431 1111111122221 11 1122
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+.++..+|+..|+++||++.|+++|
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 233468899999999999999999999987
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=346.64 Aligned_cols=248 Identities=25% Similarity=0.432 Sum_probs=203.8
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC----Cc-ccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN----SY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~----~~-~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~L 599 (854)
.|.+.+.||+|.||.|+.|... ++..||+|++... .. .....+.+|+.++++++ ||||+++++++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 4556789999999999999765 6899999977653 12 23456778999999998 9999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeeecccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKF 678 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~ 678 (854)
||||+.+|+|.+++. ...++.+.....++.|++.|++|||+. +|+||||||+|||++.+ +++||+|||++..
T Consensus 98 vmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 999999999999995 356788899999999999999999998 99999999999999999 9999999999986
Q ss_pred ccCCCCceeecccccccccCccccccCc-CC-CcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQQ-LT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
.. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++..... +.. .+..++..
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----l~~----ki~~~~~~ 241 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----LYR----KIRKGEFK 241 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----HHH----HHhcCCcc
Confidence 64 3344556778999999999999877 86 68999999999999999999998754221 111 12222210
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+ ..... ...+..|+.+|+..+|.+|+++.+|+++
T Consensus 242 --~----p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 242 --I----PSYLL---SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred --C----CCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 0 01110 3467899999999999999999999944
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=355.08 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=206.2
Q ss_pred HhhccccccCceEEEEEEECC--C--cE-EEEEEEccC---CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLKD--G--KE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~--~--~~-VAvK~l~~~---~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
.+.++||+|+||.||+|+++. + .. ||||..+.. ......+|.+|+++|+.++|||||+++|++..+..+++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 456899999999999998763 2 23 899998852 245567899999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
||+|.||+|.++|... ...++..++..++.++|.||+|||++ +++||||.++|+|++.++.+||+|||+++...
T Consensus 240 mEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999643 23689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.... ......-+..|+|||.+..+.++.++|||||||++||+++ |..||.+.... .+..++. ..+.
T Consensus 314 ~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~---~~~~----- 380 (474)
T KOG0194|consen 314 QYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIV---KNGY----- 380 (474)
T ss_pred ceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHH---hcCc-----
Confidence 1111 1111235689999999999999999999999999999999 88999876622 2222221 1111
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
+...+......+..+..+|+..+|++||+|.+|.+.|+.+....
T Consensus 381 ----r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 381 ----RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred ----cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 11112233445777888999999999999999999999976543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=334.84 Aligned_cols=246 Identities=22% Similarity=0.306 Sum_probs=198.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCccc---HHHHHHHHHHHccCCCCceeeEeeeeee----cCeEEEEEEec
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFM 604 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~---~~~~~~Ev~~L~~l~HpnIv~l~g~~~~----~~~~~LV~E~~ 604 (854)
..||+|++|.||+|.+. |+.||||+++...... .+.+.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 46999999999999984 8999999987653332 3567899999999999999999999876 34679999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ...+++.....++.+++.||.|||+.. +++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999853 356889999999999999999999742 77899999999999999999999999987543321
Q ss_pred ceeecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 685 HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+... ....+. . +.
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----~~~~~---i~~~~~-~----~~ 242 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----EIYDL---IINKNN-S----LK 242 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----HHHHH---HHhcCC-C----CC
Confidence 22357899999999976 68999999999999999999999999765421 12111 111111 0 01
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.+......+.+++.+||+.+|++|||+.||++.|+...
T Consensus 243 ----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 ----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11123346889999999999999999999999998763
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=334.43 Aligned_cols=256 Identities=22% Similarity=0.342 Sum_probs=203.6
Q ss_pred HHHHHhhccccccCceEEEEEEEC----CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
...+.+.+.||+|+||.||+|.++ .+..||+|+++.... .....+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 345567789999999999999764 356899999876532 334578899999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998532 34688999999999999999999998 9999999999999999999999999987643
Q ss_pred cCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
............++..|+|||.+.+..++.++|||||||++||+++ |..||...... .+... +..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~~----~~~~~~~-- 227 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKA----VEDGFRL-- 227 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHH----HHCCCCC--
Confidence 2222111222335678999999999999999999999999999875 99999765421 11121 1222110
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
..+......+.+++..|++.+|++||+++||.+.|+++
T Consensus 228 -------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112334688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.28 Aligned_cols=264 Identities=25% Similarity=0.401 Sum_probs=201.7
Q ss_pred HHHHhhccccccCceEEEEEEECC-----------------CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQF 587 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~~-----------------~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l 587 (854)
..+.+.++||+|+||.||++.+++ +..||+|++.... .....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 345567899999999999997642 3369999987543 2335678999999999999999999
Q ss_pred eeeeeecCeEEEEEEeccCCCHHhhhccccc---------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 003039 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT---------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIH 652 (854)
Q Consensus 588 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 652 (854)
++++...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 9999999999999999999999998854211 113467888999999999999999998 9999
Q ss_pred CCCCCCCEEEcCCCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh--CCcc
Q 003039 653 RDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEA 729 (854)
Q Consensus 653 rDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt--G~~p 729 (854)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999755433221 1223345789999999998899999999999999999997 4567
Q ss_pred cccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 730 ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 730 f~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
|...... .+...+.......... .. ...+......+.+++.+|++.+|++||||.||.+.|++
T Consensus 242 ~~~~~~~----~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE----QVIENAGEFFRDQGRQ-VY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH----HHHHHHHHHhhhcccc-cc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7544311 2222222222111100 00 00111223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=339.72 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=210.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.+.||+|.||+||||+-+ +.+.||+|.+.+.. .++.+.+.+|++++++++||||+.++++|+...+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 445678999999999999866 57889999987543 234567899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
.| +|..+|. ....+++..+..|+.++..||.|||+. +|+|||+||.|||++..+.+|++|||+|+.+.. .+
T Consensus 84 ~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 84 VG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 87 9999884 567899999999999999999999999 999999999999999999999999999997655 34
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
...+...||+-|||||+..++.|+..+|+||+|||+||+++|++||-... +.+-++....+.-
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~I~~d~v---------- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKSILKDPV---------- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHHHhcCCC----------
Confidence 55566789999999999999999999999999999999999999996543 3333333332211
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAIVI 806 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~~~~~ 806 (854)
.++......+..++...+..||.+|.+-.+++.| .++.+..
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~ 260 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI 260 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence 1122344568889999999999999999999877 4444333
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=349.50 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=202.8
Q ss_pred HHHHHhhccccccCceEEEEEEE------CCCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCe
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 596 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~------~~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~ 596 (854)
...+.+.+.||+|+||.||+|++ .++..||||+++... ......+.+|++++..+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44466789999999999999974 235689999987543 23345688999999999 89999999999999999
Q ss_pred EEEEEEeccCCCHHhhhccccc----------------------------------------------------------
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------- 618 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 618 (854)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999854210
Q ss_pred -------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 619 -------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 619 -------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 112478889999999999999999998 9999999999999999999999999999755432221
Q ss_pred e-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 686 V-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 686 ~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..+..+ +..+... ..+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~----~~~~~~~--~~~-- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKM----IKEGYRM--LSP-- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHH----HHhCccC--CCC--
Confidence 1 122335678999999999999999999999999999998 88888654311 112222 1111100 001
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
. ....++.+++.+|++.+|++||+|.||++.|++.
T Consensus 340 --~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 --E---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1 1123588999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.53 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=207.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+++.||+|+.|.|..|++. +|+.+|||++.+... .....+++|+-+|+.+.||||+++++++.+..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 346788999999999999875 799999999976522 2245588999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|-|.+++. ..+.+.+.++.+++.||..|+.|+|.. +|+|||+||+|+|||..+++||+|||+|.+..++
T Consensus 94 v~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 94 VPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred cCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 99999999984 567788999999999999999999998 9999999999999999999999999999765443
Q ss_pred CceeecccccccccCccccccCcCC-CcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s-~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
..-.+.||++.|.|||++.+.+|. .++||||+|||||.||||+.||++.+ .+.+. .++..|.++.
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir~LL----lKV~~G~f~M----- 231 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IRVLL----LKVQRGVFEM----- 231 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HHHHH----HHHHcCcccC-----
Confidence 344567899999999999999986 58999999999999999999998655 22332 3344443321
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
+.....++.+|+.+|+..||+.|.|++||.+|-
T Consensus 232 -----Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 232 -----PSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -----CCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 112234577899999999999999999999983
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=308.21 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=212.9
Q ss_pred ccccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeee
Q 003039 515 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGY 590 (854)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~ 590 (854)
...+++.+++ +++.||+|.||.||.|+.+ ++-.||+|++.+.. .+..+++.+|+++-+.++||||++++++
T Consensus 16 ~~~~~l~dfe-----igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 16 TKTWTLDDFE-----IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred ccccchhhcc-----ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence 3456666654 6889999999999999876 56789999987543 3446789999999999999999999999
Q ss_pred eeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 003039 591 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 670 (854)
Q Consensus 591 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 670 (854)
|.++...||++||..+|.+...|.+. ...++++.....+..|+|.||.|+|.+ .|+||||||+|+|++..+..||
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lki 165 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKI 165 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeec
Confidence 99999999999999999999999643 345677888889999999999999998 9999999999999999999999
Q ss_pred EeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 671 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 671 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
+|||.+.... .....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||+....++.++.+..
T Consensus 166 AdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k------ 236 (281)
T KOG0580|consen 166 ADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK------ 236 (281)
T ss_pred cCCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH------
Confidence 9999985432 4455677899999999999999999999999999999999999999987664444333322
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.++.+| ........+++..|+..+|.+|.+..||++|
T Consensus 237 -----~~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 -----VDLKFP-------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----ccccCC-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 112222 2223457899999999999999999999987
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.28 Aligned_cols=271 Identities=25% Similarity=0.381 Sum_probs=220.1
Q ss_pred cCHHHHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCccc-HHHHHHHHHHHccCCCCceeeEeeeeeecCe
Q 003039 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 596 (854)
Q Consensus 518 ~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~-~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~ 596 (854)
-.+.|+.+..-.|.++||+|.||.|..+....+..||||+++...... .++|.+|+++|.+++||||+.++|+|..++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 345667777777889999999999999999878999999999875544 5899999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
+++|+|||++|+|.+++.....+ .+.-....+|+.|||.||+||.+. .+|||||.++|||++.++++||+|||++
T Consensus 610 icmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 99999999999999999654222 244456677999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceee-cccccccccCccccccCcCCCcchhhhHHHHHHHHHh--CCcccccccccccccchHHHHHHhhhcC
Q 003039 677 KFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 677 ~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt--G~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
+.+..+..+... ...-+.+|||||.+.-++++.++|||+||+.|||+++ ...||+.... +++++-....+..+
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQ 760 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCC
Confidence 976665554432 3345789999999999999999999999999999876 6678876542 23333222222222
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
...- ....+.-+..++.+++.+|+..+-++||+++++..+|++.
T Consensus 761 ~~~~------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQV------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred Ccce------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111 1122445566789999999999999999999999999874
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=333.09 Aligned_cols=249 Identities=26% Similarity=0.367 Sum_probs=198.4
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
..+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 4578999999999999865 68999999986542 2223457889999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 84 GGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred CCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999887532 233578899999999999999999998 99999999999999999999999999997653322
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... .-.......+. .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~----------~ 222 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR----EEVDRRVKEDQ----------E 222 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH----HHHHHHhhccc----------c
Confidence 223346899999999999999999999999999999999999999765421111 11111111110 0
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
.+.......+.+|+.+|++.+|++||+ ++++++|
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 111112345789999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=346.60 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=203.4
Q ss_pred HHHHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecC
Q 003039 524 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 595 (854)
Q Consensus 524 ~~~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~ 595 (854)
....+.+.+.||+|+||.||+|+.. ++..||||+++... ......+.+|+++++.+ +|+||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3445667899999999999999752 24579999997543 23345688999999999 8999999999999999
Q ss_pred eEEEEEEeccCCCHHhhhcccc----------------------------------------------------------
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTL---------------------------------------------------------- 617 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~---------------------------------------------------------- 617 (854)
..++||||+++|+|.++++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999885321
Q ss_pred --------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc-eee
Q 003039 618 --------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSS 688 (854)
Q Consensus 618 --------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~ 688 (854)
.....+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 0113478888999999999999999998 9999999999999999999999999999754333221 112
Q ss_pred cccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 689 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 689 ~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
...++..|+|||++....++.++|||||||++|||++ |+.||....... .+.. ....+. .+.....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~----~~~~~~-----~~~~~~~- 339 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYK----MVKRGY-----QMSRPDF- 339 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHH----HHHccc-----CccCCCC-
Confidence 2335678999999998999999999999999999997 999997543211 1111 111110 0000011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
....+.+++.+|++.+|++||++.+|++.|++++
T Consensus 340 ---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 ---APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1246889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=327.41 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=205.6
Q ss_pred HHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
...+.+.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34556778999999999999998888899999987543 33567899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999986432 45688999999999999999999998 999999999999999999999999999986543222
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
........+..|+|||++.+..++.++||||||+++|||++ |+.||...... .+.. .+..+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~----~~~~~~~-------- 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQ----QVDQGYR-------- 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHH----HHHcCCC--------
Confidence 21122223468999999999999999999999999999999 99998654311 1111 1111110
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
...+......+.+++.+|++.+|++||+|.++++.|++
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 -MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00111223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=326.84 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=199.6
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecC-----eEEEEEEec
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYEFM 604 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~-----~~~LV~E~~ 604 (854)
.+.+|+|+||.||+|.+. +++.||||+.-.+. +.-.+|+++|+++.|||||+++-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 478999999999999876 46899999875442 23357899999999999999999885432 346899999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeeeccccccCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~~~~~ 683 (854)
+. +|.+.++......++++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+....+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 76 89999976655677888888899999999999999997 99999999999999977 999999999999888776
Q ss_pred CceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh--c-------C
Q 003039 684 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE--S-------G 753 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~--~-------~ 753 (854)
...+.. -|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+++.. .+++..++..-. . .
T Consensus 181 pniSYi--cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~---dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 181 PNISYI--CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV---DQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred CceeEE--EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH---HHHHHHHHHhCCCCHHHHhhcCc
Confidence 665554 4889999999986 67999999999999999999999999875522 223332221100 0 0
Q ss_pred CcccccCccccCc-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 754 DIQGIIDPSLLDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 754 ~~~~~id~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+.-.+.+... +........++++.++++.+|.+|.++.|+++|
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0011111222111 222334568899999999999999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=333.00 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=206.5
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+...||+|+||.||+|+-+ +|+.+|+|++++.... ....+..|-.+|....+|.||+|+-.|.+.+.+||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 4578999999999999866 6999999999876433 33457789999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC----
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---- 681 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~---- 681 (854)
||++..+|. ....|++..+..++.+++.|++-||+. |+|||||||+|+|||..|++||+||||+.-+..
T Consensus 225 GGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 225 GGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred CccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 999999984 456788888999999999999999998 999999999999999999999999999842110
Q ss_pred ------------------C--C-----Cce-----------------eecccccccccCccccccCcCCCcchhhhHHHH
Q 003039 682 ------------------G--A-----SHV-----------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 719 (854)
Q Consensus 682 ------------------~--~-----~~~-----------------~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvv 719 (854)
. . ... ....+|||.|||||++.+..|+..+|.||+|||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0 0 000 112359999999999999999999999999999
Q ss_pred HHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCC---HHHH
Q 003039 720 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEV 796 (854)
Q Consensus 720 l~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---m~eV 796 (854)
|||||.|.+||......+.++.++.|........+. ....+..+||.+|+. ||++|-. +.||
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--------------~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--------------DLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--------------cccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 999999999999998888899999986544222111 111467799999999 9999985 6676
Q ss_pred HHH
Q 003039 797 LKD 799 (854)
Q Consensus 797 ~~~ 799 (854)
.+|
T Consensus 443 K~H 445 (550)
T KOG0605|consen 443 KKH 445 (550)
T ss_pred hcC
Confidence 655
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.81 Aligned_cols=265 Identities=21% Similarity=0.252 Sum_probs=199.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 445678999999999999986 57889999987542 223456788999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
+++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9887765442 234578888999999999999999998 999999999999999999999999999986544333
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH--------HHHHhhhcCCcc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ--------WAKLHIESGDIQ 756 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~--------~~~~~~~~~~~~ 756 (854)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. +...........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 233345689999999999988899999999999999999999999976432111111110 000001111111
Q ss_pred cccCccccCc------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDE------YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+..... ........+.+++.+|++.+|++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111111000 001123458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=339.39 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=195.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.||+|+||.||+++.+ +|+.||||+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999875 68899999987542 222346778999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 99988853 45678899999999999999999998 9999999999999999999999999998743222 1222
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +..+.. .+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~----~~~~~~------~~p~~- 217 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFEL----ILMEEI------RFPRT- 217 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHHHH----HHcCCC------CCCCC-
Confidence 3456999999999999999999999999999999999999999654311 11111 111110 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
....+.+++.+|++.||++|| ++.|+++|
T Consensus 218 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 ---LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 234578999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.08 Aligned_cols=249 Identities=30% Similarity=0.510 Sum_probs=201.0
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.+.||+|+||.||++.++++..+|+|.+.... ....++.+|++++++++||||+++++++...+..++||||+++|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 34567899999999999999888899999886443 33567889999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.++++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 85 CLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999988642 23578999999999999999999998 999999999999999999999999999875543322222
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+...+ ..+.. ...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----~~~~~i----~~~~~--~~~~~~--- 225 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----EVVEMI----SRGFR--LYRPKL--- 225 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH----HCCCC--CCCCCC---
Confidence 23345678999999998889999999999999999999 89998654411 222221 11110 111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
....+.+++.+|++.+|++||+|.|+++.|
T Consensus 226 ----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 124688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=326.05 Aligned_cols=253 Identities=24% Similarity=0.439 Sum_probs=204.3
Q ss_pred HHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 445678999999999999998888899999886433 2356788999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 86 ~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 86 GSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 9999998643 244678888999999999999999998 99999999999999999999999999998654432222
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....++..|+|||++....++.++|||||||++|||++ |+.||...... .+.... ..+... + ...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~----~~~~~~----~-~~~ 227 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSAL----QRGYRM----P-RME 227 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHHH----HcCCCC----C-CCC
Confidence 223346778999999998889999999999999999998 99998654311 122221 111100 0 011
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
. ....+.+++.+|++.+|++||+++++.+.|++
T Consensus 228 ~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 N----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 22457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.74 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=208.8
Q ss_pred HHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
..+.+.++||+|+||.||+|...+++.+|+|++..........+..|+++++.++|+||+++++++......++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 45667899999999999999998899999999987665556788999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.........
T Consensus 86 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 86 KGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999653 245678999999999999999999998 9999999999999999999999999999765433221
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.....++..|+|||.+....++.++||||||+++++|++ |+.||..... ........ .+..
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~--------- 222 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQIT----AGYR--------- 222 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHHH----hCCc---------
Confidence 123346778999999998899999999999999999998 8999965441 12222211 1100
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
...+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01111223467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=339.77 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=200.9
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||.||+|+.. +++.||||+++... ......+..|++++..++||||+++++++...+..++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 45688999999999999987 58899999987542 223456888999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 84 PGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999843 34578888999999999999999998 999999999999999999999999999975433
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..|... +.....
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------~~~~~~ 222 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------LQRPVY 222 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----------ccCCCC
Confidence 223456899999999999999999999999999999999999999765422222222222100 000000
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..........+.+++.+|+..+|++||++.|++++
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00001223457889999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=326.09 Aligned_cols=253 Identities=29% Similarity=0.445 Sum_probs=203.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.++||+|+||.||+|..+ .++.||+|++.... ....++.+|++++++++|+||+++++++..++..++||||+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 445688999999999999876 58899999987543 3356788999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++... ....+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 87 ~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 87 GNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999998542 234578999999999999999999998 99999999999999999999999999997654432222
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+.. .+..+. .+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~----~~~~~~-----~~---- 224 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYE----LLEKGY-----RM---- 224 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH----HHHCCC-----CC----
Confidence 222334678999999999999999999999999999998 99998654311 1111 111110 00
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
..+......+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.25 Aligned_cols=257 Identities=26% Similarity=0.474 Sum_probs=205.7
Q ss_pred HHHHHhhccccccCceEEEEEEECC------CcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecCeE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 597 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~~------~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~ 597 (854)
...+.+.+.||+|+||.||+|...+ ++.||||+++..... ....+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3456678899999999999998743 478999998765433 457899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHhhhcccc----------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc
Q 003039 598 VLVYEFMHNGTLKEHLYGTL----------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 667 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 667 (854)
++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999996431 2234578899999999999999999998 9999999999999999999
Q ss_pred EEEEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHH
Q 003039 668 AKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW 745 (854)
Q Consensus 668 vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~ 745 (854)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... .+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIEC 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH
Confidence 99999999875432221 11223345788999999999999999999999999999998 99998654311 22222
Q ss_pred HHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 746 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 746 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
. ..+..... +......+.+++.+|++.+|++||++.||++.|+
T Consensus 237 ~----~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 I----TQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H----HcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 12221110 1122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=328.73 Aligned_cols=248 Identities=33% Similarity=0.538 Sum_probs=193.0
Q ss_pred hccccccCceEEEEEEEC-----CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 531 EKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-----~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.||.|.||.||+|.+. .+..|+||+++... ......+.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 568999999999999887 35789999996543 234678999999999999999999999999888899999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.++|... ....+++..+..|+.|+++||+|||+. +++|+||+++|||++.++.+||+|||+++.......
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999654 245689999999999999999999998 999999999999999999999999999976532222
Q ss_pred -ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 685 -HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 685 -~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.......+...|+|||.+....++.++||||||+++|||++ |+.||..... ..+...+ .++....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~~~----~~~~~~~----- 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EEIIEKL----KQGQRLP----- 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHHHH----HTTEETT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccc----cccccce-----
Confidence 22233457789999999999999999999999999999999 7788865431 1222221 2221111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
.+......+.+++.+||+.+|++||+|.+|++.|
T Consensus 226 ----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111234578999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.79 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=202.6
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
.+.||+|.||.||+|... .++.||+|++.-.. .....++.+|+.+|..++++||.+++|.+..+..++++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 478999999999999875 68899999997553 3345678899999999999999999999999999999999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceee
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 688 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 688 (854)
+.+.|.. ...+++....-|+++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+-......... .
T Consensus 98 v~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~ 169 (467)
T KOG0201|consen 98 VLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-K 169 (467)
T ss_pred hhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-c
Confidence 9998843 33346666777899999999999999 99999999999999999999999999997655443333 6
Q ss_pred cccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCC
Q 003039 689 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 768 (854)
Q Consensus 689 ~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~ 768 (854)
++.||+.|||||++....|+.|+||||||+..+||.+|.+|+.....-... .+ +..-.-|.+.+.++
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-fl------------Ipk~~PP~L~~~~S 236 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-FL------------IPKSAPPRLDGDFS 236 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-Ee------------ccCCCCCccccccC
Confidence 678999999999999889999999999999999999999999876521111 00 11222344444443
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 769 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 769 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+.+++..|+..+|+.||++.++++|
T Consensus 237 ----~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 237 ----PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 347889999999999999999999976
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.28 Aligned_cols=255 Identities=28% Similarity=0.474 Sum_probs=203.5
Q ss_pred HHhhccccccCceEEEEEEECC------CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~------~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
+.+.+.||+|+||.||+|.... ...||+|.+.... ......+.+|++++++++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 3467899999999999998653 2579999986543 23345688999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcE
Q 003039 601 YEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 668 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 668 (854)
|||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 999999999999864321 114578889999999999999999998 99999999999999999999
Q ss_pred EEEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHH
Q 003039 669 KVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 746 (854)
Q Consensus 669 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~ 746 (854)
||+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |..||...... .+...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----~~~~~- 238 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EVIEM- 238 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH-
Confidence 9999999975433221 12223346889999999998899999999999999999998 99998754421 22222
Q ss_pred HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 747 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 747 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
+..+.... .+.....++.+|+.+|++.+|++||++.||+++|++
T Consensus 239 ---i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ---IRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 22222111 112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.01 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=203.4
Q ss_pred HHHhhccccccCceEEEEEEECC----CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.+.||+|+||.||+|.++. ...||||+++... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 34567899999999999998752 4579999987543 233567889999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 85 EYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999998542 23688999999999999999999998 999999999999999999999999999986642
Q ss_pred CCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 682 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 682 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+... +..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~----~~~~~~~~-- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKA----VEDGYRLP-- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHH----HHcCCCCC--
Confidence 2221 2222345678999999998899999999999999999998 99998654311 12221 11111100
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
.+......+.+++.+|++.+|++||++.||+++|+++
T Consensus 229 -------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.58 Aligned_cols=240 Identities=24% Similarity=0.333 Sum_probs=193.6
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEEccC---CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~---~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
||+|+||.||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 5789999998643 223345678899999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 998853 34688899999999999999999998 99999999999999999999999999987533222 22334
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ +.. .+...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~~~~-~~~------~~~~~--- 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRKILQ-EPL------RFPDG--- 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHHHHc-CCC------CCCCc---
Confidence 56999999999999999999999999999999999999999754321 11111111 110 01111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 799 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPs---m~eV~~~ 799 (854)
....+.+++.+|++.+|++||+ +.|+++|
T Consensus 216 -~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 -FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred -CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 2245779999999999999985 6676665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=333.29 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=200.3
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.+.||+|+||.||+++.. ++..||+|++.... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 3445678999999999999876 57889999987542 233467899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 86 DGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999853 345788889999999999999999851 6999999999999999999999999998754332
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC---cc-----
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD---IQ----- 756 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~---~~----- 756 (854)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .+..........+. ..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK----ELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhcccccccccCCccccCcc
Confidence 223346899999999999999999999999999999999999999643311 11111000000000 00
Q ss_pred ----------------------c----ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 757 ----------------------G----IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 757 ----------------------~----~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
+ +................+.+++.+|++.+|++|||++|+++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 0000000000011234688999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=332.24 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=197.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 345678999999999999876 68899999986432 22345688899999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 83 VPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999853 34678888999999999999999998 9999999999999999999999999998755332
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ .+..+.. .+
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----~~~~----~i~~~~~------~~ 217 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYE----KILAGKL------EF 217 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHHhCCc------CC
Confidence 12346899999999999988999999999999999999999999764411 1111 1111111 01
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
.... ...+.+++.+|++.||.+||+ +.|+++|
T Consensus 218 ~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 PRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111 235789999999999999995 8888877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.07 Aligned_cols=249 Identities=22% Similarity=0.408 Sum_probs=211.8
Q ss_pred HHHHHHhhccccccCceEEEEEEE-CCCcEEEEEEEccCCcccHH---HHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 524 EDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 524 ~~~~~~~~~~iG~G~fg~Vy~a~~-~~~~~VAvK~l~~~~~~~~~---~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
.+.+|.|.+.||+|.||.|-+|.. ..|+.||||.+++.....+. .+.+|++||+.++||||+.++.+|...+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 356788889999999999999975 57999999999877655544 46789999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||..+|.|.+++ ...+.+++.+...++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++.++
T Consensus 131 vMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999999 4567899999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCceeecccccccccCccccccCcCC-CcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
.+. ...++++|++-|.+||++.+.+|. +.+|-||+||+||-|+.|.-||++.+. ..++. ++..|...+
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvr----QIs~GaYrE- 272 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVR----QISRGAYRE- 272 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHH----HhhcccccC-
Confidence 543 345678999999999999999885 679999999999999999999987652 23333 233343322
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
|. ......-|+.+|+..+|++|.|+.+|..|.
T Consensus 273 --P~--------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 --PE--------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --CC--------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11 112245688999999999999999999885
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=325.15 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=196.7
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
||+|+||+||++... +++.||+|++...... ....+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999876 6889999998654222 234567899999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444456789999999999999999999998 999999999999999999999999999875543322 2233
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ....+.. .++.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~~----------~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RILNDSV----------TYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH----hhcccCC----------CCcc
Confidence 4689999999999999999999999999999999999999975431111111111 1101100 1111
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
.....+.+++..|++.+|++|| +++++++|
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2234578999999999999999 67777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=350.81 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=203.4
Q ss_pred HHhhccccccCceEEEEEEEC-C-CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~-~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.+.||+|+||.||+|... + ++.||+|.+..........+..|+++++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 556789999999999999765 3 57889998765544445667889999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC-
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 684 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~- 684 (854)
+|+|.++++........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999999876544455688889999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.......||++|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .. ..+....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~---~~-~~~~~~~------- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----EIMQ---QV-LYGKYDP------- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HH-HhCCCCC-------
Confidence 2233456999999999999999999999999999999999999999754311 1111 11 1111110
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+......+.+++.+|++.+|++||++.+++++
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111122457899999999999999999999754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.80 Aligned_cols=264 Identities=20% Similarity=0.282 Sum_probs=196.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.++||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+.
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 445688999999999999876 68899999986443 2234567789999999999999999999999999999999997
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 87 S-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred c-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 5 898887532 33467888899999999999999998 999999999999999999999999999875432221
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh--------hcCCcc
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI--------ESGDIQ 756 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~--------~~~~~~ 756 (854)
......|++.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+........ ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2233458999999999875 5689999999999999999999999976542221111111100000 000000
Q ss_pred cccCccccCcC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDEY----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+...... .........+++.+|++.+|++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111110000 00112357799999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.63 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.||+|+||.||+++.+ +|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999875 68999999987542 223445678999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9988874 234688999999999999999999998 99999999999999999999999999987432221 122
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... .. .+.. .+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~---~~-~~~~------~~p~~- 217 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFEL---IL-MEEI------RFPRT- 217 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHHH---Hh-cCCC------CCCCC-
Confidence 3356999999999999999999999999999999999999999754311 11111 11 1110 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
....+.+++.+|++.+|++|| ++.++++|
T Consensus 218 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ---CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 224577999999999999998 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.26 Aligned_cols=239 Identities=26% Similarity=0.364 Sum_probs=196.0
Q ss_pred cCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeee
Q 003039 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQE 593 (854)
Q Consensus 518 ~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~ 593 (854)
+.+.|++ +.+.||.|+||+|.+++.+ +|..+|+|++.....- ..+...+|..+|+.+.||+++++.+.|.+
T Consensus 41 ~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 4555543 4678999999999999987 5788999999765432 23456789999999999999999999999
Q ss_pred cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 003039 594 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 673 (854)
Q Consensus 594 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 673 (854)
.+.++|||||++||.|..+++ ..+++++..+.-++.||+.||+|||+. .|++||+||+|||||.+|.+||+||
T Consensus 116 ~~~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred CCeEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 999999999999999999995 457899999999999999999999998 9999999999999999999999999
Q ss_pred eccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC
Q 003039 674 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 674 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
|+|+.... ...+.+||+.|+|||.+.+..+..++|.|||||++|||+.|..||...+.-..++ ++-++
T Consensus 189 GFAK~v~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~--------KI~~~ 256 (355)
T KOG0616|consen 189 GFAKRVSG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE--------KILEG 256 (355)
T ss_pred cceEEecC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH--------HHHhC
Confidence 99987643 2456789999999999999999999999999999999999999998765211111 11122
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCC
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR 790 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 790 (854)
++ .++.--...+.+|+...++.|-.+|
T Consensus 257 ~v----------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 KV----------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cc----------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11 1111122346677777788887777
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.17 Aligned_cols=249 Identities=28% Similarity=0.467 Sum_probs=199.9
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.+.||+|+||.||+|.++++..+|+|++.... .....+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 45678899999999999998877889999986433 23457888999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...+......
T Consensus 85 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 85 CLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999998642 23688999999999999999999998 999999999999999999999999999876543322222
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+... ...+. .. .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~----~~~~~-----~~----~ 221 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVES----VSAGY-----RL----Y 221 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHHH----HHcCC-----cC----C
Confidence 22234568999999999999999999999999999999 88898654311 11111 11110 00 0
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
.+.....++.+++.+|++.+|++||+|.||++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111234688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=334.10 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=203.7
Q ss_pred HHHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeee-cC
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE-EG 595 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~-~~ 595 (854)
...+.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346778899999999999999643 24789999987543 22345678899999999 89999999998864 45
Q ss_pred eEEEEEEeccCCCHHhhhccccc---------------------------------------------------------
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLT--------------------------------------------------------- 618 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 618 (854)
..++++||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999998853211
Q ss_pred ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce-eeccccccccc
Q 003039 619 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYL 697 (854)
Q Consensus 619 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~Y~ 697 (854)
....++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 013678999999999999999999998 99999999999999999999999999998654332222 22334677899
Q ss_pred CccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHH
Q 003039 698 DPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 776 (854)
Q Consensus 698 aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~ 776 (854)
|||++.+..++.++|||||||++|||++ |..||......+ .+ ...+..+.... .+.....++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EF----CRRLKEGTRMR---------APEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HH----HHHHhccCCCC---------CCccCCHHHH
Confidence 9999999999999999999999999998 999986533111 11 11122221100 0112234688
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 777 EKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 777 ~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+++.+|++.+|++||++.||+++|+.++.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=334.22 Aligned_cols=243 Identities=27% Similarity=0.368 Sum_probs=198.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|+.+ +++.||||++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 456789999999999999886 58899999986532 22345688999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+.+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 100 VVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred CCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999998853 34677888889999999999999998 99999999999999999999999999997653321
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+..+.+. +
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~----~~i~~~~~~------~ 234 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIY----EKILAGRLK------F 234 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHH----HHHhcCCcC------C
Confidence 2346999999999999999999999999999999999999999654311 111 112222110 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
.... ...+.+++..|++.||++||+ ++++++|
T Consensus 235 p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 PNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 235779999999999999996 7888876
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=330.08 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=209.7
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCe-EEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYE 602 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~-~~LV~E 602 (854)
.|...+.+|+|+||.++..+++ +++.+++|.+.-.. ...++...+|+.++++++|||||.+.+.+..++. .++||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 3556789999999999999876 57889999886543 3345578899999999999999999999999988 999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|++||++.+.+.... +.-+++.+++.++.|++.|+.|||++ .|+|||||+.|||++.+..|||+|||+|+.+...
T Consensus 85 Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred ecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999996543 56688999999999999999999988 9999999999999999999999999999987665
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.. ....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.......+.+ .
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~-----------------~ 221 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR-----------------G 221 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh-----------------c
Confidence 42 44556799999999999999999999999999999999999999987663322211111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+.....++..++..|++.+|+.||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1112233344568899999999999999999999987
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.25 Aligned_cols=250 Identities=30% Similarity=0.486 Sum_probs=201.2
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.+.||+|+||.||+|++.++..+|+|.+.... ....++.+|++++++++||||+++++++......++||||+.+|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 44567899999999999998877789999887443 33567899999999999999999999999988999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++..........
T Consensus 85 ~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 85 CLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999998542 23688999999999999999999998 999999999999999999999999999876544332222
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+... ...+....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~----~~~~~~~~--------- 221 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEK----VSQGLRLY--------- 221 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHH----HhcCCCCC---------
Confidence 22345678999999998889999999999999999999 99998654311 11111 11111100
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
........+.+++.+|++.+|++||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00112356889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=346.71 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=209.7
Q ss_pred HHhhccccccCceEEEEEEECCC-cEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeee-eee------cCeEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGY-CQE------EGRSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~-~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~-~~~------~~~~~ 598 (854)
..+++.|.+|||+.||.|....+ .++|+|++-..+....+.+.+|+++|++|+ |+|||.+++. ... .-+.+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34578999999999999998765 999999987777777888999999999996 9999999993 221 23678
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
|.||||.+|.|-+++..+.. .+|.+.++++|+.++++|+++||.. .++|||||||-+||||+.+++.||||||.|.-
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred eehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 99999999999999976653 3499999999999999999999984 67899999999999999999999999999863
Q ss_pred ccCCCCce--------eecccccccccCcccc---ccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH
Q 003039 679 AVDGASHV--------SSIVRGTVGYLDPEYY---ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 747 (854)
Q Consensus 679 ~~~~~~~~--------~~~~~gt~~Y~aPE~~---~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~ 747 (854)
........ .-...-|+.|+|||++ .+..+++|+|||+|||+||-|+....||+...
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------- 262 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------- 262 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------------
Confidence 32222110 0113369999999997 46789999999999999999999999998653
Q ss_pred HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 748 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
-..|++....-.........+.+||..||+++|.+||++.||++++.++...+
T Consensus 263 -------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 -------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 11233333322222456678999999999999999999999999999887543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=340.83 Aligned_cols=261 Identities=24% Similarity=0.385 Sum_probs=203.5
Q ss_pred HHHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCC-CCceeeEeeeeeecCe
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 596 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~ 596 (854)
...+.+.++||+|+||.||+|+.. .+..||||+++.... .....+.+|+++++++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 334556789999999999999863 134799999975432 33457889999999996 9999999999999999
Q ss_pred EEEEEEeccCCCHHhhhccccc----------------------------------------------------------
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------- 618 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 618 (854)
.++||||+++|+|.++++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864210
Q ss_pred ----------------------------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 003039 619 ----------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 664 (854)
Q Consensus 619 ----------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 664 (854)
....+++..++.++.|+++||+|||+. +|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 012477888899999999999999998 9999999999999999
Q ss_pred CCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccch
Q 003039 665 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 742 (854)
Q Consensus 665 ~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l 742 (854)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---~~ 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---TF 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---HH
Confidence 999999999999755432222 1222346788999999999899999999999999999997 889986543111 11
Q ss_pred HHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 743 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 743 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
. ..+..+... ..+......+.+++.+|++.+|++||++.+|++.|++++
T Consensus 350 ~----~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 Y----NKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H----HHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 111111100 011122346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=333.73 Aligned_cols=261 Identities=27% Similarity=0.402 Sum_probs=215.8
Q ss_pred HHHHHHHHhhccccccCceEEEEEEECC-CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 522 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 522 ~~~~~~~~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
|+++......++||-|.||.||.|.|+. .-.||||.++.+.. ..++|.+|+.+|+.++|||+|+|+|+|..+...|+|
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3333333446899999999999999984 56799999986543 467899999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
+|||..|+|.++|+.. ....++-...+.|+.||+.||+||..+ .+|||||.++|+|+.++..|||+|||+++++.
T Consensus 342 TEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999754 234466667788999999999999998 99999999999999999999999999999876
Q ss_pred CCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
...........-...|.|||-+....++.|+|||+|||+|||+.| |..||.+-... .+...++
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------qVY~LLE-------- 480 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYGLLE-------- 480 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------HHHHHHh--------
Confidence 543333233334678999999999999999999999999999999 88998765421 1222222
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
...+-+.+..+..++.+|+..||+++|.+||++.|+.+.+|.++.
T Consensus 481 -kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 481 -KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 223334455667789999999999999999999999999998873
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=331.56 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=200.8
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCc----EEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~----~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
..+.+.+.||+|+||.||+|++. +++ .||+|+++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 34556789999999999999864 333 48999987543 33456788999999999999999999999765 5679
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999998642 34578888999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCcee-ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 680 VDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 680 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
........ ....++..|+|||++....++.++|||||||++|||++ |+.||...... .+.. ....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----~~~~----~~~~~~~~~ 231 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISS----ILEKGERLP 231 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHH----HHhCCCCCC
Confidence 44332221 22234678999999999999999999999999999998 99998754311 1111 111111000
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+......+.+++.+|++.+|++||++.+|++.|..+..
T Consensus 232 ---------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 232 ---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 001122357899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=334.42 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=195.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.||+|+||.||+++.+ +++.||||++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999876 68999999997542 223456788999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99888743 34688999999999999999999998 99999999999999999999999999987532221 222
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ... .+. ..+....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~---~~~-~~~------~~~p~~~ 218 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFE---LIL-MED------IKFPRTL 218 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----HHHH---Hhc-cCC------ccCCCCC
Confidence 3456999999999999989999999999999999999999999754311 1111 111 110 1111112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
...+.+++.+|++.+|++|| ++.|+++|
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 ----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 23577899999999999997 89999887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=318.73 Aligned_cols=253 Identities=27% Similarity=0.450 Sum_probs=202.7
Q ss_pred HHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
..+.+.++||+|+||.||+|...++..||+|.+..... ....+.+|+.++++++|+|++++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 45667889999999999999988888999999875433 35678999999999999999999998854 56789999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999998642 234578999999999999999999998 9999999999999999999999999999765433222
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+.... ..+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~----~~~~~--------- 221 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLEQV----ERGYR--------- 221 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH----HcCCC---------
Confidence 2222335678999999988899999999999999999999 8889865431 1122211 11100
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
...+......+.+++.+|+..+|++|||+.++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01111223468899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=320.42 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=203.5
Q ss_pred HHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
..+.+.++||+|+||.||+|++.+...||+|+++... .....+.+|++++++++||||+++++++.. ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 4567788999999999999998877789999987533 234678999999999999999999998754 55799999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999642 234578899999999999999999998 9999999999999999999999999999765443322
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......++..|+|||+..+..++.++|||||||++|||++ |..||...... .+.. ....+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~----~~~~~~~--------- 221 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERGYR--------- 221 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHH----HHhcCCC---------
Confidence 2223346778999999998899999999999999999999 88888654311 1111 1111100
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.....+....+.+++.+|++.+|++||++.++++.|++..
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0111233456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=322.20 Aligned_cols=266 Identities=24% Similarity=0.374 Sum_probs=200.8
Q ss_pred HhhccccccCceEEEEEEE-----CCCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 600 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~-----~~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV 600 (854)
.+.+.||+|+||+||++.. .+++.||+|+++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5568899999999988653 3578899999875432 3456788999999999999999999988653 457899
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999843 3589999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCc--eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 681 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 681 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
..... ......++..|+|||.+....++.++|||||||+++||++|+.|+..... ....+..+.........+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK--KFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc--hhhhhhcccccccchhhhhhh
Confidence 33221 11222356779999999888899999999999999999999999854321 011111111000001111111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
++.......+.....++.+++..|++.+|++||++++|++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111111112223457899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.91 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=196.8
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--------------cHHHHHHHHHHHccCCCCceeeEeeee
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------------GKREFTNEVTLLSRIHHRNLVQFLGYC 591 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--------------~~~~~~~Ev~~L~~l~HpnIv~l~g~~ 591 (854)
.|.+.+.||+|.||.|-+|+.. +++.||||++.+.... ..+...+|+.+|++++|||||+|+++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 4566788999999999999865 6899999999653211 124678999999999999999999998
Q ss_pred ee--cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEE
Q 003039 592 QE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 669 (854)
Q Consensus 592 ~~--~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 669 (854)
.+ .+..|||+|||..|.+...= .....+...++++++.++..||+|||.+ +||||||||+|+||+++|+||
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 65 45789999999998875432 1222388999999999999999999998 999999999999999999999
Q ss_pred EEeeeccccccCCCC----ceeecccccccccCccccccCc----CCCcchhhhHHHHHHHHHhCCcccccccccccccc
Q 003039 670 VSDFGLSKFAVDGAS----HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 741 (854)
Q Consensus 670 l~DFGla~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~----~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~ 741 (854)
|+|||.+.....+.. .......||+.|+|||...++. .+.+.||||+||.||.|+.|+.||-+...-+..
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~-- 328 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF-- 328 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH--
Confidence 999999976533211 1123367999999999998743 345789999999999999999999765521111
Q ss_pred hHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 742 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 742 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
.+ ++...|.-.-..+.-..+.+|+++++..||+.|.+..+|..|.-
T Consensus 329 ------~K--------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 329 ------DK--------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ------HH--------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 11 12222221112244567889999999999999999999988854
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=324.78 Aligned_cols=260 Identities=27% Similarity=0.468 Sum_probs=206.4
Q ss_pred HHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
..+.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 34556789999999999999752 345689999876555556678999999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhcccc---------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 003039 600 VYEFMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 670 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 670 (854)
||||+++++|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1223589999999999999999999998 9999999999999999999999
Q ss_pred EeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHH
Q 003039 671 SDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 748 (854)
Q Consensus 671 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~ 748 (854)
+|||+++........ ......++..|+|||++.+..++.++|||||||+++||++ |..||...... .+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~----~~~~---- 233 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIE---- 233 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH----
Confidence 999999755332211 1122345778999999998899999999999999999998 89998654311 1111
Q ss_pred hhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 749 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 749 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+..+.... .... ....+.+++.+|++.+|.+||++.||.+.|+++..
T Consensus 234 ~i~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 234 CITQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 112222111 0111 22458899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=318.94 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=205.7
Q ss_pred HHHHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 523 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 523 ~~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+..+.+.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 44566778899999999999999988899999999875443 3567899999999999999999999874 456899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+.+++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999988543 244688899999999999999999998 9999999999999999999999999998765432
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.........++..|+|||++....++.++|||||||+++|+++ |+.||...... .+... +..+....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~----~~~~~~~~---- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVIQN----LERGYRMP---- 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HHHHH----HHcCCCCC----
Confidence 2222223346778999999998889999999999999999999 99999754421 12111 11111000
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
... ....++.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 -~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -RPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111 122468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=325.13 Aligned_cols=258 Identities=26% Similarity=0.461 Sum_probs=206.8
Q ss_pred HHhhccccccCceEEEEEEEC------CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
+.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 445688999999999999753 34568999987665555678999999999999999999999999999999999
Q ss_pred EeccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEE
Q 003039 602 EFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 669 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 669 (854)
||+++++|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999864321 224588999999999999999999998 999999999999999999999
Q ss_pred EEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHH
Q 003039 670 VSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAK 747 (854)
Q Consensus 670 l~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~ 747 (854)
|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~--- 236 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIE--- 236 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH---
Confidence 999999975443221 11223446788999999999999999999999999999999 99998654311 1222
Q ss_pred HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 748 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+..+..... .......+.+++.+|++.+|++||++.+|++.|+++..
T Consensus 237 -~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 -CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1222222111 11123468899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.68 Aligned_cols=259 Identities=28% Similarity=0.423 Sum_probs=196.4
Q ss_pred hhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHcc--CCCCceeeEeeeeeecC----eEEEEEEe
Q 003039 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEG----RSVLVYEF 603 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~--l~HpnIv~l~g~~~~~~----~~~LV~E~ 603 (854)
+.+.||+|+||.||||++. ++.||||++.. +.+..|..|-+|.+. ++|+||++++++-.... .++||+||
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4578999999999999997 69999999864 345667777777654 58999999999876555 88999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC------CCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
.++|+|.++|. ...++|....+|+..+++||+|||+.. .|+|+|||||++||||..|+++.|+|||+|.
T Consensus 290 h~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999995 446899999999999999999999743 3689999999999999999999999999998
Q ss_pred cccCCCCc-eeecccccccccCccccccCc-CC-----CcchhhhHHHHHHHHHhCCcccccccccc-------------
Q 003039 678 FAVDGASH-VSSIVRGTVGYLDPEYYISQQ-LT-----DKSDVYSFGVILLELISGQEAISNEKFGA------------- 737 (854)
Q Consensus 678 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~-~s-----~~~DVwSlGvvl~elltG~~pf~~~~~~~------------- 737 (854)
.+..+... .....+||.+|||||++.+.- +. .+.||||+|.|||||++....+.....++
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 66654332 223367999999999997632 22 36899999999999999875543111000
Q ss_pred cccchHHHHHHhhhcCCcccccCccccCcC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 738 NCRNIVQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 738 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
...++...+...- .-|.+.+.. ....+..+.+.+..||..||+.|-|+.=|.+.+.++..
T Consensus 445 t~e~mq~~VV~kK--------~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 445 TLEEMQELVVRKK--------QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CHHHHHHHHHhhc--------cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 0111111111111 111111111 12445678899999999999999999999998888754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=327.03 Aligned_cols=200 Identities=28% Similarity=0.407 Sum_probs=172.3
Q ss_pred HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
...|.+.++||+|+||.||++.+. ++..+|+|++.... ......+.+|++++++++||||++++++|..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 445667889999999999999887 57889999887542 2334678899999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ...+++.....++.|++.||+|||+. .+++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999853 34578888899999999999999974 27999999999999999999999999998754322
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 733 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~ 733 (854)
......||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122346899999999999888999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=332.40 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=196.7
Q ss_pred HhhccccccCceEEEEEEEC----CCcEEEEEEEccCC----cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~----~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~L 599 (854)
.+.+.||+|+||.||+++.. +++.||+|++.... ......+..|+++++++ +|+||+++++++...+..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 45688999999999999753 57899999986432 12234577899999999 59999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 83 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 83 ILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999998853 34578889999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ ...+..
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~----~~~~~~------ 225 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV----SRRILK------ 225 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH----HHHHhc------
Confidence 44333333445699999999999865 4788999999999999999999999654321111111 111111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
.++.+.... ...+.+++.+|++.+|++|| ++.|+++|
T Consensus 226 ~~~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDPPFPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111222 23577899999999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=332.15 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=189.7
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.++||+|+||.||+|++. +++.||||++..... .....+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4678999999999999876 689999999865432 33467889999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 158 ~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 225 (353)
T PLN00034 158 SLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC 225 (353)
T ss_pred cccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence 986532 234566778999999999999998 999999999999999999999999999976543221 12
Q ss_pred ecccccccccCcccccc-----CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 688 SIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
....||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ...+.. .. ..... +
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~---~~-~~~~~-----~- 294 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMC---AI-CMSQP-----P- 294 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHH---HH-hccCC-----C-
Confidence 33468999999998753 233468999999999999999999997433111 111111 00 00000 0
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........++.+++.+|++.+|++||++.||++|
T Consensus 295 ---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 ---EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223468899999999999999999999986
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=315.28 Aligned_cols=247 Identities=27% Similarity=0.415 Sum_probs=198.7
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHH
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 610 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 610 (854)
+.||+|+||.||+|...+++.+|+|++..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988889999999875532 23456889999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeecc
Q 003039 611 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 690 (854)
Q Consensus 611 ~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 690 (854)
+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988532 34578999999999999999999998 999999999999999999999999999875433322222223
Q ss_pred cccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 691 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 691 ~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
.++..|+|||++.+..++.++|||||||++||+++ |..||...... .. ......+... ..+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~----~~~~~~~~~~---------~~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QA----REQVEKGYRM---------SCPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HH----HHHHHcCCCC---------CCCC
Confidence 45678999999998899999999999999999998 99998654311 11 1111111110 1111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
.....+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 22356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=315.71 Aligned_cols=247 Identities=29% Similarity=0.433 Sum_probs=195.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
+.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 68899999876442 33456789999999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce-ee
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SS 688 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~ 688 (854)
.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......... ..
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998532 34578999999999999999999998 99999999999999999999999999987543221111 11
Q ss_pred cccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 689 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 689 ~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
...++..|+|||.+.++.++.++|||||||++|||++ |..||...... .. ......+. ....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----~~----~~~~~~~~---------~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----QT----REAIEQGV---------RLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----HH----HHHHHcCC---------CCCC
Confidence 1123457999999999899999999999999999998 88888643311 11 11111110 0011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
+......+.+++.+|++.+|++||++.||.+.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=324.33 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=192.7
Q ss_pred HHhhccccccCceEEEEEEEC--CCcEEEEEEEccCCc--ccHHHHHHHHHHHccC---CCCceeeEeeeee-----ecC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQ-----EEG 595 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~--~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l---~HpnIv~l~g~~~-----~~~ 595 (854)
|.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+++++.+ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 456688999999999999873 467899999865432 2234556677776665 6999999999985 345
Q ss_pred eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeec
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 675 (854)
..++||||+. ++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 6899999996 6898888542 234578899999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
++..... .......||+.|+|||.+....++.++|||||||++|||++|+.||......+....+.+...........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9754332 22334568999999999998899999999999999999999999997654222222222111000000000
Q ss_pred c------cccCcccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 Q------GIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~------~~id~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ..+.+.-. ..........+.+++.+|++.+|++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 00000000 00001122456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=330.51 Aligned_cols=242 Identities=26% Similarity=0.359 Sum_probs=194.0
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEEccCC----cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 532 KKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~----~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.||+|+||.||+++.. .++.||||+++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999753 57899999987532 12234577899999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+.+|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998843 34567778888999999999999998 99999999999999999999999999987433222
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +..+.. .+
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~-~~~~~~------~~ 219 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDK-ILKGKL------NL 219 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHH-HHcCCC------CC
Confidence 1223356999999999999888999999999999999999999999764411 11111 111111 01
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
... ....+.+++.+|++.+|++|| ++.+++++
T Consensus 220 ~~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPY----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCC----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111 123578999999999999999 88988876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.59 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=196.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|+.+ +++.||+|+++... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999987542 22334577888888776 899999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 99988874 235688899999999999999999998 99999999999999999999999999987432221 12
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccccc-ccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~-~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--------- 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--------- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---------
Confidence 2345699999999999999999999999999999999999999964321111 112223333332222110
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs------m~eV~~~ 799 (854)
.+......+.+++.+|++.+|++||+ +.++++|
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11122345779999999999999998 5787766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.86 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=205.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|+.. +++.||||.++... ......+.+|+++++.++||||+++++++...+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 345688999999999999875 68999999876432 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999998854333345578888999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+... +..... +..
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~-~~~~~~-----~~~ 228 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQK-IEQCDY-----PPL 228 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHH-HhcCCC-----CCC
Confidence 1 12234588899999999988899999999999999999999999864331 11222221 111111 111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 229 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 ---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1112335688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=321.94 Aligned_cols=255 Identities=24% Similarity=0.428 Sum_probs=200.4
Q ss_pred HHhhccccccCceEEEEEEE-----CCCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~-----~~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
+.+.+.||+|+||.||+|.+ ..++.||+|.+.... ......+.+|++++++++||||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 44678999999999999985 246789999987433 233467889999999999999999999999999999999
Q ss_pred EeccCCCHHhhhccccc-------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcE
Q 003039 602 EFMHNGTLKEHLYGTLT-------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 668 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 668 (854)
||+++|+|.+++..... ....+++.+.+.++.|++.||+|||++ +++||||||+|||++.++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 99999999999853211 123578889999999999999999998 99999999999999999999
Q ss_pred EEEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHH
Q 003039 669 KVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 746 (854)
Q Consensus 669 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~ 746 (854)
||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+...+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~~~~~~ 239 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QEVIEMV 239 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH
Confidence 9999999975533221 12223345778999999998889999999999999999998 8888865331 1222221
Q ss_pred HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 747 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 747 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
..+.... .... ...++.+++.+|++.+|++||++.+|.++|..
T Consensus 240 ----~~~~~~~-----~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQLLP-----CSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCCcCC-----CCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111 1111 22457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.85 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=202.8
Q ss_pred HhhccccccCceEEEEEEEC------CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..++|+
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 35678999999999999763 235789998865432 33467889999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccc--------------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 003039 602 EFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 661 (854)
||+.+|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 9999999999985421 1123578899999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccc
Q 003039 662 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 739 (854)
Q Consensus 662 l~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~ 739 (854)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---- 235 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---- 235 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 999999999999999754333221 1223345778999999988889999999999999999999 9999865431
Q ss_pred cchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 740 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 740 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..+.... ..+.- ...+......+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 236 ~~~~~~~----~~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLL----KTGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHH----hCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1222221 11110 00111122468899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.24 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=201.7
Q ss_pred HHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~ 598 (854)
..+.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34567889999999999999864 2478999998754322 2456889999999999999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccc------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC
Q 003039 599 LVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 666 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 666 (854)
+++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1123578888999999999999999998 999999999999999999
Q ss_pred cEEEEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHH
Q 003039 667 RAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQ 744 (854)
Q Consensus 667 ~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~ 744 (854)
.+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||..... ..+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVIE 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 999999999875533221 11223346789999999988889999999999999999998 8888865331 12222
Q ss_pred HHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 745 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 745 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
. +..+.... .+......+.+++..|++.+|++||+++||++.|+.
T Consensus 238 ~----i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 M----IRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H----HHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 11221111 111223457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=321.45 Aligned_cols=257 Identities=24% Similarity=0.425 Sum_probs=200.6
Q ss_pred HHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~ 598 (854)
..+.+.+.||+|+||.||+|.+. .+..||||++.... .....++.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 34566789999999999999764 24679999986432 233456889999999999999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccc------cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 003039 599 LVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 672 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 672 (854)
+||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence 999999999999998643211 23467888899999999999999998 999999999999999999999999
Q ss_pred eeccccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhh
Q 003039 673 FGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 673 FGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ..... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----~~~~~----~ 234 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRF----V 234 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----H
Confidence 99987544322211 112345788999999998899999999999999999999 68888654311 11111 1
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
..+..... +......+.+++.+|++.+|++||++.|++++|++
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 11123468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=324.85 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=218.3
Q ss_pred HHHHHHHHhhccccccCceEEEEEEECC---Cc--EEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecC
Q 003039 522 DIEDATKMLEKKIGSGGFGVVYYGKLKD---GK--EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 595 (854)
Q Consensus 522 ~~~~~~~~~~~~iG~G~fg~Vy~a~~~~---~~--~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~ 595 (854)
++.++...+.++||.|-||.||+|.+.+ |+ .||||..+.+. ....+.|..|..+|+.++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3445555667899999999999997642 33 48889888753 45577899999999999999999999999875
Q ss_pred eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeec
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 675 (854)
..++|||.++-|.|.++|.. ....++......++.||+.||+|||+. .+|||||.++|||+...--|||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 57999999999999999964 345688888999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCC
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
++.+.+......+...-+..|||||.+.-++++.++|||-|||.|||++. |..||.+....+.... ++.|+
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~--------iEnGe 609 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH--------IENGE 609 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE--------ecCCC
Confidence 99988877666666666789999999999999999999999999999987 9999986553322211 12221
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
+...+..+...+..|..+||+.+|.+||.+.|+...|+.++..
T Consensus 610 ---------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 610 ---------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred ---------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 2233456667889999999999999999999999999998764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=330.64 Aligned_cols=244 Identities=23% Similarity=0.265 Sum_probs=197.4
Q ss_pred HHHhhccccccCceEEEEEEECC--CcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~--~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.+.||+|+||.||+|.++. +..||+|++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 35567899999999999998653 3689999986432 223456788999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 111 Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 111 EFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999853 34688888999999999999999998 999999999999999999999999999976532
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ...+..+..
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~----~~~i~~~~~------ 245 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----LI----YQKILEGII------ 245 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----HH----HHHHhcCCC------
Confidence 2 23356999999999999888999999999999999999999999754311 11 111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
.+.... ...+.+++.+|++.+|++|+ +++|+.+|
T Consensus 246 ~~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 YFPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011111 23467899999999999995 89999887
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.71 Aligned_cols=266 Identities=22% Similarity=0.254 Sum_probs=201.6
Q ss_pred ccccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--cHHHHHHHHHHHccCCCCceeeEeeee
Q 003039 515 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYC 591 (854)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--~~~~~~~Ev~~L~~l~HpnIv~l~g~~ 591 (854)
..|-+.+|.+ ..++|++|.||.||+|+.+ +++.||+|+++..... -.-...+|+.+|.+++|||||.+-.+.
T Consensus 70 ~gCrsv~efe-----~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVV 144 (419)
T KOG0663|consen 70 GGCRSVEEFE-----KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVV 144 (419)
T ss_pred cCcccHHHHH-----HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEE
Confidence 3444555544 4578999999999999876 6889999999754321 123467899999999999999998887
Q ss_pred ee--cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEE
Q 003039 592 QE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 669 (854)
Q Consensus 592 ~~--~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 669 (854)
.. -+..++|||||+. +|...+... .+++...++..++.|+++|++|||.. .|+|||||++|+|+...|.+|
T Consensus 145 vG~~~d~iy~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lK 217 (419)
T KOG0663|consen 145 VGSNMDKIYIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILK 217 (419)
T ss_pred eccccceeeeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEE
Confidence 54 3578999999986 888888644 36788888999999999999999999 999999999999999999999
Q ss_pred EEeeeccccccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHH
Q 003039 670 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 748 (854)
Q Consensus 670 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~ 748 (854)
|+|||+||.+...... .+..+-|.+|+|||++.+ ..|+.+.|+||+|||+.||+++++.|.+....+ ++-..+ .
T Consensus 218 iaDFGLAR~ygsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d---Ql~~If-~ 292 (419)
T KOG0663|consen 218 IADFGLAREYGSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID---QLDKIF-K 292 (419)
T ss_pred ecccchhhhhcCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH---HHHHHH-H
Confidence 9999999977665333 344457999999999986 569999999999999999999999998765211 111111 1
Q ss_pred hhhcCCcccccCcc-------------------ccCcCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 749 HIESGDIQGIIDPS-------------------LLDEYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 749 ~~~~~~~~~~id~~-------------------l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+ |...+.+-|. +...+... ....-.+|....+..||++|-|+.|-++|
T Consensus 293 ll--GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 293 LL--GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred Hh--CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11 1111111111 11122211 22456788889999999999999998876
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=334.04 Aligned_cols=238 Identities=26% Similarity=0.367 Sum_probs=197.9
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.+..+||+|.||+|+++..+ +++.+|||++++...- +.+....|.+++... +||.++.++..|...+++++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 36789999999999999887 5788999999987543 344566788887777 599999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+.||++..+. ..+.+++..+.-++..++.||+|||++ +|||||||.+|||||.+|.+||+|||+++... ..
T Consensus 451 ~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-~~ 521 (694)
T KOG0694|consen 451 VAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-GQ 521 (694)
T ss_pred cCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC-CC
Confidence 9999944333 456789999999999999999999999 99999999999999999999999999998432 23
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
...+.+.+||+.|||||++.+..|+.++|.|||||+|||||.|..||.+.+..+....|+. |
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~---------------d--- 583 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN---------------D--- 583 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------------C---
Confidence 3466778999999999999999999999999999999999999999987763333322221 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI 793 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm 793 (854)
...|+.-...+.+.++.+.+..+|++|-.+
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 012334444567889999999999999976
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.56 Aligned_cols=261 Identities=24% Similarity=0.319 Sum_probs=194.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++++.++||||+++++++..+...++||||+.
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 456789999999999999886 688999999875432 223467789999999999999999999999999999999996
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 87 -~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 158 (303)
T cd07869 87 -TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SH 158 (303)
T ss_pred -cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC-Cc
Confidence 678777743 234578888899999999999999998 9999999999999999999999999998744322 12
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC---cc-----
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD---IQ----- 756 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~---~~----- 756 (854)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ............... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI---QDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhCCCChhhccchhhc
Confidence 2233458999999999875 45788999999999999999999999754311 011111111000000 00
Q ss_pred cccCcc-cc--CcCCHH-------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPS-LL--DEYDIQ-------SMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~-l~--~~~~~~-------~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...++. .. ...... ....+.+++.+|++.+|++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000 00 000000 11356789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.93 Aligned_cols=242 Identities=24% Similarity=0.333 Sum_probs=194.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.||+|+||.||++... +++.||+|++.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68899999997542 223356678999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 9998874 33468899999999999999999997 5 89999999999999999999999999987433221 12
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +..+.. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----~~~~~----i~~~~~------~~p~~ 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFEL----ILMEEI------RFPRT 218 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----HHHHH----HhcCCC------CCCCC
Confidence 23346999999999999999999999999999999999999999654311 11111 111110 11111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
. ...+.+++.+|++.+|++|+ ++.++++|
T Consensus 219 ~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 L----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2 23578899999999999996 89999887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=323.83 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=204.6
Q ss_pred HHHHhhccccccCceEEEEEEECC------CcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 597 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~~------~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~ 597 (854)
..+.+.+.||+|+||.||+|.... ...+|+|++.... ......+.+|++++.++ +|+||+++++++..++..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 344567899999999999998642 3679999987542 23345688999999999 799999999999999999
Q ss_pred EEEEEeccCCCHHhhhcccc------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC
Q 003039 598 VLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 665 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 665 (854)
+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCC
Confidence 99999999999999986421 2345688999999999999999999998 99999999999999999
Q ss_pred CcEEEEeeeccccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchH
Q 003039 666 MRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIV 743 (854)
Q Consensus 666 ~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~ 743 (854)
+.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+ +.
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~ 244 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----LF 244 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----HH
Confidence 999999999998654332211 122235678999999998899999999999999999998 989986544211 11
Q ss_pred HHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 744 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 744 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
. ....+... ..+......+.+++.+|++.+|++||||.||++.|++++
T Consensus 245 ~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 K----LLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 11111110 111122346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=333.42 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=194.3
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.|.+.+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 4566789999999999999875 68899999753 2346789999999999999999999999999999999985
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+........
T Consensus 167 -~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 167 -TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred -CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 688887742 34678899999999999999999998 9999999999999999999999999999754333223
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccc-ccccc---cchHHHHHHhhh-cCC------
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK-FGANC---RNIVQWAKLHIE-SGD------ 754 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~-~~~~~---~~l~~~~~~~~~-~~~------ 754 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||-... ..... ..+.......-. ...
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 3344579999999999999999999999999999999999998764322 11000 011110000000 000
Q ss_pred --cccc---------cCccccCcC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 --IQGI---------IDPSLLDEY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 --~~~~---------id~~l~~~~--~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.+. ..+...... .......+.+++.+|++.||++|||++|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 000000000 01223468899999999999999999999875
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.13 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=197.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|+.+ +++.||||+++... ......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999876 58899999997542 22234577899999888 799999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 99988874 235689999999999999999999998 9999999999999999999999999998743221 122
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccccc-ccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~-~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+....+..+... +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------CCC
Confidence 2345699999999999999999999999999999999999999964332111 112223333333222211 111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs------m~eV~~~ 799 (854)
. ....+.+++.+|++.+|++||+ +.|+++|
T Consensus 227 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 S----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred C----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1 2235789999999999999997 7788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.66 Aligned_cols=266 Identities=22% Similarity=0.259 Sum_probs=200.1
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCc-eeeEeeeeeecC------eEEE
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEG------RSVL 599 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~Hpn-Iv~l~g~~~~~~------~~~L 599 (854)
..++||+|+||+||+|+.+ +|+.||+|+++-... .......+|+.+|+.++|+| |+++++++...+ ..++
T Consensus 15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 3467999999999999876 689999999975533 23455689999999999999 999999998877 7889
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
|+||++. +|..++.........++...+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||+|+..
T Consensus 95 vfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 95 VFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 9999965 89999865432224566678899999999999999999 9999999999999999999999999999854
Q ss_pred cCCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHH---hhhcCCc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL---HIESGDI 755 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~---~~~~~~~ 755 (854)
.-. ....+...+|.+|+|||++.+. .|+...||||+||++.||++++..|.+... ..++...+.. .-++.+.
T Consensus 171 ~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 171 SIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred cCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCccCCC
Confidence 422 2223445689999999999876 799999999999999999999999977652 1111111111 1111111
Q ss_pred ccccCcccc----CcC---C--HH---HHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHH
Q 003039 756 QGIIDPSLL----DEY---D--IQ---SMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 803 (854)
Q Consensus 756 ~~~id~~l~----~~~---~--~~---~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~~ 803 (854)
....-+... ... + .. ......+++.+|++.+|++|.|++..++| +...
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111111110 000 0 00 01357899999999999999999999987 5543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.65 Aligned_cols=265 Identities=20% Similarity=0.281 Sum_probs=209.9
Q ss_pred HHHHHhhccccccCceEEEEEE-ECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeec-----CeEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSV 598 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~-~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-----~~~~ 598 (854)
..+|.+.+.+|+|||+-||.++ ..+++.+|+|++.....++.+...+|++..++++|||++++++++..+ ...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4466788999999999999997 457889999999877777788899999999999999999999988543 3589
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
++++|...|+|.+.+.....++..+++.+.+.|+.++++||++||+. .++++||||||.|||+.+.+.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999987766777899999999999999999999997 34699999999999999999999999998864
Q ss_pred ccCCCC----c----eeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH
Q 003039 679 AVDGAS----H----VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 747 (854)
Q Consensus 679 ~~~~~~----~----~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~ 747 (854)
..-... . ......-|..|+|||.+. +...++++|||||||+||+|+.|..||+..-..+....
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla------ 252 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA------ 252 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE------
Confidence 321110 0 011123588999999986 45678999999999999999999999975331111100
Q ss_pred HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 748 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
..+..+.+.-..+....+.+.+++..|++.||.+||++.+++.+++.++
T Consensus 253 --------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 --------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0111112211111224457889999999999999999999999998753
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.65 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=206.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|... +++.+|||.+.... .....++.+|+.+++.++||||+++++++..++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 456788999999999999864 78999999876432 22345788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999998864333455689999999999999999999998 99999999999999999999999999987554322
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
. ......|+..|+|||.+.+..++.++||||||+++|||++|..||..... ......+.. ... ..+.+
T Consensus 161 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~-----~~~~~ 228 (267)
T cd08229 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKI-EQC-----DYPPL 228 (267)
T ss_pred c-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhh-hcC-----CCCCC
Confidence 2 12234588999999999988899999999999999999999999864431 111111111 111 11111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
. .......+.+++.+|++.+|++||||.+|++.++++
T Consensus 229 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 P---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 112334688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=328.35 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=189.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHcc-CCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~-l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 57889999987532 1223345556666664 4899999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999988843 34678888999999999999999998 99999999999999999999999999997543322 22
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +.... +.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----~~~~~----i~~~~------~~---- 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----ELFDS----ILNDR------PH---- 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----HHHHH----HHcCC------CC----
Confidence 33456999999999999989999999999999999999999999764411 11111 11110 01
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~-eV~~~ 799 (854)
++......+.+++.+|++.+|++||++. ++.++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1111223567899999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.22 Aligned_cols=264 Identities=20% Similarity=0.285 Sum_probs=193.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeec-----CeEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-----~~~~L 599 (854)
|.+.++||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 345688999999999999876 6899999998643 223345688999999999999999999988543 24799
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+. ++|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 v~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999995 68888874 334688999999999999999999998 9999999999999999999999999999754
Q ss_pred cCCCC--ceeecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH-------HH
Q 003039 680 VDGAS--HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------KL 748 (854)
Q Consensus 680 ~~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~-------~~ 748 (854)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 12234568999999999875 678999999999999999999999997543111000000000 00
Q ss_pred hhhcCCcccc---cCccccCcCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 749 HIESGDIQGI---IDPSLLDEYD---IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 749 ~~~~~~~~~~---id~~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+......+. +.+....... ......+.+++.+|++.+|++||+++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 0000000000 0112356799999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=334.62 Aligned_cols=263 Identities=24% Similarity=0.389 Sum_probs=203.6
Q ss_pred HHHHHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCCcc-cHHHHHHHHHHHccCC-CCceeeEeeeeeec
Q 003039 523 IEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIH-HRNLVQFLGYCQEE 594 (854)
Q Consensus 523 ~~~~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~ 594 (854)
+....+.+.++||+|+||.||+|++. .++.||||+++..... ....+.+|+++|.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33344556789999999999999864 2468999999754322 2346889999999997 99999999999999
Q ss_pred CeEEEEEEeccCCCHHhhhccccc--------------------------------------------------------
Q 003039 595 GRSVLVYEFMHNGTLKEHLYGTLT-------------------------------------------------------- 618 (854)
Q Consensus 595 ~~~~LV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 618 (854)
+..++||||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999864311
Q ss_pred --------------------------------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 003039 619 --------------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 660 (854)
Q Consensus 619 --------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 660 (854)
....+++...+.++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 112367778889999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCccccccccccc
Q 003039 661 LLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN 738 (854)
Q Consensus 661 Ll~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~ 738 (854)
|+++++.+||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~- 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE- 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence 9999999999999999754332211 1122346789999999998889999999999999999998 888986543111
Q ss_pred ccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 739 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 739 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.....+..+... ..+......+.+++.+|+..+|.+||+++||++.|++++
T Consensus 350 ------~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ------QFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ------HHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111111100 011112346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=335.25 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=197.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 4456788999999999999876 58899999986432 2233457789999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 y~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 124 YMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred CCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999998853 2467777888999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeecccccccccCccccccC----cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ............
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~~~~~- 267 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------YSKIMDHKNSLT- 267 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-------HHHHHcCCCcCC-
Confidence 22223345699999999998653 478899999999999999999999976542111 111111100000
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 799 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eV~~~ 799 (854)
... .......+.+++..|++.+|++ ||++.|+++|
T Consensus 268 ----~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 ----FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 001 0112345778999999999987 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=329.08 Aligned_cols=242 Identities=23% Similarity=0.332 Sum_probs=193.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|+.+ +++.||||+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 47899999987542 22334567788888866 799999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|...+. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 99998884 334688889999999999999999998 99999999999999999999999999987432222 22
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +..+.. ..+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----~~~~~----i~~~~~---~~p---~- 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED----DLFES----ILHDDV---LYP---V- 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----HHHHH----HHcCCC---CCC---C-
Confidence 23456899999999999999999999999999999999999999765421 11111 111111 001 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRP-------SISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RP-------sm~eV~~~ 799 (854)
.....+.+++..|++.+|++|| ++.+++++
T Consensus 218 ---~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 ---WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ---CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1123578999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.82 Aligned_cols=246 Identities=28% Similarity=0.427 Sum_probs=195.1
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 533 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
.||+|+||.||+|.++ +++.+|+|+++.... ...+++.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 578899999864432 235678899999999999999999998864 4678999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999843 34688899999999999999999998 999999999999999999999999999976544332211
Q ss_pred --ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 688 --SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 688 --~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+... +..+.... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~----i~~~~~~~-----~~ 220 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----EVTQM----IESGERME-----CP 220 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HHCCCCCC-----CC
Confidence 12234678999999988889999999999999999998 99999754311 12221 22221111 11
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
. .....+.+++.+|++.+|++||+|.+|++.|++.
T Consensus 221 ~----~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 Q----RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C----CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1 1234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.99 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=201.4
Q ss_pred HHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
..+.+.+.||+|+||.||+|.+..+..+|+|.+.... .....+.+|++++++++|+|++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 3456678999999999999998877789999876443 234678899999999999999999998854 56789999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999643 234578899999999999999999998 9999999999999999999999999999765433222
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......++..|+|||+..+..++.++|||||||++|||++ |+.||...... ....+. ..+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~----~~~~~~-------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQV----ERGYRM-------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCCC--------
Confidence 2223346778999999998899999999999999999999 89998754311 122221 111100
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
..+......+.+++.+|++.+|++||++++|++.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=336.69 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=200.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 345688999999999999876 68999999987532 23345688899999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 83 MPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999853 25688889999999999999999998 99999999999999999999999999997554332
Q ss_pred ----------------------------CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccc
Q 003039 684 ----------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 735 (854)
Q Consensus 684 ----------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~ 735 (854)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122334689999999999999999999999999999999999999976542
Q ss_pred cccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 003039 736 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-ISEVLKD 799 (854)
Q Consensus 736 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-m~eV~~~ 799 (854)
......+..|. ..+. + +. ... ....+.+++.+|++ +|.+||+ ++|+++|
T Consensus 236 ~~~~~~i~~~~------~~~~--~-p~-~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWK------ESLR--F-PP-DPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccC------Cccc--C-CC-CCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111110 0000 0 00 001 23457789999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.78 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=195.1
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 533 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 355799999875532 234568899999999999999999998864 56899999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee-
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS- 687 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~- 687 (854)
|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988532 34688999999999999999999998 999999999999999999999999999975443322211
Q ss_pred -ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 688 -SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 688 -~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
....++..|+|||.+....++.++|||||||++||+++ |..||...... .+.. .+..+.. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~----~~~~~~~---------~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMS----FIEQGKR---------L 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHH----HHHCCCC---------C
Confidence 11223578999999988889999999999999999996 99999754411 1111 1222211 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
..+.....++.+++.+|+..+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11122335678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=312.59 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=207.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|... +|+.||+|.++... ......+.+|++++++++|+|++++++++...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 445688999999999999887 78999999886432 22356788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.........+++.+++.++.+++.||+|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999865444456688999999999999999999998 99999999999999999999999999987554322
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.+.... ...+.....
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~-~~~~~~~~~----- 228 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKK-IEKCDYPPL----- 228 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhh-hhcCCCCCC-----
Confidence 21 223458899999999998889999999999999999999999986443 122222111 111111110
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
........+.+++.+|+..+|++||++.+|++.|+++
T Consensus 229 ---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 ---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0112334688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.26 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=204.9
Q ss_pred HHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
...+.+.++||+|+||.||+|..++++.||||.+.... ....++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 34556778999999999999998888899999987543 33567899999999999999999999999989999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999653 234688999999999999999999998 999999999999999999999999999876543222
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......++..|+|||.+.+..++.++|||||||+++|+++ |+.||..... ....... ..+ ...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~~----~~~-~~~------ 223 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLEQV----ERG-YRM------ 223 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----HcC-CCC------
Confidence 22222234678999999998889999999999999999999 9999865431 1111211 111 000
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
..+......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0001113468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=345.13 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=202.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecC--------
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-------- 595 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~-------- 595 (854)
.|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++..++|+||+++++.+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 5567789999999999999865 68999999986542 233456788999999999999999988775432
Q ss_pred eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeec
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 675 (854)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 36799999999999999976554556788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC-CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 676 SKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 676 a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+.
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~-~~~ 261 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTL-AGR 261 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHh-cCC
Confidence 97654322 1223345699999999999999999999999999999999999999975431 11111111 111
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... + +......+.+++.+|++.+|++||++.+++++
T Consensus 262 ~~~-----~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP-----L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 110 1 11123458899999999999999999999875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=328.59 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=192.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|+.+ +++.||||++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999876 57899999987432 22345567788888776 699999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999988843 34688889999999999999999998 99999999999999999999999999987532221 22
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +..+.. .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~----i~~~~~---~~---~~~ 218 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEA----ILNDEV---VY---PTW 218 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHH----HhcCCC---CC---CCC
Confidence 33456999999999999999999999999999999999999999765421 11111 111111 00 111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm------~eV~~~ 799 (854)
....+.+++.+|++.+|++||++ +++++|
T Consensus 219 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 219 ----LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred ----CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 12357889999999999999998 666655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.43 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=192.1
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4578999999999999875 57899999997542 2234568899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC-
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 684 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~- 684 (854)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 85 GGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999853 34578888889999999999999998 999999999999999999999999999753211000
Q ss_pred ---------------------------------------------ceeecccccccccCccccccCcCCCcchhhhHHHH
Q 003039 685 ---------------------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 719 (854)
Q Consensus 685 ---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvv 719 (854)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123469999999999998899999999999999
Q ss_pred HHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHH--ccCCCCCCCCCHHHHH
Q 003039 720 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVL 797 (854)
Q Consensus 720 l~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPsm~eV~ 797 (854)
+|||++|+.||......+....+..| ...+ . +.+ ....+ .++.+++.+ |...++..||++.||+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~------~~~~-~-~~~--~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINW------ENTL-H-IPP--QVKLS----PEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHcc------cccc-C-CCC--CCCCC----HHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999764421111111111 0000 0 000 01122 235566655 6667777899999999
Q ss_pred HH
Q 003039 798 KD 799 (854)
Q Consensus 798 ~~ 799 (854)
+|
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 87
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.23 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=199.7
Q ss_pred hhccccccCceEEEEEEECC----CcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCe------E
Q 003039 530 LEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------S 597 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~------~ 597 (854)
+.+.||+|+||.||+|.+.. +..||+|+++.... .....+.+|+++++.++||||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 56789999999999998752 36799999875432 234578899999999999999999998866554 7
Q ss_pred EEEEEeccCCCHHhhhccccc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeec
Q 003039 598 VLVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 675 (854)
++|+||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 999999999999999854321 234688899999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcC
Q 003039 676 SKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 676 a~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.++. ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~----~~~ 231 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYL----RHG 231 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----HcC
Confidence 98654332221 122335678999999988899999999999999999999 8888865431 1222221 111
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
.... .+......+.+++.+|++.+|++||++.||+++|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 1112334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.08 Aligned_cols=265 Identities=25% Similarity=0.431 Sum_probs=206.4
Q ss_pred HHHHHHHhhccccccCceEEEEEEEC--------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeee
Q 003039 523 IEDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 592 (854)
Q Consensus 523 ~~~~~~~~~~~iG~G~fg~Vy~a~~~--------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~ 592 (854)
+...++.+.+.||+|+||.||+|... .+..||+|+++... .....++.+|+++++++ +||||++++++|.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 33445677899999999999999753 12368999887542 23356788999999999 7999999999999
Q ss_pred ecCeEEEEEEeccCCCHHhhhcccc------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 003039 593 EEGRSVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 660 (854)
Q Consensus 593 ~~~~~~LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 660 (854)
..+..++++||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 9999999999999999999986432 1234688899999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeeeccccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCccccccccccc
Q 003039 661 LLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN 738 (854)
Q Consensus 661 Ll~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~ 738 (854)
|++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 99999999999999997554322111 112234567999999999999999999999999999998 8888865431
Q ss_pred ccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 739 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 739 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
...... +..+...+ .......++.+++.+|++.+|++||+|.|+++.|+++....
T Consensus 243 ----~~~~~~-~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 ----EELFKL-LKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ----HHHHHH-HHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 111111 11111111 11122346889999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.45 Aligned_cols=253 Identities=25% Similarity=0.441 Sum_probs=200.7
Q ss_pred HHhhccccccCceEEEEEEEC-CC---cEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DG---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~---~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+...+.||+|+||.||+|+.+ ++ ..+|+|.+.... ......+..|++++++++||||+++.+++...+..++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 344688999999999999875 23 379999986542 3335678899999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 87 YMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999853 235688999999999999999999998 9999999999999999999999999998755433
Q ss_pred CCceee--cccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 683 ASHVSS--IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 683 ~~~~~~--~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
...... ....+..|+|||++....++.++|||||||++|||++ |+.||...... .+... +..+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----~~~~~----i~~~~----- 227 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----EVMKA----INDGF----- 227 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHHH----HhcCC-----
Confidence 222211 1223467999999998889999999999999999998 99999654311 11111 11110
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
...........+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001112235688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.96 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=199.2
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
...++||+|+||.||++... +++.||||++..... .....+.+|++++++++||||+++++.+..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence 34578999999999999875 688999999865422 22345778999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 83 NGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999888542 234588999999999999999999998 999999999999999999999999999876533221
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ....+...+..+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~---------- 221 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKEDQ---------- 221 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhcc----------
Confidence 123468999999999998899999999999999999999999997644211 1111111111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
..+.......+.+++.+|++.||++|| ++++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111122334578999999999999999 88898776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.63 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=198.7
Q ss_pred HHhhccccccCceEEEEEEEC-----CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-----~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~LV 600 (854)
+.+.+.||+|+||.||++..+ +++.||+|++........+.+.+|++++++++||||+++++++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 445688999999999999753 578999999876655556788999999999999999999998754 3467899
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 86 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 86 MEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999998532 34588999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCcee--ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccc------cc-c-cchHHHHHHhh
Q 003039 681 DGASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG------AN-C-RNIVQWAKLHI 750 (854)
Q Consensus 681 ~~~~~~~--~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~------~~-~-~~l~~~~~~~~ 750 (854)
....... ....++..|+|||++.+..++.++|||||||+++||++|..++...... .. . ..+........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 4322211 1122345699999999888999999999999999999988765332100 00 0 00001111111
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
..+. ...........+.+++.+|++.+|++||||.||++.|+.+
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1110 0001112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.57 Aligned_cols=262 Identities=24% Similarity=0.432 Sum_probs=205.2
Q ss_pred HHHHHhhccccccCceEEEEEEEC--------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeec
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 594 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~--------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~ 594 (854)
...+.+.+.||+|+||.||+|+.. +...+|+|.+.... .....++..|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 345677899999999999999753 23569999987542 23345688899999999 799999999999999
Q ss_pred CeEEEEEEeccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE
Q 003039 595 GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 662 (854)
Q Consensus 595 ~~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 662 (854)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999965321 224588999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeeeccccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCccccccccccccc
Q 003039 663 DKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 740 (854)
Q Consensus 663 ~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~ 740 (854)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 999999999999987553321111 111224568999999998889999999999999999998 88888654311
Q ss_pred chHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 741 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 741 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.+.. ....+... ..+.....++.+++.+|++.+|++||+|.+|++.|++++..
T Consensus 250 ~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFK----LLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHH----HHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111 11222111 11112234678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=335.58 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=195.1
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++..++||||+++++++..++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 34678999999999999876 58899999997532 223455788999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 84 PGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999853 34588899999999999999999998 999999999999999999999999999864322110
Q ss_pred c-------------------------------------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCC
Q 003039 685 H-------------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727 (854)
Q Consensus 685 ~-------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~ 727 (854)
. ......||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011245999999999999999999999999999999999999
Q ss_pred cccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003039 728 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 799 (854)
Q Consensus 728 ~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---m~eV~~~ 799 (854)
.||......+....+..|. ..+ . +. .. ......+.+++.+|+. +|.+|++ +.|+++|
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~------~~~-~-~~----~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQETYRKIINWK------ETL-Q-FP----DE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHHHHHHHcCC------Ccc-C-CC----CC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9997654221111111110 000 0 00 00 0112346678888886 8999998 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.32 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=197.1
Q ss_pred HhhccccccCceEEEEEEEC-CCc----EEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~----~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.+.||+|+||+||+|.+. +++ .+++|.+..... ....++..|+.+++++.||||+++++++.. ...++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence 35678999999999999875 344 477787754322 233567788889999999999999998864 45788999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 89 LSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred eCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999998632 34688999999999999999999998 9999999999999999999999999999865433
Q ss_pred CC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 683 AS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 683 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
.. .......++..|+|||.+.++.++.++|||||||++||+++ |+.||...... .+.+. +..+.... .
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~----~~~~~~~~--~ 232 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDL----LEKGERLA--Q 232 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----HHCCCcCC--C
Confidence 22 12233457789999999998999999999999999999998 99998754311 11121 22222111 1
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+.. ....+.+++.+|+..+|++||++.|+++.|..+..
T Consensus 233 ~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 PQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111 12346788999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.53 Aligned_cols=264 Identities=23% Similarity=0.419 Sum_probs=207.0
Q ss_pred HHHHHHhhccccccCceEEEEEEEC--------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeee
Q 003039 524 EDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE 593 (854)
Q Consensus 524 ~~~~~~~~~~iG~G~fg~Vy~a~~~--------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~ 593 (854)
....+.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3445567789999999999999742 24579999986442 33456788999999999 89999999999999
Q ss_pred cCeEEEEEEeccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 003039 594 EGRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661 (854)
Q Consensus 594 ~~~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 661 (854)
....++||||+++|+|.+++..... ....+++.+++.++.|+++||+|||+. +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999865321 234578889999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccc
Q 003039 662 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 739 (854)
Q Consensus 662 l~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~ 739 (854)
++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---- 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence 999999999999999765432222 1222345678999999998889999999999999999998 7888865431
Q ss_pred cchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 740 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 740 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
.+... .+..+.... .+......+.+++.+|++.+|++||+|.||++.|++++...
T Consensus 246 ---~~~~~-~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 246 ---EELFK-LLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ---HHHHH-HHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111 112111100 11123356888999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=332.55 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=194.7
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.+.+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 3455678999999999999886 57899999986421 2234567889999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 y~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 124 YMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred CCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999998843 2467888889999999999999998 9999999999999999999999999999865433
Q ss_pred CCceeecccccccccCccccccC----cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
.........||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .............
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~- 267 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-------TYSKIMDHKNSLN- 267 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCcccC-
Confidence 22233455799999999998754 37889999999999999999999997554211 1111111110000
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 799 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eV~~~ 799 (854)
... .......+.+++..|+..++.+ ||++.|+++|
T Consensus 268 ----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 1112335677888888755543 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.38 Aligned_cols=199 Identities=26% Similarity=0.368 Sum_probs=170.9
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||+||+|... +++.||||+++... ......+..|+.++.+++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 34678999999999999876 58899999997532 222356788999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 84 PGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999853 35688899999999999999999998 999999999999999999999999999875422110
Q ss_pred ----------------------------------ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccc
Q 003039 685 ----------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 730 (854)
Q Consensus 685 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf 730 (854)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346999999999999999999999999999999999999999
Q ss_pred cccc
Q 003039 731 SNEK 734 (854)
Q Consensus 731 ~~~~ 734 (854)
....
T Consensus 237 ~~~~ 240 (363)
T cd05628 237 CSET 240 (363)
T ss_pred CCCC
Confidence 7654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.97 Aligned_cols=242 Identities=25% Similarity=0.380 Sum_probs=191.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHcc-CCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~-l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++.. ++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999876 47899999987542 1223455667777776 4899999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 999998853 34578888999999999999999998 99999999999999999999999999987432221 12
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ ..+. +.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i----~~~~------~~~~~~ 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSI----RMDN------PCYPRW 218 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHH----HhCC------CCCCcc
Confidence 23456899999999999989999999999999999999999999754421 122211 1110 111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~-eV~~~ 799 (854)
....+.+++.+|++.+|++||++. ++.++
T Consensus 219 ----~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 219 ----LTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred ----CCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 123577899999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.24 Aligned_cols=265 Identities=22% Similarity=0.363 Sum_probs=200.3
Q ss_pred HHHHHhhccccccCceEEEEEEECC---------------CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEe
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLKD---------------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFL 588 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~~---------------~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~ 588 (854)
...+.+.+.||+|+||.||++...+ ...||+|+++... ......+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4456677899999999999987642 2348999987543 23345789999999999999999999
Q ss_pred eeeeecCeEEEEEEeccCCCHHhhhccccc--------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 003039 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLT--------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 660 (854)
Q Consensus 589 g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 660 (854)
+++...+..++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999854211 112467889999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh--CCcccccccccc
Q 003039 661 LLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGA 737 (854)
Q Consensus 661 Ll~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt--G~~pf~~~~~~~ 737 (854)
+++.++.+||+|||+++........ ......++..|+|||.+..+.++.++|||||||+++||++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 9999999999999998754332211 1122335778999999998899999999999999999998 55677643311
Q ss_pred cccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 738 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 738 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
.++................ ..+......+.+++.+|++.+|++||+|++|++.|++
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ---QVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1222111111111000000 0011122468999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=332.40 Aligned_cols=250 Identities=21% Similarity=0.216 Sum_probs=198.5
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||+||+++.. +++.||+|+++... ......+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 45678999999999999876 68899999997542 223456888999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 84 PGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999998542 24688888999999999999999998 999999999999999999999999999986554433
Q ss_pred ceeecccccccccCccccc------cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~------~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~~~~ 230 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNFQRFLKF 230 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcCCCccCC
Confidence 3334456899999999986 4567889999999999999999999997544211 11111111111000
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
- . .......+.+++..|++ +|++||++.++++|
T Consensus 231 ~-----~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 P-----E--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C-----C--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 0 01122457788899998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.06 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=196.8
Q ss_pred hhccccccCceEEEEEEECCC-c--EEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeEE
Q 003039 530 LEKKIGSGGFGVVYYGKLKDG-K--EIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 598 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~-~--~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~~ 598 (854)
+.+.||+|+||.||+|++.+. + .||+|.++... ......+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 467899999999999987643 2 58999886542 23356788899999999999999999987432 2468
Q ss_pred EEEEeccCCCHHhhhcccc--cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 599 LVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
+++||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874221 1234588999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCC
Q 003039 677 KFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 677 ~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
+......... .....++..|+|||+..+..++.++|||||||++|||++ |+.||..... ..+.. .+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~----~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SEIYD----YLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH----HHHcCC
Confidence 8654332211 122346778999999999999999999999999999999 7888865331 11211 122222
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
... ........+.+++.+|++.+|++|||+.+|++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 0111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.13 Aligned_cols=242 Identities=26% Similarity=0.356 Sum_probs=191.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|+.+ +|+.||+|+++... ......+..|..++... +||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999886 58899999987532 12334566777777654 899999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999988843 34678888999999999999999998 99999999999999999999999999987432221 22
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... ..+. +.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~----~~~~------~~~~~~ 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFESI----RVDT------PHYPRW 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH----HhCC------CCCCCC
Confidence 34456999999999999999999999999999999999999999754311 111111 1110 111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~-eV~~~ 799 (854)
...++.+++.+|++.+|++||++. ++.+|
T Consensus 219 ----~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 219 ----ITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred ----CCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 123577899999999999999984 66644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.35 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=198.6
Q ss_pred HHhhccccccCceEEEEEEECC------CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~------~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
+.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+..|+.++++++|+||+++++++.+.+..++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 4456889999999999998753 5678999876443 23345688999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhccccc---ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEeee
Q 003039 601 YEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFG 674 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DFG 674 (854)
|||+++++|.+++..... ....+++..++.++.||+.||+|||+. +++||||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCc
Confidence 999999999999864321 223588999999999999999999998 999999999999998764 59999999
Q ss_pred ccccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhc
Q 003039 675 LSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIES 752 (854)
Q Consensus 675 la~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~ 752 (854)
+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----~~~~~---~~~~ 237 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVMEF---VTGG 237 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH---HHcC
Confidence 998653221111 112223568999999999999999999999999999997 99999764421 12111 1111
Q ss_pred CCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 753 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 753 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
... ..+......+.+++.+|++.+|++||++.+|+++|+
T Consensus 238 ~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111 111122346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.00 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=191.6
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHH---ccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLL---SRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L---~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+.||+|+||.||+|... +++.||||+++... ......+..|++++ +.++||||+++++++...+..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4578999999999999876 58999999997532 12234566666554 56789999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|...+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 83 YAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999988874 24588999999999999999999998 9999999999999999999999999998743222
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. . +..+.. .
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----~~~~---~-i~~~~~------~ 219 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----EVFD---S-IVNDEV------R 219 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----HHHH---H-HHhCCC------C
Confidence 1 2223456999999999999999999999999999999999999999754421 1111 1 111111 0
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
.... ....+.+++.+|++.+|++|| ++.+++++
T Consensus 220 ~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 YPRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111 123577899999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.85 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=206.1
Q ss_pred HHHHHhhccccccCceEEEEEEECC-----CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeee-cCeE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRS 597 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~~-----~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~-~~~~ 597 (854)
...+.+.+.||+|+||.||+|.+.+ +..|++|++.... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3455567899999999999998875 6889999987542 3335668899999999999999999998866 4678
Q ss_pred EEEEEeccCCCHHhhhcccccc----cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 673 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 673 (854)
++++||+.+|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998543221 25688999999999999999999998 9999999999999999999999999
Q ss_pred eccccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhh
Q 003039 674 GLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 674 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
|+++.+.....+. .....++..|+|||++....++.++|||||||++||+++ |+.||..... ..+..+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~--- 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYLKD--- 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHHHHc---
Confidence 9998654333221 122346778999999998889999999999999999999 9999965431 122222211
Q ss_pred cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
...+. ........+.+++.+|++.+|++||++.||++.|+.+..
T Consensus 235 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11110 011123467899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=340.17 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=192.2
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeec--------CeE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--------GRS 597 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--------~~~ 597 (854)
.|.+.++||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 3556789999999999999875 58899999885432 2345799999999999999999876432 246
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeeecc
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLS 676 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla 676 (854)
++||||+++ +|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 789999975 77777754434456788999999999999999999998 999999999999999664 7999999999
Q ss_pred ccccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHH----h--
Q 003039 677 KFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL----H-- 749 (854)
Q Consensus 677 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~----~-- 749 (854)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+.+.... .
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 86543222 223458999999999876 46899999999999999999999999765422111111111000 0
Q ss_pred -h----hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 750 -I----ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 750 -~----~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+ ..-.+..+....+...++.....++.+++.+|++.+|.+|||+.|+++|
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000000000111111111223468899999999999999999999877
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=309.88 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=197.6
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccC--CCCceeeEeeeeeecC----eEEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNLVQFLGYCQEEG----RSVLVYE 602 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l--~HpnIv~l~g~~~~~~----~~~LV~E 602 (854)
.+.+.||+|.||.||+|+|+ |+.||||++... +++.+.+|.++.+.+ +|+||+.+++.-..+. .++||.+
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 45788999999999999998 999999998643 356677888888765 9999999999876543 6799999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHh-----CCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
|.+.|||.|||. ...++-...++++..+|.||+|||. +..|.|.|||||+.||||..++.+.|+|+|||-
T Consensus 290 YHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 290 YHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred cccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999994 3567888899999999999999996 345899999999999999999999999999997
Q ss_pred cccCCCC---ceeecccccccccCccccccCc------CCCcchhhhHHHHHHHHHhCC----------ccccccccccc
Q 003039 678 FAVDGAS---HVSSIVRGTVGYLDPEYYISQQ------LTDKSDVYSFGVILLELISGQ----------EAISNEKFGAN 738 (854)
Q Consensus 678 ~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~------~s~~~DVwSlGvvl~elltG~----------~pf~~~~~~~~ 738 (854)
....... ......+||.+|||||++...- --..+||||||.|+||+.-.. .||.+.-..+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 5544322 2335567999999999986431 123689999999999998642 34432110000
Q ss_pred ccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 739 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 739 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
++.+ .+..+-..++...++.+ -.+.+.+..+.+++..||..+|..|-|+-.|.+.|.++..
T Consensus 445 --s~ee-MrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 --SFEE-MRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred --CHHH-HhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 0000 00000001111111111 1245788899999999999999999999999999998764
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=319.88 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=200.5
Q ss_pred HHhhccccccCceEEEEEEECC-Cc--EEEEEEEccC-CcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~-~~--~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+.+.||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 3467889999999999998763 33 4788888643 233456788999999999 79999999999999999999999
Q ss_pred eccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 003039 603 FMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 670 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 670 (854)
|+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 9999999999864221 123588899999999999999999998 9999999999999999999999
Q ss_pred EeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHh
Q 003039 671 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 671 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~ 749 (854)
+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||...... .+...
T Consensus 161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~----~~~~~---- 230 (297)
T cd05089 161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----ELYEK---- 230 (297)
T ss_pred CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----
Confidence 9999986322111 1111223567999999998899999999999999999998 99999754421 11111
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
...+. .... +......+.+++.+|++.+|.+||++++|++.|+.++...
T Consensus 231 ~~~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LPQGY-----RMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HhcCC-----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11110 0001 1112245789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.44 Aligned_cols=245 Identities=24% Similarity=0.308 Sum_probs=193.1
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCC-CceeeEeeeeeecCeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~H-pnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.+.+.||+|+||.||+|+.+ +++.||||++.... ......+..|++++..++| ++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 45688999999999999876 47889999987532 2234567789999999876 5688899999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 83 VNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999988843 34578889999999999999999998 99999999999999999999999999986432211
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+...+ .... ..+
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i----~~~~------~~~ 220 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSI----MEHN------VSY 220 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH----HcCC------CCC
Confidence 2233456999999999999999999999999999999999999999754411 111111 1111 011
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm-----~eV~~~ 799 (854)
... ....+.+++.+|++.+|++||+. .++.+|
T Consensus 221 ~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 221 PKS----LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 22357889999999999999976 566655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=318.70 Aligned_cols=264 Identities=23% Similarity=0.384 Sum_probs=200.8
Q ss_pred HHHHhhccccccCceEEEEEEEC-----------------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-----------------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQF 587 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-----------------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l 587 (854)
..+.+.++||+|+||.||++... ++..||+|++.... .....++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 34567789999999999998543 23468999987543 2335678999999999999999999
Q ss_pred eeeeeecCeEEEEEEeccCCCHHhhhccccc-------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 003039 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 660 (854)
Q Consensus 588 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 660 (854)
++++...+..++||||+.+|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999865321 123477889999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeeeccccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh--CCcccccccccc
Q 003039 661 LLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGA 737 (854)
Q Consensus 661 Ll~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt--G~~pf~~~~~~~ 737 (854)
|++.++.++|+|||+++......... .....++..|+|||....+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999997553332211 122234678999999888899999999999999999998 667876543221
Q ss_pred cccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 738 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 738 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
+................. +. +..+...+.+++.+|++.+|++||+|.||++.|++
T Consensus 242 ----~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ----VIENTGEFFRDQGRQVYL-PK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ----HHHHHHHHHhhccccccC-CC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111000000 00 11123568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=312.89 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=203.3
Q ss_pred HHHHhhccccccCceEEEEEEECC------CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~~------~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~ 598 (854)
..+.+.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+++++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 345567899999999999998752 3689999986543 233457889999999999999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccc------cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 003039 599 LVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 672 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 672 (854)
+||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 999999999999998653321 23478889999999999999999998 999999999999999999999999
Q ss_pred eeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhh
Q 003039 673 FGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 673 FGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
||+++....... .......++..|+|||.+....++.++|||||||++||+++ |..||..... ..+..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~---- 234 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKFV---- 234 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH----HHHHHHH----
Confidence 999875543321 11223346789999999988889999999999999999998 8999865431 1222221
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
..+..... ... ....+.+++.+|++.+|++|||+.|+++.|++
T Consensus 235 ~~~~~~~~-----~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDL-----PEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCC-----CCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 12211111 111 23568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=313.81 Aligned_cols=251 Identities=27% Similarity=0.450 Sum_probs=196.0
Q ss_pred ccccccCceEEEEEEECC-Cc--EEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~-~~--~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|++++ +. .+|+|.++... ......+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998864 43 46888876432 33456788999999999 799999999999999999999999999
Q ss_pred CCHHhhhcccc------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeee
Q 003039 607 GTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 674 (854)
Q Consensus 607 gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 674 (854)
|+|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1123578899999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcC
Q 003039 675 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 675 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
+++..... ........+..|+|||++....++.++|||||||++|||++ |..||...... ..... +..+
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~----~~~~ 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEK----LPQG 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----HHHHH----HhCC
Confidence 98532211 11111224567999999988889999999999999999997 99999654311 11111 1111
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
...+ ........+.+++.+|++.+|.+||++.|+++.|++++
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1000 01112245789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.41 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|..+ +++.||||+++... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999987542 22345567788888877 799999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999988843 34688999999999999999999998 99999999999999999999999999986432221 12
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+..+.. .
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~~----~i~~~~~------~---- 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELFQ----SILEDEV------R---- 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHHH----HHHcCCC------C----
Confidence 23346899999999999999999999999999999999999999754311 1111 1111111 0
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm-----~eV~~~ 799 (854)
++......+.+++.+|++.+|++||++ .+++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111122457899999999999999999 888776
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=311.56 Aligned_cols=253 Identities=20% Similarity=0.322 Sum_probs=198.9
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++|+||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 4566789999999999999875 688999999875544445678899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 90 GGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999998853 34578889999999999999999998 999999999999999999999999999975532211
Q ss_pred eeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 686 VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||......+.. .. +..... ..+.
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---~~-----~~~~~~---~~~~ 230 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FL-----MSKSNF---QPPK 230 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---ee-----eecCCC---CCCC
Confidence 122345889999999884 345788999999999999999999998643311100 00 000000 0011
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
... .......+.+++.+|++.+|++||++++|+++|
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111 111234688999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=320.92 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=200.6
Q ss_pred HHHhhccccccCceEEEEEEEC-CCc--EEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGK--EIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~--~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.+.||+|+||.||+|.++ ++. .+|+|.++... ......+.+|++++.++ +||||+++++++..++..++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 3456789999999999999875 344 45777765432 33456788999999999 8999999999999999999999
Q ss_pred EeccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEE
Q 003039 602 EFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 669 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 669 (854)
||+++|+|.++++.... ....+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEE
Confidence 99999999999864321 123578999999999999999999998 999999999999999999999
Q ss_pred EEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHH
Q 003039 670 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 748 (854)
Q Consensus 670 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~ 748 (854)
|+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||...... ....
T Consensus 165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~---- 234 (303)
T cd05088 165 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYE---- 234 (303)
T ss_pred eCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----HHHH----
Confidence 99999986321111 1111224678999999988889999999999999999998 99998654321 1111
Q ss_pred hhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 749 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 749 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
....+.. ..........+.+++.+|++.+|++||++.++++.|++++...
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 235 KLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHhcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111100 0011112235789999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=318.41 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=202.9
Q ss_pred HHHhhccccccCceEEEEEEECC-----------------CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEe
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFL 588 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~-----------------~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~ 588 (854)
.+.+.+.||+|+||.||+|...+ +..||+|++.... ......+.+|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 45567899999999999997652 2458999987553 23456788999999999999999999
Q ss_pred eeeeecCeEEEEEEeccCCCHHhhhccccc-------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 003039 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661 (854)
Q Consensus 589 g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 661 (854)
+++..++..++|+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence 999999999999999999999999865321 123688999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh--CCccccccccccc
Q 003039 662 LDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGAN 738 (854)
Q Consensus 662 l~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt--G~~pf~~~~~~~~ 738 (854)
++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--- 239 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--- 239 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh---
Confidence 99999999999999875433221 12223446788999999998889999999999999999998 6677754431
Q ss_pred ccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 739 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 739 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
..+..........+...... ..+.....++.+++.+|++.+|++||++.||++.|+
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 -QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 12222222221111111111 111112246899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.64 Aligned_cols=254 Identities=26% Similarity=0.477 Sum_probs=201.0
Q ss_pred HHHhhccccccCceEEEEEEECC-C---cEEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~-~---~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.+.||+|+||.||+|.+.. + ..||||++... ......+|..|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 34567899999999999998763 3 36999998754 2334567999999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998532 34678999999999999999999998 999999999999999999999999999875543
Q ss_pred CCCcee--eccc--ccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 682 GASHVS--SIVR--GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 682 ~~~~~~--~~~~--gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
...... .... .+..|+|||++.+..++.++|||||||++||+++ |..||..... ..+..++.. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~i~~---~~~~~ 231 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAIEQ---DYRLP 231 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHHHHc---CCcCC
Confidence 322111 1111 2457999999999999999999999999999886 9999865431 122222211 00000
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
...+....+.+++..|++.+|.+||+|.+|++.|+++
T Consensus 232 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112234578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.88 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=195.0
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeee-----cCeEEEEEE
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSVLVYE 602 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~-----~~~~~LV~E 602 (854)
.+.||+|+||.|+.|..+ +|+.||||++... .....+...+|+++|+.++|+||+.+.+.+.. -+..++|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 478999999999999876 6899999998632 33445677899999999999999999999865 346799999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
+|+ .+|...++ .++.+.......++.|+++||.|+|+. +|+|||+||+|+|++.+...||+|||+|+.....
T Consensus 107 lMe-tDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LME-TDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HHh-hHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence 994 57877774 445588888999999999999999998 9999999999999999999999999999976432
Q ss_pred -CCceeecccccccccCccccc-cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccch-----------HH-----
Q 003039 683 -ASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI-----------VQ----- 744 (854)
Q Consensus 683 -~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l-----------~~----- 744 (854)
....++....|.+|+|||++. ...|+.+.||||.|||+.||++|++.|.+.+.-.-...+ ..
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 223335556899999999986 468999999999999999999999999775521100000 00
Q ss_pred HHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 745 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 745 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.++..++.- ...--..+..-++ ......++|+.+|+..||.+|+|++|.++|
T Consensus 259 ~ar~yi~sl--p~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 259 KARPYIKSL--PQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHhC--CCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011111100 0000000000111 222457899999999999999999999987
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.25 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=203.3
Q ss_pred HHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
...+.+.++||+|+||.||+|...++..+|+|.+.... .....+.+|++++++++|+||+++.+++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 34556788999999999999998878889999886442 235678899999999999999999999887 7789999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 83 AKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999998643 244678889999999999999999998 999999999999999999999999999875543322
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......++..|+|||++....++.++|+|||||+++|+++ |+.||...... .+..+ ...+....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~----~~~~~~~~------ 223 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRA----LERGYRMP------ 223 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHH----HhCCCCCC------
Confidence 22222345678999999998889999999999999999999 89998754311 12221 11111111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.54 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=200.9
Q ss_pred HHhhccccccCceEEEEEEEC------CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
..+.++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++||
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 345688999999999999642 35679999987665555678999999999999999999999999999999999
Q ss_pred EeccCCCHHhhhccccc-----------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 003039 602 EFMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 670 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 670 (854)
||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence 99999999999864321 123578999999999999999999998 9999999999999999999999
Q ss_pred EeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHH
Q 003039 671 SDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 748 (854)
Q Consensus 671 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~ 748 (854)
+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~--- 236 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT----EAIEC--- 236 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----HHHHH---
Confidence 999998754332211 1122335788999999999999999999999999999998 89998654311 11111
Q ss_pred hhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 749 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 749 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
...+.... .+......+.+++.+|++.+|.+||++.||.+.|+
T Consensus 237 -~~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 -ITQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111100 00112245789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.43 Aligned_cols=242 Identities=28% Similarity=0.357 Sum_probs=189.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHH-HHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~-~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||+||+|+.. +|+.||||++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999886 68999999986432 122234444444 56789999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 999988843 44678888899999999999999998 9999999999999999999999999998743222 122
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...... .+.. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i~-~~~~------~~~~~ 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------EMYDNIL-NKPL------RLKPN 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-------HHHHHHH-cCCC------CCCCC
Confidence 33456999999999999999999999999999999999999999754321 1111111 1111 11111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSIS----EVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~----eV~~~ 799 (854)
. ...+.+++.+|++.+|++||++. |++++
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 219 I----SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred C----CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 2 34578899999999999999884 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=325.96 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=201.8
Q ss_pred HHHHHHhhccccccCceEEEEEEE------CCCcEEEEEEEccCCc-ccHHHHHHHHHHHccC-CCCceeeEeeeeeec-
Q 003039 524 EDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE- 594 (854)
Q Consensus 524 ~~~~~~~~~~iG~G~fg~Vy~a~~------~~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~- 594 (854)
....+.+.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 345677889999999999999974 2467899999975432 2345688899999999 789999999988654
Q ss_pred CeEEEEEEeccCCCHHhhhccccc--------------------------------------------------------
Q 003039 595 GRSVLVYEFMHNGTLKEHLYGTLT-------------------------------------------------------- 618 (854)
Q Consensus 595 ~~~~LV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 618 (854)
...++||||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999999864210
Q ss_pred -------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc-eeecc
Q 003039 619 -------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIV 690 (854)
Q Consensus 619 -------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~ 690 (854)
....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 012467888899999999999999998 9999999999999999999999999998754332221 11223
Q ss_pred cccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 691 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 691 ~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
.++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+. ..+..+..... + ...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~~~--~---~~~-- 307 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFC----RRLKEGTRMRA--P---DYT-- 307 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHH----HHHhccCCCCC--C---CCC--
Confidence 35678999999998899999999999999999997 888986543111 111 11122211110 0 111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..++.+++..|++.+|++||++.||+++|+.++.
T Consensus 308 --~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 --TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1357899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.11 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=201.6
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|++|.||+|..+ +++.|++|.+... .......+.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 34578999999999999876 6889999998643 23345678899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 83 NGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 99999998643 235688889999999999999999998 999999999999999999999999999876543322
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .... ....+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----~~~~~~~~~-------- 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALIL----KIIRGVFPP-------- 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHHcCCCCC--------
Confidence 223345889999999999999999999999999999999999999754411 1111 111111111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........+.+++.+|++.+|++||+|.+++++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.94 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=201.7
Q ss_pred HHHhhccccccCceEEEEEEEC----CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.+.||+|+||.||+|.+. .+..+|+|.++... ......+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 4456789999999999999864 23479999886543 233567899999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+|||++.++.++|+|||+++....
T Consensus 85 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 85 EYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999998532 34578899999999999999999998 999999999999999999999999999986544
Q ss_pred CCCceeec--ccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 682 GASHVSSI--VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 682 ~~~~~~~~--~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
........ ..++..|+|||++.+..++.++|||||||++||+++ |..||...... .+.... .++.-
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----~~~~~~----~~~~~--- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----DVIKAI----EEGYR--- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----HHHHHH----hCCCc---
Confidence 33222221 223568999999998899999999999999999887 99998654311 122211 11110
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
. .........+.+++.+|++.+|.+||+|.+|++.|+++
T Consensus 228 --~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=322.33 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|+.. +++.||+|+++.... .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 578899999975422 2334577899998888 699999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99998874 234688999999999999999999998 99999999999999999999999999987432221 22
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+....+...... +...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~------~p~~ 225 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEKPIR------IPRF 225 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhCCCC------CCCC
Confidence 3345699999999999999999999999999999999999999964321111 11222222222222110 1111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPs------m~eV~~~ 799 (854)
....+.+++.+|++.+|++||+ +.++.+|
T Consensus 226 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 226 ----LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1235678999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=327.92 Aligned_cols=238 Identities=26% Similarity=0.356 Sum_probs=190.8
Q ss_pred ccccccCceEEEEEEE----CCCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 532 KKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~----~~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 2578999999975422 233456789999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999998843 34688999999999999999999998 999999999999999999999999999875433322
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... . +..... .+..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~---~-i~~~~~------~~p~ 219 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMT---M-ILKAKL------GMPQ 219 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHH---H-HHcCCC------CCCC
Confidence 223456899999999999888999999999999999999999999754311 1111 1 111111 0111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISE 795 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~e 795 (854)
. ....+.+++.+|++.+|++||++.+
T Consensus 220 ~----~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 F----LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C----CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 1235778999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.70 Aligned_cols=250 Identities=30% Similarity=0.538 Sum_probs=200.4
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.+.||+|+||.||+|.+.+++.+|+|.+.... ....++.+|++++++++|||++++++++......++||||++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 34568899999999999998778899999886443 23467889999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 85 CLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999988532 34578889999999999999999998 999999999999999999999999999875543322222
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....++.+|+|||++.++.++.++|||||||++|||++ |+.||...... .+... +..+. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~----~~~~~--~~~~~~~--- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EVVET----INAGF--RLYKPRL--- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHH----HhCCC--CCCCCCC---
Confidence 22335678999999998899999999999999999998 99998654311 12211 11110 1111211
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
....+.+++.+|++.+|++||++.||+++|.
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.53 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=202.4
Q ss_pred HHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 597 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~ 597 (854)
..+.+.+.||+|+||.||+|... .+..||||+++... ......+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 34556789999999999999752 35579999987543 23345688999999999 799999999999999999
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
++||||+.+|+|.+++.... ...+++.++..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999986422 23378999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCc
Q 003039 678 FAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 678 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .+.. ....+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~ 262 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYK----LIKEGYR 262 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHH----HHHcCCc
Confidence 55433221 1122345778999999999999999999999999999998 999986544211 1111 1111110
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
. ..+.....++.+++.+|+..+|++||++.||++.|+++
T Consensus 263 ~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 M---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 00111124688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=309.39 Aligned_cols=247 Identities=30% Similarity=0.438 Sum_probs=196.7
Q ss_pred ccccccCceEEEEEEECC----CcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|+++++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997642 26899999875543 34567889999999999999999999876 4467999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.. ...+++..++.++.|++.||+|||.. +++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999953 23688999999999999999999998 99999999999999999999999999998654433222
Q ss_pred ee--cccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 687 SS--IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 687 ~~--~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.. ...++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..+.. .+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~----~~~~~~------ 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLE----SGERLP------ 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHH----cCCcCC------
Confidence 11 1223568999999998899999999999999999998 9999975431 12222221 111100
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
.+......+.+++.+|+..+|++||++.+|++.|+++
T Consensus 219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=309.69 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=197.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-----ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-----~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
+.+.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 345689999999999999865 589999999864321 12346888999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 84 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999998853 34577888899999999999999998 999999999999999999999999999875433
Q ss_pred CCCcee--ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 682 GASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 682 ~~~~~~--~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
...... ....|+..|+|||.+.+..++.++||||+||++|||++|+.||..... .... ....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~-~~~~~~~-~~--- 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAI-FKIATQP-TN--- 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHH-HHHhccC-CC---
Confidence 221111 234578899999999998899999999999999999999999865431 1110 1111111 00
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+ ..+......+.+++.+|+..+|.+||++.|++++
T Consensus 226 -~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -P----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -C----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 1111223457889999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=330.09 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=195.2
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecC-----eEEEEE
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVY 601 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~-----~~~LV~ 601 (854)
+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++...+ ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 4678999999999999875 6899999998643 2233467889999999999999999999998776 789999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 84 ELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9997 57777763 345688999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH---------------H
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------------W 745 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~---------------~ 745 (854)
..........+|+.|+|||++.+. .++.++||||+||++|||++|+.||...........+.+ .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 333333344578999999998874 578999999999999999999999976442111111110 0
Q ss_pred HHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 746 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 746 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+..........+.+. ........++.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0111100000000000000 0011123467899999999999999999999886
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.90 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=193.4
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
||+|+||.||+++.+ +|+.||+|++..... .....+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999876 589999999864321 2234556799999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9888532 234578888999999999999999998 99999999999999999999999999987654322 2233
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
..|+..|+|||++.+..++.++||||+||++|||++|+.||........ ......... .+... .. ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~~-~~~~~----~~-~~~--- 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KEELKRRTL-EDEVK----FE-HQN--- 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HHHHHHHhh-ccccc----cc-ccc---
Confidence 4689999999999988899999999999999999999999965331111 111111111 11110 00 011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
...++.+++..|++.+|++||++.|+++++.
T Consensus 222 -~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 222 -FTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred -CCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 2235789999999999999999977764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=310.06 Aligned_cols=248 Identities=30% Similarity=0.465 Sum_probs=202.1
Q ss_pred HHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++......++||||+++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 3456789999999999999876 89999999976543 467788999999999999999999999989999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 85 GSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999998543 223688999999999999999999998 999999999999999999999999999976532221
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
...++..|+|||++..+.++.++||||||++++|+++ |..||..... ..+.... ..+....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~----~~~~~~~-------- 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHV----EKGYRME-------- 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH----hcCCCCC--------
Confidence 2234678999999998899999999999999999998 9999865431 1222211 1111000
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
.+......+.+++.+|+..+|++||++.|+++.|+.
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 -APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 011123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.21 Aligned_cols=248 Identities=21% Similarity=0.270 Sum_probs=188.9
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++.+.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 4678999999999999875 57899999986532 2234568889999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC--
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-- 683 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~-- 683 (854)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 85 GGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999998853 24577888888999999999999998 99999999999999999999999999975221000
Q ss_pred --------------------------------------------CceeecccccccccCccccccCcCCCcchhhhHHHH
Q 003039 684 --------------------------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 719 (854)
Q Consensus 684 --------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvv 719 (854)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123469999999999999999999999999999
Q ss_pred HHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCC---HHHH
Q 003039 720 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEV 796 (854)
Q Consensus 720 l~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---m~eV 796 (854)
+|||++|+.||......+....+..| ..... .+. ....+ .++.+++.+|+ .+|++|++ +.|+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~------~~~~~---~p~-~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINW------QTSLH---IPP-QAKLS----PEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcc------CCCcC---CCC-cccCC----HHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999765421111111111 00000 000 01112 23455555554 48999997 8888
Q ss_pred HHH
Q 003039 797 LKD 799 (854)
Q Consensus 797 ~~~ 799 (854)
++|
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=309.66 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=199.1
Q ss_pred ccccccCceEEEEEEECC--C--cEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLKD--G--KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~--~--~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|++++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 2 3699999987655 556789999999999999999999999988 889999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc-
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 685 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 685 (854)
|+|.+++..... ..+++...+.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999865321 4688999999999999999999998 9999999999999999999999999999865443221
Q ss_pred -eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 686 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 686 -~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+..... ..+....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~---~~~~~~~------ 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----QILKKID---KEGERLE------ 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH---hcCCcCC------
Confidence 1122457789999999999899999999999999999999 99998654311 1111111 1111000
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
.+......+.+++.+|++.+|++||++.||++.|.
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=322.45 Aligned_cols=251 Identities=28% Similarity=0.397 Sum_probs=210.0
Q ss_pred HHHHHhhccccccCceEEEEEEECC-CcEEEEEEEccCCccc---HHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG---KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~---~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~L 599 (854)
...|.+.+.||+|.||.||+++.+. |+.+|+|++.+..... ...+.+|+++|+++. ||||+.+.+.+......++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3456667899999999999999875 9999999998765433 458999999999998 9999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC----CcEEEEeeec
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGL 675 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkl~DFGl 675 (854)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999998644 288999999999999999999998 99999999999999643 5799999999
Q ss_pred cccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
|..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||......+... .+..++.
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILRGDF 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHcCCC
Confidence 987665 455667789999999999999999999999999999999999999998766322221 2222222
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......-......+.+++..|+..||.+|+++.++++|
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122222334567899999999999999999999996
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=308.39 Aligned_cols=250 Identities=31% Similarity=0.501 Sum_probs=203.0
Q ss_pred ccccccCceEEEEEEECC----CcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|.... +..||+|+++..... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998764 788999999765433 367889999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccc-----cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 607 GTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 607 gsL~~~L~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999654211 46789999999999999999999998 999999999999999999999999999986554
Q ss_pred CCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 682 GAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 682 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
... .......++..|+|||.+....++.++||||+||+++||++ |..||..... ..+.+.. ..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~----~~~~~~--- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEYL----RKGYRL--- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH----HcCCCC---
Confidence 321 12233457889999999988889999999999999999999 6999876531 1222211 111110
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
..+.....++.+++.+|++.+|++||++.|++++|+
T Consensus 227 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.00 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=193.2
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.+.+.||+|+||.||+|+.. +++.||||++..... .....+..|..++..+ +|++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 35678999999999999876 578999999875422 2234466778888777 589999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 83 VNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 999999988843 34578889999999999999999998 9999999999999999999999999998743221
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ .....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i----~~~~~-------- 218 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSI----MEHNV-------- 218 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HHHHHH----HhCCC--------
Confidence 12223456999999999999999999999999999999999999999764421 122111 11111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm-----~eV~~~ 799 (854)
.++.....++.+++.+|++.+|++|++. .++.++
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0111123457899999999999999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.63 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=202.1
Q ss_pred HHHHhhccccccCceEEEEEEECC----CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
..+.+.+.||+|+||.||+|.+.+ ...||||...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 345567899999999999998653 2468999887554 3445678999999999999999999999875 456899
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999998532 33578999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
...........++..|+|||.+....++.++|||||||+++|+++ |..||...... ....+ +..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~----~~~~~~~~-- 228 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGR----IENGERLP-- 228 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHH----HHcCCcCC--
Confidence 433222223335578999999988889999999999999999996 99999755421 11111 11111100
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
... .....+.+++.+|+..+|++||++.++++.|+++..
T Consensus 229 ---~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 ---MPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111 123468889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=316.12 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=199.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++|+||+++++.+......++||||+++
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 445678999999999999865 6889999998766555567788999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 102 ~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 102 GSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 999998843 3467888999999999999999998 999999999999999999999999999875433221 1
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.. ....+ ... + .
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---~~~~~----~~~~~-~~~-----~--~ 237 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYL----IATNG-TPE-----L--Q 237 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---HhHHH----HhcCC-CCC-----C--C
Confidence 22345889999999999888999999999999999999999999654311 11111 11111 000 0 0
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+......+.+++.+|+..+|++||++.||+++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 111223457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=332.26 Aligned_cols=249 Identities=25% Similarity=0.325 Sum_probs=192.4
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.++||+|+||.||+++.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 35688999999999999875 68899999986432 223456788999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 84 PGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999998853 34578888889999999999999998 999999999999999999999999999863211000
Q ss_pred c----------------------------------------------eeecccccccccCccccccCcCCCcchhhhHHH
Q 003039 685 H----------------------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 718 (854)
Q Consensus 685 ~----------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGv 718 (854)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999999999999999999999
Q ss_pred HHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCC---CCCHHH
Q 003039 719 ILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM---RPSISE 795 (854)
Q Consensus 719 vl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~---RPsm~e 795 (854)
++|||++|+.||......+....+..|. ..+ . +... ......+.+++.+|+. +|.+ ||++.|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~------~~~-~-----~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWR------ETL-Y-----FPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccC------Ccc-C-----CCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999997544211111111110 000 0 0000 0112357788889997 5665 569999
Q ss_pred HHHH
Q 003039 796 VLKD 799 (854)
Q Consensus 796 V~~~ 799 (854)
+++|
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 9987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.46 Aligned_cols=251 Identities=31% Similarity=0.474 Sum_probs=199.2
Q ss_pred hhccccccCceEEEEEEECC-CcEEEEEEEccCCcccHH--HHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKR--EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~~~--~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.||+|+||+||+++... ++.+|+|++......... ...+|+.++++++||||+++++++......++||||+++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence 46789999999999999874 668999999866543322 345699999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++. ....+++..++.++.|+++||++||+. +++|+||||+||+++.++.++|+|||.+... ......
T Consensus 83 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~ 154 (260)
T PF00069_consen 83 GSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNEN 154 (260)
T ss_dssp EBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSE
T ss_pred cccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence 99999995 456689999999999999999999998 9999999999999999999999999998754 222233
Q ss_pred eecccccccccCccccc-cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....++..|+|||.+. +..++.++||||+|+++++|++|..||...........+........... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 225 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---------SQQ 225 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---------TTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---------ccc
Confidence 34556899999999998 88899999999999999999999999986521111111111111110000 000
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.......+.+++..|++.+|++||++.|++++
T Consensus 226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00012678999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=298.44 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=201.4
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.+.+-+.||+|.|+.||+.... +|+.+|+|++... ...+.+++.+|+.|-+.++||||++|.+...+.+..++|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 4566788999999999998655 6899999987543 344677899999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeeecccccc
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAV 680 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~ 680 (854)
|.|++|..-+-. ....++..+-..+.||+++|.|+|.+ +|||||+||+|+|+.. ...+||+|||+|....
T Consensus 92 m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 92 VTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999776632 24467777788999999999999999 9999999999999953 3569999999998766
Q ss_pred CCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
.........|||+|||||++...+|+..+|||+.|||||-|+.|..||.+.... .+.+.+ ..|.. -++
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~----rlye~I----~~g~y--d~~ 232 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYEQI----KAGAY--DYP 232 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----HHHHHH----hcccc--CCC
Confidence 334455678999999999999999999999999999999999999999875532 232221 11211 122
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.-.+. ..++..+|+.+|+..||++|.|+.|.++|
T Consensus 233 ~~~w~~----is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 233 SPEWDT----VTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CcccCc----CCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 222222 22356789999999999999999987754
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=315.73 Aligned_cols=260 Identities=23% Similarity=0.411 Sum_probs=201.1
Q ss_pred HHHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 597 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~ 597 (854)
..++.+.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 345667789999999999999754 24579999876443 22345678899999999999999999999999999
Q ss_pred EEEEEeccCCCHHhhhccccc------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 003039 598 VLVYEFMHNGTLKEHLYGTLT------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 671 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 671 (854)
++||||+++|+|.+++..... ......+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999964321 123345677889999999999999998 99999999999999999999999
Q ss_pred eeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHh
Q 003039 672 DFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 672 DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~ 749 (854)
|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... .+.. ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~----~~~~---~~ 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----QVLK---FV 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH---HH
Confidence 99998754332211 1122235678999999998899999999999999999999 78888643311 1111 11
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
. .+.... .+......+.+++.+|++.+|++||+|.|+++.|++.+
T Consensus 235 ~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 M-DGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H-cCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1 111111 01112346889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=316.18 Aligned_cols=264 Identities=26% Similarity=0.392 Sum_probs=202.0
Q ss_pred HHHHHhhccccccCceEEEEEEEC-----CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeec--Ce
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GR 596 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-----~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~ 596 (854)
...+.+.+.||+|+||.||++++. ++..||+|.++... ......+.+|++++++++||||+++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345566788999999999999752 47889999987543 33346789999999999999999999998775 56
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 89999999999999998532 23578999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCc--eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccc-------cccccchHHHHH
Q 003039 677 KFAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-------GANCRNIVQWAK 747 (854)
Q Consensus 677 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~-------~~~~~~l~~~~~ 747 (854)
+........ ......++..|+|||++.+..++.++|||||||++|||++++.|...... +...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 865433221 11234467789999999888899999999999999999998776432110 000011111111
Q ss_pred HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 748 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
.....+.... ........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1122221111 0111234688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=313.68 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=199.7
Q ss_pred HHHhhccccccCceEEEEEEEC-CCc----EEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~----~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
.+.+.++||+|+||+||+|++. +++ .||+|+++... ......+.+|+.+++.++||||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEE
Confidence 3445688999999999999864 444 48999987543 33456788999999999999999999999754 46799
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
+||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 87 ~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 87 TQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999998642 34688899999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 681 DGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 681 ~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
...... .....++..|+|||...+..++.++|||||||++|||++ |..||..... ..+..+.. .+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~----~~~~~~- 231 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLE----KGERLP- 231 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH----CCCcCC-
Confidence 332221 112235678999999998899999999999999999998 8899865431 12222221 111100
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+......+.+++.+|++.+|++||++.++++.|+.+..
T Consensus 232 --------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 232 --------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred --------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011123467899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=333.67 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=191.7
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 45678999999999999876 58899999986432 123456788999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC--
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-- 682 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~-- 682 (854)
++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|......
T Consensus 84 ~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 84 PGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999853 34577888888999999999999998 9999999999999999999999999997422100
Q ss_pred ----------------------------------------CCceeecccccccccCccccccCcCCCcchhhhHHHHHHH
Q 003039 683 ----------------------------------------ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 722 (854)
Q Consensus 683 ----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~e 722 (854)
.........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0001123469999999999999999999999999999999
Q ss_pred HHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 003039 723 LISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP---SISEVLKD 799 (854)
Q Consensus 723 lltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP---sm~eV~~~ 799 (854)
|++|+.||......+....+..|. ... . + +. ....+ ..+.+++.+|+ .+|.+|+ ++.|+++|
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~------~~~-~-~-~~-~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWE------TTL-H-I-PS-QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccC------ccc-c-C-CC-CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997654211111111110 000 0 0 00 11122 23556666665 4999999 89999988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.87 Aligned_cols=254 Identities=27% Similarity=0.355 Sum_probs=191.9
Q ss_pred ccccccCceEEEEEEECC---CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~---~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.||+|+||.||+|.+.+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 4579999886543 233457889999999999999999999999999999999999999
Q ss_pred CHHhhhccccc-ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 608 TLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 608 sL~~~L~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
+|.++++.... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965322 223456777888999999999999998 99999999999999999999999999987543322111
Q ss_pred -eecccccccccCccccccC-------cCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 687 -SSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 687 -~~~~~gt~~Y~aPE~~~~~-------~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
.....|+..|+|||++... .++.++|||||||++|||++ |+.||...... ....+. .. +....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~~~---~~-~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLTYT---VR-EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHHHH---hh-cccCC
Confidence 1234578889999998642 35789999999999999996 99999654311 111111 11 11111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
..++.+.... ...+.+++.+|+ .+|++|||++||++.|+
T Consensus 230 ~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222222221 234677888998 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.80 Aligned_cols=261 Identities=25% Similarity=0.433 Sum_probs=203.4
Q ss_pred HHHHHhhccccccCceEEEEEEEC--------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeec
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 594 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~--------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~ 594 (854)
...+.+.++||+|+||.||+|+.. ....+|+|+++... ......+..|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 345567889999999999999752 24578999987542 23345688999999999 699999999999999
Q ss_pred CeEEEEEEeccCCCHHhhhcccc------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE
Q 003039 595 GRSVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 662 (854)
Q Consensus 595 ~~~~LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 662 (854)
+..++||||+++|+|.+++.... .....+++.++..++.|++.||+|||+. +++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999996432 1234588999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeeeccccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCccccccccccccc
Q 003039 663 DKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 740 (854)
Q Consensus 663 ~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~ 740 (854)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---- 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---- 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 999999999999997554322111 112234567999999998899999999999999999999 88888654311
Q ss_pred chHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 741 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 741 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+.. ....+...+ .+.....++.+++.+|++.+|++||++.|+++.|+++..
T Consensus 244 ~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 ELFK----LLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHH----HHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111 111221111 111223457789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=309.53 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=195.0
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 45678999999999999864 68899999986542 33356788999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++...... .
T Consensus 84 ~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 84 GSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9986542 356778889999999999999998 9999999999999999999999999998754332 1
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....................... .+.+..
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~- 222 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLPV- 222 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCCC-
Confidence 2234689999999999998999999999999999999999999965332111111111111111110 011100
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......+.+++.+|++.+|++||+++|++++
T Consensus 223 --~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 --GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1112357899999999999999999999887
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.92 Aligned_cols=247 Identities=33% Similarity=0.473 Sum_probs=197.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHH
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 610 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 610 (854)
++||+|+||.||++...+++.||+|++...... ....+.+|++++++++|+||+++++++......++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee-ec
Q 003039 611 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS-SI 689 (854)
Q Consensus 611 ~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~-~~ 689 (854)
+++... ...+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998542 23578888899999999999999998 999999999999999999999999999875432221111 12
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCC
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 768 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~ 768 (854)
..++..|+|||.+.++.++.++|||||||+++||++ |..||...... ..... ...+. . ...+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~~----~~~~~--~-------~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRER----IESGY--R-------MPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHHH----HhcCC--C-------CCCC
Confidence 234567999999998899999999999999999999 88888654311 11111 11110 0 0011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 769 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 769 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
......+.+++.+|+..+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=329.30 Aligned_cols=253 Identities=22% Similarity=0.252 Sum_probs=196.0
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
..+.+.+.||+|+||.||+++.+ +++.+|+|++.... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45566789999999999999887 57889999986421 223445778999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 123 EYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 99999999998853 3467778888999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCccccccC----cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
..........||+.|+|||++... .++.++|||||||++|||++|+.||...... ..............
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~ 267 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHKNSLT 267 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCccc
Confidence 333333455799999999998754 3788999999999999999999999765421 11111111111111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKDI 800 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eV~~~L 800 (854)
..+ .......+.+++..|+..++.+ ||++.|+.+|.
T Consensus 268 ~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 FPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 110 0112335778899999844443 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=324.79 Aligned_cols=240 Identities=26% Similarity=0.330 Sum_probs=187.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHH-HHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev-~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||+||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 57789999986432 12223344444 456788999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.. ...+.+.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999998853 34567778888999999999999998 99999999999999999999999999987533222 22
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +... ... ... .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~---i~~-~~~------~~~~~ 218 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDN---ILN-KPL------QLKPN 218 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----HHHH---HHh-CCc------CCCCC
Confidence 334569999999999999999999999999999999999999997544211 1111 111 111 01111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVL 797 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~ 797 (854)
....+.+++.+|++.+|.+||++.+.+
T Consensus 219 ----~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 219 ----ITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ----CCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 223578899999999999999877433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=328.05 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=199.5
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHHh
Q 003039 533 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 611 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 611 (854)
+||+|.||+||.|+..+ ...+|||-+..........+.+|+.+.++++|.|||+++|.|.+.+..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999998764 56789999987766667778899999999999999999999999999999999999999999
Q ss_pred hhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeeeccccccCCCCceeecc
Q 003039 612 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIV 690 (854)
Q Consensus 612 ~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~ 690 (854)
+|+..... -+=++.+.-.+..||++||.|||+. .|||||||-.||||+. .|.+||+|||.++.... ....+.++
T Consensus 662 LLrskWGP-lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGP-LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred HHHhccCC-CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 99765421 1125666677889999999999999 9999999999999974 68999999999986543 33445566
Q ss_pred cccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCC
Q 003039 691 RGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 768 (854)
Q Consensus 691 ~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~ 768 (854)
.||..|||||++.. +.|..++|||||||.+.||.||++||-....+.... ++-| +. .+ ....+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------FkVG-my-Kv----HP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------FKVG-MY-KV----HPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------hhhc-ce-ec----CCCCc
Confidence 79999999999975 458899999999999999999999997654322110 1111 00 01 12234
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 769 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 769 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+-..+...++++|+.++|.+||++.++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 4455667899999999999999999999864
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=324.42 Aligned_cols=237 Identities=28% Similarity=0.349 Sum_probs=186.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHH-HHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev-~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999886 588999999864321 2233445554 467889999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99988874 234577888889999999999999998 99999999999999999999999999987432222 22
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.. . +..+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~---~-i~~~~~----------~ 214 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMYD---N-ILHKPL----------Q 214 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHHH---H-HhcCCC----------C
Confidence 33456899999999999989999999999999999999999999764311 1111 1 111111 0
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSIS 794 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~ 794 (854)
.+......+.+++.+|++.+|++||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111233578999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.63 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=199.2
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+...+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4455678999999999999875 57889999987443 233457889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998842 4578889999999999999999998 999999999999999999999999999875543221
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+...... .... ....+. .+.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~----~~~~~~-----~~~~- 221 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVLF----LIPKNS-----PPTL- 221 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHHh----hhhcCC-----CCCC-
Confidence 122345788999999999888999999999999999999999998643311 1111 111111 1111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.......+.+++.+|++.+|++||+|.+|+++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11233468899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.48 Aligned_cols=238 Identities=28% Similarity=0.357 Sum_probs=187.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHH-HHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~-~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999875 68999999986432 222344555554 57779999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 99988874 345688889999999999999999998 9999999999999999999999999998743222 122
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. .... .+.+ .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~---~~~~-~~~~------~~~~~ 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----EMY---DNIL-HKPL------VLRPG 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----HHH---HHHH-cCCc------cCCCC
Confidence 23456999999999999999999999999999999999999999754421 111 1111 1111 01111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISE 795 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~e 795 (854)
....+.+++.+|++.+|.+||++.+
T Consensus 219 ----~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 219 ----ASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred ----CCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2235778999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.42 Aligned_cols=239 Identities=23% Similarity=0.371 Sum_probs=186.9
Q ss_pred cccccCceEEEEEEECC-------------------------CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeE
Q 003039 533 KIGSGGFGVVYYGKLKD-------------------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 587 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~~-------------------------~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l 587 (854)
+||+|+||.||+|.+.. ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998865444445678889999999999999999
Q ss_pred eeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-
Q 003039 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM- 666 (854)
Q Consensus 588 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~- 666 (854)
+++|......++||||+++|+|..++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999988853 234678888999999999999999998 999999999999998643
Q ss_pred ------cEEEEeeeccccccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHH-hCCccccccccccc
Q 003039 667 ------RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI-SGQEAISNEKFGAN 738 (854)
Q Consensus 667 ------~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~ell-tG~~pf~~~~~~~~ 738 (854)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3899999987543221 12347888999998875 56889999999999999985 6899986543111
Q ss_pred ccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 739 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 739 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
...+... .... .... ...+.+++.+|++.+|++||+|.+|++.|.
T Consensus 230 ---~~~~~~~---~~~~--------~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 ---KERFYEK---KHRL--------PEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHHh---ccCC--------CCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111110 0000 0111 135789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.46 Aligned_cols=239 Identities=21% Similarity=0.377 Sum_probs=188.0
Q ss_pred ccccccCceEEEEEEECC-------------CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEE
Q 003039 532 KKIGSGGFGVVYYGKLKD-------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~-------------~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~ 598 (854)
+.||+|+||.||+|++.. ...||+|++..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 2358999876554444567888999999999999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc-------EEEE
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-------AKVS 671 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-------vkl~ 671 (854)
+||||+++|+|..++... ...+++..++.++.||++||+|||+. +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999887532 34578889999999999999999998 9999999999999987664 8999
Q ss_pred eeeccccccCCCCceeecccccccccCccccc-cCcCCCcchhhhHHHHHHHHH-hCCcccccccccccccchHHHHHHh
Q 003039 672 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI-SGQEAISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 672 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvvl~ell-tG~~pf~~~~~~~~~~~l~~~~~~~ 749 (854)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+ .. .
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~-----~ 220 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KE-----R 220 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HH-----H
Confidence 99998654321 2234788999999887 567899999999999999998 5888876433111 00 0
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
...+... . .. .....+.+++.+|++.+|.+||++.+|+++|
T Consensus 221 ~~~~~~~-~-----~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 FYEGQCM-L-----VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHhcCcc-C-----CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111110 0 01 1124578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=324.30 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=206.4
Q ss_pred HhhccccccCceEEEEEEEC--CCc--EEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~--~~~--~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.+.++||+|.||.|++|.|. .|+ .||||+++..... .-.+|.+|+.+|.+|+|||+++|+|+..+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 35678999999999999887 344 5899999876544 56789999999999999999999999988 678999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
++.|+|.+.|+. .....+.......++.|||.||.||.++ ++|||||.++|+||-..-.|||+|||+.+-+....
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999986 3455677888899999999999999999 99999999999999999999999999999776554
Q ss_pred Ccee--ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 684 SHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 684 ~~~~--~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
.+.. ....-...|+|||.+..+.++.++|||+|||.+|||+| |..||.+.... .|. +.+|
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----qIL-------------~~iD 329 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----QIL-------------KNID 329 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----HHH-------------Hhcc
Confidence 4431 12234668999999999999999999999999999999 77898765511 111 1122
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
..-+-..+..+.+.+.++++.||..+|++||++..|.+.+-.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 222223345567789999999999999999999999865443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=305.40 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=190.7
Q ss_pred ccccccCceEEEEEEECCC---cEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLKDG---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~---~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976543 345667665443 334567899999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC-Cce
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHV 686 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~-~~~ 686 (854)
+|.+++..........++.....++.|+++||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975433334566777888999999999999998 99999999999999999999999999986422111 112
Q ss_pred eecccccccccCcccccc-------CcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 687 SSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~-------~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... ........ +.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~-~~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-------EVLNHVIK-DQQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHh-hccccc
Confidence 233457899999999753 245789999999999999997 56677543311 11111111 122233
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
.++.+...++ ..+.+++..|+ .+|++||+++||++.|.
T Consensus 230 ~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 4444443333 34677888999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=305.76 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=198.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 556788999999999999887 4778899998765555566788999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++.. ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999888753 234688999999999999999999998 99999999999999999999999999987543322 12
Q ss_pred eecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 687 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||...... ..... ... ........+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~----~~~-~~~~~~~~~ 231 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLK----IAK-SEPPTLAQP 231 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHHH----Hhh-cCCCCCCCc
Confidence 23345899999999984 345778999999999999999999998654311 01111 111 110011111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......+.+++.+|++.+|.+||++.+++++
T Consensus 232 -------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 -------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122457899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=315.45 Aligned_cols=256 Identities=25% Similarity=0.429 Sum_probs=201.1
Q ss_pred HHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
.+.+.+.||+|+||.||+|..+ ++..||+|++.... .....++.+|++++++++||||+++++++..+...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 3445688999999999999864 46789999987543 2335678999999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhcccc------------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 003039 600 VYEFMHNGTLKEHLYGTL------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 661 (854)
|+||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence 999999999999986421 1123478888999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccc
Q 003039 662 LDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 739 (854)
Q Consensus 662 l~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~ 739 (854)
++.++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--- 239 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--- 239 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999875432211 11122235678999999998899999999999999999998 88888643311
Q ss_pred cchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 740 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 740 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
.+.. .+..++.... +.....++.+++.+|++.+|++||++.||++.|++
T Consensus 240 -~~~~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -EVIY----YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHH----HHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 1222222110 11123468899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=343.45 Aligned_cols=261 Identities=22% Similarity=0.307 Sum_probs=202.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.++||+|+||.||+|... +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 345689999999999999876 589999999875422 2245788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhccccc-------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 604 MHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
+++|+|.+++..... ....+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999998864211 123456778899999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC-----------------ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccc
Q 003039 677 KFAVDGAS-----------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 739 (854)
Q Consensus 677 ~~~~~~~~-----------------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~ 739 (854)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~--- 237 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR--- 237 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh---
Confidence 75521110 0112246999999999999999999999999999999999999999753311
Q ss_pred cchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHHH
Q 003039 740 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIVI 806 (854)
Q Consensus 740 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-sm~eV~~~L~~~~~~ 806 (854)
.+... ... .++.-.. ...+....+.+++.+|++.+|++|| +++++.+.|+..+..
T Consensus 238 -ki~~~--~~i--------~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 -KISYR--DVI--------LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred -hhhhh--hhc--------cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11100 000 0000000 0012234578899999999999996 678888888887653
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.74 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=197.7
Q ss_pred HHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeee-ecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~-~~~~~~LV~E~~~ 605 (854)
.+.+.+.||+|+||.||+|... |..||+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..++|+||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 3456789999999999999876 7889999986432 3457889999999999999999999764 4567899999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999998643 233578889999999999999999998 99999999999999999999999999987543221
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+... +..+.... ..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~----~~~~~~~~-----~~ 221 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPR----VEKGYKMD-----AP 221 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH----HhcCCCCC-----CC
Confidence 12235678999999998899999999999999999998 9999865431 122222 11111111 11
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
......+.+++.+|++.+|++||++.++++.|+++
T Consensus 222 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 ----DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 12234678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.74 Aligned_cols=250 Identities=29% Similarity=0.454 Sum_probs=191.9
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeee-ecCeEEEEEEecc
Q 003039 532 KKIGSGGFGVVYYGKLK----DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFMH 605 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~-~~~~~~LV~E~~~ 605 (854)
+.||+|+||.||+|.+. +...||+|.+... .......+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2457999988543 2334567888999999999999999999875 4556789999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++... ...+.+..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998642 23456777888999999999999998 9999999999999999999999999998754332111
Q ss_pred ---eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhC-CcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 686 ---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 686 ---~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG-~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
......++..|+|||++.+..++.++|||||||++|||++| ..||..... ..+... . ..+.... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~---~-~~~~~~~-~-- 223 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVY---L-LQGRRLL-Q-- 223 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH---H-hcCCCCC-C--
Confidence 11223467789999999888999999999999999999995 555654321 112221 1 1111100 0
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.. .....+.+++..|++.+|++||++.||++.|+++.
T Consensus 224 --~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 --PE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01 11245889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.76 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=199.4
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCC----ccc----HHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEE
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS----YQG----KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~----~~~----~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV 600 (854)
.+.||+|..++|.++.++ +|++.|+|++.... .+. .+.-.+|+.||+++ .||+|+++.+++..+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 467999999999998766 68899999886332 111 23455799999998 699999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
+|.|+.|.|.|+|. ..-.+++....+|+.|+..|++|||.. .|+||||||+|||++++.++||+|||+|+.+.
T Consensus 102 Fdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999994 456789999999999999999999998 99999999999999999999999999998776
Q ss_pred CCCCceeecccccccccCcccccc------CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
++. .-...+|||+|+|||.+.. ..|+..+|+|++||+||-|+.|.+||.... ++.. ...+.+|+
T Consensus 175 ~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------QmlM--LR~ImeGk 244 (411)
T KOG0599|consen 175 PGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QMLM--LRMIMEGK 244 (411)
T ss_pred Cch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHHH--HHHHHhcc
Confidence 543 3456789999999999853 357888999999999999999999998665 1111 11222232
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.. +.+..-.+....+.+|+.+|++.||.+|.|++|+++|
T Consensus 245 yq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 21 0111112334467899999999999999999999987
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=305.65 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=201.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+...+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++++.||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3445678999999999999876 58899999987543 334567889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998852 3477888899999999999999998 999999999999999999999999999975543221
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......++..|+|||++.+..++.++|||||||++|||++|..||....... ... ....+. .
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~----~~~~~~---------~ 218 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLF----LIPKNN---------P 218 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hhh----hhhcCC---------C
Confidence 2223457889999999998889999999999999999999999987543111 000 011110 1
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..........+.+++.+|++.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12223445678899999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.85 Aligned_cols=264 Identities=20% Similarity=0.289 Sum_probs=194.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 445688999999999999876 57889999987543 2234467789999999999999999999999999999999997
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 88 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 159 (309)
T cd07872 88 K-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K 159 (309)
T ss_pred C-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence 5 788777432 34578888899999999999999998 99999999999999999999999999987543222 1
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH-------Hhhhc-CCcc
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHIES-GDIQ 756 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~-------~~~~~-~~~~ 756 (854)
......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+..... ..+.. ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2223457899999999865 5688999999999999999999999976542221111111000 00000 0000
Q ss_pred cccCccccCc----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDE----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..-.+..... ........+.+++.+|++.+|++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000 001122357799999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=327.51 Aligned_cols=259 Identities=21% Similarity=0.266 Sum_probs=191.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.+.||+|+||.||+|.+. .++.||||... ...+.+|+++|++++|+||+++++++...+..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 445678999999999999886 47889999642 2345689999999999999999999999999999999995
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC-c
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-H 685 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~-~ 685 (854)
++|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 244 ~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 244 SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 6888887432 34689999999999999999999998 999999999999999999999999999976533221 1
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccc-c---cccchHHHHHHhh-hcCCcccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG-A---NCRNIVQWAKLHI-ESGDIQGIID 760 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~-~---~~~~l~~~~~~~~-~~~~~~~~id 760 (854)
......||..|+|||++.+..++.++|||||||++|||++|..++-..... . ....+.+.+.... ..........
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 223456999999999999999999999999999999999988665322111 0 0011111111100 0000000000
Q ss_pred ccc------------cCcCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSL------------LDEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l------------~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+ ...... .....+.+|+.+|++.||++|||+.|+++|
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000000 111257789999999999999999999986
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=320.80 Aligned_cols=239 Identities=24% Similarity=0.316 Sum_probs=189.3
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
++.+.||+|+||.||+|..+ +++.||+|++.... ......+..|..++..+. |++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 35678999999999999876 68899999987532 223345677888888875 57888899999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 83 VNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999998843 34688999999999999999999998 99999999999999999999999999987432221
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... . .... .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i---~-~~~~------~- 219 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSI---M-EHNV------S- 219 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH---H-hCCC------C-
Confidence 1223446899999999999989999999999999999999999999765411 111111 1 1111 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI 793 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm 793 (854)
++......+.+++.+|++.+|++|++.
T Consensus 220 ---~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ---YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111122357889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.26 Aligned_cols=251 Identities=29% Similarity=0.429 Sum_probs=197.0
Q ss_pred ccccccCceEEEEEEECC-------CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 532 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~-------~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998753 2579999876443 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhccccc---ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-----cEEEEeeec
Q 003039 604 MHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-----RAKVSDFGL 675 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-----~vkl~DFGl 675 (854)
+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999965322 224578899999999999999999998 999999999999999887 899999999
Q ss_pred cccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcC
Q 003039 676 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 676 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||...... ...... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~----~~~~~~----~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ----EVLQHV----TAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----HHHHHH----hcC
Confidence 8754332211 1122235788999999999999999999999999999998 99998654311 111111 111
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
... .........+.+++.+|+..+|++||++++|.+.|++
T Consensus 230 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Ccc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 100 1111223567899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=303.64 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=200.8
Q ss_pred HHHhhccccccCceEEEEEEECC-CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.++||+|+||.||+|...+ ++.+|+|.+..... ..++.+|++++++++||||+++++++......++++||+.
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 34567889999999999999875 78999999865432 6789999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999853 235688999999999999999999998 999999999999999999999999999876543321
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .... .... ..+.+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~-----~~~~-----~~~~~-- 219 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFM-----IPNK-----PPPTL-- 219 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhh-----hccC-----CCCCC--
Confidence 2233457899999999998899999999999999999999999997543111 0000 0000 00000
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+......+.+++.+|++.+|++||++.||+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0111223468899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.89 Aligned_cols=249 Identities=26% Similarity=0.347 Sum_probs=196.6
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
..+.||+|+||+||+|... +++.||+|++..... .....+.+|++++++++|+||+++.+++..++..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 3478999999999999875 688999999865432 223457789999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 84 GGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred CccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999888542 234689999999999999999999998 999999999999999999999999999875433221
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....|+..|+|||++.+..++.++|+|||||++|||++|..||........ ..........+. .....
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~------~~~~~ 226 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETE------EVYSA 226 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccc------cccCc
Confidence 2234689999999999988999999999999999999999999975431111 111111111111 01111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
. ....+.+++..|++.+|++||+ +.+++++
T Consensus 227 ~----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 K----FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred c----CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1 2235778999999999999999 6677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.44 Aligned_cols=197 Identities=23% Similarity=0.372 Sum_probs=160.1
Q ss_pred hccccccCceEEEEEEEC---CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEEEEEEecc
Q 003039 531 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 605 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~ 605 (854)
.++||+|+||+||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 46789999986442 23457789999999999999999998854 456789999986
Q ss_pred CCCHHhhhcccc-----cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE----cCCCcEEEEeeecc
Q 003039 606 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 676 (854)
Q Consensus 606 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkl~DFGla 676 (854)
++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 47877764221 1223578888999999999999999998 99999999999999 45678999999999
Q ss_pred ccccCCCCc--eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccc
Q 003039 677 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 733 (854)
Q Consensus 677 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~ 733 (854)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 865433221 2234568999999999976 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.64 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=198.1
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++.+...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 4567789999999999999875 588999999876544445567889999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.. ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....... .
T Consensus 90 ~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 90 GGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 9999998843 34688899999999999999999998 99999999999999999999999999987543322 1
Q ss_pred eeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 686 VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
......|+..|+|||++. ...++.++|||||||++|||++|..||....... .+... ...... .+.
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~-----~~~~~~---~~~ 230 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLM-----TKSNFQ---PPK 230 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhh-----hccCCC---CCc
Confidence 223346899999999974 4568889999999999999999999985433110 01000 001100 011
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..... .....+.+++.+|++.+|++||++++|+++
T Consensus 231 ~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11100 112357899999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=307.04 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=194.7
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeec------CeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE------GRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~------~~~~ 598 (854)
.+.+.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 3455678999999999999876 57889999986543 3456788999999998 799999999998653 4679
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+.+|+|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999998642 234688889999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
..... .......|+..|+|||++. ...++.++|||||||++|||++|..||..... ...... ....
T Consensus 161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~~--~~~~ 231 (272)
T cd06637 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFL--IPRN 231 (272)
T ss_pred ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHH--HhcC
Confidence 43322 1223456899999999986 34578899999999999999999999964331 111111 0111
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......+ . .....+.+++.+|+..+|.+||++.||+++
T Consensus 232 ~~~~~~~----~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRLKS----K----KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCC----C----CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1111111 1 122357899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.68 Aligned_cols=254 Identities=26% Similarity=0.330 Sum_probs=188.7
Q ss_pred ccccccCceEEEEEEECC---CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~---~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997643 3468888775443 233456889999999999999999999999999999999999999
Q ss_pred CHHhhhccccc-ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc-
Q 003039 608 TLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 685 (854)
Q Consensus 608 sL~~~L~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 685 (854)
+|.+++..... .....++.....++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999965432 123456778889999999999999998 9999999999999999999999999998643322111
Q ss_pred eeecccccccccCcccccc-------CcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 686 VSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-------~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
......++..|+|||++.. ..++.++|||||||++|||++ |..||...... ... ......+. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~---~~~~~~~~-~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----QVL---KQVVREQD-IK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHH---HHHhhccC-cc
Confidence 1122345778999998743 356789999999999999999 77888654311 111 11111111 11
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
..++.+... ....+.+++..|+ .+|++||+++||++.|.
T Consensus 230 ~~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222222 2234567778888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=311.65 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=200.2
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++|+||+++++++..++..++||||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 4456788999999999999864 689999999976555556778899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 100 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 9999998842 3467888999999999999999998 999999999999999999999999999875433322
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .+.. ....+ ... .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~---~~~~----~~~~~-~~~-------~ 235 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYL----IATNG-TPE-------L 235 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch---heee----eccCC-CCC-------C
Confidence 1223458899999999999889999999999999999999999996543111 0000 00000 000 0
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+......+.+++.+|++.+|++||++++|+++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111222457789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.92 Aligned_cols=262 Identities=25% Similarity=0.405 Sum_probs=203.3
Q ss_pred HHHhhccccccCceEEEEEEEC-----CCcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-----~~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~ 598 (854)
.+.+.+.||+|+||.||+|++. .++.||||+++..... ....+.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3455688999999999999864 3678999999765433 46789999999999999999999999877 55789
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999643 23588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCce--eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccc-------cchHHHHHHh
Q 003039 679 AVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-------RNIVQWAKLH 749 (854)
Q Consensus 679 ~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~-------~~l~~~~~~~ 749 (854)
........ .....++..|+|||.+.+..++.++|||||||+++||++|+.|+......... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65322211 11223566799999999889999999999999999999999987543211100 0111111111
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
+..+. ....+.....++.+++.+|++.+|++||+|.||+++|+++
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 0011112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.15 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=193.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHH
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 610 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 610 (854)
..||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 57999999999999865 57789999987665556678999999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeeeccccccCCCCceeec
Q 003039 611 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 611 ~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
+++..... ....++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++........ ....
T Consensus 94 ~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 94 ALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 99864321 11126778888999999999999998 9999999999999986 67999999999875433222 1223
Q ss_pred ccccccccCccccccC--cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 690 VRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~--~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
..|+..|+|||++... .++.++||||||+++|||++|+.||...... ....+...... ..+ ..
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~~~~~~~~~~~-------~~~----~~ 233 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----QAAMFKVGMFK-------IHP----EI 233 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----hhhHhhhhhhc-------cCC----CC
Confidence 3588999999998654 3788999999999999999999998643211 11111111000 001 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+......+.+++.+|++.+|++||++.||+++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 12223457889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.85 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=199.0
Q ss_pred HhhccccccCceEEEEEEECC--CcEEEEEEEccCC----------cccHHHHHHHHHHHcc-CCCCceeeEeeeeeecC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS----------YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEG 595 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~--~~~VAvK~l~~~~----------~~~~~~~~~Ev~~L~~-l~HpnIv~l~g~~~~~~ 595 (854)
.+.+.||+|+||.||+|.+.. ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++..++
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 456789999999999999875 6889999875321 1123456678887765 79999999999999999
Q ss_pred eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeec
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 675 (854)
..++||||+++++|.+++.........+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999998865434456788999999999999999999963 1899999999999999999999999999
Q ss_pred cccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...+..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~~~~~-~~~~~~ 230 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-------SLATK-IVEAVY 230 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-------HHHHH-HhhccC
Confidence 97654432 223456899999999999888999999999999999999999998644311 11111 111111
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
.... .. .....+.+++.+|++.+|++||++.||.++++
T Consensus 231 ~~~~----~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLP----EG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCC----cc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1110 11 12245789999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=308.05 Aligned_cols=259 Identities=24% Similarity=0.317 Sum_probs=204.5
Q ss_pred HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
...+.+.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 345667789999999999999876 58899999886543 3345678899999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++++|.+++.. ...+++.....++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999988743 34578889999999999999999974 28999999999999999999999999998644222
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccc----ccccchHHHHHHhhhcCCcccc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG----ANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~----~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.........
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 230 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP---- 230 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC----
Confidence 1 12346899999999998889999999999999999999999999754421 111122333332221110
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
+.+. .......+.+++.+|++.+|++||++.||+++.-
T Consensus 231 --~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 231 --PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred --CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1111 1113346889999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.27 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=196.7
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
..+.||+|+||.||++... +++.||||.+...... ....+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 4578999999999999876 6889999998654222 23457789999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 84 g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 84 GGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred CCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999988542 234588889999999999999999998 999999999999999999999999999875433222
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.............. ..... ......
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~----~~~~~------~~~~~~ 226 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LVKEV------QEEYSE 226 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh----hhhhh------hhhcCc
Confidence 1234689999999999999999999999999999999999999975431111001111 10000 001111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
.+ ...+.+++..|++.+|++||+ ++|+++|
T Consensus 227 ~~----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 227 KF----SPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cC----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 12 234779999999999999999 8898875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.18 Aligned_cols=263 Identities=23% Similarity=0.314 Sum_probs=191.8
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccC---CCCceeeEeeeeee-----cCeE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----EGRS 597 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l---~HpnIv~l~g~~~~-----~~~~ 597 (854)
.+.+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ....
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 45678999999999999876 588999999875422 2234556777777665 69999999998864 3457
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
++||||+.+ +|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 83 TLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 999999974 888887543 234588999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc-
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ- 756 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~- 756 (854)
...... ......||..|+|||++.+..++.++||||+||++|||++|+.||......+....+..............
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 653321 12234589999999999988999999999999999999999999965442221112221110000000000
Q ss_pred -----cccCcccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 -----GIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 -----~~id~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+... ..........+.+++.+|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00111223467899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=316.46 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=192.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC---CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~---~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.++..++|+||+++++++...+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 345688999999999999876 5889999998642 122345688899999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 83 YVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999853 234578888999999999999999998 99999999999999999999999999987554433
Q ss_pred CceeecccccccccCcccccc-----CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~- 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKEHFQ- 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCccc-
Confidence 333334569999999999863 45788999999999999999999999754321 11111111111000
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVL--PHGHMRPSISEVLKD 799 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~--~~P~~RPsm~eV~~~ 799 (854)
+.+. .... ...+.+++.+|+. .++..||++.++++|
T Consensus 229 ~~~~-~~~~----~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPD-VTDV----SEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCc-cCCC----CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 0111 2345566666554 444458999999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=305.70 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=198.8
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.|.+.++||+|+||.||+|+.. +++.||+|++..........+.+|+++++.++||||+++++.+..++..++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 4567788999999999999886 488999999976655556778899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|..++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 93 ~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 93 GGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred CCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 99998877432 34588999999999999999999998 99999999999999999999999999986533221 1
Q ss_pred eeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 686 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
......++..|+|||++. ...++.++|||||||++|||++|+.||..... ....... ..........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~-~~~~~~~~~~ 237 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKI-AKSEPPTLSQ 237 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHH-hcCCCccCCC
Confidence 223345889999999985 34567899999999999999999999865431 1111111 1111111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+......+.+++.+|++.+|++||++.||+++
T Consensus 238 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 -------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11222357889999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.87 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=206.2
Q ss_pred HHhhccccccCceEEEEEEEC-CC----cEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DG----KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~----~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
..-.++||+|+||+||+|.|- +| .+||+|++.... .+...++.+|+-+|.+++|||+++|+|+|..+. ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 344678999999999999763 33 468999987653 445678999999999999999999999998776 78999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
+||+.|+|.++++. ....+.-...+.|+.|||+||.|||.+ +++||||.++||||..-..+||.|||+++....
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999975 355677778899999999999999998 999999999999999999999999999997765
Q ss_pred CCCcee-ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 682 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 682 ~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
...... ....-.+.|||-|.+....++.++|||||||.+||++| |..|+.+.... -+...++.|+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--------eI~dlle~ge----- 917 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--------EIPDLLEKGE----- 917 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--------HhhHHHhccc-----
Confidence 443332 23334678999999999999999999999999999999 99999876522 1222233331
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
+-..+.-+...+..++.+||..|+..||+++++...+.++.
T Consensus 918 ----RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 ----RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ----cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 11223334445788899999999999999999999887765
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=306.15 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=200.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.+.||.|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++|+||+++++++..+...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456688999999999999876 58899999987543 3345678899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.......
T Consensus 83 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 83 GGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 99999998532 688999999999999999999998 999999999999999999999999999976654322
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+..+.... +..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~----~~~~~~~~~~-----~~~ 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVL----FLIPKNNPPS-----LEG 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHH----HHhhhcCCCC-----Ccc
Confidence 223345888999999999888999999999999999999999999654311 111 1111111111 111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .....+.+++.+|+..+|++||++++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 022357889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=311.93 Aligned_cols=258 Identities=23% Similarity=0.320 Sum_probs=196.6
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.++||+|+||.||++... ++..+|+|.+.... .....++.+|++++++++||||+++++++..++..++||||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 45678999999999999876 57889999886542 22345688999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++.. ...+++..+..++.|+++||+|||+.+ +++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 84 GSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 999999853 355788889999999999999999732 89999999999999999999999999987543221
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc----------
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ---------- 756 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~---------- 756 (854)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ....+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK----ELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh----hHHHhhcCccccccccCCcccccCCC
Confidence 23346889999999998888999999999999999999999998643311 1111111000000000
Q ss_pred ----------cccCccc---cCcCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 ----------GIIDPSL---LDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ----------~~id~~l---~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+..+... ....+ ......+.+++.+|++.+|++||++.||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00000 0122358899999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=316.07 Aligned_cols=257 Identities=19% Similarity=0.301 Sum_probs=193.2
Q ss_pred hhcccccc--CceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 530 LEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 530 ~~~~iG~G--~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
+.++||+| +|++||+++.+ +|+.||+|++..... .....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999875 689999999875432 23456778999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++|||..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999985432 23478899999999999999999998 999999999999999999999999986543221111
Q ss_pred c------eeecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 685 H------VSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 685 ~------~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... .+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~-----~~~~~ 228 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKL-----NGTVP 228 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHh-----cCCcc
Confidence 0 1112346788999999976 4688999999999999999999999975331110 00000 00000
Q ss_pred ccc-------------------Cccc-----------------cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GII-------------------DPSL-----------------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~i-------------------d~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+ +... ...........+.+++.+|++.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 0000 001111223468899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.35 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=197.0
Q ss_pred hhccccccCceEEEEEEEC-CCc----EEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~----~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
..+.||+|+||.||+|.+. +++ .||+|++..... ....++.+|+.++++++||||++++++|... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 4578999999999999864 343 478898865432 2234688999999999999999999998754 46799999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 90 MPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred cCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcc
Confidence 9999999998532 33578888999999999999999998 99999999999999999999999999998654332
Q ss_pred Cc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 684 SH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 684 ~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.. ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+..+. ..+.... .
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~~----~~~~~~~--~- 232 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDLL----EKGERLP--Q- 232 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----HCCCCCC--C-
Confidence 22 1122345778999999998999999999999999999998 8899865431 1222222 1111100 0
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.. .....+.+++..|+..+|++||+|+++++.|+++...
T Consensus 233 --~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 233 --PP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01 1223578899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=305.86 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=196.5
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCccc---------HHHHHHHHHHHccCCCCceeeEeeeeeecCeEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~---------~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~ 598 (854)
.+...||+|+||.||+|... +++.||+|.+....... .+.+.+|++++++++||||+++++++...+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 45678999999999999875 57899999886543221 245788999999999999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 83 IFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999843 34578888899999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCc-----eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC
Q 003039 679 AVDGASH-----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 679 ~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+ .. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~-~~~~ 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAI----FK-IGEN 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHH----HH-Hhcc
Confidence 5422111 112235889999999999888999999999999999999999999754311 011 11 1111
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+.+ +......+.+++.+|++.+|.+||++.||+++
T Consensus 228 -----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 -----ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -----CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11111 11223467899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.32 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=207.6
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.|.+++.||+|.|+.|-+|++- .|+.||||++.+... .....+.+|++.|+.++|||||+|+++......+|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3556788999999999999765 799999999976543 3356788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcEEEEeeeccccccCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkl~DFGla~~~~~~ 682 (854)
-.+|+|.+||. ..+..+.+....+++.||+.|+.|+|+. .+|||||||+||.+- .-|-|||.|||++..+.++
T Consensus 99 GD~GDl~DyIm---KHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIM---KHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHH---hhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999995 3456788889999999999999999998 899999999998664 5689999999999766655
Q ss_pred CCceeecccccccccCccccccCcCCC-cchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~-~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
. ..++.+|+..|-|||++.+..|+. ++||||+|||||.|++|+.||+..+..+.. ..++|.
T Consensus 173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----------------TmImDC 234 (864)
T KOG4717|consen 173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----------------TMIMDC 234 (864)
T ss_pred c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh----------------hhhhcc
Confidence 3 345678999999999999999875 679999999999999999999876633322 223443
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.. ..+.....++.+|+..|+..||++|.+.+||+..
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 32 1234455678999999999999999999998753
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=319.44 Aligned_cols=261 Identities=23% Similarity=0.301 Sum_probs=192.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecC------eE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS 597 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~------~~ 597 (854)
.|.+.+.||+|+||.||++... +|+.||||++... .......+.+|+.+++.++||||+++++++...+ ..
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 4556789999999999999875 5889999998643 2233456788999999999999999999986543 47
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 102 YLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred EEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 999999975 5655553 2367778888999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccc-----------h----
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN-----------I---- 742 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~-----------l---- 742 (854)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... +
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 54322 122334689999999999999999999999999999999999999975431110000 0
Q ss_pred HHHHHHhhhcC-Cc-----ccccCcccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 743 VQWAKLHIESG-DI-----QGIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 743 ~~~~~~~~~~~-~~-----~~~id~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+....... .. .+....-.. ..........+.+++.+|++.||++|||+.|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00011110000 00 000000000 00011123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=303.62 Aligned_cols=238 Identities=24% Similarity=0.416 Sum_probs=188.6
Q ss_pred ccccccCceEEEEEEECCCc-----------EEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 532 KKIGSGGFGVVYYGKLKDGK-----------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~-----------~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
+.||+|+||.||+|.+.+.. .|++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999886432 5788877654333 6788899999999999999999999988 778999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-------cEEEEee
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-------RAKVSDF 673 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-------~vkl~DF 673 (854)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998642 22678888999999999999999998 999999999999999888 7999999
Q ss_pred eccccccCCCCceeecccccccccCccccccC--cCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhh
Q 003039 674 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 674 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
|+++.... .....++..|+|||++... .++.++|||||||++|||++ |..|+...... ....+..
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~----~~~~~~~--- 220 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS----EKERFYQ--- 220 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch----hHHHHHh---
Confidence 99875433 1223467889999999876 78999999999999999999 56777554311 1111111
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
..... .. .....+.+++.+|+..+|.+||++.||++.|+
T Consensus 221 ~~~~~---------~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHRL---------PM---PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCCC---------CC---CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 00 01156889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=322.49 Aligned_cols=262 Identities=19% Similarity=0.253 Sum_probs=197.8
Q ss_pred HHHHHHhhccccccCceEEEEEEEC---CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 524 EDATKMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 524 ~~~~~~~~~~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
....+.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3445677889999999999999754 3578999987543 3456899999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
||++. ++|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 165 ~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99986 68888872 345689999999999999999999998 99999999999999999999999999997554
Q ss_pred CCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc--cc
Q 003039 681 DGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI--QG 757 (854)
Q Consensus 681 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~--~~ 757 (854)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....+ .+..... ..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~ 315 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQ 315 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCC
Confidence 33222 22345699999999999999999999999999999999999999976543221111111111 0000000 00
Q ss_pred -----------ccCccccCcCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 -----------IIDPSLLDEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 -----------~id~~l~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.......+.. .....+.+++.+|++.+|++||++.|++.+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 012356788999999999999999999987
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.04 Aligned_cols=240 Identities=24% Similarity=0.401 Sum_probs=188.3
Q ss_pred ccccccCceEEEEEEECC--------CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 532 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~--------~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.||+|+||.||+|..+. ..+||+|.+..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 234888887655444456788899999999999999999999998999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc--------EEEEeeec
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGL 675 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--------vkl~DFGl 675 (854)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998643 23578888999999999999999998 9999999999999987765 69999998
Q ss_pred cccccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCC-cccccccccccccchHHHHHHhhhcC
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~-~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
+..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+...... .... .....
T Consensus 155 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~----~~~~----~~~~~ 221 (258)
T cd05078 155 SITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ----KKLQ----FYEDR 221 (258)
T ss_pred ccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH----HHHH----HHHcc
Confidence 864432 122457889999999986 45789999999999999999995 555432210 0011 11110
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
. ..+.....++.+++.+|++.+|++|||++++++.|+
T Consensus 222 -------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -------H----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------c----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 011111245889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.28 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=199.9
Q ss_pred HhhccccccCceEEEEEEEC------CCcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.||+|+||.||+|+.+ +.+.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (275)
T cd05046 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL 87 (275)
T ss_pred eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence 34678999999999999864 2467999988654333 3467899999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccc-----cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 602 EFMHNGTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccc
Confidence 999999999998643311 12589999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCc
Q 003039 677 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 677 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
+..............++..|+|||.+.+..++.++|||||||+++||++ |..||..... ..+... ...+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~~----~~~~~~ 236 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNR----LQAGKL 236 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHHH----HHcCCc
Confidence 7443322222233346788999999988888999999999999999999 7788854331 112221 111221
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
.... ... ....+.+++.+|++.+|++||++.|+++.|.
T Consensus 237 ~~~~----~~~----~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ELPV----PEG----CPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCC----CCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111 111 2246889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.85 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=191.3
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.||+|+||.||++..+ +++.||+|+++... ......+..|+.++..++||||+++++.+...+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4578999999999999876 58899999987432 2234567889999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC-
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 684 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~- 684 (854)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 85 GGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999853 34688889999999999999999998 999999999999999999999999999864322100
Q ss_pred ---------------------------------ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccc
Q 003039 685 ---------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 731 (854)
Q Consensus 685 ---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~ 731 (854)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred cccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003039 732 NEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 799 (854)
Q Consensus 732 ~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---m~eV~~~ 799 (854)
..........+..| ...+ .+.+. . ....++.+++.+|+ .+|++|++ +.|+.+|
T Consensus 238 ~~~~~~~~~~i~~~------~~~~--~~p~~----~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNW------KETL--VFPPE----V--PISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcC------CCce--ecCCC----C--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 65422111111111 0000 01111 0 01224566666665 49999985 6777776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=304.18 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=197.1
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCc------ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~------~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
...+.||+|+||.||+|...+++.+|||.+..... .....+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 34678999999999999988899999998864321 123458889999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 83 FVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999853 24578888899999999999999998 9999999999999999999999999998754221
Q ss_pred C-----CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 683 A-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 683 ~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
. ........|+..|+|||++.+..++.++|||||||+++||++|+.||..... ...........+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~~--- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR------LAAMFYIGAHRGL--- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh------HHHHHHhhhccCC---
Confidence 1 1112234589999999999998899999999999999999999999965431 1111000000011
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.+... ....+.+++.+|++.+|++||++.|++++
T Consensus 227 --~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 --MPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred --CCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1112222 23457889999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=318.08 Aligned_cols=189 Identities=22% Similarity=0.346 Sum_probs=161.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.|.+.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++...+..++|+|++.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 4566789999999999999876 4678999975422 23568999999999999999999999999999999995
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++|.+++.. ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 141 -~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 211 (357)
T PHA03209 141 -SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--P 211 (357)
T ss_pred -CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--c
Confidence 688888753 245688999999999999999999998 9999999999999999999999999998753322 1
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 730 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf 730 (854)
......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223346899999999999999999999999999999999965554
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=303.70 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=200.7
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~LV~E~ 603 (854)
.+.+.||+|+||.||++... +++.||+|++.... ......+..|++++++++||||+++++++.. ....+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 35578999999999999865 67899999986442 2334568889999999999999999998754 4567999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC--CCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
+++++|.+++.........+++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 9999999999655444567899999999999999999999322 23999999999999999999999999999986544
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.... .....|+..|+|||.+.+..++.++||||||+++++|++|+.||..... ..+.+. +..+...
T Consensus 163 ~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~----~~~~~~~----- 228 (265)
T cd08217 163 DSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLASK----IKEGKFR----- 228 (265)
T ss_pred Cccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHHHH----HhcCCCC-----
Confidence 3321 2234589999999999988899999999999999999999999975431 122221 1222111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+......+.+++.+|++.+|++||++.||+++
T Consensus 229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112233568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=311.03 Aligned_cols=197 Identities=24% Similarity=0.382 Sum_probs=159.6
Q ss_pred hccccccCceEEEEEEEC---CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEEEEEEecc
Q 003039 531 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 605 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~ 605 (854)
..+||+|+||.||+|+.+ ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999875 35789999986543 23457789999999999999999998853 567899999987
Q ss_pred CCCHHhhhcccc-----cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE----cCCCcEEEEeeecc
Q 003039 606 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 676 (854)
Q Consensus 606 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkl~DFGla 676 (854)
+ +|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7777664211 1233578889999999999999999998 99999999999999 56679999999999
Q ss_pred ccccCCCCc--eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccc
Q 003039 677 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 733 (854)
Q Consensus 677 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~ 733 (854)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 865433221 1233468999999999876 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.16 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=195.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeee-----ecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ-----EEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~-----~~~~~~LV 600 (854)
+.+.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.+++++ +||||+++++++. .++..++|
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 345678999999999999875 57899999876432 2345688899999999 6999999999884 34568999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++++|.+++.........+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999998865444456788899999999999999999998 99999999999999999999999999987553
Q ss_pred CCCCceeecccccccccCcccccc-----CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
... .......|+..|+|||++.. ..++.++||||+||++|||++|+.||....... .+.. ...+..
T Consensus 176 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---~~~~-----~~~~~~ 246 (286)
T cd06638 176 STR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---ALFK-----IPRNPP 246 (286)
T ss_pred cCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---HHhh-----ccccCC
Confidence 322 12233458999999999853 457889999999999999999999987543111 1111 001111
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
....++.. ....+.+++.+|++.+|++||++.||+++.
T Consensus 247 ~~~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 247 PTLHQPEL-------WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CcccCCCC-------cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11111111 123588999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.69 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=200.1
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.+.||+|+||.||+|... +++.||+|++..........+..|++++++++||||+++++++..+...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 4667789999999999999875 588999999876655556678899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 86 GGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999988532 34588899999999999999999998 999999999999999999999999999865433221
Q ss_pred eeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 686 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||...... +.+.. +..+.......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~-----~~~~~~~~~~~ 230 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLK-----ILKSEPPTLDQ 230 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHH-----HhcCCCCCcCC
Confidence 223345899999999975 345678999999999999999999999754311 11111 11111111000
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+......+.+++..|++.+|++||++.+|+++
T Consensus 231 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 -------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11122357789999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.46 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=199.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
+.+.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++|+||+++++++..++..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 345678999999999999887 57899999886432 233567899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
+++.+..+.. ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 83 ERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9877766553 234478889999999999999999998 999999999999999999999999999876554433
Q ss_pred ceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH--------HhhhcCC-
Q 003039 685 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK--------LHIESGD- 754 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~--------~~~~~~~- 754 (854)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+..... .......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233344578999999999887 889999999999999999999999875432111101100000 0000000
Q ss_pred ----cccccCccc-cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 ----IQGIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ----~~~~id~~l-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+..++.. ...++.....++.+++.+|+..+|++||++++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000000 001111224678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.67 Aligned_cols=253 Identities=21% Similarity=0.240 Sum_probs=194.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..++|+||+++++++...+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345688999999999999876 57889999986421 22334578899999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 83 YVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999998532 34578888899999999999999998 99999999999999999999999999997654433
Q ss_pred CceeecccccccccCcccccc-----CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
........||+.|+|||++.+ +.++.++|||||||++|||++|+.||...... ............. .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~-~ 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHEERF-Q 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCCCcc-c
Confidence 333334569999999999875 46788999999999999999999999754421 1111111111000 0
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 799 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eV~~~ 799 (854)
+.+.. . .....+.+++.+|+..++++ |++++++.+|
T Consensus 229 ~p~~~-~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSHI-T----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCcc-c----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111 1 12345778888888765544 5689999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=310.10 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=199.1
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
.+.+.||.|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++...+..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 34578999999999999864 68999999987655555677889999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ..
T Consensus 102 ~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 102 SLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 99998842 3578999999999999999999998 999999999999999999999999999875433322 12
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ........ ....... .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-------~~~~~~~~-~~~~~~~-------~ 237 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIAT-NGTPELQ-------N 237 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-cCCcccC-------C
Confidence 2345889999999999888999999999999999999999999764411 11111111 1110000 0
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+......+.+++.+|+..+|++||++.+|+++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11122357789999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=302.55 Aligned_cols=248 Identities=22% Similarity=0.364 Sum_probs=198.9
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+..++..++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 35688999999999999876 6889999998643 233456788899999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++... ....+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++...... ..
T Consensus 83 ~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 83 GDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 9999988532 234578888999999999999999998 99999999999999999999999999987553322 12
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||...... ... . ....+.... +
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~---~-~~~~~~~~~-~------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK----NLI---L-KVCQGSYKP-L------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH----HHH---H-HHhcCCCCC-C-------
Confidence 23345889999999999888999999999999999999999999754311 111 1 111222111 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+......+.+++.+|++.+|++||++.+|+..
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122357799999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=301.47 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=198.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeee-cCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~-~~~~~LV~E~ 603 (854)
|.+.+.||+|++|.||++..+ +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. +...++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 346788999999999999876 57889999986442 2335568899999999999999999998764 4467899999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++++|.+++... ....+++.++..++.+++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999998642 234588999999999999999999998 99999999999999999999999999987653322
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......|++.|+|||++.+..++.++|||||||+++||++|+.||..... ....... ..+.+..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~-~~~~~~~------ 221 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRI-IEGKLPP------ 221 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHH-HhcCCCC------
Confidence 222334588999999999999999999999999999999999999875431 1111111 1122111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+......+.+++.+|++.+|++||++.+++++
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111233468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=318.45 Aligned_cols=261 Identities=22% Similarity=0.303 Sum_probs=193.1
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 597 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~ 597 (854)
.|.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 4455788999999999999865 58899999986532 22345677899999999999999999988543 356
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 98 ~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 98 YLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred EEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 999999975 5666553 2467788889999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH-------------
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ------------- 744 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~------------- 744 (854)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 54332 222334689999999999998999999999999999999999999975442111110000
Q ss_pred --HHHHhhhc-CCcccccCccc-----c---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 745 --WAKLHIES-GDIQGIIDPSL-----L---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 745 --~~~~~~~~-~~~~~~id~~l-----~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........ ........+.. . ..........+.+++.+|++.||++|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 01111110 00000000000 0 00111123467899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.77 Aligned_cols=264 Identities=23% Similarity=0.259 Sum_probs=194.6
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|++|.||+|+.. +++.||||+++... ......+.+|+.++++++||||+++++++..++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 34578999999999999876 68899999986432 2234678899999999999999999999999999999999997
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++|.+++... .....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 83 -~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~ 156 (285)
T cd07861 83 -MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R 156 (285)
T ss_pred -CCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence 6888887543 2235688999999999999999999998 99999999999999999999999999987543221 1
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh----hh--------c
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH----IE--------S 752 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~----~~--------~ 752 (854)
......+++.|+|||.+.+ ..++.++|||||||+++||++|+.||................... +. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 1222347889999998865 457889999999999999999999997543111000000000000 00 0
Q ss_pred CCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 753 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 753 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..........+. ........++.+++.+|++.+|++|||+.+|+++
T Consensus 237 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 0001123456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=317.13 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=192.4
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.++||+|+||.||+++.+ +++.+|+|++.... ......+.+|+.++..++|+||+++++++...+..++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 45688999999999999887 47789999986421 222345788999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 84 VGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999532 34578888899999999999999998 999999999999999999999999999875443333
Q ss_pred ceeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 685 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .............. +
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~-~ 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKERFQ-F 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCCcccc-C
Confidence 3334456999999999986 346788999999999999999999999754421 11111111110000 0
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPH--GHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~--P~~RPsm~eV~~~ 799 (854)
. .... .....+.+++.+|+..+ +..||++.|+++|
T Consensus 230 p-~~~~----~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 P-AQVT----DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C-Cccc----cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0001 12234667777777544 4447899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=311.42 Aligned_cols=260 Identities=22% Similarity=0.319 Sum_probs=194.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||+.
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 445678999999999999876 57899999986443 2234567789999999999999999999999999999999997
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++|.+++... ...+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 88 -~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 88 -KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred -cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 5888887532 34578888999999999999999998 999999999999999999999999999875432221
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh---cCCcccccC-
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE---SGDIQGIID- 760 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~---~~~~~~~id- 760 (854)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+ .......... ......+++
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE----QLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCChhhchhhhcc
Confidence 1223347889999999875 457889999999999999999999997544211 1111111100 000000000
Q ss_pred --------ccccCc----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 --------PSLLDE----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 --------~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+..... ........+.+++.+|++.+|.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 001122357799999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=300.83 Aligned_cols=249 Identities=31% Similarity=0.501 Sum_probs=199.8
Q ss_pred hhccccccCceEEEEEEECC-----CcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 530 LEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~-----~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.||+|+||.||+++..+ +..||+|++...... ....+..|+++++.++|+||+++++++...+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999998764 378999999765433 567889999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 83 MEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred cCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999986432 12289999999999999999999998 99999999999999999999999999997665442
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
........++..|+|||.+.+..++.++||||+||+++||++ |+.||..... ..+.+.. ..+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~----~~~~~~~~---- 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEYL----KKGYRLPK---- 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----hcCCCCCC----
Confidence 222222337789999999988889999999999999999998 7888865331 1222211 11111110
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
......++.+++.+|+..+|++|||+.|+++.|
T Consensus 226 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 -----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111234688899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=320.29 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=192.9
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 597 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~ 597 (854)
.|.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 4556789999999999999875 58899999987532 23345678899999999999999999987543 357
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 105 YIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 999999975 6766663 2367788889999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH-------------
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ------------- 744 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~------------- 744 (854)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 54332 122334689999999999999999999999999999999999999975442111111110
Q ss_pred --HHHHhhhcC-Ccccc----cCcccc----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 745 --WAKLHIESG-DIQGI----IDPSLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 745 --~~~~~~~~~-~~~~~----id~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......... ..... +.+... ..........+.+++.+|++.||++|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00000 000000 00011123467899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.66 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=197.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
+.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 345678999999999999887 58899999886432 223456889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
+++.|..++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 83 DHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred CccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9988887763 234588999999999999999999998 999999999999999999999999999976543321
Q ss_pred ceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh-------hhcCC-c
Q 003039 685 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IESGD-I 755 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~-------~~~~~-~ 755 (854)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+....... ..... .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1223347889999999876 567899999999999999999999997544211111111100000 00000 0
Q ss_pred ccccCccccCcCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 QGIIDPSLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~~~id~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+......+. .....+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00001111111111 113467899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=305.60 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=201.8
Q ss_pred HHHHhhccccccCceEEEEEEECC-Cc----EEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLKD-GK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~~-~~----~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
..+.+.+.||+|+||.||+|.+++ |+ .||+|++..... .....+.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 344567899999999999998752 33 589998875543 335678899999999999999999999987 78899
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998642 33588999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCcee-ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 680 VDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 680 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
........ ....++..|+|||.+....++.++|||||||++||+++ |+.||..... ..+.+. +..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~----~~~~~~~- 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEIPDL----LEKGERL- 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHH----HhCCCCC-
Confidence 43322221 12224578999999988899999999999999999999 9999975431 122222 1111110
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..+......+.+++.+|+..+|.+||++.++++.|+++..
T Consensus 231 --------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 --------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122357889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=340.48 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=196.7
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLV 600 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~LV 600 (854)
..|.+.+.||+|+||+||+|+.. .++.||+|++.... ......+..|+.++++++||||++++++|.. ....++|
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 34566789999999999999876 46789999886542 2335678899999999999999999998854 4568999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCC----CceecCCCCCCCEEEcC------------
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV----PAIIHRDLKSSNILLDK------------ 664 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDIkp~NILl~~------------ 664 (854)
|||+++|+|.++|.........+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 99999999999997544445678999999999999999999998521 25999999999999964
Q ss_pred -----CCcEEEEeeeccccccCCCCceeecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCcccccccccc
Q 003039 665 -----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGA 737 (854)
Q Consensus 665 -----~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~ 737 (854)
.+.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~--- 247 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN--- 247 (1021)
T ss_pred cccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC---
Confidence 235899999999755332 12234569999999999864 458899999999999999999999996533
Q ss_pred cccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 738 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 738 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+..... .+..+... . .... ...+.+|+..||+.+|.+||++.|++++
T Consensus 248 ---~~~qli~-~lk~~p~l-----p-i~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 ---NFSQLIS-ELKRGPDL-----P-IKGK----SKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred ---cHHHHHH-HHhcCCCC-----C-cCCC----CHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 1111111 11111100 0 0111 2457899999999999999999999864
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.96 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=201.0
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|+||.||.++.. +++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 34678999999999999765 5889999987644 23445678899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 83 GGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999986432 34678899999999999999999998 999999999999999999999999999876544332
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......|+..|+|||+..+..++.++||||||+++|||++|..||...... +...... .+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~~-~~~~~~~------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------NLVVKIV-QGNYTPV------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHH-cCCCCCC-------
Confidence 223345899999999999888899999999999999999999998654311 1111111 1211111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
.......+.+++.+|++.+|++||++.|+++++
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 --VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112234578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=306.12 Aligned_cols=261 Identities=23% Similarity=0.294 Sum_probs=198.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 345678999999999999875 68999999987553 233567889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
+++|.+++... ...+++.++..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999988532 25588999999999999999999998 999999999999999999999999999876544332
Q ss_pred ceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC---------C
Q 003039 685 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---------D 754 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~---------~ 754 (854)
.......|+..|+|||++.+. .++.++||||+||+++||++|..+|....... ...+........ .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChHHHhhccC
Confidence 223334689999999998754 46889999999999999999988876433111 111111110000 0
Q ss_pred c---ccccCcccc----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 I---QGIIDPSLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~---~~~id~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+ ..+..+.-. .....+....+.+++.+|++.+|++||+++++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000000 00001123678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.19 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=200.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++...+..+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 345678999999999999875 5788999999866555667889999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....... ..
T Consensus 85 ~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 85 GSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999988532 24678889999999999999999998 99999999999999999999999999987543321 12
Q ss_pred eecccccccccCccccccC---cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 687 SSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~---~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.....++..|+|||.+... .++.++|||||||++|||++|+.||....... .... .....+. .+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~---~~~~-----~~~~~~~---~~~~ 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---ALFL-----ISKSNFP---PPKL 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-----HHhccCC---Cccc
Confidence 2334578899999999876 88999999999999999999999996543110 1111 1111000 0111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ........+.+++.+|+..+|.+||++.+|+.+
T Consensus 227 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 K--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 112234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.63 Aligned_cols=245 Identities=25% Similarity=0.378 Sum_probs=197.2
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
...||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 356999999999999875 5889999998765555566788999999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 107 ~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 107 TDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 99874 23578889999999999999999998 999999999999999999999999999875433222 1223
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... ........ .+.+.+....
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~---------~~~~~~~~~~-- 242 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRIRD---------NLPPRVKDSH-- 242 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh---------cCCCcccccc--
Confidence 45899999999998888999999999999999999999998654311 11111111 0111111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+.+++..|+..+|++|||++|++++
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122357788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=301.02 Aligned_cols=246 Identities=29% Similarity=0.475 Sum_probs=196.0
Q ss_pred HHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.+.||+|+||.||++.. .++.||+|+++... ....+.+|+.++++++|||++++++++... ..++||||+.+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 345678999999999999975 47889999986432 345788999999999999999999998765 47999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999998643 234578889999999999999999998 99999999999999999999999999987543221
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. ....+...+
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~----~~~~~~~~~-------- 217 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK----EVKE----CVEKGYRME-------- 217 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----HHHH----HHhCCCCCC--------
Confidence 12234578999999998899999999999999999998 99998754421 1111 111121110
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
........+.+++.+|++.+|++||++++|++.|++
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011223467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=308.47 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=196.9
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.++||+|+||.||+|.++ +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|+||++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 45678999999999999986 588999998764322 234568899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.++... ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++....... .
T Consensus 84 ~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 155 (286)
T cd07846 84 HTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 155 (286)
T ss_pred ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence 9998877642 33478999999999999999999998 99999999999999999999999999987554332 2
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHH-------hhhcCCc-c
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIESGDI-Q 756 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~-------~~~~~~~-~ 756 (854)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..+... ......+ .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2223457899999999875 45788999999999999999999998654321111111111110 0000000 0
Q ss_pred cccCccccCcC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+..+...... .......+.+++.+|++.+|++||+|.+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00001100000 01123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.22 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=197.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.+.||+|+||.||++..+ +++.||+|.++.. .......+.+|++++++++|+||+++++.+...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456789999999999999886 6899999988654 22334578899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.... ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 83 AGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 999998885431 234688999999999999999999964 28999999999999999999999999998754322
Q ss_pred eeecccccccccCccccccCc------CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQ------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~------~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
......|+..|+|||.+.+.. ++.++|||||||++|||++|+.||...... ........ ...+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~-~~~~~~~--- 228 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----NIFAQLSA-IVDGDPP--- 228 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh----hHHHHHHH-HhhcCCC---
Confidence 122335788999999986543 478999999999999999999999654311 11111111 1111111
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .+......+.+++.+|++.+|++||++.+++++
T Consensus 229 --~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 --T----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --C----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1 112233457899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.12 Aligned_cols=250 Identities=25% Similarity=0.300 Sum_probs=205.3
Q ss_pred HhhccccccCceEEEEEEECC-CcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
++.+.||+|.-|+||++++++ +...|+|++.+.... .......|-+||+.+.||.+..|++.+..++..|||||||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 356789999999999999884 578999999766433 3345677999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC---
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD--- 681 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~--- 681 (854)
+||+|...++. +.++.+++..+.-++.+++-||+|||.. |||+|||||+||||.++|++.|+||.|+....-
T Consensus 160 pGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 160 PGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred CCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999988864 4577899999999999999999999998 999999999999999999999999998742210
Q ss_pred ------------------------------CCC----------------------ceeecccccccccCccccccCcCCC
Q 003039 682 ------------------------------GAS----------------------HVSSIVRGTVGYLDPEYYISQQLTD 709 (854)
Q Consensus 682 ------------------------------~~~----------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ 709 (854)
... ..+..++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 0112346999999999999999999
Q ss_pred cchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCC
Q 003039 710 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM 789 (854)
Q Consensus 710 ~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~ 789 (854)
++|.|+|||++|||+.|..||.+.+..+...+++. +.+.-.........+.+||...+..||.+
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----------------~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----------------QPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----------------CCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999999999999999988775444444433 11111111244567889999999999999
Q ss_pred CCC----HHHHHHH
Q 003039 790 RPS----ISEVLKD 799 (854)
Q Consensus 790 RPs----m~eV~~~ 799 (854)
|-. +.||.+|
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 998 8888877
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.64 Aligned_cols=246 Identities=25% Similarity=0.395 Sum_probs=189.3
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-----ccHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEEEEE
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVY 601 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-----~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~LV~ 601 (854)
..+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.. ....++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 4678999999999999875 588999998864321 223468889999999999999999998865 35678999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++++|.+++.. ...+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 86 EYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 99999999998853 23478888899999999999999998 999999999999999999999999999875432
Q ss_pred CC--CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 682 GA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 682 ~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.. ........++..|+|||++.+..++.++|||||||++|||++|+.||..... ... ........ .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~-~~~~~~~~-----~ 226 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAA-IFKIATQP-----T 226 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHH-HHHHhcCC-----C
Confidence 11 1111234588999999999988899999999999999999999999975431 111 11111111 1
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.+ +......+.+++ .|+..+|++||+|+||++|
T Consensus 227 ~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1111 111223345555 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=301.16 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=198.8
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.++||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4456678999999999999875 68899999886443 233467889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999998842 3578889999999999999999998 99999999999999999999999999987553322
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.......|+..|+|||.+.+...+.++|||||||++|||++|..||..... ..... ....+.. +.+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~----~~~~~~~-----~~~~ 222 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLF----LIPKNNP-----PTLE 222 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHH----HHhcCCC-----CCCC
Confidence 122234578899999999888889999999999999999999999864331 01111 1111111 1111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .....+.+++.+|++.+|.+||++.+++++
T Consensus 223 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 G----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred c----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 223457889999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=315.96 Aligned_cols=241 Identities=26% Similarity=0.315 Sum_probs=185.9
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccC---CCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l---~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
||+|+||+||+|+.. +++.||||++...... ....+..|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 5899999998643211 123344566666655 699999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99998884 345688899999999999999999998 99999999999999999999999999987533221 22
Q ss_pred eecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||...... .+. ..+..+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----~~~----~~i~~~~~------~~~~ 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----QMY----RNIAFGKV------RFPK 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----HHH----HHHHcCCC------CCCC
Confidence 2345699999999998764 4789999999999999999999999754311 111 11111111 0100
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRP----SISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RP----sm~eV~~~ 799 (854)
. .....+.+++.+|++.+|++|| ++.|+++|
T Consensus 219 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0 1123467899999999999998 56676664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=312.59 Aligned_cols=259 Identities=23% Similarity=0.305 Sum_probs=190.9
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 597 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~ 597 (854)
.|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 4556789999999999999865 67899999986532 22345677899999999999999999987543 356
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
++++|++ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 96 YLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 8999987 778887773 34588899999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH-------Hh
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LH 749 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~-------~~ 749 (854)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... ..
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54332 223458999999999876 5688999999999999999999999975432111111111000 00
Q ss_pred hhcC-------CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 750 IESG-------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 750 ~~~~-------~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+... .+...-...+...+ ......+.+++.+|++.||++|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000000000000 0011246799999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=298.46 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=196.0
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---c-------cHHHHHHHHHHHccCCCCceeeEeeeeeecCeE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---Q-------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 597 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~-------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~ 597 (854)
...+.||+|+||.||+|... +++.||+|.++.... . ..+.+.+|++++++++|||++++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34678999999999999765 688999998753211 0 123577899999999999999999999999999
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
++||||+.+++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999998543 4678888899999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCc-eeecccccccccCccccccCc--CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 678 FAVDGASH-VSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 678 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~--~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
........ ......|+..|+|||.+.... ++.++||||||+++||+++|..||..... .... .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~-~~~~-~~~ 228 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAM-FKLG-NKR 228 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHH-HHhh-ccc
Confidence 54332111 123345889999999987654 78999999999999999999999864331 1111 1111 111
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....++..... .....+.+++..|++.+|++||+++||+++
T Consensus 229 ~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11112222111 223568889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=326.19 Aligned_cols=261 Identities=19% Similarity=0.266 Sum_probs=187.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCC------CceeeEeeeeeec-CeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH------RNLVQFLGYCQEE-GRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~H------pnIv~l~g~~~~~-~~~~ 598 (854)
.|.+.++||+|+||+||+|... .++.||||+++... ...+++..|+++++.++| .+++++++++... ++.+
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 4556789999999999999875 57889999986432 223455667777776654 4588999988654 5788
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC------------
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM------------ 666 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~------------ 666 (854)
+|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccC
Confidence 999987 6788888742 34688999999999999999999973 2899999999999998765
Q ss_pred ----cEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccch
Q 003039 667 ----RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 742 (854)
Q Consensus 667 ----~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l 742 (854)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+
T Consensus 282 ~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 49999999875322 2223456999999999999999999999999999999999999999754411111000
Q ss_pred H--------HHHHH--------hh-hcCCcccccCcccc----C---cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003039 743 V--------QWAKL--------HI-ESGDIQGIIDPSLL----D---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798 (854)
Q Consensus 743 ~--------~~~~~--------~~-~~~~~~~~id~~l~----~---~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~ 798 (854)
. .|... .+ ..+.+....++.-. . .........+.+|+.+|++.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0 01000 00 00000000111000 0 000011245779999999999999999999998
Q ss_pred H
Q 003039 799 D 799 (854)
Q Consensus 799 ~ 799 (854)
|
T Consensus 438 H 438 (467)
T PTZ00284 438 H 438 (467)
T ss_pred C
Confidence 6
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.83 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=197.0
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
...||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 357999999999999875 6899999998755545566788999999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 106 TDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred HHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 98773 24578889999999999999999998 99999999999999999999999999987543322 12233
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
..|+..|+|||++.+..++.++|||||||+++||++|+.||...... ..... +....... ... ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~----~~~~~~~~-----~~~--~~ 241 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKR----LRDSPPPK-----LKN--AH 241 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HhccCCCC-----ccc--cC
Confidence 45899999999999888999999999999999999999998643311 11111 11111000 000 01
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+.+++.+|++.+|++||++.+|+++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 112357889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.87 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=196.4
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC-----cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-----~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++......++|+||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 4578999999999999887 78999999986533 12346788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 84 VPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999999853 23578888999999999999999998 99999999999999999999999999987543322
Q ss_pred CceeecccccccccCccccccCc-CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||..... ...............
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~----- 222 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPP----- 222 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCCC-----
Confidence 223345889999999988766 89999999999999999999999865431 111111111111111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+......+.+++.+|++.+|++||++.+++++
T Consensus 223 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 ----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111123457789999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.33 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=199.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.+.||+|+||.+|++... +++.||+|.+... ......++.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 345678999999999999875 6889999998643 2233467899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
.+++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999988532 233578888999999999999999998 999999999999999999999999999875533221
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......|+..|+|||+..+..++.++|||||||+++||++|+.||..... ...+.... .+....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~-~~~~~~------- 220 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKII-RGSYPP------- 220 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHh-cCCCCC-------
Confidence 12234588999999999988999999999999999999999999865431 11111111 111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+......+.+++.+|++.+|++||+|.||+++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111223458899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.52 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=196.6
Q ss_pred hhccccccCceEEEEEEEC----CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecC------eE
Q 003039 530 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS 597 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~------~~ 597 (854)
+.+.||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4678999999999999864 36889999987542 233566889999999999999999999886532 24
Q ss_pred EEEEEeccCCCHHhhhcccc--cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeec
Q 003039 598 VLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 675 (854)
++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 78899999999998875322 1223578888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcC
Q 003039 676 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 676 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
++........ ......++..|++||.+....++.++|||||||++|||++ |+.||..... ..+..+.. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~---~~~ 232 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLI---KGN 232 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHH---cCC
Confidence 8855432211 1122345678999999998889999999999999999999 8888865431 12222211 111
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
... . +......+.+++.+|++.+|++||++.||++.|+++
T Consensus 233 ~~~------~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RLK------Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0 111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=316.08 Aligned_cols=262 Identities=23% Similarity=0.266 Sum_probs=200.1
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-C-----CceeeEeeeeeecCeEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-H-----RNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-H-----pnIv~l~g~~~~~~~~~L 599 (854)
+|.+.+.||+|.||.|-+|... +++.||||+++... .-.++...|+.+|..++ | -|+|+++++|.-.++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6677899999999999999765 69999999998543 33456678999999997 4 499999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC--CcEEEEeeeccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSK 677 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~--~~vkl~DFGla~ 677 (854)
|+|.+. .+|.++|+.. ....++...+..|+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.|+
T Consensus 266 VfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence 999885 5999999764 345588888999999999999999998 99999999999999754 479999999998
Q ss_pred cccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH-----------HH
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-----------WA 746 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~-----------~~ 746 (854)
+...... ....+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.+..+-...+++ ..
T Consensus 340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 6544322 33468899999999999999999999999999999999888876542111111111 00
Q ss_pred HH---hhhc-CCccc-c---------------------cCcccc--------CcCCHHHHHHHHHHHHHccCCCCCCCCC
Q 003039 747 KL---HIES-GDIQG-I---------------------IDPSLL--------DEYDIQSMWKIEEKALMCVLPHGHMRPS 792 (854)
Q Consensus 747 ~~---~~~~-~~~~~-~---------------------id~~l~--------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs 792 (854)
.. .+.. ..... . .+.... ..........+++++++|+.+||++|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00 0001 00000 0 010000 1112244567899999999999999999
Q ss_pred HHHHHHH
Q 003039 793 ISEVLKD 799 (854)
Q Consensus 793 m~eV~~~ 799 (854)
..|.++|
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999987
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=303.32 Aligned_cols=252 Identities=28% Similarity=0.402 Sum_probs=196.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeec-----CeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-----GRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~-----~~~~LV 600 (854)
+.+.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++... +..++|
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 345678999999999999875 68899999986432 2345678899999998 899999999998653 358999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
+||+++|+|.+++.........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999998865444456788999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeecccccccccCccccccC-----cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
.... ......|+..|+|||.+... .++.++|||||||++|||++|+.||...... ..+.. ...+..
T Consensus 180 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~-----~~~~~~ 250 (291)
T cd06639 180 STRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFK-----IPRNPP 250 (291)
T ss_pred cccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHH-----HhcCCC
Confidence 3221 12234588999999998643 3688999999999999999999999754311 11111 111111
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+.++ ......+.+++.+|++.+|++||++.|++++
T Consensus 251 ~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 251 PTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111 1122458899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.42 Aligned_cols=257 Identities=25% Similarity=0.330 Sum_probs=200.2
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV~E~~~ 605 (854)
..++||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||++++++|... +..++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 3578999999999999985 578999999875432 3456789999999999999999999998653 46899999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.........+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 9999998765444456688889999999999999999998 999999999999999999999999999865432211
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccc-ccccchHHHHHHhhhcCCcccccCcccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG-ANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~-~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
....++..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+.... .... +.....
T Consensus 161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~ 233 (287)
T cd06621 161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPE-LKDEPG 233 (287)
T ss_pred --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchh-hccCCC
Confidence 2335788999999999999999999999999999999999999765321 1111222322211 1101 110100
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .......+.+++.+|++.+|++||||.||+++
T Consensus 234 ~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 234 N--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred C--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 01123568899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=298.92 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=198.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.+.||+|+||.||+|... +++.||+|+++..... ..+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 345678999999999999875 6889999998765432 5677899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++++|.+++.. ...+++..+..++.++++||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999998853 34577888899999999999999998 999999999999999999999999999876544332
Q ss_pred ceee---cccccccccCccccccCc---CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 685 HVSS---IVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 685 ~~~~---~~~gt~~Y~aPE~~~~~~---~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
.... ...++..|+|||++.+.. .+.++||||||+++||+++|+.||...... ...... ...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~----~~~~~---- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFH----VGAGH---- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHH----HhcCC----
Confidence 2221 345789999999998766 889999999999999999999999654210 011111 11111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.+... ......+.+++.+|++.+|.+||++.|++.+
T Consensus 224 -~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 -KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111111 1123457789999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=297.78 Aligned_cols=251 Identities=28% Similarity=0.400 Sum_probs=200.6
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.||+|+||.||++..+ +++.||+|++.... .....++.+|++++++++||||+++++.+......++|+||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 45678999999999999887 58899999987653 34456788999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++|.+++.... ..+++.....++.|++.||+|||+ . +++|+||||+||+++.++.+||+|||.+.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 84 GSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred CcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999985431 567888889999999999999999 7 9999999999999999999999999998654322211
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
...++..|+|||++.+..++.++|||||||++++|++|+.||...... .....+.......... +.+..
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~------~~~~~ 226 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPP------PRLPS 226 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCC------CCCCh
Confidence 156889999999999999999999999999999999999999654311 1122222222221110 11111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .....+.+++..|+..+|++||++.|++.+
T Consensus 227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred h---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 133458899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=302.83 Aligned_cols=263 Identities=21% Similarity=0.256 Sum_probs=196.2
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc-----cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~-----~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.+.||+|+||.||+|... +++.||||.++..... ....+..|++++++++|+||+++++++...+..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 34578999999999999876 6899999998755322 23456789999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+ +|+|.+++... ...+++..+..++.|+++||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 83 FM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred cc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 99 89999998542 13688999999999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh-----cCCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE-----SGDIQ 756 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~-----~~~~~ 756 (854)
... .....++..|+|||.+.+ ..++.++|||||||+++||++|..+|......+....+......... .....
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 221 122346788999998865 46788999999999999999998877654311111111110000000 00000
Q ss_pred cccCccccCcCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...........+ ......+.+++.+|++.+|++||++.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 111000001111 1223568899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=298.67 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=191.2
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-----cccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 600 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-----~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV 600 (854)
.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++.+. ...++|
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 34678999999999999875 58899999875321 12235678899999999999999999988663 467899
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++++|.+++.. ...+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 85 MEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999998853 23467788889999999999999998 99999999999999999999999999987543
Q ss_pred CCCC--ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 681 DGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 681 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
.... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... .... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~-~~~~~~~----- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAI-FKIATQP----- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHH-HHHhcCC-----
Confidence 2111 112234588999999999888899999999999999999999999965321 1111 1111110
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ....+......+.+++.+|+. +|++||+++||+++
T Consensus 226 ~----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 T----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 111222334467788888884 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=296.61 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=201.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.+.||.|+||+||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+..++..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 345688999999999999865 57899999986543 2345778999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++..... ...+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 83 GGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 9999999864321 24678899999999999999999998 9999999999999999999999999998755443222
Q ss_pred ---eeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 686 ---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 686 ---~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
......|+..|+|||++... .++.++|||||||++|||++|+.||....... .+..... .. .+
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~----~~------~~ 225 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQ----ND------PP 225 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhc----CC------CC
Confidence 22334589999999998876 78999999999999999999999997544211 1111111 10 01
Q ss_pred cccCcC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.... .......+.+++.+|++.+|++||++.||+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111110 11223567899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.18 Aligned_cols=263 Identities=20% Similarity=0.257 Sum_probs=192.1
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++|+||+.
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 34578999999999999886 688999999864322 223567789999999999999999999999999999999997
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++|.+++... ...+++..+..++.||++||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 83 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 83 -QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred -CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 5787776432 34588999999999999999999998 999999999999999999999999999875433221
Q ss_pred eeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCccccccc-ccccccchH---------HHHHHhh-hcC
Q 003039 686 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK-FGANCRNIV---------QWAKLHI-ESG 753 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~-~~~~~~~l~---------~~~~~~~-~~~ 753 (854)
......++..|+|||.+.+. .++.++|||||||++|||++|..|+.... ..+....+. .|..... ...
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12233578899999998764 46889999999999999999998864322 111000110 0100000 000
Q ss_pred CcccccCcccc-CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 754 DIQGIIDPSLL-DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 754 ~~~~~id~~l~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........... ..........+.+++.+|++.+|.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000000 00011123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=299.79 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=192.7
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHH-HccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~-L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|+||.||+|+.+ +|+.||+|+++... ......+..|+.+ ++..+||||+++++++..++..++||||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 34678999999999999876 68999999987543 2234455566665 566789999999999999999999999996
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
|+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-- 158 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence 6888887654444567899999999999999999999852 79999999999999999999999999987553321
Q ss_pred eeecccccccccCcccccc----CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 686 VSSIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~----~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||..... ....+.. ... +.. +
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~----~~~-~~~-----~ 226 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQ----VVE-EPS-----P 226 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHH----HHh-cCC-----C
Confidence 1223458899999998865 4568899999999999999999999864321 1111111 111 111 1
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.. ......+.+++.+|+..+|++||++.||+++
T Consensus 227 ~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 QLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 0122457899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.23 Aligned_cols=240 Identities=27% Similarity=0.438 Sum_probs=194.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.||.|+||.||.|+.. +.+.||||++.-... +.-.++.+|+..|++++|||++.+-|+|..+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 56999999999999865 678899999864432 3345788999999999999999999999999999999999964
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+-.|.+.- ....+.+..+..|+.+.++||+|||+. +.||||||+.|||+++.|.|||+|||.|....+ .
T Consensus 111 SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----A 179 (948)
T KOG0577|consen 111 SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----A 179 (948)
T ss_pred cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----h
Confidence 66676632 345677888999999999999999998 999999999999999999999999999876533 3
Q ss_pred ecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 688 SIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
..++|||.|||||++. .+.|+.++||||+|+...||.-.++|+-.++. +. +...+-..+ .|.|.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MS--ALYHIAQNe-----sPtLq 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MS--ALYHIAQNE-----SPTLQ 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HH--HHHHHHhcC-----CCCCC
Confidence 4567999999999986 47899999999999999999999999765541 11 111111111 11121
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+-...+..++..|++.-|.+|||.++++.|
T Consensus 247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 23344568899999999999999999988765
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=299.82 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=197.8
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecC------eEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG------RSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~------~~~ 598 (854)
.+.+.+.||+|+||.||+|..+ +++.+++|++..... ....+.+|+++++++ +|+||+++++++.... ..+
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 4556789999999999999986 578899999875543 356789999999999 6999999999997644 489
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 99999999999998865433356788999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeecccccccccCcccccc-----CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
..... .......|+..|+|||++.. ..++.++|||||||+++||++|+.||...... ..+.. +..+
T Consensus 163 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~-----~~~~ 233 (275)
T cd06608 163 LDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFK-----IPRN 233 (275)
T ss_pred cccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHH-----hhcc
Confidence 43322 22233458899999998753 34678899999999999999999999643211 11111 1111
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... .+. ........+.+++.+|+..+|++|||+.||+++
T Consensus 234 ~~~-----~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 PPP-----TLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCC-----CCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 111 111233468899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=297.35 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=196.9
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc------ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~------~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
..+.||+|+||.||+|... +++.||+|++..... ...+.+..|++++++++|+||+++++++.+.+..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 4578999999999999864 689999999864321 124578899999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeeeccccccC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 681 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~ 681 (854)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||.+.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 84 WMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred ccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999998853 34578889999999999999999998 999999999999998776 599999999875543
Q ss_pred CCC---ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 682 GAS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 682 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
... .......|+..|+|||.+.+..++.++||||+||++++|++|..||....... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~---- 228 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN----HLALIFKIASATT---- 228 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc----hHHHHHHHhccCC----
Confidence 211 11223457899999999988889999999999999999999999996443211 1111111111000
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+......+.+++.+|+..+|++||++.|++++
T Consensus 229 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 -----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 111222233568889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=315.40 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=193.0
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEE---EEEcc-CCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCe--EEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAV---KVLTS-NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR--SVLVY 601 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAv---K~l~~-~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~--~~LV~ 601 (854)
.+..+||+|+|-+||+|.+. +|.+||= |.-.. .+......|..|+.+|+.|+||||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 35678999999999999875 4777753 22111 123334678999999999999999999999976654 78999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeeecccccc
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV 680 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~~ 680 (854)
|.|..|+|..|+. +.++++......|+.||++||.|||++ .|+|+|||||..||+|+.+ |.|||+|.|||....
T Consensus 123 EL~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999984 456677888999999999999999996 6799999999999999865 899999999998654
Q ss_pred CCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
.. +. ..+.|||.|||||++. ..|.+.+||||||+.|+||+|+..||.... +-.+.- +++-.|.-...+.
T Consensus 198 ~s--~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~AQIY-KKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 198 KS--HA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT------NPAQIY-KKVTSGIKPAALS 266 (632)
T ss_pred cc--cc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC------CHHHHH-HHHHcCCCHHHhh
Confidence 32 22 2367999999999987 789999999999999999999999997644 222322 2222332221111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... -.++.++|.+|+.. .++|||+.|++++
T Consensus 267 -----kV~---dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 -----KVK---DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----ccC---CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111 12477899999999 8899999999875
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=301.31 Aligned_cols=265 Identities=21% Similarity=0.223 Sum_probs=196.3
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--cHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY 601 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV~ 601 (854)
.+.+.+.||+|+||.||+|..+ +++.+|+|.++..... ....+.+|++++++++||||+++++++... ...++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3456788999999999999987 5889999998754322 234567899999999999999999999877 8899999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+. ++|.+.+... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 86 EYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred hhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 9997 4898887532 23588999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH-------Hhh---
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHI--- 750 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~-------~~~--- 750 (854)
... ......++..|+|||.+.+. .++.++|+|||||++|||++|+.||...........+..... ...
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 321 12233478899999998764 468899999999999999999999975442111111111000 000
Q ss_pred ---hcCCcccccCccccCcCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ---ESGDIQGIIDPSLLDEYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ---~~~~~~~~id~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
............+...+... ....+.+++.+|++.+|++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000111111111111 24457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=301.85 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=199.6
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++++++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 4455688999999999999864 678999999865544456678899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 100 ~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 100 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 9999998853 3467888899999999999999998 999999999999999999999999998875443322
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......|++.|+|||.+....++.++|||||||++||+++|+.||........ +.. ....+. . . .
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~----~~~~~~-~-----~--~ 235 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYL----IATNGT-P-----E--L 235 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eee----hhcCCC-C-----C--C
Confidence 22234588999999999888899999999999999999999999975432111 000 000000 0 0 0
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.........+.+++.+|++.+|++||++.++++|
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223457899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=306.66 Aligned_cols=250 Identities=23% Similarity=0.283 Sum_probs=196.8
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||.||+|... +++.||+|.+...... ..+.+..|++++++++|+||+++++.+......++||||+
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 34578999999999999876 4899999998755332 3456889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
.+++|.+++... ....+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 84 PGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999988532 235688899999999999999999998 999999999999999999999999999864422111
Q ss_pred c----------------------------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccc
Q 003039 685 H----------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 736 (854)
Q Consensus 685 ~----------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~ 736 (854)
. ......||..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 111235788999999999888999999999999999999999999755421
Q ss_pred ccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 003039 737 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS----ISEVLKD 799 (854)
Q Consensus 737 ~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs----m~eV~~~ 799 (854)
.. +. ... .... .... .......+.+++.+|++.+|++||+ ++|++++
T Consensus 239 ~~------~~-~~~-~~~~------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ET------FS-NIL-KKEV------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HH------HH-HHh-cCCc------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11 10 011 1100 0000 1113456889999999999999999 6666554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=295.06 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=197.6
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|+||.||++... +++.+|||.+.... ......+.+|++++++++|||++++++.+..++..++||||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 45678999999999999875 68899999986542 2345678899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeeeccccccCCCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~~~~~~ 684 (854)
+++|.+++... ....+++..+..++.+++.||+|||++ +++|+||||+||+++.+ +.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 83 GGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999643 234578889999999999999999998 99999999999999865 468999999997654322
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... ... +....+ .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~---~~~-~~~~~~-----~ 222 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLK---IMS-GTFAPI-----S 222 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHH---HHh-cCCCCC-----C
Confidence 122345889999999999888999999999999999999999999754421 11111 111 111111 1
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .....+.+++.+|++.+|++|||+.|++++
T Consensus 223 ~----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 D----RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred C----CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.61 Aligned_cols=262 Identities=21% Similarity=0.270 Sum_probs=194.0
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
..+.||+|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 4578999999999999876 68899999886442 2234578899999999999999999999999999999999996
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++........
T Consensus 83 ~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 156 (284)
T cd07860 83 QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 156 (284)
T ss_pred cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence 6888887542 245688999999999999999999998 9999999999999999999999999998754332211
Q ss_pred eecccccccccCccccccCc-CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh------------cC
Q 003039 687 SSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------------SG 753 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~------------~~ 753 (854)
.....++..|+|||.+.+.. ++.++|||||||++|||+||+.||...........+..+...... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 12234688999999887644 688999999999999999999999654321111111111000000 00
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.........+... .......+.+++.+|++.+|++||+++|++++
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 237 SFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 00112356789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=297.25 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=196.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCC---CCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~---HpnIv~l~g~~~~~~~~~LV~E 602 (854)
|.+.+.||+|+||.||+|.+. +++.||+|++.... .....++.+|++++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 345678999999999999874 68999999986542 334467888999999986 9999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++++|.+++.. ..+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 83 YAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred cCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999998843 2678899999999999999999998 9999999999999999999999999998765443
Q ss_pred CCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.. ......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...... .+.. ..... ..+
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~-~~~~~-----~~~ 220 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMM-LIPKS-----KPP 220 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhhh-ccccC-----CCC
Confidence 32 22334588999999998754 5688999999999999999999999754311 1110 01111 111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+... .....+.+++.+|++.+|++||++.|++++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 123468899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=298.43 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=192.5
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeee------cCeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~------~~~~~ 598 (854)
.+.+.+.||+|+||.||+|... +++.+|+|++.... ....++..|+.+++++ +|+||+++++++.. ....+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4456689999999999999875 57899999986543 2345688899999998 79999999999853 45789
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 9999999999999885432 34577888889999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
...... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....... .+.. ....
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~~~-----~~~~ 241 (282)
T cd06636 171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR---ALFL-----IPRN 241 (282)
T ss_pred hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh---hhhh-----HhhC
Confidence 432211 123345899999999986 3467889999999999999999999996533111 0100 0000
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .+.+.. ......+.+++.+|++.+|.+||++.||+++
T Consensus 242 ~-----~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 242 P-----PPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred C-----CCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 011110 1122468899999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=301.56 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=192.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++|+||+++++++...+..++||||+.
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 345678999999999999876 688999999865432 223456789999999999999999999999999999999998
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+ +|.+++... ...+++.....++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 87 ~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 87 T-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred C-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 5 898887532 23578888999999999999999998 99999999999999999999999999986432211 1
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhc---CCcc-----
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDIQ----- 756 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~---~~~~----- 756 (854)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||....... .........+.. ....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE---DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1122346889999999875 458899999999999999999999996543110 000000000000 0000
Q ss_pred -c--------ccCccccCcC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 -G--------IIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 -~--------~id~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+ .....+.... .......+.+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0000000000 01112467799999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.20 Aligned_cols=245 Identities=25% Similarity=0.362 Sum_probs=197.6
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
.+.||+|++|.||+|... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 468999999999999865 6889999998655445556788999999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+++.. .++++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++....... .....
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 174 (285)
T cd06648 104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKS 174 (285)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccccc
Confidence 998853 4578889999999999999999998 99999999999999999999999999886543322 12233
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ...... ...+.. +.+.. ..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~-~~~~~~-----~~~~~--~~ 239 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKR-IRDNLP-----PKLKN--LH 239 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHH-HHhcCC-----CCCcc--cc
Confidence 4589999999999888899999999999999999999999865431 111111 111111 11110 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+.+++.+|++.+|++||++.+++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 122468899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.10 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=195.3
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||.||++... .++.||+|.+..... .....+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 34578999999999999876 578999999875432 23456788999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC-
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 683 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~- 683 (854)
++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 84 EGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999843 34578888899999999999999998 99999999999999999999999999986321110
Q ss_pred -------------CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 684 -------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 684 -------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
........|+..|+|||.+....++.++|+|||||++|||++|..||.+.... .+. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~---~~~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELF---GQVI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHH---HHHH
Confidence 00111235788999999998888999999999999999999999999654311 111 1111
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
. +.. ..+.... .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 230 ~-~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 S-DDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred h-ccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1 111 0111111 122357899999999999999996655555555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=300.50 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=194.2
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.||.|++|.||+|... +|+.||+|++.... ......+.+|++++++++|||++++++++...+..+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 4578999999999999875 68999999987543 2233568889999999999999999999999999999999995
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++.... ...+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++........
T Consensus 82 ~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 68998885322 24688999999999999999999998 9999999999999999999999999998754322111
Q ss_pred eecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC--------C---
Q 003039 687 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG--------D--- 754 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~--------~--- 754 (854)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...........+.++........ .
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1222468899999988764 578899999999999999999999965432111111111100000000 0
Q ss_pred -cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 -IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 -~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......+.. ..........+.+++.+|++.+|++||+++|++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 00011112467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=287.87 Aligned_cols=247 Identities=30% Similarity=0.479 Sum_probs=201.2
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
..+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 4578999999999999986 688999999976655556789999999999999999999999999999999999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceee
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 688 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 688 (854)
|.+++... ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 84 L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 84 LKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred HHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99988543 25688999999999999999999997 999999999999999999999999999876544332 23
Q ss_pred cccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCC
Q 003039 689 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 768 (854)
Q Consensus 689 ~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~ 768 (854)
...|+..|+|||++.+..++.++||||||+++++|++|+.||...... .... .. .........+ .
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~---~~-~~~~~~~~~~-------~ 220 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM----KALF---KI-ATNGPPGLRN-------P 220 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH----HHHH---HH-HhcCCCCcCc-------c
Confidence 456889999999999888999999999999999999999998754310 1111 01 0011111111 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 769 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 769 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......+.+++.+|++.+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1113468899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.92 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=193.4
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++||||++++++|...+..++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3556788999999999999876 689999999864322 233568899999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+. |++.+.+.. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 96 YCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred hhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 997 577666642 234588999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCceeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
....|+..|+|||++. ...++.++||||||+++|||++|+.||....... .... ......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~-~~~~~~---- 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH-IAQNDS---- 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHH-HhcCCC----
Confidence 2245788999999884 4568889999999999999999999986543111 0111 111111
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.+. .......+.+++.+|++.+|++||+|.+|+++
T Consensus 232 -~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0110 11233468899999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=301.76 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=197.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 345688999999999999876 58999999986432 22345688899999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 83 VPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999853 35688889999999999999999998 9999999999999999999999999998765433
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.....|++.|+|||.+.+...+.++||||||+++|||++|+.||...... .... ....+.. .+
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----~~~~~~~------~~ 217 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYE----KILEGKV------RF 217 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHhcCCc------cC
Confidence 23345899999999998888899999999999999999999999654311 1111 1111111 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
.... ...+.+++.+|+..+|.+|| +++|++++
T Consensus 218 ~~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 218 PSFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1111 24577899999999999999 77777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.25 Aligned_cols=249 Identities=29% Similarity=0.409 Sum_probs=202.7
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.||+|++|.||+|+.. +++.||||++..... .....+.+|++.+.+++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 35688999999999999887 489999999876543 4467899999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++|.+++.. ...+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||.+.........
T Consensus 84 ~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 84 GSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999853 2568889999999999999999999 8 9999999999999999999999999998765433222
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+..+.. .... +.+
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~----~~~~-----~~~-- 223 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAIC----DGPP-----PSL-- 223 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHh----cCCC-----CCC--
Confidence 12345789999999999989999999999999999999999999765321 1112222211 1111 111
Q ss_pred cCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~-~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.. ....+.+++..|++.+|++||++.|++++
T Consensus 224 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 --PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 33568899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=305.12 Aligned_cols=267 Identities=21% Similarity=0.264 Sum_probs=195.0
Q ss_pred HhhccccccCceEEEEEEECC---CcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 600 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~---~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV 600 (854)
.+.++||+|+||.||+|.... ++.||+|.+.... ......+.+|++++++++||||+++++++... ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 456789999999999998754 7899999987632 23345678899999999999999999999888 789999
Q ss_pred EEeccCCCHHhhhcccccc-cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC----CCcEEEEeeec
Q 003039 601 YEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFGL 675 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkl~DFGl 675 (854)
|||+++ +|.+.+...... ...++...+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999975 666666433222 23688889999999999999999998 9999999999999999 99999999999
Q ss_pred cccccCCCC--ceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccc------cchHHHH
Q 003039 676 SKFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC------RNIVQWA 746 (854)
Q Consensus 676 a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~------~~l~~~~ 746 (854)
++....... .......++..|+|||.+.+ ..++.++|||||||+++||++|+.||......... ..+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 976543322 12233457899999998876 45789999999999999999999999755422100 0011100
Q ss_pred HHh-----------hhcCCcccccCccccCcCC---------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 747 KLH-----------IESGDIQGIIDPSLLDEYD---------I--QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 747 ~~~-----------~~~~~~~~~id~~l~~~~~---------~--~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... .+........+......++ . ....++.+++.+|++.+|++|||+.|++++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 0000000000000000011 0 223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=299.33 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=196.8
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEEEEec
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM 604 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV~E~~ 604 (854)
+.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 4578999999999999887 48899999997653 23345688999999999999999999999888 8899999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++ +|.+++... ...+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 83 DH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 75 888887532 24688999999999999999999998 999999999999999999999999999976544332
Q ss_pred ceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhc--CCc------
Q 003039 685 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--GDI------ 755 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~--~~~------ 755 (854)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.......... ...
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22233456889999998765 467899999999999999999999997654221111111110000000 000
Q ss_pred -----ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 -----QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 -----~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.......+...+...+...+.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000011111124578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=323.08 Aligned_cols=271 Identities=20% Similarity=0.269 Sum_probs=186.8
Q ss_pred HHHHHhhccccccCceEEEEEEECC--CcEEEEEEE--------------cc---CCcccHHHHHHHHHHHccCCCCcee
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVL--------------TS---NSYQGKREFTNEVTLLSRIHHRNLV 585 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~~--~~~VAvK~l--------------~~---~~~~~~~~~~~Ev~~L~~l~HpnIv 585 (854)
...|.+.++||+|+||+||++.++. +...++|.+ .. ........+.+|+++|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3456778899999999999987642 222222211 00 1112245678999999999999999
Q ss_pred eEeeeeeecCeEEEEEEeccCCCHHhhhcccc-cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 003039 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 664 (854)
Q Consensus 586 ~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 664 (854)
++++++...+..++|+|++. ++|.+++.... .............++.|++.||+|||++ +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 57777764322 1122334556778999999999999998 9999999999999999
Q ss_pred CCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH
Q 003039 665 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 744 (854)
Q Consensus 665 ~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~ 744 (854)
++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|..++...........+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999986654433333445799999999999999999999999999999999998754322211111111111
Q ss_pred HHHHhh-hcCCcc-------cccCccccC----cC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 745 WAKLHI-ESGDIQ-------GIIDPSLLD----EY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 745 ~~~~~~-~~~~~~-------~~id~~l~~----~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...... ....+. +.++..... .. .......+.+++.+|++.||++|||+.|++++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111000 000000 000000000 00 00011246678899999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=300.03 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=194.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+...+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++|||++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3455678999999999999875 688999999864422 223568889999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+. |+|.+.+.. ....+++.++..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 997 577776642 234588999999999999999999998 9999999999999999999999999998654322
Q ss_pred CCceeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||....... .+.. ....+. .
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~----~~~~~~-~--- 242 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH----IAQNES-P--- 242 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHH----HHhccC-C---
Confidence 2335888999999974 4568899999999999999999999986532110 1111 111110 0
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
... .......+.+++.+|++.+|.+||++.+|++++-
T Consensus 243 --~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 --TLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred --CCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 000 1122345789999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=298.17 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=196.7
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.++||+|++|.||+|+.. +|+.||||+++.... .....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 34678999999999999986 588999999875532 2345677899999999999999999999999999999999985
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....... .
T Consensus 83 -~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 83 -DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred -cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 8888875432 234689999999999999999999998 999999999999999999999999999875433211 1
Q ss_pred eecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh-------hhc-CCc--
Q 003039 687 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IES-GDI-- 755 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~-------~~~-~~~-- 755 (854)
.....++..|++||.+.+ ..++.++|||||||++|||++|+.||......+....+....... +.. ...
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 223347889999999865 456889999999999999999999997654222211111110000 000 000
Q ss_pred --ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 --QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 --~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+... ..........+.+++.+|++.+|.+||++.||+++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 00011223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=293.88 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=202.1
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.++||+|+||.||+++.. +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 34678999999999999765 67899999987542 2334567889999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++.....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999865444456788999999999999999999998 9999999999999999999999999999765543
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... .+.. ....+...
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~----~~~~~~~~--------- 219 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLRY----KVQRGKYP--------- 219 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHhcCCCC---------
Confidence 222245789999999999989999999999999999999999999754411 1111 11112111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+......+.+++.+|++.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=296.79 Aligned_cols=253 Identities=26% Similarity=0.349 Sum_probs=193.0
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEeccC
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 4578999999999999876 58999999986543 234567889999999996 99999999999999999999999864
Q ss_pred CCHHhhhccc-ccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 607 GTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 607 gsL~~~L~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++.++.... ......+++..+..++.+++.||+|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 163 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA- 163 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence 555443211 11235688899999999999999999974 2899999999999999999999999999875433221
Q ss_pred eeecccccccccCccccccC---cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 686 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~---~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ........... +. .+.
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~-~~-----~~~ 230 (288)
T cd06616 164 -KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVK-GD-----PPI 230 (288)
T ss_pred -cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcC-CC-----CCc
Confidence 1223588999999999766 68899999999999999999999986543 11111111111 11 111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+..........++.+++.+|++.+|++||+++||+++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112234468899999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=296.26 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=199.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.+.||+|+||.||+|.++ +++.||+|++..... ....+.+|++++++++|+|++++++++...+..++|+||+++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 334578999999999999887 688999999975543 466788999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 100 ~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 100 GSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 99999996421 3789999999999999999999998 999999999999999999999999998865433221 2
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||....... .... .. ........+
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~~~----~~-~~~~~~~~~------ 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALFL----IT-TKGIPPLKN------ 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HH-hcCCCCCcc------
Confidence 223357889999999988889999999999999999999999986543110 1111 11 111111110
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.......+.+++.+|++.+|.+||++.+|+++
T Consensus 239 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 -PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11123467899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=296.60 Aligned_cols=265 Identities=21% Similarity=0.211 Sum_probs=192.4
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCC-CCceeeEeeeeeecCe-----EEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR-----SVL 599 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~-----~~L 599 (854)
.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++ ||||+++++++...+. .++
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 44678999999999999876 689999998765422 22456888999999995 6999999999977665 899
Q ss_pred EEEeccCCCHHhhhcccccc-cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeeeccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSK 677 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~ 677 (854)
||||+++ +|.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 9999985 788887543222 34689999999999999999999998 9999999999999998 8999999999987
Q ss_pred cccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
....... ......+++.|+|||++.+ ..++.++|||||||++|||++|..||...........+....... ......
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 237 (295)
T cd07837 160 AFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP-TEQVWP 237 (295)
T ss_pred ecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC-ChhhCc
Confidence 5432211 1122346889999998865 457899999999999999999999997543211111111110000 000000
Q ss_pred cccC-------cccc----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIID-------PSLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id-------~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+ +... .........++.+++.+|++.+|++||++.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0000 00001123568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=302.01 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=192.6
Q ss_pred cccccc--CceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G--~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
..||+| +||+||++++. +|+.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 68999999986543 22346788899999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999886542 23578888899999999999999998 99999999999999999999999998653222111100
Q ss_pred ------eecccccccccCccccccC--cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHH----------
Q 003039 687 ------SSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL---------- 748 (854)
Q Consensus 687 ------~~~~~gt~~Y~aPE~~~~~--~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~---------- 748 (854)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||........ +......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccc
Confidence 1112356679999999763 478999999999999999999999975431111 1000000
Q ss_pred ------h-------hh---------cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 749 ------H-------IE---------SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 749 ------~-------~~---------~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .. .+....+.+..+...........+.+++.+|++.+|++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00 000001111112222223445678999999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=290.62 Aligned_cols=246 Identities=21% Similarity=0.349 Sum_probs=203.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
..+.++||+|+||.||+|.++ .|+.||||.+... .+..++.+|+.+|+++..|++|+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 345678999999999999877 6999999988654 3457788999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|++.+.++. ....+.+.++..++...++||+|||.. .-+|||||+.|||++.+|.+||+|||.|-.+.+. ...
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK 185 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK 185 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence 999999964 456788999999999999999999987 7799999999999999999999999998655433 223
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
..++.||+.|||||++..-.|..++||||+|+...||..|++||.+-..-. .+. ++...-...
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIF--------------MIPT~PPPT 248 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIF--------------MIPTKPPPT 248 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---eeE--------------eccCCCCCC
Confidence 456779999999999999999999999999999999999999997643100 000 000000111
Q ss_pred C--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 767 Y--DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 767 ~--~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+ +..-..++.+++..|+-..|++|-|+.++++|
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1 22334468899999999999999999999887
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=294.79 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=191.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++.+++..++..++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 345678999999999999875 688999999865432 223467789999999999999999999999999999999996
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++|.+++... ...+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++++||+|||+++...... .
T Consensus 87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 158 (291)
T cd07870 87 -TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-Q 158 (291)
T ss_pred -CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC-C
Confidence 6777666422 23467778888999999999999998 99999999999999999999999999987543221 1
Q ss_pred eeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh-------------
Q 003039 686 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------------- 751 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~------------- 751 (854)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ...+.. ....+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEK-IWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHH-HHHHcCCCChhhhhhhhhc
Confidence 12233478999999998754 5788999999999999999999999754311 111111 000000
Q ss_pred cCCcccccCccccCcC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+.......... .......+.+++.+|++.+|++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000000 00113467789999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.98 Aligned_cols=244 Identities=27% Similarity=0.359 Sum_probs=190.6
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
||+|+||+||++..+ +|+.||+|++.... ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 68899999986532 22244567899999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++...... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 99986432 24688999999999999999999998 9999999999999999999999999998755432 11223
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
..++..|+|||++.+..++.++|||||||++++|++|+.||...........+.. .... ....+...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~------~~~~~~~~--- 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR----RTLE------MAVEYPDK--- 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh----cccc------ccccCCcc---
Confidence 4578899999999888899999999999999999999999965442111111111 0000 00011111
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRP-----SISEVLK 798 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~ 798 (854)
....+.+++.+|++.+|++|| ++.++++
T Consensus 221 -~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 -FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 233578999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.84 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=203.7
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|+||.||++... +++.+|+|++..... .....+.+|+++++.++|+|++++++.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 34578999999999999876 588999999875533 455678899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.........+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D 158 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence 9999999976543456789999999999999999999998 99999999999999999999999999987654432 2
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......|++.|+|||......++.++||||+|+++++|++|+.||...... +...... ...... +..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~-~~~~~~-----~~~ 225 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-------ELALKIL-KGQYPP-----IPS 225 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-------HHHHHHh-cCCCCC-----CCC
Confidence 233346889999999999888999999999999999999999998654311 1111111 111111 111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+.+++.+|+..+|++||++.|++++
T Consensus 226 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 ----QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 223457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.80 Aligned_cols=242 Identities=26% Similarity=0.331 Sum_probs=185.8
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHH---ccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 533 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLL---SRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L---~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998865422 1123344454433 33479999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999988853 34689999999999999999999998 99999999999999999999999999986543221
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.....|+..|+|||.+.. ..++.++||||+||+++||++|..||....... ...+.. ... ..+..+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~---~~~-------~~~~~~~ 219 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDR---MTL-------TVNVELP 219 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHHHHH---Hhh-------cCCcCCc
Confidence 123458999999999864 568899999999999999999999997543111 111111 000 0111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
. .....+.+++.+|++.+|++|| +++|+++|
T Consensus 220 ~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 D----SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred c----ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 2234678899999999999999 69999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.21 Aligned_cols=242 Identities=23% Similarity=0.310 Sum_probs=193.9
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 488999999865432 3346788999999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999853 23478888999999999999999998 99999999999999999999999999997654432 2233
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
..|+..|+|||.+....++.++|+||+|+++|||++|..||..... +.......... +. ....++.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~-~~--------~~~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILK-GN--------GKLEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhc-cC--------CCCCCCc
Confidence 4588999999999888899999999999999999999999975431 11111111111 00 0111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPS-----ISEVLK 798 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~ 798 (854)
.....+.+++.+|++.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 12346889999999999999999 566655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=290.93 Aligned_cols=248 Identities=28% Similarity=0.420 Sum_probs=198.0
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|+||.||+|..+ +|..+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 34678999999999999886 58899999986532 2345678899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeeeccccccCCCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~~~~ 684 (854)
+++|.+++... ....+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 83 GGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999988542 233578999999999999999999998 999999999999999885 469999999876543222
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......|+..|+|||+..+..++.++|||||||+++||++|..||.... ..++...... +....+ .
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~~~~-----~ 223 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQ-GYFAPI-----S 223 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhc-ccCCCC-----C
Confidence 2233458899999999988889999999999999999999999986543 1122222111 111111 1
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .....+.+++.+|+..+|++||++.||+++
T Consensus 224 ~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 P----NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred C----CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1 122358899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.42 Aligned_cols=260 Identities=20% Similarity=0.232 Sum_probs=190.9
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCC-CCceeeEeeeeeec--CeEEEEEEec
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYEFM 604 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~--~~~~LV~E~~ 604 (854)
+.++||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 4578999999999999875 68899999987542 222334457888888885 99999999999887 8899999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
+ |+|.+.+... ...+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.......
T Consensus 83 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 83 D-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred C-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 7 5787777432 24688999999999999999999998 9999999999999999 9999999999976543222
Q ss_pred ceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH-------HHhhhcCCcc
Q 003039 685 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------KLHIESGDIQ 756 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~-------~~~~~~~~~~ 756 (854)
. ....++..|+|||++.. ..++.++|||||||++|||++|..||...+..+....+.... ..........
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 1 22347899999997654 557889999999999999999999997644211111111000 0000000000
Q ss_pred cccCccccC----cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+.... .........+.+++.+|++.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 0011234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=306.77 Aligned_cols=261 Identities=22% Similarity=0.302 Sum_probs=193.7
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 597 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~ 597 (854)
.+...+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++... ...
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 3455688999999999999875 6899999998643 223345677899999999999999999988643 357
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
++||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 97 ~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 97 YLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred EEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 99999996 478777732 277888889999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH-------------
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ------------- 744 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~------------- 744 (854)
...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 653322 12234578999999999999999999999999999999999999965431111101100
Q ss_pred --HHHHhhhcC------CcccccCccc----cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 745 --WAKLHIESG------DIQGIIDPSL----LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 745 --~~~~~~~~~------~~~~~id~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......... .+.+.+...+ ...........+.+++.+|++.+|++||++.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0001111111 111112234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=300.39 Aligned_cols=252 Identities=27% Similarity=0.343 Sum_probs=199.3
Q ss_pred HHHHHhhccccccCceEEEEEEECCCcEEEEEEEcc--CCcccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~--~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~ 601 (854)
...|.+.++||+||.+.||++...+.+.+|+|++.- .+.+...-|.+|++.|.+++ |.+|++|++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 445667889999999999999988888889887643 34445667999999999995 999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||- ..+|...|.... ..++-..+..+..|++.++.++|.+ ||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 440 E~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 965 569999996432 2233226778999999999999999 9999999999999864 6899999999987665
Q ss_pred CCCc-eeecccccccccCccccccCc-----------CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh
Q 003039 682 GASH-VSSIVRGTVGYLDPEYYISQQ-----------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 682 ~~~~-~~~~~~gt~~Y~aPE~~~~~~-----------~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~ 749 (854)
..+. .....+||+.||+||.+.... .+.++||||+|||||+|+.|+.||..-. +. |.+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n~--~aK-- 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------NQ--IAK-- 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------HH--HHH--
Confidence 5444 345567999999999985432 5578999999999999999999996422 22 222
Q ss_pred hhcCCcccccCccccCcCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+..+.||.-.-+|+ ....+++.++++.|++.||++||++.|+++|
T Consensus 582 -----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 -----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 33455554322222 2233448999999999999999999999987
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=304.84 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=201.7
Q ss_pred HHHhhccccccCceEEEEEEECCCc-EEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~~~-~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+...||-|+||.||+|..++-. --|.|++...+.....+|.-|++||..+.||+||+|++.|.-.+.+++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 3455667999999999999887433 346788877777778889999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
||-++..+- .-++.|.+.++..++.|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+..... ...
T Consensus 113 GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 113 GGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred CchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 999988774 3366788999999999999999999999 999999999999999999999999998743221 122
Q ss_pred eeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 686 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
....+.||+.|||||+.. ..+|+.++||||||+.|.||..+.+|-...+ ...+...+...+...++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHHHHHHHhhcCCCcccC
Confidence 344567999999999875 4689999999999999999999999865433 111222222222223333
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
|. .-...+.++..+|+..+|..||++.|+++|
T Consensus 258 PS-------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 PS-------HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cc-------hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22 233468899999999999999999999876
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.72 Aligned_cols=245 Identities=26% Similarity=0.357 Sum_probs=195.0
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
||+|+||.||++... +|+.+|+|++..... .....+.+|++++++++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999875533 3456788899999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC-----
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS----- 684 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~----- 684 (854)
.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 998853 23688999999999999999999998 999999999999999999999999999875433211
Q ss_pred --ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 685 --HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 685 --~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.......++..|+|||.......+.++||||||++++|+++|..||...... .+... . ..+....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~---~-~~~~~~~----- 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EIFQN---I-LNGKIEW----- 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHH---H-hcCCcCC-----
Confidence 1223345788999999998888999999999999999999999999754411 11111 1 1111110
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
.. .......+.+++.+|++.+|++||++.+|.+.|+
T Consensus 221 -~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 -PE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -Cc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 0001356789999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=284.74 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=200.6
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEEEEec
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM 604 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV~E~~ 604 (854)
..+.||+|++|.||+|... +++.|++|++..... .....+.+|++++++++|+||+++++.+... ...++|+||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 4578999999999999987 689999999875542 3466788999999999999999999999888 8899999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 84 SGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999998532 3789999999999999999999998 999999999999999999999999999876544322
Q ss_pred c-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 685 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 685 ~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
. ......++..|+|||.+.....+.++||||||+++++|++|..||.... ............+..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~-------- 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEP-------- 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCC--------
Confidence 1 1233458899999999998889999999999999999999999997544 111111111110111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+......+.+++.+|++.+|++||++.|++++
T Consensus 223 -~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 -PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11112224568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=296.03 Aligned_cols=244 Identities=25% Similarity=0.364 Sum_probs=195.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHH
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 610 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 610 (854)
.+||+|+||.||+|..+ +++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999875 68999999986555455667889999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeecc
Q 003039 611 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 690 (854)
Q Consensus 611 ~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 690 (854)
+++.. ..+++.....++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ......
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 87732 3478888999999999999999998 99999999999999999999999999986543322 122334
Q ss_pred cccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHH
Q 003039 691 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 770 (854)
Q Consensus 691 ~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~ 770 (854)
.|+..|+|||.+.+..++.++||||+||++|||++|..||...... .......... .+.+... ..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----~~~~~~~~~~---------~~~~~~~--~~ 241 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRDNL---------PPKLKNL--HK 241 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhhC---------CcccCCc--cc
Confidence 5889999999998888899999999999999999999998654311 1111111110 0111000 01
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 771 SMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 771 ~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+.+++.+|++.+|.+||++.+|+++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 12346789999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.93 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=198.0
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++.+......++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 45678999999999999886 589999999875432 34567889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
.+++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 83 LGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999853 24678889999999999999999998 99999999999999999999999999987554332
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...+........ .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~--~-------- 218 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQETA--D-------- 218 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhccc--c--------
Confidence 223345888999999999888999999999999999999999999765421 111111111110 0
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSI--SEVLK 798 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm--~eV~~ 798 (854)
...+......+.+++.+|++.+|.+||++ +|+.+
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11111122568899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=301.93 Aligned_cols=262 Identities=21% Similarity=0.199 Sum_probs=193.1
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCccc--------------HHHHHHHHHHHccCCCCceeeEeeeeee
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--------------KREFTNEVTLLSRIHHRNLVQFLGYCQE 593 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~--------------~~~~~~Ev~~L~~l~HpnIv~l~g~~~~ 593 (854)
.+.+.||+|+||+||+|... +++.||||+++...... ...+.+|++++++++|+||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 34678999999999999876 68999999986442221 1247789999999999999999999999
Q ss_pred cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 003039 594 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 673 (854)
Q Consensus 594 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 673 (854)
.+..++||||+. |+|.+++. ....+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 999999999997 68888874 234578889999999999999999998 9999999999999999999999999
Q ss_pred eccccccCCC-------------CceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccc
Q 003039 674 GLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANC 739 (854)
Q Consensus 674 Gla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~ 739 (854)
|+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9987554110 1111223468899999998764 4688999999999999999999999765422111
Q ss_pred cchHHHHHHhhhcCCcc-----------cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 740 RNIVQWAKLHIESGDIQ-----------GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 740 ~~l~~~~~~~~~~~~~~-----------~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+.............. ....+.+... .......+.+++.+|++.+|++||+++|++.+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111110000000000 0000000000 01123457899999999999999999999874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=296.30 Aligned_cols=264 Identities=22% Similarity=0.260 Sum_probs=191.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
+.+.+.||+|++|.||+|..+ +++.||+|++..... .....+.+|++++++++||||+++++++......++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 345678999999999999876 688999998864322 23456888999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeeeccccccCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~~~ 683 (854)
+ ++|.+++... ....+++.....++.||+.||+|||+. +++||||||+||+++. ++.+||+|||+++......
T Consensus 84 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 84 D-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred c-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 6 5787777432 223357778888999999999999998 9999999999999985 5679999999997543321
Q ss_pred CceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC-----Cccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG-----DIQG 757 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~-----~~~~ 757 (854)
.......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||......+....+........... .+.+
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 11123347889999998876 4578999999999999999999999975432111111111000000000 0000
Q ss_pred c-------cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 I-------IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ~-------id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ....+. ........++.+++.+|++.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000 0011122457889999999999999999999975
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=295.28 Aligned_cols=265 Identities=23% Similarity=0.284 Sum_probs=194.6
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecC-------
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------- 595 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~------- 595 (854)
..+.+.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 44566789999999999999986 58899999987543 223356778999999999999999999987654
Q ss_pred ---eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 003039 596 ---RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 672 (854)
Q Consensus 596 ---~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 672 (854)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 666666432 34688999999999999999999998 999999999999999999999999
Q ss_pred eeccccccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh
Q 003039 673 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 673 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
||++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+....+........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 238 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC- 238 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-
Confidence 99997654433222223346788999998865 4578899999999999999999999975432111111111100000
Q ss_pred cCCcccc--------cCc------cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 752 SGDIQGI--------IDP------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 752 ~~~~~~~--------id~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......+ .++ ....... .....+.+++.+|++.+|.+||++.+|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 000 0000000 113468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=293.88 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=194.2
Q ss_pred HhhccccccCceEEEEEEEC----CCcEEEEEEEccCC----cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~----~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~L 599 (854)
.+.+.||+|+||.||+++.. +|+.||+|+++... ....+.+.+|+++++++ +|+||+++++++..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 34678999999999999863 68899999987532 22345678899999999 59999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 83 ILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999853 34577888888999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCceeecccccccccCccccccC--cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
............|+..|+|||.+... .++.++||||||+++|+|++|+.||....... .............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~---- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSE---- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHHhhccC----
Confidence 43322222345589999999998753 46789999999999999999999986432111 1122222211111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
+. ++......+.+++.+|++.+|++|| +++++..+
T Consensus 229 ---~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ---PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00 1111224577999999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=283.85 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=199.3
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+|++++++++..++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 45678999999999999876 578999999976543 345678999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 83 NGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999998843 25688999999999999999999998 9999999999999999999999999999765443322
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....++..|+|||...+..++.++||||+|+++++|++|+.||..... ...... ...... +.+
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~--~~~~~~-----~~~-- 219 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFR--IVQDDH-----PPL-- 219 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH--HhccCC-----CCC--
Confidence 2334588999999999888889999999999999999999999865431 111101 011111 011
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+......+.+++.+|+..+|++||++.|++.+
T Consensus 220 --~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 220 --PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred --CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 11123467899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=288.11 Aligned_cols=244 Identities=23% Similarity=0.282 Sum_probs=187.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHH-HccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~-L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|... +++.||||+++..... ....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 5889999998654321 12334445444 3455899999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999998853 34578888999999999999999998 999999999999999999999999999875432
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||...... .+.. . ...+... ..+....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~---~-~~~~~~~--~~~~~~~- 218 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFD---N-ILSRRIN--WPEEVKE- 218 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHH---H-HHhcccC--CCCcccc-
Confidence 22345888999999998888999999999999999999999999654311 1111 1 1111110 0011111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
.....+.+++.+|++.+|++||++.++.+.|.
T Consensus 219 ---~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 ---FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ---cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 12345889999999999999998765555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=303.12 Aligned_cols=245 Identities=24% Similarity=0.424 Sum_probs=202.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
+.+...||+|.|+.|.+|++. ++..||||.+.+.... ....+.+|+++|..++|||||+++.+...+..+++||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 345688999999999999876 6999999999765432 2345789999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
.+|.+.+++. ...++....+..++.|+.+|++|||++ .|+|||||++||||+.+.++||+|||++..+.. .
T Consensus 138 ~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~ 208 (596)
T KOG0586|consen 138 SGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY--G 208 (596)
T ss_pred cCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--c
Confidence 9999999995 345566678888999999999999999 999999999999999999999999999987653 3
Q ss_pred ceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
......+|++.|.|||++.+.+| .+++|+||+|+++|-|+.|..||++....+.....+. ..+
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~----------------gk~ 272 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR----------------GKY 272 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------------eee
Confidence 45567789999999999998776 4689999999999999999999997664332211111 111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+-.+.+ ...+.+++++++-.+|.+|++++++.++
T Consensus 273 rIp~~m--s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 RIPFYM--SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccccee--echhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111 1246688999999999999999999887
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=295.64 Aligned_cols=264 Identities=22% Similarity=0.248 Sum_probs=192.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--cHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV~E 602 (854)
+.+.+.||+|+||.||+|... +|+.||+|+++..... ....+.+|+.++++++|+||+++++++... +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 445678999999999999876 5899999998644322 233566899999999999999999998754 56899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+.+ +|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 89 YCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred cCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9974 788877532 25688999999999999999999998 9999999999999999999999999999765432
Q ss_pred CCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh-------hhcCC
Q 003039 683 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IESGD 754 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~-------~~~~~ 754 (854)
.. ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.+..... .....
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 21 1222335788999999875 457899999999999999999999997544222111111110000 00000
Q ss_pred ccccc--CccccCcC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGII--DPSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~i--d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+ ........ .......+.+++.+|++.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00000000 00123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=298.49 Aligned_cols=265 Identities=24% Similarity=0.334 Sum_probs=193.5
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccC-CCCceeeEeeeeeec--CeEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE--GRSVL 599 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~--~~~~L 599 (854)
..+.+.+.||+|+||.||+|... +++.+|||++... .......+..|+.+++++ +||||++++++|... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 34566789999999999999876 5889999988543 223345677899999999 999999999998653 36799
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 87 VFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred Eecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 999997 588888743 2678888899999999999999998 9999999999999999999999999999755
Q ss_pred cCCCC----ceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH-------
Q 003039 680 VDGAS----HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK------- 747 (854)
Q Consensus 680 ~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~------- 747 (854)
..... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 43321 12223458999999998765 5578899999999999999999999965432111111111100
Q ss_pred HhhhcCCcccccCcccc------CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 748 LHIESGDIQGIIDPSLL------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 748 ~~~~~~~~~~~id~~l~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+.......+++.... .........++.+++.+|++.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000100000 00001123468899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=305.73 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=191.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeec-----CeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-----~~~~LV 600 (854)
+.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 445789999999999999865 68999999986432 22345678899999999999999999987544 357999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
+||+.+ +|.+.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 87 QELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred ehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999974 7777663 34588889999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCc--eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC---C
Q 003039 681 DGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---D 754 (854)
Q Consensus 681 ~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~---~ 754 (854)
..... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ............ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCCHHH
Confidence 32221 1123468999999998764 568899999999999999999999996543211 011111000000 0
Q ss_pred cccccCccc-------c--CcCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSL-------L--DEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l-------~--~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+.+... . ...+ .....++.+++.+|++.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0 0000 1123468899999999999999999999988
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=289.98 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=196.4
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.||+|++|.||+|... +++.+|+|.+..... .....+..|++++++++|+||+++++++..+...++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 3468999999999999876 688999999865432 2356788899999999999999999999999999999999975
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
+|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus 83 -~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 83 -DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred -CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 888877532 25688999999999999999999998 99999999999999999999999999987654432 11
Q ss_pred eecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC---CcccccC--
Q 003039 687 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---DIQGIID-- 760 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~---~~~~~id-- 760 (854)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+....+.. ..... ......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR----TLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----HcCCCchHhcccchhhh
Confidence 2223478899999998876 789999999999999999999999965442111101110 00000 0000000
Q ss_pred ----ccc-------cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 ----PSL-------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ----~~l-------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... ..........++.+++..|++.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 000112234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=293.08 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=197.0
Q ss_pred HhhccccccCceEEEEEEEC----CCcEEEEEEEccCC----cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~----~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~L 599 (854)
.+.+.||+|+||.||+++.. +++.||||+++... ......+.+|++++.++ +||||+++++.+......++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 34678999999999999753 56889999986432 22345678899999999 59999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+.+|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 83 ILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999998853 34578888899999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCceeecccccccccCccccccCc--CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
............|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~----- 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKS----- 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHcc-----
Confidence 443332233345889999999987655 7889999999999999999999986432111 111111111111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
++.....+ ...+.+++.+|++.+|++|||+.++.+.|+..
T Consensus 228 --~~~~~~~~----~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 --KPPFPKTM----SAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CCCCCccc----CHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 01111111 23477899999999999999998888777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=288.24 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=192.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC-----CcccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~-----~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~L 599 (854)
+.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++... ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 345789999999999999875 5899999987532 122345788999999999999999999998654 46789
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 9999999999998853 23477888899999999999999998 9999999999999999999999999999754
Q ss_pred cCCC--CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 680 VDGA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 680 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
.... ........|+..|+|||++.+..++.++|||||||+++||++|+.||...... ..+ ......+ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~-~-- 226 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAI----FKIATQP-T-- 226 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHH----HHHHcCC-C--
Confidence 3211 11112345889999999999888999999999999999999999999654311 011 1111111 0
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+......+.+++.+|++ +|..||+..+++.|
T Consensus 227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 011122233568899999999 47999999988765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=305.17 Aligned_cols=268 Identities=23% Similarity=0.385 Sum_probs=203.0
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecC------eEEEEEE
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVYE 602 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~------~~~LV~E 602 (854)
.+.||+|+||.||+|+.+ .|+.||||.++... ....+....|+++|++++|+|||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 568999999999999966 69999999987654 334556788999999999999999999865543 5689999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc--CCCc--EEEEeeecccc
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMR--AKVSDFGLSKF 678 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~--vkl~DFGla~~ 678 (854)
||.+|+|...|... .....|++.+.+.++.+++.||.|||++ +|+||||||.||++- .+|+ -||+|||.|+-
T Consensus 98 yC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999765 3456689999999999999999999998 999999999999984 3343 69999999997
Q ss_pred ccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
..++. .....+||..|++||++.. +.|+..+|.|||||++||+.||..||.....+..... +.|....-.......
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~-~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE-IMWHIITKKPSGVAI 250 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch-hhhhhhccCCCceeE
Confidence 76544 5566789999999999995 8889999999999999999999999976543322111 122221111111111
Q ss_pred ccCccccC------------cCCHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHHHHH
Q 003039 758 IIDPSLLD------------EYDIQSMWKIEEKALMCVLPHGHMRP--SISEVLKDIQDAIV 805 (854)
Q Consensus 758 ~id~~l~~------------~~~~~~~~~l~~l~~~Cl~~~P~~RP--sm~eV~~~L~~~~~ 805 (854)
..++...+ .........+-.+...++..+|++|. ...+....+..++.
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 12222221 11233344566677777888888898 77777777766664
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=322.17 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=207.5
Q ss_pred HhhccccccCceEEEEEEEC----C----CcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK----D----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~----~----~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~ 598 (854)
.+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|..++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 45679999999999999754 1 3569999997653 34567899999999998 6999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccc----------ccc--ccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC
Q 003039 599 LVYEFMHNGTLKEHLYGTL----------THE--QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 666 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~----------~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 666 (854)
+|+||+..|+|.++|+... ... ..+...+.+.++.|||.|++||++. +++||||.++|||++.+.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999997544 011 1388889999999999999999998 999999999999999999
Q ss_pred cEEEEeeeccccccCCCCceeecccc--cccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchH
Q 003039 667 RAKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIV 743 (854)
Q Consensus 667 ~vkl~DFGla~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~ 743 (854)
.+||+|||+|+...+..........| ...|||||.+....++.++|||||||+||||+| |..|+.+... ...+.
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~---~~~l~ 532 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP---TEELL 532 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc---HHHHH
Confidence 99999999998655544333232233 456999999999999999999999999999999 8888875221 11222
Q ss_pred HHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 744 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 744 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+ .+++|. +.+.+..+..++.+++..||+.+|++||++.|+++.++..+.
T Consensus 533 ~----~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 533 E----FLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred H----HHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 2 233332 122233345578899999999999999999999999999643
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=295.64 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=190.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecC--------e
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------R 596 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~--------~ 596 (854)
|.+.++||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...+ .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 455788999999999999876 688999998864422 22345678999999999999999999986654 4
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
.++||||+.+ +|.+.+.. ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 94 ~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred EEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 5999999974 77777743 233588999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCc---eeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhc
Q 003039 677 KFAVDGASH---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 752 (854)
Q Consensus 677 ~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~ 752 (854)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......... ..+......+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL-TLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCh
Confidence 755432211 11233578899999988664 4788999999999999999999998654311110 111111000000
Q ss_pred CCccc------------------ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 753 GDIQG------------------IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 753 ~~~~~------------------~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..... .+...+... .....+.+++.+|++.+|++||+++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 000000000 012356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=291.72 Aligned_cols=261 Identities=18% Similarity=0.254 Sum_probs=192.1
Q ss_pred hhccccccCceEEEEEEECCCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.+|.|+++.||++.. +++.||||++... .......+.+|++++++++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445556666666666655 5899999998754 2334567899999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC---
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--- 684 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~--- 684 (854)
+|.+++.... ...+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999986432 23577888899999999999999998 999999999999999999999999998864432111
Q ss_pred ---ceeecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh----hh----
Q 003039 685 ---HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH----IE---- 751 (854)
Q Consensus 685 ---~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~----~~---- 751 (854)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.+..... +.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCccccccCch
Confidence 11123347789999999875 458899999999999999999999997543111 111111000 00
Q ss_pred ---cCCccc----ccCccc----cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 752 ---SGDIQG----IIDPSL----LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 752 ---~~~~~~----~id~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...... ..++.. ...........+.+++.+|++.+|++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 000000 011112233568899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=289.85 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=194.5
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEeccC
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.||+|++|+||+|+.. +++.||||++..... .......+|+..+++++ |+||+++++++..++..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 4678999999999999986 478899999865432 22334567899999999 999999999999999999999999 8
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.... ...+++..++.++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||+++.......
T Consensus 82 ~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 82 GNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred CCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 89988885432 34689999999999999999999998 999999999999999999999999999975543222
Q ss_pred eecccccccccCccccc-cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH---------HHHHhhhcCCcc
Q 003039 687 SSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQ 756 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~---------~~~~~~~~~~~~ 756 (854)
.....++..|+|||++. ...++.++|+||||++++||++|+.||......+....+.. |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 12245788999999885 45678999999999999999999999865432111111111 111110000111
Q ss_pred cccCcccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+..... ..........+.+++.+|++.+|++||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00000113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=293.74 Aligned_cols=257 Identities=19% Similarity=0.240 Sum_probs=181.4
Q ss_pred HHHHHhhccccccCceEEEEEEECC----CcEEEEEEEccCCccc--H---------HHHHHHHHHHccCCCCceeeEee
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQG--K---------REFTNEVTLLSRIHHRNLVQFLG 589 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~~~~--~---------~~~~~Ev~~L~~l~HpnIv~l~g 589 (854)
...+.+.+.||+|+||.||+|.+.+ +..+|+|+........ + .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3456678899999999999998764 3456667543222111 0 11223344566778999999999
Q ss_pred eeeecC----eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC
Q 003039 590 YCQEEG----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 665 (854)
Q Consensus 590 ~~~~~~----~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 665 (854)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 775543 34677776643 55555432 22346777889999999999999998 99999999999999999
Q ss_pred CcEEEEeeeccccccCCCCc------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccc
Q 003039 666 MRAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 739 (854)
Q Consensus 666 ~~vkl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~ 739 (854)
+.++|+|||+|+........ ......||+.|+|||++.+..++.++|||||||+++||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999765322111 112346999999999999999999999999999999999999999765321111
Q ss_pred cch--HHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 740 RNI--VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 740 ~~l--~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
... .++.. .+..+.+. .. .....+.+++..|++.+|++||++.++.+.|+
T Consensus 243 ~~~~~~~~~~-~~~~~~~~-------~~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIK-RLHEGKIK-------IK----NANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHH-Hhhhhhhc-------cC----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111 11111 11111110 01 11356889999999999999999999998763
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=289.59 Aligned_cols=262 Identities=22% Similarity=0.280 Sum_probs=192.7
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccC---CCCceeeEeeeeeecCe-----EE
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGR-----SV 598 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l---~HpnIv~l~g~~~~~~~-----~~ 598 (854)
+.+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|+.+++++ +|+|++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 4578999999999999987 489999999874322 1234566787777665 59999999999988776 89
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
++|||+.+ +|.+++.... ...+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 83 l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999974 7888875422 23588999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc--
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ-- 756 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~-- 756 (854)
...... .....++..|+|||++.+..++.++|||||||++|||++|+.||......+....+.+............
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 533221 1223478899999999998999999999999999999999999876542221111111110000000000
Q ss_pred ----cccCcccc---CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 ----GIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ----~~id~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........ ..........+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 00111233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=292.98 Aligned_cols=248 Identities=26% Similarity=0.355 Sum_probs=199.2
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
-++||+|+||.||.++.+ +|+.+|.|.+.+.. .+++.-..+|-++|.+++.+.||.+--.|...+.++||+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 478999999999999876 68999999886442 33455678899999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.-+|+... ...+++..+..++.+|+.||++||+. +||+||+||+|||+|+.|+++|+|.|+|..+..+..+.
T Consensus 270 GDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~ 344 (591)
T KOG0986|consen 270 GDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR 344 (591)
T ss_pred CceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence 99999997653 35688999999999999999999999 99999999999999999999999999998777665544
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
. .+||.+|||||++....|+...|.||+||++|||+.|+.||........-+.+ .....+. ..+
T Consensus 345 ~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv----drr~~~~----------~~e 408 (591)
T KOG0986|consen 345 G--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV----DRRTLED----------PEE 408 (591)
T ss_pred c--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH----HHHHhcc----------hhh
Confidence 3 36999999999999999999999999999999999999999765411111011 1111110 112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
++..-.++...+....++.||++|-. +.+|.+|
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 22222345667777888999999874 5566655
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=290.12 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=195.8
Q ss_pred HHhhccccccCceEEEEEEECC-CcEEEEEEEccCC-----cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~-----~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
|.+.+.||+|+||.||++.... +..+++|+++... .....++..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567889999999999998763 4556666655321 223345778999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++++|.+++.........+++..++.++.|+++||+|||+. +++|+||||+||+++. +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998865444456789999999999999999999998 9999999999999975 5699999999876543
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.. .......|+..|+|||...+..++.++|+||||+++|+|++|..||.... ........ ..+.. +
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~-~~~~~-----~ 223 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRI-VEGPT-----P 223 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHH-HcCCC-----C
Confidence 22 22233458899999999988888999999999999999999999986432 11111111 11111 1
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .+......+.+++.+|++.+|++||++.|++++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1 122333468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=294.00 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=193.7
Q ss_pred HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
..++...+.||+|+||.||+|+.. +++.+|+|.+.... .....++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 334555678999999999999876 57889999886432 22345678899999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+. |++.+.+.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 678777642 234578889999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
.. ....|+..|+|||.+. ...++.++|||||||++|||++|+.||....... .+.. ...+...
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~-----~~~~~~~- 232 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH-----IAQNESP- 232 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHH-----HhhcCCC-
Confidence 22 2235788999999975 3567889999999999999999999986533110 0111 1111111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
... .......+.+++.+|++.+|++||++.+|+++-.
T Consensus 233 ----~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 ----ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ----CcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 100 1122345789999999999999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=288.63 Aligned_cols=242 Identities=25% Similarity=0.328 Sum_probs=186.4
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHH---HHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 533 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVT---LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~---~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.||+|+||.||+|... +++.||+|++...... ....+..|.. +++...||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 5889999998654221 1223344433 4444579999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988842 34689999999999999999999998 99999999999999999999999999987543322
Q ss_pred eeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........ ....... .. .+..+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~~~~~~-~~------~~~~~~ 219 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMT-LT------MAVELP 219 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HHHHHHh-hc------cCCCCC
Confidence 1234689999999999754 688999999999999999999999976531111 1110100 00 111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
... ...+.+++.+|+..+|.+|| ++.+++++
T Consensus 220 ~~~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CcC----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111 34688999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=301.44 Aligned_cols=267 Identities=23% Similarity=0.299 Sum_probs=199.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecC-----eEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~-----~~~L 599 (854)
+.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 345678999999999999976 48999999987543 334567889999999999999999999997765 7899
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||++ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++...
T Consensus 82 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 999998 478888743 33788999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCC--ceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh------
Q 003039 680 VDGAS--HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI------ 750 (854)
Q Consensus 680 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~------ 750 (854)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 44321 112234578899999999887 889999999999999999999999976542211111111100000
Q ss_pred -hcCCcccccCc-cccCc-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHH
Q 003039 751 -ESGDIQGIIDP-SLLDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQD 802 (854)
Q Consensus 751 -~~~~~~~~id~-~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~ 802 (854)
......+.+.. ..... ........+.+++.+|++.+|++||++.+++++ ++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 00000000000 00000 001123467899999999999999999999986 554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=302.33 Aligned_cols=265 Identities=21% Similarity=0.300 Sum_probs=194.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeec-----CeEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-----~~~~L 599 (854)
|.+.+.||+|+||+||+|+.. +++.||||.+... .......+.+|+.+++.++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 445678999999999999875 6899999998653 223345677899999999999999999988644 34799
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
|+||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 87 VYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 999996 68888774 235688899999999999999999998 9999999999999999999999999999755
Q ss_pred cCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHH-------hhh
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIE 751 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~-------~~~ 751 (854)
.... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+...... .+.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4322 22233457889999998865 56889999999999999999999999654311111111110000 000
Q ss_pred cCCc-------ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHH
Q 003039 752 SGDI-------QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQD 802 (854)
Q Consensus 752 ~~~~-------~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~ 802 (854)
.+.. ....++.+.. ........+.+++.+|++.+|++||+++|++++ ++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000 0000000000 011223567899999999999999999999998 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=300.11 Aligned_cols=264 Identities=19% Similarity=0.273 Sum_probs=193.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeee----cCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~----~~~~~LV 600 (854)
+.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.. ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 445678999999999999876 68999999987542 2334567789999999999999999998753 3468999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+. |+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 87 MDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred Eehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99996 688888743 34588999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCC---ceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHH-------HHHh
Q 003039 681 DGAS---HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW-------AKLH 749 (854)
Q Consensus 681 ~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~-------~~~~ 749 (854)
.... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 3221 11223468899999999865 56889999999999999999999999764321100000000 0000
Q ss_pred hhcCCcccccCcc-ccCcC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 750 IESGDIQGIIDPS-LLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 750 ~~~~~~~~~id~~-l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+.+.++.. ..... .......+.+++.+|++.+|++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000 00000 11224568899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=290.94 Aligned_cols=242 Identities=26% Similarity=0.404 Sum_probs=190.0
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
..++||+|+||+||+|+.. +++.||+|++..... .....+.+|+++++.++|||++++++++.+....++||||+.
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 3567999999999999875 688999999864422 223467889999999999999999999999999999999996
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
|++.+.+.. ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 105 -~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 105 -GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred -CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 577777642 234588999999999999999999998 999999999999999999999999999864322
Q ss_pred eeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 686 VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.....|+..|+|||++. ...++.++|||||||++|||++|..||...... .... .... .......
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----~~~~---~~~~-~~~~~~~--- 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALY---HIAQ-NDSPTLQ--- 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHH---HHHh-cCCCCCC---
Confidence 12345889999999984 456888999999999999999999998654311 1111 1111 1111111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... ....+.+++.+|++.+|.+||++.+++.+
T Consensus 242 -~~~----~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -SNE----WTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -ccc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 12357889999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=289.21 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=190.2
Q ss_pred HHhhccccccCceEEEEEEECC-CcEEEEEEEccCC-cccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
+.+.+.||+|+||.||+|.+++ ++.||||+++... ......+..|+.++.+.+ ||||+++++++..+...++||||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 3457899999999999999875 8999999987543 223455667777776665 999999999999999999999998
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
. +++.+++... ...+++..+..++.|++.||+|||+. .+|+||||+|+||+++.++.+||+|||++........
T Consensus 97 ~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 97 S-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred C-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 5 4676665321 23688889999999999999999973 2899999999999999999999999999875543222
Q ss_pred ceeecccccccccCccccccCc----CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~----~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+......... ...
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~~--- 238 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEE-PPS--- 238 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCC-CCC---
Confidence 1 2234788999999987553 788999999999999999999999653211 11111111111 100
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.. ......++.+++.+|++.+|++||++.+++++
T Consensus 239 --~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 --LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00123468899999999999999999999877
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=282.71 Aligned_cols=235 Identities=20% Similarity=0.309 Sum_probs=182.1
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccCCCHHh
Q 003039 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 611 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 611 (854)
||+|+||.||++..+ ++..+|+|++....... . |+.....+ +||||+++++.+...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999875 67889999986432211 1 22222222 79999999999999999999999999999999
Q ss_pred hhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeeeccccccCCCCceeecc
Q 003039 612 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV 690 (854)
Q Consensus 612 ~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~~~~~~~~~~ 690 (854)
++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||+++..... ...
T Consensus 99 ~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~ 166 (267)
T PHA03390 99 LLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCY 166 (267)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccC
Confidence 9853 23789999999999999999999998 999999999999999998 9999999998754322 123
Q ss_pred cccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHH
Q 003039 691 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 770 (854)
Q Consensus 691 ~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~ 770 (854)
.|+..|+|||++.+..++.++|||||||+++||++|+.||....... .....+.... .. ... ... .
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--~~-~~~-----~~~----~ 232 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ--QK-KLP-----FIK----N 232 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh--cc-cCC-----ccc----c
Confidence 58899999999999899999999999999999999999997443111 1122222111 00 000 011 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 003039 771 SMWKIEEKALMCVLPHGHMRPS-ISEVLKD 799 (854)
Q Consensus 771 ~~~~l~~l~~~Cl~~~P~~RPs-m~eV~~~ 799 (854)
....+.+++.+|++.+|.+||+ ++|++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 2345789999999999999995 6888864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=274.41 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=196.6
Q ss_pred hccccccCceEEEEEE-ECCCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 531 EKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~-~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
++.||+|+|+.|--+. ..+|.++|||++.+.....+....+|++++.+++ |+||+.|+++|.++...|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 5789999999998885 5689999999998887777888899999999995 9999999999999999999999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEeeecccccc-----
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAV----- 680 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DFGla~~~~----- 680 (854)
|..+|. +..-+++.++-++..+||.||.+||.+ ||.|||+||+|||-.... -+||+||.++.-..
T Consensus 163 lLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999995 345688889999999999999999999 999999999999997653 48999998874221
Q ss_pred -CCCCceeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCccccccc-------ccccccchHHHHH
Q 003039 681 -DGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEK-------FGANCRNIVQWAK 747 (854)
Q Consensus 681 -~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~-------~~~~~~~l~~~~~ 747 (854)
...+....+.+|+..|||||+.. ...|+.++|.||||||||-|++|.+||.+.- .++.++.-..-..
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 11122223456889999999873 2457889999999999999999999997533 2333322222222
Q ss_pred HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 748 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.-+.+|.. +.-|. --.....+..+++...+..++.+|-++.+++.+
T Consensus 316 esIQEGkY-eFPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 316 ESIQEGKY-EFPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHhccCC-cCChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 22333322 11110 011223355677777788999999999998874
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=289.05 Aligned_cols=261 Identities=24% Similarity=0.279 Sum_probs=196.2
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.||+|+||.||+|+.. +++.+|+|++.... ......+..|++++++++|+|++++++++...+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3467999999999999887 48999999987653 2334667889999999999999999999999999999999998
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++... ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||+++....... .
T Consensus 82 ~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 82 MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 5899988532 14688999999999999999999998 999999999999999999999999999876543222 1
Q ss_pred eecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHH-------hhh-----cC
Q 003039 687 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIE-----SG 753 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~-------~~~-----~~ 753 (854)
.....++..|+|||.+.+. .++.++|||||||+++||++|+.||......+....+.+.... .+. ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2223457889999998776 7899999999999999999999999765422111111111000 000 00
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.............. ......+.+++..|++.+|++||++.+|+.+
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000000 0113468999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=290.09 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=197.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E 602 (854)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+..|++++++++ ||||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 345678999999999999876 68999999986532 233466888999999998 9999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
++++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 83 YAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999853 33689999999999999999999998 9999999999999999999999999998755432
Q ss_pred CC-------------------ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchH
Q 003039 683 AS-------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 743 (854)
Q Consensus 683 ~~-------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~ 743 (854)
.. .......|+..|+|||......++.++||||||++++++++|+.||...... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~ 231 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LTF 231 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----HHH
Confidence 21 1122345789999999998888999999999999999999999999754411 111
Q ss_pred HHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 003039 744 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI----SEVLKD 799 (854)
Q Consensus 744 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm----~eV~~~ 799 (854)
. ...... ...+......+.+++.+|++.+|.+||++ +|++++
T Consensus 232 ~---~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 Q---KILKLE-----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H---HHHhcC-----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1 111100 01111113458899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=276.15 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=195.9
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHH---HHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~---~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.++||+|.||.|-+++-+ .++.+|+|++++...-.+.+ -..|-++|+..+||.+..+--.|...+++|+||||+.
T Consensus 172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence 5689999999999999876 68899999998765433333 3568899999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
||.|.-+|. ..+.+++.....+..+|..||.|||++ +||.||||.+|+|+|.+|++||+|||+++..- ....
T Consensus 252 GGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~ 323 (516)
T KOG0690|consen 252 GGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGD 323 (516)
T ss_pred CceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-cccc
Confidence 999988883 456678888888999999999999998 99999999999999999999999999987422 2234
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.+.+.+||+.|+|||++....|..++|.|.+|||||||++|+.||....-.....-+ .+++-+
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI------l~ed~k----------- 386 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI------LMEDLK----------- 386 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH------Hhhhcc-----------
Confidence 556789999999999999999999999999999999999999999765522221111 111111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
++.....+...|....+..||++|. .++||.++
T Consensus 387 -FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 387 -FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1111222455677788899999997 46666654
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-33 Score=325.69 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=193.3
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
...||.|.||.||-|... +|+-.|+|-++... ....+...+|+.++..++|||+|+.+|+-...+..++.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 357999999999999754 68888999776443 333456889999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce-
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV- 686 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~- 686 (854)
+|.+.+. .++-.++.....+..|++.|++|||+. |||||||||.||+|+.+|.+|++|||.|..........
T Consensus 1320 sLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred cHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999883 344456666677889999999999998 99999999999999999999999999998665543221
Q ss_pred --eecccccccccCccccccC---cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH-HhhhcCCcccccC
Q 003039 687 --SSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-LHIESGDIQGIID 760 (854)
Q Consensus 687 --~~~~~gt~~Y~aPE~~~~~---~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~-~~~~~~~~~~~id 760 (854)
-....||+.|||||++.+. ....++||||+|||+.||+||++||...+. .|+- .++.-|...
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e~aIMy~V~~gh~P---- 1460 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------EWAIMYHVAAGHKP---- 1460 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------hhHHHhHHhccCCC----
Confidence 2345699999999999764 355689999999999999999999975441 1221 112222221
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.+.....+=.+++.+|+..||++|.++.|++++
T Consensus 1461 -----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 -----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2222233445688999999999999988877664
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=293.45 Aligned_cols=264 Identities=20% Similarity=0.270 Sum_probs=190.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--cHHHHHHHHHHHccCCCCceeeEeeeeeecC--------e
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------R 596 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~--------~ 596 (854)
+.+.++||+|+||.||+|..+ +++.+|||++...... ....+.+|++++++++||||+++++++.... .
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 445688999999999999876 5889999988644322 2345678999999999999999999875433 4
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
.++|+||+.+ +|.+.+.. ....+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++
T Consensus 90 ~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred EEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 6999999975 66666643 234689999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCc----------eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHH
Q 003039 677 KFAVDGASH----------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 745 (854)
Q Consensus 677 ~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~ 745 (854)
+........ ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 754322111 1123357888999998865 45889999999999999999999999754421111111110
Q ss_pred HHHhhh-----cCCccccc--------CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 746 AKLHIE-----SGDIQGII--------DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 746 ~~~~~~-----~~~~~~~i--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...... ...+.... .+.+...+ ......+.+++.+|++.+|++|||+.|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000 00000000 00000000 0112468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=276.11 Aligned_cols=203 Identities=25% Similarity=0.367 Sum_probs=168.1
Q ss_pred HHHhhccccccCceEEEEEEEC---C--CcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeee-cCeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK---D--GKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~---~--~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~-~~~~~ 598 (854)
.|+....||+|.||.||+|.-+ + .+.+|+|.++.... .-.....+|+.+++.++||||+.|..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 3455678999999999999543 2 33789999875532 123457899999999999999999999977 78899
Q ss_pred EEEEeccCCCHHhhhccc-ccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC----CcEEEEee
Q 003039 599 LVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDF 673 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkl~DF 673 (854)
|++||.+. +|.+.|+-. ....+.++...+..|+.||+.|+.|||++ -|+||||||.||||..+ |.|||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999987 788877432 23446789999999999999999999999 89999999999999887 89999999
Q ss_pred eccccccCCCCce--eecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccc
Q 003039 674 GLSKFAVDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 733 (854)
Q Consensus 674 Gla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~ 733 (854)
|+++.+...-... ...++-|.+|+|||.+.+ ..|+.+.|||+.|||+.||+|-.+.|.+.
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999776553332 344667999999999987 56899999999999999999998877543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=290.91 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=189.8
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVL 599 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~~L 599 (854)
.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 34578999999999999875 68999999986432 22235678999999999999999999998654 34689
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
|+||+.. +|.+++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 98 v~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 98 VMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred Eeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 9999964 666554 23478888999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH-------HHhhh
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------KLHIE 751 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~-------~~~~~ 751 (854)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.... .....
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 321 122357889999999876 468899999999999999999999997643211110110000 00000
Q ss_pred cCC-------cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHHH
Q 003039 752 SGD-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAI 804 (854)
Q Consensus 752 ~~~-------~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~~~ 804 (854)
... ........+...+ ......+.+++.+|++.+|++||++.|+++| ++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 0000000000000 0122357899999999999999999999977 66653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=293.52 Aligned_cols=262 Identities=20% Similarity=0.253 Sum_probs=189.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeec------------
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------------ 594 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------------ 594 (854)
+.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 445688999999999999875 5889999998766555567788999999999999999999876543
Q ss_pred --CeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEE
Q 003039 595 --GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVS 671 (854)
Q Consensus 595 --~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~ 671 (854)
...++|+||++ ++|.+++. ...+++.....++.|++.||+|||+. +++||||||+||+++. ++.+||+
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 58887773 23578889999999999999999998 9999999999999974 5678999
Q ss_pred eeeccccccCCCCce--eecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH--
Q 003039 672 DFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-- 746 (854)
Q Consensus 672 DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~-- 746 (854)
|||+++......... .....|+..|+|||.+.. ..++.++|||||||++|||++|+.||......+....+..-.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999987543321111 122357889999998754 567889999999999999999999997543111110100000
Q ss_pred -----HHhhhcCCcccccC-ccccCcCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 747 -----KLHIESGDIQGIID-PSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 747 -----~~~~~~~~~~~~id-~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....... +...+. .......+ .....++.+++.+|++.+|++||++.|++++
T Consensus 238 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000 000000 00000000 0122457899999999999999999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=277.81 Aligned_cols=236 Identities=29% Similarity=0.360 Sum_probs=190.6
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 534 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
||+|+||.||++... +++.+|+|++...... ....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 5889999998755322 345788999999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 999853 33588999999999999999999998 99999999999999999999999999987554322 12233
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
..++..|+|||...+...+.++|+||||+++||+++|+.||..... ..+...+. . +.. ..+.
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~---~-~~~----------~~~~ 214 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKIL---K-DPL----------RFPE 214 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHh---c-CCC----------CCCC
Confidence 4578899999999888889999999999999999999999965431 11111111 1 110 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPSISE 795 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPsm~e 795 (854)
.....+.+++.+|+..+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11345789999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=290.26 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=189.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecC------eEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~------~~~ 598 (854)
|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.... ..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 445678999999999999865 68999999985432 223456789999999999999999999986543 458
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 97 lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 97 LVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 999998 678888774 24578899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH--------HHHHh
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ--------WAKLH 749 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~--------~~~~~ 749 (854)
..... ....+++.|+|||.+.+ ..++.++|+|||||+++++++|+.||...........+.. +....
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 43221 22357889999999876 4588999999999999999999999975431111111100 00000
Q ss_pred hhcCC-------cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 750 IESGD-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 750 ~~~~~-------~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... +.......+ ..........+.+++.+|++.+|++|||+.+++++
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 244 -QSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred -cchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000 00001122357899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=288.69 Aligned_cols=259 Identities=19% Similarity=0.270 Sum_probs=190.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeee-cCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~-~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|... +++.||||++... .....+.+..|++++++++||||+++.+++.. ....++|+||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 445688999999999999866 7899999987543 22234667889999999999999999998865 5578999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+ +++|.+++.. ..+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 92 ~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 92 L-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred h-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 8 5688887742 3467777888999999999999998 9999999999999999999999999998743221
Q ss_pred CceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH--------HHHHhhhcCC
Q 003039 684 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ--------WAKLHIESGD 754 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~--------~~~~~~~~~~ 754 (854)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.+ +.........
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 122347889999998866 5689999999999999999999999965432111111111 1100000000
Q ss_pred cccccCccccCcCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..-...-......+. .....+.+++.+|++.+|++||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000011111 123568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=287.30 Aligned_cols=245 Identities=25% Similarity=0.379 Sum_probs=196.9
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
++.||+|.||+||-|+++ +|+.||||++.+. ....+.++.+|++||+.++||.||.+..-|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 689999999999999876 7999999999765 344567899999999999999999999999999999999999965
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEeeeccccccCCCC
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkl~DFGla~~~~~~~~ 684 (854)
+..+.+-. .+.+++++.....++.||+.||.|||.+ +|+|+||||+|||+... .++||||||.|+.+.. .
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--k 720 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--K 720 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--h
Confidence 54444432 3567888888888999999999999998 99999999999999754 4799999999998754 3
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.....+.||+.|+|||++....|...-|+||.|||+|--++|..||.... ++-+.+.+. .-+..+.-.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE------dIndQIQNA------aFMyPp~PW 788 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE------DINDQIQNA------AFMYPPNPW 788 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc------chhHHhhcc------ccccCCCch
Confidence 45566789999999999999999999999999999999999999997543 222222211 011112212
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. +.....++++...++..-.+|-+.++-+.|
T Consensus 789 ~----eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 789 S----EISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred h----hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 2 223356788888888888889888876654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=291.59 Aligned_cols=262 Identities=21% Similarity=0.265 Sum_probs=188.7
Q ss_pred HhhccccccCceEEEEEEEC-C--CcEEEEEEEccCC--cccHHHHHHHHHHHccC-CCCceeeEeeeeeec----CeEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-D--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE----GRSV 598 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~--~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~----~~~~ 598 (854)
.+.+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|+++++++ +||||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 35678999999999999876 3 6789999986432 22345678899999999 599999999875432 4568
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+++||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 83 LYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 8888886 68888874 345688999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCc---eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH--------
Q 003039 679 AVDGASH---VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------- 746 (854)
Q Consensus 679 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~-------- 746 (854)
....... ......||..|+|||++.+ ..++.++||||+||++|+|++|+.||...........+....
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4432211 1123468999999998765 468899999999999999999999997544211111111100
Q ss_pred HHhhhcC------CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 747 KLHIESG------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 747 ~~~~~~~------~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....... .....-...+ ..........+.+++.+|++.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000000000 00000113468899999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=263.33 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=191.5
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccC-CcccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
...||.|..|.||+++.+ .|..+|||.+... ..++.+.+...+.++.+.+ .|.||+.+|||..+...++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 456999999999999887 5889999998765 3445567777888877765 89999999999999888999998853
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
.++.++... .+.+++.-.-++...+.+||.||.++ .+|+|||+||+|||+|+.|++|+||||++-.+.+...+
T Consensus 176 C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 176 CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 455555322 34477777778899999999999998 49999999999999999999999999999776655443
Q ss_pred ecccccccccCcccccc---CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 688 SIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
+...|.+.|||||.+.- ..|+.++||||||+.++||.||+.||...+.. + ..... ... +....+++...
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--F-e~ltk---vln--~ePP~L~~~~g 320 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--F-EVLTK---VLN--EEPPLLPGHMG 320 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--H-HHHHH---HHh--cCCCCCCcccC
Confidence 34468999999999964 46888999999999999999999999874411 1 11111 111 11122222211
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
++ ..+.+++..|++.|+.+||...++++|
T Consensus 321 --FS----p~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 321 --FS----PDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --cC----HHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 33 347889999999999999999999887
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=307.66 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=183.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeee----------------
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE---------------- 593 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~---------------- 593 (854)
+.||+||||.||+++.+ ||+.+|||++.... ......+.+|+.+|.+++|||||+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 57999999999999987 89999999997653 3334567899999999999999997632100
Q ss_pred --------------------------------------------------------------------------------
Q 003039 594 -------------------------------------------------------------------------------- 593 (854)
Q Consensus 594 -------------------------------------------------------------------------------- 593 (854)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------c--------CeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCce
Q 003039 594 ---------------E--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 650 (854)
Q Consensus 594 ---------------~--------~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 650 (854)
+ ..+|+-||||+.-++.++++...-.. .....++++.+|+.||+|+|+. ||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~---gi 718 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQ---GI 718 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhC---ce
Confidence 0 12467788998888887775432111 3456788999999999999998 99
Q ss_pred ecCCCCCCCEEEcCCCcEEEEeeecccccc------C-----------CCCceeecccccccccCccccccC---cCCCc
Q 003039 651 IHRDLKSSNILLDKHMRAKVSDFGLSKFAV------D-----------GASHVSSIVRGTVGYLDPEYYISQ---QLTDK 710 (854)
Q Consensus 651 vHrDIkp~NILl~~~~~vkl~DFGla~~~~------~-----------~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~ 710 (854)
|||||||.||+++++..|||+|||+|+... + ......+...||.-|+|||++.+. .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999997621 0 111123456799999999999754 59999
Q ss_pred chhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCC
Q 003039 711 SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR 790 (854)
Q Consensus 711 ~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 790 (854)
+|+||+|||++||+.- |.... +.. .+...++.+.+..- .++....+..-..++.++++.||.+|
T Consensus 799 iDmYSLGIVlFEM~yP---F~TsM-----ERa--~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLYP---FGTSM-----ERA--SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred hhhHHHHHHHHHHhcc---CCchH-----HHH--HHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccC
Confidence 9999999999999963 54321 111 12223444544332 22333445556789999999999999
Q ss_pred CCHHHHHHH
Q 003039 791 PSISEVLKD 799 (854)
Q Consensus 791 Psm~eV~~~ 799 (854)
||+.|++..
T Consensus 863 PtA~eLL~s 871 (1351)
T KOG1035|consen 863 PTATELLNS 871 (1351)
T ss_pred CCHHHHhhc
Confidence 999998853
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=287.79 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=188.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~~ 598 (854)
+.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 334578999999999999864 68899999986432 22345677899999999999999999988543 3467
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
++++++ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 99 LVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 888876 778988774 23578899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH-------Hhh
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHI 750 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~-------~~~ 750 (854)
.... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..... ..+
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 4322 223457899999999866 5688899999999999999999999965432111111111000 000
Q ss_pred hcCC-------cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGD-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~-------~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... +.......... ........+.+++.+|++.+|.+||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 00000000000 000112357899999999999999999999877
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=290.65 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=191.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCe------EE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~------~~ 598 (854)
|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|||++++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 345678999999999999886 57899999986432 2234567789999999999999999998866554 89
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 97 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 999998 5699888843 4588999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH-------Hhh
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHI 750 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~-------~~~ 750 (854)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.+... ..+
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 4332 223357889999999865 4678899999999999999999999975432111111111000 000
Q ss_pred hcCCcccccC---ccccCcC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGDIQGIID---PSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~~~~~id---~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........+. ..-...+ ......++.+++.+|++.+|++|||+.||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000 0000000 00123568899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=276.15 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=204.1
Q ss_pred HHHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeec-Ce
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-GR 596 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-~~ 596 (854)
+.+..+...+-+|.||.||+|.|. +.+.|.||.++... .-....+..|..++..+.|||+.++.+++.++ ..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 333344567889999999999765 34567788776543 23345678899999999999999999999765 45
Q ss_pred EEEEEEeccCCCHHhhhcc----cccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 003039 597 SVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 672 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 672 (854)
.+.+|.++.-|+|..+|.. .....+.+.-.+...++.|++.|++|||+. ++||.||.++|++||+..++||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEecc
Confidence 6888999999999999962 112345677888899999999999999998 999999999999999999999999
Q ss_pred eeccccccCCCCce-eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhh
Q 003039 673 FGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 673 FGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
=.++|...+...+. ......+..||+||.+....|+.++|||||||+||||+| |+.|+..-+.. .+..+ +
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf----Em~~y----l 511 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF----EMEHY----L 511 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH----HHHHH----H
Confidence 99998665554443 233346789999999999999999999999999999999 88888654311 11111 1
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
++| .+-..+..+..++..+..-||+..|++||++.|++.-|.+.-
T Consensus 512 kdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 512 KDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred hcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 122 112234456678999999999999999999999999998864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=271.84 Aligned_cols=220 Identities=21% Similarity=0.176 Sum_probs=174.4
Q ss_pred cCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHHhhhcc
Q 003039 537 GGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 615 (854)
Q Consensus 537 G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~ 615 (854)
|.+|.||+++.. +++.+|+|+++... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999876 68899999986542 233455555556799999999999999999999999999999998853
Q ss_pred cccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeeccccccc
Q 003039 616 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695 (854)
Q Consensus 616 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~ 695 (854)
...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 23588999999999999999999998 9999999999999999999999999987654322 122345778
Q ss_pred ccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHH
Q 003039 696 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 775 (854)
Q Consensus 696 Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l 775 (854)
|+|||.+.+..++.++||||+||++|||++|+.|+...... + . ......+... ....+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~--------~-----~~~~~~~~~~----~~~~~ 205 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I--------N-----THTTLNIPEW----VSEEA 205 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c--------c-----cccccCCccc----CCHHH
Confidence 99999998888999999999999999999999887532210 0 0 0000001111 22457
Q ss_pred HHHHHHccCCCCCCCCCHH
Q 003039 776 EEKALMCVLPHGHMRPSIS 794 (854)
Q Consensus 776 ~~l~~~Cl~~~P~~RPsm~ 794 (854)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=311.38 Aligned_cols=142 Identities=31% Similarity=0.430 Sum_probs=126.2
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.++||+|+||.||+|... +++.||||+++.... .....+..|+.++..++||||+++++++......++||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 45688999999999999887 688999999875432 22366888999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
.+++|.+++.. ...+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999853 34577888899999999999999998 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=267.76 Aligned_cols=264 Identities=27% Similarity=0.371 Sum_probs=197.8
Q ss_pred ccccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHcc-CCCCceeeEeeee
Q 003039 515 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSR-IHHRNLVQFLGYC 591 (854)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~-l~HpnIv~l~g~~ 591 (854)
.+.|+-.++++. ..||.|+||+|+|-.++ .|+..|||+++.... .+.+++..|.+...+ -+.||||+++|.+
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 345555555432 46899999999999887 689999999987654 456678888876544 4789999999999
Q ss_pred eecCeEEEEEEeccCCCHHhhhcc-cccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 003039 592 QEEGRSVLVYEFMHNGTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 670 (854)
Q Consensus 592 ~~~~~~~LV~E~~~~gsL~~~L~~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 670 (854)
..++..++.||.|. -+|+.+-.. ......++++.-.-.|..-...||.||.+. ..|||||+||+|||++..|.+||
T Consensus 133 F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEee
Confidence 99999999999995 355443211 112455677777778888889999999987 48999999999999999999999
Q ss_pred EeeeccccccCCCCceeecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHH
Q 003039 671 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 748 (854)
Q Consensus 671 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~ 748 (854)
||||++-.+.+. ...+.-.|...|||||.+.. ..|+.++||||+|+.|+|+.||+.|+.... ++.+.+..
T Consensus 210 CDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~ 281 (361)
T KOG1006|consen 210 CDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQ 281 (361)
T ss_pred ecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHH
Confidence 999998654432 22334468899999999964 348899999999999999999999997654 23333222
Q ss_pred hhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 749 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 749 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.. .|+...+. . +.-..+....+...+..|+..+-..||...++.++
T Consensus 282 Vv-~gdpp~l~-~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 282 VV-IGDPPILL-F---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HH-cCCCCeec-C---cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22 22221111 1 11123344568889999999999999999998765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=266.29 Aligned_cols=265 Identities=20% Similarity=0.289 Sum_probs=191.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeee--------cCe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EGR 596 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--------~~~ 596 (854)
+.-..+||+|.||.||+|+.+ .|+.||+|++--. ...-.....+|+.+|..++|+|++.+++.|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 333468999999999999876 5778899765322 22223456789999999999999999998843 235
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
.++||.+|+. +|...|.. ...+++..++.+++.++..||.|+|+. .|+|||+||.|+||+.++.+||+|||++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 7999999986 77777743 246788889999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCC---CceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccc-------cchHHH
Q 003039 677 KFAVDGA---SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-------RNIVQW 745 (854)
Q Consensus 677 ~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~-------~~l~~~ 745 (854)
+.+.... ....+..+-|.+|++||.+.+ +.|+.+.|||+.||||.||+||.+-+.+....... .++-.-
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7554322 122334456999999999986 67999999999999999999999988765421111 011111
Q ss_pred HHHhhhcCCccccc--CccccCcCC--HHHHH------HHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 746 AKLHIESGDIQGII--DPSLLDEYD--IQSMW------KIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 746 ~~~~~~~~~~~~~i--d~~l~~~~~--~~~~~------~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
++..+.+-.+...+ .|--.+.+. .+..+ ..++|+..++..||.+|+++++++.|
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11111111111111 110011110 11112 56789999999999999999998865
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=274.39 Aligned_cols=241 Identities=24% Similarity=0.312 Sum_probs=191.5
Q ss_pred HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHH---HHHHHHHHccC-CCCceeeEeeeeeecCeEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~---~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~L 599 (854)
....+|..+||+|+||.|-+|.-+ +.+.+|||+++++..-...+ -..|-++|... +-|.+++++.+|..-+++++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 334567889999999999999766 45679999998764332222 23466666655 56899999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+.||+|.-++. .-+++.+..+.-+|.+||-||-+||++ +|+.||||..|||+|.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999988884 445677888899999999999999999 9999999999999999999999999998732
Q ss_pred cCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.- ......+.+||+.|+|||++...+|+.++|.|||||+||||+.|++||++++..+..+.+.+.
T Consensus 501 i~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------------- 565 (683)
T KOG0696|consen 501 IF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------------- 565 (683)
T ss_pred cc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--------------
Confidence 21 234456678999999999999999999999999999999999999999987644333332221
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCC
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP 791 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 791 (854)
. -.++..-..+...+...-+..+|.+|.
T Consensus 566 --n--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 --N--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --c--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 123333334566777777888898886
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=288.18 Aligned_cols=238 Identities=21% Similarity=0.320 Sum_probs=189.4
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+...+|.|+|+.|-++.+. +++..+||++... ..+..+|+.++... +||||+++.+.+.+..+.++|||.+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 4556778999999999998765 6888999998755 23344567665555 7999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE-cCCCcEEEEeeeccccccCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl-~~~~~vkl~DFGla~~~~~~~ 683 (854)
.++-+.+.+... ......+..|+.+|+.|+.|||++ |++||||||+|||+ ++.++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred cccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 999887777432 122256667999999999999998 99999999999999 58899999999999865443
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
....+-|..|.|||+.....|++++|+||||++||+|++|+.||.....+ .+ +...+..+..
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~e----i~~~i~~~~~-------- 531 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IE----IHTRIQMPKF-------- 531 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HH----HHHhhcCCcc--------
Confidence 22234588999999999999999999999999999999999999765422 11 1222222222
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+........+|+.+|++.+|.+||+|.|+..|
T Consensus 532 ----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 532 ----SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 22333457899999999999999999999876
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=261.24 Aligned_cols=247 Identities=23% Similarity=0.255 Sum_probs=192.6
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeee----cCeEEEEEEec
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFM 604 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~----~~~~~LV~E~~ 604 (854)
.++||-|-.|.|-.+..+ +++..|+|++.. .....+|+++.-.. .|||||.+++++.. ...+++|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 478999999999999776 688999999863 23456788875544 69999999998854 45788999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeeeccccccC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~~ 681 (854)
+||.|...+.+. ..+.+.+.++..|+.||+.|+.|||+. .|.||||||+|+|... |..+||+|||+|+....
T Consensus 142 eGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 142 EGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999988653 345688999999999999999999998 9999999999999974 45799999999986543
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.....+.+-|+.|.|||++-..+|+..+|+||+||++|-|++|.+||-.... .-+.--.+..+..|... .
T Consensus 217 --~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~rI~~gqy~-F--- 286 (400)
T KOG0604|consen 217 --PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKRRIRTGQYE-F--- 286 (400)
T ss_pred --CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHhHhhccCcc-C---
Confidence 2233445679999999999999999999999999999999999999965441 12222233333333210 0
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...--....+...+++...++.+|++|-|+.|++.+
T Consensus 287 --P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 --PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred --CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 000012334567789999999999999999999876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=289.68 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=202.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeee-----cCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE-----EGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~-----~~~~~LV 600 (854)
..|.+.||+|.+|.||+++.. +++.+|||++.... ....+.+.|.++|+.. +|||++.++|++.. ++.++||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 346789999999999999865 68889999986543 4466788899999887 69999999999853 5689999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
||||.+|+..|++.+.. +.++.|..+.-|+++++.||.|||.. .++|||||-.|||++.++.||++|||++....
T Consensus 100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 99999999999998765 78899999999999999999999999 99999999999999999999999999987544
Q ss_pred CCCCceeecccccccccCccccccC-----cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
.. .....+..||+.|||||++... .|+..+|+||+|++..||--|.+|+-++..- .+...+.
T Consensus 175 sT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raLF~Ip---- 241 (953)
T KOG0587|consen 175 ST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RALFLIP---- 241 (953)
T ss_pred cc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhhccCC----
Confidence 33 3344566799999999999643 4677899999999999999999998765511 1111111
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
-.|......+..-..++.+.+..|+..|-++||++.++++|
T Consensus 242 ---RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 ---RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111122234445679999999999999999999998865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=271.32 Aligned_cols=261 Identities=24% Similarity=0.330 Sum_probs=198.9
Q ss_pred HHHHHHHHhhccccccCceEEEEEEE-CCCcEEEEEEEccCCccc-------HHHHHHHHHHHccCCCCceeeEeeeeee
Q 003039 522 DIEDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIHHRNLVQFLGYCQE 593 (854)
Q Consensus 522 ~~~~~~~~~~~~iG~G~fg~Vy~a~~-~~~~~VAvK~l~~~~~~~-------~~~~~~Ev~~L~~l~HpnIv~l~g~~~~ 593 (854)
-....+|.+.+.||+|+|+.||+|.. ...+.||||+-.-+..+. .+...+|..|.+.+.||.||++++++.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34456777889999999999999964 467889999875432221 2346789999999999999999999964
Q ss_pred -cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEE
Q 003039 594 -EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAK 669 (854)
Q Consensus 594 -~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vk 669 (854)
.+..|-|.|||+|.+|+-+|. ..+.+++.++..|+.||+.||.||.+. .++|||-||||.|||+-. .|.+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred ccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 457799999999999999984 455688999999999999999999986 569999999999999954 47899
Q ss_pred EEeeeccccccCCCCc------eeecccccccccCcccccc----CcCCCcchhhhHHHHHHHHHhCCcccccccccccc
Q 003039 670 VSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 739 (854)
Q Consensus 670 l~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~----~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~ 739 (854)
|.|||+++.+.+.... ......||.+|++||.+.- .+++.|+||||.|||+|+++.|+.||..... .
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---Q 690 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---Q 690 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---H
Confidence 9999999977654322 3345679999999999864 3578899999999999999999999976431 1
Q ss_pred cchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 740 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 740 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.+.+. ..+...-.-.+ ........+...++.+|++..-++|....|+..+
T Consensus 691 QdILqe-------NTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 691 QDILQE-------NTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred HHHHhh-------hchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 223322 11111111011 0112223456788999999999999888887654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=239.56 Aligned_cols=258 Identities=20% Similarity=0.279 Sum_probs=188.7
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
.++||+|.||+|++|+.. .++.||+|.++-+. ........+|+-+|+.++|+|||++++....++.+.+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 468999999999999866 57889999987543 33356678999999999999999999999999999999999964
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|..+... -.+.++......++.|+++||.++|++ .+.|||+||.|.||+.+|+.|++|||+++-++-.....+
T Consensus 86 dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 86 DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 67666542 245677888889999999999999998 999999999999999999999999999986654332222
Q ss_pred ecccccccccCccccccC-cCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHh--hhcCCc---ccccC
Q 003039 688 SIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH--IESGDI---QGIID 760 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~--~~~~~~---~~~id 760 (854)
...-|.+|++|.++.+. -|+...|+||.||++.|+.. |++.|.+.+.. .++...++.. ..++.. ...-|
T Consensus 160 -aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd---dqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 160 -AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred -ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH---HHHHHHHHHhCCCccccCCccccCCC
Confidence 23468999999999875 47888999999999999997 66666654422 1222222211 111111 11111
Q ss_pred ccccCcCCH-----HHH----HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDI-----QSM----WKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~-----~~~----~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
=.....++. +.+ ..=.++....+.-+|.+|.++++.+++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111222221 111 122456666777789999998877664
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=260.61 Aligned_cols=239 Identities=27% Similarity=0.423 Sum_probs=192.7
Q ss_pred CceEEEEEEEC-CCcEEEEEEEccCCccc-HHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHHhhhcc
Q 003039 538 GFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 615 (854)
Q Consensus 538 ~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~-~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~ 615 (854)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997665444 67899999999999999999999999999999999999999999998853
Q ss_pred cccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeeccccccc
Q 003039 616 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695 (854)
Q Consensus 616 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~ 695 (854)
. ..+++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2278889999999999999999998 99999999999999999999999999987654432 2234458889
Q ss_pred ccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHH
Q 003039 696 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 775 (854)
Q Consensus 696 Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l 775 (854)
|++||......++.++||||||++++++++|..||.... ....+.++.. .+.... . ........++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~~~~~~----~~~~~~-~------~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLELFKKIG----KPKPPF-P------PPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHh----ccCCCC-c------cccccCCHHH
Confidence 999999998889999999999999999999999986522 1112222211 111100 0 0000023468
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 003039 776 EEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 776 ~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+++.+|+..+|++||++.+++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhhC
Confidence 899999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=300.24 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=199.7
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC---CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~---~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
..+.+.++||+|+||.|...+++ .++.+|+|++.+. .......|.+|-.+|...+.+-|+.++-.|.+..++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 34456789999999999999987 5788999999763 2334567889999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
|||+||+|-.++. ...++++.-+..++..|..||.-||+. |+|||||||.|||||..|++||+|||.+-.+..
T Consensus 155 dY~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred ecccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 9999999999884 334788888889999999999999998 999999999999999999999999998866665
Q ss_pred CCCceeecccccccccCcccccc-----CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
.....+...+|||.|++||++.. +.|+..+|.||+||++|||+.|..||.....-+.+..|... ....
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-------k~~l 300 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-------KESL 300 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-------hhhc
Confidence 55556666789999999999863 56889999999999999999999999876543333333222 1100
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---m~eV~~~ 799 (854)
.. ....+...+..+||..-+. +|+.|-. +.++..|
T Consensus 301 ~F-------P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 301 SF-------PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CC-------CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 00 0012233456677766554 4555666 8888877
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=293.94 Aligned_cols=259 Identities=24% Similarity=0.269 Sum_probs=167.5
Q ss_pred HHhhccccccCceEEEEEEEC-C----CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeee------eeecCe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-D----GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY------CQEEGR 596 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~----~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~------~~~~~~ 596 (854)
+.+.+.||+|+||.||+|++. + +..||||++..... .+....| .+....+.++..++.. +.....
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 446789999999999999886 4 68999998764321 1111111 1122222223222221 245667
Q ss_pred EEEEEEeccCCCHHhhhccccc----------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLT----------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 660 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 660 (854)
.++||||+.+++|.+++..... .........+..++.|++.||+|||+. +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 8999999999999998853210 001112334567999999999999998 999999999999
Q ss_pred EEcC-CCcEEEEeeeccccccCCCCceeecccccccccCccccccC----------------------cCCCcchhhhHH
Q 003039 661 LLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ----------------------QLTDKSDVYSFG 717 (854)
Q Consensus 661 Ll~~-~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~~~DVwSlG 717 (854)
|++. ++.+||+|||+|+..............+|+.|+|||.+... .+..++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9986 58999999999986554444444556789999999965322 234567999999
Q ss_pred HHHHHHHhCCcccccccc------cccccchHHHHHHhhhcCCcccccCccccCcCC--HHHHHHHHHHHHHccCCCCCC
Q 003039 718 VILLELISGQEAISNEKF------GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD--IQSMWKIEEKALMCVLPHGHM 789 (854)
Q Consensus 718 vvl~elltG~~pf~~~~~------~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~--~~~~~~l~~l~~~Cl~~~P~~ 789 (854)
|++|||+++..+++.... ......+..|....... ..+.+...++ ........+|+.+|++.||++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999998766542210 00011122232211100 0000000000 001123458999999999999
Q ss_pred CCCHHHHHHH
Q 003039 790 RPSISEVLKD 799 (854)
Q Consensus 790 RPsm~eV~~~ 799 (854)
|||++|+++|
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=284.26 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=177.5
Q ss_pred HHhhccccccCceEEEEEEE-----------------CCCcEEEEEEEccCCcccHHH--------------HHHHHHHH
Q 003039 528 KMLEKKIGSGGFGVVYYGKL-----------------KDGKEIAVKVLTSNSYQGKRE--------------FTNEVTLL 576 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~-----------------~~~~~VAvK~l~~~~~~~~~~--------------~~~Ev~~L 576 (854)
+.+.++||+|+||+||+|.+ ..++.||||++........++ ...|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 44578999999999999964 235679999986543222222 33466777
Q ss_pred ccCCCCce-----eeEeeeeee--------cCeEEEEEEeccCCCHHhhhccccc--------------------ccccc
Q 003039 577 SRIHHRNL-----VQFLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLT--------------------HEQRI 623 (854)
Q Consensus 577 ~~l~HpnI-----v~l~g~~~~--------~~~~~LV~E~~~~gsL~~~L~~~~~--------------------~~~~l 623 (854)
.+++|.++ ++++++|.. .+..+|||||+++|+|.++++.... ....+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766554 677887753 3568999999999999999864211 11235
Q ss_pred cHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeecccccccccCccccc
Q 003039 624 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703 (854)
Q Consensus 624 ~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 703 (854)
++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..............+|+.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 6778889999999999999998 9999999999999999999999999999754333222222233578999999875
Q ss_pred cCcC----------------------CCcchhhhHHHHHHHHHhCCc-cccccccc-----ccccchHHHHHHhhhcCCc
Q 003039 704 SQQL----------------------TDKSDVYSFGVILLELISGQE-AISNEKFG-----ANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 704 ~~~~----------------------s~~~DVwSlGvvl~elltG~~-pf~~~~~~-----~~~~~l~~~~~~~~~~~~~ 755 (854)
.... ..+.||||+||+++||++|.. |+.....- .....+..|.. .....
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~- 460 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQK- 460 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccC-
Confidence 4321 124699999999999999875 66432210 00111222221 11111
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHG---HMRPSISEVLKD 799 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPsm~eV~~~ 799 (854)
++-...+. ......+++.+++..+| .+|+|++|+++|
T Consensus 461 ---~~~~~~d~----~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 ---YDFSLLDR----NKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ---CCcccccc----cChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111111 22356788888888755 689999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=240.84 Aligned_cols=199 Identities=27% Similarity=0.399 Sum_probs=169.0
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccC-CcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
...||+|++|.|-+-++. +|+..|+|.+... ..+..+...+|+.+..+. .+|.+|.++|.....+..++.||.|. .
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence 467999999999888765 7899999999765 334456677888775554 79999999999999999999999995 4
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|+.+-......+..+++.-.-+|+..+.+||.|||++ ..++|||+||+|||++.+|++|+||||++-++.+.. ..
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--Ak 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--AK 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh--HH
Confidence 88887777777888999999999999999999999998 589999999999999999999999999997665432 22
Q ss_pred ecccccccccCcccccc----CcCCCcchhhhHHHHHHHHHhCCccccccc
Q 003039 688 SIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEK 734 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~----~~~s~~~DVwSlGvvl~elltG~~pf~~~~ 734 (854)
+...|...|||||.+.. ..|+-++||||+|+.+.||.+++.|++...
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 23458899999999863 368899999999999999999999997654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=264.70 Aligned_cols=272 Identities=20% Similarity=0.262 Sum_probs=205.4
Q ss_pred ccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCC--C----ceeeEee
Q 003039 517 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--R----NLVQFLG 589 (854)
Q Consensus 517 ~~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~H--p----nIv~l~g 589 (854)
.+..+|....+|.+...+|+|.||.|-.+... .+..||||+++... .-.+...-|+++|+++.+ | -++.+.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 35667777888888999999999999999765 46889999997543 224456679999999942 2 3678889
Q ss_pred eeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc------
Q 003039 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD------ 663 (854)
Q Consensus 590 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~------ 663 (854)
||.-.++.|+|+|.+ |-++.++|... ....++..++..|+.|+++++++||+. +++|-||||+|||+.
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence 999999999999987 55899999653 456788889999999999999999998 999999999999993
Q ss_pred --------------CCCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcc
Q 003039 664 --------------KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 729 (854)
Q Consensus 664 --------------~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~p 729 (854)
.+..+||+|||.|++..... ...+.|..|+|||++.+-.++..+||||+||||.|+.||...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 24468999999998654332 345579999999999999999999999999999999999998
Q ss_pred ccccccc-----------ccccchHHHH--HHhhhcCCcc-----------cccCccc----cCcCCHHHHHHHHHHHHH
Q 003039 730 ISNEKFG-----------ANCRNIVQWA--KLHIESGDIQ-----------GIIDPSL----LDEYDIQSMWKIEEKALM 781 (854)
Q Consensus 730 f~~~~~~-----------~~~~~l~~~~--~~~~~~~~~~-----------~~id~~l----~~~~~~~~~~~l~~l~~~ 781 (854)
|.....- .....++... ...+..|++. .+.++.. .-.....+..++.+|+..
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 8643311 1111222211 1111222211 0111110 011234566789999999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 003039 782 CVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 782 Cl~~~P~~RPsm~eV~~~ 799 (854)
++..||.+|+|+.|.++|
T Consensus 389 mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSH 406 (415)
T ss_pred HHccCccccccHHHHhcC
Confidence 999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=271.11 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=198.6
Q ss_pred hccccccCceEEEEEEECCCc-EEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 531 EKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~-~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
...||-|+||.|=+.+.+... ..|+|++++... ...+....|-.+|..++.|.||+++--|.++...|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 356999999999999887433 378898876532 3344567899999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|.|...|+ ..+.++..+...++..+.+|++|||++ +||+|||||+|++++.+|-+||.|||+|+....+ ..
T Consensus 505 GElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~K 575 (732)
T KOG0614|consen 505 GELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RK 575 (732)
T ss_pred chhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--Cc
Confidence 99999995 456678888888999999999999999 9999999999999999999999999999977654 34
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
+.+++||+.|.|||++.....+.++|.||+|+++|||++|.+||.+.+.-..+..+.. | +| .-.
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk--------G-----id---~i~ 639 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK--------G-----ID---KIE 639 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh--------h-----hh---hhh
Confidence 5667899999999999999999999999999999999999999987652111111111 1 00 012
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
++....+...+|+.+.++.+|.+|.. +.+|-+|
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 33344456778888999999999985 6777666
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=284.91 Aligned_cols=244 Identities=27% Similarity=0.384 Sum_probs=187.6
Q ss_pred hccccccCce-EEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 531 EKKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 531 ~~~iG~G~fg-~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
.+.+|.|+.| .||+|... |++||||++-.. ......+|+..|+.- .|||||++++.-.+++..|+..|.|. .+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 4678999998 67999986 899999987533 234567899999988 69999999999999999999999996 49
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---C--CcEEEEeeeccccccCCC
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---H--MRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~--~~vkl~DFGla~~~~~~~ 683 (854)
|.+++.....+.....-...+.+..|++.||+|||+. +||||||||.||||+. + ..++|+|||+++....+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999975311111122245577899999999999997 9999999999999976 2 579999999999776655
Q ss_pred Ccee--ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhC-CcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 684 SHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 684 ~~~~--~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG-~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
.... ....||-||+|||++....-+.++||||+|||+|..++| .+||.+.-. ...+|+.-. ..+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~------~~L~---- 733 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGN------YTLV---- 733 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCc------ccee----
Confidence 4433 456799999999999988888899999999999999996 899975331 111221100 0000
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.. ..++ +..+|+.+|++++|..||++.+|+.|
T Consensus 734 -~L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 -HLEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -eecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0011 1111 67899999999999999999999976
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-30 Score=255.61 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=193.4
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecC-----eEEEEEE
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYE 602 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~-----~~~LV~E 602 (854)
++.||.|+||.||..++. +|+.||+|++... .....+.+.+|+++|...+|.|++..+++..... +.++++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 467999999999999765 7999999988643 2234567789999999999999999988765443 4567778
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
.|.. +|...+ ...+.++-..+.-+..||++||.|||+. +|.||||||.|.|++.+...||||||+++.....
T Consensus 138 LmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 7743 555544 5667788888888999999999999998 9999999999999999999999999999976655
Q ss_pred CCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccc---------------cccchHHHH
Q 003039 683 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGA---------------NCRNIVQWA 746 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~---------------~~~~l~~~~ 746 (854)
....++...-|..|+|||++++ +.|+.+.||||.||++.|++..+..|.....-+ ..+.-.+.+
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 5555556667999999999987 579999999999999999999888876433111 111112222
Q ss_pred HHhhhcCCcccccCccccCc-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 747 KLHIESGDIQGIIDPSLLDE-YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 747 ~~~~~~~~~~~~id~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
+..+-.+....---+.+..- -....-.+...+.+.++..+|..|.+..+.+.++..
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 22222221111000111000 011122345677788899999999999998887654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=258.23 Aligned_cols=277 Identities=22% Similarity=0.346 Sum_probs=205.1
Q ss_pred ccccccCHHHHHH-HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-----C---C
Q 003039 513 EAAHCFTLSDIED-ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----H---R 582 (854)
Q Consensus 513 ~~~~~~~~~~~~~-~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-----H---p 582 (854)
...|....+|... .+|.+.++||-|.|++||++.+. ..+.||+|+.+... .-.+....|+++|++++ | .
T Consensus 64 GGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 64 GGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred CCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 3456677777776 88889999999999999999765 57789999987543 33456778999999984 2 4
Q ss_pred ceeeEeeeeee----cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 003039 583 NLVQFLGYCQE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 658 (854)
Q Consensus 583 nIv~l~g~~~~----~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~ 658 (854)
.||+|+++|.. +.+.|||+|+. |-+|..+|.. ...+.++...+.+|+.||+.||.|||++| +|||-||||+
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPE 217 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPE 217 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcc
Confidence 79999999964 45899999988 4577777743 24567889999999999999999999998 9999999999
Q ss_pred CEEEc---------------------------------------------------------------------------
Q 003039 659 NILLD--------------------------------------------------------------------------- 663 (854)
Q Consensus 659 NILl~--------------------------------------------------------------------------- 663 (854)
|||+.
T Consensus 218 NvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~ 297 (590)
T KOG1290|consen 218 NVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEE 297 (590)
T ss_pred eeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 99991
Q ss_pred ---------------------------------------C----------------------------------------
Q 003039 664 ---------------------------------------K---------------------------------------- 664 (854)
Q Consensus 664 ---------------------------------------~---------------------------------------- 664 (854)
.
T Consensus 298 ~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n 377 (590)
T KOG1290|consen 298 PNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASN 377 (590)
T ss_pred ccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccc
Confidence 0
Q ss_pred ------------CCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccc
Q 003039 665 ------------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 732 (854)
Q Consensus 665 ------------~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~ 732 (854)
+.++||+|||-|+.... ..+.-..|..|+|||++.+..|+..+||||++|+++||+||...|+.
T Consensus 378 ~~v~p~~~~~~~di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFeP 453 (590)
T KOG1290|consen 378 PLVNPDIPLPECDIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEP 453 (590)
T ss_pred cccCCCCCCCccceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecC
Confidence 01256677776654321 11222358899999999999999999999999999999999988864
Q ss_pred cc---ccccccchHHHHHH-------hhhc-----------CCcccccCcc-------ccC--cCCHHHHHHHHHHHHHc
Q 003039 733 EK---FGANCRNIVQWAKL-------HIES-----------GDIQGIIDPS-------LLD--EYDIQSMWKIEEKALMC 782 (854)
Q Consensus 733 ~~---~~~~~~~l~~~~~~-------~~~~-----------~~~~~~id~~-------l~~--~~~~~~~~~l~~l~~~C 782 (854)
.. ...+..+|...+.. .... |++..|-.-. |.. +++.++..++.+++.-|
T Consensus 454 hsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~Pm 533 (590)
T KOG1290|consen 454 HSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPM 533 (590)
T ss_pred CCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHH
Confidence 33 22222233222111 1111 2222221111 111 34678888999999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 003039 783 VLPHGHMRPSISEVLKD 799 (854)
Q Consensus 783 l~~~P~~RPsm~eV~~~ 799 (854)
++.+|++|||+.+.++|
T Consensus 534 Lef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 534 LEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HhcCccccccHHHHhcC
Confidence 99999999999999976
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=248.77 Aligned_cols=244 Identities=22% Similarity=0.296 Sum_probs=191.2
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEec
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
+.++||+|+|+.|-.++++ +.+.+|+|++++... +...-...|-.+..+. +||.+|-++.+|..+.++++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 4678999999999999876 577899999876422 2223344455555444 7999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
+||+|.-++ ...+++++..+..+..+|..||.|||+. ||+.||||..|||+|..|.+||.|+|+++.-. ...
T Consensus 334 ~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-~~g 405 (593)
T KOG0695|consen 334 NGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GPG 405 (593)
T ss_pred cCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-CCC
Confidence 999997766 4567799999999999999999999999 99999999999999999999999999987432 234
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
....+++||+.|+|||++.+..|...+|.|++||+|+||+.|+.||+-.......++-.++..+.+-+..+ +
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--------r 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--------R 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--------c
Confidence 45667899999999999999999999999999999999999999997544333334444444444333222 1
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRP 791 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP 791 (854)
- +..-..+...+.+.-+..||++|.
T Consensus 478 i--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 I--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred c--cceeehhhHHHHHHhhcCCcHHhc
Confidence 1 111112345667778899999886
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=263.14 Aligned_cols=209 Identities=25% Similarity=0.383 Sum_probs=173.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCccc---HHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~---~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.||-|+||+|.+++-. +...+|+|.+++.+.-. ....+.|-.||.....+-||+|+-.|.+++.+|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 56999999999999644 46678999987654322 334678999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccc---------c
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK---------F 678 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~---------~ 678 (854)
++..+|.. -+-+.+..+..++.+++.|+++.|.. |+|||||||.|||||.+|++||.||||+. +
T Consensus 715 DmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 715 DMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99998843 23456666777889999999999998 99999999999999999999999999984 1
Q ss_pred ccCCCCc--------------------------------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhC
Q 003039 679 AVDGASH--------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726 (854)
Q Consensus 679 ~~~~~~~--------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG 726 (854)
+..+.-+ .....+||+.|+|||++....++..+|.||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 1111000 01123499999999999999999999999999999999999
Q ss_pred CcccccccccccccchHHHHH
Q 003039 727 QEAISNEKFGANCRNIVQWAK 747 (854)
Q Consensus 727 ~~pf~~~~~~~~~~~l~~~~~ 747 (854)
+.||-.....+....++.|-.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred CCCccCCCCCcceeeeeehhh
Confidence 999988887777777778744
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=235.10 Aligned_cols=211 Identities=35% Similarity=0.609 Sum_probs=182.8
Q ss_pred ccccCceEEEEEEECC-CcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHHh
Q 003039 534 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 611 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 611 (854)
||+|.+|.||++...+ ++.+++|++...... ....+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998755432 34678999999999999999999999999999999999999999999
Q ss_pred hhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeeeccccccCCCCceeecc
Q 003039 612 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIV 690 (854)
Q Consensus 612 ~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~ 690 (854)
++.... ..+++..+..++.+++++|++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 985321 4578889999999999999999998 9999999999999999 89999999999875543321 12234
Q ss_pred cccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCH
Q 003039 691 RGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769 (854)
Q Consensus 691 ~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 769 (854)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999887 888999999999999999
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 770 ~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
..+.+++..|++.+|++||++.++++++
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3577899999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=224.47 Aligned_cols=256 Identities=20% Similarity=0.327 Sum_probs=193.6
Q ss_pred HHHhhccccccCceEEEEEEE-CCCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeeeeeec--CeEEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYE 602 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~-~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~--~~~~LV~E 602 (854)
.|.+.+++|+|.|+.|+.|.. .+.++++||+++.. ..+.+.+|+.+|+.+. ||||+++++...+. ....||+|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 466789999999999999974 46889999999743 3567899999999997 99999999998765 45689999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeeeccccccC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD 681 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~~~ 681 (854)
|+.+.+....- ..+....+..++.+++.||.|+|+. ||+|||+||.|++||.. -..+|+|+|+|.+..+
T Consensus 116 ~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 116 YVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99997765433 3466677888999999999999998 99999999999999965 5699999999987765
Q ss_pred CCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhc------CC
Q 003039 682 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES------GD 754 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~------~~ 754 (854)
+... .....+..|..||.+.. ..|+..-|+|||||++..|+..+.||-... +...+++..++-.-.+ ++
T Consensus 186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~--dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC--CCHHHHHHHHHHhChHHHHHHHHH
Confidence 5433 33456788999999875 567888999999999999999999985433 1223444433221000 00
Q ss_pred cccccCccccC---cCC-------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLD---EYD-------------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~---~~~-------------~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..-.+||.+.+ ..+ .-...+.++++...+..|-.+|||++|.+.|
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11113333321 100 1112567889999999999999999999887
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-27 Score=238.17 Aligned_cols=249 Identities=25% Similarity=0.336 Sum_probs=186.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecC------eEEEEEE
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVYE 602 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~------~~~LV~E 602 (854)
..+|.|.- .|..|.+. .++.||+|++... .....+...+|..++..+.|+||++++.++.... ..++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45777877 56566443 5889999987533 2334566778999999999999999999996543 5689999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
+|. ++|.+.+. -.++-.+...|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+.....
T Consensus 102 ~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 102 LMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence 995 57887774 2356667788999999999999998 9999999999999999999999999999754332
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc-------
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI------- 755 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~------- 755 (854)
-..+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.. .+-+|.+..-.-|..
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d------~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD------HIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch------HHHHHHHHHHHhcCCCHHHHHH
Confidence 34455668999999999999889999999999999999999999887543 233333221111110
Q ss_pred --------------------cccc-CccccC--cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 --------------------QGII-DPSLLD--EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 --------------------~~~i-d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.+ |..... +.+.-......+++.+|+-.+|++|-+++++++|
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 000000 1111223457789999999999999999999987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-27 Score=252.74 Aligned_cols=279 Identities=18% Similarity=0.277 Sum_probs=208.9
Q ss_pred cccccccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC------CCce
Q 003039 512 AEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH------HRNL 584 (854)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~------HpnI 584 (854)
++..-.+.++|+.+.+|.+....|+|-|++|.+|... .|..||||++..+..- .+.=..|+++|++|+ --+.
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHH
Confidence 3455667889999999998889999999999999876 4889999999866432 344467999999995 3578
Q ss_pred eeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 003039 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 664 (854)
Q Consensus 585 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 664 (854)
++|+-.|...+++|||+|-+ ..+|.+.|... .....|....+..++.|+.-||..|..+ +|+|.||||.|||+++
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence 99999999999999999976 46888888643 3455677888999999999999999998 9999999999999997
Q ss_pred C-CcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchH
Q 003039 665 H-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 743 (854)
Q Consensus 665 ~-~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~ 743 (854)
. ..+||||||.|........ +...-+..|.|||++.+.+|+...|+||.||.||||.||+..|.+........-..
T Consensus 572 ~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred CcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 6 5689999999876544321 11223567999999999999999999999999999999999997654221111000
Q ss_pred H----HHHHhhhcCCcc-cccCcc--------------------------------ccC-----cCCHHHHHHHHHHHHH
Q 003039 744 Q----WAKLHIESGDIQ-GIIDPS--------------------------------LLD-----EYDIQSMWKIEEKALM 781 (854)
Q Consensus 744 ~----~~~~~~~~~~~~-~~id~~--------------------------------l~~-----~~~~~~~~~l~~l~~~ 781 (854)
+ +....+..|.+. .-+|.. |.. +-....+..+.+|...
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 0 000111111110 001111 100 1123455678899999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 003039 782 CVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 782 Cl~~~P~~RPsm~eV~~~ 799 (854)
|+..||++|-|..|.++|
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999998876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=232.21 Aligned_cols=196 Identities=35% Similarity=0.547 Sum_probs=170.2
Q ss_pred hhccccccCceEEEEEEECC-CcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.||+|++|.||++...+ ++.+|+|.+...... ....+.+|++.+++++|+|++++++++......++++|+++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999999875 889999999765544 5678899999999999999999999999999999999999999
Q ss_pred CHHhhhccccccccc-ccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 608 TLKEHLYGTLTHEQR-INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 608 sL~~~L~~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
+|.+++... .. +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 83 DLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999988542 22 78889999999999999999998 99999999999999999999999999987665432112
Q ss_pred eecccccccccCcccc-ccCcCCCcchhhhHHHHHHHHHhCCccccc
Q 003039 687 SSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAISN 732 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~-~~~~~s~~~DVwSlGvvl~elltG~~pf~~ 732 (854)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334578899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=249.23 Aligned_cols=192 Identities=22% Similarity=0.415 Sum_probs=163.4
Q ss_pred hhccccccCceEEEEEEECC-CcEEEEEEEccCCccc--------HHHHHHHHHHHccCC---CCceeeEeeeeeecCeE
Q 003039 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG--------KREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRS 597 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~--------~~~~~~Ev~~L~~l~---HpnIv~l~g~~~~~~~~ 597 (854)
..+.+|.|+||.|+.|.++. ..+|+||.+.+...-. ......|++||..++ |+||++++++|++++.+
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 35789999999999999874 5679999987542211 123567999999997 99999999999999999
Q ss_pred EEEEEecc-CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 598 VLVYEFMH-NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 598 ~LV~E~~~-~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
+|+||-.. +-+|.+++ ....++++.....|+.|++.|+++||+. +|||||||-+||.++.+|-+||+|||.|
T Consensus 645 yl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred EEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence 99999754 45788887 3466789999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeecccccccccCccccccCcCCC-cchhhhHHHHHHHHHhCCcccc
Q 003039 677 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGVILLELISGQEAIS 731 (854)
Q Consensus 677 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-~~DVwSlGvvl~elltG~~pf~ 731 (854)
.+...+. ...++||.+|.|||++.+.+|-- .-|||++|++||-++....||-
T Consensus 718 a~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 7765543 34567999999999999988765 4699999999999998888764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-26 Score=250.43 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=197.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.+++|+|.||.||||+.+ .++..|||+++-.......-..+|+-+++.++||||+.++|.+...+..++.||||.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 445688999999999999876 6888999999876666667778899999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|++.-+. -..+++.+...++++.++||+|||+. +=+|||||-.|||+++.|.+|++|||.+-.+... ...
T Consensus 97 gslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~K 168 (829)
T KOG0576|consen 97 GSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAK 168 (829)
T ss_pred Ccccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-hhh
Confidence 999986643 34677888888999999999999998 8899999999999999999999999987543322 122
Q ss_pred eecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 687 SSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
...+.||+.|||||+.. .+.|...+|||++|+...|+---+.|..+.. ...+...+...... .+.+
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--------pmr~l~LmTkS~~q---pp~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--------PMRALFLMTKSGFQ---PPTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--------hHHHHHHhhccCCC---CCcc
Confidence 34467999999999874 5678999999999999999987777654322 12222222221111 1111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+. ..--..+-++++.|+..+|++||+++.+++|
T Consensus 238 kDk--~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 238 KDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cCC--ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111 1122357789999999999999999988764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=271.92 Aligned_cols=196 Identities=18% Similarity=0.268 Sum_probs=139.0
Q ss_pred cCCC-CceeeEeeee-------eecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc
Q 003039 578 RIHH-RNLVQFLGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649 (854)
Q Consensus 578 ~l~H-pnIv~l~g~~-------~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 649 (854)
.++| +||++++++| ......++++|++ +++|.++|.. ....+++.+++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3455 6888888877 2334567788877 5699999963 235589999999999999999999998 9
Q ss_pred eecCCCCCCCEEEcCC-------------------CcEEEEeeeccccccCCCC---------------ceeeccccccc
Q 003039 650 IIHRDLKSSNILLDKH-------------------MRAKVSDFGLSKFAVDGAS---------------HVSSIVRGTVG 695 (854)
Q Consensus 650 ivHrDIkp~NILl~~~-------------------~~vkl~DFGla~~~~~~~~---------------~~~~~~~gt~~ 695 (854)
|+||||||+||||+.. +.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999653 4556666666653211000 00112357899
Q ss_pred ccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHH
Q 003039 696 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 775 (854)
Q Consensus 696 Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l 775 (854)
|||||++.+..++.++|||||||+||||++|..|+.... ..+...... .+.+.. .....+.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~---------~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR---------VLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh---------hcChhh-----hhcCHHH
Confidence 999999999999999999999999999999988865321 011111000 011111 1112345
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 003039 776 EEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 776 ~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..++.+|++++|.+||+|.||+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 678889999999999999999764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=212.31 Aligned_cols=251 Identities=20% Similarity=0.312 Sum_probs=180.5
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeee-eeecCeEEEEEEe
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY-CQEEGRSVLVYEF 603 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~-~~~~~~~~LV~E~ 603 (854)
.|.+.+.+|+|.||.+-++.++ ..+.+++|.++.. ....++|.+|..-=-.+ .|.||+.-++. |...+..++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 4667889999999999999987 4678999987643 34467888887654444 68999987764 6777888999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc--CCCcEEEEeeeccccccC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkl~DFGla~~~~~ 681 (854)
++.|+|.+.+.. ..+.+....+++.|++.||.|+|++ .+||||||.+||||- +..++||||||+++..+.
T Consensus 104 aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999987732 4466777788999999999999999 999999999999994 335899999999864322
Q ss_pred CCCceeecccccccccCccccccC-----cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
......-+..|.+||..... ...+.+|||.||++++.++||+.||.... ..+....+|.. +..+...
T Consensus 176 ----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~~d~~Y~~~~~--w~~rk~~ 247 (378)
T KOG1345|consen 176 ----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--IMDKPYWEWEQ--WLKRKNP 247 (378)
T ss_pred ----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--ccCchHHHHHH--HhcccCc
Confidence 11223346789999987542 35667899999999999999999998433 22233333322 2222221
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
. -|..-..++ .++.++-.+-+.++|++|=...++.+..
T Consensus 248 ~--~P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 A--LPKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred c--CchhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 1 111122222 2455666777889999885555555443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=209.57 Aligned_cols=168 Identities=20% Similarity=0.199 Sum_probs=126.4
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++... ...+++.+++.++.|+++||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6888888532 44689999999999999999999997 4 999999999999999 99987654322
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............... ++.-. .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~------~~~~~-~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPAD------DPRDR-S 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhccC------Ccccc-c
Confidence 2589999999999999999999999999999999999999965431 111111111111110 00000 0
Q ss_pred CCHHHH--HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 767 YDIQSM--WKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 767 ~~~~~~--~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
...... ..+.+++.+|++.+|++||++.|+++++....
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 011111 25899999999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=223.73 Aligned_cols=192 Identities=26% Similarity=0.420 Sum_probs=157.9
Q ss_pred HhhccccccCceEEEEEEEC----CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
...++||+|.|++||+|.+. ..+.||+|.+...+. ......|+++|..+ .+.||+++.+++...+..++|+||
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 44689999999999999764 367899998865543 34578999999998 589999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeeecccccc--
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV-- 680 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~~-- 680 (854)
++.....++... ++...+..+++.+..||+++|.. |||||||||+|+|.+.. +.-.|.|||+|....
T Consensus 117 ~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 117 FEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred cCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999888887743 45677888999999999999999 99999999999999865 678999999996110
Q ss_pred ---------------C--C--------------CC----------ceeecccccccccCcccccc-CcCCCcchhhhHHH
Q 003039 681 ---------------D--G--------------AS----------HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGV 718 (854)
Q Consensus 681 ---------------~--~--------------~~----------~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGv 718 (854)
. + .. .......||+||+|||++.. ...+.++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0 00 00112459999999999875 56788999999999
Q ss_pred HHHHHHhCCccccc
Q 003039 719 ILLELISGQEAISN 732 (854)
Q Consensus 719 vl~elltG~~pf~~ 732 (854)
|++-+++++.||-.
T Consensus 267 I~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFK 280 (418)
T ss_pred eeehhhcccccccc
Confidence 99999999999853
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-22 Score=216.47 Aligned_cols=160 Identities=19% Similarity=0.181 Sum_probs=124.4
Q ss_pred HHhhccccccCceEEEEEEEC--CCcEEEEEEEccCC-----cccHHHHHHHHHHHccCCCCceee-EeeeeeecCeEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQ-FLGYCQEEGRSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~--~~~~VAvK~l~~~~-----~~~~~~~~~Ev~~L~~l~HpnIv~-l~g~~~~~~~~~L 599 (854)
|.+.+.||+|+||+||+|.++ +++.||||++.... ......+.+|+++|++++|+|+++ ++++ +..++
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~L 95 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGL 95 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEE
Confidence 556789999999999999875 47778999875331 122456899999999999999985 4432 45799
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCC-CCCCEEEcCCCcEEEEeeecccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI-kp~NILl~~~~~vkl~DFGla~~ 678 (854)
||||+++++|.. +. ... ...++.++++||+|||+. +|+|||| ||+|||++.++++||+|||+|+.
T Consensus 96 VmE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 96 VRGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 999999999963 21 111 135788999999999998 9999999 99999999999999999999986
Q ss_pred ccCCCCce-------eecccccccccCccccccC
Q 003039 679 AVDGASHV-------SSIVRGTVGYLDPEYYISQ 705 (854)
Q Consensus 679 ~~~~~~~~-------~~~~~gt~~Y~aPE~~~~~ 705 (854)
........ -....+++.|+|||++...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 54432111 1345688999999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=202.24 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=189.5
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
++..+|.+...|..|+|+|+ |..+++|++.... ....++|.+|.-.|+.+.||||+.++|.|.......++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 35567889999999999998 6777888876443 23357899999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE--eeeccccccCCCC
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS--DFGLSKFAVDGAS 684 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~--DFGla~~~~~~~~ 684 (854)
|+|...|++. ..-..+-.++.+++.++|+|++|||+.. +-|..--+.+..|++|++.+++|+ |--++- ..
T Consensus 272 gslynvlhe~--t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf---qe-- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---QE-- 343 (448)
T ss_pred hHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---ec--
Confidence 9999999864 3445677889999999999999999963 233344689999999999998885 322211 00
Q ss_pred ceeecccccccccCccccccCcCC---CcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLT---DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s---~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
....-.+.||+||.++..+-+ .++|+|||++++||+.|...||.+...-+.. .+ +.-+
T Consensus 344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mk----------iale 404 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MK----------IALE 404 (448)
T ss_pred ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hh----------hhhc
Confidence 111236889999999876543 4789999999999999999999765411110 01 1111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.++...+......+.+|+.-|+..||.+||.++.|+-.||++.
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2233333344456778899999999999999999999999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-21 Score=208.64 Aligned_cols=261 Identities=21% Similarity=0.251 Sum_probs=193.2
Q ss_pred HHHhhccccccCceEEEEEEECCC--cEEEEEEEccCCcccHHHHHHHHHHHccCCC----CceeeEeeee-eecCeEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKDG--KEIAVKVLTSNSYQGKREFTNEVTLLSRIHH----RNLVQFLGYC-QEEGRSVL 599 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~~--~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~H----pnIv~l~g~~-~~~~~~~L 599 (854)
.+.+.++||+|+||.||++..... ..+|+|+...........+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 456788999999999999987653 4789998765433333367888888888863 6888888888 47778899
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-----CcEEEEeee
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFG 674 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-----~~vkl~DFG 674 (854)
||+.+ |.+|.++..... .++++..+.+.|+.|++.+|++||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99976 679998764332 57899999999999999999999998 99999999999999865 469999999
Q ss_pred ccc--cccCCCC----ce---eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHH
Q 003039 675 LSK--FAVDGAS----HV---SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 745 (854)
Q Consensus 675 la~--~~~~~~~----~~---~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~ 745 (854)
+++ ....... .. .....||..|+++....+...+.+.|+||++.++.|++.|..||...........+..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~- 251 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK- 251 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH-
Confidence 998 3221111 11 2335699999999999999999999999999999999999999965442211111111
Q ss_pred HHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 746 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 746 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
..... .... ........+.++...+-..+...+|....+...|+.....
T Consensus 252 ---~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 ---DPRKL----LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ---Hhhhh----cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11110 0110 1111223455566666668999999999999998887653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.9e-20 Score=198.88 Aligned_cols=259 Identities=29% Similarity=0.421 Sum_probs=195.4
Q ss_pred hhccccccCceEEEEEEECCCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCC-ceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHR-NLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~Hp-nIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 4578999999999999887 88999998765332 367789999999999988 79999999977777899999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeeeccccccCCCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~~~~ 684 (854)
++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.......
T Consensus 82 ~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 82 GGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999666432111 3677888899999999999999998 899999999999999998 799999999975443332
Q ss_pred c-----eeecccccccccCcccccc---CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 685 H-----VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 685 ~-----~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
. ......||..|+|||.+.+ ..+....|+||+|++++++++|..||................... ...
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~ 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL----PTP 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc----CCc
Confidence 2 2355679999999999987 578889999999999999999999965543110011111111111 100
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.................+.+++..|+..+|..|.++.+...+
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000001111012223467889999999999999999988876
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=183.55 Aligned_cols=139 Identities=19% Similarity=0.182 Sum_probs=107.1
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCcc--c------------------------HHHHHHHHHHHccCCCCce
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--G------------------------KREFTNEVTLLSRIHHRNL 584 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~--~------------------------~~~~~~Ev~~L~~l~HpnI 584 (854)
...||+|+||.||+|...+|+.||||+++..... . ......|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999754211 1 0122459999999987776
Q ss_pred eeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHH-HhCCCCceecCCCCCCCEEEc
Q 003039 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRDLKSSNILLD 663 (854)
Q Consensus 585 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDIkp~NILl~ 663 (854)
.....+.. ...++||||++++++..... ....++......++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 43322222 22389999999887654431 234578888999999999999999 677 999999999999998
Q ss_pred CCCcEEEEeeeccccc
Q 003039 664 KHMRAKVSDFGLSKFA 679 (854)
Q Consensus 664 ~~~~vkl~DFGla~~~ 679 (854)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-20 Score=218.33 Aligned_cols=252 Identities=23% Similarity=0.268 Sum_probs=181.9
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEc----cCC-c-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLT----SNS-Y-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~----~~~-~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.+.+|.|++|.|+..... ..+..+.|..+ ... . .....+..|+.+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 578999999987777543 33334444332 111 1 1112256677888889999999888887776666666999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC-
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG- 682 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~- 682 (854)
|+. +|..++. ....+...++..++.|+..|+.|+|+. ||.|||+|++|++++.+|.+||+|||.+....-.
T Consensus 403 ~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 403 CPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred ccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 999 9988883 234677788889999999999999998 9999999999999999999999999998644322
Q ss_pred CC--ceeecccccccccCccccccCcCCC-cchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 683 AS--HVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 683 ~~--~~~~~~~gt~~Y~aPE~~~~~~~s~-~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.. +......|+..|+|||.+....|.. ..||||.|+++..|++|+.||......+.. . ......++.. +
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~--~----~~~~~~~~~~--~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS--F----KTNNYSDQRN--I 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc--h----hhhccccccc--c
Confidence 22 5666778999999999999999987 469999999999999999999654422111 0 0000000000 0
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..-..........+...++.++++++|.+|-||++|++.
T Consensus 547 -~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 547 -FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred -ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000001112334567789999999999999999999863
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=175.71 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=190.2
Q ss_pred HHHHHhhccccccCceEEEEEEE-CCCcEEEEEEEccCCcccHHHHHHHHHHHccCCC-CceeeEeeeeeecCeEEEEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~-~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~H-pnIv~l~g~~~~~~~~~LV~E 602 (854)
...+.+.++||+|+||.+|.|.. .+|++||||+-+... ...++.-|..+.+.++| ..|..+..|..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34556789999999999999964 579999999865443 23567778888888875 677777888888899999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEeeeccccc
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA 679 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkl~DFGla~~~ 679 (854)
.. |-+|.++.. --.++++-.+++-++-|++.-++|+|.+ +++||||||+|.|..-+ ..+.++|||+|+..
T Consensus 92 LL-GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 87 668888763 1245678889999999999999999999 89999999999999743 56899999999866
Q ss_pred cCCCCc--e----eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC
Q 003039 680 VDGASH--V----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 680 ~~~~~~--~----~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
.+..+. . .....||.+|.+--...+...+.+.|+-|+|.||..+.-|..||.+.......+.. ..+.+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy-----EkI~Ek 239 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY-----EKISEK 239 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH-----HHHHHh
Confidence 543322 1 23456999999888777777888999999999999999999999876532211111 111111
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
++.-.+ ..|...++. ++...+.-|-...-++-|+..-+-+.+.-+.
T Consensus 240 K~s~~i-e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 240 KMSTPI-EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred hcCCCH-HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 111111 112233333 3556666777777777888766666555443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=186.19 Aligned_cols=174 Identities=14% Similarity=0.171 Sum_probs=133.9
Q ss_pred HHHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHH---------HHHHHHHHccCCCCceeeEeeee
Q 003039 521 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---------FTNEVTLLSRIHHRNLVQFLGYC 591 (854)
Q Consensus 521 ~~~~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~---------~~~Ev~~L~~l~HpnIv~l~g~~ 591 (854)
.++...++...+.+|.|+||.||.... ++..+|||+++......... +++|++.+.+++|++|..+.+++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 345555666788999999999999766 57789999997553332222 68999999999999999998886
Q ss_pred eec--------CeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 003039 592 QEE--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 663 (854)
Q Consensus 592 ~~~--------~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 663 (854)
... +..++||||++|.+|.+... ++. ....+++.+|..+|+. +++|||+||+||+++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 533 35789999999999987631 111 2456899999999998 999999999999999
Q ss_pred CCCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHH
Q 003039 664 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 724 (854)
Q Consensus 664 ~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ell 724 (854)
.++ ++|+|||..+........ ..+.....+..++|+||||+.+..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987644221111 11344556778999999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-19 Score=200.01 Aligned_cols=216 Identities=25% Similarity=0.400 Sum_probs=166.8
Q ss_pred HccCCCCceeeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCce-ecCC
Q 003039 576 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI-IHRD 654 (854)
Q Consensus 576 L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vHrD 654 (854)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....++|.....+.++++.||+|||.. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 4678999999999999999999999999999999999964 467899999999999999999999997 44 8999
Q ss_pred CCCCCEEEcCCCcEEEEeeeccccccCC-CCceeecccccccccCccccccC-------cCCCcchhhhHHHHHHHHHhC
Q 003039 655 LKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELISG 726 (854)
Q Consensus 655 Ikp~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~~~DVwSlGvvl~elltG 726 (854)
++++|+++|....+||+|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998755321 01111111234579999998763 146679999999999999999
Q ss_pred CcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 727 QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 727 ~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
+.||...........++.+++. + -...+-|.+.... +....+..++..||..+|++||++++|-..++.+.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~----~-~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK----G-GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cCccccccccCChHHHHHHHHh----c-CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9999875544433455555443 1 1112222222111 33336899999999999999999999988877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3e-18 Score=176.60 Aligned_cols=259 Identities=20% Similarity=0.296 Sum_probs=190.4
Q ss_pred HHhhccccccCceEEEEEE-ECCCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~-~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.++++||+|.||+++.|+ +-+++.||||.-... ....++..|.+..+.|. .++|...+-|-.++.+-.||+|..
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 4568999999999999997 347999999975433 23456788888888874 689988888888888889999987
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-----CcEEEEeeecccccc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFGLSKFAV 680 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-----~~vkl~DFGla~~~~ 680 (854)
|-+|.|+.. --+++++..+++.+|.|+..-++|+|++ .+|.|||||+|.||... ..+.|+|||+|+...
T Consensus 107 GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 668888763 2367899999999999999999999999 99999999999999743 358999999999776
Q ss_pred CCCCce------eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC-
Q 003039 681 DGASHV------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG- 753 (854)
Q Consensus 681 ~~~~~~------~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~- 753 (854)
+..+.. .....||.+||+--...++..+.+.|+-|+|-++...|-|..||.+...+...+.. + ++.+.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY-e----KIGe~K 255 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY-E----KIGETK 255 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH-H----Hhcccc
Confidence 554322 22346999999999999999999999999999999999999999876633221111 1 11111
Q ss_pred CcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 754 ~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
+... ++ .|...+ +++....++.+.. .+-.+-|+.+-+...+..++..
T Consensus 256 r~T~-i~-~Lc~g~-P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 256 RSTP-IE-VLCEGF-PEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ccCC-HH-HHHhcC-HHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHh
Confidence 1000 00 011112 2333444444433 4455678888888777777654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=176.32 Aligned_cols=140 Identities=20% Similarity=0.203 Sum_probs=109.5
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCccc--------------------------HHHHHHHHHHHccCCCCce
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--------------------------KREFTNEVTLLSRIHHRNL 584 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~--------------------------~~~~~~Ev~~L~~l~HpnI 584 (854)
...||+|+||.||+|...+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998789999999987542110 1123578899999999987
Q ss_pred eeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEc
Q 003039 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD 663 (854)
Q Consensus 585 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~ 663 (854)
.....+... ..++||||++++++..... ....++......++.|++.++.++|+ . +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 544443332 2489999999886543321 12346677888999999999999999 7 999999999999999
Q ss_pred CCCcEEEEeeecccccc
Q 003039 664 KHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 664 ~~~~vkl~DFGla~~~~ 680 (854)
++.++|+|||+++...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.4e-20 Score=211.85 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=176.5
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCC-cccHHHHHHHHHH--HccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS-YQGKREFTNEVTL--LSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~-~~~~~~~~~Ev~~--L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||++.|=.|.+|++++|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-+-......+||-+|..
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 34678999999999999998777 9999986543 3334444443332 455689999998888777777788888875
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc--ccCCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGA 683 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~--~~~~~ 683 (854)
+ +|.|.| ..+..+...+...|+.|++.||..+|+. +|+|||||.+||||+.-.-+.|+||.--+. +....
T Consensus 105 h-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 105 H-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 4 666666 4455677788889999999999999998 999999999999999999999999986552 22222
Q ss_pred Ccee----ecccccccccCccccccC-----------cCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHH
Q 003039 684 SHVS----SIVRGTVGYLDPEYYISQ-----------QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAK 747 (854)
Q Consensus 684 ~~~~----~~~~gt~~Y~aPE~~~~~-----------~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~ 747 (854)
.... .+...-.+|+|||.+... ..+++.||||+|||++||++ |+++|.-.. +..+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------L~aY-- 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------LLAY-- 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------HHhH--
Confidence 2111 122234579999998541 15678899999999999998 678875322 2221
Q ss_pred HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 748 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
+.+. .......|.. .+ -..+.+++..|++.||++|-++++.++.-+..
T Consensus 248 ---r~~~-~~~~e~~Le~-Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 248 ---RSGN-ADDPEQLLEK-IE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ---hccC-ccCHHHHHHh-Cc---CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1110 0000000000 00 01477899999999999999999999984443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.4e-18 Score=168.83 Aligned_cols=185 Identities=14% Similarity=0.138 Sum_probs=138.6
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCcccH----HHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEecc
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK----REFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~----~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
...|++|+||+||.+.- .+.+++.+.+........ ..+.+|+++|++++ |+++.+++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999997765 578888887765543222 24789999999995 5889999886 34699999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCC-CCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI-kp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
|.+|.+.+. . ....++.|++++|.++|+. ||+|||| ||+|||++.++.++|+|||+|........
T Consensus 82 G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 998865431 1 1134678999999999998 9999999 79999999999999999999985433221
Q ss_pred c----e--------eecccccccccCccccccC-cCC-CcchhhhHHHHHHHHHhCCccccccc
Q 003039 685 H----V--------SSIVRGTVGYLDPEYYISQ-QLT-DKSDVYSFGVILLELISGQEAISNEK 734 (854)
Q Consensus 685 ~----~--------~~~~~gt~~Y~aPE~~~~~-~~s-~~~DVwSlGvvl~elltG~~pf~~~~ 734 (854)
. . ......++.|++|+...-. ..+ ...+.++-|+-+|.++|++.+.-...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 1122357778888754322 222 46688999999999999998765443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-18 Score=193.82 Aligned_cols=186 Identities=29% Similarity=0.400 Sum_probs=156.5
Q ss_pred cccccCceEEEEEE----ECCCcEEEEEEEccCCccc--HHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEecc
Q 003039 533 KIGSGGFGVVYYGK----LKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~----~~~~~~VAvK~l~~~~~~~--~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+|+|.||.|+..+ .+.|+-+|+|++++..... +.....|..++..++ ||.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998763 3357778999887553211 124456788888887 9999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|.|...+. ....+.+.....+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++........
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999988774 445667777778889999999999998 9999999999999999999999999999866544322
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 732 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~ 732 (854)
+||..|||||++. ....++|-||||++++||+||..||..
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999998 667899999999999999999999975
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.9e-17 Score=170.65 Aligned_cols=230 Identities=18% Similarity=0.202 Sum_probs=146.0
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCC----------CceeeEeeee-----
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHH----------RNLVQFLGYC----- 591 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~H----------pnIv~l~g~~----- 591 (854)
.+.||.|+++.||.+++. +++++|||+..... ...-+++++|.-....+.+ -.++.-++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 568999999999999987 48999999875432 2234566666655555322 1111111111
Q ss_pred ----eec---C-----eEEEEEEeccCCCHHhhhcc---cccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCC
Q 003039 592 ----QEE---G-----RSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 656 (854)
Q Consensus 592 ----~~~---~-----~~~LV~E~~~~gsL~~~L~~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIk 656 (854)
... . ..+++|+-+ .++|.+++.- .......+....++.+..|+.+.+++||+. |++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 1 236778877 4688877532 111233455666778889999999999999 99999999
Q ss_pred CCCEEEcCCCcEEEEeeeccccccCCCCceeecccccccccCccccccC--------cCCCcchhhhHHHHHHHHHhCCc
Q 003039 657 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--------QLTDKSDVYSFGVILLELISGQE 728 (854)
Q Consensus 657 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~s~~~DVwSlGvvl~elltG~~ 728 (854)
|+|++++.+|.++|+||+....... .......+..|.+||..... .++.+.|.|++|+++|.|.+|+.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999987653322 11112346789999987542 47888999999999999999999
Q ss_pred ccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCC
Q 003039 729 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR 790 (854)
Q Consensus 729 pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 790 (854)
||........... ...... +..+.+..|+..+++.+|.+|
T Consensus 249 Pf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9976542111100 112223 455678899999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.1e-17 Score=166.19 Aligned_cols=134 Identities=18% Similarity=0.258 Sum_probs=104.3
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccC-----CCCceeeEeeeeeecC---e-EEEEE
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-----HHRNLVQFLGYCQEEG---R-SVLVY 601 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-----~HpnIv~l~g~~~~~~---~-~~LV~ 601 (854)
.+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36799999999996 443333479988765445567899999999999 5799999999998763 3 33789
Q ss_pred Ee--ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHH-HHHHhCCCCceecCCCCCCCEEEcC----CCcEEEEeee
Q 003039 602 EF--MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI-EYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFG 674 (854)
Q Consensus 602 E~--~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkl~DFG 674 (854)
|| +.+|+|.+++... .+++. ..++.+++.++ +|||+. +|+||||||+|||++. +++++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 5589999999532 24443 35677888777 999998 9999999999999974 3489999954
Q ss_pred cc
Q 003039 675 LS 676 (854)
Q Consensus 675 la 676 (854)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.4e-16 Score=190.10 Aligned_cols=253 Identities=19% Similarity=0.232 Sum_probs=180.1
Q ss_pred HHHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCC---CCceeeEeeeeeecCeEEEE
Q 003039 524 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 524 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~---HpnIv~l~g~~~~~~~~~LV 600 (854)
....+.+.+.||+|+||.||+|...+|+.||+|+-+....++.--. .+++.+|+ -+-|..+...+.-.+..+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~---~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC---LQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh---HHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3344556788999999999999988899999999876655532111 12233333 23444555555566778999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-------CCcEEEEee
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------HMRAKVSDF 673 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------~~~vkl~DF 673 (854)
+||.+.|+|.+++. ..+.++|.-.+.+..|++..+++||.. +||||||||+|.||.. ...++|+||
T Consensus 773 ~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence 99999999999995 456789999999999999999999998 9999999999999952 346899999
Q ss_pred eccccccCC-CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhc
Q 003039 674 GLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 752 (854)
Q Consensus 674 Gla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~ 752 (854)
|.+--+.-- ........++|-.+-.+|+..++.++..+|.|.++-+++-||.|+.-= ...
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------------~~~ 906 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------------VKN 906 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------------hcC
Confidence 998533221 223455677899999999999999999999999999999999997421 001
Q ss_pred CCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 003039 753 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIERE 809 (854)
Q Consensus 753 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~~~ 809 (854)
| -...++..+ ..+...++| -++....|.++-..=|...++...|++++....+
T Consensus 907 g-~~~~~~~~~-~Ry~~~~~W--~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 907 G-SSWMVKTNF-PRYWKRDMW--NKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred C-cceeccccc-hhhhhHHHH--HHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 1 111122221 112222222 2333344446666677888888888887765433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=165.00 Aligned_cols=140 Identities=22% Similarity=0.252 Sum_probs=107.9
Q ss_pred HHhhccccccCceEEEEEE--ECCCcEEEEEEEccCCcc------------------------cHHHHHHHHHHHccCCC
Q 003039 528 KMLEKKIGSGGFGVVYYGK--LKDGKEIAVKVLTSNSYQ------------------------GKREFTNEVTLLSRIHH 581 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~--~~~~~~VAvK~l~~~~~~------------------------~~~~~~~Ev~~L~~l~H 581 (854)
+.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999998 457999999998754210 01235689999999975
Q ss_pred Cc--eeeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc-eecCCCCCC
Q 003039 582 RN--LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSS 658 (854)
Q Consensus 582 pn--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDIkp~ 658 (854)
.. +.+.+++ ...++||||+++++|...... ...+.......++.|++.+|++||+. + ++||||||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 33 3344443 235899999999888665421 22344556678999999999999998 8 999999999
Q ss_pred CEEEcCCCcEEEEeeeccccc
Q 003039 659 NILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 659 NILl~~~~~vkl~DFGla~~~ 679 (854)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4e-16 Score=160.97 Aligned_cols=134 Identities=25% Similarity=0.427 Sum_probs=112.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcc--------cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~--------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.||+|++|.||+|.+ .|..|++|+....... ....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999988 5788999987643221 123577899999999999998877777777888999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
++|++|.+.+... .+ .+..++.+++.+|.+||+. +++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988432 11 6788999999999999998 999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=7e-16 Score=157.62 Aligned_cols=130 Identities=26% Similarity=0.450 Sum_probs=106.3
Q ss_pred cccccCceEEEEEEECCCcEEEEEEEccCCcc--------cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 533 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~--------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.||+|+||.||+|.+. +..|++|+....... ....+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999964 789999986543211 1245678999999999887665555566667779999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+|++|.+.+... .. .++.+++++|.+||+. +++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999877421 10 6899999999999998 999999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=156.44 Aligned_cols=135 Identities=21% Similarity=0.238 Sum_probs=106.7
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcc----------------------cHHHHHHHHHHHccCCCCc--
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----------------------GKREFTNEVTLLSRIHHRN-- 583 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~----------------------~~~~~~~Ev~~L~~l~Hpn-- 583 (854)
+.+.+.||+|+||.||++..++|+.||||+++..... ....+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5567899999999999999888999999987643200 1123567888899888774
Q ss_pred eeeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 003039 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 663 (854)
Q Consensus 584 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 663 (854)
+...++. ...++||||+++++|.+.... .....++.+++.++.++|+. +|+||||||+||+++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 4444432 345899999999998765420 23456889999999999998 999999999999999
Q ss_pred CCCcEEEEeeeccccc
Q 003039 664 KHMRAKVSDFGLSKFA 679 (854)
Q Consensus 664 ~~~~vkl~DFGla~~~ 679 (854)
++++++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=159.26 Aligned_cols=197 Identities=19% Similarity=0.215 Sum_probs=135.0
Q ss_pred CCCceeeEeeeeee---------------------------cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHH
Q 003039 580 HHRNLVQFLGYCQE---------------------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 632 (854)
Q Consensus 580 ~HpnIv~l~g~~~~---------------------------~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~ 632 (854)
+|||||++.++|.+ ...+++||.... .+|.+++.. +..+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999887743 235688888764 488888843 234555667789
Q ss_pred HHHHHHHHHHHhCCCCceecCCCCCCCEEEc--CC--CcEEEEeeeccccccCC-----CCceeecccccccccCccccc
Q 003039 633 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KH--MRAKVSDFGLSKFAVDG-----ASHVSSIVRGTVGYLDPEYYI 703 (854)
Q Consensus 633 ~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~--~~vkl~DFGla~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~ 703 (854)
.|+++|+.|||++ ||.|||+|++||||. +| ....|+|||++--.... -....-..-|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999998 999999999999994 33 35789999987421110 001112234777899999987
Q ss_pred cCc------CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHH
Q 003039 704 SQQ------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEE 777 (854)
Q Consensus 704 ~~~------~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~ 777 (854)
..+ ...|+|.|+.|.+.||+++...||-... +..-+... ..+.++ |.+.+ .+...+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--em~L~~r~-----Yqe~qL-----Palp~----~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--EMLLDTRT-----YQESQL-----PALPS----RVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc--hheechhh-----hhhhhC-----CCCcc----cCChHHHH
Confidence 543 2468999999999999999999996532 11111111 111212 22222 23334678
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHH
Q 003039 778 KALMCVLPHGHMRPSISEVLKDIQ 801 (854)
Q Consensus 778 l~~~Cl~~~P~~RPsm~eV~~~L~ 801 (854)
++...++.+|.+||+..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 888899999999999765555444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=176.89 Aligned_cols=132 Identities=23% Similarity=0.341 Sum_probs=108.5
Q ss_pred hhccccccCceEEEEEEECCCcEEEEEEEccCC--c------ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--Y------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~--~------~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
..+.||+|+||+||+|.+.. ..+++|+..... . .....+.+|++++++++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 36789999999999998864 444444432211 1 11245788999999999999998888887777889999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ .++.++|+|||+++.
T Consensus 416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999998873 3467899999999999998 99999999999999 678999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.2e-16 Score=175.48 Aligned_cols=176 Identities=28% Similarity=0.369 Sum_probs=131.0
Q ss_pred CeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeee
Q 003039 595 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 674 (854)
Q Consensus 595 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 674 (854)
...++.|++|...+|.++|.... .....++...+.++.|++.|++| + +.+|+|+||.||+...+.++||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 35789999999999999996443 34456778889999999999999 5 89999999999999999999999999
Q ss_pred ccccccCCC-----CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHH
Q 003039 675 LSKFAVDGA-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 748 (854)
Q Consensus 675 la~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~ 748 (854)
+........ ....+...||..||+||.+.+..|+.|+||||||++|+|++. =..+++... +..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----------t~~ 470 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----------TLT 470 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------hhh
Confidence 986544333 223345569999999999999999999999999999999998 222222111 111
Q ss_pred hhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 003039 749 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 797 (854)
Q Consensus 749 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~ 797 (854)
-++.|. ++|....+++. -..+..+++.+.|.+||++.++.
T Consensus 471 d~r~g~----ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 471 DIRDGI----IPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhhcCC----CChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHHh
Confidence 122222 33333333333 24678899999999999554443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.5e-17 Score=153.23 Aligned_cols=176 Identities=22% Similarity=0.320 Sum_probs=144.0
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
.++.++.|.|++|.++.+||.|..+.+|++|++.+|+++. .+..+.++..++.++.. -+ ...-.+-.++.+|.
T Consensus 31 ~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvg-mn-----rl~~lprgfgs~p~ 103 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVG-MN-----RLNILPRGFGSFPA 103 (264)
T ss_pred chhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecc-hh-----hhhcCccccCCCch
Confidence 3556788999999999999999999999999999999987 56667777666665321 11 01112223456789
Q ss_pred eeEEEecCCCCC-ccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 343 ITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 343 l~~L~L~~n~l~-g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
|+.|||+.|+|. ..+|..|.-|+.|+-|+|++|.+.-++|++++|++|+.|.|..|.|- ++|..++.|++|+.|++++
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 999999999997 46899999999999999999999999999999999999999999999 8999999999999999999
Q ss_pred cccccccccccc-----cccccccccCcccc
Q 003039 422 NMLSGTVPSSLL-----SKNVVLNYAGNINL 447 (854)
Q Consensus 422 N~l~g~~p~~l~-----~~~~~l~~~~n~~l 447 (854)
|+|+ .+|+.+. .....+.+..||+.
T Consensus 183 nrl~-vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 183 NRLT-VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred ceee-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 9999 8988872 22244455666653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.8e-13 Score=162.91 Aligned_cols=90 Identities=31% Similarity=0.475 Sum_probs=80.6
Q ss_pred CCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCC-CCCcee
Q 003039 340 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNL-PNLREL 417 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l-~~L~~l 417 (854)
+++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|+ +++|++|+.|+|++|+|+|.+|..++.+ .++..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 45899999999999999999999999999999999999998886 8999999999999999999999998874 467889
Q ss_pred eccccccccccc
Q 003039 418 YVQNNMLSGTVP 429 (854)
Q Consensus 418 ~l~~N~l~g~~p 429 (854)
++++|......|
T Consensus 521 ~~~~N~~lc~~p 532 (623)
T PLN03150 521 NFTDNAGLCGIP 532 (623)
T ss_pred EecCCccccCCC
Confidence 999998543333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.6e-14 Score=144.38 Aligned_cols=135 Identities=22% Similarity=0.270 Sum_probs=96.4
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCccc--HHH----------------------HHHHHHHHccCCCCc--e
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KRE----------------------FTNEVTLLSRIHHRN--L 584 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~--~~~----------------------~~~Ev~~L~~l~Hpn--I 584 (854)
.+.||+|+||.||+|...+++.||||+++...... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987542211 111 134555555554332 3
Q ss_pred eeEeeeeeecCeEEEEEEeccCCCHHhh-hcccccccccccHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEE
Q 003039 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILL 662 (854)
Q Consensus 585 v~l~g~~~~~~~~~LV~E~~~~gsL~~~-L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl 662 (854)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 344433 245899999999654321 11100 01 4567889999999999999 6 99999999999999
Q ss_pred cCCCcEEEEeeeccccc
Q 003039 663 DKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 663 ~~~~~vkl~DFGla~~~ 679 (854)
+ ++.++|+|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 899999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.1e-15 Score=174.88 Aligned_cols=202 Identities=25% Similarity=0.310 Sum_probs=137.3
Q ss_pred hccccccCceEEEEEEECC-CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 531 EKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
.+.|..|+||.||..+++. .+..|+|+=+.+ .+.+- ++.....|.+| |+=
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------chh
Confidence 4789999999999998873 567888542211 11110 33333444443 232
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC------
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA------ 683 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~------ 683 (854)
...+.. .+.++. +++.+++|||+. +|+|||+||+|.+|+.-|.+|+.|||+++......
T Consensus 139 ~tllk~----~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 139 ATLLKN----IGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hhhccc----CCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 333321 122221 237899999998 99999999999999999999999999986332111
Q ss_pred --------CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 684 --------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 684 --------~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
.-....++||+.|+|||++....|...+|.|++|+|+||.+-|+.||.++...+.+..++.....+.++
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~--- 280 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE--- 280 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc---
Confidence 011234689999999999999999999999999999999999999998876444444443322222111
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCC
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP 791 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 791 (854)
| .....+..+++.+.++.+|..|-
T Consensus 281 ----d--------ea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 ----D--------EALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----C--------cCCCHHHHHHHHHHHHhChHhhc
Confidence 1 11223466777888888888886
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=4e-14 Score=136.63 Aligned_cols=134 Identities=25% Similarity=0.296 Sum_probs=113.4
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCC--CceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
.+.||+|.++.||++...+ ..+++|....... ...+..|+.+++.++| ..+.+++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 3679999999999999864 7899999865433 5678899999999976 589999998888888999999999877
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+..+ +......++.+++++|++||.....+++|+|++|+||+++..+.++++|||.++.
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6543 4456677899999999999986545799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.4e-15 Score=186.99 Aligned_cols=109 Identities=35% Similarity=0.586 Sum_probs=102.0
Q ss_pred CCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 340 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
.++|+.|+|++|+++|.+|..+.+|++|+.|+|++|++.+.+|. +.+|++|++|+|++|+++|.+|..++.+++|+.|+
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 35899999999999999999999999999999999999998885 88999999999999999999999999999999999
Q ss_pred cccccccccccccc--ccccccccccCccccc
Q 003039 419 VQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 448 (854)
Q Consensus 419 l~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~ 448 (854)
|++|+++|.+|..+ +..+..+++++|+..+
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 99999999999988 6678899999998664
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.1e-13 Score=143.23 Aligned_cols=135 Identities=19% Similarity=0.240 Sum_probs=104.5
Q ss_pred hcccc-ccCceEEEEEEECCCcEEEEEEEccCC-------------cccHHHHHHHHHHHccCCCCce--eeEeeeeeec
Q 003039 531 EKKIG-SGGFGVVYYGKLKDGKEIAVKVLTSNS-------------YQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEE 594 (854)
Q Consensus 531 ~~~iG-~G~fg~Vy~a~~~~~~~VAvK~l~~~~-------------~~~~~~~~~Ev~~L~~l~HpnI--v~l~g~~~~~ 594 (854)
...|| .|+.|+||+.... +..++||.+.... ......+.+|++++.+++|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999886 7889999875321 1223457889999999998875 6777765433
Q ss_pred C----eEEEEEEeccC-CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEE
Q 003039 595 G----RSVLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 669 (854)
Q Consensus 595 ~----~~~LV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 669 (854)
. ..++|+|++++ .+|.+++.. ..++. ..+.+++.+|.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 689888743 12332 2367899999999998 999999999999999999999
Q ss_pred EEeeecccc
Q 003039 670 VSDFGLSKF 678 (854)
Q Consensus 670 l~DFGla~~ 678 (854)
|+|||.++.
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.6e-15 Score=163.27 Aligned_cols=166 Identities=23% Similarity=0.298 Sum_probs=113.4
Q ss_pred cccccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCC
Q 003039 261 NLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 340 (854)
Q Consensus 261 ~~~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~ 340 (854)
-+.|+-|..|+|++|.+-+|||.+.+|..|+.|.|++|.+.--.+..+-.+.++.-+..++..-- ..-++-+.+.+
T Consensus 146 finLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT----l~N~Ptsld~l 221 (1255)
T KOG0444|consen 146 FINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT----LDNIPTSLDDL 221 (1255)
T ss_pred HHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch----hhcCCCchhhh
Confidence 35677889999999999999999999999999999999987766655555554444322111111 11122233455
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
.+|..+|||.|+|. .+|+.+.++.+|+.|+||+|+|+.+--....-.+|+.|+||.|+|+ .+|+.+.+|++|+.|++.
T Consensus 222 ~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n 299 (1255)
T KOG0444|consen 222 HNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYAN 299 (1255)
T ss_pred hhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhc
Confidence 67777777777777 7777777777777777777777766555555666777777777777 667666666666666666
Q ss_pred ccccc-ccccccc
Q 003039 421 NNMLS-GTVPSSL 432 (854)
Q Consensus 421 ~N~l~-g~~p~~l 432 (854)
+|+|+ ..||+++
T Consensus 300 ~NkL~FeGiPSGI 312 (1255)
T KOG0444|consen 300 NNKLTFEGIPSGI 312 (1255)
T ss_pred cCcccccCCccch
Confidence 66654 1344443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.3e-13 Score=140.66 Aligned_cols=203 Identities=23% Similarity=0.339 Sum_probs=143.3
Q ss_pred HHccCCCCceeeEeeeeeec-----CeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc
Q 003039 575 LLSRIHHRNLVQFLGYCQEE-----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649 (854)
Q Consensus 575 ~L~~l~HpnIv~l~g~~~~~-----~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 649 (854)
-|-++-|.||++++.|+.+. .+..++.|||..|++.++|+........+......+++.||..||.|||+ |.|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 34455799999999998654 35789999999999999998877777788888889999999999999999 6889
Q ss_pred eecCCCCCCCEEEcCCCcEEEEeeeccccccC---CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhC
Q 003039 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726 (854)
Q Consensus 650 ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG 726 (854)
|+|+++..+-|++..++-+|+.----...... ........-.+-++|.+||+-.....+.++|||+||+..+||.-|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999888742111000000 001111122367899999998888888999999999999999887
Q ss_pred Ccc-cccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 727 QEA-ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 727 ~~p-f~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..- -..........++.. +....+++ .-...+..|++..|..||+|++++-|
T Consensus 279 Eiq~tnseS~~~~ee~ia~-~i~~len~--------------------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIAN-VIIGLENG--------------------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhhhhhh-heeeccCc--------------------cccCcCcccccCCCCCCcchhhhhcC
Confidence 643 211110011111111 00000110 01245678999999999999998766
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.2e-14 Score=168.41 Aligned_cols=253 Identities=20% Similarity=0.273 Sum_probs=181.5
Q ss_pred HhhccccccCceEEEEEEECC--CcEEEEEEEccCC--cccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~--~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++.....+..+++.+|
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 345669999999998886643 3446666654332 222233445777766776 99999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHH-hCCCCceecCCCCCCCEEEcCCC-cEEEEeeeccccccC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 681 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~ 681 (854)
..++++.+.+.. ......+....-.++.|+..++.|+| .. ++.|+||||+|.+++..+ ..+++|||+|.....
T Consensus 103 s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 103 SDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999887731 11113444556678999999999999 76 999999999999999999 999999999976554
Q ss_pred --CCCceeecccc-cccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 682 --GASHVSSIVRG-TVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 682 --~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
+........+| ++.|+|||...+. -.....|+||.|+++.-+++|..|+....... .....|.... +.
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~---~~--- 249 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK---GR--- 249 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccc---cc---
Confidence 44445556678 9999999999885 44567899999999999999999987544221 1122222111 00
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......... .....++...++..+|..|.+.+++...
T Consensus 250 -~~~~~~~~~----~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 250 -FTQLPWNSI----SDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -cccCccccC----ChhhhhcccccccCCchhcccccccccc
Confidence 000111111 1235567778888999999999887654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.7e-13 Score=150.64 Aligned_cols=195 Identities=19% Similarity=0.103 Sum_probs=106.8
Q ss_pred ceEEEEEECCcccccccccccccccCcceEEeccc-cc------cccccceeeeecccCCCCCCCcc-cchhhhceeccC
Q 003039 224 SRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPG-YT------NLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLER 295 (854)
Q Consensus 224 ~R~F~v~~n~~~~~~~~~~~~~~~~~~~~~~~~~~-~~------~~~l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l 295 (854)
.|..|.+-|.....+.+.++.... - ++-..+++ +| .-+|.+|..|.|++|.+++||+. +.+|..|+.|+|
T Consensus 151 lrslDLSrN~is~i~~~sfp~~~n-i-~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdL 228 (873)
T KOG4194|consen 151 LRSLDLSRNLISEIPKPSFPAKVN-I-KKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDL 228 (873)
T ss_pred hhhhhhhhchhhcccCCCCCCCCC-c-eEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhc
Confidence 577777777766555544431000 0 00111111 11 12366889999999999999998 666999999999
Q ss_pred CCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCC
Q 003039 296 NDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGN 375 (854)
Q Consensus 296 ~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N 375 (854)
.-|++....-..+..|.+++++..-.++--.- -.|+- -.+..+++|+|+.|+++..--.++.+|++|+.|+||.|
T Consensus 229 nrN~irive~ltFqgL~Sl~nlklqrN~I~kL--~DG~F---y~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~N 303 (873)
T KOG4194|consen 229 NRNRIRIVEGLTFQGLPSLQNLKLQRNDISKL--DDGAF---YGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYN 303 (873)
T ss_pred cccceeeehhhhhcCchhhhhhhhhhcCcccc--cCcce---eeecccceeecccchhhhhhcccccccchhhhhccchh
Confidence 99998776555555555444432211111100 01100 11224556666666665333345555666666666666
Q ss_pred CCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccccc
Q 003039 376 SLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 376 ~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~ 425 (854)
.|+..-++ +..+++|++|+||+|+|+..-|++|..|.+|+.|+|++|.++
T Consensus 304 aI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~ 354 (873)
T KOG4194|consen 304 AIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID 354 (873)
T ss_pred hhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence 66554443 555556666666666665333334555555555555555554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2e-12 Score=147.39 Aligned_cols=140 Identities=23% Similarity=0.263 Sum_probs=98.4
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCccc----------------------------------------HHHHHH
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------KREFTN 571 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~----------------------------------------~~~~~~ 571 (854)
+.||+|++|.||+|++++|+.||||+.+...... +-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986542110 012445
Q ss_pred HHHHHccCC----CCceeeEeeee-eecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHH-HHHHHHhC
Q 003039 572 EVTLLSRIH----HRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-GIEYLHTG 645 (854)
Q Consensus 572 Ev~~L~~l~----HpnIv~l~g~~-~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 645 (854)
|++.+.+++ |.+-+.+-..+ ......+|||||++|++|.+...... ... .+..++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence 555555552 32223322222 22345799999999999988763211 111 23456666666 47788987
Q ss_pred CCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 646 ~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|++|+|+||.||+++.+++++++|||++....
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-13 Score=150.55 Aligned_cols=178 Identities=20% Similarity=0.270 Sum_probs=140.7
Q ss_pred ccceeeeecccCC--CCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCC
Q 003039 264 LPFVLSFKFGKTY--DSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 341 (854)
Q Consensus 264 l~~l~~l~l~~n~--~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~ 341 (854)
+++|..|.++++. +..+|+.|..|.+|..++++.|.+.. .++.+..+.+++.++++++. .+.++...+.-.
T Consensus 196 mtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~-vPecly~l~~LrrLNLS~N~------iteL~~~~~~W~ 268 (1255)
T KOG0444|consen 196 MTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPI-VPECLYKLRNLRRLNLSGNK------ITELNMTEGEWE 268 (1255)
T ss_pred chhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCc-chHHHhhhhhhheeccCcCc------eeeeeccHHHHh
Confidence 4555556666554 55778888888888888888887764 46666666666665442111 111221111223
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCC--CCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~--~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
+|+.|+||.|+|+ .+|+.+++|++|+.|++.+|+|. |+|..++.|.+|+++++++|+|. .+|+.++.+..|+.|.|
T Consensus 269 ~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L 346 (1255)
T KOG0444|consen 269 NLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKL 346 (1255)
T ss_pred hhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcc
Confidence 7999999999999 99999999999999999999975 66667999999999999999999 99999999999999999
Q ss_pred ccccccccccccc--ccccccccccCccccccCC
Q 003039 420 QNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 420 ~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~~~~ 451 (854)
++|+|- .+|+.+ +..+..|++..||++.-.+
T Consensus 347 ~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 347 DHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred ccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 999999 999987 7888999999999987555
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.7e-12 Score=141.34 Aligned_cols=176 Identities=15% Similarity=0.092 Sum_probs=146.2
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCee-EeCCCCCCC
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWL-QCNSDPQPS 342 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~-~c~~~~~~~ 342 (854)
..++.|+|+.|.++++-.. +..+..|..|.|+.|++....+..+|+|..+..+.+. -+- ..-+ .-.+.++++
T Consensus 173 ~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLn-rN~-----irive~ltFqgL~S 246 (873)
T KOG4194|consen 173 VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLN-RNR-----IRIVEGLTFQGLPS 246 (873)
T ss_pred CCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcc-ccc-----eeeehhhhhcCchh
Confidence 4679999999999999877 8888899999999999999999999999887766331 111 1112 134578899
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
|+.|.|..|+++..-...|..|.++++|+|+.|+++..-.. +-+|++|+.||||+|.|+-.-++++.-.++|+.|+|++
T Consensus 247 l~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~ 326 (873)
T KOG4194|consen 247 LQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSS 326 (873)
T ss_pred hhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccc
Confidence 99999999999955556788999999999999999987775 78899999999999999988889999999999999999
Q ss_pred ccccccccccc---ccccccccccCcccc
Q 003039 422 NMLSGTVPSSL---LSKNVVLNYAGNINL 447 (854)
Q Consensus 422 N~l~g~~p~~l---~~~~~~l~~~~n~~l 447 (854)
|+|+ .+|+.- +..+..|+++.|...
T Consensus 327 N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~ 354 (873)
T KOG4194|consen 327 NRIT-RLDEGSFRVLSQLEELNLSHNSID 354 (873)
T ss_pred cccc-cCChhHHHHHHHhhhhcccccchH
Confidence 9999 777654 556677888887543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.6e-10 Score=133.42 Aligned_cols=138 Identities=20% Similarity=0.239 Sum_probs=89.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEEccCCccc----------------------------------H------HHHH
Q 003039 532 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG----------------------------------K------REFT 570 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~----------------------------------~------~~~~ 570 (854)
+.||+|++|.||+|++++ |++||||+.+..-... . -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999997542100 0 1233
Q ss_pred HHHHHHccCC----CCceeeEeeeeee-cCeEEEEEEeccCCCHHhhh--cccccccccccHHHHHHHHHHHHHHHHHHH
Q 003039 571 NEVTLLSRIH----HRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643 (854)
Q Consensus 571 ~Ev~~L~~l~----HpnIv~l~g~~~~-~~~~~LV~E~~~~gsL~~~L--~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH 643 (854)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+++.+.- .........+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4444444442 3333333333322 44678999999999998742 1110011123222233333333 3
Q ss_pred hCCCCceecCCCCCCCEEEcCCC----cEEEEeeeccccc
Q 003039 644 TGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGLSKFA 679 (854)
Q Consensus 644 ~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFGla~~~ 679 (854)
.. |++|+|+||.||+++.++ +++++|||++...
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 44 999999999999999988 9999999998644
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.3e-13 Score=139.66 Aligned_cols=104 Identities=25% Similarity=0.312 Sum_probs=71.5
Q ss_pred CCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCC-CCCCccEEEeCCCccCCCCCccccCCCCCcee
Q 003039 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFS-GCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~-~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l 417 (854)
.+.+|..|+|..|+|. .+| +|+.+..|.+|+++.|+|+-++.+.+ +|.+|.+|||..|+|+ ..|+.+.-|.+|..|
T Consensus 204 ~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rL 280 (565)
T KOG0472|consen 204 GLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERL 280 (565)
T ss_pred chhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhh
Confidence 3456666677777777 666 67777777777777777766555543 5777777777777777 777777777777777
Q ss_pred eccccccccccccccc-cccccccccCccc
Q 003039 418 YVQNNMLSGTVPSSLL-SKNVVLNYAGNIN 446 (854)
Q Consensus 418 ~l~~N~l~g~~p~~l~-~~~~~l~~~~n~~ 446 (854)
|+|+|.|+ .+|.++- -.+..|.+.|||-
T Consensus 281 DlSNN~is-~Lp~sLgnlhL~~L~leGNPl 309 (565)
T KOG0472|consen 281 DLSNNDIS-SLPYSLGNLHLKFLALEGNPL 309 (565)
T ss_pred cccCCccc-cCCcccccceeeehhhcCCch
Confidence 77777777 6666651 1556667777764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.6e-11 Score=117.85 Aligned_cols=129 Identities=20% Similarity=0.165 Sum_probs=95.7
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCcee-eEeeeeeecCeEEEEEEeccCCCHH
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QFLGYCQEEGRSVLVYEFMHNGTLK 610 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv-~l~g~~~~~~~~~LV~E~~~~gsL~ 610 (854)
+.|+.|.++.||+++.. ++.|++|+...... ....+..|+.+++.+.+.+++ +++.+.. ...++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 46899999999999876 78899998754422 233567899999988665554 4444432 3457999999998775
Q ss_pred hhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC--CCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 611 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 611 ~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
+.- .....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 420 011235678999999999973 12369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.8e-10 Score=128.05 Aligned_cols=166 Identities=19% Similarity=0.232 Sum_probs=124.2
Q ss_pred ECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHH
Q 003039 547 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 626 (854)
Q Consensus 547 ~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~ 626 (854)
..++.+|.|++.+...........+-++.|+.++||||++++.....++..|+|+|.+. .|..++... ...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 34688999998876655445567788899999999999999999999999999999885 466666322 234
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeecccccccccCccccccCc
Q 003039 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706 (854)
Q Consensus 627 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 706 (854)
....-+.||+.||.+||..| +++|++|...-|+|+..|+.||++|-++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 45567899999999999775 899999999999999999999999988753322111 011111122456666543222
Q ss_pred CCCcchhhhHHHHHHHHHhC
Q 003039 707 LTDKSDVYSFGVILLELISG 726 (854)
Q Consensus 707 ~s~~~DVwSlGvvl~elltG 726 (854)
-..|.|.|||+++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.8e-11 Score=135.07 Aligned_cols=253 Identities=21% Similarity=0.201 Sum_probs=178.1
Q ss_pred HHHHHHHHhhccccc--cCceEEEEEEE--C-CCcEEEEEEEccC--CcccHHHHHHHHHHHccC-CCCceeeEeeeeee
Q 003039 522 DIEDATKMLEKKIGS--GGFGVVYYGKL--K-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE 593 (854)
Q Consensus 522 ~~~~~~~~~~~~iG~--G~fg~Vy~a~~--~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~ 593 (854)
+..+....+.+.+|. |.+|.||.+.. . ++..+|+|.-+.. .......=.+|+....++ .|+|.++....+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 444455556788999 99999999987 3 5788999874322 112222233566666666 49999999999999
Q ss_pred cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHH----HHHHHHhCCCCceecCCCCCCCEEEcCC-CcE
Q 003039 594 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----GIEYLHTGCVPAIIHRDLKSSNILLDKH-MRA 668 (854)
Q Consensus 594 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~v 668 (854)
.+..++-.|++. .+|.++.+.. ...++....+.+..+..+ ||.++|.. .++|-|+||.||++..+ ...
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred CCcceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence 999999999885 6888877533 233455556667777777 99999998 99999999999999999 899
Q ss_pred EEEeeeccccccCCCCce----eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH
Q 003039 669 KVSDFGLSKFAVDGASHV----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 744 (854)
Q Consensus 669 kl~DFGla~~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~ 744 (854)
+++|||+...+.+..-.. .....|...|++||... +-++.+.|+|++|.+..|..++..+...... ..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------~~ 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-------SS 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-------CC
Confidence 999999987766554221 12235788999999875 4568899999999999999998776543311 11
Q ss_pred HHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 745 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 745 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
|.. .+.+. +..++......++.....++++.+|..|++...+..+
T Consensus 335 W~~--~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 335 WSQ--LRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccc--ccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 111 11111 1112211122344558889999999999988777653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3e-12 Score=120.98 Aligned_cols=152 Identities=22% Similarity=0.287 Sum_probs=114.6
Q ss_pred cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEEecCCCCCccCCccccc
Q 003039 284 LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTK 363 (854)
Q Consensus 284 in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~L~~n~l~g~lp~~i~~ 363 (854)
+-.+++.+.|.|+.|++.+. +..+..+.++..++.++.. .+.++.+...++.|+.|+++-|+|. .+|..|+.
T Consensus 29 Lf~~s~ITrLtLSHNKl~~v-ppnia~l~nlevln~~nnq------ie~lp~~issl~klr~lnvgmnrl~-~lprgfgs 100 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVV-PPNIAELKNLEVLNLSNNQ------IEELPTSISSLPKLRILNVGMNRLN-ILPRGFGS 100 (264)
T ss_pred ccchhhhhhhhcccCceeec-CCcHHHhhhhhhhhcccch------hhhcChhhhhchhhhheecchhhhh-cCccccCC
Confidence 45567788899999998874 3344444444333222221 2233334456778999999999998 88999999
Q ss_pred CccCcEEeccCCCCCC-CCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccccccccc--ccccccc
Q 003039 364 LSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVL 439 (854)
Q Consensus 364 l~~L~~L~L~~N~l~~-~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l 439 (854)
++.|+.|||..|++.. .+|. |..|+.|+.|+|+.|.|. .+|..+++|++|+.|.+..|+|- ++|..+ +..+..|
T Consensus 101 ~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrel 178 (264)
T KOG0617|consen 101 FPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLREL 178 (264)
T ss_pred CchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHH
Confidence 9999999999999876 4554 788888999999999999 89999999999999999999988 888887 5666777
Q ss_pred cccCcc
Q 003039 440 NYAGNI 445 (854)
Q Consensus 440 ~~~~n~ 445 (854)
-+.||.
T Consensus 179 hiqgnr 184 (264)
T KOG0617|consen 179 HIQGNR 184 (264)
T ss_pred hcccce
Confidence 777774
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=1e-09 Score=110.60 Aligned_cols=135 Identities=19% Similarity=0.187 Sum_probs=95.9
Q ss_pred ccccccCceEEEEEEECC-------CcEEEEEEEccCCc--c--------------------cHHH----HHHHHHHHcc
Q 003039 532 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNSY--Q--------------------GKRE----FTNEVTLLSR 578 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~-------~~~VAvK~l~~~~~--~--------------------~~~~----~~~Ev~~L~~ 578 (854)
..||.|.-+.||.|...+ +..+|||+.+.... + ..+. .++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997553 47999998753110 0 0112 2379999999
Q ss_pred CCC--CceeeEeeeeeecCeEEEEEEeccCCCHHh-hhcccccccccccHHHHHHHHHHHHHHHHHH-HhCCCCceecCC
Q 003039 579 IHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRD 654 (854)
Q Consensus 579 l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~-~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrD 654 (854)
+.. -++.+.+++ ...++||||+.++.+.. .+. ...++..+...+..+++.+|..| |+. +++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 853 455556654 45689999998754321 121 11233345567789999999999 777 999999
Q ss_pred CCCCCEEEcCCCcEEEEeeeccccc
Q 003039 655 LKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 655 Ikp~NILl~~~~~vkl~DFGla~~~ 679 (854)
|++.|||++ ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3e-12 Score=135.49 Aligned_cols=170 Identities=19% Similarity=0.252 Sum_probs=95.8
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeC--CCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN--SDPQ 340 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~--~~~~ 340 (854)
.|..++.|++..|..+.+||.|+.+|.++.|..+.|++.. .++++..+..+..+. |. ...-+.|. ...+
T Consensus 66 nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls~-lp~~i~s~~~l~~l~------~s--~n~~~el~~~i~~~ 136 (565)
T KOG0472|consen 66 NLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLSE-LPEQIGSLISLVKLD------CS--SNELKELPDSIGRL 136 (565)
T ss_pred cccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHhh-ccHHHhhhhhhhhhh------cc--ccceeecCchHHHH
Confidence 3557788999999999999999999999999999998876 455555554433321 10 01111221 1122
Q ss_pred CCeeEEEecCCCCCccCCccccc-----------------------CccCcEEeccCCCCCCCCCCCCCCCCccEEEeCC
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTK-----------------------LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 397 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~-----------------------l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~ 397 (854)
-.+..|+..+|+++ ++|+.+++ |+.|+.||+.+|-+..+||++++|.+|.-|+|.+
T Consensus 137 ~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~ 215 (565)
T KOG0472|consen 137 LDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRR 215 (565)
T ss_pred hhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhh
Confidence 23444445555555 44444444 4555555555555555555555555555555555
Q ss_pred CccCCCCCccccCCCCCceeeccccccccccccccc---cccccccccCcc
Q 003039 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNI 445 (854)
Q Consensus 398 N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l~---~~~~~l~~~~n~ 445 (854)
|+|. .+| +|+.+..|++|+++.|+|+ .+|...+ ..+..|++..|.
T Consensus 216 Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNk 263 (565)
T KOG0472|consen 216 NKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNK 263 (565)
T ss_pred cccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccc
Confidence 5555 444 4555555555555555555 5555543 233555666553
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.2e-11 Score=139.80 Aligned_cols=214 Identities=21% Similarity=0.252 Sum_probs=143.8
Q ss_pred CCCCCceEEEEEECCcccccccccccccccCcceEEecccc--------ccccccceeeeecccCCCCCCCcccchhhhc
Q 003039 219 LDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGY--------TNLSLPFVLSFKFGKTYDSSRGPLLNAMEIN 290 (854)
Q Consensus 219 ~~~~~~R~F~v~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~l~~l~~l~l~~n~~s~lpP~in~le~l 290 (854)
+.+.-.-.||++.|.-..+++ |.......+.+ ..++ +....++|..|+...|.++-+||.+..+..|
T Consensus 238 p~p~nl~~~dis~n~l~~lp~----wi~~~~nle~l-~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL 312 (1081)
T KOG0618|consen 238 PVPLNLQYLDISHNNLSNLPE----WIGACANLEAL-NANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSL 312 (1081)
T ss_pred cccccceeeecchhhhhcchH----HHHhcccceEe-cccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCccccccee
Confidence 345556667777776544432 22222322222 1221 1223556677777777777777777777777
Q ss_pred eeccCCCCCccHHHHHHHHhhcC-----------CCCc-----------------cCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 291 KYLERNDGSIDGVAIVSVISLYS-----------SADW-----------------AQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 291 ~~L~l~~~~~~~~~~~~l~~l~~-----------~~~w-----------------~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
+.|+|..|.+.......++-+.. +... +..-+|-| |+-+.| .+.
T Consensus 313 ~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c----~p~l~~----~~h 384 (1081)
T KOG0618|consen 313 RTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSC----FPVLVN----FKH 384 (1081)
T ss_pred eeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccc----hhhhcc----ccc
Confidence 77777766654311111111100 0000 00023444 333332 468
Q ss_pred eeEEEecCCCCCccCCc-ccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 343 ITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~-~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
|+.|+|++|+|. ++|+ .+.+|..|++|+||+|+|+.++..+..+..|++|...+|+|. ..| .+..++.|+.+||+.
T Consensus 385 LKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~ 461 (1081)
T KOG0618|consen 385 LKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSC 461 (1081)
T ss_pred eeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEeccc
Confidence 999999999999 6765 678899999999999999998878999999999999999999 888 899999999999999
Q ss_pred cccc-cccccccc-cccccccccCccccc
Q 003039 422 NMLS-GTVPSSLL-SKNVVLNYAGNINLH 448 (854)
Q Consensus 422 N~l~-g~~p~~l~-~~~~~l~~~~n~~l~ 448 (854)
|+|+ +.+|..+- ++++.|+++||..+-
T Consensus 462 N~L~~~~l~~~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 462 NNLSEVTLPEALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred chhhhhhhhhhCCCcccceeeccCCcccc
Confidence 9998 34555554 788999999998643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.8e-09 Score=103.70 Aligned_cols=131 Identities=24% Similarity=0.404 Sum_probs=101.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcc--------cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~--------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
..+++|+-+.+|.+.+. |.++++|.-...... ......+|+.++.+++--.|..-+-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876 555677754333211 123456799999998766666666677777888999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
++|-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888432 245677888888999999 999999999999998765 99999999863
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-09 Score=110.82 Aligned_cols=142 Identities=18% Similarity=0.335 Sum_probs=107.7
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCC--CceeeEeeeeeec---CeEEEEEEecc
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHH--RNLVQFLGYCQEE---GRSVLVYEFMH 605 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~H--pnIv~l~g~~~~~---~~~~LV~E~~~ 605 (854)
+.||.|.++.||++...+|+.+++|+...... .....+..|+++++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999887778999998754322 134578899999999975 3456777777654 35689999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--------------------------------------- 646 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 646 (854)
+.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765421 23556666777888888888888521
Q ss_pred --------------CCceecCCCCCCCEEEcC--CCcEEEEeeecccc
Q 003039 647 --------------VPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKF 678 (854)
Q Consensus 647 --------------~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~ 678 (854)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.6e-09 Score=129.52 Aligned_cols=157 Identities=22% Similarity=0.178 Sum_probs=79.3
Q ss_pred cceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
++|+.|+|..|.++.+|... ..|+.|++++|++.... ..... +..+.. .-|. ...++. .+.+|+
T Consensus 282 ~~L~~L~Ls~N~Lt~LP~~p---~~L~~LdLS~N~L~~Lp-~lp~~---L~~L~L---s~N~---L~~LP~---lp~~Lq 345 (788)
T PRK15387 282 SGLCKLWIFGNQLTSLPVLP---PGLQELSVSDNQLASLP-ALPSE---LCKLWA---YNNQ---LTSLPT---LPSGLQ 345 (788)
T ss_pred hhcCEEECcCCccccccccc---cccceeECCCCccccCC-CCccc---cccccc---ccCc---cccccc---cccccc
Confidence 45677788888888887643 45777788888766421 00011 111100 0010 111110 113566
Q ss_pred EEEecCCCCCccCCccccc-----------------CccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCcc
Q 003039 345 VIHLSSKNLTGNIPSDLTK-----------------LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 407 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~i~~-----------------l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~ 407 (854)
.|+|++|+|+ .+|....+ +.+|+.|+|++|+|++.++. .++|+.|+|++|+|+ .+|..
T Consensus 346 ~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Ls-sIP~l 420 (788)
T PRK15387 346 ELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVL---PSELKELMVSGNRLT-SLPML 420 (788)
T ss_pred eEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCcccCCCCc---ccCCCEEEccCCcCC-CCCcc
Confidence 6777777766 45542211 12445555555555543321 234555666666665 35542
Q ss_pred ccCCCCCceeecccccccccccccc--ccccccccccCccc
Q 003039 408 LMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 408 l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n~~ 446 (854)
. .+|+.|+|++|+|+ .+|..+ +..+..+++++|+.
T Consensus 421 ~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 421 P---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred h---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCC
Confidence 2 34555666666666 566654 44555666666653
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.5e-11 Score=132.74 Aligned_cols=172 Identities=18% Similarity=0.155 Sum_probs=128.2
Q ss_pred cceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
+-....+|+.|..+.+|....++..|+.|.|+.|.+.. .++.++.+..+..+..+.++-- ...---|.. -|+
T Consensus 75 tdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~-ip~~i~~L~~lt~l~ls~NqlS---~lp~~lC~l----pLk 146 (722)
T KOG0532|consen 75 TDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRT-IPEAICNLEALTFLDLSSNQLS---HLPDGLCDL----PLK 146 (722)
T ss_pred cchhhhhccccccccCchHHHHHHHHHHHHHHhcccee-cchhhhhhhHHHHhhhccchhh---cCChhhhcC----cce
Confidence 33355677888888888888888888887777766544 2344444433222111111100 001111322 489
Q ss_pred EEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccc
Q 003039 345 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l 424 (854)
.|-+++|+|+ .+|++|+.+..|..||.+.|.|..+++.+++|.+|+.|.+..|++. .+|+.+..| .|..||+|+|++
T Consensus 147 vli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki 223 (722)
T KOG0532|consen 147 VLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI 223 (722)
T ss_pred eEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence 9999999999 9999999999999999999999999999999999999999999999 788888876 688999999999
Q ss_pred cccccccc--ccccccccccCccccc
Q 003039 425 SGTVPSSL--LSKNVVLNYAGNINLH 448 (854)
Q Consensus 425 ~g~~p~~l--~~~~~~l~~~~n~~l~ 448 (854)
+ .||.++ +..++.|.+..||-..
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCCC
Confidence 9 999988 7778888999998653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.7e-11 Score=137.75 Aligned_cols=174 Identities=22% Similarity=0.292 Sum_probs=120.5
Q ss_pred cceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
..+..+++++|.++.+|..+.++..|+.|+.+.|.+.. .+..+.....+..+... -| ....+.-...++..|+
T Consensus 241 ~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l~~-lp~ri~~~~~L~~l~~~---~n---el~yip~~le~~~sL~ 313 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSNLPEWIGACANLEALNANHNRLVA-LPLRISRITSLVSLSAA---YN---ELEYIPPFLEGLKSLR 313 (1081)
T ss_pred ccceeeecchhhhhcchHHHHhcccceEecccchhHHh-hHHHHhhhhhHHHHHhh---hh---hhhhCCCcccccceee
Confidence 35688999999999999889999999999999999843 55555555544443110 01 0111111123355788
Q ss_pred EEEecCCCCCccCCcccc--------------------------cCccCcEEeccCCCCCC-CCCCCCCCCCccEEEeCC
Q 003039 345 VIHLSSKNLTGNIPSDLT--------------------------KLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLED 397 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~i~--------------------------~l~~L~~L~L~~N~l~~-~~p~~~~l~~L~~L~Ls~ 397 (854)
+|+|..|+|. .+|+.+. .+..|+.|+|.+|.|+. .+|-+-+.++|+.|||++
T Consensus 314 tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsy 392 (1081)
T KOG0618|consen 314 TLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSY 392 (1081)
T ss_pred eeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecc
Confidence 8888888888 6666432 13456778888888876 556678888888888888
Q ss_pred CccCCCCCc-cccCCCCCceeecccccccccccccc--ccccccccccCccccc
Q 003039 398 NQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 448 (854)
Q Consensus 398 N~l~g~~P~-~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~ 448 (854)
|+|. ++|+ .+.+|..|+.|+||+|+|+ .+|.++ +..+..|...+|.-.|
T Consensus 393 NrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~ 444 (1081)
T KOG0618|consen 393 NRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS 444 (1081)
T ss_pred cccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee
Confidence 8888 6776 5778888888888888888 787766 3444555555554444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.4e-09 Score=126.69 Aligned_cols=155 Identities=22% Similarity=0.189 Sum_probs=79.8
Q ss_pred cceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
++|+.|+|+.|.++.+|+.+ ..|+.|.+..|.+.... ...+.+ ..+.. .++- ...+.. .+++|+
T Consensus 242 ~~Lk~LdLs~N~LtsLP~lp---~sL~~L~Ls~N~L~~Lp-~lp~~L---~~L~L-s~N~-----Lt~LP~---~p~~L~ 305 (788)
T PRK15387 242 PELRTLEVSGNQLTSLPVLP---PGLLELSIFSNPLTHLP-ALPSGL---CKLWI-FGNQ-----LTSLPV---LPPGLQ 305 (788)
T ss_pred CCCcEEEecCCccCcccCcc---cccceeeccCCchhhhh-hchhhc---CEEEC-cCCc-----cccccc---cccccc
Confidence 46788888899999888754 45677888888766421 111222 11111 0111 111111 124566
Q ss_pred EEEecCCCCCccCCccccc-----------------CccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCcc
Q 003039 345 VIHLSSKNLTGNIPSDLTK-----------------LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 407 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~i~~-----------------l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~ 407 (854)
.|+|++|+|++ +|..... ..+|+.|+|++|+|+++++.. .+|+.|++++|+|+ .+|..
T Consensus 306 ~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~LP~lp---~~L~~L~Ls~N~L~-~LP~l 380 (788)
T PRK15387 306 ELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASLPTLP---SELYKLWAYNNRLT-SLPAL 380 (788)
T ss_pred eeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccCCCCCCC---cccceehhhccccc-cCccc
Confidence 66666666663 3331111 136778888888887654322 24444555555555 34432
Q ss_pred ccCCCCCceeeccccccccccccccccccccccccCcc
Q 003039 408 LMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 445 (854)
Q Consensus 408 l~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~l~~~~n~ 445 (854)
. .+|+.|+|++|+|+ .+|.. ..++..|++++|.
T Consensus 381 ~---~~L~~LdLs~N~Lt-~LP~l-~s~L~~LdLS~N~ 413 (788)
T PRK15387 381 P---SGLKELIVSGNRLT-SLPVL-PSELKELMVSGNR 413 (788)
T ss_pred c---cccceEEecCCccc-CCCCc-ccCCCEEEccCCc
Confidence 2 34555666666655 34432 2344455555553
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.9e-09 Score=99.96 Aligned_cols=140 Identities=26% Similarity=0.305 Sum_probs=104.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCc--------ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~--------~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
..|-||+-+.|+++.+. |+...||.-..... -..+...+|+++|.+++--.|.--.-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 56889999999999987 77777775432211 1245677899999999766666556667777777899999
Q ss_pred ccC-CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEeeeccc
Q 003039 604 MHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSK 677 (854)
Q Consensus 604 ~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DFGla~ 677 (854)
+++ .++.+++....... ........++..|-+.+.-||.+ .|+|+||..+||+|..++ .+.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 976 47888876543221 11222357888999999999999 999999999999997654 35899999985
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-09 Score=130.56 Aligned_cols=95 Identities=27% Similarity=0.455 Sum_probs=65.8
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+..++.+ .++|+.|++++|+|+ .+|..+. ++|+.|+|++
T Consensus 284 sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l--~~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~ 355 (754)
T PRK15370 284 ELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETL--PPGLKTLEAGENALT-SLPASLP--PELQVLDVSK 355 (754)
T ss_pred CCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCccc--cccceeccccCCccc-cCChhhc--CcccEEECCC
Confidence 5667777777776 4565443 35666777777776544333 257788888888887 4776664 5788888888
Q ss_pred cccccccccccccccccccccCcc
Q 003039 422 NMLSGTVPSSLLSKNVVLNYAGNI 445 (854)
Q Consensus 422 N~l~g~~p~~l~~~~~~l~~~~n~ 445 (854)
|+|+ .+|..+...+..|++++|.
T Consensus 356 N~L~-~LP~~lp~~L~~LdLs~N~ 378 (754)
T PRK15370 356 NQIT-VLPETLPPTITTLDVSRNA 378 (754)
T ss_pred CCCC-cCChhhcCCcCEEECCCCc
Confidence 8887 6777777777788888774
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=4e-09 Score=126.71 Aligned_cols=159 Identities=20% Similarity=0.228 Sum_probs=106.2
Q ss_pred ceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeE
Q 003039 266 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 345 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~ 345 (854)
+|+.|+|+.|.+..+|+.+. ..|+.|+++.|++... +..+. ..+..+... + |. ...++ ..-.++|+.
T Consensus 242 ~L~~L~Ls~N~L~~LP~~l~--s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls-~--N~---Lt~LP--~~lp~sL~~ 308 (754)
T PRK15370 242 TIQEMELSINRITELPERLP--SALQSLDLFHNKISCL-PENLP--EELRYLSVY-D--NS---IRTLP--AHLPSGITH 308 (754)
T ss_pred cccEEECcCCccCcCChhHh--CCCCEEECcCCccCcc-ccccC--CCCcEEECC-C--Cc---cccCc--ccchhhHHH
Confidence 45666666666666665543 3566666666665532 11111 122222111 0 10 11110 001236889
Q ss_pred EEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccccc
Q 003039 346 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 346 L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~ 425 (854)
|+|++|+|+ .+|..+. ++|+.|++++|+|++.+..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+
T Consensus 309 L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt 380 (754)
T PRK15370 309 LNVQSNSLT-ALPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT 380 (754)
T ss_pred HHhcCCccc-cCCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC
Confidence 999999999 6787664 689999999999998655553 78999999999999 7888764 68999999999999
Q ss_pred cccccccccccccccccCccc
Q 003039 426 GTVPSSLLSKNVVLNYAGNIN 446 (854)
Q Consensus 426 g~~p~~l~~~~~~l~~~~n~~ 446 (854)
.+|..+...+..|++++|..
T Consensus 381 -~LP~~l~~sL~~LdLs~N~L 400 (754)
T PRK15370 381 -NLPENLPAALQIMQASRNNL 400 (754)
T ss_pred -CCCHhHHHHHHHHhhccCCc
Confidence 88888877788888888754
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.2e-10 Score=120.37 Aligned_cols=90 Identities=24% Similarity=0.258 Sum_probs=60.0
Q ss_pred cccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccccccccccccc---ccc
Q 003039 361 LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKN 436 (854)
Q Consensus 361 i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l~---~~~ 436 (854)
|..|++|+.|+|++|+|++.-+. |.++.+|+.|.|..|+|.-.--..|.+|..|+.|+|.+|+|+ .+-...+ ..+
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it-~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQIT-TVAPGAFQTLFSL 348 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeE-EEeccccccccee
Confidence 45677777777777777776664 667777777777777776433446777777777777777777 4433333 334
Q ss_pred ccccccCccccccCC
Q 003039 437 VVLNYAGNINLHEGG 451 (854)
Q Consensus 437 ~~l~~~~n~~l~~~~ 451 (854)
..|++.+||..|.+.
T Consensus 349 ~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 349 STLNLLSNPFNCNCR 363 (498)
T ss_pred eeeehccCcccCccc
Confidence 666777777777653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.7e-09 Score=105.36 Aligned_cols=101 Identities=33% Similarity=0.527 Sum_probs=40.3
Q ss_pred CeeEEEecCCCCCccCCcccc-cCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccc-cCCCCCceeec
Q 003039 342 SITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSL-MNLPNLRELYV 419 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l-~~l~~L~~l~l 419 (854)
++++|+|++|+|+ .|. .++ .|.+|+.|+|++|+|+. ++.+..|++|+.|+|++|+|+ .+++.+ ..+++|+.|+|
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEEC
Confidence 7899999999999 664 576 58999999999999996 567889999999999999999 676655 46899999999
Q ss_pred ccccccccccc----ccccccccccccCcccc
Q 003039 420 QNNMLSGTVPS----SLLSKNVVLNYAGNINL 447 (854)
Q Consensus 420 ~~N~l~g~~p~----~l~~~~~~l~~~~n~~l 447 (854)
++|+|. .+-. .-++++..|++.|||..
T Consensus 96 ~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 96 SNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TTS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred cCCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence 999998 4322 22677889999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.1e-07 Score=104.97 Aligned_cols=169 Identities=21% Similarity=0.307 Sum_probs=129.6
Q ss_pred eEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeee----ecCeEEEEEEeccC-CCHHhhh
Q 003039 540 GVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ----EEGRSVLVYEFMHN-GTLKEHL 613 (854)
Q Consensus 540 g~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~----~~~~~~LV~E~~~~-gsL~~~L 613 (854)
.+.||+... ||..|++|+++............-+++++++.|.|+|++.+++. .+..+++||+|.++ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 588999765 89999999996554433333445688999999999999999886 34578999999876 5777765
Q ss_pred cccc-----------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 614 YGTL-----------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 614 ~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
.... ..+..+++...+.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 3321 2344577889999999999999999998 9999999999999999999999888876544332
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 729 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~p 729 (854)
.. |.+.+ -.+-|.=.||.+++-|.||...
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 20 11221 2357888999999999999754
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.9e-10 Score=123.89 Aligned_cols=157 Identities=18% Similarity=0.239 Sum_probs=113.7
Q ss_pred ceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccC-CCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 266 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQ-EGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~-~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
+|..+.|..|.+..+|+-|..++.|+.|+++.|++...+. .+-.+ .++-+.. ++.--|.|-+ .+.++.|.
T Consensus 99 ~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~-~lC~l-pLkvli~sNNkl~~lp~~-------ig~~~tl~ 169 (722)
T KOG0532|consen 99 SLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLPD-GLCDL-PLKVLIVSNNKLTSLPEE-------IGLLPTLA 169 (722)
T ss_pred HHHHHHHHhccceecchhhhhhhHHHHhhhccchhhcCCh-hhhcC-cceeEEEecCccccCCcc-------cccchhHH
Confidence 3455566666666776667777777777666666544111 11111 1111100 0111222211 12356899
Q ss_pred EEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccc
Q 003039 345 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l 424 (854)
.||.+.|++. .+|+.++.|.+|+.|.+..|++...+++++ .-.|..||+|.|+++ .||-.|.+|..|++|-|.+|.|
T Consensus 170 ~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 170 HLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred Hhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCC
Confidence 9999999999 999999999999999999999999999988 446899999999999 9999999999999999999999
Q ss_pred ccccccccccc
Q 003039 425 SGTVPSSLLSK 435 (854)
Q Consensus 425 ~g~~p~~l~~~ 435 (854)
. +.|..++.+
T Consensus 247 q-SPPAqIC~k 256 (722)
T KOG0532|consen 247 Q-SPPAQICEK 256 (722)
T ss_pred C-CChHHHHhc
Confidence 9 888877443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.9e-09 Score=118.26 Aligned_cols=242 Identities=21% Similarity=0.199 Sum_probs=165.8
Q ss_pred hhccccccCceEEEEEEEC--CCcEEEEEEEccCCcccHH--HHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEec
Q 003039 530 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQGKR--EFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~--~~~~VAvK~l~~~~~~~~~--~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
+...||.|.|+.|++...+ ++..+++|.+......... .-..|+.+...+ .|.+++.....+..-...++=-||+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 3567999999999988644 5778899987655333222 234566665555 4777777766666666667888999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeeeccccccCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~~~~~ 683 (854)
+++++...+ .-...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||++..+.-.
T Consensus 349 ~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 349 EGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred cCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee-
Confidence 999887665 2344567778889999999999999987 99999999999999986 88899999988532110
Q ss_pred Cceeeccccccccc--CccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 684 SHVSSIVRGTVGYL--DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~--aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
. ......-++. +++......+..+.|++|||.-+.|.++|..--+.. .+|.. +..+.+.
T Consensus 421 --~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---------~~~~~--i~~~~~p----- 481 (524)
T KOG0601|consen 421 --S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---------VQSLT--IRSGDTP----- 481 (524)
T ss_pred --c-ccccccccccccchhhccccccccccccccccccccccccCcccCccc---------cccee--eeccccc-----
Confidence 0 1111223334 555555677888999999999999999986532211 11111 1111111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
.+. . ....+..++..+..+++..||.+.++..+.+..
T Consensus 482 ~~~----~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 482 NLP----G-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred CCC----c-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111 1 114466777888999999999998887766543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.4e-08 Score=97.17 Aligned_cols=125 Identities=26% Similarity=0.315 Sum_probs=81.3
Q ss_pred EEEEEEECCCcEEEEEEEccCCc--c------------------------cHHHHHHHHHHHccCCCC--ceeeEeeeee
Q 003039 541 VVYYGKLKDGKEIAVKVLTSNSY--Q------------------------GKREFTNEVTLLSRIHHR--NLVQFLGYCQ 592 (854)
Q Consensus 541 ~Vy~a~~~~~~~VAvK~l~~~~~--~------------------------~~~~~~~Ev~~L~~l~Hp--nIv~l~g~~~ 592 (854)
.||.|...+|..+|||+.+.... . ......+|++.|.++... ++.+.+++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999998753210 0 012456899999999765 455555442
Q ss_pred ecCeEEEEEEecc--CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHH-HhCCCCceecCCCCCCCEEEcCCCcEE
Q 003039 593 EEGRSVLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRDLKSSNILLDKHMRAK 669 (854)
Q Consensus 593 ~~~~~~LV~E~~~--~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDIkp~NILl~~~~~vk 669 (854)
..++||||++ |..+..+... .++......++.+++..+..+ |.. ||+|+|+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 5455433211 111334556778888866664 676 99999999999999988 999
Q ss_pred EEeeeccccc
Q 003039 670 VSDFGLSKFA 679 (854)
Q Consensus 670 l~DFGla~~~ 679 (854)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.5e-09 Score=101.89 Aligned_cols=119 Identities=22% Similarity=0.302 Sum_probs=41.5
Q ss_pred ccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEEecCCC
Q 003039 273 GKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKN 352 (854)
Q Consensus 273 ~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~L~~n~ 352 (854)
..+-+...|-..|.. .++.|+|.+|++..+ ++++ ..+.+|+.|+|++|+
T Consensus 5 t~~~i~~~~~~~n~~-~~~~L~L~~n~I~~I---------------------------e~L~---~~l~~L~~L~Ls~N~ 53 (175)
T PF14580_consen 5 TANMIEQIAQYNNPV-KLRELNLRGNQISTI---------------------------ENLG---ATLDKLEVLDLSNNQ 53 (175)
T ss_dssp -----------------------------------------------------------S-----TT-TT--EEE-TTS-
T ss_pred ccccccccccccccc-ccccccccccccccc---------------------------cchh---hhhcCCCEEECCCCC
Confidence 344455554444444 468888888887751 1111 013479999999999
Q ss_pred CCccCCcccccCccCcEEeccCCCCCCCCCCC-CCCCCccEEEeCCCccCCCCC--ccccCCCCCceeeccccccc
Q 003039 353 LTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 353 l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~-~~l~~L~~L~Ls~N~l~g~~P--~~l~~l~~L~~l~l~~N~l~ 425 (854)
|+ .++ .+..|+.|+.|+|++|+|+...+.+ ..+++|+.|+|++|+|.. +- ..+..|++|+.|+|.+|+++
T Consensus 54 I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 54 IT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EEE-TT-GGG
T ss_pred Cc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcceeeccCCccc
Confidence 99 675 5888999999999999999765555 358999999999999873 32 46778899999999999998
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=4e-09 Score=112.17 Aligned_cols=87 Identities=26% Similarity=0.363 Sum_probs=81.0
Q ss_pred CCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCcee
Q 003039 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l 417 (854)
.+++|+.|+|++|+|++.-+.+|..+..|++|.|..|+|...-.. |.++..|+.|+|.+|+|+-.-|.+|..+..|..|
T Consensus 272 ~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l 351 (498)
T KOG4237|consen 272 KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTL 351 (498)
T ss_pred hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeee
Confidence 368999999999999988889999999999999999999876654 7889999999999999998899999999999999
Q ss_pred eccccccc
Q 003039 418 YVQNNMLS 425 (854)
Q Consensus 418 ~l~~N~l~ 425 (854)
+|-.|++.
T Consensus 352 ~l~~Np~~ 359 (498)
T KOG4237|consen 352 NLLSNPFN 359 (498)
T ss_pred ehccCccc
Confidence 99999986
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.2e-08 Score=82.85 Aligned_cols=59 Identities=37% Similarity=0.573 Sum_probs=31.4
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCcc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 400 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l 400 (854)
+|+.|+|++|+|+..-+..|.+|++|++|+|++|+|+...|+ |.+|++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666622223445555555555555555554443 45555555555555543
|
... |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.3e-08 Score=123.95 Aligned_cols=174 Identities=21% Similarity=0.158 Sum_probs=96.0
Q ss_pred ccceeeeecccCC-CCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 264 LPFVLSFKFGKTY-DSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 264 l~~l~~l~l~~n~-~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
++.|+.|+|+.+. +..+ |.+..+..|+.|.+.+|..-...+..+..+..+..+.. .-|.. ...++.. .++++
T Consensus 633 l~~Lk~L~Ls~~~~l~~i-p~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L---~~c~~--L~~Lp~~-i~l~s 705 (1153)
T PLN03210 633 LTGLRNIDLRGSKNLKEI-PDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM---SRCEN--LEILPTG-INLKS 705 (1153)
T ss_pred CCCCCEEECCCCCCcCcC-CccccCCcccEEEecCCCCccccchhhhccCCCCEEeC---CCCCC--cCccCCc-CCCCC
Confidence 4455555555433 3333 33555555556666554433334445555555544422 11210 0011110 12345
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCC------------------------------CCCCCccE
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF------------------------------SGCPDLRI 392 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~------------------------------~~l~~L~~ 392 (854)
|+.|+|++|...+.+|.. +++|+.|+|++|.+...++.+ ..+++|+.
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~ 782 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchh
Confidence 555555555443344432 234555555555554433211 11357888
Q ss_pred EEeCCCccCCCCCccccCCCCCceeecccccccccccccc-ccccccccccCcccc
Q 003039 393 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 447 (854)
Q Consensus 393 L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l-~~~~~~l~~~~n~~l 447 (854)
|+|++|...+.+|.++++|++|+.|+|++|+..+.+|..+ +.++..|++++|..+
T Consensus 783 L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L 838 (1153)
T PLN03210 783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRL 838 (1153)
T ss_pred eeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcc
Confidence 8888888777899999999999999999876444888776 667788888887654
|
syringae 6; Provisional |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.3e-08 Score=81.26 Aligned_cols=60 Identities=45% Similarity=0.608 Sum_probs=55.2
Q ss_pred ccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccc
Q 003039 365 SSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424 (854)
Q Consensus 365 ~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l 424 (854)
++|+.|+|++|+|+..+++ |.++++|++|+|++|+|+...|..|..|++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4799999999999988875 78899999999999999976667999999999999999986
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2e-08 Score=114.11 Aligned_cols=173 Identities=25% Similarity=0.308 Sum_probs=133.0
Q ss_pred cceeeeecccCCCCCCCcccchhh-hceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAME-INKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le-~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+.+..|++..|.++.+||.+..+. .|+.|+++.|++.... ..++.+..+..+.....+ +..+.-....++.|
T Consensus 116 ~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N~------l~~l~~~~~~~~~L 188 (394)
T COG4886 116 TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFND------LSDLPKLLSNLSNL 188 (394)
T ss_pred cceeEEecCCcccccCccccccchhhcccccccccchhhhh-hhhhccccccccccCCch------hhhhhhhhhhhhhh
Confidence 567889999999999999999995 9999999999988742 344555555554321111 11222111145689
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|++++|+++ .+|..+..+..|++|++++|.+...+..+..+.+|..|.+++|++. .+|..++.+++|+.|++++|.
T Consensus 189 ~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~ 266 (394)
T COG4886 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ 266 (394)
T ss_pred hheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhccccccceecccccc
Confidence 99999999999 8998888888899999999987777777888999999999999988 568889999999999999999
Q ss_pred cccccccc-cccccccccccCcccc
Q 003039 424 LSGTVPSS-LLSKNVVLNYAGNINL 447 (854)
Q Consensus 424 l~g~~p~~-l~~~~~~l~~~~n~~l 447 (854)
++ .++.- -+.++..|++++|...
T Consensus 267 i~-~i~~~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 267 IS-SISSLGSLTNLRELDLSGNSLS 290 (394)
T ss_pred cc-ccccccccCccCEEeccCcccc
Confidence 99 77661 1566778888887543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.5e-07 Score=97.33 Aligned_cols=140 Identities=14% Similarity=0.107 Sum_probs=97.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcc-----------cHHHHHHHHHHHccCCCCce--eeEeeeeee-----
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNL--VQFLGYCQE----- 593 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~-----------~~~~~~~Ev~~L~~l~HpnI--v~l~g~~~~----- 593 (854)
+.+-.-....|.+..+. |+.+.||........ ....+.+|...+.++...+| ...+++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33443444456677664 789999976433211 01137789888888854333 344555432
Q ss_pred cCeEEEEEEeccCC-CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-------C
Q 003039 594 EGRSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------H 665 (854)
Q Consensus 594 ~~~~~LV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------~ 665 (854)
....++|+|++++- +|.+++.... ....+...+..++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999886 7888874321 12334456678999999999999999 9999999999999985 4
Q ss_pred CcEEEEeeeccc
Q 003039 666 MRAKVSDFGLSK 677 (854)
Q Consensus 666 ~~vkl~DFGla~ 677 (854)
+.+.++||+.++
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 689999999875
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.8e-07 Score=119.70 Aligned_cols=154 Identities=15% Similarity=0.119 Sum_probs=97.8
Q ss_pred ceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeE
Q 003039 266 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 345 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~ 345 (854)
.|+.|.+..+.+..+|+.+ ..+.|..|++..|++.. ....++.+..++.............+ ....+++|+.
T Consensus 590 ~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip------~ls~l~~Le~ 661 (1153)
T PLN03210 590 KLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIP------DLSMATNLET 661 (1153)
T ss_pred ccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCC------ccccCCcccE
Confidence 4677788888888888877 46788888888877654 22333444444444221111111111 1223568888
Q ss_pred EEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccccc
Q 003039 346 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 346 L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~ 425 (854)
|+|++|.....+|..|.+|++|+.|+|++|..-+.+|...++++|+.|+|++|...+.+|.. ..+|+.|+|++|.+.
T Consensus 662 L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 662 LKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE 738 (1153)
T ss_pred EEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence 88888776668888888888888888888654455554447778888888877655556643 245666667666665
Q ss_pred cccccc
Q 003039 426 GTVPSS 431 (854)
Q Consensus 426 g~~p~~ 431 (854)
.+|..
T Consensus 739 -~lP~~ 743 (1153)
T PLN03210 739 -EFPSN 743 (1153)
T ss_pred -ccccc
Confidence 55543
|
syringae 6; Provisional |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=9.7e-09 Score=121.39 Aligned_cols=203 Identities=20% Similarity=0.214 Sum_probs=138.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+-+|.++.++.+.-. .|.-.++|+...... ...+....+-.++-..+||-++...--+.......||++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 46778999988877533 233334443322111 11112222333333345677766555555667889999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC------
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD------ 681 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~------ 681 (854)
+|...|+..- ..+..........+.++++|||.. .+.|+|++|.|+|+..++..+++|||.......
T Consensus 890 ~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 890 DLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 9998886432 233333344556678899999997 689999999999999999999999984321100
Q ss_pred C--C----------------C------ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccc
Q 003039 682 G--A----------------S------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 737 (854)
Q Consensus 682 ~--~----------------~------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~ 737 (854)
. . . .......||+.|.+||...+......+|.|+.|++++|.++|..||.......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0 0 0 01123458999999999999999999999999999999999999998766444
Q ss_pred cccc
Q 003039 738 NCRN 741 (854)
Q Consensus 738 ~~~~ 741 (854)
..++
T Consensus 1043 ~f~n 1046 (1205)
T KOG0606|consen 1043 IFEN 1046 (1205)
T ss_pred hhhc
Confidence 3333
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.5e-06 Score=90.23 Aligned_cols=299 Identities=12% Similarity=0.106 Sum_probs=169.2
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeee------eee-cCeEEEEEE
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY------CQE-EGRSVLVYE 602 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~------~~~-~~~~~LV~E 602 (854)
.+.||+|+-+.+|-.-- -..-+.|+..........+. ++.|... .||-+-.-+.+ -.+ +....+.|.
T Consensus 16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 56799999999995421 12234577765543333322 2233333 45543321111 111 223567777
Q ss_pred eccCCC-HHhhhcc--cccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 603 FMHNGT-LKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 603 ~~~~gs-L~~~L~~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
.+.+.- ...+... ........+|...++.+..+|.+.+.||.. |.+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 776642 2222211 112233468999999999999999999998 9999999999999999999999975432222
Q ss_pred cCCCCceeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhC-CcccccccccccccchHHHHHHhhhcC
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESG 753 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG-~~pf~~~~~~~~~~~l~~~~~~~~~~~ 753 (854)
.. .....-.+|...|.+||.-. +-.-+...|.|.+||++++++.| ++||.+-......-.-.+ ..+-.|
T Consensus 168 ~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g 242 (637)
T COG4248 168 AN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHG 242 (637)
T ss_pred cC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcc
Confidence 22 22223345889999999865 23456678999999999999986 999976442111111000 000111
Q ss_pred CcccccCccc--c---CcCCHH-HHHHHHHHHHHccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhhcCCC--CCCCCC
Q 003039 754 DIQGIIDPSL--L---DEYDIQ-SMWKIEEKALMCVLP--HGHMRPSISEVLKDIQDAIVIEREAAAARDGN--SDDMSR 823 (854)
Q Consensus 754 ~~~~~id~~l--~---~~~~~~-~~~~l~~l~~~Cl~~--~P~~RPsm~eV~~~L~~~~~~~~~~~~~~~~~--~~~~~~ 823 (854)
.+...-|... . .+.+.+ -...+-.+-.+|+.. ++.-||+++-.+..|.++..... ....+... .-....
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~-~C~v~a~H~y~~hl~~ 321 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK-KCTVSAMHVYPVHLTD 321 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh-hhhhcccccccCCCCC
Confidence 1111111110 0 011111 112344555677764 46789999999999887654322 22222222 233455
Q ss_pred CCCCcccccCCCCCCCCCcC
Q 003039 824 NSLHSSLNVGSFGGTENFLS 843 (854)
Q Consensus 824 ~~~~~~~~~~s~~~~~~~~~ 843 (854)
|++-.--+.|.....++-++
T Consensus 322 CPwCa~~~~g~~~~~~e~it 341 (637)
T COG4248 322 CPWCALDNQGVIYFGEEVIT 341 (637)
T ss_pred CchhhhcccCccccCcceee
Confidence 66665555555544444433
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.8e-07 Score=92.82 Aligned_cols=134 Identities=21% Similarity=0.253 Sum_probs=96.2
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCc----------------------ccHHHHHHHHHHHccCCCC--c
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----------------------QGKREFTNEVTLLSRIHHR--N 583 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~----------------------~~~~~~~~Ev~~L~~l~Hp--n 583 (854)
+.++..||-|.-+.||.|...+|.++|||.-+.... ......++|.++|+++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999997442110 0123467899999988644 5
Q ss_pred eeeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 003039 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 663 (854)
Q Consensus 584 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 663 (854)
+.+.+++ ++..+||||+++-.|...- ++....-.++..|++-+..+-.. ||||+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 5555443 4668999999986553321 12223334555555555555555 999999999999999
Q ss_pred CCCcEEEEeeeccc
Q 003039 664 KHMRAKVSDFGLSK 677 (854)
Q Consensus 664 ~~~~vkl~DFGla~ 677 (854)
++|.+.++||-.+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999997664
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.52 E-value=9.7e-09 Score=105.38 Aligned_cols=130 Identities=19% Similarity=0.190 Sum_probs=97.9
Q ss_pred ceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeE
Q 003039 266 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 345 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~ 345 (854)
.|+.++|+.|.++.+-..+--+..++.|+++.|.+.++. +...+++|+.
T Consensus 285 ~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~-------------------------------nLa~L~~L~~ 333 (490)
T KOG1259|consen 285 ELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQ-------------------------------NLAELPQLQL 333 (490)
T ss_pred hhhhccccccchhhhhhhhhhccceeEEeccccceeeeh-------------------------------hhhhcccceE
Confidence 457788888888888877777777888888888776511 0123457888
Q ss_pred EEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCC--ccccCCCCCceeeccccc
Q 003039 346 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 346 L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P--~~l~~l~~L~~l~l~~N~ 423 (854)
||||+|.|+ .+-.+=.+|-+.+.|.|+.|.|.. +..+..|-+|..||+++|+|. .+- ..||+|++|+.|.|.+|+
T Consensus 334 LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~-LSGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 334 LDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET-LSGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred eecccchhH-hhhhhHhhhcCEeeeehhhhhHhh-hhhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCC
Confidence 889888888 676666778888888888888753 345666778888999999888 333 368889999999999998
Q ss_pred ccccccc
Q 003039 424 LSGTVPS 430 (854)
Q Consensus 424 l~g~~p~ 430 (854)
|. .+|.
T Consensus 411 l~-~~vd 416 (490)
T KOG1259|consen 411 LA-GSVD 416 (490)
T ss_pred cc-ccch
Confidence 88 3443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.5e-08 Score=108.38 Aligned_cols=156 Identities=18% Similarity=0.212 Sum_probs=97.5
Q ss_pred ccceeeeecccCCCCC-CCcccchhhh---ceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCC
Q 003039 264 LPFVLSFKFGKTYDSS-RGPLLNAMEI---NKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP 339 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~-lpP~in~le~---l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~ 339 (854)
+.+++.|+|+.|.+.. .++.+.++.. |+.|+++.|.+...++..+.... ..
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l-------------------------~~ 134 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGL-------------------------KD 134 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHH-------------------------Hh
Confidence 4566777777777763 4444656555 77777777776643333332210 01
Q ss_pred -CCCeeEEEecCCCCCcc----CCcccccCccCcEEeccCCCCCCC-----CCCCCCCCCccEEEeCCCccCCC----CC
Q 003039 340 -QPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHLEDNQLTGP----LP 405 (854)
Q Consensus 340 -~~~l~~L~L~~n~l~g~----lp~~i~~l~~L~~L~L~~N~l~~~-----~p~~~~l~~L~~L~Ls~N~l~g~----~P 405 (854)
.++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ...+..+++|+.|+|++|.+++. ++
T Consensus 135 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 214 (319)
T cd00116 135 LPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALA 214 (319)
T ss_pred CCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHH
Confidence 14688888888888743 344566677888888888888742 11244556888888888887633 34
Q ss_pred ccccCCCCCceeecccccccccccccc-------ccccccccccCc
Q 003039 406 SSLMNLPNLRELYVQNNMLSGTVPSSL-------LSKNVVLNYAGN 444 (854)
Q Consensus 406 ~~l~~l~~L~~l~l~~N~l~g~~p~~l-------~~~~~~l~~~~n 444 (854)
..+..+++|+.|++++|++++.....+ ...+..|++.+|
T Consensus 215 ~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n 260 (319)
T cd00116 215 ETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260 (319)
T ss_pred HHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCC
Confidence 456667788888888888875322222 135566666665
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.4e-08 Score=108.45 Aligned_cols=178 Identities=20% Similarity=0.164 Sum_probs=98.2
Q ss_pred ceeeeecccCCC-----CCCCcccchhhhceeccCCCCCcc------HHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeE
Q 003039 266 FVLSFKFGKTYD-----SSRGPLLNAMEINKYLERNDGSID------GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ 334 (854)
Q Consensus 266 ~l~~l~l~~n~~-----s~lpP~in~le~l~~L~l~~~~~~------~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~ 334 (854)
.++.|+|..+.+ ..+++.+.....++.|.+..+.+. ...+..++.+..+..+...+ .+-.......+.
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~-~~~~~~~~~~~~ 102 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSD-NALGPDGCGVLE 102 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccC-CCCChhHHHHHH
Confidence 456667776666 334455555555677777666554 12223344333444442211 111000000000
Q ss_pred eCCCCCCCeeEEEecCCCCCc----cCCcccccC-ccCcEEeccCCCCCCCCC-----CCCCCCCccEEEeCCCccCCC-
Q 003039 335 CNSDPQPSITVIHLSSKNLTG----NIPSDLTKL-SSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQLTGP- 403 (854)
Q Consensus 335 c~~~~~~~l~~L~L~~n~l~g----~lp~~i~~l-~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~g~- 403 (854)
.-... ++|+.|+|++|++++ .+...+..+ ++|+.|+|++|.+++... .+..+.+|+.|+|++|.+++.
T Consensus 103 ~l~~~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 181 (319)
T cd00116 103 SLLRS-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAG 181 (319)
T ss_pred HHhcc-CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHH
Confidence 00111 458888888887772 344455666 778888888888874322 255667788888888887742
Q ss_pred ---CCccccCCCCCceeecccccccccccccc------ccccccccccCcc
Q 003039 404 ---LPSSLMNLPNLRELYVQNNMLSGTVPSSL------LSKNVVLNYAGNI 445 (854)
Q Consensus 404 ---~P~~l~~l~~L~~l~l~~N~l~g~~p~~l------~~~~~~l~~~~n~ 445 (854)
++..+..+++|+.|+|++|.+++.-...+ ++++..|++++|+
T Consensus 182 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~ 232 (319)
T cd00116 182 IRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNN 232 (319)
T ss_pred HHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCc
Confidence 34455566678888888887764332222 3456677777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.1e-06 Score=101.15 Aligned_cols=140 Identities=24% Similarity=0.283 Sum_probs=90.7
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCccc----------------------------------------HHHHHH
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------KREFTN 571 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~----------------------------------------~~~~~~ 571 (854)
+.|+.++-|.||+|++++|+.||||+.+..-... +-++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999976532110 012334
Q ss_pred HHHHHccCC-----CCceeeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHH-HHHHHhC
Q 003039 572 EVTLLSRIH-----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG-IEYLHTG 645 (854)
Q Consensus 572 Ev~~L~~l~-----HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~ 645 (854)
|...+.+++ .+++.----|..-.+...|+|||++|-.+.+...- +...++ +..++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d---~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGID---RKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCC---HHHHHHHHHHHHHHHHHhc
Confidence 554444442 23332222222335677999999999888877421 112233 22233333332 2223333
Q ss_pred CCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 646 ~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|++|.|.+|.||+++.++++.+.|||+.....
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 89999999999999999999999999986543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1e-07 Score=109.12 Aligned_cols=150 Identities=18% Similarity=0.306 Sum_probs=101.0
Q ss_pred HHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc--------eeecccccccccCcccccc
Q 003039 633 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--------VSSIVRGTVGYLDPEYYIS 704 (854)
Q Consensus 633 ~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~--------~~~~~~gt~~Y~aPE~~~~ 704 (854)
.+++.||.|+|.. .++||++|.|++|.++..+..||+.|+.+......... ......-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999987 69999999999999999999999999987543331111 1111224567999999999
Q ss_pred CcCCCcchhhhHHHHHHHHHhC-CcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHcc
Q 003039 705 QQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCV 783 (854)
Q Consensus 705 ~~~s~~~DVwSlGvvl~elltG-~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl 783 (854)
...+.++|+||+||++|-+..| +.-+...... ....... . .+..-.-.++.+...++.+-+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~---~----------~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSR---N----------LLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhh---c----------ccccccccccccCcHHHHHHHHHHh
Confidence 8899999999999999999954 4434332211 0000000 0 0001111222334456777788889
Q ss_pred CCCCCCCCCHHHHHH
Q 003039 784 LPHGHMRPSISEVLK 798 (854)
Q Consensus 784 ~~~P~~RPsm~eV~~ 798 (854)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.3e-06 Score=86.74 Aligned_cols=106 Identities=26% Similarity=0.312 Sum_probs=81.0
Q ss_pred HHHHHHHHHHHccCCCC--ceeeEeeeeeec----CeEEEEEEeccCC-CHHhhhcccccccccccHHHHHHHHHHHHHH
Q 003039 566 KREFTNEVTLLSRIHHR--NLVQFLGYCQEE----GRSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638 (854)
Q Consensus 566 ~~~~~~Ev~~L~~l~Hp--nIv~l~g~~~~~----~~~~LV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~g 638 (854)
.....+|...+.++... .+.+.+++.... ...++|+|++++. +|.+++.... ..+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 44577888887777533 334555655442 2458999999874 7888885321 14455667899999999
Q ss_pred HHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEeeecccc
Q 003039 639 IEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKF 678 (854)
Q Consensus 639 L~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DFGla~~ 678 (854)
++-||.. ||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.1e-07 Score=102.53 Aligned_cols=157 Identities=22% Similarity=0.244 Sum_probs=120.5
Q ss_pred ceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeE
Q 003039 266 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 345 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~ 345 (854)
.++.|+++.|.+..+|..+..+..|+.|.++.|++....... ..+..+..+...+. ...-+.+....+..|+.
T Consensus 141 nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~-~~~~~L~~L~ls~N------~i~~l~~~~~~~~~L~~ 213 (394)
T COG4886 141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLL-SNLSNLNNLDLSGN------KISDLPPEIELLSALEE 213 (394)
T ss_pred hcccccccccchhhhhhhhhccccccccccCCchhhhhhhhh-hhhhhhhheeccCC------ccccCchhhhhhhhhhh
Confidence 688999999999999988999999999999999987643321 02222222211000 12223332223445999
Q ss_pred EEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccccc
Q 003039 346 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 346 L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~ 425 (854)
|.+++|.+. .++..+.++++|..|.+++|++...+..+..+++|+.|++++|+++ .++. ++.+.+|+.|++++|.++
T Consensus 214 l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 214 LDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred hhhcCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc-cccc-ccccCccCEEeccCcccc
Confidence 999999766 6888899999999999999999987667889999999999999999 6776 999999999999999999
Q ss_pred ccccccc
Q 003039 426 GTVPSSL 432 (854)
Q Consensus 426 g~~p~~l 432 (854)
..+|...
T Consensus 291 ~~~~~~~ 297 (394)
T COG4886 291 NALPLIA 297 (394)
T ss_pred ccchhhh
Confidence 6666554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.7e-08 Score=109.24 Aligned_cols=126 Identities=29% Similarity=0.384 Sum_probs=100.0
Q ss_pred CCCCCCCCCCCe---eEeCCCC----------CCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC-CCCC
Q 003039 321 GGDPCLPVPWSW---LQCNSDP----------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSG 386 (854)
Q Consensus 321 ~~~pc~~~~~~~---~~c~~~~----------~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~ 386 (854)
+||-|....|.- +.|+.+. ++.|+.|||++|+++ ..- .|-.|++|+.|||+.|.|.-.+- ...+
T Consensus 154 ggd~~ns~~Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~g 231 (1096)
T KOG1859|consen 154 GGDISNSPVWNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVG 231 (1096)
T ss_pred ccccccchhhhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhccccccchhh
Confidence 678887666664 4454332 578899999999999 454 78899999999999999985443 2445
Q ss_pred CCCccEEEeCCCccCCCCCccccCCCCCceeeccccccccc---cccccccccccccccCccccccCC
Q 003039 387 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT---VPSSLLSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 387 l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~---~p~~l~~~~~~l~~~~n~~l~~~~ 451 (854)
+. |+.|.|++|-++ ++ -.+.+|.+|+.|||++|-|.+. .|-+.+..+..|.+.|||-.|...
T Consensus 232 c~-L~~L~lrnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 232 CK-LQLLNLRNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred hh-heeeeecccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 66 999999999999 44 3588999999999999998864 355557788999999999999754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.5e-05 Score=79.09 Aligned_cols=137 Identities=18% Similarity=0.177 Sum_probs=100.9
Q ss_pred ccccCceEEEEEEECCCcEEEEEEEccC---C---cccHHHHHHHHHHHccCCCC--ceeeEeeeee-e----cCeEEEE
Q 003039 534 IGSGGFGVVYYGKLKDGKEIAVKVLTSN---S---YQGKREFTNEVTLLSRIHHR--NLVQFLGYCQ-E----EGRSVLV 600 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~~~~~VAvK~l~~~---~---~~~~~~~~~Ev~~L~~l~Hp--nIv~l~g~~~-~----~~~~~LV 600 (854)
-|+||-+.|++-.+. |+.+-+|.-... + +.....|.+|...|.++... .+.+.+ ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477899999998776 557888875421 1 33567899999999998532 244444 332 1 1246899
Q ss_pred EEeccC-CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc--EEEEeeeccc
Q 003039 601 YEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSK 677 (854)
Q Consensus 601 ~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkl~DFGla~ 677 (854)
+|-+.+ -+|.+++... .-.+.+...+..+..++++.++-||.. |+.|+|+.+.|||++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 4888887432 122445666778999999999999999 9999999999999986666 9999998765
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=2e-05 Score=82.08 Aligned_cols=138 Identities=15% Similarity=0.220 Sum_probs=84.6
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCc--eeeEeeeeeecCeEEEEEEeccCCC-
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQEEGRSVLVYEFMHNGT- 608 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hpn--Iv~l~g~~~~~~~~~LV~E~~~~gs- 608 (854)
..||+|..+.||+. .+..+++|..+... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 25567888876432 3445688999998886433 3567777777777889999999863
Q ss_pred HHhhh---------------------cccccccccccHHHHH-HHHH----------HHHH-HHHHHHhC-CCCceecCC
Q 003039 609 LKEHL---------------------YGTLTHEQRINWIKRL-EIAE----------DAAK-GIEYLHTG-CVPAIIHRD 654 (854)
Q Consensus 609 L~~~L---------------------~~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~~-~~~~ivHrD 654 (854)
+...+ |........+. ... .+.. .+.+ ...+|... ..+.++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~--~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQ--SYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHH--HHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 11000000110 000 0000 0111 12222211 123678999
Q ss_pred CCCCCEEEcCCCcEEEEeeeccc
Q 003039 655 LKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 655 Ikp~NILl~~~~~vkl~DFGla~ 677 (854)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.6e-07 Score=91.73 Aligned_cols=99 Identities=24% Similarity=0.358 Sum_probs=66.4
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
.|+.||||+|.|+ .+..++.-++.++.|+||+|+|.. +..+..|.+|+.||||+|.|+ .+-.+=.+|-+.+.|.|++
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceee-ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 5777888888887 777777777888888888888764 333677778888888888877 5555555666677777777
Q ss_pred ccccccccccc--ccccccccccCcc
Q 003039 422 NMLSGTVPSSL--LSKNVVLNYAGNI 445 (854)
Q Consensus 422 N~l~g~~p~~l--~~~~~~l~~~~n~ 445 (854)
|.|. .+. ++ +-++..|++.+|.
T Consensus 362 N~iE-~LS-GL~KLYSLvnLDl~~N~ 385 (490)
T KOG1259|consen 362 NKIE-TLS-GLRKLYSLVNLDLSSNQ 385 (490)
T ss_pred hhHh-hhh-hhHhhhhheeccccccc
Confidence 7665 221 11 2234555666554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.1e-06 Score=99.64 Aligned_cols=182 Identities=16% Similarity=0.169 Sum_probs=134.0
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCc-eeeEeeeeeecCeEEEEEEeccCC-C
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYEFMHNG-T 608 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hpn-Iv~l~g~~~~~~~~~LV~E~~~~g-s 608 (854)
-+.+++|+++.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..+....++++++.+| +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 3557899999999987654444445554322 34556889999999999 777777777778889999999887 2
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceee
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 688 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 688 (854)
-.... ...+..+...+...++..-++++++||+. .=+|+| ||+..+ ...|..||+.+..+.... ...
T Consensus 322 ~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 322 SALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred ccccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 22111 12233455556666778888999999986 447888 777665 689999999876554432 334
Q ss_pred cccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccc
Q 003039 689 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 730 (854)
Q Consensus 689 ~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf 730 (854)
...+|+.++|||+.....+..+.|+|+.|+-..++--|-+|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 556899999999999999999999999998777777776654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.05 E-value=8.7e-07 Score=96.00 Aligned_cols=178 Identities=18% Similarity=0.170 Sum_probs=111.8
Q ss_pred ccceeeeecccCCCCCCCcc---cchhhhceeccCCCCCccHH-HHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPL---LNAMEINKYLERNDGSIDGV-AIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP 339 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~---in~le~l~~L~l~~~~~~~~-~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~ 339 (854)
++.++.|+|+.|-+...-|. +..|..|+.|+++.|.+..- .-..-..+..++.+ ...-|+ .+|..|.--...
T Consensus 145 ~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L---~l~~CG-ls~k~V~~~~~~ 220 (505)
T KOG3207|consen 145 LPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQL---VLNSCG-LSWKDVQWILLT 220 (505)
T ss_pred CCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheE---EeccCC-CCHHHHHHHHHh
Confidence 56778999999998887766 56777788899998875320 00000011122223 334453 123333311123
Q ss_pred CCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCC--CCCCCCCCccEEEeCCCccCCC-CCcc-----ccCC
Q 003039 340 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGP-LPSS-----LMNL 411 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~Ls~N~l~g~-~P~~-----l~~l 411 (854)
.|+|..|+|..|...+.--....-+..|+.|||++|++-... +-.+.|+.|+.|+++.+.+... +|+. ...+
T Consensus 221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f 300 (505)
T KOG3207|consen 221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTF 300 (505)
T ss_pred CCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccc
Confidence 578889999888533333344555788899999999887655 4577888888899988888732 2333 3567
Q ss_pred CCCceeecccccccccccccc----ccccccccccCccc
Q 003039 412 PNLRELYVQNNMLSGTVPSSL----LSKNVVLNYAGNIN 446 (854)
Q Consensus 412 ~~L~~l~l~~N~l~g~~p~~l----~~~~~~l~~~~n~~ 446 (854)
++|++|+++.|++. ..++-- +.++..|.+.+|+.
T Consensus 301 ~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~l 338 (505)
T KOG3207|consen 301 PKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYL 338 (505)
T ss_pred ccceeeecccCccc-cccccchhhccchhhhhhcccccc
Confidence 78999999999886 444321 44555666666654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.9e-05 Score=78.07 Aligned_cols=136 Identities=22% Similarity=0.259 Sum_probs=90.4
Q ss_pred cccccCceEEEEEEECCCcEEEEEEEccCCcccH------------------------HHHHHHHHHHccCC--CCceee
Q 003039 533 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK------------------------REFTNEVTLLSRIH--HRNLVQ 586 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~------------------------~~~~~Ev~~L~~l~--HpnIv~ 586 (854)
.|+.|.-+.||+|.-.++..+|||+.+......+ .-..+|+.-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 5778888999999988899999999875422111 11345777777663 223333
Q ss_pred EeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC
Q 003039 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 666 (854)
Q Consensus 587 l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 666 (854)
-+++. .-.|||||+...-. -...+ ....+.......+..++++.+.-|-..+ ++||+||..-|||+. ++
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~---pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGL---PAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeec----CCeEEEEeccCCCC---CCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CC
Confidence 34333 34799999965311 01111 1111222245667778888888887732 899999999999999 88
Q ss_pred cEEEEeeeccccc
Q 003039 667 RAKVSDFGLSKFA 679 (854)
Q Consensus 667 ~vkl~DFGla~~~ 679 (854)
.+.|+|||.|...
T Consensus 204 ~p~iID~~QaV~~ 216 (268)
T COG1718 204 EPYIIDVSQAVTI 216 (268)
T ss_pred eEEEEECcccccc
Confidence 9999999988543
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.7e-06 Score=62.52 Aligned_cols=36 Identities=33% Similarity=0.557 Sum_probs=16.6
Q ss_pred cCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccC
Q 003039 366 SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 401 (854)
Q Consensus 366 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~ 401 (854)
+|++|+|++|+|+..+|.+++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 445555555555543333445555555555555444
|
... |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=4e-07 Score=83.78 Aligned_cols=88 Identities=25% Similarity=0.397 Sum_probs=50.5
Q ss_pred CeeEEEecCCCCCccCCcccccC---ccCcEEeccCCCCCCCCCCCCC-CCCccEEEeCCCccCCCCCccccCCCCCcee
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKL---SSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l---~~L~~L~L~~N~l~~~~p~~~~-l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l 417 (854)
.+..|+|++++|- .+++.+..+ ..|+..+|++|.+...++.|.. .+.++.|+|++|+|+ .+|.++..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 3455566666655 455443333 3344446666666665555543 345666666666666 566666666666666
Q ss_pred ecccccccccccccc
Q 003039 418 YVQNNMLSGTVPSSL 432 (854)
Q Consensus 418 ~l~~N~l~g~~p~~l 432 (854)
+++.|.|. ..|.-+
T Consensus 106 Nl~~N~l~-~~p~vi 119 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVI 119 (177)
T ss_pred ccccCccc-cchHHH
Confidence 66666666 555544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.8e-05 Score=88.26 Aligned_cols=141 Identities=21% Similarity=0.227 Sum_probs=87.3
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCccc-------------------------------------HHHHHHHHH
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-------------------------------------KREFTNEVT 574 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~-------------------------------------~~~~~~Ev~ 574 (854)
+.||.-+.|.||+|++++|+.||||+-+..-... +-+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999966431110 012444554
Q ss_pred HHccC----CCCce---eeEeeee-eecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC
Q 003039 575 LLSRI----HHRNL---VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646 (854)
Q Consensus 575 ~L~~l----~HpnI---v~l~g~~-~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 646 (854)
-..++ .|-+. |.+=.++ .-.....|+||||+|..+.+.-.- ....++... ++..+.++. ++.--
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~---i~~~l~~~~--~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHD---ILNKLVEAY--LEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHH---HHHHHHHHH--HHHHH
Confidence 43333 34441 1111222 223467999999999877665321 122333333 333333321 11111
Q ss_pred CCceecCCCCCCCEEEcC----CCcEEEEeeecccccc
Q 003039 647 VPAIIHRDLKSSNILLDK----HMRAKVSDFGLSKFAV 680 (854)
Q Consensus 647 ~~~ivHrDIkp~NILl~~----~~~vkl~DFGla~~~~ 680 (854)
..|++|+|=+|.||+++. ++++.+-|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 128999999999999994 6789999999986543
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.97 E-value=4.7e-06 Score=62.49 Aligned_cols=36 Identities=47% Similarity=0.720 Sum_probs=18.4
Q ss_pred CccEEEeCCCccCCCCCccccCCCCCceeeccccccc
Q 003039 389 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 389 ~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~ 425 (854)
+|++|+|++|+|+ .+|+.|++|++|+.|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 45545555555555555555555
|
... |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=9.6e-07 Score=81.34 Aligned_cols=89 Identities=24% Similarity=0.311 Sum_probs=81.2
Q ss_pred CCeeEEEecCCCCCccCCcccccC-ccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKL-SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l-~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
..|+.++|++|.+. ..|+.|... +.++.|+|++|.|+..|.++..++.|+.|+++.|.|. ..|..+..|.+|..|+.
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 46888999999999 788877754 5899999999999999989999999999999999999 89999999999999999
Q ss_pred ccccccccccccc
Q 003039 420 QNNMLSGTVPSSL 432 (854)
Q Consensus 420 ~~N~l~g~~p~~l 432 (854)
.+|.+. .||-.+
T Consensus 131 ~~na~~-eid~dl 142 (177)
T KOG4579|consen 131 PENARA-EIDVDL 142 (177)
T ss_pred CCCccc-cCcHHH
Confidence 999999 888776
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.93 E-value=9.9e-05 Score=76.71 Aligned_cols=143 Identities=19% Similarity=0.234 Sum_probs=84.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCC--ceeeEeeeee---ecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR--NLVQFLGYCQ---EEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hp--nIv~l~g~~~---~~~~~~LV~E~~~~ 606 (854)
+.|+.|..+.||+....+ ..+++|+.... .....+..|..+++.+... .+.+++.++. .....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999886 69999997543 4456778898888888533 3456666442 23356899999999
Q ss_pred CCHHh----------------hh---cccccccccccH-H--------HHHH------------HHHHHHH-HHHHHHh-
Q 003039 607 GTLKE----------------HL---YGTLTHEQRINW-I--------KRLE------------IAEDAAK-GIEYLHT- 644 (854)
Q Consensus 607 gsL~~----------------~L---~~~~~~~~~l~~-~--------~~~~------------i~~~ia~-gL~yLH~- 644 (854)
..+.. .+ +..........+ . .... ....+.+ .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88777 11 111000000000 0 0000 0112222 3334432
Q ss_pred ---CCCCceecCCCCCCCEEEc-CCCcEEEEeeeccc
Q 003039 645 ---GCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSK 677 (854)
Q Consensus 645 ---~~~~~ivHrDIkp~NILl~-~~~~vkl~DFGla~ 677 (854)
.....++|+|+.+.|||++ +++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234799999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 854 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-56 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-33 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-31 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-26 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-26 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-26 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-26 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-26 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-26 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-26 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-26 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-26 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-26 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-25 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-25 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-25 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-25 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-24 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-24 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-24 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-24 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-24 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-22 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-22 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-06 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 448 bits (1155), Expect = e-152
Identities = 122/312 (39%), Positives = 187/312 (59%), Gaps = 7/312 (2%)
Query: 502 RPVSSLNDAPAEAAHCFTLSDIEDATKMLEKK--IGSGGFGVVYYGKLKDGKEIAVKVLT 559
S + ++ L D+E+AT + K IG G FG VY G L+DG ++A+K T
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT 72
Query: 560 SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH 619
S QG EF E+ LS H +LV +G+C E +L+Y++M NG LK HLYG+
Sbjct: 73 PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 620 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-F 678
++W +RLEI AA+G+ YLHT IIHRD+KS NILLD++ K++DFG+SK
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 738
+H+S++V+GT+GY+DPEY+I +LT+KSDVYSFGV+L E++ + AI +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPRE 248
Query: 739 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
N+ +WA +G ++ I+DP+L D+ +S+ K + A+ C+ RPS+ +VL
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 799 DIQDAIVIEREA 810
++ A+ ++
Sbjct: 309 KLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-124
Identities = 103/288 (35%), Positives = 168/288 (58%), Gaps = 4/288 (1%)
Query: 515 AHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTN 571
F+L +++ A+ + +G GGFG VY G+L DG +AVK L QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 572 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 631
EV ++S HRNL++ G+C +LVY +M NG++ L + ++W KR I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 632 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 691
A +A+G+ YLH C P IIHRD+K++NILLD+ A V DFGL+K +HV++ VR
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 692 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHI 750
GT+G++ PEY + + ++K+DV+ +GV+LLELI+GQ A + + ++ W K +
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
+ ++ ++D L Y + + ++ + AL+C RP +SEV++
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 357 bits (918), Expect = e-117
Identities = 97/305 (31%), Positives = 166/305 (54%), Gaps = 27/305 (8%)
Query: 516 HCFTLSDIEDATK--------MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTS----NSY 563
H F+ ++++ T + K+G GGFGVVY G + + +AVK L + +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 564 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 623
+ K++F E+ ++++ H NLV+ LG+ + LVY +M NG+L + L L +
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 624 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDG 682
+W R +IA+ AA GI +LH IHRD+KS+NILLD+ AK+SDFGL++
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 742
+ ++S + GT Y+ PE + ++T KSD+YSFGV+LLE+I+G A+ + + +
Sbjct: 188 QTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR---EPQLL 243
Query: 743 VQWAK-LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV---LK 798
+ + + E I+ ID +++ D S+ + A C+ + RP I +V L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 799 DIQDA 803
++ +
Sbjct: 303 EMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 4e-76
Identities = 77/310 (24%), Positives = 124/310 (40%), Gaps = 33/310 (10%)
Query: 518 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTL 575
++ + L+ + G FG V+ +L + +AVK+ Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 576 LSRIHHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 631
L + H N++QF+G + L+ F G+L + L ++W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126
Query: 632 AEDAAKGIEYLHT-------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684
AE A+G+ YLH G PAI HRD+KS N+LL ++ A ++DFGL+ G S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 685 HVSSIVR-GTVGYLDPEY-----YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 738
+ + GT Y+ PE + + D+Y+ G++L EL S A
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP-VDEY 245
Query: 739 CRNIVQWAKLHIESGDIQGII-----DPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPS 792
+ H D+Q ++ P L D + M + E C R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 793 ISEVLKDIQD 802
V + I
Sbjct: 306 AGCVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-70
Identities = 82/240 (34%), Positives = 125/240 (52%), Gaps = 6/240 (2%)
Query: 491 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDG 550
K H H + + + + A DI +++KIG+G FG V+ + G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-G 60
Query: 551 KEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608
++AVK+L + + EF EV ++ R+ H N+V F+G + +V E++ G+
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 668
L L+ + EQ ++ +RL +A D AKG+ YLH P I+HR+LKS N+L+DK
Sbjct: 121 LYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178
Query: 669 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 728
KV DFGLS+ S GT ++ PE + +KSDVYSFGVIL EL + Q+
Sbjct: 179 KVCDFGLSRLKASTFLSSKS-AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 4e-63
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLV 585
LE+ IG GGFG VY G E+AVK + + E L + + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
G C +E LV EF G L L +RI + A A+G+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 646 CVPAIIHRDLKSSNILLDK--------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 697
+ IIHRDLKSSNIL+ + + K++DFGL++ + S G ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWM 181
Query: 698 DPEYYISQQLTDKSDVYSFGVILLELISGQE 728
PE + + SDV+S+GV+L EL++G+
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-63
Identities = 80/338 (23%), Positives = 141/338 (41%), Gaps = 59/338 (17%)
Query: 520 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 579
+IE +E+ +G G FGVV K + K++A+K + S S ++ F E+ LSR+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRV 58
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
+H N+V+ G C LV E+ G+L L+G + ++G+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGV 115
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
YLH+ A+IHRDLK N+LL K+ DFG + + +G+ ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMA 171
Query: 699 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758
PE + ++K DV+S+G+IL E+I+ ++ + ++ + I
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKP---------------FDEIGGPAFRIMWA 216
Query: 759 ID----PSLLDEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 808
+ P L+ + W + P RPS+ E++K + + R
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKD--------P--SQRPSMEEIVKIMTH---LMR 263
Query: 809 EAAAARDGNSDDMSRNSLHSSLNVGSFGGTENFLSLDE 846
+D+ + SL G G E ++ E
Sbjct: 264 YFP-----GADEPLQYPCQHSLPPGEDGRVEPYVDFAE 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-62
Identities = 85/291 (29%), Positives = 137/291 (47%), Gaps = 45/291 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRIHH 581
EK+IG GGFG+V+ G+L D +A+K L +G+ +EF EV ++S ++H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
N+V+ G +V EF+ G L L I W +L + D A GIEY
Sbjct: 83 PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEY 137
Query: 642 LHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
+ P I+HRDL+S NI L + AKV+DFGLS+ + H S + G +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 697 LDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG- 753
+ PE +++ T+K+D YSF +IL +++G+ +G +++ + E G
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGL 247
Query: 754 --DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
I P L + I+ W + P RP S ++K++ +
Sbjct: 248 RPTIPEDCPPRLRNV--IELCWSGD--------P--KKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 2e-62
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 587
K+ G ++ G+ + G +I VKVL + + R+F E L H N++
Sbjct: 14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 588 LGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYL 642
LG CQ L+ +M G+L L HE ++ + ++ A D A+G+ +L
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVL-----HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 702
HT P I L S ++++D+ M A++S + ++ PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG------RMYAPAWVAPEAL 180
Query: 703 ISQQL---TDKSDVYSFGVILLELISGQE 728
+ +D++SF V+L EL++ +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREV 209
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 9e-62
Identities = 71/322 (22%), Positives = 122/322 (37%), Gaps = 46/322 (14%)
Query: 518 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--V 573
S+ L+ + IG G +G VY G L D + +AVKV + + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKR 628
+ + H N+ +F+ + LV E+ NG+L ++L +W+
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSS 113
Query: 629 LEIAEDAAKGIEYLHT------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---- 678
+A +G+ YLHT PAI HRDL S N+L+ +SDFGLS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 679 ---AVDGASHVSSIVRGTVGYLDPEY-------YISQQLTDKSDVYSFGVILLELISGQE 728
+ + GT+ Y+ PE + + D+Y+ G+I E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 729 AISNEKFGANCRNIVQW-AKLHIESGDIQGIID-----PSLLDEYDIQSMWKIEEKALM- 781
+ + + Q H D+Q ++ P + + S+ K +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 782 -CVLPHGHMRPSISEVLKDIQD 802
C R + + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-60
Identities = 70/205 (34%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 587
+ ++IGSG FG VY GK ++AVK+L + + + F NEV +L + H N++ F
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+GY ++ V ++ +L HL+ E + K ++IA A+G++YLH
Sbjct: 86 MGYSTAPQLAI-VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA--- 138
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPE---YYI 703
+IIHRDLKS+NI L + K+ DFGL+ + SH + G++ ++ PE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 704 SQQLTDKSDVYSFGVILLELISGQE 728
S + +SDVY+FG++L EL++GQ
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQL 223
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 4e-60
Identities = 61/290 (21%), Positives = 111/290 (38%), Gaps = 44/290 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 587
+ + IG G FG VY+G+ E+A++++ + F EV + H N+V F
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+G C ++ TL + + ++ K +IA++ KG+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----AVDGASHVSSIVRGTVGYLDPEYYI 703
I+H+DLKS N+ D + ++DFGL I G + +L PE
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 704 SQQL---------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754
+ SDV++ G I EL + + + A + W + +G
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----IIWQ---MGTGM 259
Query: 755 IQGIIDPSLLDEYD--IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
+ + E + W E RP+ ++++ ++
Sbjct: 260 KPNLSQIGMGKEISDILLFCWAFE--------Q--EERPTFTKLMDMLEK 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-59
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ +G G FG ++ G+ + +K L + +R F EV ++ + H N+++F+
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
G ++ R + E++ GTL+ + + + + W +R+ A+D A G+ YLH+
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---M 127
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-------------VRGTVG 695
IIHRDL S N L+ ++ V+DFGL++ VD + + V G
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 729
++ PE + +K DV+SFG++L E+I A
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-55
Identities = 69/303 (22%), Positives = 126/303 (41%), Gaps = 45/303 (14%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 587
+ K+IG G +G V+ GK + G+++AVKV + + + E + + H N++ F
Sbjct: 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGF 96
Query: 588 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+ + S L+ ++ NG+L ++L ++ L++A + G+ +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 644 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 695
T PAI HRDLKS NIL+ K+ ++D GL+ + + V + GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 696 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 749
Y+ PE Q +D+YSFG+IL E+ + + + + +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 750 IESGDIQGIID--------PSLLDEYDIQSMWK--IEEKALMCVLPHGHMRPSISEVLKD 799
E D++ I+ P+ + + E C + R + V K
Sbjct: 272 YE--DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE----CWAHNPASRLTALRVKKT 325
Query: 800 IQD 802
+
Sbjct: 326 LAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 8e-55
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 587
L + +G G +G V+ G + G+ +AVK+ +S + ++ + E + + H N++ F
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGF 67
Query: 588 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+ S L+ + G+L ++L ++ + L I A G+ +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 644 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG--- 695
PAI HRDLKS NIL+ K+ + ++D GL+ + + VG
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 696 YLDPE------YYISQQLTDKSDVYSFGVILLELISG 726
Y+ PE + D+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-52
Identities = 65/303 (21%), Positives = 128/303 (42%), Gaps = 45/303 (14%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 587
L++ IG G FG V+ GK + G+E+AVK+ +S + +R + E + + H N++ F
Sbjct: 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101
Query: 588 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+ ++ + LV ++ +G+L ++L + + +++A A G+ +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 644 -----TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 695
T PAI HRDLKS NIL+ K+ ++D GL+ + + GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 696 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 749
Y+ PE + ++D+Y+ G++ E+ + + +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 750 IESGDIQGI---------IDPSLLDEYDIQSMWK-IEEKALMCVLPHGHMRPSISEVLKD 799
+E +++ + I ++ M K + E C +G R + + K
Sbjct: 277 VE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE----CWYANGAARLTALRIKKT 330
Query: 800 IQD 802
+
Sbjct: 331 LSQ 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 40/282 (14%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+ +IG G F VY G + E+A + ++ F E +L + H N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 587 FLGY----CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 640
F + + VLV E M +GTLK +L + + + +W + +I + G++
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR--QILK----GLQ 143
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
+LHT P IIHRDLK NI + K+ D GL+ + AS +++ GT ++ P
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT--LKRASFAKAVI-GTPEFMAP 199
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759
E Y ++ + DVY+FG+ +LE+ + E + C+N Q + + SG
Sbjct: 200 EMY-EEKYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRR-VTSGVKPASF 251
Query: 760 DPSLLDEYDIQSMWKIEEKA--LMCVLPHGHMRPSISEVLKD 799
+ E K C+ + R SI ++L
Sbjct: 252 -DKVAIP---------EVKEIIEGCIRQNKDERYSIKDLLNH 283
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-40
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 587
L ++IG G FG V+ G+L+ +AVK + K +F E +L + H N+V+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+G C ++ +V E + G L T R+ L++ DAA G+EYL + C
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-----VRGTVGYLDPEYY 702
IHRDL + N L+ + K+SDFG+S+ DG S V+ T PE
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEAL 287
Query: 703 ISQQLTDKSDVYSFGVILLELIS 725
+ + +SDV+SFG++L E S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-38
Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 46/280 (16%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+KIG G FG K +DG++ +K ++ S + + E EV +L+ + H N+VQ+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 644
+E G +V ++ G L + + G L E +I +W ++ ++++H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHD 143
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
I+HRD+KS NI L K ++ DFG+++ + + GT YL PE +
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 705 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764
+ +KSD+++ G +L EL + + A I+ G P +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--------GSF-----PPVS 246
Query: 765 DEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
Y + ++K RPS++ +L+
Sbjct: 247 LHYSYDLRSLVSQLFKRNP----------RDRPSVNSILE 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 52/262 (19%)
Query: 493 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGSGGFGVVYYGKL-- 547
H H P + F D E+ +++G G FG V +
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 548 ---KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYE 602
G+ +AVK L ++ + R+F E+ +L + H N+V++ G C GR L+ E
Sbjct: 65 LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNIL 661
++ G+L+++L H++RI+ IK L+ KG+EYL T IHRDL + NIL
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRNIL 177
Query: 662 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-------------- 707
++ R K+ DFGL+K D EYY ++
Sbjct: 178 VENENRVKIGDFGLTKVLPQ----------------DKEYYKVKEPGESPIFWYAPESLT 221
Query: 708 ----TDKSDVYSFGVILLELIS 725
+ SDV+SFGV+L EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 65/315 (20%), Positives = 118/315 (37%), Gaps = 40/315 (12%)
Query: 496 HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIA 554
S +Q P + + + KKIG G F VY L DG +A
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIE--KKIGRGQFSEVYRAACLLDGVPVA 61
Query: 555 VK---VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 611
+K + + + + E+ LL +++H N++++ E+ +V E G L
Sbjct: 62 LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121
Query: 612 HL-----YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 665
+ L E+ + + +L +E++H+ ++HRD+K +N+ +
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQL------CSALEHMHS---RRVMHRDIKPANVFITAT 172
Query: 666 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
K+ D GL +F + S+V GT Y+ PE KSD++S G +L E+ +
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 726 GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD--IQSMWKIEEKALMCV 783
Q F + N+ IE D + +E + +
Sbjct: 232 LQSP-----FYGDKMNLYS-LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP------ 279
Query: 784 LPHGHMRPSISEVLK 798
RP ++ V
Sbjct: 280 ----EKRPDVTYVYD 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 47/286 (16%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
IG+G +G + DGK + K S + K+ +EV LL + H N+V++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 589 GYCQEEGRSVL--VYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 641
+ + L V E+ G L + E+ + L + ++
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-----LRVMTQLTLALKE 126
Query: 642 LHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
H ++HRDLK +N+ LD K+ DFGL++ S + V GT Y+ P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759
E +KSD++S G +L EL + F A + + A I G
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAF--SQKELAGK-IREGKF---- 233
Query: 760 DPSLLDEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ Y I M +++ + RPS+ E+L++
Sbjct: 234 -RRIPYRYSDELNEIITRMLNLKD----------YHRPSVEEILEN 268
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 49/222 (22%)
Query: 530 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 584
+++G G FG V + G+ +AVK L ++ + R+F E+ +L + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 585 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
V++ G C GR L+ E++ G+L+++L H++RI+ IK L+ KG+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 643 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
T IHRDL + NIL++ R K+ DFGL+K D E+
Sbjct: 131 GTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQ----------------DKEF 170
Query: 702 YISQQ------------------LTDKSDVYSFGVILLELIS 725
+ ++ + SDV+SFGV+L EL +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
++IGSG FG+V+ G + ++A+K + + + +F E ++ ++ H LVQ G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
C E+ LV EFM +G L ++L T L + D +G+ YL CV
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV-- 125
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 705
IHRDL + N L+ ++ KVSDFG+++F +D +S + V+ PE +
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFS 180
Query: 706 QLTDKSDVYSFGVILLELIS 725
+ + KSDV+SFGV++ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-37
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 648
EE +V E+M G+L + L + + + +++A A G+ Y+
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 709 DKSDVYSFGVILLELIS 725
KSDV+SFG++L EL +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 60/293 (20%), Positives = 108/293 (36%), Gaps = 44/293 (15%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+K+G GGF V + L DG A+K + + Q + E E + +H N+++ +
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 589 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
YC E + L+ F GTL + + + L + +G+E +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--------GTVGY 696
HRDLK +NILL + + D G A + T+ Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 697 LDPE---YYISQQLTDKSDVYSFGVILLELISGQ-----EAISNEKFGANCRNIVQWAKL 748
PE + +++DV+S G +L ++ G+ + +N + +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269
Query: 749 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801
S + ++ ++M V P H RP I +L ++
Sbjct: 270 PRHSSALWQLL------------------NSMMTVDP--HQRPHIPLLLSQLE 302
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
K++G+G FGVV YGK + ++A+K++ S + EF E ++ + H LVQ G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
C ++ ++ E+M NG L +L R + LE+ +D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQF-- 141
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 705
+HRDL + N L++ KVSDFGLS++ +D +S S VR + PE +
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLMYS 196
Query: 706 QLTDKSDVYSFGVILLELIS 725
+ + KSD+++FGV++ E+ S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 65/298 (21%), Positives = 106/298 (35%), Gaps = 58/298 (19%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
+ +G GGFGVV+ K K D A+K + N + + EV L+++ H +V++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 590 YCQEEG---------RSVLVY---EFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAE 633
E+ V +Y + LK+ + L I
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC-----LHIFL 125
Query: 634 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-----------FAVDG 682
A+ +E+LH+ ++HRDLK SNI KV DFGL
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 742
A + GT Y+ PE + K D++S G+IL EL+ F +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------PFSTQMERV 234
Query: 743 VQWAKLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ + + EY +Q M + P RP ++++
Sbjct: 235 RTLTD--VRNLKFPPLFTQKYPCEYVMVQDM--------LSPSP--MERPEAINIIEN 280
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 65/200 (32%), Positives = 112/200 (56%), Gaps = 15/200 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
L K++GSG FGVV GK K ++AVK++ S + EF E + ++ H LV+F G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
C +E +V E++ NG L +L +H + + + LE+ D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 705
IHRDL + N L+D+ + KVSDFG++++ +D +S + V+ + PE +
Sbjct: 126 -IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----PEVFHYF 180
Query: 706 QLTDKSDVYSFGVILLELIS 725
+ + KSDV++FG+++ E+ S
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 509 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 562
+AP +A +++ K +GSG FG VY G E +A+K L + S
Sbjct: 2 EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 563 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 622
+ +E +E +++ + + ++ + LG C L+ + M G L +++ H+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113
Query: 623 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682
I L AKG+ YL ++HRDL + N+L+ K++DFGL+K
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 683 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ G + ++ E + + T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-36
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 648
EE +V E+M G+L + L + + + +++A A G+ Y+
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 709 DKSDVYSFGVILLELIS 725
KSDV+SFG++L EL +
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 524 EDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI 579
D + + ++G G FG V G + K+ +A+KVL E E ++ ++
Sbjct: 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
+ +V+ +G CQ E +LV E G L + L + + I E+ + G+
Sbjct: 68 DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGM 123
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYL 697
+YL +HRDL + N+LL AK+SDFGLSK S+ ++ G + +
Sbjct: 124 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 698 DPEYYISQQLTDKSDVYSFGVILLELIS 725
PE ++ + +SDV+S+GV + E +S
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 50/223 (22%)
Query: 530 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRN 583
+ +G G FG V + G+++AVK L + + E+ +L ++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 584 LVQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
+V++ G C E+G + L+ EF+ +G+LKE+L ++ +IN ++L+ A KG++Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 642 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
L + +HRDL + N+L++ + K+ DFGL+K D E
Sbjct: 142 LGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAI----------------ETDKE 181
Query: 701 YYISQQL------------------TDKSDVYSFGVILLELIS 725
YY + SDV+SFGV L EL++
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 530 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 584
++G G FG V + G +AVK L + +R+F E+ +L +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 585 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
V++ G GR LV E++ +G L++ L H R++ + L + KG+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYL 143
Query: 643 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
+ C +HRDL + NIL++ K++DFGL+K D +Y
Sbjct: 144 GSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPL----------------DKDY 183
Query: 702 YISQQL------------------TDKSDVYSFGVILLELIS 725
Y+ ++ + +SDV+SFGV+L EL +
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-36
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 282
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCV 647
G C E ++ EFM G L ++L Q ++ + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
IHR+L + N L+ ++ KV+DFGLS+ + + + + PE +
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 708 TDKSDVYSFGVILLELIS 725
+ KSDV++FGV+L E+ +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-36
Identities = 72/341 (21%), Positives = 126/341 (36%), Gaps = 24/341 (7%)
Query: 391 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 450
I + + P + L L V+ L L + + A N +
Sbjct: 212 LISQDKAGKYCIPEGTKFDTLWQL----VEYLKLKADGLIYCLKEACPNSSASNASGAAA 267
Query: 451 GRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDA 510
H + + L +P+ V +
Sbjct: 268 PTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSP-------DKPRPMPMDTSVFESPFS 320
Query: 511 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGK 566
E L D + + ++G G FG V G + K+ +A+KVL
Sbjct: 321 DPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT 380
Query: 567 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 626
E E ++ ++ + +V+ +G CQ E +LV E G L + L + + I
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVS 436
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686
E+ + G++YL +HR+L + N+LL AK+SDFGLSK S+
Sbjct: 437 NVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493
Query: 687 SSIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
++ G + + PE ++ + +SDV+S+GV + E +S
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-36
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 15/199 (7%)
Query: 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ L
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLL 252
Query: 589 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
G +E+G +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN- 309
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 706
+HRDL + N+L+ + AKVSDFGL+K + V+ T PE ++
Sbjct: 310 --FVHRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWTA----PEALREKK 362
Query: 707 LTDKSDVYSFGVILLELIS 725
+ KSDV+SFG++L E+ S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 58/261 (22%)
Query: 492 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--- 548
H H + L P + + + +G G FG V
Sbjct: 3 HHHHHHHHHHGALEVLFQGPGDP------TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN 56
Query: 549 DGKEI--AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYEF 603
DG AVK L Q + + E+ +L ++H +++++ G C++ G + LV E+
Sbjct: 57 DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILL 662
+ G+L+++L I + L A+ +G+ YLH IHRDL + N+LL
Sbjct: 117 VPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQHY----IHRDLAARNVLL 167
Query: 663 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL--------------- 707
D K+ DFGL+K EYY ++
Sbjct: 168 DNDRLVKIGDFGLAKAV----------------PEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 708 ---TDKSDVYSFGVILLELIS 725
SDV+SFGV L EL++
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 529 MLEKKIGSGGFGVVYYGKLK--DGKEI--AVKVL---TSNSYQGKREFTNEVTLLSRIHH 581
L +K+G G FGVV G+ GK + AVK L + + +F EV + + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
RNL++ G +V E G+L + L H+ A A+G+ Y
Sbjct: 81 RNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
L + IHRDL + N+LL K+ DFGL + + D Y
Sbjct: 137 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA---------------LPQNDDHY 178
Query: 702 YISQ-----------------QLTDKSDVYSFGVILLELIS 725
+ + + SD + FGV L E+ +
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 528 KMLEKKIGSGGFGVVYYGKLKDGK---EIAVKVL--TSNSYQGKREFTNEVTLLSRIHHR 582
+ +K++GSG FG V G + K +AVK+L +N K E E ++ ++ +
Sbjct: 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
+V+ +G C+ E +LV E G L ++L + + +E+ + G++YL
Sbjct: 79 YIVRMIGICEAE-SWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE 700
+HRDL + N+LL AK+SDFGLSK ++ + G V + PE
Sbjct: 134 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 701 YYISQQLTDKSDVYSFGVILLELIS 725
+ + KSDV+SFGV++ E S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 29/254 (11%)
Query: 489 YDKEQHRHS-LPVQR---PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 544
Y H +P ++ P +A FT ++I + +K IG+G FG VY
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFT-TEIHPSCVTRQKVIGAGEFGEVYK 62
Query: 545 GKLKDGKE-----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598
G LK +A+K L + + + + +F E ++ + H N+++ G + +
Sbjct: 63 GMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122
Query: 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 657
++ E+M NG L + L + + ++ + + A G++YL +HRDL +
Sbjct: 123 IITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMNY----VHRDLAA 175
Query: 658 SNILLDKHMRAKVSDFGLSKFAVDG-----ASHVSSI-VRGTVGYLDPEYYISQQLTDKS 711
NIL++ ++ KVSDFGLS+ D + I +R T PE ++ T S
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAISYRKFTSAS 231
Query: 712 DVYSFGVILLELIS 725
DV+SFG+++ E+++
Sbjct: 232 DVWSFGIVMWEVMT 245
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 58/289 (20%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
+ IGSGGFG V+ K DGK +K + N + EV L+++ H N+V + G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGC 72
Query: 591 CQEEGRSVLVYEFMHNGTLKEHLY--------GTLTHEQRINWIKR-----------LEI 631
+ + + L+ GTL WI++ LE+
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ-----WIEKRRGEKLDKVLALEL 127
Query: 632 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 691
E KG++Y+H+ +I+RDLK SNI L + K+ DFGL + S
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 692 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWAKLHI 750
GT+ Y+ PE SQ + D+Y+ G+IL EL+ + A KF + R+ +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF-- 240
Query: 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ ++ + L+ P RP+ SE+L+
Sbjct: 241 -DKKEKTLL------------------QKLLSKKP--EDRPNTSEILRT 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 67/269 (24%), Positives = 122/269 (45%), Gaps = 48/269 (17%)
Query: 482 HKGKKNNYDKEQHRHSLPVQRPV--SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGF 539
H + + + LP + + P A FT +IE + +EK IGSG
Sbjct: 4 HHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFT-REIEASRIHIEKIIGSGDS 62
Query: 540 GVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 594
G V YG+L+ +++ A+K L + + + +R+F +E +++ + H N+++ G
Sbjct: 63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122
Query: 595 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 654
+++V E+M NG+L L TH+ + ++ + + G+ YL +HRD
Sbjct: 123 RLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---VHRD 176
Query: 655 LKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-------- 706
L + N+L+D ++ KVSDFGLS+ D DP+ +
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLED----------------DPDAAYTTTGGKIPIRW 220
Query: 707 ----------LTDKSDVYSFGVILLELIS 725
+ SDV+SFGV++ E+++
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-35
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
LEKK+G+G FG V+ ++AVK + F E ++ + H LV+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
+E + + EFM G+L + L + K ++ + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 304
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
IHRDL+++NIL+ + K++DFGL++ D + + + PE T
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 710 KSDVYSFGVILLELIS 725
KSDV+SFG++L+E+++
Sbjct: 365 KSDVWSFGILLMEIVT 380
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 584
L + +G G FG VY G G++I AVK + + K +F +E ++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
V+ +G +EE + ++ E G L +L ++ + + + + K + YL +
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 645 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 698
C +HRD+ NIL+ K+ DFGLS++ D + +V L
Sbjct: 132 INC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-----EDYYKASVTRLPIKWMS 182
Query: 699 PEYYISQQLTDKSDVYSFGVILLELIS 725
PE ++ T SDV+ F V + E++S
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 70/250 (28%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 490 DKEQHRHSLPVQRP-VSSLND-----APAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 543
+K H + ++ P + + D P + H F +++ ++K +G+G FG V
Sbjct: 4 EKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVC 62
Query: 544 YGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598
G+LK KEI A+K L + + +R+F E +++ + H N+++ G + +
Sbjct: 63 SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 657
+V E+M NG+L L H+ + I+ + + A G++YL G V HRDL +
Sbjct: 123 IVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----HRDLAA 175
Query: 658 SNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYISQQLTDKSDVYS 715
NIL++ ++ KVSDFGL + D + G + + PE ++ T SDV+S
Sbjct: 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235
Query: 716 FGVILLELIS 725
+G++L E++S
Sbjct: 236 YGIVLWEVMS 245
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
L +++G+G FG V+ G ++AVK L S F E L+ ++ H+ LV+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
+E + + E+M NG+L + L ++ K L++A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 705
IHRDL+++NIL+ + K++DFGL++ D A + ++ T PE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYG 185
Query: 706 QLTDKSDVYSFGVILLELIS 725
T KSDV+SFG++L E+++
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
G C E ++ EFM G L ++L + Q ++ + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNF- 132
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
IHRDL + N L+ ++ KV+DFGLS+ + + + + PE + +
Sbjct: 133 --IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 709 DKSDVYSFGVILLELIS 725
KSDV++FGV+L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 584
L + IG G FG V+ G + +A+K + S + +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
V+ +G E ++ E G L+ L + ++ + A + + YL +
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 645 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703
+HRD+ + N+L+ + K+ DFGLS++ D + +S + + ++ PE
Sbjct: 135 KRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 704 SQQLTDKSDVYSFGVILLELIS 725
++ T SDV+ FGV + E++
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 41/275 (14%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQF 587
++G G +G V+ + K DG+ AVK S + + EV ++ H V+
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
+E G L E +L++H +G E ++ D + +LH+
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV-----WGYLRDTLLALAHLHS- 175
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
++H D+K +NI L R K+ DFGL + A G Y+ PE +
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPE-LLQG 230
Query: 706 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765
+DV+S G+ +LE+ E + W +L QG + P
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQL------RQGYLPPEFTA 275
Query: 766 EY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
+++S+ M + P +R + +L
Sbjct: 276 GLSSELRSVLV------MMLEPDPKLRATAEALLA 304
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 17/199 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ LG
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 590 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCV 647
+E+G +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 706
+HRDL + N+L+ + AKVSDFGL+K A + V+ T PE ++
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASS-TQDTGKLPVKWTA----PEALREKK 190
Query: 707 LTDKSDVYSFGVILLELIS 725
+ KSDV+SFG++L E+ S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 509 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 562
+AP +A +++ K +GSG FG VY G E +A+K L + S
Sbjct: 2 EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 563 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 622
+ +E +E +++ + + ++ + LG C L+ + M G L +++ H+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113
Query: 623 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682
I L AKG+ YL ++HRDL + N+L+ K++DFGL+K
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 683 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
+ G + ++ E + + T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 26/284 (9%)
Query: 454 AKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAE 513
A + + GS + + + + L+ G +N Y + + + + S+LN +
Sbjct: 22 AAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDL----SALNPELVQ 77
Query: 514 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKRE 568
A + + IG G FG VY+G L D AVK L +
Sbjct: 78 AVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136
Query: 569 FTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 627
F E ++ H N++ LG C + EG ++V +M +G L+ +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKD 193
Query: 628 RLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686
+ AKG+++L + V HRDL + N +LD+ KV+DFGL++ D
Sbjct: 194 LIGFGLQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 248
Query: 687 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
S+ T L E +Q+ T KSDV+SFGV+L EL++
Sbjct: 249 -SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 505 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTS 560
S+LN +A + + IG G FG VY+G L D AVK L
Sbjct: 5 SALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 561 N-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLT 618
+F E ++ H N++ LG C + EG ++V +M +G L+ +
Sbjct: 64 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RN 120
Query: 619 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
+ AKG++YL + V HRDL + N +LD+ KV+DFGL++
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 678 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
D + H + + V ++ E +Q+ T KSDV+SFGV+L EL++
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 584
+ K+G GG VY + ++A+K + + K E F EV S++ H+N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNI 73
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
V + +E+ LV E++ TL E++ ++ + GI++ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
I+HRD+K NIL+D + K+ DFG++K + + ++ V GTV Y PE
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 705 QQLTDKSDVYSFGVILLELISGQ 727
+ + +D+YS G++L E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 529 MLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHR 582
K +GSG FG V+ G E + +KV+ + Q + T+ + + + H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
++V+ LG C LV +++ G+L +H+ H + L AKG+ YL
Sbjct: 76 HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 699
++HR+L + N+LL + +V+DFG++ + + ++
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMAL 186
Query: 700 EYYISQQLTDKSDVYSFGVILLELIS 725
E + T +SDV+S+GV + EL++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 529 MLEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIH 580
+ + +G G F ++ G ++ E+ +KVL F +++S++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 581 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
H++LV G C ++LV EF+ G+L +L ++ IN + +LE+A+ A +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMH 127
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGLSKFAVDGASHVSSIVRG 692
+L + IH ++ + NILL + K+SD G+S + I++
Sbjct: 128 FLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQE 179
Query: 693 TVGYLDPE---YYISQQLTDKSDVYSFGVILLELIS 725
+ ++ PE + L +D +SFG L E+ S
Sbjct: 180 RIPWVPPECIENP--KNLNLATDKWSFGTTLWEICS 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 584
++ IG G FGVVY+G+ D + A+K L+ Q F E L+ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 585 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+ +G EG ++ +M +G L + + + ++ + A+G+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 644 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 699
+HRDL + N +LD+ KV+DFGL++ +D + R V +
Sbjct: 142 EQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 700 EYYISQQLTDKSDVYSFGVILLELIS 725
E + + T KSDV+SFGV+L EL++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 43/257 (16%)
Query: 503 PVSSLNDAPAEAAHCFTLS-DIEDATKMLE-----KKIGSGGFGVVYYGKLKDGKEIAVK 556
P+ S+ D + ++ L+ +++ K + + + G F + + KD K A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60
Query: 557 VLTSNSYQGKREFT-----------------NEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599
+ + KR+FT NE+ +++ I + + G +
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120
Query: 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAII 651
+YE+M N ++ + + ++ I K Y+H I
Sbjct: 121 IYEYMENDSILKFD----EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NIC 174
Query: 652 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 709
HRD+K SNIL+DK+ R K+SDFG S++ VD S RGT ++ PE++ ++ +
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGA 231
Query: 710 KSDVYSFGVILLELISG 726
K D++S G+ L +
Sbjct: 232 KVDIWSLGICLYVMFYN 248
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 63/299 (21%), Positives = 103/299 (34%), Gaps = 53/299 (17%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 587
+ + + GGF VY + + G+E A+K L SN + R EV + ++ H N+VQF
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 588 LGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAA 636
L+ + G L E L + + L+I
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-----LKIFYQTC 146
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI------- 689
+ ++++H P IIHRDLK N+LL K+ DFG + + S
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 690 ----VRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 742
T Y PE Y + + +K D+++ G IL L Q +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265
Query: 743 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801
+ +I + + R SI+EV+ +Q
Sbjct: 266 YSIPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQ 304
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 584
L + +G GG V+ + L+D +++AVKVL ++ F E + ++H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 585 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
V + E + +V E++ TL++ + E + + +E+ DA + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALN 130
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLD 698
+ H IIHRD+K +NI++ KV DFG+++ D + V ++ V GT YL
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 699 PEYYISQQLTDKSDVYSFGVILLELISGQ 727
PE + +SDVYS G +L E+++G+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 67/306 (21%), Positives = 113/306 (36%), Gaps = 67/306 (21%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+G G FG V + D + A+K + ++ + +EV LL+ ++H+ +V++
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 589 GYCQEEGRSV-------------LVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIA 632
E V + E+ NGTL + + + +I
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QIL 126
Query: 633 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR- 691
E + Y+H+ IIHRDLK NI +D+ K+ DFGL+K + +
Sbjct: 127 E----ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 692 ------------GTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNE 733
GT Y+ E +Y +K D+YS G+I E+I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP------- 227
Query: 734 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI 793
R + K + S I+ P D+ ++ KI L+ P + RP
Sbjct: 228 FSTGMERVNI-LKK--LRSVSIE---FPPDFDDNKMKVEKKIIRL-LIDHDP--NKRPGA 278
Query: 794 SEVLKD 799
+L
Sbjct: 279 RTLLNS 284
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 60/232 (25%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNL 584
+ IG G FG V ++K A+K + S R+F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEIA 632
+ LG C+ G L E+ +G L + L + ++ + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 633 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 691
D A+G++YL IHRDL + NIL+ ++ AK++DFGLS+
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190
Query: 692 GTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 725
E Y+ + + T SDV+S+GV+L E++S
Sbjct: 191 ------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 51/229 (22%), Positives = 97/229 (42%), Gaps = 19/229 (8%)
Query: 503 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVL 558
P+ + IE L + IG G FG V+ G + +A+K
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIE-----LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC 426
Query: 559 TSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL 617
+ S + +F E + + H ++V+ +G E ++ E G L+ L
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---Q 482
Query: 618 THEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676
+ ++ + A + + YL + V HRD+ + N+L+ + K+ DFGLS
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLS 538
Query: 677 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 725
++ D + +S + + ++ PE ++ T SDV+ FGV + E++
Sbjct: 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 583
L+ ++G G FG V+ + + +AVK L S +++F E LL+ + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----------YGTLTHEQRINWIKRLEIA 632
+V+F G C E ++V+E+M +G L L G + + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 633 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 692
A G+ YL +HRDL + N L+ + + K+ DFG+S+ + G
Sbjct: 165 SQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVG 217
Query: 693 TVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
L PE + ++ T +SDV+SFGV+L E+ +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 582
+ +++G G FG+VY G K + +A+K + S + + EF NE +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAA 636
++V+ LG + ++++ E M G LK +L + K +++A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
G+ YL+ +HRDL + N ++ + K+ DFG+++ + +G G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYRKGGKGL 201
Query: 697 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
L PE T SDV+SFGV+L E+ +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 573
+ L D E + + +G G FG VY + K +A+KVL + + EV
Sbjct: 6 WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 633
+ S + H N+++ GY + R L+ E+ GT+ Y L + + +
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYIT 116
Query: 634 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-- 691
+ A + Y H+ +IHRD+K N+LL K++DFG S H S R
Sbjct: 117 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV-------HAPSSRRTD 166
Query: 692 --GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
GT+ YL PE + +K D++S GV+ E + G
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 583
L++++G G FG V+ + + +AVK L + +++F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEI 631
+V+F G C + ++V+E+M +G L + L + + + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 632 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 691
A A G+ YL + +HRDL + N L+ ++ K+ DFG+S+ +
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RV 191
Query: 692 GTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
G L PE + ++ T +SDV+SFGVIL E+ +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 505 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY 563
S + + D E +G G +G+VY G+ L + IA+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 564 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTL-TH 619
+ + E+ L + H+N+VQ+LG E G + E + G+L +G L +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 620 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKF 678
EQ I + + +I E G++YLH I+HRD+K N+L++ + K+SDFG SK
Sbjct: 121 EQTIGFYTK-QILE----GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 727
+ GT+ Y+ PE I + +D++S G ++E+ +G+
Sbjct: 173 LAGINPCTET-FTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVL--TSNSYQGKREFTNEVTLLSRIHHRN 583
L K +G G FG V G LK +AVK + ++S + EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 584 LVQFLGYCQEEG-----RSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAA 636
+++ LG C E + +++ FM G L +L T + I L+ D A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
G+EYL +HRDL + N +L M V+DFGLSK G + +G +
Sbjct: 158 LGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAK 210
Query: 697 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
+ E + T KSDV++FGV + E+ +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN--SYQGKREFTNEVTLLSRIHHRN 583
L + +G G FG V +LK +AVK+L ++ + EF E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 584 LVQFLGYCQEEGRSV------LVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDA 635
+ + +G ++ FM +G L L + + + D
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 636 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695
A G+EYL + IHRDL + N +L + M V+DFGLS+ G + +G
Sbjct: 147 ACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199
Query: 696 YL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
L E T SDV++FGV + E+++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--V 585
+ K+IGSGG V+ + + A+K L Q + NE+ L+++ + +
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+ Y + +V E N L L ++ +R ++ K + E + +H
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIH 144
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-- 700
I+H DLK +N L+ M K+ DFG++ D S V GTV Y+ PE
Sbjct: 145 QH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 701 ---------YYISQQLTDKSDVYSFGVILLELISGQ 727
+++ KSDV+S G IL + G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 582
L + +G G FG VY G++ ++AVK L S Q + +F E ++S+ +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGI 639
N+V+ +G + ++ E M G LK L + + + L +A D A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
+YL IHRD+ + N LL AK+ DFG+++ S +G
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAM 206
Query: 697 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
L PE ++ T K+D +SFGV+L E+ S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 52/292 (17%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI--HHRNLV 585
+ K+IGSGG V+ + + A+K L Q + NE+ L+++ H ++
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+ Y + +V E N L L ++ +R ++ K + + + +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM------LEAVHTIH 125
Query: 644 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE- 700
G I+H DLK +N L+ M K+ DFG++ D S V GTV Y+ PE
Sbjct: 126 QHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 701 ----------YYISQQLTDKSDVYSFGVILLELISGQ---EAISNEKFGANCRNIVQWAK 747
+++ KSDV+S G IL + G+ + I N+ + I+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIID-PN 237
Query: 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
IE I + L D ++ K + K R SI E+L
Sbjct: 238 HEIE---FPDIPEKDLQDV--LKCCLKRDPK----------QRISIPELLAH 274
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 573
FT+ D + + + +G G FG VY + K +A+KVL + + E+
Sbjct: 11 FTIDDFD-----IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 633
+ S + H N+++ Y + R L+ EF G L Y L R + E
Sbjct: 66 EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFD--------E 113
Query: 634 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685
+ + Y H V IHRD+K N+L+ K++DFG S A
Sbjct: 114 QRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
Query: 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
GT+ YL PE + +K D++ GV+ E + G
Sbjct: 171 TMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 28/267 (10%)
Query: 480 FMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGS 536
F E L ++ N A ++SD + L + +G
Sbjct: 22 FQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGH 81
Query: 537 GGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 589
G FG VY G++ ++AVK L S Q + +F E ++S+ +H+N+V+ +G
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
+ ++ E M G LK L + + + L +A D A G +YL
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201
Query: 647 VPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 698
IHRD+ + N LL AK+ DFG+++ +G L
Sbjct: 202 ---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLPVKWMP 254
Query: 699 PEYYISQQLTDKSDVYSFGVILLELIS 725
PE ++ T K+D +SFGV+L E+ S
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 51/234 (21%), Positives = 88/234 (37%), Gaps = 59/234 (25%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 582
+++G FG VY G L +A+K L + EF +E L +R+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 630
N+V LG ++ +++ + +G L E L T + + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 631 IAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689
+ A G+EYL + V H+DL + N+L+ + K+SD GL +
Sbjct: 133 LVAQIAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAA------- 181
Query: 690 VRGTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 725
+YY + SD++S+GV+L E+ S
Sbjct: 182 ----------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 34/262 (12%)
Query: 485 KKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 544
K+ K + +H + A + A C + ++ + K+IGSGG V+
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECIS---VKGRIYSILKQIGSGGSSKVFQ 74
Query: 545 GKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEEGRSVLV 600
+ + A+K L Q + NE+ L+++ + ++ Y + +V
Sbjct: 75 VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134
Query: 601 YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 657
E N L L ++ +R ++ K + E + +H G I+H DLK
Sbjct: 135 MEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIHQHG----IVHSDLKP 183
Query: 658 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-----------YYISQ 705
+N L+ M K+ DFG++ D S V G V Y+ PE
Sbjct: 184 ANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 706 QLTDKSDVYSFGVILLELISGQ 727
+++ KSDV+S G IL + G+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGK 264
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 588
+ +G G G + Y + D +++AVK + + EV LL H N++++
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRY- 83
Query: 589 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 645
+C E+ R + E TL+E++ + ++ + + + G+ +LH+
Sbjct: 84 -FCTEKDRQFQYIAIELC-AATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 646 CVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLD 698
I+HRDLK NIL+ ++A +SDFGL K G S V GT G++
Sbjct: 139 ----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 699 PEYY---ISQQLTDKSDVYSFGVILLELISG 726
PE + T D++S G + +IS
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 579
L K +G G FG V + + +AVK+L + + + + +E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 627
H+N++ LG C ++G ++ E+ G L+E+L E+++ +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687
+ A+G+EYL + IHRDL + N+L+ ++ K++DFGL++ +
Sbjct: 159 LVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----D 211
Query: 688 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
+ T G L PE + T +SDV+SFGV++ E+ +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 581
L K +G G FG V + +AVK+L ++ R +E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 582 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHL------------YGTLTHEQRINWIKR 628
N+V LG C + G ++V EF G L +L ++ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 629 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 688
+ + AKG+E+L + IHRDL + NILL + K+ DFGL++
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PD 203
Query: 689 IVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
VR L PE + T +SDV+SFGV+L E+ S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRN 583
L + +G GG G VY + + +A+K+++ ++ + E R+ +
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR--MQREARTAGRLQEPH 95
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 641
+V + + +G+ + ++ L L G L + + I ++
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA------VAIVRQIGSALDA 149
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDP 699
H HRD+K NIL+ A + DFG++ A + + V GT+ Y+ P
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTV-GTLYYMAP 204
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQ 727
E + T ++D+Y+ +L E ++G
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGS 232
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-30
Identities = 70/300 (23%), Positives = 117/300 (39%), Gaps = 54/300 (18%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 588
EK +G G G V + G+ +AVK + + E+ LL+ H N++++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRY- 74
Query: 589 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYLH 643
YC E + E N L++ + ++ + K A G+ +LH
Sbjct: 75 -YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 644 TGCVPAIIHRDLKSSNILLD-------------KHMRAKVSDFGLSKFAVDGASHVSSIV 690
+ IIHRDLK NIL+ +++R +SDFGL K G S + +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 691 R---GTVGYLDPE-------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 740
GT G+ PE ++LT D++S G + ++S FG
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK----GKHPFGDKYS 245
Query: 741 NIVQWAKLHIESGDIQGIIDPSLLDE-YD-IQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
+ +++ + D SL+ E D I M + P RP+ +VL+
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM--------IDHDP--LKRPTAMKVLR 295
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 581
K +G+G FG V + +AVK+L + + +E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------YGTLTHEQRINWIK 627
N+V LG C G ++++ E+ G L L E ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 628 RLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686
L + AKG+ +L C IHRDL + NILL K+ DFGL++ +
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND---- 198
Query: 687 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
S+ V L PE + T +SDV+S+G+ L EL S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 45/231 (19%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 582
L K +G G FG V K +AVK+L N S R+ +E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 622
++++ G C ++G +L+ E+ G+L+ L E+
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 623 INWIKRLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679
+ + A ++G++YL ++HRDL + NIL+ + + K+SDFGLS+
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK------LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 680 VDGASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
+ S V+ + G + E T +SDV+SFGV+L E+++
Sbjct: 201 YEE----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 13/249 (5%)
Query: 481 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFG 540
MH ++ + +L Q V + A D K IG G G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVK-IGEGSTG 59
Query: 541 VVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599
+V + G+++AVK++ Q + NEV ++ H N+V+ +
Sbjct: 60 IVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119
Query: 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 659
+ EF+ G L + + +E++I + + + YLH +IHRD+KS +
Sbjct: 120 LMEFLQGGALTDIVSQVRLNEEQIATVCE-----AVLQALAYLHA---QGVIHRDIKSDS 171
Query: 660 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGV 718
ILL R K+SDFG S+V GT ++ PE IS+ L + D++S G+
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPE-VISRSLYATEVDIWSLGI 229
Query: 719 ILLELISGQ 727
+++E++ G+
Sbjct: 230 MVIEMVDGE 238
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 587
L +G G V+ G+ K G A+KV + S+ + E +L +++H+N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 588 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 642
+E VL+ EF G+L L + E D G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 643 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
I+HR++K NI+ D K++DFG ++ D VS GT YL
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183
Query: 699 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 727
P+ Y ++ D++S GV +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSN-SYQGKREFTNEVTLLSRI- 579
L K +G G FG V + ++AVK+L S+ + + + +E+ ++ I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 627
H+N++ LG C ++G ++ E+ G L+E+L + E++++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++
Sbjct: 193 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----D 245
Query: 688 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
+ T G L PE + T +SDV+SFGV+L E+ +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 585
+ +G GGF + + A K++ + + + E+++ + H+++V
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
F G+ ++ +V E +L E LT + +++++ G +YLH
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 132
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 702
V IHRDLK N+ L++ + K+ DFGL+ K DG GT Y+ PE
Sbjct: 133 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 186
Query: 703 ISQQLTD-KSDVYSFGVILLELISG 726
+S++ + DV+S G I+ L+ G
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 45/207 (21%), Positives = 84/207 (40%), Gaps = 26/207 (12%)
Query: 530 LEKKIGSGGFGVVYYGK--LKDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
++ I GG G +Y +G+ + +K L S + + E L+ + H ++VQ
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 587 FLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
+ + R +V E++ +LK L + I + + Y
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI------AYLLEILPALSY 197
Query: 642 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
LH+ G +++ DLK NI+L + + K+ D G ++ ++ GT G+ PE
Sbjct: 198 LHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAPE 247
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQ 727
+ T +D+Y+ G L L
Sbjct: 248 I-VRTGPTVATDIYTVGRTLAALTLDL 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 585
+ +G GGF + + A K++ + + + E+++ + H+++V
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
F G+ ++ +V E +L E LT + +++++ G +YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 158
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 702
V IHRDLK N+ L++ + K+ DFGL+ K DG GT Y+ PE
Sbjct: 159 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 212
Query: 703 ISQQLTD-KSDVYSFGVILLELISG 726
+S++ + DV+S G I+ L+ G
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 581
K +G+G FG V + +AVK+L S K +E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEI 631
N+V LG C G +++ E+ G L L + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 632 AEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 690
+ A+G+ +L + C IHRD+ + N+LL AK+ DFGL++ ++ S+ +
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYI 221
Query: 691 RGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
L PE T +SDV+S+G++L E+ S
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLV 585
+ +G G F VY + + G E+A+K++ + + NEV + ++ H +++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
+ Y ++ LV E HNG + +L + + +++ ++ G+ YL
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYL 128
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEY 701
H+ + +HRDL SN+LL ++M K++DFGL+ + + H + GT Y+ PE
Sbjct: 129 HSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEI 183
Query: 702 YISQQLTDKSDVYSFGVILLELISG 726
+SDV+S G + L+ G
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 579
L K +G G FG V + + +AVK+L + + + + +E+ ++ I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 627
H+N++ LG C ++G ++ E+ G L+E+L E+++ +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 628 RLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684
+ A+G+EYL IHRDL + N+L+ ++ K++DFGL++ +
Sbjct: 205 LVSCTYQLARGMEYLASQK------CIHRDLAARNVLVTENNVMKIADFGLARDINNI-- 256
Query: 685 HVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
+ T G L PE + T +SDV+SFGV++ E+ +
Sbjct: 257 --DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 587
L +G G V+ G+ K G A+KV + S+ + E +L +++H+N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 588 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 642
+E VL+ EF G+L L + E D G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 643 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
I+HR++K NI+ D K++DFG ++ D VS GT YL
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183
Query: 699 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 727
P+ Y ++ D++S GV +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
++G G FG V+ K + G + AVK + ++ E+ + + +V G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 591 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
+E + E + G+L + + G L E R + A +G+EYLHT
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLG-----QALEGLEYLHTRR-- 170
Query: 649 AIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSI----VRGTVGYLDPEYYI 703
I+H D+K+ N+LL RA + DFG + S + + GT ++ PE +
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 704 SQQLTDKSDVYSFGVILLELISGQ 727
+ K D++S ++L +++G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 39/228 (17%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 581
K +GSG FG V + +AVK+L + +E+ +++++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-------------YGTLTHEQRINWIKR 628
N+V LG C G L++E+ G L +L Y + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 629 L------EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682
L A AKG+E+L +HRDL + N+L+ K+ DFGL++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 683 ASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
S+ V L PE T KSDV+S+G++L E+ S
Sbjct: 226 ----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 41/229 (17%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 582
+ IG G FG V+ + +AVK+L S + +F E L++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 622
N+V+ LG C L++E+M G L E L +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 623 INWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681
++ ++L IA A G+ YL V HRDL + N L+ ++M K++DFGLS+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 682 GASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 725
+ PE + T +SDV+++GV+L E+ S
Sbjct: 227 A----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 9e-29
Identities = 27/271 (9%), Positives = 67/271 (24%), Gaps = 41/271 (15%)
Query: 491 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD- 549
+E + + V++ +L + L + + G VV+ + +
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86
Query: 550 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRS--------- 597
++ A+KV T + + E +R+ + + + S
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 598 -----------------VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638
+L+ L L + + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
L + ++H N+ + R + D V Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAP 259
Query: 699 PEYYISQ--QLTDKSDVYSFGVILLELISGQ 727
E+ + T + + G+ + +
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-28
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 587
+++++G+GGFG V +D G+++A+K RE + E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 588 L------GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKG 638
+L E+ G L+++L + +K I D +
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISSA 133
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695
+ YLH IIHRDLK NI+L + + K+ D G +K G + V GT+
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQ 188
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
YL PE ++ T D +SFG + E I+G
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 63/338 (18%), Positives = 111/338 (32%), Gaps = 91/338 (26%)
Query: 531 EKKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ +G GGFGVV+ K K D A+K + N + + EV L+++ H +V++
Sbjct: 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI------------------------- 623
E E E L+ +
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 624 -------------------NWIKR------------LEIAEDAAKGIEYLHTGCVPAIIH 652
+W+ R L I A+ +E+LH+ ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMH 187
Query: 653 RDLKSSNILLDKHMRAKVSDFGLSK---FAVDGASHVSSIVR--------GTVGYLDPEY 701
RDLK SNI KV DFGL + + ++ + GT Y+ PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 702 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761
+ K D++S G+IL EL+ F + +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYS--------FSTQMERVRIITDVR------NLKFPL 293
Query: 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+Y + M + + ++ P RP ++++++
Sbjct: 294 LFTQKYPQEHMM-V--QDMLSPSP--TERPEATDIIEN 326
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 12/212 (5%)
Query: 519 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 575
++ + D K + KIG G G VY + G+E+A++ + K NE+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 576 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 635
+ + N+V +L +V E++ G+L + + T E +I + R +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----EC 125
Query: 636 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695
+ +E+LH+ +IHRD+KS NILL K++DFG S S++V GT
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 181
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
++ PE + K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLV 585
++ +G G FG V K K G+E AVKV++ + K + EV LL ++ H N++
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 637
+ + +++G LV E G L + I I R +E A
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFD----------EI--ISRKRFSEVDAARIIRQVLS 137
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
GI Y+H I+HRDLK N+LL K ++ DFGLS I GT
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTA 192
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 40/217 (18%), Positives = 69/217 (31%), Gaps = 22/217 (10%)
Query: 530 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 583
+ +G G F VY D ++ +KV + T + L
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
++F + SVLV E GTL + T E+ + + A IE +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRA-----------KVSDFGLSKFA-VDGASHVSSIV 690
H IIH D+K N +L + D G S + + +
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 691 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
T G+ E ++ + D + + ++ G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 61/295 (20%), Positives = 116/295 (39%), Gaps = 56/295 (18%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 587
++K+GSG FG V+ + + G E +K + + Q E E+ +L + H N+++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 588 LGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
++ +V E G L + L+ +K++ + Y
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM------MNALAY 139
Query: 642 LHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 697
H+ ++H+DLK NIL H K+ DFGL++ H ++ GT Y+
Sbjct: 140 FHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA-GTALYM 193
Query: 698 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757
PE + +T K D++S GV++ L++G F ++
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP-----F---------TGT------SLEE 232
Query: 758 IIDPSLLDEYDIQSMWK-IEEKA------LMCVLPHGHMRPSISEVLKD--IQDA 803
+ + E + + + +A ++ P RPS ++VL + A
Sbjct: 233 VQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDP--ERRPSAAQVLHHEWFKQA 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 68/250 (27%), Positives = 103/250 (41%), Gaps = 34/250 (13%)
Query: 493 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLK-D 549
H H R F S ++M KK+GSG +G V + K
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 550 GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607
E A+K++ S EV +L + H N+++ + +++ LV E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSN 659
L + I I R++ E A G+ YLH I+HRDLK N
Sbjct: 122 ELFD----------EI--IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPEN 166
Query: 660 ILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 716
+LL +K K+ DFGLS + + GT Y+ PE + ++ +K DV+S
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPE-VLRKKYDEKCDVWSI 223
Query: 717 GVILLELISG 726
GVIL L++G
Sbjct: 224 GVILFILLAG 233
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ +GSG F V+ K + GK A+K + + NE+ +L +I H N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIE 640
+ LV + + G L + RI ++R E DA+ ++
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFD----------RI--LERGVYTEKDASLVIQQVLSAVK 120
Query: 641 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
YLH G I+HRDLK N+L +++ + ++DFGLSK +G +S+ GT GY
Sbjct: 121 YLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGY 173
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELISG 726
+ PE + + D +S GVI L+ G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 511 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF 569
E H D + +++ + +G G FG VY K + G A KV+ + S + ++
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY 63
Query: 570 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWI 626
E+ +L+ H +V+ LG +G+ ++ EF G + L LT E +I +
Sbjct: 64 IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQVV 122
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686
R + + +LH+ IIHRDLK+ N+L+ +++DFG+S +
Sbjct: 123 CR-----QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 687 SSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 727
S + GT ++ PE + + + D K+D++S G+ L+E+ +
Sbjct: 175 DSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 27/213 (12%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 583
L + IG G F VV ++ G++ AVK+ TS+ + E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAK 637
+V+ L +G +V+EFM L + + ++++++ +
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI------LE 141
Query: 638 GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 693
+ Y H IIHRD+K +LL + K+ FG++ + V GT
Sbjct: 142 ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 694 VGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
++ PE + DV+ GVIL L+SG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 586
+ +G G FG V K + +E AVKV+ S + K EV LL ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 638
++ +V E G L + I IKR +E DAA+ G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133
Query: 639 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
I Y+H I+HRDLK NILL +K K+ DFGLS + + + GT
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 43/308 (13%), Positives = 86/308 (27%), Gaps = 61/308 (19%)
Query: 492 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDG 550
VS+ + + T + +G + G
Sbjct: 39 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 98
Query: 551 KEIAVKVLTSNSYQG-------KRE---------------------FTNEVTLLSRIHHR 582
+ V V K E F L+ +
Sbjct: 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 583 NLVQFLGYCQEEGRS--VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638
+++ ++ +Y M T E L + + + RL++ +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218
Query: 639 IEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 697
+ LH G ++H L+ +I+LD+ ++ F DGA VS + G+
Sbjct: 219 LASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVS---SVSRGFE 269
Query: 698 DPEYYISQQL-----------TDKSDVYSFGVILLELISGQ-------EAISNEKFGANC 739
PE + T D ++ G+++ + +E +C
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329
Query: 740 RNIVQWAK 747
+NI Q +
Sbjct: 330 KNIPQPVR 337
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 341 PSITVIHLSSKN-LTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDN 398
P + +++ N L G IP + KL+ L L++ +++G IPDF S L + N
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
L+G LP S+ +LPNL + N +SG +P S
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 29/107 (27%), Positives = 44/107 (41%), Gaps = 1/107 (0%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 401
++ + LS L G+ + ++ L NSL + +L + L +N++
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 402 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 447
G LP L L L L V N L G +P L + V YA N L
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 9/145 (6%)
Query: 307 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP-SITVIHLSSKNLTG--NIPSDLTK 363
+ + + + W C W + C++D Q + + LS NL IPS L
Sbjct: 17 DLGNPTTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74
Query: 364 LSSLVELWL-DGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
L L L++ N+L GPIP + L +++ ++G +P L + L L
Sbjct: 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134
Query: 422 NMLSGTVPSSL--LSKNVVLNYAGN 444
N LSGT+P S+ L V + + GN
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGN 159
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 28/109 (25%), Positives = 55/109 (50%), Gaps = 12/109 (11%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 399
+ ++++ N++G IP L+++ +LV L N+L+G +P S P+L I + N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 400 LTGPLPSSLMNLPNLRE-LYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 447
++G +P S + L + + N L+G +P + N+NL
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF----------ANLNL 199
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 7e-22
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 1/91 (1%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVE-LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 399
P++ I ++G IP S L + + N LTG IP +L + L N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 430
L G + N +++++ N L+ +
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 2/68 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ + L + + G +P LT+L L L + N+L G IP + +N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 401 T--GPLPS 406
PLP+
Sbjct: 304 LCGSPLPA 311
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 497 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AV 555
+ P S + P D + K +G G F V + A+
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPEDFK-----FGKILGEGSFSTVVLARELATSREYAI 60
Query: 556 KVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 612
K+L + + E ++SR+ H V+ Q++ + + NG L ++
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 613 LYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDK 664
+ + E + +EYLH IIHRDLK NILL++
Sbjct: 121 IR----KIGSFD--------ETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNE 165
Query: 665 HMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILL 721
M +++DFG +K + +S V GT Y+ PE ++++ KS D+++ G I+
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPE-LLTEKSACKSSDLWALGCIIY 223
Query: 722 ELISGQ 727
+L++G
Sbjct: 224 QLVAGL 229
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-27
Identities = 22/118 (18%), Positives = 50/118 (42%), Gaps = 4/118 (3%)
Query: 327 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 386
W+ + + + +S ++G++ +++ +L L + N+ + IP
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
Query: 387 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
C L+ + + N+L+G ++ L+ L + +N G +P L L+ A N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAEN 279
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 39/111 (35%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
+ +HLS L+G IPS L LS L +L L N L G IP L + L+ N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 448
LTG +PS L N NL + + NN L+G +P + L +L + N +
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN-SFS 527
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-25
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 6/121 (4%)
Query: 327 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFS 385
P+ + Q P+ ++ ++L + TG IP L+ S LV L L N L+G IP
Sbjct: 383 PILPNLCQN---PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 386 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAG 443
LR + L N L G +P LM + L L + N L+G +PS L + ++ +
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 444 N 444
N
Sbjct: 500 N 500
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-24
Identities = 31/128 (24%), Positives = 58/128 (45%), Gaps = 3/128 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 399
++ + L +LTG IPS L+ ++L + L N LTG IP +L I+ L +N
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGGRGAKHL 457
+G +P+ L + +L L + N+ +GT+P+++ S + N+
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 458 NIIIGSSV 465
++
Sbjct: 586 ECHGAGNL 593
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 39/95 (41%), Positives = 54/95 (56%), Gaps = 3/95 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 397
S+ + LSS N +G I +L ++L EL+L N TG IP S C +L +HL
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
N L+G +PSSL +L LR+L + NML G +P L
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-23
Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 13/124 (10%)
Query: 327 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPD-F 384
P+P L S+ + L+ TG IP L+ +L L L GN G +P F
Sbjct: 262 PIPPLPL-------KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
Query: 385 SGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSL--LSKN-VVLN 440
C L + L N +G LP +L+ + L+ L + N SG +P SL LS + + L+
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374
Query: 441 YAGN 444
+ N
Sbjct: 375 LSSN 378
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-23
Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 4/97 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG--CPDLRIIHLEDN 398
+ ++++SS G IP L SL L L N TG IPDF C L + L N
Sbjct: 247 TELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
G +P + L L + +N SG +P L K
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 9e-21
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ + LSS N +G +P D L K+ L L L N +G +P+ + L + L
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 398 NQLTGPLPSSLMN--LPNLRELYVQNNMLSGTVPSSL 432
N +GP+ +L L+ELY+QNN +G +P +L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-20
Identities = 36/128 (28%), Positives = 53/128 (41%), Gaps = 16/128 (12%)
Query: 315 ADWAQEGGDPCLPVPWSWL--QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVE 369
DW +PC ++ C D +T I LSSK L + S L L+ L
Sbjct: 31 PDW-SSNKNPC-----TFDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81
Query: 370 LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS--SLMNLPNLRELYVQNNMLSGT 427
L+L + + G + F L + L N L+GP+ + SL + L+ L V +N L
Sbjct: 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP 141
Query: 428 VPSSLLSK 435
S K
Sbjct: 142 GKVSGGLK 149
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-19
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 7/111 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTG--PIPDFSGCPDLRIIHLE 396
S+T + LS +L+G + + L S L L + N+L + L ++ L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 397 DNQLTGPLPSSLM---NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
N ++G + L+ L + N +SG V S L+ + N
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSN 210
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-19
Identities = 32/108 (29%), Positives = 50/108 (46%), Gaps = 2/108 (1%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 400
S+ + +S L+G IP ++ + L L L N ++G IPD L I+ L N+L
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSS-LLSKNVVLNYAGNINL 447
G +P ++ L L E+ + NN LSG +P + N L
Sbjct: 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-17
Identities = 18/97 (18%), Positives = 37/97 (38%), Gaps = 1/97 (1%)
Query: 337 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHL 395
+D + G L +LS+ + G F + + +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 396 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
N L+G +P + ++P L L + +N +SG++P +
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-13
Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 5/102 (4%)
Query: 348 LSSKNLTGNIPSDLTKLSSLVELWLDGN--SLTGPIP-DFSGCPDLRIIHLEDNQLTGPL 404
+++ + G + E GN G + ++ G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 405 PSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
+ N ++ L + NMLSG +P + + +LN N
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 14/56 (25%), Positives = 26/56 (46%), Gaps = 4/56 (7%)
Query: 393 IHLEDNQLT---GPLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 444
I L L + SSL++L L L++ N+ ++G+V + L+ + N
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-27
Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 45/223 (20%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-------------TSNSYQGKREFTNEVTL 575
+K+GSG +G V K K E A+KV+ N + E NE++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 576 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 635
L + H N+++ +++ LV EF G L E +I I R + E
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE----------QI--INRHKFDECD 147
Query: 636 AK--------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGA 683
A GI YLH I+HRD+K NILL + + K+ DFGLS F
Sbjct: 148 AANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD- 202
Query: 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
+ + GT Y+ PE + ++ +K DV+S GVI+ L+ G
Sbjct: 203 YKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVT- 574
D+E ++G G +GVV + G+ +AVK + + +++ ++
Sbjct: 4 VKADDLEP-----IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58
Query: 575 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIA 632
+ + V F G EG + E M + +L + + Q I + + + IA
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IA 115
Query: 633 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 692
K +E+LH+ ++IHRD+K SN+L++ + K+ DFG+S + VD + G
Sbjct: 116 VSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--G 171
Query: 693 TVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 727
Y+ PE I+ +L KSD++S G+ ++EL +
Sbjct: 172 CKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 32/210 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
LE IG G +G V K A K + + F E+ ++ + H N+++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 640
++ LV E G L E R+ + + E A +
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFE----------RV--VHKRVFRESDAARIMKDVLSAVA 120
Query: 641 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
Y H + HRDLK N L K+ DFGL+ G + + V GT Y
Sbjct: 121 YCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYY 174
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELISG 726
+ P+ + + D +S GV++ L+ G
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 589
+G GGFG V+ ++K ++ A K L + ++ + E +L+++H R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 590 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 640
Y + + LV M+ G ++ H+Y E A G+E
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--------EPRAIFYTAQIVSGLE 303
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
+LH II+RDLK N+LLD ++SD GL+ G + GT G++ PE
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQ 727
+ ++ D ++ GV L E+I+ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 18/230 (7%)
Query: 501 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 559
QR + D E ++G+G GVV+ K + A K++
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFE-----KISELGAGNGGVVFKVSHKPSGLVMARKLIH 67
Query: 560 SNSYQGKREF-TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTL 617
R E+ +L + +V F G +G + E M G+L + L
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR 127
Query: 618 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
EQ + +++ KG+ YL I+HRD+K SNIL++ K+ DFG+S
Sbjct: 128 IPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
+D S +S V GT Y+ PE + +SD++S G+ L+E+ G+
Sbjct: 181 QLID--SMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 47/206 (22%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ +++GSG FGVV+ K G+ K + + K NE+++++++HH L+
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 589 GYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
+++ VL+ EF+ G L +++ + + IN+++ + E G++++
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKM---SEAEVINYMR--QACE----GLKHM 165
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
H +I+H D+K NI+ + + K+ DFGL+ + + T + PE
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPE 220
Query: 701 YYISQQLTDKSDVYSFGVILLELISG 726
+ + +D+++ GV+ L+SG
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV--------LTSNSYQGKRE-FTNEVTLLSRI 579
++ +G G VV K KE AVK+ ++ Q RE EV +L ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 580 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 637
H N++Q + LV++ M G L + + +++ ++E +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD----------YL--TEKVTLSEKETRK 128
Query: 638 -------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689
I LH I+HRDLK NILLD M K++DFG S +D + +
Sbjct: 129 IMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREV 183
Query: 690 VRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 726
GT YL PE + D++S GVI+ L++G
Sbjct: 184 C-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 586
+ +G G FG V K + +E AVKV+ S + K EV LL ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 638
++ +V E G L + I IKR +E A G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133
Query: 639 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
I Y+H I+HRDLK NILL +K K+ DFGLS + + + GT
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 587
+KIG G FG V+ G + K +A+K++ + + E E+T+LS+ + ++
Sbjct: 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
G ++ + ++ E++ G+ + L E +I I R + KG++YLH+
Sbjct: 86 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE-- 138
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
IHRD+K++N+LL +H K++DFG++ D ++ V GT ++ PE I Q
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSA 195
Query: 708 TD-KSDVYSFGVILLELISGQ 727
D K+D++S G+ +EL G+
Sbjct: 196 YDSKADIWSLGITAIELARGE 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 71/310 (22%), Positives = 114/310 (36%), Gaps = 54/310 (17%)
Query: 521 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRI 579
ED ++ E +G G V +E AVK++ + EV +L +
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC 67
Query: 580 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK 637
HRN+++ + + +EE R LV+E M G++ I KR E +A+
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS----------HI--HKRRHFNELEASV 115
Query: 638 -------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVS 687
+++LH I HRDLK NIL ++ K+ DF L
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 688 SIVR------GTVGYLDPE----YYISQQLTDKS-DVYSFGVILLELISGQEAISNEKFG 736
G+ Y+ PE + + DK D++S GVIL L+SG F
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP-----FV 227
Query: 737 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS-MWK-IEEKA------LMCVLPHGH 788
C + W + + + +Y+ W I A L+
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDA--K 285
Query: 789 MRPSISEVLK 798
R S ++VL+
Sbjct: 286 QRLSAAQVLQ 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-26
Identities = 56/258 (21%), Positives = 112/258 (43%), Gaps = 24/258 (9%)
Query: 482 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAP-AEAAHCFTLSDIEDATK------MLEKKI 534
+ ++ YD ++ + + VSS D + + +E + +++
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEEL 165
Query: 535 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 593
G+G FGVV+ + G A K + + K E+ +S + H LV ++
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED 225
Query: 594 EGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 650
+ V++YEFM G L E + + ++ ++ + +++ ++ + G+ ++H
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR--QVCK----GLCHMHEN---NY 276
Query: 651 IHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
+H DLK NI+ K+ DFGL+ +D V GT + PE + +
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT-GTAEFAAPEVAEGKPVG 334
Query: 709 DKSDVYSFGVILLELISG 726
+D++S GV+ L+SG
Sbjct: 335 YYTDMWSVGVLSYILLSG 352
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 513 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREF 569
E FT D++ +IG G +G V K G+ +AVK T + + K+
Sbjct: 14 EQHWDFTAEDLK-----DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 570 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIK 627
+ ++ +VQF G EG + E M K + Y + I +
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687
+ I K + +L IIHRD+K SNILLD+ K+ DFG+S VD +
Sbjct: 129 K--ITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 688 SIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 727
G Y+ PE I + +SDV+S G+ L EL +G+
Sbjct: 185 DA--GCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 52/296 (17%), Positives = 109/296 (36%), Gaps = 62/296 (20%)
Query: 532 KKIGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 587
+KIGSG FG V+ K DG A+K ++ EV + + H ++V++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
E+ ++ E+ + G+L + + + ++ +G+ Y+H+
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--- 133
Query: 648 PAIIHRDLKSSNILLDKH-------------------MRAKVSDFGLSKFAVDGASHVSS 688
+++H D+K SNI + + + K+ D G + +SS
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH-------VTRISS 186
Query: 689 --IVRGTVGYLDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 744
+ G +L E + + K+D+++ + ++ + N Q
Sbjct: 187 PQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------Q 236
Query: 745 WAKLHIESGDIQGIIDPSLLDEY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
W + I G + P + + + K + + P RPS ++K
Sbjct: 237 WHE--IRQGRL-----PRIPQVLSQEFTELLK------VMIHPDPERRPSAMALVK 279
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 55/247 (22%), Positives = 83/247 (33%), Gaps = 54/247 (21%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 583
L+ IG G +GVV A+K+ + + + EV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------------------------YG 615
+ + ++E LV E H G L + L
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 616 TLTHEQRINWIKRLEIAEDAAK--------GIEYLHT-GCVPAIIHRDLKSSNILL--DK 664
E + YLH G I HRD+K N L +K
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNK 205
Query: 665 HMRAKVSDFGLSKFAVDGASHVSSIVR---GTVGYLDPE--YYISQQLTDKSDVYSFGVI 719
K+ DFGLSK + + GT ++ PE ++ K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 720 LLELISG 726
L L+ G
Sbjct: 266 LHLLLMG 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 30/239 (12%)
Query: 508 NDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQ 564
+D+PA + LS + D + L + +G+G +G VY G+ +K G+ A+KV+
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-D 62
Query: 565 GKREFTNEVTLLSRI-HHRNLVQFLG-YCQEEGRSV-----LVYEFMHNGT----LKEHL 613
+ E E+ +L + HHRN+ + G + ++ + LV EF G+ +K
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 614 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 673
TL E+ I +I R + +G+ +LH V IHRD+K N+LL ++ K+ DF
Sbjct: 123 GNTLK-EEWIAYICR-----EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDF 173
Query: 674 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 727
G+S ++ + GT ++ PE + D KSD++S G+ +E+ G
Sbjct: 174 GVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 521 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEV 573
S +ED + + +++GSG F +V + K GKE A K + +S + E EV
Sbjct: 1 SMVEDHYE-MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEI 631
+L I H N++ + + VL+ E + G L + L +LT ++ ++K +I
Sbjct: 60 NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK--QI 117
Query: 632 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVS 687
+ G+ YLH+ I H DLK NI+L + R K+ DFG++ ++ +
Sbjct: 118 LD----GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFK 169
Query: 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
+I GT ++ PE + L ++D++S GVI L+SG
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 582
+ +++GSG F +V + K G E A K + S + E EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 640
N++ + VL+ E + G L + L +L+ E+ ++IK +I + G+
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129
Query: 641 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
YLHT I H DLK NI+L K+ DFGL+ ++ +I GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELISG 726
+ PE + L ++D++S GVI L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 534 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 589
+G GGFG V +++ ++ A K L + ++ NE +L +++ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 590 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTH---EQRINWIKRLEIAEDAAKGIEYLHTG 645
Y + + LV M+ G LK H+Y E R AE G+E LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA----VFYAAE-ICCGLEDLHRE 305
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
I++RDLK NILLD H ++SD GL+ +G + + V GTVGY+ PE ++
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 360
Query: 706 QLTDKSDVYSFGVILLELISGQ 727
+ T D ++ G +L E+I+GQ
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 28/235 (11%), Positives = 59/235 (25%), Gaps = 43/235 (18%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIH--- 580
+G + G+ V V K E L +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 581 ---------------HRNLVQFLGYCQEEGRSVLVYEF-------MHNGTLKEHLYGTLT 618
+ + +E ++ F + T E L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 619 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
+ + RL++ + + LH G ++H L+ +I+LD+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQ-----LTDKSDVYSFGVILLELISGQ 727
A Q +T D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 521 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLS 577
+ + + K++G G F VV K G+E A K L + E +E+ +L
Sbjct: 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 578 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIA 632
++ + +L+ E+ G + L ++ I IK +I
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK--QIL 141
Query: 633 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 688
E G+ YLH I+H DLK NILL K+ DFG+S+ + A +
Sbjct: 142 E----GVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELRE 192
Query: 689 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
I+ GT YL PE +T +D+++ G+I L++
Sbjct: 193 IM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 582
+ +++GSG F +V + K G E A K + S + E EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 640
N++ + VL+ E + G L + L +L+ E+ ++IK +I + G+
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129
Query: 641 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
YLHT I H DLK NI+L K+ DFGL+ ++ +I GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELISG 726
+ PE + L ++D++S GVI L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 529 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 587
+ +K+G G +G VY + G+ +A+K + +E E++++ + ++V++
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKY 89
Query: 588 LGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
G + +V E+ G++ TLT E I I + KG+EYLH
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT-EDEIATILQ-----STLKGLEYLHF 143
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
IHRD+K+ NILL+ AK++DFG++ D + ++++ GT ++ PE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199
Query: 705 QQLTDKSDVYSFGVILLELISGQ 727
+D++S G+ +E+ G+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-25
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIH---HRNL 584
+ IG GGFG VY + D ++ A+K L + K+ T NE +LS + +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 585 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEY 641
V + Y + + + M+ G L HL G + E + R AE G+E+
Sbjct: 255 VC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADM----RFYAAE-IILGLEH 307
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
+H +++RDLK +NILLD+H ++SD GL+ H + V GT GY+ PE
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361
Query: 702 YISQQLTDKS-DVYSFGVILLELISGQ 727
D S D +S G +L +L+ G
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 587
L++ IGSG VV +++A+K + Q + E+ +S+ HH N+V +
Sbjct: 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 588 LGYCQEEGRSVLVYEFMHNGTL----------KEHLYGTLTHEQRINWIKRLEIAEDAAK 637
+ LV + + G++ EH G L E I I R + +
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILR-----EVLE 132
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VG- 695
G+EYLH IHRD+K+ NILL + +++DFG+S F G + VR T VG
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 696 --YLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 727
++ PE + +Q+ K+D++SFG+ +EL +G
Sbjct: 190 PCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEV-T 574
++D+E ++GSG G V+ + + + AVK + + + + + ++
Sbjct: 22 AEINDLE-----NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV 76
Query: 575 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 634
+L +VQ G + E M K L + + + +
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGK--MTVA 132
Query: 635 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
K + YL +IHRD+K SNILLD+ + K+ DFG+S VD + S G
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCA 188
Query: 695 GYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 727
Y+ PE T ++DV+S G+ L+EL +GQ
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 30/252 (11%)
Query: 491 KEQHRHSLPVQRPVSSLNDAPAEAA---HCFTLS---DIEDATKMLEKK-IGSGGFGVVY 543
R + +R + D PA A H + + + + + +G G FG V+
Sbjct: 47 DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106
Query: 544 YGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602
+ G ++A K++ + + K E NE+++++++ H NL+Q + + VLV E
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166
Query: 603 FMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 656
++ G L + + T I ++K +I E GI ++H I+H DLK
Sbjct: 167 YVDGGELFDRIIDESYNL---TELDTILFMK--QICE----GIRHMHQM---YILHLDLK 214
Query: 657 SSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVY 714
NIL K+ DFGL++ + GT +L PE ++ +D++
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMW 272
Query: 715 SFGVILLELISG 726
S GVI L+SG
Sbjct: 273 SVGVIAYMLLSG 284
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 31/211 (14%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 586
+++++G G F VV K G E A K++ + + E + ++ H N+V+
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 638
QEE LV++ + G L E I + R +E A +
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 117
Query: 639 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695
I Y H+ I+HR+LK N+LL K K++DFGL+ D GT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFA-GTPG 172
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELISG 726
YL PE + D+++ GVIL L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 585
+ + IG G FG V + D K++ A+K + + E N E+ ++ + H LV
Sbjct: 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 586 QFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYL 642
L Y Q+E +V + + G L+ HL E+ + +L I E ++YL
Sbjct: 79 N-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETV----KLFICE-LVMALDYL 131
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 702
IIHRD+K NILLD+H ++DF ++ + + GT Y+ PE +
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186
Query: 703 ISQQLT--DKS-DVYSFGVILLELISGQ 727
S++ + D +S GV EL+ G+
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 580
+ IG G VV + G E AVK++ + + E E +L ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 581 -HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 637
H +++ + + LV++ M G L + + +++ ++E +
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFD----------YL--TEKVALSEKETRSI 205
Query: 638 ------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 690
+ +LH I+HRDLK NILLD +M+ ++SDFG S G + +
Sbjct: 206 MRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELC 260
Query: 691 RGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 726
GT GYL PE + D+++ GVIL L++G
Sbjct: 261 -GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 583
L + +G G +G V + +AVK++ K+E + + ++H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 637
+V+F G+ +E L E+ G L + + + + E A+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114
Query: 638 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 694
G+ YLH I HRD+K N+LLD+ K+SDFGL+ + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 695 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 726
Y+ PE + ++ DV+S G++L +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 62/291 (21%), Positives = 110/291 (37%), Gaps = 55/291 (18%)
Query: 492 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM-----LEKKIGSGGFGVVYYGK 546
H H + AP H L+ ++ + + +GSGGFG VY G
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 547 -LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIHHR--NLVQFLGYCQEEGRS 597
+ D +A+K + + E N EV LL ++ +++ L + +
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123
Query: 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPA 649
VL+ E ++ L+ +T + E+ A+ + + H V
Sbjct: 124 VLILERPEPV--QD-LFDFITERGALQ--------EELARSFFWQVLEAVRHCHNCGV-- 170
Query: 650 IIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
+HRD+K NIL+D K+ DFG D GT Y PE +I
Sbjct: 171 -LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE-WIRYHRY 225
Query: 709 D--KSDVYSFGVILLELISG------QEAISNEKFG------ANCRNIVQW 745
+ V+S G++L +++ G E I + + C+++++W
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 40/219 (18%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH-- 580
L +G GGFG V+ G L D ++A+KV+ N G ++ EV LL ++
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 581 --HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 637
H +++ L + + + +LV E + L+ +T + + E ++
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLG--------EGPSRC 143
Query: 638 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSI 689
I++ H+ V +HRD+K NIL+D AK+ DFG D
Sbjct: 144 FFGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 690 VRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 726
GT Y PE +IS+ + V+S G++L +++ G
Sbjct: 200 --GTRVYSPPE-WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 582
+++GSG F VV + K G + A K + +S + + EV++L I H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 640
N++ + + +L+ E + G L + L +LT E+ ++K +I G+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK--QILN----GVY 128
Query: 641 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
YLH+ I H DLK NI+L R K+ DFGL+ +D + +I GT +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIF-GTPEF 183
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELISG 726
+ PE + L ++D++S GVI L+SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 580
+ K +GSG G V + K++A+++++ + E+ +L +++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 581 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 637
H +++ + E +V E M G L + ++ + + E K
Sbjct: 199 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 244
Query: 638 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 688
++YLH IIHRDLK N+LL ++ K++DFG SK + S + +
Sbjct: 245 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 300
Query: 689 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 726
+ GT YL PE + D +S GVIL +SG
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 37/203 (18%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ + +G G FG+V+ K K + + E+++L+ HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
+ V+++EF+ + E + L + ++++ ++ E +++LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH--QVCE----ALQFLHSH 121
Query: 646 CVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703
I H D++ NI+ + K+ +FG ++ + + + Y PE +
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAPEVHQ 176
Query: 704 SQQLTDKSDVYSFGVILLELISG 726
++ +D++S G ++ L+SG
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 586
+++++G G F VV K G E A K++ + + E + ++ H N+V+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 638
QEE LV++ + G L E I + R +E A +
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 140
Query: 639 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695
I Y H+ I+HR+LK N+LL K K++DFGL+ V+ + GT G
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPG 195
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELISG 726
YL PE + D+++ GVIL L+ G
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 28/216 (12%)
Query: 530 LEKKIGSG--GFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL 584
L IG G V + G+ + V+ L + S + E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
V + + +V FM G+ + H + E I +I + K ++
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQ-----GVLKALD 142
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------GTV 694
Y+H +HR +K+S+IL+ + +S + + + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 695 GYLDPEYYISQQL---TDKSDVYSFGVILLELISGQ 727
+L PE + Q L KSD+YS G+ EL +G
Sbjct: 200 PWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 586
L +++G G F VV G+E A ++ + + E + + H N+V+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 638
EEG L+++ + G L E I + R +E DA+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFE----------DI--VAREYYSEADASHCIQQILEA 122
Query: 639 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
+ + H G ++HR+LK N+LL K K++DFGL+ GT
Sbjct: 123 VLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
GYL PE D+++ GVIL L+ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 26/240 (10%)
Query: 497 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAV 555
+P SL D + A F D E L + IG G FG VY+ + +++ + +A+
Sbjct: 28 PMPAGGRAGSLKDP--DVAELFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAI 84
Query: 556 KVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG--TLK 610
K ++ + Q ++ EV L ++ H N +Q+ G E + LV E+ L
Sbjct: 85 KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL 144
Query: 611 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 670
E L E I + A +G+ YLH+ +IHRD+K+ NILL + K+
Sbjct: 145 EVHKKPLQ-EVEIAAVTH-----GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195
Query: 671 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 727
DFG + S V GT ++ PE ++ K DV+S G+ +EL +
Sbjct: 196 GDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 583
L + +G G +G V + +AVK++ K+E + + ++H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 637
+V+F G+ +E L E+ G L + + + + E A+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114
Query: 638 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 694
G+ YLH I HRD+K N+LLD+ K+SDFGL+ + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 695 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 726
Y+ PE + ++ DV+S G++L +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 69/267 (25%), Positives = 108/267 (40%), Gaps = 42/267 (15%)
Query: 481 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCF--------TLSDIEDATKMLEK 532
MH ++ + +L Q S A A + D + +E
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFE-VES 59
Query: 533 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 591
++G G +VY K K K A+KVL K+ E+ +L R+ H N+++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 592 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIEYLH 643
+ LV E + G L + RI +++ +E DAA + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFD----------RI--VEKGYYSERDAADAVKQILEAVAYLH 165
Query: 644 T-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
G I+HRDLK N+L K++DFGLSK V+ + ++ GT GY P
Sbjct: 166 ENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC-GTPGYCAP 219
Query: 700 EYYISQQLTDKSDVYSFGVILLELISG 726
E + D++S G+I L+ G
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 580
+GSG FG V+ + KE+ VK + + T E+ +LSR+
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 581 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--- 637
H N+++ L + +G LV E +G L+ + R++ E A
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLD--------EPLASYIF 136
Query: 638 -----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVR 691
+ YL IIHRD+K NI++ + K+ DFG + + G +
Sbjct: 137 RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 692 GTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 726
GT+ Y PE + + +++S GV L L+
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 580
+ K +GSG G V + K++A+K+++ + E+ +L +++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 581 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 637
H +++ + E +V E M G L + ++ + + E K
Sbjct: 74 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 119
Query: 638 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 688
++YLH IIHRDLK N+LL ++ K++DFG SK + S + +
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 175
Query: 689 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 726
+ GT YL PE + D +S GVIL +SG
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 521 SDIEDATKM--LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLS 577
S + +K +G G F + K + AVK+++ + E+T L
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALK 60
Query: 578 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DA 635
H N+V+ ++ + LV E ++ G L E RI K+ +E +A
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE----------RI--KKKKHFSETEA 108
Query: 636 AK-------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGAS 684
+ + ++H G ++HRDLK N+L + ++ K+ DFG ++
Sbjct: 109 SYIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 685 HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 726
+ + T+ Y PE ++Q D+S D++S GVIL ++SG
Sbjct: 165 PLKTPC-FTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 46/222 (20%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 580
+ +G G +G V + AVK+L + K+E + LL R+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLR 64
Query: 581 HRNLVQFLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 637
H+N++Q + E + +V E+ G ++E + ++ KR A
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQE-MLDSVPE-------KRFP--VCQAHG 113
Query: 638 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS----KFAVDGASHV 686
G+EYLH+ I+H+D+K N+LL K+S G++ FA D
Sbjct: 114 YFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 687 SSIVRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 726
S G+ + PE K D++S GV L + +G
Sbjct: 171 SQ---GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 38/213 (17%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQF 587
+++ IG G + V K E AVK++ + E + +L R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITL 81
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GI 639
+ +V E M G L + +I +++ +E +A+ +
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLD----------KI--LRQKFFSEREASAVLFTITKTV 129
Query: 640 EYLHT-GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
EYLH G ++HRDLK SNIL ++ DFG +K + + T
Sbjct: 130 EYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTA 184
Query: 695 GYLDPEYYISQQLTDKS-DVYSFGVILLELISG 726
++ PE + +Q D + D++S GV+L +++G
Sbjct: 185 NFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 585
K IGSG FGV + + +AVK + + +RE + + H N+V
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIV 79
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 637
+F ++ E+ G L E + +ED A+
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERI------------CNAGRFSEDEARFFFQQLLS 127
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGASHVSSIVRGTVG 695
G+ Y H+ + HRDLK N LLD R K+ DFG SK +V + S++ GT
Sbjct: 128 GVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPA 182
Query: 696 YLDPEYYISQQLTD--KSDVYSFGVILLELISG 726
Y+ PE + +Q D +DV+S GV L ++ G
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 58/211 (27%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 587
K IG G F V K+K ++ A+K++ + E F E +L R + Q
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ- 125
Query: 588 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
L + Q+E LV E+ G L L +G + R +AE I+ +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA----RFYLAE-IVMAIDSVHR 180
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 703
+HRD+K NILLD+ +++DFG DG V GT YL PE
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQ 236
Query: 704 SQQLTDKSDVY-------SFGVILLELISGQ 727
+ + Y + GV E+ GQ
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 581
L +G G FG V G+ G ++AVK+L + KRE + L H
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRH 70
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 637
++++ +V E++ G L +++ K + E A+
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYI------------CKHGRVEEMEARRLFQ 118
Query: 638 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 693
++Y H ++HRDLK N+LLD HM AK++DFGLS DG +S G+
Sbjct: 119 QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 173
Query: 694 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 726
Y PE IS +L + D++S GVIL L+ G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 30/243 (12%)
Query: 499 PVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVK-V 557
P+ N A + + K IG+G FGVV+ KL + E+A+K V
Sbjct: 13 VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV 72
Query: 558 LTSNSYQGKREFTN-EVTLLSRIHHRNLVQFLGYCQEEGRSV------LVYEFMHNGTLK 610
L Q KR F N E+ ++ + H N+V + G LV E++ T+
Sbjct: 73 L-----QDKR-FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVY 125
Query: 611 EHLYGTLTHEQRI--NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 666
+Q + IK ++ + + Y+H+ I HRD+K N+LLD
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPS 178
Query: 667 RA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI 724
K+ DFG +K + G +VS I + Y PE + T D++S G ++ EL+
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236
Query: 725 SGQ 727
GQ
Sbjct: 237 QGQ 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 582
L K IG G F V + + G+E+A+K++ ++ + RE V ++ ++H
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE----VRIMKILNHP 74
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 637
N+V+ + E L+ E+ G + ++L + + E A+
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYL------------VAHGRMKEKEARSKFRQ 122
Query: 638 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
++Y H I+HRDLK+ N+LLD M K++DFG S G + + G
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAP 177
Query: 695 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 726
Y PE + D + DV+S GVIL L+SG
Sbjct: 178 PYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 587
K IG G FG V KLK+ ++ A+K+L + E F E +L + +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT- 138
Query: 588 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 638
L Y Q++ LV ++ G L L E R+ E+ A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLS---KFEDRLP--------EEMARFYLAEMVIA 187
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
I+ +H +HRD+K NIL+D + +++DFG ++ + SS+ GT Y+
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 699 PEYYISQQLTDKS-----DVYSFGVILLELISGQ 727
PE + + D +S GV + E++ G+
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 62/307 (20%), Positives = 111/307 (36%), Gaps = 70/307 (22%)
Query: 521 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 578
+ D ++ ++ +G G G V + G++ A+K+L EV +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQ 77
Query: 579 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 632
++V L + ++ E M G L RI +R + A
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----------RI--QERGDQAF 125
Query: 633 --EDAAK-------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 680
+AA+ I++LH+ I HRD+K N+L +K K++DFG +K
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 740
A + + T Y+ PE ++ D++S GVI+ L+ G F +N
Sbjct: 183 QNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP-----FYSNTG 234
Query: 741 NIVQWAKLH-IESGDIQGIIDPSLLDEYDIQSMW-KIEEKA------LMCVLPHGHMRPS 792
+ I G + W ++ E A L+ P R +
Sbjct: 235 QAISPGMKRRIRLGQY------GFPNPE-----WSEVSEDAKQLIRLLLKTDP--TERLT 281
Query: 793 ISEVLKD 799
I++ +
Sbjct: 282 ITQFMNH 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 47/255 (18%)
Query: 494 HRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKE 552
H + P P ++ + I D K+ + +G G G V K ++
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89
Query: 553 IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV----LVYEFMHN 606
A+K+L EV L R ++V+ + + +V E +
Sbjct: 90 FALKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143
Query: 607 GTLKEHLYGTLTHEQRINWIKRLEIA---EDAA-------KGIEYLHT-GCVPAIIHRDL 655
G L RI R + A +A+ + I+YLH+ I HRD+
Sbjct: 144 GELFS----------RI--QDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDV 187
Query: 656 KSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS- 711
K N+L + K++DFG +K + +++ T Y+ PE + + DKS
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPC-YTPYYVAPE-VLGPEKYDKSC 244
Query: 712 DVYSFGVILLELISG 726
D++S GVI+ L+ G
Sbjct: 245 DMWSLGVIMYILLCG 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 573
L + K +G+G FG V K K+ A+K+L ++ NE
Sbjct: 38 AQLDQFD-----RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 633
+L ++ LV+ ++ +V E++ G + HL R + E
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFS--------E 140
Query: 634 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685
A+ EYLH+ +I+RDLK N+L+D+ +V+DFG +K
Sbjct: 141 PHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193
Query: 686 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
+ + GT L PE I + +K+ D ++ GV++ E+ +G
Sbjct: 194 RTWTLCGTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 573
++L D + + + +G+G FG V+ + + A+KVL ++ +E
Sbjct: 3 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 57
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 633
+LS + H +++ G Q+ + ++ +++ G L L QR
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFP--------N 105
Query: 634 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685
AK +EYLH+ II+RDLK NILLDK+ K++DFG +K+ D
Sbjct: 106 PVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160
Query: 686 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
+ GT Y+ PE +S + +KS D +SFG+++ E+++G
Sbjct: 161 --YTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-21
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 581
L +G G FG V GK G ++AVK+L + +RE + L H
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRH 75
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 637
++++ +V E++ G L +++ K + E ++
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRRLFQ 123
Query: 638 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 693
G++Y H V +HRDLK N+LLD HM AK++DFGLS DG +S G+
Sbjct: 124 QILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 178
Query: 694 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 726
Y PE IS +L + D++S GVIL L+ G
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-21
Identities = 68/251 (27%), Positives = 103/251 (41%), Gaps = 23/251 (9%)
Query: 485 KKNNYDKEQHRHSLPVQRP-VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 543
KK + R P + + A+ H T+++ E K +G G FG V
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE-----YLKLLGKGTFGKVI 165
Query: 544 YGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLGYC-QEEGRSV 598
K K A+K+L K E + E +L H L L Y Q R
Sbjct: 166 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA-LKYSFQTHDRLC 224
Query: 599 LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 656
V E+ + G L HL + E R R AE ++YLH+ +++RDLK
Sbjct: 225 FVMEYANGGELFFHLSRERVFS-EDRA----RFYGAE-IVSALDYLHSEK--NVVYRDLK 276
Query: 657 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 716
N++LDK K++DFGL K + + + + GT YL PE D +
Sbjct: 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 717 GVILLELISGQ 727
GV++ E++ G+
Sbjct: 336 GVVMYEMMCGR 346
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 71/245 (28%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------------------TSNSYQGKREF 569
L+ +IG G +GVV D A+KVL T + G +
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 570 TN-------EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------- 614
E+ +L ++ H N+V+ + E + + ++HLY
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVK-------------LVEVLDDPN-EDHLYMVFELVNQ 122
Query: 615 GTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHM 666
G + + ++ED A+ GIEYLH IIHRD+K SN+L+ +
Sbjct: 123 GPV-----MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDG 174
Query: 667 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD----KSDVYSFGVILLE 722
K++DFG+S + +S+ V GT ++ PE +S+ DV++ GV L
Sbjct: 175 HIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYC 232
Query: 723 LISGQ 727
+ GQ
Sbjct: 233 FVFGQ 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 529 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+E+ G G FG V GK K G +A+K V+ ++ RE + L+ +HH N+VQ
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQ-IMQDLAVLHHPNIVQ 83
Query: 587 ----FLGYCQEEGRSV---LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 637
F + + R + +V E++ TL R + +++ K
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC--------RNYYRRQVAPPPILIKVF 134
Query: 638 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV 690
I LH V + HRD+K N+L+++ K+ DFG +K +V+ I
Sbjct: 135 LFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 691 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 727
+ Y PE +Q T D++S G I E++ G+
Sbjct: 194 --SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 27/247 (10%)
Query: 490 DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 549
+ + + P P +N P+ H SD K IG G FG V + K
Sbjct: 8 PELMNANPAPPPAPSQQINLGPSSNPH-AKPSDFH-----FLKVIGKGSFGKVLLARHKA 61
Query: 550 GKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEF 603
+ AVKVL + K+E + ++ LL + H LV L + Q + V ++
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-LHFSFQTADKLYFVLDY 120
Query: 604 MHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661
++ G L HL E R R AE A + YLH+ I++RDLK NIL
Sbjct: 121 INGGELFYHLQRERCFL-EPRA----RFYAAE-IASALGYLHSL---NIVYRDLKPENIL 171
Query: 662 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVIL 720
LD ++DFGL K ++ S S+ GT YL PE + +Q D++ D + G +L
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPE-VLHKQPYDRTVDWWCLGAVL 229
Query: 721 LELISGQ 727
E++ G
Sbjct: 230 YEMLYGL 236
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 529 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTN-EVTLLSRIHHRNLV 585
K IG+G FGVVY KL D G+ +A+K VL Q KR F N E+ ++ ++ H N+V
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKR-FKNRELQIMRKLDHCNIV 110
Query: 586 QFLGYCQEEGRSV------LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 637
+ + G LV +++ E +Y H R + K
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAK----QTLPVIYVKLY 161
Query: 638 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIV 690
+ Y+H+ I HRD+K N+LLD K+ DFG +K V G +VS I
Sbjct: 162 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 691 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 727
+ Y PE + T DV+S G +L EL+ GQ
Sbjct: 219 --SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-20
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 587
K IG G FG V + K +++ A+K+L+ + + F E +++ + +VQ
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ- 133
Query: 588 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 638
L Y Q++ +V E+M G L + ++ E A+
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM-------------SNYDVPEKWARFYTAEVVLA 180
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
++ +H+ IHRD+K N+LLDK K++DFG GT Y+
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 699 PEYYISQQLT---DKS-DVYSFGVILLELISGQ 727
PE SQ + D +S GV L E++ G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 581
+ + +G G FG V K +++A+K + + + +RE ++ L + H
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRH 68
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 637
++++ V+V E+ G L +++ +++ + ED +
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYI------------VEKKRMTEDEGRRFFQ 115
Query: 638 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRG 692
IEY H I+HRDLK N+LLD ++ K++DFGLS DG S G
Sbjct: 116 QIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---G 169
Query: 693 TVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 726
+ Y PE I+ +L + DV+S G++L ++ G
Sbjct: 170 SPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 24/203 (11%), Positives = 56/203 (27%), Gaps = 43/203 (21%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLV 585
L G + +++A+ + +E + LSRI +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-T 644
+ L ++V E++ G+L+E + + + + A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAHRA 148
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
G + S + + ++ T+ +P+
Sbjct: 149 G----VALSIDHPSRVRVSIDGDVVLAYP------------------ATMPDANPQ---- 182
Query: 705 QQLTDKSDVYSFGVILLELISGQ 727
D+ G L L+ +
Sbjct: 183 ------DDIRGIGASLYALLVNR 199
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 70/232 (30%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 506 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSN 561
++ E S E L K +G G FG V+ D +++ A+KVL
Sbjct: 9 AITHHVKEGHEKADPSQFE-----LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA 63
Query: 562 SYQGKREF--TNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GT 616
+ + + E +L ++H +V+ L Y Q EG+ L+ +F+ G L L
Sbjct: 64 TLKVRDRVRTKMERDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 617 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676
T E+ + + +AE A +++LH+ II+RDLK NILLD+ K++DFGLS
Sbjct: 123 FT-EEDV----KFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173
Query: 677 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
K ++D S GTV Y+ PE ++++ +S D +SFGV++ E+++G
Sbjct: 174 KESIDHEKKAYSFC-GTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-19
Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 4/108 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
++ + +S + LSSL L + GNS F+ +L + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 444
QL P++ +L +L+ L + +N N VL+Y+ N
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 5/109 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 398
S+ V+ ++ + N D T+L +L L L L P F+ L+++++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGN 444
L +L+ L N + + S LN N
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-18
Identities = 23/96 (23%), Positives = 36/96 (37%), Gaps = 1/96 (1%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
P + V+ LS + LS L L L GN + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
L + +L L+EL V +N++ S
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-17
Identities = 20/106 (18%), Positives = 37/106 (34%), Gaps = 2/106 (1%)
Query: 330 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCP 388
++L ++T + LS L P+ LSSL L + N+ +
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 389 DLRIIHLEDNQLTGPLPSSLMNLP-NLRELYVQNNMLSGTVPSSLL 433
L+++ N + L + P +L L + N + T
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-17
Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 3/97 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
S+ + LS + + S+ L L L ++L F +L + +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
L +L L + N + ++
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-15
Identities = 27/109 (24%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 341 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 398
PS+ + LS L+ G +SL L L N + +F G L + + +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 399 QLTGPLPSS-LMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
L S ++L NL L + + LS VL AGN
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-15
Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDN 398
S+ + NL + L +L EL + N + +P+ FS +L + L N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 399 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 444
++ + L L + L + N ++ P + L N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 399
P+IT N IP +L S L L N L F P+L+++ L +
Sbjct: 8 PNITY-QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
+ + +L +L L + N + +
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-12
Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 4/107 (3%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPD-FSGCPDLRIIH 394
++ L+ + G L SL L L N L+ G G L+ +
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 395 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
L N + + S+ + L L L Q++ L S+ L Y
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 16/102 (15%), Positives = 31/102 (30%), Gaps = 5/102 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSL----VELWLDGNSLTGPIPDFSGCPDLRIIHLE 396
++ + LSS + +DL L + + L L N + P L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 397 DNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 437
+N + + + L L + K+
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-10
Identities = 15/125 (12%), Positives = 36/125 (28%), Gaps = 11/125 (8%)
Query: 331 SWLQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG----PIPDFS 385
+++Q + + + + L + + N+ + L+ L L D S
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 386 GCPDLRIIHLEDNQLT------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 439
L + +E+ +L + L N+ + + + S L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 440 NYAGN 444
Sbjct: 310 ELVNC 314
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 22/130 (16%), Positives = 43/130 (33%), Gaps = 25/130 (19%)
Query: 339 PQPSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 397
+I L+ + + I L+++ L ++ + DFS + + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313
Query: 398 NQLT-------------------GPLPSSLMNLPNLRELYVQNNMLS--GTVPSSL--LS 434
+ G S ++LP+L L + N LS G S +
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 435 KNVVLNYAGN 444
L+ + N
Sbjct: 374 SLKYLDLSFN 383
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 16/100 (16%), Positives = 25/100 (25%), Gaps = 28/100 (28%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD-LRIIHLEDN 398
S+ V+++S N L+SL L N + P L ++L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 399 QLTG--------------------------PLPSSLMNLP 412
PS +P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 587
K +G G FG V + K A+K+L K E + E +L H L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA- 69
Query: 588 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 638
L Y Q R V E+ + G L HL E+ E+ A+
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFT--------EERARFYGAEIVSA 117
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
+EYLH+ +++RD+K N++LDK K++DFGL K + + + + GT YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLA 173
Query: 699 PEYYISQQLTDKS-DVYSFGVILLELISGQ 727
PE + ++ D + GV++ E++ G+
Sbjct: 174 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 36/214 (16%)
Query: 532 KKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRN 583
+ +G GG+G V+ + +I A+KVL + T E +L + H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 584 LVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 637
+V L Y Q G+ L+ E++ G L L E ED A
Sbjct: 83 IVD-LIYAFQTGGKLYLILEYLSGGELFMQLE----REGIFM--------EDTACFYLAE 129
Query: 638 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
+ +LH II+RDLK NI+L+ K++DFGL K ++ + + GT+
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTI 185
Query: 695 GYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
Y+ PE + + +++ D +S G ++ ++++G
Sbjct: 186 EYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLG 589
+K+G G + V+ + + +++ VK+L K++ E+ +L + N++
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 98
Query: 590 --YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
LV+E ++N K LY TLT ++ + K ++Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDIRFYMYEI------LKALDYCHSM-- 149
Query: 648 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
I+HRD+K N+++D R ++ D+GL++F G + + + + PE + Q
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVDYQ 206
Query: 707 LTDKS-DVYSFGVILLELISGQEAI 730
+ D S D++S G +L +I +E
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-19
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 586
+K+G G +GVVY K G+ +A+K + ++ + E T E++LL +HH N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVS 83
Query: 587 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
+ E LV+EFM + + L Q ++ +L +G+ + H
Sbjct: 84 LIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL------LRGVAHCHQ 137
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 703
I+HRDLK N+L++ K++DFGL++ F + S+ +V T+ Y P+ +
Sbjct: 138 HR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLM 192
Query: 704 -SQQLTDKSDVYSFGVILLELISGQ 727
S++ + D++S G I E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 529 MLEK-----KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN--EVTLLSRIH 580
M+EK KIG G +GVV+ + +D G+ +A+K + + E+ +L ++
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 581 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAK 637
H NLV L + + R LV+E+ + T+ L Y E + + + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT------LQ 113
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 696
+ + H IHRD+K NIL+ KH K+ DFG ++ + + T Y
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWY 168
Query: 697 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
PE + DV++ G + EL+SG
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-18
Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 2/96 (2%)
Query: 342 SITVIHLSSKNL-TGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
I +I++ NL T + + L K+ L L N L G +P F L ++L NQ+
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI 365
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 436
T + + L +N L +P+ +K+
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-16
Identities = 15/111 (13%), Positives = 32/111 (28%), Gaps = 8/111 (7%)
Query: 326 LPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-F 384
PV S + + ++ L G +P+ L L L N +T +
Sbjct: 320 FPVETSLQKM-----KKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFC 373
Query: 385 SGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
+ + N+L P ++ + + N + +
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-16
Identities = 25/119 (21%), Positives = 40/119 (33%), Gaps = 14/119 (11%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--------PIPDFSGCPDLRI 392
+++ I+LS+ ++ + S L + L GN LT +F L
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 393 IHLEDNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 447
I L N+LT L LP L + + N S P+ S +
Sbjct: 493 IDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 26/117 (22%), Positives = 43/117 (36%), Gaps = 12/117 (10%)
Query: 341 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 397
+T I L LT + D T L LV + L NS + P L+ + +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 398 ------NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448
N+ P + P+L +L + +N + V + VL+ N N+
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-15
Identities = 19/115 (16%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL------WLDGNSLTGPIPD-FSGCPDLRII 393
P + I LS + + P+ S+L GN P+ + CP L +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 394 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 446
+ N + + + PN+ L +++N S + + + +
Sbjct: 572 QIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 12/104 (11%), Positives = 32/104 (30%), Gaps = 10/104 (9%)
Query: 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 397
+ + L L ++ + +P P++++I++
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282
Query: 398 NQLT--------GPLPSSLMNLPNLRELYVQNNML-SGTVPSSL 432
N+ + ++ +Y+ N L + V +SL
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 16/128 (12%), Positives = 36/128 (28%), Gaps = 22/128 (17%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP------------------- 382
T I S N+T + + +L+ L + ++ +
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242
Query: 383 -DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
+ DL + + + LP+ L LP ++ + V N + +
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADA 301
Query: 442 AGNINLHE 449
+
Sbjct: 302 PVGEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-14
Identities = 21/163 (12%), Positives = 52/163 (31%), Gaps = 19/163 (11%)
Query: 301 DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ--CNSDPQPSITV--------IHLSS 350
D +A+ + + +W+Q+G W++ + QP +++ + L
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEG 90
Query: 351 KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-----SGCPDLRIIHLEDNQLTGPLP 405
+G +P + +L+ L L L + F S
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 406 SSLM--NLPNLRELYVQNNMLSGTVPSS--LLSKNVVLNYAGN 444
+ +L + + ++ ++ S + K+ + N
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSN 193
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 16/104 (15%), Positives = 31/104 (29%), Gaps = 5/104 (4%)
Query: 346 IHLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQLTG 402
+ + S L++ ++ + I S I N +T
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 403 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 446
+ ++M L LR+ Y+ N+ +N YA
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPFVAENICEAW-ENENSEYAQQYK 239
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-13
Identities = 15/102 (14%), Positives = 31/102 (30%), Gaps = 11/102 (10%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 397
+ ++L+ +T + + L N L IP+ + I
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411
Query: 398 NQLTG-------PLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
N++ PL + N+ + + NN +S
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-13
Identities = 17/124 (13%), Positives = 37/124 (29%), Gaps = 21/124 (16%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 401
+ ++S +I ++ N++T LR ++ ++
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 402 GP-------------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLN 440
NL +L ++ V N +P+ L L + ++N
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 441 YAGN 444
A N
Sbjct: 280 VACN 283
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 11/109 (10%)
Query: 341 PSITVIHLSSKNLTGNIPS--DLTKLSSLVELWLDGNSLTGPI--------PDFSGCPDL 390
+ + + L IP+ D +S + + N + P ++
Sbjct: 377 EQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 391 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 439
I+L +NQ++ L + + NML+ +SL +N
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 14/113 (12%), Positives = 32/113 (28%), Gaps = 10/113 (8%)
Query: 341 PSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPDFSG---CPDLRII 393
+ V+ L S N P ++ S + D+ DL
Sbjct: 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD 164
Query: 394 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
+ + + S ++ +N ++ V ++ L+K +
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 501 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 559
+ N +++ + + E + +G G FG V ++K+ ++ AVKVL
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFE-----FIRVLGKGSFGKVMLARVKETGDLYAVKVL- 56
Query: 560 SNSYQGKREF---TNEVT--------LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNG 607
K++ ++V L +H L Q L C Q R V EF++ G
Sbjct: 57 ------KKDVILQDDDVECTMTEKRILSLARNHPFLTQ-LFCCFQTPDRLFFVMEFVNGG 109
Query: 608 TLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 665
L H+ E R R AE + +LH II+RDLK N+LLD
Sbjct: 110 DLMFHIQKSRRFD-EARA----RFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHE 160
Query: 666 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELI 724
K++DFG+ K + ++ GT Y+ PE + + L + D ++ GV+L E++
Sbjct: 161 GHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218
Query: 725 SGQ 727
G
Sbjct: 219 CGH 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQF 587
+G G +G+V + KD I A+K L S+ + + E+ LL ++ H NLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNL 89
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 644
L C+++ R LV+EF+ + T+ + L + Q + ++ ++ GI + H+
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI------INGIGFCHS 142
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 703
IIHRD+K NIL+ + K+ DFG ++ A G + + T Y PE +
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELLV 197
Query: 704 -SQQLTDKSDVYSFGVILLELISGQ 727
+ DV++ G ++ E+ G+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT--- 570
+ + E L K +G+G +G V+ D ++ A+KVL + K + T
Sbjct: 51 VGIENFE-----LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 105
Query: 571 -NEVTLLSRI-HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 627
E +L I LV L Y Q E + L+ ++++ G L HL +R
Sbjct: 106 RTERQVLEHIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLS----QRERFT--- 157
Query: 628 RLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679
E + +E+LH II+RD+K NILLD + ++DFGLSK
Sbjct: 158 -----EHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 680 VDGASHVSSIVRGTVGYLDPE-YYISQQLTDKS-DVYSFGVILLELISGQ 727
V + + GT+ Y+ P+ DK+ D +S GV++ EL++G
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 533 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQF 587
KIG G +GVVY + G+ A+K + + E T E+++L + H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKL 65
Query: 588 LGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
+ R VLV+E + L + G L +++ +L GI Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL------LNGIAYCHDR 119
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI- 703
++HRDLK N+L+++ K++DFGL++ F + + IV T+ Y P+ +
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMG 174
Query: 704 SQQLTDKSDVYSFGVILLELISGQ 727
S++ + D++S G I E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 586
+ IG G + V +LK I A+KV+ + T +H LV
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 587 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
L C Q E R V E+++ G L H+ L E+ R AE + + YLH
Sbjct: 75 -LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHA----RFYSAE-ISLALNYLH 127
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703
II+RDLK N+LLD K++D+G+ K + S+ GT Y+ PE +
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE-IL 182
Query: 704 SQQLTDKS-DVYSFGVILLELISGQ 727
+ S D ++ GV++ E+++G+
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 533 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLVQ 586
K+G+G + VY G K A+K + +S +G RE ++L+ + H N+V+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIVR 67
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA------KGI 639
E + LV+EFM ++ L + N + LE+ +G+
Sbjct: 68 LYDVIHTENKLTLVFEFM------DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 698
+ H I+HRDLK N+L++K + K+ DFGL++ F + + S +V T+ Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRA 176
Query: 699 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 727
P+ + S+ + D++S G IL E+I+G+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 1e-17
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 586
+G G FG V + K E+ AVK+L + + + L L Q
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 587 FLGYC-QEEGRSVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHT 644
L C Q R V E+++ G L H+ E AE A G+ +L +
Sbjct: 407 -LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFYAAE-IAIGLFFLQS 460
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
II+RDLK N++LD K++DFG+ K + + GT Y+ PE I+
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE-IIA 515
Query: 705 QQLTDKS-DVYSFGVILLELISGQ 727
Q KS D ++FGV+L E+++GQ
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 49/235 (20%)
Query: 523 IEDATKMLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSYQGKREFTN--EVTLLS 577
+ED + K+G G +G VY K KD K+ A+K + + E+ LL
Sbjct: 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLR 73
Query: 578 RIHHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTL-THEQRINWIKRLEIAE 633
+ H N++ R V L++++ EH L+ + H K +++
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPR 127
Query: 634 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKF--- 678
K GI YLH ++HRDLK +NIL+ + R K++D G ++
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 679 AVDGASHVSSIVRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQ 727
+ + + +V T Y PE +Y T D+++ G I EL++ +
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSE 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 26/236 (11%)
Query: 501 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 559
+ + +A+ L D + L + IG G + V +LK I A++V+
Sbjct: 32 EEKEAMNTRESGKASSSLGLQDFD-----LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK 86
Query: 560 SNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY 614
+ T +H LV L C Q E R V E+++ G L H+
Sbjct: 87 KELVNDDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ 145
Query: 615 --GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 672
L E+ R AE + + YLH II+RDLK N+LLD K++D
Sbjct: 146 RQRKLP-EEHA----RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196
Query: 673 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
+G+ K + S+ GT Y+ PE + + S D ++ GV++ E+++G+
Sbjct: 197 YGMCKEGLRPGDTTSTFC-GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVT--------LLSRI 579
+G G FG V + K E+ AVK+L K++ ++V L
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPG 78
Query: 580 HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAA 636
L Q L C Q R V E+++ G L H+ G E AE A
Sbjct: 79 KPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHA----VFYAAE-IA 131
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
G+ +L + II+RDLK N++LD K++DFG+ K + + GT Y
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDY 187
Query: 697 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
+ PE I+ Q KS D ++FGV+L E+++GQ
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 533 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 586
KIG G +G V+ K ++ EI A+K + + E + E+ LL + H+N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVR 65
Query: 587 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
+ + LV+EF + G L E +++ +L KG+ + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLGFCHS 119
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 703
++HRDLK N+L++++ K+++FGL++ F + + + +V T+ Y P+
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLF 174
Query: 704 -SQQLTDKSDVYSFGVILLELISGQEAI 730
++ + D++S G I EL + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 532 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 586
K +G G FG V+ + K + A+K L + + + L H L
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 587 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+ Q + V E+++ G L H+ + AE G+++LH
Sbjct: 83 -MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-----TFYAAE-IILGLQFLH 135
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 703
+ I++RDLK NILLDK K++DFG+ K + G + ++ GT Y+ PE +
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE-IL 190
Query: 704 SQQLTDKS-DVYSFGVILLELISGQ 727
Q + S D +SFGV+L E++ GQ
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLV 585
+G G F VY + + +A+K + ++ T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 586 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
L + LV++FM + + LT ++ +G+EYLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT------LQGLEYLH 129
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY- 701
I+HRDLK +N+LLD++ K++DFGL+K F ++ +V T Y PE
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELL 184
Query: 702 YISQQLTDKSDVYSFGVILLELISGQ 727
+ ++ D+++ G IL EL+
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-17
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 5/109 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
P + V++L L+ ++L EL L NS+ + F +L + L N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKNVVLNYAGN 444
L+ + + L NL+EL + NN + L S L + N
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-16
Identities = 25/107 (23%), Positives = 41/107 (38%), Gaps = 3/107 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
+T + + ++ P KL L L L N L+ F+ C +L +HL N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
+ + + NL L + +N LS T + L L + N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-16
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 397
++ + LS L+ +L +L EL L N + + L+ + L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
NQ+ P + L L++ N L ++ L
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-16
Identities = 20/112 (17%), Positives = 45/112 (40%), Gaps = 6/112 (5%)
Query: 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 396
+ +++L+ ++ + L L L L N + + + G ++ I+L
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 397 DNQLTGPLPSSLMNLPNLRELYVQNNMLSG--TVPSSL--LSKNVVLNYAGN 444
N+ +S +P+L+ L ++ L + PS L +L+ + N
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-16
Identities = 26/116 (22%), Positives = 40/116 (34%), Gaps = 12/116 (10%)
Query: 341 PSITVIHLSSKNLT--------GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR 391
+ ++ L NL G L LS L L L+ N + F +L+
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 392 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 444
II L N L S N +L+ L +Q N+++ L+ N
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 25/100 (25%), Positives = 40/100 (40%), Gaps = 8/100 (8%)
Query: 334 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRI 392
+C S V S LT +P DL +++ L L N L +F+ L
Sbjct: 1 KCTV----SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTS 53
Query: 393 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
+ + N ++ P LP L+ L +Q+N LS +
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF 93
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-15
Identities = 24/112 (21%), Positives = 39/112 (34%), Gaps = 4/112 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 397
+I I+LS + + SL L L +L F +L I+ L +
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 449
N + L L L L +Q+N L+ + + G +LH
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHI 540
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 15/106 (14%), Positives = 36/106 (33%), Gaps = 5/106 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG---PIPDFSGCP--DLRIIHL 395
+ +++ ++ G + T L +L L L + + F L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 396 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
N+++ + L +L L + N + + +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-14
Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 3/104 (2%)
Query: 335 CNSDPQPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPD-FSGCPDLR 391
C SI + LS+ L+ + K ++L L L N+L D F+ P L
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 392 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
LE N + SL L N+R L ++ + ++ + L K
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 20/100 (20%), Positives = 38/100 (38%), Gaps = 6/100 (6%)
Query: 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIH 394
S+ + LSS + P + L L+L+ L + + +R +
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 395 LEDNQLTGPLPSSLMNL--PNLRELYVQNNMLSGTVPSSL 432
L ++QL+ ++ + L NL L + N L+ S
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 10/110 (9%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----------FSGCPDL 390
P + L N+ L L ++ L L + I F L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 391 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 440
+++EDN + G + L NL+ L + N+ S ++ ++ +
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 15/69 (21%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 366 SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 425
S LT +PD ++ +++L NQL ++ L L V N +S
Sbjct: 5 SHEVADCSHLKLTQ-VPDDLP-TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 426 GTVPSSLLS 434
P
Sbjct: 63 KLEPELCQK 71
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 24/157 (15%)
Query: 533 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 588
KIG G FG V+ + + + A+K VL N +G T E+ +L + H N+V +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLI 82
Query: 589 GYCQEEGRSV--------LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638
C+ + LV++F + L ++ T + ++ L G
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML------LNG 136
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675
+ Y+H I+HRD+K++N+L+ + K++DFGL
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 532 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLV 585
K+G G + VY GK K +A+K + +G RE V+LL + H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63
Query: 586 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
E LV+E++ + + ++ +L +G+ Y H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL------LRGLAYCH 117
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 702
++HRDLK N+L+++ K++DFGL++ ++ ++ + +V T+ Y P+
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 703 I-SQQLTDKSDVYSFGVILLELISGQ 727
+ S + + D++ G I E+ +G+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 60/272 (22%), Positives = 95/272 (34%), Gaps = 83/272 (30%)
Query: 530 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 581
L K +G G FG V + +AVK+L + R +E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 582 RN--------------------------LVQFL-------------GYCQEEGRSVLVYE 602
N L +L G +G+ +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 603 FMH----------------NGTLKEHLYGTLTHEQRINWIKR--------LEIAEDAAKG 638
+ +G ++E + E+ + + + + AKG
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
+E+L + IHRDL + NILL + K+ DFGL++ VR L
Sbjct: 206 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLP 258
Query: 699 -----PEYYISQQLTDKSDVYSFGVILLELIS 725
PE + T +SDV+SFGV+L E+ S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 51/227 (22%), Positives = 82/227 (36%), Gaps = 66/227 (29%)
Query: 521 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 578
+ I D K+ + +G G G V K ++ A+K+L EV L R
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWR 66
Query: 579 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 632
++V+ + + +V E + G L RI R + A
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS----------RI--QDRGDQAF 114
Query: 633 --EDAA-------KGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFA 679
+A+ + I+YLH+ I HRD+K N+L + K++DFG +K
Sbjct: 115 TEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 168
Query: 680 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 726
G Y D D++S GVI+ L+ G
Sbjct: 169 ---------ETTGE-KY-DKS----------CDMWSLGVIMYILLCG 194
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 587
K IGSG G+V + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 89
Query: 588 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
L EE + V +V E M L + + L HE+ + ++ GI++
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 142
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
LH+ + IHRDLK SNI++ K+ DFGL++ A +V T Y PE
Sbjct: 143 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEV 197
Query: 702 YISQQLTDKSDVYSFGVILLELISGQ 727
+ + D++S G I+ E+I G
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 47/254 (18%), Positives = 94/254 (37%), Gaps = 65/254 (25%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRI 579
+ L K +G+G FG+V + GK A+K + + + N E+ ++ +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVL 57
Query: 580 HHRNLVQFLGYCQEEGRSV--------------------------------------LVY 601
H N+++ + Y G ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------DAAKGIEYLHTGCVPAIIHRDL 655
E++ + L+ L R + + + + + ++H+ I HRD+
Sbjct: 118 EYV-----PDTLHKVLKSFIRSG--RSIPMNLISIYIYQLFRAVGFIHSL---GICHRDI 167
Query: 656 KSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDV 713
K N+L++ K+ DFG +K + V+ I + Y PE + + + T D+
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDL 225
Query: 714 YSFGVILLELISGQ 727
+S G + ELI G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 8e-16
Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 13/116 (11%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI----------PDFSGCPDL 390
+T + L + +P L L L L + N D P +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 391 RIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 444
+I ++ N L P +SL + L L +N + + + K L N
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN 605
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-14
Identities = 19/113 (16%), Positives = 34/113 (30%), Gaps = 10/113 (8%)
Query: 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 397
+ N + L L ++ L +PD P+L+ +++
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524
Query: 398 NQLTGP---------LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
N+ L P ++ Y+ N L S+ L K V L
Sbjct: 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 23/120 (19%), Positives = 38/120 (31%), Gaps = 16/120 (13%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---------FSGCPDLRI 392
+ + + LS + S + + L N +T IP+ + L
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPENSLKPKDGNYKNTYLLTT 732
Query: 393 IHLEDNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 448
I L N+LT L LP L + V N S + P+ S+ +
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAE 790
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-14
Identities = 24/117 (20%), Positives = 44/117 (37%), Gaps = 12/117 (10%)
Query: 341 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE- 396
+T I L LT + D T L L + + N + P L+ +
Sbjct: 728 YLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785
Query: 397 -----DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448
N++ P+ + P+L +L + +N + V L + +L+ A N N+
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 5/98 (5%)
Query: 341 PSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 399
P I + ++ NL + L K+ L L N + + F L + L+ NQ
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQ 606
Query: 400 LTGPLPSSLM-NLPNLRELYVQNNMLSGTVPSSLLSKN 436
+ +P + L +N L +P+ +K+
Sbjct: 607 IEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 17/110 (15%), Positives = 30/110 (27%), Gaps = 20/110 (18%)
Query: 347 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--------------------FSG 386
+ N I + +L+ L ++ + T +S
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSN 489
Query: 387 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 436
DL + L + LP L +LP L+ L + N
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 15/115 (13%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL------WLDGNSLTGPIPD-FSGCPDLRII 393
P ++ + +S + P+ S L +GN + P + CP L +
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 394 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS----GTVPSSLLSKNVVLNYAGN 444
+ N + + L P L L + +N +V + + VL Y
Sbjct: 812 QIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 13/102 (12%), Positives = 33/102 (32%), Gaps = 10/102 (9%)
Query: 341 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPDFSGCPD------LRI 392
+ + S L IP+ + + + N + + S D
Sbjct: 619 DQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 393 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
+ L N++ + + + NN+++ ++P + L
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLK 718
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 6e-10
Identities = 20/118 (16%), Positives = 35/118 (29%), Gaps = 21/118 (17%)
Query: 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP---- 403
++ I D ++ N +T L+II+ ++ T
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467
Query: 404 ---------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
S NL +L ++ + N +P L L + LN A N
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 22/164 (13%), Positives = 48/164 (29%), Gaps = 16/164 (9%)
Query: 293 LERNDGSI-DGVAIVSVISLYSSADWAQEGGDP-CLPVPWSWLQ----CNSDPQPSI--- 343
L+ I D A+ ++ +W G +W QP +
Sbjct: 261 LKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD 320
Query: 344 -----TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLED 397
T + L+ G +P + +L+ L L +S T F +
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 398 NQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 440
+++ L L + + ++ + K+ ++
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 17/122 (13%), Positives = 41/122 (33%), Gaps = 11/122 (9%)
Query: 337 SDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHL 395
D + + + + + L L L +++ P+ I L
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISL 425
Query: 396 ED-------NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448
+D N++T + ++ L L+ +Y N+ + ++ ++ +YA
Sbjct: 426 KDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDYAKQYENE 483
Query: 449 EG 450
E
Sbjct: 484 EL 485
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 9/62 (14%), Positives = 22/62 (35%), Gaps = 3/62 (4%)
Query: 390 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGNIN 446
+ + L G +P ++ L L+ L + + + L+ ++ I
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 447 LH 448
+H
Sbjct: 385 MH 386
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 533 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 586
K+G G +G VY + +A+K + + + E T EV+LL + HRN+++
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
R L++E+ N LK+++ ++ +++ +L G+ + H+
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL------INGVNFCHS 150
Query: 645 GCVPAIIHRDLKSSNILLDKHMRA-----KVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 698
+HRDLK N+LL + K+ DFGL++ F + I+ T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRP 205
Query: 699 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 727
PE + S+ + D++S I E++
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 18/108 (16%), Positives = 34/108 (31%), Gaps = 4/108 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 398
S+ + ++ + N S+ ++L L L L F L+++++ N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
L S L +L L N + + N N
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 15/101 (14%), Positives = 30/101 (29%), Gaps = 3/101 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDN 398
S+ + LS + ++ L L L ++L F L + +
Sbjct: 376 NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 439
+ L +L L + N S++ + L
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 20/96 (20%), Positives = 33/96 (34%), Gaps = 1/96 (1%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
+ + LS + L L L L GN + P FSG L + + +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
L + L L++L V +N + + S
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 18/99 (18%), Positives = 32/99 (32%), Gaps = 4/99 (4%)
Query: 335 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRII 393
+ L+ +P D+ SS + L N L FS +L+ +
Sbjct: 5 NPCIEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWL 61
Query: 394 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
L ++ + L +L L + N + P S
Sbjct: 62 DLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF 100
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-14
Identities = 14/86 (16%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
++T + LS L L L L + N+L ++ L + N+
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLS 425
+ +L + NN ++
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 9e-12
Identities = 21/116 (18%), Positives = 37/116 (31%), Gaps = 7/116 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDN 398
S+ + L + +L +L +L + N + +P FS +L + L N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 399 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHE 449
+ + L L L + N + + K L GN N
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSN 219
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 9e-12
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 341 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 398
PS++ + LS L+ G +SL L L N +F G +L+ + + +
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHS 409
Query: 399 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
L S+ ++L L L + L+ L AGN
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-11
Identities = 20/106 (18%), Positives = 39/106 (36%), Gaps = 4/106 (3%)
Query: 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 398
+I L+ N + L+++ + L G S+ + D + + +
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRC 317
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
QL P+ +LP L+ L + N S + L L+ + N
Sbjct: 318 QLKQ-FPTL--DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRN 360
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 9/108 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + L DL L L L N + P L + L N L
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNAL 362
Query: 401 T--GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
+ G S + +LR L + N + ++ L + L++ +
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 14/114 (12%), Positives = 24/114 (21%), Gaps = 10/114 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-------PIPDFSGCPDLRI 392
+ + L + NI L L+ L L G D+ I
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 393 IHLED--NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
L N+ + + + K L+
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRC 317
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 14/102 (13%), Positives = 30/102 (29%), Gaps = 5/102 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLS----SLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 396
++ + LS + +DL L + L + N + L + L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 397 DNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 437
N + + + L NL L + + ++
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 14/98 (14%), Positives = 31/98 (31%), Gaps = 5/98 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 397
S+ + LS + + S+ L L L ++L + + F +L + +
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 430
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
L +L L + N + ++
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-14
Identities = 26/110 (23%), Positives = 45/110 (40%), Gaps = 6/110 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
++ + +S + LSSL L + GNS F+ +L + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448
QL P++ +L +L+ L + +N L +VP + + L I LH
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQK---IWLH 526
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 5/97 (5%)
Query: 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 402
N IP +L S L L N L F P+L+++ L ++
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 403 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 439
+ +L +L L + N + ++ S L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-12
Identities = 21/104 (20%), Positives = 37/104 (35%), Gaps = 4/104 (3%)
Query: 341 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 398
PS+ + LS L+ G +SL L L N + +F G L + + +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 399 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
L S ++L NL L + + + + + L
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEV 449
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 19/89 (21%), Positives = 39/89 (43%), Gaps = 2/89 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 398
S+ V+ ++ + N D T+L +L L L L P F+ L+++++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGT 427
QL L +L+++++ N +
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 20/115 (17%), Positives = 40/115 (34%), Gaps = 8/115 (6%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE 396
++ + L+ + + LSSL +L +L L+ +++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 397 DNQLT-GPLPSSLMNLPNLRELYVQNNMLSGTVP------SSLLSKNVVLNYAGN 444
N + LP NL NL L + +N + + N+ L+ + N
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 1/86 (1%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 399
P + V+ LS + LS L L L GN + + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLS 425
L + +L L+EL V +N++
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-GPIPD-FSGCPDLRIIHLEDN 398
S+ + NL + L +L EL + N + +P+ FS +L + L N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 399 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 444
++ + L L + L + N ++ P + L N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 20/73 (27%), Positives = 29/73 (39%), Gaps = 3/73 (4%)
Query: 330 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGC 387
++L ++T + LS L P+ LSSL L + N L +PD F
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRL 517
Query: 388 PDLRIIHLEDNQL 400
L+ I L N
Sbjct: 518 TSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 17/107 (15%), Positives = 38/107 (35%), Gaps = 5/107 (4%)
Query: 339 PQPSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 397
+I L+ + + I L+++ L ++ + DFS + + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ P+ + L +L+ L +N L L+ + N
Sbjct: 314 CKFGQ-FPT--LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 587
K IGSG G+V + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 126
Query: 588 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
L EE + V LV E M L + + L HE+ + ++ GI++
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 179
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
LH+ + IHRDLK SNI++ K+ DFGL++ + ++ V T Y PE
Sbjct: 180 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYV-VTRYYRAPEV 234
Query: 702 YISQQLTDKSDVYSFGVILLELISGQ 727
+ + D++S G I+ E++ +
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-15
Identities = 20/96 (20%), Positives = 33/96 (34%)
Query: 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 398
+ S+ I+L + S L EL L L+ G L+ + L N
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSAN 311
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
+ S N P+L L ++ N + + L
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-15
Identities = 23/109 (21%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLE 396
+ V++LS L + L +L L L GN L I+ L
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 397 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGN 444
L+ + +L + + + +N L+ + +L K + LN A N
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASN 533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-15
Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 3/107 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
S + S L + ++L +L L L + D F L + L N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
L ++L L+ L+ +S L L N
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-14
Identities = 19/109 (17%), Positives = 37/109 (33%), Gaps = 5/109 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
+ + L++ L + L+ +L L+ ++ L ++L N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS----KNVVLNYAGN 444
++ L+ L QNN + + S N+ LN GN
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-14
Identities = 21/123 (17%), Positives = 45/123 (36%), Gaps = 4/123 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
++ + ++ L +L L+L N ++ L+++ ++N
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 400 LTGPLPSSLMNLPNLR--ELYVQNNMLSGTVPSSLLSKNV-VLNYAGNINLHEGGRGAKH 456
+ + +L L + N ++G P + S LN+ G NL +G K+
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 457 LNI 459
I
Sbjct: 225 STI 227
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 16/94 (17%), Positives = 27/94 (28%), Gaps = 2/94 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
+ ++LS + L L L L F L++++L +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
L LP L+ L +Q N
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-13
Identities = 18/99 (18%), Positives = 30/99 (30%), Gaps = 4/99 (4%)
Query: 335 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRII 393
+ + + L IP L +S L N L FS +L +
Sbjct: 6 QKCIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 394 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
L Q+ + + L L + N L ++L
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETAL 101
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 20/111 (18%), Positives = 36/111 (32%), Gaps = 7/111 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLE 396
PS+T + + + + L L +L EL L + + L+ ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 397 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN---VVLNYAGN 444
N+ + P L L + L S VLN + +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 2/88 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
+ ++ LS +L+ T L + + L N LT + S + + +L N
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNH 534
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGT 427
++ LPS L L R + ++ N L T
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 21/121 (17%), Positives = 41/121 (33%), Gaps = 8/121 (6%)
Query: 331 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGC 387
+ ++ + ++ I L + + SL + P F G
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 388 PD--LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAG 443
+ + I+L+ + ++ L+EL + LS +PS L LS L +
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 444 N 444
N
Sbjct: 311 N 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 62/233 (26%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVK--VLTSNSYQGKREFTN---------EVTLLSR 578
+++ I SG +G V G +G +A+K T + + ++ E+ LL+
Sbjct: 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 579 IHHRNLVQ----FLGYCQEEGRSV-LVYEFM----------HNGTLKEH-----LYGTLT 618
HH N++ F+ + + + LV E M + +Y L
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL- 144
Query: 619 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678
G+ LH V +HRDL NILL + + DF L++
Sbjct: 145 ------------------LGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLARE 183
Query: 679 AVDGAS---HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
A+ +V+ Y PE + + K D++S G ++ E+ + +
Sbjct: 184 DTADANKTHYVT-----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 533 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFTN----EVTLLSRIH---HRN 583
+IG G +G VY + G +A+K V N G EV LL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 584 LVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDA 635
+V+ + E + LV+E + L + L E + +++
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF------ 129
Query: 636 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVRGT 693
+G+++LH C I+HRDLK NIL+ K++DFGL++ ++ A + V +V T
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--VV--T 182
Query: 694 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
+ Y PE + D++S G I E+ +
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 587
+GSG +G V + G+++A+K L+ + KR + E+ LL + H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGL 88
Query: 588 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
L LV FM L++ + + E+ + ++ KG++Y
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQML------KGLKY 141
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLD 698
+H+ ++HRDLK N+ +++ K+ DFGL A H + + G V Y
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGL-------ARHADAEMTGYVVTRWYRA 191
Query: 699 PEYYISQQLTDKS-DVYSFGVILLELISGQ 727
PE +S +++ D++S G I+ E+++G+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 53/252 (21%), Positives = 92/252 (36%), Gaps = 68/252 (26%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 585
++ IG G +G VY K +A+K + + KR E+T+L+R+ ++
Sbjct: 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYII 88
Query: 586 Q----FLGYCQEEGRSV-LVYEFM---------HNGTLK-EH----LYGTLTHEQRINWI 626
+ + + + +V E L EH LY L
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL--------- 139
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASH 685
G ++H IIHRDLK +N LL++ KV DFGL+ + ++
Sbjct: 140 ----------LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 686 VSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVILLELI 724
+ + + + +QLT KS D++S G I EL+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 725 SGQEAISNEKFG 736
+ ++ N+
Sbjct: 247 NMLQSHINDPTN 258
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 54/229 (23%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 586
L+ +G G +GVV G+ +A+K + R E+ +L H N++
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIIT 73
Query: 587 ----FLGYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 628
E V ++ E M L +H +Y TL
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL----------- 122
Query: 629 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 688
+ ++ LH V IHRDLK SN+L++ + KV DFGL++ + A+ S
Sbjct: 123 --------RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 689 IVRGTVG---------YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
G Y PE ++ ++ DV+S G IL EL +
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 14/98 (14%), Positives = 31/98 (31%), Gaps = 5/98 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 397
S+ + LS + + S+ L L L ++L + + F +L + +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 135
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
L +L L + N + ++
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 25/104 (24%), Positives = 38/104 (36%), Gaps = 4/104 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG---PIPDFSGCPDLRIIHLED 397
S T + L S L KL+ L +L L N L+ G L+ + L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
N + + S+ + L L L Q++ L S+ L Y
Sbjct: 88 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 19/97 (19%), Positives = 39/97 (40%), Gaps = 5/97 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
++ + +S + + LSSL L + GNS F+ +L + L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
QL P++ +L +L+ L + +N ++ +
Sbjct: 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
S+ V+ ++ + N D T+L +L L L L + F+ L+++++
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSH 208
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
N L +L+ L N + T L
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ 244
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 341 PSITVIHLSSKNLT-GNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 398
+T + LSS L+ S +SL L L N + +F G L + + +
Sbjct: 52 TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 111
Query: 399 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
L S ++L NL L + + + + +
Sbjct: 112 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
++T + LS L + LSSL L + N+ + + L+++
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232
Query: 398 NQLTGPLPSSLMNLP-NLRELYVQNNMLS 425
N + L + P +L L + N +
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 21/104 (20%), Positives = 44/104 (42%), Gaps = 3/104 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+T + + + ++ + + L+ L L + N ++ I + L + L +NQL
Sbjct: 243 SQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQL 299
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ L NL L++ N ++ P + LSK ++A
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 5/107 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
SIT + ++ + + +I + L++L L L+GN +T I S L +++ N++
Sbjct: 44 ESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 447
T S+L NL NLRELY+ + +S P + L+K LN N NL
Sbjct: 101 TDI--SALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNL 145
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 18/86 (20%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
+ ++++ S ++ S L LS L L+L+ N L + G +L + L N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLS 425
+T L +L + N ++
Sbjct: 323 ITDI--RPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-12
Identities = 22/104 (21%), Positives = 46/104 (44%), Gaps = 4/104 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+T +++ + +T S L L++L EL+L+ ++++ I + + ++L N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
S L N+ L L V + + P + L+ L+ N
Sbjct: 145 LS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYN 187
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 25/104 (24%), Positives = 41/104 (39%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + L+ + P L L+SL N +T I + L + + +N++
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKI 233
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
T S L NL L L + N +S L+K +LN N
Sbjct: 234 TDL--SPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSN 275
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 6e-11
Identities = 21/104 (20%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + ++ + P + L+ L L L+ N + I + L NQ+
Sbjct: 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQI 211
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
T + + N+ L L + NN ++ P + LS+ L N
Sbjct: 212 TDI--TPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 8e-11
Identities = 15/86 (17%), Positives = 36/86 (41%), Gaps = 4/86 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ ++L+ N++ S L L+ + L L N + S L + + ++++
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSG 426
+ + NL +L L + N +
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 15/86 (17%), Positives = 28/86 (32%), Gaps = 3/86 (3%)
Query: 359 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418
L+ + L S+T + + + + ++ + L NL L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 419 VQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ N ++ P S L K L N
Sbjct: 73 LNGNQITDISPLSNLVKLTNLYIGTN 98
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 8e-14
Identities = 26/104 (25%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ + L+ L L L++L +L L N ++ + SG L + L NQ+
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ S L L L L + N L P S L L N
Sbjct: 278 SNI--SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 319
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++T + L++ ++ P L+ L+ L EL L N ++ I +G L + L +NQL
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
S + NL NL L + N +S P S L+K L + N
Sbjct: 300 EDI--SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 17/106 (16%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++T + L N++ P ++ L+ L L+ N ++ + + ++ + NQ+
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 446
+ + L NL + +L + + + P + + + N N+
Sbjct: 366 SDL--TPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-13
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+T + L + ++ P L L++L L L+ N L I S +L + L N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ P + +L L+ L+ NN +S + L+ L+ N
Sbjct: 322 SDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHN 363
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+T + + + L++L ++ N LT I L I + +NQ+
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ L NL NL L + NN ++ P L+ L + N
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 144
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-11
Identities = 24/104 (23%), Positives = 44/104 (42%), Gaps = 6/104 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
S+ + + +T P L L++L L + N ++ I + +L + +NQ+
Sbjct: 156 TSLQQLSFGN-QVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQI 211
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ + L L NL EL + N L + L+ L+ A N
Sbjct: 212 SDI--TPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANN 253
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 28/105 (26%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++T I+ S+ LT P L L+ LV++ ++ N + I + +L + L +NQ+
Sbjct: 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQI 124
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 445
T L NL NL L + +N +S S L+ L++ +
Sbjct: 125 TDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV 167
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ + LSS ++ S L+ L+SL +L GN +T P + L + + N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP-LANLTTLERLDISSNKV 189
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ S L L NL L NN +S P +L+ L+ GN
Sbjct: 190 SDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGN 231
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 7/101 (6%)
Query: 348 LSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 403
L S +T + P T L+ ++ L ++T + + + + + +
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI 61
Query: 404 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ L NL ++ NN L+ P L+K V + N
Sbjct: 62 --DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNN 100
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 12/104 (11%), Positives = 30/104 (28%), Gaps = 3/104 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + + ++ S L L+++ L N ++ + + + + L D
Sbjct: 331 TKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAW 387
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
T + N+ + L S + N
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWN 431
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 9e-14
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 533 KIGSGGFGVVYYGK-LKDGKEI-AVK-VLTSNSYQGK-----REFTNEVTLL---SRIHH 581
+IG G +G V+ + LK+G A+K V +G RE V +L H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHLETFEH 73
Query: 582 RNLVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAE 633
N+V+ E + LV+E + L + + E + + +L
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL---- 129
Query: 634 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVR 691
+G+++LH+ ++HRDLK NIL+ + K++DFGL++ ++ A + V +V
Sbjct: 130 --LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VV- 181
Query: 692 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
T+ Y PE + D++S G I E+ +
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ-- 586
IG G +G+V + +A+K ++ + +R E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIN 91
Query: 587 --FLGYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKRLE 630
E+ + V +V + M L +H LY L
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL------------- 138
Query: 631 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI- 689
+G++Y+H+ V +HRDLK SN+LL+ K+ DFGL++ A H +
Sbjct: 139 ------RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 690 --VRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
V T Y PE ++ + KS D++S G IL E++S +
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 64/239 (26%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 584
L KK+G G +G+V+ + G+ +AVK + NS +R F E+ +L+ + H N+
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENI 71
Query: 585 VQFLGYCQ-EEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKRL 629
V L + + R V LV+++M L+ H +Y +
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI------------ 119
Query: 630 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689
K I+YLH+G + +HRD+K SNILL+ KV+DFGLS+ V+ ++I
Sbjct: 120 -------KVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 690 VRGTVGYLDPEYYISQQLTD---------------------KSDVYSFGVILLELISGQ 727
+ LTD D++S G IL E++ G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 51/271 (18%), Positives = 109/271 (40%), Gaps = 64/271 (23%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIH------- 580
+K+G G F V+ K + + +A+K++ + + E + LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKE 80
Query: 581 ----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH-----------LYGTL--THEQRI 623
++++ L + F H G H L + + I
Sbjct: 81 DSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128
Query: 624 N--WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA------KVSDFGL 675
++K+ I++ G++Y+H C IIH D+K N+L++ K++D G
Sbjct: 129 PLIYVKQ--ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 735
+ + + H ++ ++ T Y PE + +D++S ++ ELI+G ++
Sbjct: 185 ACWYDE---HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 736 GANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766
+ ++ A+ I ++ G + LL
Sbjct: 241 HSYTKDDDHIAQ--II--ELLGELPSYLLRN 267
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 399
PS+ + L I L +L L L ++ +P+ + L + + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLS 425
P S L +L++L+V N+ +S
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 4/96 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
+ ++L N+ L L L L NS+ I F+G L + L DN
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDN 133
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
LT + L LREL+++NN + ++PS +
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 25/95 (26%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
++ ++L N+ ++P +LT L L EL + GN P F G L+ + + ++Q
Sbjct: 196 FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
++ ++ L +L EL + +N LS ++P L +
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 21/85 (24%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ V+ L ++ I L+SL L L N LT IP F LR + L +
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRN 156
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNN 422
N + + +P+L L +
Sbjct: 157 NPIESIPSYAFNRVPSLMRLDLGEL 181
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 5/87 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ + +S + I LSSL +LW+ + ++ I F G L ++L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAH 275
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNML 424
N L+ L L EL++ +N
Sbjct: 276 NNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 3/101 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ ++L + ++ + + L L L N L P+F + I L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
+ +L NL ++ N SKN +
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 19/86 (22%), Positives = 34/86 (39%), Gaps = 3/86 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
+ ++ +L + S ++ EL L GN L+ + L +++L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLS 425
L L +L LR L + NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 18/107 (16%), Positives = 41/107 (38%), Gaps = 7/107 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
PSI +H ++ N++ + ++L N +T + D ++ + L+ N
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154
Query: 399 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
++ + L L +Q N + + +K L+ + N
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 1/82 (1%)
Query: 364 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422
+ + +SL + +++ + L N L+ + L L L + +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 423 MLSGTVPSSLLSKNVVLNYAGN 444
+L T+ LS L+ N
Sbjct: 69 VLYETLDLESLSTLRTLDLNNN 90
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 14/84 (16%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 352 NLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 410
+L N +L S+ L N+++ G + I+L +N++T
Sbjct: 86 DLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGC 142
Query: 411 LPNLRELYVQNNMLSGTVPSSLLS 434
++ L ++ N + + L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 14/108 (12%), Positives = 28/108 (25%), Gaps = 2/108 (1%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+T I L + L I L +L L GN + R+ + +
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448
+ + +P+ + + L + L
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLS 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 12/96 (12%), Positives = 22/96 (22%), Gaps = 3/96 (3%)
Query: 347 HLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL 404
++L L L L G+ + R I Q +
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 405 PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 440
+ L + L S+ + L+
Sbjct: 353 DQVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELD 387
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 48/250 (19%), Positives = 90/250 (36%), Gaps = 73/250 (29%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 585
+ IG+G +G V + + +A+K + + KR E+ +L+R++H ++V
Sbjct: 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVV 115
Query: 586 Q----FLGYCQEEGRSV-LVYEFMH---------NGTLK-EH----LYGTLTHEQRINWI 626
+ + E+ + +V E L H LY L
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL--------- 166
Query: 627 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAV 680
G++Y+H+ + +HRDLK +N L+++ KV DFGL+ +
Sbjct: 167 ----------VGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 681 DGASHVSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVI 719
+ + +QLT ++ DV+S G I
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 720 LLELISGQEA 729
EL++ +
Sbjct: 274 FAELLNMIKE 283
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 57/223 (25%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 587
+ +GSG +G V + G ++A+K L + KR + E+ LL + H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGL 89
Query: 588 L-----GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKR 628
L ++ LV FM + L ++ +Y L
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML----------- 138
Query: 629 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 688
KG+ Y+H IIHRDLK N+ +++ K+ DFGL A S
Sbjct: 139 --------KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQADS 180
Query: 689 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
+ G V Y PE ++ ++ D++S G I+ E+I+G+
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 57/223 (25%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 587
+GSG +G V K G +AVK L+ + KR + E+ LL + H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGL 93
Query: 588 L-----GYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 628
L EE V LV M L +H +Y L
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----------- 142
Query: 629 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 688
+G++Y+H+ IIHRDLK SN+ +++ K+ DFGL A H +
Sbjct: 143 --------RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTAD 184
Query: 689 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 727
+ G V Y PE ++ +++ D++S G I+ EL++G+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 30/170 (17%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 587
+ KKIG G FG + GK L + +A+K+ S + E ++ + Q
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 640
+ + +V E + G E L+ + R L IA +E
Sbjct: 71 YYFGPCGKYNAMVLELL--GPSLEDLF---------DLCDRTFSLKTVLMIAIQLISRME 119
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVS-----DFGLSKFAVDGASH 685
Y+H+ +I+RD+K N L+ + DF L+K +D +
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 52/232 (22%), Positives = 96/232 (41%), Gaps = 58/232 (25%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQF 587
K +G GG G+V+ K +A+K + ++ K E+ ++ R+ H N+V+
Sbjct: 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKV 73
Query: 588 L-------------GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHE 620
E SV +V E+M G L +EH +Y L
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL--- 130
Query: 621 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFA 679
+G++Y+H+ V +HRDLK +N+ ++ + + K+ DFGL++
Sbjct: 131 ----------------RGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLAR-I 170
Query: 680 VDGASHVSSIVRGTVG---YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 727
+D + + Y P +S T D+++ G I E+++G+
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 3/96 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ ++L + ++ + L L L N L P+F + I L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 436
+ +L NL ++ N SKN
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 18/107 (16%), Positives = 41/107 (38%), Gaps = 7/107 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
PSI +H ++ N++ + ++L N +T + D ++ + L+ N
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154
Query: 399 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
++ + L L +Q N + + +K L+ + N
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 399
+ ++ +L + S ++ EL L GN L+ D + L +++L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLS 425
L L +L LR L + NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 16/89 (17%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 357 IPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 415
I + + +SL + +++ + L N L+ + L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 416 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
L + +N+L T+ LS L+ N
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNN 90
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 352 NLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 410
+L N +L S+ L N+++ G + I+L +N++T
Sbjct: 86 DLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGC 142
Query: 411 LPNLRELYVQNNMLSGTVPSSLLSK 435
++ L ++ N + + L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 9/77 (11%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+T I L + L I L +L L GN C LR ++ ++
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH--------CGTLRDFFSKNQRV 264
Query: 401 TGPLPSSLMNLPNLREL 417
++ L E
Sbjct: 265 QTVAKQTVKKLTGQNEE 281
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 25/188 (13%), Positives = 59/188 (31%), Gaps = 46/188 (24%)
Query: 530 LEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNS----------YQGKREFT 570
L+ G++Y ++ ++K+ + K
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 571 NEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKR 628
N+ L + +G+ + + LV G L + ++ +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSL--QSALDVSPK 153
Query: 629 --------LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKF 678
L++A +E+LH +H ++ + NI +D +++V + +G +
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 679 AVDGASHV 686
HV
Sbjct: 211 YCPSGKHV 218
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 2/86 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 399
PS+ + L I LS+L L L +L IP+ + L + L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLS 425
L+ P S L +L++L++ + +
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 23/96 (23%), Positives = 44/96 (45%), Gaps = 4/96 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
+ +++L + + L L L L N + I F+G +L + L DN
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDN 122
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
+LT + + L L+EL+++NN + ++PS +
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 9/109 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
++ ++L+ NL IP +LT L L EL L GN L+ I F G L+ + + +
Sbjct: 185 SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQS 241
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 444
Q+ ++ NL +L E+ + +N L+ +P L L ++ N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ ++ LS ++ I L++L L L N LT IP+ F L+ + L +
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145
Query: 398 NQLTGPLPSSLMNLPNLRELYVQ-NNMLS 425
N + + +P+LR L + LS
Sbjct: 146 NPIESIPSYAFNRIPSLRRLDLGELKRLS 174
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 5/87 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ + LS +L+ I L L +LW+ + + I F L I+L
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAH 264
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNML 424
N LT L +L +++ +N
Sbjct: 265 NNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 20/98 (20%), Positives = 38/98 (38%), Gaps = 6/98 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ +HL L + L++L L+L N+L +PD F +L + L
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
N+++ + L +L L + N ++ V
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 29/112 (25%), Positives = 52/112 (46%), Gaps = 9/112 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
++ ++L L +P D L +L L+L GN ++ +P+ F G L + L
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQ 186
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 449
N++ P + +L L LY+ N LS +P+ L+ L Y + L++
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQY---LRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 23/112 (20%), Positives = 43/112 (38%), Gaps = 11/112 (9%)
Query: 324 PCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIP 382
PC C +P +T + L +P + ++ ++L GN ++ P
Sbjct: 1 PCPGA------CVCYNEPKVTT-SCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAA 50
Query: 383 DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
F C +L I+ L N L ++ L L +L + +N +V +
Sbjct: 51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 23/98 (23%), Positives = 35/98 (35%), Gaps = 5/98 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
+ I L ++ + +L LWL N L I F+G L + L DN
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDN 90
Query: 399 -QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
QL P++ L L L++ L + L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRG 127
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 19/85 (22%), Positives = 35/85 (41%), Gaps = 5/85 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
++T + L ++ ++P L SL L L N + + F L ++L
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNN 422
N L+ +L L L+ L + +N
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDN 235
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
++ I ++ N+T IP L SL EL LDGN +T + G +L + L N
Sbjct: 171 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFN 226
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
++ SL N P+LREL++ NN L VP L
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 22/105 (20%), Positives = 43/105 (40%), Gaps = 9/105 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLT-GPIPD--FSGCPDLRIIHLE 396
++ + + +T + L+ ++ + L N L I + F G L I +
Sbjct: 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 397 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
D +T +P L P+L EL++ N ++ V ++ L L
Sbjct: 180 DTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAK 220
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 28/114 (24%), Positives = 43/114 (37%), Gaps = 8/114 (7%)
Query: 324 PCLPVPWSW-LQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 382
P +P C Q + V+ S L +P DL L L N +T I
Sbjct: 13 PEVPEIEPMGPVCPFRCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITE-IK 68
Query: 383 --DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
DF +L + L +N+++ P + L L LY+ N L +P +
Sbjct: 69 DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK 121
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 14/115 (12%), Positives = 40/115 (34%), Gaps = 12/115 (10%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 399
++ + LS +++ + + L L EL L+ N L + +++++L +N
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 400 LTG------PLPSSLMNLPNLRELYVQNNMLSGT-VPSSL---LSKNVVLNYAGN 444
++ P + + + +N + + S + +
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 21/108 (19%), Positives = 36/108 (33%), Gaps = 24/108 (22%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
P ++ L + +T D L +L L L N ++ I F+ L ++L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKN 110
Query: 399 QLT---GPLPSSLM------------------NLPNLRELYVQNNMLS 425
QL +P +L L + + + N L
Sbjct: 111 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 42/224 (18%), Positives = 84/224 (37%), Gaps = 48/224 (21%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 587
+ ++IG G FGV++ G L + +++A+K S + +E + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 640
+ QE +VLV + + G E L + R A+ ++
Sbjct: 72 YYFGQEGLHNVLVIDLL--GPSLEDLL---------DLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAK-----VSDFGLSKFAVDGASHV------SSI 689
+H +++RD+K N L+ + V DFG+ KF D +
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 690 VRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQ 727
+ GT Y+S ++ + + D+ + G + + + G
Sbjct: 178 LSGTA------RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 587
L +KIGSG FG +Y G + G+E+A+K+ + + E + + +
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTI 70
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
E +V+V E + G E L+ + + + + L +A+ IEY+H+
Sbjct: 71 RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHSKN- 125
Query: 648 PAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVRGTVGYLD 698
IHRD+K N L+ + + DFGL+K D +H + + GT Y
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 699 PEYYISQQLTDKSDVYSFGVILLELISGQ 727
++ + + + D+ S G +L+ G
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 7/109 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
+ V+ +S + + +L L + +LT +P LR ++L N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYN 258
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 444
++ S L L L+E+ + L+ V L+ VLN +GN
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN 306
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 6/97 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
++T + +S + + + L +L L + N L I FSG L + LE
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
LT +L +L L L +++ ++ +
Sbjct: 162 CNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 24/104 (23%), Positives = 45/104 (43%), Gaps = 6/104 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
S+ + L NLT +IP++ L+ L L+ L L ++ I D F L+++ +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISH 209
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
+ + + NL L + + L+ VP + V L +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRF 252
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 6/97 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
P + + L+ ++ + L +L L L N L IP F+G +L + + +
Sbjct: 56 PHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISE 113
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
N++ L +L NL+ L V +N L + S
Sbjct: 114 NKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 5/96 (5%)
Query: 340 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDN 398
+ K +P + + L L N + +F+ P L + L +N
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
++ P + NL NLR L +++N L +P + +
Sbjct: 67 IVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 5/88 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ ++LS ++ I L +L L E+ L G L + F G LR++++
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSG 305
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLS 425
NQLT S ++ NL L + +N L+
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 23/105 (21%), Positives = 38/105 (36%), Gaps = 4/105 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 399
P + + LS L I K+ L L++ N L P L+++ L N
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNH 312
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
L + + L LY+ +N + T+ S L + N
Sbjct: 313 LLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 7e-12
Identities = 22/107 (20%), Positives = 44/107 (41%), Gaps = 6/107 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+I +++ + +P + + L L L+ N L+ +P F P L + + +
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
N L + +L+ L + +N L+ V SL+ N + N
Sbjct: 157 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYN 202
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 9e-12
Identities = 21/109 (19%), Positives = 39/109 (35%), Gaps = 7/109 (6%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 397
++ + S ++ + + L L L N+LT P L + L
Sbjct: 208 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSY 263
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
N+L + + + L LY+ NN L + + VL+ + N
Sbjct: 264 NELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 17/102 (16%), Positives = 40/102 (39%), Gaps = 6/102 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ ++ + + +P+ L + L L+ + I F+ ++ +++
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 108
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 439
N + P N+P L L ++ N LS ++P + L
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 341 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
P +TV+ L +L+ ++P + L L + N+L I D F L+ + L
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLS 425
N+LT + SL +P+L V N+LS
Sbjct: 181 NRLTH-VDLSL--IPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 16/104 (15%), Positives = 33/104 (31%), Gaps = 4/104 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ +++S+ L + + +L L L N L + L ++L+ N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
L S L+ L + +N +L
Sbjct: 337 V-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA 377
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 7/86 (8%), Positives = 30/86 (34%), Gaps = 2/86 (2%)
Query: 357 IPSDLTKLSSLVELWLDGNSLTGP-IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 415
I S+L ++ +D + + + +I+ +++ + + L + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 416 ELYVQNNMLSGTVPSSLLSKNVVLNY 441
L + + + + + + +
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQK 103
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 32/122 (26%), Positives = 44/122 (36%), Gaps = 24/122 (19%)
Query: 335 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWLD 373
C S ++ +NLT ++P D T L + L +L LD
Sbjct: 4 CEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 374 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 433
LT + P L + L NQL LP LP L L V N L+ ++P L
Sbjct: 64 RAELTK-LQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 434 SK 435
Sbjct: 121 RG 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 5/100 (5%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHL 395
P + + LS L ++P L +L L + N LT +P G +L+ ++L
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYL 131
Query: 396 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
+ N+L P L P L +L + NN L+ +P+ LL+
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNG 170
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
P++TV+ +S LT ++P L L EL+L GN L +P + P L + L +
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 429
N LT L L NL L +Q N L T+P
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 22/107 (20%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+I +++ + +P + L L L+ N L+ +P F P L + + +
Sbjct: 93 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 150
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
N L + +L+ L + +N L+ V SL+ N + N
Sbjct: 151 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYN 196
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 4/88 (4%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 397
++ + S ++ + + L L L N+LT P L + L
Sbjct: 202 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSY 257
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLS 425
N+L + + + L LY+ NN L
Sbjct: 258 NELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 18/110 (16%), Positives = 43/110 (39%), Gaps = 9/110 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ ++ + + +P+ L + L L+ + I F+ ++ +++
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN---VVLNYAGN 444
N + P N+P L L ++ N LS ++P + L+ + N
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 151
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 5/95 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 399
+T++ L NLT + L LVE+ L N L F L +++ +N+
Sbjct: 226 VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
L L +P L+ L + +N L V +
Sbjct: 284 LVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 8/88 (9%)
Query: 341 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
P +TV+ L +L+ ++P + L L + N+L I D F L+ + L
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLS 425
N+LT + S +P+L V N+LS
Sbjct: 175 NRLTH-VDLS--LIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 11/100 (11%), Positives = 34/100 (34%), Gaps = 6/100 (6%)
Query: 340 QPSITVIHLSSKNLTGNIPSDLTK--LSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHL 395
Q + T ++ L++ + +++ +P + +++L
Sbjct: 18 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNL 76
Query: 396 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
D Q+ + +++LY+ N + +P +
Sbjct: 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 115
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 22/97 (22%), Positives = 39/97 (40%), Gaps = 7/97 (7%)
Query: 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 398
P P++ V+ LS +L ++ + + L L+LD NS+ + S L+ + L N
Sbjct: 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHN 349
Query: 399 QLTGPLPSSLMNLP-NLRELYVQNNMLSGTVPSSLLS 434
+SL L N+ V + + L
Sbjct: 350 DWD---CNSLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 8/104 (7%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++T + + ++T ++ + KL+ L +L N++T D S +L + + N+L
Sbjct: 42 ATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKL 97
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
T L + L L L N L+ + S LN A N
Sbjct: 98 TN-LD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARN 137
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 23/104 (22%), Positives = 39/104 (37%), Gaps = 9/104 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+T + S +T D+++ L L D N++T D + L + N+L
Sbjct: 170 TQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK--LDLNQNIQLTFLDCSSNKL 224
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
T + + L L N L+ + S LSK L+
Sbjct: 225 TE-IDVT--PLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 9/109 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ ++ + N+T + DL + L L N LT D + L N L
Sbjct: 191 KLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFDCSVNPL 245
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 449
T L S L L L+ L + + ++ + G + E
Sbjct: 246 T-ELDVS--TLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIKE 290
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 5/99 (5%)
Query: 346 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP 405
I+ ++ D+T + L L +T + D S P L ++L + +LT L
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELTE-LD 334
Query: 406 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
S + L+ L N + + A
Sbjct: 335 VS--HNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 16/105 (15%), Positives = 42/105 (40%), Gaps = 7/105 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ ++ + +T + DL++ LV L+L+ LT + D S L+ + + +
Sbjct: 297 TQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 445
S + +P L + +L + ++ + + ++
Sbjct: 352 QD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 407
++ + +L++L L +S+T + L + N +T L S
Sbjct: 25 AAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNITT-LDLS 82
Query: 408 LMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
NL L +N L+ + + L+K LN N
Sbjct: 83 --QNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTN 116
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 8/104 (7%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++T + S LT N+ +T L+ L L D N LT D S P L ++ N L
Sbjct: 85 TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL--DVSQNPLLTYLNCARNTL 139
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
T + S + L EL N + + ++ L+ + N
Sbjct: 140 T-EIDVS--HNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFN 180
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 19/104 (18%), Positives = 38/104 (36%), Gaps = 8/104 (7%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
P +T ++ + LT I D++ + L EL N D + L + N++
Sbjct: 127 PLLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKI 182
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
T + L L N ++ + + + L+ + N
Sbjct: 183 TE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 25/123 (20%), Positives = 35/123 (28%), Gaps = 25/123 (20%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+T + SS LT I D+T L+ L N LT D S L +H L
Sbjct: 212 IQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT--ELDVSTLSKLTTLHCIQTDL 266
Query: 401 T----GPLPS---------------SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
+ + L L Q ++ + S K V L
Sbjct: 267 LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYL 325
Query: 442 AGN 444
Sbjct: 326 NNT 328
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 8/106 (7%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
P + ++L++ LT + D++ + L L + P L + Q
Sbjct: 318 PKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQT 373
Query: 401 TGPLPSSLMNLPNLRELYVQNNML--SGTVPSSLLSKNVVLNYAGN 444
+P + +L + V ++L G + V + A N
Sbjct: 374 IT-MPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATN 417
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 399
+ V S++ T +IPS L +++ L L N +T D C +L+++ L+ ++
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
+ + +L +L L + +N LS ++ SS
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGP 96
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 9e-11
Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 3/97 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
++ + LS +T DL ++L L L + + I F L + L DN
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDN 84
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
L+ S L +L+ L + N +SL
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 5/111 (4%)
Query: 341 PSITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
++ + + + I D L+SL EL + SL D+ + L
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHL 181
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448
++ L L ++R L +++ L+ S L + V + +
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFR 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ V+ +S+ NL + L L EL++ N L +PD S P L ++ + NQL
Sbjct: 431 QTLEVLDVSNNNLD-SFSLFLP---RLQELYISRNKLKT-LPDASLFPVLLVMKISRNQL 485
Query: 401 TGPLPSSLMNLPNLRELYVQNN 422
L +L+++++ N
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 21/124 (16%)
Query: 341 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 398
PS+ + LS +L L L +L L + N+ +R ++L
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSST 420
Query: 399 QLT---GPLPSSL--------------MNLPNLRELYVQNNMLSGTVPSSLLSKN-VVLN 440
+ +P +L + LP L+ELY+ N L T+P + L +V+
Sbjct: 421 GIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMK 479
Query: 441 YAGN 444
+ N
Sbjct: 480 ISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 18/108 (16%), Positives = 38/108 (35%), Gaps = 7/108 (6%)
Query: 328 VPWSWLQCNSDPQPSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIP--DF 384
+ SW P S+ ++L + S L++L L + I DF
Sbjct: 89 LSSSWFG----PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 385 SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
+G L + ++ L SL ++ ++ L + + + +
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 13/88 (14%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 400
+I +H+ L ++ + + L + + ++ + + P L + L +N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 401 T---GPLPSSLMNLPNLRELYVQNNMLS 425
+ P+L+ L + N L
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 8e-09
Identities = 23/104 (22%), Positives = 37/104 (35%), Gaps = 4/104 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
++ V+ L S + L SL L L N L+ + F L+ ++L N
Sbjct: 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGN 108
Query: 399 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
+ S NL NL+ L + N + + LN
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 21/107 (19%), Positives = 43/107 (40%), Gaps = 12/107 (11%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ ++LSS + + + + +L L + N+L P L+ +++ N+L
Sbjct: 410 EKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS-FS--LFLPRLQELYISRNKL 463
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 444
LP + P L + + N L +VP + L+ + N
Sbjct: 464 KT-LPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 13/109 (11%), Positives = 38/109 (34%), Gaps = 8/109 (7%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 400
+ + S ++ + + ++ L + L + +S ++ I +E++++
Sbjct: 265 GLGDFNPSESDVVSELGK--VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSG-----TVPSSLLSKNVVLNYAGN 444
S +L +L L + N++ + L + N
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 11/89 (12%), Positives = 22/89 (24%), Gaps = 1/89 (1%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLE 396
I + L + LSS+ L L +L +
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228
Query: 397 DNQLTGPLPSSLMNLPNLRELYVQNNMLS 425
+ + S L L ++ + +
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 19/109 (17%), Positives = 49/109 (44%), Gaps = 5/109 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
S+T I L++ N+T ++ + + ++ +L ++ T SG +L + + +
Sbjct: 44 NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDV 100
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 447
T +L L +L L + ++ ++ + + L K ++ + N +
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 15/86 (17%), Positives = 37/86 (43%), Gaps = 2/86 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
S+T++ +S +I + + L + + L N I P+L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSG 426
+ + P L +LY + + G
Sbjct: 172 HD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 2/105 (1%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 399
++ + + K++T + +L+ L+SL L + ++ + + P + I L N
Sbjct: 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ L LP L+ L +Q + + K L
Sbjct: 148 AITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 33/93 (35%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQ 399
+ + +S LT IP DL +L EL LD N + I L + L NQ
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
+ SL LP LREL++ NN LS VP+ L
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 26/113 (23%), Positives = 46/113 (40%), Gaps = 7/113 (6%)
Query: 334 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLR 391
C + V+ S L +P +++ L L N ++ + DF G L
Sbjct: 26 MCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISE-LRKDDFKGLQHLY 81
Query: 392 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ L +N+++ + L L++LY+ N L +P +L S V L N
Sbjct: 82 ALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDN 133
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 17/91 (18%), Positives = 36/91 (39%), Gaps = 10/91 (10%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-------GPIPDFSGCPDLRII 393
P++ +HL + L+ +P+ L L L ++L N++T P+ I
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 394 HLEDNQLTGPL--PSSLMNLPNLRELYVQNN 422
L +N + P++ + + + N
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 24/110 (21%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
P T++ L + +++ D L L L L N ++ I + FS L+ +++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKN 112
Query: 399 QLT---GPLPSSL------------------MNLPNLRELYVQNNMLSGT 427
L LPSSL L N+ + + N L +
Sbjct: 113 HLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 17/92 (18%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 399
+ + L + I + L+ L +L EL LD N L+ L++++L N
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNN 275
Query: 400 LTG------PLPSSLMNLPNLRELYVQNNMLS 425
+T + + + NN +
Sbjct: 276 ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 31/111 (27%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 340 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 398
QP + L S L P +LS L + +D L +PD L + L N
Sbjct: 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARN 137
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 449
L LP+S+ +L LREL ++ +P L S + + G +NL
Sbjct: 138 PLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 22/112 (19%), Positives = 46/112 (41%), Gaps = 7/112 (6%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED-NQL 400
++ + L + ++P+ + L +L L + + L+ P P L + L L
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL 242
Query: 401 TGPLPSSLMNLPNLRELYVQN-NMLSGTVPSSL--LSKNVVLNYAGNINLHE 449
P L+ L +++ + L T+P + L++ L+ G +NL
Sbjct: 243 RN-YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 18/95 (18%), Positives = 29/95 (30%), Gaps = 4/95 (4%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWL-DGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
+ + L N P + L L L D ++L +P L + L
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCV 288
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
LPS + LP + V + L +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 18/119 (15%), Positives = 40/119 (33%), Gaps = 12/119 (10%)
Query: 342 SITVIHLSSKNLTGNIPSDL---------TKLSSLVELWLDGNSLTGPIPDFSGCPDLRI 392
+ + + + +P L L +L L L+ + + +L+
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKS 210
Query: 393 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 449
+ + ++ L+ L ++ +LP L EL ++ P + L NL
Sbjct: 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 26/124 (20%), Positives = 46/124 (37%), Gaps = 12/124 (9%)
Query: 331 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS--LVELWLDGNSLTGPIPD-FSGC 387
+W Q NS+ + + + + L L + V L L L PD
Sbjct: 49 AWRQANSN---NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRL 103
Query: 388 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 445
L+ + ++ L LP ++ L L + N L +P+S+ L++ L+
Sbjct: 104 SHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161
Query: 446 NLHE 449
L E
Sbjct: 162 ELTE 165
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-09
Identities = 20/115 (17%), Positives = 42/115 (36%), Gaps = 15/115 (13%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED-NQ 399
+ + + + L +P + + + L L L N L +P + LR + + +
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPE 162
Query: 400 LT--------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444
LT L NL+ L ++ + ++P+S+ L L +
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 33/179 (18%), Positives = 64/179 (35%), Gaps = 28/179 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEI------AVKVLTSNSYQGKREFTNEVTLLSRIHHRN 583
+ IG GGFG +Y + + + VKV S++ E ++
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL-KFYQRAAKPEQIQ 97
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEH------LYGT-LTHEQRINWIKR-------L 629
+ G +H+ K + +G+ L ++ + L
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL--QKIYEANAKRFSRKTVL 155
Query: 630 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVDGASHV 686
+++ +EY+H +H D+K+SN+LL+ +V D+GL+ H
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QF 587
L +KIGSG FG +Y G ++ +E+A+K+ + + E + + +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNV 68
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 640
+ E +VLV + + G E L+ N+ R L +A+ +E
Sbjct: 69 RWFGVEGDYNVLVMDLL--GPSLEDLF---------NFCSRKLSLKTVLMLADQMINRVE 117
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVR 691
++H+ +HRD+K N L+ RA + DFGL+K D ++H + +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 692 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
GT Y ++ + + + D+ S G +L+ + G
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 2e-11
Identities = 38/268 (14%), Positives = 73/268 (27%), Gaps = 68/268 (25%)
Query: 515 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--------TSNSYQGK 566
+HC ++ +KIG G FG V+ +A+K++ + +
Sbjct: 14 SHCLPTEKLQRC-----EKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 567 REFTNEVTLLSRIH---------HRNLVQFLGYCQEEGRS-------------------- 597
E E+ + + + +G
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 598 ----------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+V EF G E + + + I +
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEA--S 180
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
HRDL N+LL K K+ K + + + V +D Y +S+
Sbjct: 181 LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL------QVSIID--YTLSRLE 232
Query: 708 TDKSDVYSFGVILLELISGQEAISNEKF 735
D V+ + +L +G + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIY 260
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 23/99 (23%), Positives = 43/99 (43%), Gaps = 6/99 (6%)
Query: 344 TVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 400
+ LS +L I S+ + +L L L N L + + FS L ++ L +N +
Sbjct: 67 HSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHI 124
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 439
++ ++ L++LY+ N +S P L+ L
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 7/99 (7%)
Query: 341 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 396
++ LS NL+ + ++ T+L++L L L N L I F P+LR + L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLS 96
Query: 397 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
N L +L L L + NN + V +
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED 134
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 12/116 (10%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
P++ + LSS +L + + L +L L L N + + F L+ ++L
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQ 145
Query: 398 NQLTGPLP----SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 449
NQ++ P LP L L + +N L +P + L K G + LH
Sbjct: 146 NQISR-FPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNG-LYLHN 198
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 25/112 (22%), Positives = 48/112 (42%), Gaps = 9/112 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPD------FSGCPDLRI 392
P + ++ L+ + + D ++ SL +L+L N L F G L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 393 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
++L N L P +L LR L + +N L+ + L + +L+ + N
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 6e-11
Identities = 22/104 (21%), Positives = 34/104 (32%), Gaps = 3/104 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
+ + LS + S L L L L I F P+LRI+ L +
Sbjct: 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLS-GTVPSSLLSKNVVLNY 441
++ P + L +L EL + LS + L
Sbjct: 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 8e-10
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 2/97 (2%)
Query: 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLED 397
+ S+ + LS + L L L L N + F G +L++++L
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
N L S+ LP + + +Q N ++ +
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK 359
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 7/99 (7%)
Query: 345 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGP 403
+ NLT +P L ++ L L N + F L+++ L
Sbjct: 8 IAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 404 L-PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
+ + NLPNLR L + ++ + + L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFE 101
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 8e-09
Identities = 30/110 (27%), Positives = 42/110 (38%), Gaps = 9/110 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTK-----LSSLVELWLDGNSLTG-PIPDFSGCPDLRIIH 394
PS+ + L L ++L LS L L+L+ N L P FS LR +
Sbjct: 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLS 510
Query: 395 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
L N+LT + L NL L + N L + VL+ N
Sbjct: 511 LNSNRLTVLSHNDL--PANLEILDISRNQLL-APNPDVFVSLSVLDITHN 557
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 23/120 (19%), Positives = 48/120 (40%), Gaps = 2/120 (1%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 399
+ V++L+ + L +L L L N L +F G P + I L+ N
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNI 459
+ + L L+ L +++N L+ T+ ++ L+ + L + A +++
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHL 408
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 22/115 (19%), Positives = 33/115 (28%), Gaps = 9/115 (7%)
Query: 341 PSITVIHLSSKNLTGNI--PSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLE 396
+ + L L+ + L +L L L N + P F L+ I
Sbjct: 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 397 DNQLTGPLPSSLMNL--PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 449
NQ+ L L L + N L V +N N+ L
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK---CMNPFRNMVLEI 208
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 23/100 (23%), Positives = 43/100 (43%), Gaps = 9/100 (9%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + L LT + + S+ +++L GN L +P + +IHL +N+L
Sbjct: 362 EKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKIN--LTANLIHLSENRL 413
Query: 401 TG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 439
+ L+ +P+L+ L + N S S+N L
Sbjct: 414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 15/116 (12%), Positives = 36/116 (31%), Gaps = 22/116 (18%)
Query: 340 QPSITVIHLSSKNLTGNIPSDLTKLS------SLVELWLDGNSLTGPIPD---------- 383
+++ L++ +L + D K L L + GN T I
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 384 ---FSGCPDLRIIHLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPSSLLS 434
+ + + P ++ L ++R L + + + ++ S +
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFE 287
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ + + + ++ ++ + L LS L L D N ++ I + P+L +HL++NQ+
Sbjct: 151 TNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 446
+ S L N NL + + N ++ P + VV N +
Sbjct: 208 SDV--SPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
SI + L+S +T P L LS+L L+LD N +T I +G +L+ + + + Q+
Sbjct: 107 QSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ + L NL L L +N +S P + L + ++ N
Sbjct: 164 SDL--TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 25/104 (24%), Positives = 51/104 (49%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ V++L +T NI S L L++L L + ++ + + L + +DN++
Sbjct: 129 SNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ S L +LPNL E++++NN +S P + S ++
Sbjct: 186 SDI--SPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
IT + +T I + L++L+ L L N +T + + + L N L
Sbjct: 41 DGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
S++ L +++ L + + ++ P + LS VL N
Sbjct: 98 KNV--SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 14/86 (16%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 359 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418
L++ +++ +++T + + + + +T + L NL L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLE 69
Query: 419 VQNNMLSGTVPSSLLSKNVVLNYAGN 444
+++N ++ P L+K L +GN
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGN 95
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 17/100 (17%), Positives = 39/100 (39%), Gaps = 5/100 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+T + ++ +I S L L +L+E+ L N ++ + + +L I+ L + +
Sbjct: 173 SKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 440
T NL V+ + P+++ +
Sbjct: 230 TNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYAS 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 36/185 (19%), Positives = 64/185 (34%), Gaps = 43/185 (23%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL--SRIHHRNLVQ 586
L KKIGSGGFG++Y ++ A V+ K E+ L + + R
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVV-------KVEYQENGPLFSELKFYQR---- 89
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-----------------INWIKR- 628
+ + + + + G + G + R
Sbjct: 90 -VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF 148
Query: 629 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVD 681
L++ +EY+H +H D+K++N+LL +V +D+GLS
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 682 GASHV 686
+H
Sbjct: 206 NGNHK 210
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 27/114 (23%), Positives = 44/114 (38%), Gaps = 6/114 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
++ + LS+ +T SDL + +L L L N + I + FS L + L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYN 110
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHE 449
L+ S L +L L + N +SL L+K +L +
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 24/132 (18%), Positives = 40/132 (30%), Gaps = 30/132 (22%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLT------------------ 378
S+ + LS L+ N+ S LSSL L L GN
Sbjct: 97 SSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 379 -------GPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 429
I F+G L + ++ + L P SL ++ N+ L + +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLL 214
Query: 430 SSLLSKNVVLNY 441
+ +
Sbjct: 215 EIFVDVTSSVEC 226
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 16/114 (14%), Positives = 35/114 (30%), Gaps = 3/114 (2%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHL 395
+ ++ + + + I L+ L EL +D + L ++ + L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 396 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 449
Q L + ++ L +++ L T S LS +
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLD-TFHFSELSTGETNSLIKKFTFRN 258
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 7/93 (7%)
Query: 332 WLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR 391
L+ + H S L+ + L K + + + SL + + L
Sbjct: 228 ELRDTD-----LDTFHFSE--LSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLL 280
Query: 392 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424
+ NQL L +L+++++ N
Sbjct: 281 ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 13/107 (12%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSL---------TGPIPDFSGC 387
+++ + L K + SS+ L L L TG
Sbjct: 195 KSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253
Query: 388 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
R + + D L + L + L EL N L +VP +
Sbjct: 254 FTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFD 298
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 23/117 (19%), Positives = 42/117 (35%), Gaps = 10/117 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
PS + L +L IPS + L ++ +++ + + F + I + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 398 NQ-LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGNINLHE 449
+ LT P +L LP L+ L + N L P +L N +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 13/111 (11%)
Query: 334 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLR 391
+C+ + ++ K++ IPS S L L L IP FS P++
Sbjct: 9 ECHQE-----EDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRT-IPSHAFSNLPNIS 58
Query: 392 IIHLEDN-QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
I++ + L S NL + + ++N + L + +L +
Sbjct: 59 RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 21/113 (18%), Positives = 40/113 (35%), Gaps = 9/113 (7%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSS-LVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 396
++ ++ +IP + L + + L L N T + F+G L ++L
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNG-TKLDAVYLN 187
Query: 397 DNQ-LTGPLPSSLMNLPN-LRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 447
N+ LT + + + L V ++ +PS L L L
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 19/102 (18%), Positives = 36/102 (35%), Gaps = 5/102 (4%)
Query: 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 402
++ S L ++P DL+ L + N ++ D LRI+ + N++
Sbjct: 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 403 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
S L L + +N L + L+ + N
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDLSFN 100
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 22/93 (23%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 396
S+ + +S +++ + + SL+ L + N LT I P ++++ L
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-CLPPRIKVLDLH 429
Query: 397 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 429
N++ +P ++ L L+EL V +N L +VP
Sbjct: 430 SNKIKS-IPKQVVKLEALQELNVASNQLK-SVP 460
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 20/109 (18%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD----LRIIHLE 396
+ S+ LT + + L+ L L L N L + + L+ + +
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDIS 382
Query: 397 DNQLTGPLPSSL-MNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
N ++ +L L + +N+L+ T+ L + VL+ N
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN 431
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 19/102 (18%), Positives = 35/102 (34%), Gaps = 4/102 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
T++++S ++ SD+ LS L L + N + F +L + L N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
L + NL+ L + N L +
Sbjct: 81 LVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 12/85 (14%), Positives = 27/85 (31%), Gaps = 1/85 (1%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 400
++++ + S S++ + + S + +N L
Sbjct: 277 ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL 336
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLS 425
T + + +L L L +Q N L
Sbjct: 337 TDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 9/96 (9%)
Query: 327 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 386
SW S+ +++SS LT I L + L L N +
Sbjct: 392 KGDCSWT-------KSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVK 442
Query: 387 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422
L+ +++ NQL L +L+++++ N
Sbjct: 443 LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 16/105 (15%), Positives = 27/105 (25%), Gaps = 5/105 (4%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHL 395
+ + LS L I +L L L N+ +F L+ + L
Sbjct: 66 KFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 396 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 440
L + +L + L V L +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
P + V+ LS + I LS L L L GN + + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVE 109
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLS 425
L + +L L+EL V +N++
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 18/92 (19%), Positives = 37/92 (40%), Gaps = 8/92 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLED 397
S+ + NL ++ + L +L EL + N + +P+ FS +L + L
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 398 NQLTGPLPSSLMNLPNLR----ELYVQNNMLS 425
N++ + L L + L + N ++
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 19/115 (16%), Positives = 42/115 (36%), Gaps = 13/115 (11%)
Query: 341 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLE- 396
++ ++++ + + + L++L L L N + D + +++L
Sbjct: 124 KTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 397 ---DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448
N + + L+EL + N L +VP + + L I LH
Sbjct: 183 DLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLH 232
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 10/89 (11%)
Query: 341 PSITVIHLSSKNLTGNIPSD----LTKLSSL-VELWLDGNSLTGPIPD--FSGCPDLRII 393
++ + LSS + +I L ++ L + L L N + I F L+ +
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE-IRLKEL 205
Query: 394 HLEDNQLTGPLPSSLMNLPNLRELYVQNN 422
L+ NQL L +L+++++ N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 14/93 (15%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT 401
+ + + + L +L EL+++ + G +LR + + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 402 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
P + P L L + N L ++ +
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ 101
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 15/115 (13%)
Query: 323 DPCLPVPWSWLQCNSD----------PQPSITVIHLSSKNLTGNIPS-DLTKLSSLVELW 371
D C P S L+C D ++T +++ ++ ++ DL L L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 372 LDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424
+ + L + F P L ++L N L L + +L+EL + N L
Sbjct: 63 IVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 28/111 (25%), Positives = 45/111 (40%), Gaps = 9/111 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ + L+ + I + L+ L++L L N L I F L ++ L
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448
N + S + LPNL+EL + N L +VP + + L I LH
Sbjct: 357 NHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLH 403
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 3/104 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
+ + LS ++ + ++L L L ++ + I + F G L I+ L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNML-SGTVPSSLLSKNVVLNY 441
Q + L NL L + L + + L
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 23/85 (27%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 397
+ ++LS N G+I S + L L L L N + + D F G P+L+ + L+
Sbjct: 323 THLLKLNLSQ-NFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDT 380
Query: 398 NQLTGPLPSSLMNLPNLRELYVQNN 422
NQL L +L+++++ N
Sbjct: 381 NQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 22/118 (18%), Positives = 43/118 (36%), Gaps = 7/118 (5%)
Query: 338 DPQPSITVIHLSSKNLTG-NIPSDL-TKLSSLVELWLDGNSLT--GPIPDFSGCPDLRII 393
+ ++ V+ L+ NL G + + L+SL L L N++ P F ++
Sbjct: 100 NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL 159
Query: 394 HLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 449
L N++ L+N + L + + L + L N N ++
Sbjct: 160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNPFKNTSITT 216
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + +S LT ++P + L EL + GN LT +P L + + NQL
Sbjct: 221 SGLKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQL 273
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 449
T LP SL++L + + ++ N LS +L Y+G I +
Sbjct: 274 TR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 26/97 (26%), Positives = 40/97 (41%), Gaps = 12/97 (12%)
Query: 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 403
V+++ LT +P L + + L + N+LT +P P+LR + + NQLT
Sbjct: 43 AVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLTS- 95
Query: 404 LPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 436
LP L L L +PS L + N
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGN 131
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 12/92 (13%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + + LT ++P + L EL + N L +P +L + +N+L
Sbjct: 161 SELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLAS-LPTLPS--ELYKLWAYNNRL 213
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
T LP+ L+EL V N L+ ++P
Sbjct: 214 T-SLPALP---SGLKELIVSGNRLT-SLPVLP 240
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 30/120 (25%), Positives = 48/120 (40%), Gaps = 33/120 (27%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 383
P + + +S LT ++P L S L +LW+ GN LT +P
Sbjct: 81 PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LPV 138
Query: 384 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-------LSKN 436
L+ + + DNQL LP+ L +L+ NN L+ ++P +S N
Sbjct: 139 LPP--GLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPMLPSGLQELSVSDN 191
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 14/100 (14%), Positives = 27/100 (27%), Gaps = 9/100 (9%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + + LT +P L LSS + L+GN L+ ++ +
Sbjct: 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA--LREITSAPGYSGPI 317
Query: 401 T------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
P L ++ P+
Sbjct: 318 IRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH 357
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 51/262 (19%), Positives = 92/262 (35%), Gaps = 80/262 (30%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 590
+K+G G F V+ ++ K +A+KV+ S + + +E+ LL + + +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDP------ 95
Query: 591 CQEEGRSVLVY---EFMHNGTLKEH-------LYGTLTHEQRINWIKRL------EIAED 634
+ R ++V +F +G H L L + + L +I +
Sbjct: 96 -NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 635 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------------- 662
+G++YLHT C IIH D+K NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 663 -----------------DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
+ ++ K++D G A H + ++ T Y E I
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGN---ACWVHKHFTEDIQ-TRQYRSLEVLIGS 268
Query: 706 QLTDKSDVYSFGVILLELISGQ 727
+D++S + EL +G
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 24/111 (21%), Positives = 41/111 (36%), Gaps = 26/111 (23%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ +I + + +L +P SL + N L +P+ P L I+ ++N L
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSL 207
Query: 401 TGPLPSSLMNL-------------------PNLRELYVQNNMLSGTVPSSL 432
LP ++L P L +Y NN+L T+P
Sbjct: 208 KK-LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLP 256
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 28/130 (21%), Positives = 42/130 (32%), Gaps = 40/130 (30%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 383
P + + S +LT +P L L L + N L +P+
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LPE 148
Query: 384 FSGCPDLRIIHLEDNQLTGPLPSSLMNL-------------------PNLRELYVQNNML 424
L+II +++N L LP +L P L +Y NN L
Sbjct: 149 LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 207
Query: 425 SGTVPSSLLS 434
+P LS
Sbjct: 208 K-KLPDLPLS 216
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 9e-09
Identities = 27/99 (27%), Positives = 40/99 (40%), Gaps = 11/99 (11%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 401
S+ I + L +L L L ++ D N L +PD P L +++ DN LT
Sbjct: 216 SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPD--LPPSLEALNVRDNYLT 270
Query: 402 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 436
LP +L L + LS +P +L S N
Sbjct: 271 D-LPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSN 307
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 12/92 (13%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
P++ ++ SS + ++ SL EL + N L +P + P L + N L
Sbjct: 297 PNLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIE-LP--ALPPRLERLIASFNHL 349
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
+P NL++L+V+ N L P
Sbjct: 350 AE-VPEL---PQNLKQLHVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 24/113 (21%), Positives = 36/113 (31%), Gaps = 22/113 (19%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLS-------------SLVELWLDGNSLTGPIPDFSGC 387
S T + + N P + EL L+ L+ +P+
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL--P 90
Query: 388 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 436
P L + N LT LP +L +L LS +P L +S N
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-LPPLLEYLGVSNN 141
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 9e-07
Identities = 26/109 (23%), Positives = 46/109 (42%), Gaps = 23/109 (21%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
PS+ +++S+ L +P+ +L L N L +P +L+ +H+E N L
Sbjct: 317 PSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VP--ELPQNLKQLHVEYNPL 369
Query: 401 TG--PLPSSLMNL-------------PNLRELYVQNNMLSGTVPSSLLS 434
+P S+ +L NL++L+V+ N L P S
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES 417
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 19/99 (19%), Positives = 31/99 (31%), Gaps = 20/99 (20%)
Query: 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG--------------CPDLRII 393
S NLT +P + + S E + + P +G +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 394 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
L + L+ LP P+L L N L+ +P
Sbjct: 77 ELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 10/79 (12%), Positives = 26/79 (32%), Gaps = 6/79 (7%)
Query: 347 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 406
L + +P +L +L ++ N L PD + + + ++ P
Sbjct: 381 DLRMNSHLAEVPE---LPQNLKQLHVETNPLRE-FPDIPE--SVEDLRMNSERVVDPYEF 434
Query: 407 SLMNLPNLRELYVQNNMLS 425
+ L + +++
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 26/106 (24%), Positives = 38/106 (35%), Gaps = 20/106 (18%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
P +T I+ + L +P SL L + N LT L + + L
Sbjct: 237 PFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 292
Query: 401 TGPLPSSLMNL--------------PNLRELYVQNNMLSGTVPSSL 432
+ LP +L L P+L EL V NN L +P+
Sbjct: 293 S-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP 336
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 6e-10
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + L ++ +I + L L L L+L N +T I S L + LEDNQ+
Sbjct: 109 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ L L L+ LY+ N +S + L VL
Sbjct: 166 SDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQ 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 3e-09
Identities = 26/104 (25%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ + L + ++ S L L L L L+ N ++ I P L ++L +N++
Sbjct: 87 KNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
T + L L L L +++N +S VP + L+K L + N
Sbjct: 144 TDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
P + ++L + +T +I + L++L+ L L L+ N ++ I +G L+ ++L N +
Sbjct: 131 PQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 446
+ +L L NL L + + + S VV N N +
Sbjct: 188 SDL--RALAGLKNLDVLELFSQECLNKPINH-QSNLVVPNTVKNTD 230
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+L K++T + +L+S+ ++ + + + + P++ + L N+L
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
T L NL NL L++ N + L K L+ N
Sbjct: 78 TDI--KPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHN 119
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 14/86 (16%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 359 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418
+ ++ L S+T + + I ++ + + LPN+ +L+
Sbjct: 15 FPDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLF 71
Query: 419 VQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ N L+ P + L L N
Sbjct: 72 LNGNKLTDIKPLTNLKNLGWLFLDEN 97
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 16/107 (14%)
Query: 334 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCP 388
+C + T + S++ L +IP EL L+ N T F P
Sbjct: 8 KCRCEG----TTVDCSNQKLNKIPEHIPQYTA------ELRLNNNEFTVLEATGIFKKLP 57
Query: 389 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
LR I+ +N++T + + E+ + +N L V +
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKG 103
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 23/91 (25%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDN 398
P + I+ S+ +T +I S + E+ L N L F G L+ + L N
Sbjct: 57 PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN 115
Query: 399 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 429
++T S + L ++R L + +N ++ TV
Sbjct: 116 RITCVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 394
+ + I L+S L N+ + L SL L L N +T + + F G +R++
Sbjct: 78 EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLS 135
Query: 395 LEDNQLTGPLPSSLMNLPNLRELYVQNN 422
L DNQ+T P + L +L L + N
Sbjct: 136 LYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + L ++ +I + L L L L+L N +T I S L + LEDNQ+
Sbjct: 112 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ L L L+ LY+ N +S + L VL
Sbjct: 169 SDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 26/106 (24%), Positives = 50/106 (47%), Gaps = 6/106 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
P + ++L + +T +I + L++L+ L L L+ N ++ I +G L+ ++L N +
Sbjct: 134 PQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 190
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 446
+ +L L NL L + + P + S VV N N +
Sbjct: 191 SDL--RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTD 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+L K++T + +L+S+ ++ + + + + P++ + L N+L
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 80
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
T L NL NL L++ N + L K L+ N
Sbjct: 81 TDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 22/85 (25%), Positives = 47/85 (55%), Gaps = 5/85 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
SI I ++ ++ ++ + L ++ +L+L+GN LT I + +L + L++N++
Sbjct: 46 NSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLS 425
SSL +L L+ L +++N +S
Sbjct: 103 KDL--SSLKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 7/101 (6%)
Query: 348 LSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 403
L S+ +T P + ++ L S+T + + I ++ +
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKS- 60
Query: 404 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ LPN+ +L++ N L+ P + L L N
Sbjct: 61 -VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDEN 100
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 23/86 (26%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+T + LS L +P L L L L N+L + + P L+ + L +N+L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520
Query: 401 TG-PLPSSLMNLPNLRELYVQNNMLS 425
L++ P L L +Q N L
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 2e-08
Identities = 31/115 (26%), Positives = 48/115 (41%), Gaps = 9/115 (7%)
Query: 334 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRII 393
+ V+HL+ K+LT + L +L + L L N L P + L ++
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVL 491
Query: 394 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGN 444
DN L + + NLP L+EL + NN L + + V+LN GN
Sbjct: 492 QASDNALEN-VD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 21/82 (25%), Positives = 33/82 (40%), Gaps = 7/82 (8%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGP--IPDFSGCPDLRIIHLEDN 398
+ V+ S L N+ + L L EL L N L I CP L +++L+ N
Sbjct: 486 RCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
Query: 399 QLTG--PLPSSLMN-LPNLREL 417
L + L LP++ +
Sbjct: 544 SLCQEEGIQERLAEMLPSVSSI 565
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 582
K IG G FG V K + +A+K++ + Q E+ +L + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNT 158
Query: 583 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638
N++ L + +E + +K++ + + + +++ A +
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFS----LPLVRK--FAHSILQC 212
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGY 696
++ LH IIH DLK NILL + R+ KV DFG S + V + ++ + Y
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFY 265
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
PE + + D++S G IL EL++G
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 1/76 (1%)
Query: 350 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 409
S++ G + + L L LT I + L+ + L DN+++G L
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRVSGGLEVLAE 85
Query: 410 NLPNLRELYVQNNMLS 425
PNL L + N +
Sbjct: 86 KCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 336 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFS-GCPDLRIIH 394
+D + + + LT +I ++L KL+ L +L L N ++G + + CP+L ++
Sbjct: 37 LTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94
Query: 395 LEDNQLTGPL-PSSLMNLPNLRELYVQNN 422
L N++ L L NL+ L + N
Sbjct: 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 30/129 (23%), Positives = 52/129 (40%), Gaps = 16/129 (12%)
Query: 332 WLQCNS---------DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG-P 380
L+ N+ P + I LS+ ++ + D L SL L L GN +T P
Sbjct: 38 RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELP 96
Query: 381 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 440
F G L+++ L N++ + +L NL L + +N L T+ S +
Sbjct: 97 KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQ 155
Query: 441 YAGNINLHE 449
++L +
Sbjct: 156 T---MHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 13/92 (14%)
Query: 349 SSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGP 403
K LT N+P +T E+ L+ N++ IP FS LR I L +NQ++
Sbjct: 19 RGKGLTEIPTNLPETIT------EIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISEL 71
Query: 404 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
P + L +L L + N ++ +P SL
Sbjct: 72 APDAFQGLRSLNSLVLYGNKIT-ELPKSLFEG 102
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 22/88 (25%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
+IT I L + P + L + L N ++ + F G L + L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90
Query: 399 QLTGPLPSSLM-NLPNLRELYVQNNMLS 425
++T LP SL L +L+ L + N ++
Sbjct: 91 KITE-LPKSLFEGLFSLQLLLLNANKIN 117
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 394
S+ + L +T +P L L SL L L+ N + + F +L ++
Sbjct: 77 QGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLS 134
Query: 395 LEDNQLTGPLPSSLMNLPNLRELYVQNN 422
L DN+L + L ++ +++ N
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 17/106 (16%), Positives = 35/106 (33%), Gaps = 6/106 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
++ + L + L + L L +L L + N L I L ++ L N++
Sbjct: 106 ACLSRLFLDNNELR-DT-DSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEI 162
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 446
T L L + + + P + + N + +
Sbjct: 163 TNT--GGLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPD 205
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 352 NLTGNIPSDLTKLS--SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 409
++ N +L + L L+LD N L +L I+ + +N+L L
Sbjct: 91 SVNRNRLKNLNGIPSACLSRLFLDNNELRD-TDSLIHLKNLEILSIRNNKLKSI--VMLG 147
Query: 410 NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
L L L + N ++ T + L K ++ G
Sbjct: 148 FLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 27/123 (21%), Positives = 49/123 (39%), Gaps = 22/123 (17%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ + + N+ ++ + + ++L EL L N ++ + L + + N+L
Sbjct: 41 SGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRL 97
Query: 401 TG--PLP-----------------SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
+P SL++L NL L ++NN L V LSK VL+
Sbjct: 98 KNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDL 157
Query: 442 AGN 444
GN
Sbjct: 158 HGN 160
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 16/86 (18%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 359 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418
L++ V+ L S+T + ++ + +++ + + + NL+EL+
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELH 69
Query: 419 VQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ +N +S P L+K L+ N
Sbjct: 70 LSHNQISDLSPLKDLTKLEELSVNRN 95
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 17/101 (16%), Positives = 27/101 (26%), Gaps = 21/101 (20%)
Query: 347 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT--- 401
+ + +G + L L L NSL L ++L L
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 402 GPLPSSL----------------MNLPNLRELYVQNNMLSG 426
LP+ L LP + L ++ N
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 18/109 (16%), Positives = 36/109 (33%), Gaps = 8/109 (7%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPD----LRIIHL 395
P + V+ ++ + + +L L L N G + CP L+++ L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 396 EDNQLT---GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
+ + G + L+ L + +N L + LN
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 22/115 (19%), Positives = 42/115 (36%), Gaps = 4/115 (3%)
Query: 323 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 382
+PC S SDP+P + + L L +D + G
Sbjct: 4 EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62
Query: 383 DFSGCPDLRIIHLEDNQLTGPLPSS---LMNLPNLRELYVQNNMLSGTVPSSLLS 434
D L+ + + ++ + ++ + L+EL ++N ++GT P LL
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 14/63 (22%), Positives = 22/63 (34%), Gaps = 4/63 (6%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
+ ++LS L +P L + L L L N L P P + + L+ N
Sbjct: 253 SQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPF 308
Query: 401 TGP 403
Sbjct: 309 LDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 11/110 (10%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKL---SSLVELWLDGNSLTGPIPD---FSGCPDLRIIHL 395
S+ + + + + I ++ S L EL L+ +TG P + PDL I++L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 396 EDNQLTG--PLPSSLMNL--PNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
+ + L P L+ L + + L+
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPALST 177
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 24/139 (17%), Positives = 47/139 (33%), Gaps = 25/139 (17%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD- 383
+ I+ + LT +P T L SL L + N L +P
Sbjct: 141 LLEYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLLES-LPAV 198
Query: 384 FSGCPDLR----IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 439
+N++T +P ++++L + +++N LS + SL +
Sbjct: 199 PVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP 257
Query: 440 NYAGNINLHEGGRGAKHLN 458
+Y G G ++
Sbjct: 258 DYHGPRIYFSMSDGQQNTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 26/109 (23%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 383
P ITV+ ++ L ++P L +SL L +D N LT +P+
Sbjct: 80 PQITVLEITQNALI-SLPELPASLEYLDACDNRLSTLPELPASLKHLDVDNNQLTM-LPE 137
Query: 384 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
L I+ ++NQLT LP +L L V+NN L+ +P
Sbjct: 138 LPA--LLEYINADNNQLTM-LPEL---PTSLEVLSVRNNQLT-FLPELP 179
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 11/91 (12%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 401
+ + L+ NL+ ++P +L + L + N+L +P+ L + DN+L+
Sbjct: 60 QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA--SLEYLDACDNRLS 113
Query: 402 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
LP +L+ L V NN L+ +P
Sbjct: 114 T-LPEL---PASLKHLDVDNNQLT-MLPELP 139
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 21/87 (24%), Positives = 35/87 (40%), Gaps = 9/87 (10%)
Query: 350 SKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 407
S L ++ EL L+ +L+ +PD + P + ++ + N L LP
Sbjct: 42 PGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPD-NLPPQITVLEITQNALI-SLPEL 98
Query: 408 LMNLPNLRELYVQNNMLSGTVPSSLLS 434
+L L +N LS T+P S
Sbjct: 99 ---PASLEYLDACDNRLS-TLPELPAS 121
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 582
IG G FG V + + +A+K++ + Q + EV LL ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115
Query: 583 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638
+V + LV+E + L+ + ++ +N ++ A+
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS----LNLTRK--FAQQMCTA 169
Query: 639 IEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
+ +L T + +IIH DLK NILL K K+ DFG S + ++ + Y
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQ-SRFY 224
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
PE + D++S G IL+E+ +G+
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 9/85 (10%)
Query: 344 TVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
TV+ S+K L IP D+T EL+LDGN T + S L +I L +N++
Sbjct: 13 TVVRCSNKGLKVLPKGIPRDVT------ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRI 66
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLS 425
+ S N+ L L + N L
Sbjct: 67 STLSNQSFSNMTQLLTLILSYNRLR 91
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)
Query: 350 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 409
K+ G I + +L L L L + + P L+ + L +N++ G L
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENRIFGGLDMLAE 92
Query: 410 NLPNLRELYVQNNMLS 425
LPNL L + N L
Sbjct: 93 KLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 4/89 (4%)
Query: 336 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIH 394
+ ++ + L + L ++ S+L KL L +L L N + G + + P+L ++
Sbjct: 44 LTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101
Query: 395 LEDNQLTGPLP-SSLMNLPNLRELYVQNN 422
L N+L L L L+ L + N
Sbjct: 102 LSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 34/115 (29%), Positives = 48/115 (41%), Gaps = 30/115 (26%)
Query: 335 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWLD 373
CN++ +V SSK LT NIP+D KL + L L+L+
Sbjct: 14 CNNNKN---SV-DCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 374 GNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLM-NLPNLRELYVQNNMLS 425
N L +P F +L + + DN+L LP + L NL EL + N L
Sbjct: 70 DNKLQT-LPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 6/101 (5%)
Query: 344 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 400
+ L L ++P + L+ L L L N L +P F L+ + L +NQL
Sbjct: 112 AELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQL 169
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
+ L L+ L + NN L VP L
Sbjct: 170 KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKM 209
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 344 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 400
T + L L ++P + KL+SL EL L N L +P+ F +L+ + L++NQL
Sbjct: 136 TYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQL 193
Query: 401 TGPLPSSLMNLPNLRELYVQNN 422
+ +L L+ L +Q N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 6/116 (5%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSD-LTKLSS-LVELWLDGNSLTGPIPD--FSGCPDLRII 393
++ + I + LS V LWL+ N + I + F+G +
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELN 183
Query: 394 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 449
++N L L + + ++PS L L NL +
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKK 238
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 17/99 (17%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 341 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWL-DGNSLTGPIPD--FSGCPDLRIIHLE 396
+ I +S ++ I +D + L L E+ + N+L I F P+L+ + +
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLIS 112
Query: 397 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
+ + ++ L +Q+N+ T+ +
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 17/84 (20%), Positives = 26/84 (30%), Gaps = 9/84 (10%)
Query: 342 SITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
+ + NL +P+D S V L + + +P LR
Sbjct: 179 LDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--Y 234
Query: 399 QLTGPLPSSLMNLPNLRELYVQNN 422
L LP+ L L L E +
Sbjct: 235 NLKK-LPT-LEKLVALMEASLTYP 256
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 4/89 (4%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKL-SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
S+ + +S +L + S++ L L N LTG + P ++++ L +N++
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRI 462
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVP 429
+P + +L L+EL V +N L +VP
Sbjct: 463 MS-IPKDVTHLQALQELNVASNQLK-SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 24/144 (16%), Positives = 43/144 (29%), Gaps = 25/144 (17%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 398
P + LS +++ D++ LS L L L N + + F DL + + N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHN 110
Query: 399 QLTG----------------------PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 436
+L P+ NL L L + + +
Sbjct: 111 RLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 437 VVLNYAGNINLHEGGRGAKHLNII 460
+ ++ H G + L I
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIP 194
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 38/272 (13%), Positives = 80/272 (29%), Gaps = 21/272 (7%)
Query: 179 PQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVS 238
+ + V + + L L + L
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 239 KAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERND 297
K V + + + V NL++ + + +++ L + ++ +L +
Sbjct: 264 KCSVKLFQFFWPRP-VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 298 GSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNI 357
A +++ L S P + + C S T ++ + T ++
Sbjct: 323 ALYSVFAEMNIKMLSIS-------DTPFIHMV-----C-PPSPSSFTFLNFTQNVFTDSV 369
Query: 358 PSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD-LRIIHLEDNQLT----GPLPSSLMNLP 412
+ L L L L N L + + + D L +
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 413 NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
++ L + +NML+G+V L K VL+ N
Sbjct: 429 SILVLNLSSNMLTGSVFRCLPPKVKVLDLHNN 460
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400
SI V++LSS LTG++ L + L L N + D + L+ +++ NQL
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL 485
Query: 401 TGPLPSSLMNLPNLRELYVQNN 422
L +L+ +++ +N
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 21/112 (18%), Positives = 40/112 (35%), Gaps = 30/112 (26%)
Query: 330 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 389
S +++ +++ S++NLT ++P DL L L NS++
Sbjct: 23 GSMTPFSNE---LESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSIS----------- 65
Query: 390 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 441
L + L LR L + +N + ++ + N L Y
Sbjct: 66 ----ELR--------MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEY 104
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 19/113 (16%), Positives = 42/113 (37%), Gaps = 10/113 (8%)
Query: 332 WLQCNS-------DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF 384
L N+ ++ ++ L + I + +L ELW+ N + +
Sbjct: 54 ALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGI 111
Query: 385 SGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 436
+LR++++ +N++T L L L +L + N L + +
Sbjct: 112 EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 18/79 (22%), Positives = 34/79 (43%), Gaps = 3/79 (3%)
Query: 347 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 406
H + + + L+ L + L L N++ I SG +LRI+ L N + + +
Sbjct: 31 HGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK-IEN 87
Query: 407 SLMNLPNLRELYVQNNMLS 425
L EL++ N ++
Sbjct: 88 LDAVADTLEELWISYNQIA 106
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 99/672 (14%), Positives = 204/672 (30%), Gaps = 195/672 (29%)
Query: 249 QGKYR----VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVA 304
Q +Y+ V+E FV +F D + +L+ EI+ + D ++ G
Sbjct: 15 QYQYKDILSVFED-------AFVDNFDCKDVQDMPK-SILSKEEIDHIIMSKD-AVSGTL 65
Query: 305 IVSVISLYSSADWAQEGGDPCLPVPWSWL------QCNSDPQPS-ITVIHLSSKNLTGNI 357
+ L + Q+ + L + + +L + QPS +T +++ ++ N
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR---QPSMMTRMYIEQRDRLYND 122
Query: 358 PSDLTKLS------------SLVEL------WLDG------NSLTGPIPDFSGCPDLRII 393
K + +L+EL +DG + C ++
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL-----DVCLSYKVQ 177
Query: 394 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRG 453
D ++ +NL N P ++L L Y + N
Sbjct: 178 CKMDFKI------FWLNLKNCNS------------PETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 454 AKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAE 513
+ ++ + I S + + L K + + L V V + A
Sbjct: 220 SSNIKLRIHS--------IQAELRRLLKSK---------PYENCLLVLLNVQNAKAWNAF 262
Query: 514 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEV 573
C K+L + T ++ T+ +
Sbjct: 263 NLSC----------KIL--------------------------LTTRF-----KQVTDFL 281
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 632
+ + H + +E +S+L+ Y L + T+ +R++ I I
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV--LTTNPRRLSIIAES-IR 338
Query: 633 EDAAKGIEYLHTGCVPAIIHRDLKSS-NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 691
+ A + H C + ++SS N+L R + F +H+ +I+
Sbjct: 339 DGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSV--FPPS--AHIPTILL 392
Query: 692 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWAK 747
+ + D + +K YS L+E + IS + N
Sbjct: 393 SLI-WFDVIKSDVMVVVNKLHKYS----LVEKQPKESTISIPSIYLELKVKLENEYA--- 444
Query: 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCV-------LPHGHMRPS-------- 792
LH S++D Y+I + ++ + + H H++
Sbjct: 445 LHR-----------SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTL 492
Query: 793 ISEVLKD---IQDAIVIEREAAAARDGNSDD----------MSRNSLHSSLNVGSFGGTE 839
V D ++ I + A A + + N V +
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI---L 549
Query: 840 NFL-SLDESIVR 850
+FL ++E+++
Sbjct: 550 DFLPKIEENLIC 561
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 13/62 (20%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 364 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423
L + N + + F L+ + + +N++ LP+L EL + NN
Sbjct: 41 LDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
Query: 424 LS 425
L
Sbjct: 100 LV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 347 HLSSKNLTGN-IPS--DLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT 401
+ + + N I L L L ++ N + I + PDL + L +N L
Sbjct: 43 QFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV 101
Query: 402 GPLP-SSLMNLPNLRELYVQNN 422
L +L +L L + N
Sbjct: 102 ELGDLDPLASLKSLTYLCILRN 123
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 25/97 (25%), Positives = 39/97 (40%), Gaps = 16/97 (16%)
Query: 334 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD 389
QC+ T + SK IP++ L +L N +T P F +
Sbjct: 16 QCSCSG----TTVDCRSKRHASVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLIN 65
Query: 390 LRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNMLS 425
L+ ++L NQL LP + + L L L + N L+
Sbjct: 66 LKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 28/111 (25%)
Query: 344 TVIHLSSKNLT---GNIPSDLT-------------------KLSSLVELWLDGNSLTGPI 381
T + + + L +IP T +L LV+L L N LTG I
Sbjct: 11 TTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-I 69
Query: 382 PD--FSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNMLSGTVP 429
F G ++ + L +N++ + + + L L+ L + +N +S V
Sbjct: 70 EPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 394
P + + L LT I + S + EL L N + I + F G L+ ++
Sbjct: 51 GRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLN 108
Query: 395 LEDNQLTGPLPSSLMNLPNLRELYVQNN 422
L DNQ++ +P S +L +L L + +N
Sbjct: 109 LYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 3/83 (3%)
Query: 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 402
+ L S L + L+ L L LD N L F +L + L +NQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 403 PLPSSLM-NLPNLRELYVQNNML 424
LP + +L L +LY+ N L
Sbjct: 98 -LPLGVFDHLTQLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 25/86 (29%), Positives = 37/86 (43%), Gaps = 7/86 (8%)
Query: 344 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 400
T ++L L + + + L+ L L L N L +P F L ++L NQL
Sbjct: 62 TWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQL 119
Query: 401 TGPLPSSLM-NLPNLRELYVQNNMLS 425
LPS + L L+EL + N L
Sbjct: 120 KS-LPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 5/88 (5%)
Query: 338 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 394
D + ++L L +PS + +L+ L EL L+ N L IP F +L+ +
Sbjct: 104 DHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLS 161
Query: 395 LEDNQLTGPLPSSLMNLPNLRELYVQNN 422
L NQL + L L+ + + N
Sbjct: 162 LSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 49/229 (21%), Positives = 83/229 (36%), Gaps = 50/229 (21%)
Query: 532 KKIGSGGFGVVY--YGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRIHHR---- 582
+G G FG V + ++A+K++ + Y + E + +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKEN 80
Query: 583 --NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAK 637
V + G + +E + T LKE+ + ++ +A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPH----VRH--MAYQLCH 134
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILL-------------------DKHMRAKVSDFGLSKF 678
+ +LH + H DLK NIL K+ +V+DFG + F
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
+ H ++IV T Y PE + DV+S G IL E G
Sbjct: 192 DHE---HHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 59/238 (24%), Positives = 90/238 (37%), Gaps = 64/238 (26%)
Query: 532 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRI-----HHR 582
+K+G G FG V+ + + K AVKV+ + Y K E +L +I ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNN 96
Query: 583 NLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 634
N+V++ G L+ YE + + Y E IK +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEI-----ITRNNYNGFHIED----IKL--YCIE 145
Query: 635 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------DKHMRAK 669
K + YL ++ H DLK NILL K K
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 670 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
+ DFG + F D + SI+ T Y PE ++ SD++SFG +L EL +G
Sbjct: 203 LIDFGCATFKSD---YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 5/65 (7%)
Query: 363 KLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYV 419
+L++L L L GN L +P+ F +L+ + L +NQL LP + + L NL L +
Sbjct: 83 ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNL 140
Query: 420 QNNML 424
+N L
Sbjct: 141 AHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 17/92 (18%), Positives = 40/92 (43%), Gaps = 12/92 (13%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 401
+L K++T + + +L+S+ ++ + + + + P++R + L N+L
Sbjct: 20 ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLH 76
Query: 402 GPLPSSLM---NLPNLRELYVQNNMLSGTVPS 430
+ L NL L + N L ++P+
Sbjct: 77 -----DISALKELTNLTYLILTGNQLQ-SLPN 102
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 28/114 (24%)
Query: 334 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWL 372
+C+ T + S+ T IP+ T L +SL +L+L
Sbjct: 4 RCSCSG----TTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYL 59
Query: 373 DGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNML 424
GN L P F+ L ++L NQL LP+ + + L L+EL + N L
Sbjct: 60 GGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQL 112
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 854 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.7 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.67 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.64 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.63 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.63 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.63 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.63 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.62 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.62 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.62 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.62 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.62 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.62 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.6 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.59 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.59 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.58 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.57 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.55 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.54 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.53 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.53 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.53 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.52 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.52 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.51 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.51 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.5 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.5 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.5 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.49 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.49 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.49 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.49 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.48 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.48 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.48 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.48 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.48 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.48 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.48 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.48 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.47 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.47 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.47 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.47 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.46 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.46 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.46 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.46 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.46 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.46 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.45 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.45 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.45 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.44 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.44 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.43 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.43 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.43 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.43 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.43 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.42 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.42 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.42 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.42 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.42 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.42 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.41 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.41 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.41 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.4 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.4 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.4 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.4 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.4 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.4 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.4 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.39 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.39 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.38 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.38 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.38 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.38 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.36 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.36 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.35 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.35 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.34 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.34 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.34 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.33 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.33 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.33 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.32 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.32 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.32 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.32 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.32 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.31 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.31 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.31 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.31 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.31 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.3 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.3 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.3 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.29 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.28 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.27 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.27 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.27 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.26 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.19 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.18 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.16 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.16 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.16 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.14 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.14 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.09 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.86 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.85 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.83 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.76 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.67 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.65 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.54 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.53 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.41 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.36 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.33 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.32 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.29 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.29 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.22 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.18 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.17 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.12 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.08 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.03 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.02 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.96 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.88 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.78 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.75 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.72 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.67 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.61 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.53 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.46 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.16 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.74 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.65 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.63 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.58 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.5 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.49 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.45 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.72 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.54 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.05 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.26 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.23 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.54 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 92.88 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.1 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 91.08 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 90.68 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 89.94 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 89.02 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.93 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.55 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=447.84 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=205.9
Q ss_pred HhhccccccCceEEEEEEEC------CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35688999999999999875 478899999987766667889999999999999999999999999999999999
Q ss_pred eccCCCHHhhhccccc-----------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 003039 603 FMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 671 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 671 (854)
||++|+|.++++.... ....++|.+++.|+.|||+||+|||+. +|+||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 9999999999965321 234689999999999999999999998 99999999999999999999999
Q ss_pred eeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHh
Q 003039 672 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 672 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~ 749 (854)
|||+|+....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||...... .+...
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~---- 272 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----EAIDC---- 272 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH----HHHHH----
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH----HHHHH----
Confidence 9999986544322 23345679999999999999999999999999999999999 89999765421 22222
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+..+.-.+ .+.....++.+|+.+||+.||++||||.||+++|+.+..
T Consensus 273 i~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 273 ITQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 22221111 111223468899999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=445.05 Aligned_cols=256 Identities=27% Similarity=0.478 Sum_probs=211.1
Q ss_pred HhhccccccCceEEEEEEEC------CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 46789999999999999874 467899999987766667889999999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccc---------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 003039 603 FMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 673 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 673 (854)
||++|+|.++|+... .....++|.+++.|+.|||+||+|||++ +|+||||||+||||+.++.+||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence 999999999996532 2345799999999999999999999998 9999999999999999999999999
Q ss_pred eccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhh
Q 003039 674 GLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 674 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
|+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+... +.
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~----i~ 244 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIEC----IT 244 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHH----HH
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----HH
Confidence 999865443222 2234569999999999999999999999999999999999 89999765421 22222 22
Q ss_pred cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.+.... .+.....++.+|+.+||+.+|++||||.||++.|+++.
T Consensus 245 ~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 245 QGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 232211 11122346889999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=450.34 Aligned_cols=256 Identities=22% Similarity=0.374 Sum_probs=210.2
Q ss_pred HHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
..|.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 456789999999999999873 46789999997543 33457899999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccc------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcE
Q 003039 601 YEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 668 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 668 (854)
||||++|+|.++|+... .....++|..++.|+.|||+||+|||++ +|+||||||+||||++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence 99999999999996432 1234689999999999999999999998 99999999999999999999
Q ss_pred EEEeeeccccccCCC-CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHH
Q 003039 669 KVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 746 (854)
Q Consensus 669 kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~ 746 (854)
||+|||+|+...... ........||+.|||||++.++.++.++|||||||+||||+| |+.||.+... ..+...
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----~~~~~~- 259 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVVEM- 259 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----HHHHHH-
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----HHHHHH-
Confidence 999999998654332 223345679999999999999999999999999999999999 8999976542 123222
Q ss_pred HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 747 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 747 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
+..+.... .+..+...+.+|+.+||+.+|++||||.||+++|+..
T Consensus 260 ---i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 ---IRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22332211 1122334688999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=430.85 Aligned_cols=254 Identities=31% Similarity=0.520 Sum_probs=199.5
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.++||+|+||+||+|+++ ..||||+++... ....+.|.+|+++|++++|||||+++|+|.+ +..++|||||++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 35789999999999999976 369999987543 3345679999999999999999999999865 568999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC-Cc
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SH 685 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~-~~ 685 (854)
|+|.++|+.. ...++|.+++.|+.|||+||+|||++ +|+||||||+||||++++.+||+|||+|+...... ..
T Consensus 116 GsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 116 SSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999642 45699999999999999999999998 99999999999999999999999999998654332 22
Q ss_pred eeecccccccccCcccccc---CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 686 VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
......||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+.... ..+ ...+..+.. .|.
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~----~~~~~~~~~----~p~ 258 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQI----IFMVGRGYA----SPD 258 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHH----HHHHHTTCC----CCC
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHH----HHHHhcCCC----CCC
Confidence 3445679999999999964 46899999999999999999999999764411 111 112222211 111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
+. .....+...+.+|+.+||+.+|++||||.||+++|+.+
T Consensus 259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 11122334688999999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=427.60 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=203.4
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
.+.++||+|+||+||+|+++ +|+.||||+++.... ..+|+.+|++++|||||++++++.+++..++|||||++|
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 34678999999999999986 689999999975432 246999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeeeccccccCCCCc-
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASH- 685 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~~~~~- 685 (854)
+|.++|.. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++ ++||+|||+|+........
T Consensus 136 ~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 136 SLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999953 45689999999999999999999998 999999999999999988 6999999999866443211
Q ss_pred ---eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 686 ---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 686 ---~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+.. +... . ..
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--------~~~~-~--~~ 277 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS--------EPPP-I--RE 277 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH--------SCCG-G--GG
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc--------CCCC-c--hh
Confidence 22345799999999999999999999999999999999999999986553322212111 1100 0 01
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+... ....+.+++.+|++.||++|||+.||+++|..++.
T Consensus 278 ~~~~----~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 278 IPPS----CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp SCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcc----CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1122 23457899999999999999999999999988765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=421.38 Aligned_cols=266 Identities=23% Similarity=0.342 Sum_probs=202.6
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecC----eEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~----~~~LV~E~~ 604 (854)
.+.++||+|+||+||+|+++ |+.||||+++... .....++.|+..+.+++|||||+++|+|.+++ ..+||||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 45789999999999999985 8999999996442 22233455777778899999999999998764 579999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
++|+|.++|+. ..++|..+.+++.|+|+||+|||+++ .++|+||||||+||||+.++++||+|||+|+..
T Consensus 84 ~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 84 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999953 45899999999999999999999863 358999999999999999999999999999876
Q ss_pred cCCCCce---eecccccccccCccccccC------cCCCcchhhhHHHHHHHHHhCCccccccccccc-c------cchH
Q 003039 680 VDGASHV---SSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGAN-C------RNIV 743 (854)
Q Consensus 680 ~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~-~------~~l~ 743 (854)
....... .....||+.|||||++.+. .++.++|||||||+||||+||+.|+......+. . ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5443322 2345799999999998754 477899999999999999999888754321110 0 0011
Q ss_pred HHHHHhhhcCCcccccCccccCc-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 744 QWAKLHIESGDIQGIIDPSLLDE-YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 744 ~~~~~~~~~~~~~~~id~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
......+..+ .++|.+... .+.+....+.+|+.+||+.||++||||.||++.|+++..
T Consensus 239 ~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 239 EEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1122222111 122333222 234566788999999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=430.13 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=205.1
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
.+.++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||++|
T Consensus 77 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 156 (346)
T 4fih_A 77 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 156 (346)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 34578999999999999986 68999999997665555677899999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+...... ...
T Consensus 157 ~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 157 ALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp EHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred cHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 99998842 4589999999999999999999998 99999999999999999999999999998664432 233
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... .+...+ ..+. .+.+..
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i----~~~~-----~~~~~~-- 292 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMI----RDNL-----PPRLKN-- 292 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHH----HHSS-----CCCCSC--
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHH----HcCC-----CCCCCc--
Confidence 4567999999999999999999999999999999999999999765421 111111 1111 111110
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.......+.+|+.+|++.||++|||+.|+++|
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01112357899999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=435.57 Aligned_cols=265 Identities=26% Similarity=0.396 Sum_probs=213.0
Q ss_pred HHHHHHHhhccccccCceEEEEEEECC------CcEEEEEEEccCCc-ccHHHHHHHHHHHccCCC-CceeeEeeeeeec
Q 003039 523 IEDATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHH-RNLVQFLGYCQEE 594 (854)
Q Consensus 523 ~~~~~~~~~~~iG~G~fg~Vy~a~~~~------~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~H-pnIv~l~g~~~~~ 594 (854)
+....+.+.+.||+|+||+||+|++.. ++.||||+++.... ...+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 334455667899999999999998752 36799999976543 345679999999999965 9999999999764
Q ss_pred -CeEEEEEEeccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 003039 595 -GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661 (854)
Q Consensus 595 -~~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 661 (854)
+..++|||||++|+|.++|+.... ....++|.+++.++.|||+||+|||++ +||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 568999999999999999965321 134589999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccc
Q 003039 662 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 739 (854)
Q Consensus 662 l~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~ 739 (854)
+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....+
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-- 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999866544333 3345679999999999999999999999999999999998 999997654221
Q ss_pred cchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 740 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 740 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.+ ...+..+.-.. .... ...++.+++.+||+.||++||||.||+++|+++++.
T Consensus 296 -~~----~~~i~~g~~~~-----~p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 296 -EF----CRRLKEGTRMR-----APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp -HH----HHHHHHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HH----HHHHHcCCCCC-----CCcc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 12 22222332111 1111 234578999999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=413.57 Aligned_cols=247 Identities=28% Similarity=0.414 Sum_probs=196.8
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeee----cCeEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 601 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~----~~~~~LV~ 601 (854)
.++++||+|+||+||+|.+. +++.||||++.... ....+.|.+|+++|++++|||||+++++|.. ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 35678999999999999886 58899999996542 3345679999999999999999999999865 34689999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeeecccccc
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAV 680 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~ 680 (854)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++. ++|+||||||+||||+. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999953 456899999999999999999999971 13999999999999984 7999999999998543
Q ss_pred CCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ... +...+..+.....++
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~-~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQ-IYRRVTSGVKPASFD 252 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHH-HHHHHTTTCCCGGGG
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHH-HHHHHHcCCCCCCCC
Confidence 2 23345679999999998864 699999999999999999999999975431 111 111222222111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+ .++.+|+.+|++.||++|||+.|+++|
T Consensus 253 ----~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 ----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----ccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112 347889999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=429.72 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=199.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 456789999999999999876 68999999997543 233567899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.++|... ....+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+..... .
T Consensus 106 ~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 106 EGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp TTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 999999999542 234578889999999999999999998 9999999999999999999999999999865322 1
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. .+.. .. ..+.... +.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~---~i-~~~~~~~-----~~ 246 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK----NLVL---KI-ISGSFPP-----VS 246 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH---HH-HHTCCCC-----CC
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHH---HH-HcCCCCC-----CC
Confidence 2234567999999999999999999999999999999999999999765421 1111 11 1222211 11
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..++ ..+.+|+.+|++.||++|||+.|+++|
T Consensus 247 ~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 247 LHYS----YDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222 357899999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=420.66 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=205.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 567889999999999999876 68999999997532 23356789999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
|++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 114 ~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 114 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999995 345789999999999999999999998 99999999999999999999999999998765432
Q ss_pred -CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 684 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 684 -~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+ +.. .+..+++ .
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~----~i~~~~~------~ 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL----IFA----KIIKLEY------D 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHTCC------C
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHHcCCC------C
Confidence 234456789999999999999999999999999999999999999997654221 211 1112221 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+....+ .++.+|+.+|++.||++|||++|+..+
T Consensus 253 ~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 FPEKFF----PKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp CCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred CCcccC----HHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 112222 357899999999999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=427.77 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=206.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.++||+|+||.||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 344578999999999999986 6899999999876666667789999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+...... ..
T Consensus 233 G~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 233 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred CcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 99999884 34589999999999999999999998 99999999999999999999999999998664432 23
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... .+... +..+.....- ....
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~----i~~~~~~~~~---~~~~ 372 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKM----IRDNLPPRLK---NLHK 372 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH----HHHSCCCCCS---CTTS
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHH----HHcCCCCCCc---cccc
Confidence 34567999999999999999999999999999999999999999765421 11111 1111110000 0112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+ ..+.+|+.+||+.||++|||+.|+++|
T Consensus 373 ~s----~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 373 VS----PSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SC----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC----HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22 357899999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=407.67 Aligned_cols=245 Identities=23% Similarity=0.400 Sum_probs=190.1
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.|.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++|++++||||+++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3567789999999999999875 68999999997542 2335678999999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+ +|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+...+.
T Consensus 94 y~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 94 YA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp CC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred CC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99 6899998853 45689999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||...... .+.+ .+..+...
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~----~i~~~~~~----- 230 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFK----NISNGVYT----- 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHTCCC-----
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHH----HHHcCCCC-----
Confidence 22345679999999999998876 57999999999999999999999765422 1111 12222211
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+....+ ..+.+++.+|++.||++|||++|+++|
T Consensus 231 -~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 -LPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCCCCC----HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111222 357789999999999999999999885
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=413.80 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=194.8
Q ss_pred HHhhccccccCceEEEEEEEC----CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
|.+.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 556789999999999999863 47889999997542 223456889999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
|||++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 106 Ey~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 106 DFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp CCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999995 345689999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+ +... +..+..
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~----i~~~~~------ 243 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTM----ILKAKL------ 243 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHCCC------
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----HHHH----HHcCCC------
Confidence 32 22345679999999999999999999999999999999999999998654221 1111 111211
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
.+....+ .++.+|+.+|++.||++||| ++|+++|
T Consensus 244 ~~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 GMPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1111222 35789999999999999998 4677664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=397.82 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=186.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecC----------
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG---------- 595 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~---------- 595 (854)
|.+.+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|+++|++++|||||++++++...+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 445689999999999999976 689999999975433 33467899999999999999999999987554
Q ss_pred --eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 003039 596 --RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 673 (854)
Q Consensus 596 --~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 673 (854)
..++|||||++|+|.+++.... .....++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 3689999999999999996432 222345666788999999999999998 9999999999999999999999999
Q ss_pred eccccccCCCCc-----------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccch
Q 003039 674 GLSKFAVDGASH-----------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 742 (854)
Q Consensus 674 Gla~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l 742 (854)
|+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||.... ..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------~~ 233 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ER 233 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------HH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------HH
Confidence 999865443211 1234579999999999999999999999999999999996 665322 11
Q ss_pred HHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 743 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 743 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... ........... .......+.+++.+|++.||++|||+.|+++|
T Consensus 234 ~~~~-~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTL-TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH-HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH-HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 11112211111 11222346789999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=385.82 Aligned_cols=273 Identities=42% Similarity=0.744 Sum_probs=239.9
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
.+.+.||+|+||.||+|++++++.||||++........+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 34678999999999999988899999999877666667789999999999999999999999999999999999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC-CCcee
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVS 687 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~-~~~~~ 687 (854)
|.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 122 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp TGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999976544455689999999999999999999998 9999999999999999999999999999754332 22223
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... +.....+..|.......+.+...+++.+....
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL-PREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS-SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC-cHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 44568999999999999999999999999999999999999997654 33344677777777777888888898888888
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..+....+.+++.+|++.+|++|||+.||+++|+.++.
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 88899999999999999999999999999999999865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=389.37 Aligned_cols=288 Identities=35% Similarity=0.657 Sum_probs=248.5
Q ss_pred cccCHHHHHHHHH--HhhccccccCceEEEEEEECCCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeee
Q 003039 516 HCFTLSDIEDATK--MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQ 592 (854)
Q Consensus 516 ~~~~~~~~~~~~~--~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~ 592 (854)
..++..++..... .+.+.||+|+||.||+|+.++++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 3456666665443 34688999999999999988899999999875532 23447899999999999999999999999
Q ss_pred ecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 003039 593 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 672 (854)
Q Consensus 593 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 672 (854)
..+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999977655566799999999999999999999998777999999999999999999999999
Q ss_pred eeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccc-cccccchHHHHHHhhh
Q 003039 673 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHIE 751 (854)
Q Consensus 673 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~-~~~~~~l~~~~~~~~~ 751 (854)
||+++..............||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..|......
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 999987655555555566799999999999999999999999999999999999999975442 2334467788888888
Q ss_pred cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
...+..+.+..+...+..+....+.+++.+|++.+|++|||+.||+++|+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 8888888999888888999999999999999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=394.91 Aligned_cols=259 Identities=20% Similarity=0.309 Sum_probs=197.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeee------cCeEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~------~~~~~ 598 (854)
|.+.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+..+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 456789999999999999886 69999999997543 2334568899999999999999999998754 36789
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+|||||+ |+|.+++. ..+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 136 ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 136 VVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 9999996 68998884 345789999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCC---CceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 679 AVDGA---SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 679 ~~~~~---~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+... .....
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~----~g~p~ 283 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV----LGTPS 283 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH----HCCCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh----cCCCC
Confidence 54321 2233456899999999998875 5689999999999999999999999765422211111111 00000
Q ss_pred cccccCc-----------ccc--CcCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDP-----------SLL--DEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~-----------~l~--~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.... .+. ...+. .....+.+|+.+|++.||++|||+.|+++|
T Consensus 284 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 -PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 000 00000 112357899999999999999999999886
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=408.56 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=207.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.+.||+|+||+||+|+.+ +|+.||||++..........+.+|+++|+.++||||+++++++.+.+..++|||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 456789999999999999886 6899999999876655667889999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC--CcEEEEeeeccccccCCCC
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~--~~vkl~DFGla~~~~~~~~ 684 (854)
|+|.++|.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 239 g~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 239 GELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 999998853 245689999999999999999999998 99999999999999854 89999999999876543
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .+.. .+..+.. .+++...
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~----~~~~----~i~~~~~--~~~~~~~ 380 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----ETLR----NVKSCDW--NMDDSAF 380 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHH----HHHTTCC--CCCSGGG
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHH----HHHhCCC--CCCcccc
Confidence 2334567999999999999999999999999999999999999999765421 1111 1111111 0111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+ ..+.+|+.+||+.||++|||+.|+++|
T Consensus 381 ~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 381 SGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222 347799999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=383.41 Aligned_cols=194 Identities=25% Similarity=0.376 Sum_probs=165.6
Q ss_pred HHhhccccccCceEEEEEEEC----CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
|.+.++||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +||||+++++++.+.++.++|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 456789999999999999764 46789999986543 345678999999988 69999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeeeccccccC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD 681 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~~~ 681 (854)
|+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 101 ~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 101 YLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999883 378888999999999999999998 99999999999999877 7999999999975443
Q ss_pred CCC---------------------------ceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccc
Q 003039 682 GAS---------------------------HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNE 733 (854)
Q Consensus 682 ~~~---------------------------~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~ 733 (854)
... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 112335799999999999875 5899999999999999999999999543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=398.85 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=196.6
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHH---HHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~---~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.||+|+||+||+|+.+ +|+.||||++.+.. ......+. .++++++.++|||||++++++.+.+.+++||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34578999999999999987 68999999996432 11222233 3467778889999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
|||+||+|.++|. ....+++..+..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+....
T Consensus 272 Ey~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 272 DLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp CCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999995 345789999999999999999999998 999999999999999999999999999986644
Q ss_pred CCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 682 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
.. ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||........ ..+.. . ......
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~---~-i~~~~~----- 411 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR---M-TLTMAV----- 411 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHH---H-HHHCCC-----
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH---h-hcCCCC-----
Confidence 32 344679999999999975 5799999999999999999999999976542211 11111 1 111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
.+...++ .++.+|+.+|++.||++|++ ++||.+|
T Consensus 412 -~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 -ELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -CCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1112222 35789999999999999998 7888876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=364.50 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=208.7
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
.+.+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 45689999999999999986 58999999987666666788999999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce-
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV- 686 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~- 686 (854)
+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 93 TLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp BHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred cHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999642 45689999999999999999999998 99999999999999999999999999998654332211
Q ss_pred ------------eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccccc--ccchHHHHHHhhhc
Q 003039 687 ------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN--CRNIVQWAKLHIES 752 (854)
Q Consensus 687 ------------~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~--~~~l~~~~~~~~~~ 752 (854)
.....||+.|+|||.+.+..++.++|||||||++|||++|..|+........ ...........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--- 243 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY--- 243 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT---
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc---
Confidence 1145699999999999999999999999999999999999999865432111 11111111111
Q ss_pred CCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 753 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 753 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.... ....+.+++.+|++.+|++|||+.||++.|+.+...
T Consensus 244 ----------~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 244 ----------CPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ----------CCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0111 113478899999999999999999999999988654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=361.29 Aligned_cols=258 Identities=31% Similarity=0.484 Sum_probs=200.4
Q ss_pred HHHhhccccccCceEEEEEEECCCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.+.||+|+||+||+|+.. ++.||||++..... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred HceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence 3456789999999999999885 89999999976532 33457889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 117 SRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp TTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999996431 233588999999999999999999998 7 999999999999999999999999999754332
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+....... .
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~~--------~ 259 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA----QVVAAVGFKCKRL--------E 259 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHHHSCCCC--------C
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCC--------C
Confidence 1 2233456999999999999999999999999999999999999999765411 1222111111100 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
+.... ...+.+++.+|++.+|++|||+.||++.|+.++..
T Consensus 260 ~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 260 IPRNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11122 23588999999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.43 Aligned_cols=281 Identities=35% Similarity=0.585 Sum_probs=227.0
Q ss_pred ccccCHHHHHHHHHHhh--------ccccccCceEEEEEEECCCcEEEEEEEccCC----cccHHHHHHHHHHHccCCCC
Q 003039 515 AHCFTLSDIEDATKMLE--------KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHR 582 (854)
Q Consensus 515 ~~~~~~~~~~~~~~~~~--------~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~----~~~~~~~~~Ev~~L~~l~Hp 582 (854)
.+.|++.++...+..+. +.||+|+||.||+|.. +++.||||++.... ......+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 35678889988888774 5699999999999987 48999999986532 23356789999999999999
Q ss_pred ceeeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE
Q 003039 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 662 (854)
Q Consensus 583 nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 662 (854)
||+++++++...+..++||||+++|+|.+++... .....+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998643 2345689999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccc
Q 003039 663 DKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 741 (854)
Q Consensus 663 ~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~ 741 (854)
+.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999999765443222 2334569999999998764 588999999999999999999999987653333222
Q ss_pred hHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 742 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 742 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
+..... .....+.+.+++.+ ..........+.+++.+|++.+|++||++.||+++|+++.
T Consensus 246 ~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIE--DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHH--TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhh--hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 222111 11222344455444 3345667788999999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=372.17 Aligned_cols=260 Identities=23% Similarity=0.437 Sum_probs=209.9
Q ss_pred HHhhccccccCceEEEEEEEC--------CCcEEEEEEEccCCc-ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 597 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~--------~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~ 597 (854)
+.+.+.||+|+||.||+|++. ++..||||+++.... .....+.+|+++++++ +||||++++++|...+..
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 446789999999999999863 356799999976532 3346789999999999 899999999999999999
Q ss_pred EEEEEeccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC
Q 003039 598 VLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 665 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 665 (854)
++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCC
Confidence 999999999999999965321 234588999999999999999999998 99999999999999999
Q ss_pred CcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchH
Q 003039 666 MRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIV 743 (854)
Q Consensus 666 ~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~ 743 (854)
+.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----~~~ 315 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----ELF 315 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHH
Confidence 99999999999865443221 2233457889999999999999999999999999999999 99999765422 222
Q ss_pred HHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 744 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 744 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
.. +..+... ..+......+.+++.+|++.+|++||++.||+++|++++...
T Consensus 316 ~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 316 KL----LKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HH----HHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH----HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 22 1122111 111122346889999999999999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=355.71 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=203.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.+.||+|+||+||+|... +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 345678999999999999864 6899999999766656677889999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 102 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 102 GSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 999999853 3578889999999999999999998 999999999999999999999999999976544332 2
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .........+.. ....
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~-~~~~------ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTP-ELQN------ 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSC-CCSC------
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC-CCCC------
Confidence 33456999999999999999999999999999999999999999754411 111111111110 0000
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+......+.+++.+|++.||++|||+.|++++
T Consensus 239 -~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 -PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11122357899999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=370.07 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=207.1
Q ss_pred HHHHHhhccccccCceEEEEEEEC----CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
...+.+.+.||+|+||.||+|.+. .+..||||+++... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 344556789999999999999985 34569999997653 3345679999999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999853 234689999999999999999999998 9999999999999999999999999999866
Q ss_pred cCCCCc--eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 680 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 680 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+... +..+..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~----~~~~~~- 272 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DVISS----VEEGYR- 272 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHH----HHTTCC-
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----HHHHH----HHcCCC-
Confidence 443222 2233346788999999999999999999999999999999 99999765421 12221 111110
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
...+......+.+++..|++.+|++||++.||++.|+.++.
T Consensus 273 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 273 --------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 01111223468899999999999999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.11 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=208.8
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.+.||+|+||.||+|++.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 34568999999999999999889999999997553 33567999999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 91 ~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 91 CLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp BHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred cHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999532 34588999999999999999999998 999999999999999999999999999986544322233
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....+|+.|+|||.+.+..++.++||||+||++|||++ |+.||...... .+... +..+. ....+ ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----~~~~~----~~~~~--~~~~~---~~ 231 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVED----ISTGF--RLYKP---RL 231 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH----HHTTC--CCCCC---TT
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----HHHHH----HhcCc--cCCCC---Cc
Confidence 34457888999999999999999999999999999999 99999764421 11111 11110 00111 11
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
....+.+++.+|++.+|++||++.|++++|+++..
T Consensus 232 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 232 ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 12357899999999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=354.25 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=211.2
Q ss_pred cccCHHHHHHHHHH------------hhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCC
Q 003039 516 HCFTLSDIEDATKM------------LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 582 (854)
Q Consensus 516 ~~~~~~~~~~~~~~------------~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hp 582 (854)
..++..++..++.. ..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777776653 2457999999999999987 6999999999876666677899999999999999
Q ss_pred ceeeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE
Q 003039 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 662 (854)
Q Consensus 583 nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 662 (854)
||+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999998842 3589999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccch
Q 003039 663 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 742 (854)
Q Consensus 663 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l 742 (854)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----~~ 249 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----QA 249 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HH
T ss_pred CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH
Confidence 9999999999999976543322 223456999999999999999999999999999999999999999754311 11
Q ss_pred HHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 743 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 743 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... +..... +.+.. .......+.+++.+|++.+|++|||+.|++++
T Consensus 250 ~~~----~~~~~~-----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKR----LRDSPP-----PKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHH----HHHSSC-----CCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHH----HhcCCC-----CCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111111 11111 01112357899999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=374.74 Aligned_cols=257 Identities=25% Similarity=0.446 Sum_probs=197.2
Q ss_pred HHHhhccccccCceEEEEEEEC----CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.+.||+|+||.||+|++. ++..||||+++... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3456789999999999999875 56789999997543 334567999999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 126 e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 126 EYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp ECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred eCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999963 234688999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCce--eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 682 GASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 682 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
..... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+... +..+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----~~~~~----i~~~~---- 267 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKA----VDEGY---- 267 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH----HHHHH----HHTTE----
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HHcCC----
Confidence 32221 122335788999999999999999999999999999998 99999754411 12221 11110
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
....+......+.+++.+|++.+|++||+|.||++.|++++..
T Consensus 268 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 -----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0111112335688999999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.02 Aligned_cols=255 Identities=29% Similarity=0.465 Sum_probs=209.8
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.+.||+|+||.||+|+++++..||||+++.... ...++.+|++++++++||||+++++++...+..++||||++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (268)
T 3sxs_A 10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG 88 (268)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCC
Confidence 445789999999999999999888999999975543 3567899999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 89 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 89 CLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp BHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred cHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 999999532 34588999999999999999999998 999999999999999999999999999986655443334
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+.. ...+. .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~----~~~~~~~--~~~~~---~ 229 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----EVVL----KVSQGHR--LYRPH---L 229 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHH----HHHTTCC--CCCCT---T
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH----HHHH----HHHcCCC--CCCCC---c
Confidence 44557788999999999899999999999999999999 99999754421 1111 1111110 01111 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
. ...+.+++..|++.+|++|||+.||+++|+.+...
T Consensus 230 ~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 A----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp S----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred C----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1 23588999999999999999999999999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.37 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=206.9
Q ss_pred HHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.+.||+|+||.||+|++.++..||||+++.... ..+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 3456789999999999999999888999999975543 356789999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 104 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 104 GCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999642 34689999999999999999999998 99999999999999999999999999998654432222
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .... .+..+.. ... ..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----~~~~----~~~~~~~--~~~---~~ 244 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAE----HIAQGLR--LYR---PH 244 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHH----HHHTTCC--CCC---CT
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh----HHHH----HHhcccC--CCC---CC
Confidence 333457788999999998899999999999999999998 99999764421 1111 1111100 000 11
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.. ...+.+++.+|++.+|++|||+.|++++|++++..
T Consensus 245 ~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 245 LA----SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11 23588999999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=361.48 Aligned_cols=266 Identities=27% Similarity=0.351 Sum_probs=205.4
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecC----eEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~----~~~LV~E~ 603 (854)
+.+.++||+|+||+||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.... ..++||||
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred chhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 445789999999999999987 8999999996543 23445677999999999999999999998754 36999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC-------CCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-------VPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 104 HEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999953 34899999999999999999999852 238999999999999999999999999999
Q ss_pred ccccCCCCc-eeecccccccccCcccccc-----CcCCCcchhhhHHHHHHHHHhCCcccccccccccc---------cc
Q 003039 677 KFAVDGASH-VSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC---------RN 741 (854)
Q Consensus 677 ~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~---------~~ 741 (854)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 765443322 2233569999999999986 45667899999999999999999999754321110 01
Q ss_pred hHHHHHHhhhcCCcccccCccccCc-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 742 IVQWAKLHIESGDIQGIIDPSLLDE-YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 742 l~~~~~~~~~~~~~~~~id~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
...+...... ... .+.+... ........+.+++.+|++.||++|||+.||++.|+++..
T Consensus 259 ~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 259 LEDMQEVVVH-KKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHHHTT-SCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhhhc-ccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111 111 1111111 123455679999999999999999999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=371.65 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=206.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.+.||+|+||.||+|++. +++.||||+++.... .....+.+|+++|++++||||+++++++...+..++||||++
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 345789999999999999987 689999999875432 234568899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 196 ~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 196 GGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp TCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999999963 244688999999999999999999998 9999999999999999999999999999754332111
Q ss_pred ee-ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 686 VS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 686 ~~-~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.. ....+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+.. .+..+....
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~~~~----~~~~~~~~~------ 335 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTRE----FVEKGGRLP------ 335 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----HHHH----HHHTTCCCC------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCCCCC------
Confidence 11 12235778999999999999999999999999999998 99999765411 1111 222221100
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+......+.+++.+|++.+|++|||+.+|++.|+++..
T Consensus 336 ---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 336 ---CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 111123457899999999999999999999999999764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=361.51 Aligned_cols=245 Identities=24% Similarity=0.402 Sum_probs=201.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 445689999999999999984 79999999997542 233566889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 97 SGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp TTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 99999999853 35688999999999999999999998 99999999999999999999999999997654332
Q ss_pred ceeecccccccccCccccccCcCC-CcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s-~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
......||+.|+|||++.+..+. .++||||+||++|||++|+.||...... .+.. .+..+... +
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~----~i~~~~~~------~ 233 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----ELRE----RVLRGKYR------I 233 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCCC------C
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHH----HHHhCCCC------C
Confidence 23445799999999999988775 7899999999999999999999765421 1111 11222111 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... ....+.+++.+|++.||++|||++|+++|
T Consensus 234 p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 PFY----MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCC----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 12357789999999999999999999886
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.60 Aligned_cols=264 Identities=27% Similarity=0.397 Sum_probs=204.7
Q ss_pred HHHhhccccccCceEEEEEEEC-----CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVL 599 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-----~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~L 599 (854)
.+.+.+.||+|+||+||+|++. +++.||||++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 3456789999999999999852 588999999987666666789999999999999999999999854 356899
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 91 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999643 34588999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCc--eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccc--------ccccchHHHHHHh
Q 003039 680 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG--------ANCRNIVQWAKLH 749 (854)
Q Consensus 680 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~--------~~~~~l~~~~~~~ 749 (854)
...... ......+|..|+|||.+.+..++.++|||||||++|||++|..|+...... .............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 443221 223345778899999999999999999999999999999999988643210 0000111112222
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+..+.. ...+......+.+++.+|++.+|++|||+.||++.|+++..
T Consensus 245 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 245 LKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 222111 11112223468899999999999999999999999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.10 Aligned_cols=271 Identities=21% Similarity=0.287 Sum_probs=211.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecC--eEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~--~~~LV~E~ 603 (854)
|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 345689999999999999987 48999999997543 234567889999999999999999999997655 77999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE----cCCCcEEEEeeeccccc
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkl~DFGla~~~ 679 (854)
+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 91 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 91 CPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999996532 223489999999999999999999998 99999999999999 78889999999999865
Q ss_pred cCCCCceeecccccccccCccccc--------cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYI--------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||...........+.........
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 44322 23356999999999986 577899999999999999999999999754433222222222221111
Q ss_pred cCCcccc---------cCccc--cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 752 SGDIQGI---------IDPSL--LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 752 ~~~~~~~---------id~~l--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
......+ .++.+ ...........+.+++.+|++.||++|||++|++++..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111110 00111 12345667778899999999999999999999999988754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=354.15 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=202.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 456789999999999999876 689999999865432 2346788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 93 IEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999853 34688999999999999999999998 99999999999999999999999999998665443
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .......... ... .....
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~-~~~-~~~~~ 236 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDS-VPN-VTTDV 236 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSC-CCC-HHHHS
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhcc-CCC-cchhc
Confidence 33344567999999999999999999999999999999999999999765411 1111111111 110 00111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIV 805 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-sm~eV~~~L~~~~~ 805 (854)
... ....+.+++.+|++.+|++|| ++.++.+.|+.++.
T Consensus 237 ~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 237 RKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 112 234688999999999999999 89999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.58 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=208.8
Q ss_pred HHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
+.+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 446789999999999999862 45789999997543 33456788999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhccccc--------------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 003039 601 YEFMHNGTLKEHLYGTLT--------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 660 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 660 (854)
|||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence 999999999999965322 124588999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCccccccccccc
Q 003039 661 LLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN 738 (854)
Q Consensus 661 Ll~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~ 738 (854)
|++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 259 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE-- 259 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 9999999999999999865443322 2233457889999999999999999999999999999999 99999765421
Q ss_pred ccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 739 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 739 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+.... ..+... ..... ....+.+++.+|++.+|++||++.||+++|++++.
T Consensus 260 --~~~~~~----~~~~~~-----~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 260 --RLFNLL----KTGHRM-----ERPDN----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp --GHHHHH----HTTCCC-----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHh----hcCCcC-----CCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 222221 111111 11112 22458899999999999999999999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=361.11 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=203.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc------cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
|.+.+.||+|+||.||+|+.+ +|+.||||+++..... ....+.+|+.+|++++||||+++++++...+..++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 456789999999999999987 5899999999754322 346789999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC----cEEEEeeecc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGLS 676 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFGla 676 (854)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 94 LELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999843 45689999999999999999999998 999999999999998877 7999999999
Q ss_pred ccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 677 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 677 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.. .+..+..
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~----~~~~----~i~~~~~- 235 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLA----NITAVSY- 235 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHH----HHHTTCC-
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHHhcCC-
Confidence 8654432 223456999999999999999999999999999999999999999765421 1111 1111111
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+++...... ...+.+++.+|+..||++|||+.|+++|
T Consensus 236 -~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 -DFDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -CCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -CCCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111111122 2357899999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=366.20 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=207.4
Q ss_pred HHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCCc-ccHHHHHHHHHHHccC-CCCceeeEeeeeeecC-e
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG-R 596 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~-~ 596 (854)
..+.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++.++ +||||+++++++...+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 34556789999999999999742 467899999976533 3346789999999999 7999999999998755 4
Q ss_pred EEEEEEeccCCCHHhhhcccccc---------------------------------------------------------
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTH--------------------------------------------------------- 619 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~--------------------------------------------------------- 619 (854)
.++||||+++|+|.+++......
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 89999999999999999654211
Q ss_pred -----cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC-ceeeccccc
Q 003039 620 -----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGT 693 (854)
Q Consensus 620 -----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt 693 (854)
...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......||
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 11288999999999999999999998 999999999999999999999999999986543322 233445689
Q ss_pred ccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHH
Q 003039 694 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSM 772 (854)
Q Consensus 694 ~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~ 772 (854)
+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .+. ..+..+.... ..... .
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~~~~-----~~~~~----~ 322 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFC----RRLKEGTRMR-----APDYT----T 322 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHH----HHHHHTCCCC-----CCTTC----C
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHH----HHHHcCCCCC-----CCCCC----C
Confidence 99999999999999999999999999999998 999997654221 111 1122221111 11112 2
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 773 WKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 773 ~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
..+.+++..|++.+|++||||.||+++|++++..
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 3578999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=354.86 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=203.5
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc------cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~ 598 (854)
..|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34667889999999999999986 5899999998754321 3567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC----cEEEEeee
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG 674 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFG 674 (854)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999843 45689999999999999999999998 999999999999999887 89999999
Q ss_pred ccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 675 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 675 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ....
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~~----~~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANV----SAVN 233 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHH----HHTC
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHH----HhcC
Confidence 998654322 223456999999999999999999999999999999999999999754421 111111 1111
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.. ......... ...+.+++.+|++.+|++|||+.|+++|
T Consensus 234 ~~--~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YE--FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC--CCHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC--cCccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000111111 2357899999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=348.27 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=198.0
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHcc--CCCCceeeEeeeeee----cCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQE----EGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~--l~HpnIv~l~g~~~~----~~~~~LV~ 601 (854)
+.+.+.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++.. ....++||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 44578999999999999998 4899999998643 34455566666655 799999999998754 34579999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHH--------hCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--------TGCVPAIIHRDLKSSNILLDKHMRAKVSDF 673 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 673 (854)
||+++|+|.+++. ...+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 86 e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 86 HYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp CCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999994 346889999999999999999999 66 9999999999999999999999999
Q ss_pred eccccccCCCCce---eecccccccccCccccccC------cCCCcchhhhHHHHHHHHHhC----------Cccccccc
Q 003039 674 GLSKFAVDGASHV---SSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISG----------QEAISNEK 734 (854)
Q Consensus 674 Gla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~s~~~DVwSlGvvl~elltG----------~~pf~~~~ 734 (854)
|+++......... .....||+.|+|||.+.+. .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997655443322 2234699999999999876 556799999999999999999 77775433
Q ss_pred ccccccchHHHHHHhhhcCCcccccCcccc-CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 735 FGANCRNIVQWAKLHIESGDIQGIIDPSLL-DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 735 ~~~~~~~l~~~~~~~~~~~~~~~~id~~l~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
.... ............+. .+.+. ..........+.+++.+|++.+|++|||+.||++.|+++
T Consensus 238 ~~~~--~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDP--SFEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSC--CHHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCc--chhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2111 11111111111111 11111 112334567899999999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.54 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=201.4
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccC---CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~---~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||.||+|+.+ +|+.||||+++.. .......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 45688999999999999886 6899999999753 2233566889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 88 ~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 159 (337)
T 1o6l_A 88 NGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-G 159 (337)
T ss_dssp TTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-T
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC-C
Confidence 9999999884 345688999999999999999999998 9999999999999999999999999999753322 2
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ... .+.. .+.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~---~i~-~~~~------~~p 225 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFE---LIL-MEEI------RFP 225 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH---HHH-HCCC------CCC
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----HHHH---HHH-cCCC------CCC
Confidence 2334557999999999999999999999999999999999999999754421 1111 111 1111 111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
... ...+.+++.+|++.+|++|| +++||++|
T Consensus 226 ~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 RTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112 23578999999999999999 89999887
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=376.56 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=206.8
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+++|++++||||+++++++. .+..++||||+++|
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g 267 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKG 267 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred eEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCC
Confidence 44678999999999999999888999999997644 34678999999999999999999999987 56789999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 268 ~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 268 SLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp BHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred cHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 999999643 234578889999999999999999998 999999999999999999999999999986543222222
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....+|..|+|||.+....++.++|||||||++|||++ |+.||...... .+...+ ..+... .
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i----~~~~~~---------~ 405 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRAL----ERGYRM---------P 405 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHH----HHTCCC---------C
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCCC---------C
Confidence 33446789999999999999999999999999999999 99999765421 222211 111100 0
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.+......+.+++.+|++.+|++||||.+|++.|+.+.
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11122346889999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=365.75 Aligned_cols=260 Identities=25% Similarity=0.432 Sum_probs=210.3
Q ss_pred HHHhhccccccCceEEEEEEEC--------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCe
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 596 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~--------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~ 596 (854)
.+.+.+.||+|+||.||+|+.. .+..||||+++... ......+.+|+++++++ +||||+++++++...+.
T Consensus 70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 149 (382)
T 3tt0_A 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149 (382)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence 4556789999999999999863 24579999997653 23346788999999999 99999999999999999
Q ss_pred EEEEEEeccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 664 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 664 (854)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 226 (382)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcC
Confidence 9999999999999999965421 134589999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccch
Q 003039 665 HMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 742 (854)
Q Consensus 665 ~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l 742 (854)
++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~----~~ 302 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----EL 302 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HH
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HH
Confidence 99999999999986544322 22333457899999999999999999999999999999999 99999765421 22
Q ss_pred HHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 743 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 743 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.. .+..+.... .... ....+.+++.+|++.+|++||++.||+++|++++..
T Consensus 303 ~~----~~~~~~~~~-----~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 303 FK----LLKEGHRMD-----KPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HH----HHHTTCCCC-----CCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHHcCCCCC-----CCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22 122221111 1111 224588999999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.28 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=195.6
Q ss_pred HHHhhccccccCceEEEEEEECC----CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 34567899999999999998753 4579999987543 334567889999999999999999999985 45689999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 95 ELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp ECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999998532 34588999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
..........+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .+...+ ..+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----~~~~~i----~~~~~~~--- 237 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRI----ENGERLP--- 237 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHH----HTTCCCC---
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----HHHHHH----HcCCCCC---
Confidence 43333344457889999999998899999999999999999997 99999765422 222221 1111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
+... ....+.+++.+|++.+|++||++.||+++|++++..+
T Consensus 238 --~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 238 --MPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp --CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1112 2345789999999999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=355.36 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=205.1
Q ss_pred HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-----cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-----~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~ 598 (854)
...|.+.+.||+|+||.||+|..+ +++.||||++.... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345677899999999999999876 68999999986321 224577899999999999999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc---EEEEeeec
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGL 675 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkl~DFGl 675 (854)
+||||+++|+|.+.+.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988865433445688999999999999999999998 9999999999999987655 99999999
Q ss_pred cccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.. .+..+..
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~----~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ERLFE----GIIKGKY 249 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHHHH----HHHHTCC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHHHH----HHHcCCC
Confidence 98654432 22334569999999999999999999999999999999999999997643 11111 1111111
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .++...... ...+.+++.+|++.||++|||+.|+++|
T Consensus 250 ~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 K--MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 111111112 2457899999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=352.16 Aligned_cols=260 Identities=21% Similarity=0.278 Sum_probs=198.2
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.++||+|+||+||+|+..+++.||||++..... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 345689999999999999998899999999875432 224678899999999999999999999999999999999998
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+ +|.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 103 ~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 103 K-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp E-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred C-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 5 78777753 234588999999999999999999998 999999999999999999999999999986543322
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc---c-----
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI---Q----- 756 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~---~----- 756 (854)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.. ....... .
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS----ILGTPNPREWPQVQEL 250 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH----HHCCCCTTTSGGGTTS
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH----HHCCCChHHhhhhhcc
Confidence 2233468999999999876 5689999999999999999999999976543222212111 1111000 0
Q ss_pred --------cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 --------GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 --------~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+.............++.+++.+|++.||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000000001112457899999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=378.29 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=209.7
Q ss_pred HHhhccccccCceEEEEEEECC-CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.++||+|+||.||+|+++. +..||||+++... ...+.|.+|+++|++++||||++++++|...+..++||||+++
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 300 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCC
Confidence 4467899999999999999874 8899999997543 3467899999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 301 g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 301 GNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp CBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 9999999643 234588999999999999999999998 99999999999999999999999999998664433223
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....+|..|+|||.+....++.++|||||||++|||++ |+.||...... .+...+ ..+. ..
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~~~~~~----~~~~---------~~ 438 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELL----EKDY---------RM 438 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHH----HTTC---------CC
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCC---------CC
Confidence 333456789999999999999999999999999999999 99999765422 222221 1111 01
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
..+......+.+|+.+|++.+|++||||.||++.|+.++
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111122346889999999999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=365.59 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=207.2
Q ss_pred HHHhhccccccCceEEEEEEEC------CCcEEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
.+.+.+.||+|+||+||+|++. +++.||||+++.. .......+.+|+.++++++||||+++++++...+..++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 3456789999999999999854 4678999999754 33445678899999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhcccc---cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEee
Q 003039 600 VYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDF 673 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DF 673 (854)
||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999996543 2234689999999999999999999998 999999999999999555 5999999
Q ss_pred eccccccCC-CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhh
Q 003039 674 GLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 674 Gla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
|+++..... .........||+.|+|||.+.+..++.++|||||||++|||++ |..||...... .+... +.
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~----~~~~~----i~ 300 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEF----VT 300 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHH----HH
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HH
Confidence 999744221 1122234458999999999999999999999999999999998 99999765411 22221 11
Q ss_pred cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.+.... .+......+.+++.+|++.+|++||++.||+++|+.+...
T Consensus 301 ~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 SGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 111100 1111224588999999999999999999999999987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.44 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=208.5
Q ss_pred HHHhhccccccCceEEEEEEE-----CCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeee--ecCeEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVL 599 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~-----~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~--~~~~~~L 599 (854)
.+.+.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 345678999999999999985 358899999998766666677999999999999999999999886 4567899
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999998532 34589999999999999999999998 9999999999999999999999999999866
Q ss_pred cCCCCc--eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccc-------cccchHHHHHHhh
Q 003039 680 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA-------NCRNIVQWAKLHI 750 (854)
Q Consensus 680 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~-------~~~~l~~~~~~~~ 750 (854)
...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||....... .............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 543322 2233458889999999999999999999999999999999999986533110 0000111111111
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
..+. ....+......+.+++.+|++.+|++|||+.||+++|+.+....
T Consensus 258 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 258 EEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111 11112223346889999999999999999999999999986543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=349.49 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=212.9
Q ss_pred HHHhhccccccCceEEEEEEECC-CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.+.||+|+||.||+|.+.. ++.||+|++.... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 92 (288)
T 3kfa_A 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 92 (288)
T ss_dssp GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence 34567899999999999999874 7889999997543 345778999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 93 ~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 93 YGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp TEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred CCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 99999999642 235588999999999999999999998 9999999999999999999999999999876554444
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .+...... +. ..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~~~~~~~~----~~-----~~--- 231 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEK----DY-----RM--- 231 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHHT----TC-----CC---
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhc----cC-----CC---
Confidence 4445567889999999999999999999999999999999 99999765422 22222111 10 00
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
..+......+.+++..|++.+|++||++.||++.|+.+....
T Consensus 232 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 232 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111112246889999999999999999999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=356.44 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=199.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCc----EEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~----~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
+.+.+.||+|+||+||+|++. +++ +||+|.++.. .....+.+.+|+.++++++||||++++++|.... .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 445689999999999999875 344 3688887543 2345678999999999999999999999998764 78999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 96 QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp ECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999998642 35688999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 682 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 682 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.... ..+..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~----~~~~~---- 237 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSIL----EKGER---- 237 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHH----HTTCC----
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----HHHHHH----HcCCC----
Confidence 3322 2233457889999999999999999999999999999999 99999765421 222221 11110
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
...+......+.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 238 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 238 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 011112234688999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=355.42 Aligned_cols=265 Identities=26% Similarity=0.385 Sum_probs=206.4
Q ss_pred HHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 597 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~ 597 (854)
..+.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.+++++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 34556789999999999999862 45689999997542 33456789999999999 899999999999999999
Q ss_pred EEEEEeccCCCHHhhhcccccc-------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTH-------------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 658 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~ 658 (854)
++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 9999999999999999653211 13478999999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCccccccccc
Q 003039 659 NILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 736 (854)
Q Consensus 659 NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~ 736 (854)
|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999986544332 22334567889999999999999999999999999999998 99999765422
Q ss_pred ccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 003039 737 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIERE 809 (854)
Q Consensus 737 ~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~~~ 809 (854)
. .+.. .+..+.. . ..+......+.+++.+|++.+|++||++.||+++|+.++...++
T Consensus 282 ~---~~~~----~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 282 A---NFYK----LIQNGFK-----M----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp H---HHHH----HHHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred H---HHHH----HHhcCCC-----C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 1 1111 1121111 0 01111234688999999999999999999999999998765443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=346.44 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=196.6
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence 45678999999999999998899999999965432 2346788999999999999999999999999999999999985
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 85 -~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (288)
T 1ob3_A 85 -DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (288)
T ss_dssp -EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred -CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence 898888532 35688889999999999999999998 99999999999999999999999999997654322 12
Q ss_pred eecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc-----cccC
Q 003039 687 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ-----GIID 760 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~-----~~id 760 (854)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+....... ...... ...+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP-NSKNWPNVTELPKYD 235 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGSTTCC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCC-Chhhchhhhcccccc
Confidence 233468999999999976 458999999999999999999999997654221111111100000 000000 0011
Q ss_pred cccc-------CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLL-------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.+. ..........+.+++.+|++.||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1110 00111123457899999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=352.99 Aligned_cols=249 Identities=18% Similarity=0.300 Sum_probs=202.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 345688999999999999887 58899999987443 3456688999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--CCcEEEEeeeccccccCCCC
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~~~~~~~ 684 (854)
|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 86 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 86 LDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 999999853 234688999999999999999999998 9999999999999997 7899999999998664432
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.. .. ..+... .++...
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~---~i-~~~~~~--~~~~~~ 227 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIE---NI-MNAEYT--FDEEAF 227 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHH---HH-HHTCCC--CCHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----HHHH---HH-HcCCCC--CChhhh
Confidence 234456999999999999988999999999999999999999999765421 1111 11 111110 011111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... ...+.+++.+|++.||++|||+.|+++|
T Consensus 228 ~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 228 KEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112 2357899999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.97 Aligned_cols=251 Identities=30% Similarity=0.429 Sum_probs=191.6
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCc----ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~----~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 345689999999999999986 89999999865432 2246788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--------CCcEEEEeeec
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--------HMRAKVSDFGL 675 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~--------~~~vkl~DFGl 675 (854)
+++++|.+++. ...+++..++.++.|++.||+|||+....+|+||||||+|||++. ++.+||+|||+
T Consensus 88 ~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 88 ARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp CTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred CCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999884 346889999999999999999999983223999999999999986 77899999999
Q ss_pred cccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ... .....
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~---~~~-~~~~~ 231 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----AVA---YGV-AMNKL 231 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----HHH---HHH-HTSCC
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHH---Hhh-hcCCC
Confidence 97554322 22346899999999999999999999999999999999999999764411 111 111 11111
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
. ...+......+.+++.+|++.+|++|||+.|++++|+++
T Consensus 232 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 A--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1 111112234688999999999999999999999999863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.60 Aligned_cols=254 Identities=28% Similarity=0.485 Sum_probs=207.7
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 345688999999999999998889999999976543 3567899999999999999999999999999999999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 89 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 89 CLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred cHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999998532 34578999999999999999999998 999999999999999999999999999976543222222
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. .+..+.. ...+ ..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~----~i~~~~~--~~~~---~~ 229 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVE----DISTGFR--LYKP---RL 229 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH----HHHTTCC--CCCC---TT
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH----HHHH----HHhcCCc--CCCC---cc
Confidence 33457889999999998899999999999999999999 89999764411 1111 1111110 0011 11
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
....+.+++.+|++.+|++||++.|++++|+++..
T Consensus 230 ----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 230 ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12357899999999999999999999999999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=366.81 Aligned_cols=248 Identities=28% Similarity=0.439 Sum_probs=202.8
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecC-eEEEEEEeccCC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFMHNG 607 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~-~~~LV~E~~~~g 607 (854)
.+.+.||+|+||.||+|.++ ++.||||+++... ..+.|.+|+++|++++||||+++++++...+ ..++||||+++|
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred EEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 45688999999999999987 7899999997553 4567999999999999999999999987665 789999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 273 ~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 343 (450)
T 1k9a_A 273 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 343 (450)
T ss_dssp BHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----c
Confidence 999999643 223468889999999999999999998 9999999999999999999999999999754322 1
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+... +..+... .
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~~----i~~~~~~---------~ 406 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPR----VEKGYKM---------D 406 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT----THHHH----HHTTCCC---------C
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HHcCCCC---------C
Confidence 22357899999999999999999999999999999998 99999765422 22221 1222110 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+......+.+++.+|++.+|++|||+.||++.|+.+..
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111223468899999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=344.75 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=207.6
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.+.||+|+||.||+|...+++.||||++.... .....+.+|++++++++||||+++++++.. +..++||||++++
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (279)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCC
Confidence 44678999999999999999888899999997543 346778999999999999999999999874 4689999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 93 ~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 93 SLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp BHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999532 233688999999999999999999998 999999999999999999999999999986654433333
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+... +..+.. ......
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~----~~~~~~-----~~~~~~ 234 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQN----LERGYR-----MVRPDN 234 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHH----HHTTCC-----CCCCTT
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----HHHHH----HhcccC-----CCCccc
Confidence 34457889999999998899999999999999999999 99999754421 12111 111110 011111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
....+.+++.+|++.+|++|||+.+|++.|+++...
T Consensus 235 ----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 235 ----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 224688999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=371.97 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=201.6
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.++||+|+||.||+|.++++..||||+++... ...+.|.+|+++|++++||||+++++++.. +..++||||+++|
T Consensus 186 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~g 263 (452)
T 1fmk_A 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 263 (452)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred ceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCC
Confidence 44678999999999999999988889999997544 345689999999999999999999999876 6789999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 264 sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 264 SLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp BHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 999999632 234588999999999999999999998 999999999999999999999999999986554332233
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....+|..|+|||.+....++.++|||||||++|||++ |+.||...... .+.. .+..+... .
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~----~i~~~~~~---------~ 401 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERGYRM---------P 401 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH----HHHTTCCC---------C
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCCCC---------C
Confidence 34457889999999999999999999999999999999 99999765421 1222 12222110 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.+......+.+++.+|++.+|++|||+.+|++.|+.+.
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11122346889999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=358.89 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=207.3
Q ss_pred HHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
+.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++++++||||+++++++...+..++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 445788999999999999875 34789999997653 23356789999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccccc--------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 003039 601 YEFMHNGTLKEHLYGTLTH--------------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 660 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 660 (854)
|||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence 9999999999999653211 25689999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCccccccccccc
Q 003039 661 LLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN 738 (854)
Q Consensus 661 Ll~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~ 738 (854)
|++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 283 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 283 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH--
Confidence 999999999999999975432211 12233458899999999999999999999999999999999 99999754411
Q ss_pred ccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 739 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 739 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.+.. .+..+.... .... ....+.+++.+|++.+|++||++.||+++|+++...
T Consensus 284 --~~~~----~~~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 284 --EVIY----YVRDGNILA-----CPEN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp --HHHH----HHHTTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred --HHHH----HHhCCCcCC-----CCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 1111 222222211 1112 224588999999999999999999999999998653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.85 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=193.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--------------------------cHHHHHHHHHHHccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------------------------GKREFTNEVTLLSRIH 580 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--------------------------~~~~~~~Ev~~L~~l~ 580 (854)
|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 446789999999999999876 6889999998654311 1246889999999999
Q ss_pred CCceeeEeeeeee--cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 003039 581 HRNLVQFLGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 658 (854)
Q Consensus 581 HpnIv~l~g~~~~--~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~ 658 (854)
||||+++++++.. .+..++||||+++++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 9999999999986 568899999999999987652 34688999999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEeeeccccccCCCCceeecccccccccCccccccCc---CCCcchhhhHHHHHHHHHhCCcccccccc
Q 003039 659 NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKF 735 (854)
Q Consensus 659 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~~DVwSlGvvl~elltG~~pf~~~~~ 735 (854)
|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999986544322 233456999999999998655 47789999999999999999999975431
Q ss_pred cccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 736 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 736 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... ...+....... + .....+ ..+.+++.+|++.+|++||++.|+++|
T Consensus 246 -------~~~-~~~~~~~~~~~---~-~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 -------MCL-HSKIKSQALEF---P-DQPDIA----EDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp -------HHH-HHHHHHCCCCC---C-SSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred -------HHH-HHHHhcccCCC---C-CccccC----HHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 111 11111111110 0 011122 357899999999999999999999865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=352.33 Aligned_cols=258 Identities=18% Similarity=0.227 Sum_probs=205.7
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+|+++++++ +||||+++++++...+..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 45688999999999999874 689999999875432 34688999999999 9999999999999999999999999 9
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc-----EEEEeeeccccccC
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAVD 681 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----vkl~DFGla~~~~~ 681 (854)
++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 89 ~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 89 PSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999998642 45789999999999999999999998 9999999999999999887 99999999986544
Q ss_pred CCCc------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 682 GASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 682 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......... ...
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~ 241 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-TPI 241 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-SCH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-CCH
Confidence 3221 123457999999999999999999999999999999999999999865422211111111111110 000
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
+.+... .. ++.+++..|++.+|.+||++.+|.+.|+++...
T Consensus 242 -----~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 242 -----EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp -----HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 000011 11 688999999999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=352.60 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=206.9
Q ss_pred HhhccccccCceEEEEEEEC-----CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 600 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-----~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV 600 (854)
.+.+.||+|+||+||++.++ +++.||||+++... ......+.+|++++++++||||+++++++... ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 56789999999999998753 57899999997653 23456789999999999999999999999874 678999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp ECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999853 3488999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCc--eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccc-----cccc--hHHHHHHhhh
Q 003039 681 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA-----NCRN--IVQWAKLHIE 751 (854)
Q Consensus 681 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~-----~~~~--l~~~~~~~~~ 751 (854)
..... ......||..|+|||.+.+..++.++|||||||++|||++|+.||....... .... -.........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 44322 2234458889999999999999999999999999999999999986533110 0000 0001111111
Q ss_pred cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 808 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~~ 808 (854)
.+. ....+......+.+++.+|++.+|++|||+.||++.|+++.....
T Consensus 266 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 266 RGE---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ccc---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 111 111122223468899999999999999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=359.83 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=196.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+.+.||+|+||.||+|+.+ +++.||||+++... ......+..|..+++.+ +||||+++++++...+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 445789999999999999986 58999999997542 22345677899999988 79999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 105 FVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999853 45689999999999999999999998 9999999999999999999999999999753322
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.. .+..+.. .
T Consensus 178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~----~i~~~~~------~ 242 (353)
T 3txo_A 178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----LFE----AILNDEV------V 242 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHCCC------C
T ss_pred -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----HHH----HHHcCCC------C
Confidence 223345679999999999999999999999999999999999999997654221 111 1111111 0
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm------~eV~~~ 799 (854)
+... ....+.+++.+|++.+|++||++ .||++|
T Consensus 243 ~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 YPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 0111 22357889999999999999998 788775
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.65 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=198.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 345689999999999999887 789999999865432 234568899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC-C
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-S 684 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 684 (854)
+|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 89 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 89 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999884 345689999999999999999999998 99999999999999999999999999997553322 2
Q ss_pred ceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ......|... ... ..+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~----~~~---~~~-- 230 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKEK----KTY---LNP-- 230 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHHHTT----CTT---STT--
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhcc----ccc---CCc--
Confidence 22334579999999999987765 77899999999999999999999764411 1112222111 100 000
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... ....+.+++.+|++.+|++|||+.|++++
T Consensus 231 ~~~----~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 WKK----IDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGG----SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccc----CCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011 12356789999999999999999999876
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.27 Aligned_cols=250 Identities=20% Similarity=0.333 Sum_probs=204.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.+.||+|+||.||+|... +++.||+|++..........+.+|+++|++++||||+++++++...+..++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 456789999999999999886 6889999999766555567889999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--CCcEEEEeeeccccccCCCC
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~~~~~~~ 684 (854)
|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 133 g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 133 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 999998853 234689999999999999999999998 9999999999999974 4789999999998654432
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+ ..... ..++...
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i----~~~~~--~~~~~~~ 274 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNV----KRCDW--EFDEDAF 274 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHH----HHCCC--CCCSSTT
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH----HHHHHH----HhCCC--CCCcccc
Confidence 233446999999999999999999999999999999999999999764411 111111 11111 0111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+ ..+.+++.+|++.||++|||+.|++++
T Consensus 275 ~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 SSVS----PEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccCC----HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 2222 357899999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=353.57 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=194.7
Q ss_pred HHHhhccccccCceEEEEEEECCC----cEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeE---
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS--- 597 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~~----~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~--- 597 (854)
.+.+.+.||+|+||.||+|++... ..||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 455678999999999999987643 27999998754 234457789999999999999999999999877655
Q ss_pred ---EEEEEeccCCCHHhhhccccc--ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 003039 598 ---VLVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 672 (854)
Q Consensus 598 ---~LV~E~~~~gsL~~~L~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 672 (854)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence 999999999999999854321 222588999999999999999999998 999999999999999999999999
Q ss_pred eeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhh
Q 003039 673 FGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 673 FGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.... .
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~---~ 253 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA----EIYNYL---I 253 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHH---H
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH----HHHHHH---h
Confidence 9999765443221 2233457889999999999999999999999999999999 99999765422 222211 1
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.+... ..+......+.+++.+|++.+|++|||+.|+++.|++++..
T Consensus 254 -~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 254 -GGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp -TTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -cCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11100 01111224688999999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.09 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=197.1
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
.+.||+|+||.||+|... +|+.||+|+++.........+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 457999999999999875 6899999999876656677899999999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE--cCCCcEEEEeeeccccccCCCCcee
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl--~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 998853 234688999999999999999999998 99999999999999 5678999999999986544322 2
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ........ .. +.+......
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~---~~~i~~~~-~~--~~~~~~~~~ 315 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE----T---LNNILACR-WD--LEDEEFQDI 315 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----H---HHHHHHTC-CC--SCSGGGTTS
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----H---HHHHHhcc-CC--CChhhhccC
Confidence 33469999999999999999999999999999999999999997654211 1 11111111 00 111111122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+ ..+.+++.+|++.+|++||++.|++++
T Consensus 316 ~----~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 316 S----EEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp C----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 2 357899999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=351.13 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=209.1
Q ss_pred HHHhhccccccCceEEEEEEE------CCCcEEEEEEEccCCc-ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~------~~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~ 598 (854)
.+.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 345678999999999999985 2467899999975533 3456789999999999 9999999999999999999
Q ss_pred EEEEeccCCCHHhhhccccc--------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 003039 599 LVYEFMHNGTLKEHLYGTLT--------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 664 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 664 (854)
+||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcC
Confidence 99999999999999964321 123588999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccch
Q 003039 665 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 742 (854)
Q Consensus 665 ~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l 742 (854)
++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .+
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~ 257 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---KF 257 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---HH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---HH
Confidence 999999999999866544332 2234457889999999999999999999999999999999 999997654221 11
Q ss_pred HHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 743 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 743 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
... ...+.. ...... ....+.+++.+|++.+|++|||+.||+++|++++.
T Consensus 258 ~~~----~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 YKM----IKEGFR-----MLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHH----HHHTCC-----CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----hccCCC-----CCCccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111 111110 000111 22458899999999999999999999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=364.38 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=202.4
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
..|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 34566789999999999999875 689999999975532 234568899999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc---CCCcEEEEeeeccccc
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFA 679 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkl~DFGla~~~ 679 (854)
|+.+|+|.+.+.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 91 ~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 91 LVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999998853 35688999999999999999999998 999999999999998 4678999999999765
Q ss_pred cCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.... .......||+.|+|||++.+..++.++||||+||++|||++|..||...... .+... +..+... .
T Consensus 164 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~----~~~~~----i~~~~~~--~ 232 (444)
T 3soa_A 164 EGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH----RLYQQ----IKAGAYD--F 232 (444)
T ss_dssp CTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH----HHHTCCC--C
T ss_pred cCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH----HHHHH----HHhCCCC--C
Confidence 4432 2233457999999999999999999999999999999999999999765421 12221 1222111 0
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........ ...+.+++.+|++.||++|||+.|+++|
T Consensus 233 ~~~~~~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEWDTV----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CccccccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01111122 2357899999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=350.93 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=196.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecC---------
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------- 595 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~--------- 595 (854)
.+.+.+.||+|+||.||+|+++ +++.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 3455789999999999999987 78999999997543 334577999999999999999999999986543
Q ss_pred ------------------------------------------------eEEEEEEeccCCCHHhhhcccccccccccHHH
Q 003039 596 ------------------------------------------------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 627 (854)
Q Consensus 596 ------------------------------------------------~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~ 627 (854)
..++||||+++|+|.+++.... ......+..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~ 165 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGV 165 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHH
Confidence 3799999999999999996543 233456667
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC-----------ceeecccccccc
Q 003039 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-----------HVSSIVRGTVGY 696 (854)
Q Consensus 628 ~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~-----------~~~~~~~gt~~Y 696 (854)
++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 889999999999999998 999999999999999999999999999986654321 122334699999
Q ss_pred cCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHH
Q 003039 697 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 776 (854)
Q Consensus 697 ~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~ 776 (854)
+|||.+.+..++.++|||||||++|||++|..|+.... .+.. ........ .........+.
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~------~~~~----~~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV------RIIT----DVRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH------HHHH----HHHTTCCC---------HHHHHHCHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH------HHHH----HhhccCCC---------cccccCChhHH
Confidence 99999999999999999999999999999977653221 1111 11111111 11122334578
Q ss_pred HHHHHccCCCCCCCCCHHHHHHH
Q 003039 777 EKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 777 ~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+++.+|++.+|++||++.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.83 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=202.9
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
..|.+.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45667889999999999999886 589999999975432 334678899999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEeeeccccc
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFA 679 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DFGla~~~ 679 (854)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 109 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 109 LVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999998853 34688999999999999999999998 999999999999998654 5999999999765
Q ss_pred cCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +..+... .
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~----i~~~~~~--~ 249 (362)
T 2bdw_A 182 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQ----IKAGAYD--Y 249 (362)
T ss_dssp TTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHTCCC--C
T ss_pred cCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHH----HHhCCCC--C
Confidence 4332 223456999999999999999999999999999999999999999764411 12221 1122111 0
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........ ...+.+++.+|++.||++||++.|+++|
T Consensus 250 ~~~~~~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPEWDTV----TPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTGGGGS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CcccccCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00011112 2357899999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=353.43 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=199.9
Q ss_pred HhhccccccCceEEEEEEEC-CCc----EEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~----~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.+.||+|+||.||+|++. +++ +||+|++.... ......+.+|+.++++++||||+++++++. .+..++|||
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence 45688999999999999875 344 37888875442 233456778999999999999999999986 456899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 95 YLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp CCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred eCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999998642 45688899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 683 ASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 683 ~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
... ......||..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+... +..+.... .
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~----~~~~~~~~--~ 238 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPDL----LEKGERLA--Q 238 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HHHHH----HHTTCBCC--C
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HHHHH----HHcCCCCC--C
Confidence 322 2344568889999999999999999999999999999999 99999765422 22221 11111100 0
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
+. .....+.+++.+|++.+|++||++.||+++|+.+...
T Consensus 239 ~~-------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 239 PQ-------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CT-------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CC-------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 1112467899999999999999999999999998653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.97 Aligned_cols=259 Identities=17% Similarity=0.240 Sum_probs=206.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.+.||+|+||.||+|... +++.||||++.... ....+.+|+.+++++ +|+|++++++++......++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 445688999999999999874 68999999986443 234578899999999 7999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc-----EEEEeeecccccc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAV 680 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----vkl~DFGla~~~~ 680 (854)
+++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999999632 34589999999999999999999998 9999999999999987776 9999999998665
Q ss_pred CCCCc------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 681 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 681 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....+........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-HHHHHHHhhccCcc
Confidence 43221 234456999999999999999999999999999999999999999765422211 11111111111111
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..+ +.... ...+.+++.+|++.+|++||++.+|++.|++++.
T Consensus 242 ~~~-----~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 242 LRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHH-----HHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 110 11112 2468899999999999999999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=343.90 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=204.5
Q ss_pred HHhhccccccCceEEEEEEECC----CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+.+.||+|+||.||+|++.. +..||||++.... ....+.+.+|++++++++||||+++++++.++ ..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEe
Confidence 3457899999999999998653 3469999987653 33457789999999999999999999998754 5689999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 93 LYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred cCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 9999999999953 234588999999999999999999998 9999999999999999999999999999865544
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+..... .+....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~----~~~~~~~----~~~~~~---- 234 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIGVLE----KGDRLP---- 234 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG----GHHHHHH----HTCCCC----
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH----HHHHHHh----cCCCCC----
Confidence 3333344557889999999998899999999999999999998 99999754321 2222111 111100
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA 811 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~~~~~ 811 (854)
.... ....+.+++.+|++.+|++||++.||+++|+++...+.+.+
T Consensus 235 -~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~i~ 279 (281)
T 3cc6_A 235 -KPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 279 (281)
T ss_dssp -CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHH
T ss_pred -CCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhhhh
Confidence 0111 12458899999999999999999999999999987765543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=365.95 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=203.0
Q ss_pred HhhccccccCceEEEEEEECC-CcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.++||+|+||+||+|+++. ++.||||+++.... .....+.+|+.++..++||||++++++|.+.+..++||||+
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence 346789999999999999874 78899999964321 12334889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 157 ~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 157 VGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 999999999642 45689999999999999999999998 999999999999999999999999999986655544
Q ss_pred ceeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 685 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..+... -.+.
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----~~~p--- 303 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER----FQFP--- 303 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCCC---
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc----ccCC---
Confidence 4455567999999999997 567899999999999999999999999865532222222221111 1111
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eV~~~ 799 (854)
......+ ..+.+++.+|+..+|++ ||+++|+++|
T Consensus 304 --~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 304 --TQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --SSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --cccccCC----HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1111122 35778999999888888 9999999987
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=356.49 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=200.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+.++||+|+||.||+|+.+ +++.||||+++.... .....+..|..++.++ +||||+++++++...+..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 345789999999999999987 578899999975422 2234578899999887 89999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 ~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 134 YVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999998853 45689999999999999999999998 9999999999999999999999999999753322
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccccc-ccchHHHHHHhhhcCCcccccCc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~-~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...........+..+.+
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 2234456799999999999999999999999999999999999999965332111 11112222222222221
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm------~eV~~~ 799 (854)
.+.... ...+.+++.+|++.||++||++ .||++|
T Consensus 280 ~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 RIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCCCcC----CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 111112 2357899999999999999985 677665
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.83 Aligned_cols=250 Identities=24% Similarity=0.421 Sum_probs=200.0
Q ss_pred HHhhccccccCceEEEEEEECC-C-------cEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD-G-------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~-~-------~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
+.+.+.||+|+||.||+|.... + ..||+|++........+.+.+|++++++++||||+++++++..++..++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 4567899999999999998663 3 5799999976666667789999999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc--------EEEE
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVS 671 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--------vkl~ 671 (854)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999642 34488899999999999999999998 9999999999999998887 9999
Q ss_pred eeeccccccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcc-cccccccccccchHHHHHHh
Q 003039 672 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEA-ISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 672 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~p-f~~~~~~~~~~~l~~~~~~~ 749 (854)
|||+++.... .....||+.|+|||.+.+ ..++.++|||||||++|||++|..| +..... ...... .
T Consensus 164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~~~~~---~ 231 (289)
T 4fvq_A 164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS----QRKLQF---Y 231 (289)
T ss_dssp CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHH---H
T ss_pred cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch----HHHHHH---h
Confidence 9999864422 123458999999999987 7789999999999999999996544 433221 011111 1
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
.....+.. .. ...+.+++.+|++.+|++|||+.|++++|++++...
T Consensus 232 ~~~~~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 232 EDRHQLPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HTTCCCCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred hccCCCCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 11111111 11 124778999999999999999999999999987643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.07 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=194.8
Q ss_pred HHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCe
Q 003039 521 SDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 596 (854)
Q Consensus 521 ~~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~ 596 (854)
+++....+.+.++||+|+||+||+|++. +++.||||++..... .....+..|+..+.++ +||||++++++|.+.+.
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 4455566777889999999999999987 689999999865432 2233455566555555 89999999999999999
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
.++||||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceee
Confidence 99999999 67998888542 34689999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 677 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 677 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
+..... .......||++|+|||++.+ .++.++|||||||++|||++|..|+.... .| ..+..+...
T Consensus 205 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~--~~~~~~~~~ 270 (311)
T 3p1a_A 205 VELGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GW--QQLRQGYLP 270 (311)
T ss_dssp EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HH--HHHTTTCCC
T ss_pred eecccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HH--HHHhccCCC
Confidence 765432 22334569999999998875 78999999999999999999977664322 01 111111111
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.+... ....+.+++.+|++.+|++|||+.|++++
T Consensus 271 ----~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 ----PEFTAG----LSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cccccC----CCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111111 22468899999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.32 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=204.9
Q ss_pred HHHhhccccccCceEEEEEEE-----CCCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~-----~~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~ 598 (854)
.+.+.+.||+|+||.||+|++ .+++.||||++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 345678999999999999984 368899999997543 33457789999999999999999999999876 6689
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 102 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999998532 34588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCc--eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccc-------cccccchHHHHHHh
Q 003039 679 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-------GANCRNIVQWAKLH 749 (854)
Q Consensus 679 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~-------~~~~~~l~~~~~~~ 749 (854)
....... ......||..|+|||.+.+..++.++|||||||++|||++|+.|+..... +.............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6544322 22345688899999999999999999999999999999999998753210 00001111111122
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
...+.. ...+......+.+++.+|++.+|++|||+.||++.|++++
T Consensus 256 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 222211 1111122346889999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.77 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=191.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.+.||+|+||.||+|..+ +++.||||+++... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4556789999999999999876 58999999997543 233467889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccc--cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 605 HNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 605 ~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
+ |+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 69999885432 1224588899999999999999999998 9999999999999999999999999999865432
Q ss_pred CCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhc--------C
Q 003039 683 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--------G 753 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~--------~ 753 (854)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.......... .
T Consensus 162 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 162 V-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp C-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred c-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 2 22233468999999999976 468999999999999999999999997654221111111110000000 0
Q ss_pred C------------cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 754 D------------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 754 ~------------~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. +...+.+..... ....+.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 000001111111 12368899999999999999999999886
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.63 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=180.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
+.||+|+||.||+|..+ +++.||||++... ....+.+|+.+++++. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999986 6899999998643 3567788999999997 99999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEeeeccccccCCCCce
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DFGla~~~~~~~~~~ 686 (854)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~ 165 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QP 165 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cc
Confidence 999853 45689999999999999999999998 999999999999998765 89999999998654332 22
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+.. ..+..+... . ...
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~~~~--~----~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFS--F----EGE 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTTCCC--C----CSH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcCCCC--C----Ccc
Confidence 334568999999999999999999999999999999999999997654322222222222 222222211 0 000
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........+.+++.+|++.||++|||+.|+++|
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 001123468899999999999999999999865
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=364.94 Aligned_cols=248 Identities=22% Similarity=0.274 Sum_probs=200.5
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 4578999999999999987 58899999986431 1223457889999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 153 gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 153 GGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp TEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred CCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 9999998853 3578889999999999999999998 9999999999999999999999999999866544433
Q ss_pred eeecccccccccCccccccCc----CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~----~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+..+... -....
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----~~~p~---- 296 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS----LTFPD---- 296 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCCCT----
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc----ccCCC----
Confidence 445667999999999998655 889999999999999999999999765432222222221110 00000
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eV~~~ 799 (854)
....+ ..+.+|+.+|++.+|++ ||+++||++|
T Consensus 297 --~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 --DNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --TCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --ccccc----HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 01112 35789999999999988 9999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.87 Aligned_cols=260 Identities=20% Similarity=0.240 Sum_probs=196.0
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 45678999999999999986 589999999975432 234678899999999999999999999999999999999998
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 156 (292)
T 3o0g_A 85 Q-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R 156 (292)
T ss_dssp E-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-S
T ss_pred C-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-c
Confidence 6 55555532 245689999999999999999999998 99999999999999999999999999998654322 2
Q ss_pred eeecccccccccCccccccCc-CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC---Ccccc---
Q 003039 686 VSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---DIQGI--- 758 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~---~~~~~--- 758 (854)
......||+.|+|||++.+.. ++.++|||||||++|||++|..|+..... ............... .....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS---HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC---HHHHHHHHHHHhCCCChhhhhhhccc
Confidence 233456899999999998765 79999999999999999998888533221 111111111111100 00000
Q ss_pred cC---------ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 759 ID---------PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 759 id---------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+ ..............+.+++.+|++.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000000111223457899999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.09 Aligned_cols=257 Identities=22% Similarity=0.262 Sum_probs=197.6
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC-----CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~-----~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
..|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 34566889999999999999875 6889999998643 23445678999999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccc------------------------------------cccccHHHHHHHHHHHHHHHHHHH
Q 003039 600 VYEFMHNGTLKEHLYGTLTH------------------------------------EQRINWIKRLEIAEDAAKGIEYLH 643 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH 643 (854)
||||+++|+|.+++...... ...+++..+..++.|++.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998532111 223467778899999999999999
Q ss_pred hCCCCceecCCCCCCCEEEcCCC--cEEEEeeeccccccCCC---CceeecccccccccCcccccc--CcCCCcchhhhH
Q 003039 644 TGCVPAIIHRDLKSSNILLDKHM--RAKVSDFGLSKFAVDGA---SHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSF 716 (854)
Q Consensus 644 ~~~~~~ivHrDIkp~NILl~~~~--~vkl~DFGla~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSl 716 (854)
+. +|+||||||+|||++.++ .+||+|||+++...... ........||+.|+|||.+.+ ..++.++|||||
T Consensus 186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 98 999999999999998776 89999999998553321 112344569999999999975 678999999999
Q ss_pred HHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 003039 717 GVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 796 (854)
Q Consensus 717 Gvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV 796 (854)
||++|||++|+.||......+ ........... ...+. .... ...+.+++.+|++.+|++||++.|+
T Consensus 263 G~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~--~~~~~-~~~~----~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDAD-------TISQVLNKKLC--FENPN-YNVL----SPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC--TTSGG-GGGS----CHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHCCCCCCCCChHH-------HHHHHHhcccc--cCCcc-cccC----CHHHHHHHHHHcCCChhHCCCHHHH
Confidence 999999999999997654211 11111111100 00000 1111 2357899999999999999999999
Q ss_pred HHH
Q 003039 797 LKD 799 (854)
Q Consensus 797 ~~~ 799 (854)
+++
T Consensus 329 l~h 331 (345)
T 3hko_A 329 LQH 331 (345)
T ss_dssp HHS
T ss_pred hcC
Confidence 875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.67 Aligned_cols=266 Identities=16% Similarity=0.229 Sum_probs=203.9
Q ss_pred HHHhhccccccCceEEEEEEECC------CcEEEEEEEccCCcccH-----------HHHHHHHHHHccCCCCceeeEee
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGK-----------REFTNEVTLLSRIHHRNLVQFLG 589 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~------~~~VAvK~l~~~~~~~~-----------~~~~~Ev~~L~~l~HpnIv~l~g 589 (854)
.|.+.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..++.++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 34567899999999999998864 47899999875532111 12344666778889999999999
Q ss_pred eeeec----CeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc--
Q 003039 590 YCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-- 663 (854)
Q Consensus 590 ~~~~~----~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-- 663 (854)
++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 98764 4589999999 9999999853 235689999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeeccccccCCCCc------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccc
Q 003039 664 KHMRAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 737 (854)
Q Consensus 664 ~~~~vkl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~ 737 (854)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 8899999999999765432111 113345999999999999999999999999999999999999999864311
Q ss_pred cccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 738 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 738 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.....+...... ..+.+++++.+.... ....+.+++..|++.+|++||++.+|++.|++++..
T Consensus 268 --~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 268 --PKYVRDSKIRYR-ENIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp --HHHHHHHHHHHH-HCHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHHHhh-hhHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 122222222211 123333443332111 124588999999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.23 Aligned_cols=264 Identities=24% Similarity=0.385 Sum_probs=209.1
Q ss_pred HHHhhccccccCceEEEEEEECC------CcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~------~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~ 598 (854)
.+.+.+.||+|+||.||+|.... ...||+|++.... ......+.+|+++++++ +||||+++++++...+..+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 126 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence 34567899999999999998752 2479999997653 23456789999999999 8999999999999999999
Q ss_pred EEEEeccCCCHHhhhccccc----------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcE
Q 003039 599 LVYEFMHNGTLKEHLYGTLT----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 668 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 668 (854)
+||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeE
Confidence 99999999999999864321 133578899999999999999999998 99999999999999999999
Q ss_pred EEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHH
Q 003039 669 KVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 746 (854)
Q Consensus 669 kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~ 746 (854)
||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||....... .+...
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~- 279 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---KFYKL- 279 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---HHHHH-
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---HHHHH-
Confidence 99999999865433222 2234457889999999999999999999999999999999 999997644221 11111
Q ss_pred HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 003039 747 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIERE 809 (854)
Q Consensus 747 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~~~ 809 (854)
...+.. ... +......+.+++..|++.+|++|||+.||+++|+++....+.
T Consensus 280 ---~~~~~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 330 (333)
T 2i1m_A 280 ---VKDGYQ-----MAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330 (333)
T ss_dssp ---HHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ---HhcCCC-----CCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence 111110 000 111124578999999999999999999999999998765443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.26 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=205.3
Q ss_pred ccccccCceEEEEEEEC---CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999864 57889999997653 33456789999999999999999999999 556789999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce-
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV- 686 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~- 686 (854)
+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 95 ~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 95 PLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp EHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence 99999853 245688999999999999999999998 99999999999999999999999999998664433222
Q ss_pred -eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 687 -SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 687 -~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.....||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+... +..+... .
T Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~----i~~~~~~-----~-- 233 (287)
T 1u59_A 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAF----IEQGKRM-----E-- 233 (287)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHH----HHTTCCC-----C--
T ss_pred ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHHHH----HhcCCcC-----C--
Confidence 123346899999999998899999999999999999998 99999765421 12221 1222111 1
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 808 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~~ 808 (854)
.+......+.+++..|++.+|++||++.||+++|+++.....
T Consensus 234 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 234 --CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp --CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111223468899999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.04 Aligned_cols=242 Identities=24% Similarity=0.395 Sum_probs=200.3
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||.||+|+.+ +|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~ 88 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 88 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence 45688999999999999886 68999999997532 233466788999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 89 EGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp CSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence 99999999853 34688899999999999999999998 999999999999999999999999999986533
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ..... .+.. .+.
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~---~~~i~-~~~~------~~p 223 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----T---YEKIL-NAEL------RFP 223 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----H---HHHHH-HCCC------CCC
T ss_pred -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----H---HHHHH-hCCC------CCC
Confidence 2234579999999999999999999999999999999999999997644211 1 11111 1111 111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
..++ ..+.+++.+|++.+|++|| +++||++|
T Consensus 224 ~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 224 PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1222 3578999999999999999 89999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=342.39 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=199.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 556789999999999999875 68999999997532 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 999999999865444456688999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ....... .+..+......
T Consensus 191 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~~~~~~~---- 259 (310)
T 2wqm_A 191 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK-KIEQCDYPPLP---- 259 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHH-HHHTTCSCCCC----
T ss_pred -ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHH-HhhcccCCCCc----
Confidence 222334689999999999999999999999999999999999999965431 1122211 12222221111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
...+ ...+.+++.+|++.||++||++.||++.|+++....
T Consensus 260 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 260 SDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1122 235889999999999999999999999999986544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.56 Aligned_cols=244 Identities=23% Similarity=0.359 Sum_probs=199.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 445789999999999999974 68999999986432 22245788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+ +|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 91 A-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp C-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred C-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9 7899888843 45688999999999999999999998 99999999999999999999999999998654432
Q ss_pred CceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...........+. .+. ..
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--------~~~------~~ 226 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--------SCV------YV 226 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC--------SSC------CC
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH--------cCC------CC
Confidence 2234569999999999988776 679999999999999999999997655332221110 000 00
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.... ...+.+++.+|++.||++|||+.|++++
T Consensus 227 ~p~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 227 MPDFL----SPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCTTS----CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CcccC----CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11112 2357899999999999999999999886
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.93 Aligned_cols=250 Identities=32% Similarity=0.572 Sum_probs=198.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCccc-------HHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~-------~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
+.+.+.||+|+||.||+|++. +++.||||++....... .+.+.+|++++++++||||+++++++.... ++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 445789999999999999885 68999999986543221 167889999999999999999999997665 69
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEcCCCc-----EEEEe
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMR-----AKVSD 672 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILl~~~~~-----vkl~D 672 (854)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +||+|
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 9999999999988853 345689999999999999999999998 7 999999999999988776 99999
Q ss_pred eeccccccCCCCceeecccccccccCccccc--cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 673 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 673 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
||+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||....... ........
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIR 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHHHHHh
Confidence 999974332 233456999999999984 5567889999999999999999999997654211 11111111
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
..+ . .+.+.... ...+.+++.+|++.+|++||++.||++.|+++
T Consensus 244 ~~~-~----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEG-L----RPTIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSC-C----CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccC-C----CCCCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 1 11111222 34688999999999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=352.48 Aligned_cols=263 Identities=23% Similarity=0.429 Sum_probs=209.3
Q ss_pred HHHHhhccccccCceEEEEEEEC--------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeecC
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 595 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~--------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~ 595 (854)
..+.+.+.||+|+||.||+|++. +++.||||+++... ......+.+|+++++++ +||||+++++++...+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 34556789999999999999873 46789999997553 23356788999999999 8999999999999999
Q ss_pred eEEEEEEeccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 663 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~ 663 (854)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence 99999999999999999965421 123588999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccc
Q 003039 664 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 741 (854)
Q Consensus 664 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~ 741 (854)
.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~ 267 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----E 267 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----H
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----H
Confidence 9999999999999865443222 2233457889999999998899999999999999999999 99999764421 1
Q ss_pred hHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 003039 742 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 808 (854)
Q Consensus 742 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~~ 808 (854)
+... +..+.... .... ....+.+++.+|++.+|++||++.||+++|++++....
T Consensus 268 ~~~~----~~~~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 LFKL----LKEGHRMD-----KPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHH----HHHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHH----HhcCCCCC-----CCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 2221 11221111 1111 22458899999999999999999999999999976543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=336.60 Aligned_cols=249 Identities=21% Similarity=0.310 Sum_probs=201.1
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec--CeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~--~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|+++ ++.||||+++... ....+.+.+|+.++++++||||+++++++... +..++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 345789999999999999986 8999999997653 23456799999999999999999999999877 788999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
+++|+|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.++|+|||++.....
T Consensus 91 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 91 MPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp CTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999642 233589999999999999999999997 7 99999999999999999999999998754222
Q ss_pred CCCceeecccccccccCccccccCcCCC---cchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
....||+.|+|||.+.+..++. ++|||||||++|||++|+.||...... .........+.
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~---- 228 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALEGL---- 228 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHSCC----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhcCC----
Confidence 2235899999999998766555 799999999999999999999764411 11111111111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.+.+.... ...+.+++..|++.+|++|||+.||++.|+++.
T Consensus 229 -~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 -RPTIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -CCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11111222 235889999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=340.75 Aligned_cols=252 Identities=29% Similarity=0.472 Sum_probs=195.0
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
.+.+.||+|+||.||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++|+
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~ 85 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGS 85 (307)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCB
T ss_pred eeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCC
Confidence 45688999999999999986 789999998643 345678999999999999999999999874 4789999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc-EEEEeeeccccccCCCCcee
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-vkl~DFGla~~~~~~~~~~~ 687 (854)
|.+++.... ....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++..... .
T Consensus 86 L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~ 160 (307)
T 2eva_A 86 LYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----M 160 (307)
T ss_dssp HHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred HHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----c
Confidence 999996432 2234678889999999999999999933238999999999999998886 799999999754322 2
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....|. ...+... .+....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~---~~~~~~~-----~~~~~~ 229 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---FRIMWA---VHNGTRP-----PLIKNL 229 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---HHHHHH---HHTTCCC-----CCBTTC
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---HHHHHH---HhcCCCC-----Cccccc
Confidence 23458999999999999999999999999999999999999997543110 011111 1111111 111222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+ ..+.+++.+|++.+|++|||+.||+++|+.+..
T Consensus 230 ~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 230 P----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred C----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2 357899999999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=354.55 Aligned_cols=272 Identities=21% Similarity=0.281 Sum_probs=211.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecC--eEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~--~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 445789999999999999987 48999999997543 234567889999999999999999999998755 77999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE----cCCCcEEEEeeeccccc
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkl~DFGla~~~ 679 (854)
+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 91 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 91 CPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred CCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999996432 223389999999999999999999998 99999999999999 78888999999999865
Q ss_pred cCCCCceeecccccccccCcccccc--------CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYIS--------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 4322 2234569999999999875 56788999999999999999999999754432222222221111111
Q ss_pred cCCcccc---------cCccc--cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 752 SGDIQGI---------IDPSL--LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 752 ~~~~~~~---------id~~l--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
...+..+ ....+ ...........+.+++.+|++.||++||++.|+++.+++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111100 00011 123346677788999999999999999999999999998875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=355.40 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=199.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+.+.||+|+||.||+|+.+ +++.||||+++... ......+..|..++..+ +||||+++++++.+.+..++|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 345689999999999999986 58899999997542 22345677899998876 89999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 99 YLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999853 35688999999999999999999998 9999999999999999999999999999754322
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +..+.. .
T Consensus 172 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~----i~~~~~------~ 236 (345)
T 1xjd_A 172 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHS----IRMDNP------F 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHCCC------C
T ss_pred C-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----HHHHH----HHhCCC------C
Confidence 2 2234567999999999999999999999999999999999999999765421 12111 111111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~-eV~~~ 799 (854)
+.... ...+.+++.+|++.+|++||++. ||.+|
T Consensus 237 ~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 237 YPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp CCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCccc----CHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11112 23578999999999999999997 77654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.73 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=191.6
Q ss_pred HHhhccccccCceEEEEEEE----CCCcEEEEEEEccCC----cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~----~~~~~VAvK~l~~~~----~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
+.+.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++...+..++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 45678999999999999987 468999999997542 2234567889999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 99 ILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999853 34578889999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ... .+..
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~---~i~-~~~~---- 238 (327)
T 3a62_A 172 IHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK----KTID---KIL-KCKL---- 238 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH---HHH-HTCC----
T ss_pred ccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH----HHHH---HHH-hCCC----
Confidence 3221 2233456999999999999999999999999999999999999999765421 1111 111 1111
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
.+.... ...+.+++.+|++.+|++|| ++.|+++|
T Consensus 239 --~~p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 --NLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --CCCTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --CCCCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011112 23578999999999999999 78888876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.35 Aligned_cols=268 Identities=24% Similarity=0.361 Sum_probs=200.8
Q ss_pred HHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHcc--CCCCceeeEeeeeeec----C
Q 003039 522 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEE----G 595 (854)
Q Consensus 522 ~~~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~--l~HpnIv~l~g~~~~~----~ 595 (854)
......+.+.+.||+|+||.||+|++. ++.||||++... ....+..|.+++.. ++||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 334456677899999999999999987 899999998643 23344455555555 4899999999999877 7
Q ss_pred eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCCEEEcCCCcEEE
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKV 670 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~vkl 670 (854)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 88999999999999999943 35889999999999999999999852 238999999999999999999999
Q ss_pred EeeeccccccCCCCce---eecccccccccCccccccCcCCCc------chhhhHHHHHHHHHhC----------Ccccc
Q 003039 671 SDFGLSKFAVDGASHV---SSIVRGTVGYLDPEYYISQQLTDK------SDVYSFGVILLELISG----------QEAIS 731 (854)
Q Consensus 671 ~DFGla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~s~~------~DVwSlGvvl~elltG----------~~pf~ 731 (854)
+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997554332221 124469999999999987766665 9999999999999999 55554
Q ss_pred cccccccccchHHHHHHhhhcCCcccccCccccCcC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 732 NEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 732 ~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
....... . ............. .+.+.... .......+.+++.+|++.+|++|||+.||+++|+++..
T Consensus 264 ~~~~~~~--~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 264 DLVPSDP--S-YEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTSCSSC--C-HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCCC--c-hhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 3321111 1 1111111111111 11111111 22566779999999999999999999999999999764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=348.31 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=199.8
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.+.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+|..++.++ +||||+++++++...+..++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 45688999999999999987 588999999975432 2345678899999987 899999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 92 VNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 999999999853 35688999999999999999999998 99999999999999999999999999997533222
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccc-cchHHHHHHhhhcCCcccccCcc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-RNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~-~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..........+..+...
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 237 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 237 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC------
T ss_pred -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC------
Confidence 2334557999999999999999999999999999999999999999653211110 01112222222222211
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm------~eV~~~ 799 (854)
+.... ...+.+++.+|++.+|++||++ .|+++|
T Consensus 238 ~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 238 IPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCC----CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11122 2357899999999999999995 677665
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=351.78 Aligned_cols=242 Identities=24% Similarity=0.324 Sum_probs=200.6
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||.||+|+.+ +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 34678999999999999986 68999999986432 233467889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 ~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 124 AGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp TTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 99999999853 34688999999999999999999998 9999999999999999999999999999865432
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+..+.. .+.
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~----~i~~~~~------~~p 258 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYE----KIVSGKV------RFP 258 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCC------CCC
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH----HHHH----HHHcCCC------CCC
Confidence 23456999999999999999999999999999999999999999764421 1111 1112211 111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
..+ ...+.+++.+|++.+|++||+ ++||.+|
T Consensus 259 ~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 SHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 122 235789999999999999998 8888876
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=351.66 Aligned_cols=250 Identities=25% Similarity=0.300 Sum_probs=191.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.+.||+|+||+||+++.. +++.||||++..... ....+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 556789999999999999987 689999999975432 346688999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc--EEEEeeeccccccCCCC
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkl~DFGla~~~~~~~~ 684 (854)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 101 ~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 101 GELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 999998843 45689999999999999999999998 9999999999999987765 999999999743222
Q ss_pred ceeecccccccccCccccccCcCCCc-chhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~-~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...........+.. .... .... +..
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---~~~~-~~~~--~~~-- 243 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---RILS-VKYS--IPD-- 243 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---HHHT-TCCC--CCT--
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---HHhc-CCCC--CCC--
Confidence 12233469999999999988887665 8999999999999999999976553322222222 1111 1110 000
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... ...+.+++.+|++.+|++|||+.|+++|
T Consensus 244 ~~~~----s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRI----SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCC----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCC----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0011 2357899999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.52 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=208.0
Q ss_pred HHHhhccccccCceEEEEEEE------CCCcEEEEEEEccCCc-ccHHHHHHHHHHHccC-CCCceeeEeeeeeecC-eE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG-RS 597 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~------~~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~-~~ 597 (854)
.+.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++...+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 455678999999999999975 2468899999976533 3346788999999999 7999999999987654 58
Q ss_pred EEEEEeccCCCHHhhhcccccc------------cccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTH------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 665 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 665 (854)
++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC
Confidence 9999999999999999654321 12388999999999999999999998 99999999999999999
Q ss_pred CcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchH
Q 003039 666 MRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIV 743 (854)
Q Consensus 666 ~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~ 743 (854)
+.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .+.
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~ 261 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFC 261 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH---HHH
Confidence 99999999999865443322 2334568899999999999999999999999999999998 999997644211 111
Q ss_pred HHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 744 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 744 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
. .+..+.... ..... ...+.+++.+|++.+|++|||+.||+++|++++...
T Consensus 262 ~----~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 262 R----RLKEGTRMR-----APDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp H----HHHHTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H----HhccCccCC-----CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1 112221111 11111 235789999999999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=349.87 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=192.9
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCC--cccHHHHHHHHHHHccCCC--CceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~H--pnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|...+++.||||++.... ......+.+|+++|++++| |||+++++++...+..++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 34568999999999999999889999999987543 2334678899999999976 999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+.+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 90 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 90 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 568899999853 45688999999999999999999998 999999999999997 5789999999998654432
Q ss_pred Cc-eeecccccccccCcccccc-----------CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh
Q 003039 684 SH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 684 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~ 235 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIID 235 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------hHHHHHHHHhc
Confidence 22 2334579999999999865 678889999999999999999999996532 11111111111
Q ss_pred cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.....++......+.+++.+|++.+|++|||+.|+++|
T Consensus 236 ---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 236 ---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111111112457899999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.90 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=198.5
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 4667899999999999999876 58899999987543 334678899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeeeccccccC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~~ 681 (854)
++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 99999999865544456789999999999999999999998 99999999999999 4568899999999976543
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
. .......||+.|+|||.+. +.++.++|||||||++|||++|+.||...... .+..... .........
T Consensus 180 ~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~----~~~~~~~----~~~~~~~~~- 247 (285)
T 3is5_A 180 D--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE----EVQQKAT----YKEPNYAVE- 247 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCCCCCCC--
T ss_pred c--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH----HHHhhhc----cCCcccccc-
Confidence 2 2233456899999999875 56889999999999999999999999765421 1111111 111000000
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... ...+.+++.+|++.+|++|||+.||+++
T Consensus 248 --~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 --CRPL----TPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ---CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred --cCcC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 2357799999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.93 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=199.3
Q ss_pred HhhccccccCceEEEEEEECC-----CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~-----~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.+.||+|+||.||+|.+.. +..||||+++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 345789999999999998753 2359999997553 2335578899999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 127 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 127 YMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp CCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred CCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 9999999999853 235688999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCc--eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 683 ASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 683 ~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.. .+..+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~~----~~~~~~~~--- 269 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMK----AINDGFRL--- 269 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH----HHHTTCCC---
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----HHHH----HHHCCCcC---
Confidence 221 1222346789999999999999999999999999999999 99999654311 1111 11122100
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
..+......+.+++.+|++.+|++||++.||+++|++++..
T Consensus 270 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 ------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00112234688999999999999999999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=337.17 Aligned_cols=250 Identities=21% Similarity=0.269 Sum_probs=202.5
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
..|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 34566789999999999999887 47789999998765566788999999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeeeccccccC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~~ 681 (854)
++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++.....
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 89 TGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999998843 45588999999999999999999998 99999999999999 7889999999999976543
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.. ......||+.|+|||.+.+. ++.++|||||||++|||++|+.||...... .+.. .+..+.... ..
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~----~~~~~~~~~--~~ 228 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS----EVML----KIREGTFTF--PE 228 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCCCC--CH
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH----HHHH----HHHhCCCCC--Cc
Confidence 32 22344699999999988654 899999999999999999999999764421 1111 111111100 00
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..... ....+.+++.+|++.+|++||++.|++++
T Consensus 229 ~~~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 KDWLN----VSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhhhc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001 12467899999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.21 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=203.3
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeee----ecCeEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ----EEGRSVLVY 601 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~----~~~~~~LV~ 601 (854)
.|.+.+.||+|+||.||+++.. +++.||||++..........+.+|++++++++||||+++++++. .....++||
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 3456789999999999999974 68999999987666566778999999999999999999999986 334789999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999976544566789999999999999999999998 999999999999999999999999999865421
Q ss_pred CCCc--------eeecccccccccCccccccCc---CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 682 GASH--------VSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 682 ~~~~--------~~~~~~gt~~Y~aPE~~~~~~---~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
.... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....... ..+.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~- 263 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--DSVALAVQNQ- 263 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--SCHHHHHHCC-
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--chhhHHhhcc-
Confidence 1100 012234799999999987543 7899999999999999999999996532111 1111111110
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
... ...... ...+.+++.+|++.+|++||++.||+++|+.+.
T Consensus 264 --~~~------~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 264 --LSI------PQSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ----C------CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --CCC------CccccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 000 001112 245889999999999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=344.74 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=204.0
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc------cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~ 598 (854)
..|.+.+.||+|+||.||+|+.. +|+.||||++...... ....+.+|++++++++||||+++++++...+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34667889999999999999986 5899999999754321 3567999999999999999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC----cEEEEeee
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG 674 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFG 674 (854)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999853 45688999999999999999999998 999999999999999888 79999999
Q ss_pred ccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 675 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 675 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... . +....
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~---~-i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLA---N-ITSVS 234 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHH---H-HHTTC
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH----HHHH---H-HHhcc
Confidence 998654432 223446999999999999999999999999999999999999999754311 1111 1 11111
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ..++...... ...+.+++.+|++.+|++|||+.|+++|
T Consensus 235 ~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y--DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0111111122 2357899999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.20 Aligned_cols=269 Identities=23% Similarity=0.379 Sum_probs=210.3
Q ss_pred cCHHHHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHcc--CCCCceeeEeeeeeecC
Q 003039 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEG 595 (854)
Q Consensus 518 ~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~--l~HpnIv~l~g~~~~~~ 595 (854)
+...+.....+.+.+.||+|+||.||+|+.. ++.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3345555667778899999999999999985 899999998643 34567788888877 78999999999998776
Q ss_pred ----eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHH--------hCCCCceecCCCCCCCEEEc
Q 003039 596 ----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--------TGCVPAIIHRDLKSSNILLD 663 (854)
Q Consensus 596 ----~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDIkp~NILl~ 663 (854)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+|||++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 78999999999999999953 35889999999999999999999 66 999999999999999
Q ss_pred CCCcEEEEeeeccccccCCCCc---eeecccccccccCccccccC------cCCCcchhhhHHHHHHHHHhC--------
Q 003039 664 KHMRAKVSDFGLSKFAVDGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISG-------- 726 (854)
Q Consensus 664 ~~~~vkl~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~s~~~DVwSlGvvl~elltG-------- 726 (854)
.++.+||+|||+++........ ......||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999866544322 22345699999999999765 344689999999999999999
Q ss_pred --CcccccccccccccchHHHHHHhhhcCCcccccCccccCc-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 727 --QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE-YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 727 --~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
..||........ ....+.... .... ..+.+... ...+....+.+++.+|++.+|++|||+.||+++|+++
T Consensus 262 ~~~~p~~~~~~~~~--~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 262 DYQLPYYDLVPSDP--SVEEMRKVV-CEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCTTTTTSCSSC--CHHHHHHHH-TTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCccccCcCcc--cHHHHHHHH-HHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 667754432111 122222221 1111 11222111 1345667899999999999999999999999999997
Q ss_pred HH
Q 003039 804 IV 805 (854)
Q Consensus 804 ~~ 805 (854)
..
T Consensus 335 ~~ 336 (342)
T 1b6c_B 335 SQ 336 (342)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.30 Aligned_cols=258 Identities=17% Similarity=0.265 Sum_probs=197.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 445789999999999999976 6889999998754322 246788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 116 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 116 INGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp CCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999999999853 34688999999999999999999998 99999999999999999999999999997654433
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..... .. ...
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~-~~--~~~ 257 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAIP-RP--STV 257 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCCC-CG--GGT
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCCC-Cc--ccc
Confidence 33334456899999999999999999999999999999999999999765411 11111111110 00 001
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIVIE 807 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-sm~eV~~~L~~~~~~~ 807 (854)
.... ...+.+++.+|++.+|++|| +++++++.|++++...
T Consensus 258 ~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 258 RPGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp STTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 1112 23578899999999999999 9999999999876544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=352.85 Aligned_cols=248 Identities=24% Similarity=0.324 Sum_probs=199.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++|+.++||||+++++++...+..++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 446789999999999999877 58899999986432 23346788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+.+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 97 LLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 999999999853 45688999999999999999999998 9999999999999999999999999999865433
Q ss_pred CceeecccccccccCcccccc---CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 684 SHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ...+.... .....
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~----~~~~~----- 237 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTF----ETTVV----- 237 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHH----HHCCC-----
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHH----hhccc-----
Confidence 22345679999999999974 458999999999999999999999997543211 11222211 11110
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-ISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-m~eV~~~ 799 (854)
.++......+.+++.+|++.+|++||+ +.+|.+|
T Consensus 238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 011112245889999999999999998 7777654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=351.65 Aligned_cols=246 Identities=24% Similarity=0.298 Sum_probs=199.8
Q ss_pred HHhhccccccCceEEEEEEECC-CcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+.+.||+|+||.||+|+.+. ++.||||+++... ......+..|..++..+ +||||+++++++...+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 3456889999999999999874 7889999997542 23345678899999988 89999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 102 YVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999853 34688999999999999999999998 9999999999999999999999999999753322
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ ... .+.. .
T Consensus 175 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~---~i~-~~~~------~ 239 (353)
T 2i0e_A 175 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQ---SIM-EHNV------A 239 (353)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH---HHH-HCCC------C
T ss_pred -CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH----HHHH---HHH-hCCC------C
Confidence 22334567999999999999999999999999999999999999999765421 1111 111 1111 0
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
+.... ...+.+++.+|++.+|++||+ ++||.+|
T Consensus 240 ~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 YPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11122 245789999999999999995 5788776
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=375.63 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=206.2
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.++||+|+||.||+|+++++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+++|
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~g 346 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 346 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTE
T ss_pred hhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCC
Confidence 44678999999999999999988899999997654 345689999999999999999999999976 6789999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 347 sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 347 SLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp EHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred cHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 999999632 234588999999999999999999998 999999999999999999999999999986543221122
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+.. .+..+... .
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----~~~~----~i~~~~~~---------~ 484 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERGYRM---------P 484 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----HHHH----HHHTTCCC---------C
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCCCC---------C
Confidence 23446789999999999999999999999999999999 99999764411 1222 12222110 0
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.+......+.+|+.+|++.+|++|||+.+|++.|+.+.
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11122346889999999999999999999999999865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=357.76 Aligned_cols=251 Identities=23% Similarity=0.260 Sum_probs=200.3
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||.||+|+.+ +|+.||||+++... ......+.+|..++..++||||+++++++.+.+..++||||+
T Consensus 64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~ 143 (412)
T 2vd5_A 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY 143 (412)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence 34578999999999999986 68999999996432 122345788999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 144 ~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 144 VGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999999532 34688999999999999999999998 999999999999999999999999999986654443
Q ss_pred ceeecccccccccCccccc-------cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 685 HVSSIVRGTVGYLDPEYYI-------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~-------~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..+... -..
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----~~~-- 291 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH----LSL-- 291 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCC--
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----cCC--
Confidence 3444567999999999997 357899999999999999999999999765532222222221110 001
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR---PSISEVLKD 799 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Psm~eV~~~ 799 (854)
+......+ .++.+++.+|+. +|++| |+++||.+|
T Consensus 292 ---p~~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 ---PLVDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---C----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ---CccccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11111122 357899999999 99988 699999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=338.70 Aligned_cols=258 Identities=27% Similarity=0.406 Sum_probs=204.9
Q ss_pred Hhhc-cccccCceEEEEEEEC---CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 529 MLEK-KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 529 ~~~~-~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.+ .||+|+||.||+|.+. .++.||||+++.... ...+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 3445 8999999999999653 468899999975432 2356789999999999999999999999 5677899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 98 MAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp CCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred eCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 9999999999953 34588999999999999999999998 9999999999999999999999999999866544
Q ss_pred CCcee--ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 683 ASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 683 ~~~~~--~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
..... ....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.. .+..+....
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~----~~~~~~~~~-- 240 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTA----MLEKGERMG-- 240 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH----HHHTTCCCC--
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHH----HHHcCCCCC--
Confidence 33222 22346789999999998889999999999999999999 99999765421 1222 122221111
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA 811 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~~~~~ 811 (854)
. +......+.+++.+|++.+|++||++.||++.|+++........
T Consensus 241 ---~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 241 ---C----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp ---C----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ---C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 1 11223468899999999999999999999999999987765544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=364.69 Aligned_cols=246 Identities=23% Similarity=0.315 Sum_probs=192.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC---CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~---~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+++++.++||||+++++++...+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 445789999999999999876 6899999999753 223345677899999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 230 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 230 ANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999998843 4568899999999999999999998 7 9999999999999999999999999999754332
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ . .+.. .
T Consensus 303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i---~-~~~~------~ 367 (446)
T 4ejn_A 303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELI---L-MEEI------R 367 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH---H-HCCC------C
T ss_pred C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHH---H-hCCC------C
Confidence 2 2234467999999999999999999999999999999999999999765421 111111 1 1111 0
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
+.... ...+.+++.+|++.||++|| +++|+++|
T Consensus 368 ~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 FPRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11112 23578999999999999999 99999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.18 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=197.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCc----EEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~----~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
+.+.+.||+|+||.||+|++. +++ +||+|.+... .......+.+|+.++++++||||+++++++.... .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 445689999999999999875 344 3577777543 3445678999999999999999999999998765 78999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 96 QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999998642 34688999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 682 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 682 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.... ..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~----~~~~~~--- 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSIL----EKGERL--- 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHH----HTTCCC---
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHH----HcCCCC---
Confidence 3222 2233457889999999999999999999999999999999 99999765422 222221 111110
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
..+......+.+++.+|++.+|++||++.||++.|+++...
T Consensus 239 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 ------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 01111223588999999999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.20 Aligned_cols=268 Identities=22% Similarity=0.288 Sum_probs=198.2
Q ss_pred HHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-----cccHHHHHHHHHHHccCC---CCceeeEeeeeee
Q 003039 523 IEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIH---HRNLVQFLGYCQE 593 (854)
Q Consensus 523 ~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-----~~~~~~~~~Ev~~L~~l~---HpnIv~l~g~~~~ 593 (854)
+....|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34445667889999999999999974 68999999986432 112346777888877775 9999999999977
Q ss_pred cC-----eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcE
Q 003039 594 EG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 668 (854)
Q Consensus 594 ~~-----~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 668 (854)
.. ..++||||+. |+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 65 5799999997 5999998643 233489999999999999999999998 99999999999999999999
Q ss_pred EEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHH
Q 003039 669 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 748 (854)
Q Consensus 669 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~ 748 (854)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+......
T Consensus 160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999765432 2234456899999999999999999999999999999999999999765422211111111100
Q ss_pred hhhcCCccccc---Ccccc--CcC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 749 HIESGDIQGII---DPSLL--DEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 749 ~~~~~~~~~~i---d~~l~--~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ......... ...+. ... ..+....+.+++.+|++.||++|||+.|+++|
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 P-PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp C-CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C-ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0 000000000 00000 000 01122467899999999999999999999876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=341.05 Aligned_cols=261 Identities=32% Similarity=0.546 Sum_probs=194.5
Q ss_pred HHHHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 523 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 523 ~~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
+....+.+.++||+|+||.||+|+.. ..||||+++... ....+.+.+|++++++++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 33444566789999999999999865 469999997543 23346789999999999999999999966 45568999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999853 245688999999999999999999998 99999999999999999999999999997544
Q ss_pred CCC-CceeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 681 DGA-SHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 681 ~~~-~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
... ........||+.|+|||.+. +..++.++|||||||++|||++|+.||...... ..+... ...+...
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~----~~~~~~~ 244 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEM----VGRGSLS 244 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH---HHHHHH----HHHTSCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH---HHHHHH----hcccccC
Confidence 321 22233456999999999986 567888999999999999999999999764311 112221 2222221
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
..+. .+... ....+.+++.+|++.+|++||++.||++.|+++.
T Consensus 245 ~~~~-~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLS-KVRSN----CPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTT-SSCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchh-hcccc----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1111 11112 2346889999999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.46 Aligned_cols=254 Identities=25% Similarity=0.324 Sum_probs=186.4
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeeeee--------ecCe
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQ--------EEGR 596 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~--------~~~~ 596 (854)
.+.+.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 3456789999999999999975 68999999987666666778899999999996 999999999984 3445
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEcCCCcEEEEeee
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFG 674 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkl~DFG 674 (854)
.++||||+. |+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred EEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 799999996 79999885432 344689999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccCCCCce-----------eecccccccccCcccc---ccCcCCCcchhhhHHHHHHHHHhCCccccccccccccc
Q 003039 675 LSKFAVDGASHV-----------SSIVRGTVGYLDPEYY---ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 740 (854)
Q Consensus 675 la~~~~~~~~~~-----------~~~~~gt~~Y~aPE~~---~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~ 740 (854)
+++......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---- 259 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---- 259 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence 998654332211 1134589999999998 5667889999999999999999999999754311
Q ss_pred chHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 741 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 741 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+.. +.... ...... ...+.+++.+|++.+|++||++.|++++|+.+..
T Consensus 260 ~~~~--------~~~~~----~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 RIVN--------GKYSI----PPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------CCC----CTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hhhc--------CcccC----Cccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1100 00000 000111 1236789999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=347.74 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=185.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 445789999999999999987 57899999997543 345688999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeeeccccccCCC
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~~~~ 683 (854)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 133 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 133 GELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 999998853 34588999999999999999999998 9999999999999975 889999999999765432
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+.. .+..+... .. ...
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~----~i~~~~~~-~~-~~~ 274 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFR----RILNCEYY-FI-SPW 274 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---HHHH----HHHTTCCC-CC-TTT
T ss_pred -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH---HHHH----HHHhCCCc-cC-Cch
Confidence 22234569999999999999999999999999999999999999996543111 1111 11111110 00 111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... ...+.+++.+|++.||++|||+.|++++
T Consensus 275 ~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 WDEV----SLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122 2457899999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=373.57 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=200.4
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 533 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
.||+|+||.||+|.++ ++..||||+++... ....+.+.+|+++|++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 46679999997653 3356789999999999999999999999976 56899999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee-
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS- 687 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~- 687 (854)
|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999953 245689999999999999999999998 999999999999999999999999999986543322211
Q ss_pred -ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 688 -SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 688 -~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. .+..+...
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~~----~i~~~~~~--------- 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMA----FIEQGKRM--------- 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----HHHH----HHHTTCCC---------
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHH----HHHcCCCC---------
Confidence 22345789999999999999999999999999999998 99999765421 2222 22222111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
..+......+.+++.+|++.+|++||++.+|++.|+.+...
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11112334688999999999999999999999999997653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=352.86 Aligned_cols=271 Identities=18% Similarity=0.252 Sum_probs=202.5
Q ss_pred HHhhcccccc--CceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G--~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
|.+.++||+| +||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 4567899999 99999999987 68999999997543 2334668889999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 107 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 107 FMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp CCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred ccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999998643 234588999999999999999999998 9999999999999999999999999998643221
Q ss_pred C------CceeecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh-hh--
Q 003039 683 A------SHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-IE-- 751 (854)
Q Consensus 683 ~------~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~-~~-- 751 (854)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||................... ..
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 1 111223468999999999987 679999999999999999999999997644222111110000000 00
Q ss_pred ----------------cCCcccccCccc---------cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHH
Q 003039 752 ----------------SGDIQGIIDPSL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 803 (854)
Q Consensus 752 ----------------~~~~~~~id~~l---------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~~ 803 (854)
.....+.+.... ...........+.+|+.+|++.||++|||+.|+++| ++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 000000000000 000111223468899999999999999999999987 5544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.18 Aligned_cols=261 Identities=22% Similarity=0.320 Sum_probs=203.7
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeee-eecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~-~~~~~~~LV~E~~ 604 (854)
.|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+|+++++.++|++++..++++ ...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 4556789999999999999874 688999998764432 24578899999999988777666655 6677889999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeeeccccccC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~~ 681 (854)
+++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 88 -~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 88 -GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp -CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 99999998532 34589999999999999999999998 99999999999999 7889999999999986554
Q ss_pred CCCc------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 682 GASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 682 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......... ..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hh
Confidence 3321 2234569999999999999999999999999999999999999998755333322222222222111 00
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
+.+...+ ...+.+++..|++.+|++||++.||++.|++++..
T Consensus 240 -----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 240 -----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 0001112 24688999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=341.71 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=195.4
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence 45688999999999999986 589999999865432 224668899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 86 HTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp EEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 9999888742 34588999999999999999999998 999999999999999999999999999976543322
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH-------HHhhhcCCc-c
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------KLHIESGDI-Q 756 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~-------~~~~~~~~~-~ 756 (854)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.... ......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2234468999999999976 678999999999999999999999997654221111111100 000000000 0
Q ss_pred --cccCccccCcC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 --GIIDPSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 --~~id~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.++.-.... .......+.+++.+|++.+|++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00011000000 01123457899999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=356.56 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=193.7
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCC--cccHHHHHHHHHHHccCC--CCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~--HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|...+++.||||++.... ......+.+|+++|++++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 45678999999999999998889999999987543 234567899999999996 5999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+.+++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 137 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 137 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 678899999853 34678888999999999999999998 999999999999995 5899999999998654432
Q ss_pred Cc-eeecccccccccCcccccc-----------CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh
Q 003039 684 SH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 684 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~~~~~ 282 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIID 282 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHHC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh------HHHHHHHHHhC
Confidence 22 2344579999999999865 368889999999999999999999996532 11111111111
Q ss_pred cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.....++......+.+++.+|++.+|++||++.||+++
T Consensus 283 ---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 ---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111111112357899999999999999999999976
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=352.50 Aligned_cols=254 Identities=30% Similarity=0.495 Sum_probs=192.8
Q ss_pred HhhccccccCceEEEEEEEC--CC--cEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeee-cCeEEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK--DG--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYE 602 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~--~~--~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~-~~~~~LV~E 602 (854)
.+.+.||+|+||.||+|++. ++ ..||||+++... ....+.+.+|+.++++++||||++++++|.. ++..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 34578999999999999864 22 368999986543 3445779999999999999999999998754 567899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 172 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 172 YMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999953 234578889999999999999999998 9999999999999999999999999999855432
Q ss_pred CCc---eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 683 ASH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 683 ~~~---~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .+.... ..+.. .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~----~~~~~~----~~~~~--~ 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYL----LQGRR--L 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS----CHHHHH----HTTCC--C
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH----HHHHHH----HcCCC--C
Confidence 211 1233457889999999999999999999999999999999 67777654421 222221 11111 0
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..+ . .....+.+++.+|++.+|++||++.||+++|++++.
T Consensus 316 ~~p---~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 316 LQP---E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCC---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 1 122358899999999999999999999999999865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=339.36 Aligned_cols=254 Identities=30% Similarity=0.496 Sum_probs=198.5
Q ss_pred HhhccccccCceEEEEEEECC----CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeee-ecCeEEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYE 602 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~-~~~~~~LV~E 602 (854)
.+.+.||+|+||.||+|++.+ ...||+|++.... ......+.+|+.++++++||||+++++++. .++..++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 456889999999999998653 2358999987543 334567899999999999999999999864 4567899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 108 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 108 YMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999953 245578889999999999999999998 9999999999999999999999999999755432
Q ss_pred CC---ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 683 AS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 683 ~~---~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
.. .......||+.|+|||.+.+..++.++|||||||++|||++ |..||...... .+..... .+.. .
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----~~~~~~~----~~~~--~ 251 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLL----QGRR--L 251 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT----THHHHHH----TTCC--C
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH----HHHHHHh----cCCC--C
Confidence 21 12233457889999999999999999999999999999999 55566543311 1222111 1110 0
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..+ ... ...+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 252 ~~~---~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 LQP---EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CCC---TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 001 111 2358899999999999999999999999999865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.17 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=192.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCe----EEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR----SVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~----~~L 599 (854)
|.+.+.||+|+||.||+|+.. +++.||||+++..... ....+.+|++++++++||||+++++++..... .++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 456789999999999999974 6889999999765322 23568899999999999999999999876543 499
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 9999999999999853 34688999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCc--eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 680 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 680 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIPP 239 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCCH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCCCc
Confidence 433221 223356899999999999999999999999999999999999999765411 11111122111110
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-HHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK-DIQDA 803 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~-~L~~~ 803 (854)
....... ...+.+++.+|++.+|++||++.++++ .|...
T Consensus 240 ---~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 ---SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---HHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---ccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0001111 235789999999999999997666554 45443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.77 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=203.9
Q ss_pred HHhhccccccCceEEEEEEE-CCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeee-eecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~-~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~-~~~~~~~LV~E~~~ 605 (854)
+.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+|+.++++++|++++..++++ ...+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 34568899999999999997 4789999999875432 34688999999999988876666655 5667889999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeeeccccccCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~~~ 682 (854)
+++|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 ~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 9999999853 234689999999999999999999998 99999999999999 48899999999999865543
Q ss_pred CCc------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 683 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 683 ~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......... ..
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH-
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-ch-
Confidence 321 1234569999999999999999999999999999999999999998654322222222222211111 00
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
+.+...++ ..+.+++.+|++.+|++||++.||++.|+++...
T Consensus 240 ----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 240 ----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp ----HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----HHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 00111222 4588999999999999999999999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=344.95 Aligned_cols=268 Identities=23% Similarity=0.379 Sum_probs=194.3
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHH--HHHHHccCCCCceeeEeeeeee-----cCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFLGYCQE-----EGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~--Ev~~L~~l~HpnIv~l~g~~~~-----~~~~~LV 600 (854)
+.+.+.||+|+||.||+|+.. ++.||||++.... ...+.. |+..+..++||||+++++++.. ....++|
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 345689999999999999874 8999999986432 233444 4444556899999999986532 3367899
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC------CCceecCCCCCCCEEEcCCCcEEEEeee
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFG 674 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDIkp~NILl~~~~~vkl~DFG 674 (854)
|||+++|+|.+++.. ...++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 91 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 999999999999943 33478889999999999999999863 2389999999999999999999999999
Q ss_pred ccccccCCC-------CceeecccccccccCcccccc-------CcCCCcchhhhHHHHHHHHHhCCccccccccccccc
Q 003039 675 LSKFAVDGA-------SHVSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 740 (854)
Q Consensus 675 la~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~~-------~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~ 740 (854)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 997654321 112234469999999999986 466789999999999999999987764322111111
Q ss_pred -chH---------HHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 741 -NIV---------QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 741 -~l~---------~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.+. ...............+.+... ........+.+++.+|++.+|++|||+.||++.|++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 111 011111111111111111111 1223556799999999999999999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.68 Aligned_cols=251 Identities=28% Similarity=0.434 Sum_probs=204.3
Q ss_pred HHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeee--------
Q 003039 523 IEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-------- 593 (854)
Q Consensus 523 ~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~-------- 593 (854)
.....+.+.+.||+|+||.||+|+.. +++.||||++.... ..+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34445666789999999999999987 78999999997543 356789999999999999999998854
Q ss_pred --------cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC
Q 003039 594 --------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 665 (854)
Q Consensus 594 --------~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 665 (854)
....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 45579999999999999999643 235688999999999999999999998 99999999999999999
Q ss_pred CcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHH
Q 003039 666 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 745 (854)
Q Consensus 666 ~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~ 745 (854)
+.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|..|+.... ...
T Consensus 159 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~~-- 228 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFF-- 228 (284)
T ss_dssp TEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------HHH--
T ss_pred CCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------HHH--
Confidence 999999999997654432 2233468999999999999999999999999999999999998875321 111
Q ss_pred HHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 746 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 746 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.....+.+. ..++ ..+.+++.+|++.+|++||++.|++++|+.+...
T Consensus 229 --~~~~~~~~~--------~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 229 --TDLRDGIIS--------DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp --HHHHTTCCC--------TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred --HHhhccccc--------ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111222221 1222 3477899999999999999999999999987543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=345.60 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=201.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcE--EEEEEEccC-CcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKE--IAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~--VAvK~l~~~-~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+.+.||+|+||.||+|+.. ++.. ||||+++.. .....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 446789999999999999875 4554 499988753 233456789999999999 89999999999999999999999
Q ss_pred eccCCCHHhhhcccc------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 003039 603 FMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 670 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 670 (854)
|+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence 999999999996532 2234689999999999999999999998 9999999999999999999999
Q ss_pred EeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHh
Q 003039 671 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 671 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~ 749 (854)
+|||+++..... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+ ...
T Consensus 184 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~----~~~ 253 (327)
T 1fvr_A 184 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----EL----YEK 253 (327)
T ss_dssp CCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HH----HHH
T ss_pred cccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----HH----HHH
Confidence 999998743211 11223357889999999998889999999999999999998 99999765421 11 111
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+..+.. ...... ....+.+++.+|++.+|++||++.|++++|++++.
T Consensus 254 ~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 254 LPQGYR-----LEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp GGGTCC-----CCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCC-----CCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 222210 011111 22458899999999999999999999999999865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=375.45 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=199.1
Q ss_pred ccccccCceEEEEEEEC---CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|+++|++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999663 467899999975432 335789999999999999999999999964 568899999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc-
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 685 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 685 (854)
|+|.+++. ....+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++........
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999995 345688999999999999999999998 9999999999999999999999999999866443321
Q ss_pred -eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 686 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 686 -~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+. ..+..+....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~----~~i~~~~~~~------ 592 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVT----AMLEKGERMG------ 592 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHH----HHHHTTCCCC------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHH----HHHHcCCCCC------
Confidence 2233457889999999999999999999999999999998 99999765421 111 2222222111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+......+.+++..|++.+|++||++.+|++.|+++..
T Consensus 593 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111223468899999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=351.69 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=200.7
Q ss_pred HHhhccccccCceEEEEEEE----CCCcEEEEEEEccCC----cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~----~~~~~VAvK~l~~~~----~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~ 598 (854)
+.+.+.||+|+||.||+|+. .+++.||||+++... ......+.+|+++++++ +||||+++++++...+..+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 45678999999999999987 368999999986532 12345677899999999 6999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 136 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999853 34688999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+. .......
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~--- 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKSE--- 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH---HHHHHCC---
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH---HHHhccC---
Confidence 54433334445679999999999985 457899999999999999999999997544222221222 2211111
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKDI 800 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~L 800 (854)
+...... ...+.+++.+|++.||++|| +++|++++.
T Consensus 283 ----~~~~~~~----~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----PPYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CCCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----CCCCccc----CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1111122 23578999999999999999 999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.54 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=200.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 345688999999999999876 58899999986543 233467889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc---EEEEeeeccccccC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVD 681 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkl~DFGla~~~~~ 681 (854)
++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++.....
T Consensus 88 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 88 TGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999988843 35688999999999999999999998 9999999999999987655 99999999976543
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+... +..+.... ..+
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~----~~~~~~~~-~~~ 229 (284)
T 3kk8_A 161 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQ----IKAGAYDY-PSP 229 (284)
T ss_dssp SC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHTCCCC-CTT
T ss_pred Cc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh----HHHHH----HHhccccC-Cch
Confidence 32 223456999999999999999999999999999999999999999764411 11111 11111110 000
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..... ...+.+++.+|++.+|++|||+.|++++
T Consensus 230 -~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 -EWDTV----TPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -TTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -hhccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01112 2357899999999999999999999885
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=344.50 Aligned_cols=251 Identities=18% Similarity=0.165 Sum_probs=202.3
Q ss_pred HHhhccccccCceEEEEEE------ECCCcEEEEEEEccCCcccHHHHHHHHHHHccCC---CCceeeEeeeeeecCeEE
Q 003039 528 KMLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~------~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~---HpnIv~l~g~~~~~~~~~ 598 (854)
+.+.+.||+|+||+||+|. ..+++.||||+++.. ...++..|++++++++ |+||+++++++...+..+
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 4456889999999999994 346889999999754 3456777888877776 999999999999999999
Q ss_pred EEEEeccCCCHHhhhccccc-ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-----------CC
Q 003039 599 LVYEFMHNGTLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----------HM 666 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----------~~ 666 (854)
+||||+++|+|.+++..... ....+++..++.|+.|++.||+|||+. +|+||||||+|||++. ++
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999964322 345699999999999999999999998 9999999999999998 89
Q ss_pred cEEEEeeeccccccC-CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHH
Q 003039 667 RAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 745 (854)
Q Consensus 667 ~vkl~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~ 745 (854)
.+||+|||+|+.... ..........||++|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------- 293 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------- 293 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-------
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-------
Confidence 999999999975432 223344556799999999999999999999999999999999999999965431110
Q ss_pred HHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHHHHHH
Q 003039 746 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR-PSISEVLKDIQDAIVI 806 (854)
Q Consensus 746 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Psm~eV~~~L~~~~~~ 806 (854)
.++..+..... ...+.+++..|++.+|.+| |++.++.+.|++.+..
T Consensus 294 ------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 ------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 01111111111 2346688889999999988 6889999999988754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=336.18 Aligned_cols=244 Identities=25% Similarity=0.405 Sum_probs=197.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 345688999999999999876 57789999986432 22356788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 91 APLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 999999998853 34688999999999999999999998 9999999999999999999999999998644322
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ... .+..... .+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~----~~~~~~~------~~ 226 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYK----RISRVEF------TF 226 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH----HHHHTCC------CC
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH----HHH----HHHhCCC------CC
Confidence 2234468999999999999999999999999999999999999997654211 111 1111111 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... ....+.+++.+|++.+|++||++.||++|
T Consensus 227 ~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 PDF----VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CTT----SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCc----CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111 22357899999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=337.29 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=200.0
Q ss_pred hccccccCceEEEEEEECC----CcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeE-EEEEEec
Q 003039 531 EKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS-VLVYEFM 604 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~-~LV~E~~ 604 (854)
.++||+|+||+||+|.+.+ +..||+|++..... ...+.+.+|++++++++||||+++++++...+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4789999999999998642 23799999875432 3456788999999999999999999999776655 9999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC-
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 683 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~- 683 (854)
.+|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 106 CHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred cCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999964 245678899999999999999999998 99999999999999999999999999997543321
Q ss_pred --CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 684 --SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 684 --~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
........+|+.|+|||.+.+..++.++|||||||++|||++|..|+..... ...+..... .+...
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~----~~~~~----- 247 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID---PFDLTHFLA----QGRRL----- 247 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---GGGHHHHHH----TTCCC-----
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC---HHHHHHHhh----cCCCC-----
Confidence 1122334578999999999999999999999999999999996655432221 112222211 11100
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
..... ....+.+++.+|++.+|++|||+.|+++.|++++..
T Consensus 248 ~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 PQPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00111 123588999999999999999999999999998653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.70 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=200.7
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
..+.+.+.||+|+||.||+|+.. +|+.||+|+++.........+.+|++++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 35566789999999999999986 68999999998655445567899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeeeccccccC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~~ 681 (854)
++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++....
T Consensus 89 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 89 SGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999998843 34688899999999999999999998 99999999999999 7889999999999875432
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.. .+..+... ...
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~----~i~~~~~~--~~~ 228 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES----KLFE----KIKEGYYE--FES 228 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH----HHHHCCCC--CCT
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHH----HHHcCCCC--CCc
Confidence 2 223346899999999999999999999999999999999999999754411 1111 11222110 111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...... ...+.+++.+|++.+|++||++.|++++
T Consensus 229 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 229 PFWDDI----SESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTTS----CHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111222 2458899999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=335.81 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=195.5
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
.+.||+|+||.||+|+.. +++.||||++..........+.+|++++.++ +||||+++++++...+..++||||+++|+
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 367999999999999865 6899999999876555677899999999885 79999999999999999999999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc---EEEEeeeccccccCCC--
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVDGA-- 683 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkl~DFGla~~~~~~~-- 683 (854)
|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 98 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 98 ILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 9999853 34688999999999999999999998 9999999999999998776 9999999987543211
Q ss_pred ----CceeecccccccccCcccccc-----CcCCCcchhhhHHHHHHHHHhCCcccccccccccc-------cchHHHHH
Q 003039 684 ----SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-------RNIVQWAK 747 (854)
Q Consensus 684 ----~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~-------~~l~~~~~ 747 (854)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.. ........
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 111223459999999999875 56889999999999999999999999765421100 00001111
Q ss_pred HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 748 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+..+... +....... ....+.+++.+|++.||++|||+.|+++|
T Consensus 251 ~~i~~~~~~--~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 251 ESIQEGKYE--FPDKDWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHCCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhccCcc--cCchhccc----CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 122222110 00000011 12458899999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=343.42 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=203.0
Q ss_pred cCHHHHHHHHHHhh-ccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccC-CCCceeeEeeeee
Q 003039 518 FTLSDIEDATKMLE-KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 592 (854)
Q Consensus 518 ~~~~~~~~~~~~~~-~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~ 592 (854)
+...+.....|.+. +.||+|+||.||+|... +++.||||++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34344444555554 88999999999999887 58999999987542 33467889999999999 5699999999999
Q ss_pred ecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEE
Q 003039 593 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAK 669 (854)
Q Consensus 593 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vk 669 (854)
..+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999988542 245688999999999999999999998 9999999999999998 78999
Q ss_pred EEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh
Q 003039 670 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 670 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~ 749 (854)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~---- 244 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE----TYLN---- 244 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHHH----
Confidence 99999998654322 2233569999999999999999999999999999999999999997654211 1111
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+...... ....... .....+.+++.+|++.+|++|||++|++++
T Consensus 245 i~~~~~~--~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQVNVD--YSEETFS----SVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHTCCC--CCTTTTT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhcccc--cCchhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111000 0011111 123457899999999999999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=334.86 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=200.3
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc------ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~------~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~ 598 (854)
..+.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 34566789999999999999987 689999999875422 13577999999999999999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC----cEEEEeee
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG 674 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFG 674 (854)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999843 35688999999999999999999998 999999999999999877 89999999
Q ss_pred ccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 675 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 675 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .... .+....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ----ETLT----NISAVN 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHH----HHHTTC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH----HHHH----HhHhcc
Confidence 997654322 223346899999999999999999999999999999999999999764411 1111 111111
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ..++...... ...+.+++.+|++.+|++||++.|++++
T Consensus 228 ~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 Y--DFDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp C--CCCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred c--CCcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0 0111111111 2357899999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=360.88 Aligned_cols=245 Identities=24% Similarity=0.416 Sum_probs=201.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|++. +|+.||||++.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 446789999999999999987 79999999996432 12345788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 98 VSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999985 345689999999999999999999998 99999999999999999999999999998654432
Q ss_pred CceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+.. .+..+...
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~----~i~~~~~~------ 234 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFK----KICDGIFY------ 234 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHH----HHHTTCCC------
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHH----HHhcCCcC------
Confidence 2334579999999999988765 67999999999999999999999765421 1111 11222110
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+ ..+.+++.+|++.||++|||+.||++|
T Consensus 235 ~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 TPQYLN----PSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCccCC----HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 011112 357899999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=347.88 Aligned_cols=246 Identities=22% Similarity=0.251 Sum_probs=188.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHc-cCCCCceeeEeeeeee----cCeEEEEEEecc
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLS-RIHHRNLVQFLGYCQE----EGRSVLVYEFMH 605 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~-~l~HpnIv~l~g~~~~----~~~~~LV~E~~~ 605 (854)
+.||+|+||+||+|... +++.||||++.. ...+.+|++++. ..+||||+++++++.. .+..++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999886 688999999863 245678888874 4589999999999875 567899999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeeeccccccCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~~~ 682 (854)
+|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 143 gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 143 GGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp SEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999999642 234689999999999999999999998 9999999999999998 789999999999855432
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+ ..+.... -.+
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~~-~~~- 289 (400)
T 1nxk_A 218 --NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEF-PNP- 289 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCCC-CTT-
T ss_pred --CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcccC-CCc-
Confidence 22234568999999999999999999999999999999999999997654222222222221 1121110 000
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..... ...+.+++.+|++.||++|||+.||++|
T Consensus 290 ~~~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EWSEV----SEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01112 2457899999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=351.60 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=188.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHH-HccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~-L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+.+.||+|+||.||+|+.+ +++.||||+++.... .....+..|..+ ++.++||||+++++++...+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 456789999999999999987 578999999975532 223455667776 577899999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 120 YINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999853 45678888999999999999999998 9999999999999999999999999999854332
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.. ... .+.. .
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~---~i~-~~~~------~ 257 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYD---NIL-NKPL------Q 257 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH----HHH---HHH-HSCC------C
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----HHH---HHH-hccc------C
Confidence 2 23345679999999999999999999999999999999999999997654221 111 111 1111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISE 795 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~e 795 (854)
+....+ ..+.+++.+|++.+|++||++.+
T Consensus 258 ~~~~~~----~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 LKPNIT----NSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCSSSC----HHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCCC----HHHHHHHHHHcccCHHhCCCCCC
Confidence 111222 35789999999999999999853
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.60 Aligned_cols=260 Identities=24% Similarity=0.413 Sum_probs=207.0
Q ss_pred HHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
.+.+.+.||+|+||.||+|++. .++.||||++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 3456789999999999999765 36789999987543 2334568899999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhccccc------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 003039 600 VYEFMHNGTLKEHLYGTLT------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 673 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 673 (854)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcC
Confidence 9999999999999864321 113468889999999999999999998 9999999999999999999999999
Q ss_pred eccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhh
Q 003039 674 GLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 674 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
|+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.. .+.
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~----~~~ 254 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVLR----FVM 254 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----HHHH----HHH
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH----HHHH----HHH
Confidence 999755432211 1223356889999999999999999999999999999999 88998754311 1111 112
Q ss_pred cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.+..... .. .....+.+++.+|++.+|++||++.|++++|++++..
T Consensus 255 ~~~~~~~-----~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 255 EGGLLDK-----PD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp TTCCCCC-----CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred cCCcCCC-----CC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 2221111 11 1224588999999999999999999999999987653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=335.40 Aligned_cols=246 Identities=19% Similarity=0.302 Sum_probs=198.1
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
..+.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+..+.++ +||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 34556789999999999999987 78999999987542 33456788999999999 9999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC----------------
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---------------- 665 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---------------- 665 (854)
||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999965433345689999999999999999999998 99999999999999844
Q ss_pred ---CcEEEEeeeccccccCCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccc
Q 003039 666 ---MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 741 (854)
Q Consensus 666 ---~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~ 741 (854)
..+||+|||+++...... ...||+.|+|||.+.+. .++.++|||||||++|||++|..++.... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~ 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------Q 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------H
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------H
Confidence 479999999997654322 23489999999999865 56689999999999999999988764322 1
Q ss_pred hHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 742 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 742 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ..+..+... .+....+ ..+.+++.+|++.+|++|||+.|+++|
T Consensus 237 ~-----~~~~~~~~~-----~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 W-----HEIRQGRLP-----RIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H-----HHHHTTCCC-----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H-----HHHHcCCCC-----CCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 111222221 1112222 357899999999999999999999876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=348.08 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=206.6
Q ss_pred HHhhccccccCceEEEEEEE-----CCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecC--eEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~-----~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~--~~~LV 600 (854)
+.+.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 45678999999999999984 368899999998766566678999999999999999999999986644 78999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 123 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp ECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999642 34588999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCCce--eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccc------c--ccccchHHHHHHhh
Q 003039 681 DGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF------G--ANCRNIVQWAKLHI 750 (854)
Q Consensus 681 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~------~--~~~~~l~~~~~~~~ 750 (854)
...... .....++..|+|||.+.+..++.++|||||||++|||++|..|+..... . .............+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 433221 2234577889999999988899999999999999999999998864310 0 00001111111222
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..+... ..+......+.+++.+|++.+|++||++.||++.|+++..
T Consensus 277 ~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 277 KNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 221110 0111223468899999999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=342.13 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=196.5
Q ss_pred HHHhhccccccCceEEEEEEEC----CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecC-----
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----- 595 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~----- 595 (854)
.+.+.+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|+.++++++||||+++++++...+
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 4456788999999999999765 24589999987543 233467889999999999999999999997655
Q ss_pred eEEEEEEeccCCCHHhhhcccc--cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 673 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 673 (854)
..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeec
Confidence 3499999999999999985322 2345689999999999999999999998 9999999999999999999999999
Q ss_pred eccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhh
Q 003039 674 GLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 674 Gla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
|+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+.....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~---- 263 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH----EMYDYLL---- 263 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHH----
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH----HHHHHHH----
Confidence 99976543322 12233457889999999999999999999999999999999 88998765421 2222111
Q ss_pred cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
.+... ..... ....+.+++.+|++.+|++||++.+|+++|++++..
T Consensus 264 ~~~~~-----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 264 HGHRL-----KQPED----CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp TTCCC-----CCBTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCC-----CCCcc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11110 11111 224688999999999999999999999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.98 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=179.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 345688999999999999874 68999999986432 12246788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 93 CHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp CTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred CCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999998632 35688999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... . ... +..+
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~-~~~------~~~~ 231 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-------V-VLA------DYEM 231 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------C-CSS------CCCC
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-------H-hhc------ccCC
Confidence 1 22335689999999999998999999999999999999999999976542211100 0 000 0111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... ...+.+++.+|++.+|++||++.|++++
T Consensus 232 ~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 232 PSFL----SIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CTTS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccc----CHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1112 2357899999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=336.09 Aligned_cols=249 Identities=30% Similarity=0.460 Sum_probs=195.8
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeec-CeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-GRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-~~~~LV~E~~~~ 606 (854)
+.+.+.||+|+||.||+|+.. |+.||||+++... ..+.+.+|++++++++||||+++++++... +..++||||+++
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred ceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 446789999999999999986 8999999987543 456789999999999999999999997554 578999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 170 (278)
T 1byg_A 100 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 170 (278)
T ss_dssp EEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence 9999998532 123478889999999999999999998 9999999999999999999999999998754322
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+... +..+.. .....
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~----~~~~~~-----~~~~~ 237 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPR----VEKGYK-----MDAPD 237 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHH----HTTTCC-----CCCCT
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HhcCCC-----CCCcc
Confidence 123357889999999999999999999999999999998 99999765421 22211 111111 11111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
. ....+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 238 ~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 238 G----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 2 23468899999999999999999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.34 Aligned_cols=262 Identities=19% Similarity=0.210 Sum_probs=195.6
Q ss_pred HHHhhccccccCceEEEEEEEC----CCcEEEEEEEccCCcc-----------cHHHHHHHHHHHccCCCCceeeEeeee
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNLVQFLGYC 591 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~~~-----------~~~~~~~Ev~~L~~l~HpnIv~l~g~~ 591 (854)
.|.+.+.||+|+||.||+|... .+..||||++...... ....+.+|+..++.++||||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 4556789999999999999986 5778999998755321 123466788899999999999999999
Q ss_pred ee----cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-
Q 003039 592 QE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM- 666 (854)
Q Consensus 592 ~~----~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~- 666 (854)
.. ....++||||+ +++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 87 67899999999 9999999853 33789999999999999999999998 999999999999999887
Q ss_pred -cEEEEeeeccccccCCCC------ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccc
Q 003039 667 -RAKVSDFGLSKFAVDGAS------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 739 (854)
Q Consensus 667 -~vkl~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~ 739 (854)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-- 267 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP-- 267 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH--
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc--
Confidence 999999999976532211 11134569999999999999999999999999999999999999996532111
Q ss_pred cchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 740 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 740 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
............. +...+...... ......+.+++.+|++.+|++||++.+|++.|+++
T Consensus 268 -~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 -VAVQTAKTNLLDE-LPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp -HHHHHHHHHHHHT-TTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred -HHHHHHHHhhccc-ccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1111111111111 11111000000 01223688999999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=344.41 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=198.4
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--------cHHHHHHHHHHHccCCCCceeeEeeeeeecCe
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 596 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~ 596 (854)
..|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 34556789999999999999875 6889999999765321 23457789999999999999999999999999
Q ss_pred EEEEEEeccCC-CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeec
Q 003039 597 SVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675 (854)
Q Consensus 597 ~~LV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 675 (854)
.++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 99999999777 99998853 44689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... . .. .
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~-------~~-~- 239 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------T-------VE-A- 239 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G-------TT-T-
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------H-------Hh-h-
Confidence 986544322 233569999999999988776 7899999999999999999999965321 0 00 0
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+ .... ...+.+++.+|++.+|++|||+.|++++
T Consensus 240 ---~~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 ---AIHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---CCCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---ccCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111 2357899999999999999999999997
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.64 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=198.1
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEe
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
..|.+.+.||+|+||.||+|..+ +++.||||++..... ...+|++++.++ +||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 34566789999999999999886 588999999975432 235688888887 799999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC----CcEEEEeeeccccc
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFA 679 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkl~DFGla~~~ 679 (854)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+..+ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999998853 34688999999999999999999998 99999999999998543 35999999999865
Q ss_pred cCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+.. .+..+... +
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~----~i~~~~~~--~ 242 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILA----RIGSGKFS--L 242 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHH----HHHHCCCC--C
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHH----HHccCCcc--c
Confidence 44322 23345689999999999988899999999999999999999999975321 11112222 22222221 1
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........ ...+.+++.+|++.||++||++.|+++|
T Consensus 243 ~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 243 SGGYWNSV----SDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CSTTTTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111122 2457899999999999999999999876
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=347.65 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=196.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 445678999999999999874 6899999999754322 235688999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+. |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 136 CL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp CS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred CC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 97 688887743 235688999999999999999999998 9999999999999999999999999999765332
Q ss_pred CceeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 684 SHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .......... .....
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~- 274 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE-SPALQ- 274 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC-CCCCC-
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcC-CCCCC-
Confidence 2346999999999985 567899999999999999999999999754311 1111111111 11111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+ ..+.+++.+|++.+|++|||+.|++++
T Consensus 275 ---~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 ---SGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11122 357889999999999999999999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.98 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=202.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~LV~E 602 (854)
|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 345688999999999999886 68999999997543 2345678899999999999999999998854 678899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc-----eecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-----IIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
|+++|+|.+++.........+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999975443445589999999999999999999998 6 9999999999999999999999999997
Q ss_pred cccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.. .+..+....
T Consensus 165 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAG----KIREGKFRR 235 (279)
T ss_dssp HC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHTCCCC
T ss_pred eecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH----HHHH----HHhhccccc
Confidence 654322 1223346899999999999989999999999999999999999999765411 1211 222222211
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
+...+ ...+.+++.+|++.+|++||++.||++++..
T Consensus 236 -----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 -----IPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----CCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11122 2458899999999999999999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=363.52 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=203.4
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.||+|+||.||+|+.+ +|+.||||++.... ......+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 34678999999999999986 68999999996532 233456889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 267 ~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~- 340 (576)
T 2acx_A 267 NGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 340 (576)
T ss_dssp CSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc-
Confidence 999999998643 234588999999999999999999998 99999999999999999999999999998664432
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+ .... ..+.
T Consensus 341 -~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i----~~~~------~~~p 409 (576)
T 2acx_A 341 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KEVP------EEYS 409 (576)
T ss_dssp -CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH----HHCC------CCCC
T ss_pred -cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh----hccc------ccCC
Confidence 2234579999999999999999999999999999999999999997654222111222211 1111 0111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
..++ ..+.+++.+|++.||++|| ++.||++|
T Consensus 410 ~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 ERFS----PQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1222 3578999999999999999 78999877
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=360.38 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=202.4
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.||+|+||.||+|+.+ +|+.||||++.... ......+..|++++++++||||+++++++...+..++||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 467999999999999986 68999999996542 22345688999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-~ 345 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-K 345 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-C
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-c
Confidence 999999975544455789999999999999999999998 999999999999999999999999999986544322 2
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ... .+.. .+...
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~-~~~~------~~p~~ 415 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVL-EQAV------TYPDK 415 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHH-HCCC------CCCTT
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHh-hccc------CCCcc
Confidence 2345799999999999999999999999999999999999999976542211112222 111 1111 01112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm-----~eV~~~ 799 (854)
+ ...+.+++.+|++.+|++||++ .||.+|
T Consensus 416 ~----s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 416 F----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp S----CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred c----CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 2 2357889999999999999965 667654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.98 Aligned_cols=251 Identities=22% Similarity=0.371 Sum_probs=201.2
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
.+.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 4556789999999999999986 68999999986443 334577899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC-
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 683 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~- 683 (854)
++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 88 SGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp TTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 9999999884 345688999999999999999999998 99999999999999999999999999997543322
Q ss_pred CceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
........||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...... ...+..|.. .... ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~----~~~~---~~-- 229 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKE----KKTY---LN-- 229 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHHHT----TCTT---ST--
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhhh----cccc---cC--
Confidence 122334568999999999987665 77899999999999999999999764411 111222211 1100 00
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..... ...+.+++.+|++.+|++|||+.|++++
T Consensus 230 ~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 PWKKI----DSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TGGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred chhhc----CHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01112 2357789999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=348.44 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=187.3
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCC-CCceeeEeeeeeecC--eEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG--RSVLV 600 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~--~~~LV 600 (854)
.|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++++. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 3456789999999999999876 6899999998643 2334556788999999997 999999999997544 78999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 90 ~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 90 FDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred ecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99997 589888853 4578888999999999999999998 99999999999999999999999999997543
Q ss_pred CC--------------------CCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccc
Q 003039 681 DG--------------------ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 739 (854)
Q Consensus 681 ~~--------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~ 739 (854)
.. .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 1112234579999999999986 67899999999999999999999999765422111
Q ss_pred cchHHHHHHhhhcCCccc---cc------------------CccccCcCC------------HHHHHHHHHHHHHccCCC
Q 003039 740 RNIVQWAKLHIESGDIQG---II------------------DPSLLDEYD------------IQSMWKIEEKALMCVLPH 786 (854)
Q Consensus 740 ~~l~~~~~~~~~~~~~~~---~i------------------d~~l~~~~~------------~~~~~~l~~l~~~Cl~~~ 786 (854)
..+.. ......... +- .......++ ......+.+|+.+|++.|
T Consensus 241 ~~i~~----~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 241 ERIIG----VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHH----HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHH----hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 11111 100000000 00 000000000 011235789999999999
Q ss_pred CCCCCCHHHHHHH
Q 003039 787 GHMRPSISEVLKD 799 (854)
Q Consensus 787 P~~RPsm~eV~~~ 799 (854)
|++|||++|+++|
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=342.75 Aligned_cols=199 Identities=27% Similarity=0.372 Sum_probs=171.9
Q ss_pred HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-----CCceeeEeeeeeecCeEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----HRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-----HpnIv~l~g~~~~~~~~~ 598 (854)
...|.+.++||+|+||.||+|+.. +++.||||+++.. ......+..|++++++++ ||||+++++++...+..+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 345566789999999999999985 6889999999643 233556778999999886 999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--------------
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------------- 664 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------------- 664 (854)
+||||+ +++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred EEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccc
Confidence 999999 89999998643 233588899999999999999999998 9999999999999975
Q ss_pred -----------CCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccc
Q 003039 665 -----------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 733 (854)
Q Consensus 665 -----------~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~ 733 (854)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 789999999999864332 23456899999999999999999999999999999999999999764
Q ss_pred c
Q 003039 734 K 734 (854)
Q Consensus 734 ~ 734 (854)
.
T Consensus 263 ~ 263 (360)
T 3llt_A 263 E 263 (360)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=344.76 Aligned_cols=264 Identities=22% Similarity=0.342 Sum_probs=197.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 445689999999999999987 489999999865432 23456789999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 107 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 107 DHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp SEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 9999988763 234588999999999999999999998 99999999999999999999999999997554322
Q ss_pred ceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH-------HHhhh-cCCc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------KLHIE-SGDI 755 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~-------~~~~~-~~~~ 755 (854)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.... ...+. ....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 222345689999999999875 78999999999999999999999997654221111111100 00000 0001
Q ss_pred ccccCccccCcCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 QGIIDPSLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~~~id~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+.+...... .....+.+++.+|++.||++|||+.|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111111111111 123568899999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=344.76 Aligned_cols=261 Identities=18% Similarity=0.222 Sum_probs=189.7
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.|.+.++||+|+||+||+|+.. +++.||||+++..... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 3456789999999999999876 6889999998754322 245677999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-----CCCcEEEEeeecccc
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-----KHMRAKVSDFGLSKF 678 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-----~~~~vkl~DFGla~~ 678 (854)
++ |+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 ~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 115 AE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp CS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred CC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 98 499998853 34588999999999999999999998 999999999999994 555699999999976
Q ss_pred ccCCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh--cCCc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE--SGDI 755 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~--~~~~ 755 (854)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+......... ....
T Consensus 187 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 187 FGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTS
T ss_pred cCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCchhhh
Confidence 54322 222344689999999999874 58999999999999999999999997654211 11111111000 0000
Q ss_pred ccc-----c---CccccCc-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 QGI-----I---DPSLLDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~~~-----i---d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... . .+..... ........+.+++.+|++.||++|||+.|+++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000 0 0000000 000022467899999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=331.97 Aligned_cols=246 Identities=21% Similarity=0.345 Sum_probs=201.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 345689999999999999987 57889999986542 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 97 CRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp CTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999998742 35688999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ . .. .+..+.. .+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~---~~-~~~~~~~------~~ 234 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----T---YL-RIKKNEY------SI 234 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----H---HH-HHHTTCC------CC
T ss_pred -cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H---HH-HHhhccC------CC
Confidence 22234568999999999999899999999999999999999999997654211 1 11 1111111 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+ ..+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PKHIN----PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11222 357889999999999999999999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.46 Aligned_cols=245 Identities=29% Similarity=0.431 Sum_probs=194.9
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeee----cCeEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 601 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~----~~~~~LV~ 601 (854)
.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 45678999999999999876 57889999987542 3345678899999999999999999999865 35689999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEc-CCCcEEEEeeecccc
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLD-KHMRAKVSDFGLSKF 678 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILl~-~~~~vkl~DFGla~~ 678 (854)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+. + |+||||||+|||++ .++.+||+|||++..
T Consensus 109 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999953 35688899999999999999999998 7 99999999999998 789999999999975
Q ss_pred ccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
.... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||.... ........ ...+.....
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~-~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRR-VTSGVKPAS 250 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHH-HTTTCCCGG
T ss_pred cccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC------cHHHHHHH-HhccCCccc
Confidence 4332 223456999999999876 458999999999999999999999997543 11111111 111111111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+ ... ...+.+++..|++.+|++|||+.||++|
T Consensus 251 ~~----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 FD----KVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GG----GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cC----CCC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11 111 2358899999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=343.12 Aligned_cols=261 Identities=14% Similarity=0.196 Sum_probs=203.3
Q ss_pred HHHhhccccccCceEEEEEEECC---------CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceee-----------
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD---------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ----------- 586 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~---------~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~----------- 586 (854)
.|.+.+.||+|+||.||+|+... ++.||||++... ..+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 34567899999999999998864 789999998643 46789999999999999988
Q ss_pred ----Eeeeeee-cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 003039 587 ----FLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 661 (854)
Q Consensus 587 ----l~g~~~~-~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 661 (854)
+++++.. .+..++||||+ +++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 5677765 67889999999 99999999643 246789999999999999999999998 9999999999999
Q ss_pred EcCCC--cEEEEeeeccccccCCCCc------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccc
Q 003039 662 LDKHM--RAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 733 (854)
Q Consensus 662 l~~~~--~vkl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~ 733 (854)
++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999755432111 123346999999999999999999999999999999999999999765
Q ss_pred cccccccchHHHHHHhhhcCCcccccCcccc-CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 734 KFGANCRNIVQWAKLHIESGDIQGIIDPSLL-DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 734 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
... ...+......... ......+.... ...+ ..+.+++.+|++.+|++||++.||++.|++++..
T Consensus 272 ~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 272 LPN--TEDIMKQKQKFVD--KPGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TTC--HHHHHHHHHHHHH--SCCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CcC--HHHHHHHHHhccC--ChhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 311 1122222221111 11122221111 1112 4588999999999999999999999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=355.77 Aligned_cols=260 Identities=21% Similarity=0.295 Sum_probs=192.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~~ 598 (854)
|.+.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+|+.++||||+++++++... ...+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 445788999999999999876 5889999999754 233456788999999999999999999999654 4579
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||++++ |.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 144 lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 144 LVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999864 656553 2378888999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHH-------------
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW------------- 745 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~------------- 745 (854)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....+...
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 5432 2234457999999999999999999999999999999999999999765421111111110
Q ss_pred --HHHhhhcC-C-----cccccCccccCc---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 746 --AKLHIESG-D-----IQGIIDPSLLDE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 746 --~~~~~~~~-~-----~~~~id~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........ . +...+...+... ........+.+|+.+|++.||++|||++|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0 000000000000 011224568899999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=350.96 Aligned_cols=266 Identities=20% Similarity=0.233 Sum_probs=197.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeec------------
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------------ 594 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------------ 594 (854)
|.+.+.||+|+||.||+|+.. +|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 456789999999999999875 689999999865432 234799999999999999999998443
Q ss_pred --------------------------CeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 003039 595 --------------------------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648 (854)
Q Consensus 595 --------------------------~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 648 (854)
...++||||++ |+|.+.+.........+++..+..++.|++.||+|||+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 160 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--- 160 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34789999998 588888876555567799999999999999999999998
Q ss_pred ceecCCCCCCCEEEc-CCCcEEEEeeeccccccCCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhC
Q 003039 649 AIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISG 726 (854)
Q Consensus 649 ~ivHrDIkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG 726 (854)
+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||++|||++|
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 999999999999998 689999999999986544322 2334689999999998864 589999999999999999999
Q ss_pred CcccccccccccccchHHHHHH-------hh----hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 003039 727 QEAISNEKFGANCRNIVQWAKL-------HI----ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISE 795 (854)
Q Consensus 727 ~~pf~~~~~~~~~~~l~~~~~~-------~~----~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~e 795 (854)
+.||......+....++..... .+ .+-..............+......+.+++.+|++.+|++|||+.|
T Consensus 239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999765422211111110000 00 000000000011011111122345889999999999999999999
Q ss_pred HHHH--HHHH
Q 003039 796 VLKD--IQDA 803 (854)
Q Consensus 796 V~~~--L~~~ 803 (854)
+++| ++++
T Consensus 319 ~l~hp~f~~~ 328 (383)
T 3eb0_A 319 AMAHPFFDHL 328 (383)
T ss_dssp HHTSGGGHHH
T ss_pred HhcCHHHHHH
Confidence 9976 4443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=353.18 Aligned_cols=240 Identities=14% Similarity=0.132 Sum_probs=186.0
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccC---CcccHHHHHHHH---HHHccCCCCceeeEe-------eeeeec
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEV---TLLSRIHHRNLVQFL-------GYCQEE 594 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~---~~~~~~~~~~Ev---~~L~~l~HpnIv~l~-------g~~~~~ 594 (854)
.+.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+ +++++++||||++++ +++...
T Consensus 76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 34688999999999999964 6899999999743 233457788999 555566899999998 555544
Q ss_pred C-----------------eEEEEEEeccCCCHHhhhcccc---cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCC
Q 003039 595 G-----------------RSVLVYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 654 (854)
Q Consensus 595 ~-----------------~~~LV~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 654 (854)
+ ..++||||+ +|+|.+++.... .....+++..++.|+.||+.||+|||+. +|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 231 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 231 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 3 278999999 689999996421 1124466788889999999999999998 999999
Q ss_pred CCCCCEEEcCCCcEEEEeeeccccccCCCCceeecccccccccCccccccC-----------cCCCcchhhhHHHHHHHH
Q 003039 655 LKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-----------QLTDKSDVYSFGVILLEL 723 (854)
Q Consensus 655 Ikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~~~DVwSlGvvl~el 723 (854)
|||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++|||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999999999999999998532 23344567 999999999887 899999999999999999
Q ss_pred HhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 724 ISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 724 ltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
++|+.||...........+ .. . ....+ ..+.+++.+|++.||++||++.|++++
T Consensus 307 ltg~~Pf~~~~~~~~~~~~----------------~~-~-~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWI----------------FR-S-CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHSSCCC------CCSGGG----------------GS-S-CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHCCCCCcccccccchhhh----------------hh-h-ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999764422111111 00 0 01222 357899999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=338.68 Aligned_cols=246 Identities=21% Similarity=0.347 Sum_probs=201.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 445789999999999999987 47899999987542 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 123 ~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 123 CRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999998743 35688999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. . .+..+.. .+
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~---~-~~~~~~~------~~ 260 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TY---L-RIKKNEY------SI 260 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH---H-HHHHTCC------CC
T ss_pred -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----HH---H-HHhcCCC------CC
Confidence 22334569999999999999999999999999999999999999997644211 11 1 1111111 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+ ..+.+++.+|++.||++||++.|++++
T Consensus 261 ~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 PKHIN----PVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11222 357789999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=332.93 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=195.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCHH
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 610 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 610 (854)
..||+|+||.||+|... +++.||||++..........+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999875 68899999998766556678999999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeeeccccccCCCCceeec
Q 003039 611 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 611 ~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...... .....
T Consensus 108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 182 (295)
T 2clq_A 108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTET 182 (295)
T ss_dssp HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccccc
Confidence 9986432 233466888889999999999999998 9999999999999997 8999999999997654322 12234
Q ss_pred ccccccccCccccccCc--CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 690 VRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~--~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
..||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....... . ........ . ..+.+....
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~-~~~~~~~~-~-----~~~~~~~~~ 251 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----A-AMFKVGMF-K-----VHPEIPESM 251 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----H-HHHHHHHH-C-----CCCCCCTTS
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----H-HHHhhccc-c-----ccccccccC
Confidence 56899999999997643 7889999999999999999999996543111 0 11111000 0 111122222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+ ..+.+++.+|++.+|++||++.|++++
T Consensus 252 ~----~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 252 S----AEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp C----HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred C----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2 357889999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.16 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=203.2
Q ss_pred HHHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~ 598 (854)
..+.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++...+..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 34556789999999999999842 47789999997543 344567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHhhhccccc---ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEe
Q 003039 599 LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSD 672 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~D 672 (854)
+||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999965421 224588999999999999999999998 9999999999999994 44699999
Q ss_pred eeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhh
Q 003039 673 FGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 673 FGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+... +
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~----~ 258 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEF----V 258 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHH----H
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH----HHHHH----H
Confidence 999975433222 22234457899999999999999999999999999999998 99999754311 12221 1
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
..+.... .... ....+.+++.+|++.+|++||++.||+++|+.+...
T Consensus 259 ~~~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 259 TSGGRMD-----PPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HTTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCCCCC-----CCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 1111110 1111 224588999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=342.56 Aligned_cols=264 Identities=21% Similarity=0.225 Sum_probs=196.2
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc-----cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~-----~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
.|.+.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 4566789999999999999986 5899999998643221 134678999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 91 FDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999986 88888753 234678889999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc--
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG-- 757 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~-- 757 (854)
... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||......+....+....... ......+
T Consensus 164 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~ 241 (346)
T 1ua2_A 164 SPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP-TEEQWPDMC 241 (346)
T ss_dssp SCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-CTTTSSSTT
T ss_pred CCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC-Chhhhhhhc
Confidence 322 223345689999999999764 58889999999999999999999987654211111111100000 0000000
Q ss_pred ----ccCccccCcCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 ----IIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ----~id~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+........+ ......+.+++.+|++.+|++|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000011 1122468899999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=349.09 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=189.6
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--------ccHHHHHHHHHHHccCCCCceeeEeeeeeecCe
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 596 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--------~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~ 596 (854)
..|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+++|++++||||+++++++.. +.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 34566789999999999999876 578999999865321 112347899999999999999999999854 55
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEee
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDF 673 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DF 673 (854)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 214 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp EEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred eEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeec
Confidence 799999999999998884 345689999999999999999999998 999999999999997544 5999999
Q ss_pred eccccccCCCCceeecccccccccCcccccc---CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 674 GLSKFAVDGASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 674 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
|+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+... +
T Consensus 287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~~----i 357 (419)
T 3i6u_A 287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQ----I 357 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---CHHHH----H
T ss_pred ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---HHHHH----H
Confidence 999865432 23344679999999999863 567889999999999999999999997543211 22221 1
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+.... .+..... ....+.+++.+|++.+|++||++.|+++|
T Consensus 358 ~~~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TSGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111110 0111111 12458899999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=329.64 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=200.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 445789999999999999886 57889999986432 22346788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 96 APRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 999999999853 34688999999999999999999998 9999999999999999999999999998654332
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ . .. .+.... ..+
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~---~~-~~~~~~------~~~ 231 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----T---HR-RIVNVD------LKF 231 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----H---HH-HHHTTC------CCC
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH----H---HH-HHhccc------cCC
Confidence 2234568999999999999999999999999999999999999997544111 1 11 111111 111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+ ..+.+++.+|++.+|++||++.|+++|
T Consensus 232 ~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 PPFLS----DGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCcCC----HHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11222 357899999999999999999999886
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=344.35 Aligned_cols=259 Identities=21% Similarity=0.307 Sum_probs=191.3
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc-cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~-~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.||+|+||+||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence 45678999999999999987 6899999998654322 12245579999999999999999999999999999999997
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 84 ~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 156 (324)
T 3mtl_A 84 KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 156 (324)
T ss_dssp EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence 5888888532 34588899999999999999999998 99999999999999999999999999997543322 22
Q ss_pred eecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC---CcccccCc-
Q 003039 687 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---DIQGIIDP- 761 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~---~~~~~id~- 761 (854)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ....+....... ........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhchhhhcch
Confidence 234468999999999876 568999999999999999999999997654221 112111111110 00000000
Q ss_pred --------cccC----cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 --------SLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 --------~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... .........+.+++.+|++.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0001112457899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.15 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=203.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 345688999999999999875 68899999997553 3345788999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 104 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 104 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp TEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 9999999842 4688999999999999999999998 99999999999999999999999999997654432 1
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... .+..+.. +.+..
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----~~~~~~~-----~~~~~ 241 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM----KVLF----LIPKNNP-----PTLEG 241 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH----HHHHSCC-----CCCCS
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH----HHHH----HhhcCCC-----CCCcc
Confidence 223456899999999999999999999999999999999999999754311 1111 1111111 11222
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
.++ ..+.+++..|++.+|++|||+.||+++.
T Consensus 242 ~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 242 NYS----KPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp SCC----HHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ccC----HHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 223 3578999999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=355.40 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=197.6
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
..|.+.+.||+|+||+||+|+.+ ++..||||++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45667889999999999999986 68899999997543 3345678999999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEeeeccccc
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA 679 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkl~DFGla~~~ 679 (854)
|+++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.. +.+||+|||+++..
T Consensus 117 ~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999988843 35688999999999999999999998 99999999999999764 55999999999865
Q ss_pred cCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.... ......||+.|+|||++. ..++.++||||+||++|||++|+.||...... .+.. .+..+... .
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~----~i~~~~~~--~ 256 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ----EILR----KVEKGKYT--F 256 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHTCCC--C
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHHhCCCC--C
Confidence 4432 233456999999999876 56999999999999999999999999765421 1222 11222111 1
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.......+ ..+.+++.+|++.+|++|||+.|+++|
T Consensus 257 ~~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 DSPEWKNVS----EGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSGGGTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CchhcccCC----HHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 111111222 357899999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.94 Aligned_cols=261 Identities=24% Similarity=0.390 Sum_probs=183.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 445789999999999999865 68999999986443 2335678899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccc----cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 606 NGTLKEHLYGTL----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 606 ~gsL~~~L~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
+++|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 999999986421 1234588999999999999999999998 999999999999999999999999999875543
Q ss_pred CCC----ceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 682 GAS----HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 682 ~~~----~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ................
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM----KVLMLTLQNDPPSLET 249 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG----GHHHHHHTSSCCCTTC
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh----hHHHHHhccCCCcccc
Confidence 211 12234468999999999876 56899999999999999999999999764421 1111111000000001
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...++.+...++ ..+.+++.+|++.+|++||++.|++++
T Consensus 250 ~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 250 GVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111222222333 357899999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=344.34 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=198.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 345678999999999999987 68999999997653 3345678999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 115 ~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 115 GGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp TCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 9999999853 346889999999999999999999831 7999999999999999999999999998654321
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccc------------------------
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN------------------------ 741 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~------------------------ 741 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 22334689999999999999999999999999999999999999975432111000
Q ss_pred -----------hHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 742 -----------IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 742 -----------l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......... .+.. +.+ ........+.+++.+|++.+|++|||+.|+++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIV-NEPP-----PKL---PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------CCCHHHHHHHHH-HSCC-----CCC---CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCCCcccchhhhhHHh-ccCC-----CCC---CcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000 0000 000 001112358899999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=354.84 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=200.3
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
..|.+.+.||+|+||+||+|+.. +++.||||++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 45677899999999999999986 6899999998643 22345778999999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc---CCCcEEEEeeeccccc
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFA 679 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkl~DFGla~~~ 679 (854)
|+.+|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 102 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 102 LYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999998843 35688999999999999999999998 999999999999995 4567999999999865
Q ss_pred cCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...... .+.. .+..+....
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~----~i~~~~~~~-- 241 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILK----RVETGKYAF-- 241 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHTCCCS--
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHHhCCCCC--
Confidence 4332 2334569999999999875 5899999999999999999999999765421 1111 112222110
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+....... ...+.+++.+|++.+|++|||+.|+++|
T Consensus 242 ~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSGGGGGS----CHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCcccCCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001112 2357899999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.36 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=193.9
Q ss_pred HHhhccccccCceEEEEEEEC--CCc--EEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~--~~~--~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
+.+.+.||+|+||.||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++.... .++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence 456789999999999999864 233 68999987542 234567889999999999999999999998765 8899
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 99 TELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999998632 35688999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCce--eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 681 DGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 681 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
...... .....+|..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.. .....+...
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~---~~~~~~~~~- 244 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILH---KIDKEGERL- 244 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH---HHHTSCCCC-
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----HHHH---HHHccCCCC-
Confidence 433221 233457889999999998889999999999999999999 99999765411 1111 111111100
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..... ....+.+++.+|++.+|++||++.+|+++|+++..
T Consensus 245 ----~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 245 ----PRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ----CCCcC----cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 01111 23468899999999999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=328.81 Aligned_cols=245 Identities=24% Similarity=0.428 Sum_probs=192.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 445789999999999999987 68999999986432 22345788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 93 VSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred cCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999853 34588899999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... .+.. .+..+...
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~----~~~~~~~~------ 229 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP----TLFK----KIRGGVFY------ 229 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCCC------
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHH----HhhcCccc------
Confidence 2233468999999999987765 68999999999999999999999754321 1111 11112110
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+.... ...+.+++.+|++.+|++||++.||+++
T Consensus 230 ~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 IPEYL----NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cchhc----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 2357899999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=356.11 Aligned_cols=251 Identities=28% Similarity=0.403 Sum_probs=203.6
Q ss_pred HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
...|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 345677889999999999999987 78999999996542 33467789999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeeeccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSK 677 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~ 677 (854)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998853 45689999999999999999999998 99999999999999 567899999999998
Q ss_pred cccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...... .+.. .+..+....
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~----~i~~~~~~~ 246 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY----DILK----KVEKGKYTF 246 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCCCC
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH----HHHH----HHHcCCCCC
Confidence 654432 2234569999999999865 6899999999999999999999999765421 1222 122222110
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+....... ...+.+++.+|++.+|++|||+.|+++|
T Consensus 247 --~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 --ELPQWKKV----SESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --CSGGGGGS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCcccccC----CHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00001112 2457899999999999999999999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=351.39 Aligned_cols=259 Identities=24% Similarity=0.278 Sum_probs=193.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~~LV 600 (854)
|.+.+.||+|+||.||+|++. +++.||||++.... ....+|+++|++++||||+++++++... ...++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 345688999999999999986 58999999986542 2234799999999999999999998542 236799
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeeeccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFA 679 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~ 679 (854)
|||+++ +|.+.+.........+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999986 66666654334456789999999999999999999998 99999999999999965 67899999999865
Q ss_pred cCCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh-------hh
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IE 751 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~-------~~ 751 (854)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+ .+...++.. +.
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHHH
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHH
Confidence 44322 2334689999999999764 78999999999999999999999997654211 222221110 00
Q ss_pred --cCCcccccCccccC-----cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 752 --SGDIQGIIDPSLLD-----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 752 --~~~~~~~id~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+..-+.+.. .+.......+.+|+.+|++.||++||++.|+++|
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 01111111111110 0111123468899999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.26 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=198.0
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
..+.+.+.||+|+||.||+|... +|+.||||++.... ....+.+|+.++++++||||+++++++...+..++||||+
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 34456789999999999999887 58999999997543 3467889999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 107 ~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 107 GAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp TTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999852 245688999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..... ...........+
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~-~~~~~~~~~~~~--- 248 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIFM-IPTNPPPTFRKP--- 248 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHH-HHHSCCCCCSSG---
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHHH-HhcCCCcccCCc---
Confidence 223446899999999999999999999999999999999999999754311 11111 111111111001
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+ ...+.+++.+|++.+|++||++.|++++
T Consensus 249 ~~~----~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 249 ELW----SDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp GGS----CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111 2358899999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.70 Aligned_cols=250 Identities=21% Similarity=0.352 Sum_probs=195.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.+.||+|+||.||+|+.. +++.||+|++..........+.+|++++++++||||+++++++...+..++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 445788999999999999987 5889999999776666678899999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 101 ~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 173 (302)
T 2j7t_A 101 GAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK 173 (302)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred CcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence 999998853 235588999999999999999999998 9999999999999999999999999987532211 111
Q ss_pred eecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 687 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.....||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ........ +.......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~~~~- 244 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAK-SDPPTLLT- 244 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHH-SCCCCCSS-
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhc-cCCcccCC-
Confidence 22345899999999984 567889999999999999999999999754411 11111111 11111111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+ ...+.+++.+|++.+|++|||+.|+++|
T Consensus 245 --~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 --PSKW----SVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --GGGS----CHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --cccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111 2357899999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=340.84 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=190.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecC------eEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~------~~~ 598 (854)
|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 445688999999999999885 68999999986432 223467889999999999999999999997653 459
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 999999 7899998853 4588889999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH-----------
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA----------- 746 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~----------- 746 (854)
.... .....||+.|+|||++.+ ..++.++||||+||+++||++|+.||.+....+....+....
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 5332 234468999999999987 789999999999999999999999997654211111111100
Q ss_pred -----HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 747 -----KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 747 -----~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+.. +...-...+. .........+.+|+.+|++.||++|||+.|+++|
T Consensus 254 ~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 254 QSDEAKNYMKG--LPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCHHHHHHHHH--SCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHh--CCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000 0000000000 0011123457899999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=345.33 Aligned_cols=196 Identities=24% Similarity=0.355 Sum_probs=163.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec-----CeEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-----~~~~L 599 (854)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++... ...++
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 456789999999999999876 57889999997542 23456788999999999999999999999766 57899
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+. |+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 999986 599998843 45689999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCC---------------------ceeecccccccccCcccc-ccCcCCCcchhhhHHHHHHHHHhCCcccc
Q 003039 680 VDGAS---------------------HVSSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAIS 731 (854)
Q Consensus 680 ~~~~~---------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~~~DVwSlGvvl~elltG~~pf~ 731 (854)
..... .......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 43221 122456799999999986 45679999999999999999998666553
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=337.26 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=199.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc--------cHHHHHHHHHHHccC-CCCceeeEeeeeeecCe
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 596 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~--------~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~ 596 (854)
.|.+.+.||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+.+++++ +||||+++++++...+.
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 3444689999999999999986 6999999998754311 134678899999999 79999999999999999
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 175 ~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 9999999999999999853 35688999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeecccccccccCcccccc------CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 677 KFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 677 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..... +
T Consensus 248 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~----i 317 (365)
T 2y7j_A 248 CHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----LMLRM----I 317 (365)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----H
T ss_pred cccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH----HHHHH----H
Confidence 7654432 2234569999999999863 35888999999999999999999999754311 11111 1
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+.... ..+ ..... ...+.+++.+|++.+|++||++.|++++
T Consensus 318 ~~~~~~~-~~~-~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 MEGQYQF-SSP-EWDDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHTCCCC-CHH-HHSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCCCCC-CCc-ccccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111100 000 00111 2358899999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=346.83 Aligned_cols=262 Identities=22% Similarity=0.265 Sum_probs=193.0
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCe------EEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~------~~LV~ 601 (854)
|.+.+.||+|+||+||+|++..+..||+|++..... ...+|+++++.++||||+++++++...+. .++||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 456789999999999999998777899998864422 22369999999999999999999965443 78999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcEEEEeeecccccc
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkl~DFGla~~~~ 680 (854)
||++++.+ +.+.........+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 118 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 118 EYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp ECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99987544 33332223356788999999999999999999998 999999999999999 79999999999998654
Q ss_pred CCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH--------H---H
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--------K---L 748 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~--------~---~ 748 (854)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+.... . .
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 4332 2334689999999998764 58999999999999999999999997654221111111110 0 0
Q ss_pred hhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 749 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 749 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......+..+....+...+.......+.+|+.+|++.||++|||+.|+++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000001111000000001111123468899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=354.37 Aligned_cols=192 Identities=24% Similarity=0.371 Sum_probs=150.7
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec-----CeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-----~~~~ 598 (854)
.|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++... ...+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 3556789999999999999876 68999999986532 23456788999999999999999999999443 5789
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+ +|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.
T Consensus 134 lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 999998 468988884 345689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCC--------------------------ceeecccccccccCcccc-ccCcCCCcchhhhHHHHHHHHHhC
Q 003039 679 AVDGAS--------------------------HVSSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISG 726 (854)
Q Consensus 679 ~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~~~DVwSlGvvl~elltG 726 (854)
...... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 542211 122345689999999986 456799999999999999999993
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=339.36 Aligned_cols=265 Identities=19% Similarity=0.270 Sum_probs=197.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeee--------cC
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EG 595 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--------~~ 595 (854)
.|.+.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 3456789999999999999985 689999999865432 234578899999999999999999999976 45
Q ss_pred eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeec
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 675 (854)
..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 68999999985 777776432 34588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC---CceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh
Q 003039 676 SKFAVDGA---SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 676 a~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... ...
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG-SIT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCC
Confidence 97654221 122234568999999999876 5589999999999999999999999976542211111111100 000
Q ss_pred cCCcccccCccc--------cCcCCH-HH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 752 SGDIQGIIDPSL--------LDEYDI-QS------MWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 752 ~~~~~~~id~~l--------~~~~~~-~~------~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.......-+... ...... +. ...+.+|+.+|++.||++|||+.|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000000000 000011 11 2347899999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=343.34 Aligned_cols=251 Identities=10% Similarity=0.012 Sum_probs=176.8
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccC--CCCceeeEe-------eeeeec-
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI--HHRNLVQFL-------GYCQEE- 594 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l--~HpnIv~l~-------g~~~~~- 594 (854)
.+.+.||+|+||.||+|++. +++.||||++..... .....+.+|+.+++.+ +||||++++ +++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence 35688999999999999976 689999999986543 2345567785444444 699988855 344332
Q ss_pred ----------------CeEEEEEEeccCCCHHhhhcccccccccccHHHH------HHHHHHHHHHHHHHHhCCCCceec
Q 003039 595 ----------------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------LEIAEDAAKGIEYLHTGCVPAIIH 652 (854)
Q Consensus 595 ----------------~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ivH 652 (854)
...++||||++ |+|.+++... ...+.+..+ ..++.||+.||+|||++ +|+|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 33799999999 8999999643 223344455 67889999999999998 9999
Q ss_pred CCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCccc
Q 003039 653 RDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAI 730 (854)
Q Consensus 653 rDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf 730 (854)
|||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999985532 2224457799999999987 78999999999999999999999999
Q ss_pred ccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 731 SNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 731 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......... . .............+...........+.+++.+|++.+|++|||+.|+++|
T Consensus 294 ~~~~~~~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGIKG-S--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTCTT-C--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCccccc-c--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 765421100 0 00000000001111111011223468899999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=349.35 Aligned_cols=260 Identities=20% Similarity=0.333 Sum_probs=204.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCC-CceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~H-pnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.++||+|+||.||+|++. +++.||||++..... ..++..|+++++.++| +++..+..++...+..++||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 345789999999999999874 689999999865432 2457889999999976 56666777777888899999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeeeccccccCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~~~ 682 (854)
+++|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.....
T Consensus 86 g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999998532 45689999999999999999999998 99999999999999 68899999999999866543
Q ss_pred CCc------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 683 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 683 ~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-TSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-SCHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-ccHH
Confidence 322 122457999999999999999999999999999999999999999865532222222221111111 1110
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
. +...+ ..++.+++..|++.+|++||++.+|++.|++++..
T Consensus 239 ~-----l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 239 A-----LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp H-----HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H-----HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0 11122 24688999999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.14 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=186.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-cc-HHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~-~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
+.+.+.||+|+||.||+|+.. +++.||||+++.... .. .+.+.++...++.++||||+++++++...+..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 345689999999999999975 689999999975432 22 233445556688899999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
+ |+|.+++.........+++..++.++.|++.||+|||++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 164 (290)
T 3fme_A 89 D-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV- 164 (290)
T ss_dssp S-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred c-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc-
Confidence 7 588888865555567799999999999999999999985 289999999999999999999999999997654332
Q ss_pred ceeecccccccccCcccc----ccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 685 HVSSIVRGTVGYLDPEYY----ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~----~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
......||+.|+|||.+ .+..++.++|||||||++|||++|+.||..... -............. ...
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-~~~- 235 (290)
T 3fme_A 165 -AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQQLKQVVEEPSP-QLP- 235 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HHHHHHHHHHSCCC-CCC-
T ss_pred -cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hHHHHHHHhccCCC-Ccc-
Confidence 22334689999999996 556788999999999999999999999975321 11111112221111 100
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+ ...+.+++.+|++.+|++|||+.|+++|
T Consensus 236 ---~~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 236 ---ADKF----SAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---cccC----CHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1112 2357899999999999999999999885
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.52 Aligned_cols=256 Identities=19% Similarity=0.292 Sum_probs=195.8
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeeeeee--cCeEEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE--EGRSVLVYE 602 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~--~~~~~LV~E 602 (854)
.|.+.+.||+|+||.||+|+.. +++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++|||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 3456789999999999999875 6899999998743 3567899999999997 9999999999987 667899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeeeccccccC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 681 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~ 681 (854)
|+.+++|.+++. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++....
T Consensus 114 ~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 114 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999998873 377888999999999999999998 999999999999999776 899999999986544
Q ss_pred CCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH--------Hhhhc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK--------LHIES 752 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~--------~~~~~ 752 (854)
... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+..... ..+..
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHHHH
Confidence 322 234468999999999987 67899999999999999999999999543211 011111100 00000
Q ss_pred CCc--------------ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 753 GDI--------------QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 753 ~~~--------------~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... ...................+.+++.+|++.||++|||++|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 00000000111111123468899999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=333.97 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=195.7
Q ss_pred HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--------ccHHHHHHHHHHHccCCCCceeeEeeeeeecC
Q 003039 525 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 595 (854)
Q Consensus 525 ~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--------~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~ 595 (854)
...|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 345667899999999999999876 578999999865321 12235789999999999999999999987655
Q ss_pred eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc---EEEEe
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSD 672 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkl~D 672 (854)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 899999999999999884 345688999999999999999999998 9999999999999987664 99999
Q ss_pred eeccccccCCCCceeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh
Q 003039 673 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 673 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~ 749 (854)
||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+....
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~--- 232 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQI--- 232 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHH---
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHH---
Confidence 9999765432 2223456899999999974 4678899999999999999999999997544221 222211
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+... ..+...... ...+.+++.+|++.+|++||++.|++++
T Consensus 233 -~~~~~~--~~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 -TSGKYN--FIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -HHTCCC--CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HhCccc--cCchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111111 001111111 2467899999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=367.31 Aligned_cols=246 Identities=24% Similarity=0.292 Sum_probs=200.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
+.+.+.||+|+||.||+|+.+ +++.||||+++... ......+..|..++..+ +||+|+++++++.+.+..++|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 345678999999999999986 57889999997531 23345677899999987 79999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 423 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 423 YVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred CcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 9999999999953 35689999999999999999999998 9999999999999999999999999999853322
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ .. ..+.+ .
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----~~~~---~i-~~~~~------~ 560 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQ---SI-MEHNV------A 560 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH---HH-HSSCC------C
T ss_pred C-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----HHHH---HH-HhCCC------C
Confidence 2 2344567999999999999999999999999999999999999999765421 1111 11 11111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm-----~eV~~~ 799 (854)
+... ...++.+|+..|++.+|++||++ +||.+|
T Consensus 561 ~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 561 YPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCcc----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1111 22457899999999999999997 777765
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=338.23 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=189.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecC------eEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~------~~~ 598 (854)
|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 445688999999999999876 68899999997542 233466889999999999999999999997654 789
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99999975 7877773 2478888999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchH---------------
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV--------------- 743 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~--------------- 743 (854)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 5332 12234568999999999999999999999999999999999999997644211100000
Q ss_pred HHHHHhhhcCC------cccccCccccC---cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 744 QWAKLHIESGD------IQGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 744 ~~~~~~~~~~~------~~~~id~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
........... +...+...... .........+.+++.+|++.||++|||++|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000010000 00000000000 0112234678999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.09 Aligned_cols=249 Identities=27% Similarity=0.321 Sum_probs=198.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---------ccHHHHHHHHHHHccCC-CCceeeEeeeeeecCe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---------QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 596 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---------~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~ 596 (854)
|.+.+.||+|+||.||+|..+ +++.||||++..... ...+.+.+|+++++++. ||||+++++++...+.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 345688999999999999986 588999999975431 12356788999999995 9999999999999999
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 99 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999853 35688999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeecccccccccCccccc------cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 677 KFAVDGASHVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 677 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
+...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .... .+
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~----~~ 241 (298)
T 1phk_A 172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----LMLR----MI 241 (298)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HH
T ss_pred hhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH----HHHH----HH
Confidence 7654332 223356899999999985 456888999999999999999999999754311 1111 11
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+.... ..+ .... ....+.+++.+|++.+|++||++.|++++
T Consensus 242 ~~~~~~~-~~~-~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 242 MSGNYQF-GSP-EWDD----YSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHTCCCC-CTT-TGGG----SCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hcCCccc-Ccc-cccc----cCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 1111110 000 0111 22458899999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=344.37 Aligned_cols=272 Identities=21% Similarity=0.276 Sum_probs=203.3
Q ss_pred cCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC--------CCceeeEe
Q 003039 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH--------HRNLVQFL 588 (854)
Q Consensus 518 ~~~~~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~--------HpnIv~l~ 588 (854)
+..+++....|.+.++||+|+||+||+|+.. +++.||||+++.. ......+.+|++++++++ |+||++++
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 3444444455677889999999999999875 5889999999743 234567889999999985 78899999
Q ss_pred eeee----ecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 003039 589 GYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 664 (854)
Q Consensus 589 g~~~----~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 664 (854)
+++. .....++||||+ +++|.+.+... ....+++..++.++.||+.||+|||+++ +|+||||||+|||++.
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~ 182 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV 182 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence 9987 556889999999 56666666432 2356889999999999999999999953 8999999999999997
Q ss_pred CC-------------------------------------------------cEEEEeeeccccccCCCCceeeccccccc
Q 003039 665 HM-------------------------------------------------RAKVSDFGLSKFAVDGASHVSSIVRGTVG 695 (854)
Q Consensus 665 ~~-------------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~gt~~ 695 (854)
++ .+||+|||+++..... .....||+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~ 258 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQ 258 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCc
Confidence 75 7999999999765432 233468999
Q ss_pred ccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccch--HHHHHHhhh--------cCC-----------
Q 003039 696 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI--VQWAKLHIE--------SGD----------- 754 (854)
Q Consensus 696 Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l--~~~~~~~~~--------~~~----------- 754 (854)
|+|||++.+..++.++|||||||++|||++|+.||............ ......... .+.
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 99999999999999999999999999999999999765422211111 111111000 000
Q ss_pred cccccCccc---------cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l---------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+.+... ....+......+.+|+.+|++.||++|||+.|+++|
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000000 012345666789999999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=353.77 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=197.7
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-------------ccHHHHHHHHHHHccCCCCceeeEeeeee
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-------------QGKREFTNEVTLLSRIHHRNLVQFLGYCQ 592 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-------------~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~ 592 (854)
.|.+.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3556789999999999999986 578999999875431 23467889999999999999999999999
Q ss_pred ecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEE
Q 003039 593 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAK 669 (854)
Q Consensus 593 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vk 669 (854)
..+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+|
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999998843 45689999999999999999999998 999999999999999776 699
Q ss_pred EEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh
Q 003039 670 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 749 (854)
Q Consensus 670 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~ 749 (854)
|+|||+++...... ......||+.|+|||++. +.++.++||||+||++|+|++|..||...... .+.. .
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~----~ 258 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ----DIIK----K 258 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----H
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----H
Confidence 99999998654432 233456999999999986 56899999999999999999999999765421 1211 1
Q ss_pred hhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 750 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 750 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+..+.... +....... ...+.+++.+|++.+|++|||+.|+++|
T Consensus 259 i~~~~~~~--~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEKGKYYF--DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHCCCCC--CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHcCCCCC--CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 22222110 00001111 2457899999999999999999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=366.78 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=203.1
Q ss_pred HHHHhhccccccCceEEEEEEECC----CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
..+.+.+.||+|+||.||+|.+.. +..||||+++... ....+.+.+|+.++++++||||+++++++. ++..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 345567889999999999998752 4579999987543 233467899999999999999999999985 4568999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 469 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 469 MELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999532 34588999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
...........+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .+... +..+....
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~~~~----i~~~~~~~-- 612 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGR----IENGERLP-- 612 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH----HHHTCCCC--
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHH----HHcCCCCC--
Confidence 443333344557889999999998999999999999999999997 99999765421 12221 11121111
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
+.. .....+.+++.+|++.+|++||++.||++.|++++..+
T Consensus 613 ---~~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 ---MPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ---CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 111 12246889999999999999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=343.16 Aligned_cols=259 Identities=20% Similarity=0.250 Sum_probs=190.2
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcc-----------cHHHHHHHHHHHccCCCCceeeEeeeeee---
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNLVQFLGYCQE--- 593 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~-----------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--- 593 (854)
|.+.+.||+|+||.||+|...+++.||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 103 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence 3446889999999999999888999999998643221 12678999999999999999999999843
Q ss_pred --cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 003039 594 --EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 671 (854)
Q Consensus 594 --~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 671 (854)
....++||||+. |+|.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 104 ~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 104 PAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEE
Confidence 346899999998 688888753 344689999999999999999999998 99999999999999999999999
Q ss_pred eeeccccccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 672 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 672 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+... .
T Consensus 177 Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~----~ 250 (362)
T 3pg1_A 177 DFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV----V 250 (362)
T ss_dssp CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH----H
T ss_pred ecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH----c
Confidence 99999744332 22234568999999999887 67899999999999999999999999765422221111111 0
Q ss_pred hcCCcc-----------cccCcccc-------CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGDIQ-----------GIIDPSLL-------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~~~-----------~~id~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...... +.+...+. ..........+.+++.+|++.+|++|||+.|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000 00000000 00011123458899999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=335.89 Aligned_cols=259 Identities=21% Similarity=0.289 Sum_probs=197.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeec-----CeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-----~~~~LV 600 (854)
|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 456789999999999999876 688899999975432 3346788999999999999999999998654 468999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+. |+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 109 QDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 99997 58988884 24588999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCce--eecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc-
Q 003039 681 DGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ- 756 (854)
Q Consensus 681 ~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~- 756 (854)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+... .......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~ 255 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI----LGSPSQED 255 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH----HCSCCHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH----hCCCCHHH
Confidence 322211 234579999999998765 45899999999999999999999999765533222222111 0000000
Q ss_pred --------------cccCcccc--CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 --------------GIIDPSLL--DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 --------------~~id~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+.-. ..........+.+++.+|++.||++|||+.|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00001112457899999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.45 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=200.8
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCccc-----------------HHHHHHHHHHHccCCCCceeeEeee
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----------------KREFTNEVTLLSRIHHRNLVQFLGY 590 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~-----------------~~~~~~Ev~~L~~l~HpnIv~l~g~ 590 (854)
|.+.+.||+|+||.||+|+. +++.||||++....... ...+.+|++++++++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 44678999999999999999 79999999986432111 1789999999999999999999999
Q ss_pred eeecCeEEEEEEeccCCCHHhhhccc--cc--ccccccHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCC
Q 003039 591 CQEEGRSVLVYEFMHNGTLKEHLYGT--LT--HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKH 665 (854)
Q Consensus 591 ~~~~~~~~LV~E~~~~gsL~~~L~~~--~~--~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~ 665 (854)
+...+..++||||+++|+|.+++... .. ....+++..++.++.|++.||+|||+ . +|+||||||+|||++.+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKN 188 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCC
Confidence 99999999999999999999983211 11 25678999999999999999999999 7 99999999999999999
Q ss_pred CcEEEEeeeccccccCCCCceeecccccccccCccccccC-cCCC-cchhhhHHHHHHHHHhCCcccccccccccccchH
Q 003039 666 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIV 743 (854)
Q Consensus 666 ~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~ 743 (854)
+.+||+|||+++..... ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||...... ..+.
T Consensus 189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~ 262 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---VELF 262 (348)
T ss_dssp SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---HHHH
T ss_pred CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHH
Confidence 99999999999765433 33445699999999999877 6666 999999999999999999999765421 1111
Q ss_pred HHHHHhhhcCCcccccCc-----ccc----CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 744 QWAKLHIESGDIQGIIDP-----SLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 744 ~~~~~~~~~~~~~~~id~-----~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.. +..+......+. .+. ..........+.+++.+|++.+|++||++.|+++|
T Consensus 263 ~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 122211100000 000 00001223468899999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=344.90 Aligned_cols=196 Identities=26% Similarity=0.341 Sum_probs=168.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC------CCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI------HHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l------~HpnIv~l~g~~~~~~~~~LV 600 (854)
|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|+++++.+ +|+||+++++++...+..++|
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 556789999999999999876 5889999999753 23345677888888777 577999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc--EEEEeeecccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKF 678 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkl~DFGla~~ 678 (854)
|||+. ++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 178 ~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 178 FELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp ECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 99996 6899988543 234588999999999999999999998 9999999999999999987 99999999975
Q ss_pred ccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 734 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~ 734 (854)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 4322 233468999999999999999999999999999999999999997654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.19 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=194.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC----cccHHHHHHHHHHHccCCCCceeeEeeee--eecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYC--QEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~----~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~--~~~~~~~LV 600 (854)
|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++ ...+..++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 345789999999999999875 68899999986532 23456789999999999999999999998 445688999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||++++ |.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999876 76766432 245688999999999999999999998 99999999999999999999999999997654
Q ss_pred CCC-CceeecccccccccCccccccCc--CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 681 DGA-SHVSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 681 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~--~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .+.. .+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----~i~~~~~-- 230 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY----KLFE----NIGKGSY-- 230 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH----HHHHCCC--
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHH----HHhcCCC--
Confidence 322 22334456999999999987643 477999999999999999999999764411 1111 1122211
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.... ...+.+++.+|++.+|++||++.|++++
T Consensus 231 ----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111222 2357899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=340.64 Aligned_cols=263 Identities=19% Similarity=0.266 Sum_probs=180.6
Q ss_pred hccccccCceEEEEEEEC---CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEEEEEEecc
Q 003039 531 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 605 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~ 605 (854)
+++||+|+||+||+|+++ +++.||||++.... ....+.+|+++|++++||||+++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 468999999999999976 47889999987543 23568899999999999999999999954 678999999997
Q ss_pred CCCHHhhhcccc-----cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE----cCCCcEEEEeeecc
Q 003039 606 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 676 (854)
Q Consensus 606 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkl~DFGla 676 (854)
+ +|.+++.... .....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 4 7877774221 1223488999999999999999999998 99999999999999 67899999999999
Q ss_pred ccccCCCC--ceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCccccccccccc-----ccchHHHHHH
Q 003039 677 KFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-----CRNIVQWAKL 748 (854)
Q Consensus 677 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~-----~~~l~~~~~~ 748 (854)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .......+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 86543221 22344579999999999987 4589999999999999999999999965432100 0011111111
Q ss_pred hhhcCC---cccc------------cCccccCcCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 749 HIESGD---IQGI------------IDPSLLDEYDI---------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 749 ~~~~~~---~~~~------------id~~l~~~~~~---------~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.... ...+ +.......... .....+.+|+.+|++.||++|||++|+++|
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111000 0000 00000000000 002357899999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=323.22 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=189.2
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeee------------
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------------ 593 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~------------ 593 (854)
.+.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|++++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 3456789999999999999975 6899999998643 2335678899999999999999999998865
Q ss_pred -cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 003039 594 -EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 672 (854)
Q Consensus 594 -~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 672 (854)
.+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 4567999999999999999963 234577888899999999999999998 999999999999999999999999
Q ss_pred eeccccccCCC-------------CceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCccccccccccc
Q 003039 673 FGLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGAN 738 (854)
Q Consensus 673 FGla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~ 738 (854)
||+++...... ........||+.|+|||.+.+. .++.++|||||||++|||++ ||.... .
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---~ 233 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---E 233 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---H
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---h
Confidence 99997654221 1122345689999999999864 78999999999999999998 443211 0
Q ss_pred ccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 739 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 739 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+.. .+.... ..+....+......+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~----~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILK----KLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHH----HHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHH----hccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 001111 111111 111112222333457899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.13 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=195.5
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
+.+.+.||+|+||.||+|+.++ .||+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 3457899999999999999863 59999986542 2234567889999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC--
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-- 683 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~-- 683 (854)
+++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 113 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 113 GRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp SEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999542 34688999999999999999999998 999999999999998 6799999999987543211
Q ss_pred --CceeecccccccccCcccccc---------CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhc
Q 003039 684 --SHVSSIVRGTVGYLDPEYYIS---------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 752 (854)
Q Consensus 684 --~~~~~~~~gt~~Y~aPE~~~~---------~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~ 752 (854)
........||+.|+|||.+.. ..++.++|||||||++|||++|+.||...... .+.. .+..
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~----~~~~ 257 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE----AIIW----QMGT 257 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----HHHH----HHHT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----Hhcc
Confidence 112233458999999999874 35788999999999999999999999754411 1111 1122
Q ss_pred CCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 753 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 753 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
+........ .. ...+.+++.+|++.+|++|||+.||++.|+++...
T Consensus 258 ~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 258 GMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 211111111 11 12478999999999999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=327.80 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=192.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeee------cCeEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~------~~~~~L 599 (854)
+.+.+.||+|+||.||+|++. +++.||||++.... .....+.+|+.+++++ +||||+++++++.. .+..++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 345689999999999999985 68999999987543 3456788999999998 89999999999976 467899
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 99999999999999643 235688889999999999999999998 9999999999999999999999999998755
Q ss_pred cCCCCceeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
.... .......||+.|+|||.+. +..++.++|||||||++|||++|+.||...... .... . +....
T Consensus 180 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~---~-~~~~~ 250 (326)
T 2x7f_A 180 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALF---L-IPRNP 250 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH---H-HHHSC
T ss_pred CcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHH---H-hhcCc
Confidence 3322 1223346899999999987 567889999999999999999999999654311 1111 1 11111
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..... ...++ ..+.+++.+|++.+|++||++.|++++
T Consensus 251 ~~~~~----~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 251 APRLK----SKKWS----KKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCCS----CSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccCC----ccccC----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111 11122 357899999999999999999999885
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.19 Aligned_cols=266 Identities=20% Similarity=0.253 Sum_probs=187.1
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCe-------EE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-------SV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~-------~~ 598 (854)
.+.+.+.||+|+||.||+|+.. +++.||||++..... ......+|++.++.++||||+++++++...+. .+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 4455789999999999999986 689999999865432 23456678888899999999999999966443 78
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHH--hCCCCceecCCCCCCCEEEcC-CCcEEEEeeec
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--TGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGL 675 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGl 675 (854)
+||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 99999986 565555444345667888899999999999999999 76 9999999999999997 89999999999
Q ss_pred cccccCCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH-------
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK------- 747 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~------- 747 (854)
++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.....
T Consensus 179 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 986544322 2344689999999998765 489999999999999999999999976542222212211100
Q ss_pred Hhhhc-CCcccccCcc------ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 748 LHIES-GDIQGIIDPS------LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 748 ~~~~~-~~~~~~id~~------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+.. .......+.. ............+.+++.+|++.||++|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 0000000000 0011112234578999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.38 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=179.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~~ 598 (854)
|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++... ...+
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 445688999999999999875 68899999986532 23456788999999999999999999998654 5679
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+|+|++ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 111 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp EEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 999999 6899888742 4688999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.. ..... ..+
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~----~~g~p-~~~ 252 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----LVGTP-GAE 252 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----HHCSC-CHH
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----HhCCC-CHH
Confidence 4322 234568999999999887 6789999999999999999999999976542111111111 10000 000
Q ss_pred ccCc-----------cc--cCcCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 IIDP-----------SL--LDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ~id~-----------~l--~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+.. .+ ...... .....+.+|+.+|++.||++|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 00 000011 112457899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=327.43 Aligned_cols=262 Identities=21% Similarity=0.258 Sum_probs=190.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeee--------------
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-------------- 592 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~-------------- 592 (854)
|.+.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 345688999999999999987 48999999998666566678899999999999999999999873
Q ss_pred ecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcEEEE
Q 003039 593 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVS 671 (854)
Q Consensus 593 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkl~ 671 (854)
.....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999998 699998842 4578889999999999999999998 999999999999997 56799999
Q ss_pred eeeccccccCCCC--ceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH--
Q 003039 672 DFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-- 746 (854)
Q Consensus 672 DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~-- 746 (854)
|||+++....... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999986543211 12233457999999998875 678999999999999999999999997654211111111000
Q ss_pred -----HHhhhcCCcccccCcccc-Cc-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 747 -----KLHIESGDIQGIIDPSLL-DE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 747 -----~~~~~~~~~~~~id~~l~-~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+. ..+...+..... .. ........+.+++.+|++.+|++|||+.|+++|
T Consensus 244 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 244 VHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Cchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000 000000000000 00 001123468899999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=337.93 Aligned_cols=259 Identities=22% Similarity=0.279 Sum_probs=194.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeec-----CeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-----~~~~LV 600 (854)
+.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 345688999999999999986 68899999996543 23355688999999999999999999988654 678999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+. |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp ECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99997 589888843 4588999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc---------eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 681 DGASH---------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 681 ~~~~~---------~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~ 239 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----LLLIFGII 239 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHh
Confidence 32211 1223468999999998764 6789999999999999999999999976542111 11111111
Q ss_pred hcCC----cccccCc-------cc--cCcCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGD----IQGIIDP-------SL--LDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~----~~~~id~-------~l--~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... ...+..+ .+ ..... ......+.+++.+|++.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000000 00 00000 1122457899999999999999999999885
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.76 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=191.8
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCC--cccHHHHHHHHHHHccCC--CCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~--HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|...+++.||||++.... ......+.+|++++++++ ||||+++++++...+..++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 44578999999999999999889999999997543 234567889999999997 5999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+.+++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++ +.+||+|||+++......
T Consensus 109 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 109 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 668899999853 34688889999999999999999998 9999999999999964 899999999998654332
Q ss_pred Cc-eeecccccccccCcccccc-----------CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh
Q 003039 684 SH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 751 (854)
Q Consensus 684 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~ 751 (854)
.. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ..........
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~ 254 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIID 254 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------HHHHHHHHHh
Confidence 22 2234568999999999875 4678899999999999999999999965331 1111111111
Q ss_pred cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003039 752 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800 (854)
Q Consensus 752 ~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L 800 (854)
.. ....++......+.+++.+|++.+|++||++.|++++-
T Consensus 255 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 255 PN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp TT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11 11111111124578999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=330.75 Aligned_cols=264 Identities=21% Similarity=0.290 Sum_probs=195.3
Q ss_pred HHhhccccccCceEEEEEEEC--CCcEEEEEEEccCCc--ccHHHHHHHHHHHccC---CCCceeeEeeeee-----ecC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQ-----EEG 595 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~--~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l---~HpnIv~l~g~~~-----~~~ 595 (854)
|.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 446789999999999999983 578999999864321 2233566777777766 8999999999987 556
Q ss_pred eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeec
Q 003039 596 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 675 (854)
Q Consensus 596 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 675 (854)
..++||||+. |+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred eEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcc
Confidence 7899999998 6999998643 233488999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.............
T Consensus 167 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 167 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 9754322 12234568999999999999999999999999999999999999997654221111111110000000000
Q ss_pred ccc------cC---ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 QGI------ID---PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~~~------id---~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
... +. ..............+.+++.+|++.+|++||++.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00 000001111223457899999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=334.04 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=192.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeE------E
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS------V 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~------~ 598 (854)
|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++||||+++++++...+.. +
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 445688999999999999876 689999999975432 2356788999999999999999999999877654 9
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+. ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 124 lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 9999997 58887773 3488999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhh--cCCc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE--SGDI 755 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~--~~~~ 755 (854)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......... ...+
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 4322 234568999999999987 78899999999999999999999999765422211111110000000 0000
Q ss_pred c--------cccCccccCc---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 Q--------GIIDPSLLDE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~--------~~id~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ..+....... ........+.+++.+|++.+|++|||+.|+++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 0000000000 001123468899999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=320.82 Aligned_cols=252 Identities=27% Similarity=0.370 Sum_probs=200.9
Q ss_pred HHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 524 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 524 ~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
....|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3446667899999999999999986 68999999986542 23467789999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEeeeccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSK 677 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkl~DFGla~ 677 (854)
+||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999988843 34688999999999999999999998 99999999999999764 479999999997
Q ss_pred cccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
....... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... .+.. .+..+....
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~----~~~~~~~~~ 241 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILK----RVETGKYAF 241 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCCCC
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH----HHHH----HHHcCCCCC
Confidence 6543321 223458999999998865 4899999999999999999999999764411 1111 122222111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+....... ...+.+++.+|++.+|++|||+.|++++
T Consensus 242 --~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 --DLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp --CSGGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --Cchhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00001112 2357899999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.45 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=198.7
Q ss_pred HHHhhccccccCceEEEEEEE-C-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCC------ceeeEeeeeeecCeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKL-K-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR------NLVQFLGYCQEEGRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~-~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hp------nIv~l~g~~~~~~~~~ 598 (854)
.|.+.+.||+|+||.||+|.. . +++.||||+++.. ......+.+|+++++.++|+ +++++++++...+..+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 455678999999999999987 3 6889999999643 23356788899999988765 4999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--------------
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------------- 664 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------------- 664 (854)
+||||+ +++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 999999 88999998542 223578899999999999999999998 9999999999999987
Q ss_pred -----CCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccc
Q 003039 665 -----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 739 (854)
Q Consensus 665 -----~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~ 739 (854)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999764332 23346899999999999999999999999999999999999999764421111
Q ss_pred cchHHHHHH----hhhcCCcccccC--------------------ccc--cCcCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 003039 740 RNIVQWAKL----HIESGDIQGIID--------------------PSL--LDEYDIQSMWKIEEKALMCVLPHGHMRPSI 793 (854)
Q Consensus 740 ~~l~~~~~~----~~~~~~~~~~id--------------------~~l--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm 793 (854)
..+...... ............ ..+ ...........+.+++.+|++.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 111000000 000000000000 000 001123445678999999999999999999
Q ss_pred HHHHHH
Q 003039 794 SEVLKD 799 (854)
Q Consensus 794 ~eV~~~ 799 (854)
.||++|
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=339.33 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=185.5
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
.+.||+|+||+||.+...+|+.||||++... ....+.+|+++++++ +||||+++++++...+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 5789999999998776677999999998643 245678899999876 89999999999999999999999996 699
Q ss_pred Hhhhccccccccc---ccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-------------CcEEEEee
Q 003039 610 KEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-------------MRAKVSDF 673 (854)
Q Consensus 610 ~~~L~~~~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-------------~~vkl~DF 673 (854)
.+++......... ..+..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9999654222111 23445678999999999999998 99999999999999754 48999999
Q ss_pred eccccccCCCCc---eeecccccccccCcccccc-------CcCCCcchhhhHHHHHHHHHh-CCcccccccccccccch
Q 003039 674 GLSKFAVDGASH---VSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 742 (854)
Q Consensus 674 Gla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~-------~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l 742 (854)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...... .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~ 247 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-----E 247 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-----H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-----H
Confidence 999866543322 1234569999999999975 678999999999999999999 99999654311 1
Q ss_pred HHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 743 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 743 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
......... . +.+...........+.+++.+|++.+|++|||+.||++|
T Consensus 248 ~~i~~~~~~---~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 SNIIRGIFS---L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHHTCCC---C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCC---c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111111100 0 011111234455678999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=330.31 Aligned_cols=199 Identities=25% Similarity=0.299 Sum_probs=166.7
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CC-----ceeeEeeeeeecCeEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HR-----NLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-Hp-----nIv~l~g~~~~~~~~~L 599 (854)
.|.+.+.||+|+||+||+|... +++.||||+++.. .....++..|+++++.++ |+ +|+++++++...+..++
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 3456789999999999999876 5789999999743 233456778888888874 44 49999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc--CCCcEEEEeeeccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSK 677 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkl~DFGla~ 677 (854)
||||+. |+|.+++... ....+++..+..++.|++.||+|||+. ..+|+||||||+|||++ .++.+||+|||+++
T Consensus 134 v~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999996 5999998643 224588999999999999999999952 12899999999999995 47889999999998
Q ss_pred cccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccc
Q 003039 678 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 734 (854)
Q Consensus 678 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~ 734 (854)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432 233568999999999999999999999999999999999999998654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.44 Aligned_cols=253 Identities=26% Similarity=0.330 Sum_probs=174.9
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHH-HHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~-~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
+.+.||+|+||.||+|... +++.||||++..... ....++..|+. +++.++||||+++++++...+..++||||+++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 4678999999999999986 689999999976532 23345555665 77888999999999999999999999999985
Q ss_pred CCHHhhhcccc-cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 607 GTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 607 gsL~~~L~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|.+++.... .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 180 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-- 180 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc--
Confidence 7877774321 1245688999999999999999999985 289999999999999999999999999997654322
Q ss_pred eeecccccccccCcccc----ccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 686 VSSIVRGTVGYLDPEYY----ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~----~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
......||+.|+|||.+ .+..++.++|||||||++|||++|+.||...... .+.... ...+.. +
T Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~-~~~~~~-----~ 248 (327)
T 3aln_A 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV------FDQLTQ-VVKGDP-----P 248 (327)
T ss_dssp -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CC-CCCSCC-----C
T ss_pred ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH------HHHHHH-HhcCCC-----C
Confidence 12233689999999998 4567899999999999999999999999753310 000000 001111 1
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+...........+.+++.+|++.+|++||++.||+++
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11111111123468899999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=328.10 Aligned_cols=255 Identities=21% Similarity=0.306 Sum_probs=191.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCe------EE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~------~~ 598 (854)
|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+. .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 345678999999999999876 689999999975432 234678899999999999999999999977654 49
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+. |+|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 106 lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 9999997 58887763 2488899999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH-----------
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA----------- 746 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~----------- 746 (854)
.... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 4322 233468999999999887 678999999999999999999999997654211111111100
Q ss_pred -----HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 747 -----KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 747 -----~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..... .+.....+.+. .........+.+++.+|++.||++|||+.|+++|
T Consensus 252 ~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 252 NDKAAKSYIQ--SLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCHHHHHHHH--TSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhHHHHHHHH--hCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 00000000000 0111223468899999999999999999999876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=325.06 Aligned_cols=247 Identities=20% Similarity=0.261 Sum_probs=167.9
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeee----cCeEEEEEEecc
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFMH 605 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~----~~~~~LV~E~~~ 605 (854)
.+.||+|+||.||+|+.. +++.||||++... .....+....++.++||||+++++++.. ....++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 356999999999999987 6899999998643 1222233344566799999999999876 455899999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeeeccccccCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~~~ 682 (854)
+|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 110 gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~ 184 (336)
T 3fhr_A 110 GGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184 (336)
T ss_dssp TEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence 99999999643 234689999999999999999999998 9999999999999986 455999999999755432
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .+..+... ....
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~~~--~~~~ 255 (336)
T 3fhr_A 185 ---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----RIRLGQYG--FPNP 255 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------C--CCTT
T ss_pred ---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH----hhhccccc--cCch
Confidence 22345689999999999988999999999999999999999999975542211111111 11111000 0000
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... ....+.+++.+|++.+|++|||+.|++++
T Consensus 256 ~~~~----~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 256 EWSE----VSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TSTT----CCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhcc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111 23457899999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=326.80 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=189.6
Q ss_pred HHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc------cHHHHHHHHHHHccC----CCCceeeEeee
Q 003039 522 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRI----HHRNLVQFLGY 590 (854)
Q Consensus 522 ~~~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~------~~~~~~~Ev~~L~~l----~HpnIv~l~g~ 590 (854)
+.....|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344456777899999999999999875 6889999999754321 223456788888888 89999999999
Q ss_pred eeecCeEEEEEEe-ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcE
Q 003039 591 CQEEGRSVLVYEF-MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRA 668 (854)
Q Consensus 591 ~~~~~~~~LV~E~-~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~v 668 (854)
+...+..++|+|+ +.+++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999853 34588999999999999999999998 999999999999999 88999
Q ss_pred EEEeeeccccccCCCCceeecccccccccCccccccCcCC-CcchhhhHHHHHHHHHhCCcccccccccccccchHHHHH
Q 003039 669 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 747 (854)
Q Consensus 669 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~ 747 (854)
||+|||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||.... .+.
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~---- 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EIL---- 246 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH----
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHh----
Confidence 999999998654322 2344689999999999876664 48999999999999999999996532 110
Q ss_pred HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 748 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... .+.... ...+.+++.+|++.+|++||++.|++++
T Consensus 247 ----~~~~------~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 ----EAEL------HFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----HTCC------CCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----hhcc------CCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0100 011122 2357899999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.94 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=197.1
Q ss_pred HHHHhhccccccCceEEEEEEEC-CC-cEEEEEEEccCCcccHHHHHHHHHHHccCCCCc------eeeEeeeeeecCeE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN------LVQFLGYCQEEGRS 597 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~-~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hpn------Iv~l~g~~~~~~~~ 597 (854)
..|.+.+.||+|+||.||+|... ++ +.||||+++.. ......+.+|++++++++|++ ++.+.+++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 34566789999999999999875 34 68999999743 234567888999999997665 89999999999999
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---------------
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL--------------- 662 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl--------------- 662 (854)
++||||+ +++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 66777776432 234688999999999999999999998 99999999999999
Q ss_pred ----cCCCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccccc
Q 003039 663 ----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 738 (854)
Q Consensus 663 ----~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~ 738 (854)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 67889999999999764332 2334699999999999999999999999999999999999999976442111
Q ss_pred ccchHHHHHHhhhc--------CCcccc-cCcc-------------------c--cCcCCHHHHHHHHHHHHHccCCCCC
Q 003039 739 CRNIVQWAKLHIES--------GDIQGI-IDPS-------------------L--LDEYDIQSMWKIEEKALMCVLPHGH 788 (854)
Q Consensus 739 ~~~l~~~~~~~~~~--------~~~~~~-id~~-------------------l--~~~~~~~~~~~l~~l~~~Cl~~~P~ 788 (854)
.......... ...... .... + .......+...+.+++.+|++.||+
T Consensus 248 ----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 248 ----LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp ----HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred ----HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 1111111000 000000 0000 0 0011223345788999999999999
Q ss_pred CCCCHHHHHHH
Q 003039 789 MRPSISEVLKD 799 (854)
Q Consensus 789 ~RPsm~eV~~~ 799 (854)
+|||+.|+++|
T Consensus 324 ~Rpt~~e~l~h 334 (355)
T 2eu9_A 324 QRITLAEALLH 334 (355)
T ss_dssp TSCCHHHHTTS
T ss_pred hCcCHHHHhcC
Confidence 99999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.64 Aligned_cols=263 Identities=20% Similarity=0.339 Sum_probs=196.3
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-----------CCceeeEeeeeeec
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQEE 594 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-----------HpnIv~l~g~~~~~ 594 (854)
.|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|++++++++ ||||+++++++...
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 4556789999999999999875 6899999999743 233567888999998886 89999999999765
Q ss_pred C----eEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc------C
Q 003039 595 G----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD------K 664 (854)
Q Consensus 595 ~----~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~------~ 664 (854)
+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+|||++ .
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 4 789999999 88999998643 2345889999999999999999999952 899999999999994 4
Q ss_pred CCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccccc---ccc
Q 003039 665 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN---CRN 741 (854)
Q Consensus 665 ~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~---~~~ 741 (854)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999765432 2334689999999999999999999999999999999999999975442111 111
Q ss_pred hHHHHHHh-----------------hhcCC-cccccCccc---------cCcCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 003039 742 IVQWAKLH-----------------IESGD-IQGIIDPSL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 794 (854)
Q Consensus 742 l~~~~~~~-----------------~~~~~-~~~~id~~l---------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~ 794 (854)
+....... +.... ...+..... ...++......+.+++.+|++.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 11111000 00000 000000000 1123456677899999999999999999999
Q ss_pred HHHHH
Q 003039 795 EVLKD 799 (854)
Q Consensus 795 eV~~~ 799 (854)
||++|
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99885
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=328.04 Aligned_cols=244 Identities=23% Similarity=0.380 Sum_probs=197.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc------cHHHHHHHHHHHccCC--CCceeeEeeeeeecCeE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRS 597 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~------~~~~~~~Ev~~L~~l~--HpnIv~l~g~~~~~~~~ 597 (854)
.|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++ |+||+++++++...+..
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence 4556789999999999999875 6889999998754321 2245678999999996 59999999999999999
Q ss_pred EEEEEeccC-CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcEEEEeeec
Q 003039 598 VLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGL 675 (854)
Q Consensus 598 ~LV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkl~DFGl 675 (854)
++|+|++.+ ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+
T Consensus 124 ~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999986 899999853 45688999999999999999999998 999999999999999 789999999999
Q ss_pred cccccCCCCceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+ . .+.
T Consensus 197 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~-------~-~~~ 259 (320)
T 3a99_A 197 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI-------I-RGQ 259 (320)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH-------H-HCC
T ss_pred ccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hh-------h-ccc
Confidence 9865432 2233468999999999987665 678999999999999999999996532 00 0 111
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAI 804 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~~~ 804 (854)
. .+....+ ..+.+++.+|++.+|++||++.||+++ +++..
T Consensus 260 ~------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 260 V------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp C------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred c------cccccCC----HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 0 0111222 357899999999999999999999986 44443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=329.51 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=183.2
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
.+.+.||+|+||+||.....+++.||||++...... .+.+|+++|+++ +||||+++++++.+.+..++||||+. |
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 345789999999976655667999999998654322 356799999999 79999999999999999999999996 5
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-----CCcEEEEeeeccccccCC
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkl~DFGla~~~~~~ 682 (854)
+|.+++... ...+.+..++.++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 103 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 103 TLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp EHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 999998643 22344556678999999999999998 9999999999999953 346889999999865433
Q ss_pred CC--ceeecccccccccCccccc---cCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 683 AS--HVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 683 ~~--~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
.. .......||+.|+|||++. ...++.++|||||||++|||++ |..||..... ............
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~~- 247 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------RQANILLGACSL- 247 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--------HHHHHHTTCCCC-
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--------HHHHHHhccCCc-
Confidence 22 2234456999999999997 4567889999999999999999 9999854321 111111111111
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... ........+.+++.+|++.+|++|||+.||++|
T Consensus 248 ~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1110 112233457899999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.26 Aligned_cols=248 Identities=24% Similarity=0.296 Sum_probs=175.4
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc-c-HHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-G-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~-~-~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|+||.||+|+.. +|+.||||++...... . .+.+.++..+++.++||||+++++++...+..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 35678999999999999986 6899999999755322 2 233445556788889999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++.+..+... ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++......
T Consensus 107 ~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 107 GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 4455444421 23568899999999999999999998 4 89999999999999999999999999997554322
Q ss_pred ceeecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 685 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
......||+.|+|||.+. ...++.++|||||||++|||++|+.||..... ............. ....
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~-~~~~ 251 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------DFEVLTKVLQEEP-PLLP 251 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHHSCC-CCCC
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cHHHHHHHhccCC-CCCC
Confidence 223346899999999984 45688999999999999999999999975331 1111111111111 0000
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. .... ...+.+++.+|++.+|.+||++.||+++
T Consensus 252 ~---~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 252 G---HMGF----SGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp S---SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred c---cCCC----CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 0112 2357899999999999999999999876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=345.96 Aligned_cols=240 Identities=19% Similarity=0.276 Sum_probs=192.8
Q ss_pred HHHhhccccccCceEEEEEEEC--CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCe-----EE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-----SV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~--~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~-----~~ 598 (854)
.|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++...+. .+
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 4566789999999999999986 58999999986443 3345678899999999999999999999987665 79
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+++++|.+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.+ .+||+|||+++.
T Consensus 161 lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 99999999999887632 688999999999999999999998 99999999999999986 999999999986
Q ss_pred ccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 758 (854)
.... ....||++|+|||++.+.. +.++|||||||++|||++|..||.........
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------- 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------- 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-------------------
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-------------------
Confidence 5432 3346999999999987654 88999999999999999999888653211100
Q ss_pred cCccccCcCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHHH
Q 003039 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIVI 806 (854)
Q Consensus 759 id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-sm~eV~~~L~~~~~~ 806 (854)
...........+.+++.+|++.+|++|| +++++.+.|..++..
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0000112234688999999999999999 567777778776543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=344.36 Aligned_cols=267 Identities=23% Similarity=0.328 Sum_probs=200.4
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeee------cCeE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRS 597 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~------~~~~ 597 (854)
..|.+.+.||+|+||.||+|... +|+.||||+++.. .......+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 35677899999999999999875 6899999998754 33345678999999999999999999999765 6678
Q ss_pred EEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc---EEEEeee
Q 003039 598 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFG 674 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkl~DFG 674 (854)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999996532 234588889999999999999999998 9999999999999997765 9999999
Q ss_pred ccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 675 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 675 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...|.......+.
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~------~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ------PVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH------HHHSSTTCC----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc------hhhhhhhhhcccc
Confidence 998654432 22345699999999999999999999999999999999999999965421 1111111000000
Q ss_pred c----ccccCcc------c--cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHH-----HHHHHHHH
Q 003039 755 I----QGIIDPS------L--LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV-----LKDIQDAI 804 (854)
Q Consensus 755 ~----~~~id~~------l--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV-----~~~L~~~~ 804 (854)
. .+..... + ...........+.+++..|++.||++|||+.|+ .+.++.++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0 0000000 0 112233455678999999999999999999884 44455544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=324.50 Aligned_cols=239 Identities=13% Similarity=0.094 Sum_probs=179.0
Q ss_pred hhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCC-Cceee------------------
Q 003039 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHH-RNLVQ------------------ 586 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~H-pnIv~------------------ 586 (854)
+.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.+++.++| +|...
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 3578999999999999965 689999999874322 235678999999999987 32211
Q ss_pred ---Eeeeeee-----cCeEEEEEEeccCCCHHhhhccc---ccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCC
Q 003039 587 ---FLGYCQE-----EGRSVLVYEFMHNGTLKEHLYGT---LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 655 (854)
Q Consensus 587 ---l~g~~~~-----~~~~~LV~E~~~~gsL~~~L~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI 655 (854)
+..++.. ....+++|+++ +++|.+++... ......+++..++.++.|+++||+|||+. +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 1111111 12456777755 68999888422 22355688999999999999999999998 9999999
Q ss_pred CCCCEEEcCCCcEEEEeeeccccccCCCCceeecccccccccCcccc----------ccCcCCCcchhhhHHHHHHHHHh
Q 003039 656 KSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY----------ISQQLTDKSDVYSFGVILLELIS 725 (854)
Q Consensus 656 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~~~DVwSlGvvl~ellt 725 (854)
||+|||++.++.+||+|||+++.... ......| +.|+|||++ ....++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999875432 2344567 999999999 55668889999999999999999
Q ss_pred CCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 726 GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 726 G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
|+.||......+.... ++.. ....+ ..+.+++.+|++.+|++||++.|++++
T Consensus 313 g~~Pf~~~~~~~~~~~----------------~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEW----------------IFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp SSCCCCTTGGGSCSGG----------------GGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCcchhhhHHH----------------HHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999976542221111 1110 01122 458899999999999999999998765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=307.88 Aligned_cols=232 Identities=15% Similarity=0.152 Sum_probs=180.9
Q ss_pred HHHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 526 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 526 ~~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
..|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 34667789999999999999986 4899999999765332 2367889999999999999999999999999999999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++++|.+++... ....++..++.|++.||+|||+. +|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999998432 23446788999999999999998 99999999999999999999997443
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
|++| ++.++|||||||++|||++|+.||.............. .. .+.. ..+
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~----~~-~~~~---~~~ 225 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER----DT-AGQP---IEP 225 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB----CT-TSCB---CCH
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH----Hh-ccCC---CCh
Confidence 3333 67899999999999999999999986552211100000 00 0000 000
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 806 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~ 806 (854)
..........+.+++.+|++.||++| |+.|+++.|+++...
T Consensus 226 ---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 226 ---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp ---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00011122458899999999999999 999999999997654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=314.13 Aligned_cols=245 Identities=18% Similarity=0.189 Sum_probs=184.4
Q ss_pred HHHHHHhhccccccCceEEEEEEECCCcEEEEEEEccCCc--------ccHHHHHHHHHHHccCC---------CCceee
Q 003039 524 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIH---------HRNLVQ 586 (854)
Q Consensus 524 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~--------~~~~~~~~Ev~~L~~l~---------HpnIv~ 586 (854)
....|.+.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+++++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345677889999999999999998 589999999975421 22367889999988885 777777
Q ss_pred Eeeee-----------------ee-------------cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHH
Q 003039 587 FLGYC-----------------QE-------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 636 (854)
Q Consensus 587 l~g~~-----------------~~-------------~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia 636 (854)
+.+.+ .. .+..++||||+++|++.+.+.. ..+++..+..++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 66653 22 6789999999999977666632 4578999999999999
Q ss_pred HHHHHHH-hCCCCceecCCCCCCCEEEcCCC--------------------cEEEEeeeccccccCCCCceeeccccccc
Q 003039 637 KGIEYLH-TGCVPAIIHRDLKSSNILLDKHM--------------------RAKVSDFGLSKFAVDGASHVSSIVRGTVG 695 (854)
Q Consensus 637 ~gL~yLH-~~~~~~ivHrDIkp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~gt~~ 695 (854)
.||+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999865432 2369999
Q ss_pred ccCccccccCcCCCcchhhhHHHH-HHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCCHHHHHH
Q 003039 696 YLDPEYYISQQLTDKSDVYSFGVI-LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWK 774 (854)
Q Consensus 696 Y~aPE~~~~~~~s~~~DVwSlGvv-l~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~ 774 (854)
|+|||++.+.. +.++||||+|++ .+++++|..||...... ..+.+ ........ ...............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~---~~~~~---~~~~~~~~----~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL---HYLTD---KMLKQMTF----KTKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH---HHHHH---HHHHTCCC----SSCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh---hHHHH---hhhhhhcc----CcccchhhhhhcCHH
Confidence 99999998766 889999998777 78899999998542100 00111 11111000 011111122345667
Q ss_pred HHHHHHHccCCCCCCCCCHHHHH-HH
Q 003039 775 IEEKALMCVLPHGHMRPSISEVL-KD 799 (854)
Q Consensus 775 l~~l~~~Cl~~~P~~RPsm~eV~-~~ 799 (854)
+.+|+.+|++.+ |++|++ +|
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHhccC-----CHHHHHhcC
Confidence 999999999976 899988 54
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=298.89 Aligned_cols=222 Identities=22% Similarity=0.269 Sum_probs=173.9
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHH-ccCCCCceeeEeeeeee----cCeEEEEEEec
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLL-SRIHHRNLVQFLGYCQE----EGRSVLVYEFM 604 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L-~~l~HpnIv~l~g~~~~----~~~~~LV~E~~ 604 (854)
.+.||+|+||.||+|... +++.||||+++. ...+.+|++++ +..+||||+++++++.. ....++||||+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 367999999999999875 689999999863 34567888887 55699999999999976 67889999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeeeccccccC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~~ 681 (854)
++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 98 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 98 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 999999999643 234689999999999999999999998 9999999999999998 7899999999986432
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
+..++.++|||||||++|||++|+.||...........+ ...+...
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~------------~~~~~~~ 217 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------KTRIRMG 217 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS------------CCSSCTT
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH------------HHHHhhc
Confidence 235678999999999999999999999654311100000 0000000
Q ss_pred cccCcCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDI----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ...+. .....+.+++.+|++.+|++|||+.|+++|
T Consensus 218 ~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 218 Q--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp C--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred c--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 00111 123468899999999999999999999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-28 Score=285.56 Aligned_cols=186 Identities=16% Similarity=0.111 Sum_probs=130.8
Q ss_pred cccccCceEEEEEE-ECCCcEEEEEEEccCCc----------ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEE
Q 003039 533 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY----------QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~-~~~~~~VAvK~l~~~~~----------~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV 600 (854)
..+.|++|.+..++ ..-|+.+|||++..... ...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45677777666653 23588999999975421 1235689999999999 799999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||++|++|.+.|.. ...++. .+|+.||+.||+|||++ |||||||||+||||+.++++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999953 334443 35899999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccc
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 730 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf 730 (854)
... ......+||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 432 23345679999999999875 4677899999999999888776654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-25 Score=259.27 Aligned_cols=182 Identities=18% Similarity=0.227 Sum_probs=145.6
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCcc--------cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~--------~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.+.||+|+||.||+|... ++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999654 789999987543221 13457899999999999999976666667778899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999853 457899999999999998 9999999999999999 9999999999876543
Q ss_pred CCce------eecccccccccCcccccc--CcCCCcchhhhHHHHHHHHHhCCccc
Q 003039 683 ASHV------SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAI 730 (854)
Q Consensus 683 ~~~~------~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvvl~elltG~~pf 730 (854)
.... .....||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 235679999999999987 67888999999998888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.5e-22 Score=210.85 Aligned_cols=141 Identities=17% Similarity=0.101 Sum_probs=114.5
Q ss_pred hccccccCceEEEEEEECCCcEEEEEEEccCCc------------------ccHHHHHHHHHHHccCCCCceeeEeeeee
Q 003039 531 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY------------------QGKREFTNEVTLLSRIHHRNLVQFLGYCQ 592 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~------------------~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~ 592 (854)
.+.||+|+||.||+|.+.+|+.||||+++.... .....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 488999999999999997799999999964321 12456889999999999 4 56666554
Q ss_pred ecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 003039 593 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 672 (854)
Q Consensus 593 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 672 (854)
. +..++||||+++|+|.+ +.. .....++.|++.||+|||+. +|+||||||+|||++ ++.+||+|
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECC
T ss_pred c-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEE
Confidence 3 55699999999999988 421 12346999999999999998 999999999999999 99999999
Q ss_pred eeccccccCCCCceeecccccccccCcccccc
Q 003039 673 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704 (854)
Q Consensus 673 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 704 (854)
||+|+. +..++|||++..
T Consensus 236 FG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHHH
Confidence 999863 445789998753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=4.7e-19 Score=216.51 Aligned_cols=113 Identities=28% Similarity=0.433 Sum_probs=106.0
Q ss_pred CCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCcee
Q 003039 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l 417 (854)
.+++|+.|||++|+|+|.+|.+|++|++|+.|+|++|+|+|.+|. +++|++|+.|||++|+|+|.+|..++.|++|+.|
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 457899999999999999999999999999999999999999886 8999999999999999999999999999999999
Q ss_pred ecccccccccccccc-ccccccccccCccccccCC
Q 003039 418 YVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 418 ~l~~N~l~g~~p~~l-~~~~~~l~~~~n~~l~~~~ 451 (854)
+|++|+|+|.||... +..+..+++.||+++|+.+
T Consensus 710 ~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp ECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred ECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 999999999999875 6777788899999999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.5e-18 Score=179.14 Aligned_cols=134 Identities=24% Similarity=0.267 Sum_probs=103.4
Q ss_pred hhccccccCceEEEEEEE-CCCcE--EEEEEEccCCcc------------------------cHHHHHHHHHHHccCCCC
Q 003039 530 LEKKIGSGGFGVVYYGKL-KDGKE--IAVKVLTSNSYQ------------------------GKREFTNEVTLLSRIHHR 582 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~-~~~~~--VAvK~l~~~~~~------------------------~~~~~~~Ev~~L~~l~Hp 582 (854)
+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+++|.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 357899999999999998 57888 999997543111 013578899999999887
Q ss_pred ce--eeEeeeeeecCeEEEEEEeccC-C----CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHH-hCCCCceecCC
Q 003039 583 NL--VQFLGYCQEEGRSVLVYEFMHN-G----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHRD 654 (854)
Q Consensus 583 nI--v~l~g~~~~~~~~~LV~E~~~~-g----sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrD 654 (854)
++ ...+++ +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|+|||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 64 334432 356899999953 4 56554421 234567789999999999999 87 999999
Q ss_pred CCCCCEEEcCCCcEEEEeeeccccc
Q 003039 655 LKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 655 Ikp~NILl~~~~~vkl~DFGla~~~ 679 (854)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.70 E-value=7.2e-18 Score=183.53 Aligned_cols=181 Identities=20% Similarity=0.173 Sum_probs=145.9
Q ss_pred ccceeeeecccCCCC-CCCcccchhhhceeccCCCCCccHHHHHHHHhhc-CCCCccCCCCCCCCCCCCCee-EeCCCCC
Q 003039 264 LPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY-SSADWAQEGGDPCLPVPWSWL-QCNSDPQ 340 (854)
Q Consensus 264 l~~l~~l~l~~n~~s-~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~-~~~~w~~~~~~pc~~~~~~~~-~c~~~~~ 340 (854)
+++|+.|+|+.|.++ .+|..+..+..|+.|+++.|.+....+..+.++. .++.+...+ | ...+. .-....+
T Consensus 124 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~---N---~l~~~~~~~~~~l 197 (313)
T 1ogq_A 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR---N---RLTGKIPPTFANL 197 (313)
T ss_dssp CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCS---S---EEEEECCGGGGGC
T ss_pred CCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcC---C---eeeccCChHHhCC
Confidence 567888888888888 6777788888899999988887644445555554 444442211 1 01110 0111223
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
+ |+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|.+..+++|++|+|++|+|+|.+|..+..+++|+.|+|+
T Consensus 198 ~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 276 (313)
T 1ogq_A 198 N-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276 (313)
T ss_dssp C-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECC
T ss_pred c-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECc
Confidence 3 999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccc-ccccccccccCccccccCC
Q 003039 421 NNMLSGTVPSSL-LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 421 ~N~l~g~~p~~l-~~~~~~l~~~~n~~l~~~~ 451 (854)
+|+|+|.+|... ++++..+++.+|+.+|+.+
T Consensus 277 ~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred CCcccccCCCCccccccChHHhcCCCCccCCC
Confidence 999999999864 6778899999999999864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.67 E-value=6.9e-17 Score=176.98 Aligned_cols=109 Identities=18% Similarity=0.278 Sum_probs=98.3
Q ss_pred CCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
.+++|+.|+|++|+|+ .+|..+++|++|+.|+|++|++++.++.+..+++|++|+|++|++.+.+|..++.+++|+.|+
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 259 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence 3678999999999999 899999999999999999999999888899999999999999999999999999999999999
Q ss_pred cccccccccccccc--ccccccccccCccccc
Q 003039 419 VQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 448 (854)
Q Consensus 419 l~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~ 448 (854)
|++|++.+.+|..+ +.+++.|++++|+...
T Consensus 260 L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp CTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred CCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 99999999999887 6778889999987543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-16 Score=194.83 Aligned_cols=83 Identities=28% Similarity=0.436 Sum_probs=60.9
Q ss_pred CccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccccccccc--cccccccc
Q 003039 364 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLN 440 (854)
Q Consensus 364 l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~ 440 (854)
+++|+.|+|++|+++|.+|. +++|++|+.|+|++|+|+|.+|..|++|++|+.|+|++|+|+|.+|..+ +..+..|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 45667777777777776664 6777777777777777777777777777777777777777777777776 55667777
Q ss_pred ccCccc
Q 003039 441 YAGNIN 446 (854)
Q Consensus 441 ~~~n~~ 446 (854)
+++|+.
T Consensus 711 ls~N~l 716 (768)
T 3rgz_A 711 LSNNNL 716 (768)
T ss_dssp CCSSEE
T ss_pred CcCCcc
Confidence 777753
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=164.62 Aligned_cols=156 Identities=23% Similarity=0.263 Sum_probs=124.9
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.|+.|+|+.|.++.+|+. ..+..|+.|+++.|++.. + .-....+++|
T Consensus 54 l~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~Ls~N~l~~-----------l-------------------~~~~~~l~~L 102 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSHNQLQS-----------L-------------------PLLGQTLPAL 102 (290)
T ss_dssp CTTCCEEECTTSCCCEEECC-SCCTTCCEEECCSSCCSS-----------C-------------------CCCTTTCTTC
T ss_pred CCCCCEEECCCCccCcccCC-CCCCcCCEEECCCCcCCc-----------C-------------------chhhccCCCC
Confidence 45666777777777777665 666667777777766542 0 0012346789
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N 422 (854)
+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+..+++|+.|+|++|
T Consensus 103 ~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N 182 (290)
T 1p9a_G 103 TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182 (290)
T ss_dssp CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCC
Confidence 9999999999966667899999999999999999998887 688999999999999999544456788999999999999
Q ss_pred ccccccccccc--cccccccccCccccccCC
Q 003039 423 MLSGTVPSSLL--SKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 423 ~l~g~~p~~l~--~~~~~l~~~~n~~l~~~~ 451 (854)
+|+ .+|..++ ..+..+.+.+|+..|.+.
T Consensus 183 ~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 183 SLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 999 8998884 457889999999999763
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=5e-17 Score=187.84 Aligned_cols=171 Identities=13% Similarity=0.093 Sum_probs=95.1
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCC------
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS------ 337 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~------ 337 (854)
++.|+.|+|+.|.++.++| +..+..|+.|++++|.+.... ....+..+.. .-| .+.++.|..
T Consensus 57 l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L---~~N---~l~~~~~~~l~~L~~ 124 (487)
T 3oja_A 57 FTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELL-----VGPSIETLHA---ANN---NISRVSCSRGQGKKN 124 (487)
T ss_dssp CTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEEC---CSS---CCCCEEECCCSSCEE
T ss_pred CCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCC-----CCCCcCEEEC---cCC---cCCCCCccccCCCCE
Confidence 4567777777777777766 777777777777777665321 1122222211 011 122233321
Q ss_pred ----------------CCCCCeeEEEecCCCCCccCCcccc-cCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCcc
Q 003039 338 ----------------DPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 400 (854)
Q Consensus 338 ----------------~~~~~l~~L~L~~n~l~g~lp~~i~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l 400 (854)
..+++|+.|+|++|+|++.+|..+. .|++|+.|+|++|.|++. |.+..+++|+.|+|++|+|
T Consensus 125 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~l 203 (487)
T 3oja_A 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKL 203 (487)
T ss_dssp EECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCC
T ss_pred EECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCCCC
Confidence 1234555555555555555555554 455555555555555554 2333466666666666666
Q ss_pred CCCCCccccCCCCCceeecccccccccccccc--ccccccccccCcccccc
Q 003039 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 449 (854)
Q Consensus 401 ~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~~ 449 (854)
++ +|+.+..+++|+.|+|++|+|+ .+|..+ +.++..|++++|+..|+
T Consensus 204 ~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 204 AF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHH
T ss_pred CC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCc
Confidence 63 4444666666666666666666 455554 34556666666666553
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.8e-15 Score=159.03 Aligned_cols=157 Identities=18% Similarity=0.197 Sum_probs=131.2
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
..++.|+|+.|.++.++|. +..+..|+.|++++|.+... .+- ....+++|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-------------------~~~----------~~~~l~~L 85 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL-------------------SAG----------VFDDLTEL 85 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCC-------------------CTT----------TTTTCTTC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCcc-------------------CHh----------HhccCCcC
Confidence 3578899999999999885 88999999999999987641 110 01245689
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N 422 (854)
+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|+.+++|+.|+|++|
T Consensus 86 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 165 (251)
T 3m19_A 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN 165 (251)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence 9999999999976667889999999999999999998887 688999999999999999766668999999999999999
Q ss_pred cccccccccc--ccccccccccCccccccC
Q 003039 423 MLSGTVPSSL--LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 423 ~l~g~~p~~l--~~~~~~l~~~~n~~l~~~ 450 (854)
+|++..|..+ +.++..|++++|+..|..
T Consensus 166 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 166 QLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred cCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 9994444344 567889999999988863
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=7.3e-16 Score=163.83 Aligned_cols=179 Identities=20% Similarity=0.145 Sum_probs=130.0
Q ss_pred ceeeeecccCCCCCCCc-ccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCCCCe
Q 003039 266 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQPSI 343 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP-~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~~~l 343 (854)
.++.|+|+.|.++.+|+ .+..+..|+.|++++|.+.......+..+..++.+.... +. ...+.- ....+++|
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~-n~-----l~~~~~~~~~~l~~L 111 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD-NK-----LQALPIGVFDQLVNL 111 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS-SC-----CCCCCTTTTTTCSSC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC-Cc-----CCcCCHhHcccccCC
Confidence 34566666666666665 366666666666666665543322233333333332110 00 111111 12356799
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N 422 (854)
+.|+|++|++++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 112 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 112 AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence 9999999999977777889999999999999999998886 788999999999999999766667999999999999999
Q ss_pred cccccccccc---ccccccccccCccccccCC
Q 003039 423 MLSGTVPSSL---LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 423 ~l~g~~p~~l---~~~~~~l~~~~n~~l~~~~ 451 (854)
+|+ .+|... +.++..|++.+|+..|.+.
T Consensus 192 ~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 192 QLK-RVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCS-CCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred cCC-cCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 999 566654 4567889999999988764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.1e-16 Score=173.18 Aligned_cols=175 Identities=15% Similarity=0.145 Sum_probs=133.7
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHh---------hcCCCCccCCCCCCCCCCCCCee
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVIS---------LYSSADWAQEGGDPCLPVPWSWL 333 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~---------l~~~~~w~~~~~~pc~~~~~~~~ 333 (854)
.+++|+.|+|+.|.++.+|+.+..+..|+.|+++.|......+..+.. +..++.+.... | ....+
T Consensus 125 ~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~---n---~l~~l 198 (328)
T 4fcg_A 125 QFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW---T---GIRSL 198 (328)
T ss_dssp GGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEE---E---CCCCC
T ss_pred ccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcC---C---CcCcc
Confidence 356788888999999989888888889999988876543322222211 22233221110 0 01111
Q ss_pred EeCCCCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCC
Q 003039 334 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLP 412 (854)
Q Consensus 334 ~c~~~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~ 412 (854)
.-....+++|+.|+|++|+++ .+|+.+.+|++|+.|+|++|++.+.+|. +.++++|+.|+|++|++.+.+|..+++++
T Consensus 199 p~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~ 277 (328)
T 4fcg_A 199 PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277 (328)
T ss_dssp CGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCT
T ss_pred hHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCC
Confidence 112235679999999999999 5888999999999999999999998886 89999999999999999999999999999
Q ss_pred CCceeecccccccccccccc--ccccccccccCc
Q 003039 413 NLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444 (854)
Q Consensus 413 ~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n 444 (854)
+|+.|+|++|++.|.+|..+ +.++..+.+..|
T Consensus 278 ~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~ 311 (328)
T 4fcg_A 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311 (328)
T ss_dssp TCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGG
T ss_pred CCCEEeCCCCCchhhccHHHhhccCceEEeCCHH
Confidence 99999999999999999988 556666666554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-15 Score=156.12 Aligned_cols=153 Identities=20% Similarity=0.202 Sum_probs=128.2
Q ss_pred eeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEE
Q 003039 268 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 347 (854)
Q Consensus 268 ~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~ 347 (854)
..+++..+.++.+|+.+. +.++.|++++|.+..+ .+- ....+++|+.|+
T Consensus 14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i-------------------~~~----------~~~~l~~L~~L~ 62 (220)
T 2v9t_B 14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVI-------------------PPG----------AFSPYKKLRRID 62 (220)
T ss_dssp TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEE-------------------CTT----------SSTTCTTCCEEE
T ss_pred CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCc-------------------CHh----------HhhCCCCCCEEE
Confidence 346778899999998775 6789999999987641 000 113456899999
Q ss_pred ecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccc
Q 003039 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 426 (854)
Q Consensus 348 L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g 426 (854)
|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++
T Consensus 63 Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 142 (220)
T 2v9t_B 63 LSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT 142 (220)
T ss_dssp CCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCE
Confidence 999999988899999999999999999999988887 6889999999999999998888999999999999999999994
Q ss_pred cccccc--ccccccccccCccccccCC
Q 003039 427 TVPSSL--LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 427 ~~p~~l--~~~~~~l~~~~n~~l~~~~ 451 (854)
..+..+ +.++..|++++|+..|.+.
T Consensus 143 ~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 143 IAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 444334 5677899999999998653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.6e-16 Score=167.46 Aligned_cols=181 Identities=17% Similarity=0.179 Sum_probs=124.8
Q ss_pred cceeeeecccCCCCCCCc-ccchhhhceeccCCCCC-ccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeE-eCCCCCC
Q 003039 265 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGS-IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQP 341 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP-~in~le~l~~L~l~~~~-~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~-c~~~~~~ 341 (854)
++|+.|+|+.|.++.++| .+..+..|+.|+++.|. +....+..+..+..++.+...+ |. ...+. -....++
T Consensus 56 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~---n~---l~~~~~~~~~~l~ 129 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR---CG---LQELGPGLFRGLA 129 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTT---SC---CCCCCTTTTTTCT
T ss_pred CCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCC---Cc---CCEECHhHhhCCc
Confidence 344555555555555533 25555555555555554 3332233333333333332110 10 11110 1123567
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
+|+.|+|++|++++..+..|.++++|+.|+|++|+|++.++. +.++++|+.|+|++|++++..|..|..+++|+.|+|+
T Consensus 130 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 209 (285)
T 1ozn_A 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209 (285)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCC
Confidence 899999999999966666799999999999999999988876 8889999999999999998889999999999999999
Q ss_pred cccccccccccc--ccccccccccCccccccCC
Q 003039 421 NNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 421 ~N~l~g~~p~~l--~~~~~~l~~~~n~~l~~~~ 451 (854)
+|++++..|..+ +.++..|++++|+..|.+.
T Consensus 210 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp SSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 999995444334 5677889999999888653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=6.1e-16 Score=176.46 Aligned_cols=180 Identities=20% Similarity=0.176 Sum_probs=147.6
Q ss_pred ccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP 341 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~~ 341 (854)
+++|+.|+|+.|.++.+|+. +..+..|+.|++++|.+.......+..+..++.+...+ |. ....+.- ....++
T Consensus 111 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~---~~--~l~~i~~~~~~~l~ 185 (440)
T 3zyj_A 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGE---LK--RLSYISEGAFEGLS 185 (440)
T ss_dssp CSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCC---CT--TCCEECTTTTTTCS
T ss_pred CccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCC---CC--CcceeCcchhhccc
Confidence 56789999999999999985 89999999999999998765555566666666553321 11 0111221 234678
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
+|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|+.|+|+
T Consensus 186 ~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 263 (440)
T 3zyj_A 186 NLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263 (440)
T ss_dssp SCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECT
T ss_pred ccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECC
Confidence 9999999999999 787 599999999999999999998775 8999999999999999998888999999999999999
Q ss_pred cccccccccccc---ccccccccccCccccccCC
Q 003039 421 NNMLSGTVPSSL---LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 421 ~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~~ 451 (854)
+|+|+ .+|... +.++..|++++|+..|.+.
T Consensus 264 ~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 264 HNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TSCCC-CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred CCCCC-ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 99999 666655 5667889999999999874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-15 Score=161.36 Aligned_cols=179 Identities=16% Similarity=0.088 Sum_probs=134.9
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeC-CCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN-SDPQPS 342 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~-~~~~~~ 342 (854)
+..++.|++..|.++.++ .+..+..|+.|+++.|.+... ..+..+..++.+... -| ....+... ...+++
T Consensus 40 l~~L~~L~l~~~~i~~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~---~n---~l~~~~~~~~~~l~~ 110 (272)
T 3rfs_A 40 LNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT---GN---QLQSLPNGVFDKLTN 110 (272)
T ss_dssp HTTCCEEECTTSCCCCCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT---TS---CCCCCCTTTTTTCTT
T ss_pred ccceeeeeeCCCCccccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC---CC---ccCccChhHhcCCcC
Confidence 456677777777777664 366677777777777776542 344444445444221 11 11222211 245679
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
|+.|+|++|++++..|..+.+|++|+.|+|++|+|++.++. +..+++|+.|+|++|+|++..|..++.+++|+.|+|++
T Consensus 111 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 190 (272)
T 3rfs_A 111 LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQ 190 (272)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCC
Confidence 99999999999977777789999999999999999998887 68899999999999999977777789999999999999
Q ss_pred ccccccccccc--ccccccccccCccccccCC
Q 003039 422 NMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 422 N~l~g~~p~~l--~~~~~~l~~~~n~~l~~~~ 451 (854)
|++++..|..+ +.++..|++.+|+..|..+
T Consensus 191 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 191 NQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 99996555444 6778999999999887654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=156.96 Aligned_cols=154 Identities=18% Similarity=0.182 Sum_probs=123.8
Q ss_pred eeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEE
Q 003039 268 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 347 (854)
Q Consensus 268 ~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~ 347 (854)
+.++++.|.++.+|+.+.. .++.|+++.|.+... .+- . ....+++|+.|+
T Consensus 14 ~~l~~s~n~l~~iP~~~~~--~~~~L~L~~N~l~~~-------------------~~~------~---~~~~l~~L~~L~ 63 (220)
T 2v70_A 14 TTVDCSNQKLNKIPEHIPQ--YTAELRLNNNEFTVL-------------------EAT------G---IFKKLPQLRKIN 63 (220)
T ss_dssp TEEECCSSCCSSCCSCCCT--TCSEEECCSSCCCEE-------------------CCC------C---CGGGCTTCCEEE
T ss_pred CEeEeCCCCcccCccCCCC--CCCEEEcCCCcCCcc-------------------Cch------h---hhccCCCCCEEE
Confidence 3577889999999887643 457889998877641 000 0 012356899999
Q ss_pred ecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccc
Q 003039 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 426 (854)
Q Consensus 348 L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g 426 (854)
|++|+|++..|..|.++++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++
T Consensus 64 L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 143 (220)
T 2v70_A 64 FSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT 143 (220)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCC
T ss_pred CCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCE
Confidence 999999976677899999999999999999998886 8889999999999999998888899999999999999999996
Q ss_pred cccccc--ccccccccccCccccccCC
Q 003039 427 TVPSSL--LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 427 ~~p~~l--~~~~~~l~~~~n~~l~~~~ 451 (854)
..|..+ +.++..|++++|+..|.+.
T Consensus 144 ~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 144 VAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp BCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 667666 5677889999999888653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.60 E-value=4.5e-16 Score=169.30 Aligned_cols=176 Identities=25% Similarity=0.219 Sum_probs=137.9
Q ss_pred cccceeeeecccCCCC-CCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCe-eEeCCCCC
Q 003039 263 SLPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW-LQCNSDPQ 340 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s-~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~-~~c~~~~~ 340 (854)
.+++|+.|+|+.|.++ .+|..+..+..|+.|+++.|.+....+..+..+..++.+...+ | ...+ +......+
T Consensus 99 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~---N---~l~~~~p~~l~~l 172 (313)
T 1ogq_A 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG---N---RISGAIPDSYGSF 172 (313)
T ss_dssp GCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS---S---CCEEECCGGGGCC
T ss_pred cCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC---C---cccCcCCHHHhhh
Confidence 4678899999999998 7777899999999999999998865556666776666653321 1 1111 11122234
Q ss_pred C-CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 341 P-SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 341 ~-~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
+ +|+.|+|++|+++|.+|..+..++ |+.|+|++|++++.+|. +..+++|+.|+|++|++++.+|. +..+++|+.|+
T Consensus 173 ~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~ 250 (313)
T 1ogq_A 173 SKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLD 250 (313)
T ss_dssp CTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEE
T ss_pred hhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEE
Confidence 4 789999999999988998888887 99999999999887775 78899999999999999876665 88889999999
Q ss_pred cccccccccccccc--ccccccccccCccc
Q 003039 419 VQNNMLSGTVPSSL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 419 l~~N~l~g~~p~~l--~~~~~~l~~~~n~~ 446 (854)
|++|+|+|.+|..+ +.+++.|++++|..
T Consensus 251 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 280 (313)
T 1ogq_A 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280 (313)
T ss_dssp CCSSCCEECCCGGGGGCTTCCEEECCSSEE
T ss_pred CcCCcccCcCChHHhcCcCCCEEECcCCcc
Confidence 99999998888877 56778888888854
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.9e-15 Score=161.05 Aligned_cols=173 Identities=21% Similarity=0.226 Sum_probs=131.4
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+++++.+++..+.++.+|+.+. ..++.|+++.|.+....+..+..+..++.+...+ + ....+... ..+++|
T Consensus 9 l~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~---n---~l~~~~~~-~~l~~L 79 (290)
T 1p9a_G 9 VASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR---A---ELTKLQVD-GTLPVL 79 (290)
T ss_dssp STTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTT---S---CCCEEECC-SCCTTC
T ss_pred cCCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCC---C---ccCcccCC-CCCCcC
Confidence 3455666667777777776654 4566677777766554444555555555443211 1 12233322 457899
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N 422 (854)
+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 99999999999 8999999999999999999999999876 899999999999999999766677899999999999999
Q ss_pred cccccccccc---ccccccccccCcccc
Q 003039 423 MLSGTVPSSL---LSKNVVLNYAGNINL 447 (854)
Q Consensus 423 ~l~g~~p~~l---~~~~~~l~~~~n~~l 447 (854)
+|+ .+|... +.+++.|++++|...
T Consensus 159 ~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 159 NLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp CCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 999 777766 466788999988654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.5e-15 Score=173.85 Aligned_cols=180 Identities=18% Similarity=0.191 Sum_probs=146.6
Q ss_pred ccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP 341 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~~ 341 (854)
+++|+.|+|+.|.++.+|+. +..+..|+.|+++.|.+.......+..+..+..+... -|. ....+.- ....++
T Consensus 122 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~---~~~--~l~~i~~~~~~~l~ 196 (452)
T 3zyi_A 122 LASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG---ELK--KLEYISEGAFEGLF 196 (452)
T ss_dssp CTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECC---CCT--TCCEECTTTTTTCT
T ss_pred cccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCC---CCC--CccccChhhccCCC
Confidence 56789999999999999987 8889999999999998876555555566566555321 111 1112221 234678
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
+|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|+.|+|+
T Consensus 197 ~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 274 (452)
T 3zyi_A 197 NLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274 (452)
T ss_dssp TCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECC
Confidence 9999999999999 566 599999999999999999998875 8999999999999999998889999999999999999
Q ss_pred cccccccccccc---ccccccccccCccccccCC
Q 003039 421 NNMLSGTVPSSL---LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 421 ~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~~ 451 (854)
+|+|+ .+|... +.++..|++++|+..|.+.
T Consensus 275 ~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 275 HNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp SSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CCcCC-ccChHHhccccCCCEEEccCCCcCCCCC
Confidence 99999 666655 5667899999999999875
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.58 E-value=8.8e-15 Score=151.58 Aligned_cols=151 Identities=23% Similarity=0.190 Sum_probs=125.5
Q ss_pred eeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEE
Q 003039 268 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 347 (854)
Q Consensus 268 ~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~ 347 (854)
+.++++.+.+..+|+.+. ..++.|++++|.+... .|- ....+++|+.|+
T Consensus 22 ~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~-------------------~~~----------~~~~l~~L~~L~ 70 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKL-------------------EPG----------VFDSLINLKELY 70 (229)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCC-------------------CTT----------TTTTCTTCCEEE
T ss_pred CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCcc-------------------CHH----------HhhCccCCcEEE
Confidence 457788999999998765 7899999999987741 110 012456899999
Q ss_pred ecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccc
Q 003039 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 426 (854)
Q Consensus 348 L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g 426 (854)
|++|+|++..+..|..|++|+.|+|++|+|++.++. |..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+
T Consensus 71 L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~- 148 (229)
T 3e6j_A 71 LGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK- 148 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC-
T ss_pred CCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC-
Confidence 999999844445678999999999999999998887 688999999999999999 89999999999999999999999
Q ss_pred cccccc---ccccccccccCccccccCC
Q 003039 427 TVPSSL---LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 427 ~~p~~l---~~~~~~l~~~~n~~l~~~~ 451 (854)
.+|... +.++..|++.+|+..|.+.
T Consensus 149 ~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 149 SIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred ccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 566543 5677889999999888653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=8.1e-16 Score=166.42 Aligned_cols=182 Identities=14% Similarity=0.072 Sum_probs=142.9
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHH-HHHHhhcCCCCccCCCCCCCCCCCCCeeE-eCCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQP 341 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~-~~l~~l~~~~~w~~~~~~pc~~~~~~~~~-c~~~~~~ 341 (854)
+++|+.|+|+.|.++.+|+.+..+..|+.|+++.|.+..... ..+..+..++.+... -|. ...+. .....++
T Consensus 77 ~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~---~n~---l~~~~~~~~~~l~ 150 (306)
T 2z66_A 77 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS---HTH---TRVAFNGIFNGLS 150 (306)
T ss_dssp CSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECT---TSC---CEECSTTTTTTCT
T ss_pred ccccCEEECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECC---CCc---CCccchhhcccCc
Confidence 567888899999998888888888999999998888765332 334444455544221 110 11111 1134567
Q ss_pred CeeEEEecCCCCCc-cCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 342 SITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 342 ~l~~L~L~~n~l~g-~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
+|+.|+|++|++++ .+|..+..+++|+.|+|++|++++.+|. +.++++|+.|+|++|+|++..+..+..+++|+.|+|
T Consensus 151 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 230 (306)
T 2z66_A 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 230 (306)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEEC
T ss_pred CCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeEC
Confidence 99999999999997 5899999999999999999999998775 888999999999999999766778999999999999
Q ss_pred ccccccccccccc--c-cccccccccCccccccCC
Q 003039 420 QNNMLSGTVPSSL--L-SKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 420 ~~N~l~g~~p~~l--~-~~~~~l~~~~n~~l~~~~ 451 (854)
++|++++..|..+ + .++..|++++|+..|.+.
T Consensus 231 ~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 231 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp TTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 9999998888776 3 477899999999887653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=6e-16 Score=170.61 Aligned_cols=135 Identities=15% Similarity=0.142 Sum_probs=96.9
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCc-----c---------cHH--------HHHHHHHHHccCCCCceee
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-----Q---------GKR--------EFTNEVTLLSRIHHRNLVQ 586 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~-----~---------~~~--------~~~~Ev~~L~~l~HpnIv~ 586 (854)
.+..+||+|+||.||+|...+|+.||||+++.... . ... ...+|...|.++++.++..
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 34678999999999999999999999999763210 0 011 1234666666665444322
Q ss_pred EeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC
Q 003039 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 666 (854)
Q Consensus 587 l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 666 (854)
..-+... ..+|||||+++++|.+... ......++.|++.+|.|||+. +||||||||.|||+++++
T Consensus 178 p~p~~~~--~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 178 PEPIAQS--RHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCEEEEE--TTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred Ceeeecc--CceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 1111111 2379999999988865432 113356789999999999998 999999999999999877
Q ss_pred c----------EEEEeeecccc
Q 003039 667 R----------AKVSDFGLSKF 678 (854)
Q Consensus 667 ~----------vkl~DFGla~~ 678 (854)
. +.|+||+.+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 3 89999997753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.57 E-value=5.1e-15 Score=149.00 Aligned_cols=154 Identities=18% Similarity=0.171 Sum_probs=122.1
Q ss_pred eeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEE
Q 003039 268 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 347 (854)
Q Consensus 268 ~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~ 347 (854)
+.++++.|.+..+|..+.. .++.|++++|.+... .+- + ....+++|+.|+
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~-------------------~~~------~---~~~~l~~L~~L~ 60 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRI-------------------SSD------G---LFGRLPHLVKLE 60 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSB-------------------CCS------C---SGGGCTTCCEEE
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCcc-------------------CCc------c---ccccCCCCCEEE
Confidence 4678889999999987654 788999999887640 000 0 012456899999
Q ss_pred ecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccc
Q 003039 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 426 (854)
Q Consensus 348 L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g 426 (854)
|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|++|+|++|+|++.+|..|..+++|+.|+|++|++++
T Consensus 61 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 999999988899999999999999999999998886 8889999999999999999889999999999999999999998
Q ss_pred ccccccccc-cccccccCccccccCC
Q 003039 427 TVPSSLLSK-NVVLNYAGNINLHEGG 451 (854)
Q Consensus 427 ~~p~~l~~~-~~~l~~~~n~~l~~~~ 451 (854)
..+...+.. +....+.++...|..+
T Consensus 141 ~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 141 NCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 877544322 3333455565566554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=5e-15 Score=158.50 Aligned_cols=177 Identities=15% Similarity=0.133 Sum_probs=139.4
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeE-eCCCCCCC
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQPS 342 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~-c~~~~~~~ 342 (854)
..++.|+|+.|.++.+|+. +..+..|+.|+++.|.+....+..+..+..++.+...+ +.- ...+. -....+++
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~~----l~~~~~~~~~~l~~ 106 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD-NAQ----LRSVDPATFHGLGR 106 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS-CTT----CCCCCTTTTTTCTT
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC-CCC----ccccCHHHhcCCcC
Confidence 4678999999999999975 89999999999999998775556666666666553321 110 11111 12335678
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
|+.|+|++|++++..|..+.++++|++|+|++|++++.++. +.++++|+.|+|++|+|++..+..+..+++|+.|+|++
T Consensus 107 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 186 (285)
T 1ozn_A 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186 (285)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCC
Confidence 99999999999977788899999999999999999988876 78899999999999999965555799999999999999
Q ss_pred ccccccccccc--ccccccccccCccc
Q 003039 422 NMLSGTVPSSL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 422 N~l~g~~p~~l--~~~~~~l~~~~n~~ 446 (854)
|++++..|..+ +.++..|++++|..
T Consensus 187 n~l~~~~~~~~~~l~~L~~L~l~~n~l 213 (285)
T 1ozn_A 187 NRVAHVHPHAFRDLGRLMTLYLFANNL 213 (285)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcccccCHhHccCcccccEeeCCCCcC
Confidence 99997667766 56788888888853
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=5e-15 Score=157.70 Aligned_cols=180 Identities=13% Similarity=0.116 Sum_probs=123.1
Q ss_pred ccceeeeecccCCCCCCCc-ccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP 341 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP-~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~~ 341 (854)
++.|+.|+|+.|.++.+++ .+..+..|+.|+++.|.+....+..+..+..++.+...+ |. ...+.. ....++
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~---n~---l~~~~~~~~~~l~ 124 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE---TN---LASLENFPIGHLK 124 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT---SC---CCCSTTCCCTTCT
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC---CC---ccccCchhcccCC
Confidence 3455666666666666665 356666666666666665543333344444443332111 00 000000 123567
Q ss_pred CeeEEEecCCCCCc-cCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCcc----EEEeCCCccCCCCCccccCCCCCc
Q 003039 342 SITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR----IIHLEDNQLTGPLPSSLMNLPNLR 415 (854)
Q Consensus 342 ~l~~L~L~~n~l~g-~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~----~L~Ls~N~l~g~~P~~l~~l~~L~ 415 (854)
+|+.|+|++|++++ .+|..+.++++|+.|+|++|++++.++. +..+.+|+ .|+|++|++++ +|.......+|+
T Consensus 125 ~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~-~~~~~~~~~~L~ 203 (276)
T 2z62_A 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLK 203 (276)
T ss_dssp TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCE-ECTTSSCSCCEE
T ss_pred CCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccc-cCccccCCCccc
Confidence 89999999999986 3799999999999999999999987764 55555555 89999999995 554445556899
Q ss_pred eeecccccccccccccc---ccccccccccCccccccCC
Q 003039 416 ELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 416 ~l~l~~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~~ 451 (854)
.|+|++|+|+ .+|... +.++..|++++|+..|.++
T Consensus 204 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 204 ELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp EEECCSSCCS-CCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred EEECCCCcee-ecCHhHhcccccccEEEccCCcccccCC
Confidence 9999999999 666655 5567889999999988764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.6e-14 Score=162.17 Aligned_cols=186 Identities=14% Similarity=0.083 Sum_probs=124.1
Q ss_pred cceeeeecccCCCCCCCccc---------chhhhceeccCCCCCccHHHHHHHHhhc---CCCCccCCCC----------
Q 003039 265 PFVLSFKFGKTYDSSRGPLL---------NAMEINKYLERNDGSIDGVAIVSVISLY---SSADWAQEGG---------- 322 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~i---------n~le~l~~L~l~~~~~~~~~~~~l~~l~---~~~~w~~~~~---------- 322 (854)
..++.|++..|.+..+++.. ..+..|+.|+++.|.+....+..+.... .+..+...+.
T Consensus 180 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~ 259 (455)
T 3v47_A 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259 (455)
T ss_dssp CEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCC
T ss_pred ccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchh
Confidence 45566666666666665542 2346799999999999888888877662 1211111000
Q ss_pred -----CC-----CCCCCCCeeE----------e-CCCCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCC
Q 003039 323 -----DP-----CLPVPWSWLQ----------C-NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI 381 (854)
Q Consensus 323 -----~p-----c~~~~~~~~~----------c-~~~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~ 381 (854)
.+ +.......+. . ....+++|+.|+|++|++++..|..|.++++|+.|+|++|++++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 339 (455)
T 3v47_A 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSID 339 (455)
T ss_dssp SSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred hhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcC
Confidence 00 0000011111 0 1234567888888888888777778888888888888888887776
Q ss_pred CC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccccccccc---ccccccccccCccccccCC
Q 003039 382 PD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 382 p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~~ 451 (854)
|. +.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|... +++++.|++++|+..|.++
T Consensus 340 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 340 SRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp GGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccc-cCCHhHhccCCcccEEEccCCCcccCCC
Confidence 64 677888888888888888777888888888888888888888 455544 4567778888888777654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.7e-15 Score=176.96 Aligned_cols=182 Identities=13% Similarity=0.017 Sum_probs=144.1
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHH-HHHHhhcCCCCccCCCCCCCCCCCCCee-EeCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWL-QCNSDPQ 340 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~-~~l~~l~~~~~w~~~~~~pc~~~~~~~~-~c~~~~~ 340 (854)
.++.|+.|+|+.|.++.+|+.+..+..|+.|++++|.+....+ ..+..+..++.+... -|. .... .-....+
T Consensus 374 ~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~---~n~---l~~~~~~~~~~l 447 (606)
T 3vq2_A 374 GTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS---YTN---TKIDFDGIFLGL 447 (606)
T ss_dssp CCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECT---TSC---CEECCTTTTTTC
T ss_pred cCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECc---CCC---CCccchhhhcCC
Confidence 3567788888888888888888888888888888888765433 344455555544221 111 1111 1123456
Q ss_pred CCeeEEEecCCCCCc-cCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 341 PSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g-~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
++|+.|+|++|++++ .+|..+..+++|+.|+|++|++++.+|. +.++++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 448 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 527 (606)
T 3vq2_A 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527 (606)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEE
Confidence 799999999999998 4788999999999999999999998886 88999999999999999988899999999999999
Q ss_pred cccccccccccccc--cc-ccccccccCccccccCC
Q 003039 419 VQNNMLSGTVPSSL--LS-KNVVLNYAGNINLHEGG 451 (854)
Q Consensus 419 l~~N~l~g~~p~~l--~~-~~~~l~~~~n~~l~~~~ 451 (854)
|++|+|+ .+|..+ +. .+..+++++|+..|.+.
T Consensus 528 l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 528 CSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999 898876 33 47889999999998765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=6e-15 Score=174.96 Aligned_cols=180 Identities=17% Similarity=0.144 Sum_probs=98.5
Q ss_pred ccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCC---CCCCCCCeeEeC---
Q 003039 264 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDP---CLPVPWSWLQCN--- 336 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~p---c~~~~~~~~~c~--- 336 (854)
+++|+.|+|+.|.++.+||. +..+..|+.|++++|.+....+..+..+ ..+....... ..+.....+.++
T Consensus 146 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L---~~L~l~~n~l~~l~~~~~L~~L~ls~n~ 222 (597)
T 3oja_B 146 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL---FHANVSYNLLSTLAIPIAVEELDASHNS 222 (597)
T ss_dssp CTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTC---SEEECCSSCCSEEECCTTCSEEECCSSC
T ss_pred CCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhh---hhhhcccCccccccCCchhheeeccCCc
Confidence 55677777888877777774 7777778888887777654322222222 1110000000 000000111100
Q ss_pred ---------------------------CCCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCC
Q 003039 337 ---------------------------SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 389 (854)
Q Consensus 337 ---------------------------~~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~ 389 (854)
...+++|+.|+|++|.|++.+|..|++|++|+.|+|++|+|++.++.+..+++
T Consensus 223 l~~~~~~~~~~L~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~ 302 (597)
T 3oja_B 223 INVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPT 302 (597)
T ss_dssp CCEEECSCCSCCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTT
T ss_pred ccccccccCCCCCEEECCCCCCCCChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCC
Confidence 11234566666666666655566666666666666666666665444555666
Q ss_pred ccEEEeCCCccCCCCCccccCCCCCceeeccccccccccccccccccccccccCccccc
Q 003039 390 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448 (854)
Q Consensus 390 L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~l~~~~n~~l~ 448 (854)
|+.|+|++|.|+ .+|..++.+++|+.|+|++|+|+ .+|...+..+..|++++|+..|
T Consensus 303 L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp CCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CCCCCTTCCCSEEECCSSCEEH
T ss_pred CcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCC-CcChhhcCCCCEEEeeCCCCCC
Confidence 666666666666 45656666666666666666666 4454445556666666666554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=6.9e-15 Score=164.82 Aligned_cols=180 Identities=17% Similarity=0.144 Sum_probs=97.0
Q ss_pred ccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCC---CCCCCCCeeEeC---
Q 003039 264 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDP---CLPVPWSWLQCN--- 336 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~p---c~~~~~~~~~c~--- 336 (854)
+++|+.|+|+.|.++.++|. +..+..|+.|+++.|.+....+..+.++ ..+....... ..+.....+..+
T Consensus 140 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L---~~L~l~~n~l~~~~~~~~L~~L~l~~n~ 216 (390)
T 3o6n_A 140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL---FHANVSYNLLSTLAIPIAVEELDASHNS 216 (390)
T ss_dssp CTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTC---SEEECCSSCCSEEECCSSCSEEECCSSC
T ss_pred CCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcccccccccc---ceeecccccccccCCCCcceEEECCCCe
Confidence 56777888888888888765 7778888888888877655332222222 1110000000 000001111100
Q ss_pred ---------------------------CCCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCC
Q 003039 337 ---------------------------SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 389 (854)
Q Consensus 337 ---------------------------~~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~ 389 (854)
...+++|+.|+|++|++++..|..|.++++|+.|+|++|++++.++.+..+++
T Consensus 217 l~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~ 296 (390)
T 3o6n_A 217 INVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPT 296 (390)
T ss_dssp CCEEECCCCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTT
T ss_pred eeeccccccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCC
Confidence 11234555566666666555555566666666666666666555444555566
Q ss_pred ccEEEeCCCccCCCCCccccCCCCCceeeccccccccccccccccccccccccCccccc
Q 003039 390 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448 (854)
Q Consensus 390 L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~l~~~~n~~l~ 448 (854)
|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|+ .+|...+.++..|++++|+..|
T Consensus 297 L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CCCCCTTCCCSEEECCSSCEEH
T ss_pred CCEEECCCCcce-ecCccccccCcCCEEECCCCccc-eeCchhhccCCEEEcCCCCccc
Confidence 666666666665 45555555666666666666665 4454445555666666665544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.3e-14 Score=146.28 Aligned_cols=138 Identities=19% Similarity=0.233 Sum_probs=118.8
Q ss_pred ceeeeecccCCCCCCCcc--cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 266 FVLSFKFGKTYDSSRGPL--LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~--in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
.++.|+|+.|.++.++|. +..+..|+.|++++|++... .+- ....+++|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i-------------------~~~----------~~~~l~~L 83 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI-------------------EEG----------AFEGASGV 83 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEE-------------------CTT----------TTTTCTTC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEE-------------------CHH----------HhCCCCCC
Confidence 346889999999999764 89999999999999987751 000 12345689
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N 422 (854)
+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 84 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 163 (220)
T 2v70_A 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163 (220)
T ss_dssp CEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCc
Confidence 9999999999977777799999999999999999999775 899999999999999999888999999999999999999
Q ss_pred cccccccccc
Q 003039 423 MLSGTVPSSL 432 (854)
Q Consensus 423 ~l~g~~p~~l 432 (854)
++.+..+...
T Consensus 164 ~l~c~c~l~~ 173 (220)
T 2v70_A 164 PFNCNCYLAW 173 (220)
T ss_dssp CEECSGGGHH
T ss_pred CCcCCCchHH
Confidence 9997766443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.51 E-value=8.3e-14 Score=146.19 Aligned_cols=149 Identities=19% Similarity=0.170 Sum_probs=124.5
Q ss_pred eeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEE
Q 003039 267 VLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVI 346 (854)
Q Consensus 267 l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L 346 (854)
.+.+++..+.++.+|+.+. ..++.|+++.|.+... ... ....+++|+.|
T Consensus 16 ~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~------------------~~~-----------~~~~l~~L~~L 64 (251)
T 3m19_A 16 KKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATL------------------SDA-----------TFRGLTKLTWL 64 (251)
T ss_dssp GTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCC------------------CTT-----------TTTTCTTCCEE
T ss_pred CeEEecCCCCccccCCCCC--CCCCEEEccCCCcCcc------------------CHh-----------HhcCcccCCEE
Confidence 4567889999999999876 5789999999987641 000 01245689999
Q ss_pred EecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccccc
Q 003039 347 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 347 ~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~ 425 (854)
+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus 65 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 144 (251)
T 3m19_A 65 NLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144 (251)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCC
Confidence 9999999987888899999999999999999998886 788999999999999999666667899999999999999999
Q ss_pred ccccc-cc--ccccccccccCcccc
Q 003039 426 GTVPS-SL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 426 g~~p~-~l--~~~~~~l~~~~n~~l 447 (854)
.+|. .+ +.+++.|++++|...
T Consensus 145 -~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 145 -SIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp -CCCTTTTTTCTTCCEEECCSSCCS
T ss_pred -ccCHHHcCcCcCCCEEECCCCcCC
Confidence 5555 34 567889999998643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.5e-14 Score=152.12 Aligned_cols=159 Identities=20% Similarity=0.179 Sum_probs=113.9
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQPS 342 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~~~ 342 (854)
+++|+.|+|+.|.++.+ +.+..+..|+.|++++|.+.......+..+..++.+...+ |. ...+.. ....+++
T Consensus 62 l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~---n~---l~~~~~~~~~~l~~ 134 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE---NQ---LQSLPDGVFDKLTN 134 (272)
T ss_dssp CTTCCEEECTTSCCCCC-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT---SC---CCCCCTTTTTTCTT
T ss_pred CCCCcEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCC---Cc---CCccCHHHhccCCC
Confidence 34556666666666654 3555666666666666665543333334444444332211 10 111111 1245679
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++. +.++++|+.|+|++|+|++..|..+..+++|+.|+|++
T Consensus 135 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 214 (272)
T 3rfs_A 135 LTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHD 214 (272)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccC
Confidence 99999999999966666789999999999999999998887 68899999999999999988777899999999999999
Q ss_pred cccccccc
Q 003039 422 NMLSGTVP 429 (854)
Q Consensus 422 N~l~g~~p 429 (854)
|++.+..|
T Consensus 215 N~~~~~~~ 222 (272)
T 3rfs_A 215 NPWDCTCP 222 (272)
T ss_dssp SCBCCCTT
T ss_pred CCccccCc
Confidence 99997766
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.50 E-value=5.1e-14 Score=168.20 Aligned_cols=182 Identities=16% Similarity=0.120 Sum_probs=129.4
Q ss_pred ceeeeecccCCCCCCCcc-cc-------hhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeC-
Q 003039 266 FVLSFKFGKTYDSSRGPL-LN-------AMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN- 336 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~-in-------~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~- 336 (854)
.|+.|+|+.|.++...|. |. .+..|+.|+++.|.+.......+..+..+..+...+.. -...+-......
T Consensus 403 ~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~-l~~i~~~~~~~~~ 481 (636)
T 4eco_A 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM-LTEIPKNSLKDEN 481 (636)
T ss_dssp CEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSC-CSBCCSSSSEETT
T ss_pred ccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCC-CCCcCHHHhcccc
Confidence 455555555555553332 44 44566666666666654433334445555444321111 001111111100
Q ss_pred --CCCCCCeeEEEecCCCCCccCCcccc--cCccCcEEeccCCCCCCCCCCCCCCCCccEEEe------CCCccCCCCCc
Q 003039 337 --SDPQPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHL------EDNQLTGPLPS 406 (854)
Q Consensus 337 --~~~~~~l~~L~L~~n~l~g~lp~~i~--~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L------s~N~l~g~~P~ 406 (854)
...+++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++.++.+.++++|+.|+| ++|++.+.+|.
T Consensus 482 ~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~ 560 (636)
T 4eco_A 482 ENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560 (636)
T ss_dssp EECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCT
T ss_pred ccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccChH
Confidence 112338999999999999 8999998 999999999999999995556889999999999 56889999999
Q ss_pred cccCCCCCceeeccccccccccccccccccccccccCccccccC
Q 003039 407 SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 407 ~l~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~l~~~~n~~l~~~ 450 (854)
.++.+++|+.|+|++|+| +.+|..+.+.++.|++++|+..|..
T Consensus 561 ~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 561 GITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp TGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred HHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence 999999999999999999 5999999999999999999887643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=9.5e-15 Score=162.12 Aligned_cols=155 Identities=20% Similarity=0.180 Sum_probs=125.2
Q ss_pred ceeeeecccCCCCCCCcc-cc-hhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 266 FVLSFKFGKTYDSSRGPL-LN-AMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~-in-~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
.++.|+|+.|.++.+|+. +. .+..|+.|++++|++.... +- ....+++|
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~-------------------~~----------~~~~l~~L 90 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFIS-------------------SE----------AFVPVPNL 90 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEEC-------------------TT----------TTTTCTTC
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccC-------------------hh----------hccCCCCC
Confidence 357789999999999987 44 8999999999999876410 00 12345789
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccc----cCCCCCceee
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSL----MNLPNLRELY 418 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l----~~l~~L~~l~ 418 (854)
+.|+|++|+|++..+..|.+|++|+.|+|++|+|++..|. |.++++|+.|+|++|+|+ .+|..+ ..+++|+.|+
T Consensus 91 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~ 169 (361)
T 2xot_A 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLD 169 (361)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEE
T ss_pred CEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEE
Confidence 9999999999976666899999999999999999998775 899999999999999999 566654 6799999999
Q ss_pred ccccccccccccccccc-----cccccccCccccccCC
Q 003039 419 VQNNMLSGTVPSSLLSK-----NVVLNYAGNINLHEGG 451 (854)
Q Consensus 419 l~~N~l~g~~p~~l~~~-----~~~l~~~~n~~l~~~~ 451 (854)
|++|+|+ .+|...+.. +..|++.+|+..|.+.
T Consensus 170 L~~N~l~-~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 170 LSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCSSCCC-CCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCCCCCC-ccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 9999999 677544332 2568999999998753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.7e-13 Score=139.44 Aligned_cols=88 Identities=26% Similarity=0.309 Sum_probs=47.8
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
++|+.|+|++|+|++..+..+.++++|+.|+|++|+|++.++. +.++++|+.|+|++|+|++..+..+..+++|+.|+|
T Consensus 76 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 155 (208)
T 2o6s_A 76 TSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWL 155 (208)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred CCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEe
Confidence 4555555555555533333345555555555555555555554 455555555555555555433334555555555555
Q ss_pred ccccccccc
Q 003039 420 QNNMLSGTV 428 (854)
Q Consensus 420 ~~N~l~g~~ 428 (854)
++|++.+..
T Consensus 156 ~~N~~~~~~ 164 (208)
T 2o6s_A 156 HDNPWDCTC 164 (208)
T ss_dssp CSCCBCCCT
T ss_pred cCCCeecCC
Confidence 555555443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.49 E-value=5e-14 Score=138.22 Aligned_cols=136 Identities=20% Similarity=0.168 Sum_probs=117.6
Q ss_pred ccceeeeecccCCCC--CCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCC
Q 003039 264 LPFVLSFKFGKTYDS--SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 341 (854)
Q Consensus 264 l~~l~~l~l~~n~~s--~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~ 341 (854)
.+.++.|+|+.|.++ .+|+.+..+..|+.|+++.|.+... . ....++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-----------~--------------------~~~~l~ 71 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-----------S--------------------NLPKLP 71 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-----------S--------------------SCCCCS
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-----------h--------------------hhccCC
Confidence 467899999999999 9999999999999999999987640 0 112456
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCC--CCCCCCCCccEEEeCCCccCCCCC---ccccCCCCCce
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGPLP---SSLMNLPNLRE 416 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~Ls~N~l~g~~P---~~l~~l~~L~~ 416 (854)
+|+.|+|++|++++.+|..+.++++|+.|+|++|+|++.+ +.+..+++|+.|+|++|.+++..+ ..+..+++|+.
T Consensus 72 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~ 151 (168)
T 2ell_A 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY 151 (168)
T ss_dssp SCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCE
T ss_pred CCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcE
Confidence 8999999999999878988888999999999999999965 568999999999999999995444 48999999999
Q ss_pred eeccccccccccccc
Q 003039 417 LYVQNNMLSGTVPSS 431 (854)
Q Consensus 417 l~l~~N~l~g~~p~~ 431 (854)
|++++|.+. .+|..
T Consensus 152 L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 152 LDGYDREDQ-EAPDS 165 (168)
T ss_dssp ETTEETTSC-BCCSS
T ss_pred ecCCCCChh-hcccc
Confidence 999999998 77754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.49 E-value=3.7e-14 Score=162.26 Aligned_cols=177 Identities=19% Similarity=0.163 Sum_probs=139.5
Q ss_pred cccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 340 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~ 340 (854)
.++.|+.|+|+.|.++.++|. +..+..|+.|+++.|.+.......+..+..++.+...+ | ....+.. ....+
T Consensus 97 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~---N---~l~~~~~~~~~~l 170 (452)
T 3zyi_A 97 HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRN---N---PIESIPSYAFNRV 170 (452)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCS---C---CCCEECTTTTTTC
T ss_pred CCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCC---C---CcceeCHhHHhcC
Confidence 366889999999999999875 89999999999999998765555555565666553321 1 1222222 24567
Q ss_pred CCeeEEEecCCCCCccCCc-ccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~-~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
++|+.|+|++|+..+.+|. .|.+|++|+.|+|++|+|++. |.+..+++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 171 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 249 (452)
T 3zyi_A 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV 249 (452)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEEC
T ss_pred CcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCcccccCccCCCEEEe
Confidence 8999999998554446665 588999999999999999875 67899999999999999999888999999999999999
Q ss_pred ccccccccccccc--ccccccccccCccc
Q 003039 420 QNNMLSGTVPSSL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 420 ~~N~l~g~~p~~l--~~~~~~l~~~~n~~ 446 (854)
++|++++..|..+ +.++..|++++|..
T Consensus 250 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 278 (452)
T 3zyi_A 250 MNSQVSLIERNAFDGLASLVELNLAHNNL 278 (452)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCcCceECHHHhcCCCCCCEEECCCCcC
Confidence 9999996666655 56788899998854
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.5e-14 Score=143.36 Aligned_cols=148 Identities=16% Similarity=0.130 Sum_probs=123.4
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
.+..++.|+++.|.++.+| .+..+..|+.|++++|.+.. ... ...+++
T Consensus 42 ~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~-----------~~~--------------------l~~l~~ 89 (197)
T 4ezg_A 42 QMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATN-----------YNP--------------------ISGLSN 89 (197)
T ss_dssp HHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSC-----------CGG--------------------GTTCTT
T ss_pred hcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCc-----------chh--------------------hhcCCC
Confidence 4567889999999999998 68999999999999885542 000 123568
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCc-cCCCCCccccCCCCCceeecc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ-LTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l~~L~~l~l~ 420 (854)
|+.|+|++|++++..|..|..|++|+.|+|++|++++..| .+..+++|++|+|++|+ ++ .+| .+..+++|+.|+++
T Consensus 90 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~ 167 (197)
T 4ezg_A 90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQ 167 (197)
T ss_dssp CCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECT
T ss_pred CCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECC
Confidence 9999999999998889999999999999999999998655 48899999999999998 55 677 69999999999999
Q ss_pred ccccccccc-cccccccccccccCcc
Q 003039 421 NNMLSGTVP-SSLLSKNVVLNYAGNI 445 (854)
Q Consensus 421 ~N~l~g~~p-~~l~~~~~~l~~~~n~ 445 (854)
+|++++ ++ -.-+++++.|++++|+
T Consensus 168 ~n~i~~-~~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 168 FDGVHD-YRGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp TBCCCC-CTTGGGCSSCCEEEECBC-
T ss_pred CCCCcC-hHHhccCCCCCEEEeeCcc
Confidence 999995 54 3337788999999886
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.1e-14 Score=161.33 Aligned_cols=178 Identities=19% Similarity=0.183 Sum_probs=138.8
Q ss_pred cccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 340 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~ 340 (854)
.+++|+.|+|+.|.++.+++. +..+..|+.|+++.|.+.......+..+..++.+...+ + ....+.. ....+
T Consensus 86 ~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N-----~i~~~~~~~~~~l 159 (440)
T 3zyj_A 86 HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRN-N-----PIESIPSYAFNRI 159 (440)
T ss_dssp SCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCS-C-----CCCEECTTTTTTC
T ss_pred CCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCC-C-----cccccCHHHhhhC
Confidence 356789999999999999975 89999999999999998765544555555565553321 1 1222221 23467
Q ss_pred CCeeEEEecCCCCCccCCc-ccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~-~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
++|+.|+|++|+..+.+|. .|.+|++|+.|+|++|+|+. +|.+..+++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 160 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 238 (440)
T 3zyj_A 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238 (440)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCccChhhhccCccCCEEEC
Confidence 8999999998555446665 68899999999999999985 567899999999999999999888899999999999999
Q ss_pred ccccccccccccc--ccccccccccCcccc
Q 003039 420 QNNMLSGTVPSSL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 420 ~~N~l~g~~p~~l--~~~~~~l~~~~n~~l 447 (854)
++|+|++..|..+ +.+++.|++++|...
T Consensus 239 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 268 (440)
T 3zyj_A 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLT 268 (440)
T ss_dssp TTCCCCEECTTSSTTCTTCCEEECTTSCCC
T ss_pred CCCceeEEChhhhcCCCCCCEEECCCCCCC
Confidence 9999995555554 567888999988543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=169.42 Aligned_cols=179 Identities=16% Similarity=0.140 Sum_probs=134.9
Q ss_pred ceeeeecccCCCCCCCcccc------hhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCC---eeEeC
Q 003039 266 FVLSFKFGKTYDSSRGPLLN------AMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWS---WLQCN 336 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~in------~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~---~~~c~ 336 (854)
.|+.|+|+.|.++..+|.+. .+..|+.|+++.|.+.......+..+..+..+...+.. -...+-. +....
T Consensus 645 ~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~-L~~ip~~~~~~~~~~ 723 (876)
T 4ecn_A 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL-MTSIPENSLKPKDGN 723 (876)
T ss_dssp CEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCC-CSCCCTTSSSCTTSC
T ss_pred CCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCc-CCccChHHhcccccc
Confidence 47778888888776655443 33467888888888775444444455556555332111 1000000 00000
Q ss_pred CCCCCCeeEEEecCCCCCccCCcccc--cCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCC------CccCCCCCccc
Q 003039 337 SDPQPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED------NQLTGPLPSSL 408 (854)
Q Consensus 337 ~~~~~~l~~L~L~~n~l~g~lp~~i~--~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~------N~l~g~~P~~l 408 (854)
..++++|+.|+|++|+|+ .+|..+. .|++|+.|+|++|+|++.++.+.++++|+.|+|++ |++.+.+|..|
T Consensus 724 l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l 802 (876)
T 4ecn_A 724 YKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802 (876)
T ss_dssp CTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTG
T ss_pred ccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHH
Confidence 112348999999999999 8999998 99999999999999999666789999999999976 88999999999
Q ss_pred cCCCCCceeeccccccccccccccccccccccccCcccc
Q 003039 409 MNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 447 (854)
Q Consensus 409 ~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~l~~~~n~~l 447 (854)
..|++|+.|+|++|+| +.+|..+.+.+..|++++|+..
T Consensus 803 ~~L~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 803 TTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNI 840 (876)
T ss_dssp GGCSSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTC
T ss_pred hcCCCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCC
Confidence 9999999999999999 6999999999999999999754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=4.6e-14 Score=154.32 Aligned_cols=172 Identities=17% Similarity=0.211 Sum_probs=102.2
Q ss_pred ceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccH--HHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 266 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG--VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~--~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
.|+.|+++.|.++.+++. +..+..|+.|+++.|.+.. .....+..+..++.+... -|. ...+. ..-.++
T Consensus 122 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~---~n~---l~~l~--~~~~~~ 193 (330)
T 1xku_A 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA---DTN---ITTIP--QGLPPS 193 (330)
T ss_dssp TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECC---SSC---CCSCC--SSCCTT
T ss_pred cccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECC---CCc---cccCC--cccccc
Confidence 445555555555555543 4555555555555555432 122223333333332111 010 01111 011256
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
|+.|+|++|++++..|..|.++++|+.|+|++|++++.++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus 194 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~ 272 (330)
T 1xku_A 194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272 (330)
T ss_dssp CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCS
T ss_pred CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCC
Confidence 7788888888877667777788888888888888877766 3677788888888888887 7777777888888888888
Q ss_pred cccccccccccc---------cccccccccCcccc
Q 003039 422 NMLSGTVPSSLL---------SKNVVLNYAGNINL 447 (854)
Q Consensus 422 N~l~g~~p~~l~---------~~~~~l~~~~n~~l 447 (854)
|+|+ .+|...+ ..+..+++.+|+..
T Consensus 273 N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 273 NNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp SCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CcCC-ccChhhcCCcccccccccccceEeecCccc
Confidence 8887 4544332 23355667777654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.2e-14 Score=165.22 Aligned_cols=181 Identities=20% Similarity=0.102 Sum_probs=133.6
Q ss_pred ccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
+++|+.|+|..|.++.+|+. +..+..|+.|++..|.+.......+..+..++.+...+ |.. ...+.-......+
T Consensus 151 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~---~~~--~~~~~~~~~~~~~ 225 (477)
T 2id5_A 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH---WPY--LDTMTPNCLYGLN 225 (477)
T ss_dssp CTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEEC---CTT--CCEECTTTTTTCC
T ss_pred CCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCC---Ccc--ccccCcccccCcc
Confidence 45667777777777777765 77777777777777766553333333333333332110 100 0111111122348
Q ss_pred eeEEEecCCCCCccCC-cccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 343 ITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp-~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
|+.|+|++|+|+ .+| ..+.++++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+|+
T Consensus 226 L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (477)
T 2id5_A 226 LTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304 (477)
T ss_dssp CSEEEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred ccEEECcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence 999999999999 566 5789999999999999999998876 8899999999999999999889999999999999999
Q ss_pred cccccccccccc---ccccccccccCccccccCC
Q 003039 421 NNMLSGTVPSSL---LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 421 ~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~~ 451 (854)
+|+|+ .+|... +.++..|++++|+..|.+.
T Consensus 305 ~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 305 GNQLT-TLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp SSCCS-CCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred CCcCc-eeCHhHcCCCcccCEEEccCCCccCccc
Confidence 99999 566554 4677899999999988753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.48 E-value=9.3e-14 Score=139.72 Aligned_cols=111 Identities=26% Similarity=0.334 Sum_probs=99.3
Q ss_pred CCeeEEEecCCCCCccCCc-ccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 341 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~-~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
.+|+.|+|++|+|++..|. .|.+|++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..|..|..+++|+.|+
T Consensus 29 ~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 3899999999999955554 489999999999999999999775 89999999999999999988888899999999999
Q ss_pred cccccccccccccc--ccccccccccCccccccCC
Q 003039 419 VQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 419 l~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~~~~ 451 (854)
|++|+|++.+|..+ +.++..|++++|+..|.+.
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99999998778776 6778999999999887653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.9e-13 Score=138.99 Aligned_cols=150 Identities=21% Similarity=0.198 Sum_probs=106.3
Q ss_pred eeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEEe
Q 003039 269 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL 348 (854)
Q Consensus 269 ~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~L 348 (854)
.+++..+.++.+|..+. +.++.|+++.|++... ...+ ...+++|+.|+|
T Consensus 11 ~v~c~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~----------~~~~-------------------~~~l~~L~~L~l 59 (208)
T 2o6s_A 11 TVECYSQGRTSVPTGIP--AQTTYLDLETNSLKSL----------PNGV-------------------FDELTSLTQLYL 59 (208)
T ss_dssp EEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCC----------CTTT-------------------TTTCTTCSEEEC
T ss_pred EEEecCCCccCCCCCCC--CCCcEEEcCCCccCcC----------Chhh-------------------hcccccCcEEEC
Confidence 34556677777776553 4677778877766530 0000 123457888888
Q ss_pred cCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccccccc
Q 003039 349 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 427 (854)
Q Consensus 349 ~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~ 427 (854)
++|+|++..+..|.++++|++|+|++|+|++.++. +.++++|++|+|++|+|++..+..+..+++|+.|+|++|+|+ .
T Consensus 60 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~ 138 (208)
T 2o6s_A 60 GGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-S 138 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-C
T ss_pred CCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc-e
Confidence 88888854445567888888888888888877776 677888888888888888655566788888888888888888 4
Q ss_pred ccccc---ccccccccccCccccccC
Q 003039 428 VPSSL---LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 428 ~p~~l---~~~~~~l~~~~n~~l~~~ 450 (854)
+|... +.+++.|++++|+..|..
T Consensus 139 ~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 139 VPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred eCHHHhccCCCccEEEecCCCeecCC
Confidence 55443 556778888888776654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.8e-13 Score=141.69 Aligned_cols=136 Identities=18% Similarity=0.133 Sum_probs=116.2
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+.++.|+|+.|.++.++|. +..+..|+.|++++|++.. ..+. ....+++|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-------------------i~~~----------~~~~l~~L 90 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-------------------LPVG----------VFDSLTQL 90 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-------------------CCTT----------TTTTCTTC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC-------------------cChh----------hcccCCCc
Confidence 5778999999999999765 8999999999999998754 1110 01345789
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|+|++..+..|..|++|+.|+|++|+|+..+..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 91 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 170 (229)
T 3e6j_A 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170 (229)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCC
Confidence 99999999999655666889999999999999999777789999999999999999996666789999999999999999
Q ss_pred cccccc
Q 003039 424 LSGTVP 429 (854)
Q Consensus 424 l~g~~p 429 (854)
+.+..+
T Consensus 171 ~~c~c~ 176 (229)
T 3e6j_A 171 WDCECR 176 (229)
T ss_dssp BCTTBG
T ss_pred ccCCcc
Confidence 996654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.5e-14 Score=148.72 Aligned_cols=171 Identities=19% Similarity=0.166 Sum_probs=125.9
Q ss_pred eeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeC-CCCCCCeeE
Q 003039 267 VLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN-SDPQPSITV 345 (854)
Q Consensus 267 l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~-~~~~~~l~~ 345 (854)
.+.++++.+.++.+|+.+. ..++.|+++.|.+.......+..+..++.+...+ |. ...+.-. ...+++|+.
T Consensus 18 ~~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~---n~---l~~i~~~~~~~l~~L~~ 89 (270)
T 2o6q_A 18 KNSVDCSSKKLTAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLND---NK---LQTLPAGIFKELKNLET 89 (270)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCS---SC---CSCCCTTTTSSCTTCCE
T ss_pred CCEEEccCCCCCccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCC---Cc---cCeeChhhhcCCCCCCE
Confidence 4578889999999998775 5789999999988765444555555555553311 10 1122211 235678999
Q ss_pred EEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccc
Q 003039 346 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424 (854)
Q Consensus 346 L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l 424 (854)
|+|++|+|++..+..+.++++|+.|+|++|++++.++. |.++++|++|+|++|+|++..+..|..+++|+.|+|++|++
T Consensus 90 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 90 LWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp EECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence 99999999865555678889999999999999888876 68899999999999999865555688889999999999999
Q ss_pred ccccccc-c--ccccccccccCccc
Q 003039 425 SGTVPSS-L--LSKNVVLNYAGNIN 446 (854)
Q Consensus 425 ~g~~p~~-l--~~~~~~l~~~~n~~ 446 (854)
+ .+|.. + +.++..|++++|..
T Consensus 170 ~-~~~~~~~~~l~~L~~L~L~~N~l 193 (270)
T 2o6q_A 170 K-RVPEGAFDKLTELKTLKLDNNQL 193 (270)
T ss_dssp S-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred c-EeChhHhccCCCcCEEECCCCcC
Confidence 8 45544 3 46678888888743
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=142.21 Aligned_cols=133 Identities=17% Similarity=0.225 Sum_probs=114.2
Q ss_pred cceeeeecccCCCCCCCc-ccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 265 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP-~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+.++.|+|..|.++.+|+ .+..+..|+.|+++.|++... .|- ....+++|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~-------------------~~~----------~~~~l~~L 82 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL-------------------APD----------AFQGLRSL 82 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE-------------------CTT----------TTTTCSSC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc-------------------CHH----------HhhCCcCC
Confidence 467899999999999998 599999999999999988641 000 12345689
Q ss_pred eEEEecCCCCCccCCc-ccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 344 TVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~-~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
+.|+|++|+|+ .+|+ .|..|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 83 ~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 161 (220)
T 2v9t_B 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161 (220)
T ss_dssp CEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCC
Confidence 99999999999 5555 468899999999999999999875 88999999999999999977777899999999999999
Q ss_pred cccccc
Q 003039 422 NMLSGT 427 (854)
Q Consensus 422 N~l~g~ 427 (854)
|++...
T Consensus 162 N~~~c~ 167 (220)
T 2v9t_B 162 NPFICD 167 (220)
T ss_dssp SCEECS
T ss_pred CCcCCC
Confidence 999743
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.5e-14 Score=154.63 Aligned_cols=175 Identities=17% Similarity=0.091 Sum_probs=109.2
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHH--HHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCC
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVA--IVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 341 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~--~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~ 341 (854)
+.++.|+|+.|.++.+|+. +..+..|+.|++++|.+.... +..+..+..++.+... -|. ...+......++
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls---~n~---i~~l~~~~~~l~ 101 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS---FNG---VITMSSNFLGLE 101 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC---SCS---EEEEEEEEETCT
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC---CCc---cccChhhcCCCC
Confidence 4678888999999999886 688899999999988876321 2344445555554321 110 112222223455
Q ss_pred CeeEEEecCCCCCccCC-cccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCC-CCCccccCCCCCceee
Q 003039 342 SITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELY 418 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp-~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~l~ 418 (854)
+|+.|+|++|++++..+ ..+.++++|+.|+|++|++.+.++. +.++++|++|+|++|++++ .+|..+..+++|+.|+
T Consensus 102 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 181 (306)
T 2z66_A 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181 (306)
T ss_dssp TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEE
Confidence 67777777777664333 3566667777777777776666554 5666677777777776664 4566666666777777
Q ss_pred cccccccccccccc--ccccccccccCcc
Q 003039 419 VQNNMLSGTVPSSL--LSKNVVLNYAGNI 445 (854)
Q Consensus 419 l~~N~l~g~~p~~l--~~~~~~l~~~~n~ 445 (854)
|++|++++..|..+ +.+++.|++++|.
T Consensus 182 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 210 (306)
T 2z66_A 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210 (306)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCCCcCCcCHHHhcCCCCCCEEECCCCc
Confidence 77777664444444 3455666666664
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.47 E-value=5e-14 Score=152.72 Aligned_cols=170 Identities=18% Similarity=0.261 Sum_probs=129.9
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.|+.|+|+.|.++.+|+ +..+..|+.|+++.|.+... ..+..+..++.+... -|. ...+.. ...+++|
T Consensus 62 l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~---~n~---l~~~~~-l~~l~~L 131 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLT---STQ---ITDVTP-LAGLSNL 131 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECT---TSC---CCCCGG-GTTCTTC
T ss_pred cCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECC---CCC---CCCchh-hcCCCCC
Confidence 5678899999999999999 89999999999999987653 345555555555331 121 112211 3456789
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|++++ +|. +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++ +|. +..+++|+.|+|++|+
T Consensus 132 ~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 132 QVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp CEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSC
T ss_pred CEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEEccCCc
Confidence 999999999984 554 8899999999999999988666 8889999999999999984 444 8889999999999999
Q ss_pred cccccccccccccccccccCccccc
Q 003039 424 LSGTVPSSLLSKNVVLNYAGNINLH 448 (854)
Q Consensus 424 l~g~~p~~l~~~~~~l~~~~n~~l~ 448 (854)
+++..|-.-+.++..|++++|+..+
T Consensus 207 l~~~~~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 207 ISDVSPLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCBCGGGTTCTTCCEEEEEEEEEEC
T ss_pred cCccccccCCCCCCEEEccCCeeec
Confidence 9955543336778888888887543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.5e-14 Score=169.59 Aligned_cols=174 Identities=18% Similarity=0.139 Sum_probs=88.4
Q ss_pred cccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 340 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~ 340 (854)
.++.|+.|+|+.|.++.+||. +..+..|+.|+++.|.+.......+..+..+..+...+ | ...++.. ....+
T Consensus 97 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~---N---~l~~~~~~~~~~l 170 (597)
T 3oja_B 97 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSN---N---NLERIEDDTFQAT 170 (597)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS---S---CCCBCCTTTTTTC
T ss_pred CCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeC---C---cCCCCChhhhhcC
Confidence 356778888888888888876 58888888888888877653333334444444432211 1 0111111 12334
Q ss_pred CCeeEEEecCCCCCccCCcccccC-------------------------------------ccCcEEeccCCCCCCCCCC
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKL-------------------------------------SSLVELWLDGNSLTGPIPD 383 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l-------------------------------------~~L~~L~L~~N~l~~~~p~ 383 (854)
++|+.|+|++|+|++.-+..+.+| ++|+.|+|++|++++ ++.
T Consensus 171 ~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~-~~~ 249 (597)
T 3oja_B 171 TSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD-TAW 249 (597)
T ss_dssp TTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC-CGG
T ss_pred CcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC-Chh
Confidence 556666666666653211111111 112223333333332 123
Q ss_pred CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccccccccc--ccccccccccCc
Q 003039 384 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444 (854)
Q Consensus 384 ~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n 444 (854)
+..+++|+.|+|++|.|++.+|..|+.+++|+.|+|++|+|+ .+|..+ ++++..|++++|
T Consensus 250 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~Ls~N 311 (597)
T 3oja_B 250 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311 (597)
T ss_dssp GGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC-EEECSSSCCTTCCEEECCSS
T ss_pred hccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC-CCCcccccCCCCcEEECCCC
Confidence 444555555555555555555555555555555555555555 344433 344555555555
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=6.3e-14 Score=153.27 Aligned_cols=176 Identities=24% Similarity=0.216 Sum_probs=141.8
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
.+++|+.|+|+.|.++.+|+.+. ..|+.|++++|.+.......+..+..+..+... ..... ...........+++
T Consensus 98 ~l~~L~~L~Ls~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~-~n~l~--~~~~~~~~~~~l~~ 172 (330)
T 1xku_A 98 PLVKLERLYLSKNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELG-TNPLK--SSGIENGAFQGMKK 172 (330)
T ss_dssp TCTTCCEEECCSSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECC-SSCCC--GGGBCTTGGGGCTT
T ss_pred CCCCCCEEECCCCcCCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECC-CCcCC--ccCcChhhccCCCC
Confidence 35688999999999999998875 789999999999887777778777777766432 11110 00001112234679
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
|+.|+|++|+++ .+|..+. ++|+.|+|++|++++..|. +.++++|+.|+|++|++++..|..+..+++|+.|+|++
T Consensus 173 L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 249 (330)
T 1xku_A 173 LSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 249 (330)
T ss_dssp CCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCS
T ss_pred cCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCC
Confidence 999999999999 6887775 8999999999999998764 89999999999999999987777999999999999999
Q ss_pred ccccccccccc--ccccccccccCcccc
Q 003039 422 NMLSGTVPSSL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 422 N~l~g~~p~~l--~~~~~~l~~~~n~~l 447 (854)
|+|+ .+|..+ +.+++.|++++|...
T Consensus 250 N~l~-~lp~~l~~l~~L~~L~l~~N~i~ 276 (330)
T 1xku_A 250 NKLV-KVPGGLADHKYIQVVYLHNNNIS 276 (330)
T ss_dssp SCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred CcCc-cCChhhccCCCcCEEECCCCcCC
Confidence 9999 899887 567888999988654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-13 Score=145.93 Aligned_cols=152 Identities=16% Similarity=0.134 Sum_probs=118.5
Q ss_pred cceeeeecccCCCCCCCc-ccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 265 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP-~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
..++.|+|+.|.++.+|+ .+..+..|+.|++++|.+...... ....+++|
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----------------------------~~~~l~~L 78 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-----------------------------AYQSLSHL 78 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTT-----------------------------TTTTCTTC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHH-----------------------------HccCCcCC
Confidence 357899999999999998 599999999999999987641100 01235688
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCccCC-CCCccccCCCCCceeeccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~l~l~~ 421 (854)
+.|+|++|++++..|..|.++++|+.|+|++|++++..+ .+.++++|++|+|++|++++ .+|..++.+++|+.|+|++
T Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~ 158 (276)
T 2z62_A 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158 (276)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCS
T ss_pred CEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCC
Confidence 999999999987777788889999999999999988777 48888999999999999886 3688888899999999999
Q ss_pred ccccccccccc--ccccc----cccccCcc
Q 003039 422 NMLSGTVPSSL--LSKNV----VLNYAGNI 445 (854)
Q Consensus 422 N~l~g~~p~~l--~~~~~----~l~~~~n~ 445 (854)
|++++..+..+ +..+. .|++++|.
T Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp SCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 99884444443 23333 56666664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.5e-14 Score=158.19 Aligned_cols=39 Identities=8% Similarity=0.033 Sum_probs=27.6
Q ss_pred ccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccH
Q 003039 264 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG 302 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~ 302 (854)
++.|+.|+|+.|.++.+||. +..+..|+.|+++.|.+..
T Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 131 (390)
T 3o6n_A 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCc
Confidence 45667777777777777665 6777777777777776654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=138.36 Aligned_cols=109 Identities=25% Similarity=0.292 Sum_probs=99.5
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 47999999999999 8999999999999999999999998886 899999999999999999877788999999999999
Q ss_pred ccccccccccccc---ccccccccccCccccccCC
Q 003039 420 QNNMLSGTVPSSL---LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 420 ~~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~~ 451 (854)
++|+|+ .+|... +.++..|++.+|+..|.+.
T Consensus 110 ~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 110 HGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCCC-eeChhhhhcCccccEEEeCCCCeecCCc
Confidence 999999 677654 5677899999999998754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.7e-14 Score=172.52 Aligned_cols=141 Identities=20% Similarity=0.244 Sum_probs=120.2
Q ss_pred ccHHHHHHHHhhcCCCCccCCC----CCC--CCCCCC------------CeeEeCCCCCCCeeEEEecCCCCCccCCccc
Q 003039 300 IDGVAIVSVISLYSSADWAQEG----GDP--CLPVPW------------SWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 361 (854)
Q Consensus 300 ~~~~~~~~l~~l~~~~~w~~~~----~~p--c~~~~~------------~~~~c~~~~~~~l~~L~L~~n~l~g~lp~~i 361 (854)
.|..++.++++...-.+|.... .+| | .| .||.|+. ..+++.|+|++|+|+|.+|++|
T Consensus 269 ~d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C---~W~~~~~~~~w~~~~GV~C~~--~~~V~~L~Ls~~~L~G~ip~~l 343 (876)
T 4ecn_A 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSL---NWNFNKELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGRVPDAI 343 (876)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCCSSCSSCCCCC---SCCCSSCGGGTTCCTTEEECT--TSCEEEEECTTTCCEEEECGGG
T ss_pred HHHHHHHHHHHHcCCCCCCcCCCcccccCCcc---ccccccccccccCcCceEecC--CCCEEEEECccCCCCCcCchHH
Confidence 3667888999887766897644 467 7 48 9999975 2589999999999999999999
Q ss_pred ccCccCcEEec-cCCCCCCC------------------------------------------------------------
Q 003039 362 TKLSSLVELWL-DGNSLTGP------------------------------------------------------------ 380 (854)
Q Consensus 362 ~~l~~L~~L~L-~~N~l~~~------------------------------------------------------------ 380 (854)
++|++|+.|+| ++|.++|.
T Consensus 344 ~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l 423 (876)
T 4ecn_A 344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423 (876)
T ss_dssp GGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCC
T ss_pred hccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccccc
Confidence 99999999999 77755433
Q ss_pred ----------------CC-CCCCCCCccEEEeCCCccCC-----------------CCCcccc--CCCCCceeecccccc
Q 003039 381 ----------------IP-DFSGCPDLRIIHLEDNQLTG-----------------PLPSSLM--NLPNLRELYVQNNML 424 (854)
Q Consensus 381 ----------------~p-~~~~l~~L~~L~Ls~N~l~g-----------------~~P~~l~--~l~~L~~l~l~~N~l 424 (854)
+| .+++|++|+.|+|++|+|+| .+|..++ +|++|+.|+|++|++
T Consensus 424 ~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l 503 (876)
T 4ecn_A 424 SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN 503 (876)
T ss_dssp CCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTT
T ss_pred chhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCC
Confidence 44 48889999999999999998 4999988 999999999999999
Q ss_pred cccccccc--ccccccccccCcc
Q 003039 425 SGTVPSSL--LSKNVVLNYAGNI 445 (854)
Q Consensus 425 ~g~~p~~l--~~~~~~l~~~~n~ 445 (854)
.|.+|..+ +++++.|++++|.
T Consensus 504 ~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 504 MTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CCSCCGGGGGCSSCCEEECTTCT
T ss_pred CccChHHHhCCCCCCEEECcCCC
Confidence 99999877 6788999999886
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=5.3e-14 Score=155.43 Aligned_cols=181 Identities=14% Similarity=0.098 Sum_probs=126.1
Q ss_pred ccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHH-HHHHhhcCCCCccCCCCCCCCCCCCCeeE-eCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ 340 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~-~~l~~l~~~~~w~~~~~~pc~~~~~~~~~-c~~~~~ 340 (854)
+++|+.|+|+.|.++.+|+. +..+..|+.|++++|.+..... ..+..+..++.+...+.+ ....+. .....+
T Consensus 99 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~-----~~~~~~~~~~~~l 173 (353)
T 2z80_A 99 LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD-----TFTKIQRKDFAGL 173 (353)
T ss_dssp CTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS-----SCCEECTTTTTTC
T ss_pred CCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCc-----cccccCHHHccCC
Confidence 45667777777777777776 6777777777777776654221 123333333333211100 011111 123456
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCC----------------
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP---------------- 403 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~---------------- 403 (854)
++|+.|+|++|++++..|..+.++++|+.|+|++|+++..++. +..+++|+.|+|++|++++.
T Consensus 174 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~ 253 (353)
T 2z80_A 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253 (353)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCE
T ss_pred CCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhc
Confidence 7888888988888887888888888888888888888765554 34588899999999998863
Q ss_pred ---------------CCccccCCCCCceeecccccccccccccc---ccccccccccCccccccC
Q 003039 404 ---------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 404 ---------------~P~~l~~l~~L~~l~l~~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~ 450 (854)
+|..+..+++|+.|+|++|+|+ .+|..+ +++++.|++++|+..|.+
T Consensus 254 l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 254 FTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp EEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 3456778899999999999999 888876 456788999999887754
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.7e-14 Score=156.67 Aligned_cols=174 Identities=18% Similarity=0.118 Sum_probs=85.3
Q ss_pred ccceeeeecccCCCC-CCCccc--chhhhceeccCCCCCccHHHHHHHHhh-----cCCCCccCCCCCCCCCCCCCeeEe
Q 003039 264 LPFVLSFKFGKTYDS-SRGPLL--NAMEINKYLERNDGSIDGVAIVSVISL-----YSSADWAQEGGDPCLPVPWSWLQC 335 (854)
Q Consensus 264 l~~l~~l~l~~n~~s-~lpP~i--n~le~l~~L~l~~~~~~~~~~~~l~~l-----~~~~~w~~~~~~pc~~~~~~~~~c 335 (854)
++.|+.|+|+.|.++ .+|..+ ..+..|+.|++++|++... +..+..+ ..++.+...+ | ....+.+
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~---N---~l~~~~~ 166 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQ---A---HSLNFSC 166 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEES---C---SCCCCCT
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeC---C---CCccchH
Confidence 445556666666655 344443 5556666666666555443 3333333 2333221110 0 0111111
Q ss_pred -CCCCCCCeeEEEecCCCCCcc--CCccc--ccCccCcEEeccCCCCCCCC--C-C-CCCCCCccEEEeCCCccCCCCC-
Q 003039 336 -NSDPQPSITVIHLSSKNLTGN--IPSDL--TKLSSLVELWLDGNSLTGPI--P-D-FSGCPDLRIIHLEDNQLTGPLP- 405 (854)
Q Consensus 336 -~~~~~~~l~~L~L~~n~l~g~--lp~~i--~~l~~L~~L~L~~N~l~~~~--p-~-~~~l~~L~~L~Ls~N~l~g~~P- 405 (854)
....+++|+.|+|++|++.|. +|..+ .++++|+.|+|++|+|++.. + . +.++++|+.|+|++|+|++.+|
T Consensus 167 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 246 (312)
T 1wwl_A 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246 (312)
T ss_dssp TTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC
T ss_pred HHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch
Confidence 122344566666666665544 23333 55566666666666655321 1 1 2345566666666666665443
Q ss_pred ccccCCCCCceeeccccccccccccccccccccccccCcc
Q 003039 406 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 445 (854)
Q Consensus 406 ~~l~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~l~~~~n~ 445 (854)
..+..+++|+.|+|++|+|+ .+|..+..+++.|++++|.
T Consensus 247 ~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N~ 285 (312)
T 1wwl_A 247 PSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNR 285 (312)
T ss_dssp SCCCCCTTCCEEECTTSCCS-SCCSSCCSEEEEEECCSSC
T ss_pred hhhhhcCCCCEEECCCCccC-hhhhhccCCceEEECCCCC
Confidence 33444556666666666665 5555555555555555553
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.1e-14 Score=158.16 Aligned_cols=198 Identities=17% Similarity=0.082 Sum_probs=128.0
Q ss_pred CCceEEEEEECCcccccccccccccccCcceEEeccccccccccceeeeecccCCCCCCCcccchh-----hhceeccCC
Q 003039 222 DESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAM-----EINKYLERN 296 (854)
Q Consensus 222 ~~~R~F~v~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~l~l~~n~~s~lpP~in~l-----e~l~~L~l~ 296 (854)
.+.|..|+.-|.....-+.. ++ ...+++|+.|+|+.|.++.+|+.+..+ ..|+.|+++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~------------~~-----~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~ 157 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPP------------LL-----EATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCC------------SS-----SCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEE
T ss_pred CCccEEEccCCcccchhHHH------------HH-----HhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEee
Confidence 46788888888754211000 00 012344555555555555555445555 555555555
Q ss_pred CCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCe---eE--eCCCCCCCeeEEEecCCCCCc--cCCc-ccccCccCc
Q 003039 297 DGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW---LQ--CNSDPQPSITVIHLSSKNLTG--NIPS-DLTKLSSLV 368 (854)
Q Consensus 297 ~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~---~~--c~~~~~~~l~~L~L~~n~l~g--~lp~-~i~~l~~L~ 368 (854)
.|++....+..+..+..++.+...+.. ..+ +. -....+++|+.|+|++|+|++ .++. .+.++++|+
T Consensus 158 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~------l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~ 231 (312)
T 1wwl_A 158 QAHSLNFSCEQVRVFPALSTLDLSDNP------ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ 231 (312)
T ss_dssp SCSCCCCCTTTCCCCSSCCEEECCSCT------TCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCS
T ss_pred CCCCccchHHHhccCCCCCEEECCCCC------cCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCC
Confidence 555544333344444444433221100 000 00 001356799999999999993 3333 345789999
Q ss_pred EEeccCCCCCCCCC--CCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccccccccc--ccccccccccCc
Q 003039 369 ELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 444 (854)
Q Consensus 369 ~L~L~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n 444 (854)
.|+|++|+|++.+| .+..+++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. + +.+++.|++++|
T Consensus 232 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N 306 (312)
T 1wwl_A 232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGN 306 (312)
T ss_dssp EEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTC
T ss_pred EEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCC
Confidence 99999999999874 4677999999999999999 8998887 8999999999999954 66 4 667788999999
Q ss_pred ccc
Q 003039 445 INL 447 (854)
Q Consensus 445 ~~l 447 (854)
+..
T Consensus 307 ~l~ 309 (312)
T 1wwl_A 307 PFL 309 (312)
T ss_dssp TTT
T ss_pred CCC
Confidence 753
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=4.3e-14 Score=167.70 Aligned_cols=112 Identities=22% Similarity=0.233 Sum_probs=86.7
Q ss_pred CCCCeeEEEecCCCCCcc---CCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCC
Q 003039 339 PQPSITVIHLSSKNLTGN---IPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 414 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g~---lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L 414 (854)
.+++|+.|+|++|++++. .+..+..+++|+.|+|++|++++.+|. +.++++|+.|+|++|+|++..|..+..+++|
T Consensus 447 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 526 (606)
T 3t6q_A 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI 526 (606)
T ss_dssp TCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC
T ss_pred CCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc
Confidence 456788888888888762 335677888888888888888887664 7778888888888888888888888888888
Q ss_pred ceeecccccccccccccc--ccccccccccCccccccCC
Q 003039 415 RELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 415 ~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~~~~ 451 (854)
.|+|++|++++..|..+ +.++..+++++|+..|.+.
T Consensus 527 -~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 527 -YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp -EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred -EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 88888888886555544 5677888888998888653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-14 Score=169.55 Aligned_cols=181 Identities=20% Similarity=0.165 Sum_probs=122.6
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCC-------------ccHHHHHHHHhhcCCCCccCCCCCCCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGS-------------IDGVAIVSVISLYSSADWAQEGGDPCLPVP 329 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~-------------~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~ 329 (854)
..++++.|+|+.|.++.||+.|..+..|+.|++++|. .....+..+..+..+..+..-........+
T Consensus 347 ~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~ 426 (567)
T 1dce_A 347 TDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLR 426 (567)
T ss_dssp TTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHH
T ss_pred cCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhh
Confidence 3567788999999999999999999999999997764 122222333333222222000000000000
Q ss_pred CCeeE---eCCCCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCc
Q 003039 330 WSWLQ---CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 406 (854)
Q Consensus 330 ~~~~~---c~~~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~ 406 (854)
--.+. ...-....|+.|+|++|+|++ +|. |++|++|+.|+|++|+|+..++.+++|++|+.|+|++|+|++ +|
T Consensus 427 ~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp- 502 (567)
T 1dce_A 427 SKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD- 502 (567)
T ss_dssp HHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-
T ss_pred hhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-
Confidence 00000 000001257888999998884 776 888889999999999888665568888899999999999885 77
Q ss_pred cccCCCCCceeecccccccccc-cccc--ccccccccccCcccc
Q 003039 407 SLMNLPNLRELYVQNNMLSGTV-PSSL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 407 ~l~~l~~L~~l~l~~N~l~g~~-p~~l--~~~~~~l~~~~n~~l 447 (854)
.|+.|++|+.|+|++|+|++.. |..+ ++++..|++++|+..
T Consensus 503 ~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 7888888999999999988665 7776 677888888888643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.1e-13 Score=161.97 Aligned_cols=177 Identities=12% Similarity=0.012 Sum_probs=121.6
Q ss_pred cceeeeecccCCCCCCCccc-chhhhceeccCCCCCccHHHHHH---HHhhcCCCCccCCCCCCCCCCCCCeeE---eCC
Q 003039 265 PFVLSFKFGKTYDSSRGPLL-NAMEINKYLERNDGSIDGVAIVS---VISLYSSADWAQEGGDPCLPVPWSWLQ---CNS 337 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~i-n~le~l~~L~l~~~~~~~~~~~~---l~~l~~~~~w~~~~~~pc~~~~~~~~~---c~~ 337 (854)
..++.|++..|.+..+|+.+ ..+..|+.|+++.|.+....+.. +..+..++.+... -|. ...+. -..
T Consensus 310 ~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls---~N~---l~~~~~~~~~~ 383 (549)
T 2z81_A 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS---QNH---LRSMQKTGEIL 383 (549)
T ss_dssp TTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECT---TSC---CCCHHHHHHHG
T ss_pred ccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEcc---CCc---ccccccchhhh
Confidence 45778888888888888776 56888888888888887655433 3333444444221 111 11110 012
Q ss_pred CCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCC------------------CCCCCccEEEeCCCc
Q 003039 338 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF------------------SGCPDLRIIHLEDNQ 399 (854)
Q Consensus 338 ~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~------------------~~l~~L~~L~Ls~N~ 399 (854)
..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+..+ ..+++|++|+|++|+
T Consensus 384 ~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~ 462 (549)
T 2z81_A 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNK 462 (549)
T ss_dssp GGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSC
T ss_pred hcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCc
Confidence 34567788888888877 67777777777777777777776543321 367888999999999
Q ss_pred cCCCCCccccCCCCCceeecccccccccccccc--ccccccccccCccccccC
Q 003039 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 400 l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~~~ 450 (854)
|+ .+|. ...+++|+.|+|++|+|++.+|..+ +.+++.|++++|+..|.+
T Consensus 463 l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 463 LK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp CS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred cC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 98 7886 5678899999999999996666544 567788899999887754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.44 E-value=4.2e-14 Score=147.22 Aligned_cols=102 Identities=17% Similarity=0.094 Sum_probs=71.8
Q ss_pred eeEEEecCC-CCCccCCcccccCccCc-EEeccCCCCCCCCCCCCCCCCccEEEeCCCc-cCCCCCccccCC-CCCceee
Q 003039 343 ITVIHLSSK-NLTGNIPSDLTKLSSLV-ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ-LTGPLPSSLMNL-PNLRELY 418 (854)
Q Consensus 343 l~~L~L~~n-~l~g~lp~~i~~l~~L~-~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l-~~L~~l~ 418 (854)
|+.|+|++| ++++..+..|.++++|+ .|+|++|+++..++.....++|+.|+|++|+ |++..|..|..+ ++|+.|+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~ 211 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEE
Confidence 338888888 77754445577788888 8888888887555543333778888888884 775445667777 7888888
Q ss_pred ccccccccccccccccccccccccCcc
Q 003039 419 VQNNMLSGTVPSSLLSKNVVLNYAGNI 445 (854)
Q Consensus 419 l~~N~l~g~~p~~l~~~~~~l~~~~n~ 445 (854)
|++|+|+ .+|...+.++..|.+.++.
T Consensus 212 l~~N~l~-~l~~~~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 212 VSQTSVT-ALPSKGLEHLKELIARNTW 237 (239)
T ss_dssp CTTCCCC-CCCCTTCTTCSEEECTTC-
T ss_pred CCCCccc-cCChhHhccCceeeccCcc
Confidence 8888887 6777667777777766654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.2e-13 Score=162.46 Aligned_cols=183 Identities=17% Similarity=0.112 Sum_probs=134.3
Q ss_pred cccceeeeecccCCCCCC---CcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCee--EeCC
Q 003039 263 SLPFVLSFKFGKTYDSSR---GPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWL--QCNS 337 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~l---pP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~--~c~~ 337 (854)
.+++|+.|+|+.|.++.+ |..+..+..|+.|+++.|.+...... +..+..+..+... -|. ...+ ....
T Consensus 345 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~---~n~---l~~~~~~~~~ 417 (570)
T 2z63_A 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQ---HSN---LKQMSEFSVF 417 (570)
T ss_dssp BCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECT---TSE---EESCTTSCTT
T ss_pred cCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEcc---CCc---cccccchhhh
Confidence 455677777777777766 34466677777777777765442211 3333333333211 010 0000 0112
Q ss_pred CCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCC-CCCC-CCCCCCCccEEEeCCCccCCCCCccccCCCCCc
Q 003039 338 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-GPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 415 (854)
Q Consensus 338 ~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~-~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~ 415 (854)
..+++|+.|+|++|++++.+|..+.++++|+.|+|++|+++ +.+| .+..+++|+.|+|++|++++..|..+..+++|+
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 497 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence 35679999999999999999999999999999999999998 4555 588999999999999999988899999999999
Q ss_pred eeecccccccccccccc--ccccccccccCccccccCCC
Q 003039 416 ELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGGR 452 (854)
Q Consensus 416 ~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~~~~~ 452 (854)
.|+|++|++++..|..+ +.+++.|++++|+..|.++.
T Consensus 498 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99999999996555544 56788999999999887653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.2e-13 Score=164.91 Aligned_cols=175 Identities=13% Similarity=0.084 Sum_probs=132.7
Q ss_pred cccceeeeecccCCCC-CCCcccchhhhceeccCCCCC-ccH-HHHHHHHhh------cCCCCccCCCCCCCCCCCCCee
Q 003039 263 SLPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGS-IDG-VAIVSVISL------YSSADWAQEGGDPCLPVPWSWL 333 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s-~lpP~in~le~l~~L~l~~~~-~~~-~~~~~l~~l------~~~~~w~~~~~~pc~~~~~~~~ 333 (854)
.+++|+.|+|+.|.++ .+|+.|..+..|+.|+++.|+ +.. ..+..+..+ ..++.+... -|. ...+
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~---~n~---l~~i 320 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG---YNN---LKTF 320 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECC---SSC---CSSC
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECC---CCc---CCcc
Confidence 4678999999999854 577779999999999999998 887 678888876 666665332 111 1122
Q ss_pred Ee--CCCCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCC-ccEEEeCCCccCCCCCccccC
Q 003039 334 QC--NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD-LRIIHLEDNQLTGPLPSSLMN 410 (854)
Q Consensus 334 ~c--~~~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~-L~~L~Ls~N~l~g~~P~~l~~ 410 (854)
.- ....+++|+.|+|++|+++|.+| .|+++++|+.|+|++|+++..++.+.++++ |+.|+|++|+|+ .+|..++.
T Consensus 321 p~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~ 398 (636)
T 4eco_A 321 PVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDA 398 (636)
T ss_dssp CCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCT
T ss_pred CchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhh
Confidence 22 23456788888888888888888 888888888888888888855556888888 888888888888 78887776
Q ss_pred CC--CCceeeccccccccccccccc---------cccccccccCcc
Q 003039 411 LP--NLRELYVQNNMLSGTVPSSLL---------SKNVVLNYAGNI 445 (854)
Q Consensus 411 l~--~L~~l~l~~N~l~g~~p~~l~---------~~~~~l~~~~n~ 445 (854)
++ +|+.|+|++|+++|.+|..+. .+++.|++++|.
T Consensus 399 ~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~ 444 (636)
T 4eco_A 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQ 444 (636)
T ss_dssp TCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSC
T ss_pred cccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCc
Confidence 55 788888888888887776653 256777777774
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=1.2e-13 Score=157.92 Aligned_cols=107 Identities=21% Similarity=0.168 Sum_probs=92.4
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
++|+.|+|++|++++.+|..+.++++|+.|+|++|++++.+| .|.++++|+.|+|++|+|++..|..++.+++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 478888888888888888889999999999999999998877 4888999999999999999777888999999999999
Q ss_pred ccccccccccccc--ccccccccccCcccc
Q 003039 420 QNNMLSGTVPSSL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 420 ~~N~l~g~~p~~l--~~~~~~l~~~~n~~l 447 (854)
++|++++..|..+ +++++.|++++|...
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 384 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLK 384 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCcccccChhhccccccccEEECCCCccc
Confidence 9999996667666 677888899888543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.43 E-value=2.1e-13 Score=147.85 Aligned_cols=170 Identities=22% Similarity=0.243 Sum_probs=133.6
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
.+..++.|++..+.++.+| .+..+..|+.|+++.|.+..... +..+..++.+... + |. ...+. ....+++
T Consensus 39 ~l~~L~~L~l~~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~-~--n~---l~~~~-~~~~l~~ 108 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS-G--NP---LKNVS-AIAGLQS 108 (308)
T ss_dssp HHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC-S--CC---CSCCG-GGTTCTT
T ss_pred HcCCcCEEEeeCCCccCch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEcc-C--Cc---CCCch-hhcCCCC
Confidence 3678899999999999997 68899999999999999876433 6666666665332 1 11 11121 2345779
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N 422 (854)
|+.|+|++|++++ +|. +..|++|+.|+|++|++++.++ +..+++|+.|+|++|++++ +|. +..+++|+.|+|++|
T Consensus 109 L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n 183 (308)
T 1h6u_A 109 IKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDN 183 (308)
T ss_dssp CCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSS
T ss_pred CCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCC
Confidence 9999999999994 654 9999999999999999998766 8889999999999999995 555 899999999999999
Q ss_pred ccccccccccccccccccccCcccc
Q 003039 423 MLSGTVPSSLLSKNVVLNYAGNINL 447 (854)
Q Consensus 423 ~l~g~~p~~l~~~~~~l~~~~n~~l 447 (854)
++++..|-.-+.+++.|++++|...
T Consensus 184 ~l~~~~~l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 184 KISDISPLASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp CCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred ccCcChhhcCCCCCCEEEccCCccC
Confidence 9995444334677888999888543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.43 E-value=7.1e-14 Score=153.02 Aligned_cols=172 Identities=16% Similarity=0.169 Sum_probs=114.9
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccH--HHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCC
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG--VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 341 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~--~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~ 341 (854)
++|+.|+|+.|.++.+|+. +..+..|+.|+++.|.+.. ..+..+..+ .+..+.. .-|. ...+.. .-.+
T Consensus 123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l---~~n~---l~~l~~--~~~~ 193 (332)
T 2ft3_A 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRI---SEAK---LTGIPK--DLPE 193 (332)
T ss_dssp TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBC---CSSB---CSSCCS--SSCS
T ss_pred ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEEC---cCCC---CCccCc--cccC
Confidence 4567777777777777765 6777777777777776642 111112211 2222211 0010 111111 1124
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
+|+.|+|++|++++..|..|.++++|+.|+|++|++++.++. +..+++|+.|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~ 272 (332)
T 2ft3_A 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272 (332)
T ss_dssp SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECC
T ss_pred CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECC
Confidence 788888888888876677888888888888888888887774 778888888888888888 788888888888888888
Q ss_pred ccccccccccccc---------cccccccccCcccc
Q 003039 421 NNMLSGTVPSSLL---------SKNVVLNYAGNINL 447 (854)
Q Consensus 421 ~N~l~g~~p~~l~---------~~~~~l~~~~n~~l 447 (854)
+|+|+ .+|...+ ..+..+++.+|+..
T Consensus 273 ~N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp SSCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred CCCCC-ccChhHccccccccccccccceEeecCccc
Confidence 88888 4544332 23456777888754
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.42 E-value=9.2e-14 Score=151.20 Aligned_cols=105 Identities=15% Similarity=0.138 Sum_probs=59.3
Q ss_pred CCeeEEEecCCCCCccCCcccc-cCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
++|+.|+|++|++++..|..+. .+++|+.|+|++|+|++. +....+++|+.|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L 221 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEEC
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC-cchhhhcccCcccEEEC
Confidence 4455555555555544444442 455555555555555544 33334566666666666666 34455666666666666
Q ss_pred ccccccccccccc--ccccccccccCccccc
Q 003039 420 QNNMLSGTVPSSL--LSKNVVLNYAGNINLH 448 (854)
Q Consensus 420 ~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~ 448 (854)
++|+|+ .+|..+ +.++..|++++|+..|
T Consensus 222 ~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp TTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred cCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 666666 556554 3455666666666554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.5e-13 Score=163.39 Aligned_cols=139 Identities=15% Similarity=0.149 Sum_probs=119.1
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+.++.|+|+.|.++.+||. |..+..|+.|+|+.|++..+ ++- ...++++|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i-------------------~~~----------~f~~L~~L 102 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI-------------------EDG----------AYQSLSHL 102 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEE-------------------CTT----------TTTTCTTC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCc-------------------Chh----------HhcCCCCC
Confidence 3678999999999999986 99999999999999987641 000 12346799
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCC-CCCccccCCCCCceeeccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~l~l~~ 421 (854)
++|+|++|+|++..|..|.+|++|++|+|++|+|++.++. |++|++|++|+|++|+|++ .+|..++.+++|+.|+|++
T Consensus 103 ~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~ 182 (635)
T 4g8a_A 103 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 182 (635)
T ss_dssp CEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCS
T ss_pred CEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccC
Confidence 9999999999965556789999999999999999998885 8999999999999999985 4688999999999999999
Q ss_pred ccccccccccc
Q 003039 422 NMLSGTVPSSL 432 (854)
Q Consensus 422 N~l~g~~p~~l 432 (854)
|+|++..|..+
T Consensus 183 N~l~~~~~~~l 193 (635)
T 4g8a_A 183 NKIQSIYCTDL 193 (635)
T ss_dssp SCCCEECGGGG
T ss_pred ccccccccccc
Confidence 99996666554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.1e-13 Score=148.88 Aligned_cols=148 Identities=20% Similarity=0.241 Sum_probs=123.9
Q ss_pred eeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEE
Q 003039 268 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 347 (854)
Q Consensus 268 ~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~ 347 (854)
..++++.+.++.+|..+.. .++.|+++.|.+... ...+ + ...+++|+.|+
T Consensus 21 ~~l~c~~~~l~~iP~~~~~--~l~~L~Ls~N~l~~l----------~~~~------------~------~~~l~~L~~L~ 70 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSLPS--YTALLDLSHNNLSRL----------RAEW------------T------PTRLTNLHSLL 70 (361)
T ss_dssp TEEECCSSCCSSCCSSCCT--TCSEEECCSSCCCEE----------CTTS------------S------SSCCTTCCEEE
T ss_pred CEEEeCCCCcCccCccCCC--CCCEEECCCCCCCcc----------Chhh------------h------hhcccccCEEE
Confidence 4578899999999987653 478999999987641 0011 0 01456899999
Q ss_pred ecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccc
Q 003039 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 426 (854)
Q Consensus 348 L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g 426 (854)
|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus 71 L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~- 149 (361)
T 2xot_A 71 LSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS- 149 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-
T ss_pred CCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-
Confidence 999999976777899999999999999999998886 889999999999999999888899999999999999999999
Q ss_pred cccccc------ccccccccccCccc
Q 003039 427 TVPSSL------LSKNVVLNYAGNIN 446 (854)
Q Consensus 427 ~~p~~l------~~~~~~l~~~~n~~ 446 (854)
.+|..+ +.++..|++++|..
T Consensus 150 ~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 150 RFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp SCCGGGTC----CTTCCEEECCSSCC
T ss_pred eeCHHHhcCcccCCcCCEEECCCCCC
Confidence 677765 46678899998854
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.42 E-value=4.3e-13 Score=158.42 Aligned_cols=169 Identities=20% Similarity=0.203 Sum_probs=119.3
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
|..|+.|+|..|.++.+| .|..+..|+.|+|+.|.+..... +..+..+..+...+ |. ...+. ....+++|
T Consensus 42 L~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~---N~---l~~l~-~l~~l~~L 111 (605)
T 1m9s_A 42 LNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE---NK---IKDLS-SLKDLKKL 111 (605)
T ss_dssp HTTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS---SC---CCCCT-TSTTCTTC
T ss_pred CCCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC---CC---CCCCh-hhccCCCC
Confidence 455666666666666665 35666667777776666554322 44444454443211 11 11111 23456789
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|+|++ + +.+..|++|+.|+|++|+|++. +.+..|++|+.|+|++|+|++..| +..|++|+.|+|++|+
T Consensus 112 ~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 112 KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp CEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred CEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence 999999999994 5 4689999999999999999987 778899999999999999996555 8999999999999999
Q ss_pred ccccccc-ccccccccccccCccccc
Q 003039 424 LSGTVPS-SLLSKNVVLNYAGNINLH 448 (854)
Q Consensus 424 l~g~~p~-~l~~~~~~l~~~~n~~l~ 448 (854)
|++ +|. .-+.++..|++++|+...
T Consensus 187 i~~-l~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 187 ISD-LRALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCB-CGGGTTCTTCSEEECCSEEEEC
T ss_pred CCC-ChHHccCCCCCEEEccCCcCcC
Confidence 994 543 226778888898886543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.1e-13 Score=159.15 Aligned_cols=176 Identities=18% Similarity=0.117 Sum_probs=122.4
Q ss_pred ceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCCCCe
Q 003039 266 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQPSI 343 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~~~l 343 (854)
.++.|+|+.|.++.++|. +..+..|+.|+++.|.+....+..+..+..++.+...+ | ....+.. ....+++|
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~---n---~l~~~~~~~~~~l~~L 106 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS---N---RLKLIPLGVFTGLSNL 106 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS---S---CCCSCCTTSSTTCTTC
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC---C---cCCccCcccccCCCCC
Confidence 456777788888887654 77788888888887777665455555555555543311 1 0111211 12346788
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N 422 (854)
+.|+|++|++++..|..|.+|++|+.|+|++|++++..+. |.++++|+.|+|++|++++..+..|..+++|+.|+|++|
T Consensus 107 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n 186 (477)
T 2id5_A 107 TKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186 (477)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESC
T ss_pred CEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCC
Confidence 8888888888877788888888888888888888887664 788888888888888888655556888888888888888
Q ss_pred cccccccccc--ccccccccccCcccc
Q 003039 423 MLSGTVPSSL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 423 ~l~g~~p~~l--~~~~~~l~~~~n~~l 447 (854)
++++..+..+ +.+++.|++++|+..
T Consensus 187 ~i~~~~~~~~~~l~~L~~L~l~~~~~~ 213 (477)
T 2id5_A 187 NINAIRDYSFKRLYRLKVLEISHWPYL 213 (477)
T ss_dssp CCCEECTTCSCSCTTCCEEEEECCTTC
T ss_pred cCcEeChhhcccCcccceeeCCCCccc
Confidence 8885444333 455677777776543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.42 E-value=2.6e-13 Score=145.78 Aligned_cols=169 Identities=20% Similarity=0.179 Sum_probs=110.8
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.++.|++..|.++.+|. +..+..|+.|+++.|++..... +..+..++.+...+ |. ...+. ....+++|
T Consensus 45 l~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~---n~---l~~~~-~l~~l~~L 114 (291)
T 1h6t_A 45 LNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE---NK---VKDLS-SLKDLKKL 114 (291)
T ss_dssp HHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS---SC---CCCGG-GGTTCTTC
T ss_pred cCcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC---Cc---CCCCh-hhccCCCC
Confidence 3445555666666655533 5555566666666555544221 33333333332211 10 01111 12345689
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|++++ + +.+..|++|+.|+|++|++++. +.+..+++|+.|+|++|+|++. +. +..+++|+.|+|++|+
T Consensus 115 ~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~-~~-l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 115 KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDI-VP-LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp CEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred CEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccc-hh-hcCCCccCEEECCCCc
Confidence 999999999984 4 4688899999999999999876 6788899999999999999854 43 8889999999999999
Q ss_pred cccccccc-cccccccccccCccccc
Q 003039 424 LSGTVPSS-LLSKNVVLNYAGNINLH 448 (854)
Q Consensus 424 l~g~~p~~-l~~~~~~l~~~~n~~l~ 448 (854)
|+ .+|.- -+.++..|++++|+..+
T Consensus 190 i~-~l~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 190 IS-DLRALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CC-BCGGGTTCTTCSEEEEEEEEEEC
T ss_pred CC-CChhhccCCCCCEEECcCCcccC
Confidence 98 45541 15677888888886543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=3.4e-13 Score=160.24 Aligned_cols=183 Identities=14% Similarity=0.076 Sum_probs=139.3
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHH-HHHHHHhhcCCCCccCCCCCCCCCCCCCeeE-eCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGV-AIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ 340 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~-~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~-c~~~~~ 340 (854)
.+.++..+++..+....+++.+..++.|+.+.+..+..... ....+..+..+..... ..+ ....+. .....+
T Consensus 395 ~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~l---s~n---~l~~~~~~~~~~~ 468 (635)
T 4g8a_A 395 GTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI---SHT---HTRVAFNGIFNGL 468 (635)
T ss_dssp SCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEEC---TTS---CCEECCTTTTTTC
T ss_pred hhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccc---ccc---ccccccccccccc
Confidence 35677889999999999999999999999999886654321 1111222222222111 000 011111 123456
Q ss_pred CCeeEEEecCCCCC-ccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 341 PSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 341 ~~l~~L~L~~n~l~-g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
+.|+.|+|++|++. +.+|..|..|++|+.|+|++|+|++.+|. |.+|++|++|+|++|+|++..|..|..|++|+.|+
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 79999999999854 45788999999999999999999999886 89999999999999999988888999999999999
Q ss_pred cccccccccccccc--c-cccccccccCccccccCC
Q 003039 419 VQNNMLSGTVPSSL--L-SKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 419 l~~N~l~g~~p~~l--~-~~~~~l~~~~n~~l~~~~ 451 (854)
|++|+|++..|..+ + .++..|++++||..|.+.
T Consensus 549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999997777766 2 568899999999999874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.41 E-value=3.7e-13 Score=158.29 Aligned_cols=156 Identities=17% Similarity=0.204 Sum_probs=121.4
Q ss_pred ccceeeeecccCCCCC-CCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 264 LPFVLSFKFGKTYDSS-RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~-lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
+++++.|+|+.|.++. +|+.+..+..|+.|++++|++.... .+.-....+++
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------------------------~~~~~~~~l~~ 404 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF---------------------------KVALMTKNMSS 404 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTT---------------------------HHHHTTTTCTT
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcc---------------------------cchhhhcCCCC
Confidence 4566777777777766 4445677777777777777665310 00011234568
Q ss_pred eeEEEecCCCCCccCCcc-cccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 343 ITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~-i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
|+.|+|++|++++.+|.. +..+++|+.|+|++|+|++.+|. +. ++|+.|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 405 L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~ 481 (562)
T 3a79_B 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVA 481 (562)
T ss_dssp CCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECC
T ss_pred CCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECC
Confidence 999999999999867765 78899999999999999887664 33 79999999999999 899988899999999999
Q ss_pred cccccccccccc---ccccccccccCccccccC
Q 003039 421 NNMLSGTVPSSL---LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 421 ~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~ 450 (854)
+|+|+ .+|... +.+++.+++++|+..|.+
T Consensus 482 ~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 482 SNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp SSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred CCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 99999 788873 567788999999998865
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.6e-13 Score=150.14 Aligned_cols=176 Identities=27% Similarity=0.226 Sum_probs=136.6
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
.+++|+.|+|+.|.++.+|+.+. ..|+.|+++.|.+.......+..+..++.+... ++.-.. ..........+ +
T Consensus 100 ~l~~L~~L~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~-~n~l~~--~~~~~~~~~~l-~ 173 (332)
T 2ft3_A 100 PLRKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG-GNPLEN--SGFEPGAFDGL-K 173 (332)
T ss_dssp TCTTCCEEECCSSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECC-SCCCBG--GGSCTTSSCSC-C
T ss_pred CcCCCCEEECCCCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECC-CCcccc--CCCCcccccCC-c
Confidence 35688999999999999999876 789999999998876544445556556555331 111100 00001112223 7
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
|+.|+|++|+++ .+|..+. ++|+.|+|++|++++.++. +.++++|+.|+|++|+|++..|..+..+++|+.|+|++
T Consensus 174 L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 250 (332)
T 2ft3_A 174 LNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN 250 (332)
T ss_dssp CSCCBCCSSBCS-SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCS
T ss_pred cCEEECcCCCCC-ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCC
Confidence 999999999999 5887775 7999999999999998864 88999999999999999987777999999999999999
Q ss_pred ccccccccccc--ccccccccccCccccc
Q 003039 422 NMLSGTVPSSL--LSKNVVLNYAGNINLH 448 (854)
Q Consensus 422 N~l~g~~p~~l--~~~~~~l~~~~n~~l~ 448 (854)
|+|+ .+|..+ +.+++.|++++|....
T Consensus 251 N~l~-~lp~~l~~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 251 NKLS-RVPAGLPDLKLLQVVYLHTNNITK 278 (332)
T ss_dssp SCCC-BCCTTGGGCTTCCEEECCSSCCCB
T ss_pred CcCe-ecChhhhcCccCCEEECCCCCCCc
Confidence 9999 899877 5678899999886543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=5.3e-13 Score=155.29 Aligned_cols=155 Identities=17% Similarity=0.218 Sum_probs=125.8
Q ss_pred cccceeeeecccCCCCC-CCcccchhhhceeccCCCCCccHHH--HHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCC
Q 003039 263 SLPFVLSFKFGKTYDSS-RGPLLNAMEINKYLERNDGSIDGVA--IVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP 339 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~-lpP~in~le~l~~L~l~~~~~~~~~--~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~ 339 (854)
.++.|+.|+|+.|.++. +|+.+..+..|+.|+++.|.+.... +..+ ..
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~-----------------------------~~ 372 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT-----------------------------TQ 372 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHH-----------------------------TT
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHH-----------------------------hh
Confidence 45677888888888887 5666888888888888888876421 1111 23
Q ss_pred CCCeeEEEecCCCCCccCCcc-cccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCcee
Q 003039 340 QPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~~-i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l 417 (854)
+++|+.|+|++|++++.+|.. +..+++|+.|+|++|++++.+|. +. ++|+.|+|++|+|+ .+|..+..+++|+.|
T Consensus 373 l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L 449 (520)
T 2z7x_B 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449 (520)
T ss_dssp CTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEE
Confidence 458999999999999768875 78899999999999999887764 33 79999999999999 899988899999999
Q ss_pred ecccccccccccccc---ccccccccccCccccccC
Q 003039 418 YVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 418 ~l~~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~ 450 (854)
+|++|+|+ .+|... +.++..|++++|+..|.+
T Consensus 450 ~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 450 NVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccC
Confidence 99999999 788873 556788999999988864
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.9e-13 Score=148.87 Aligned_cols=169 Identities=17% Similarity=0.213 Sum_probs=110.3
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.|+.|+++.|.++.+++ +..+..|+.|.++.|.+..... +..+..++.+... -|. ...+.. ...+++|
T Consensus 176 l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~---~n~---l~~~~~-~~~l~~L 245 (347)
T 4fmz_A 176 LTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIG---NNK---ITDLSP-LANLSQL 245 (347)
T ss_dssp CTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECC---SSC---CCCCGG-GTTCTTC
T ss_pred CCCCCEEEccCCccccccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEcc---CCc---cCCCcc-hhcCCCC
Confidence 4456666777777776666 6666667777776666554222 3334444443221 111 111111 2345678
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|++++ + +.+..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++..|..++.+++|+.|+|++|+
T Consensus 246 ~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 246 TWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp CEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred CEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence 888888888874 4 3577788888888888888775 557778888888888888887777778888888888888888
Q ss_pred cccccccccccccccccccCcc
Q 003039 424 LSGTVPSSLLSKNVVLNYAGNI 445 (854)
Q Consensus 424 l~g~~p~~l~~~~~~l~~~~n~ 445 (854)
+++..|-.-++++..|++++|+
T Consensus 323 l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 323 ITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp CCCCGGGGGCTTCSEESSSCC-
T ss_pred cccccChhhhhccceeehhhhc
Confidence 8866664446777777777775
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=5e-14 Score=155.63 Aligned_cols=171 Identities=18% Similarity=0.122 Sum_probs=85.0
Q ss_pred ceeeeecccCCCCCCCc-ccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeC-CCCCCCe
Q 003039 266 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN-SDPQPSI 343 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP-~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~-~~~~~~l 343 (854)
.++.|+|+.|.++.+|+ .+..+..|+.|+++.|.+....+..+..+..++.+...+ | ....+... ...+++|
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~---n---~l~~~~~~~~~~l~~L 126 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY---N---YLSNLSSSWFKPLSSL 126 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS---S---CCSSCCHHHHTTCTTC
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC---C---cCCcCCHhHhCCCccC
Confidence 56788888888888887 588888888888888877653222233332232221100 0 00111110 1223445
Q ss_pred eEEEecCCCCCccCCc--ccccCccCcEEeccCCC-CCCCCC-CCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 344 TVIHLSSKNLTGNIPS--DLTKLSSLVELWLDGNS-LTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~--~i~~l~~L~~L~L~~N~-l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
+.|+|++|+++ .+|. .+.++++|+.|+|++|+ +.+.++ .+.++++|+.|+|++|++++..|..+..+++|+.|++
T Consensus 127 ~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l 205 (353)
T 2z80_A 127 TFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205 (353)
T ss_dssp SEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEE
T ss_pred CEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecC
Confidence 55555555555 3333 44445555555555542 333333 2444555555555555555444555555555555555
Q ss_pred ccccccccccccc---ccccccccccCc
Q 003039 420 QNNMLSGTVPSSL---LSKNVVLNYAGN 444 (854)
Q Consensus 420 ~~N~l~g~~p~~l---~~~~~~l~~~~n 444 (854)
++|+++ .+|... +.+++.|++++|
T Consensus 206 ~~n~l~-~~~~~~~~~~~~L~~L~L~~n 232 (353)
T 2z80_A 206 HMKQHI-LLLEIFVDVTSSVECLELRDT 232 (353)
T ss_dssp ECSCST-THHHHHHHHTTTEEEEEEESC
T ss_pred CCCccc-cchhhhhhhcccccEEECCCC
Confidence 555544 344332 233444444444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=3.1e-13 Score=160.37 Aligned_cols=177 Identities=20% Similarity=0.189 Sum_probs=123.4
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQPS 342 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~~~ 342 (854)
++.|+.|+|+.|.++.+|+.+..+..|+.|++++|.+....+..+..+..++.+...+..--. .+.. ....+++
T Consensus 277 l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~-----~~~~~~~~~l~~ 351 (606)
T 3t6q_A 277 FSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL-----ELGTGCLENLEN 351 (606)
T ss_dssp CTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCC-----BCCSSTTTTCTT
T ss_pred ccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCccc-----ccchhhhhccCc
Confidence 567888999999999999989999999999999988876555566666666655332110000 0000 1234567
Q ss_pred eeEEEecCCCCCccC--CcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCcc-ccCCCCCceee
Q 003039 343 ITVIHLSSKNLTGNI--PSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSS-LMNLPNLRELY 418 (854)
Q Consensus 343 l~~L~L~~n~l~g~l--p~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~-l~~l~~L~~l~ 418 (854)
|+.|+|++|++++.. |..+.++++|+.|+|++|++.+.+|. +..+++|+.|+|++|++++..|.. +..+++|+.|+
T Consensus 352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 431 (606)
T 3t6q_A 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431 (606)
T ss_dssp CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEE
T ss_pred CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEE
Confidence 777888887777554 66777777788888887777776664 677777778888877777665543 77777777788
Q ss_pred cccccccccccccc--ccccccccccCcc
Q 003039 419 VQNNMLSGTVPSSL--LSKNVVLNYAGNI 445 (854)
Q Consensus 419 l~~N~l~g~~p~~l--~~~~~~l~~~~n~ 445 (854)
+++|.+++..|..+ +++++.|++++|.
T Consensus 432 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 460 (606)
T 3t6q_A 432 LSHSLLDISSEQLFDGLPALQHLNLQGNH 460 (606)
T ss_dssp CTTCCCBTTCTTTTTTCTTCCEEECTTCB
T ss_pred CCCCccCCcCHHHHhCCCCCCEEECCCCC
Confidence 87777776666555 5566777777774
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.5e-12 Score=128.76 Aligned_cols=131 Identities=18% Similarity=0.215 Sum_probs=81.3
Q ss_pred eeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEE
Q 003039 268 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 347 (854)
Q Consensus 268 ~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~ 347 (854)
+.+++..+.++.+|..+. +.++.|++++|++... .+- ....+++|+.|+
T Consensus 10 ~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~-------------------~~~----------~~~~l~~L~~L~ 58 (177)
T 2o6r_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSL-------------------PHG----------VFDKLTQLTKLS 58 (177)
T ss_dssp TEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCC-------------------CTT----------TTTTCTTCSEEE
T ss_pred CEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEe-------------------CHH----------HhcCcccccEEE
Confidence 345566777777765443 4666777776655430 000 012234677777
Q ss_pred ecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccc
Q 003039 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 426 (854)
Q Consensus 348 L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g 426 (854)
|++|+|++..+..+.++++|+.|+|++|+|++.++. +.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++++
T Consensus 59 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 59 LSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 777777744444466777777777777777776665 5667777777777777774444445667777777777777775
Q ss_pred ccc
Q 003039 427 TVP 429 (854)
Q Consensus 427 ~~p 429 (854)
..|
T Consensus 139 ~~~ 141 (177)
T 2o6r_A 139 SCP 141 (177)
T ss_dssp CHH
T ss_pred cCc
Confidence 554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=6.9e-14 Score=151.65 Aligned_cols=177 Identities=16% Similarity=0.079 Sum_probs=117.4
Q ss_pred cccceeeeecccCCCCCCCcc-c--chhhhceeccCCCCCccHH----HHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe
Q 003039 263 SLPFVLSFKFGKTYDSSRGPL-L--NAMEINKYLERNDGSIDGV----AIVSVISLYSSADWAQEGGDPCLPVPWSWLQC 335 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~-i--n~le~l~~L~l~~~~~~~~----~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c 335 (854)
.++.++.|+|+.|.++..+|. + ..+..|+.|+++.|.+... ....+..+..++.+...+ | ....+.|
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~---n---~l~~~~~ 162 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQ---A---HSPAFSC 162 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEEC---C---SSCCCCT
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeC---C---CcchhhH
Confidence 345678889999988865554 5 8888899999998887641 112223344444442211 1 0122222
Q ss_pred -CCCCCCCeeEEEecCCCCCcc--CC--cccccCccCcEEeccCCCCCCCCCC----CCCCCCccEEEeCCCccCCCCCc
Q 003039 336 -NSDPQPSITVIHLSSKNLTGN--IP--SDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLEDNQLTGPLPS 406 (854)
Q Consensus 336 -~~~~~~~l~~L~L~~n~l~g~--lp--~~i~~l~~L~~L~L~~N~l~~~~p~----~~~l~~L~~L~Ls~N~l~g~~P~ 406 (854)
....+++|+.|+|++|++.+. ++ ..+.++++|++|+|++|+|+...+. +.++++|++|+|++|+|++.+|.
T Consensus 163 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~ 242 (310)
T 4glp_A 163 EQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNP 242 (310)
T ss_dssp TSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCS
T ss_pred HHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchh
Confidence 123566788888888887652 32 2346778888888888888654332 35678888888888888877777
Q ss_pred cccCC---CCCceeeccccccccccccccccccccccccCccc
Q 003039 407 SLMNL---PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 446 (854)
Q Consensus 407 ~l~~l---~~L~~l~l~~N~l~g~~p~~l~~~~~~l~~~~n~~ 446 (854)
.++.+ ++|+.|+|++|+|+ .+|..+.++++.|++++|..
T Consensus 243 ~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l 284 (310)
T 4glp_A 243 SAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRL 284 (310)
T ss_dssp CCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCC
T ss_pred hHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcC
Confidence 77776 58888888888888 77877777778888877753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-12 Score=129.27 Aligned_cols=121 Identities=25% Similarity=0.276 Sum_probs=102.6
Q ss_pred CCCeeEeCCCC--------CCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCc
Q 003039 329 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399 (854)
Q Consensus 329 ~~~~~~c~~~~--------~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~ 399 (854)
.|..+.|+..+ .++|+.|+|++|++++..+..+.++++|+.|+|++|+|++.++. +.++++|+.|+|++|+
T Consensus 8 ~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp ETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 36677775432 35899999999999966666789999999999999999998887 6899999999999999
Q ss_pred cCCCCCccccCCCCCceeecccccccccccccc---ccccccccccCccccccC
Q 003039 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 400 l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~ 450 (854)
|++..|..+..+++|+.|+|++|+|+ .+|... +.++..|++++|+..|..
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence 99776677899999999999999999 666655 567788999999877643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=6.3e-13 Score=133.75 Aligned_cols=130 Identities=18% Similarity=0.172 Sum_probs=109.0
Q ss_pred eeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEE
Q 003039 268 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 347 (854)
Q Consensus 268 ~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~ 347 (854)
+.++++.|.++.+|+.+. ..++.|++++|.+... .. ....+++|+.|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~~i-----------p~-------------------~~~~l~~L~~L~ 60 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFTLV-----------PK-------------------ELSNYKHLTLID 60 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCCSC-----------CG-------------------GGGGCTTCCEEE
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCchh-----------HH-------------------HhhcccCCCEEE
Confidence 357788999999998764 5789999999987641 00 012356899999
Q ss_pred ecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccc
Q 003039 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 426 (854)
Q Consensus 348 L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g 426 (854)
|++|+|++..|..|.+|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 61 Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 61 LSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999999977777899999999999999999999885 8999999999999999995555579999999999999999985
Q ss_pred ccc
Q 003039 427 TVP 429 (854)
Q Consensus 427 ~~p 429 (854)
.-.
T Consensus 141 ~c~ 143 (193)
T 2wfh_A 141 DCN 143 (193)
T ss_dssp SGG
T ss_pred CCc
Confidence 443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=8.1e-13 Score=156.73 Aligned_cols=154 Identities=15% Similarity=0.148 Sum_probs=123.4
Q ss_pred cceeeeecccCCCCCCCc-ccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 265 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP-~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+.++.|+|+.|.++.+|| .+..+..|+.|+++.|.+... .|- ....+++|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i-------------------~~~----------~~~~l~~L 82 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI-------------------EDK----------AWHGLHHL 82 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEE-------------------CTT----------TTTTCTTC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCccccc-------------------CHH----------Hhhchhhc
Confidence 567889999999999998 599999999999999877641 000 11245689
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCccCC-CCCccccCCCCCceeeccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~l~l~~ 421 (854)
+.|+|++|++++..|..|++|++|++|+|++|++++.++ .++++++|++|+|++|++++ .+|..|+++++|+.|+|++
T Consensus 83 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~ 162 (606)
T 3vq2_A 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162 (606)
T ss_dssp CEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCS
T ss_pred CEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccC
Confidence 999999999997778899999999999999999998875 48889999999999999986 6799999999999999999
Q ss_pred ccccccccccc--cccc----ccccccCcccc
Q 003039 422 NMLSGTVPSSL--LSKN----VVLNYAGNINL 447 (854)
Q Consensus 422 N~l~g~~p~~l--~~~~----~~l~~~~n~~l 447 (854)
|++++..|..+ +.++ ..+++++|...
T Consensus 163 n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~ 194 (606)
T 3vq2_A 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194 (606)
T ss_dssp SCCCEECTTTTHHHHHCTTCCCEEECTTCCCC
T ss_pred CcceecChhhhhhhhccccccceeeccCCCcc
Confidence 99996555544 2222 35777777543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.38 E-value=2.7e-13 Score=130.15 Aligned_cols=127 Identities=17% Similarity=0.189 Sum_probs=101.7
Q ss_pred ccceeeeecccCCCC--CCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCC
Q 003039 264 LPFVLSFKFGKTYDS--SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 341 (854)
Q Consensus 264 l~~l~~l~l~~n~~s--~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~ 341 (854)
.++++.|+++.|.++ .+|+.+..+..|+.|+++.|.+... . ....++
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------~--------------------~~~~l~ 64 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-----------A--------------------NLPKLN 64 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-----------T--------------------TCCCCT
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-----------h--------------------hhhcCC
Confidence 356788899999998 8888888999999999988877641 0 012345
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCC--CCCCCCCCccEEEeCCCccCCCCC---ccccCCCCCce
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGPLP---SSLMNLPNLRE 416 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~Ls~N~l~g~~P---~~l~~l~~L~~ 416 (854)
+|+.|+|++|++++.+|..+.++++|+.|+|++|++++.+ +.+..+++|++|+|++|++++..+ ..+..+++|+.
T Consensus 65 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~ 144 (149)
T 2je0_A 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTY 144 (149)
T ss_dssp TCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCE
T ss_pred CCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccc
Confidence 8899999999999778888888999999999999998854 568889999999999999986544 47888889998
Q ss_pred eeccc
Q 003039 417 LYVQN 421 (854)
Q Consensus 417 l~l~~ 421 (854)
|++++
T Consensus 145 L~l~d 149 (149)
T 2je0_A 145 LDGYD 149 (149)
T ss_dssp ETTBC
T ss_pred ccCCC
Confidence 88764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.38 E-value=9e-13 Score=139.42 Aligned_cols=148 Identities=20% Similarity=0.210 Sum_probs=92.8
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.++.|++..|.++.+| .+..+..|+.|++++|++..... ...+++|
T Consensus 40 l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~-------------------------------l~~l~~L 87 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP-------------------------------LKDLTKL 87 (263)
T ss_dssp HTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-------------------------------GTTCSSC
T ss_pred cCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh-------------------------------hccCCCC
Confidence 456667777777777776 56667777777777776553110 1234567
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|+|+ .+|... . ++|+.|+|++|+|++. +.+..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|+
T Consensus 88 ~~L~L~~N~l~-~l~~~~-~-~~L~~L~L~~N~l~~~-~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~ 161 (263)
T 1xeu_A 88 EELSVNRNRLK-NLNGIP-S-ACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNE 161 (263)
T ss_dssp CEEECCSSCCS-CCTTCC-C-SSCCEEECCSSCCSBS-GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSC
T ss_pred CEEECCCCccC-CcCccc-c-CcccEEEccCCccCCC-hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCc
Confidence 77777777777 355422 2 6777777777777763 456777777777777777773 44 56777777777777777
Q ss_pred cccccccccccccccccccCcccccc
Q 003039 424 LSGTVPSSLLSKNVVLNYAGNINLHE 449 (854)
Q Consensus 424 l~g~~p~~l~~~~~~l~~~~n~~l~~ 449 (854)
+++.-.-.-+.++..|++++|+..+.
T Consensus 162 i~~~~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 162 ITNTGGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred CcchHHhccCCCCCEEeCCCCcccCC
Confidence 77441111145566667777655443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.3e-13 Score=161.36 Aligned_cols=91 Identities=24% Similarity=0.200 Sum_probs=54.1
Q ss_pred cccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccccccccc---cccc
Q 003039 361 LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKN 436 (854)
Q Consensus 361 i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l---~~~~ 436 (854)
+.+|++|+.|+|++|+|+..++. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+ +.++
T Consensus 532 ~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L 611 (680)
T 1ziw_A 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611 (680)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTC
T ss_pred hcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhccccccc
Confidence 44555555555555555544443 5666666666666666664333445666666666666666664333322 3556
Q ss_pred ccccccCccccccCC
Q 003039 437 VVLNYAGNINLHEGG 451 (854)
Q Consensus 437 ~~l~~~~n~~l~~~~ 451 (854)
..+++++|+..|.+.
T Consensus 612 ~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 612 TELDMRFNPFDCTCE 626 (680)
T ss_dssp SEEECTTCCCCBCCC
T ss_pred CEEEccCCCcccCCc
Confidence 677777887777664
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=7.2e-13 Score=143.61 Aligned_cols=155 Identities=20% Similarity=0.198 Sum_probs=121.2
Q ss_pred cccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 341 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~ 341 (854)
.++.|+.|+|+.|.++.+||. +..+..|+.|+++.|++..... +. ..-| ...++
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~------------~~~~-----------~~~l~ 197 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERG--LM------------AALC-----------PHKFP 197 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHH--HH------------TTSC-----------TTSSC
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchh--hh------------HHHh-----------hhcCC
Confidence 466889999999999999875 8899999999999998653110 00 0111 12356
Q ss_pred CeeEEEecCCCCCccCCcc----cccCccCcEEeccCCCCCCCCC-CCCCC---CCccEEEeCCCccCCCCCccccCCCC
Q 003039 342 SITVIHLSSKNLTGNIPSD----LTKLSSLVELWLDGNSLTGPIP-DFSGC---PDLRIIHLEDNQLTGPLPSSLMNLPN 413 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~----i~~l~~L~~L~L~~N~l~~~~p-~~~~l---~~L~~L~Ls~N~l~g~~P~~l~~l~~ 413 (854)
+|+.|+|++|+|+ .+|.. +.++++|++|+|++|+|++..| .+..+ ++|++|+|++|+|+ .+|..+. ++
T Consensus 198 ~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~ 273 (310)
T 4glp_A 198 AIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AK 273 (310)
T ss_dssp CCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SC
T ss_pred CCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CC
Confidence 8999999999998 45542 5788999999999999999854 46665 79999999999999 8898875 79
Q ss_pred Cceeecccccccccccc-ccccccccccccCcccc
Q 003039 414 LRELYVQNNMLSGTVPS-SLLSKNVVLNYAGNINL 447 (854)
Q Consensus 414 L~~l~l~~N~l~g~~p~-~l~~~~~~l~~~~n~~l 447 (854)
|+.|+|++|+|++ +|. .-+++++.|++++|+..
T Consensus 274 L~~L~Ls~N~l~~-~~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 274 LRVLDLSSNRLNR-APQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CSCEECCSCCCCS-CCCTTSCCCCSCEECSSTTTS
T ss_pred CCEEECCCCcCCC-CchhhhCCCccEEECcCCCCC
Confidence 9999999999995 333 23677889999999754
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=9.3e-13 Score=129.65 Aligned_cols=105 Identities=25% Similarity=0.314 Sum_probs=84.3
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
+.+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..|..|..+++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3567888888888 6887774 7888999999999888775 7888899999999999986555667888899999999
Q ss_pred ccccccccccc-c--ccccccccccCccccccC
Q 003039 421 NNMLSGTVPSS-L--LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 421 ~N~l~g~~p~~-l--~~~~~~l~~~~n~~l~~~ 450 (854)
+|+|+ .+|.. + +.++..|++++|+..|.+
T Consensus 87 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 87 DNQLK-SIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SSCCC-CCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCccC-EeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 99988 45554 3 566788888888887765
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.36 E-value=8.8e-13 Score=141.69 Aligned_cols=155 Identities=21% Similarity=0.260 Sum_probs=124.4
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.|+.|+|+.|.++.++| +..+..|+.|+++.|.+.. +..+..+..++.+... -|. ...+. ....+++|
T Consensus 67 l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~L~---~n~---i~~~~-~l~~l~~L 136 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD--LSSLKDLKKLKSLSLE---HNG---ISDIN-GLVHLPQL 136 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC--GGGGTTCTTCCEEECT---TSC---CCCCG-GGGGCTTC
T ss_pred CCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC--ChhhccCCCCCEEECC---CCc---CCCCh-hhcCCCCC
Confidence 5678899999999999998 9999999999999998876 3346666666665332 121 11111 12346799
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|++++ + +.+..+++|+.|+|++|+|++.++ +..+++|+.|+|++|+|+ .+|. +..+++|+.|+|++|+
T Consensus 137 ~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~-~l~~-l~~l~~L~~L~l~~n~ 211 (291)
T 1h6t_A 137 ESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQE 211 (291)
T ss_dssp CEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-BCGG-GTTCTTCSEEEEEEEE
T ss_pred CEEEccCCcCCc-c-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCC-CChh-hccCCCCCEEECcCCc
Confidence 999999999995 4 679999999999999999999877 999999999999999999 5664 9999999999999999
Q ss_pred ccccccccccc
Q 003039 424 LSGTVPSSLLS 434 (854)
Q Consensus 424 l~g~~p~~l~~ 434 (854)
++ ..|.....
T Consensus 212 i~-~~~~~~~~ 221 (291)
T 1h6t_A 212 CL-NKPINHQS 221 (291)
T ss_dssp EE-CCCEECCS
T ss_pred cc-CCcccccc
Confidence 98 56655433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.36 E-value=5.6e-13 Score=138.63 Aligned_cols=149 Identities=19% Similarity=0.124 Sum_probs=103.0
Q ss_pred ceeeeecccCCCCCCCc-ccchhhhceeccCCCCC-ccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 266 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGS-IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP-~in~le~l~~L~l~~~~-~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
.++.|+|+.|.++.+|+ .+..+..|+.|+++.|. +..+.... ...+++|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~-----------------------------f~~l~~L 82 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS-----------------------------FYNLSKV 82 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTT-----------------------------EESCTTC
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhH-----------------------------cCCCcCC
Confidence 56788889999999988 48888999999998886 65311000 0123467
Q ss_pred eEEEecC-CCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCcc---EEEeCCC-ccCCCCCccccCCCCCc-ee
Q 003039 344 TVIHLSS-KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR---IIHLEDN-QLTGPLPSSLMNLPNLR-EL 417 (854)
Q Consensus 344 ~~L~L~~-n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~---~L~Ls~N-~l~g~~P~~l~~l~~L~-~l 417 (854)
+.|+|++ |+|++..+..|.++++|+.|+|++|++++ +|.+..+++|+ .|+|++| ++++..+..|..+++|+ .|
T Consensus 83 ~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L 161 (239)
T 2xwt_C 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161 (239)
T ss_dssp CEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEE
T ss_pred cEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcceeEE
Confidence 7777777 77775444567777777777777777776 34466666666 7777777 77754445677777777 77
Q ss_pred eccccccccccccccc--cccccccccCcc
Q 003039 418 YVQNNMLSGTVPSSLL--SKNVVLNYAGNI 445 (854)
Q Consensus 418 ~l~~N~l~g~~p~~l~--~~~~~l~~~~n~ 445 (854)
++++|+++ .+|...+ .+++.|++++|.
T Consensus 162 ~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp ECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred EcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 77777777 6766543 245666677664
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.2e-12 Score=130.02 Aligned_cols=131 Identities=12% Similarity=0.205 Sum_probs=107.0
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+++|+.|+|+.|.++.++ .+..+..|+.|+++.|.+.... ... ...+++|
T Consensus 65 l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~~---------~~~--------------------l~~l~~L 114 (197)
T 4ezg_A 65 AHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDK---------IPN--------------------LSGLTSL 114 (197)
T ss_dssp CTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGGG---------SCC--------------------CTTCTTC
T ss_pred CCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCccc---------Chh--------------------hcCCCCC
Confidence 457899999999887764 7888999999999999876410 000 1235689
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|++++..|..+.++++|+.|+|++|.+.+.+|.+..+++|+.|+|++|++++ ++ .+..+++|+.|++++|+
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 99999999999889999999999999999999944445689999999999999999995 65 79999999999999999
Q ss_pred ccc
Q 003039 424 LSG 426 (854)
Q Consensus 424 l~g 426 (854)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 873
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.1e-13 Score=156.04 Aligned_cols=171 Identities=13% Similarity=-0.008 Sum_probs=101.9
Q ss_pred ccceeeeecccCCCCCCCc-ccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeE--------
Q 003039 264 LPFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-------- 334 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP-~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~-------- 334 (854)
.+.|+.|+|+.|.++.+|| .|..+..|+.|++++|.+..... +..+..+..+... -| ...++.
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls---~N---~l~~l~~~~~L~~L 104 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN---NN---YVQELLVGPSIETL 104 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECC---SS---EEEEEEECTTCCEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEec---CC---cCCCCCCCCCcCEE
Confidence 3478999999999999987 59999999999999999864222 5555555555321 11 012222
Q ss_pred -eCCCCC--------CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CC-CCCCccEEEeCCCccCCC
Q 003039 335 -CNSDPQ--------PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FS-GCPDLRIIHLEDNQLTGP 403 (854)
Q Consensus 335 -c~~~~~--------~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~-~l~~L~~L~Ls~N~l~g~ 403 (854)
.+...+ ++|+.|+|++|+|++..|..++++++|+.|+|++|.|++.+|. +. .+++|+.|+|++|+|++.
T Consensus 105 ~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 105 HAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp ECCSSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred ECcCCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 111111 2345556666666655555666666666666666666665443 33 466666666666666643
Q ss_pred CCccccCCCCCceeecccccccccccccc--ccccccccccCcc
Q 003039 404 LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 445 (854)
Q Consensus 404 ~P~~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n~ 445 (854)
|. +..+++|+.|+|++|+|++ +|..+ +.++..|++++|.
T Consensus 185 -~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~ 225 (487)
T 3oja_A 185 -KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225 (487)
T ss_dssp -EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSC
T ss_pred -cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCc
Confidence 22 3346666666666666663 33333 4455666666654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2e-12 Score=155.63 Aligned_cols=162 Identities=14% Similarity=0.071 Sum_probs=113.3
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCCCC
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQPS 342 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~~~ 342 (854)
+.++.|+|+.|.++.+|+. +..+..|+.|+++.|.+....+..+.++..++.+...+ |. ...+.. ....+++
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~---n~---l~~l~~~~~~~l~~ 98 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH---NE---LSQLSDKTFAFCTN 98 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS---SC---CCCCCTTTTTTCTT
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC---Cc---cCccChhhhccCCC
Confidence 4678899999999999986 99999999999999988776666666666666553321 10 112221 1334567
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCcccc--CCCCCceeec
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLM--NLPNLRELYV 419 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~--~l~~L~~l~l 419 (854)
|+.|+|++|++++..|..|++|++|++|+|++|++++.+|. +.++++|++|+|++|++++..|..+. .+++|+.|++
T Consensus 99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 178 (680)
T 1ziw_A 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178 (680)
T ss_dssp CSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEEC
T ss_pred CCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEEC
Confidence 77777777777755556777777777777777777776664 66777777777777777765555543 4567777777
Q ss_pred ccccccccccccc
Q 003039 420 QNNMLSGTVPSSL 432 (854)
Q Consensus 420 ~~N~l~g~~p~~l 432 (854)
++|++++..|..+
T Consensus 179 ~~n~l~~~~~~~~ 191 (680)
T 1ziw_A 179 SSNQIKEFSPGCF 191 (680)
T ss_dssp TTCCCCCBCTTGG
T ss_pred CCCcccccChhhh
Confidence 7777775555433
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.8e-12 Score=126.74 Aligned_cols=104 Identities=22% Similarity=0.349 Sum_probs=89.2
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
-+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 478999999998 8998875 8999999999999999875 88899999999999999965555678999999999999
Q ss_pred cccccccccc-c--ccccccccccCccccccC
Q 003039 422 NMLSGTVPSS-L--LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 422 N~l~g~~p~~-l--~~~~~~l~~~~n~~l~~~ 450 (854)
|+|+ .+|.. + +.++..|++++|+..|.+
T Consensus 91 N~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 91 NHLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp SCCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred Cccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 9999 66665 3 567788999999988765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.34 E-value=3.7e-12 Score=125.36 Aligned_cols=89 Identities=27% Similarity=0.328 Sum_probs=80.9
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 4789999999999987788999999999999999999999887 689999999999999999766667999999999999
Q ss_pred cccccccccc
Q 003039 420 QNNMLSGTVP 429 (854)
Q Consensus 420 ~~N~l~g~~p 429 (854)
++|+++...+
T Consensus 110 ~~N~~~c~c~ 119 (170)
T 3g39_A 110 LNNPWDCACS 119 (170)
T ss_dssp CSSCBCTTBG
T ss_pred CCCCCCCCch
Confidence 9999995443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=2e-12 Score=159.61 Aligned_cols=161 Identities=16% Similarity=0.069 Sum_probs=83.7
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCc-cHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeE-eCCCCCC
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSI-DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQP 341 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~-~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~-c~~~~~~ 341 (854)
+.++.|+|+.|.++.++|. +..+..|+.|+++.|.. ..+.+.++..+..++.+...+ | ....+. -....++
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~---N---~l~~~~p~~~~~l~ 97 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS---S---KIYFLHPDAFQGLF 97 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT---C---CCCEECTTSSCSCS
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC---C---cCcccCHhHccCCc
Confidence 5678888999999888654 88999999999988743 221122333333333332110 0 011111 1122344
Q ss_pred CeeEEEecCCCCCccCCcc--cccCccCcEEeccCCCCCCCCC--CCCCCCCccEEEeCCCccCCCCCccccCC--CCCc
Q 003039 342 SITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSSLMNL--PNLR 415 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~--i~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l--~~L~ 415 (854)
+|+.|+|++|+|++.+|.. |.+|++|+.|+|++|++++..+ .|++|++|++|+|++|++++..|..++.+ ++|+
T Consensus 98 ~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~ 177 (844)
T 3j0a_A 98 HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS 177 (844)
T ss_dssp SCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSC
T ss_pred ccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccc
Confidence 5555555555555444443 5555555555555555554433 24555555555555555555555555544 4555
Q ss_pred eeeccccccccccccc
Q 003039 416 ELYVQNNMLSGTVPSS 431 (854)
Q Consensus 416 ~l~l~~N~l~g~~p~~ 431 (854)
.|+|++|.+++.+|..
T Consensus 178 ~L~L~~n~l~~~~~~~ 193 (844)
T 3j0a_A 178 FFSLAANSLYSRVSVD 193 (844)
T ss_dssp CCEECCSBSCCCCCCC
T ss_pred eEECCCCccccccccc
Confidence 5555555555444443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.9e-12 Score=150.53 Aligned_cols=153 Identities=16% Similarity=0.150 Sum_probs=122.9
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
..++.|+|+.|.++.+++. +..+..|+.|+++.|++.... +- ....+++|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~-------------------~~----------~~~~l~~L 78 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE-------------------DG----------AYQSLSHL 78 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEEC-------------------TT----------TTTTCTTC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccC-------------------cc----------cccCchhC
Confidence 3578899999999999875 999999999999999776410 00 01235689
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCccCC-CCCccccCCCCCceeeccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~l~l~~ 421 (854)
+.|+|++|++++..|..|.+|++|++|+|++|++++.++ .++++++|++|+|++|++++ .+|..|+++++|+.|++++
T Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~ 158 (570)
T 2z63_A 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158 (570)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTT
T ss_pred CEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcC
Confidence 999999999997777889999999999999999998777 48899999999999999986 4799999999999999999
Q ss_pred ccccccccccc--cccc----ccccccCccc
Q 003039 422 NMLSGTVPSSL--LSKN----VVLNYAGNIN 446 (854)
Q Consensus 422 N~l~g~~p~~l--~~~~----~~l~~~~n~~ 446 (854)
|++++..|..+ +.++ ..+++++|..
T Consensus 159 n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l 189 (570)
T 2z63_A 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189 (570)
T ss_dssp SCCCEECGGGGHHHHTCTTCCCEEECTTCCC
T ss_pred CccceecHHHccchhccchhhhhcccCCCCc
Confidence 99995555544 3344 5567777754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.6e-12 Score=151.15 Aligned_cols=144 Identities=13% Similarity=0.032 Sum_probs=95.5
Q ss_pred eeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEE
Q 003039 268 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 347 (854)
Q Consensus 268 ~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~ 347 (854)
+.|+++.|.++.+|+.+. +.++.|+++.|.+....+..+. .+++|+.|+
T Consensus 3 ~~l~ls~n~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~-----------------------------~l~~L~~L~ 51 (520)
T 2z7x_B 3 FLVDRSKNGLIHVPKDLS--QKTTILNISQNYISELWTSDIL-----------------------------SLSKLRILI 51 (520)
T ss_dssp CEEECTTSCCSSCCCSCC--TTCSEEECCSSCCCCCCHHHHT-----------------------------TCTTCCEEE
T ss_pred ceEecCCCCccccccccc--ccccEEECCCCcccccChhhcc-----------------------------ccccccEEe
Confidence 467788888888888766 7888888888877653222222 234677777
Q ss_pred ecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCC-CCCccccCCCCCceeecccccccc
Q 003039 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSG 426 (854)
Q Consensus 348 L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~l~l~~N~l~g 426 (854)
|++|+|++..|..|.+|++|++|+|++|+|++.++. .+++|++|+|++|+|++ .+|..|+++++|+.|+|++|++++
T Consensus 52 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~ 129 (520)
T 2z7x_B 52 ISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129 (520)
T ss_dssp CCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG
T ss_pred cCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch
Confidence 777777766666777777777777777777744333 67777777777777775 466777777777777777777764
Q ss_pred cccccccccc--ccccccCcc
Q 003039 427 TVPSSLLSKN--VVLNYAGNI 445 (854)
Q Consensus 427 ~~p~~l~~~~--~~l~~~~n~ 445 (854)
..-.-+.++ +.|++++|.
T Consensus 130 -~~~~~l~~L~L~~L~l~~n~ 149 (520)
T 2z7x_B 130 -SSVLPIAHLNISKVLLVLGE 149 (520)
T ss_dssp -GGGGGGTTSCEEEEEEEECT
T ss_pred -hhccccccceeeEEEeeccc
Confidence 222223444 566666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.1e-13 Score=163.47 Aligned_cols=89 Identities=33% Similarity=0.392 Sum_probs=48.3
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
+|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|+.+++.|++|++|++|+|++|+|+ .+|..|++|++|+.|+|++
T Consensus 248 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~ 325 (727)
T 4b8c_D 248 FLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEG 325 (727)
T ss_dssp SCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTT
T ss_pred CCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCC
Confidence 4555555555555 5555555555555555555555543334555555555555555554 4555555555555555555
Q ss_pred ccccccccccc
Q 003039 422 NMLSGTVPSSL 432 (854)
Q Consensus 422 N~l~g~~p~~l 432 (854)
|+|+|.+|..+
T Consensus 326 N~l~~~~p~~~ 336 (727)
T 4b8c_D 326 NPLEKQFLKIL 336 (727)
T ss_dssp SCCCSHHHHHH
T ss_pred CccCCCChHHH
Confidence 55555554443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.1e-12 Score=158.51 Aligned_cols=159 Identities=23% Similarity=0.270 Sum_probs=97.6
Q ss_pred cccccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCC
Q 003039 261 NLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 340 (854)
Q Consensus 261 ~~~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~ 340 (854)
..+.+.++.|+|..|.+...|.. .++.+.|+.|.+....+. |.. .....-....+
T Consensus 169 ~~s~~~~~~l~L~~n~~~~~~~~-----~l~~l~Ls~~~i~~~~~~------------------~n~--~~~~~~~~~~l 223 (727)
T 4b8c_D 169 AVSTPLTPKIELFANGKDEANQA-----LLQHKKLSQYSIDEDDDI------------------ENR--MVMPKDSKYDD 223 (727)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred eecCCccceEEeeCCCCCcchhh-----HhhcCccCcccccCcccc------------------ccc--eecChhhhccC
Confidence 34445677888888888776544 355566666665542110 000 00001112346
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecc
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 420 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~ 420 (854)
+.|+.|+|++|+|. .+|..+++|++|+.|+|++|+|+.+++.|++|++|++|+|++|+|+ .+|..|++|++|+.|+|+
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301 (727)
T ss_dssp CCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred CCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence 78999999999999 8999999999999999999999966667999999999999999999 899999999999999999
Q ss_pred cccccccccccc--ccccccccccCcccc
Q 003039 421 NNMLSGTVPSSL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 421 ~N~l~g~~p~~l--~~~~~~l~~~~n~~l 447 (854)
+|.|+ .+|..+ +.++..|++++|...
T Consensus 302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp SSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 99998 999887 677899999999643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.7e-12 Score=153.30 Aligned_cols=155 Identities=22% Similarity=0.266 Sum_probs=123.6
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.|+.|+|+.|.++.+|| +..+..|+.|.|+.|.+.. +..+..+..+..+... -|. ...+. ....+++|
T Consensus 64 l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~--l~~l~~l~~L~~L~Ls---~N~---l~~l~-~l~~l~~L 133 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKD--LSSLKDLKKLKSLSLE---HNG---ISDIN-GLVHLPQL 133 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCC--CTTSTTCTTCCEEECT---TSC---CCCCG-GGGGCTTC
T ss_pred CCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCC--ChhhccCCCCCEEEec---CCC---CCCCc-cccCCCcc
Confidence 5678999999999999998 8999999999999998875 2345555555555332 121 11111 12356799
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|+|++ + +.|..|++|+.|+|++|+|++.+| +..|++|+.|+|++|+|++ +| .|..|++|+.|+|++|+
T Consensus 134 ~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 134 ESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQE 208 (605)
T ss_dssp SEEECCSSCCCC-C-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEE
T ss_pred CEEECCCCccCC-c-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCc
Confidence 999999999995 4 679999999999999999999888 9999999999999999995 54 69999999999999999
Q ss_pred ccccccccccc
Q 003039 424 LSGTVPSSLLS 434 (854)
Q Consensus 424 l~g~~p~~l~~ 434 (854)
++ ..|...+.
T Consensus 209 l~-~~p~~~~~ 218 (605)
T 1m9s_A 209 CL-NKPINHQS 218 (605)
T ss_dssp EE-CCCCCCCS
T ss_pred Cc-CCcccccc
Confidence 99 45544433
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.32 E-value=6e-12 Score=124.38 Aligned_cols=90 Identities=23% Similarity=0.321 Sum_probs=80.7
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 4799999999999987788999999999999999999998887 688999999999999999655556999999999999
Q ss_pred cccccccccccc
Q 003039 420 QNNMLSGTVPSS 431 (854)
Q Consensus 420 ~~N~l~g~~p~~ 431 (854)
++|++. ..|..
T Consensus 113 ~~N~~~-c~~~~ 123 (174)
T 2r9u_A 113 YNNPWD-CECRD 123 (174)
T ss_dssp CSSCBC-TTBGG
T ss_pred CCCCcc-ccccc
Confidence 999999 55543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.32 E-value=2.5e-12 Score=126.00 Aligned_cols=105 Identities=22% Similarity=0.256 Sum_probs=89.2
Q ss_pred CCCeeEEEecCCCCC-ccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 340 QPSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~-g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
+++|+.|+|++|+++ |.+|..+..+++|+.|+|++|+|++. +.+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 457999999999998 88898889999999999999999887 7788899999999999999977888888899999999
Q ss_pred ccccccccccc--ccc--ccccccccccCccc
Q 003039 419 VQNNMLSGTVP--SSL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 419 l~~N~l~g~~p--~~l--~~~~~~l~~~~n~~ 446 (854)
|++|+|+ .+| ..+ +.++..|++++|+.
T Consensus 102 Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l 132 (168)
T 2ell_A 102 LSGNKLK-DISTLEPLKKLECLKSLDLFNCEV 132 (168)
T ss_dssp CBSSSCC-SSGGGGGGSSCSCCCEEECCSSGG
T ss_pred ccCCccC-cchhHHHHhcCCCCCEEEeeCCcC
Confidence 9999998 444 344 56778888888853
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.8e-12 Score=150.45 Aligned_cols=89 Identities=26% Similarity=0.297 Sum_probs=82.7
Q ss_pred CCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCC-CccccCCCCCcee
Q 003039 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL-PSSLMNLPNLREL 417 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~-P~~l~~l~~L~~l 417 (854)
.+++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|+++ |.+++|++|+.|+|++|+|++.+ |..|+.|++|+.|
T Consensus 461 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred ccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCC-cccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 3568999999999999 9999999999999999999999984 58999999999999999999776 9999999999999
Q ss_pred eccccccccccc
Q 003039 418 YVQNNMLSGTVP 429 (854)
Q Consensus 418 ~l~~N~l~g~~p 429 (854)
+|++|+|++..|
T Consensus 539 ~L~~N~l~~~~~ 550 (567)
T 1dce_A 539 NLQGNSLCQEEG 550 (567)
T ss_dssp ECTTSGGGGSSS
T ss_pred EecCCcCCCCcc
Confidence 999999995544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.31 E-value=1.9e-12 Score=124.14 Aligned_cols=106 Identities=19% Similarity=0.204 Sum_probs=91.5
Q ss_pred CCCeeEEEecCCCCC-ccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 340 QPSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~-g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
.++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++. +.+.++++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 357999999999998 88999899999999999999999988 7789999999999999999977888888899999999
Q ss_pred ccccccccc-ccccc--ccccccccccCccc
Q 003039 419 VQNNMLSGT-VPSSL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 419 l~~N~l~g~-~p~~l--~~~~~~l~~~~n~~ 446 (854)
+++|++++. .|..+ ++++..|++++|..
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGG
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcc
Confidence 999999952 23444 66778889988853
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.2e-13 Score=146.88 Aligned_cols=153 Identities=16% Similarity=0.152 Sum_probs=117.0
Q ss_pred ccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
+++|+.|+|+.|.++.++|. +..+..|+.|+++.|.+....+. .+ ...+++
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---------~~-------------------~~~l~~ 170 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA---------EL-------------------AASSDT 170 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG---------GG-------------------GGGTTT
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH---------HH-------------------hhccCc
Confidence 45567777777777777764 67777777777777766531000 00 013468
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N 422 (854)
|+.|+|++|+|++ +|. ...+++|+.|+|++|+|++.++.+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus 171 L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N 247 (317)
T 3o53_A 171 LEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247 (317)
T ss_dssp CCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTC
T ss_pred CCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCC
Confidence 9999999999994 443 44699999999999999999888999999999999999999 68999999999999999999
Q ss_pred ccc-ccccccc--ccccccccccCcccc
Q 003039 423 MLS-GTVPSSL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 423 ~l~-g~~p~~l--~~~~~~l~~~~n~~l 447 (854)
+++ +.+|..+ +..+..+++.++..+
T Consensus 248 ~~~~~~~~~~~~~~~~L~~l~l~~~~~l 275 (317)
T 3o53_A 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKL 275 (317)
T ss_dssp CCBHHHHHHHHHTCHHHHHHHHHHHHHH
T ss_pred CccCcCHHHHHhccccceEEECCCchhc
Confidence 998 6666655 445566666655443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.2e-12 Score=140.44 Aligned_cols=169 Identities=17% Similarity=0.197 Sum_probs=121.3
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+++|+.|++..|.++.+++ +..+..|+.|+++.|.+..... +..+..+...... -|. ...+.. ...+++|
T Consensus 154 l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~---~n~---l~~~~~-~~~~~~L 223 (347)
T 4fmz_A 154 MTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAY---VNQ---ITDITP-VANMTRL 223 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECC---SSC---CCCCGG-GGGCTTC
T ss_pred CCCCcEEEecCCCcCCchh-hccCCCCCEEEccCCccccccc--ccCCCccceeecc---cCC---CCCCch-hhcCCcC
Confidence 4567778888888888777 7777888888888777654222 4444444443221 111 111111 2345689
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|+++ .+|. +..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++ + +.+..+++|+.|+|++|+
T Consensus 224 ~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~ 298 (347)
T 4fmz_A 224 NSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQ 298 (347)
T ss_dssp CEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSC
T ss_pred CEEEccCCccC-CCcc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCc
Confidence 99999999998 4555 88899999999999998874 668888999999999999985 4 458888999999999999
Q ss_pred ccccccccc--ccccccccccCcccc
Q 003039 424 LSGTVPSSL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 424 l~g~~p~~l--~~~~~~l~~~~n~~l 447 (854)
+++..|..+ +++++.|++++|+..
T Consensus 299 l~~~~~~~l~~l~~L~~L~L~~n~l~ 324 (347)
T 4fmz_A 299 LGNEDMEVIGGLTNLTTLFLSQNHIT 324 (347)
T ss_dssp CCGGGHHHHHTCTTCSEEECCSSSCC
T ss_pred CCCcChhHhhccccCCEEEccCCccc
Confidence 987666655 667788888888643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4.7e-13 Score=156.71 Aligned_cols=174 Identities=17% Similarity=0.128 Sum_probs=90.1
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeC-CCCCCC
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN-SDPQPS 342 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~-~~~~~~ 342 (854)
..++.|+|+.|.++.++|. +..+..|+.|+++.|.+....+.++..+..++.+...+ |. ..++... ...+++
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~---n~---l~~~~~~~~~~l~~ 99 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD---NH---LSSLSSSWFGPLSS 99 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT---SC---CCSCCHHHHTTCTT
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC---Cc---cCccCHHHhccCCC
Confidence 3567777888888777654 77778888888887776653333333333333321110 00 1111100 123345
Q ss_pred eeEEEecCCCCCc-cCCcccccCccCcEEeccCCCCCCCCC--CCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 343 ITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 343 l~~L~L~~n~l~g-~lp~~i~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
|+.|+|++|++++ .+|..+++|++|+.|+|++|++.+.+| .+.++++|++|+|++|++++.+|..++.+++|+.|++
T Consensus 100 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l 179 (549)
T 2z81_A 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179 (549)
T ss_dssp CCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEE
T ss_pred CcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEec
Confidence 5555555555553 234455555555555555555333222 2555555555555555555555555555555555555
Q ss_pred ccccccccccccc---ccccccccccCcc
Q 003039 420 QNNMLSGTVPSSL---LSKNVVLNYAGNI 445 (854)
Q Consensus 420 ~~N~l~g~~p~~l---~~~~~~l~~~~n~ 445 (854)
++|.+. .+|..+ +.+++.|++++|.
T Consensus 180 ~~n~~~-~~~~~~~~~l~~L~~L~L~~n~ 207 (549)
T 2z81_A 180 HLSESA-FLLEIFADILSSVRYLELRDTN 207 (549)
T ss_dssp ECSBST-THHHHHHHSTTTBSEEEEESCB
T ss_pred ccCccc-ccchhhHhhcccccEEEccCCc
Confidence 555554 444433 3455566666654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.2e-12 Score=135.20 Aligned_cols=132 Identities=15% Similarity=0.202 Sum_probs=112.8
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+++|+.|+|+.|.++.+|| +..+..|+.|+++.|++.. . ++. . . ++|
T Consensus 62 l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~--------------l-----~~~-----~-------~-~~L 108 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN--------------L-----NGI-----P-------S-ACL 108 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC--------------C-----TTC-----C-------C-SSC
T ss_pred CCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC--------------c-----Ccc-----c-------c-Ccc
Confidence 5688999999999999999 9999999999999998764 0 111 0 1 489
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|+|++ +| .+.+|++|+.|+|++|+|++. +.+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+
T Consensus 109 ~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~ 183 (263)
T 1xeu_A 109 SRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK 183 (263)
T ss_dssp CEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred cEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence 999999999995 55 699999999999999999986 5789999999999999999965 679999999999999999
Q ss_pred ccccccccccc
Q 003039 424 LSGTVPSSLLS 434 (854)
Q Consensus 424 l~g~~p~~l~~ 434 (854)
++ ..|.....
T Consensus 184 ~~-~~~~~~~~ 193 (263)
T 1xeu_A 184 CV-NEPVKYQP 193 (263)
T ss_dssp EE-CCCEECCS
T ss_pred cc-CCcccccc
Confidence 99 44655433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3e-12 Score=157.89 Aligned_cols=106 Identities=22% Similarity=0.231 Sum_probs=85.2
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
++|+.|+|++|.+++..|..+..+++|+.|+|++|++++.+|. |.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 345 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEEC
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEEC
Confidence 5788888888888877788888888888888888888887774 788888888888888888777888888888888888
Q ss_pred ccccccccccccc--ccccccccccCccc
Q 003039 420 QNNMLSGTVPSSL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 420 ~~N~l~g~~p~~l--~~~~~~l~~~~n~~ 446 (854)
++|++++..|..+ +.+++.|++++|..
T Consensus 346 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 374 (844)
T 3j0a_A 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374 (844)
T ss_dssp CSCCCCCCCSSCSCSCCCCCEEEEETCCS
T ss_pred CCCCCCccChhhhcCCCCCCEEECCCCCC
Confidence 8888884444333 55667777777753
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.30 E-value=7e-12 Score=146.59 Aligned_cols=145 Identities=18% Similarity=0.144 Sum_probs=79.6
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+++|+.|+|+.|.++.+|+ +.. .|+.|++++|.+..+.. .+..+..+...+ | ...+++. .+++|
T Consensus 99 l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~---N---~l~~lp~---~l~~L 162 (571)
T 3cvr_A 99 PASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTMLPE----LPALLEYINADN---N---QLTMLPE---LPTSL 162 (571)
T ss_dssp CTTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSCCCC----CCTTCCEEECCS---S---CCSCCCC---CCTTC
T ss_pred cCCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCCCCC----cCccccEEeCCC---C---ccCcCCC---cCCCc
Confidence 3567888888888888888 555 78888888887764111 112222221100 0 0111111 23456
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCc-------cEEEeCCCccCCCCCccccCCCCCce
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL-------RIIHLEDNQLTGPLPSSLMNLPNLRE 416 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L-------~~L~Ls~N~l~g~~P~~l~~l~~L~~ 416 (854)
+.|+|++|+|++ +|. |. ++|+.|+|++|+|+..++ +.. +| +.|+|++|+|+ .+|..+..+++|+.
T Consensus 163 ~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~ 234 (571)
T 3cvr_A 163 EVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234 (571)
T ss_dssp CEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEE
T ss_pred CEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCE
Confidence 666666666663 555 44 566666666666664333 333 44 66666666666 45665555666666
Q ss_pred eecccccccccccccc
Q 003039 417 LYVQNNMLSGTVPSSL 432 (854)
Q Consensus 417 l~l~~N~l~g~~p~~l 432 (854)
|+|++|+|+|.+|..+
T Consensus 235 L~L~~N~l~~~~p~~l 250 (571)
T 3cvr_A 235 IILEDNPLSSRIRESL 250 (571)
T ss_dssp EECCSSSCCHHHHHHH
T ss_pred EEeeCCcCCCcCHHHH
Confidence 6666666665555554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.29 E-value=5.2e-12 Score=144.95 Aligned_cols=104 Identities=24% Similarity=0.289 Sum_probs=67.2
Q ss_pred CCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
.+++|+.|+|++|++++ +++ +..+++|+.|+|++|++++.+| +..+++|+.|+|++|++++. ..+..+++|+.|+
T Consensus 285 ~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 359 (466)
T 1o6v_A 285 GLTALTNLELNENQLED-ISP-ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLS 359 (466)
T ss_dssp TCTTCSEEECCSSCCSC-CGG-GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred CCCccCeEEcCCCcccC-chh-hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCCCCCEEe
Confidence 34566666666666664 332 6666777777777777766655 56667777777777777643 3566777777777
Q ss_pred ccccccccccccccccccccccccCcccc
Q 003039 419 VQNNMLSGTVPSSLLSKNVVLNYAGNINL 447 (854)
Q Consensus 419 l~~N~l~g~~p~~l~~~~~~l~~~~n~~l 447 (854)
+++|++++..|..-+.++..|++++|+..
T Consensus 360 l~~n~l~~~~~~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 360 AGHNQISDLTPLANLTRITQLGLNDQAWT 388 (466)
T ss_dssp CCSSCCCBCGGGTTCTTCCEEECCCEEEE
T ss_pred CCCCccCccchhhcCCCCCEEeccCCccc
Confidence 77777776666444566666666666544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.28 E-value=2.3e-13 Score=152.18 Aligned_cols=181 Identities=14% Similarity=0.133 Sum_probs=135.3
Q ss_pred cccceeeeecccCCCCC-----CCcccchhhhceeccCCCCCccHHHHHHHHhh-------------cCCCCccCCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISL-------------YSSADWAQEGGDP 324 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~-----lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l-------------~~~~~w~~~~~~p 324 (854)
.++.|+.|+|+.|.++. +|..+..+..|+.|++++|.+....+..+... ..++.+... -
T Consensus 92 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~---~ 168 (386)
T 2ca6_A 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG---R 168 (386)
T ss_dssp TCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECC---S
T ss_pred hCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECC---C
Confidence 35788999999999998 77889999999999999999976655555543 566665331 1
Q ss_pred CCCCCCCeeE---eCCCCCCCeeEEEecCCCCC--c---cCCcccccCccCcEEeccCCCCC----CCCC-CCCCCCCcc
Q 003039 325 CLPVPWSWLQ---CNSDPQPSITVIHLSSKNLT--G---NIPSDLTKLSSLVELWLDGNSLT----GPIP-DFSGCPDLR 391 (854)
Q Consensus 325 c~~~~~~~~~---c~~~~~~~l~~L~L~~n~l~--g---~lp~~i~~l~~L~~L~L~~N~l~----~~~p-~~~~l~~L~ 391 (854)
|. ....++. -....+++|+.|+|++|+|+ | .+|..+.++++|+.|+|++|.|+ +.+| .+..+++|+
T Consensus 169 n~-l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~ 247 (386)
T 2ca6_A 169 NR-LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 247 (386)
T ss_dssp SC-CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred CC-CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcC
Confidence 21 0001111 01123458999999999998 3 35558889999999999999995 4444 478899999
Q ss_pred EEEeCCCccCCC----CCccc--cCCCCCceeecccccccc----cccccc---ccccccccccCcccc
Q 003039 392 IIHLEDNQLTGP----LPSSL--MNLPNLRELYVQNNMLSG----TVPSSL---LSKNVVLNYAGNINL 447 (854)
Q Consensus 392 ~L~Ls~N~l~g~----~P~~l--~~l~~L~~l~l~~N~l~g----~~p~~l---~~~~~~l~~~~n~~l 447 (854)
.|+|++|+|++. +|..+ +.+++|+.|+|++|+|++ .+|..+ ++++..|++++|+..
T Consensus 248 ~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 248 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred EEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 999999999865 57777 348999999999999996 488877 577888999988643
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=141.86 Aligned_cols=159 Identities=18% Similarity=0.173 Sum_probs=97.2
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.|+.|+|+.|.++.+| +..+..|+.|+++.|.+... .+..+..+..+... -|.. ...+ ....+++|
T Consensus 105 l~~L~~L~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~---~n~~--~~~~--~~~~l~~L 172 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCH---LNKK--ITKL--DVTPQTQL 172 (457)
T ss_dssp CTTCCEEECCSSCCSCCC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECT---TCSC--CCCC--CCTTCTTC
T ss_pred CCcCCEEECCCCcCCeec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECC---CCCc--cccc--ccccCCcC
Confidence 445666667777666664 66666677777766665542 12233333333111 1100 0001 12345677
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|+|++ +| +..+++|+.|+|++|+|++. .+..+++|+.|+|++|+|++ +| ++.+++|+.|++++|+
T Consensus 173 ~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~ 244 (457)
T 3bz5_A 173 TTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNP 244 (457)
T ss_dssp CEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSC
T ss_pred CEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCc
Confidence 778888887774 55 77777788888888877775 37777778888888888875 66 7777778888888888
Q ss_pred cccccccccccccccccccC
Q 003039 424 LSGTVPSSLLSKNVVLNYAG 443 (854)
Q Consensus 424 l~g~~p~~l~~~~~~l~~~~ 443 (854)
|++ +|...+.++..|.+.+
T Consensus 245 l~~-~~~~~l~~L~~L~l~~ 263 (457)
T 3bz5_A 245 LTE-LDVSTLSKLTTLHCIQ 263 (457)
T ss_dssp CSC-CCCTTCTTCCEEECTT
T ss_pred CCC-cCHHHCCCCCEEeccC
Confidence 774 4444445444444433
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.27 E-value=6.7e-12 Score=144.01 Aligned_cols=167 Identities=22% Similarity=0.227 Sum_probs=105.6
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.|+.|+++.|.++.+++ +..+..|+.|++++|.+....+ +..+..+..+... -|. ...+. ....+++|
T Consensus 176 l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~---~n~---l~~~~-~l~~l~~L 245 (466)
T 1o6v_A 176 LTTLERLDISSNKVSDISV-LAKLTNLESLIATNNQISDITP--LGILTNLDELSLN---GNQ---LKDIG-TLASLTNL 245 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECC---SSC---CCCCG-GGGGCTTC
T ss_pred CCCCCEEECcCCcCCCChh-hccCCCCCEEEecCCccccccc--ccccCCCCEEECC---CCC---cccch-hhhcCCCC
Confidence 4566777777777777643 6677777777777776654222 3334444444221 111 11111 11234577
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|++++..| +..+++|+.|+|++|++++.++ +..+++|+.|+|++|++++. |. ++.+++|+.|+|++|+
T Consensus 246 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~L~~n~ 320 (466)
T 1o6v_A 246 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDI-SP-ISNLKNLTYLTLYFNN 320 (466)
T ss_dssp SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCC-GG-GGGCTTCSEEECCSSC
T ss_pred CEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCc-hh-hcCCCCCCEEECcCCc
Confidence 777777777775433 7777777777777777777655 77777777777777777753 33 6777777777777777
Q ss_pred cccccccccccccccccccCcc
Q 003039 424 LSGTVPSSLLSKNVVLNYAGNI 445 (854)
Q Consensus 424 l~g~~p~~l~~~~~~l~~~~n~ 445 (854)
+++..|..-+.+++.|++++|.
T Consensus 321 l~~~~~~~~l~~L~~L~l~~n~ 342 (466)
T 1o6v_A 321 ISDISPVSSLTKLQRLFFYNNK 342 (466)
T ss_dssp CSCCGGGGGCTTCCEEECCSSC
T ss_pred CCCchhhccCccCCEeECCCCc
Confidence 7766664456667777777764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.27 E-value=4.9e-12 Score=125.07 Aligned_cols=129 Identities=16% Similarity=0.111 Sum_probs=83.9
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
...++.|+|+.|.++.+|........|+.|+++.|.+... . ....+++|
T Consensus 18 ~~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~l~~~-----------~--------------------~l~~l~~L 66 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-----------D--------------------GFPLLRRL 66 (176)
T ss_dssp TTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE-----------C--------------------CCCCCSSC
T ss_pred cCCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCCCCcc-----------c--------------------ccccCCCC
Confidence 4567778888888887754333333677777777765530 0 01234467
Q ss_pred eEEEecCCCCCccCCcc-cccCccCcEEeccCCCCCCCCC--CCCCCCCccEEEeCCCccCCCCCcc----ccCCCCCce
Q 003039 344 TVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSS----LMNLPNLRE 416 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~-i~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~P~~----l~~l~~L~~ 416 (854)
+.|+|++|+|++ +|+. +..+++|+.|+|++|+|+..++ .+..+++|+.|+|++|.++ .+|.. +..+++|+.
T Consensus 67 ~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~ 144 (176)
T 1a9n_A 67 KTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV 144 (176)
T ss_dssp CEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSE
T ss_pred CEEECCCCcccc-cCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccce
Confidence 777777777773 4433 3677777777777777765544 4666777777777777777 55653 777777777
Q ss_pred eeccccccc
Q 003039 417 LYVQNNMLS 425 (854)
Q Consensus 417 l~l~~N~l~ 425 (854)
|++++|.+.
T Consensus 145 Ld~~~n~~~ 153 (176)
T 1a9n_A 145 LDFQKVKLK 153 (176)
T ss_dssp ETTEECCHH
T ss_pred eCCCcCCHH
Confidence 777777665
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.26 E-value=8.4e-12 Score=145.91 Aligned_cols=154 Identities=17% Similarity=0.177 Sum_probs=90.9
Q ss_pred cceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
++|+.|+|+.|.++.+| ..+..|+.|++++|.+..+.. +.. .+..+...+.. ..+++- .+++|+
T Consensus 80 ~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~--l~~--~L~~L~Ls~N~------l~~lp~---~l~~L~ 143 (571)
T 3cvr_A 80 PQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPE--LPA--SLKHLDVDNNQ------LTMLPE---LPALLE 143 (571)
T ss_dssp TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC--CCT--TCCEEECCSSC------CSCCCC---CCTTCC
T ss_pred CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcch--hhc--CCCEEECCCCc------CCCCCC---cCcccc
Confidence 45677777777777776 345667777777776654111 211 22222211100 111111 345677
Q ss_pred EEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCC-------cee
Q 003039 345 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL-------REL 417 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L-------~~l 417 (854)
.|+|++|+|++ +|. .+++|+.|+|++|+|++.++ |. ++|+.|+|++|+|+ .+|. |.. +| +.|
T Consensus 144 ~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L 212 (571)
T 3cvr_A 144 YINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFF 212 (571)
T ss_dssp EEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEE
T ss_pred EEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEE
Confidence 77777777774 665 46677777777777777444 44 67777777777777 6666 554 56 777
Q ss_pred ecccccccccccccc--ccccccccccCccc
Q 003039 418 YVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 418 ~l~~N~l~g~~p~~l--~~~~~~l~~~~n~~ 446 (854)
+|++|+|+ .+|..+ +.++..|++++|+.
T Consensus 213 ~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l 242 (571)
T 3cvr_A 213 RCRENRIT-HIPENILSLDPTCTIILEDNPL 242 (571)
T ss_dssp ECCSSCCC-CCCGGGGGSCTTEEEECCSSSC
T ss_pred ecCCCcce-ecCHHHhcCCCCCEEEeeCCcC
Confidence 77777777 677665 44566677777754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.25 E-value=5.8e-12 Score=148.11 Aligned_cols=144 Identities=15% Similarity=0.019 Sum_probs=81.8
Q ss_pred eeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEE
Q 003039 268 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 347 (854)
Q Consensus 268 ~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~ 347 (854)
+.++++.|.++.+|+.+. ..++.|+++.|.+......+ ...+++|+.|+
T Consensus 34 ~~l~ls~~~L~~ip~~~~--~~L~~L~Ls~N~i~~~~~~~-----------------------------~~~l~~L~~L~ 82 (562)
T 3a79_B 34 SMVDYSNRNLTHVPKDLP--PRTKALSLSQNSISELRMPD-----------------------------ISFLSELRVLR 82 (562)
T ss_dssp CEEECTTSCCCSCCTTSC--TTCCEEECCSSCCCCCCGGG-----------------------------TTTCTTCCEEE
T ss_pred cEEEcCCCCCccCCCCCC--CCcCEEECCCCCccccChhh-----------------------------hccCCCccEEE
Confidence 456667777777776553 56677777776655311000 12344566666
Q ss_pred ecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCC-CCCccccCCCCCceeecccccccc
Q 003039 348 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSG 426 (854)
Q Consensus 348 L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~l~l~~N~l~g 426 (854)
|++|+|++..|..|.+|++|++|+|++|+|+..++. .+++|++|+|++|+|++ .+|..|+++++|+.|+|++|++++
T Consensus 83 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~ 160 (562)
T 3a79_B 83 LSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160 (562)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred CCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc
Confidence 666666655566666666666666666666643333 56666666666666664 334566666666666666666653
Q ss_pred cccccccccc--ccccccCcc
Q 003039 427 TVPSSLLSKN--VVLNYAGNI 445 (854)
Q Consensus 427 ~~p~~l~~~~--~~l~~~~n~ 445 (854)
..-.-+..+ +.|++++|.
T Consensus 161 -~~~~~l~~L~L~~L~L~~n~ 180 (562)
T 3a79_B 161 -LDLLPVAHLHLSCILLDLVS 180 (562)
T ss_dssp -TTTGGGTTSCEEEEEEEESS
T ss_pred -CchhhhhhceeeEEEeeccc
Confidence 221112333 555555553
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.5e-11 Score=140.74 Aligned_cols=162 Identities=17% Similarity=0.072 Sum_probs=95.4
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.++.|+|+.|.++.+| .+..+..|+.|+++.|.+.... +..+..++.+... -|. ..++. ...+++|
T Consensus 41 l~~L~~L~Ls~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls---~N~---l~~~~--~~~l~~L 108 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACD---SNK---LTNLD--VTPLTKL 108 (457)
T ss_dssp HTTCCEEECCSSCCCCCT-TGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECC---SSC---CSCCC--CTTCTTC
T ss_pred cCCCCEEEccCCCcccCh-hhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECc---CCC---Cceee--cCCCCcC
Confidence 556677777777777774 5677777777777777766531 3334444443221 111 11221 3345667
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|+|++ +| ++++++|+.|+|++|+|++. +++++++|++|+|++|+..+.+ .++.+++|+.|++++|+
T Consensus 109 ~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~ 181 (457)
T 3bz5_A 109 TYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNK 181 (457)
T ss_dssp CEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSC
T ss_pred CEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCc
Confidence 777777777774 44 66777777777777777664 2566666666666666554455 25566666666666666
Q ss_pred cccccccccccccccccccCcc
Q 003039 424 LSGTVPSSLLSKNVVLNYAGNI 445 (854)
Q Consensus 424 l~g~~p~~l~~~~~~l~~~~n~ 445 (854)
+++ +|-.-+.+++.|++++|.
T Consensus 182 l~~-l~l~~l~~L~~L~l~~N~ 202 (457)
T 3bz5_A 182 ITE-LDVSQNKLLNRLNCDTNN 202 (457)
T ss_dssp CCC-CCCTTCTTCCEEECCSSC
T ss_pred cce-eccccCCCCCEEECcCCc
Confidence 663 553334455555555553
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=1e-11 Score=136.52 Aligned_cols=104 Identities=18% Similarity=0.204 Sum_probs=87.0
Q ss_pred EEEecCC-CCCccCCcccccCccCcEEeccC-CCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 345 VIHLSSK-NLTGNIPSDLTKLSSLVELWLDG-NSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 345 ~L~L~~n-~l~g~lp~~i~~l~~L~~L~L~~-N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
.++++++ +|+ .||. |..+++|+.|+|++ |+|++.++. |.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3567777 888 6888 99999999999996 999988875 88899999999999999988888899999999999999
Q ss_pred cccccccccccccc--cccccccCccccccCC
Q 003039 422 NMLSGTVPSSLLSK--NVVLNYAGNINLHEGG 451 (854)
Q Consensus 422 N~l~g~~p~~l~~~--~~~l~~~~n~~l~~~~ 451 (854)
|+|+ .+|..++.. +..|++.+|+..|.+.
T Consensus 90 N~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 90 NALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred Cccc-eeCHHHcccCCceEEEeeCCCccCCCc
Confidence 9999 667665433 7888889998888653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.1e-10 Score=137.98 Aligned_cols=74 Identities=36% Similarity=0.420 Sum_probs=46.6
Q ss_pred ccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccccccccc--cccccccccc
Q 003039 365 SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYA 442 (854)
Q Consensus 365 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~ 442 (854)
++|+.|+|++|+|++.+ ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+ ++++..|+++
T Consensus 221 ~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 55666666666666533 34566667777777766 4555 4566667777777776 666655 4455666666
Q ss_pred Cccc
Q 003039 443 GNIN 446 (854)
Q Consensus 443 ~n~~ 446 (854)
+|+.
T Consensus 293 ~N~l 296 (622)
T 3g06_A 293 GNPL 296 (622)
T ss_dssp SCCC
T ss_pred CCCC
Confidence 6653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.1e-10 Score=135.73 Aligned_cols=53 Identities=32% Similarity=0.403 Sum_probs=39.1
Q ss_pred CCccEEEeCCCccCCCCCccccCCCCCceeeccccccccccccccccccccccccCccc
Q 003039 388 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 446 (854)
Q Consensus 388 ~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~l~~~~n~~ 446 (854)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+.++..|++++|..
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~-~~~~L~~L~Ls~N~L 273 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM-LPSGLLSLSVYRNQL 273 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC-CCTTCCEEECCSSCC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc-ccccCcEEeCCCCCC
Confidence 667788888888874 66 45577888888888888 6777 566777788877743
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.16 E-value=1.5e-12 Score=142.27 Aligned_cols=176 Identities=15% Similarity=0.170 Sum_probs=100.0
Q ss_pred ccceeeeecccCCCCC--CCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCC
Q 003039 264 LPFVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 341 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~--lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~ 341 (854)
+++|+.|+|+.|.++. +|..+..+..|+.|+++.|.+....+..+.++..++.+.. .-|......++......++
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L---~~~~~l~~~~l~~~~~~~~ 168 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL---SGCSGFSEFALQTLLSSCS 168 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC---TTCBSCCHHHHHHHHHHCT
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC---CCCCCCCHHHHHHHHhcCC
Confidence 4566677777776654 5566677777777777777766666666666555555532 2221111001111111245
Q ss_pred CeeEEEecCC-CCCcc-CCcccccCc-cCcEEeccCC--CCC-CCCCC-CCCCCCccEEEeCCCc-cCCCCCccccCCCC
Q 003039 342 SITVIHLSSK-NLTGN-IPSDLTKLS-SLVELWLDGN--SLT-GPIPD-FSGCPDLRIIHLEDNQ-LTGPLPSSLMNLPN 413 (854)
Q Consensus 342 ~l~~L~L~~n-~l~g~-lp~~i~~l~-~L~~L~L~~N--~l~-~~~p~-~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l~~ 413 (854)
+|+.|+|++| ++++. ++..+..++ +|+.|+|++| .++ +.+|. +.++++|+.|+|++|. +++..+..+..+++
T Consensus 169 ~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~ 248 (336)
T 2ast_B 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 248 (336)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred CCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCC
Confidence 6777777777 66643 566666666 7777777776 343 23332 4556677777777776 55556666667777
Q ss_pred Cceeeccccccccccccc---c--ccccccccccCc
Q 003039 414 LRELYVQNNMLSGTVPSS---L--LSKNVVLNYAGN 444 (854)
Q Consensus 414 L~~l~l~~N~l~g~~p~~---l--~~~~~~l~~~~n 444 (854)
|+.|+|++|. +..|.. + +++++.|++.||
T Consensus 249 L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 249 LQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc
Confidence 7777777764 122221 2 445566666655
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.16 E-value=4.4e-11 Score=118.14 Aligned_cols=104 Identities=18% Similarity=0.150 Sum_probs=85.5
Q ss_pred CCCeeEEEecCCCCCccCCcccccCc-cCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 340 QPSITVIHLSSKNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~~i~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
+++|+.|+|++|+++ .+|. +..+. +|+.|+|++|+|++. +.+..+++|++|+|++|+|++..|..+..+++|+.|+
T Consensus 18 ~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 347999999999999 6664 66665 999999999999987 7889999999999999999954334458999999999
Q ss_pred cccccccccccc--cc--ccccccccccCcccc
Q 003039 419 VQNNMLSGTVPS--SL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 419 l~~N~l~g~~p~--~l--~~~~~~l~~~~n~~l 447 (854)
|++|+|+ .+|. .+ ++++..|++++|+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 9999997 7776 44 567788899998753
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.16 E-value=9.2e-12 Score=139.17 Aligned_cols=177 Identities=17% Similarity=0.150 Sum_probs=134.7
Q ss_pred ccceeeeecccCCCCCC----Cccc-------chhhhceeccCCCCCccH----HHHHHHHhhcCCCCccCCCCCCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSR----GPLL-------NAMEINKYLERNDGSIDG----VAIVSVISLYSSADWAQEGGDPCLPV 328 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~l----pP~i-------n~le~l~~L~l~~~~~~~----~~~~~l~~l~~~~~w~~~~~~pc~~~ 328 (854)
++.|+.|+|+.|.+..+ |+.+ ..+..|+.|+++.|.+.. ..+..+..+..++.+... -|.
T Consensus 59 ~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~---~n~-- 133 (386)
T 2ca6_A 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLH---NNG-- 133 (386)
T ss_dssp CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECC---SSC--
T ss_pred CCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECc---CCC--
Confidence 56788999998766644 4444 567889999999999877 355567777777776432 221
Q ss_pred CCCeeE----e-CCCCC---------CCeeEEEecCCCCC-ccCC---cccccCccCcEEeccCCCCC--C---CCC-CC
Q 003039 329 PWSWLQ----C-NSDPQ---------PSITVIHLSSKNLT-GNIP---SDLTKLSSLVELWLDGNSLT--G---PIP-DF 384 (854)
Q Consensus 329 ~~~~~~----c-~~~~~---------~~l~~L~L~~n~l~-g~lp---~~i~~l~~L~~L~L~~N~l~--~---~~p-~~ 384 (854)
..... + ....+ ++|+.|+|++|+|+ +.+| ..+..+++|+.|+|++|+|+ | ..| .+
T Consensus 134 -l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l 212 (386)
T 2ca6_A 134 -LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL 212 (386)
T ss_dssp -CHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTG
T ss_pred -CCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHh
Confidence 11100 0 00011 68999999999998 5666 57888999999999999998 4 456 68
Q ss_pred CCCCCccEEEeCCCccC----CCCCccccCCCCCceeeccccccccc----ccccc----ccccccccccCccc
Q 003039 385 SGCPDLRIIHLEDNQLT----GPLPSSLMNLPNLRELYVQNNMLSGT----VPSSL----LSKNVVLNYAGNIN 446 (854)
Q Consensus 385 ~~l~~L~~L~Ls~N~l~----g~~P~~l~~l~~L~~l~l~~N~l~g~----~p~~l----~~~~~~l~~~~n~~ 446 (854)
..+++|+.|+|++|+|+ +.+|..+..+++|+.|+|++|+|++. +|..+ ++++..|++++|..
T Consensus 213 ~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i 286 (386)
T 2ca6_A 213 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286 (386)
T ss_dssp GGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCC
T ss_pred hcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcC
Confidence 89999999999999996 67899999999999999999999965 56655 56788899998853
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.6e-10 Score=132.01 Aligned_cols=138 Identities=27% Similarity=0.372 Sum_probs=92.6
Q ss_pred cceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
++|+.|+|+.|.++.+| .+..+..|+.|+++.|++... .. ..++|+
T Consensus 131 ~~L~~L~L~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~l-----------p~----------------------~~~~L~ 176 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKKL-----------PD----------------------LPPSLE 176 (454)
T ss_dssp TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSCC-----------CC----------------------CCTTCC
T ss_pred CCCCEEECcCCCCCCCc-ccCCCCCCCEEECCCCcCccc-----------CC----------------------Cccccc
Confidence 45677777777777776 477777777777777765420 00 113677
Q ss_pred EEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccc
Q 003039 345 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l 424 (854)
.|+|++|++++ +| .+++|++|+.|+|++|++++.+. + .++|+.|+|++|+++ .+|. ++.+++|+.|++++|++
T Consensus 177 ~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~-~--~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l 249 (454)
T 1jl5_A 177 FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD-L--PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLL 249 (454)
T ss_dssp EEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCC
T ss_pred EEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC-C--cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcC
Confidence 77777777774 66 57777777777777777776332 2 247777777777777 6773 77777777777777777
Q ss_pred ccccccccccccccccccCcc
Q 003039 425 SGTVPSSLLSKNVVLNYAGNI 445 (854)
Q Consensus 425 ~g~~p~~l~~~~~~l~~~~n~ 445 (854)
+ .+|.. ..+++.|++++|.
T Consensus 250 ~-~l~~~-~~~L~~L~l~~N~ 268 (454)
T 1jl5_A 250 K-TLPDL-PPSLEALNVRDNY 268 (454)
T ss_dssp S-SCCSC-CTTCCEEECCSSC
T ss_pred C-ccccc-ccccCEEECCCCc
Confidence 7 45543 3566667776664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.14 E-value=2e-12 Score=147.83 Aligned_cols=164 Identities=20% Similarity=0.144 Sum_probs=71.1
Q ss_pred cccccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhc-------------CCCCccCCCCCCCCC
Q 003039 261 NLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY-------------SSADWAQEGGDPCLP 327 (854)
Q Consensus 261 ~~~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~-------------~~~~w~~~~~~pc~~ 327 (854)
++..++++.|+++.|.+..+|+.|..+..|+.|+++.|.+....+..+.++. .+..+.. .-|.
T Consensus 7 ~~~~~~L~~L~l~~n~l~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l---~~~~- 82 (454)
T 1jl5_A 7 NVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELEL---NNLG- 82 (454)
T ss_dssp ---------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEEC---TTSC-
T ss_pred ccccccchhhhcccCchhhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEe---cCCc-
Confidence 4456778889999999999999999999999999987765432222222111 1122211 0110
Q ss_pred CCCCeeEeCCCCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCcc
Q 003039 328 VPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 407 (854)
Q Consensus 328 ~~~~~~~c~~~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~ 407 (854)
..+++ .-+++|+.|+|++|++++ +|+.+ ++|+.|+|++|++++... + .++|++|+|++|++++ +| .
T Consensus 83 --l~~lp---~~~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~l~~-~--~~~L~~L~L~~n~l~~-lp-~ 148 (454)
T 1jl5_A 83 --LSSLP---ELPPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKALSD-L--PPLLEYLGVSNNQLEK-LP-E 148 (454)
T ss_dssp --CSCCC---SCCTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSCCCS-C--CTTCCEEECCSSCCSS-CC-C
T ss_pred --cccCC---CCcCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCcccC-C--CCCCCEEECcCCCCCC-Cc-c
Confidence 11111 112467777777777774 66432 556666666666655321 1 1456666666666663 55 3
Q ss_pred ccCCCCCceeeccccccccccccccccccccccccCc
Q 003039 408 LMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444 (854)
Q Consensus 408 l~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~l~~~~n 444 (854)
++++++|+.|++++|+++ .+|... .+++.|++++|
T Consensus 149 ~~~l~~L~~L~l~~N~l~-~lp~~~-~~L~~L~L~~n 183 (454)
T 1jl5_A 149 LQNSSFLKIIDVDNNSLK-KLPDLP-PSLEFIAAGNN 183 (454)
T ss_dssp CTTCTTCCEEECCSSCCS-CCCCCC-TTCCEEECCSS
T ss_pred cCCCCCCCEEECCCCcCc-ccCCCc-ccccEEECcCC
Confidence 666666666666666666 354432 35555555555
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-10 Score=122.38 Aligned_cols=138 Identities=18% Similarity=0.107 Sum_probs=107.7
Q ss_pred hhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
+...+|.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||||++|.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 3566788888999999865 7899999987532223446889999999884 6778889999998889999999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------ 646 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------ 646 (854)
|.+.+.. ......++.+++++|+.||+..
T Consensus 97 l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 97 CSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp HHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred hhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 8775311 1123467889999999999810
Q ss_pred --------------CCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 647 --------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 647 --------------~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
.+.++|+|+++.|||++++..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876666799999764
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.09 E-value=2.3e-11 Score=134.09 Aligned_cols=176 Identities=15% Similarity=0.141 Sum_probs=108.9
Q ss_pred cceeeeecccCCCCCCCcc-cchhhhceeccCCCCCc-cHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCCCC
Q 003039 265 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSI-DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP 341 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~-~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~~~ 341 (854)
++++.|+|+.|.++.+|+. +.++..|+.|++++|++ +.+....+..+..+..+.....+ ....+.- ....++
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N-----~l~~l~~~~f~~l~ 104 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN-----NLLYINPEAFQNLP 104 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET-----TCCEECTTSBCCCT
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC-----cccccCchhhhhcc
Confidence 3567889999999999985 88999999999998885 32222223333222221000000 0111111 123455
Q ss_pred CeeEEEecCCCCCccCCc-------------------------ccccC-ccCcEEeccCCCCCCCCCCCCCCCCccEEEe
Q 003039 342 SITVIHLSSKNLTGNIPS-------------------------DLTKL-SSLVELWLDGNSLTGPIPDFSGCPDLRIIHL 395 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~-------------------------~i~~l-~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L 395 (854)
+|+.|++++|+|++..+. .+..+ ..|+.|+|++|+|+..++......+|+.|+|
T Consensus 105 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l 184 (350)
T 4ay9_X 105 NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNL 184 (350)
T ss_dssp TCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEEC
T ss_pred ccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhh
Confidence 666666666666532222 22333 2467778888888777666666677888888
Q ss_pred CC-CccCCCCCc-cccCCCCCceeeccccccccccccccccccccccccCcccc
Q 003039 396 ED-NQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 447 (854)
Q Consensus 396 s~-N~l~g~~P~-~l~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~l~~~~n~~l 447 (854)
++ |+++ .+|. .|..+++|+.|+|++|+|+ .+|...+.++..|...++..+
T Consensus 185 ~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~l~~~~l 236 (350)
T 4ay9_X 185 SDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNL 236 (350)
T ss_dssp TTCTTCC-CCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEECTTCTTC
T ss_pred ccCCccc-CCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhhccCCCc
Confidence 75 5555 5664 5788888888888888888 788877777766666555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.3e-12 Score=131.95 Aligned_cols=123 Identities=17% Similarity=0.259 Sum_probs=103.3
Q ss_pred cCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEEecCCCC
Q 003039 274 KTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNL 353 (854)
Q Consensus 274 ~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~L~~n~l 353 (854)
.+.++.+|..+..+..|+.|++++|.+... .. ...+++|+.|+|++|+|
T Consensus 34 ~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-----------~~--------------------~~~l~~L~~L~l~~n~l 82 (198)
T 1ds9_A 34 IPPIEKMDATLSTLKACKHLALSTNNIEKI-----------SS--------------------LSGMENLRILSLGRNLI 82 (198)
T ss_dssp CTTCCCCHHHHHHTTTCSEEECSEEEESCC-----------CC--------------------HHHHTTCCEEEEEEEEE
T ss_pred cCcHhhhhHHHhcCCCCCEEECCCCCCccc-----------cc--------------------cccCCCCCEEECCCCCc
Confidence 346777777899999999999999877640 00 01245899999999999
Q ss_pred CccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCC--ccccCCCCCceeecccccccccccc
Q 003039 354 TGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNMLSGTVPS 430 (854)
Q Consensus 354 ~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P--~~l~~l~~L~~l~l~~N~l~g~~p~ 430 (854)
+ .+|..+..+++|+.|+|++|+|++. |.+..+++|+.|+|++|+|++ +| ..+..+++|+.|++++|++++.+|.
T Consensus 83 ~-~l~~~~~~~~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 83 K-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp C-SCSSHHHHHHHCSEEEEEEEECCCH-HHHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred c-cccchhhcCCcCCEEECcCCcCCcC-CccccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9 8999999999999999999999985 578889999999999999994 44 4799999999999999999977775
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.1e-11 Score=135.46 Aligned_cols=176 Identities=14% Similarity=0.082 Sum_probs=138.1
Q ss_pred cceeeeecccCCCCCCCcccchhhhceeccCCCCCccHH-HHHHHHhhcCCCCccCCCCCCCCCCCCCeeE-eCCCCCCC
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGV-AIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQPS 342 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~-~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~-c~~~~~~~ 342 (854)
..++.|++..|.++..++.+..+..|+.|+++.|.+... .+..+..+..++.+... -|. ..... -....+++
T Consensus 70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~---~~~---l~~~~~~~l~~~~~ 143 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE---GLR---LSDPIVNTLAKNSN 143 (336)
T ss_dssp TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT---TCB---CCHHHHHHHTTCTT
T ss_pred ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCc---Ccc---cCHHHHHHHhcCCC
Confidence 567889999999999999999999999999999998765 45556667777776432 221 11111 01224679
Q ss_pred eeEEEecCC-CCCc-cCCcccccCccCcEEeccCC-CCCCC-CCC-CCCCC-CccEEEeCCC--ccC-CCCCccccCCCC
Q 003039 343 ITVIHLSSK-NLTG-NIPSDLTKLSSLVELWLDGN-SLTGP-IPD-FSGCP-DLRIIHLEDN--QLT-GPLPSSLMNLPN 413 (854)
Q Consensus 343 l~~L~L~~n-~l~g-~lp~~i~~l~~L~~L~L~~N-~l~~~-~p~-~~~l~-~L~~L~Ls~N--~l~-g~~P~~l~~l~~ 413 (854)
|+.|+|++| .+++ .+|..+.++++|+.|+|++| .+++. ++. +..++ +|++|+|++| .++ +.+|..+..+++
T Consensus 144 L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~ 223 (336)
T 2ast_B 144 LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 223 (336)
T ss_dssp CSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTT
T ss_pred CCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCC
Confidence 999999999 7886 37888999999999999999 99864 444 67799 9999999999 555 567888889999
Q ss_pred Cceeeccccc-ccccccccc--ccccccccccCccc
Q 003039 414 LRELYVQNNM-LSGTVPSSL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 414 L~~l~l~~N~-l~g~~p~~l--~~~~~~l~~~~n~~ 446 (854)
|+.|+|++|. +++..+..+ +++++.|++++|..
T Consensus 224 L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~ 259 (336)
T 2ast_B 224 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 259 (336)
T ss_dssp CSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTT
T ss_pred CCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCC
Confidence 9999999999 777777766 56788899998863
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.05 E-value=2.5e-10 Score=125.38 Aligned_cols=97 Identities=27% Similarity=0.285 Sum_probs=81.6
Q ss_pred CCeeEeCCC----------CCCCeeEEEecC-CCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCC
Q 003039 330 WSWLQCNSD----------PQPSITVIHLSS-KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 397 (854)
Q Consensus 330 ~~~~~c~~~----------~~~~l~~L~L~~-n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~ 397 (854)
|..+.|+.. .+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++.+|. |.+|++|+.|+|++
T Consensus 10 ~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp SSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 455666543 345799999996 999977778899999999999999999999986 79999999999999
Q ss_pred CccCCCCCccccCCCCCceeeccccccccc
Q 003039 398 NQLTGPLPSSLMNLPNLRELYVQNNMLSGT 427 (854)
Q Consensus 398 N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~ 427 (854)
|+|++..|..+..++ |+.|+|++|+|...
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 999965445565555 99999999999843
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.6e-11 Score=135.94 Aligned_cols=175 Identities=17% Similarity=0.153 Sum_probs=118.7
Q ss_pred cceeeeecccCCCCCCCc-----ccchhh-hceeccCCCCCccHHHHHHHHhh-----cCCCCccCCCCCCCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGP-----LLNAME-INKYLERNDGSIDGVAIVSVISL-----YSSADWAQEGGDPCLPVPWSWL 333 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP-----~in~le-~l~~L~l~~~~~~~~~~~~l~~l-----~~~~~w~~~~~~pc~~~~~~~~ 333 (854)
..++.|+|+.|.++..++ .+..+. .|+.|+++.|.+....+..+..+ ..++.+... -|. ....
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls---~n~---l~~~ 95 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLS---GNF---LSYK 95 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECC---SSC---GGGS
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECc---CCc---CChH
Confidence 347889999999999886 355565 79999999999887667777665 555555331 111 1111
Q ss_pred EeC-----CCCC-CCeeEEEecCCCCCccCCccccc-----CccCcEEeccCCCCCCCCC-----CCCCCC-CccEEEeC
Q 003039 334 QCN-----SDPQ-PSITVIHLSSKNLTGNIPSDLTK-----LSSLVELWLDGNSLTGPIP-----DFSGCP-DLRIIHLE 396 (854)
Q Consensus 334 ~c~-----~~~~-~~l~~L~L~~n~l~g~lp~~i~~-----l~~L~~L~L~~N~l~~~~p-----~~~~l~-~L~~L~Ls 396 (854)
.+. .... ++|+.|+|++|+|++..+..+.. .++|+.|+|++|+|++... .+..++ +|++|+|+
T Consensus 96 ~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls 175 (362)
T 3goz_A 96 SSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLR 175 (362)
T ss_dssp CHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECT
T ss_pred HHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeec
Confidence 110 1112 57889999999988655555443 3689999999998885332 234554 88899999
Q ss_pred CCccCCCCCcccc----CC-CCCceeeccccccccc----ccccc---ccccccccccCcc
Q 003039 397 DNQLTGPLPSSLM----NL-PNLRELYVQNNMLSGT----VPSSL---LSKNVVLNYAGNI 445 (854)
Q Consensus 397 ~N~l~g~~P~~l~----~l-~~L~~l~l~~N~l~g~----~p~~l---~~~~~~l~~~~n~ 445 (854)
+|+|++..+..++ .+ ++|+.|+|++|+|++. ++..+ ..+++.|++++|.
T Consensus 176 ~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 236 (362)
T 3goz_A 176 GNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236 (362)
T ss_dssp TSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSC
T ss_pred CCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCC
Confidence 9998876665444 44 5899999999988852 55554 2367888888885
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=6e-10 Score=116.63 Aligned_cols=130 Identities=19% Similarity=0.119 Sum_probs=97.6
Q ss_pred ccc-ccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCc--eeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 533 KIG-SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 533 ~iG-~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hpn--Iv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
.++ .|..+.||+....+|+.+++|+.... ....+..|+++++.+++.+ +.+++++...++..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55669999998777888999997643 2345788999999886544 45688888887889999999999887
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------- 646 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 646 (854)
. ... . ....++.++++.|+.||+..
T Consensus 103 ~--~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 103 L--SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp T--TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred C--cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 4 211 0 12256777888888888642
Q ss_pred ------------CCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 647 ------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 647 ------------~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
...++|+|++|.||+++++..+.|+|||.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667799999875
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.96 E-value=4.7e-11 Score=132.29 Aligned_cols=176 Identities=16% Similarity=0.131 Sum_probs=113.2
Q ss_pred cceeeeecccCCCCCCCcc-----cchh-hhceeccCCCCCccHHHHHHHHhh-----cCCCCccCCCCCCCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGPL-----LNAM-EINKYLERNDGSIDGVAIVSVISL-----YSSADWAQEGGDPCLPVPWSWL 333 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~-----in~l-e~l~~L~l~~~~~~~~~~~~l~~l-----~~~~~w~~~~~~pc~~~~~~~~ 333 (854)
+.|+.|+|+.|.++..++. +..+ ..|+.|+++.|.+....+..+.+. ..++.+... -|. ....
T Consensus 80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls---~N~---l~~~ 153 (362)
T 3goz_A 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLR---GND---LGIK 153 (362)
T ss_dssp TTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECT---TSC---GGGS
T ss_pred CCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEcc---CCc---CCHH
Confidence 5678888888888877765 3333 778888888888877666666554 244444321 111 1110
Q ss_pred E----eC-CCCC-CCeeEEEecCCCCCccCCcccccC-----ccCcEEeccCCCCCCC-----CCCCCC-CCCccEEEeC
Q 003039 334 Q----CN-SDPQ-PSITVIHLSSKNLTGNIPSDLTKL-----SSLVELWLDGNSLTGP-----IPDFSG-CPDLRIIHLE 396 (854)
Q Consensus 334 ~----c~-~~~~-~~l~~L~L~~n~l~g~lp~~i~~l-----~~L~~L~L~~N~l~~~-----~p~~~~-l~~L~~L~Ls 396 (854)
. |. .... ++|+.|+|++|+|++..+..+..+ ++|+.|+|++|.|++. ...+.. .++|+.|+|+
T Consensus 154 ~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls 233 (362)
T 3goz_A 154 SSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLC 233 (362)
T ss_dssp CHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECC
T ss_pred HHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECc
Confidence 0 00 0112 378888999988887666555543 6888999999988872 223444 4588889999
Q ss_pred CCccCCCCC----ccccCCCCCceeecccccccccccc-------cc--ccccccccccCccc
Q 003039 397 DNQLTGPLP----SSLMNLPNLRELYVQNNMLSGTVPS-------SL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 397 ~N~l~g~~P----~~l~~l~~L~~l~l~~N~l~g~~p~-------~l--~~~~~~l~~~~n~~ 446 (854)
+|+|++..+ ..+..+++|+.|+|++|.+++..+. .+ ++.+..|++++|..
T Consensus 234 ~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l 296 (362)
T 3goz_A 234 LNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296 (362)
T ss_dssp SSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBC
T ss_pred CCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcC
Confidence 998886444 3356778888999998886632222 12 34456778888863
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.88 E-value=7e-11 Score=134.90 Aligned_cols=136 Identities=18% Similarity=0.167 Sum_probs=64.4
Q ss_pred ceeeeecccCCCCC-----CCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCC
Q 003039 266 FVLSFKFGKTYDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 340 (854)
Q Consensus 266 ~l~~l~l~~n~~s~-----lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~ 340 (854)
.|+.|+|+.|.++. ++..+..+..|+.|+++.|.+....+..+.... ....
T Consensus 200 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~------------------------~~~~ 255 (461)
T 1z7x_W 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGL------------------------LHPS 255 (461)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHH------------------------TSTT
T ss_pred CceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHH------------------------hcCC
Confidence 55666666666665 344455566666666666666554444443210 0012
Q ss_pred CCeeEEEecCCCCCcc----CCcccccCccCcEEeccCCCCCCCCCC-C-----CCCCCccEEEeCCCccCCC----CCc
Q 003039 341 PSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPD-F-----SGCPDLRIIHLEDNQLTGP----LPS 406 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~----lp~~i~~l~~L~~L~L~~N~l~~~~p~-~-----~~l~~L~~L~Ls~N~l~g~----~P~ 406 (854)
++|+.|+|++|++++. ++..+.++++|+.|+|++|.+++..+. + ...++|+.|+|++|++++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 3455555555555532 444444455555555555554432111 1 1123444555555544432 333
Q ss_pred cccCCCCCceeeccccccc
Q 003039 407 SLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 407 ~l~~l~~L~~l~l~~N~l~ 425 (854)
.+..+++|+.|+|++|+++
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~ 354 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLE 354 (461)
T ss_dssp HHHHCSSCCEEECCSSBCH
T ss_pred HHhhCCCccEEEccCCccc
Confidence 4444444444455444444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.86 E-value=7.1e-10 Score=122.15 Aligned_cols=165 Identities=18% Similarity=0.129 Sum_probs=102.4
Q ss_pred eeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEe-CCCC-CCCeeE
Q 003039 269 SFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDP-QPSITV 345 (854)
Q Consensus 269 ~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c-~~~~-~~~l~~ 345 (854)
.+.+..|.++.+||. +..+..|+.|++++|.+.......+..+..+..+...+ +. ....+.- .... ...++.
T Consensus 84 ~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~---~~--~i~~l~~~~f~~~~~~l~~ 158 (350)
T 4ay9_X 84 IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD---NI--NIHTIERNSFVGLSFESVI 158 (350)
T ss_dssp EEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES---CT--TCCEECTTSSTTSBSSCEE
T ss_pred hhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcc---cc--ccccccccchhhcchhhhh
Confidence 345567888888765 67788888888887776542111111111111110000 00 0111111 0111 236899
Q ss_pred EEecCCCCCccCCcccccCccCcEEeccC-CCCCCCCCC-CCCCCCccEEEeCCCccCCCCCc-cccCCCCCceeecccc
Q 003039 346 IHLSSKNLTGNIPSDLTKLSSLVELWLDG-NSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQNN 422 (854)
Q Consensus 346 L~L~~n~l~g~lp~~i~~l~~L~~L~L~~-N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~-~l~~l~~L~~l~l~~N 422 (854)
|+|++|+|+ .+|+.+..+.+|+.|+|++ |.++.++++ |.++++|++|||++|+|+ .+|. .+.+|++|+.+++ +
T Consensus 159 L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~l~~--~ 234 (350)
T 4ay9_X 159 LWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--Y 234 (350)
T ss_dssp EECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEECTTC--T
T ss_pred hcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhhccC--C
Confidence 999999999 7888888899999999985 667766665 789999999999999999 6665 4555555544332 4
Q ss_pred ccccccccc-cccccccccccC
Q 003039 423 MLSGTVPSS-LLSKNVVLNYAG 443 (854)
Q Consensus 423 ~l~g~~p~~-l~~~~~~l~~~~ 443 (854)
+++ .+|.- -+.++..+.+..
T Consensus 235 ~l~-~lP~l~~l~~L~~l~l~~ 255 (350)
T 4ay9_X 235 NLK-KLPTLEKLVALMEASLTY 255 (350)
T ss_dssp TCC-CCCCTTTCCSCCEEECSC
T ss_pred CcC-cCCCchhCcChhhCcCCC
Confidence 465 77752 255666666653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.85 E-value=3.3e-10 Score=129.32 Aligned_cols=158 Identities=22% Similarity=0.199 Sum_probs=106.6
Q ss_pred ccceeeeecccCCCC-----CCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCC
Q 003039 264 LPFVLSFKFGKTYDS-----SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD 338 (854)
Q Consensus 264 l~~l~~l~l~~n~~s-----~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~ 338 (854)
++.++.|+|+.|.++ .+|..+..+..|+.|++++|.+....+..+..... .
T Consensus 27 ~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~------------------------~ 82 (461)
T 1z7x_W 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ------------------------T 82 (461)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC------------------------S
T ss_pred cCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh------------------------h
Confidence 345667777777766 44555666677777777777776655554433210 0
Q ss_pred CCCCeeEEEecCCCCCc----cCCcccccCccCcEEeccCCCCCCCCCC------CCCCCCccEEEeCCCccCCC----C
Q 003039 339 PQPSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGPIPD------FSGCPDLRIIHLEDNQLTGP----L 404 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g----~lp~~i~~l~~L~~L~L~~N~l~~~~p~------~~~l~~L~~L~Ls~N~l~g~----~ 404 (854)
..++|+.|+|++|+++. .+|..+.++++|+.|+|++|.+++..+. ...+++|++|+|++|++++. +
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 01268888888888883 5678888888888888888888754331 23356788888888888863 3
Q ss_pred CccccCCCCCceeeccccccccccccccc-------cccccccccCcc
Q 003039 405 PSSLMNLPNLRELYVQNNMLSGTVPSSLL-------SKNVVLNYAGNI 445 (854)
Q Consensus 405 P~~l~~l~~L~~l~l~~N~l~g~~p~~l~-------~~~~~l~~~~n~ 445 (854)
+..+..+++|+.|+|++|++++..+..+. ..++.|++++|.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 210 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG 210 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSC
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCC
Confidence 56677778888888888888754444432 266777777763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.83 E-value=5.1e-09 Score=115.59 Aligned_cols=140 Identities=16% Similarity=0.304 Sum_probs=104.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEc--cCC-cccHHHHHHHHHHHccCC--CCceeeEeeeeeec---CeEEEEEEe
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLT--SNS-YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEE---GRSVLVYEF 603 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~--~~~-~~~~~~~~~Ev~~L~~l~--HpnIv~l~g~~~~~---~~~~LV~E~ 603 (854)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+++++.++ +..+.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 46899999999999876 4678888765 322 123456888999999986 45678888888776 458999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------- 646 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 646 (854)
++|..+.+.. -..++...+..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9987774422 123566777889999999999999731
Q ss_pred ------------------CCceecCCCCCCCEEEcCCCc--EEEEeeecccc
Q 003039 647 ------------------VPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKF 678 (854)
Q Consensus 647 ------------------~~~ivHrDIkp~NILl~~~~~--vkl~DFGla~~ 678 (854)
.+.++|||+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.81 E-value=9.9e-11 Score=117.95 Aligned_cols=105 Identities=27% Similarity=0.262 Sum_probs=85.3
Q ss_pred CCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
.+++|+.|+|++|+|++ +| .+.++++|+.|+|++|+|+..++.+..+++|+.|+|++|+|++ +| .+..+++|+.|+
T Consensus 46 ~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 46 TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp HTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred cCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 45689999999999995 88 8999999999999999998654445667899999999999995 66 688899999999
Q ss_pred cccccccccccc--cc--ccccccccccCccccc
Q 003039 419 VQNNMLSGTVPS--SL--LSKNVVLNYAGNINLH 448 (854)
Q Consensus 419 l~~N~l~g~~p~--~l--~~~~~~l~~~~n~~l~ 448 (854)
|++|+++ .+|. .+ +.++..|++++|+..+
T Consensus 122 l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp ESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CCCCcCC-chhHHHHHhcCCCCCEEEecCCcccc
Confidence 9999998 4443 33 6677888888886543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.76 E-value=3.9e-09 Score=113.77 Aligned_cols=186 Identities=21% Similarity=0.253 Sum_probs=119.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCc--eeeEeeeeeecC---eEEEEEEecc
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRN--LVQFLGYCQEEG---RSVLVYEFMH 605 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-Hpn--Iv~l~g~~~~~~---~~~LV~E~~~ 605 (854)
+.++.|....||+.. ..+++|+-... .....+.+|+++|+.+. +.. +.+.+......+ ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458899999999863 56889986432 33567889999998873 322 344555443333 3478999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG---------------------------------------- 645 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 645 (854)
|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988765331 2345556667777888888888751
Q ss_pred ---------------CCCceecCCCCCCCEEEcC--CCcEEEEeeeccccccCCCCceeeccc--------------ccc
Q 003039 646 ---------------CVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGASHVSSIVR--------------GTV 694 (854)
Q Consensus 646 ---------------~~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~~~~~~~~~~~~~~--------------gt~ 694 (854)
..+.++|+|+++.||+++. ...+.|+||+.+...... ........ ...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHc
Confidence 1146899999999999998 556889999988643221 11100000 000
Q ss_pred cccC-ccccccCcCCCcchhhhHHHHHHHHHhCCccccc
Q 003039 695 GYLD-PEYYISQQLTDKSDVYSFGVILLELISGQEAISN 732 (854)
Q Consensus 695 ~Y~a-PE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~ 732 (854)
+... |+.... .....+.|+++.++|++.+|+.+|..
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 1111 221111 11235899999999999999988743
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.67 E-value=1.6e-09 Score=120.20 Aligned_cols=156 Identities=15% Similarity=0.100 Sum_probs=73.0
Q ss_pred ccceeeeecccCCCCCCCcc-cchh-----hhceeccCCCCCccHHHHHHHHhh-cCCCCccCCCCCCCCCCCCCeeE--
Q 003039 264 LPFVLSFKFGKTYDSSRGPL-LNAM-----EINKYLERNDGSIDGVAIVSVISL-YSSADWAQEGGDPCLPVPWSWLQ-- 334 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~-in~l-----e~l~~L~l~~~~~~~~~~~~l~~l-~~~~~w~~~~~~pc~~~~~~~~~-- 334 (854)
++.++.|+|+.|.++..... |..+ ..|+.|+++.|.+....+..+... ..+..+... -|. .....
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls---~n~---l~~~~~~ 144 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQ---LNS---LGPEACK 144 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECC---SSC---CCHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcC---CCC---CCHHHHH
Confidence 34566677777766654332 2222 466677777777665444443322 111111110 000 00000
Q ss_pred --eC--CCCCCCeeEEEecCCCCCc----cCCcccccCccCcEEeccCCCCCCCC----C-CCCCCCCccEEEeCCCccC
Q 003039 335 --CN--SDPQPSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGPI----P-DFSGCPDLRIIHLEDNQLT 401 (854)
Q Consensus 335 --c~--~~~~~~l~~L~L~~n~l~g----~lp~~i~~l~~L~~L~L~~N~l~~~~----p-~~~~l~~L~~L~Ls~N~l~ 401 (854)
|. ....++|+.|+|++|+|+. .++..+..+++|++|+|++|+|+..- . .+..+++|+.|+|++|+|+
T Consensus 145 ~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 145 DLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp HHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred HHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 00 0012356666666666542 23334455556666666666655321 1 2344555666666666655
Q ss_pred C----CCCccccCCCCCceeeccccccc
Q 003039 402 G----PLPSSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 402 g----~~P~~l~~l~~L~~l~l~~N~l~ 425 (854)
. .++..+...++|+.|+|++|+|+
T Consensus 225 ~~g~~~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 225 DTAALALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred HHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence 3 12333444455666666666655
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.65 E-value=3.5e-09 Score=117.57 Aligned_cols=140 Identities=16% Similarity=0.087 Sum_probs=98.8
Q ss_pred cceeeeecccCCCCCC--CcccchhhhceeccCCCCCccHHHHHHHHhh-----cCCCCccCCCCCCCCCCCCCeeEeC-
Q 003039 265 PFVLSFKFGKTYDSSR--GPLLNAMEINKYLERNDGSIDGVAIVSVISL-----YSSADWAQEGGDPCLPVPWSWLQCN- 336 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~l--pP~in~le~l~~L~l~~~~~~~~~~~~l~~l-----~~~~~w~~~~~~pc~~~~~~~~~c~- 336 (854)
..|+.|+|+.|.++.. ..+..++..|+.|++++|.+....+..+... ..+..+.. .-|. ....+|.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~L---s~n~---l~~~~~~~ 174 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRL---SNNP---LTAAGVAV 174 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEEC---CSSC---CHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeC---CCCC---CChHHHHH
Confidence 4788999999998763 3446678889999999999988777777654 23454432 1121 1111110
Q ss_pred ----CCCCCCeeEEEecCCCCCcc----CCcccccCccCcEEeccCCCCCCCCC-----CCCCCCCccEEEeCCCccCCC
Q 003039 337 ----SDPQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQLTGP 403 (854)
Q Consensus 337 ----~~~~~~l~~L~L~~n~l~g~----lp~~i~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~g~ 403 (854)
....++|+.|+|++|+|+.. ++..+..+++|+.|+|++|+|+.... .+..+++|++|+|++|.|+..
T Consensus 175 l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 175 LMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 02356899999999999852 46677888999999999999986322 245678999999999999854
Q ss_pred CCccccC
Q 003039 404 LPSSLMN 410 (854)
Q Consensus 404 ~P~~l~~ 410 (854)
-...|..
T Consensus 255 g~~~L~~ 261 (372)
T 3un9_A 255 GRQVLRD 261 (372)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 4444443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.54 E-value=6e-08 Score=105.61 Aligned_cols=93 Identities=24% Similarity=0.365 Sum_probs=77.7
Q ss_pred CCCeeEEEecCCCCCccCCc-ccccCccCcEEeccCCCCCCCCCC-CCCCCCcc-EEEeCCCccCCCCCccccCCCCCce
Q 003039 340 QPSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR-IIHLEDNQLTGPLPSSLMNLPNLRE 416 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~-~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~-~L~Ls~N~l~g~~P~~l~~l~~L~~ 416 (854)
+++|+.|+|++|+++ .||+ .|.+|++|+.|+|++| ++...+. |.+|++|+ .|+|.+ +++..-+.+|.+|++|+.
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 468999999999999 5654 6889999999999998 7765554 89999999 999998 777444578999999999
Q ss_pred eecccccccccccccccccc
Q 003039 417 LYVQNNMLSGTVPSSLLSKN 436 (854)
Q Consensus 417 l~l~~N~l~g~~p~~l~~~~ 436 (854)
|++++|+++ .|+...+...
T Consensus 302 l~l~~n~i~-~I~~~aF~~~ 320 (329)
T 3sb4_A 302 VLATGDKIT-TLGDELFGNG 320 (329)
T ss_dssp EEECSSCCC-EECTTTTCTT
T ss_pred EEeCCCccC-ccchhhhcCC
Confidence 999999999 8887765443
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=9.1e-08 Score=94.04 Aligned_cols=107 Identities=18% Similarity=0.160 Sum_probs=69.4
Q ss_pred EEeeccCCCCCCCccCCCCCCCCccccCccccccccccccCCccccccccccCCCCCCCChHHHhhhcccccCCceEEee
Q 003039 119 SARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRL 198 (854)
Q Consensus 119 ~~r~~~g~~~~~~iryp~D~~dR~W~~~~~~~~~~~~~~~~~~~~~st~~~i~~~~~~~pP~~v~qtA~t~~~~~l~~~~ 198 (854)
..|.|||+.. +. |..+|.|+++......... . ...+ .+.....+..|..|+|||=... .++.|..
T Consensus 7 ~~~INcGg~~---~~---d~~gr~w~~D~~~~~~g~~---~---~~~~--~~~~~~~~~~~~~lY~TaR~~~-~~~tY~f 71 (174)
T 2jwp_A 7 IWAVNAGGES---HV---DVHGIHYRKDPLEGRVGRA---S---DYGM--KLPILRSNPEDQVLYQTERYNE-DSFGYDI 71 (174)
T ss_dssp EEEEEETSSS---EE---ETTTEEECSSCSSTTCCCC---C---CCCT--TSCCSSSCHHHHHTTTCCCCCC-SCEEEEE
T ss_pred EEEEECCCCC---cc---CCCCCEEcCCcCcccCCcc---c---cccc--ceEecccCCCCchhhhhhccCC-CCeEEEE
Confidence 5699999843 22 6789999998532110100 0 0001 1111123456889999997643 4677777
Q ss_pred cCCCCCCcceEEEEeccccCCCCCCceEEEEEECCccccccccc
Q 003039 199 NLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIV 242 (854)
Q Consensus 199 ~~~~~~~~~y~~~yFae~~~~~~~~~R~F~v~~n~~~~~~~~~~ 242 (854)
+.+. +..+.+-|||+|+.. ...+.|+|||++||+...++..+
T Consensus 72 ~v~~-~G~Y~VrLhF~ei~~-~~~~~rvFdV~ing~~~l~~fdi 113 (174)
T 2jwp_A 72 PIKE-EGEYVLVLKFAEVYF-AQSQQKVFDVRVNGHTVVKDLDI 113 (174)
T ss_dssp ECCS-CEEEEEEEEEECCSC-CCSSSSCEEEEETTEEEEEEECH
T ss_pred EeCC-CeEEEEEEEEecccc-CCCCCeEeEEEECCEEeecCcCH
Confidence 7653 345459999999974 46789999999999988776544
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.41 E-value=1.1e-07 Score=99.75 Aligned_cols=78 Identities=26% Similarity=0.363 Sum_probs=44.8
Q ss_pred CCCeeEEEecCCCCCc--cCCcccccCccCcEEeccCCCCCCC--CCCCCCCCCccEEEeCCCccCCCCCc-------cc
Q 003039 340 QPSITVIHLSSKNLTG--NIPSDLTKLSSLVELWLDGNSLTGP--IPDFSGCPDLRIIHLEDNQLTGPLPS-------SL 408 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g--~lp~~i~~l~~L~~L~L~~N~l~~~--~p~~~~l~~L~~L~Ls~N~l~g~~P~-------~l 408 (854)
+++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. +..+..+ +|+.|+|++|.|.+.+|. .+
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccCcchhHHHHHH
Confidence 3466666666666665 4455556666666666666666654 1122333 666666666666655552 24
Q ss_pred cCCCCCceee
Q 003039 409 MNLPNLRELY 418 (854)
Q Consensus 409 ~~l~~L~~l~ 418 (854)
..+++|+.||
T Consensus 248 ~~~P~L~~LD 257 (267)
T 3rw6_A 248 ERFPKLLRLD 257 (267)
T ss_dssp HHCTTCCEES
T ss_pred HHCcccCeEC
Confidence 5556665543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.3e-08 Score=117.81 Aligned_cols=105 Identities=18% Similarity=0.078 Sum_probs=55.8
Q ss_pred CCeeEEEec----CCCCCcc-----CCcccccCccCcEEeccCCC--CCCCCC-CCC-CCCCccEEEeCCCccCC-CCCc
Q 003039 341 PSITVIHLS----SKNLTGN-----IPSDLTKLSSLVELWLDGNS--LTGPIP-DFS-GCPDLRIIHLEDNQLTG-PLPS 406 (854)
Q Consensus 341 ~~l~~L~L~----~n~l~g~-----lp~~i~~l~~L~~L~L~~N~--l~~~~p-~~~-~l~~L~~L~Ls~N~l~g-~~P~ 406 (854)
++|+.|+|+ .|++++. ++..+.++++|+.|+|++|. +++... .+. .+++|+.|+|++|++++ .++.
T Consensus 403 ~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 482 (592)
T 3ogk_B 403 KNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482 (592)
T ss_dssp CSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHH
T ss_pred CCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHH
Confidence 456666664 5556542 33335556666666665322 443222 222 25666666666666654 2344
Q ss_pred cccCCCCCceeecccccccccccccc---ccccccccccCcc
Q 003039 407 SLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNI 445 (854)
Q Consensus 407 ~l~~l~~L~~l~l~~N~l~g~~p~~l---~~~~~~l~~~~n~ 445 (854)
.+..+++|+.|+|++|+|++.....+ +++++.|++++|.
T Consensus 483 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 483 FSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 45566666666666666654322222 4455666666665
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.33 E-value=1e-07 Score=112.16 Aligned_cols=106 Identities=17% Similarity=0.126 Sum_probs=73.1
Q ss_pred CCCeeEEEecCCCCCccCCccccc-CccCcEEecc----CCCCCCCCC-----C-CCCCCCccEEEeCCC--ccCCCCCc
Q 003039 340 QPSITVIHLSSKNLTGNIPSDLTK-LSSLVELWLD----GNSLTGPIP-----D-FSGCPDLRIIHLEDN--QLTGPLPS 406 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~~i~~-l~~L~~L~L~----~N~l~~~~p-----~-~~~l~~L~~L~Ls~N--~l~g~~P~ 406 (854)
+++|+.|+|+.|++++..+..++. +++|+.|+|+ .|++++.+. . +.++++|+.|+|++| .+++..+.
T Consensus 377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~ 456 (592)
T 3ogk_B 377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS 456 (592)
T ss_dssp CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHH
T ss_pred CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHH
Confidence 467888888888888777777766 7888888885 677776432 2 455788888888743 36655555
Q ss_pred cccC-CCCCceeeccccccccc-ccccc--ccccccccccCcc
Q 003039 407 SLMN-LPNLRELYVQNNMLSGT-VPSSL--LSKNVVLNYAGNI 445 (854)
Q Consensus 407 ~l~~-l~~L~~l~l~~N~l~g~-~p~~l--~~~~~~l~~~~n~ 445 (854)
.++. +++|+.|+|++|++++. ++..+ +++++.|++++|+
T Consensus 457 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~ 499 (592)
T 3ogk_B 457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCC 499 (592)
T ss_dssp HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCC
T ss_pred HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCC
Confidence 5543 77888888888888753 33222 4667778888775
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.29 E-value=1e-06 Score=95.83 Aligned_cols=79 Identities=18% Similarity=0.093 Sum_probs=58.1
Q ss_pred CccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCc-eeeccccccccccccccc---ccccc
Q 003039 364 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR-ELYVQNNMLSGTVPSSLL---SKNVV 438 (854)
Q Consensus 364 l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~-~l~l~~N~l~g~~p~~l~---~~~~~ 438 (854)
+++|+.|+|++|+++..++. |.+|++|+.|+|++| ++..-+.+|.++++|+ .|++.+ +++ .|+...+ .+++.
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCE
Confidence 67888888888888876664 788888888888888 6634445788888888 888877 777 6766553 34566
Q ss_pred ccccCcc
Q 003039 439 LNYAGNI 445 (854)
Q Consensus 439 l~~~~n~ 445 (854)
+.+.+|.
T Consensus 302 l~l~~n~ 308 (329)
T 3sb4_A 302 VLATGDK 308 (329)
T ss_dssp EEECSSC
T ss_pred EEeCCCc
Confidence 6665553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.22 E-value=1.8e-07 Score=98.13 Aligned_cols=82 Identities=23% Similarity=0.371 Sum_probs=63.8
Q ss_pred EEecCCCCCccCCc----ccccCccCcEEeccCCCCCCC--CCC-CCCCCCccEEEeCCCccCCCCCccccCCC--CCce
Q 003039 346 IHLSSKNLTGNIPS----DLTKLSSLVELWLDGNSLTGP--IPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLP--NLRE 416 (854)
Q Consensus 346 L~L~~n~l~g~lp~----~i~~l~~L~~L~L~~N~l~~~--~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~--~L~~ 416 (854)
++++.|+.. .++. ...+|++|+.|+|++|+|+++ +|. +..+++|+.|+|++|+|++. ..+..+. +|+.
T Consensus 148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~ 224 (267)
T 3rw6_A 148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEE 224 (267)
T ss_dssp CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSE
T ss_pred ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcce
Confidence 566677543 3333 235689999999999999994 445 56799999999999999964 4455555 9999
Q ss_pred eecccccccccccc
Q 003039 417 LYVQNNMLSGTVPS 430 (854)
Q Consensus 417 l~l~~N~l~g~~p~ 430 (854)
|+|++|++++.+|.
T Consensus 225 L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 225 LWLDGNSLCDTFRD 238 (267)
T ss_dssp EECTTSTTGGGCSS
T ss_pred EEccCCcCccccCc
Confidence 99999999988873
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=8.4e-06 Score=85.63 Aligned_cols=134 Identities=17% Similarity=0.120 Sum_probs=94.1
Q ss_pred cccccCce-EEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 533 KIGSGGFG-VVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 533 ~iG~G~fg-~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
.+..|..| .||+.... ++..+++|+-... ....+..|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44556555 68987765 4667899986532 3456888999988874 33366788899989999999999999887
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG-------------------------------------------- 645 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------- 645 (854)
.+..... ......++.+++..|+.||+.
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 6654211 112234555566666666641
Q ss_pred -----------CCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 646 -----------CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 646 -----------~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
..+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01247999999999999988777899999875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.1e-08 Score=114.16 Aligned_cols=180 Identities=15% Similarity=0.037 Sum_probs=104.1
Q ss_pred ccceeeeecccCCCCC--CCcccchhhhceeccCCCCCccHHHHHHHHh-hcCCCCccCCCC-----CCCCCCCCCeeEe
Q 003039 264 LPFVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVIS-LYSSADWAQEGG-----DPCLPVPWSWLQC 335 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~--lpP~in~le~l~~L~l~~~~~~~~~~~~l~~-l~~~~~w~~~~~-----~pc~~~~~~~~~c 335 (854)
+++|+.|+|+.|.++. ++..+..+..|+.|.+.+| +....+..+.. +..++.+..... ..|......++..
T Consensus 288 ~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~ 366 (594)
T 2p1m_B 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366 (594)
T ss_dssp HTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHH
T ss_pred hCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHH
Confidence 5678888888888554 2233567788888888877 44444554443 445555522110 1222111111110
Q ss_pred CCCCCCCeeEEEecCCCCCccCCcccc-cCccCcEEecc--C----CCCCCCCCC------CCCCCCccEEEeCCCccCC
Q 003039 336 NSDPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLD--G----NSLTGPIPD------FSGCPDLRIIHLEDNQLTG 402 (854)
Q Consensus 336 ~~~~~~~l~~L~L~~n~l~g~lp~~i~-~l~~L~~L~L~--~----N~l~~~~p~------~~~l~~L~~L~Ls~N~l~g 402 (854)
-...+++|+.|+++.|++++..+..+. .+++|+.|+|+ + |++++.+.+ +.++++|+.|+|++ .+++
T Consensus 367 l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 001245778887888888766555565 47788888887 4 556543221 34566777777766 5554
Q ss_pred CCCccccC-CCCCceeecccccccccccccc---ccccccccccCcc
Q 003039 403 PLPSSLMN-LPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNI 445 (854)
Q Consensus 403 ~~P~~l~~-l~~L~~l~l~~N~l~g~~p~~l---~~~~~~l~~~~n~ 445 (854)
..+..++. +++|+.|+|++|.+++..+..+ +++++.|++++|+
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~ 492 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP 492 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCS
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCC
Confidence 44445554 6677777777777765544443 4566666666664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=9.1e-06 Score=87.37 Aligned_cols=135 Identities=20% Similarity=0.245 Sum_probs=89.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCC---ceeeEeeeee-ecCeEEEEEEeccCC
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR---NLVQFLGYCQ-EEGRSVLVYEFMHNG 607 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hp---nIv~l~g~~~-~~~~~~LV~E~~~~g 607 (854)
+.++.|....||+. +..+++|+-. .......+..|+++|+.+.+. .+.+.+.++. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888999987 5778888843 223356788999999998652 3556666664 445678999999998
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG------------------------------------------ 645 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 645 (854)
++.+.... .++...+..++.++++.|+.||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 87653211 112222333333444444443331
Q ss_pred ---------------CCCceecCCCCCCCEEEcC---CCc-EEEEeeecccc
Q 003039 646 ---------------CVPAIIHRDLKSSNILLDK---HMR-AKVSDFGLSKF 678 (854)
Q Consensus 646 ---------------~~~~ivHrDIkp~NILl~~---~~~-vkl~DFGla~~ 678 (854)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2236799999999999997 455 48999998753
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=2e-05 Score=77.23 Aligned_cols=97 Identities=14% Similarity=0.143 Sum_probs=66.3
Q ss_pred CceeccCCCCCcceeeecccCCceeEEEEEeeecCcCCCCCCCeeEEEeCCcee-eeEEec---CCCCceEEEEEEE---
Q 003039 1 MTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHW-STIVIS---DAATIEVRELIFL--- 73 (854)
Q Consensus 1 ~tlr~fp~~~~~~cy~~~~~~~~~y~~r~~~~~g~~d~~~~~p~fd~~~~~~~w-~~v~~~---~~~~~~~~e~~~~--- 73 (854)
.|-|.||. +.+|.+|+.++|+|+||.-|.--.|.. ....+||++|+|..- .-.+.. ....+.+.|..+.
T Consensus 58 ~TaR~~~~---~~tY~f~v~~~G~Y~VrLhF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~ 133 (174)
T 2jwp_A 58 QTERYNED---SFGYDIPIKEEGEYVLVLKFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKK 133 (174)
T ss_dssp TCCCCCCS---CEEEEEECCSCEEEEEEEEEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEET
T ss_pred hhhccCCC---CeEEEEEeCCCeEEEEEEEEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEec
Confidence 37789884 579999999999999999997666654 456799999999532 222221 1222444444443
Q ss_pred ----------ecCCCceEEEecCCCCCcceeeeeeeec
Q 003039 74 ----------ASSPKIDVCLSNATTGQPFISTLELRQF 101 (854)
Q Consensus 74 ----------~~~~~~~vcl~~~~~~~pfis~le~~~l 101 (854)
..+..+.|.|.....+.|||++||+.+-
T Consensus 134 ~~l~i~~~~~~~~g~L~I~f~p~~~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 134 GKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKG 171 (174)
T ss_dssp TEEEETTEEEECCSEEEEEEECSSSCSSSEEEEEEESS
T ss_pred CceeeeeeecccCCeEEEEEeccCCCCcEEEEEEEEeC
Confidence 2345677777753356799999999863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=6e-06 Score=90.64 Aligned_cols=79 Identities=4% Similarity=0.037 Sum_probs=54.8
Q ss_pred ccc-cccCceEEEEEEEC-------CCcEEEEEEEccCC---cccHHHHHHHHHHHccCC-C--CceeeEeeeeeec---
Q 003039 532 KKI-GSGGFGVVYYGKLK-------DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-H--RNLVQFLGYCQEE--- 594 (854)
Q Consensus 532 ~~i-G~G~fg~Vy~a~~~-------~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~-H--pnIv~l~g~~~~~--- 594 (854)
+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998764 26788899764322 111245778888888874 2 3466778877655
Q ss_pred CeEEEEEEeccCCCHH
Q 003039 595 GRSVLVYEFMHNGTLK 610 (854)
Q Consensus 595 ~~~~LV~E~~~~gsL~ 610 (854)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.96 E-value=2e-06 Score=85.40 Aligned_cols=118 Identities=10% Similarity=0.093 Sum_probs=85.1
Q ss_pred ccchhhhceeccCCCC-CccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEEecCCCCCcc----C
Q 003039 283 LLNAMEINKYLERNDG-SIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGN----I 357 (854)
Q Consensus 283 ~in~le~l~~L~l~~~-~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~L~~n~l~g~----l 357 (854)
.+.....|+.|+|+.| .+.......+..... ..++|+.|+|++|+|... +
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~-------------------------~~~~L~~L~Ls~n~i~~~g~~~l 85 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALK-------------------------TNTYVKKFSIVGTRSNDPVAFAL 85 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHT-------------------------TCCSCCEEECTTSCCCHHHHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHH-------------------------hCCCcCEEECcCCCCChHHHHHH
Confidence 3455566888888888 888777776665421 113688999999998742 4
Q ss_pred CcccccCccCcEEeccCCCCCCC-----CCCCCCCCCccEEEe--CCCccCCC----CCccccCCCCCceeeccccccc
Q 003039 358 PSDLTKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHL--EDNQLTGP----LPSSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 358 p~~i~~l~~L~~L~L~~N~l~~~-----~p~~~~l~~L~~L~L--s~N~l~g~----~P~~l~~l~~L~~l~l~~N~l~ 425 (854)
...+...++|+.|+|++|.|... ...+...+.|++|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 86 ~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 86 AEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 44566668899999999998763 234667788999999 78888743 3455666688999999988876
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.88 E-value=2.1e-06 Score=94.58 Aligned_cols=153 Identities=15% Similarity=0.184 Sum_probs=90.4
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
.+.|+.|+|..+....+|+ +. +..|+.|.+..+.+....+..+... .+|+|
T Consensus 171 ~P~L~~L~L~g~~~l~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~---------------------------~lp~L 221 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNLSIGK-KP-RPNLKSLEIISGGLPDSVVEDILGS---------------------------DLPNL 221 (362)
T ss_dssp CTTCCEEEEECCBTCBCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHS---------------------------BCTTC
T ss_pred CCCCcEEEEeCCCCceecc-cc-CCCCcEEEEecCCCChHHHHHHHHc---------------------------cCCCC
Confidence 3567777887765456666 33 6778888887777776665555421 23466
Q ss_pred eEEEecC--CCCCcc-----CCccc--ccCccCcEEeccCCCCCCCCC----CCCCCCCccEEEeCCCccCCC----CCc
Q 003039 344 TVIHLSS--KNLTGN-----IPSDL--TKLSSLVELWLDGNSLTGPIP----DFSGCPDLRIIHLEDNQLTGP----LPS 406 (854)
Q Consensus 344 ~~L~L~~--n~l~g~-----lp~~i--~~l~~L~~L~L~~N~l~~~~p----~~~~l~~L~~L~Ls~N~l~g~----~P~ 406 (854)
+.|+|+. |...|. +...+ ..+++|+.|+|++|.+....+ ....+++|+.|+|+.|+|++. ++.
T Consensus 222 ~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~ 301 (362)
T 2ra8_A 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLD 301 (362)
T ss_dssp CEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHT
T ss_pred cEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHh
Confidence 7776642 211111 11122 246788888888887764322 123467888888888888753 444
Q ss_pred cccCCCCCceeeccccccccccccccccc-cccccccCcc
Q 003039 407 SLMNLPNLRELYVQNNMLSGTVPSSLLSK-NVVLNYAGNI 445 (854)
Q Consensus 407 ~l~~l~~L~~l~l~~N~l~g~~p~~l~~~-~~~l~~~~n~ 445 (854)
.+..+++|+.|+|++|.|+...-..+... ...+++++|.
T Consensus 302 ~L~~l~~L~~L~L~~n~i~d~~~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 302 HVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp THHHHTTCSEEECCSBBCCHHHHHHHHHHCCSEEECCSBC
T ss_pred hcccCCcceEEECCCCcCCHHHHHHHHHHcCCEEEecCCc
Confidence 45567888888888888774332222221 2445555554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.78 E-value=2.8e-06 Score=84.24 Aligned_cols=106 Identities=18% Similarity=0.259 Sum_probs=80.7
Q ss_pred CCCeeEEEecCC-CCCcc----CCcccccCccCcEEeccCCCCCCC----C-CCCCCCCCccEEEeCCCccCCC----CC
Q 003039 340 QPSITVIHLSSK-NLTGN----IPSDLTKLSSLVELWLDGNSLTGP----I-PDFSGCPDLRIIHLEDNQLTGP----LP 405 (854)
Q Consensus 340 ~~~l~~L~L~~n-~l~g~----lp~~i~~l~~L~~L~L~~N~l~~~----~-p~~~~l~~L~~L~Ls~N~l~g~----~P 405 (854)
.++|+.|+|++| +|... +...+...++|++|+|++|+|... + ..+...+.|++|+|++|+|... +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 358999999999 88742 455667789999999999999752 1 1255568899999999999843 56
Q ss_pred ccccCCCCCceeec--ccccccccccccc------ccccccccccCcc
Q 003039 406 SSLMNLPNLRELYV--QNNMLSGTVPSSL------LSKNVVLNYAGNI 445 (854)
Q Consensus 406 ~~l~~l~~L~~l~l--~~N~l~g~~p~~l------~~~~~~l~~~~n~ 445 (854)
..+...++|+.|+| ++|.|...--..+ ...+..|++++|.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~ 162 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 162 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence 67888899999999 8899985432222 2456778887774
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.75 E-value=5.9e-06 Score=90.91 Aligned_cols=106 Identities=18% Similarity=0.308 Sum_probs=74.5
Q ss_pred CCCeeEEEecCCCCCccCCcccc--cCccCcEEeccC--CCCCCC--C----CCC--CCCCCccEEEeCCCccCCCCCcc
Q 003039 340 QPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDG--NSLTGP--I----PDF--SGCPDLRIIHLEDNQLTGPLPSS 407 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~~i~--~l~~L~~L~L~~--N~l~~~--~----p~~--~~l~~L~~L~Ls~N~l~g~~P~~ 407 (854)
+++|+.|+|..++++...-..+. .|++|+.|+|+. |...+. + +.+ ..+++|+.|+|++|++.+..+..
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 45899999999888754444555 789999999863 332221 1 223 34889999999999988544444
Q ss_pred cc---CCCCCceeeccccccccc----ccccc--ccccccccccCcc
Q 003039 408 LM---NLPNLRELYVQNNMLSGT----VPSSL--LSKNVVLNYAGNI 445 (854)
Q Consensus 408 l~---~l~~L~~l~l~~N~l~g~----~p~~l--~~~~~~l~~~~n~ 445 (854)
+. .+++|+.|+|+.|.|++. ++..+ +.++..|+++.|.
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence 43 578999999999999864 33332 4567888887773
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.0001 Score=79.93 Aligned_cols=140 Identities=14% Similarity=0.216 Sum_probs=79.3
Q ss_pred cccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCC-----CCceeeEe-e--eeeecCeEEEEEEec
Q 003039 533 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----HRNLVQFL-G--YCQEEGRSVLVYEFM 604 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-----HpnIv~l~-g--~~~~~~~~~LV~E~~ 604 (854)
.|+.|..+.||+....+| .+++|+.... ...+..|+.+++.+. .|.++... | +....+..++||+|+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 455677889999987644 5899988642 234445566555553 24443311 1 123456789999999
Q ss_pred cCCCHH--------------hhhccccc----c-c-----ccccHHHH-------------------------------H
Q 003039 605 HNGTLK--------------EHLYGTLT----H-E-----QRINWIKR-------------------------------L 629 (854)
Q Consensus 605 ~~gsL~--------------~~L~~~~~----~-~-----~~l~~~~~-------------------------------~ 629 (854)
+|..+. ..+|.... . . ..-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 11121100 0 0 00112110 0
Q ss_pred HHHHHHHHHHHHHHh----------CCCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 630 EIAEDAAKGIEYLHT----------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 630 ~i~~~ia~gL~yLH~----------~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
.+...+..++++|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111234446667763 023489999999999999888899999999764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.72 E-value=2.7e-06 Score=99.91 Aligned_cols=37 Identities=22% Similarity=0.314 Sum_probs=18.6
Q ss_pred CCCCccEEEeCCCccCCCCC-ccccCCCCCceeecccc
Q 003039 386 GCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNN 422 (854)
Q Consensus 386 ~l~~L~~L~Ls~N~l~g~~P-~~l~~l~~L~~l~l~~N 422 (854)
.+++|+.|+|++|.+++..+ ..+..+++|+.|++++|
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 324 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc
Confidence 34555555665555443221 12345555555555555
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00011 Score=81.81 Aligned_cols=74 Identities=15% Similarity=0.119 Sum_probs=48.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCc-------ccHHHHHHHHHHHccCCC--Cc-eeeEeeeeeecCeEEEE
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-------QGKREFTNEVTLLSRIHH--RN-LVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-------~~~~~~~~Ev~~L~~l~H--pn-Iv~l~g~~~~~~~~~LV 600 (854)
+.||.|.++.||++... +++.++||....... .....+..|.++++.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999764 468899998653211 123456778888887742 33 3355544 34456899
Q ss_pred EEeccCC
Q 003039 601 YEFMHNG 607 (854)
Q Consensus 601 ~E~~~~g 607 (854)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00015 Score=76.86 Aligned_cols=73 Identities=21% Similarity=0.225 Sum_probs=54.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCC---CceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH---RNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~H---pnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
+.+|.|..+.||+.++.+|+.|.||+-..........|..|++.|+.+.. --+.+.+++. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 56899999999999999999999998765544445678889998888742 1234445432 2478999998764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.61 E-value=6.5e-05 Score=83.91 Aligned_cols=169 Identities=12% Similarity=0.042 Sum_probs=103.5
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeC-CCCCCC
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN-SDPQPS 342 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~-~~~~~~ 342 (854)
..+|+.++|..|.++.+|+..-....|+.+.+.++ +..+...++.....+....... ....++-. ..+ .+
T Consensus 179 c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~-------~l~~I~~~aF~~-~~ 249 (401)
T 4fdw_A 179 CYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE-------NVSTIGQEAFRE-SG 249 (401)
T ss_dssp CTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT-------TCCEECTTTTTT-CC
T ss_pred cccCCeeecCCCcceEechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC-------CccCcccccccc-CC
Confidence 45677788888888888877444667777777643 3332233333333333331100 01111110 111 46
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCC-----CCCC-CCCCCCCccEEEeCCCccCCCCCccccCCCCCce
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-----GPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 416 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~-----~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 416 (854)
|+.|.| .++++..-+..|.+|++|+.|+|.+|.+. ...+ .|.+|++|+.++|. |.++..-..+|.+|++|+.
T Consensus 250 L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~ 327 (401)
T 4fdw_A 250 ITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQ 327 (401)
T ss_dssp CSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCE
T ss_pred ccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccE
Confidence 888888 45566333557888899999999888876 2222 38888899999988 4477333457888888999
Q ss_pred eecccccccccccccccc--ccccccccCcc
Q 003039 417 LYVQNNMLSGTVPSSLLS--KNVVLNYAGNI 445 (854)
Q Consensus 417 l~l~~N~l~g~~p~~l~~--~~~~l~~~~n~ 445 (854)
|.|..| ++ .|+...+. ++..+.+.+|.
T Consensus 328 l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~ 356 (401)
T 4fdw_A 328 LTIPAN-VT-QINFSAFNNTGIKEVKVEGTT 356 (401)
T ss_dssp EEECTT-CC-EECTTSSSSSCCCEEEECCSS
T ss_pred EEECcc-cc-EEcHHhCCCCCCCEEEEcCCC
Confidence 888544 66 66665533 45666777663
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00039 Score=74.68 Aligned_cols=138 Identities=20% Similarity=0.234 Sum_probs=90.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCC---CCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~---HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
+.|+.|....+|+.... +..+++|+.... ....+..|++.|+.+. ...+.+.++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 45889999999998864 778899987532 3566888999888884 3567788888887888999999999876
Q ss_pred HH--------h---hhccccc-c-----------------cccccHHHHH---HHH----------------HHHHHH-H
Q 003039 609 LK--------E---HLYGTLT-H-----------------EQRINWIKRL---EIA----------------EDAAKG-I 639 (854)
Q Consensus 609 L~--------~---~L~~~~~-~-----------------~~~l~~~~~~---~i~----------------~~ia~g-L 639 (854)
+. + .||.... . ...-+|.... ++. ..+... .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 42 1 1222111 0 0011343221 111 111111 2
Q ss_pred HHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeee
Q 003039 640 EYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFG 674 (854)
Q Consensus 640 ~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 674 (854)
..|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23421 2246899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00014 Score=81.70 Aligned_cols=79 Identities=15% Similarity=0.146 Sum_probs=48.2
Q ss_pred CceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeecccccccccCccccccC---cCCCcchhhhHHHHHHHHH
Q 003039 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELI 724 (854)
Q Consensus 648 ~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~~DVwSlGvvl~ell 724 (854)
+.++|+|+++.|||++.++ ++|+||+.+...............-...|++|+..... ......++......+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 99999998864321111100000012346666655321 1112345667888888887
Q ss_pred hCC
Q 003039 725 SGQ 727 (854)
Q Consensus 725 tG~ 727 (854)
++.
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 763
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00043 Score=77.17 Aligned_cols=154 Identities=11% Similarity=0.022 Sum_probs=99.5
Q ss_pred ceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeE-eCCCCCCCe
Q 003039 266 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQPSI 343 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~-c~~~~~~~l 343 (854)
+|+.+.|. +.++.+++. +..+..|+.+.+..+ +..+...++.. ..+..... |.....++ ....++++|
T Consensus 204 ~L~~l~lp-~~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-------p~~i~~I~~~aF~~c~~L 273 (401)
T 4fdw_A 204 GIEEVLLP-VTLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-------PNGVTNIASRAFYYCPEL 273 (401)
T ss_dssp CCSEEECC-TTCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-------ETTCCEECTTTTTTCTTC
T ss_pred ccCEEEeC-CchheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-------CCCccEEChhHhhCCCCC
Confidence 45566665 447777766 777778888888754 22111111111 11211110 00011111 123445689
Q ss_pred eEEEecCCCCC-----ccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCcee
Q 003039 344 TVIHLSSKNLT-----GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417 (854)
Q Consensus 344 ~~L~L~~n~l~-----g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l 417 (854)
+.|+|.+|.+. ..-+..|.+|++|+.|.|. |+++..... |.+|++|+.|+|..| ++..-+.+|.++ +|+.|
T Consensus 274 ~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l 350 (401)
T 4fdw_A 274 AEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEV 350 (401)
T ss_dssp CEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEE
T ss_pred CEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEE
Confidence 99999998875 2344578899999999999 457765554 899999999999666 663445689999 99999
Q ss_pred eccccccccccccccc
Q 003039 418 YVQNNMLSGTVPSSLL 433 (854)
Q Consensus 418 ~l~~N~l~g~~p~~l~ 433 (854)
++++|.+. .++...+
T Consensus 351 ~l~~n~~~-~l~~~~F 365 (401)
T 4fdw_A 351 KVEGTTPP-QVFEKVW 365 (401)
T ss_dssp EECCSSCC-BCCCSSC
T ss_pred EEcCCCCc-ccccccc
Confidence 99999887 5655543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00012 Score=71.33 Aligned_cols=85 Identities=12% Similarity=0.086 Sum_probs=65.2
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCC-CCC-CCCCCCCC----CCccEEEeCCCc-cCCCCCccccCCCC
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS-LTG-PIPDFSGC----PDLRIIHLEDNQ-LTGPLPSSLMNLPN 413 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~-l~~-~~p~~~~l----~~L~~L~Ls~N~-l~g~~P~~l~~l~~ 413 (854)
.+|+.|||+++.++..--..|.+|++|+.|+|++|. |+. .+..++.+ ++|++|+|+++. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 379999999999885544567899999999999995 654 23335554 479999999975 77433346788999
Q ss_pred Cceeeccccc-cc
Q 003039 414 LRELYVQNNM-LS 425 (854)
Q Consensus 414 L~~l~l~~N~-l~ 425 (854)
|+.|+|+++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999986 54
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0034 Score=70.58 Aligned_cols=72 Identities=14% Similarity=0.316 Sum_probs=49.1
Q ss_pred ccccccCceEEEEEEECC--------CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCce-eeEeeeeeecCeEEEEEE
Q 003039 532 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~--------~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnI-v~l~g~~~~~~~~~LV~E 602 (854)
+.|+.|....+|+....+ ++.+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457888889999998753 578999987432 112455678888888753333 566766542 38999
Q ss_pred eccCCCH
Q 003039 603 FMHNGTL 609 (854)
Q Consensus 603 ~~~~gsL 609 (854)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.008 Score=64.81 Aligned_cols=141 Identities=14% Similarity=0.134 Sum_probs=71.6
Q ss_pred cccccCceE-EEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCC--CceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 533 KIGSGGFGV-VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 533 ~iG~G~fg~-Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
.|+.|.... +|+....+++.+++|...... ...+..|+.+++.+.. -.+.+++.+....+ +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 455555444 667665446777777654321 1234556676666632 23455666544333 789999977666
Q ss_pred Hhhhcccc---------------------cc-ccccc-------------HHHH--H-----HHHHHHHHHHHHHH---h
Q 003039 610 KEHLYGTL---------------------TH-EQRIN-------------WIKR--L-----EIAEDAAKGIEYLH---T 644 (854)
Q Consensus 610 ~~~L~~~~---------------------~~-~~~l~-------------~~~~--~-----~i~~~ia~gL~yLH---~ 644 (854)
.+.+.... .. ...++ |... + .....+...++.+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 54332110 00 00011 0000 0 00011122222221 1
Q ss_pred CCCCceecCCCCCCCEEEcCC----CcEEEEeeecccc
Q 003039 645 GCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKF 678 (854)
Q Consensus 645 ~~~~~ivHrDIkp~NILl~~~----~~vkl~DFGla~~ 678 (854)
.....++|||+.+.|||++.+ ..+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123489999999999999875 6899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0027 Score=68.07 Aligned_cols=143 Identities=15% Similarity=0.198 Sum_probs=79.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCc--eeeEeee------eeecCeEEEEEEe
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGY------CQEEGRSVLVYEF 603 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hpn--Iv~l~g~------~~~~~~~~LV~E~ 603 (854)
+.|+.|....+|+....+| .+++|+.... .....+..|+.+++.+...+ +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3467788889999987655 6889988652 12345566777777664222 2233321 1224567899999
Q ss_pred ccCCCHHh--------------hhccc---cccc-----ccccHHHHHH------------HHHHHHHHHHHHHhC----
Q 003039 604 MHNGTLKE--------------HLYGT---LTHE-----QRINWIKRLE------------IAEDAAKGIEYLHTG---- 645 (854)
Q Consensus 604 ~~~gsL~~--------------~L~~~---~~~~-----~~l~~~~~~~------------i~~~ia~gL~yLH~~---- 645 (854)
++|..+.. .+|.. .... ....|..... +...+...++++++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865321 01211 0000 0012322110 111244455566532
Q ss_pred CCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 646 ~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
...+++|+|+++.|||++.+..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12479999999999999987666899998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0026 Score=58.74 Aligned_cols=36 Identities=33% Similarity=0.339 Sum_probs=18.6
Q ss_pred CccEEEeCCCccCCCCCccccCCCCCceeecccccc
Q 003039 389 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424 (854)
Q Consensus 389 ~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l 424 (854)
+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 355555666665522223455555555555555544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0025 Score=58.96 Aligned_cols=56 Identities=32% Similarity=0.520 Sum_probs=47.6
Q ss_pred eEEEecCCCCC-ccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccC
Q 003039 344 TVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLT 401 (854)
Q Consensus 344 ~~L~L~~n~l~-g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~ 401 (854)
..++.++++|+ ..+|..|. .+|+.|+|++|+|+.++++ |..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 37888999997 46776654 4799999999999998886 788999999999999876
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0034 Score=66.75 Aligned_cols=70 Identities=11% Similarity=0.140 Sum_probs=42.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCce-eeEeeeeeecCeEEEEEEec-cCCCH
Q 003039 532 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYEFM-HNGTL 609 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnI-v~l~g~~~~~~~~~LV~E~~-~~gsL 609 (854)
+.|+.|....+|+. +.+++|+....... ......|+.+++.+...++ .++++++. +.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCccC
Confidence 56888999999998 56888887543211 1223467777776643222 35555443 3346899999 55444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.50 E-value=0.012 Score=63.06 Aligned_cols=141 Identities=13% Similarity=0.125 Sum_probs=80.0
Q ss_pred cccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCc--eeeEeee-----eeecCeEEEEEEecc
Q 003039 533 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGY-----CQEEGRSVLVYEFMH 605 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hpn--Iv~l~g~-----~~~~~~~~LV~E~~~ 605 (854)
.++ |....||+....+|+.+++|+..... .....+..|..+++.+.... +.+++.. ....+..+++|++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 77789999877777789999986332 23456777888887774222 3334432 123456688999998
Q ss_pred CCCHHh-----------h---hccccc-----ccccccHHHH----HH---------------HHHHHHHHHHHHHhC--
Q 003039 606 NGTLKE-----------H---LYGTLT-----HEQRINWIKR----LE---------------IAEDAAKGIEYLHTG-- 645 (854)
Q Consensus 606 ~gsL~~-----------~---L~~~~~-----~~~~l~~~~~----~~---------------i~~~ia~gL~yLH~~-- 645 (854)
|..+.. . +|.... ....+++... .. +...+...++.+.+.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 754321 0 111100 0011111110 00 011111223333221
Q ss_pred --CCCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 646 --CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 646 --~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 224689999999999999 4 89999998775
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0061 Score=67.11 Aligned_cols=141 Identities=16% Similarity=0.215 Sum_probs=80.0
Q ss_pred ccccccCceEEEEEEEC--------CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCc-eeeEeeeeeecCeEEEEEE
Q 003039 532 KKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~--------~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hpn-Iv~l~g~~~~~~~~~LV~E 602 (854)
+.|..|-...+|+.... +++.+++|+... .......+.+|.++++.+.-.+ ..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 35667778889998874 247899998532 2233556678999888874222 3566666653 28999
Q ss_pred eccCCCHHhh-----------------hcccccc-cccc--cHHHHHHHHHHHH-------------------HHHHHH-
Q 003039 603 FMHNGTLKEH-----------------LYGTLTH-EQRI--NWIKRLEIAEDAA-------------------KGIEYL- 642 (854)
Q Consensus 603 ~~~~gsL~~~-----------------L~~~~~~-~~~l--~~~~~~~i~~~ia-------------------~gL~yL- 642 (854)
|++|.+|..- ||..... .... -|.+..++..++. ..+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655311 1111000 1111 1233333333321 122333
Q ss_pred ---HhC-CCCceecCCCCCCCEEEcCC----CcEEEEeeeccc
Q 003039 643 ---HTG-CVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSK 677 (854)
Q Consensus 643 ---H~~-~~~~ivHrDIkp~NILl~~~----~~vkl~DFGla~ 677 (854)
... ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 221 12378999999999999876 789999998774
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0095 Score=67.36 Aligned_cols=73 Identities=12% Similarity=0.126 Sum_probs=47.3
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCce-eeEeeeeeecCeEEEEEEeccCCCH
Q 003039 532 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnI-v~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
+.|+.|-...+|+....+ +..+++|+..... ...-+...|..+++.+...++ .++++++. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467888889999998875 4788899874332 111122578888888865444 46777663 2 259999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0088 Score=65.57 Aligned_cols=73 Identities=15% Similarity=0.166 Sum_probs=43.5
Q ss_pred ccccccCceEEEEEEECC---------CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCc-eeeEeeeeeecCeEEEEE
Q 003039 532 KKIGSGGFGVVYYGKLKD---------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~---------~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hpn-Iv~l~g~~~~~~~~~LV~ 601 (854)
+.|+.|....+|+....+ ++.+++|+..... ....+...|.++++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457788888999998764 2688888865432 11112457888887774333 33566544 2 26899
Q ss_pred EeccCCCH
Q 003039 602 EFMHNGTL 609 (854)
Q Consensus 602 E~~~~gsL 609 (854)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.72 E-value=0.045 Score=59.18 Aligned_cols=31 Identities=16% Similarity=0.334 Sum_probs=27.6
Q ss_pred CceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 648 ~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.54 E-value=0.0028 Score=61.57 Aligned_cols=92 Identities=10% Similarity=0.070 Sum_probs=63.7
Q ss_pred cCCcccccCccCcEEeccCCCCCC-CCCCCCCCCCccEEEeCCCc-cCCCCCccccCC----CCCceeeccccc-ccccc
Q 003039 356 NIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ-LTGPLPSSLMNL----PNLRELYVQNNM-LSGTV 428 (854)
Q Consensus 356 ~lp~~i~~l~~L~~L~L~~N~l~~-~~p~~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l----~~L~~l~l~~N~-l~g~~ 428 (854)
.+|.....--+|+.|||+++.|+. .+..+.+|++|+.|+|+++. |+..--..|+.+ ++|+.|+|++|. +|..-
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 345433233479999999999875 34557899999999999995 774333446664 379999999985 77321
Q ss_pred cccc--ccccccccccCcccc
Q 003039 429 PSSL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 429 p~~l--~~~~~~l~~~~n~~l 447 (854)
=..+ +++++.|++++.+..
T Consensus 132 l~~L~~~~~L~~L~L~~c~~I 152 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDLPGV 152 (176)
T ss_dssp HHHGGGCTTCCEEEEESCTTC
T ss_pred HHHHhcCCCCCEEECCCCCCC
Confidence 1112 567788888877654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.97 E-value=0.0073 Score=59.82 Aligned_cols=82 Identities=11% Similarity=0.081 Sum_probs=41.5
Q ss_pred CeeEEEecCCCCCcc----CCcccccCccCcEEeccCCCCCCCC-----CCCCCCCCccEEEeCCCcc---CC----CCC
Q 003039 342 SITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPI-----PDFSGCPDLRIIHLEDNQL---TG----PLP 405 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~----lp~~i~~l~~L~~L~L~~N~l~~~~-----p~~~~l~~L~~L~Ls~N~l---~g----~~P 405 (854)
.|+.|+|++|+|... |...+..-+.|+.|+|++|.|...- ..+..-+.|+.|+|++|.. .. .+-
T Consensus 71 ~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia 150 (197)
T 1pgv_A 71 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMM 150 (197)
T ss_dssp CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHH
T ss_pred CcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHH
Confidence 467777777777632 2223334466777777777765321 1233344566666665422 21 122
Q ss_pred ccccCCCCCceeeccccc
Q 003039 406 SSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 406 ~~l~~l~~L~~l~l~~N~ 423 (854)
..+..-+.|+.|+++.|.
T Consensus 151 ~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 151 MAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCCcCeEeccCCC
Confidence 333444555555555444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.26 E-value=0.38 Score=47.98 Aligned_cols=102 Identities=14% Similarity=0.065 Sum_probs=65.8
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
-+|.+.|.. .+..+++.+++.++.|.+.+|.-+-.+.. . ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 378888853 36789999999999999999877622100 1 1223346899999999888763 1110
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 728 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~ 728 (854)
.....+.|||... ...+.+.=|||+|+++|..+-=..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0123466888763 455678899999999999887433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.23 E-value=0.079 Score=59.06 Aligned_cols=73 Identities=14% Similarity=0.140 Sum_probs=46.7
Q ss_pred ccccccCceEEEEEEECC--------CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCc-eeeEeeeeeecCeEEEEEE
Q 003039 532 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~--------~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~Hpn-Iv~l~g~~~~~~~~~LV~E 602 (854)
+.+..|-...+|+....+ ++.+++|+..... ...-+..+|.++++.+...+ ..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 456778888999998763 5789999864332 11223457888887774222 345555332 268999
Q ss_pred eccCCCH
Q 003039 603 FMHNGTL 609 (854)
Q Consensus 603 ~~~~gsL 609 (854)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.54 E-value=0.014 Score=57.74 Aligned_cols=82 Identities=15% Similarity=0.271 Sum_probs=59.4
Q ss_pred CCeeEEEecCC-CCCc----cCCcccccCccCcEEeccCCCCCCCCC-C----CCCCCCccEEEeCCCccCCC----CCc
Q 003039 341 PSITVIHLSSK-NLTG----NIPSDLTKLSSLVELWLDGNSLTGPIP-D----FSGCPDLRIIHLEDNQLTGP----LPS 406 (854)
Q Consensus 341 ~~l~~L~L~~n-~l~g----~lp~~i~~l~~L~~L~L~~N~l~~~~p-~----~~~l~~L~~L~Ls~N~l~g~----~P~ 406 (854)
+.|+.|+|++| +|.. .|-..+..-+.|+.|+|++|+|...-- . +..-+.|+.|+|++|+|... +-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 37999999986 7753 244456667899999999999974211 1 33457899999999998842 334
Q ss_pred cccCCCCCceeecccc
Q 003039 407 SLMNLPNLRELYVQNN 422 (854)
Q Consensus 407 ~l~~l~~L~~l~l~~N 422 (854)
.+..-+.|+.|+|++|
T Consensus 121 aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTTTCCCSEEECCCC
T ss_pred HHhhCCceeEEECCCC
Confidence 5556677999999865
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=92.88 E-value=0.17 Score=55.62 Aligned_cols=80 Identities=19% Similarity=0.156 Sum_probs=54.4
Q ss_pred CCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCccCCCCCccccCCCCCceee
Q 003039 340 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 418 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~ 418 (854)
..+|+.+.+.++ ++..-...|.++++|+.++|.++ ++.... .|.+|.+|+.++|..| ++..-..+|.++++|+.++
T Consensus 296 ~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 296 CSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVE 372 (394)
T ss_dssp CTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEE
T ss_pred cccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEE
Confidence 346778887654 66222346778888888888654 554444 3788888888888776 6623345788888888887
Q ss_pred cccc
Q 003039 419 VQNN 422 (854)
Q Consensus 419 l~~N 422 (854)
|..|
T Consensus 373 lp~~ 376 (394)
T 4fs7_A 373 LPKR 376 (394)
T ss_dssp EEGG
T ss_pred ECCC
Confidence 7544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.10 E-value=0.29 Score=53.73 Aligned_cols=75 Identities=13% Similarity=0.290 Sum_probs=32.6
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
.|+.+.+.++-.+ .-...+.++++|+.+.+. +.++..... |.+|.+|+.++|..| ++..-..+|.++.+|+.+.|
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 4455554433222 222344445555555553 233332222 455555555555433 33112234555555555555
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=91.08 E-value=0.37 Score=52.44 Aligned_cols=75 Identities=17% Similarity=0.327 Sum_probs=42.1
Q ss_pred CeeEEEecCCCCCccCC-cccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCC-ccccCCCCCceee
Q 003039 342 SITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELY 418 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp-~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P-~~l~~l~~L~~l~ 418 (854)
+|+.+.+.++ ++ .++ ..|.++++|+.+.|.+|.++...+. |.+|.+|+.+.|..| ++ .|. .+|.++++|+.+.
T Consensus 264 ~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ 339 (379)
T 4h09_A 264 ALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTIS 339 (379)
T ss_dssp TCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCC
T ss_pred hhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEE
Confidence 4555655432 44 233 3455666666666666666554443 666666666666544 44 333 3566666666665
Q ss_pred cc
Q 003039 419 VQ 420 (854)
Q Consensus 419 l~ 420 (854)
+.
T Consensus 340 ip 341 (379)
T 4h09_A 340 YP 341 (379)
T ss_dssp CC
T ss_pred EC
Confidence 54
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=90.68 E-value=0.52 Score=51.24 Aligned_cols=98 Identities=15% Similarity=0.209 Sum_probs=69.1
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
..|+.+.+..+ ++..-...+.++.+|+.+.+..+ +..... .|.++.+|+.+.|.+|.++..-..+|.++.+|+.+.|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 46888888765 66333456778899999999755 544443 3888999999999999888333458999999999998
Q ss_pred cccccccccccccc---ccccccccc
Q 003039 420 QNNMLSGTVPSSLL---SKNVVLNYA 442 (854)
Q Consensus 420 ~~N~l~g~~p~~l~---~~~~~l~~~ 442 (854)
..+ ++ .|....+ .+|..+.+.
T Consensus 318 p~~-l~-~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 318 PTA-LK-TIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CTT-CC-EECTTTTTTCTTCCCCCCC
T ss_pred Ccc-cc-EEHHHHhhCCCCCCEEEEC
Confidence 654 66 6666553 334444443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=89.94 E-value=0.57 Score=51.38 Aligned_cols=80 Identities=24% Similarity=0.405 Sum_probs=61.6
Q ss_pred CCeeEEEecCCCCCccCC-cccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCccCCCCC-ccccCCCCCcee
Q 003039 341 PSITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLREL 417 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp-~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P-~~l~~l~~L~~l 417 (854)
+.|+.+.+. ++++ .|+ ..|.++++|+.+.|..| ++..-. .|.+|.+|+.+.|..| ++ .|. .+|.++++|+.+
T Consensus 288 ~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i 362 (394)
T 4gt6_A 288 PALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNI 362 (394)
T ss_dssp TTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEE
T ss_pred cccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEE
Confidence 478888886 5666 454 46788999999999865 554444 3899999999999765 66 454 589999999999
Q ss_pred eccccccc
Q 003039 418 YVQNNMLS 425 (854)
Q Consensus 418 ~l~~N~l~ 425 (854)
++.+|...
T Consensus 363 ~~~~~~~~ 370 (394)
T 4gt6_A 363 EYSGSRSQ 370 (394)
T ss_dssp EESSCHHH
T ss_pred EECCceee
Confidence 99887643
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=89.02 E-value=0.78 Score=50.26 Aligned_cols=96 Identities=15% Similarity=0.086 Sum_probs=61.9
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
..++.+.+..+.+. ...+..+.+|+.+.+.+| ++.... .|.++.+|+.++|.++ ++..-..+|.++++|+.+.|
T Consensus 276 ~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~l 350 (394)
T 4fs7_A 276 SGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINF 350 (394)
T ss_dssp TTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECC
T ss_pred cccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEE
Confidence 35666666554322 235677888888888765 554433 3788899999998754 66233457888899999988
Q ss_pred cccccccccccccc---cccccccccC
Q 003039 420 QNNMLSGTVPSSLL---SKNVVLNYAG 443 (854)
Q Consensus 420 ~~N~l~g~~p~~l~---~~~~~l~~~~ 443 (854)
..| ++ .|+...+ .+|+.+.+..
T Consensus 351 p~~-l~-~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 351 PLS-LR-KIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp CTT-CC-EECTTTBTTCTTCCEEEEEG
T ss_pred Ccc-cc-EehHHHhhCCCCCCEEEECC
Confidence 766 66 6666553 3344444433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.93 E-value=1.4 Score=48.47 Aligned_cols=29 Identities=31% Similarity=0.484 Sum_probs=24.4
Q ss_pred ceecCCCCCCCEEE------cCCCcEEEEeeeccc
Q 003039 649 AIIHRDLKSSNILL------DKHMRAKVSDFGLSK 677 (854)
Q Consensus 649 ~ivHrDIkp~NILl------~~~~~vkl~DFGla~ 677 (854)
.++|+|+.+.|||+ +++..++++||-.|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 445679999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.55 E-value=4 Score=40.51 Aligned_cols=117 Identities=9% Similarity=0.121 Sum_probs=78.7
Q ss_pred CCCceeeEeeeeeecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 003039 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 659 (854)
Q Consensus 580 ~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~N 659 (854)
.||+.+.. .+-...+...+.|+.-+.+ ..+ ..-..++...+++++.+|+....+++.. +|--++|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f-----~~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPF-----DNIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTS--EEG-----GGGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCccc--CCH-----HHHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 67888865 4555566666666544322 111 2234567778899999999888777654 788899999
Q ss_pred EEEcCCCcEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccc
Q 003039 660 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 732 (854)
Q Consensus 660 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~ 732 (854)
|+++.++.+++.-.|+...+ +|. ..++..=.-.+=|++..+++++..|+.
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999887764322 222 111122233567888999999988853
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 854 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-65
Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 23/276 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
+ ++IGSG FG VY GK + + +T+ + Q + F NEV +L + H N++ F+G
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
Y +V ++ +L HL+ E + IK ++IA A+G++YLH +
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA---KS 124
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYISQQ-- 706
IIHRDLKS+NI L + + K+ DFGL+ + SH + G++ ++ PE Q
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 707 -LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765
+ +SDVY+FG++L EL++GQ SN N + +G + P L
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNI-------NNRDQIIFMVG----RGYLSPD-LS 232
Query: 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801
+ ++ C+ RP ++L I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-63
Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
K++G+G FGVV YGK + ++A+K++ + EF E ++ + H LVQ G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
C ++ ++ E+M NG L +L R + LE+ +D + +EYL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
+HRDL + N L++ KVSDFGLS++ +D S + V + PE + + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 710 KSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 768
KSD+++FGV++ E+ S G+ +I Q +L+ P L E
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------RPHLASE-- 228
Query: 769 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
K+ C RP+ +L +I D
Sbjct: 229 -----KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-62
Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 23/273 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
++IGSG FG+V+ G + ++A+K + + +F E ++ ++ H LVQ G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
C E+ LV+EFM +G L ++ T L + D +G+ YL C
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
+IHRDL + N L+ ++ KVSDFG+++F +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 710 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769
KSDV+SFGV++ E+ S + + + + + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------LYKPRLAST--- 229
Query: 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
+ + C RP+ S +L+ + +
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-61
Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 23/273 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
L +++G+G FG V+ G ++AVK L F E L+ ++ H+ LV+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
+E ++ E+M NG+L + L ++ K L++A A+G+ ++
Sbjct: 76 VVTQEPI-YIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
IHRDL+++NIL+ + K++DFGL++ D + + + PE T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 710 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769
KSDV+SFG++L E+++ G ++Q ++E G ++ P E
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYP---GMTNPEVIQ----NLERG--YRMVRPDNCPE--- 237
Query: 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
++ + +C RP+ + ++D
Sbjct: 238 ----ELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-60
Identities = 62/295 (21%), Positives = 126/295 (42%), Gaps = 29/295 (9%)
Query: 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+L++ IG G FG V+ GK + G+E+AVK+ +S + E+ + H N++ F+
Sbjct: 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFI 63
Query: 589 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
++ + LV ++ +G+L ++L + + +++A A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 645 GCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVGY 696
V PAI HRDLKS NIL+ K+ ++D GL+ A D + GT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 697 LDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGANC---RNIVQWAK 747
+ PE + ++D+Y+ G++ E+ + +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 748 LHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801
+ + + P++ + + +++ + + C +G R + + K +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-57
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 587
++G+G GVV+ K G +A K++ R E+ +L + +V F
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
G +G + E M G+L + L RI +++ KG+ YL
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH- 124
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
I+HRD+K SNIL++ K+ DFG+S +D +++ GT Y+ PE
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 180
Query: 708 TDKSDVYSFGVILLELISGQ 727
+ +SD++S G+ L+E+ G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 7e-57
Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 23/273 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 589
LE K+G G FG V+ G +A+K L F E ++ ++ H LVQ
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 590 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 649
EE +V E+M G+L + L G + + + +++A A G+ Y+
Sbjct: 80 VVSEEPI-YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 650 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 709
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 710 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 769
KSDV+SFG++L EL + + ++ ++
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGM----------------VNREVLDQVERGYRMPCPP 237
Query: 770 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
+ + + C RP+ + ++D
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-56
Identities = 63/277 (22%), Positives = 109/277 (39%), Gaps = 25/277 (9%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+ IG+G +G + K DGK + K L S + K+ +EV LL + H N+V+
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 587 FLGYCQEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH- 643
+ + +V E+ G L + Q ++ L + ++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 644 -TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 702
+ ++HRDLK +N+ LD K+ DFGL++ S + GT Y+ PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQM 186
Query: 703 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762
+KSD++S G +L EL + + I + I
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-----YSDE 241
Query: 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
L + I M +++ RPS+ E+L++
Sbjct: 242 LNE--IITRMLNLKDY----------HRPSVEEILEN 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (491), Expect = 4e-56
Identities = 72/307 (23%), Positives = 137/307 (44%), Gaps = 42/307 (13%)
Query: 518 FTLSDIEDATK-----------MLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN- 561
FT D +A + +E+ IG+G FG V G LK + +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 562 SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ 621
+ + +R+F +E +++ + H N++ G + +++ EFM NG+L L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG 123
Query: 622 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681
+ I+ + + A G++YL +HRDL + NIL++ ++ KVSDFGLS+F D
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 682 GASHVSSI----VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 737
S + + + + PE ++ T SDV+S+G+++ E++S E +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---- 236
Query: 738 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 797
+ + D+ I+ + + + L C + RP +++
Sbjct: 237 ------------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 798 KDIQDAI 804
+ I
Sbjct: 285 NTLDKMI 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-56
Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+ +IG G F VY G + E+A L + ++ F E +L + H N+V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 587 FLGYCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
F + + VLV E M +GTLK +L + + KG+++L
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128
Query: 643 HTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
HT P IIHRDLK NI + K+ D GL+ + + V GT ++ PE
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 184
Query: 702 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761
++ + DVY+FG+ +LE+ + + S + N I + ++ + P
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKPASFDKVAIP 240
Query: 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ + I+ + + R SI ++L
Sbjct: 241 EVKEI--IEGCIRQNKDE----------RYSIKDLLNH 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (489), Expect = 4e-56
Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 23/274 (8%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 79
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
G C E ++ EFM G L ++L + Q ++ + L +A + +EYL
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---K 134
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
IHRDL + N L+ ++ KV+DFGLS+ + + + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 709 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 768
KSDV++FGV+L E+ + + + + +++ E
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYRMERP 238
Query: 769 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
K+ E C + RPS +E+ + +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 1e-55
Identities = 66/285 (23%), Positives = 123/285 (43%), Gaps = 37/285 (12%)
Query: 524 EDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLS 577
+D K+ ++IG G FG VY+ + +++ + +A+K ++ + Q ++ EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 578 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 637
++ H N +Q+ G E + LV E+ H++ + ++ + A +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQ 126
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 697
G+ YLH+ +IHRD+K+ NILL + K+ DFG + S V GT ++
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM 178
Query: 698 DPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754
PE ++ Q K DV+S G+ +EL + + N + +I Q ++SG
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ + S + + RP+ +LK
Sbjct: 239 ----WSEYFRNF--VDSCLQKIPQD----------RPTSEVLLKH 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-55
Identities = 61/284 (21%), Positives = 114/284 (40%), Gaps = 29/284 (10%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 580
+ ED +++ ++G G FG VY + K+ A KV+ + S + ++ E+ +L+
Sbjct: 9 NPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 581 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
H N+V+ L E ++ EF G + + E+ + + + + +
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALN 124
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
YLH IIHRDLK+ NIL K++DFG+S S + GT ++ PE
Sbjct: 125 YLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPE 180
Query: 701 YYISQQLTD-----KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755
+ + D K+DV+S G+ L+E+ + I + +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS- 239
Query: 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ D ++ + A R + S++L+
Sbjct: 240 --RWSSNFKDF--LKKCLEKNVDA----------RWTTSQLLQH 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 5e-55
Identities = 60/271 (22%), Positives = 115/271 (42%), Gaps = 25/271 (9%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+KIG G G VY + G+E+A++ + K NE+ ++ + N+V +L
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
+V E++ G+L + + E ++ + + + + +E+LH+
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 649 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 708
+IHRD+KS NILL K++DFG S S++V GT ++ PE +
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 709 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 768
K D++S G++ +E+I G+ NE I +++ + + D
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE---KLSAIFRDF-- 249
Query: 769 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ ++ + R S E+L+
Sbjct: 250 LNRCLDMDVE----------KRGSAKELLQH 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 37/286 (12%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK---REFTNEV 573
+ L D E + + +G G FG VY + K +A+KVL + + EV
Sbjct: 3 WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 633
+ S + H N+++ GY + R L+ E+ GT+ L + + +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 113
Query: 634 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 693
+ A + Y H+ +IHRD+K N+LL K++DFG S A + GT
Sbjct: 114 ELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGT 167
Query: 694 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 753
+ YL PE + +K D++S GV+ E + G+ + + I +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEF 221
Query: 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ D I + K RP + EVL+
Sbjct: 222 TFPDFVTEGARDL--ISRLLKHNPSQ----------RPMLREVLEH 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 74/286 (25%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 577
+ +++ L + IG G FG V G + G ++AVK + +++ + F E ++++
Sbjct: 4 LNMKELK-----LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMT 55
Query: 578 RIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 636
++ H NLVQ LG +E+G +V E+M G+L ++L + L+ + D
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVC 113
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
+ +EYL +HRDL + N+L+ + AKVSDFGL+K A S + V +
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKW 166
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756
PE ++ + KSDV+SFG++L E+ S +++V +E G
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVP----RVEKGYKM 219
Query: 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
D Y++ C MRPS ++ + ++
Sbjct: 220 DAPDGCPPAVYEV---------MKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 4e-54
Identities = 79/308 (25%), Positives = 127/308 (41%), Gaps = 32/308 (10%)
Query: 504 VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGK----EIAVKVLT 559
+S+LN +A + + IG G FG VY+G L D AVK L
Sbjct: 6 LSALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 560 SNSYQGK-REFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTL 617
+ G+ +F E ++ H N++ LG C EG ++V +M +G L+ +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--- 121
Query: 618 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
+ AKG + +HRDL + N +LD+ KV+DFGL++
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 678 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 734
D + H + + V ++ E +Q+ T KSDV+SFGV+L EL++ +
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 735 FGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 794
N ++ L EY ++++ L C P MRPS S
Sbjct: 239 ------NTFDITVYLLQG-------RRLLQPEYCPDPLYEV---MLKCWHPKAEMRPSFS 282
Query: 795 EVLKDIQD 802
E++ I
Sbjct: 283 ELVSRISA 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-54
Identities = 69/280 (24%), Positives = 123/280 (43%), Gaps = 33/280 (11%)
Query: 531 EKKIGSGGFGVVYYGKLKD---GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV 585
+K++GSG FG V G + K +AVK+L +N K E E ++ ++ + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
+ +G C+ E +LV E G L ++L + + +E+ + G++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS--IVRGTVGYLDPEYYI 703
+HRDL + N+LL AK+SDFGLSK ++ + + V + PE
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 704 SQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762
+ + KSDV+SFGV++ E S GQ+ K + + ++ +G
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG-----CPRE 238
Query: 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
+ D + W + + RP + V +++
Sbjct: 239 MYDL--MNLCWTYDVE----------NRPGFAAVELRLRN 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (474), Expect = 7e-54
Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 47/300 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHR 582
+ IG G FG V+ + +AVK+L + + +F E L++ +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--------------------EQR 622
N+V+ LG C L++E+M G L E L H
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 623 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682
++ ++L IA A G+ YL +HRDL + N L+ ++M K++DFGLS+
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 683 -ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 741
+ ++ PE + T +SDV+++GV+L E+ S +G
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---YGMAHEE 250
Query: 742 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801
++ + + G+I + L+ Y++ +C RPS + + +Q
Sbjct: 251 VIYY----VRDGNILACPENCPLELYNL---------MRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 26/274 (9%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 587
L + +G G +G V + + +AVK++ + E+ + ++H N+V+F
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
G+ +E L E+ G L + + + + G+ YLH
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG--- 121
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
I HRD+K N+LLD+ K+SDFGL+ F + + + + GT+ Y+ PE ++
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 707 L-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765
+ DV+S G++L +++G+ + + K ++ ID + L
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK---KIDSAPLA 238
Query: 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ + A R +I ++ KD
Sbjct: 239 --LLHKILVENPSA----------RITIPDIKKD 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 66/283 (23%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 583
+K IG+G FG VY G LK +A+K L + + +R +F E ++ + H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+++ G + +++ E+M NG L + L + + ++ + + A G++YL
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEY 701
+HRDL + NIL++ ++ KVSDFGLS+ D A++ +S + + + PE
Sbjct: 128 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 702 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761
++ T SDV+SFG+++ E+++ E E + + ++ I+
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------------LSNHEVMKAIND 228
Query: 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804
+ I + + C RP ++++ + I
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-53
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 31/282 (10%)
Query: 528 KMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRN 583
+ + ++G G FG V G + ++A+KVL + + E E ++ ++ +
Sbjct: 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 70
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+V+ +G CQ E +LV E G L + L G + I E+ + G++YL
Sbjct: 71 IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE 126
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEY 701
+HRDL + N+LL AK+SDFGLSK A D S + + + PE
Sbjct: 127 E---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 702 YISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760
++ + +SDV+S+GV + E +S GQ+ K I Q ++
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE-----CP 238
Query: 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802
P L Y + C + RP V + ++
Sbjct: 239 PEL---YAL---------MSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-52
Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 41/298 (13%)
Query: 530 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 581
K +G+G FG V +AVK+L +++ +RE +E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--------------TLTHEQRINWIK 627
N+V LG C G ++++ E+ G L L E ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-V 686
L + AKG+ +L + IHRDL + NILL K+ DFGL++ + +++ V
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 746
R V ++ PE + T +SDV+S+G+ L EL S +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PY 248
Query: 747 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804
+I + ++ + C RP+ ++++ I+ I
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-51
Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 46/297 (15%)
Query: 530 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 581
K +GSG FG V ++AVK+L + +RE +E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 582 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------------EQR 622
N+V LG C G L++E+ G L +L
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 623 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682
+ + L A AKG+E+L + +HRDL + N+L+ K+ DFGL++ +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 683 ASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 741
+++V R V ++ PE T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----------- 266
Query: 742 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
+ + +++ + +I + + +I C RPS +
Sbjct: 267 ---YPGIPVDA-NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 59/285 (20%), Positives = 114/285 (40%), Gaps = 30/285 (10%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 584
L + IG G FG V+ G + +A+K + + RE F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
V+ +G E ++ E G L+ L + ++ + A + + YL +
Sbjct: 71 VKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 126
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
+HRD+ + N+L+ + K+ DFGLS++ D + +S + + ++ PE
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 705 QQLTDKSDVYSFGVILLELI-SGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763
++ T SDV+ FGV + E++ G + K I +L + P+L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN-----CPPTL 238
Query: 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 808
+ W + RP +E+ + + E+
Sbjct: 239 YSL--MTKCWAYDPS----------RRPRFTELKAQLSTILEEEK 271
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 5e-50
Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 25/273 (9%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ +++G+G FGVV+ G A K + + K E+ +S + H LV
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
+++ V++YEFM G L E + +++ + +E KG+ ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 649 AIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
+H DLK NI+ + K+ DFGL+ S GT + PE +
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKP 201
Query: 707 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766
+ +D++S GV+ L+SG E RN+ +++ G I D
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSG-ISEDGKDF 259
Query: 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
I+ + + R +I + L+
Sbjct: 260 --IRKLLLADPNT----------RMTIHQALEH 280
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 7e-50
Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 38/292 (13%)
Query: 530 LEKKIGSGGFGVVYYGKLKDG---KEIAVKVL-TSNSYQGKREFTNEVTLLSRI-HHRNL 584
+ IG G FG V ++K + A+K + S R+F E+ +L ++ HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIA 632
+ LG C+ G L E+ +G L + L + E ++ + L A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 633 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 692
D A+G++YL IHRDL + NIL+ ++ AK++DFGLS+ R
Sbjct: 134 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--GRL 188
Query: 693 TVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 752
V ++ E T SDV+S+GV+L E++S G C + +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCAELYEK------- 238
Query: 753 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804
+ E + ++ + C + RPS +++L + +
Sbjct: 239 ------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-48
Identities = 64/283 (22%), Positives = 106/283 (37%), Gaps = 31/283 (10%)
Query: 530 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHR 582
L +K+G G FGVV G+ +AVK L + + +F EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
NL++ G +V E G+L + L H+ A A+G+ YL
Sbjct: 72 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPE 700
+ IHRDL + N+LL K+ DFGL + H + + + PE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760
++ + SD + FGV L E+ + + N Q + G+ +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG------LNGSQILHKIDKEGERLPRPE 238
Query: 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803
D Y++ + C RP+ + + +A
Sbjct: 239 DCPQDIYNV---------MVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 2e-48
Identities = 55/273 (20%), Positives = 121/273 (44%), Gaps = 25/273 (9%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ +++GSG FGVV+ G+ K + + K NE+++++++HH L+
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
+++ VL+ EF+ G L + + + +++ + + A +G++++H
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE---H 146
Query: 649 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
+I+H D+K NI+ + K K+ DFGL+ + + T + PE +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREP 204
Query: 707 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766
+ +D+++ GV+ L+SG + E +N+ + E D + P D
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--DAFSSVSPEAKDF 262
Query: 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
I+++ + E + R ++ + L+
Sbjct: 263 --IKNLLQKEPRK----------RLTVHDALEH 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-48
Identities = 57/279 (20%), Positives = 116/279 (41%), Gaps = 30/279 (10%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 583
K +GSG FG VY G +G+++ + V + S + +E +E +++ + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 584 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 643
+ + LG C L+ + M G L +++ H+ I L AKG+ YL
Sbjct: 73 VCRLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL- 127
Query: 644 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 702
++HRDL + N+L+ K++DFGL+K + + + + + ++ E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 703 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762
+ + T +SDV+S+GV + EL++ + + +I I++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----------------PASEISSILEKG 229
Query: 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 801
+ + C + RP E++ +
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 57/274 (20%), Positives = 104/274 (37%), Gaps = 30/274 (10%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 585
K +G G F V + L +E A+K+L T E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
+ Q++ + + NG L +++ + + +EYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG- 126
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 704
IIHRDLK NILL++ M +++DFG +K + + ++ GT Y+ PE
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 705 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764
+ SD+++ G I+ +L++G + I++ D P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------LEYDFPEKFFPKAR 238
Query: 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
D ++ + ++ R E+
Sbjct: 239 DL--VEKLLVLDATK----------RLGCEEMEG 260
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 63/289 (21%), Positives = 122/289 (42%), Gaps = 33/289 (11%)
Query: 530 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 582
+ +++G G FG+VY G K +A+K + + S + + EF NE +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------GTLTHEQRINWIKRLEIAEDAA 636
++V+ LG + ++++ E M G LK +L + K +++A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVG 695
G+ YL+ +HRDL + N ++ + K+ DFG+++ + V
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 696 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755
++ PE T SDV+SFGV+L E+ + E + + G +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFVMEGGL 253
Query: 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804
D +++ MC + MRPS E++ I++ +
Sbjct: 254 LDKPDNCPDMLFEL---------MRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 3e-47
Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 40/297 (13%)
Query: 530 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 581
L K +G G FG V + +AVK+L + R +E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 582 RNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYG------------TLTHEQRINWIKR 628
N+V LG C + G + ++ EF G L +L ++ +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 629 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-S 687
+ + AKG+E+L + IHRDL + NILL + K+ DFGL++ +V
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 747
R + ++ PE + T +SDV+SFGV+L E+ S + I +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV------KIDEEFC 247
Query: 748 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804
++ G D + + Y L C RP+ SE+++ + + +
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQT---------MLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-45
Identities = 50/273 (18%), Positives = 107/273 (39%), Gaps = 26/273 (9%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ + +G G FG+V+ K K + + E+++L+ HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
+ V+++EF+ + E + T +N + + + +++LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---H 121
Query: 649 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
I H D++ NI+ + K+ +FG ++ G + ++ Y PE +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179
Query: 707 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766
++ +D++S G ++ L+SG E NI+ A+ + + I +D
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-AEYTFDEEAFKE-ISIEAMDF 237
Query: 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ + E K R + SE L+
Sbjct: 238 --VDRLLVKERK----------SRMTASEALQH 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (412), Expect = 3e-45
Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 29/283 (10%)
Query: 522 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 579
DI D +G+G F V + + K +A+K + + +GK NE+ +L +I
Sbjct: 6 DIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
H N+V + G L+ + + G L + + + + +
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAV 120
Query: 640 EYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 696
+YLH I+HRDLK N+L D+ + +SDFGLSK G V S GT GY
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175
Query: 697 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756
+ PE + + D +S GVI L+ G +E I++ A+ +S
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-AEYEFDSPYWD 234
Query: 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
I S D I+ + + + + R + + L+
Sbjct: 235 D-ISDSAKDF--IRHLMEKDPEK----------RFTCEQALQH 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-45
Identities = 62/298 (20%), Positives = 127/298 (42%), Gaps = 42/298 (14%)
Query: 530 LEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRI- 579
L K +G G FG V + ++AVK+L S++ + + +E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWIK 627
H+N++ LG C ++G ++ E+ G L+E+L + E++++
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 628 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ +
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 688 SIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 746
+ R V ++ PE + T +SDV+SFGV+L E+ + +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------------ 241
Query: 747 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804
++ ++ + ++ C RP+ ++++D+ +
Sbjct: 242 ----PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (404), Expect = 4e-44
Identities = 58/285 (20%), Positives = 118/285 (41%), Gaps = 33/285 (11%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL---TSNSYQGKREFTNEV 573
++L D + + + +G+G FG V+ + + +G+ A+KVL + +E
Sbjct: 1 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55
Query: 574 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 633
+LS + H +++ G Q+ + ++ +++ G L L + + E+
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115
Query: 634 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 693
L II+RDLK NILLDK+ K++DFG +K+ D + GT
Sbjct: 116 -------ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGT 164
Query: 694 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 753
Y+ PE ++ D +SFG+++ E+++G + I+ A+L
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-AELRFPPF 223
Query: 754 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
+ + D + + + + G+++ +V
Sbjct: 224 -----FNEDVKDL--LSRLITRDLSQRL-----GNLQNGTEDVKN 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 3e-43
Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 17/225 (7%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLV 585
L + +G GG V+ + L+ +++AVKVL ++ + F E + ++H +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 586 QFLGYCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
+ E +V E++ TL++ ++ E + + +E+ DA + + +
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 126
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDP 699
H IIHRD+K +NI++ KV DFG+++ D + V ++ V GT YL P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 700 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 744
E + +SDVYS G +L E+++G+ + + + V+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (390), Expect = 1e-42
Identities = 66/287 (22%), Positives = 108/287 (37%), Gaps = 40/287 (13%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---------TSNSYQGKREFTNEVTLLSRI 579
++ +G G VV KE AVK++ + + EV +L ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 580 H-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638
H N++Q + LV++ M G L ++L T + ++ + +I +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEV 122
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
I LH I+HRDLK NILLD M K++DFG S G V GT YL
Sbjct: 123 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLA 177
Query: 699 PEYYISQQL------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 752
PE + D++S GVI+ L++G + K R I+ S
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-NYQFGS 236
Query: 753 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ ++ D + ++ + R + E L
Sbjct: 237 PEWDD-YSDTVKDL--VSRFLVVQPQK----------RYTAEEALAH 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 2e-41
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 28/277 (10%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEV---TLLSRIHHR 582
+ + IG GGFG VY + D GK A+K L QG+ NE +L+S
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 583 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
+V + + + M+ G L HL + + A + G+E++
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHM 123
Query: 643 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 702
H +++RDLK +NILLD+H ++SD GL+ H GT GY+ PE
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVL 177
Query: 703 ISQQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761
D +D +S G +L +L+ G K + +E + P
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE---LPDSFSP 234
Query: 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 798
L ++ + + + + G + EV +
Sbjct: 235 ELRSL--LEGLLQRDVNRRL-----GCLGRGAQEVKE 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 584
L K +G G FG V+ + K + A+K L + + + L H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 585 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 644
Q + V E+++ G L H+ + + + A + G+++LH+
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 645 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
I++RDLK NILLDK K++DFG+ K + G + ++ GT Y+ PE +
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 177
Query: 705 QQLTDKSDVYSFGVILLELISGQ 727
Q+ D +SFGV+L E++ GQ
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 8e-41
Identities = 54/288 (18%), Positives = 104/288 (36%), Gaps = 34/288 (11%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
L +KIGSG FG +Y G + G+E+A+K+ + + E + + + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTI 68
Query: 589 GYCQEEGRS-VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+C EG V+V E + + ++ + L +A+ IEY+H+
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN- 123
Query: 648 PAIIHRDLKSSNIL---LDKHMRAKVSDFGLSKFAVDGASHV------SSIVRGTVGYLD 698
IHRD+K N L K + DFGL+K D +H + + GT Y
Sbjct: 124 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 699 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--KLHIESGDIQ 756
++ + + + D+ S G +L+ G K + + + K+ +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804
+ + +P S + + ++
Sbjct: 242 KGYPSEFATY--LNFCRSLRFDD----------KPDYSYLRQLFRNLF 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 58/276 (21%), Positives = 104/276 (37%), Gaps = 27/276 (9%)
Query: 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-----FTNEVTLLSRIHHRNLV 585
+G G F VY + K + +A+K + ++ E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 586 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
L + LV++FM + + +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 646 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 705
I+HRDLK +N+LLD++ K++DFGL+K + V T Y PE
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 706 QLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764
++ D+++ G IL EL+ + + I + + P+
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI------------FETLGTPTEE 223
Query: 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800
D+ S+ +P H+ + + L D+
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 1e-40
Identities = 52/283 (18%), Positives = 97/283 (34%), Gaps = 20/283 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQF 587
+KIG G +GVVY + G+ A+K + E+++L + H N+V+
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+ R VLV+E + K E + + GI Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
++HRDLK N+L+++ K++DFGL++ + + S++
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 708 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQGI 758
+ D++S G I E+++G I + W +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 759 IDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 799
L L+ + + R + + L+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 518 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL------TSNSYQGKREFT 570
F +++D +++GSG F VV + K G + A K + +S + +
Sbjct: 3 FRQENVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 571 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 630
EV++L I H N++ + + +L+ E + G L + L ++ + + E
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATE 117
Query: 631 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFAVDGASHV 686
+ G+ YLH+ I H DLK NI+L R K+ DFGL+ G
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173
Query: 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 746
+ GT ++ PE + L ++D++S GVI L+SG + N+
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV- 231
Query: 747 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
E + D I+ + + K R +I + L+
Sbjct: 232 NYEFED-EYFSNTSALAKDF--IRRLLVKDPK----------KRMTIQDSLQH 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-40
Identities = 57/291 (19%), Positives = 104/291 (35%), Gaps = 29/291 (9%)
Query: 530 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRI---HHR 582
+IG G +G V+ + G+ +A+K + + + EV +L + H
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 583 NLVQFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 637
N+V+ C E + LV+E + E + ++ +
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLR 127
Query: 638 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 697
G+++LH+ ++HRDLK NIL+ + K++DFGL++ + S V T+ Y
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYR 182
Query: 698 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757
PE + D++S G I E+ + I+ L E +
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 758 IIDPSLLDEYDIQSMWKI-------EEKALM--CVLPHGHMRPSISEVLKD 799
+ P + K L+ C+ + R S L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 54/284 (19%), Positives = 106/284 (37%), Gaps = 20/284 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+KIG G +GVVY + K G+ +A+K + + + E++LL ++H N+V+
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
L E + LV+EF+H K + I +G+ + H+
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
++HRDLK N+L++ K++DFGL++ + V +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 707 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQG 757
+ D++S G I E+++ + + I + W +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 758 IIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 799
+ D + + ++L+ + + R S L
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-40
Identities = 55/288 (19%), Positives = 107/288 (37%), Gaps = 22/288 (7%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 587
IG G +G+V + +A+K ++ +Q + E+ +L R H N++
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 71
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
+ + ++ L L Q ++ +G++Y+H+
Sbjct: 72 NDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 129
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPEYYISQ 705
++HRDLK SN+LL+ K+ DFGL++ A H + T Y PE ++
Sbjct: 130 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 706 QLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764
+ KS D++S G IL E++S + + + +I+ + I +
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 765 DEYDIQSMWKIEEKALM-------------CVLPHGHMRPSISEVLKD 799
+ K+ L + + H R + + L
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-39
Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 37/284 (13%)
Query: 528 KMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLV 585
K+ + +G G G V + ++ A+K+L Q + EV L R ++V
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIV 68
Query: 586 QFLGYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 641
+ + + ++V E + G L + +Q + EI + + I+Y
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQY 126
Query: 642 LHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 698
LH+ I HRD+K N+L K++DFG +K S + T Y+
Sbjct: 127 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVA 181
Query: 699 PEYYISQQLTDKSDVYSFGVILLELISGQ---EAISNEKFGANCRNIVQWAKLHIESGDI 755
PE ++ D++S GVI+ L+ G + + ++ + + +
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ + I+++ K E R +I+E +
Sbjct: 242 SE-VSEEVKML--IRNLLKTEPT----------QRMTITEFMNH 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-39
Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 28/289 (9%)
Query: 530 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
K IG+G FGVVY KL D G+ +A+K + Q KR E+ ++ ++ H N+V+
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 589 GYCQEEGRS------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 642
+ G LV +++ + + +Q + I + + Y+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 643 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 701
H+ I HRD+K N+LLD K+ DFG +K V G S +
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194
Query: 702 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIES 752
+ + T DV+S G +L EL+ GQ + I++ +++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 753 GDIQGIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 799
+ + + + E AL + R + E
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (362), Expect = 1e-38
Identities = 44/289 (15%), Positives = 105/289 (36%), Gaps = 34/289 (11%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 588
+ ++IG G FGV++ G L + +++A+K S + +E + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 589 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 648
Y +EG ++ + +L++ L ++ + A+ ++ +H
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 649 AIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAVDGASHVSSI------VRGTVGYL 697
+++RD+K N L+ + V DFG+ KF D + + GT Y+
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 698 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757
++ ++ + + D+ + G + + + G K A + + +S ++
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-AATNKQKYERIGEKKQSTPLRE 239
Query: 758 IID--PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804
+ P +Y + + A P + +
Sbjct: 240 LCAGFPEEFYKY-MHYARNLAFDA----------TPDYDYLQGLFSKVL 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 52/281 (18%), Positives = 98/281 (34%), Gaps = 44/281 (15%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE------FTNEVTLLSRIH-- 580
+ +GSGGFG VY G + D +A+K + + E EV LL ++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 581 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
+++ L + + VL+ E +T + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVLEAVR 124
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 699
+ H ++HRD+K NIL+D + K+ DFG D V + GT Y P
Sbjct: 125 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 178
Query: 700 EYYISQQLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 758
E+ + +S V+S G++L +++ G ++ + ++
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQVFFRQR----- 226
Query: 759 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799
+ I+ + RP+ E+
Sbjct: 227 VSSECQHL--IRWCLALRPSD----------RPTFEEIQNH 255
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 50/285 (17%), Positives = 104/285 (36%), Gaps = 22/285 (7%)
Query: 530 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+KIG G +G V+ K + + +A+K + + E+ LL + H+N+V+
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
+ + LV+EF K ++ KG+ + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
++HRDLK N+L++++ K+++FGL++ S+ V + ++
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 707 LTDKSDVYSFGVILLELISG----------QEAISNEKFGANCRNIVQWAKLHIESGDIQ 756
+ D++S G I EL + + + QW +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 757 GIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 799
+ P+ ++ + L+ + + R S E L+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 17/213 (7%)
Query: 519 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVT 574
T++D + K +G G FG V + K G+ A+K+L K E E
Sbjct: 3 TMNDFD-----YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 575 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 634
+L H L Q R V E+ + G L HL R
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFY 110
Query: 635 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 694
A+ + L +++RD+K N++LDK K++DFGL K + + + + GT
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 169
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 727
YL PE D + GV++ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-36
Identities = 55/286 (19%), Positives = 103/286 (36%), Gaps = 22/286 (7%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+ +GSG +G V + G ++A+K L S + E+ LL + H N++
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
L + +F G L +++ + + KG+ Y+H
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
IIHRDLK N+ +++ K+ DFGL++ A S ++ V +
Sbjct: 142 ---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMR 195
Query: 707 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQG 757
T D++S G I+ E+I+G+ + I++ +L +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 758 IIDPSLLDEYDIQSMWKIEEKAL----MCVLPHGHMRPSISEVLKD 799
P L + + A+ ++ R + E L
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 7e-36
Identities = 53/300 (17%), Positives = 110/300 (36%), Gaps = 38/300 (12%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 586
KIG G FG V+ + K G+++A+K + + + E+ +L + H N+V
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 587 FLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 638
+ C+ +G LV++F + + EI
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEIKRVMQML 126
Query: 639 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVG 695
+ L+ I+HRD+K++N+L+ + K++DFGL++ A + + + T+
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 696 YLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754
Y PE + ++ D++ G I+ E+ + + I Q I
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ-LCGSITPEV 245
Query: 755 IQGIIDPSLLDEYDIQSMWKIEEKALM---------------CVLPHGHMRPSISEVLKD 799
+ + L ++ ++ K + K + ++ R + L
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 2e-35
Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 33/290 (11%)
Query: 532 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 587
K +G+G FG V K + G A+K+L ++ NE +L ++ LV+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 588 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 647
++ +V E++ G + HL R + A EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD- 161
Query: 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 707
+I+RDLK N+L+D+ +V+DFG +K + GT L PE +S+
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGY 215
Query: 708 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767
D ++ GV++ E+ +G ++ IV L D
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKD-- 267
Query: 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVL-----KDIQDAIVIEREAAA 812
++++ +++ G+++ ++++ + +R+ A
Sbjct: 268 LLRNLLQVDLTKRF-----GNLKNGVNDIKNHKWFATTDWIAIYQRKVEA 312
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 2e-33
Identities = 52/277 (18%), Positives = 114/277 (41%), Gaps = 23/277 (8%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 587
L +K+G G + V+ + + +++ VK+L K++ E+ +L + N++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITL 95
Query: 588 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 645
++ LV+E ++N K+ Q + + K ++Y H+
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 646 CVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 704
I+HRD+K N+++D +H + ++ D+GL++F G + + + + PE +
Sbjct: 149 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVD 203
Query: 705 QQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763
Q+ D D++S G +L +I +E + N +V+ AK+ I ++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 800
+ + + H + +S D
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 530 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVL----TSNSYQGKREFTNEVTLLSRI-H 580
L K +G+G +G V+ + GK A+KVL + E +L I
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 581 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
LV Q E + L+ ++++ G L HL + I EI
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL------- 140
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
L II+RD+K NILLD + ++DFGLSK V + + GT+ Y+ P+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 701 YYISQQ--LTDKSDVYSFGVILLELISGQ 727
D +S GV++ EL++G
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-30
Identities = 56/276 (20%), Positives = 104/276 (37%), Gaps = 22/276 (7%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
+GSG +G V K G +AVK L S + E+ LL + H N++
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 587 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 646
L + L + Q++ + +G++Y+H+
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 706
IIHRDLK SN+ +++ K+ DFGL++ + T Y PE ++
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWM 194
Query: 707 LTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765
+ D++S G I+ EL++G+ + I++ + G LL
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----------LVGTPGAELLK 244
Query: 766 EYDIQSMWK-IEEKALMCVLPHGHMRPSISEVLKDI 800
+ +S I+ M + ++ + + D+
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 6e-30
Identities = 50/225 (22%), Positives = 92/225 (40%), Gaps = 21/225 (9%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 586
K IGSG G+V + +A+K L + + E+ L+ ++H+N++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 587 FLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 640
L +E LV E M + + ++ + + GI+
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQ-------VIQMELDHERMSYLLYQMLCGIK 133
Query: 641 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 700
+LH+ IIHRDLK SNI++ K+ DFGL++ G S + + T Y PE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 188
Query: 701 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 745
+ + D++S G I+ E++ + + +++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 2e-28
Identities = 42/241 (17%), Positives = 97/241 (40%), Gaps = 18/241 (7%)
Query: 530 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL---- 584
L +K+G G F V+ K + + +A+K++ +E+ LL R++ +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 585 -------VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAA 636
++ L + +G + + + + L +E R + + +I++
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 637 KGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-SIVRGTV 694
G++Y+H C IIH D+K N+L++ + ++ + T
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 695 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754
Y PE + +D++S ++ ELI+G ++ + ++ A++ G+
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 755 I 755
+
Sbjct: 254 L 254
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 3e-22
Identities = 29/158 (18%), Positives = 48/158 (30%), Gaps = 21/158 (13%)
Query: 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL----------TSNSYQGKREFTNEVTLLSRI 579
+ K +G G V+ + E VK G F+ +R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 580 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 639
R L + G VY + N L E R+ E+ + + +
Sbjct: 64 EFRALQKLQGLAV-----PKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEV 116
Query: 640 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677
+ I+H DL N+L+ + + DF S
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.9 bits (180), Expect = 2e-14
Identities = 15/93 (16%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 330 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 389
++T + L N++ P ++ L+ L L+ N ++ + +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352
Query: 390 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422
+ + NQ++ P L NL + +L + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 2e-12
Identities = 21/81 (25%), Positives = 37/81 (45%), Gaps = 3/81 (3%)
Query: 364 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423
L +L L L N+++ P S L+ + +N+++ SSL NL N+ L +N
Sbjct: 306 LKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQ 362
Query: 424 LSGTVPSSLLSKNVVLNYAGN 444
+S P + L++ L
Sbjct: 363 ISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 4e-07
Identities = 39/146 (26%), Positives = 56/146 (38%), Gaps = 27/146 (18%)
Query: 325 CLPVPWSWLQCN---SDPQPSITVIHLSSKNLTGNI---PSDLTKLSSLVELWLDGNSLT 378
L S + N SD P + +L +L GN L L++L +L L N ++
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQIS 254
Query: 379 GPIPDFSGCPDLRIIHLEDNQLTGPLP--------------------SSLMNLPNLRELY 418
P SG L + L NQ++ P S + NL NL L
Sbjct: 255 NLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 313
Query: 419 VQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ N +S P S L+K L +A N
Sbjct: 314 LYFNNISDISPVSSLTKLQRLFFANN 339
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 7e-06
Identities = 13/78 (16%), Positives = 30/78 (38%), Gaps = 3/78 (3%)
Query: 364 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423
L+ ++ L ++T + + + + + + + L NL ++ NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 77
Query: 424 LSGTVPSSLLSKNVVLNY 441
L+ P L+K V +
Sbjct: 78 LTDITPLKNLTKLVDILM 95
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.2 bits (170), Expect = 1e-13
Identities = 19/79 (24%), Positives = 34/79 (43%), Gaps = 2/79 (2%)
Query: 330 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 389
++ ++ + L + + G +P LT+L L L + N+L G IP
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292
Query: 390 LRIIHLEDNQ-LTG-PLPS 406
+ +N+ L G PLP+
Sbjct: 293 FDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 21/62 (33%), Positives = 28/62 (45%), Gaps = 1/62 (1%)
Query: 387 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNI 445
+L + L +N++ G LP L L L L V N L G +P L + V YA N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 446 NL 447
L
Sbjct: 303 CL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 3e-09
Identities = 15/58 (25%), Positives = 22/58 (37%), Gaps = 3/58 (5%)
Query: 371 WLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN-MLSG 426
L N + G +P + L +++ N L G +P NL NN L G
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.9 bits (154), Expect = 2e-11
Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 5/104 (4%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 400
+ V+ S L +P DL L L N +T DF +L + L +N++
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 401 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 444
+ P + L L LY+ N L +P + L N
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 1e-08
Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 4/93 (4%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399
P ++ L + +T D L +L L L N ++ P F+ L ++L NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
L LP + L+EL V N ++ S
Sbjct: 91 LKE-LPEKMPK--TLQELRVHENEITKVRKSVF 120
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.3 bits (111), Expect = 4e-06
Identities = 16/128 (12%), Positives = 38/128 (29%), Gaps = 25/128 (19%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--------------------- 379
++ + L + ++ P L L L+L N L
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 380 ---PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 436
+ + + + + +G + + L + + + ++ T+P L
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL 173
Query: 437 VVLNYAGN 444
L+ GN
Sbjct: 174 TELHLDGN 181
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.4 bits (93), Expect = 6e-04
Identities = 17/115 (14%), Positives = 38/115 (33%), Gaps = 30/115 (26%)
Query: 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD------------------------GNS 376
PS+T +HL +T + L L++L +L L N
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 377 LTGPIPDFSGCPDLRIIHLEDNQLTG------PLPSSLMNLPNLRELYVQNNMLS 425
L + +++++L +N ++ P + + + +N +
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 19/71 (26%), Positives = 31/71 (43%), Gaps = 4/71 (5%)
Query: 363 KLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
+VEL + +G F G L I + D +T +P L P+L EL++
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 180
Query: 422 NMLSGTVPSSL 432
N ++ +SL
Sbjct: 181 NKITKVDAASL 191
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 56.3 bits (135), Expect = 3e-10
Identities = 24/105 (22%), Positives = 38/105 (36%), Gaps = 25/105 (23%)
Query: 345 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL-------------- 390
V+HL+ K+LT + L +L + L L N L P + L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 391 --------RIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSG 426
+ + L +N+L L++ P L L +Q N L
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 6e-04
Identities = 11/40 (27%), Positives = 17/40 (42%), Gaps = 2/40 (5%)
Query: 391 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 430
R++HL LT L L + L + +N L P+
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA 38
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 4e-08
Identities = 25/97 (25%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 325 CLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF 384
L + + + S + +LS N + + L LS L L D N ++ I
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPL 191
Query: 385 SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
+ P+L +HL++NQ++ P L N NL + + N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 15/59 (25%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 382 PDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 440
+ L + +DN+++ P L +LPNL E++++NN +S P + S ++
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 8/61 (13%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 364 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423
L++ +++ +++T + + + + +T + L NL L +++N
Sbjct: 18 LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 424 L 424
+
Sbjct: 75 I 75
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 23/118 (19%), Positives = 37/118 (31%), Gaps = 9/118 (7%)
Query: 317 WAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS 376
P + + + I S SL EL + N
Sbjct: 236 LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 295
Query: 377 LTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG--TVPSSL 432
L +P + P L + N L +P NL++L+V+ N L +P S+
Sbjct: 296 LIE-LP--ALPPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 9e-07
Identities = 15/75 (20%), Positives = 28/75 (37%), Gaps = 6/75 (8%)
Query: 366 SLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYV 419
+ L + L+ +++ L+D LT + S+L P L EL +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 420 QNNMLSGTVPSSLLS 434
++N L +L
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 4e-06
Identities = 20/103 (19%), Positives = 34/103 (33%), Gaps = 14/103 (13%)
Query: 329 PWSWLQCNSDPQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPD- 383
Q P + V+ L+ +++ + + + L SL EL L N L
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 384 -----FSGCPDLRIIHLEDNQLTGPLPSSLMNL----PNLREL 417
L + L D + + L L P+LR +
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 4/55 (7%)
Query: 384 FSGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 434
LR++ L D ++ L ++L+ +LREL + NN L L+
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 6e-06
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 360 DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419
+++K++S +E+ D +LT PD D I+HL +N L ++LM L +L +
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 420 QNNM 423
Sbjct: 63 DRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 16/100 (16%), Positives = 30/100 (30%), Gaps = 3/100 (3%)
Query: 325 CLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDG-NSLTGPIPD 383
+ L + N +P L + +E N+LT
Sbjct: 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166
Query: 384 -FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422
+G +L + L++N L +P L ++ N
Sbjct: 167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 8/107 (7%)
Query: 327 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FS 385
P + L + +HL L P L++L L+L N+L D F
Sbjct: 98 PATFHGLGR-------LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 386 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 432
+L + L N+++ + L +L L + N ++ P +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (86), Expect = 0.004
Identities = 13/61 (21%), Positives = 20/61 (32%), Gaps = 3/61 (4%)
Query: 366 SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 425
+L L L+ N L+ +++ LP L L+ L N L
Sbjct: 226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRD-LKRL--AANDLQ 282
Query: 426 G 426
G
Sbjct: 283 G 283
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 3e-05
Identities = 12/76 (15%), Positives = 28/76 (36%), Gaps = 2/76 (2%)
Query: 350 SKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTGPLPSS 407
++ ++ + + L + + S C L+ + LE +L+ P+ ++
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 408 LMNLPNLRELYVQNNM 423
L NL L +
Sbjct: 91 LAKNSNLVRLNLSGCS 106
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 12/73 (16%), Positives = 29/73 (39%), Gaps = 3/73 (4%)
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
+ ++ L S+T + + + I ++ + + LPN+ +L++
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 422 NMLSGTVPSSLLS 434
N L+ P + L
Sbjct: 78 NKLTDIKPLANLK 90
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 10/41 (24%), Positives = 19/41 (46%), Gaps = 2/41 (4%)
Query: 381 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
I +G L+ ++L N ++ +L L NL L + +
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 11/66 (16%), Positives = 25/66 (37%), Gaps = 3/66 (4%)
Query: 330 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 389
+ + L ++ +P L L+ L L+L N ++ + +G +
Sbjct: 145 KITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKN 201
Query: 390 LRIIHL 395
L ++ L
Sbjct: 202 LDVLEL 207
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 2e-04
Identities = 16/72 (22%), Positives = 27/72 (37%), Gaps = 2/72 (2%)
Query: 356 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG--PLPSSLMNLPN 413
DL + V L + P+L ++L +N+L + S + PN
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPN 92
Query: 414 LRELYVQNNMLS 425
L+ L + N L
Sbjct: 93 LKILNLSGNELK 104
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 3/90 (3%)
Query: 347 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 406
L + + + ++K + LD L PD +++ + L
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS-DPDLVAQNIDVVLNRRSSMAAT-LRI 59
Query: 407 SLMNLPNLRELYVQNNMLSGTVPSSLLSKN 436
N+P L L + NN L S + +
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQK 89
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 11/51 (21%), Positives = 17/51 (33%), Gaps = 3/51 (5%)
Query: 380 PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 430
P F G I+ + ++ L NL LR N +P+
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 14/88 (15%), Positives = 24/88 (27%), Gaps = 12/88 (13%)
Query: 329 PWSWLQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSG 386
+ + + ++LS N +P+D S V L + +
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223
Query: 387 CPDLRIIHLEDNQLTGPLPSSLMNLPNL 414
LR +L LP L
Sbjct: 224 LKKLRARST----------YNLKKLPTL 241
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 2e-04
Identities = 16/109 (14%), Positives = 35/109 (32%), Gaps = 3/109 (2%)
Query: 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQ 399
+ + + + L +L EL+++ + G +LR + + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 448
L P + P L L + N L ++ ++ LH
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 10/65 (15%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 362 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421
T L+ ++ L ++T + + + + + + + L NL ++ N
Sbjct: 15 TALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 422 NMLSG 426
N L+
Sbjct: 72 NQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)
Query: 371 WLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417
N +T P + L + + N+++ S L L NL L
Sbjct: 156 NFSSNQVTDLKP-LANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 6/55 (10%), Positives = 17/55 (30%), Gaps = 1/55 (1%)
Query: 381 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 435
++ R + L ++ + + L + +N + LL +
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRR 64
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 15/80 (18%), Positives = 22/80 (27%), Gaps = 3/80 (3%)
Query: 350 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 409
+ L T EL L G + + I DN++
Sbjct: 4 TAELIEQAAQ-YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP-- 60
Query: 410 NLPNLRELYVQNNMLSGTVP 429
L L+ L V NN +
Sbjct: 61 LLRRLKTLLVNNNRICRIGE 80
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 854 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.65 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.6 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.57 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.49 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.49 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.41 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.4 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.37 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.34 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.34 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.24 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.23 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.2 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.19 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.17 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.16 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.16 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.15 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.14 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.13 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.06 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.95 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.94 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.92 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.78 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.4 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.31 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.22 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.21 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.11 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.01 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.93 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.83 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.79 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.77 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.66 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.72 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.71 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.16 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.56 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.77 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.81 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.23 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=417.49 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=198.3
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
.+.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++||||++++|+|..++..++||||+++|+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 3567899999999999999988999999997543 446789999999999999999999999999999999999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceee
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 688 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 688 (854)
|.+++.. ....+++..++.++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+|+...........
T Consensus 87 L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 87 LSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9999863 245688999999999999999999998 9999999999999999999999999999876555444444
Q ss_pred cccccccccCccccccCcCCCcchhhhHHHHHHHHHhC-CcccccccccccccchHHHHHHhhhcCCcccccCccccCcC
Q 003039 689 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 767 (854)
Q Consensus 689 ~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG-~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 767 (854)
...||+.|+|||++.+..++.++|||||||++|||+|+ ++|+..... ..+.+.+. .+.. ...|.
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----~~~~~~i~----~~~~--~~~p~----- 225 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDIS----TGFR--LYKPR----- 225 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----HHHHHHHH----HTCC--CCCCT-----
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH----HHHHHHHH----hcCC--CCCcc-----
Confidence 56799999999999999999999999999999999995 555543321 12222222 1211 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 768 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 768 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
....++.+++.+|++.+|++||||+||+++|+++..
T Consensus 226 --~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 --LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 122467899999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=417.71 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=207.9
Q ss_pred HHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 607 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 607 (854)
+.+.++||+|+||+||+|++++++.||||+++... ...+.|.+|+++|++++|||||+++|++.+ +..++||||+++|
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence 44678899999999999999988999999997543 346789999999999999999999998865 5678999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.+++... ....+++..++.|+.|||+||+|||++ +|+||||||+||||++++.+||+|||+|+..........
T Consensus 93 ~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 93 SLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp BHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred cHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 999987543 344689999999999999999999998 999999999999999999999999999997765544445
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccc-ccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI-SNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf-~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....||+.|+|||++.++.++.++|||||||++|||+||..|+ ..... ..+.+. +..+.- +.....
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----~~~~~~----i~~~~~-----~~~p~~ 234 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQN----LERGYR-----MVRPDN 234 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHH----HHTTCC-----CCCCTT
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----HHHHHH----HHhcCC-----CCCccc
Confidence 5567999999999999999999999999999999999966554 33221 122222 222211 111112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
...++.+|+.+|++.+|++||||+||++.|+++..
T Consensus 235 ----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 235 ----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 22457899999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-48 Score=419.27 Aligned_cols=253 Identities=27% Similarity=0.461 Sum_probs=196.5
Q ss_pred hhccccccCceEEEEEEECC-C---cEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 530 LEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~-~---~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
+.+.||+|+||+||+|+++. + ..||||++.... ....+.|.+|+++|++++|||||+++|+|..++..++|||||
T Consensus 30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence 35789999999999998862 2 358999886543 334567999999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
++|+|.+++.. ....++|.+++.++.|||+||+|||++ +|+||||||+||||+.++.+||+|||+|+.......
T Consensus 110 ~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 110 ENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp TTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 99999998853 245689999999999999999999998 999999999999999999999999999986654322
Q ss_pred ce----eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 685 HV----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 685 ~~----~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.. .....||+.|||||.+.++.++.++|||||||++|||+| |+.||.+... ..+...+ ..+.-
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----~~~~~~i----~~~~~---- 251 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----QDVINAI----EQDYR---- 251 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHH----HTTCC----
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----HHHHHHH----HcCCC----
Confidence 21 122457999999999999999999999999999999998 8999976542 1222222 22211
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
...+......+.+|+.+||+.+|++||||.||++.|++++.
T Consensus 252 -----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 -----LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11112233468899999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=409.82 Aligned_cols=255 Identities=32% Similarity=0.547 Sum_probs=199.1
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++||||++++|++.+ +..++||||+++
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence 45688999999999999875 46999998754 33445789999999999999999999999865 468999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC-c
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-H 685 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~-~ 685 (854)
|+|.++++.. ...+++..++.++.|||+||+|||++ +|+||||||+||||+.++.+||+|||+|+....... .
T Consensus 88 g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 88 SSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999632 35689999999999999999999998 999999999999999999999999999986654322 2
Q ss_pred eeecccccccccCcccccc---CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 686 VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
......||+.|||||++.+ ..++.++|||||||++|||+||+.||.+..... .+. .....+... +.
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~----~~~~~~~~~----p~ 230 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QII----FMVGRGYLS----PD 230 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHH----HHHHHTSCC----CC
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHH----HHHhcCCCC----Cc
Confidence 3345679999999999864 357899999999999999999999997644111 111 112222111 11
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
+ ..........+.+++.+||+.+|++||||+||+++|+.+.
T Consensus 231 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 231 L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 1111222346889999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-48 Score=418.99 Aligned_cols=256 Identities=28% Similarity=0.402 Sum_probs=210.9
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.+.||+|+||+||+|+++ +++.||||+++... ...++|.+|+++|++++||||++++|+|.+++..++||||++
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 3456789999999999999987 58899999987543 346789999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++... ....+++..++.++.|+|+||+|||++ +|+||||||+||||+.++.+||+|||+|+........
T Consensus 97 ~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 97 YGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp TCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred CcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 99999998643 345689999999999999999999998 9999999999999999999999999999876655555
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ....+.+. +..+.. .
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---~~~~~~~~----i~~~~~---------~ 235 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYEL----LEKDYR---------M 235 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHH----HHTTCC---------C
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc---hHHHHHHH----HhcCCC---------C
Confidence 5555678999999999999999999999999999999999776654322 11122221 222211 1
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
..+......+.+|+.+|++.||++||||.||++.|+.+.
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111122346889999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=404.67 Aligned_cols=249 Identities=30% Similarity=0.515 Sum_probs=209.9
Q ss_pred hhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
+.++||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||+++|+|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 568899999999999999988899999998654 3467899999999999999999999999999999999999999999
Q ss_pred HhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCceeec
Q 003039 610 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 689 (854)
Q Consensus 610 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 689 (854)
.+++.. ....+++..+..++.|+|+||+|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 87 ~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 87 LNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp HHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred HHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 998753 345688899999999999999999998 99999999999999999999999999998765554444445
Q ss_pred ccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCcCC
Q 003039 690 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 768 (854)
Q Consensus 690 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~ 768 (854)
..||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+.. .+..+.. ...|.
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----~~~~----~i~~~~~--~~~p~------ 224 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAE----HIAQGLR--LYRPH------ 224 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHH----HHHTTCC--CCCCT------
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH----HHHH----HHHhCCC--CCCcc------
Confidence 679999999999999999999999999999999998 89999765522 1222 2222211 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 769 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 769 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
....++.+++.+||+.+|++|||+.||+++|.+
T Consensus 225 -~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 -LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122468899999999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=404.62 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=205.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++||||+++++++..++..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 445688999999999999875 6999999999766555667899999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....... .
T Consensus 102 g~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 102 GSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp CBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 99998774 24588999999999999999999998 999999999999999999999999999986644332 2
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... +........+.. .. .....
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~~~-~~---~~~~~ 241 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTP-EL---QNPEK 241 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSC-CC---SSGGG
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCCC-CC---CCccc
Confidence 34457999999999999999999999999999999999999999754411 111111222211 10 01111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ...+.+++.+|++.||++|||+.|+++|
T Consensus 242 ~----s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 242 L----SAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp S----CHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred C----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2 2357899999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=406.23 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=199.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 345689999999999999986 68999999997543 2334568999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC-C
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-S 684 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 684 (854)
+|+|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 87 gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 87 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999984 345789999999999999999999998 99999999999999999999999999998654332 2
Q ss_pred ceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||...... ...... ......... .
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~~----~~~~~~~~~-----~ 228 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSD----WKEKKTYLN-----P 228 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT--SHHHHH----HHTTCTTST-----T
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH--HHHHHH----HhcCCCCCC-----c
Confidence 23345679999999999988776 57899999999999999999999754411 111111 111111100 0
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+ .++.+|+.+|++.||++|||++|+++|
T Consensus 229 ~~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 229 WKKID----SAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp GGGSC----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCC----HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11122 356789999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=401.16 Aligned_cols=244 Identities=25% Similarity=0.414 Sum_probs=203.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||+||+|+.+ +++.||||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 456789999999999999986 68899999986432 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 ~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 88 APLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp CTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred cCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 99999999985 345689999999999999999999998 9999999999999999999999999999765433
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+..++. .+
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~----~i~~~~~------~~ 223 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYK----RISRVEF------TF 223 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHH----HHHTTCC------CC
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHH----HHHcCCC------CC
Confidence 233457999999999999999999999999999999999999999765421 1111 1122211 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+ .++.+++.+|++.||++|||++|+++|
T Consensus 224 p~~~s----~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 PDFVT----EGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CccCC----HHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11122 357889999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=405.63 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=194.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeee--cCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--~~~~~LV~E 602 (854)
|.+.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|++++||||+++++++.+ .+..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 345689999999999999876 689999999975532 334668899999999999999999999864 456899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC--CCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|+++|+|.+++.........+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 99999999999765555667999999999999999999999862 1249999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+..+....
T Consensus 166 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~----~i~~~~~~~--- 233 (269)
T d2java1 166 HDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAG----KIREGKFRR--- 233 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH----HHHHTCCCC---
T ss_pred cCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH----HHHH----HHHcCCCCC---
Confidence 432 2234467999999999999999999999999999999999999999765421 1221 222332221
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+...++ .++.+|+.+|++.||++|||+.|+++|
T Consensus 234 --~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 --IPYRYS----DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 112222 357899999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=404.78 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=200.3
Q ss_pred ccccccCceEEEEEEECC---CcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 532 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~---~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
++||+|+||+||+|.+++ ++.||||+++... ....+.|.+|+++|++++||||++++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998753 4689999996542 2335679999999999999999999999965 457899999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++. ....+++..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999985 345689999999999999999999998 99999999999999999999999999998665443332
Q ss_pred --eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 687 --SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 687 --~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.... .+.. .+..+....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~~----~i~~~~~~~------ 230 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTA----MLEKGERMG------ 230 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH----HHHTTCCCC------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----HHHH----HHHcCCCCC------
Confidence 234568999999999999999999999999999999998 89999765421 2222 222222111
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+.....++.+|+.+||+.+|++||||.||++.|+....
T Consensus 231 ---~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 111223467899999999999999999999999988653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=404.16 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=203.8
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccCCC
Q 003039 533 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 608 (854)
Q Consensus 533 ~iG~G~fg~Vy~a~~~---~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 608 (854)
+||+|+||+||+|.++ ++..||||+++... ....+.|.+|+++|++++|||||+++|+|.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999875 35579999997553 3345779999999999999999999999865 46899999999999
Q ss_pred HHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce--
Q 003039 609 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-- 686 (854)
Q Consensus 609 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-- 686 (854)
|.+++.. ....+++..++.++.|+|+||+|||++ +|+||||||+||||+.++.+||+|||+|+.........
T Consensus 95 L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 95 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred HHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 9998753 245689999999999999999999998 99999999999999999999999999998765443322
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccC
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 765 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 765 (854)
.....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+.. .+..+...+
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----~~~~----~i~~~~~~~-------- 232 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMA----FIEQGKRME-------- 232 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHH----HHHTTCCCC--------
T ss_pred ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCCCCC--------
Confidence 234468999999999999999999999999999999998 99999765422 2222 222332111
Q ss_pred cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 766 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 766 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+.....++.+|+.+||+.+|++||||.+|++.|+.+..
T Consensus 233 -~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 -CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111223467899999999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=403.96 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=197.9
Q ss_pred hhccccccCceEEEEEEECCC-----cEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 530 LEKKIGSGGFGVVYYGKLKDG-----KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~-----~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
+.+.||+|+||.||+|.++.. ..||||+++... .....+|.+|++++++++|||||+++|++.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 467899999999999987632 369999997543 33345789999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+.+|++.+.+.. ....+++.+++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+|+......
T Consensus 91 ~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 91 MENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp CTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred cccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 999999988753 345689999999999999999999998 99999999999999999999999999998765432
Q ss_pred C--ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 684 S--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 684 ~--~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
. .......||+.|+|||++.++.++.++|||||||++|||++|..|+..... ...+... +..+.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---~~~~~~~----i~~~~------- 230 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKA----INDGF------- 230 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH----HHTTC-------
T ss_pred ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---HHHHHHH----HhccC-------
Confidence 2 223345689999999999999999999999999999999997665543221 1122222 22221
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
....+.....++.+|+.+||+.+|++||||.||++.|++++.
T Consensus 231 --~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 --RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp --CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111122233568899999999999999999999999998765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=405.72 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=203.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.+.||+|+||+||+|+.. +++.||||+++.......+.+.+|+++|++++||||+++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 345688999999999999986 6889999999876666677899999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+...... ..
T Consensus 94 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 94 GAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999998753 235689999999999999999999998 99999999999999999999999999997543221 12
Q ss_pred eecccccccccCccccc-----cCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 687 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .+... .. .+.......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----~~~~~---i~-~~~~~~~~~- 237 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM----RVLLK---IA-KSEPPTLAQ- 237 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG----GHHHH---HH-HSCCCCCSS-
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH----HHHHH---HH-cCCCCCCCc-
Confidence 23456999999999984 456889999999999999999999999765422 11111 11 111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+......+.+|+.+|++.||++|||+.|+++|
T Consensus 238 ------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 238 ------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122457899999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-46 Score=392.63 Aligned_cols=247 Identities=28% Similarity=0.412 Sum_probs=195.5
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeee----cCeEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 601 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~----~~~~~LV~ 601 (854)
.++++||+|+||+||+|++. +++.||+|++.... ....+.+.+|+++|++++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 35678999999999999986 58899999986542 3335678999999999999999999999865 34579999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcEEEEeeecccccc
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkl~DFGla~~~~ 680 (854)
||+++|+|.+++. ....+++..+..++.||++||+|||++. ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999985 3456889999999999999999999971 1399999999999997 57899999999998543
Q ss_pred CCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
.. ......||+.|||||++.+ .++.++|||||||++|||++|+.||...... ..+. ..+..+.....+
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~---~~~~----~~i~~~~~~~~~- 234 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIY----RRVTSGVKPASF- 234 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHH----HHHTTTCCCGGG-
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---HHHH----HHHHcCCCCccc-
Confidence 32 2345679999999998865 6999999999999999999999999754311 1111 122222111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
....+ .++.+++.+|++.+|++|||++|+++|
T Consensus 235 ---~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 235 ---DKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---GGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CccCC----HHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11122 347889999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=413.13 Aligned_cols=198 Identities=27% Similarity=0.407 Sum_probs=173.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.++||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.+|++++|||||+++++|.+++..++||||++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 445688999999999999976 68999999997543 3335678999999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
+|+|.+++.. ...+++..+..++.|++.||+|||+++ +|+||||||+|||++.++++||+|||+|+...+.
T Consensus 88 gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 88 GGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp TEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 9999999953 456899999999999999999999631 7999999999999999999999999999865432
Q ss_pred eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 734 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~ 734 (854)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2234579999999999999999999999999999999999999997543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=411.90 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=204.3
Q ss_pred HHHhhccccccCceEEEEEEECC------CcEEEEEEEccC-CcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~------~~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~ 598 (854)
.+.+.++||+|+||+||+|++.. ...||||++... .......+.+|+.+|.++ +|||||++++++.+.+..+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 34567899999999999998752 236999998654 334456789999999998 8999999999999999999
Q ss_pred EEEEeccCCCHHhhhccccc-------------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 003039 599 LVYEFMHNGTLKEHLYGTLT-------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 659 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~N 659 (854)
+|||||++|+|.++|+.... ....+++..++.++.|+++||+|||++ +|+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence 99999999999999965321 124588999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccc
Q 003039 660 ILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA 737 (854)
Q Consensus 660 ILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~ 737 (854)
||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+.....
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999866544333 3344568999999999999999999999999999999998 899997654221
Q ss_pred cccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 003039 738 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 802 (854)
Q Consensus 738 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~ 802 (854)
.+.. .+..+.- ...+.....++.+|+.+|++.+|++||||+||+++|..
T Consensus 275 ---~~~~----~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 275 ---NFYK----LIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp ---HHHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHH----HHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1222 1222211 11111223468899999999999999999999999964
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=405.83 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=201.0
Q ss_pred HHHhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.+.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 355788999999999999999988899999997543 446789999999999999999999999865 567899999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
|+|.+++... ....++|.+++.++.|||+||+|||+. +|+||||||+||||+.++++||+|||+|+.........
T Consensus 96 g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 9999988643 244689999999999999999999998 99999999999999999999999999998765554444
Q ss_pred eecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 687 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
.....||+.|+|||++..+.++.++|||||||++|||++|..|+.... ....+...+. .+.. .....
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~---~~~~~~~~i~----~~~~-----~~~~~- 237 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVE----RGYR-----MPCPP- 237 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHH----TTCC-----CCCCT-
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC---CHHHHHHHHH----hcCC-----CCCCc-
Confidence 455679999999999999999999999999999999999766654322 1112223222 1111 11111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
....++.+++.+|++.+|++||+|++|++.|++..
T Consensus 238 ---~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 238 ---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 22346889999999999999999999999998864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=398.19 Aligned_cols=257 Identities=21% Similarity=0.341 Sum_probs=197.1
Q ss_pred HHHhhccccccCceEEEEEEECC----CcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~----~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
.+.+.+.||+|+||.||+|++.. +..||||+++... ......+.+|+++|++++||||++++|++. ++..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 34567899999999999998753 3568999886543 333567999999999999999999999996 46789999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+++|+|.+++.. ....+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+....
T Consensus 87 E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 87 ELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp ECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999998753 345689999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
..........||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+ ..+....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----~~~~~i----~~~~~~~--- 229 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRI----ENGERLP--- 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHH----HTTCCCC---
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----HHHHHH----HcCCCCC---
Confidence 54444555678999999999999999999999999999999998 89999765522 222222 2222111
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 807 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~~~ 807 (854)
.... ....+.+|+.+|++.+|++|||+.||+++|+.++..+
T Consensus 230 --~~~~----~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 230 --MPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp --CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCC----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1112 2346889999999999999999999999999987543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-46 Score=401.98 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=188.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.+.||+|+||+||+|+.+ +++.||||++..... .....+.+|+++|++++||||+++++++.+++..++|||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 556789999999999999986 689999999975532 234568899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc---CCCcEEEEeeeccccccCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkl~DFGla~~~~~~ 682 (854)
+|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+|+.....
T Consensus 91 gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 91 GGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp SCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999995 345689999999999999999999998 999999999999995 5789999999999865433
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.... .+... +..+... .+..
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~----i~~~~~~--~~~~ 231 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA----KLFEQ----ILKAEYE--FDSP 231 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH----HHTTCCC--CCTT
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH----HHHHH----HhccCCC--CCCc
Confidence 2 233457999999999999999999999999999999999999999765421 11111 1111110 1111
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.....+ ..+.+++.+|++.||++|||+.|+++|
T Consensus 232 ~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 YWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 112222 357899999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-45 Score=405.49 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=206.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+++|++++||||+++++++.+++..++|||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 566789999999999999876 6899999999876656667889999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--CCcEEEEeeeccccccCCCC
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~~~~~~~ 684 (854)
|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+|+......
T Consensus 108 g~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 108 GELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 999999853 245689999999999999999999998 9999999999999964 5789999999998664432
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+ +.. . +..+.. ..+....
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~---~-i~~~~~--~~~~~~~ 249 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLR---N-VKSCDW--NMDDSAF 249 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---H-HHHTCC--CSCCGGG
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH----HHH---H-HHhCCC--CCCcccc
Confidence 3344579999999999999999999999999999999999999997654221 111 1 111111 0111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+ ..+.+++.+|++.||++|||++|+++|
T Consensus 250 ~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 SGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGCC----HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1222 357899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=401.46 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=201.1
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 456789999999999999986 68999999986432 23346789999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++. ..+.+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 90 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999884 345789999999999999999999998 99999999999999999999999999998765432
Q ss_pred -CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 684 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 684 -~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+.. .+..+.. .
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~----~i~~~~~------~ 228 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LIFQ----KIIKLEY------D 228 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHTTCC------C
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH----HHHH----HHHcCCC------C
Confidence 22334567999999999999999999999999999999999999999765421 1111 1112221 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+....+ ..+.+|+.+|++.||++|||++|+.++
T Consensus 229 ~p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 FPEKFF----PKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCTTCC----HHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCccCC----HHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 111222 357899999999999999999997654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-45 Score=395.62 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=198.9
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
.|...+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3455688999999999999876 6889999999765432 23568899999999999999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
||.+|+|..++. ....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999976653 345689999999999999999999998 9999999999999999999999999999865332
Q ss_pred CCceeecccccccccCcccccc---CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.... +....... +......
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-------~~~~~i~~-~~~~~~~ 235 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQ-NESPALQ 235 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHH-SCCCCCS
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHh-CCCCCCC
Confidence 33569999999999864 46899999999999999999999999754311 11111111 1111111
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+ ..++ ..+.+++.+|++.||++|||+.|+++|
T Consensus 236 ~----~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 S----GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp C----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C----CCCC----HHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1 1122 357899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-45 Score=403.15 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=206.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.+.||+|+||.||+|+.. +|+.||||+++.........+.+|+++|++++||||+++++++.+++..++|||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 556789999999999999975 6999999999876655667889999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc--CCCcEEEEeeeccccccCCCC
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkl~DFGla~~~~~~~~ 684 (854)
|+|.+++.. ....+++..+..|+.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+|+.....
T Consensus 111 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 111 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred ChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999987743 345689999999999999999999998 999999999999998 5789999999999876543
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .+... +..+... ..+...
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~----i~~~~~~--~~~~~~ 252 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQN----VKRCDWE--FDEDAF 252 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHH----HHHCCCC--CCSSTT
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HHhCCCC--CCcccc
Confidence 2334557999999999999999999999999999999999999999765421 11111 1111110 111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+ ..+.+|+.+|++.||++|||+.|+++|
T Consensus 253 ~~~s----~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 SSVS----PEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222 357899999999999999999999886
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=393.73 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=203.0
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc------ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 599 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~------~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~L 599 (854)
.|.+.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|++++||||+++++++.+++..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3556789999999999999985 689999999864321 235679999999999999999999999999999999
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC----cEEEEeeec
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGL 675 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFGl 675 (854)
|||||++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 91 v~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999853 45689999999999999999999998 999999999999998776 599999999
Q ss_pred cccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 676 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 676 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .... .+..+..
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~----~i~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLA----NVSAVNY 233 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHTTCC
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH----HHHH----HHHhcCC
Confidence 98664432 233456899999999999999999999999999999999999999765421 1111 1111111
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ..+...... ...+.+++.+|++.||++|||++|+++|
T Consensus 234 ~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 E--FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C--CCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C--CCchhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000011111 2357799999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=387.13 Aligned_cols=248 Identities=29% Similarity=0.448 Sum_probs=196.7
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeee-cCeEEEEEEeccCC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNG 607 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~-~~~~~LV~E~~~~g 607 (854)
.+.++||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++||||++++|+|.+ .+..++||||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 35688999999999999996 789999999654 345679999999999999999999999865 45689999999999
Q ss_pred CHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCcee
Q 003039 608 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 687 (854)
Q Consensus 608 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 687 (854)
+|.++|+.. ....++|..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 87 ~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~ 157 (262)
T d1byga_ 87 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 157 (262)
T ss_dssp EHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----C
Confidence 999999642 234589999999999999999999998 9999999999999999999999999999864332 2
Q ss_pred ecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCcccccCccccCc
Q 003039 688 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 766 (854)
Q Consensus 688 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 766 (854)
....+|..|+|||++.+..++.++|||||||++|||+| |+.||..... .++..++. .+.-.+
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~~~~~i~----~~~~~~--------- 220 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVE----KGYKMD--------- 220 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHHHHT----TTCCCC---------
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----HHHHHHHH----cCCCCC---------
Confidence 33458999999999999999999999999999999998 6777765442 23333322 221111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 767 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 767 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.+.....++.+|+.+|++.||++||||.||+++|+++..
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 111222467899999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=396.15 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=196.7
Q ss_pred HHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccC-CCCceeeEeeeeeec-CeE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-GRS 597 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~-~~~ 597 (854)
.+.+.++||+|+||.||+|++. +++.||||+++... ....+.+.+|+.++.++ +|+||+.+++++... ...
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 4556789999999999999864 34689999987543 33456677888887776 789999999998664 468
Q ss_pred EEEEEeccCCCHHhhhccccc------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC
Q 003039 598 VLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 665 (854)
Q Consensus 598 ~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 665 (854)
++|||||++|+|.++++.... ....+++..++.++.||++||+|||++ +|+||||||+||||+.+
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCC
Confidence 999999999999999964321 134588999999999999999999998 99999999999999999
Q ss_pred CcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCC-cccccccccccccchH
Q 003039 666 MRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIV 743 (854)
Q Consensus 666 ~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~-~pf~~~~~~~~~~~l~ 743 (854)
+.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||......+ .+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---~~- 246 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF- 246 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HH-
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---HH-
Confidence 99999999999865443332 334457999999999999999999999999999999999975 5776543211 11
Q ss_pred HHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 744 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 744 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
...+..+.... .... ...++.+++.+|++.||++||||.||+++|+++++
T Consensus 247 ---~~~~~~~~~~~-----~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 ---CRRLKEGTRMR-----APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ---HHHHHHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHhcCCCCC-----CCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22222222111 1111 22357899999999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=391.56 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=202.3
Q ss_pred hhccccccCceEEEEEEECCC----cEEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeee-cCeEEEEEEe
Q 003039 530 LEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 603 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~----~~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~-~~~~~LV~E~ 603 (854)
+.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.. ++..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 357899999999999987632 35899999754 33445779999999999999999999999876 4688999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
|++|+|.+++.. ....+++..++.++.|+|+||.|||+. +|+||||||+||||++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999998864 344577888999999999999999998 99999999999999999999999999998654432
Q ss_pred Cc---eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccC
Q 003039 684 SH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 760 (854)
Q Consensus 684 ~~---~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 760 (854)
.. ......||+.|+|||.+.+..++.++|||||||++|||+||..||...... ..+..++ ..+.-. ..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---~~~~~~i----~~g~~~--~~ 255 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL----LQGRRL--LQ 255 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHH----HTTCCC--CC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCCCC--CC
Confidence 22 223356899999999999999999999999999999999988887643311 1222222 122111 11
Q ss_pred ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 761 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 761 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+ .....++.+|+.+||+.||++||+|.||+++|++++.
T Consensus 256 p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 P-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 1122458899999999999999999999999998854
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=390.80 Aligned_cols=266 Identities=23% Similarity=0.349 Sum_probs=201.2
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecC----eEEEEEEec
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEFM 604 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~----~~~LV~E~~ 604 (854)
.+.++||+|+||.||+|+++ |+.||||+++... ......+.|+..+.+++||||++++++|...+ ..++|||||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 35688999999999999985 8999999986432 11222344566667789999999999997654 579999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
++|+|.++|+. ..++|..++.++.|+|.||+|||+.+ .++|+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 84 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999953 35899999999999999999999732 249999999999999999999999999999876
Q ss_pred cCCCCc---eeecccccccccCccccccC------cCCCcchhhhHHHHHHHHHhCCccccccccccc-c------cchH
Q 003039 680 VDGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGAN-C------RNIV 743 (854)
Q Consensus 680 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~-~------~~l~ 743 (854)
...... ......||+.|+|||++... .++.++|||||||+||||+||..|+........ . ..-.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 554332 22346799999999998754 367789999999999999999988754321110 0 0111
Q ss_pred HHHHHhhhcCCcccccCccccCcC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 744 QWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 744 ~~~~~~~~~~~~~~~id~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.........+. .+|.+.... +.+....+.+|+.+||+.||++||||.||++.|+++..
T Consensus 239 ~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 239 EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 22222222211 222322222 33566779999999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=395.47 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=200.4
Q ss_pred HHhhccccccCceEEEEEEEC-CCc----EEEEEEEccC-CcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~----~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~ 601 (854)
|.+.+.||+|+||+||+|++. +|+ +||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 345689999999999999875 343 5899988654 344567899999999999999999999999865 567889
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
||+.+|+|.+++.. ....+++..++.++.|||.||+|||++ +|+||||||+||||+.++.+||+|||+|+....
T Consensus 90 e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp ECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 99999999988753 355689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 682 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 682 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
.... ......||+.|+|||++.++.++.++|||||||++|||+| |..||...... .+...+ ..+.-.
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~~i----~~~~~~--- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSIL----EKGERL--- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHHHH----HHTCCC---
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----HHHHHH----HcCCCC---
Confidence 4333 2334568999999999999999999999999999999998 78888765422 222222 122110
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..+......+.+|+.+|++.+|++||||.||+++|+.+..
T Consensus 233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1111223458899999999999999999999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-45 Score=394.77 Aligned_cols=257 Identities=25% Similarity=0.419 Sum_probs=206.0
Q ss_pred HHhhccccccCceEEEEEEEC------CCcEEEEEEEccCCc-ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
+.+.+.||+|+||+||+|+++ +++.||||+++.... ...++|.+|+++|++++||||++++++|...+..++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 345788999999999999874 357899999875433 3356799999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccc--------------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 003039 601 YEFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 660 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 660 (854)
|||+++|+|.++++... .....+++..++.|+.|++.||+|||+. +|+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 99999999999986421 1223488999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeeeccccccCCC-CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCC-ccccccccccc
Q 003039 661 LLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGAN 738 (854)
Q Consensus 661 Ll~~~~~vkl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~-~pf~~~~~~~~ 738 (854)
||+.++.+||+|||+|+...... ........||+.|+|||.+.+..++.++|||||||++|||++|. +||......
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~-- 249 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 249 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH--
Confidence 99999999999999998554332 22334456899999999999999999999999999999999986 567654421
Q ss_pred ccchHHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 003039 739 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 804 (854)
Q Consensus 739 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~ 804 (854)
.+... +..+...++ ... ....+.+|+.+||+.+|++||||.||++.|+++.
T Consensus 250 --e~~~~----v~~~~~~~~-----p~~----~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 250 --EVIYY----VRDGNILAC-----PEN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp --HHHHH----HHTTCCCCC-----CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --HHHHH----HHcCCCCCC-----Ccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22222 233332211 111 2245889999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=392.60 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=203.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 345689999999999999985 68999999997532 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
|++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+......
T Consensus 87 ~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 87 ANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999885 345688889999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+.. .+..+.+ .+
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----~~~~----~i~~~~~------~~ 224 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFE----LILMEEI------RF 224 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCC------CC
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH----HHHH----HHhcCCC------CC
Confidence 2334567999999999999999999999999999999999999999865522 1211 1122221 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
....+ .++.+|+.+|++.||++||+ +.|+++|
T Consensus 225 p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 PRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CccCC----HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11222 34778999999999999995 8888876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-44 Score=390.39 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=203.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+++..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 345789999999999999986 68999999996432 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 ~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 86 IEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred cCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 99999998884 345677888889999999999999998 9999999999999999999999999999875432
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+ +. .. +..+.. .+
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~---~~-i~~~~~------~~ 220 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TY---EK-ILNAEL------RF 220 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH---HH-HHHCCC------CC
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----HH---HH-HHcCCC------CC
Confidence 234679999999999999999999999999999999999999997654211 11 11 111211 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH--HHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD--IQDA 803 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~--L~~~ 803 (854)
....+ ..+.+++.+|++.+|++|| |++|+++| ++++
T Consensus 221 p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 221 PPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 11122 3578999999999999996 89999887 5443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=384.10 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=193.8
Q ss_pred HHhhccccccCceEEEEEEECC--C--cEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLKD--G--KEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~~--~--~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
+.+.+.||+|+||.||+|++.. + ..||||++.... ....++|.+|+++|++++||||++++|+|.++ ..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhee
Confidence 3456789999999999998642 2 378999986542 23346799999999999999999999999764 67899
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++|++.+++.. ....+++..++.++.|+|.||+|||++ +|+||||||+||||+.++++||+|||+++...
T Consensus 89 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 89 TELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999988753 345689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCce--eecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 681 DGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 681 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
...... .....||..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+.. .+..+ ..+.+.-.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~---i~~~~~~~~ 235 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHK---IDKEGERLP 235 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH---HHTSCCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----HHHHH---HHhCCCCCC
Confidence 543332 234468889999999999999999999999999999998 89999765422 22222 222221111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 803 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~ 803 (854)
..... ...+.+|+.+||+.||++||||.||.+.|+++
T Consensus 236 -----~~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 -----RPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----Ccccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122 24588999999999999999999999988874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4e-44 Score=382.08 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=199.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc---ccHHHHHHHHHHHccCCCCceeeEeeeeeecC----eEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~---~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~----~~~L 599 (854)
|.+.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++...+ ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 456789999999999999875 689999999976533 23456899999999999999999999997654 3789
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
||||+++|+|.+++. ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.++|+|||.++..
T Consensus 89 vmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 999999999998874 345689999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCC--ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc
Q 003039 680 VDGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 757 (854)
Q Consensus 680 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~ 757 (854)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.....+..+....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIPP 234 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCCG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcCCCCC
Confidence 33222 2334557999999999999999999999999999999999999999765421 12222233222111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHH
Q 003039 758 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAI 804 (854)
Q Consensus 758 ~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-sm~eV~~~L~~~~ 804 (854)
.......+ .++.+++.+|++.||++|| |++++.+.|.++.
T Consensus 235 ---~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 ---SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---chhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 01112222 3578999999999999999 8999999888753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=393.03 Aligned_cols=260 Identities=26% Similarity=0.388 Sum_probs=208.3
Q ss_pred HHHhhccccccCceEEEEEEEC------CCcEEEEEEEccCCc-ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~ 598 (854)
.+.+.++||+|+||.||+|++. +++.||||+++.... .....+.+|+.+++++ +|||||+++|+|.+.+..+
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~ 103 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence 4456789999999999999863 457899999976543 3455788999999999 6999999999999999999
Q ss_pred EEEEeccCCCHHhhhcccc--------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 003039 599 LVYEFMHNGTLKEHLYGTL--------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 664 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~--------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 664 (854)
+|||||++|+|.++++... .....+++..+..++.||++||+|||++ +++||||||+|||++.
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccccc
Confidence 9999999999999986532 1234588999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeeeccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccch
Q 003039 665 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 742 (854)
Q Consensus 665 ~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l 742 (854)
++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |.+|+......+ .+
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~---~~ 257 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---KF 257 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---HH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence 999999999999876554333 3345679999999999999999999999999999999999 555554433211 11
Q ss_pred HHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 743 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 743 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
... +..+.. ...+......+.+|+.+|++.||++||||.||++.|++++.
T Consensus 258 ~~~----i~~~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 258 YKM----IKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHH----HHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----HhcCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 222 222211 11111122458899999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=388.73 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=201.7
Q ss_pred HhhccccccCceEEEEEEECC-Cc--EEEEEEEccC-CcccHHHHHHHHHHHccC-CCCceeeEeeeeeecCeEEEEEEe
Q 003039 529 MLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~-~~--~VAvK~l~~~-~~~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
.+.++||+|+||+||+|++++ |. .||||+++.. .....+.|.+|+++|+++ +||||++++|+|...+..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 356899999999999998863 44 4788887644 333456799999999998 799999999999999999999999
Q ss_pred ccCCCHHhhhcccc------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 003039 604 MHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 671 (854)
Q Consensus 604 ~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 671 (854)
+++|+|.++|+... .....+++..+..++.|||+||.|||+. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence 99999999996531 2346789999999999999999999998 99999999999999999999999
Q ss_pred eeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCc-ccccccccccccchHHHHHHhh
Q 003039 672 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 672 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~-pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
|||+|+...... ......||..|+|||.+....++.++|||||||++|||++|.. ||...... .+.+ .+
T Consensus 170 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~----~~~~----~i 239 (309)
T d1fvra_ 170 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYE----KL 239 (309)
T ss_dssp CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH----HG
T ss_pred cccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH----HHHH----HH
Confidence 999997543221 2233468999999999999999999999999999999999764 66554321 2222 12
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
..+... ..+.....++.+|+.+|++.+|++||||.||+++|++++.
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 240 PQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp GGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222111 1111223468899999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=387.21 Aligned_cols=259 Identities=25% Similarity=0.432 Sum_probs=204.8
Q ss_pred HHHhhccccccCceEEEEEEECC--------CcEEEEEEEccCCc-ccHHHHHHHHHHHccC-CCCceeeEeeeeeecCe
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 596 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~~--------~~~VAvK~l~~~~~-~~~~~~~~Ev~~L~~l-~HpnIv~l~g~~~~~~~ 596 (854)
.+.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +||||++++++|.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 34567899999999999998642 34799999976543 3456788899998888 89999999999999999
Q ss_pred EEEEEEeccCCCHHhhhcccc------------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 003039 597 SVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 664 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 664 (854)
.++||||+++|+|.++|.... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 999999999999999996442 1235689999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeeeccccccCCCC-ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHh-CCcccccccccccccch
Q 003039 665 HMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 742 (854)
Q Consensus 665 ~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~ellt-G~~pf~~~~~~~~~~~l 742 (854)
++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++ |+.||...... .+
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----~~ 246 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----EL 246 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----HH
Confidence 99999999999986654332 23344568999999999999999999999999999999998 78888755421 22
Q ss_pred HHHHHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 743 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 743 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.. .+..+...+ .... ....+.+|+.+|++.+|++||||.||++.|++++.
T Consensus 247 ~~----~i~~~~~~~-----~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 FK----LLKEGHRMD-----KPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH----HHHTTCCCC-----CCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----HHHcCCCCC-----CCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 22 222332111 1111 22458899999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-43 Score=378.05 Aligned_cols=249 Identities=27% Similarity=0.332 Sum_probs=200.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc---------cHHHHHHHHHHHccCC-CCceeeEeeeeeecCe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---------GKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 596 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~---------~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~ 596 (854)
|.+.+.||+|+||+||+|+.. +|+.||||+++..... ....+.+|+.++++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 345789999999999999875 6899999999754321 1235788999999997 9999999999999999
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
.++||||+++|+|.+++. ....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 85 ~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999995 345789999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeecccccccccCcccccc------CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhh
Q 003039 677 KFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 750 (854)
Q Consensus 677 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~ 750 (854)
+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... + ...+
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~----~----~~~i 227 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----M----LRMI 227 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H----HHHH
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH----H----HHHH
Confidence 8765432 2344579999999999863 346889999999999999999999998654211 1 1111
Q ss_pred hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 751 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 751 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+... .........+ .++.+++.+|++.+|++|||++||++|
T Consensus 228 ~~~~~~--~~~~~~~~~s----~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQ--FGSPEWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCC--CCTTTGGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCCC--CCCcccccCC----HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 122111 0000111222 458899999999999999999999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=378.39 Aligned_cols=256 Identities=21% Similarity=0.228 Sum_probs=194.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEEccCCcc-----cHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 532 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~-----~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
++||+|+||+||+|+.+ +|+.||||+++..... ..+.+.+|+++|++++||||+++++++..++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 67999999999999976 6899999998654321 13468899999999999999999999999999999999999
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred chHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 887776552 345688889999999999999999998 999999999999999999999999999986544322
Q ss_pred eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC---ccccc--
Q 003039 686 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD---IQGII-- 759 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~---~~~~i-- 759 (854)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+ ....+........ .....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH----HHHHHHHhcCCCChhhccchhcc
Confidence 2234569999999999875 457999999999999999999999997654211 1111111110000 00000
Q ss_pred -Cc---cccCcCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 760 -DP---SLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 760 -d~---~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
+. ......+. .....+.+|+.+|++.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 00001111 112468899999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-43 Score=388.44 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=201.3
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 603 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~ 603 (854)
|.+.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++|+.++||||+++++++......++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 445689999999999999986 69999999986432 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCC
Q 003039 604 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 683 (854)
Q Consensus 604 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 683 (854)
+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 123 ~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 123 VAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999998843 34689999999999999999999998 9999999999999999999999999999865432
Q ss_pred CceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCccc
Q 003039 684 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 763 (854)
Q Consensus 684 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 763 (854)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.+.... .+.. .+..+.. ..
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~----~i~~~~~------~~ 257 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYE----KIVSGKV------RF 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCC------CC
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH----HHHH----HHhcCCC------CC
Confidence 23457999999999999999999999999999999999999999765411 1111 1112211 11
Q ss_pred cCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 764 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 764 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
....+ ..+.+++.+|++.||++|+ |++|+++|
T Consensus 258 p~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 PSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 11222 3578999999999999994 89999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=383.96 Aligned_cols=249 Identities=19% Similarity=0.313 Sum_probs=202.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
|.+.+.||+|+||+||+|..+ +++.||||+++... .....+.+|+++|++++||||+++++++.+++..++|||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 456789999999999999986 68899999997653 3345688999999999999999999999999999999999999
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC--CcEEEEeeeccccccCCCC
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~--~~vkl~DFGla~~~~~~~~ 684 (854)
|+|.+++.. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 86 g~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 86 LDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 999999853 234689999999999999999999998 99999999999999854 58999999999865433
Q ss_pred ceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcccc
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 764 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 764 (854)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .+.. . +..+... ++....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~----~~~~---~-i~~~~~~--~~~~~~ 227 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIE---N-IMNAEYT--FDEEAF 227 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHH---H-HHHTCCC--CCHHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH----HHHH---H-HHhCCCC--CChhhc
Confidence 2334456899999999999999999999999999999999999999765421 1111 1 1111110 111111
Q ss_pred CcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 765 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 765 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+ .++.+++.+|+..||++|||++|+++|
T Consensus 228 ~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 KEIS----IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122 347899999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=380.99 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=207.1
Q ss_pred HHhhccccccCceEEEEEEEC------CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~------~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
+.+.++||+|+||+||+|.++ +++.||||+++... ......|.+|++++++++||||++++|+|...+..++|
T Consensus 22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 101 (308)
T d1p4oa_ 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 101 (308)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence 346788999999999999874 25789999997543 33345689999999999999999999999999999999
Q ss_pred EEeccCCCHHhhhcccc------cccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeee
Q 003039 601 YEFMHNGTLKEHLYGTL------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 674 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 674 (854)
|||+++|+|.+++.... .....+++..+..++.|+|+||.|||++ +|+||||||+|||++.++++||+|||
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecc
Confidence 99999999999986431 1123468889999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCc-eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCC-cccccccccccccchHHHHHHhhhc
Q 003039 675 LSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIVQWAKLHIES 752 (854)
Q Consensus 675 la~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~-~pf~~~~~~~~~~~l~~~~~~~~~~ 752 (854)
+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||..... .+... .+..
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-------~~~~~-~i~~ 250 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQVLR-FVME 250 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HHHHH-HHHT
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-------HHHHH-HHHh
Confidence 99865443322 223346899999999999999999999999999999999985 66755431 12222 1222
Q ss_pred CCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 753 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 753 ~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+...+.. .. ....+.+++.+||+.+|++||||.||+++|++.+.
T Consensus 251 ~~~~~~p-----~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 GGLLDKP-----DN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TCCCCCC-----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCc-----cc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2221111 11 22468899999999999999999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=380.22 Aligned_cols=247 Identities=22% Similarity=0.246 Sum_probs=193.8
Q ss_pred hccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHcc-CCCCceeeEeeeeee----cCeEEEEEEec
Q 003039 531 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQFLGYCQE----EGRSVLVYEFM 604 (854)
Q Consensus 531 ~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~-l~HpnIv~l~g~~~~----~~~~~LV~E~~ 604 (854)
.+.||+|+||+||+|+.. +++.||||+++. ...+.+|++++.+ .+||||+++++++.+ ....++|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 356999999999999875 689999999863 3457789988765 489999999999865 46789999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeeeccccccC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~~ 681 (854)
++|+|.++|... ....+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 92 ~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 92 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence 999999999642 235699999999999999999999998 9999999999999985 46799999999986554
Q ss_pred CCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCc
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 761 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 761 (854)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....... ......+..+..
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~----~~~~~~i~~~~~------ 234 (335)
T d2ozaa1 167 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMGQY------ 234 (335)
T ss_dssp CC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSS------
T ss_pred CC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH----HHHHHHHhcCCC------
Confidence 32 234457999999999999999999999999999999999999999765422111 111111111110
Q ss_pred cccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.+..........++.+|+.+|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000011223468899999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=385.28 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=199.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHHHHHHHHc-cCCCCceeeEeeeeeecCeEEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLS-RIHHRNLVQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~~Ev~~L~-~l~HpnIv~l~g~~~~~~~~~LV~E 602 (854)
|.+.+.||+|+||+||+|+.+ +++.||||+++... ......+..|+.++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 346789999999999999986 68999999996432 223345666776665 6899999999999999999999999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 682 (854)
|+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 y~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 84 YLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999985 345688889999999999999999998 9999999999999999999999999999865433
Q ss_pred CCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcccccCcc
Q 003039 683 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 762 (854)
Q Consensus 683 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 762 (854)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .+.. .+..+.. .
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~----~i~~~~~------~ 221 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFH----SIRMDNP------F 221 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCC------C
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHH----HHHcCCC------C
Confidence 2 2334457999999999999999999999999999999999999999765421 1211 1222211 1
Q ss_pred ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 003039 763 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 799 (854)
Q Consensus 763 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~-eV~~~ 799 (854)
+....+ .++.+|+.+|++.||++||++. ||.+|
T Consensus 222 ~p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 222 YPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCccCC----HHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 111122 3578999999999999999995 78654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.4e-43 Score=386.35 Aligned_cols=247 Identities=24% Similarity=0.300 Sum_probs=196.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC---cccHHHHH---HHHHHHccCCCCceeeEeeeeeecCeEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~---~~~~~~~~---~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV 600 (854)
|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+. .|+++++.++||||+++++++...+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 345689999999999999986 68999999986432 11223333 347788888999999999999999999999
Q ss_pred EEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccccc
Q 003039 601 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 680 (854)
Q Consensus 601 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 680 (854)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp ECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999853 45678889999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccccc
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 759 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 759 (854)
... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||...... ....... ......
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~~~-~~~~~~----- 225 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDR-MTLTMA----- 225 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS----CHHHHHH-HSSSCC-----
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hcccCC-----
Confidence 432 334579999999999975 56899999999999999999999999765422 1111111 111111
Q ss_pred CccccCcCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003039 760 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 799 (854)
Q Consensus 760 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eV~~~ 799 (854)
..+....+ ..+.+|+.+|++.||++||| ++|+++|
T Consensus 226 -~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 -VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -CCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -CCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11112222 35789999999999999999 6888876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=372.79 Aligned_cols=261 Identities=21% Similarity=0.282 Sum_probs=195.2
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEecc
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
.+.+.||+|+||+||+|++. +|+.||||+++.... .....+.+|+++|++++||||+++++++.+++..++||||+.
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence 34678999999999999975 689999999965432 235678999999999999999999999999999999999997
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 685 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 685 (854)
++.+ +++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 85 ~~~~-~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 85 QDLK-KFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp EEHH-HHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred Cchh-hhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 6544 44422 2345689999999999999999999998 99999999999999999999999999998654432 2
Q ss_pred eeecccccccccCccccccCc-CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcC--Ccccc-cCc
Q 003039 686 VSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG--DIQGI-IDP 761 (854)
Q Consensus 686 ~~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~--~~~~~-id~ 761 (854)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||...+..+ .+........... ..... ..+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhcccccccc
Confidence 333456999999999987655 5789999999999999999999997644111 1111111100000 00000 000
Q ss_pred cccC------cCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 762 SLLD------EYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 762 ~l~~------~~~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.... ... ......+.+++.+|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 000 1112467899999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-42 Score=370.31 Aligned_cols=263 Identities=20% Similarity=0.267 Sum_probs=197.1
Q ss_pred HhhccccccCceEEEEEEECCCcEEEEEEEccCCc--ccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEeccC
Q 003039 529 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 606 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~--~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 606 (854)
.+.++||+|+||+||+|++++|+.||||+++.... .....+.+|+.+|++++||||+++++++...+..++++|++.+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence 35678999999999999999999999999975532 2356789999999999999999999999999999999999988
Q ss_pred CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCCce
Q 003039 607 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 686 (854)
Q Consensus 607 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 686 (854)
+.+..+.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.|....... ..
T Consensus 85 ~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 85 DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred hhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence 77766653 356789999999999999999999998 99999999999999999999999999998654432 22
Q ss_pred eecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh--------hhcCCccc
Q 003039 687 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH--------IESGDIQG 757 (854)
Q Consensus 687 ~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~--------~~~~~~~~ 757 (854)
.....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+...++....... ........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 334458999999999875 456899999999999999999999997654211111111100000 00000000
Q ss_pred ---ccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 ---IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ---~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..++.-...........+.+++.+|++.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000001111122457899999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=367.59 Aligned_cols=242 Identities=22% Similarity=0.376 Sum_probs=195.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcc------cHHHHHHHHHHHccCC--CCceeeEeeeeeecCeEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~------~~~~~~~Ev~~L~~l~--HpnIv~l~g~~~~~~~~~ 598 (854)
|.+.+.||+|+||+||+|+.. +|+.||||++...... ....+.+|+.+|++++ ||||+++++++.+++..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 556789999999999999876 6899999998753211 1234678999999986 899999999999999999
Q ss_pred EEEEeccC-CCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeeecc
Q 003039 599 LVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLS 676 (854)
Q Consensus 599 LV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla 676 (854)
+||||+.+ +++.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 86 lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 99999976 57777774 345689999999999999999999998 99999999999999854 79999999999
Q ss_pred ccccCCCCceeecccccccccCccccccCcC-CCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCc
Q 003039 677 KFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 755 (854)
Q Consensus 677 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~ 755 (854)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .+. .+..
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~--------~~~~ 221 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII--------RGQV 221 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH--------HCCC
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHh--------hccc
Confidence 865432 2344679999999999987765 567899999999999999999997532 111 1111
Q ss_pred ccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHH
Q 003039 756 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 803 (854)
Q Consensus 756 ~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~~ 803 (854)
.+....+ .++.+++.+|++.||++|||++|+++| ++++
T Consensus 222 ------~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 222 ------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1112222 357899999999999999999999986 5554
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=370.16 Aligned_cols=265 Identities=20% Similarity=0.270 Sum_probs=193.7
Q ss_pred HHHhhccccccCceEEEEEEEC-C-CcEEEEEEEccCC--cccHHHHHHHHHHHccC---CCCceeeEeeeeee-----c
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNS--YQGKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----E 594 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~-~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l---~HpnIv~l~g~~~~-----~ 594 (854)
.|.+.++||+|+||+||+|++. + ++.||||+++... ......+.+|+++|+.+ +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 3456789999999999999874 4 5679999986432 22234566788777665 79999999999853 3
Q ss_pred CeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeee
Q 003039 595 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 674 (854)
Q Consensus 595 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 674 (854)
...+++|||+.++.+..... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 46799999999887654442 2345688889999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 675 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 675 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+............
T Consensus 162 ~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 9875432 22334567999999999999999999999999999999999999999765422211111111100000000
Q ss_pred -----ccccc-C---ccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 -----IQGII-D---PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 -----~~~~i-d---~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..... . ..............+.+|+.+|++.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0 000001111122357789999999999999999999886
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=360.11 Aligned_cols=264 Identities=18% Similarity=0.246 Sum_probs=192.6
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccC--CcccHHHHHHHHHHHccCCCCceeeEeeeeee--------cCe
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EGR 596 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~--~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~--------~~~ 596 (854)
|.+.++||+|+||+||+|++. +|+.||||++... .......+.+|+++|++++||||+++++++.. .+.
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 456789999999999999975 7899999998644 22345678899999999999999999998854 346
Q ss_pred EEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecc
Q 003039 597 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 676 (854)
Q Consensus 597 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 676 (854)
.++||||++++.+..... ....++...+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp EEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 799999999887765542 345677888899999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC---ceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhc
Q 003039 677 KFAVDGAS---HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 752 (854)
Q Consensus 677 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~ 752 (854)
+....... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........+.... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC-GSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc-CCCCh
Confidence 76543221 122334699999999998765 68999999999999999999999997644211111111110 00000
Q ss_pred CCcccc--------cCccccCcCCHH-------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 753 GDIQGI--------IDPSLLDEYDIQ-------SMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 753 ~~~~~~--------id~~l~~~~~~~-------~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...... +........... ....+.+|+.+|++.||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000 000000011111 12356789999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-40 Score=355.34 Aligned_cols=259 Identities=21% Similarity=0.289 Sum_probs=197.2
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCcee-eEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv-~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.+.||+|+||+||+|++. +|+.||||++..... ..++..|++++++++|+|++ .+.+++...+..++||||+.
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 556789999999999999875 689999999875432 34578899999999876655 55555677788899999994
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeeeccccccCC
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG 682 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~~~ 682 (854)
|+|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+.....
T Consensus 87 -~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 87 -PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp -CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred -Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 566665532 345689999999999999999999998 9999999999999864 557999999999876543
Q ss_pred CCc------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 683 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 683 ~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+..+....... ..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CH-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Ch-
Confidence 322 2234579999999999999999999999999999999999999997655333332332322222111 00
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
+.+...++ .++.+++..|++.+|++||++.++.+.|+.+..
T Consensus 238 ----~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 ----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----hHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 01111222 458899999999999999999999999988754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=365.02 Aligned_cols=265 Identities=22% Similarity=0.238 Sum_probs=193.4
Q ss_pred HhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCceeeEeeeeeec------CeEEEEE
Q 003039 529 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLVY 601 (854)
Q Consensus 529 ~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~------~~~~LV~ 601 (854)
...++||+|+||+||+|++. +|+.||||++..... ...+|+++|++++||||++++++|... .+.++||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 34578999999999999986 689999999975432 234799999999999999999998543 3578999
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeeecccccc
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAV 680 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~ 680 (854)
||++++.+. .+.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 99 Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 99 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp ECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred eccCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999876443 3433333456789999999999999999999998 999999999999999775 89999999998664
Q ss_pred CCCCceeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHH--------HHHHhh-
Q 003039 681 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ--------WAKLHI- 750 (854)
Q Consensus 681 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~--------~~~~~~- 750 (854)
... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.. +.....
T Consensus 175 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 432 2234569999999998875 5789999999999999999999999976542211111111 000000
Q ss_pred --hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHH
Q 003039 751 --ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 803 (854)
Q Consensus 751 --~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~~ 803 (854)
........................+.+|+.+|++.||++|||+.|+++| ++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0001111100000001111122357899999999999999999999986 5543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-39 Score=350.31 Aligned_cols=259 Identities=17% Similarity=0.247 Sum_probs=203.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCCC-CceeeEeeeeeecCeEEEEEEecc
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFMH 605 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~H-pnIv~l~g~~~~~~~~~LV~E~~~ 605 (854)
|.+.++||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++......++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 456789999999999999976 68899999986543 23457788899998865 89999999999999999999998
Q ss_pred CCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-----CCcEEEEeeecccccc
Q 003039 606 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAV 680 (854)
Q Consensus 606 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkl~DFGla~~~~ 680 (854)
+++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 ~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 6899888753 244688999999999999999999998 9999999999999974 5789999999998665
Q ss_pred CCCCc------eeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCC
Q 003039 681 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 754 (854)
Q Consensus 681 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~ 754 (854)
..... ......||+.|||||.+.+..++.++|||||||++|||++|+.||.............. +........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~-i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-HHhccCCCC
Confidence 43221 22345799999999999999999999999999999999999999976553322211111 111111111
Q ss_pred cccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 003039 755 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 805 (854)
Q Consensus 755 ~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~L~~~~~ 805 (854)
.. .+....+ .++.+++..|++.+|++||++..+.+.|++++.
T Consensus 237 ~~-----~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 237 LR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hH-----HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 11 1112222 357889999999999999999999999988764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=360.20 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=200.3
Q ss_pred HHhhccccccCceEEEEEEEC----CCcEEEEEEEccCC----cccHHHHHHHHHHHccCCC-CceeeEeeeeeecCeEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~----~~~~VAvK~l~~~~----~~~~~~~~~Ev~~L~~l~H-pnIv~l~g~~~~~~~~~ 598 (854)
|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 556789999999999999863 47899999986432 2234567899999999966 89999999999999999
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+.+|+|.+++. ....++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 106 ~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 106 LILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999984 344567788889999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeecccccccccCccccccC--cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCcc
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 756 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~ 756 (854)
.............|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+... .. ....
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~---~~-~~~~- 253 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR---IL-KSEP- 253 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---HH-HCCC-
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---cc-cCCC-
Confidence 654444444556799999999999764 4678999999999999999999999876533332222221 11 1111
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003039 757 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 799 (854)
Q Consensus 757 ~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eV~~~ 799 (854)
.+.. ....++.+++.+|++.+|++|| |++|+++|
T Consensus 254 -----~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 254 -----PYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----CCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1111 1234688899999999999999 48898875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=358.01 Aligned_cols=259 Identities=20% Similarity=0.278 Sum_probs=190.9
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC-cccHHHHHHHHHHHccCCCCceeeEeeeeeecC----eEEEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVY 601 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~-~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~----~~~LV~ 601 (854)
|.+.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 445689999999999999875 79999999997543 233567889999999999999999999986543 234555
Q ss_pred EeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccC
Q 003039 602 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 681 (854)
Q Consensus 602 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 681 (854)
+++.+|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 90 ~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 90 THLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 6677999999984 23689999999999999999999998 999999999999999999999999999975543
Q ss_pred CCCc--eeecccccccccCcccccc-CcCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhcCCccc-
Q 003039 682 GASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG- 757 (854)
Q Consensus 682 ~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~~~~~~- 757 (854)
.... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.. ..............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL----NHILGILGSPSQEDL 237 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCSCCHHHH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH----HHHhhhccCCChhhh
Confidence 2221 2344569999999999854 56788999999999999999999999764421111 00000000000000
Q ss_pred ------------ccCccccCcCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 ------------IIDPSLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ------------~id~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...+. ....+. ....++.+++.+|++.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPH-KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCc-cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000000 011357899999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=347.91 Aligned_cols=261 Identities=19% Similarity=0.216 Sum_probs=198.8
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecCeEEEEEEec
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 604 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 604 (854)
|.+.++||+|+||+||+|++. +++.||||+++... ......+.+|+.+|++++||||+++++++......++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 345689999999999999975 68899999996543 233577899999999999999999999999999999999999
Q ss_pred cCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccccCCCC
Q 003039 605 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 684 (854)
Q Consensus 605 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 684 (854)
.+++|..++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+.......
T Consensus 84 ~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 84 DQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp SEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred cccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9999888774 345678889999999999999999998 999999999999999999999999999986544322
Q ss_pred ceeecccccccccCccccccCc-CCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHhhhc---CCcc---c
Q 003039 685 HVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDIQ---G 757 (854)
Q Consensus 685 ~~~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~~~~---~~~~---~ 757 (854)
......+++.|+|||.+.... ++.++||||+||++|||++|+.||..... .......+...... .... .
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS---HHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC---HHHHHHHHHhhcCCCChhhhhhhhh
Confidence 223345788999999987655 68999999999999999999999743321 11111111111100 0000 0
Q ss_pred ccC--------cc-ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 758 IID--------PS-LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 758 ~id--------~~-l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
..+ .. -...........+.+|+.+|++.||++|||++||++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00 0000111222457889999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=358.45 Aligned_cols=260 Identities=22% Similarity=0.281 Sum_probs=190.5
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeecC------eEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~~------~~~ 598 (854)
|.+.++||+|+||+||+|... +|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+ ..+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 445688999999999999976 69999999997542 233457889999999999999999999997654 569
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+ +++|...+. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+|+.
T Consensus 100 lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence 999999 557776653 34689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHH-----------
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA----------- 746 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~----------- 746 (854)
.... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........+....
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 5432 2345699999999998764 56899999999999999999999997654211110000000
Q ss_pred -----HHhh-hcCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHHH
Q 003039 747 -----KLHI-ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAI 804 (854)
Q Consensus 747 -----~~~~-~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~--L~~~~ 804 (854)
.... ...+....--+.+....+ ..+.+|+.+|+..||++|||+.|+++| ++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhccCCcccccchHHhccCCC----HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 000000000000111112 346789999999999999999999987 66543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.2e-39 Score=350.83 Aligned_cols=258 Identities=19% Similarity=0.282 Sum_probs=192.9
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeeeeee--cCeEEEEEE
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE--EGRSVLVYE 602 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~--~~~~~LV~E 602 (854)
.|.+.++||+|+||+||+|+.. +|+.||||+++.. ..+.+.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 3566789999999999999985 6899999998643 3567889999999995 9999999999874 456899999
Q ss_pred eccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeeeccccccC
Q 003039 603 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 681 (854)
Q Consensus 603 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~ 681 (854)
|+.+++|.... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999987654 3578889999999999999999998 999999999999998655 699999999986544
Q ss_pred CCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccc-cchHHH-----HHHhhhcCC
Q 003039 682 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANC-RNIVQW-----AKLHIESGD 754 (854)
Q Consensus 682 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~-~~l~~~-----~~~~~~~~~ 754 (854)
.. ......||+.|+|||.+.+. .++.++||||+||+++||++|+.||......... ..+... .........
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 23345689999999998765 4799999999999999999999999654311100 001000 000000000
Q ss_pred c------ccccCcc--------ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 755 I------QGIIDPS--------LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 755 ~------~~~id~~--------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
. ....... ...........++.+|+.+|++.||++|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000 0000011122357899999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-39 Score=354.55 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=187.7
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeee------cCeEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRSV 598 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~------~~~~~ 598 (854)
|.+.++||+|+||+||+|++. +|+.||||++.... ......+.+|+.+|++++||||+++++++.. ....+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 445679999999999999986 69999999997543 2334568899999999999999999999964 36789
Q ss_pred EEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 599 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 599 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+||||+.++.+. .+. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+|++|||+++.
T Consensus 99 iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 99 LVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 999999765544 442 3478889999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCcccccccccccccchH---------------
Q 003039 679 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV--------------- 743 (854)
Q Consensus 679 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~--------------- 743 (854)
.... .......||+.|+|||++.+..++.++||||+||+++||++|+.||...+.......+.
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 4432 23344568999999999999999999999999999999999999997543111111111
Q ss_pred HHHHHhhhcC-Cc-----ccccCccccC---cCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 744 QWAKLHIESG-DI-----QGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 744 ~~~~~~~~~~-~~-----~~~id~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
.......... .. .......... .........+.+|+.+|++.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0011111110 00 0011111111 1122345578899999999999999999999988
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=349.04 Aligned_cols=259 Identities=20% Similarity=0.263 Sum_probs=190.0
Q ss_pred HHhhccccccCceEEEEEEEC-CCcEEEEEEEccCC--cccHHHHHHHHHHHccCCCCceeeEeeeeeec-----CeEEE
Q 003039 528 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 599 (854)
Q Consensus 528 ~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~--~~~~~~~~~Ev~~L~~l~HpnIv~l~g~~~~~-----~~~~L 599 (854)
|.+.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++||||+++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 456789999999999999875 69999999997543 23345788999999999999999999998533 34567
Q ss_pred EEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeeeccccc
Q 003039 600 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 679 (854)
Q Consensus 600 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 679 (854)
+++|+.+|+|.+++. .+++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++...
T Consensus 100 i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 100 LVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhccc
Confidence 778888999999884 34689999999999999999999998 9999999999999999999999999998644
Q ss_pred cCCCCceeecccccccccCccccccC-cCCCcchhhhHHHHHHHHHhCCcccccccccccccchHHHHHHh----hh---
Q 003039 680 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH----IE--- 751 (854)
Q Consensus 680 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~~l~~~~~~~----~~--- 751 (854)
. .......||+.|+|||...+. .++.++||||+||++|||++|+.||.+.........+....... ..
T Consensus 172 ~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 172 D----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp T----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred C----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 2 223345689999999987765 46889999999999999999999997654211111111100000 00
Q ss_pred -------cCCcccccCccccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003039 752 -------SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 799 (854)
Q Consensus 752 -------~~~~~~~id~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV~~~ 799 (854)
...........+... .......+.+|+.+|++.||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000000000 00112357899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.3e-35 Score=321.20 Aligned_cols=268 Identities=19% Similarity=0.274 Sum_probs=190.4
Q ss_pred HHHhhccccccCceEEEEEEEC-CCcEEEEEEEccCCcccHHHHHHHHHHHccCC-----------CCceeeEeeeeee-
Q 003039 527 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQE- 593 (854)
Q Consensus 527 ~~~~~~~iG~G~fg~Vy~a~~~-~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-----------HpnIv~l~g~~~~- 593 (854)
+|.+.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3667899999999999999975 68999999997543 23456788998888775 5789999988854
Q ss_pred -cCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC------
Q 003039 594 -EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM------ 666 (854)
Q Consensus 594 -~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~------ 666 (854)
....+++++++..+....... .......+++..+..++.|++.||+|||+. .+|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccc
Confidence 356677777766554333221 113455678888999999999999999983 1899999999999998765
Q ss_pred cEEEEeeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHHHHHHHHhCCccccccccccccc---chH
Q 003039 667 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR---NIV 743 (854)
Q Consensus 667 ~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvvl~elltG~~pf~~~~~~~~~~---~l~ 743 (854)
.+|++|||.|+.... ......||+.|+|||++....++.++||||+||+++||++|+.||.......... .+.
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 399999999875432 2234569999999999999999999999999999999999999997543211111 111
Q ss_pred HHHHHh-------hhc----------CCcccccCcc----------ccCcCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 003039 744 QWAKLH-------IES----------GDIQGIIDPS----------LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 796 (854)
Q Consensus 744 ~~~~~~-------~~~----------~~~~~~id~~----------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV 796 (854)
..+... ... ......+... ............+.+|+.+|++.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111100 000 0000000000 0112345566789999999999999999999999
Q ss_pred HHH--HHH
Q 003039 797 LKD--IQD 802 (854)
Q Consensus 797 ~~~--L~~ 802 (854)
++| +++
T Consensus 326 L~Hp~f~~ 333 (362)
T d1q8ya_ 326 VNHPWLKD 333 (362)
T ss_dssp HTCGGGTT
T ss_pred hcCcccCC
Confidence 886 553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=6.7e-22 Score=197.01 Aligned_cols=166 Identities=17% Similarity=0.174 Sum_probs=118.9
Q ss_pred hhccccccCceEEEEEEECCCcEEEEEEEccCCcc------------------cHHHHHHHHHHHccCCCCceeeEeeee
Q 003039 530 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ------------------GKREFTNEVTLLSRIHHRNLVQFLGYC 591 (854)
Q Consensus 530 ~~~~iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~------------------~~~~~~~Ev~~L~~l~HpnIv~l~g~~ 591 (854)
+.++||+|+||+||+|+..+|+.||||+++..... .......|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46899999999999999989999999987632110 112345688899999999999887653
Q ss_pred eecCeEEEEEEeccCCCHHhhhcccccccccccHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 003039 592 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 671 (854)
Q Consensus 592 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 671 (854)
. .+++|||+++..+.+ ++......++.|++++|+|||++ +|+||||||+|||++++ .++|+
T Consensus 84 ~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred C----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 2 379999998755432 33445567899999999999998 99999999999999965 58999
Q ss_pred eeeccccccCCCCceeecccccccccCccccccCcCCCcchhhhHHH
Q 003039 672 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 718 (854)
Q Consensus 672 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGv 718 (854)
|||+|+...+...... .......+ .| +..+.|..++|+||..-
T Consensus 145 DFG~a~~~~~~~~~~~--l~rd~~~~-~~-~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGWREI--LERDVRNI-IT-YFSRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTHHHH--HHHHHHHH-HH-HHHHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCcHHH--HHHHHHHH-HH-HHcCCCCCcccHHHHHH
Confidence 9999975543221110 00000000 01 12467888999999654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.65 E-value=1.1e-17 Score=179.29 Aligned_cols=108 Identities=27% Similarity=0.312 Sum_probs=95.9
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
..|+++++.+.|.+|..+..+++|+.|++++|.+.+.+|.+..+++|+.|+|++|+|+|.+|+.|++|++|+.|+|++|+
T Consensus 200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~ 279 (313)
T d1ogqa_ 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCc
Confidence 45666666666677777778888999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc-ccccccccccCccccccCC
Q 003039 424 LSGTVPSSL-LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 424 l~g~~p~~l-~~~~~~l~~~~n~~l~~~~ 451 (854)
|+|.+|+.. ++++..+++.+|+.+|+.+
T Consensus 280 l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp EEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 999999754 6788899999999999865
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=6.5e-16 Score=161.41 Aligned_cols=177 Identities=22% Similarity=0.179 Sum_probs=138.7
Q ss_pred ceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 266 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
.++.|+|+.|.++.+|+. +..+..|+.|++++|++... ..+..+..++.+.... + ......-....+++|+
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l--~~~~~l~~L~~L~Ls~---N---~l~~~~~~~~~l~~L~ 103 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSH---N---QLQSLPLLGQTLPALT 103 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE--ECCSCCTTCCEEECCS---S---CCSSCCCCTTTCTTCC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccccc--cccccccccccccccc---c---cccccccccccccccc
Confidence 567788888888888865 78888888888888887642 1222333344332211 1 1111122234678999
Q ss_pred EEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 345 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
.|+|++|.+.+..+..+..+.+|+.|++++|.+++.++. +..+++|+.|++++|+|++..|..|..+++|+.|+|++|+
T Consensus 104 ~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 183 (266)
T d1p9ag_ 104 VLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183 (266)
T ss_dssp EEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred cccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCC
Confidence 999999999977777888999999999999999998887 6779999999999999998777889999999999999999
Q ss_pred ccccccccc--ccccccccccCccccccCC
Q 003039 424 LSGTVPSSL--LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 424 l~g~~p~~l--~~~~~~l~~~~n~~l~~~~ 451 (854)
|+ .+|..+ +.+++.|+++|||..|.+.
T Consensus 184 L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 184 LY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred Cc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 99 999988 4567899999999999763
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.57 E-value=1.9e-15 Score=161.55 Aligned_cols=144 Identities=30% Similarity=0.513 Sum_probs=123.0
Q ss_pred cHHHHHHHHhhcC----CCCccCCCCCCCCCCCCCeeEeCCC-CCCCeeEEEecCCCCCc--cCCcccccCccCcEEecc
Q 003039 301 DGVAIVSVISLYS----SADWAQEGGDPCLPVPWSWLQCNSD-PQPSITVIHLSSKNLTG--NIPSDLTKLSSLVELWLD 373 (854)
Q Consensus 301 ~~~~~~~l~~l~~----~~~w~~~~~~pc~~~~~~~~~c~~~-~~~~l~~L~L~~n~l~g--~lp~~i~~l~~L~~L~L~ 373 (854)
+..++.+||+... +.+|.. ++|||. ..|.||.|+.. ...+++.|+|++|+++| .+|++|++|++|++|+|+
T Consensus 7 e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~-~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls 84 (313)
T d1ogqa_ 7 DKQALLQIKKDLGNPTTLSSWLP-TTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIG 84 (313)
T ss_dssp HHHHHHHHHHHTTCCGGGTTCCT-TSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEE
T ss_pred HHHHHHHHHHHCCCCCcCCCCCC-CCCCCC-CcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccc
Confidence 4457777887642 567865 689993 34999999754 34489999999999998 589999999999999998
Q ss_pred C-CCCCCCCC-CCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccccccccccc--ccccccccccCccc
Q 003039 374 G-NSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 374 ~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n~~ 446 (854)
+ |+++|.+| .|++|++|++|+|++|+|++..|..+..+.+|+.+++++|.+.+.+|..+ +..+..+++++|..
T Consensus 85 ~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 85 GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 7 89998777 49999999999999999999999999999999999999999999999888 56778888888854
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.1e-14 Score=153.45 Aligned_cols=186 Identities=17% Similarity=0.131 Sum_probs=133.9
Q ss_pred ceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHHHHHHHhhcCCCCccC------CCCCCCCC---CCCCeeEe
Q 003039 266 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQ------EGGDPCLP---VPWSWLQC 335 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~------~~~~pc~~---~~~~~~~c 335 (854)
.++.|+|+.|.++++|+. +..+..|+.|++++|.+..+....+..+..+..... ...++..- .....+..
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 457889999999999986 888899999999888765433333222211111000 00011100 00111111
Q ss_pred -----------CCCCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCC
Q 003039 336 -----------NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP 403 (854)
Q Consensus 336 -----------~~~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~ 403 (854)
.....+.|+.|++++|+|++..+..|..+++|+.|+|++|+|++.++. |.++++|+.|++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 123456899999999999955566788899999999999999988775 78899999999999999988
Q ss_pred CCccccCCCCCceeecccccccccccccc--ccccccccccCccccccCC
Q 003039 404 LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 451 (854)
Q Consensus 404 ~P~~l~~l~~L~~l~l~~N~l~g~~p~~l--~~~~~~l~~~~n~~l~~~~ 451 (854)
.|..|..+++|+.|++++|++++..|..+ +.++..+++++|+..|.+.
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 89999999999999999999995555444 5667889999999988653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.49 E-value=2.8e-14 Score=141.20 Aligned_cols=152 Identities=20% Similarity=0.168 Sum_probs=107.6
Q ss_pred eeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEEe
Q 003039 269 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL 348 (854)
Q Consensus 269 ~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~L 348 (854)
.++.+.+.++++|+.|. +.++.|+|++|.+.. ..... ....+++|+.|+|
T Consensus 12 ~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~----------~~~~~------------------~f~~l~~L~~L~L 61 (192)
T d1w8aa_ 12 TVDCTGRGLKEIPRDIP--LHTTELLLNDNELGR----------ISSDG------------------LFGRLPHLVKLEL 61 (192)
T ss_dssp EEECTTSCCSSCCSCCC--TTCSEEECCSCCCCS----------BCCSC------------------SGGGCTTCCEEEC
T ss_pred EEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcc----------ccccc------------------ccCCCceEeeeec
Confidence 46678888888888764 567788888887753 00000 0124567888888
Q ss_pred cCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccccccc
Q 003039 349 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 427 (854)
Q Consensus 349 ~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~ 427 (854)
++|++.+..+..+..+++|+.|+|++|+|++.+|+ |.++++|++|+|++|+|++..|..|..+++|+.|+|++|++...
T Consensus 62 ~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 62 KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 88888877777888888888888888888887775 78888888888888888866667788888888888888888754
Q ss_pred ccccc-ccccccccccCccccccC
Q 003039 428 VPSSL-LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 428 ~p~~l-~~~~~~l~~~~n~~l~~~ 450 (854)
.+... ...+..+.+.+|...|..
T Consensus 142 ~~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 142 CHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp GGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred cchHHHhhhhhhhcccCCCeEeCC
Confidence 43333 222344445555555543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.41 E-value=2.5e-13 Score=134.10 Aligned_cols=120 Identities=24% Similarity=0.294 Sum_probs=102.0
Q ss_pred CCeeEeCCCC--------CCCeeEEEecCCCCCccC-CcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCc
Q 003039 330 WSWLQCNSDP--------QPSITVIHLSSKNLTGNI-PSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 399 (854)
Q Consensus 330 ~~~~~c~~~~--------~~~l~~L~L~~n~l~g~l-p~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~ 399 (854)
+..|.|+..+ +++++.|+|++|+|++.+ +..|.+|++|+.|+|++|++.+.++. +..+++|++|+|++|+
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp TTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred CCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 5567776432 247899999999998756 45678999999999999999998886 7889999999999999
Q ss_pred cCCCCCccccCCCCCceeecccccccccccccc---ccccccccccCccccccC
Q 003039 400 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 400 l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l---~~~~~~l~~~~n~~l~~~ 450 (854)
|++..|..|.+|++|+.|+|++|+|+ .+|... +.++..+++.+|+..|.+
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCccccccccccccccccc
Confidence 99777778999999999999999999 666654 556788999999987764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=4.2e-13 Score=139.67 Aligned_cols=172 Identities=20% Similarity=0.189 Sum_probs=138.8
Q ss_pred ceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeE
Q 003039 266 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 345 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~ 345 (854)
++..++.+++.++.+|+.|. ..++.|+|+.|.+......++..+..+..+...+ | ....+.- ...+++|+.
T Consensus 11 ~~~~v~C~~~~L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~---N---~l~~l~~-~~~l~~L~~ 81 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR---A---ELTKLQV-DGTLPVLGT 81 (266)
T ss_dssp TCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTT---S---CCCEEEC-CSCCTTCCE
T ss_pred CCeEEEccCCCCCeeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccc---c---ccccccc-ccccccccc
Confidence 44567889999999999875 4689999999999876667777777777764422 2 1334442 346789999
Q ss_pred EEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccc
Q 003039 346 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424 (854)
Q Consensus 346 L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l 424 (854)
|+|++|+|+ .+|..+.++++|+.|+|++|.+.+..+. +..+.+|+.|++++|.+++..+..+..+++|+.|++++|+|
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 999999999 6788899999999999999999987775 67899999999999999966667788899999999999999
Q ss_pred cccccccc--ccccccccccCcccc
Q 003039 425 SGTVPSSL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 425 ~g~~p~~l--~~~~~~l~~~~n~~l 447 (854)
++..|..+ +.+++.|++++|...
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~ 185 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY 185 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cccCccccccccccceeecccCCCc
Confidence 94444433 677889999999643
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.37 E-value=6.8e-13 Score=140.70 Aligned_cols=183 Identities=20% Similarity=0.231 Sum_probs=130.7
Q ss_pred cccceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccHHH---------------------HHHHHhhcCCCCccCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVA---------------------IVSVISLYSSADWAQE 320 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~~~---------------------~~~l~~l~~~~~w~~~ 320 (854)
.++.|+.|++..|.++.++|. +..++.|+.|++.+|++.... ...+........+..
T Consensus 53 ~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~- 131 (305)
T d1xkua_ 53 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL- 131 (305)
T ss_dssp TCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEEC-
T ss_pred ccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhccccchhhhhhhhhhcccccccccc-
Confidence 356788999999999999775 888899999888887654311 111111111111000
Q ss_pred CCCCCCCC-----------CCCeeEeC--------CCCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCC
Q 003039 321 GGDPCLPV-----------PWSWLQCN--------SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI 381 (854)
Q Consensus 321 ~~~pc~~~-----------~~~~~~c~--------~~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~ 381 (854)
...++... ....+.+. ....++|+.|++++|.+++..+..+.+++.++.|++++|.+.+.+
T Consensus 132 ~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~ 211 (305)
T d1xkua_ 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211 (305)
T ss_dssp CSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccc
Confidence 01111000 01112211 123568899999999999888999999999999999999999987
Q ss_pred CC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccccccccccccc---------cccccccccCccccc
Q 003039 382 PD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---------SKNVVLNYAGNINLH 448 (854)
Q Consensus 382 p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~g~~p~~l~---------~~~~~l~~~~n~~l~ 448 (854)
+. +.++++|++|+|++|+|+ .+|++|.++++|+.|+|++|+|+ .++...+ ..+..|++.+|+..+
T Consensus 212 ~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 212 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp TTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred cccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 76 788999999999999999 78999999999999999999999 7765432 345778889998644
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.34 E-value=1e-12 Score=119.89 Aligned_cols=99 Identities=32% Similarity=0.430 Sum_probs=75.5
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|+|+ .+| .+.+|++|++|+|++|+|+..++.++.+++|+.|+|++|+|+ .+| .++.+++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 46888888888 666 488888888888888888877667888888888888888888 455 47888888888888888
Q ss_pred ccccccc--cc--ccccccccccCcccc
Q 003039 424 LSGTVPS--SL--LSKNVVLNYAGNINL 447 (854)
Q Consensus 424 l~g~~p~--~l--~~~~~~l~~~~n~~l 447 (854)
|+ .+|. .+ ++++..+++++|+..
T Consensus 77 i~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQ-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 87 4543 22 456677888888654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.34 E-value=1.6e-12 Score=118.55 Aligned_cols=83 Identities=28% Similarity=0.347 Sum_probs=74.7
Q ss_pred CCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCC--ccccCCCCCcee
Q 003039 340 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLREL 417 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P--~~l~~l~~L~~l 417 (854)
++.|++|+|++|+|+ .+|+.++.|++|+.|+|++|+|++. |++..+++|+.|++++|+|+ .+| ..++.+++|+.|
T Consensus 19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLL 95 (124)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccC-CCCCchhhcCCCCCCEE
Confidence 347999999999999 7898999999999999999999975 57999999999999999999 444 578999999999
Q ss_pred eccccccc
Q 003039 418 YVQNNMLS 425 (854)
Q Consensus 418 ~l~~N~l~ 425 (854)
++++|+++
T Consensus 96 ~l~~N~i~ 103 (124)
T d1dcea3 96 NLQGNSLC 103 (124)
T ss_dssp ECTTSGGG
T ss_pred ECCCCcCC
Confidence 99999998
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=4.8e-12 Score=121.12 Aligned_cols=104 Identities=18% Similarity=0.147 Sum_probs=89.1
Q ss_pred CCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeec
Q 003039 340 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 419 (854)
Q Consensus 340 ~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l 419 (854)
..++++|+|++|+|+ .+|..+..+++|+.|+|++|+|+.. +.+..+++|++|+|++|+|+...+..+..+++|+.|+|
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 347999999999999 7888778899999999999999965 77999999999999999999544445678999999999
Q ss_pred ccccccccccc--cc--ccccccccccCccc
Q 003039 420 QNNMLSGTVPS--SL--LSKNVVLNYAGNIN 446 (854)
Q Consensus 420 ~~N~l~g~~p~--~l--~~~~~~l~~~~n~~ 446 (854)
++|+|+ .++. .+ ++++..+++.+|+.
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cccccc-ccccccccccccccchhhcCCCcc
Confidence 999998 6654 23 56788999999975
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=7.6e-12 Score=131.14 Aligned_cols=112 Identities=17% Similarity=0.099 Sum_probs=92.4
Q ss_pred CCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCcee
Q 003039 339 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l 417 (854)
..++|+.|+|++|+|++..|..+.++++|+.|+|++|++++..|. |.++++|++|++++|++++..|..|+++++|+.|
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L 230 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEE
Confidence 346899999999999977778899999999999999999998876 8999999999999999998888899999999999
Q ss_pred ecccccccccccccc-ccccccccccCccccccC
Q 003039 418 YVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHEG 450 (854)
Q Consensus 418 ~l~~N~l~g~~p~~l-~~~~~~l~~~~n~~l~~~ 450 (854)
+|++|++.+..+... ...++.+....+...|..
T Consensus 231 ~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~ 264 (284)
T d1ozna_ 231 RLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264 (284)
T ss_dssp ECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred EecCCCCCCCccchHHHHHHHhCcCCCCceEeCC
Confidence 999999997655433 222344444445555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.20 E-value=1.8e-11 Score=122.40 Aligned_cols=141 Identities=24% Similarity=0.362 Sum_probs=95.9
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+++|+.|+|+.|.++.++| +..+..|+.|++++|++... ..+ ..+++|
T Consensus 67 l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i~~l--~~l-----------------------------~~l~~L 114 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDL--SSL-----------------------------KDLKKL 114 (210)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCG--GGG-----------------------------TTCTTC
T ss_pred CCCCCEEeCCCccccCccc-cccCcccccccccccccccc--ccc-----------------------------cccccc
Confidence 5577888888888888876 57788888888888876531 011 124567
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|++++|.+. .++ .+..+++|+.+++++|.+++ ++.+..+++|+.|++++|++++ +++ +.++++|+.|+|++|+
T Consensus 115 ~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~-~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 115 KSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNH 189 (210)
T ss_dssp CEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSC
T ss_pred ccccccccccc-ccc-cccccccccccccccccccc-cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCC
Confidence 77777777776 443 47777777777777777765 3345667777777888777774 443 7777777777887777
Q ss_pred ccccccc-cccccccccccc
Q 003039 424 LSGTVPS-SLLSKNVVLNYA 442 (854)
Q Consensus 424 l~g~~p~-~l~~~~~~l~~~ 442 (854)
|+ .+|. .-+.+++.|+++
T Consensus 190 i~-~l~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 190 IS-DLRALAGLKNLDVLELF 208 (210)
T ss_dssp CC-BCGGGTTCTTCSEEEEE
T ss_pred CC-CChhhcCCCCCCEEEcc
Confidence 77 5653 114455555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.19 E-value=4.8e-11 Score=118.09 Aligned_cols=150 Identities=20% Similarity=0.243 Sum_probs=95.1
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+..++.|++..+.++.++ .|..++.|+.|++++|++.... .++.+..+..+.. ..|...... ....++.|
T Consensus 39 l~~l~~L~l~~~~i~~l~-~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l---~~n~~~~~~----~l~~l~~L 108 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILM---NNNQIADIT----PLANLTNL 108 (199)
T ss_dssp HTTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC---CSSCCCCCG----GGTTCTTC
T ss_pred hcCCCEEECCCCCCCCcc-ccccCCCcCcCccccccccCcc--cccCCcccccccc---ccccccccc----cccccccc
Confidence 567788888888888874 4788888888888888876422 2444444444322 111100111 12345667
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|++++|.+.. ++ .+..|++|+.|++++|++.. ++.+..+++|+.|++++|++++ ++ .++++++|+.|++++|+
T Consensus 109 ~~L~l~~~~~~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 109 TGLTLFNNQITD-ID-PLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNK 183 (199)
T ss_dssp SEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred cccccccccccc-cc-ccchhhhhHHhhhhhhhhcc-cccccccccccccccccccccC-Cc-cccCCCCCCEEECCCCC
Confidence 777777777763 32 36677777777777777764 3456777777777777777773 43 36777777777777777
Q ss_pred cccccc
Q 003039 424 LSGTVP 429 (854)
Q Consensus 424 l~g~~p 429 (854)
++ .+|
T Consensus 184 i~-~i~ 188 (199)
T d2omxa2 184 VS-DIS 188 (199)
T ss_dssp CC-CCG
T ss_pred CC-CCc
Confidence 77 444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=2.7e-11 Score=115.04 Aligned_cols=105 Identities=17% Similarity=0.178 Sum_probs=89.5
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCC-CCCCCCCC-CCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGN-SLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N-~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
+.++++++++. .+|..+..+++|+.|+|++| .|+...+. |.++++|+.|+|++|+|+...|.+|..+++|+.|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 44667778888 78888999999999999766 48877664 89999999999999999966678899999999999999
Q ss_pred ccccccccccccc--ccccccccCccccccC
Q 003039 422 NMLSGTVPSSLLS--KNVVLNYAGNINLHEG 450 (854)
Q Consensus 422 N~l~g~~p~~l~~--~~~~l~~~~n~~l~~~ 450 (854)
|+|+ .+|...+. .+..|++++|+..|.+
T Consensus 90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 90 NALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCCc-ccChhhhccccccccccCCCcccCCc
Confidence 9999 88888754 4578899999998865
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.16 E-value=5e-11 Score=119.06 Aligned_cols=145 Identities=21% Similarity=0.228 Sum_probs=120.0
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+.+++.|++..+.++.+++ |..+..|+.|++++|++.. .+++ ..+++|
T Consensus 45 L~~L~~L~l~~~~i~~l~~-l~~l~~L~~L~L~~n~i~~-------------------l~~~------------~~l~~L 92 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTD-------------------IKPL------------ANLKNL 92 (210)
T ss_dssp HHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCC-------------------CGGG------------TTCTTC
T ss_pred hcCccEEECcCCCCCCchh-HhhCCCCCEEeCCCccccC-------------------cccc------------ccCccc
Confidence 5678899999999999875 7889999999999997763 1111 235689
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
+.|+|++|+|+ .+| .+.++++|+.|++++|.+.. ++.+.++++|+.+++++|++++ +..+..+++|+.+++++|+
T Consensus 93 ~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~-~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~ 167 (210)
T d1h6ta2 93 GWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ 167 (210)
T ss_dssp CEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC-CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSC
T ss_pred ccccccccccc-ccc-cccccccccccccccccccc-cccccccccccccccccccccc--ccccccccccccccccccc
Confidence 99999999999 576 59999999999999999875 5678899999999999999984 3467889999999999999
Q ss_pred cccccccccccccccccccCcc
Q 003039 424 LSGTVPSSLLSKNVVLNYAGNI 445 (854)
Q Consensus 424 l~g~~p~~l~~~~~~l~~~~n~ 445 (854)
+++..|-.-+.+++.|++++|.
T Consensus 168 l~~i~~l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 168 ISDIVPLAGLTKLQNLYLSKNH 189 (210)
T ss_dssp CCCCGGGTTCTTCCEEECCSSC
T ss_pred ccccccccCCCCCCEEECCCCC
Confidence 9954343447788999999885
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.16 E-value=6.7e-11 Score=117.02 Aligned_cols=139 Identities=18% Similarity=0.233 Sum_probs=108.0
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+++|+.|+|+.|.++.++| +..+..|+.|+++.|.+... ..+..+..+..+.. ..|...... ....+++|
T Consensus 61 l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l---~~~~~~~~~----~~~~l~~L 130 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLTL---FNNQITDID----PLKNLTNL 130 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEEC---CSSCCCCCG----GGTTCTTC
T ss_pred CCCcCcCccccccccCccc-ccCCcccccccccccccccc--cccccccccccccc---ccccccccc----ccchhhhh
Confidence 5688999999999999987 89999999999999887652 23445555554422 222211111 12356799
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCcee
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l 417 (854)
+.|++++|++. .+| .+..+++|+.|++++|++++. +.++++++|+.|+|++|+++ .+| .++.|++|+.|
T Consensus 131 ~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~~l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~L 199 (199)
T d2omxa2 131 NRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-KPLANLTTLERLDISSNKVS-DIS-VLAKLTNLESL 199 (199)
T ss_dssp SEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred HHhhhhhhhhc-ccc-cccccccccccccccccccCC-ccccCCCCCCEEECCCCCCC-CCc-cccCCCCCCcC
Confidence 99999999998 565 599999999999999999975 45899999999999999999 465 58889998876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=2e-11 Score=116.63 Aligned_cols=121 Identities=15% Similarity=0.099 Sum_probs=78.1
Q ss_pred cceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
..++.|+|++|.++.+|.....+..|+.|++++|.+.. + ++ ...+++|+
T Consensus 18 ~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~--------------l-------------~~----~~~l~~L~ 66 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK--------------L-------------DG----FPLLRRLK 66 (162)
T ss_dssp TSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCE--------------E-------------CC----CCCCSSCC
T ss_pred CcCcEEECCCCCCCccCccccccccCCEEECCCCCCCc--------------c-------------CC----cccCcchh
Confidence 35677888888888887766777777777777776653 1 00 11245677
Q ss_pred EEEecCCCCCccCCcc-cccCccCcEEeccCCCCCCCC--CCCCCCCCccEEEeCCCccCCCCCc----cccCCCCCcee
Q 003039 345 VIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGPLPS----SLMNLPNLREL 417 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~-i~~l~~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~Ls~N~l~g~~P~----~l~~l~~L~~l 417 (854)
.|+|++|+|+ .+|+. +..+++|+.|+|++|+|+... ..+..+++|+.|+|++|.++ ..|. .+..+++|+.|
T Consensus 67 ~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~L 144 (162)
T d1a9na_ 67 TLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL 144 (162)
T ss_dssp EEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred hhhccccccc-CCCccccccccccccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCee
Confidence 7777777777 34433 455777777777777776543 24566777777777777776 4443 46666777666
Q ss_pred e
Q 003039 418 Y 418 (854)
Q Consensus 418 ~ 418 (854)
|
T Consensus 145 D 145 (162)
T d1a9na_ 145 D 145 (162)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.14 E-value=3.5e-11 Score=121.58 Aligned_cols=163 Identities=17% Similarity=0.237 Sum_probs=111.7
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
+++|+.|+|+.|.++.++| +..++.++.|.+..|.+.. +..+..+..+..+. ...|. ..+.. .....+.+
T Consensus 62 l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~--i~~l~~l~~L~~l~---l~~~~---~~~~~-~~~~~~~~ 131 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLD---LTSTQ---ITDVT-PLAGLSNL 131 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSC--CGGGTTCTTCCEEE---CTTSC---CCCCG-GGTTCTTC
T ss_pred CCCCcEeecCCceeecccc-ccccccccccccccccccc--cccccccccccccc---ccccc---ccccc-hhccccch
Confidence 5677888888888888776 6777778888887776543 22333343343331 11221 11111 11234578
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccccc
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 423 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~ 423 (854)
..|.++++.+.... .+.++++|+.|++++|++.+.. .+.++++|+.|+|++|++++ +|. ++.+++|+.|+|++|+
T Consensus 132 ~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 132 QVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQ 206 (227)
T ss_dssp CEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSC
T ss_pred hhhhchhhhhchhh--hhccccccccccccccccccch-hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCc
Confidence 88888888887433 3788899999999999987654 48889999999999999984 554 8889999999999999
Q ss_pred ccccccc-cccccccccccc
Q 003039 424 LSGTVPS-SLLSKNVVLNYA 442 (854)
Q Consensus 424 l~g~~p~-~l~~~~~~l~~~ 442 (854)
|+ .+|. .-++++..|+++
T Consensus 207 lt-~i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 207 IS-DVSPLANTSNLFIVTLT 225 (227)
T ss_dssp CC-BCGGGTTCTTCCEEEEE
T ss_pred CC-CCcccccCCCCCEEEee
Confidence 99 4543 335666666654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.13 E-value=6.6e-11 Score=128.66 Aligned_cols=165 Identities=18% Similarity=0.207 Sum_probs=105.8
Q ss_pred cceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
..++.|++..|.++.+| .+..++.|+.|++..|++... ..+.....+..+... .... .++. ....++.++
T Consensus 219 ~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~--~~~~~~~~L~~L~l~-~~~l-----~~~~-~~~~~~~l~ 288 (384)
T d2omza2 219 TNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLG-ANQI-----SNIS-PLAGLTALT 288 (384)
T ss_dssp TTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECC-SSCC-----CCCG-GGTTCTTCS
T ss_pred CCCCEEECCCCCCCCcc-hhhcccccchhccccCccCCC--CcccccccCCEeecc-Cccc-----CCCC-ccccccccc
Confidence 34566666667666654 455666666677766665431 112222223322110 0000 0111 112345778
Q ss_pred EEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccc
Q 003039 345 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l 424 (854)
.+++++|++++ + ..+..+++|+.|+|++|+|++.. .+..+++|+.|+|++|+|+ .+| .|++|++|+.|+|++|+|
T Consensus 289 ~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l 363 (384)
T d2omza2 289 NLELNENQLED-I-SPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQI 363 (384)
T ss_dssp EEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCC
T ss_pred ccccccccccc-c-cccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcC
Confidence 88888888884 3 35788888888888888888764 3778888888888888888 455 588888888888888888
Q ss_pred ccccccccccccccccccCc
Q 003039 425 SGTVPSSLLSKNVVLNYAGN 444 (854)
Q Consensus 425 ~g~~p~~l~~~~~~l~~~~n 444 (854)
++..|-.-+++++.|++++|
T Consensus 364 ~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 364 SDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CBCGGGTTCTTCSEEECCCE
T ss_pred CCChhhccCCCCCEeeCCCC
Confidence 86555344667778888776
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.06 E-value=2.8e-10 Score=120.09 Aligned_cols=141 Identities=13% Similarity=0.100 Sum_probs=111.3
Q ss_pred ccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCe
Q 003039 264 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 343 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l 343 (854)
++.++.+++..|.++.+|..+ +..++.|++..|.... ..+ +....++.+
T Consensus 149 l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~-------------------~~~----------~~~~~~~~l 197 (305)
T d1xkua_ 149 MKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITK-------------------VDA----------ASLKGLNNL 197 (305)
T ss_dssp CTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCE-------------------ECT----------GGGTTCTTC
T ss_pred ccccCccccccCCccccCccc--CCccCEEECCCCcCCC-------------------CCh----------hHhhccccc
Confidence 556778888888888887654 5677888887775443 111 122345689
Q ss_pred eEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCc-------cccCCCCCce
Q 003039 344 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS-------SLMNLPNLRE 416 (854)
Q Consensus 344 ~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~-------~l~~l~~L~~ 416 (854)
+.|++++|++++..|..+.++++|++|+|++|+|+..++.|.++++|++|+|++|+|+ .++. .+..+.+|+.
T Consensus 198 ~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~ 276 (305)
T d1xkua_ 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSG 276 (305)
T ss_dssp CEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSE
T ss_pred cccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCE
Confidence 9999999999987788999999999999999999988778999999999999999999 5543 3456788999
Q ss_pred eeccccccc-ccccccccccc
Q 003039 417 LYVQNNMLS-GTVPSSLLSKN 436 (854)
Q Consensus 417 l~l~~N~l~-g~~p~~l~~~~ 436 (854)
|+|++|+++ ..+++..++.+
T Consensus 277 L~L~~N~~~~~~~~~~~f~~~ 297 (305)
T d1xkua_ 277 VSLFSNPVQYWEIQPSTFRCV 297 (305)
T ss_dssp EECCSSSSCGGGSCGGGGTTC
T ss_pred EECCCCcCccCcCCHhHhccc
Confidence 999999985 56666665554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.95 E-value=4.5e-10 Score=121.86 Aligned_cols=145 Identities=16% Similarity=0.262 Sum_probs=108.6
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
.++.++.|++..|.++.+++ +..+..|+.|+++.+.+... ..+..+..+..... .-| ...++.+ ...+++
T Consensus 239 ~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~~--~~~~~~~~l~~l~~---~~n---~l~~~~~-~~~~~~ 308 (384)
T d2omza2 239 SLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNI--SPLAGLTALTNLEL---NEN---QLEDISP-ISNLKN 308 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC---CSS---CCSCCGG-GGGCTT
T ss_pred cccccchhccccCccCCCCc-ccccccCCEeeccCcccCCC--Cccccccccccccc---ccc---ccccccc-cchhcc
Confidence 35678889999999999887 77888899999998887541 12223322222211 111 1111111 233568
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N 422 (854)
++.|+|++|++++ ++ .+..|++|+.|+|++|+|++ ++.+.+|++|++|+|++|+|++..| +.+|++|+.|+|++|
T Consensus 309 l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 309 LTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred cCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 9999999999995 54 39999999999999999987 4579999999999999999996443 899999999999998
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.94 E-value=7.5e-10 Score=111.52 Aligned_cols=167 Identities=22% Similarity=0.256 Sum_probs=124.6
Q ss_pred cccceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 263 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 263 ~l~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
.+.+++.|++..|.++.++ .|..++.|+.|++++|.+... ..++.+..+..+.. .+.+. ..+. ....+++
T Consensus 39 ~l~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~ls~n~i~~~--~~l~~l~~l~~l~~-~~n~~-----~~i~-~l~~l~~ 108 (227)
T d1h6ua2 39 DLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDL--APLKNLTKITELEL-SGNPL-----KNVS-AIAGLQS 108 (227)
T ss_dssp HHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCC--GGGTTCCSCCEEEC-CSCCC-----SCCG-GGTTCTT
T ss_pred HcCCcCEEECCCCCCCcch-hHhcCCCCcEeecCCceeecc--cccccccccccccc-ccccc-----cccc-ccccccc
Confidence 3678899999999999995 589999999999999987652 22444444443322 11111 1111 1235678
Q ss_pred eeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccc
Q 003039 343 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 422 (854)
Q Consensus 343 l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N 422 (854)
|+.|+++++...+. + .+...+.+..|.++++.+.... .+.++++|+.|++++|++++ ++ .++++++|+.|+|++|
T Consensus 109 L~~l~l~~~~~~~~-~-~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n 183 (227)
T d1h6ua2 109 IKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDN 183 (227)
T ss_dssp CCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSS
T ss_pred cccccccccccccc-c-hhccccchhhhhchhhhhchhh-hhcccccccccccccccccc-ch-hhcccccceecccCCC
Confidence 99999999988843 2 4777889999999999887654 47788999999999999984 33 4899999999999999
Q ss_pred cccccccc-ccccccccccccCcc
Q 003039 423 MLSGTVPS-SLLSKNVVLNYAGNI 445 (854)
Q Consensus 423 ~l~g~~p~-~l~~~~~~l~~~~n~ 445 (854)
+++ .+|. .-+++++.|++++|.
T Consensus 184 ~l~-~l~~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 184 KIS-DISPLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp CCC-CCGGGGGCTTCCEEECTTSC
T ss_pred ccC-CChhhcCCCCCCEEECcCCc
Confidence 999 4554 336788999999985
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=7.3e-10 Score=104.85 Aligned_cols=101 Identities=27% Similarity=0.299 Sum_probs=82.2
Q ss_pred CCCCCCCCeeEeCC----------CCCCCeeEEEecCCC-CCccCCcccccCccCcEEeccCCCCCCCCCC-CCCCCCcc
Q 003039 324 PCLPVPWSWLQCNS----------DPQPSITVIHLSSKN-LTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR 391 (854)
Q Consensus 324 pc~~~~~~~~~c~~----------~~~~~l~~L~L~~n~-l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~ 391 (854)
.|....++.+.|+. ..+++|+.|+|++|+ |+..-+..|.+|++|+.|+|++|+|+...|. |.++++|+
T Consensus 4 ~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 34444566677753 235689999998765 8844445799999999999999999998886 89999999
Q ss_pred EEEeCCCccCCCCCccccCCCCCceeeccccccc
Q 003039 392 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 392 ~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l~ 425 (854)
+|+|++|+|+ .+|..+....+|+.|+|++|++.
T Consensus 84 ~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp EEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 9999999999 77776555668999999999985
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.83 E-value=1.9e-11 Score=120.94 Aligned_cols=116 Identities=18% Similarity=0.284 Sum_probs=71.5
Q ss_pred CCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCeeEEEecCCCCCc
Q 003039 276 YDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG 355 (854)
Q Consensus 276 ~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~~L~L~~n~l~g 355 (854)
.+..+|..|+.+..|+.|+++.|.+... ..+ ..+++|+.|+|++|+|+
T Consensus 36 ~i~~l~~sl~~L~~L~~L~Ls~n~I~~i-----------~~l--------------------~~l~~L~~L~Ls~N~i~- 83 (198)
T d1m9la_ 36 PIEKMDATLSTLKACKHLALSTNNIEKI-----------SSL--------------------SGMENLRILSLGRNLIK- 83 (198)
T ss_dssp TCCCCHHHHHHTTTCCEEECSEEEESCC-----------CCH--------------------HHHTTCCEEECCEEEEC-
T ss_pred chhhhhhHHhcccccceeECcccCCCCc-----------ccc--------------------cCCccccChhhcccccc-
Confidence 3555555566677777777766655430 000 11246777777777776
Q ss_pred cCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCC--ccccCCCCCceeeccccccc
Q 003039 356 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 356 ~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P--~~l~~l~~L~~l~l~~N~l~ 425 (854)
.+|..+..+++|+.|+|++|+|+.. +.+.++++|+.|+|++|+|+ .++ ..+..|++|+.|+|++|+++
T Consensus 84 ~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 84 KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccccccccccccccccc-ccccccccccccccccchhc-cccccccccCCCccceeecCCCccc
Confidence 5665555556677777777777653 44666667777777777776 344 35667777777777777666
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=1.7e-09 Score=109.79 Aligned_cols=168 Identities=14% Similarity=0.110 Sum_probs=90.6
Q ss_pred ceeeeecccCCCCCCCcc-cchhhhceeccCCCCCccH-HHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeC-CCCCCC
Q 003039 266 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG-VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN-SDPQPS 342 (854)
Q Consensus 266 ~l~~l~l~~n~~s~lpP~-in~le~l~~L~l~~~~~~~-~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~-~~~~~~ 342 (854)
.++.|+|+.|.++++|+. +.++..|+.|+++.|.+.. .....+..+..+..+.... |.. ..+.... ...+++
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~---~n~--l~~~~~~~~~~l~~ 104 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK---ANN--LLYINPEAFQNLPN 104 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC---CTT--CCEECTTSEECCTT
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc---ccc--cccccccccccccc
Confidence 467788888888888875 7778888888888776532 1111222222222211000 100 0111110 123456
Q ss_pred eeEEEecCCCCCcc-------------------------CCcccccCc-cCcEEeccCCCCCCCCCCCCCCCCccEE-Ee
Q 003039 343 ITVIHLSSKNLTGN-------------------------IPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRII-HL 395 (854)
Q Consensus 343 l~~L~L~~n~l~g~-------------------------lp~~i~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L-~L 395 (854)
|+.|++++|+++.. -+..+..+. .++.|++++|+++...+......+++.+ ++
T Consensus 105 L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l 184 (242)
T d1xwdc1 105 LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184 (242)
T ss_dssp CCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECT
T ss_pred ccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccc
Confidence 66666666665521 122222232 4566666677776655554444444433 45
Q ss_pred CCCccCCCCCc-cccCCCCCceeecccccccccccccccccccccc
Q 003039 396 EDNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 440 (854)
Q Consensus 396 s~N~l~g~~P~-~l~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~l~ 440 (854)
++|+|+ .+|. .|..+++|+.|+|++|+|+ .+|...+.++..|.
T Consensus 185 ~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~ 228 (242)
T d1xwdc1 185 DNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLR 228 (242)
T ss_dssp TCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEE
T ss_pred cccccc-cccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCcccc
Confidence 666777 4544 4677777777777777777 67766655554443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.77 E-value=6.4e-11 Score=117.10 Aligned_cols=106 Identities=26% Similarity=0.267 Sum_probs=87.5
Q ss_pred CCCCCeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCcee
Q 003039 338 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 417 (854)
Q Consensus 338 ~~~~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l 417 (854)
..+++|+.|+|++|+|+ .++ .|..|++|+.|+|++|+|+..++-+..+++|+.|+|++|+|+ .++ .+..+++|+.|
T Consensus 45 ~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L 120 (198)
T d1m9la_ 45 STLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVL 120 (198)
T ss_dssp HHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEE
T ss_pred hcccccceeECcccCCC-Ccc-cccCCccccChhhccccccccccccccccccccccccccccc-ccc-ccccccccccc
Confidence 34678999999999999 776 599999999999999999865433445678999999999999 454 58899999999
Q ss_pred ecccccccccccc--cc--ccccccccccCccccc
Q 003039 418 YVQNNMLSGTVPS--SL--LSKNVVLNYAGNINLH 448 (854)
Q Consensus 418 ~l~~N~l~g~~p~--~l--~~~~~~l~~~~n~~l~ 448 (854)
+|++|+|+ .++. .+ ++++..|+++||+..+
T Consensus 121 ~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 121 YMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp EESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccchhc-cccccccccCCCccceeecCCCcccc
Confidence 99999998 5553 23 6778999999997543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=2.6e-07 Score=93.02 Aligned_cols=85 Identities=26% Similarity=0.345 Sum_probs=68.0
Q ss_pred CCeeEEEecCCCCCccCCcccccCccCcEE-eccCCCCCCCCCC-CCCCCCccEEEeCCCccCCCCCc-cccCCCCCcee
Q 003039 341 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL-WLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPS-SLMNLPNLREL 417 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g~lp~~i~~l~~L~~L-~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~-~l~~l~~L~~l 417 (854)
..++.|++++|+++ .++..+.++.+++.+ ++++|+|+..++. |.++++|++|+|++|+|+ .+|. .|.+|++|+.|
T Consensus 153 ~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~l 230 (242)
T d1xwdc1 153 FESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRAR 230 (242)
T ss_dssp SSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEESS
T ss_pred ccceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCcccccC
Confidence 47899999999999 677777777776665 6788999987775 789999999999999999 5554 68888888887
Q ss_pred ecccccccccccc
Q 003039 418 YVQNNMLSGTVPS 430 (854)
Q Consensus 418 ~l~~N~l~g~~p~ 430 (854)
++. ++. .+|+
T Consensus 231 ~~~--~l~-~lp~ 240 (242)
T d1xwdc1 231 STY--NLK-KLPT 240 (242)
T ss_dssp SEE--SSS-CSCC
T ss_pred cCC--CCC-cCCC
Confidence 764 455 5553
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=2.5e-08 Score=103.87 Aligned_cols=177 Identities=14% Similarity=0.135 Sum_probs=109.0
Q ss_pred cceeeeecccCCCCC--CCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCC
Q 003039 265 PFVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 342 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~--lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~ 342 (854)
..++.|+|+.+.++. ++.++..+..|+.|.+.++.++...+..+.+...++.+.. .-|......++..-...+++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L---s~c~~itd~~l~~l~~~~~~ 122 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL---SGCSGFSEFALQTLLSSCSR 122 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC---TTCBSCCHHHHHHHHHHCTT
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccc---cccccccccccchhhHHHHh
Confidence 456777887776543 4455777788888888888877777777777666666632 22322111111100123467
Q ss_pred eeEEEecCC-CCCc-cCCcccccC-ccCcEEeccCC--CCCC-CCCCC-CCCCCccEEEeCCC-ccCCCCCccccCCCCC
Q 003039 343 ITVIHLSSK-NLTG-NIPSDLTKL-SSLVELWLDGN--SLTG-PIPDF-SGCPDLRIIHLEDN-QLTGPLPSSLMNLPNL 414 (854)
Q Consensus 343 l~~L~L~~n-~l~g-~lp~~i~~l-~~L~~L~L~~N--~l~~-~~p~~-~~l~~L~~L~Ls~N-~l~g~~P~~l~~l~~L 414 (854)
|+.|+|+++ +++. .++..+..+ ++|+.|+|+++ .++. .+..+ .++++|++|+|++| .+++..+..+.++++|
T Consensus 123 L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L 202 (284)
T d2astb2 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202 (284)
T ss_dssp CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred ccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcC
Confidence 888888875 4542 233334443 67888888764 3332 12233 45788888888875 4776777788888888
Q ss_pred ceeecccc-cccccccccc--ccccccccccCc
Q 003039 415 RELYVQNN-MLSGTVPSSL--LSKNVVLNYAGN 444 (854)
Q Consensus 415 ~~l~l~~N-~l~g~~p~~l--~~~~~~l~~~~n 444 (854)
+.|+|+++ ++++.....+ +++++.|++.|+
T Consensus 203 ~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 88888884 5765444444 445566666554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.22 E-value=3.2e-06 Score=89.22 Aligned_cols=116 Identities=22% Similarity=0.253 Sum_probs=70.4
Q ss_pred cceeeeecccCCCCCCCcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCCCCCCee
Q 003039 265 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 344 (854)
Q Consensus 265 ~~l~~l~l~~n~~s~lpP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~~~~~l~ 344 (854)
.+++.|+|+.+.++++|+.+. .|+.|+++.|++... .. .+.+|+
T Consensus 38 ~~l~~LdLs~~~L~~lp~~~~---~L~~L~Ls~N~l~~l-----------p~----------------------~~~~L~ 81 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPELPP---HLESLVASCNSLTEL-----------PE----------------------LPQSLK 81 (353)
T ss_dssp HTCSEEECTTSCCSCCCSCCT---TCSEEECCSSCCSSC-----------CC----------------------CCTTCC
T ss_pred cCCCEEEeCCCCCCCCCCCCC---CCCEEECCCCCCccc-----------cc----------------------chhhhh
Confidence 356788888888888887543 466777777776530 00 012577
Q ss_pred EEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeecccccc
Q 003039 345 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 424 (854)
Q Consensus 345 ~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~N~l 424 (854)
.|++++|+++ .++. +. +.|++|+|++|.+... |.+..+++|+.|++++|.++ ..|..+ ..+..+.+..+..
T Consensus 82 ~L~l~~n~l~-~l~~-lp--~~L~~L~L~~n~l~~l-p~~~~l~~L~~L~l~~~~~~-~~~~~~---~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 82 SLLVDNNNLK-ALSD-LP--PLLEYLGVSNNQLEKL-PELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQL 152 (353)
T ss_dssp EEECCSSCCS-CCCS-CC--TTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCC
T ss_pred hhhhhhcccc-hhhh-hc--cccccccccccccccc-cchhhhccceeecccccccc-cccccc---ccccchhhccccc
Confidence 7777777776 4442 11 3577777777777643 45566777777777777776 333332 3344444444444
Q ss_pred c
Q 003039 425 S 425 (854)
Q Consensus 425 ~ 425 (854)
.
T Consensus 153 ~ 153 (353)
T d1jl5a_ 153 E 153 (353)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.21 E-value=1.2e-06 Score=92.59 Aligned_cols=91 Identities=25% Similarity=0.249 Sum_probs=46.1
Q ss_pred CeeEEEecCCCCCccCCcccccCccCcEEeccCCCCCCCCCCCCCCCCccEEEeCCCccCCCCCccccCCCCCceeeccc
Q 003039 342 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 421 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~l~l~~ 421 (854)
+++.|||++|+|+ .+|+. +++|++|+|++|+|+..+.. +.+|+.|++++|+++ .++.. . +.|+.|++++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~-~l~~l-p--~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLK-ALSDL-P--PLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCS-CCCSC-C--TTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccc-hhhhh-c--cccccccccc
Confidence 3556666666665 45543 24556666666666533221 335555666666655 34321 1 2355666666
Q ss_pred ccccccccccc-ccccccccccCc
Q 003039 422 NMLSGTVPSSL-LSKNVVLNYAGN 444 (854)
Q Consensus 422 N~l~g~~p~~l-~~~~~~l~~~~n 444 (854)
|.++ .+|... +.+++.|++.+|
T Consensus 108 n~l~-~lp~~~~l~~L~~L~l~~~ 130 (353)
T d1jl5a_ 108 NQLE-KLPELQNSSFLKIIDVDNN 130 (353)
T ss_dssp SCCS-SCCCCTTCTTCCEEECCSS
T ss_pred cccc-cccchhhhccceeeccccc
Confidence 6665 444322 344455555444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.11 E-value=5.5e-06 Score=84.04 Aligned_cols=131 Identities=18% Similarity=0.130 Sum_probs=89.0
Q ss_pred cCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCC-CCceeeEeeeeeecCeEEEEEEeccCCCHHhhhcc
Q 003039 537 GGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 615 (854)
Q Consensus 537 G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~ 615 (854)
++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.++..++..++||+++++.++.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 33468998865 46778889876554444456778888877764 33356778888888899999999999887654321
Q ss_pred cccccccccHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------
Q 003039 616 TLTHEQRINWIKRLEIAEDAAKGIEYLHTG-------------------------------------------------- 645 (854)
Q Consensus 616 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------------- 645 (854)
. .....++.++++.++.||+.
T Consensus 104 ~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 104 E---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp C---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred c---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 1 01122344455555555531
Q ss_pred ---C---CCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 646 ---C---VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 646 ---~---~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
. .+.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0 1247899999999999987667799999774
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.01 E-value=2.2e-07 Score=99.03 Aligned_cols=146 Identities=17% Similarity=0.222 Sum_probs=72.6
Q ss_pred ccceeeeecccCCCCCC-----CcccchhhhceeccCCCCCccHHHHHHHHhhcCCCCccCCCCCCCCCCCCCeeEeCCC
Q 003039 264 LPFVLSFKFGKTYDSSR-----GPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD 338 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~l-----pP~in~le~l~~L~l~~~~~~~~~~~~l~~l~~~~~w~~~~~~pc~~~~~~~~~c~~~ 338 (854)
.+.|+.|+|+.|.++.. ...+.....|+.|.++.|.+.......+.+........ ....
T Consensus 92 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~----------------~~~~ 155 (344)
T d2ca6a1 92 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN----------------KKAK 155 (344)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHH----------------HHHH
T ss_pred CCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccc----------------cccc
Confidence 34678889998887663 33345567788999998888665444443321000000 0000
Q ss_pred CCCCeeEEEecCCCCCc----cCCcccccCccCcEEeccCCCCCCC------CCCCCCCCCccEEEeCCCccCCC----C
Q 003039 339 PQPSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGP------IPDFSGCPDLRIIHLEDNQLTGP----L 404 (854)
Q Consensus 339 ~~~~l~~L~L~~n~l~g----~lp~~i~~l~~L~~L~L~~N~l~~~------~p~~~~l~~L~~L~Ls~N~l~g~----~ 404 (854)
..+.|+.|++++|+++. .+...+..++.|+.|+|++|+|... ...+..+++|+.|+|++|.++.. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 11245555555555441 1222334445555555555555421 11234455555555555554311 2
Q ss_pred CccccCCCCCceeeccccccc
Q 003039 405 PSSLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 405 P~~l~~l~~L~~l~l~~N~l~ 425 (854)
...+..+++|+.|+|++|+|+
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCC
T ss_pred cccccccccchhhhhhcCccC
Confidence 233445555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.93 E-value=7.8e-07 Score=92.17 Aligned_cols=156 Identities=17% Similarity=0.136 Sum_probs=106.3
Q ss_pred ccceeeeecccCCCCCC-CcccchhhhceeccCCC-CCccHHHHHHHH-hhcCCCCccCCCCCCCCCCCCCeeE-eCCCC
Q 003039 264 LPFVLSFKFGKTYDSSR-GPLLNAMEINKYLERND-GSIDGVAIVSVI-SLYSSADWAQEGGDPCLPVPWSWLQ-CNSDP 339 (854)
Q Consensus 264 l~~l~~l~l~~n~~s~l-pP~in~le~l~~L~l~~-~~~~~~~~~~l~-~l~~~~~w~~~~~~pc~~~~~~~~~-c~~~~ 339 (854)
.++|++|+|..+.++.. +..|..+..|+.|+++. +.+....+..+. ....++.+. -.-|....-.++. .-...
T Consensus 70 c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~---ls~c~~~~~~~~~~~~~~~ 146 (284)
T d2astb2 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELN---LSWCFDFTEKHVQVAVAHV 146 (284)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEE---CCCCTTCCHHHHHHHHHHS
T ss_pred CCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccc---cccccccccccchhhhccc
Confidence 45778888888876642 33477778899999987 467666666654 346677663 2334221111111 00011
Q ss_pred CCCeeEEEecCC--CCCc-cCCcccccCccCcEEeccCC-CCCCC-CCCCCCCCCccEEEeCC-CccCCCCCccccCCCC
Q 003039 340 QPSITVIHLSSK--NLTG-NIPSDLTKLSSLVELWLDGN-SLTGP-IPDFSGCPDLRIIHLED-NQLTGPLPSSLMNLPN 413 (854)
Q Consensus 340 ~~~l~~L~L~~n--~l~g-~lp~~i~~l~~L~~L~L~~N-~l~~~-~p~~~~l~~L~~L~Ls~-N~l~g~~P~~l~~l~~ 413 (854)
.+.|+.|+|+++ +++. .+..-+.++++|+.|+|++| .+++. +..+.++++|++|+|++ +.+++.....++++++
T Consensus 147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~ 226 (284)
T d2astb2 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226 (284)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence 357999999864 3442 23334567899999999986 46653 44688899999999999 5788777778899999
Q ss_pred Cceeecccc
Q 003039 414 LRELYVQNN 422 (854)
Q Consensus 414 L~~l~l~~N 422 (854)
|+.|+++++
T Consensus 227 L~~L~l~~~ 235 (284)
T d2astb2 227 LKTLQVFGI 235 (284)
T ss_dssp CCEEECTTS
T ss_pred CCEEeeeCC
Confidence 999999887
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.83 E-value=1.3e-06 Score=82.41 Aligned_cols=61 Identities=26% Similarity=0.266 Sum_probs=29.2
Q ss_pred CeeEEEecCCCCCcc--CCcccccCccCcEEeccCCCCCCCCC-CCCCCCCccEEEeCCCccCC
Q 003039 342 SITVIHLSSKNLTGN--IPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG 402 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~--lp~~i~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g 402 (854)
.|+.|+|++|+|+.. ++..+..|++|+.|+|++|+|+...+ ......+|+.|+|++|.+++
T Consensus 66 ~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp TCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred CCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 455555555555521 12234445555555555555554333 12222345555555555553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.79 E-value=6.4e-07 Score=84.61 Aligned_cols=82 Identities=23% Similarity=0.283 Sum_probs=60.2
Q ss_pred EEecCCCCCccCCcccccCccCcEEeccCCCCCCCCC--C-CCCCCCccEEEeCCCccCCCCCc-cccCCCCCceeeccc
Q 003039 346 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--D-FSGCPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQN 421 (854)
Q Consensus 346 L~L~~n~l~g~lp~~i~~l~~L~~L~L~~N~l~~~~p--~-~~~l~~L~~L~Ls~N~l~g~~P~-~l~~l~~L~~l~l~~ 421 (854)
|++.++... .++....++++|++|+|++|+|+...+ . +..+++|+.|+|++|+|+ .+++ ......+|+.|++++
T Consensus 47 l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~ 124 (162)
T d1koha1 47 LNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDG 124 (162)
T ss_dssp TTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTT
T ss_pred cchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCC
Confidence 333443333 455455679999999999999987643 3 566999999999999999 5554 334455799999999
Q ss_pred cccccccc
Q 003039 422 NMLSGTVP 429 (854)
Q Consensus 422 N~l~g~~p 429 (854)
|+++....
T Consensus 125 Npl~~~~~ 132 (162)
T d1koha1 125 NSLSDTFR 132 (162)
T ss_dssp STTSSSSS
T ss_pred CCcCcCcc
Confidence 99985544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.77 E-value=1.8e-06 Score=94.59 Aligned_cols=104 Identities=23% Similarity=0.247 Sum_probs=67.6
Q ss_pred CeeEEEecCCCCCccCCcc----cccCccCcEEeccCCCCCCC----CC-CCC-CCCCccEEEeCCCccCC----CCCcc
Q 003039 342 SITVIHLSSKNLTGNIPSD----LTKLSSLVELWLDGNSLTGP----IP-DFS-GCPDLRIIHLEDNQLTG----PLPSS 407 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~lp~~----i~~l~~L~~L~L~~N~l~~~----~p-~~~-~l~~L~~L~Ls~N~l~g----~~P~~ 407 (854)
.|+.+++++|.++..-... +...++|++|+|++|+|+.. +. .+. ..+.|++|+|++|+|+. .+++.
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 392 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred ccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence 6888888888887543333 34456788888888888642 11 232 35678888888888873 24556
Q ss_pred ccCCCCCceeeccccccccccccccc-------cccccccccCcc
Q 003039 408 LMNLPNLRELYVQNNMLSGTVPSSLL-------SKNVVLNYAGNI 445 (854)
Q Consensus 408 l~~l~~L~~l~l~~N~l~g~~p~~l~-------~~~~~l~~~~n~ 445 (854)
+..+++|+.|+|++|+|+......+. ..++.|.+.+|.
T Consensus 393 l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~ 437 (460)
T d1z7xw1 393 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIY 437 (460)
T ss_dssp HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCC
T ss_pred HhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCC
Confidence 66778888888888888743333321 134556666554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.73 E-value=6.7e-05 Score=75.27 Aligned_cols=142 Identities=18% Similarity=0.104 Sum_probs=84.9
Q ss_pred cccccCc-eEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCC--CceeeEeeeeeecCeEEEEEEeccCCCH
Q 003039 533 KIGSGGF-GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTL 609 (854)
Q Consensus 533 ~iG~G~f-g~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL 609 (854)
.+..|.. +.||+...+++..+++|.-.... ...+..|+..++.+.. -.+.++++++.+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445554 68999988878888999865443 2346678887777643 3356778888888889999999988665
Q ss_pred Hhhh-----------------ccccccccccc--HHHHHH-----H---------------HHHHHHHHHHHHhCC----
Q 003039 610 KEHL-----------------YGTLTHEQRIN--WIKRLE-----I---------------AEDAAKGIEYLHTGC---- 646 (854)
Q Consensus 610 ~~~L-----------------~~~~~~~~~l~--~~~~~~-----i---------------~~~ia~gL~yLH~~~---- 646 (854)
.+.. |........+. +..... + .......+..+....
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 3311 10000000000 000000 0 000112233333221
Q ss_pred CCceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 647 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 647 ~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
.+.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1248999999999999988777899998764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.66 E-value=6.3e-06 Score=90.02 Aligned_cols=86 Identities=31% Similarity=0.431 Sum_probs=63.5
Q ss_pred CCeeEEEecCCCCCc----cCCcccccCccCcEEeccCCCCCCC----CC-CCC-CCCCccEEEeCCCccCCC----CCc
Q 003039 341 PSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGP----IP-DFS-GCPDLRIIHLEDNQLTGP----LPS 406 (854)
Q Consensus 341 ~~l~~L~L~~n~l~g----~lp~~i~~l~~L~~L~L~~N~l~~~----~p-~~~-~l~~L~~L~Ls~N~l~g~----~P~ 406 (854)
++++.|+|++|+|+- .|+..+..+++|+.|+|++|+|+.. +. .+. ...+|+.|+|++|+++.. ++.
T Consensus 27 ~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~ 106 (460)
T d1z7xw1 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 106 (460)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccc
Confidence 367788899998872 3455677888999999999988531 11 222 245799999999998743 456
Q ss_pred cccCCCCCceeecccccccc
Q 003039 407 SLMNLPNLRELYVQNNMLSG 426 (854)
Q Consensus 407 ~l~~l~~L~~l~l~~N~l~g 426 (854)
.+..+++|+.|+|++|.++.
T Consensus 107 ~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 107 TLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp HTTSCTTCCEEECCSSBCHH
T ss_pred hhhccccccccccccccchh
Confidence 77888899999999998873
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.42 E-value=1.2e-05 Score=85.22 Aligned_cols=105 Identities=18% Similarity=0.235 Sum_probs=59.0
Q ss_pred CeeEEEecCCCCCcc-----CCcccccCccCcEEeccCCCCCCC-----CCCCCCCCCccEEEeCCCccCCC----CCcc
Q 003039 342 SITVIHLSSKNLTGN-----IPSDLTKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHLEDNQLTGP----LPSS 407 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~-----lp~~i~~l~~L~~L~L~~N~l~~~-----~p~~~~l~~L~~L~Ls~N~l~g~----~P~~ 407 (854)
.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. ...+..+++|++|+|++|+|++. +-..
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~ 266 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 266 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHH
Confidence 566777777776521 333456667777777777776432 12355667777777777776632 1122
Q ss_pred ccC--CCCCceeeccccccccc----ccccc---ccccccccccCccc
Q 003039 408 LMN--LPNLRELYVQNNMLSGT----VPSSL---LSKNVVLNYAGNIN 446 (854)
Q Consensus 408 l~~--l~~L~~l~l~~N~l~g~----~p~~l---~~~~~~l~~~~n~~ 446 (854)
+.. .+.|+.|+|++|+|+.. +...+ ...++.|+++||..
T Consensus 267 l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred hhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 222 24577777777776532 22222 23456666666654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.85 E-value=0.0016 Score=69.64 Aligned_cols=75 Identities=17% Similarity=0.142 Sum_probs=46.5
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEEccC------C-cccHHHHHHHHHHHccCC-C--CceeeEeeeeeecCeEEEE
Q 003039 532 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN------S-YQGKREFTNEVTLLSRIH-H--RNLVQFLGYCQEEGRSVLV 600 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~-~~~VAvK~l~~~------~-~~~~~~~~~Ev~~L~~l~-H--pnIv~l~g~~~~~~~~~LV 600 (854)
+.||.|....||+....+ ++.|+||.-... . .........|.+.|+.+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998754 678999964321 1 112233456777776652 2 334555554 34456899
Q ss_pred EEeccCCC
Q 003039 601 YEFMHNGT 608 (854)
Q Consensus 601 ~E~~~~gs 608 (854)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.72 E-value=0.0014 Score=68.12 Aligned_cols=136 Identities=13% Similarity=0.137 Sum_probs=78.0
Q ss_pred eEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCce--eeEee-----eeeecCeEEEEEEeccCCCHHh-
Q 003039 540 GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLG-----YCQEEGRSVLVYEFMHNGTLKE- 611 (854)
Q Consensus 540 g~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnI--v~l~g-----~~~~~~~~~LV~E~~~~gsL~~- 611 (854)
-.||+.+..+|+.+++|+.+.. .....++..|...+..+...++ +..+. .+...+..+.+++++.|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4899999999999999998654 3346778889888887743222 11111 2234566788999987643211
Q ss_pred ----------h---hccc-----ccccccccHH-------------------HHHHHHHHHHHHHHHHHh----CCCCce
Q 003039 612 ----------H---LYGT-----LTHEQRINWI-------------------KRLEIAEDAAKGIEYLHT----GCVPAI 650 (854)
Q Consensus 612 ----------~---L~~~-----~~~~~~l~~~-------------------~~~~i~~~ia~gL~yLH~----~~~~~i 650 (854)
. +|.. ......+++. .+..+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 1110 0001111111 111122222233333322 223478
Q ss_pred ecCCCCCCCEEEcCCCcEEEEeeecccc
Q 003039 651 IHRDLKSSNILLDKHMRAKVSDFGLSKF 678 (854)
Q Consensus 651 vHrDIkp~NILl~~~~~vkl~DFGla~~ 678 (854)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999753 45899998753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.71 E-value=0.00046 Score=64.57 Aligned_cols=60 Identities=13% Similarity=0.138 Sum_probs=27.0
Q ss_pred CeeEEEecCCCCCcc----CCcccccCccCcEEeccCCCCCCCC-----CCCCCCCCccEEEeCCCccC
Q 003039 342 SITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPI-----PDFSGCPDLRIIHLEDNQLT 401 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~----lp~~i~~l~~L~~L~L~~N~l~~~~-----p~~~~l~~L~~L~Ls~N~l~ 401 (854)
.|+.|+|++|+|... +...|...+.|+.|+|++|.|+..- ..+...+.|++|+|++|.+.
T Consensus 45 ~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 45 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred ccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 355555555555421 1122333455555555555554311 12344445555555555433
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.16 E-value=0.00047 Score=64.51 Aligned_cols=85 Identities=15% Similarity=0.260 Sum_probs=62.4
Q ss_pred CCeeEEEecCC-CCCcc----CCcccccCccCcEEeccCCCCCCC-CCC----CCCCCCccEEEeCCCccCCC----CCc
Q 003039 341 PSITVIHLSSK-NLTGN----IPSDLTKLSSLVELWLDGNSLTGP-IPD----FSGCPDLRIIHLEDNQLTGP----LPS 406 (854)
Q Consensus 341 ~~l~~L~L~~n-~l~g~----lp~~i~~l~~L~~L~L~~N~l~~~-~p~----~~~l~~L~~L~Ls~N~l~g~----~P~ 406 (854)
+.|+.|+|+++ .++.. +-..+...+.|+.|+|++|.+... ... +...+.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 58999999975 46532 333566778899999999998742 122 44578899999999998842 234
Q ss_pred cccCCCCCceeeccccccc
Q 003039 407 SLMNLPNLRELYVQNNMLS 425 (854)
Q Consensus 407 ~l~~l~~L~~l~l~~N~l~ 425 (854)
.+...+.|+.|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 5667788999999988766
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.56 E-value=0.023 Score=60.17 Aligned_cols=72 Identities=14% Similarity=0.306 Sum_probs=49.1
Q ss_pred ccccccCceEEEEEEECC--------CcEEEEEEEccCCcccHHHHHHHHHHHccCCCCce-eeEeeeeeecCeEEEEEE
Q 003039 532 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYE 602 (854)
Q Consensus 532 ~~iG~G~fg~Vy~a~~~~--------~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnI-v~l~g~~~~~~~~~LV~E 602 (854)
+.|+.|-.-.+|+....+ .+.|.+++... ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 467888889999998764 34677777642 2234456688888888753344 467777753 58999
Q ss_pred eccCCCH
Q 003039 603 FMHNGTL 609 (854)
Q Consensus 603 ~~~~gsL 609 (854)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.77 E-value=0.0036 Score=57.93 Aligned_cols=83 Identities=11% Similarity=0.116 Sum_probs=46.3
Q ss_pred CeeEEEecCCCCCcc----CCcccccCccCcEEeccCCCCCCCC-----CCCCCCCCccEEEe--CCCccCC----CCCc
Q 003039 342 SITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPI-----PDFSGCPDLRIIHL--EDNQLTG----PLPS 406 (854)
Q Consensus 342 ~l~~L~L~~n~l~g~----lp~~i~~l~~L~~L~L~~N~l~~~~-----p~~~~l~~L~~L~L--s~N~l~g----~~P~ 406 (854)
.|+.|+|++|+++.. +-..+...++|+.|++++|.+...- ..+...++|+.++| ++|.+.. .+..
T Consensus 47 ~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~ 126 (166)
T d1io0a_ 47 YVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIAN 126 (166)
T ss_dssp SCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHH
T ss_pred ccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHH
Confidence 567777777776533 2223445567777777777665321 23455666665444 3455542 2334
Q ss_pred cccCCCCCceeecccccc
Q 003039 407 SLMNLPNLRELYVQNNML 424 (854)
Q Consensus 407 ~l~~l~~L~~l~l~~N~l 424 (854)
.+...++|+.|+++.|+.
T Consensus 127 ~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 127 MLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHCSSCCEEECCCSSH
T ss_pred HHHhCCCcCEEeCcCCCC
Confidence 455666677776665543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.81 E-value=0.0038 Score=57.78 Aligned_cols=86 Identities=20% Similarity=0.311 Sum_probs=62.2
Q ss_pred CCCeeEEEecC-CCCCcc----CCcccccCccCcEEeccCCCCCCCCC-----CCCCCCCccEEEeCCCccCCC----CC
Q 003039 340 QPSITVIHLSS-KNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQLTGP----LP 405 (854)
Q Consensus 340 ~~~l~~L~L~~-n~l~g~----lp~~i~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~g~----~P 405 (854)
.+.|+.|+|++ +.++.. +-..+...++|+.|+|++|.++..-- .+...+.|+.|++++|.++.. +-
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 35899999997 456532 33345578999999999999875321 245678999999999998732 33
Q ss_pred ccccCCCCCceeec--cccccc
Q 003039 406 SSLMNLPNLRELYV--QNNMLS 425 (854)
Q Consensus 406 ~~l~~l~~L~~l~l--~~N~l~ 425 (854)
..+...++|+.++| ++|++.
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHhCccccEEeeccCCCcCc
Confidence 56777888987555 567775
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.23 E-value=0.21 Score=50.43 Aligned_cols=141 Identities=13% Similarity=0.106 Sum_probs=72.4
Q ss_pred ccccCceEEEEEEECCCcEEEEEEEccCCcccHHHHHHHHHHHccCCCCce-----eeEe-e--eeeecCeEEEEEEecc
Q 003039 534 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-----VQFL-G--YCQEEGRSVLVYEFMH 605 (854)
Q Consensus 534 iG~G~fg~Vy~a~~~~~~~VAvK~l~~~~~~~~~~~~~Ev~~L~~l~HpnI-----v~l~-g--~~~~~~~~~LV~E~~~ 605 (854)
|..|.--+.|+.+..+| .+++|+..... ...++..|++++..+...++ +... | +....+....++.+..
T Consensus 26 i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 45666678899988755 48899886432 23455667777777643222 2110 0 1122345566677665
Q ss_pred CCCHHh-----------h---hcc---ccc---cc-cc----------------ccHHHHHHHHHHHHHHHHHHHh-CCC
Q 003039 606 NGTLKE-----------H---LYG---TLT---HE-QR----------------INWIKRLEIAEDAAKGIEYLHT-GCV 647 (854)
Q Consensus 606 ~gsL~~-----------~---L~~---~~~---~~-~~----------------l~~~~~~~i~~~ia~gL~yLH~-~~~ 647 (854)
+..... . ++. ... .. .. .........+..+...+.-.+. ...
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 542211 0 000 000 00 00 0011112222233333333332 223
Q ss_pred CceecCCCCCCCEEEcCCCcEEEEeeeccc
Q 003039 648 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK 677 (854)
Q Consensus 648 ~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 677 (854)
.++||+|+.+.||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 489999999999999998777899999874
|